@@2096642699/CD There/EX was/VBD no/DT correlation/NN between/IN serum/JJ LH/NN and/CC chronological/JJ or/CC bone/NN age/NN in/IN this/DT age/NN group/NN ,/, which/WDT suggests/VBZ that/IN the/DT correlation/NN found/VB is/VBZ not/RB due/NN to/IN age-related/JJ parallel/JJ phenomena/NNS ./.
@@79887316886/CD In/NN reviewing/VBG a/DT number/NN of/IN the/DT most/RB intensely/RB studied/VBN environmentally/RB inducible/MULTIGENE promoters/MULTIGENE it/PRP becomes/VBZ clear/JJ that/IN the/DT presence/NN of/IN two/JJ cis-acting/JJ elements/NNS are/VBP critical/JJ for/IN promoter/NN activity/NN ,/, one/PRP of/IN which/WDT is/VBZ the/DT G-box/NN (/( CCACGTGG/NNP )/SYM ./.
@@2590097654/CD Nodular/JJ involvement/NN of/IN the/DT left/NN lung/NN and/CC infiltration/NN of/IN the/DT mucosa/NN of/IN the/DT left/NN lower/JJR lobe/NN bronchus/NN followed/VBN very/RB gradually/RB and/CC a/DT monoclonal/JJ gammopathy/NN (/( IgA--Type/MULTIGENE Kappa/MULTIGENE )/SYM was/VBD demonstrated/VBN ./.
@@25572178240/CD Beta-endorphin/NN ,/, ACTH/NN and/CC cortisol/NN secretion/NN were/VBD measured/VBN in/IN twelve/CD healthy/JJ adult/JJ males/NNS after/IN nasal/JJ spray/NN administration/NN 200/CD IU/NN salmon/NN calcitonin/NN ./.
@@86266679930/CD Transcription/NNS from/IN the/DT promoter/NN containing/JJ the/DT mutated/JJ direct/JJ repeats/NNS was/VBD increased/VBN greatly/RB ,/, consistent/JJ with/IN the/DT conclusion/NN that/IN these/DT motifs/NNS functions/NNS in/IN vivo/NN to/IN repress/VB GPT/MULTIGENE gene/MULTIGENE expression/NN ./.
@@32147093906/CD Fifty/CD min/NN after/IN release/NN from/IN stress/NN ,/, increases/VBZ in/IN plasma/NN corticosterone/NN levels/NNS induced/VBN by/IN stress/NN recovered/VBN in/IN the/DT biting/JJ group/NN but/CC remained/VBN high/JJ in/IN the/DT non-biting/JJ group/NN ./.
@@107042835407/CD Analysis/NNP of/IN 1/CD Mb/NN of/IN published/VBN sequence/NN from/IN the/DT region/NN of/IN conserved/VBN synteny/NN on/IN human/JJ chromosome/NN 5q31-q33/RB identified/VBD 45/CD gene/NN candidates/NNS ,/, including/JJ 35/CD expressed/VBN genes/NNS in/IN the/DT human/MULTIGENE IL-4/MULTIGENE cytokine/MULTIGENE gene/MULTIGENE cluster/MULTIGENE ./.
@@79996047988/CD If/IN this/DT is/VBZ present/NN ,/, such/JJ patients/NNS should/MD be/VB closely/RB monitored/VBN ,/, and/CC any/DT atypical/JJ lesions/NNS biopsied/VBN ./.
@@74832765521/CD Analysis/NNP of/IN the/DT sequence/NN identified/VBN four/CD open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM which/WDT are/VBP designated/VBN UL1/GENE ,/, UL2/GENE ,/, UL3/GENE ,/, and/CC UL3/CONTEXTGENE ./CONTEXTGENE 5/CONTEXTGENE based/VBN on/IN their/PRP homology/NN with/IN proteins/NNS of/IN herpes/NN simplex/JJ virus-1/GENE (/( HSV-1/CONTEXTGENE )/SYM ,/, pseudorabies/NN virus/NN (/( PRV/NN )/SYM ,/, equine/MULTIGENE herpesvirus-1/MULTIGENE ,/, and/CC varicella-zoster/NN virus/NN ./.
@@113228201170/CD Diary/NNP ./.
@@94238562769/CD Protease/NNS activities/NNS in/IN cultures/NNS of/IN the/DT streptococcal/JJ strains/NNS were/VBD associated/VBN with/IN species/NN of/IN different/JJ molecular/JJ masses/NNS ranging/VBG from/IN 130/CD to/IN 200/CD kDa/NN ,/, suggesting/VBG posttranslational/JJ processing/NN possibly/RB as/IN a/DT result/NN of/IN autoproteolysis/NN at/IN post-proline/JJ peptide/NN bonds/NNS in/IN the/DT N-terminal/NN parts/NNS of/IN the/DT molecules/NNS ./.
@@95222979478/CD Cell/NNP lines/NNS are/VBP checked/VBN to/IN find/NN out/RB whether/IN they/PRP develop/VBP tumors/NNS in/IN nude/JJ mice/NNS followed/VBN by/IN an/DT analysis/NN of/IN the/DT karyotype/NN ./.
@@113873511244/CD PATIENTS/IN AND/CC METHODS/IN :/: Between/IN June/NN 1991/CD and/CC December/NN 1996/CD ,/, we/PRP administered/VBD the/DT nucleoside/NN analog/NN 2-chlorodeoxyadenosine/JJ (/( 2-CDA/JJ )/SYM to/IN 73/CD children/NNS with/IN primary/JJ AML/NN and/CC 20/CD children/NNS with/IN secondary/JJ AML/NN or/CC myelodysplastic/JJ syndrome/NN (/( MDS/NN )/SYM ./.
@@17794335246/CD First/RB ,/, the/DT finding/NN of/IN a/DT monomeric/JJ Alu/NN family/NN repeat/NN at/IN the/DT junction/NN between/IN nonhomology/JJ block/NN I/PRP and/CC homology/NN block/NN Y/NN of/IN the/DT alpha/MULTIGENE 2/MULTIGENE gene-containing/JJ unit/NN in/IN rhesus/NN macaque/NN suggests/VBZ that/IN the/DT dimeric/JJ Alu/NN family/NN repeat/NN ,/, Alu/NN 3/CD ,/, at/IN the/DT orthologous/JJ position/NN in/IN human/NN was/VBD generated/VBN by/IN insertion/NN of/IN a/DT monomeric/JJ Alu/NN family/NN repeat/NN into/IN the/DT 3'/CD end/NN of/IN another/DT preexisting/JJ Alu/NN family/NN repeat/NN ./.
@@86273542069/CD Vertebrate/MULTIGENE synapsins/MULTIGENE constitute/VBP a/DT family/NN of/IN synaptic/JJ proteins/NNS that/WDT participate/VBP in/IN the/DT regulation/NN of/IN neurotransmitter/NN release/NN ./.
@@91360809326/CD The/DT results/NNS indicate/VBP that/DT DNA/NN methylation/NN ,/, chromatin/NN structure/NN ,/, and/CC transactivation/NN at/IN an/DT Sp1/MULTIGENE site/MULTIGENE contribute/VB to/IN the/DT highly/RB restricted/VBN expression/NN of/IN this/DT myelomonocytic/JJ lineage/NN specific/JJ gene/NN ./.
@@77028086820/CD Within-subject/NN BP/NN differences/NNS between/IN fish/NN oil/NN and/CC corn/NN oil/NN treatment/NN were/VBD similar/JJ for/IN Dinamap/GENE (/( 3/CD ./CD 2/CD +/NN //NN -/NN 1/CD ./CD 8/CD //CD 2/CD ./CD 5/CD +/NN //NN -/NN 1/CD ./CD 0/CD mm/NN Hg/NN )/SYM and/CC for/IN 24-h/JJ ABP/NN (/( 2/CD ./CD 5/CD +/NN //NN -/NN 1/CD ./CD 0/CD //CD 2/CD ./CD 3/CD +/NN //NN -/NN 0/CD ./CD 8/CD mm/NN Hg/NN )/SYM ,/, but/CC were/VBD more/RB significant/JJ with/IN the/DT latter/NN ./.
@@1684312283/CD Steroid/NN glucuronides/NNS in/IN amniotic/JJ fluid/NN at/IN term/NN ./.
@@10866677936/CD Phd/NNP antibody-immunoreactive/MULTIGENE peptides/MULTIGENE are/VBP seen/VBP in/IN light-adapted/JJ mouse/NN retinal/JJ cytosolic/JJ and/CC nuclear/JJ extracts/NNS ./.
@@23925113051/CD Serotonin/MULTIGENE 5-HT2/MULTIGENE receptor/MULTIGENE binding/JJ on/IN blood/NN platelets/NNS as/IN a/DT state/JJ dependent/JJ marker/NN in/IN major/JJ affective/JJ disorder/NN ./.
@@15251535055/CD By/IN contrast/NN ,/, d/NN (/NN T2AG3T/NN )/NN and/CC d/NN (/NN T2G4T/NN )/NN form/NN only/RB the/DT G-quadruplex/NN monomer/NN structures/NNS independent/NN of/IN K/NN cation/NN concentration/NN as/IN reported/VBN previously/RB [/NN Sen/NN ,/, D/NN ./NN ,/, &/CC Gilbert/NNP ,/, W/NN ./NN
@@96351497506/CD Hematocrit/NNS and/CC PaO2/GENE did/VBD not/RB change/VB ./.
@@62339242343/CD Fibrin/GENE gels/NNS and/CC their/PRP possible/JJ implication/NN for/IN surface/NN hemorheology/NN in/IN health/NN and/CC disease/NN ./.
@@77178237671/CD Standard/NNP reference/NN sources/NNS indicate/VBP that/IN an/DT able-bodied/JJ 11-year-old/NN child/NN of/IN comparable/JJ height/NN requires/VBZ 1/CD ,/CD 493/CD kcal/NN //NN d/NN for/IN support/NN of/IN basal/JJ metabolic/JJ functions/NNS ./.
@@104670048046/CD The/DT intron/NN RNA/NN consists/VBZ of/IN 2492/CD nucleotides/NNS which/WDT can/MD be/VB folded/JJ into/IN a/DT secondary/JJ structure/NN with/IN all/PDT the/DT expected/VBN sequence/NN motifs/NNS of/IN subgroup-IIA1/GENE introns/NNS (/( Michel/NNP et/FW al/NNS ./NNS
@@107867425796/CD In/NN the/DT control/NN group/NN ,/, platelet/MULTIGENE markers/MULTIGENE increased/VBN 1/CD h/NN after/IN surgery/NN ./.
@@3004364413/CD It/PRP was/VBD also/RB suggested/VBN that/IN the/DT biological/JJ activities/NNS of/IN 5-FU/JJ ,/, ADM/NNS and/CC MMC/NN in/IN FAMLIP/NNP were/VBD stable/JJ in/IN FULIP/GENE ,/, ADRLIP/GENE and/CC MMCLIP/GENE ./.
@@86199108593/CD The/DT neural/JJ mechanism/NN of/IN parkinsonian/JJ motor/JJ symptoms/NNS ,/, i/FW ./FW e/FW ./FW ,/, rigidity/NN ,/, tremor/NN and/CC akinesia/NN ,/, which/WDT are/VBP the/DT result/NN of/IN nigrostriatal/JJ dopamine/NN deficiency/NN ,/, is/VBZ interpreted/VBN from/IN long-term/JJ observations/NNS on/IN the/DT effect/NN of/IN surgical/JJ and/CC pharmacological/JJ treatment/NN of/IN the/DT disease/NN in/IN relation/NN to/IN the/DT neuropathological/JJ findings/NNS within/IN the/DT substantia/NN nigra/NN zona/NN compacta/NN (/( SNc/NNS )/SYM ./.
@@25627878506/CD We/PRP have/VBP designated/VBN the/DT protein/NN "cellular/GENE NBP"/GENE (/( CNBP/CONTEXTGENE )/SYM ./.
@@63970094264/CD After/IN description/NN of/IN his/PRP short/JJ life/NN and/CC an/DT explanation/NN of/IN the/DT light/NN conductor/NN Bozzini's/GENE merit/NN is/VBZ emphasized/VBN ,/, by/IN his/PRP invention/NN as/IN first/JJ physician/NN to/IN have/NN made/VBP accessible/JJ to/IN medicine/NN endoscopic/JJ diagnostic/JJ possibilities/NNS ./.
@@20120972623/CD Paroxysmal/JJ fluctuations/NNS in/IN observed/VBN parasitemia/NN in/IN Plasmodium/NN falciparum/NN malaria/NN ./.
@@39117024564/CD We/PRP have/VBP earlier/RBR evolved/VBN an/DT experimental/JJ model/NN by/IN means/NN of/IN which/WDT changes/NNS identical/JJ to/IN the/DT microembolism/NN syndrome/NN can/MD be/VB induced/VBN from/IN a/DT reproducible/JJ musculo-skeletal/JJ trauma/NN in/IN pigs/NNS observed/VBN under/IN long-term/JJ anesthesia/NN under/IN standardized/JJ conditions/NNS ./.
@@23538752958/CD The/DT results/NNS suggest/VBP followings--1/NN )/NN both/DT eosinophils/NNS and/CC neutrophils/NNS participate/VB in/IN hypersecretion/NN of/IN type/MULTIGENE Ib/MULTIGENE in/IN atopic/JJ cases/NNS ,/, and/CC only/JJ eosinophils/NNS in/IN non-atopic/JJ cases/NNS ./.
@@115895683648/CD In/NN budding/JJ yeast/NN ,/, this/DT latter/JJ checkpoint/NN response/NN involves/VBZ the/DT proteins/MULTIGENE Mad1/MULTIGENE ,/, 2/CD ,/, 3/CD ,/, Bub1/GENE and/CC Bub3/GENE ,/, whose/WP vertebrate/JJ counterparts/NNS localize/VBP to/IN unattached/JJ kinetochores/NNS ./.
@@80982282954/CD A/DT transcript/NN of/IN about/RB 2/CD kb/NN is/VBZ expected/VBN for/IN each/DT PPO/NN ./.
@@115801738777/CD Plane/NNP wave/NN geometry/NN is/VBZ impractical/JJ for/IN clinical/JJ use/NN but/CC the/DT results/NNS of/IN this/DT work/NN encouraged/VBD us/PRP to/IN further/RB develop/VB the/DT P3/GENE approximation/NN for/IN a/DT spherical/JJ geometry/NN ,/, described/VBN in/IN this/DT paper/NN ./.
@@105128576964/CD In/NN Wnt/NN signaling/JJ ,/, beta-catenin/NN and/CC plakoglobin/NN transduce/VB signals/NNS to/IN the/DT nucleus/NN through/JJ interactions/NNS with/IN TCF-type/MULTIGENE transcription/MULTIGENE factors/MULTIGENE ./.
@@99647709962/CD Microstructure/NNS and/CC conductivity/NN of/IN hierarchical/JJ laminate/NN composites/NNS ./.
@@8543173879/CD There/EX is/VBZ no/DT TATA/MULTIGENE box/MULTIGENE around/IN the/DT transcriptional/JJ start/NN points/NNS (/( tsp/NN )/SYM ,/, as/IN determined/VBN by/IN primer/NN extension/NN analysis/NN ./.
@@112143547421/CD VE-DEF/GENE animals/NNS had/VBP significantly/RB higher/JJ (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM levels/NNS of/IN myocardial/JJ lipid/NN peroxidation/NN and/CC lower/JJR (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM protein/NN thiols/NNS following/IN I-R/DT compared/VBN to/IN the/DT CON/NN animals/NNS ./.
@@98917079893/CD Five/CD different/JJ subtypes/NNS of/IN spondyloarthropathy/NN (/( SpA/NNP )/SYM are/VBP now/RB recognized/VBN ./.
@@5640325618/CD Changes/NNS in/IN ionic/JJ content/NN of/IN the/DT mucous/JJ suggest/VB that/IN cholinergic/JJ mechanisms/NNS affect/VBP pressure/NN in/IN the/DT excretory/JJ duct/NN of/IN the/DT gland/NN ./.
@@107645741587/CD Application/NNP of/IN the/DT method/NN to/IN a/DT representative/JJ set/NN of/IN 50/CD known/VBP genes/NNS from/IN Arabidopsis/NN thaliana/NN showed/VBD significant/JJ improvement/NN in/IN prediction/NN accuracy/NN compared/VBN to/IN previous/RB spliced/VBN alignment/NN methods/NNS ./.
@@118599431748/CD All/DT adults/NNS attending/VBG the/DT outpatient/NN clinics/NNS of/IN a/DT dermatological/JJ hospital/NN on/IN predetermined/JJ days/NNS were/VBD given/VBP the/DT 12-item/NNP General/NNP Health/NNP Questionnaire/NN ./.
@@23124702961/CD The/DT BAL-to-plasma/NNP specific/JJ activity/NN of/IN urea/NN was/VBD about/RB twice/RB that/IN of/IN Na+/NN ,/, indicating/VBG that/DT urea/NN diffused/VBN into/IN the/DT ELF/GENE more/RB rapidly/RB than/IN Na+/NN during/IN the/DT 70/CD s/NN that/IN elapsed/VBN between/IN the/DT time/NN the/DT radioactive/JJ urea/NN and/CC Na+/NN were/VBD injected/VBN into/IN the/DT circulation/NN and/CC the/DT time/NN when/CC lavage/NN was/VBD complete/JJ ./.
@@109586739375/CD This/DT intracellular/JJ signaling/NN ,/, known/VBP as/IN the/DT unfolded/JJ protein/NN response/NN (/( UPR/GENE )/SYM ,/, is/VBZ mediated/JJ by/IN the/DT cis-acting/JJ ER/MULTIGENE stress/MULTIGENE response/MULTIGENE element/MULTIGENE (/( ERSE/GENE )/SYM in/IN mammals/NNS ./.
@@35670171135/CD Multiple/NNP dosing/VBG four/CD times/NNS daily/JJ for/IN 7/CD days/NNS of/IN indoprofen/NN 200/CD mg/NN ,/, a/DT non-steroidal/JJ anti-inflammatory/JJ drug/NN with/IN a/DT short/JJ half-life/NN (/( t1/NN //NN 2/NN )/SYM ,/, revealed/VBN drug/NN accumulation/NN in/IN eight/CD elderly/JJ subjects/NNS ./.
@@111327902346/CD The/DT standard/JJ method/NN for/IN calculating/JJ the/DT composite/JJ score/NN on/IN the/DT S-B/MULTIGENE IV/MULTIGENE excludes/VBZ subtests/NNS with/IN a/DT raw/JJ score/NN of/IN 0/CD ,/, which/WDT overestimates/VBZ cognitive/JJ functioning/NN in/IN young/JJ biologically/RB high/JJ risk/NN children/NNS ./.
@@33119543922/CD A/DT multicentre/JJ study/NN involving/VBG 9/CD Italian/JJ institutions/NNS was/VBD carried/VBN out/RB to/IN compare/NN the/DT efficacy/NN and/CC safety/NN of/IN ranitidine/MULTIGENE 150/MULTIGENE mg/NN b/CD ./CD i/CD ./CD d/CD ./. and/CC ranitidine/MULTIGENE 300/MULTIGENE mg/NN nocte/NN in/IN the/DT treatment/NN of/IN reflux/JJ oesophagitis/NN ./.
@@117083621549/CD The/DT astronaut/NN crew/NN operates/VBZ the/DT payload/NN and/CC documents/NNS its/PRP operation/NN ./.
@@85296307829/CD Stems/NNS contain/VBP distinctly/RB less/PRP P/MULTIGENE protein/MULTIGENE mRNA/MULTIGENE and/CC the/DT relative/JJ level/NN in/IN roots/NNS is/VBZ very/RB low/JJ but/CC still/RB clearly/RB detectable/JJ ./.
@@110940913441/CD The/DT activity/NN of/IN the/DT transcription/MULTIGENE factor/MULTIGENE CREB/MULTIGENE is/VBZ regulated/VBN by/IN extracellular/JJ stimuli/NNS that/WDT result/VBP in/IN its/PRP phosphorylation/NN at/IN a/DT critical/JJ serine/NN residue/NN ,/, Ser133/NN ./.
@@82934124838/CD A/DT randomized/JJ ,/, multicenter/JJ study/NN comparing/VBG the/DT efficacy/NN and/CC tolerability/NN of/IN tropisetron/NN ,/, a/DT new/JJ 5-HT3/MULTIGENE receptor/MULTIGENE antagonist/MULTIGENE ,/, with/IN a/DT metoclopramide-containing/JJ antiemetic/JJ cocktail/NN in/IN the/DT prevention/NN of/IN cisplatin-induced/JJ emesis/NN ./.
@@77999502669/CD In/NN studies/NNS of/IN many/JJ different/JJ phenotypically/RB distinct/JJ cells/NNS ,/, the/DT CRE/NN of/IN the/DT somatostatin/MULTIGENE gene/MULTIGENE promoter/MULTIGENE is/VBZ a/DT prototype/NN of/IN a/DT highly/RB cAMP-responsive/MULTIGENE element/MULTIGENE regulated/VBN by/IN CREB/NN ./.
@@3909324560/CD Capsular/JJ antigens/NNS of/IN Staphylococcus/NN aureus/NN ./.
@@114147545139/CD Copyright/NNP 2001/CD Academic/NNP Press/NNP ./.
@@7027736805/CD Althoug/DT RBF/NN tended/VBN to/IN increase/NN after/IN the/DT therapy/NN ,/, there/RB was/VBD no/DT statistically/RB significant/JJ change/NN in/IN RBF/NN ,/, GFR/NN and/CC cardiac/JJ output/NN ./.
@@91942508267/CD We/PRP suggest/VBP that/IN apart/RB from/IN the/DT World/NNP Summit/NNP for/IN Children's/NNP under-five/NN mortality/NN target/NN for/IN the/DT year/NN 2000/CD ,/, intraregional/MULTIGENE targets/MULTIGENE to/IN reduce/VB geographical/JJ inequalities/NNS in/IN under-five/NN mortality/NN should/MD be/VB specified/VBN ./.
@@29818406385/CD A/DT 114-base/JJ pair/NN sequence/NN of/IN predominantly/RB repeating/JJ purine-pyrimidine/MULTIGENE nucleotides/MULTIGENE separates/VBZ these/DT two/JJ d/NN (/NN AC/NN )/NN repeats/NNS ./.
@@89484403383/CD The/DT ERH/NN expression/NN profile/NN is/VBZ similar/JJ ,/, to/IN that/DT of/IN An3/GENE ,/, which/WDT localizes/VBZ to/IN the/DT animal/NN hemisphere/NN of/IN oocytes/NNS and/CC is/VBZ abundantly/RB expressed/VBN in/IN the/DT embryo/NN ./.
@@19227397546/CD It/PRP was/VBD found/VBN that/IN the/DT ROSP/GENE undergoes/VBZ a/DT number/NN of/IN fluctuations/NNS in/IN the/DT negative/JJ and/CC positive/JJ directions/NNS with/IN a/DT gradually/RB decreasing/JJ amplitude/NN in/IN the/DT course/NN of/IN 5-25/JJ days/NNS following/IN the/DT operation/NN ,/, after/IN which/WDT relatively/JJ stable/JJ negative/JJ values/NNS of/IN the/DT ROSP/GENE are/VBP established/VBN on/IN the/DT average/NN in/IN electrodes/NNS implanted/VBN to/IN the/DT level/NN of/IN the/DT dura/NN mater/JJ ,/, and/CC positive/JJ values/NNS in/IN electrodes/NNS implanted/VBN to/IN the/DT level/NN of/IN the/DT pia/MULTIGENE mater/MULTIGENE ./.
@@113526638106/CD By/IN comparison/NN ,/, in/IN nontumorigenic/JJ Ad5/IN cells/NNS ,/, class/MULTIGENE I/MULTIGENE expression/NN is/VBZ high/JJ due/NN to/IN negligible/JJ binding/NN of/IN COUP-TF/GENE and/CC strong/JJ binding/NN of/IN NF-kappaB/GENE ./.
@@83876627857/CD After/IN surgery/NN ,/, patients/NNS self/NN administered/VBN one/PRP of/IN three/CD possible/JJ postsurgical/JJ medications/NNS ,/, which/WDT included/VBD placebo/NN ,/, codeine/MULTIGENE 60/MULTIGENE mg/NN ,/, and/CC ibuprofen/NN 400/CD mg/NN ,/, when/CC their/PRP pain/NN reached/VBD a/DT moderate/JJ or/CC severe/JJ intensity/NN ./.
@@85535801365/CD A/DT short/JJ open/JJ reading/JJ frame/NN (/( ORF2/GENE )/SYM ,/, of/IN unknown/JJ function/NN ,/, is/VBZ present/VB in/IN all/DT FIV/NN isolates/NNS ./.
@@15465222156/CD Probable/JJ progressive/JJ multifocal/JJ leukoencephalopathy/NN (/( PML/NN )/SYM was/VBD diagnosed/VBN on/IN the/DT basis/NN of/IN clinical/JJ picture/NN and/CC magnetic/JJ resonance/NN imaging/JJ in/IN a/DT 63-year-old/JJ man/NN with/IN a/DT complete/JJ remission/NN of/IN a/DT non-Hodgkin's/JJ lymphoma/NN ./.
@@94369894593/CD Perhaps/RB in/IN addition/NN to/IN ,/, or/CC as/IN part/NN of/IN ,/, its/PRP essential/JJ function/NN in/IN late/JJ mitosis/NN ,/, MOB1/GENE is/VBZ required/VBN for/IN a/DT cell/NN cycle/NN reset/NN function/NN necessary/JJ for/IN the/DT initiation/NN of/IN the/DT spindle/NN pole/NN body/NN duplication/NN ./.
@@37663706493/CD High/NNP radial/JJ r/JJ values/NNS with/IN small/JJ standard/JJ deviations/NNS were/VBD observed/VBN in/IN normal/JJ LV/NEWGENE (/( 0/CD ./CD 972/CD +/NN //NN -/NN 0/CD ./CD 016/CD )/SYM and/CC in/IN non-MI/JJ regions/NNS (/( 0/CD ./CD 964/CD +/NN //NN -/NN 0/CD ./CD 018/CD )/SYM ,/, indicating/VBG temporally/RB homogeneous/JJ radial/JJ shortening/NN ./.
@@114411631314/CD Foreigners/NNS return/NN ./.
@@87392608726/CD Catha/NN edulis/NN ,/, a/DT plant/NN that/WDT has/VBZ amphetamine/NN effects/NNS ./.
@@99958972616/CD Observation/NNS of/IN dipolar/JJ interactions/NNS between/IN Pb0/NNP defects/NNS at/IN the/DT (/( 111/CD )/SYM Si/GENE //GENE SiO2/GENE interface/NN ./.
@@11595813291/CD Peripheral/JJ metabolism/NN of/IN androgens/NNS takes/VBP place/NN in/IN various/JJ areas/NNS within/IN the/DT pilosebaceous/JJ unit/NN ,/, as/IN indicated/VBN by/IN local/JJ differences/NNS in/IN the/DT activities/NNS of/IN aromatase/NN ,/, 5alpha-reductase/NNP as/NNP well/VB as/IN of/IN the/DT presence/NN of/IN the/DT androgen/MULTIGENE receptors/MULTIGENE ./.
@@13957552007/CD Consequently/RB ,/, significant/JJ differences/NNS between/IN the/DT measured/VBN and/CC calculated/VBN methods/NNS were/VBD noted/VBN in/IN oxygen/NN uptake/NN (/( 213/CD +/NN //NN -/NN 41/CD ml/NNP //NNP min/NNP vs/NNP 193/CD +/NN //NN -/NN 25/CD ml/NN //NN min/NN ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, oxygen/NN delivery/NN (/( 780/CD +/NN //NN -/NN 297/CD ml/NNP //NNP min/NNP vs/NNP 716/NN +/NN //NN -/NN 296/CD ml/NN //NN min/NN ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, and/CC cardiac/JJ output/NN (/( 5/CD ./CD 8/CD +/NN //NN -/NN 2/CD ./CD 2/CD L/NNP //NNP min/NNP vs/NNP 5/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 8/CD L/NNS //NNS min/NNS ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@99173911839/CD Transcription/NNS readthrough/NN into/IN the/DT inverted/JJ repeats/NNS has/VBZ little/JJ effect/NN on/IN this/DT event/NN ./.
@@34006944298/CD PATIENTS/IN and/CC METHODS/IN :/: Thallium-201/NN myocardial/JJ scintigraphy/NN was/VBD performed/VBN at/IN rest/NN and/CC after/IN 0/CD ./CD 56/CD mg/CD //CD kg/CD intravenous/JJ dipyridamole/NN during/IN four/CD minutes/NNS in/IN 16/CD patients/NNS with/IN sarcoidosis/NN ./.
@@8417330785/CD Previously/RB ,/, we/PRP identified/VBD a/DT 51-bp/JJ promoter/NN fragment/NN ,/, oligo31/GENE //GENE 32/GENE ,/, which/WDT conferred/VBD heat/NN shock/NN inducibility/NN on/IN the/DT heterologous/JJ CYC1-lacZ/NNP reporter/NN gene/NN in/IN S/NNP ./NNP cerevisiae/NN (/( N/NNP ./NNP
@@114860329611/CD Among/IN the/DT transcription/NN factors/NNS known/VBP to/IN interact/VB with/IN Groucho-related/MULTIGENE protein/MULTIGENE ,/, only/RB RUNX1/GENE was/VBD appreciably/RB downregulated/VBN by/IN E2A-HLF/GENE ./.
@@97554782009/CD Northern/NNP analysis/NN revealed/VBD no/DT detectable/JJ expression/NN of/IN the/DT transcript/NN in/IN diapause-/JJ or/CC nondiapause-programmed/JJ wandering/JJ larvae/NNS ,/, and/CC only/JJ trace/NN expression/NN in/IN nondiapausing/JJ pupae/NNS ./.
@@78606467952/CD Such/JJ an/DT intervention/NN may/MD be/VB of/IN considerable/JJ use/NN for/IN the/DT treatment/NN of/IN angiogenesis-dependent/JJ diseases/NNS involving/VBG FGF-2/GENE ./.
@@10090146800/CD Differential/JJ expression/NN of/IN AP-2alpha/NNP and/CC AP-2beta/NNP in/IN the/DT developing/JJ chick/NN retina/NN :/: repression/NN of/IN R-FABP/MULTIGENE promoter/MULTIGENE activity/NN by/IN AP-2/GENE ./.
@@929109864/CD A/DT specific/JJ distal/JJ promoter/NN controls/NNS gamma-glutamyl/MULTIGENE transpeptidase/MULTIGENE gene/MULTIGENE expression/NN in/IN undifferentiated/JJ rat/NN transformed/VBD liver/NN cells/NNS ./.
@@84009281131/CD INTERVENTIONS--Patients/NNS allocated/VBN to/IN treatment/NN with/IN levodopa/MULTIGENE //MULTIGENE dopa/MULTIGENE decarboxylase/MULTIGENE inhibitor/MULTIGENE alone/RB (/( arm/NN 1/CD )/SYM ,/, levodopa/NN //NN decarboxylase/NN inhibitor/NN //NN selegiline/NN in/IN combination/NN (/( arm/NN 2/CD )/SYM ,/, or/CC bromocriptine/NN (/( arm/NN 3/CD )/SYM ./SYM
@@13836951378/CD We/PRP analyzed/VBD an/DT EBV/MULTIGENE B-cell/MULTIGENE clone/MULTIGENE ,/, E29/GENE ./GENE 1/GENE ,/, derived/VBN from/IN an/DT 11/CD week-old/JJ embryo/NN ,/, and/CC secreting/JJ both/DT IgM/MULTIGENE kappa/MULTIGENE and/CC IgM/MULTIGENE lambda/MULTIGENE ./.
@@33724223554/CD The/DT maximum/JJ deflections/NNS of/IN phase/NN IV/NN for/IN Ar/NN and/CC N2/GENE from/IN extrapolated/VBN phase/NN III/NNP slopes/NNS were/VBD smaller/JJR in/IN the/DT prone/JJ position/NN ,/, suggesting/VBG more/RB uniform/JJ tracer/NN gas/NN concentrations/NNS across/IN the/DT lungs/NNS ./.
@@65423726333/CD The/DT present/NN paper/NN elucidates/VBZ the/DT existing/JJ discrepancies/NNS ,/, and/CC offers/VBP a/DT consistent/JJ terminology/NN incorporating/JJ also/RB such/JJ terms/NNS as/IN "additivity"/NN ,/, "potentiation"/NN ,/, and/CC "simple/NN similarity"/NN ./.
@@88247988505/CD Human/MULTIGENE ESP1/MULTIGENE //MULTIGENE CRP2/MULTIGENE protein/MULTIGENE has/VBZ two/JJ LIM/MULTIGENE domains/MULTIGENE ,/, and/CC each/DT shares/NN 35/CD ./CD 1%/CD and/CC 77/CD or/CC 79%/CD identical/JJ residues/NNS with/IN human/JJ cysteine-rich/JJ protein/NN (/( CRP/NN )/SYM and/CC rat/MULTIGENE CRIP/MULTIGENE ,/, respectively/RB ./.
@@2123300447/CD Human/NNP recombinant/JJ DNA-derived/JJ antihemophilic/JJ factor/NN (/( factor/MULTIGENE VIII/MULTIGENE )/SYM in/IN the/DT treatment/NN of/IN hemophilia/NN A/NNP ./NNP recombinant/JJ Factor/MULTIGENE VIII/MULTIGENE Study/NNP Group/NNP ./.
@@115759771460/CD However/RB ,/, patients/NNS with/IN isolated/VBN office/NN hypertension/NN had/VBP fewer/DT previous/JJ cardiovascular/JJ complications/NNS ./.
@@24036344664/CD Sequence/NN analysis/NN indicates/VBZ that/IN in/IN addition/NN to/IN an/DT ATA/NN and/CC GC/MULTIGENE box/MULTIGENE ,/, this/DT region/NN contains/VBZ domains/NNS that/WDT have/VBP been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN other/DT muscle-specific/MULTIGENE genes/MULTIGENE :/: a/DT CArG/MULTIGENE box/MULTIGENE at/IN -91/CD bp/NN ;/: myocyte-specific/MULTIGENE enhancer-binding/MULTIGENE nuclear/MULTIGENE factor/MULTIGENE 1/MULTIGENE binding/MULTIGENE site/MULTIGENE homologies/NNS at/IN -58/CD ,/, -535/JJ ,/, and/CC -583/JJ bp/NN ;/: and/CC a/DT muscle-CAAT/NN consensus/NN sequence/NN at/IN -394/CD bp/NN relative/JJ to/IN the/DT cap/NN site/NN ./.
@@10472836313/CD Feed/VB intake/NN and/CC BW/NN gains/NNS were/VBD decreased/VBN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM by/IN dietary/JJ treatments/NNS containing/JJ M/NNP ./NNP
@@85950126414/CD In/NN nondiabetics/NNS the/DT response/NN of/IN tcPO2/GENE but/CC not/RB of/IN LDF/NN was/VBD influenced/VBN by/IN the/DT values/NNS at/IN rest/NN ./.
@@87074243708/CD The/DT expression/NN of/IN ERV3/MULTIGENE env/MULTIGENE mRNA/MULTIGENE was/VBD found/VBN to/IN be/VB differentiation-associated/JJ ,/, with/IN high/JJ expression/NN detected/VBN in/IN the/DT late/JJ stages/NNS of/IN monocytic/JJ development/NN ./.
@@87633112/CD Phenylephrine/WDT is/VBZ a/DT pure/JJ alpha-1/MULTIGENE adrenoreceptor/MULTIGENE agonist/MULTIGENE known/VBP to/IN produce/NN marked/JJ systemic/JJ vasoconstriction/NN and/CC associated/VBN hypertension/NN with/IN occasional/JJ profound/JJ reflex/NN bradycardia/NN ./.
@@70901514663/CD Before/IN turnout/NN ,/, a/DT morantel/NN sustained/JJ release/NN bolus/NN (/( MSRB/GENE )/SYM was/VBD administered/VBN to/IN each/DT animal/NN in/IN the/DT "treated"/NN category/NN ./.
@@72772227133/CD Similar/JJ waves/NNS were/VBD seen/VBP on/IN cross-correlating/PDT a/DT motor/JJ unit/NN with/IN an/DT electronic/JJ oscillator/NN ,/, confirming/VBG that/IN their/PRP occurrence/NN does/VBP not/RB necessarily/RB demonstrate/VB the/DT existence/NN of/IN active/JJ neural/JJ interactions/NNS ./.
@@63047719825/CD Another/DT sequence/NN ,/, GGGXGGAG/NNP ,/, which/WDT is/VBZ repeated/VBN several/DT times/NNS in/IN many/JJ polyomaviruses/NNS and/CC adenoviruses/NNS ,/, and/CC which/WDT is/NNS thought/VBP to/IN play/NN a/DT role/NN in/IN DNA/NN replication/NN and/DT //DT or/DT transcription/NN ,/, is/VBZ not/RB found/VB in/IN the/PDT JCV/MULTIGENE sequence/MULTIGENE presented/VBN ./.
@@30195053731/CD Five/CD patients/NNS developed/VBD metastatic/JJ spread/NN ,/, and/CC all/DT of/IN them/PRP died/VBD of/IN tumor/NN ./.
@@35829826044/CD A/DT study/NN of/IN human/JJ genes/NNS coding/JJ for/IN U4/MULTIGENE small/MULTIGENE nuclear/MULTIGENE RNA/MULTIGENE is/VBZ presented/VBN ./.
@@82537771564/CD A/DT cAMP/MULTIGENE response/MULTIGENE element/MULTIGENE (/( CRE/CONTEXTGENE )/SYM consensus/NN signal/NN was/VBD identified/VBN in/IN the/DT 5'-noncoding/JJ region/NN ./. cAMP/NN regulates/VBZ the/DT expression/NN of/IN Kv1/MULTIGENE ./MULTIGENE 5/MULTIGENE gene/MULTIGENE in/IN a/DT cell-specific/JJ manner/NN ./.
@@62771596071/CD A/DT hypothesis/NN ./.
@@76246158895/CD Acute/JJ decrease/NN in/IN body/NN temperature/NN (/( TB/NN )/SYM lowered/VBN PaCO2/GENE (/( 32/CD ./CD 5/CD to/IN 14/CD ./CD 5/CD mmHg/NN )/SYM and/CC [/NN HCO3-/NN ]/NN a/NN (/NN 24/NN ./NN 20/NN mEq/NN //NN L/NN to/IN 17/CD ./CD 56/CD mEq/NN //NN L/NN )/NN ,/, increased/VBN pHa/NN (/( 7/CD ./CD 481/CD to/IN 7/CD ./CD 608/CD )/SYM and/CC diminished/VBD the/DT [/NN OH-/NN ]/NN //NN [/NN H+/NN ]/NN ratio/NN ,/, but/CC had/VBP no/DT significant/JJ effect/NN on/IN [/NN SID/NN ]/NN or/CC [/NN Atot/NN ]/NN ,/, although/IN both/DT total/JJ phosphorus/NN [/NN PT/NN ]/NN and/CC inorganic/JJ phosphate/NN [/NN Pi/NN ]/NN increased/VBN ./.
@@89128077086/CD However/RB ,/, the/DT truncated/JJ deer/NN receptor/NN lacks/VBZ the/DT most/JJ C-terminal/NN tyrosine/NN residue/NN in/IN the/DT intracellular/JJ domain/NN which/WDT is/VBZ believed/VBN to/IN be/VB essential/JJ for/IN activation/NN of/IN the/DT beta-casein/MULTIGENE promoter/MULTIGENE ./.
@@114206128149/CD As/IN a/DT complement/NN to/IN genome-wide/JJ mapping/NN and/CC sequencing/VBG efforts/NNS ,/, it/PRP is/VBZ often/RB important/JJ to/IN generate/VB detailed/JJ maps/NNS and/CC sequence/NN data/NN for/IN specific/JJ regions/NNS of/IN interest/NN ./.
@@70620362799/CD Rats/NNP underwent/VBD either/DT a/DT 90-95%/CD JIB/GENE or/CC a/DT sham/NN operation/NN ./.
@@29698197911/CD Ig/NN D-JH/NNP recombinations/NNS may/MD precede/VB TcR/MULTIGENE gene/MULTIGENE recombination/NN in/IN these/DT early/JJ T/NN cell/NN lines/NNS ,/, and/CC some/DT but/CC not/RB all/DT express/JJ sterile/JJ Cmu/MULTIGENE transcripts/MULTIGENE ./.
@@98029024662/CD We/PRP have/VBP previously/RB shown/VBP that/IN ARNO/ORG localizes/VBZ to/IN the/DT plasma/NN membrane/NN in/IN vivo/NN and/CC efficiently/RB catalyzes/VBZ ARF6/GENE nucleotide/NN exchange/NN in/IN vitro/FW ./.
@@95360289996/NN In/NN contrast/NN ,/, the/DT contractile/JJ action/NN of/IN arachidonic/JJ acid/NN ,/, via/NN a/DT presumed/VBN cyclooxygenase/MULTIGENE product/MULTIGENE that/IN mediated/JJ the/DT contractions/NNS caused/VBN by/IN both/DT TF/NN and/CC EGF/NN ,/, was/VBD not/RB blocked/VBN by/IN any/DT of/IN the/DT signal/JJ pathway/NN probe/NN inhibitors/NNS ./.
@@14686257706/CD Among/IN these/DT ,/, ACT1/GENE was/VBD isolated/VBN four/CD times/NNS ,/, and/CC NSR1/GENE three/CD times/NNS ./.
@@29858124260/CD An/DT unusual/JJ feature/NN of/IN these/DT replicative/JJ genes/NNS is/VBZ that/IN the/DT smaller/JJR mRNA/NN begins/VBZ within/IN a/DT long/JJ open/JJ reading/JJ frame/NN of/IN the/DT larger/JJR mRNA/NN ./.
@@83967499159/CD LDL/NN cholesterol/NN decreased/VBN from/IN 4/CD ./CD 74/CD +/NN //NN -/NN 0/CD ./CD 87/CD to/IN 3/CD ./CD 78/CD +/NN //NN -/NN 0/CD ./CD 78/CD mmol/NN //NN l/NN after/IN 8/CD weeks/NNS on/IN simvastatin/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, and/CC apo/MULTIGENE B/MULTIGENE fell/NN from/IN 142/CD +/NN //NN -/NN 31/CD to/IN 112/CD +/NN //NN -/NN 22/CD mg/NN //NN dl/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@105025224138/CD Defective/JJ provirus/NN genomes/NNS of/IN human/JJ T-cell/NN leukemia/NN virus/NN type/MULTIGENE I/MULTIGENE are/VBP frequently/RB detected/VBN in/IN lymphocytes/NNS from/IN infected/VBN individuals/NNS and/CC in/IN infected/VBN cell/NN lines/NNS ./.
@@98723268434/CD Further/RB ,/, we/PRP show/VBP that/IN this/DT EIA-inducible/GENE CBF/GENE //GENE cdc2/GENE is/VBZ related/VBN to/IN the/DT CBF/NN which/WDT was/VBD shown/VBP to/IN activate/VB the/DT heat/MULTIGENE shock/MULTIGENE protein/MULTIGENE 70/MULTIGENE promoter/MULTIGENE ./.
@@86276887122/CD This/DT result/NN suggested/VBN that/IN mutant/MULTIGENE I299/MULTIGENE has/VBZ diminished/VBN cap-binding/JJ activity/NN ./.
@@39122474567/CD The/DT volume/NN of/IN blood/NN to/IN the/DT flap/NN ranges/NNS from/IN 1/CD to/IN 2/CD ml/NN //NN min/NN ,/, collateral/JJ circulation/NN to/IN the/DT flap/NN exists/VBZ ,/, but/CC is/VBZ negligible/JJ ,/, and/CC there/RB is/VBZ little/JJ change/NN in/IN the/DT capillary/JJ blood/NN flow/NN as/IN the/DT flap/NN ages/NNS ./.
@@77607907664/CD Serum/NN induction/NN of/IN a/DT MEF2/GENE reporter/NN gene/NN was/VBD not/RB observed/VBN in/IN a/DT line/NN of/IN NIH/NN 3T3/CD cells/NNS which/WDT contain/VBP low/JJ MEF2/MULTIGENE site/MULTIGENE binding/JJ activity/NN ./.
@@1007180671/CD The/DT rate/NN of/IN resectability/NN is/VBZ low/JJ and/CC 5-year/JJ survival/NN is/VBZ very/RB poor/JJ ./.
@@79343317902/CD A/DT simple/JJ registration/NN as/IN an/DT incentive/NN for/IN improvement/NN ./.
@@21238209151/CD Effects/NNPS of/IN a/DT selective/JJ monoamine/MULTIGENE oxidase/MULTIGENE (/( MAO/CONTEXTGENE )/NN --A/NN inhibitor/NN ,/, clorgyline/NN ,/, a/DT selective/JJ MAO-B/GENE inhibitor/NN ,/, deprenyl/NN ,/, and/CC a/DT non-selective/JJ MAO/MULTIGENE inhibitor/MULTIGENE ,/, nialamide/NN ,/, were/VBD investigated/VBN on/IN footshock-induced/JJ aggression/NN (/( FIA/NN )/SYM in/IN paired/JJ rats/NNS ./.
@@15266582270/CD IFI/MULTIGENE 16/MULTIGENE mRNA/MULTIGENE was/VBD found/VBN to/IN be/VB constitutively/RB expressed/VBN in/IN lymphoid/JJ cells/NNS and/CC in/IN cell/NN lines/NNS of/IN both/PDT the/DT T/NN and/CC B/NNP lineages/NNS ./.
@@27797524594/CD 1-/NN (/NN 1-Naphthyl/NN )/NN piperazine/NN (/( 1-NP/JJ )/SYM has/VBZ been/VBN reported/VBN to/IN have/NN serotonin/MULTIGENE antagonist/MULTIGENE properties/NNS at/IN the/DT 5-HT2/MULTIGENE subtype/MULTIGENE of/IN receptor/NN ,/, and/CC it/PRP has/VBZ been/VBN suggested/VBN that/IN it/PRP may/MD have/VB agonist/NN actions/NNS at/IN the/DT 5-HT1/MULTIGENE site/MULTIGENE ./.
@@33315253634/CD "In/NN vitro"/NN study/NN of/IN dentin/NN adhesion/NN to/IN adhesives/NNS made/VBP from/IN urethane/MULTIGENE molecules/MULTIGENE with/IN free/JJ groups/NNS of/IN isocyanate/NN ./.
@@87063685489/CD RESULTS/NNS :/: The/DT LV/JJ maximum/JJ brightness/NN and/CC area/NN under/IN the/DT curve/NN showed/VBD significant/JJ negative/JJ correlations/NNS (/( p/NN =/SYM </SYM 0/CD ./CD 004/CD )/SYM with/IN the/DT FIO2/GENE ,/, while/CC the/DT minimum/JJ brightness/NN showed/VBD a/DT significant/JJ positive/JJ correlation/NN (/( p/NN =/SYM </SYM 0/CD ./CD 002/CD )/SYM ./.
@@90201382242/CD Both/DT HEF1/GENE and/CC Cas/NNS were/VBD found/VBN to/IN complex/NN with/IN the/DT related/VBN adhesion/NN focal/JJ tyrosine/MULTIGENE kinase/MULTIGENE (/( RAFTK/GENE )/SYM ,/, and/CC when/CC tyrosine/NN phosphorylated/VBN ,/, with/IN the/DT adapter/NN molecule/MULTIGENE CrkL/MULTIGENE ./.
@@33950096967/CD Statistical/NNP analysis/NN of/IN the/DT degrees/NNS of/IN secondary/JJ spinal/JJ cord/NN compression/NN was/VBD performed/VBN in/IN group-1/NNP dogs/NNS by/IN measuring/JJ and/CC comparing/VBG ratios/NNS of/IN the/DT vertical/NN to/IN the/DT horizontal/JJ diameters/NNS of/IN the/DT transverse/JJ spinal/JJ cord/NN sections/NNS from/IN locations/NNS within/IN (/( T12/GENE to/IN L1/NN )/SYM and/CC out/RB of/IN (/( T11/GENE ,/, T11-12/GENE ,/, L1-2/GENE ,/, and/CC L2/CONTEXTGENE )/SYM the/DT region/NN of/IN surgical/JJ intervention/NN ./.
@@35954187834/CD The/DT nucleotide/NN sequences/NNS of/IN the/DT human/JJ and/CC murine/MULTIGENE ornithine/MULTIGENE decarboxylase/MULTIGENE mRNAs/MULTIGENE share/VBP an/DT 85%/JJ homology/NN ,/, even/VB in/IN their/PRP 3'-noncoding/JJ regions/NNS ./.
@@13095933688/CD These/DT studies/NNS show/NN that/IN UCRBP/GENE binds/VBZ to/IN various/JJ target/NN motifs/NNS that/WDT are/VBP distinct/JJ from/IN the/DT UCR/MULTIGENE motif/MULTIGENE :/: the/DT adeno-associated/JJ virus/NN P5/MULTIGENE promoter/MULTIGENE and/CC elements/NNS in/IN the/DT immunoglobulin/NN light-/DT and/CC heavy-chain/MULTIGENE genes/MULTIGENE ,/, as/RB well/VB as/IN elements/NNS in/IN ribosomal/JJ protein/NN genes/NNS ./.
@@93262633673/CD Using/VBG 5'RACE/CD and/CC reverse/JJ transcription-PCR/NN (/( RT-PCR/NN )/SYM methodologies/NNS ,/, we/PRP cloned/VBN these/DT sequences/NNS from/IN brain/NN and/CC placenta/NN and/CC found/VB this/DT material/NN to/IN be/VB composed/VBN of/IN alternatively/RB spliced/VBN exons/NNS using/VBG a/DT previously/RB reported/VBN noncoding/JJ exon/NN (/( 1A/CD )/SYM and/CC a/DT novel/JJ 97-bp/CD noncoding/JJ exon/NN (/( 1B/GENE )/SYM ./.
@@113509574467/CD PACAP/MULTIGENE mRNA/MULTIGENE was/VBD widely/RB expressed/VBN in/IN most/RB human/JJ tissues/NNS ;/: in/IN transfected/VBN cells/NNS ,/, PACAP/NN was/VBD diffusely/RB expressed/VBN in/IN the/DT cytoplasm/NN ./.
@@37530224421/CD Malignant/NN lymphoma/NN is/VBZ very/RB heterogeneous/JJ in/IN terms/NNS of/IN its/PRP biological/JJ behavior/NN ./.
@@80403919004/CD Number/NN and/CC size/NN of/IN silver-stained/JJ nucleoli/NNS (/( Ag-NOR/MULTIGENE clusters/MULTIGENE )/SYM in/IN canine/JJ seminomas/NNS :/: correlation/NN with/IN histological/JJ features/NNS and/CC tumour/NN behaviour/NN ./.
@@98823039064/CD These/DT data/NN further/RB define/VB a/DT role/NN for/IN TRADD/GENE and/CC TRAF2/GENE in/IN JNK/NEWGENE activation/NN and/CC confirm/VB that/IN LMP1/GENE utilizes/VBZ signalling/JJ mechanisms/NNS used/VBN by/IN the/DT TNF/MULTIGENE receptor/MULTIGENE //MULTIGENE CD40/MULTIGENE family/MULTIGENE to/IN elicit/VB its/PRP pleiotropic/JJ activities/NNS ./.
@@108347075788/CD Biologically/RB significant/JJ amounts/NNS of/IN platelet/MULTIGENE activating/MULTIGENE factor/MULTIGENE were/VBD eluted/VBN from/IN the/DT sorbent/NN during/IN the/DT entire/JJ treatment/NN time/NN ./.
@@108177548334/CD H19/GENE and/CC Igf2/GENE monoallelic/JJ expression/NN is/VBZ regulated/VBN in/IN two/JJ distinct/JJ ways/NNS by/IN a/DT shared/JJ cis/JJ acting/JJ regulatory/JJ region/NN upstream/RB of/IN H19/NEWGENE ./.
@@10766493577/CD Recombination/NNS ,/, replication/NN ,/, repair/NN :/: from/IN complexity/NN to/IN harmony/NN ./.
@@113259443674/CD Elevated/NNP expression/NN of/IN full-length/JJ UhpB/GENE or/CC of/IN a/DT soluble/JJ hybrid/JJ protein/NN ,/, GST-Bc/GENE ,/, which/WDT is/VBZ glutathione/MULTIGENE S-transferase/MULTIGENE (/( GST/CONTEXTGENE )/SYM fused/VBN to/IN the/DT cytoplasmic/JJ C-terminal/NN portion/NN of/IN UhpB/GENE ,/, results/VBZ in/IN complete/JJ blockage/NN of/IN uhpT/NEWGENE expression/NN in/IN a/DT uhp/NN (/NN +/NN )/NN strain/NN ./.
@@10597317658/CD Apoptosis/NNS of/IN small/JJ cells/NNS is/VBZ still/RB observed/VBN after/IN co-transfection/NN of/IN JBD/GENE and/CC LMP1/GENE but/CC in/IN addition/NN a/DT few/JJ apoptotic/JJ HD-MyZ/NNP cells/NNS with/IN large/RB fused/VBN nuclear/JJ masses/NNS are/VBP identified/VBN suggesting/VBG that/IN specific/JJ inhibition/NN of/IN JNK/GENE leads/VBP also/RB to/IN apoptosis/NN of/IN LMP1/GENE induced/VBN RS/NN cells/NNS ./.
@@16583561466/CD Recombination/NNS between/IN feline/JJ leukemia/NN virus/NN subgroup/MULTIGENE B/MULTIGENE or/CC C/NN and/CC endogenous/JJ env/MULTIGENE elements/MULTIGENE alters/VBZ the/DT in/NN vitro/FW biological/JJ activities/NNS of/IN the/DT viruses/NNS ./.
@@9266042621/CD Propranolol/NN (/( Inderal/NN )/SYM administered/VBN in/IN a/DT dose/NN which/WDT blocks/NNS the/DT beta-adrenergic/JJ apparatus/NN of/IN the/DT heart/NN prevents/VBZ the/DT development/NN of/IN the/DT positive/JJ inotropic/JJ effect/NN of/IN therapeutic/JJ doses/NNS of/IN strophanthin/MULTIGENE K/MULTIGENE on/IN a/DT hypodynamic/JJ left/NN ventricular/JJ myocardium/NN ./.
@@34998227564/CD Multivariate/JJ logistic/JJ regression/NN analysis/NN indicated/VBD that/DT seropositivity/NN was/VBD strongly/RB associated/VBN with/IN the/DT prevalence/NN of/IN hepatitis/NN B/NN in/IN an/DT employee's/NNS country/NN of/IN birth/NN and/CC with/IN age/NN ./.
@@87903878056/CD In/NN the/DT rat/MULTIGENE rnu/MULTIGENE allele/MULTIGENE described/VBN here/RB ,/, a/DT nonsense/NN mutation/NN in/IN exon/NN 8/CD of/IN the/DT whn/MULTIGENE gene/MULTIGENE was/VBD identified/VBN ./.
@@8896804734/CD The/DT present/NN study/NN investigated/VBD dose/NN dependence/NN and/CC time/NN course/NN effects/NNS of/IN the/DT benzodiazepine/NN (/( BDZ/NN )/SYM partial/JJ inverse/JJ agonist/NN ,/, RO19-4603/GENE (/( 0/CD ./CD 005-0/CD ./CD 30/CD mg/CD //CD kg/CD )/SYM alone/RB ,/, and/CC in/IN combination/NN with/IN the/DT BDZ/MULTIGENE receptor/MULTIGENE antagonists/NNS flumazenil/NN ,/, ZK/GENE 93426/CD ,/, and/CC CGS/NNP 8216/CD (/( 20/CD mg/CD //CD kg/CD )/SYM in/IN selectively/RB bred/VBN alcohol-preferring/JJ (/( P/NN )/SYM rats/NNS provided/VBD a/DT two-bottle/JJ choice/JJ test/NN between/IN ethanol/NN (/( EtOH/NNS )/SYM (/( 10%/CD v/NN //NN v/NN )/SYM ,/, and/CC a/DT palatable/JJ saccharin/NN (/( 0/CD ./CD 0125%/CD g/NN //NN v/NN )/SYM solution/NN ./.
@@23104966996/CD Similar/JJ memory/NN impairments/NNS found/VBP in/IN medial/JJ septal-vertical/JJ diagonal/JJ band/NN of/IN Broca/NN and/CC nucleus/NN basalis/JJ lesioned/JJ rats/NNS :/: are/VBP memory/NN defects/NNS induced/VBN by/IN nucleus/NN basalis/NN lesions/NNS related/VBN to/IN the/DT degree/NN of/IN non-specific/JJ subcortical/JJ cell/NN loss/NN ?/. The/DT function/NN of/IN nucleus/NN basalis/NN (/( NB/JJ )/SYM and/CC medial/JJ septal-vertical/JJ diagonal/JJ band/NN of/IN Broca/NN (/( MS-VDBB/GENE )/SYM in/IN a/DT place/NN navigation/NN task/NN requiring/JJ reference/NN memory/NN was/VBD investigated/VBN ./.
@@66580296409/CD The/DT carcinogen/NN bioassay/NN therefore/RB is/VBZ a/DT very/RB important/JJ component/NN of/IN the/DT battery/NN of/IN toxicological/JJ tests/NNS used/VBN in/IN hazard/NN evaluation/NN ./.
@@75679809047/CD Four/CD p53/GENE DNA-binding/NN domain/NN peptides/NNS bind/VBP natural/MULTIGENE p53-response/MULTIGENE elements/MULTIGENE and/CC bend/VB the/DT DNA/NN ./.
@@93736519328/CD Bitter/JJ cassava/NN contains/VBZ cyanogenic/JJ glycosides/NNS ;/: processing/VBG breaks/NNS them/PRP down/NN to/IN acetone/MULTIGENE cyanohydrin/MULTIGENE and/CC hydrogen/NN cyanide/NN ./.
@@11094109928/CD RESULTS/NNS :/: Average/NNP age/NN at/IN symptom/NN onset/NN was/VBD 41/CD ./CD 2/CD years/NNS ./.
@@1744039481/CD The/DT fragments/NNS of/IN each/DT region/NN were/VBD amplified/VBN by/IN polymerase/NN chain/NN reaction/NN and/CC analyzed/VBN by/IN gel/NN electrophoresis/NN to/IN detect/VB single-strand/JJ conformation/NN polymorphism/NN ./.
@@7457759201/CD Two/CD out/RB of/IN five/CD patients/NNS undergoing/VBG selective/JJ spinal/JJ arteriography/NN developed/VBD transient/JJ neurological/JJ complications/NNS during/IN the/DT injection/NN of/IN Urografin/MULTIGENE 310/MULTIGENE M/NNP ./NNP
@@107447492705/CD To/TO investigate/VB the/DT molecular/JJ mechanisms/NNS of/IN this/DT Tax-mediated/JJ inhibition/NN ,/, we/PRP analyzed/VBD its/PRP effect/NN on/IN the/DT transcriptional/JJ activity/NN of/IN the/DT myogenic/JJ MyoD/MULTIGENE protein/MULTIGENE ,/, which/WDT was/VBD used/VBN as/IN a/DT paradigm/NN of/IN bHLH/MULTIGENE factors/MULTIGENE ./.
@@10517672653/CD When/WRB the/DT 73-bp/JJ fragment/NN was/VBD fused/VBN to/IN an/DT alpha1-globin/MULTIGENE promoter-CAT/MULTIGENE construct/MULTIGENE and/CC cotransfected/VBN with/IN CCAAT/MULTIGENE transcription/MULTIGENE factor/MULTIGENE 1/MULTIGENE (/( CTF1/GENE )/NN //NN NF1/NN into/IN Drosophila/NN Schneider/NN SL2/NNP insect/NN cells/NNS (/( which/WDT lack/VBP NF1-like/VBG proteins/NNS )/SYM trans-activation/NN of/IN CAT/NN activity/NN was/VBD observed/VBN ./.
@@115355327859/CD The/DT deubiquitinating/JJ enzyme/MULTIGENE DUB-2/MULTIGENE is/VBZ induced/VBN in/IN response/NN to/IN IL-2/NEWGENE but/CC as/IN yet/RB its/PRP function/NN has/VBZ not/RB been/VBN determined/VBN ./.
@@20149287111/CD Occupational/NNP asthma/NN and/CC rhinoconjunctivitis/NN from/IN inhalation/NN of/IN crystalline/MULTIGENE bovine/MULTIGENE serum/MULTIGENE albumin/MULTIGENE powder/NN ./.
@@80511519447/CD The/DT relative/JJ abundance/NN of/IN each/DT alternatively/RB spliced/VBN mRNA/NN was/VBD determined/VBN by/IN reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN in/IN various/JJ human/JJ tissues/NNS and/CC cell/NN lines/NNS ./.
@@77537961645/CD Expression/NNS of/IN this/DT cDNA/NN in/IN vitro/FW yields/VBZ a/DT peptide/NN which/WDT comigrates/VBZ with/IN natural/MULTIGENE eIF-2B/MULTIGENE alpha/MULTIGENE in/IN SDS/NNP //NNP polyacrylamide/NNP gels/NNS ./.
@@112232406442/CD Drosophila/MULTIGENE Menin1/MULTIGENE gene/MULTIGENE transcripts/MULTIGENE use/NN alternative/JJ polyadenylation/MULTIGENE sites/MULTIGENE resulting/JJ in/IN 4/CD ./CD 3/CD and/CC 5-kb/CD messages/NNS ./.
@@2349998254/CD Dopamine/IN SERS/GENE spectra/NNS from/IN these/DT electrodes/NNS are/VBP similar/JJ to/IN those/DT obtained/VBN at/IN uncoated/JJ electrodes/NNS ./.
@@98695289859/CD Lead/JJ fixation/NN in/IN dogs/NNS achieved/VBN with/IN RF/NN energy/NN ./.
@@91113147789/CD The/DT importance/NN of/IN posttranslational/JJ regulation/NN of/IN p15INK4B/GENE by/IN TGF-beta/NEWGENE is/VBZ underlined/VBN by/IN the/DT observation/NN that/IN in/IN TGF-beta-resistant/NNP 184A1L5R/CD ,/, although/IN the/DT p15/MULTIGENE transcript/MULTIGENE increased/VBN ,/, p15INK4B/MULTIGENE protein/MULTIGENE was/VBD not/RB stabilized/VBN and/CC did/VBD not/RB accumulate/VB ,/, and/CC cyclin/NN D1-cdk/NNP association/NN and/CC kinase/NN activation/NN were/VBD not/RB inhibited/VBN ./.
@@113144289922/CD Further/RB ,/, the/DT osteo-retentive/JJ ability/NN of/IN the/DT hydroxyapatite/NN in/IN the/DT sockets/NNS was/VBD seen/VBP to/IN be/VB close/JJ to/IN significance/NN (/( after/IN six/CD months/NNS width/NN differences/NNS ,/, in/IN the/DT canine/MULTIGENE region/MULTIGENE :/: P/NN =/SYM 0/CD ./CD 059/CD ,/, LHS/NN ,/, and/CC P/NN =/SYM 0/CD ./CD 065/CD ,/, RHS/GENE )/SYM ./.
@@75175447397/CD After/IN 7/CD days/NNS ,/, a/DT spontaneous/JJ regression/NN of/IN the/DT morphologic/JJ alterations/NNS caused/VBN by/IN caerulein-induced/JJ acute/JJ pancreatitis/NN occurs/VBZ ;/: however/RB ,/, recovery/NN of/IN the/DT secretory/JJ function/NN of/IN the/DT pancreas/NN was/VBD only/RB reached/VBN after/IN this/DT period/NN of/IN time/NN when/CC L-364/GENE ,/GENE 718/GENE was/VBD administered/VBN therapeutically/RB (/( 0/CD ./CD 1/CD mg/NN //NN kg/NN //NN day/NN )/SYM ./.
@@107858803422/CD CONCLUSION/IN :/: The/DT probability/NN of/IN cardiopulmonary/JJ complications/NNS increases/NNS significantly/RB when/CC patients/NNS develop/VB class/MULTIGENE 1/MULTIGENE HELLP/NNP syndrome/NN ./.
@@14527032066/CD Laboratory/NNP studies/NNS showed/VBN that/IN the/DT direct/JJ fluorescent-antibody/JJ kits/NNS were/VBD the/DT least/RB sensitive/JJ in/IN this/DT case/NN and/CC did/VBD not/RB detect/VB fewer/DT than/IN 10/NN (/NN 4/NN )/NN elementary/JJ bodies/NNS per/IN ml/NN ,/, while/CC most/JJ ELISA/NN kits/NNS detected/VBN between/IN 130/CD and/CC 600/CD elementary/JJ bodies/NNS per/IN ml/NN ./NN
@@92362248751/CD Sustained/JJ activation/NN of/IN p21/GENE expression/NN is/VBZ proposed/VBN to/IN be/VB a/DT distinguishing/JJ feature/NN of/IN the/DT activity/NN of/IN NGF/NEWGENE that/WDT contributes/VBZ to/IN PC12/GENE growth/NN arrest/NN during/IN differentiation/NN
@@108437169814/CD The/DT tryptase/MULTIGENE locus/MULTIGENE also/RB contains/VBZ at/IN least/RB four/CD tryptase-like/JJ pseudogenes/NNS ,/, including/JJ mastin/NN ,/, a/DT gene/NN expressed/VBN in/IN dogs/NNS but/CC not/RB in/IN humans/NNS ./.
@@30156286707/CD Osteocalcin/IN (/( and/CC urinary/JJ hydroxyproline/NN )/SYM were/VBD not/RB elevated/VBN in/IN isolated/VBN hyperphosphatasaemia/NN ,/, indicating/VBG that/IN mechanisms/NNS other/DT than/IN increased/VBN bone/NN turnover/NN may/MD account/VB for/IN the/DT markedly/RB elevated/VBN serum/JJ alkaline/MULTIGENE phosphatase/MULTIGENE activity/NN in/IN these/DT subjects/NNS ./.
@@37507004418/CD Possibilities/NNPS and/CC outlook/NN for/IN wrist/NN joint/JJ endoprosthesis/NN ./.
@@80495211363/CD Aberrant/JJ protein/NN phosphorylation/NN at/IN tyrosine/NN is/VBZ responsible/JJ for/IN the/DT growth-inhibitory/JJ action/NN of/IN pp60v-src/GENE expressed/VBN in/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@97042961525/CD Acute/JJ idiopathic/JJ thrombocytopenic/JJ purpura/NN presenting/VBG a/DT high/JJ serum/JJ level/NN of/IN immunoglobulin/MULTIGENE E/MULTIGENE and/CC eosinophilia/NN in/IN an/DT elderly/JJ patient/NN ./.
@@90060518195/CD PrpB/GENE showed/VBD homology/NN to/IN carboxyphosphonoenolpyruvate/MULTIGENE phosphonomutase/MULTIGENE of/IN Streptomyces/NN hygroscopicus/NN and/CC to/IN its/PRP homolog/NN in/IN the/DT carnation/NN Dianthus/NNP caryophyllus/NN ;/: PrpC/NNP was/VBD homologous/JJ to/IN both/DT archaeal/JJ and/CC bacterial/JJ citrate/MULTIGENE synthases/MULTIGENE ;/: PrpD/NNP showed/VBD homology/NN to/IN yeast/NN and/CC Bacillus/NN subtilis/JJ proteins/NNS of/IN unknown/JJ function/NN ;/: PrpE/NNP showed/VBD homology/NN to/IN acetyl/MULTIGENE coenzyme/MULTIGENE A/MULTIGENE synthetases/MULTIGENE ./.
@@86681421228/CD The/DT introduction/NN of/IN hARF4/GENE to/IN the/DT cells/NNS maintained/VBD the/DT balance/NN between/IN cytosolic/JJ and/CC membrane-associated/JJ Sec7p/GENE pools/NNS ./.
@@1628904444/CD The/DT final/JJ screening/JJ yielded/VBN a/DT clone/MULTIGENE containing/MULTIGENE a/MULTIGENE 2/MULTIGENE kilobase/MULTIGENE (/( kb/NN )/SYM insert/NN ./.
@@83555393072/CD METHODS/IN :/: Twenty-two/CD patients/NNS were/VBD grouped/VBN according/VBG to/IN their/PRP etiology/NN based/VBN on/IN the/DT study/NN of/IN antiadrenal/JJ antibodies/NNS at/IN diagnosis/NN of/IN the/DT disease/NN :/: 7/CD were/VBD positive/JJ (/( autoimmune/JJ etiology/NN or/CC EAA/NN )/SYM ,/, 11/CD were/VBD negative/JJ (/( tuberculous/JJ etiology/NN or/CC EAT/GENE )/SYM and/CC in/IN four/CD serologic/JJ study/NN was/VBD not/RB available/JJ (/( undetermined/JJ etiology/NN or/CC EAI/NN )/SYM ./.
@@54126875528/CD Antidromic/NNP invasion/NN of/IN impulses/NNS and/CC recurrent/JJ collateral/JJ inhibition/NN in/IN pyramidal/JJ tract/NN neurones/NNS ./.
@@103949191200/CD Another/DT element/NN necessary/JJ for/IN augmenting/JJ the/DT amplitude/NN of/IN the/DT oscillation/NN lies/NNS between/IN -178/CD and/CC -264/CD ./.
@@9560390855/CD In/NN addition/NN to/IN restoring/JJ checkpoint/NN control/NN ,/, overexpression/NN of/IN sum1+/GENE inhibits/VBZ the/DT normal/JJ cell/NN cycle/NN response/NN to/IN osmotic/JJ stress/NN ./.
@@92930065335/CD For/IN higher/JJ expression/NN of/IN lipA/GENE in/IN S/NNP ./NNP lividans/NNS ,/, the/DT gene/NN was/VBD cloned/VBN next/JJ to/IN the/DT strong/JJ aphII/MULTIGENE promoter/MULTIGENE ./.
@@11543662144/CD Six/CD of/IN the/DT gstC'/MULTIGENE mutants/MULTIGENE ,/, primarily/RB in/IN the/DT C-terminal/NN half/NN of/IN C'/NN ,/, exhibited/VBD a/DT defect/NN in/IN the/DT ability/NN to/IN bind/NN L/MULTIGENE protein/MULTIGENE ./.
@@110002503946/CD LMP-1/GENE is/VBZ targeted/VBN to/IN the/DT plasma/NN membrane/NN ,/, where/CC it/PRP binds/VBZ TRAF/GENE ,/, TRADD/GENE ,/, and/CC JAK/MULTIGENE molecules/MULTIGENE to/IN activate/VB NF-kappaB-/NNP ,/, AP-1-/NNP ,/, and/CC STAT-dependent/NNP pathways/NNS as/IN does/VBP CD40/VBG ./.
@@22131282847/CD 2/CD ./CD
@@21646375355/CD Disruption/NNS of/IN the/DT IRA2/MULTIGENE gene/MULTIGENE resulted/VBN in/IN (/( i/NN )/SYM increased/VBN sensitivity/NN to/IN heat/NN shock/NN and/CC nitrogen/NN starvation/NN ,/, (/( ii/NN )/SYM sporulation/NN defects/NNS ,/, and/CC (/( iii/NN )/SYM suppression/NN of/IN the/DT lethality/NN of/IN the/DT cdc25/MULTIGENE mutant/MULTIGENE ./.
@@36532264326/CD A/DT careful/JJ ,/, radiolabelled/JJ tissue-distribution/NN study/NN is/VBZ warranted/VBN to/IN elucidate/VB the/DT complicated/VBN metabolic/JJ fate/NN of/IN perhexiline/NN ./.
@@76355725323/CD CIITA/MULTIGENE mRNA/MULTIGENE is/VBZ normally/RB inducible/JJ by/IN IFN-gamma/NN in/IN class/MULTIGENE II/MULTIGENE non-inducible/JJ ,/, RB-defective/NNP lines/NNS ,/, and/CC in/IN one/PRP line/NN ,/, re-expression/NN of/IN RB/GENE has/VBZ no/DT effect/NN on/IN CIITA/MULTIGENE mRNA/MULTIGENE induction/NN levels/NNS ./.
@@103504546172/CD MutY/GENE is/VBZ an/DT adenine-DNA/MULTIGENE glycosylase/MULTIGENE with/IN specificity/NN for/IN mismatches/NNS involving/VBG 8-oxoguanine/CD (/( oG/CD ./CD A/CD )/SYM or/CC guanine/NN (/( G/NN ./NN A/NN )/SYM ./.
@@13246391956/CD Susceptibilities/NNS of/IN 540/CD anaerobic/JJ gram-negative/JJ bacilli/NNS to/IN amoxicillin/NN ,/, amoxicillin-BRL/JJ 42715/CD ,/, amoxicillin-clavulanate/NN ,/, temafloxacin/NN ,/, and/CC clindamycin/NN ./.
@@112743683141/CD This/DT effect/NN was/VBD observed/VBN in/IN the/DT absence/NN of/IN de/FW novo/FW protein/NN synthesis/NN and/CC was/VBD independent/NN of/IN histone/MULTIGENE deacetylase/MULTIGENE activity/NN ./.
@@104881482497/CD NF-kappaB/GENE plays/VBP a/DT critical/JJ role/NN in/IN activation/NN of/IN HIV-1/MULTIGENE gene/MULTIGENE expression/NN by/IN cytokines/NNS and/CC other/DT stimuli/NNS ,/, but/CC the/DT signal/JJ transduction/NN pathways/NNS that/WDT regulate/VBP the/DT switch/NN from/IN latent/JJ to/IN productive/JJ infection/NN have/NN not/RB been/VBN defined/VBN ./.
@@23628038351/CD PCR-derived/MULTIGENE fragments/MULTIGENE were/VBD used/VBN as/IN probes/NNS for/IN the/DT isolation/NN of/IN the/DT U3/MULTIGENE snRNA/MULTIGENE genes/MULTIGENE from/IN a/DT genomic/JJ library/NN of/IN Arabidopsis/NN ./.
@@111961915260/CD Thus/RB ,/, in/IN T47D/DT breast/NN carcinoma/NN cells/NNS ,/, IL-6/NEWGENE acts/NNS in/IN synergy/NN with/IN EGF/MULTIGENE receptor/MULTIGENE autocrine/JJ activity/NN to/IN signal/JJ through/RB the/DT MAPK/GENE //GENE PI3K/GENE pathways/NNS ./.
@@7509472856/CD CONCLUSION/IN :/: This/DT study/NN documents/VBZ that/DT regression/NN of/IN choroidal/JJ neovascularization/NN that/WDT occurred/VBD with/IN alpha/MULTIGENE interferon/MULTIGENE treatment/NN was/VBD minimal/JJ ./.
@@69355146712/CD The/DT Authors/NNS have/NN proposed/VBN to/IN develop/VB this/DT research/NN employing/VBG a/DT preparation/NN containing/JJ exclusively/RB a/DT cortisonic/NN ,/, the/DT desametazone/NN ,/, in/IN order/NN to/IN evaluate/VB the/DT alterations/NNS of/IN the/DT dentinogenesis/NN to/IN be/VB attributed/VBN to/IN such/JJ component/NN ./.
@@90033115858/CD A/DT 5/CD ./CD 3-kb/CD DNA/NN fragment/NN ,/, which/WDT included/VBD the/DT entire/JJ structural/MULTIGENE porin/MULTIGENE gene/MULTIGENE (/( named/VBN porCa/NN )/SYM and/CC its/PRP flanking/JJ regions/NNS ,/, was/VBD identified/VBN ./.
@@23209991782/CD The/DT procedure/NN has/VBZ been/VBN applied/VBN to/IN three/CD materials/NNS :/: particle/NN board/NN with/IN carpet/NN ;/: gypsum/NN board/NN with/IN wallpaper/NN ;/: and/CC plywood/NN with/IN polyurethane/NN lacquer/NN ,/, for/IN which/WDT the/DT steady-state/JJ emission/NN factors/NNS (/( mg/NN m-2/NN h-1/NN )/SYM of/IN several/DT compounds/NNS are/VBP given/VBP ./.
@@83862798535/CD The/DT transactivation/NN function/NN of/IN EBNA2/GENE was/VBD also/RB observed/VBN in/IN the/DT HeLa/JJ epithelial/JJ cell/NN line/NN ,/, which/WDT suggests/VBZ that/DT EBV/NN and/CC HIV-1/NNP infection/NN of/IN non-B/NNP cells/NNS may/MD result/VB in/IN HIV-1/MULTIGENE promoter/MULTIGENE activation/NN ./.
@@86845227989/CD Immunofluorescence/NNS microscopy/NN revealed/VBD extensive/JJ deposition/NN of/IN such/JJ extracellular/JJ matrices/NNS as/IN type/MULTIGENE IV/MULTIGENE collagen/MULTIGENE and/CC laminin/NN in/IN the/DT vascular/JJ wall/NN ./.
@@85063179359/CD Members/NNS of/IN the/DT C/MULTIGENE //MULTIGENE EBP/MULTIGENE family/MULTIGENE of/IN basic-leucine/MULTIGENE zipper/MULTIGENE (/( bZip/NN )/SYM transcription/NN factors/NNS form/NN heterodimers/NNS and/CC bind/VB to/IN the/DT CAAT/MULTIGENE box/MULTIGENE and/CC other/DT sequence-related/MULTIGENE enhancer/MULTIGENE motifs/MULTIGENE ./.
@@117877462276/CD Vitrectomy/GENE and/CC removal/NN of/IN retained/VBN lens/NN fragments/NNS restores/VBZ good/JJ visual/JJ acuity/NN and/CC reduces/VBZ secondary/JJ glaucoma/NN in/IN the/DT majority/NN of/IN patients/NNS ./.
@@36299748850/CD Comparison/NNS of/IN the/DT amino/JJ acid/NN sequence/NN of/IN the/DT M/MULTIGENE RNA/MULTIGENE product/MULTIGENE of/IN Uukuniemi/NNP virus/NN with/IN that/DT of/IN Punta/NNP Toro/NNP and/CC Rift/GENE Valley/NNP fever/NN viruses/NNS showed/VBN in/IN both/DT cases/VBZ a/DT weak/JJ homology/NN that/WDT was/VBD more/RB pronounced/VBN for/IN the/DT proteins/NNS located/VBN at/IN the/DT COOH-terminal/NN end/NN of/IN the/DT precursor/NN ./.
@@72059677031/CD Adverse/JJ reaction/NN of/IN the/DT apparently/RB healthy/JJ partner/NN in/IN response/NN to/IN improvement/NN in/IN the/DT overtly/RB dysfunctional/JJ partner/NN ./.
@@75585832280/CD Our/PRP study/NN was/VBD addressed/VBN to/IN the/DT synthesis/NN of/IN some/DT derivatives/NNS of/IN this/DT sequence/NN in/IN order/NN to/IN obtain/VB both/DT peptide/NN substrates/NNS suitable/JJ for/IN the/DT detection/NN of/IN the/DT Src-like/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE activity/NN and/CC active/JJ site-directed/MULTIGENE inhibitors/MULTIGENE specific/JJ for/IN this/DT class/NN of/IN enzymes/NNS ./.
@@97352868569/CD The/DT defect/NN in/IN these/DT proteins/NNS was/VBD also/RB uniformly/RB suppressed/VBN by/IN either/DT Mn2+/NN ,/, or/CC the/DT Mu/MULTIGENE B/MULTIGENE protein/MULTIGENE in/IN the/DT presence/NN of/IN ATP/NN and/CC target/NN DNA/NN ./.
@@10196597139/CD As/IN such/JJ the/DT findings/NNS support/NN existing/JJ studies/NNS that/WDT have/VBP identified/VBN given/VBP social/JJ characteristics/NNS of/IN drink/NN drivers/NNS ./.
@@7860208426/CD We/PRP have/VBP measured/VBN the/DT release/NN of/IN interleukin-1/MULTIGENE beta/MULTIGENE (/( IL-1/CONTEXTGENE )/SYM and/CC tumour/NN necrosis/MULTIGENE factor-alpha/MULTIGENE (/( TNF/CONTEXTGENE )/SYM by/IN unstimulated/JJ monocytes/NNS and/CC monocytes/NNS stimulated/VBN with/IN lipopolysaccharide/NN (/( LPS/NN )/SYM isolated/VBN from/IN the/DT peripheral/JJ blood/NN of/IN two/JJ patients/NNS with/IN acute/JJ poststreptococcal/JJ glomerulonephritis/NN (/( AGN/NNP )/SYM and/CC 16/CD healthy/JJ controls/NNS ./.
@@104007858606/CD SM/NN is/VBZ also/RB shown/VBP to/IN be/VB associated/VBN in/IN vivo/NN with/IN other/DT components/NNS of/IN the/DT CRM/MULTIGENE 1/MULTIGENE export/NN pathway/NN ,/, including/JJ the/DT small/MULTIGENE GTPase/MULTIGENE Ran/MULTIGENE and/CC the/DT nucleoporin/NNP CAN/NNP //NNP Nup214/NNP ./.
@@110272896767/CD As/IN a/DT result/NN ,/, we/PRP have/VBP defined/VBN two/JJ arginine-rich/JJ motifs/NNS (/( ARM1/GENE and/CC ARM2/GENE )/SYM that/WDT mediate/VBP the/DT RNA/NN binding/JJ activity/NN of/IN SU/NN (/NN S/NN )/NN ./.
@@58900935821/CD Study/NNP on/IN micromelias/NNS in/IN the/DT mouse/NN fetus/NN caused/VBN by/IN x-radiation/NN ,/, hypoxia/NN ,/, trypan/JJ blue/JJ injection/NN of/IN hypervitaminosis-A/GENE upon/IN mother/NN animals/NNS during/IN pregnancy/NN ./.
@@99838719980/CD Raman/JJ investigation/NN of/IN YBa2-xLaxCu3O7/GENE ceramics/NN ./.
@@81692014113/CD Therefore/RB ,/, the/DT amino-terminal/MULTIGENE sequence/MULTIGENE of/IN the/DT purified/VBN carA/MULTIGENE product/MULTIGENE is/VBZ identical/JJ to/IN that/DT derived/VBD from/IN the/DT nucleotide/NN sequence/NN in/IN both/DT organisms/NNS ,/, P/NNP ./NNP stutzeri/NN having/VBG four/CD additional/JJ amino/JJ acids/NNS ./.
@@81919108166/CD San/NNP Martin's/NNP psychological/JJ traits/NNS coupled/VBN to/IN his/PRP work/NN with/IN masonic/JJ lodges/NNS that/WDT allowed/VBD him/PRP to/IN display/NN his/PRP abilities/NNS as/IN strategist/NN and/CC political/JJ ruler/NN ./.
@@104809377457/CD A/DT novel/JJ Drosophila/MULTIGENE A/MULTIGENE kinase/MULTIGENE anchor/MULTIGENE protein/MULTIGENE ,/, Drosophila/MULTIGENE A/MULTIGENE kinase/MULTIGENE anchor/MULTIGENE protein/MULTIGENE 200/MULTIGENE (/( DAKAP200/CONTEXTGENE )/SYM ,/, is/VBZ predicted/VBN to/IN be/VB involved/VBN in/IN routing/VBG ,/, mediating/JJ ,/, and/CC integrating/JJ signals/NNS carried/VBN by/IN cAMP/NN ,/, Ca/NN (/NN 2+/NN )/NN ,/, and/CC diacylglycerol/NN (/( Li/NN ,/, Z/NNP ./NNP ,/, Rossi/NNP ,/, E/NNP ./NNP
@@17262113290/CD These/DT risk/NN factors/NNS can/MD be/VB divided/VBN into/IN 2/CD groups/NNS :/: local/JJ vessel/NN wall-related/MULTIGENE factors/MULTIGENE ,/, and/CC local/JJ (/( focal/JJ action/NN )/SYM systemic/JJ factors/NNS ./.
@@33328484012/CD Hand-held/NNP ,/, continuous-wave/JJ Doppler/NN probes/NNS ,/, coupled/VBN with/IN sound/NN spectral/JJ analysis/NN ,/, can/MD successfully/RB predict/VB carotid/JJ artery/NN stenosis/NN ./.
@@113589582780/CD Expression/NNS of/IN human/MULTIGENE RACK1/MULTIGENE efficiently/RB relieves/VBZ E1A-mediated/JJ growth/NN inhibition/NN in/IN HF7c/NNP and/CC protects/VBZ human/JJ tumor/NN cells/NNS from/IN E1A-induced/JJ apoptosis/NN ./.
@@107131762432/CD D-cyclin-cdk/GENE activity/NN is/VBZ required/VBN for/IN Rb/NN phosphorylation/NN in/IN v-Jun-transformed/JJ cells/NNS ,/, since/IN ectopic/JJ expression/NN of/IN the/DT cdk4-/NEWGENE and/CC cdk6-specific/JJ inhibitor/NN p16/NN (/NN INK4A/NN )/NN inhibits/VBZ both/DT DNA/NN synthesis/NN and/CC cell/NN proliferation/NN ./.
@@8223425626/CD The/DT yeast/MULTIGENE SSS1/MULTIGENE gene/MULTIGENE is/VBZ essential/JJ for/IN secretory/JJ protein/NN translocation/NN and/CC encodes/VBZ a/DT conserved/VBN protein/NN of/IN the/DT endoplasmic/JJ reticulum/NN ./.
@@61850145604/CD Intraoperatively/RB the/DT complement/MULTIGENE factor/MULTIGENE C3c/MULTIGENE decreased/VBD by/IN 20%/CD ,/, while/CC alpha/MULTIGENE 1-antitrypsin/MULTIGENE showed/VBD postoperatively/RB an/DT increase/NN by/IN 30%/CD ./.
@@106062452895/CD Overexpression/NNS of/IN CDP/NNP //NNP cut/NNP in/IN ROS/NN 17/CD //CD 2/CD ./CD 8/CD osteosarcoma/NN cells/NNS results/NNS in/IN repression/NN of/IN OC/MULTIGENE promoter/MULTIGENE activity/NN ;/: this/DT repression/NN is/VBZ abrogated/VBN by/IN mutating/JJ OC/NN box/NN I/NNP ./NNP
@@72565437068/CD In/NN this/DT study/NN ,/, the/DT general/JJ clinical/JJ criteria/NNS for/IN inhalation/NN injury--presence/NN of/IN facial/JJ or/CC oropharyngeal/JJ burns/NNS ,/, carboxyhemoglobin/NEWGENE levels/NNS ,/, carbonaceous/JJ sputum/NN ,/, or/CC closed/JJ space/NN injury--did/JJ not/RB differentiate/VB patients/NNS with/IN airway/NN injury/NN only/RB from/IN those/DT with/IN parenchymal/JJ injury/NN ./.
@@17010885912/CD Co-existence/NNS of/IN these/DT regulatory/JJ elements/NNS with/IN other/DT elements/NNS ,/, such/JJ as/IN the/DT AP-2/MULTIGENE element/MULTIGENE or/CC CCAAT/MULTIGENE box/MULTIGENE ,/, was/VBD also/RB found/VB ./.
@@108043794409/CD Update/NNP on/IN maternal-fetal/JJ infections/NNS by/IN hepatitis/MULTIGENE C/MULTIGENE ,/, HIV/CONTEXTGENE and/CC cytomegalovirus/NN ./.
@@32512109083/CD Many/JJ children/NNS with/IN BGC/GENE are/VBP delayed/JJ in/IN their/PRP development/NN ,/, but/CC calcifications/NNS are/VBP not/RB directly/RB related/VBN to/IN specific/JJ forms/NNS of/IN neurologic/JJ dysfunction/NN ./.
@@10392266260/CD The/DT presence/NN of/IN cutaneous/JJ xanthomas/NNS with/IN normal/JJ serum/JJ lipid/NN levels/NNS is/VBZ due/NN to/IN the/DT antibetalipoproteic/JJ activity/NN of/IN the/DT monoclonal/JJ immunoglobulin/NN ./.
@@103580319375/CD In/NN addition/NN ,/, these/DT cells/NNS contained/VBN one/PRP ,/, two/JJ ,/, or/CC multiple/JJ nuclei/NNS indicative/NN of/IN a/DT G2/NN //NN M/NN delay/NN in/IN nuclear/JJ division/NN and/CC also/RB a/DT defect/NN in/IN cytokinesis/NN and/DT //DT or/DT cell/NN separation/NN ./.
@@108879211482/CD CONCLUSIONS/IN :/: There/EX is/VBZ a/DT relation/NN in/IN the/DT topography/NN of/IN some/DT visual/JJ field/NN areas/NNS assessed/VBN by/IN SWAP/NN and/CC the/DT inferotemporal/JJ neuroretinal/JJ rim/NN area/NN ,/, which/WDT may/MD play/VB a/DT role/NN in/IN the/DT diagnosis/NN and/CC follow-up/NN of/IN suspected/VBN glaucoma/NN ./.
@@9369451630/CD Mutational/JJ analysis/NN shows/VBZ that/IN both/PDT an/DT AP-1/GENE like/JJ sequence/NN (/( -294/NN //NN -285/NN ,/, TGAATCATCA/GENE )/SYM and/CC an/DT A/MULTIGENE //MULTIGENE T-rich/MULTIGENE myocyte/MULTIGENE enhancer/MULTIGENE factor/MULTIGENE (/( MEF/GENE )/NN -2/NN like/JJ sequence/NN (/( -310/NN //NN -298/NN ,/, TTAAAAATAAAAA/GENE )/SYM in/IN the/DT 33-bp/JJ region/NN are/VBP necessary/JJ for/IN the/DT OP-1/GENE effect/NN ./.
@@7542698305/CD Sources/NNS of/IN noise/NN in/IN these/DT signals/NNS were/VBD evaluated/VBN in/IN preparations/NNS stained/VBN with/IN the/DT potentiometric/JJ probe/NN RH-414/GENE ./.
@@36155504292/CD The/DT effects/NNS of/IN several/DT opioid/JJ agonists/NNS and/CC the/DT opioid/MULTIGENE antagonist/MULTIGENE naloxone/NN were/VBD examined/VBN in/IN rats/NNS responding/VBG under/IN a/DT fixed-consecutive-number/JJ (/( FCN/NNP )/SYM schedule/NN ./.
@@102352658356/CD In/NN one/PRP mechanism/NN ,/, a/DT specialized/JJ ubiquitin-dependent/JJ proteolytic/JJ system/NN (/( called/VBN the/DT APC-dependent/NNP proteolysis/NN machinery/NN )/SYM degrades/VBZ the/DT mitotic/JJ (/( Clb/NN )/SYM cyclin/MULTIGENE subunit/MULTIGENE ./.
@@89174351443/CD An/DT essential/JJ role/NN of/IN c-Jun/GENE and/CC c-Fos/GENE in/IN basal/JJ and/CC PMA-stimulated/JJ transcription/NN of/IN the/DT PAI-1/MULTIGENE gene/MULTIGENE is/VBZ demonstrated/VBN by/IN our/PRP finding/NN that/DT antisense/NN c-jun/GENE and/CC c-fos/MULTIGENE oligodeoxynucleotides/MULTIGENE both/DT strongly/RB reduced/VBN basal/JJ and/CC PMA-stimulated/JJ PAI-1/GENE synthesis/NN ./.
@@81448529620/CD The/DT responses/NNS of/IN the/DT "stress/NN hormones"/NN cortisol/NN ,/, 11-deoxycortisol/JJ ,/, ACTH/NN ,/, vasopressin/NN (/( AVP/NN )/SYM ,/, and/CC corticotropin/MULTIGENE releasing/MULTIGENE factor/MULTIGENE (/( CRF/CONTEXTGENE )/SYM were/VBD studied/VBN in/IN 6/CD normal/JJ males/NNS in/IN response/NN to/IN acute/JJ cortisol/NN deficiency/NN induced/VBN by/IN the/DT 11-beta-hydroxylase/MULTIGENE inhibitor/MULTIGENE ,/, metyrapone/NN ./.
@@79518747930/CD Cestode/NNS invasion/NN in/IN irradiated/JJ host/NN organism/NN increases/VBZ the/DT negative/JJ effect/NN of/IN ionizing/JJ radiation/NN on/IN the/DT hamster/NN immune/JJ system/NN ./.
@@87548277412/CD Hoeben/NNP ,/, F/NNP ./NNP J/NNP ./.
@@86014908850/CD These/DT animals/NNS were/VBD viable/JJ and/CC fertile/JJ ./.
@@117528213628/CD CONCLUSION/IN :/: MMF/GENE (/( 2-3/CD g/NN //NN day/NN )/SYM is/VBZ unable/JJ to/IN control/NN the/DT signs/NNS of/IN mucocutaneous/JJ Adamantiades-Behcet's/JJ disease/NN ./.
@@6259220690/CD Five/CD experiments/NNS examined/VBD the/DT influence/NN of/IN opiate/JJ antagonists/NNS on/IN both/PDT the/DT short-term/JJ analgesic/JJ reaction/NN resulting/JJ 30/CD min/NN after/IN exposure/NN to/IN inescapable/JJ shock/NN and/CC the/DT long-term/JJ analgesic/JJ reaction/NN resulting/JJ after/IN reexposure/NN to/IN shock/MULTIGENE 24/MULTIGENE hr/NN after/IN inescapable/JJ shock/NN exposure/NN ./.
@@91728129122/CD It/PRP is/VBZ concluded/VBN that/DT fludarabine/NN is/VBZ a/DT highly/RB useful/JJ agent/NN in/IN CLL/NN ./.
@@7483285910/CD These/DT HPV16/MULTIGENE E6/MULTIGENE //MULTIGENE E7/MULTIGENE cDNAs/MULTIGENE were/VBD cloned/VBN under/IN the/DT SV40/MULTIGENE enhancer/MULTIGENE //MULTIGENE promoter/MULTIGENE and/CC the/DT MMTV/MULTIGENE LTR/MULTIGENE to/IN examine/VB the/DT activities/NNS of/IN ras-collaborative/JJ transformation/NN and/CC induction/NN of/IN cellular/JJ DNA/NN synthesis/NN ,/, both/DT of/IN which/WDT depend/VBP on/IN the/DT E7/MULTIGENE gene/MULTIGENE product/MULTIGENE ./.
@@92120595682/CD However/RB ,/, by/IN immobilized/JJ metal/NN affinity/NN chromatography/NN assay/NN ,/, self-association/NN of/IN PR-A/GENE was/VBD 3/CD ./CD 5-fold/CD more/RB efficient/JJ than/IN that/DT of/IN either/DT the/DT DhLBD/NNP or/CC hLBD/MULTIGENE constructs/MULTIGENE ./.
@@81157448088/CD The/DT GafChromic/NN method/NN has/VBZ proven/VBP to/IN be/VB an/DT accurate/JJ and/CC rapid/JJ method/NN of/IN analysis/NN and/CC could/MD be/VB easily/RB incorporated/VBN into/IN a/DT quality/JJ assurance/NN program/NN ./.
@@100921325217/CD High-level/JJ gains/NNS (/( HLGs/NNP )/SYM indicative/NN of/IN gene/NN amplifications/NNS were/VBD identified/VBN at/IN 11q13/CD in/IN two/CD cases/NNS ,/, and/CC in/IN one/PRP case/NN each/DT at/IN 2q33-34/JJ ,/, 3q25-29/CD ,/, 5p15/CONTEXTGENE ./CONTEXTGENE 1-15/CONTEXTGENE ./CONTEXTGENE 2/CONTEXTGENE ,/, 7q21-22/GENE ,/, 11p11/GENE ./GENE 2/GENE ,/, 12p11/GENE ./GENE 2-12/GENE ,/, and/CC 13q34/CONTEXTGENE ./.
@@55551498140/CD Sensitive/JJ fluorometric/JJ method/NN of/IN determining/MULTIGENE SH-/MULTIGENE and/CC S-S-groups/NNP when/CC jointly/RB present/VB ./.
@@8429019892/CD The/DT DNase/MULTIGENE I/MULTIGENE footprint/NN extended/VBN 5'/CD in/IN the/DT silencer/NN region/NN to/IN include/VB an/DT inverted/JJ repeat/NN of/IN a/DT six-nucleotide/MULTIGENE motif/MULTIGENE (/( epsilon/NN -267/CD to/IN -278/CD bp/NN )/SYM which/WDT shares/VBP 5/CD of/IN 6/CD bases/NNS with/IN the/DT GATA-1/GENE consensus/NN sequence/NN ./.
@@39974678000/CD The/DT effect/NN of/IN the/DT opiate/MULTIGENE antagonist/MULTIGENE naloxone/NN was/VBD evaluated/VBN in/IN 11/CD unselected/JJ patients/NNS with/IN cerebral/JJ ischemia/NN ./.
@@80880228065/CD Thus/RB ,/, in/IN stress-induced/JJ arrhythmic/JJ disease/NN as/RB well/VB as/IN in/IN ischemic/JJ heart/NN disease/NN ,/, the/DT main/JJ pathogenetic/JJ links/NNS are/VBP outside/RB the/DT heart/NN ,/, but/CC they/PRP differ/VBP from/IN those/DT observed/VBN in/IN ischemia/NN ./.
@@107470991663/CD Extracellular-regulated/MULTIGENE kinase/MULTIGENE (/( ERK/CONTEXTGENE )/SYM activation/NN and/CC molecular/JJ coupling/NN of/IN the/DT adaptor/MULTIGENE proteins/MULTIGENE p130/MULTIGENE Crk-associated/JJ substrate/NN (/( CAS/IN )/SYM and/CC c-CrkII/GENE (/( Crk/CONTEXTGENE )/SYM represent/VB two/JJ distinct/JJ pathways/NNS that/WDT induce/VBP cell/NN invasion/NN and/CC protect/VB cells/NNS from/IN apoptosis/NN in/IN a/DT three-dimensional/JJ collagen/NN matrix/NN ./.
@@106275329748/CD We/PRP demonstrate/VBP that/IN both/DT R/NN and/CC Z/NN activate/VB the/DT cellular/JJ stress/MULTIGENE mitogen-activated/MULTIGENE protein/MULTIGENE (/( MAP/NN )/SYM kinases/NNS ,/, p38/GENE and/CC JNK/GENE ,/, resulting/VBG in/IN phosphorylation/NN (/( and/CC activation/NN )/SYM of/IN the/DT cellular/JJ transcription/MULTIGENE factor/MULTIGENE ATF2/MULTIGENE ./.
@@108149891440/CD Hepatitis/NN C/NN virus/NN infection/NN and/CC lymphoproliferative/JJ diseases/NNS in/IN France/NN :/: a/DT national/JJ study/NN ./.
@@98195076439/CD In/NN this/DT study/NN ,/, rabbits/NNS were/VBD used/VBN to/IN evaluate/VB the/DT sutured/VBN wound/JJ reaction/NN with/IN Dexon/NN or/CC nylon/NN in/IN the/DT conjunctival/JJ flap/NN 1/NN ,/, 4/CD ,/, 7/CD ,/, 14/CD and/CC 28/CD days/NNS after/IN trabeculectomy/NN surgery/NN with/IN or/CC without/IN the/DT use/NN of/IN mitomycin-C/NN ./.
@@90083019780/CD Mutant/NNP enzyme/NN forms/NNS were/VBD prepared/VBN to/IN eliminate/VB the/DT initial/JJ autoprocessing/NN site/NN and/CC thus/RB form/VB an/DT active/JJ single-chain/MULTIGENE protein/MULTIGENE for/IN structure-function/NN studies/NNS ./.
@@112793851108/CD A/DT new/JJ echocardiographic/JJ technique/NN is/VBZ described/VBN with/IN a/DT conventional/JJ M/NN mode/NN ,/, digitalised/JJ 2D/JJ and/CC tissular/JJ Doppler/NN which/WDT has/VBZ a/DT comparable/JJ ability/NN to/IN identify/VB the/DT anomalous/JJ pathways/NNS of/IN electric/JJ conduction/NN using/VBG a/DT non-invasive/JJ method/NN ./.
@@75114445893/CD Hepatitis/MULTIGENE C/MULTIGENE virus/NN infection/NN is/VBZ a/DT risk/NN factor/NN for/IN liver/NN failure/NN from/IN veno-occlusive/JJ disease/NN after/IN bone/NN marrow/NN transplantation/NN ./.
@@115595646393/CD NB-506/GENE completely/RB inhibits/VBZ the/DT capacity/NN of/IN topoisomerase/MULTIGENE I/MULTIGENE to/IN phosphorylate/VB ,/, in/IN vitro/FW ,/, the/DT human/JJ splicing/JJ factor/NN 2/JJ //JJ alternative/JJ splicing/JJ factor/NN (/( SF2/GENE //GENE ASF/GENE )/SYM ./.
@@107816041450/CD An/DT analysis/NN of/IN synthetic/JJ peptides/NNS revealed/VBD a/DT minimal/JJ CTD/MULTIGENE sequence/MULTIGENE that/WDT is/VBZ sufficient/JJ to/IN bind/NN to/IN the/DT second/JJ Rsp5/MULTIGENE WW/MULTIGENE domain/NN (/( Rsp5/MULTIGENE WW2/MULTIGENE )/SYM in/IN vitro/FW and/CC in/IN yeast/NN two-hybrid/JJ assays/NNS ./.
@@31148293832/CD Clinical/NNP and/CC biological/JJ correlates/VBP of/IN panic/NN states/NNS ./.
@@13922774587/CD Comments/NNS are/VBP given/VBP on/IN the/DT present/NN status/NN of/IN regulations/NNS concerning/VBG water/NN in/IN swimming/JJ pools/NNS and/CC baths--1991--/NN (/NN in/NN connection/NN with/IN the/DT KOK/NN regulations--1972--and/NN the/DT Federal/JJ German/JJ standard/JJ [/NN DIN/NN ]/NN No/NN ./NN
@@81820568701/CD The/DT high/JJ degree/NN of/IN conservation/NN between/IN NQO2/GENE and/CC NQO1/MULTIGENE gene/MULTIGENE organization/NN and/CC sequence/NN confirmed/VBN that/IN NQO2/MULTIGENE gene/MULTIGENE encodes/VBZ for/IN a/DT second/JJ member/NN of/IN the/PDT NQO/MULTIGENE gene/MULTIGENE family/MULTIGENE in/IN human/NN ./.
@@77355903085/CD The/DT concentration/NN of/IN mite/NN allergen/NN was/VBD very/RB low/JJ (/( mean/JJ 0/CD ./CD 18/CD micrograms/NNS Der/NNP p/NN milligrams/NNS sieved/VBN house/JJ dust/NN )/SYM ,/, whereas/IN that/DT of/IN cat/NN allergen/NN was/VBD high/JJ in/IN homes/NNS with/IN a/DT cat/NN (/( 80/CD ./CD 8/CD micrograms/NNS Fel/NN d/NN milligrams/NNS )/SYM but/CC also/RB in/IN homes/NNS with/IN no/DT cat/NN (/( 3/CD ./CD 2/CD micrograms/NNS Fel/NN d/NN milligrams/NNS )/SYM ./.
@@75125523024/CD Joys/NNP and/CC F/NN ./NN
@@23842653036/CD These/DT results/NNS suggest/VBP an/DT increased/VBN risk/NN of/IN developing/JJ cancer/NN among/IN polyp/NN patients/NNS and/CC the/DT possibility/NN of/IN prophylactic/JJ effect/NN of/IN polypectomy/NN against/IN subsequent/JJ cancer/NN ./.
@@114649971339/CD Such/JJ knowledge/NN could/MD advance/VB diagnosis/NN and/CC treatment/NN of/IN the/DT patient/NN and/CC counseling/NN of/IN the/DT affected/VBN family/NN ./.
@@114074487459/CD Our/PRP results/NNS are/VBP reassuring/VBG and/CC we/PRP therefore/RB advise/VBP that/IN in/IN patients/NNS undergoing/VBG free/JJ jejunum/NN flap/NN reconstruction/NN of/IN the/DT hypopharyngo-esophageal/JJ tract/NN voice/NN restoration/NN should/MD be/VB attempted/VBN by/IN placing/VBG a/DT voice/NN prosthesis/NN through/RB a/DT secondary/JJ tracheo-esophageal/JJ puncture/NN and/CC providing/CC intensive/JJ speech/NN training/NN ./.
@@70042366790/CD The/DT results/NNS indicate/VBP that/IN folate/NN compounds/NNS decrease/NN formate/NN accumulation/NN after/IN methanol/NN by/IN stimulating/JJ formate/NN oxidation/NN or/CC utilization/NN and/CC suggest/VB a/DT possible/JJ use/NN for/IN folates/NNS in/IN the/DT treatment/NN of/IN certain/JJ cases/NNS of/IN human/JJ methanol/NN poisoning/VBG ./.
@@16953146417/CD Platelet/NN aggregation/NN and/CC metabolic/JJ control/NN are/VBP not/RB affected/VBN by/IN calcium/MULTIGENE antagonist/MULTIGENE treatment/NN in/IN type/NN II/NNP diabetes/NN mellitus/MD ./.
@@78657866740/CD Gene/NNP expression/NN occurs/VBZ in/IN a/DT circadian/JJ rhythm/NN and/CC induced/VBN by/IN light/NN in/IN leaves/NNS of/IN dark-adapted/JJ plants/NNS ./.
@@107641505020/CD In/NN this/DT study/NN ,/, the/DT abilities/NNS of/IN constitutive/JJ and/CC conditional/JJ forms/NNS of/IN the/DT three/CD Raf/MULTIGENE kinases/MULTIGENE to/IN abrogate/VB the/DT cytokine/NN dependency/NN of/IN FDC-P1/NNP cells/NNS were/VBD examined/VBN ./.
@@117301823678/CD There/EX was/VBD a/DT statistically/RB significant/JJ correlation/NN between/IN simultaneous/JJ weekly/JJ average/JJ pollen/NN levels/NNS in/IN Philadelphia/NN and/CC in/IN Cherry/NNP Hill/NN (/( Acer/NNP ,/, r/NN (/NN p/NN )/SYM =/SYM 0/CD ./CD 987/CD ,/, Quercus/ORG ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 645/CD ,/, Betula/ORG ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 896/CD ,/, Pinus/GENE ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 732/CD ,/, Cupressaceae/JJ ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 695/CD ,/, Poaceae/JJ ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 950/CD ,/, Ambrosia/NN ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 903/CD ,/, and/CC Rumex/NN ,/, r/NN (/NN p/NN )/NN =/SYM 0/CD ./CD 572/CD ,/, P/NN </SYM 0/NN ./NN 001/NN )/NN ./.
@@85893158564/CD Despite/IN an/DT overall/JJ survival/NN rate/NN of/IN 43%/JJ ,/, survival/NN to/IN discharge/NN varied/VBN greatly/RB (/( 0/CD to/IN 100%/CD )/SYM among/IN the/DT 24/CD diagnostic/JJ groups/NNS :/: tumor/NN lysis/NN syndrome/NN and/CC systemic/JJ lupus/NN erythematosus/NN (/( 3/CD //CD 3/CD patients/NNS each/DT ,/, 100%/CD )/SYM ,/, hemolytic/JJ uremic/JJ syndrome/NN (/( 8/CD //CD 9/CD patients/NNS ,/, 89%/CD )/SYM ./.
@@88964021437/CD Natural/MULTIGENE FL/MULTIGENE protein/MULTIGENE has/VBZ been/VBN purified/VBN from/IN a/DT stromal/JJ cell/NN line/NN and/CC shown/VBP to/IN be/VB a/DT 65/MULTIGENE kD/MULTIGENE nondisulfide-linked/MULTIGENE homodimeric/MULTIGENE glycoprotein/MULTIGENE comprised/VBN of/IN 30/MULTIGENE kD/MULTIGENE subunits/MULTIGENE ,/, each/DT containing/MULTIGENE 12/MULTIGENE kD/MULTIGENE of/IN N-/DT and/CC O-linked/JJ sugars/NNS ./.
@@65218023361/CD Scientific/NNP cooperation/NN of/IN CMEA/NN member/NN countries/NNS has/VBZ been/VBN carried/VBN out/RB since/IN 1974/CD under/IN the/DT sponsorship/NN of/IN the/DT Cancer/NNP Research/NNP Institute/NNP ,/, Slovak/JJ Academy/NNP of/IN Sciences/NNPS (/( Czechoslovakia/NN )/SYM within/IN the/DT framework/NN of/IN CMEA/NN ./.
@@93937179802/CD These/DT observations/NNS provide/VBP strong/JJ support/NN for/IN the/DT idea/NN that/DT expression/NN of/IN mutant/JJ tRNA/NN can/MD confer/VB a/DT mutator/MULTIGENE phenotype/MULTIGENE ,/, including/JJ the/DT UVM-constitutive/NNP phenotype/NN observed/VBN in/IN mutA/NN and/CC mutC/NN cells/NNS ./.
@@9324720365/CD Prior/RB to/IN meals/NNS 2/CD to/IN 3/CD times/NNS daily/JJ ,/, 1-2/CD tablespoons/NNS of/IN Alzoon/GENE are/VBP recommended/VBN ./.
@@80413623907/CD Molecular/NNP cloning/NN of/IN a/DT cysteine/MULTIGENE synthase/MULTIGENE cDNA/MULTIGENE from/IN Citrullus/NNP vulgaris/JJ (/( watermelon/NN )/SYM by/IN genetic/JJ complementation/NN in/IN an/DT Escherichia/NN coli/JJ Cys-/NNP auxotroph/NN ./.
@@104360168388/CD Gel/NNP filtration/NN and/CC co-immunoprecipitation/NN analyses/NNS reveal/VBP that/IN Mad2p/GENE tightly/RB associates/VBP with/IN another/DT spindle/NN checkpoint/NN component/NN ,/, Mad1p/GENE ./.
@@29719573690/CD The/DT absorbable/JJ perisplenic/JJ mesh/NN is/VBZ an/DT important/JJ improvement/NN ,/, and/CC in/IN some/DT cases/NNS it/PRP may/MD replace/VB other/DT techniques/NNS for/IN arresting/JJ splenic/JJ bleeding/NN ./.
@@88236469251/CD Administration/NNP of/IN adrenaline/NN resulted/VBN in/IN a/DT large/JJ overestimation/NN of/IN the/DT SaO2/GENE in/IN 6/CD of/IN the/DT 7/CD measurements/NNS ./.
@@7871754785/CD This/DT finding/NN represents/VBZ both/PDT a/DT potentially/RB important/JJ mechanism/NN by/IN which/WDT HPV/MULTIGENE gene/MULTIGENE expression/NN can/MD be/VB regulated/VBN and/CC an/DT interesting/JJ model/NN for/IN the/DT study/NN of/IN transcriptional/JJ cooperativity/NN ./.
@@78883062342/CD Expression/NNS of/IN h6/CD ./CD 1/CD in/IN COS-1/NNP cells/NNS led/VBN to/IN the/DT production/NN of/IN a/DT typical/JJ type/MULTIGENE IV/MULTIGENE PDE/NN activity/NN in/IN that/DT cAMP/NN ,/, but/CC not/RB cGMP/NN ,/, served/VBN as/IN substrate/NN and/CC its/PRP activity/NN was/VBD insensitive/JJ to/IN either/DT Ca2+/NNP //NNP CaM/NNP or/CC cGMP/NN but/CC was/VBD inhibited/VBN by/IN low/JJ concentrations/NNS of/IN rolipram/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@16206109638/CD In/NN conclusion/NN ,/, to/IN study/NN and/CC overcome/VB TI/NNP region-based/JJ expression/NN problems/NNS it/PRP is/VBZ worthwhile/JJ to/IN start/NN out/RB with/IN a/DT versatile/JJ vector/NN containing/JJ exhaustive/JJ mutations/NNS in/IN the/DT periShine-Dalgarno/MULTIGENE sequences/MULTIGENE ;/: as/IN a/DT rule/NN the/DT coding/JJ MTI/MULTIGENE subregion/MULTIGENE can/MD be/VB kept/VBP unchanged/JJ ./.
@@28004171079/CD In/NN the/DT group/NN of/IN asthmatics/NNS statistically/RB significant/JJ correlation/NN was/VBD found/VBN between/IN PC20/MULTIGENE PGF2/MULTIGENE alpha/MULTIGENE and/CC histamine/NN values/NNS (/( r/JJ =/SYM 0/CD ./CD 538/CD ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@114321121312/CD PURPOSE/NNS :/: The/DT objective/NN of/IN this/DT study/NN was/VBD to/IN assess/VB first/JJ embryo/NN cleavage/NN (/( FEC/NN )/SYM 25-27/JJ h/NN after/IN intracytoplasmic/JJ sperm/NN injection/NN (/( ICSI/NN )/SYM as/IN a/DT parameter/NN for/IN the/DT embryo/NN selection/NN process/NN ./.
@@40848964771/CD The/DT recommendation/NN is/NNS made/VBP that/IN specific/JJ sub-groups/NNS of/IN attempters/NNS need/NN to/IN be/VB identified/VBN and/CC may/MD warrant/VB specialized/JJ intervention/NN strategies/NNS ./.
@@84443451707/CD The/DT deduced/VBN bovine/JJ EFIA#1/GENE amino/JJ acid/NN (/( aa/NNS )/SYM sequence/NN is/VBZ 98%/NN identical/JJ to/IN rat/NN EFIA/GENE and/CC 100%/NN identical/JJ to/IN human/MULTIGENE EFIA/MULTIGENE //MULTIGENE DbpB/MULTIGENE //MULTIGENE YB-1/MULTIGENE family/MULTIGENE member/MULTIGENE DNA-binding/MULTIGENE protein/MULTIGENE B/MULTIGENE (/( DbpB/GENE )/SYM ./.
@@89145221715/CD The/DT STE20/MULTIGENE gene/MULTIGENE ,/, encoding/VBG a/DT protein/MULTIGENE kinase/MULTIGENE required/VBN for/IN pheromone/NN signal/JJ transduction/NN ,/, has/VBZ recently/RB been/VBN identified/VBN in/IN a/DT genetic/JJ screen/NN for/IN high-gene-dosage/NN suppressors/NNS of/IN a/DT partly/RB defective/MULTIGENE G/MULTIGENE beta/MULTIGENE mutation/MULTIGENE ./.
@@27663303466/CD The/DT author/NN gives/VBZ an/DT account/NN of/IN antipsychotic/JJ ,/, analgetic/JJ ,/, myorelaxing/VBG and/CC vasodilatating/JJ effects/NNS of/IN some/DT calcium/NN antagonists/NNS ,/, and/CC their/PRP clinical/JJ application/NN is/VBZ discussed/VBN ./.
@@34361194139/CD Quantitative/JJ computed/JJ tomography/NN for/IN measuring/JJ vertebral/JJ bone/NN mineral/JJ content/NN offers/VBP high/JJ sensitivity/NN and/CC reproducibility/NN ./.
@@113990649659/CD Autoregulation/NNS enables/VBZ different/JJ pathways/NNS to/IN control/MULTIGENE CCAAT/MULTIGENE //MULTIGENE enhancer/MULTIGENE binding/MULTIGENE protein/MULTIGENE beta/MULTIGENE (/( C/MULTIGENE //MULTIGENE EBP/MULTIGENE beta/MULTIGENE )/SYM transcription/NN ./.
@@76780066725/CD Little/NN or/CC no/DT protection/NN was/VBD detected/VBN using/VBG adrenal/JJ cortex/NN ,/, adrenal/JJ medulla/NN ,/, liver/NN ,/, kidney/NN cortex/NN ,/, spleen/NN ,/, or/CC T-lymphocyte/NN total/JJ RNA/NN ./.
@@108914414719/CD Furthermore/RB ,/, a/DT pTyr317/MULTIGENE Shc/MULTIGENE phosphopeptide/NN selectively/RB recognized/VBD Grb2/GENE ,/, Sos1/GENE ,/, SHIP/GENE ,/, and/CC the/DT p85/MULTIGENE subunit/MULTIGENE of/IN phosphatidylinositol/NN 3'/CD kinase/NN from/IN mast/NN cells/NNS ,/, as/IN characterized/VBN by/IN mass/JJ spectrometry/NN ./.
@@104825169663/CD A/DT 5'/CD RNA/NN stem-loop/NN participates/VBZ in/IN the/DT transcription/NN attenuation/NN mechanism/NN that/IN controls/NNS expression/NN of/IN the/DT Bacillus/NN subtilis/JJ trpEDCFBA/MULTIGENE operon/MULTIGENE ./.
@@17218849666/CD A/DT second/JJ even/VB more/RB significant/JJ match/NN to/IN this/DT E/NNP ./NNP coli/JJ region/NN was/VBD found/VBN in/IN the/DT retroviral/MULTIGENE ribonuclease/MULTIGENE H/MULTIGENE (/( RNase/MULTIGENE H/MULTIGENE )/SYM domain/NN ,/, and/CC corresponds/VBZ precisely/RB to/IN a/DT region/NN that/WDT has/VBZ been/VBN aligned/VBN by/IN previous/JJ investigators/NNS with/IN the/DT E/NNP ./NNP coli/JJ RNase/MULTIGENE H/MULTIGENE ,/, suggesting/VBG that/IN Pol/MULTIGENE I/MULTIGENE helices/NNS O/NN and/CC P/NN are/VBP homologous/JJ to/IN helices/NNS A/DT and/CC D/NN of/IN the/DT RNase/MULTIGENE H/MULTIGENE crystal/NN structure/NN ,/, respectively/RB ./.
@@80011362301/CD Relationship/NNP of/IN CDK-activating/JJ kinase/NN and/CC RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE CTD/MULTIGENE kinase/MULTIGENE TFIIH/GENE //GENE TFIIK/GENE ./.
@@105927911499/CD In/NN conclusion/NN :/: (/( i/NN )/SYM TECRA/MULTIGENE kit/MULTIGENE is/VBZ suggested/VBN to/IN be/VB used/VBN for/IN screening/JJ SE/NN producing/JJ strains/NNS ;/: (/( ii/NN )/SYM SET-RPLA/GENE and/CC RIDASCREEN/GENE kits/NNS are/VBP suitable/JJ for/IN epidemiological/JJ investigation/NN of/IN SE/NN types/NNS ,/, but/CC the/DT lack/NN of/IN ability/NN for/IN detecting/JJ SEE/VBP ,/, long/JJ time/NN required/VBN for/IN testing/NN with/IN SET-RPLA/GENE kit/NN and/CC high/JJ background/NN when/CC using/VBG RIDASCREEN/MULTIGENE kit/MULTIGENE must/MD be/VB overcome/VB ;/: and/CC (/( iii/NN )/SYM because/IN of/IN the/DT complicated/VBN test/NN procedures/NNS and/CC the/DT lack/NN of/IN ability/NN for/IN detecting/JJ SEE/VBP ,/, the/DT practicality/NN of/IN SET-EIA/MULTIGENE kit/MULTIGENE in/IN screening/JJ and/CC epidemiological/JJ research/NN purposes/NNS is/VBZ low/JJ ./.
@@10211919147/CD Significantly/RB greater/JJR improvement/NN (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM in/IN the/DT sertraline/NN group/NN first/NN became/VBD apparent/JJ by/IN the/DT end/NN of/IN week/NN 3/CD on/IN the/DT Y-BOCS/NNP and/CC the/DT CGI/NNP Improvement/NNP scale/NN ,/, and/CC by/IN the/DT end/NN of/IN weeks/NNS 6/CD and/CC 8/CD ,/, respectively/RB ,/, on/IN the/DT NIMH/NN and/CC CGI/DT Severity/NN scale/NN ./.
@@111086162743/CD Young/NN fish/NN (/( Oreochromis/NNP mossambicus/NN )/SYM were/VBD exposed/VBN to/IN microgravity/NN (/( mug/NN )/SYM for/IN 9/CD to/IN 10/CD days/NNS during/IN space/NN missions/NNS STS-55/GENE and/CC STS-84/GENE ,/, or/CC to/IN hypergravity/NN (/( hg/NN )/SYM for/IN 9/CD days/NNS ./.
@@108879129676/CD Both/PDT the/DT MVBF/GENE and/CC the/DT maximum/JJ EMG/JJ activity/NN in/IN the/DT right/JJ masseter/NN and/CC the/DT left/JJ anterior/JJ temporalis/JJ muscles/NNS were/VBD significantly/RB decreased/VBN during/IN muscle/NN pain/NN when/CC the/DT subjects/NNS bit/NN on/IN the/DT painful/JJ side/NN ./.
@@103813776883/CD Molecular/NNP cloning/NN of/IN rat/NN SH2-containing/JJ inositol/NN phosphatase/MULTIGENE 2/MULTIGENE (/( SHIP2/GENE )/SYM and/CC its/PRP role/NN in/IN the/DT regulation/NN of/IN insulin/NN signaling/JJ ./.
@@96948605286/CD The/DT C-terminal/MULTIGENE region/MULTIGENE contains/VBZ the/DT PTP-like/GENE domain/NN ,/, whereas/IN the/DT N-terminal/MULTIGENE region/MULTIGENE shows/VBZ no/DT homology/NN to/IN any/DT known/VBP mammalian/JJ protein/NN ./.
@@10578528405/CD It/PRP may/MD be/VB dependent/JJ on/IN location/NN of/IN a/DT focus/NN (/( according/VBG to/IN EEG/NN )/SYM as/RB well/VB as/IN on/IN the/DT character/NN and/CC manifestation/NN of/IN the/DT accompanying/JJ neuropsychologic/JJ symptomatology/NN ./.
@@19638582587/CD Selective/JJ activation/NN of/IN adrenaline/NN secretion/NN by/IN the/DT rat/NN adrenal/JJ in/IN neuroglycopenia/NN detected/VBD via/NN microdialysis/NN ./.
@@104537215792/CD A/DT limited/VBN sampling/JJ strategy/NN was/VBD used/VBN based/VBN on/IN a/DT bayesian/JJ parameter/NN estimation/NN algorithm/NN that/WDT is/VBZ part/NN of/IN the/DT ADAPT/MULTIGENE II/MULTIGENE software/NN package/NN ./.
@@112389474470/CD A/DT single/JJ base/NN change/NN (/( A8G/NNP )/SYM in/IN either/DT sequence/NN reduces/VBZ hnRNP/MULTIGENE A2/MULTIGENE binding/JJ and/CC ,/, in/IN the/DT case/NN of/IN A2RE-2/GENE ,/, inhibits/VBZ RNA/NN transport/NN ./.
@@27742718862/CD Halothane/CHEM is/VBZ metabolized/VBN by/IN an/DT oxidative/JJ pathway/NN to/IN stable/JJ ,/, nonvolatile/JJ end/JJ products/NNS ,/, trifluoroacetic/JJ acid/NN (/( TFAA/GENE )/SYM and/CC bromide/NN (/( Br-/IN )/SYM ,/, and/CC by/IN reductive/JJ pathways/NNS to/IN Br-and/NNP inorganic/JJ fluoride/NN (/( F-/DT )/SYM ./.
@@76263783149/CD Hepatitis/MULTIGENE B/MULTIGENE vaccine/NN :/: still/RB has/VBZ its/PRP problems/NNS ./.
@@94482682828/CD We/PRP have/VBP cloned/VBN a/DT kinase/NN ,/, Nlk/NNP ,/, that/WDT is/VBZ a/DT murine/MULTIGENE homolog/MULTIGENE of/IN the/DT Drosophila/MULTIGENE nemo/MULTIGENE (/( nmo/NN )/SYM gene/NN ./.
@@83556964355/CD The/DT UV/NN induction/NN of/IN c-jun/GENE is/VBZ mediated/JJ by/IN two/JJ UV/MULTIGENE response/MULTIGENE elements/MULTIGENE consisting/VBG of/IN AP-1-like/MULTIGENE sequences/MULTIGENE within/IN its/PRP 5'/CD control/NN region/NN ./.
@@107066883521/CD We/PRP found/VBP that/IN TCR/NEWGENE signaling/NN induces/VBZ AP-1/GENE binding/JJ to/IN this/DT site/NN and/CC regulates/VBZ the/DT fasl/MULTIGENE promoter/MULTIGENE function/NN in/IN a/DT fashion/NN dependent/JJ on/IN NF-kappaB/GENE binding/JJ ./.
@@96931342308/CD Specifically/RB ,/, I/PRP use/NN molecular/JJ markers/NNS that/WDT identify/VBP particular/JJ neuroectodermal/JJ domains/NNS ,/, all/DT neuroblasts/NNS or/CC individual/JJ neuroblasts/NNS ,/, to/IN show/NN that/IN in/IN DER/MULTIGENE mutant/MULTIGENE embryos/NNS (/( 1/CD )/SYM intermediate/JJ column/NN neuroblasts/NNS do/VBP not/RB form/VB ,/, (/( 2/CD )/SYM medial/JJ column/NN neuroblasts/NNS often/RB acquire/VBP identities/NNS inappropriate/JJ for/IN their/PRP position/NN ,/, while/CC (/( 3/CD )/SYM lateral/JJ neuroblasts/NNS develop/VBP normally/RB ./.
@@80631088306/CD The/DT acfD/MULTIGENE gene/MULTIGENE encompasses/VBZ 254/CD nt/NN that/WDT are/VBP predicted/VBN to/IN encode/VB an/DT 88-amino-acid/JJ (/( aa/NNS )/SYM protein/NN ./.
@@63240894348/CD The/DT primary/JJ structure/NN of/IN the/DT GAL7/NEWGENE 5'/CD flanking/JJ region/NN has/VBZ many/JJ features/NNS common/JJ to/IN those/DT of/IN multicellular/JJ eukaryotic/MULTIGENE genes/MULTIGENE ./.
@@38485276558/CD Hisako/NNP Minowa/GENE who/WP has/VBZ worked/VBN as/IN a/DT psychiatric/JJ counsellor/NN in/IN industry/NN for/IN the/DT past/JJ 20/CD years/NNS ./.
@@89903973324/CD Finally/RB ,/, nonphotosynthetic/JJ mutants/NNS ,/, including/JJ the/DT tscA-lacking/JJ photosystem/NN I/MULTIGENE mutant/MULTIGENE ,/, H13/NEWGENE ,/, did/VBD not/RB show/VB evidence/NN of/IN light-stimulated/JJ RNA/NN processing/VBG ./.
@@37993234485/CD Under/IN the/DT same/JJ hematocrit/NN and/CC flow/NN conditions/NNS ,/, the/DT rate/NN of/IN oxygen/NN saturation/NN decrease/NN was/VBD significantly/RB higher/JJ for/IN the/DT sickle/JJ cells/NNS than/IN for/IN normal/JJ cells/NNS ./.
@@9333026963/CD The/DT genomic/JJ structure/NN of/IN brk/NN consists/VBZ of/IN 8/CD exons/NNS ,/, whose/WP boundaries/NNS are/VBP distinct/JJ from/IN other/DT non-receptor/MULTIGENE PTK/MULTIGENE family/MULTIGENE members/MULTIGENE ,/, again/RB indicating/VBG a/DT structural/JJ and/CC functional/JJ divergence/NN ./.
@@72701637121/CD The/DT syncytial/JJ microvillous/JJ projections/NNS seemed/VBN to/IN be/VB more/RB numerous/JJ and/CC longer/JJR in/IN CNF/NNP ,/, otherwise/RB the/DT structure/NN of/IN the/DT trophoblastic/JJ layer/NN of/IN the/DT villi/NNS and/CC the/DT lining/NN of/IN the/DT subtrophoblastic/JJ vessels/NNS were/VBD identical/JJ in/IN CNF/NNP and/CC controls/NNS ./.
@@68330474714/CD This/DT study/NN was/VBD undertaken/VBP to/IN define/VB the/DT mechanism/NN for/IN the/DT respiratory/JJ inhibition/NN observed/VBN during/IN high-frequency/JJ oscillatory/JJ ventilation/NN (/( HFOV/GENE )/SYM ./.
@@6683876998/CD These/DT cells/NNS averaged/VBN 17/CD microns/NNS in/IN diameter/NN and/CC reproduced/VBN by/IN fission/NN ,/, forming/MULTIGENE clusters/MULTIGENE of/IN two/JJ or/CC four/CD daughter/JJ cells/NNS ./.
@@92528792185/CD Then/RB we/PRP correlated/VBD HRCT/NN findings/NNS with/IN the/DT clinical/JJ features/NNS ,/, pulmonary/JJ functions/NNS and/CC methacholine/MULTIGENE PC20/MULTIGENE (/( PC20M/CONTEXTGENE )/SYM and/CC studied/VBN their/PRP clinical/JJ significance/NN ./.
@@115350144588/CD From/IN the/DT above/RB results/VBZ ,/, we/PRP might/MD infer/VB that/IN the/DT seizure/NN type/NN of/IN TLE/NNS and/CC a/DT high/JJ frequency/NN of/IN seizure/NN are/VBP two/JJ major/JJ independent/JJ precipitate/NN factors/NNS for/IN abnormal/JJ latencies/NNS of/IN P300/GENE in/IN the/DT epileptic/JJ patients/NNS ./.
@@82182308032/CD The/DT regulatory/JJ region/NN also/RB has/VBZ a/DT sequence/NN similar/JJ to/IN the/DT binding/JJ site/NN for/IN a/DT liver-specific/MULTIGENE transcription/MULTIGENE factor/MULTIGENE ,/, hepatocyte/MULTIGENE nuclear/MULTIGENE factor/MULTIGENE 1/MULTIGENE (/( HNF-1/GENE )/SYM ,/, at/IN positions/NNS -120/CD to/IN -132/CD ./.
@@15457929479/CD Deletion/NNS mutagenesis/NN demonstrated/VBN that/IN these/DT two/JJ elements/NNS are/VBP involved/VBN in/IN the/DT positive/JJ regulation/NN of/IN MLC-2/MULTIGENE gene/MULTIGENE transcription/NN ./.
@@22098112837/CD Horseradish/NNP peroxidase/NN as/IN a/DT permeability/MULTIGENE marker/MULTIGENE in/IN injured/JJ rat/NN caudal/JJ and/CC iliac/JJ arteries/NNS ./.
@@16072238566/CD Recent/JJ investigations/NNS have/VBP detailed/VBD a/DT selective/JJ dye/NN release/NN technique/NN in/IN which/WDT a/DT pulse/NN of/IN laser/NN light/NN induces/VBZ the/DT release/NN of/IN a/DT fluorescent/JJ dye/NN from/IN temperature-sensitive/JJ liposomes/NNS circulating/JJ in/IN the/DT retinal/JJ vasculature/NN ./.
@@81882908207/CD Using/VBG the/DT sequence/NN data/NN obtained/VBN from/IN the/DT human/MULTIGENE TCRAC/MULTIGENE //MULTIGENE TCRDC/MULTIGENE region/MULTIGENE ,/, we/PRP have/VBP extended/VBN a/DT polymerase/NN chain/NN reaction-based/JJ assay/NN to/IN test/NN for/IN the/DT expression/NN of/IN the/DT individual/JJ TCRAJ/MULTIGENE gene/MULTIGENE segments/MULTIGENE ./.
@@21901342811/CD No/DT therapy/NN exists/VBZ for/IN halting/JJ the/DT progression/NN of/IN the/DT disease/NN with/IN the/DT possible/JJ exception/NN of/IN laser/NN photocoagulation/NN treatment/NN used/VBN to/IN ablate/VB subretinal/JJ neovascular/JJ membranes/NNS in/IN an/DT attempt/NN to/IN avoid/VB complications/NNS of/IN subretinal/JJ hemorrhages/NNS ./.
@@11084556923/CD Association/NNP of/IN stress/NN during/IN delivery/NN with/IN increased/VBN numbers/NNS of/IN nucleated/JJ cells/NNS and/CC hematopoietic/JJ progenitor/NN cells/NNS in/IN umbilical/JJ cord/NN blood/NN ./.
@@98159489795/CD The/DT pharmacokinetic/JJ parameters/NNS which/WDT helped/VBD predict/VB these/DT toxicities/NNS included/VBD area/NN under/IN the/DT curve/NN and/CC peak/NN plasma/NN level/NN ./.
@@82304526368/CD In/NN contrast/NN ,/, capsid/NN proteins/NNS derived/VBN from/IN the/DT P1/NEWGENE precursor/NN with/IN a/DT valine/NN substitution/NN at/IN the/DT amino/JJ terminus/NN of/IN VP1/GENE (/( VP1-G001V/GENE )/SYM assembled/VBN empty/JJ capsid/NN particles/NNS but/CC were/VBD deficient/JJ in/IN assembling/JJ RNA-containing/JJ virions/NNS ./.
@@108455229656/CD OBJECTIVE/IN :/: This/DT study/NN was/VBD conducted/VBN to/IN assess/VB the/DT relative/JJ roles/NNS of/IN 99mTc-sestamibi/GENE scintimammography/NN and/CC sonography/NN in/IN the/DT evaluation/NN of/IN breast/NN lesions/NNS that/WDT are/VBP indeterminate/JJ or/CC suspicious/JJ on/IN mammography/NN or/CC clinical/JJ examination/NN ./.
@@22343452536/CD The/DT glial/MULTIGENE cyst/MULTIGENE wall/NN was/VBD lined/VBN in/IN part/NN by/IN flattened/JJ or/CC cuboidal/JJ epithelium/NN ./.
@@92721081546/CD Analysis/NNP of/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT gene/NN also/RB revealed/VBD the/DT presence/NN of/IN multiple/JJ TATA/NN and/CC CAAT/MULTIGENE sequences/MULTIGENE ./.
@@3259437451/CD In/NN the/DT infected/VBN neonates/NNS serum/JJ alpha-amylase/NEWGENE value/NN ,/, as/IN determined/VBN by/IN the/DT blue/JJ starch/NN method/NN ,/, was/VBD only/RB 40%/CD that/IN of/IN healthy/JJ controls/NNS ;/: the/DT mean/JJ value/NN of/IN 175/CD ./CD 1/CD +/NN //NN -/NN 64/CD ./CD 9/CD IU/NNS //NNS l/NNS for/IN healthy/JJ neonates/NNS was/VBD significantly/RB higher/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 0010/CD )/SYM than/IN the/DT value/NN of/IN 82/CD ./CD 8/CD +/NN //NN -/NN 44/CD ./CD 4/CD IU/NNS //NNS l/NNS for/IN the/DT infected/VBN neonates/NNS ./.
@@88223998799/CD Motivational/JJ factors/NNS focusing/NN on/IN attitudes/NNS ,/, perceived/JJ susceptibility/NN to/IN pregnancy/NN ,/, and/CC normative/JJ factors/NNS were/VBD also/RB relevant/JJ ./.
@@630713705/CD Evaluation/NN of/IN the/DT Du/MULTIGENE Pont/MULTIGENE aca/NN ammonia/NN procedure/NN ./.
@@23102612958/CD The/DT abscess/NN was/VBD debrided/VBN and/CC the/DT septum/NN was/VBD patched/VBN with/IN a/DT single/JJ layer/NN of/IN autologous/JJ pericardium/NN ./.
@@76514247634/CD In/NN wild-type/JJ cells/NNS ,/, SSM1b/MULTIGENE transcripts/MULTIGENE accumulate/VBP to/IN twice/RB the/DT level/NN of/IN SSM1a/MULTIGENE transcripts/MULTIGENE ,/, suggesting/VBG that/IN SSM1b/GENE is/VBZ responsible/JJ for/IN the/DT majority/NN of/IN the/DT Ssm1p/GENE pool/NN ./.
@@84619462921/CD There/EX was/VBD either/DT no/DT change/NN or/CC an/DT improvement/NN in/IN renographic/JJ findings/NNS (/( t1/GENE //GENE 2/GENE time/NN and/IN //IN or/IN split/JJ function/NN )/SYM in/IN 40/CD patients/NNS (/( 93%/CD )/SYM ./.
@@98356159218/CD Biochemical/NNP analysis/NN reveals/VBZ that/IN KS1/GENE is/VBZ a/DT nuclear/JJ protein/NN containing/JJ two/JJ transcriptional/JJ repressor/NN domains/NNS ,/, R1/GENE and/CC R2/NN ./NN
@@10478951260/CD Is/VBZ criticism/NN of/IN patient/NN care/NN justified/VBN and/CC does/VBP it/PRP have/VBP educational/JJ value/NN ?/. Patients'/NN criticism/NN contributes/VBZ to/IN improved/VBN patient/NN care/NN ./.
@@96785794812/CD To/TO gain/VB insight/NN into/IN the/DT expression/NN of/IN the/DT AtCP1/MULTIGENE gene/MULTIGENE ,/, northern/JJ blot/NN analysis/NN was/VBD carried/VBN out/RB ./.
@@114355788511/CD These/DT TxRE/NNP contain/VB cyclic/JJ AMP-responsive/NNP elements/NNS (/( CRE/NN )/SYM ,/, but/CC ,/, remarkably/RB ,/, the/DT "TGACGTCA"/NN consensus/NN is/VBZ never/RB strictly/RB conserved/VBN in/IN any/DT viral/JJ strain/NN (/( e/GENE ./GENE g/GENE ./GENE ,/GENE AGACGTCA/GENE ,/, TGACGGCA/GENE ,/, TGACCTCA/GENE )/SYM ./.
@@94240129378/CD Three/CD large/JJ field/NN placement/NN errors/NNS (/( two/JJ patients/NNS with/IN 11/CD ./CD 5/CD and/CC 16/CD ./CD 0/CD mm/NN distances/NNS of/IN the/DT planned/VBN versus/IN simulated/JJ isocenter/NN ,/, respectively/RB and/CC one/PRP patient/NN with/IN a/DT 7/CD degree/NN rotational/JJ error/NN )/SYM were/VBD detected/VBN and/CC ,/, as/IN with/IN the/DT smaller/JJR errors/NNS ,/, were/VBD immediately/RB corrected/VBN ./.
@@104756109230/CD Natl/JJ ./.
@@86062674579/CD Variables/NNS evaluated/VBN were/VBD number/NN of/IN weekly/JJ anginal/JJ events/NNS ,/, data/NN from/IN ergometric/JJ exercise/NN testing/NN with/IN simultaneous/JJ electrocardiographic/JJ registration/NN ,/, semiquantitative/JJ evaluation/NN of/IN Tc-99m/GENE 2-methoxy/JJ isobutyl/NN isonitrile/NN (/( MIBI/IN )/SYM scans/NNS and/CC rheologic/JJ variables/NNS ./.
@@89694951479/CD The/DT sequencing/VBG of/IN the/DT conditional/JJ lethal/JJ mutation/NN ts-A13/JJ ,/, localized/VBN in/IN the/DT nrdE/NN cistron/NN ,/, and/CC the/DT lethality/NN of/IN insertional/JJ mutations/NNS targeted/VBN in/IN the/DT internal/JJ region/NN of/IN nrdE/NN and/CC nrdF/GENE ,/, demonstrated/VBD the/DT essential/JJ role/NN of/IN this/DT locus/NN ./.
@@97980688508/CD RESULTS/NNS :/: We/PRP identified/VBD a/DT full-length/JJ cDNA/NN with/IN an/DT open/JJ reading/JJ frame/NN of/IN 2883/CD bp/NN corresponding/JJ to/IN a/DT predicted/VBN protein/NN of/IN 961/CD amino/JJ acids/NNS that/WDT shares/VBP greater/JJR than/IN 95%/CD homology/NN with/IN the/DT rat/MULTIGENE gamma-aminobutyric/MULTIGENE acid/MULTIGENE B/MULTIGENE (/( GABAB/GENE )/SYM receptor/NN ./.
@@75338805281/CD The/DT FinO/MULTIGENE protein/MULTIGENE of/IN IncF/ORG plasmids/NNS binds/VBZ FinP/NN antisense/NN RNA/NN and/CC its/PRP target/NN ,/, traJ/MULTIGENE mRNA/MULTIGENE ,/, and/CC promotes/VBZ duplex/JJ formation/NN ./.
@@93352675061/CD Because/IN of/IN the/DT operon/NN structure/NN of/IN this/DT organism/NN ,/, traditional/JJ methods/NNS such/JJ as/IN insertional/JJ mutagenesis/NN run/NN the/DT risk/NN of/IN introducing/JJ polar/JJ effects/NNS on/IN downstream/JJ genes/NNS or/CC creating/VBG secondary/JJ mutations/NNS elsewhere/RB in/IN the/DT genome/NN ./.
@@105900923888/CD However/RB ,/, mechanisms/NNS underlying/JJ HIV-1/MULTIGENE gene/MULTIGENE expression/NN in/IN the/DT CNS/NN are/VBP poorly/RB understood/VBP ./.
@@76107167562/CD The/DT analysis/NN of/IN the/DT prevalence/NN values/NNS shows/VBZ clearly/RB that/IN the/DT global/JJ MS-frequency/GENE is/VBZ closer/RBR related/VBN to/IN the/DT geomagnetic/JJ than/IN to/IN the/DT geographic/JJ latitude/NN ./.
@@97675044365/CD A/DT single/JJ rectal/JJ dose/NN of/IN 25/CD mg/GENE //GENE kg/GENE will/MD obtain/VB this/DT lower/JJR concentration/NN within/IN 1/CD h/NN of/IN administration/NN and/CC maintain/VB it/PRP for/IN up/JJ to/IN 6/CD h/CD ./CD
@@66154033762/CD During/IN a/DT single/JJ LAD/NEWGENE occlusion/NN lasting/JJ 35/CD minutes/NNS (/( series/NN I/PRP ,/, n/NN =/SYM 10/CD )/SYM 9/CD microns/NNS TMs/NNS were/VBD infused/VBN immediately/RB and/CC 30/CD minutes/NNS after/IN ligation/NN ,/, 15/CD microns/NNS TMs/NNS being/VBP infused/VBN after/IN 15-20/CD minutes/NNS ./.
@@86662387571/CD Selective/JJ translation/NN initiation/NN by/IN ribosome/NN jumping/JJ in/IN adenovirus-infected/JJ and/CC heat-shocked/JJ cells/NNS ./.
@@62146056023/CD The/DT number/NN of/IN elements/NNS and/CC their/PRP sizes/NNS relative/JJ to/IN the/DT configuration/NN were/VBD varied/VBN in/IN a/DT series/NN of/IN five/CD experiments/NNS ./.
@@10448285295/CD The/DT median/JJ durations/NNS for/IN response/NN and/CC survival/NN time/NN in/IN the/DT late/JJ phase/NN II/NNP trial/NN were/VBD 2/CD ./CD 3/CD months/NNS and/CC 5/CD ./CD 8/CD months/NNS ,/, respectively/RB ./.
@@86643477496/CD None/NN of/IN the/DT five/CD proprotein/NN processing/VBG proteases/NNS tested/VBN were/VBD capable/JJ of/IN cleaving/JJ human/JJ pro-LPH/NN ,/, strongly/RB suggesting/VBG that/IN they/PRP are/VBP not/RB involved/VBN in/IN the/DT maturation/NN of/IN this/DT enzyme/NN ./.
@@104825653806/CD Single-alanine-substitution/NNP mutations/NNS had/VBP minimal/JJ ,/, if/IN any/DT ,/, effects/VBZ on/IN S-induced/MULTIGENE cell-to-cell/MULTIGENE fusion/MULTIGENE ./.
@@84708956090/CD Examination/NN of/IN the/DT immediate/JJ sequence/NN 5'/CD to/IN the/DT mRNA/NN start/NN site/NN reveals/VBZ no/DT TATA/MULTIGENE box/MULTIGENE and/CC multiple/JJ known/VBP enhancer/NN sequences/NNS ./.
@@15560688403/CD The/DT Klebsiella/NN aerogenes/MULTIGENE gene/MULTIGENE maoA/MULTIGENE ,/, which/WDT is/VBZ involved/VBN in/IN the/DT synthesis/NN of/IN monoamine/MULTIGENE oxidase/MULTIGENE ,/, was/VBD induced/VBN by/IN tyramine/NN and/CC the/DT related/VBN compounds/NNS ,/, subjected/VBN to/IN catabolite/NN and/CC ammonium/NN ion/NN repression/NN ,/, and/CC cloned/VBN ./.
@@1516829274/CD We/PRP show/VBP that/IN LexA-GAL4/GENE and/CC LexA-Bicoid/MULTIGENE fusion/MULTIGENE proteins/MULTIGENE are/VBP both/DT dependent/NN on/IN SNF2/GENE ,/, SNF5/GENE ,/, and/CC SNF6/NEWGENE for/IN activation/NN of/IN target/NN genes/NNS containing/JJ one/PRP or/CC multiple/JJ lexA/NN operators/NNS ./.
@@83717132991/CD Alternative/JJ transcript/NN of/IN the/DT nonselective-type/MULTIGENE endothelin/MULTIGENE receptor/MULTIGENE from/IN rat/NN brain/NN ./.
@@34204664122/CD The/DT incidence/NN of/IN cryptosporidiosis/NN in/IN young/JJ children/NNS was/VBD determined/VBN by/IN staining/NN of/IN faecal/JJ specimens/NNS with/IN a/DT modified/JJ Kinyoun/NNP stain/NN ./.
@@108367863696/CD To/TO begin/VB to/IN characterize/VB the/DT role/NN of/IN the/DT RNA/NN subunits/NNS in/IN enzyme/NN function/NN and/CC substrate/NN specificity/NN ,/, we/PRP swapped/VBD two/JJ hairpin/NN structures/NNS (/( MRP3/GENE and/CC P3/GENE )/SYM between/IN RNase/MULTIGENE MRP/MULTIGENE RNA/MULTIGENE and/CC RNase/MULTIGENE P/MULTIGENE RNA/MULTIGENE of/IN S/NNP ./NNP cerevisiae/NN ./.
@@117915851656/CD The/DT electrodes/NNS themselves/PRP do/VBP not/RB need/VB to/IN be/VB polished/VBN prior/NN to/IN their/PRP use/NN but/CC are/VBP observed/VBN to/IN be/VB slightly/RB recessed/JJ from/IN the/DT surrounding/JJ insulating/JJ surface/NN ./.
@@31687094795/CD The/DT central/NN visual/NN fields/NNS of/IN 2165/CD normal/JJ and/CC 106/CD glaucoma/NN eyes/NNS were/VBD measured/VBN using/VBG a/DT threshold/NN related/VBD suprathreshold/JJ strategy/NN ./.
@@98325059926/CD Thus/RB ,/, we/PRP have/VBP identified/VBN an/DT activation/MULTIGENE target/MULTIGENE of/IN a/DT human/JJ activator/NN ,/, Oct-1/GENE ,/, within/IN its/PRP cognate/MULTIGENE basal/MULTIGENE transcription/MULTIGENE complex/MULTIGENE ./.
@@98694001795/CD Comparisons/NNS with/IN other/DT known/VBP germins/NNS and/CC germin-like/MULTIGENE proteins/MULTIGENE indicate/VBP that/IN these/DT Arabidopsis/NN GLP/NN subfamilies/NNS are/VBP unique/JJ from/IN wheat/MULTIGENE germin/MULTIGENE ./.
@@18975152517/CD Bone/NN marrow/NN abnormalities/NNS in/IN Hodgkin's/NNP disease/NN are/VBP reviewed/VBN and/CC the/DT current/JJ understanding/NN of/IN the/DT pathological/JJ mechanisms/NNS leading/VBG to/IN aplastic/JJ anemia/NN is/VBZ discussed/VBN ./.
@@25412519872/CD That/DT of/IN the/DT T2/MULTIGENE gene/MULTIGENE contains/VBZ numerous/JJ potential/JJ sites/NNS for/IN binding/JJ the/DT mammalian/JJ transcription/MULTIGENE factor/MULTIGENE SP1/MULTIGENE ,/, but/CC no/DT TATA/NN or/CC CCAAT/MULTIGENE sequences/MULTIGENE are/VBP evident/JJ near/IN to/IN its/PRP 5'/CD end/NN ,/, although/IN these/DT latter/JJ features/NNS are/VBP associated/VBN with/IN the/DT human/MULTIGENE T1/MULTIGENE gene/MULTIGENE ./.
@@112413326336/CD For/IN this/DT purpose/NN ,/, the/DT immediate/JJ and/CC the/DT final/JJ (/( after/IN swelling/NN )/SYM fixation/NN strengths/NNS of/IN two/JJ variations/NNS of/IN the/DT swellable/JJ bone/MULTIGENE anchor/MULTIGENE designs/NNS (/( a/DT smooth/MULTIGENE anchor/MULTIGENE and/CC a/DT screw/NN anchor/NN )/SYM were/VBD measured/VBN in/IN two/JJ different/JJ foams/NNS (/( used/VBN to/IN simulate/VB bone/NN )/SYM with/IN different/JJ densities/NNS ./.
@@68300338128/CD Similar/JJ observations/NNS were/VBD made/VBP with/IN unilateral/JJ pneumothorax/NN of/IN 15/CD cmH2O/NN for/IN 30/CD min/NN ./.
@@13169031903/CD The/DT unphosphorylated/JJ form/NN of/IN RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE is/VBZ designated/VBN IIA/NEWGENE ,/, whereas/IN the/DT phosphorylated/VBN form/NN is/VBZ designated/VBN IIO/NNP ./.
@@17155932298/CD When/WRB desipramine/NN was/VBD injected/VBN 16/CD hrs/NN after/IN fluoxetine/NN injection/NN ,/, brain/NN levels/NNS of/IN desipramine/NN were/VBD no/RB longer/RB elevated/VBN ./.
@@83601809278/CD When/WRB comparing/VBG the/DT barley/NN PSI-K/GENE and/CC PSI-G/GENE with/IN the/DT reported/VBN PSI-K/MULTIGENE sequence/MULTIGENE from/IN Synechococcus/NNP vulcanus/NN ,/, the/DT degree/NN of/IN similarity/NN is/VBZ equal/VB ,/, suggesting/VBG that/IN an/DT ancestral/JJ gene/NN has/VBZ been/VBN duplicated/VBN in/IN a/DT chloroplast/NN progenitor/NN but/CC not/RB in/IN a/DT cyanobacterial/JJ ./.
@@93041239263/CD These/DT discoloration's/NNS can/MD be/VB treated/VBN in/IN several/DT ways/NNS but/CC up/JJ to/IN lately/RB tooth/NN structure/NN had/VBP to/IN be/VB removed/VBN in/IN an/DT irreversible/JJ manner/NN in/IN order/NN to/IN provide/VB sufficient/JJ bulk/NN for/IN the/DT new/JJ restorative/JJ material/NN ./.
@@86756088651/CD Outcome/NN of/IN severe/JJ congenital/JJ hypothyroidism/NN ./.
@@37121064385/CD The/DT effect/NN of/IN L-methionine/NN supplementation/NN on/IN the/DT utilization/NN of/IN a/DT soy/NN protein/NN isolate/NN (/( SPI/NNS )/SYM was/VBD evaluated/VBN by/IN short-term/JJ nitrogen/NN balance/NN studies/NNS in/IN young/JJ women/NNS ./.
@@99893342035/CD It/PRP was/VBD demonstrated/VBN that/IN the/DT processing/VBG signals/NNS in/IN the/DT transcript/NN ,/, i/NN ./NN e/NN ./. both/DT donor/NN splice/NN sites/NNS and/CC the/DT polyadenylation/MULTIGENE site/MULTIGENE located/VBN in/IN the/DT muscle-specific/JJ intron/NN ,/, have/VB to/IN be/VB weak/JJ ./.
@@96890473171/CD A/DT prerequisite/NN for/IN the/DT synthesis/NN of/IN sialylated/JJ glycoconjugates/NNS is/VBZ the/DT activated/VBN sugar-nucleotide/NN cytidine/NN 5'-monophosphate/NNP N-acetylneuraminic/NNP acid/NN (/( CMP-Neu5Ac/NNP )/SYM ,/, which/WDT provides/VBZ a/DT substrate/NN for/IN Golgi/JJ sialyltransferases/NNS ./.
@@29250133633/CD We/PRP conclude/VBP that/IN at/IN these/DT low/JJ levels/NNS studied/VBN ,/, aluminum/NN accumulates/VBZ in/IN intestinal/JJ tissue/NN ,/, and/CC that/IN this/DT accumulation/NN is/VBZ enhanced/VBN by/IN citrate/MULTIGENE ligand/MULTIGENE ./.
@@91113311840/CD The/DT Rlm1/MULTIGENE protein/MULTIGENE ,/, a/DT member/NN of/IN the/DT MADS/MULTIGENE box/MULTIGENE family/MULTIGENE of/IN transcription/NN factors/NNS ,/, functions/NNS downstream/RB of/IN Mpk1/GENE in/IN the/DT pathway/NN ./.
@@38601628651/CD Incorporation/NNS of/IN the/DT polyene/NN antibiotic/JJ amphotericin/MULTIGENE B/MULTIGENE (/( AMB/GENE )/SYM in/IN liposomes/NNS results/NNS in/IN a/DT marked/JJ reduction/NN in/IN drug/NN toxicity/NN with/IN no/DT loss/NN of/IN antifungal/JJ potency/NN ./.
@@97366975632/CD Expression/NNS of/IN constitutively/RB active/JJ MEK1/GENE ,/, the/DT kinase/NN that/WDT activates/VBZ ERKs/GENE ,/, or/CC overexpression/NN of/IN ERK2/GENE ,/, but/CC not/RB JNK1/GENE ,/, inhibited/VBN Stat3/GENE activation/NN ./.
@@106578993712/CD Pretreatment/NNS of/IN cells/NNS or/CC mouse/NN skin/NN with/IN antisense/NN oligonucleotides/NNS of/IN PKCzeta/NNP impaired/VBN UV-induced/JJ activation/NN of/IN AP-1/GENE in/IN JB6/NNP cells/NNS as/RB well/VBP as/IN in/IN AP-1-luciferase/NNP transgenic/JJ mice/NNS ./.
@@8778575926/CD Serum/NN amylase/NEWGENE became/VBD markedly/RB elevated/VBN (/( 2/CD ,/CD 624/CD CU/NNP //NNP 100/NNP ml/NN )/SYM ,/, as/IN did/VBD the/DT serum/JJ FFA/NN (/( 29/CD ./CD 19/CD mEq/NN //NN liter/NN )/SYM ./.
@@106459215519/CD Multivariate/MULTIGENE predictors/MULTIGENE were/VBD concentric/JJ remodeling/NN (/( P/CD </CD 0/CD ./CD 0001/CD ;/: odds/NNS ratio/NN ,/, 13/CD ./CD 5/CD )/SYM ,/, left/NN ventricular/JJ ejection/NN fraction/NN >/SYM 2/CD SD/NN above/RB normal/JJ (/( P/CD </CD 0/CD ./CD 0001/CD )/SYM ,/, and/CC single-vessel/JJ left/NN circumflex/JJ disease/NN (/( P/NNP </NNP 0/NNP ./NNP 0007/NNP ;/: odds/NNS ratio/NN ,/, 7/CD ./CD 6/CD )/SYM ./.
@@62462546929/CD Restriction/NNS enzyme/NN and/CC heteroduplex/JJ analyses/NNS confirmed/VBN that/IN sequences/NNS unique/JJ to/IN FeSV/NNP (/( src/MULTIGENE sequences/MULTIGENE )/SYM are/VBP located/VBN at/IN the/DT center/NN of/IN the/DT FeSV/NNP genome/NN and/CC are/VBP approximately/RB 1/CD ./CD 5/CD kilobase/NN pairs/NNS in/IN length/NN ./.
@@100749215188/CD Similar/JJ results/NNS were/VBD also/RB obtained/VBN with/IN a/DT HepG2/CELL hepatoblastoma/NN cell/NN line/NN carrying/JJ wt/NN p53/GENE ./.
@@19164051285/CD Bronchial/JJ mucosa/NN tattooing/NN in/IN persons/NNS exposed/VBN to/IN different/JJ industrial/JJ aerosols/NNS did/VBD not/RB depend/VB on/IN the/DT forms/NNS of/IN PC/CONTEXTGENE ,/, DB/GENE and/CC the/DT diseases'/NN stages/NNS ./.
@@15807382171/CD Allagille's/NNP syndrome/NN associated/VBN with/IN antenatal/JJ ascites/NN ./.
@@51723205415/CD Studies/NNS on/IN the/DT hereditary/JJ nature/NN of/IN sole/JJ prints--with/JJ special/JJ reference/NN to/IN interdigital/JJ and/CC triradii/NN ./.
@@89223859316/CD We/PRP infer/VBP that/IN the/DT dominant/JJ negative/JJ inhibition/NN results/NNS from/IN both/DT direct/JJ proteolysis/NN of/IN the/DT beta-galactosidase/MULTIGENE tetramer/MULTIGENE by/IN the/DT fusion/NN subunit/NN and/CC detour/NN of/IN the/DT tetramer/NN to/IN the/DT lysosome/NN ./.
@@15119503108/CD Exposure/NN to/IN hepatitis/MULTIGENE B/MULTIGENE virus/NN in/IN the/DT general/JJ population/NN of/IN Hisayama/NNP ,/, Japan/NN :/: significance/NN of/IN isolated/VBN antibody/NN to/IN hepatitis/MULTIGENE B/MULTIGENE surface/NN antigen/NN in/IN general/JJ population/NN ./.
@@84089638372/CD Hops/NNP ,/, and/CC L/NNP ./NNP
@@1093847757/CD The/DT correcting/VBG action/NN of/IN tropatepine/NN hydrochloride/NN upon/IN the/DT extrapyramidal/JJ effects/NNS induced/VBN by/IN neuroleptics/NNS has/VBZ been/VBN studied/VBN in/IN 32/CD acute/JJ psychotic/JJ states/NNS ./.
@@13602944182/CD From/IN August/NN 1989/CD to/IN October/NN 1990/CD ,/, 83/CD pregnant/JJ Chinese/JJ women/NNS were/VBD the/DT subjects/NNS for/IN measuring/JJ the/DT levels/NNS of/IN plasma/NN functional/JJ antithrombin/MULTIGENE III/MULTIGENE (/( AT/IN III/NNP )/SYM activity/NN ./.
@@58398446367/CD Histochemistry/NNP and/CC electron/NN microscopy/NN of/IN acute/JJ liver/NN lesions/NNS induced/VBN by/IN Aflatoxin/MULTIGENE B1/MULTIGENE in/IN ducklings/NNS ./.
@@29666714929/CD Schedule/NNP 2/CD ,/, in/IN which/WDT 2/CD ./CD 4/CD mg/CD //CD kg/CD c-DDP/GENE was/VBD administered/VBN immediately/RB before/IN X-ray/NN on/IN 5/CD consecutive/JJ days/NNS produced/VBD the/DT highest/JJS degree/NN of/IN enhancement/NN of/IN radiation/NN effect/NN (/( expressed/VBN as/IN dose-effect/NN factor/NN )/SYM ;/: and/CC the/DT next/JJ greatest/JJS enhancement/NN was/VBD produced/VBN by/IN 12/CD mg/CD //CD kg/CD c-DDP/GENE administered/VBN 24/CD h/NN before/IN the/DT start/NN of/IN fractionated/VBN daily/JJ radiotherapy/NN ./.
@@16476568487/CD The/DT relation/NN between/IN myocardial/JJ beta-adrenergic/NN receptor/NN and/CC left/NN ventricular/JJ (/( LV/JJ )/SYM function/NN was/VBD studied/VBN in/IN 10/CD patients/NNS ,/, aged/VBN 41/CD to/IN 61/CD years/NNS (/( average/JJ 51/CD )/SYM ,/, with/IN LV/JJ volume/NN overload/NN mainly/RB due/NN to/IN chronic/JJ mitral/JJ regurgitation/NN ./.
@@92869815107/CD ArgR/GENE was/VBD shown/VBP to/IN be/VB a/DT dimer/NN of/IN two/JJ equal/JJ subunits/NNS ,/, each/DT with/IN a/DT molecular/JJ mass/NN of/IN 37/CD ,/CD 000/CD Da/NNP ./NNP
@@111214909331/CD The/DT transcription/MULTIGENE factor/MULTIGENE CHOP/MULTIGENE //MULTIGENE GADD153/MULTIGENE gene/MULTIGENE is/VBZ induced/VBN by/IN cellular/JJ stress/NN and/CC is/VBZ involved/VBN in/IN mediating/JJ apoptosis/NN ./.
@@88087074942/CD Ha-RasV12/GENE and/CC activated/VBN proteins/NNS in/IN both/PDT the/DT extra-cellular/RB regulated/VBN kinase/NN (/( ERK/NN )/SYM and/CC the/DT stress-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( SAPK/GENE )/SYM or/CC Jun/MULTIGENE N-terminal/MULTIGENE kinase/MULTIGENE (/( JNK/GENE )/SYM cascades/NNS independently/RB stimulated/VBN PEA3-mediated/JJ gene/NN expression/NN ./.
@@76858743226/CD Salivary/NNP sodium/NN ,/, calcium/NN ,/, and/CC magnesium/NN concentrations/NNS were/VBD significantly/RB higher/JJ in/IN the/DT SLE/NN patients/NNS with/IN systemic/JJ lupus/NN erythematosus/NN ,/, whereas/IN potassium/NN and/CC total/JJ protein/NN concentrations/NNS and/CC amylase/NEWGENE activity/NN did/VBD not/RB differ/VB significantly/RB from/IN the/DT controls/NNS ./.
@@75596506072/CD These/DT results/NNS indicate/VBP that/IN the/DT PCNA/MULTIGENE gene/MULTIGENE is/VBZ a/DT likely/JJ target/NN gene/NN of/IN E2F/GENE ./.
@@7489502649/CD The/DT influenza/NN virus/NN NS1/MULTIGENE protein/MULTIGENE is/VBZ a/DT unique/JJ posttranscriptional/MULTIGENE regulator/MULTIGENE that/WDT has/VBZ two/JJ activities/NNS :/: inhibition/NN of/IN the/DT nuclear/JJ export/NN of/IN poly/NN A-containing/MULTIGENE mRNAs/MULTIGENE and/CC inhibition/NN of/IN pre-mRNA/NN splicing/JJ ./.
@@79617557933/CD Homology/NNS was/VBD also/RB detected/VBN between/IN the/DT putative/JJ transit/NN peptide/NN sequence/NN of/IN cysteine/MULTIGENE synthase/MULTIGENE C/MULTIGENE and/CC other/DT mitochondrion-targeting/JJ leader/NN sequences/NNS ./.
@@112759869887/CD Of/IN its/PRP gene/NN products/NNS ,/, E6/NNS binds/VBZ to/IN and/CC inactivates/VBZ p53/GENE tumor/NN suppressor/NN protein/NN by/IN ubiquitin/JJ //JJ proteasome-dependent/JJ degradation/NN ./.
@@100909432600/CD As/IN normal/JJ B/NNP cells/NNS also/RB present/VBP this/DT variant/NN ,/, the/DT mechanism/NN of/IN CD79b/NEWGENE posttranscriptional/JJ regulation/NN might/MD reflect/VB the/DT activation/NN stage/NN of/IN the/DT normal/JJ B/NNP cell/NN from/IN which/WDT B-CLL/VBP derives/VBZ ./.
@@76425385345/CD In/NN contrast/NN ,/, both/DT C-Lys/GENE and/CC C-Thr/GENE retained/VBD high/JJ levels/NNS of/IN kinase/NN activity/NN and/CC were/VBD capable/JJ of/IN responding/VBG to/IN stimulation/NN ./.
@@117079778771/CD On/IN the/PDT other/DT hand/NN ,/, hepatic/JJ arterial/JJ infusion/NN therapy/NN prolongs/VBZ the/DT survival/NN of/IN H3/GENE patients/NNS only/RB ./.
@@13784312126/CD C/NNP ./NNP ,/, Sun/NNP ,/, J/NNP ./NNP ,/, Hsu/NN ,/, M/NNP ./NNP -Y/NNP ./NNP ,/, Vallejo-Ramirez/NNP ,/, J/NNP ./NNP ,/, Inouye/NNP ,/, S/NNP ./NNP ,/, and/CC Inouye/NNP ,/, M/NNP ./NNP
@@78679441572/CD Upstream/NNS from/IN the/DT transcription/NN start/NN point/NN (/( tsp/NN )/SYM ,/, a/DT nucleotide/NN sequence/NN highly/RB homologous/JJ to/IN the/DT consensus/NN sequence/NN motif/NN for/IN the/DT sigma/NN 35-recognized/JJ promoters/NNS was/VBD found/VBN ./.
@@39337844423/CD The/DT possible/JJ origin/NN and/CC role/NN of/IN CSF/MULTIGENE prolactin/MULTIGENE are/VBP discussed/VBN ./.
@@97160959701/CD Pressure/NN ulcers/NNS ./.
@@30469318413/CD We/PRP also/RB found/VBP an/DT eIF-4A/GENE intronless/JJ retroposon/NN which/WDT ,/, when/CC compared/VBD to/IN the/DT cDNA/NN ,/, contains/VBZ a/DT single/JJ nucleotide/NN difference/NN ./.
@@23241047575/CD High/NNP levels/NNS of/IN C/MULTIGENE subunits/MULTIGENE are/VBP observed/VBN in/IN several/DT subsequent/JJ larval/JJ and/CC adult/JJ stages/NNS of/IN development/NN ./.
@@80692987607/CD These/DT alternative/JJ splice/NN variants/NNS were/VBD detected/VBN in/IN RNA/NN isolated/VBN from/IN several/DT sources/NNS ,/, including/JJ primary/JJ leptomeningeal/JJ tissue/NN and/CC an/DT established/VBN line/NN of/IN leptomeningeal/JJ cells/NNS (/( LMC/NNS )/SYM ./.
@@26746798613/CD On/IN the/DT basis/NN of/IN S1/MULTIGENE nuclease/MULTIGENE protection/NN analysis/NN of/IN RNA/NN preparations/NNS from/IN several/DT mouse/NN tissues/NNS ,/, both/DT dhfr/NN and/CC divergent/JJ genes/NNS showed/VBD similar/JJ levels/NNS of/IN expression/NN but/CC did/VBD show/VB some/DT specificity/NN in/IN start/NN site/NN utilization/NN ./.
@@7151803345/CD Effect/NN of/IN time/NN and/CC dose/NN on/IN alterations/NNS following/IN inhalation/NN of/IN plutonium-239/GENE dioxide/NN aerosol/NN in/IN rat/NN ./.
@@88941449694/CD Forty-eight/NNS 10-12-week-old/JJ male/JJ Sprague-Dawley/NN rats/NNS were/VBD randomized/JJ to/IN receive/VB ,/, daily/JJ for/IN 28/CD days/NNS :/: (/( 1/CD )/SYM CsA/NN vehicle/NN p/CD ./CD o/CD ./. plus/IN FB/GENE vehicle/NN sc/NN ;/: (/( 2/CD )/SYM CsA/NN (/( 15/CD mg/CD //CD kg/CD )/SYM p/CD ./CD o/CD ./. plus/IN FB/GENE vehicle/NN sc/NN ,/, (/( 3/CD )/SYM CsA/NN vehicle/NN p/CD ./CD o/CD ./. plus/IN FB/GENE (/( 1/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM sc/NN ;/: and/CC (/( 4/CD )/SYM CsA/NN (/( 15/CD mg/CD //CD kg/CD )/SYM p/CD ./CD o/CD ./. plus/IN FB/GENE (/( 1/CD ./CD 5/CD mg/CD //CD kg/CD )/SYM sc/CD ./CD
@@75656887714/CD Immunofluorescence/NNS microscopy/NN and/CC cell/NN fractionation/NN analyses/NNS showed/VBN that/IN the/DT 110-kDa/MULTIGENE protein/MULTIGENE was/VBD exclusively/RB nuclear/JJ ,/, whereas/IN the/DT 150-kDa/MULTIGENE protein/MULTIGENE was/VBD present/VB in/IN both/PDT the/DT cytoplasm/NN and/CC nucleus/NN of/IN human/JJ cells/NNS ./.
@@76693518348/CD The/DT properties/NNS of/IN the/DT phi/MULTIGENE 29/MULTIGENE SSB-ssDNA/MULTIGENE complex/MULTIGENE are/VBP described/VBN ./.
@@107638275015/CD Thus/RB ,/, although/IN multiple/JJ senescence/NN pathways/NNS are/VBP activated/VBN in/IN response/NN to/IN a/DT ras/MULTIGENE oncogene/MULTIGENE ,/, inactivation/NN of/IN TGFbeta1/GENE secretion/NN or/CC response/NN is/VBZ sufficient/JJ to/IN block/NN the/DT senescence/NN program/NN ./.
@@93489319302/CD An/DT end/NN to/IN the/DT lottery/NN ./.
@@324979265/CD Possible/JJ factors/NNS for/IN the/DT development/NN of/IN psychotic/JJ symptomatology/NN during/IN group/NN activities/NNS and/CC the/DT role/NN of/IN group/NN dynamics/NNS acting/JJ as/IN stress/NN factors/NN precipitating/JJ functional/JJ psychoses/NNS ,/, especially/RB bipolar/JJ manifestations/NNS ,/, are/VBP discussed/VBN ./.
@@79453301601/CD Upon/IN differentiation/NN with/IN retinoic/JJ acid/NN (/( RA/NN )/SYM ,/, transcription/NN of/IN the/DT Rex-1/MULTIGENE gene/MULTIGENE decreases/NNS rapidly/RB ./.
@@86265401164/CD They/PRP were/VBD found/VBN to/IN stimulate/VB at/IN nanomolar/JJ concentrations/NNS the/DT turnover/NN of/IN biosynthetically/RB labeled/JJ ceramide/NN ,/, glucosylceramide/NN ,/, and/CC lactosylceramide/NN ./.
@@83831298160/CD The/DT low/JJ molecular/JJ mass/JJ polypeptide/NN complex/NN is/VBZ assumed/VBN to/IN be/VB involved/VBN in/IN antigen/NN presentation/NN ,/, generating/JJ peptides/NNS from/IN cytosolic/JJ protein/NN antigens/NNS ,/, which/WDT are/VBP subsequently/RB presented/VBN to/IN cytotoxic/JJ T-lymphocytes/NNS on/IN the/DT cell/NN surface/NN ./.
@@93219306920/CD We/PRP found/VBP that/IN multiple/JJ tumor/NN suppressor/NN genes/NNS (/( e/FW ./FW g/FW ./FW ,/, p53/GENE ,/, DCC/CONTEXTGENE ,/, APC/CONTEXTGENE ,/, MCC/CONTEXTGENE ,/, BRCA1/GENE ,/, and/CC WAF1/GENE //GENE CIP1/GENE )/SYM were/VBD inactivated/VBN at/IN different/JJ frequencies/NNS via/NN various/JJ mechanisms/NNS [/NN e/NN ./NN g/NN ./NN ,/, loss/NN of/IN heterozygosity/NN (/( LOH/NN )/SYM ,/, loss/NN of/IN expression/NN (/( LOE/NNP )/SYM ,/, mutation/NN ,/, and/CC inactivation/NN by/IN cellular/JJ binding/JJ protein/NN ]/NN ./.
@@78543247729/CD The/DT expression/NN of/IN this/DT clone/NN in/IN a/DT wee1/MULTIGENE //MULTIGENE mik1-deficient/MULTIGENE mutant/MULTIGENE causes/VBZ an/DT elongated/MULTIGENE cell/MULTIGENE phenotype/MULTIGENE under/IN non-permissive/JJ growth/NN conditions/NNS ./.
@@40508214728/CD This/DT suggests/VBZ that/IN mechanisms/NNS other/DT than/IN an/DT excessive/JJ increase/NN in/IN myocardial/JJ oxygen/NN demand/NN may/MD be/VB responsible/JJ for/IN the/DT many/JJ episodes/NNS occurring/VBG outside/RB the/DT hospital/NN ./.
@@79378415712/CD These/DT results/NNS provide/VBP evidence/NN of/IN a/DT bypass/NN of/IN p53-induced/JJ Waf1/JJ //JJ Cip1-mediated/JJ cell/NN cycle/NN regulatory/JJ pathways/NNS by/IN a/DT member/NN of/IN the/DT myb/MULTIGENE oncogene/MULTIGENE family/MULTIGENE ./.
@@24568273116/CD The/DT 4-AP/CD (/( 4-20/JJ mM/NN )/SYM effect/NN resulted/VBN in/IN a/DT decrease/NN of/IN the/DT sensory/JJ activity/NN ,/, which/WDT was/VBD fully/RB restored/VBN by/IN TEA/NNP or/CC Ba2+/NN ./.
@@81906334542/CD The/DT transcription/MULTIGENE factor/MULTIGENE AP-2/MULTIGENE is/VBZ encoded/VBN by/IN a/DT gene/NN located/VBN on/IN chromosome/NN 6/CD near/IN the/DT HLA/MULTIGENE locus/MULTIGENE ./.
@@107950982879/CD Cerebral/NNP vasculitis/NN secondary/JJ to/IN Crohn's/GENE disease/NN seems/VBZ to/IN be/VB a/DT very/RB rare/JJ phenomenon/NN ./.
@@25304701037/CD The/DT overall/JJ prevalence/NN of/IN HBV/NN markers/NN was/VBD higher/JJ among/IN staff/NN members/NNS than/IN in/IN the/DT blood/NN donors/NNS of/IN our/PRP area/NN ./.
@@11686078813/CD The/DT routine/JJ administration/NN of/IN fat-soluble/JJ vitamins/NNS appears/VBZ unnecessary/JJ but/CC it/PRP is/VBZ prudent/JJ to/IN measure/NN prothrombin/NN time/NN and/CC serum/JJ vitamins/MULTIGENE A/MULTIGENE and/CC E/NN at/IN intervals/NNS ./.
@@95752178503/CD Many/JJ cytokine/MULTIGENE receptors/MULTIGENE employ/VBP Janus/MULTIGENE protein/MULTIGENE tyrosine/MULTIGENE kinases/MULTIGENE (/( Jaks/NNP )/SYM and/CC signal/MULTIGENE transducers/MULTIGENE and/CC activators/NNS of/IN transcription/NN (/( Stats/GENE )/SYM for/IN nuclear/JJ signaling/NN ./.
@@33196219828/CD In/NN contrast/NN to/IN this/DT mRNA/NN ,/, 90%/NN of/IN alpha/NN and/CC beta/MULTIGENE actin/MULTIGENE mRNAs/MULTIGENE were/VBD translated/VBN in/IN both/DT myoblasts/NNS and/CC myotubes/NNS ./.
@@74696927359/CD The/DT term/NN osteomesopycnosis/NN is/VBZ proposed/VBN for/IN a/DT sclerosing/JJ bone/NN disease/NN with/IN dominant/JJ inheritance/NN that/WDT has/VBZ been/VBN discovered/VBN in/IN five/CD members/NNS of/IN four/CD different/JJ families/NNS ./.
@@891888546/CD Kss1/GENE binds/VBZ specifically/RB to/IN a/DT GST-Dig1/MULTIGENE fusion/MULTIGENE in/IN the/DT absence/NN of/IN any/DT other/DT yeast/NN protein/NN ./.
@@27173493409/CD Men/NNS were/VBD more/RB positive/JJ about/RB their/PRP physical/JJ fitness/NN than/IN women/NNS ./.
@@10473623725/CD In/NN early/JJ Xenopus/JJ embryos/NNS ,/, the/DT transforming/MULTIGENE growth/MULTIGENE factor-beta/MULTIGENE member/MULTIGENE activin/MULTIGENE induces/VBZ the/DT gene/NN Mix/CD ./CD 2/CD by/IN stimulating/JJ the/DT formation/NN of/IN a/DT multiprotein/MULTIGENE complex/MULTIGENE ,/, activin-responsive/JJ factor/NN (/( ARF/NN )/SYM ./.
@@1347664811/CD This/DT mutation/NN also/RB results/VBZ in/IN markedly/RB decreased/VBN levels/NNS of/IN CAD/MULTIGENE mRNA/MULTIGENE and/CC protein/NN in/IN the/DT mutant/NN ./.
@@35377117876/CD W/NN ./NN
@@117654481604/CD Described/NN X-ray/NN projection/NN were/VBD performed/VBN in/IN 70/CD patients/NNS ./.
@@85756098556/CD The/DT C/NN //NN D/NN ratio/NN was/VBD equal/VB to/IN or/CC over/RB 0/CD ./CD 6/CD in/IN 9/CD cases/NNS (/( 16/CD eyes/NNS )/SYM ,/, and/CC the/DT values/NNS were/VBD inconsistent/JJ between/IN both/DT eyes/NNS in/IN 55%/NN of/IN the/DT patients/NNS ./.
@@87836668354/CD In/NN addition/NN ,/, the/DT time/NN to/IN engraftment/NN was/VBD significantly/RB shorter/JJR in/IN the/DT amifostine/MULTIGENE arm/MULTIGENE in/IN both/DT cohorts/NNS ./.
@@47524555130/CD Disability/NN insurance/NN under/IN social/JJ security/NN ./.
@@78703056238/CD In/NN nucleus/NN ventralis/NN anterior/JJ thalami-nucleus/NN ventralis/JJ lateralis/JJ thalami/NNS neurons/NNS with/IN an/DT inhibitory/JJ input/NN from/IN nucleus/NN entopeduncularis/NN ,/, a/DT shortening/NN of/IN inhibition/NN from/IN 17/CD ./CD 5/CD +/NN //NN -/NN 3/CD ./CD 6/CD to/IN 9/CD ./CD 1/CD +/NN //NN -/NN 1/CD ./CD 8/CD ms/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM under/IN the/DT haloperidol/NN influence/NN was/VBD evident/JJ ./.
@@106945115967/CD The/DT expression/NN of/IN the/DT yam8/NN (/NN +/NN )/NN cDNA/NN in/IN the/DT mid1/NEWGENE mutant/JJ cells/NNS partially/RB remediated/VBN the/DT mid/NN phenotype/NN and/CC resulted/VBN in/IN a/DT slight/JJ increase/NN in/IN Ca/NN (/NN 2+/NN )/NN uptake/NN activity/NN ./.
@@110358676809/CD OBJECTIVE/IN :/: To/TO evaluate/VB the/DT overall/JJ performance/NN of/IN a/DT new/JJ oscillometric/JJ wrist/NN blood/NN pressure/NN monitor/NN (/( Braun/NNP PrecisionSensor/NNP ,/, Braun/NNP GmbH/NN ,/, Kronberg/NNP ,/, Germany/NN )/SYM as/IN defined/VBN by/IN the/DT ANSI/NNP //NNP AAMI/NNP SP10-1992/GENE guidelines/NNS ,/, and/CC to/IN analyze/VB the/DT data/NN for/IN the/DT optimized/VBN selection/NN of/IN the/DT algorithm/NN that/WDT derives/VBZ the/DT blood/NN pressure/NN values/NNS from/IN the/DT oscillometric/JJ blood/NN pressure/NN curves/NNS ./.
@@16495391302/CD Plasma/NN vitamin/NN E/NN ,/, total/JJ lipids/NNS and/CC myeloperoxidase/NN levels/NNS during/IN spinal/JJ surgery/NN ./.
@@78290575090/CD The/DT marker/NN orders/NNS from/IN the/DT genetic/JJ and/CC RH/GENE maps/NNS were/VBD consistent/JJ ./.
@@105903685437/CD Is/VBZ radical/JJ trachelectomy/NN a/DT safe/JJ alternative/NN to/IN radical/JJ hysterectomy/NN for/IN patients/NNS with/IN stage/NN IA-B/GENE carcinoma/NN of/IN the/DT cervix/NN ?/. BACKGROUND/IN :/: The/DT prognosis/NN associated/VBN with/IN lymph/NN node/NN negative/JJ ,/, early/JJ stage/NN carcinoma/NN of/IN the/DT cervix/NN is/VBZ excellent/JJ ,/, with/IN 5-year/JJ survival/NN rates/NNS greater/JJR than/IN 90%/CD ./.
@@27403479391/CD Cosmid/NN clones/NNS containing/JJ both/DT VNTR/MULTIGENE sequences/MULTIGENE were/VBD identified/VBN ,/, and/CC restriction/NN mapping/NN showed/VBD them/PRP to/IN be/VB less/PRP than/IN 15/CD kb/NN apart/RB ./.
@@94479633431/CD Sip1/GENE was/VBD initially/RB identified/VBN by/IN virtue/NN of/IN its/PRP interaction/NN with/IN SC35/GENE ,/, a/DT splicing/JJ factor/NN of/IN the/DT SR/MULTIGENE family/MULTIGENE ./.
@@108700436956/CD The/DT administration/NN of/IN the/DT GnRH/NEWGENE agonist/NN reduced/VBD the/DT bone/NN mineral/JJ density/NN in/IN the/DT whole/JJ femur/NN to/IN 91/CD ./CD 0%/CD of/IN that/DT in/NN the/DT control/NN group/NN ./.
@@91620848996/CD This/DT association/NN appears/VBZ to/IN be/VB mediated/JJ by/IN Src-SH2/GENE domain/NN ,/, because/IN PECAM-1/GENE can/MD be/VB precipitated/VBN by/IN a/DT GST-Src-SH2/GENE affinity/NN matrix/NN ./.
@@79147001353/CD The/DT gene/NN for/IN the/DT RNA-dependent/MULTIGENE eIF-2/MULTIGENE alpha/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( PKR/CONTEXTGENE )/SYM was/VBD isolated/VBN from/IN mouse/NN genomic/JJ DNA/NN and/CC characterized/VBN ./.
@@103757182701/CD Basic/MULTIGENE fibroblast/MULTIGENE growth/MULTIGENE factor/MULTIGENE (/( bFGF/CONTEXTGENE )/SYM has/VBZ been/VBN shown/VBP to/IN induce/VB angiogenesis/NN in/IN various/JJ animal/JJ models/NNS ,/, but/CC the/DT methods/NNS of/IN administration/NN used/VBN experimentally/RB are/VBP not/RB clinically/RB feasible/JJ ./.
@@75427644553/CD 1993/CD ./.
@@7687745932/CD The/DT immunosuppressant/NN FK506/NEWGENE inhibits/VBZ amino/JJ acid/NN import/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@100928562713/CD The/DT cDNA/NN was/VBD expressed/VBN in/IN Saccharomyces/NN cerevisiae/NN under/IN the/DT control/NN of/IN the/DT yeast/MULTIGENE triose/MULTIGENE phosphate/MULTIGENE isomerase/MULTIGENE promoter/MULTIGENE ./.
@@83967498360/CD LDL/NN cholesterol/NN decreased/VBN from/IN 4/CD ./CD 74/CD +/NN //NN -/NN 0/CD ./CD 87/CD to/IN 3/CD ./CD 78/CD +/NN //NN -/NN 0/CD ./CD 78/CD mmol/NN //NN l/NN after/IN 8/CD weeks/NNS on/IN simvastatin/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ,/, and/CC apo/MULTIGENE B/MULTIGENE fell/NN from/IN 142/CD +/NN //NN -/NN 31/CD to/IN 112/CD +/NN //NN -/NN 22/CD mg/NN //NN dl/NN (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM ./.
@@36126485239/CD It/PRP is/VBZ largely/RB predicted/VBN by/IN lupus/NN anticoagulant/JJ (/( estimated/VBN by/IN activated/JJ partial/JJ thromboplastin/NEWGENE time/NN )/SYM and/DT //DT or/DT antibody/NN to/IN cardiolipin/NN ./.
@@91048167370/CD The/DT effect/NN of/IN Vpu/GENE on/IN class/MULTIGENE I/MULTIGENE biogenesis/NN was/VBD analyzed/VBN in/IN more/JJ detail/NN using/VBG a/DT Vpu-expressing/NEWGENE recombinant/JJ vaccinia/NN virus/NN (/( VV/JJ )/SYM ./.
@@10708243525/CD Following/VBG the/DT observation/NN that/IN non-organ-specific/JJ antibodies/NNS are/VBP related/VBN with/IN pregnancy/NN loss/NN and/CC preeclampsia/NN ,/, the/DT role/NN of/IN organ-specific/JJ antibodies/NNS is/VBZ currently/RB being/VBP extensively/RB investigated/VBN ./.
@@114119611278/CD Keratoconjunctivitis/NNP sicca/JJ appears/NNS to/IN be/VB a/DT common/JJ ocular/JJ complication/NN and/CC all/DT children/NNS with/IN JRA/NN should/MD be/VB screened/VBN for/IN it/PRP with/IN a/DT comprehensive/JJ battery/NN of/IN tests/NNS ./.
@@91577604139/CD Both/DT quantitative/JJ and/CC qualitative/JJ analysis/NN of/IN individual/JJ cytoarchitectonic/JJ peculiarities/NNS of/IN Meynart's/GENE nucleus/NN as/RB well/VB as/IN of/IN external/NN part/NN of/IN dorsomedial/JJ nucleus/NN of/IN thalamus/NN was/VBD performed/VBN in/IN mentally/RB normal/JJ individuals/NNS ./.
@@117264131570/CD The/DT increased/VBN clearance/NN observed/VBN in/IN young/JJ infants/NNS is/VBZ in/IN contrast/NN to/IN other/DT opioids/NNS ./.
@@40932114787/CD We/PRP also/RB observed/VBD that/IN the/DT predictive/JJ ability/NN of/IN the/DT selected/VBN attitudes/NNS and/CC orientations/NNS increased/VBN considerably/RB from/IN 1975/CD to/IN 1982/CD ./.
@@88444486034/CD An/DT open-label/NN ,/, placebo-controlled/JJ ,/, randomized/JJ ,/, two-way/JJ crossover/JJ study/NN was/VBD performed/VBN in/IN 12/CD healthy/JJ volunteers/NNS (/( between/IN 20/CD and/CC 44/CD years/NNS of/IN age/NN )/SYM to/IN assess/VB the/DT effect/NN of/IN orlistat/NN ,/, a/DT gastrointestinal/JJ lipase/MULTIGENE inhibitor/MULTIGENE that/WDT reduces/VBZ dietary/JJ fat/JJ absorption/NN and/CC is/NNS being/VBP developed/VBN for/IN weight/NN control/NN in/IN obesity/NN ,/, on/IN the/DT absorption/NN of/IN vitamins/MULTIGENE A/MULTIGENE and/CC E/NNP ./NNP
@@75630904869/CD Here/RB we/PRP demonstrate/VBP genetically/RB that/DT plus-strand/NN DNA/NN synthesis/NN of/IN the/DT yeast/MULTIGENE Ty1/MULTIGENE element/MULTIGENE is/VBZ initiated/VBN at/IN two/JJ sites/NNS located/VBN at/IN the/DT 5'/CD boundary/NN of/IN the/DT 3'/CD long/JJ terminal/JJ repeat/NN (/( PPT1/GENE )/SYM and/CC near/IN the/DT middle/NN of/IN the/DT pol/MULTIGENE gene/MULTIGENE in/IN the/DT integrase/NEWGENE coding/JJ sequence/NN (/( PPT2/GENE )/SYM ./.
@@49709181786/CD LA-3848-MS/GENE ./.
@@63725636170/CD Renal/JJ response/NN to/IN captopril/NN in/IN severe/JJ heart/NN failure/NN :/: role/NN of/IN furosemide/NN in/IN natriuresis/NN and/CC reversal/NN of/IN hyponatremia/NN ./.
@@86200032893/CD Protein/NN splicing/JJ :/: evidence/NN for/IN an/DT N-O/NNP acyl/NN rearrangement/NN as/IN the/DT initial/JJ step/NN in/IN the/DT splicing/JJ process/NN ./.
@@93228729905/CD Because/IN the/DT deletion/NN included/VBD the/DT TK/MULTIGENE gene/MULTIGENE ,/, selection/NN with/IN gancyclovir/NN against/IN cells/NNS not/RB having/VBG undergone/VBP recombination/NN was/VBD possible/JJ ./.
@@83006112883/CD Concerted/JJ action/NN of/IN three/CD distinct/JJ domains/NNS in/IN the/DT DNA/NN cleaving-joining/JJ reaction/NN catalyzed/VBN by/IN relaxase/NN (/( TraI/NNS )/SYM of/IN conjugative/JJ plasmid/NN RP4/NEWGENE ./.
@@22347313372/CD We/PRP conclude/VBP that/DT class/MULTIGENE I/MULTIGENE cytologic/JJ smears/NNS with/IN moderate/JJ to/IN severe/JJ inflammation/NN may/MD be/VB associated/VBN with/IN findings/NNS of/IN condylomata/NNS and/CC cervical/JJ dysplasia/NN ./.
@@83211996305/CD Epigenetic/JJ switching/NN of/IN transcriptional/JJ states/NNS :/: cis-/JJ and/CC trans-acting/JJ factors/NNS affecting/VBG establishment/NN of/IN silencing/VBG at/IN the/DT HMR/MULTIGENE locus/MULTIGENE in/IN Saccharomyces/NN cerevisiae/NN ./.
@@109433503/CD Flurazepam/NN thus/RB appears/VBZ to/IN be/VB an/DT effective/JJ hypnotic/JJ drug/NN with/IN the/DT optimum/JJ dose/NN for/IN use/NN in/IN general/JJ practice/NN being/VBP 15/CD mg/NN at/IN night/NN ./.
@@112501963252/CD The/DT (/( two-motif/JJ )/SYM domain/NN fold/NN contains/VBZ a/DT pair/NN of/IN calcium/MULTIGENE binding/MULTIGENE sites/MULTIGENE very/RB similar/JJ to/IN those/DT found/VB in/IN a/DT two-domain/JJ prokaryotic/JJ betagamma-crystallin/JJ fold/NN family/NN member/NN ,/, Protein/NNP S/NNP ./NNP
@@103335267070/CD The/DT hTERT/MULTIGENE gene/MULTIGENE encompasses/VBZ more/RB than/IN 37kb/NN and/CC consists/VBZ of/IN 16/CD exons/NNS ./.
@@83491042825/CD Surprisingly/RB ,/, the/DT results/NNS of/IN several/DT experiments/NNS suggest/VBP that/IN the/DT TSF/MULTIGENE genes/MULTIGENE encode/VBP global/JJ regulatory/JJ factors/NNS ./. tsf1/GENE to/IN tsf6/MULTIGENE mutations/MULTIGENE derepressed/VBN expression/NN from/IN yeast/NN CYC-GAL/NNP hybrid/JJ promoters/NNS (/( fused/VBN to/IN lacZ/NN )/SYM that/WDT harbor/VBP a/DT variety/NN of/IN operator/NN sequences/NNS ,/, and/CC caused/VBD pleiotropic/JJ defects/NNS in/IN cell/NN growth/NN ,/, mating/JJ ,/, and/CC sporulation/NN ./.
@@1544918403/CD Characterization/NNS of/IN these/DT R/MULTIGENE subunits/MULTIGENE by/IN their/PRP 8-azido-cAMP/JJ photoaffinity/NN labeling/VBG and/CC immunoreactivity/NN ,/, as/RB well/VB as/IN by/IN a/DT phosphorylation-dependent/JJ mobility/NN shift/NN on/IN sodium/NN dodecyl/NN sulfate-polyacrylamide/NN gel/NN electrophoresis/NN (/( SDS-PAGE/NN )/SYM ,/, indicated/VBN subunit/NN sizes/NNS of/IN RII/MULTIGENE beta/MULTIGENE (/( 53/CD kDa/NN )/SYM greater/JJR than/IN RII/MULTIGENE alpha/MULTIGENE dephosphoform/NN (/( 51/CD kDa/NN )/SYM greater/JJR than/IN RI/MULTIGENE alpha/MULTIGENE (/( 49/CD kDa/NN )/SYM ./.
@@110555137817/CD In/NN general/JJ lookback/NN ,/, all/DT patients/NNS who/WP received/VBD blood/NN before/IN being/VBP tested/VBN for/IN hepatitis/MULTIGENE C/MULTIGENE are/VBP advised/VBN to/IN undergo/VB testing/NN ./.
@@84860358448/CD Closure/NNS of/IN the/DT patent/JJ ductus/NN arteriosus/NN with/IN a/DT Ligaclip/NN through/RB a/DT minithoracotomy/NN ./.
@@1050400335/CD Improvement/NNP of/IN nursing/JJ instruction/NN to/IN be/VB given/VBP at/IN the/DT time/NN of/IN discharge/NN from/IN the/DT ward/NN for/IN premature/JJ infants/NN ]/NN ./.
@@104177031038/CD Taken/VBN together/RB ,/, these/DT results/NNS demonstrate/VBP that/IN the/DT RP/NN ,/, like/NN the/DT 20S/MULTIGENE proteasome/MULTIGENE ,/, is/VBZ functionally/RB and/CC structurally/RB conserved/VBN among/IN eukaryotes/NNS and/CC indicate/VB that/IN the/DT plant/NN RPT/MULTIGENE subunits/MULTIGENE ,/, like/JJ their/PRP yeast/NN counterparts/NNS ,/, have/VB non-redundant/JJ functions/NNS ./.
@@76655672324/CD Sequence/NN analysis/NN of/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT CD69/MULTIGENE gene/MULTIGENE revealed/VBD the/DT presence/NN of/IN a/DT potential/JJ TATA/MULTIGENE element/MULTIGENE 30/MULTIGENE base/NN pairs/NNS upstream/RB of/IN the/DT major/JJ transcription/NN initiation/NN site/NN and/CC several/DT putative/JJ binding/JJ sequences/NNS for/IN inducible/MULTIGENE transcription/MULTIGENE factors/MULTIGENE (/( NF-kappa/MULTIGENE B/MULTIGENE ,/, Egr-1/NEWGENE ,/, AP-1/GENE )/SYM ,/, which/WDT might/MD mediate/VB the/DT inducible/JJ expression/NN of/IN this/DT gene/NN ./.
@@60957745920/CD Histogenetic/JJ aspects/NNS of/IN mesoblastic/JJ nephroma/NN ./.
@@30080947435/CD The/DT C-terminal/NN end/NN of/IN this/DT polypeptide/NN harbors/VBP three/CD types/NNS of/IN repeated/JJ sequences/NNS ./.
@@95701072545/CD Similarly/RB ,/, PCDFs/NNP //NNP PCDDs/NNP ratio/NN in/IN ESP/NN ash/NN was/VBD lower/JJR than/IN that/DT in/NN boiler/NN ash/NN ./.
@@87709818827/CD All/DT patients/NNS had/VBP abnormal/JJ von/NNP Willebrand/NN factor/NN (/( vWF/GENE )/SYM fragmentation/NN as/IN reflected/VBN by/IN decreased/VBN high/JJ molecular/JJ weight/NN and/CC increased/VBN low/JJ molecular/JJ weight/NN vWF/MULTIGENE multimers/MULTIGENE in/IN the/DT circulation/NN ./.
@@97217989705/CD Seventy-five/NNS percent/NN of/IN children/NNS who/WP received/VBD a/DT second/JJ transplant/NN for/IN HCV/NN hepatitis/NN had/VBP early/JJ histologic/JJ recurrence/NN that/WDT led/VBD to/IN liver/NN failure/NN and/CC death/NN ./.
@@10598101126/CD In/NN addition/NN to/IN the/DT bZIP/MULTIGENE protein/MULTIGENE Opaque2/MULTIGENE (/( O2/GENE )/SYM ,/, there/RB are/VBP other/DT maize/NN endosperm/NN nuclear/JJ proteins/NNS that/WDT recognize/VBP the/DT O2/MULTIGENE box/MULTIGENE in/IN 22/CD kDa/NN zein/NEWGENE gene/NN promoters/NNS ./.
@@4291514907/CD Year/NN one/PRP of/IN the/DT first/JJ general/JJ practitioner/NN medical/JJ unit/NN in/IN the/DT greater/JJR Glasgow/NN area/NN ./.
@@28330495799/CD Variations/NNS in/IN the/DT 5'/CD half/NN of/IN U3/GENE were/VBD primarily/RB due/NN to/IN insertions/NNS and/CC deletions/NNS ./.
@@2323544772/CD Serum/NN ACTH/NEWGENE did/VBD not/RB respond/VB to/IN insulin/NN and/CC metyrapone/NN ./.
@@97635221938/CD Interestingly/RB ,/, an/DT antibody/NN against/IN N-SMase/GENE can/MD abrogate/VB Ox-LDL-/NNP and/CC TNF-alpha-induced/JJ apoptosis/NN and/CC therefore/RB may/MD be/VB useful/JJ for/IN in/IN vivo/NN studies/NNS of/IN apoptosis/NN in/IN experimental/JJ animals/NNS ./.
@@80989148078/CD During/IN exercise/NN ,/, the/DT Pes-Ves/NNP relation/NN was/VBD shifted/VBN toward/IN the/DT left/NN and/CC the/DT slope/NN [/NN end-systolic/NN elastance/NN (/( Ees/NNS )/NN ]/NN increased/VBN from/IN 7/CD ./CD 7/CD +/NN //NN -/NN 2/CD ./CD 8/CD to/IN 12/CD ./CD 7/CD +/NN //NN -/NN 4/CD ./CD 2/CD (/( SD/NN )/SYM mmHg/NN //NN ml/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@85520925839/CD In/NN addition/NN to/IN protein/NN binding/JJ at/IN sequences/NNS known/VBP to/IN be/VB involved/VBN in/IN the/DT regulation/NN of/IN transcription/NN ,/, genomic/JJ footprinting/VBG of/IN the/DT entire/JJ promoter/NN region/NN also/RB showed/VBD that/IN a/DT protein/NN factor/NN is/VBZ constitutively/RB bound/JJ to/IN the/DT first/JJ intron/NN of/IN the/DT rep3/MULTIGENE gene/MULTIGENE ./.
@@112231533832/CD The/DT BFA/GENE System/NNP reads/VBZ a/DT text/NN file/NN with/IN flows/NNS ,/, measured/VBN with/IN fluorescent/JJ microsphere/NN technique/NN ,/, and/CC constructs/VBZ the/DT lung/NN anatomy/NN with/IN volumetric/JJ pixels/NNS showing/VBG the/DT flows/NNS with/IN a/DT color/NN schema/NN ./.
@@7935997263/CD The/DT parameters/NNS of/IN nonspecific/JJ humoral/JJ immunity--serum/JJ immunoglobulins/NNS and/CC immune/JJ complexes--were/RB evaluated/VBN in/IN irradiated/JJ group/NN of/IN patients/NNS with/IN uterine/JJ cervix/NN carcinoma/NN (/( Stages/NNS IIB/GENE and/CC IIIB/GENE )/SYM ,/, during/IN one/PRP year/NN follow/VB up/RB ./RB
@@10730763550/CD Preliminary/JJ use/NN of/IN the/DT Nottingham/NN Eczema/NNS Severity/NN Score/NN would/MD support/VB further/JJ development/NN as/IN a/DT research/NN tool/NN for/IN a/DT simple/JJ assessment/NN of/IN disease/NN severity/NN that/WDT could/MD be/VB used/VBN in/IN epidemiological/JJ studies/NNS ./.
@@23534538458/CD The/DT order/NN of/IN the/DT helicase/MULTIGENE motif/MULTIGENE and/CC the/DT nsP3/MULTIGENE homology/MULTIGENE region/MULTIGENE in/IN the/DT RUB/GENE genome/NN is/VBZ reversed/VBN with/IN respect/NN to/IN the/DT alphavirus/NN genome/NN indicating/VBG that/IN a/DT genetic/JJ rearrangement/NN has/VBZ occurred/VBN during/IN the/DT evolution/NN of/IN these/DT viruses/NNS ./.
@@13394684983/CD The/DT ORF1/MULTIGENE protein/MULTIGENE was/VBD found/VBN to/IN be/VB highly/RB homologous/JJ to/IN the/DT putative/JJ potexvirus/NEWGENE RNA/MULTIGENE replicases/MULTIGENE ;/: ORF2/GENE ,/, -3/NN ,/, -5/CD and/CC -6/CD proteins/NNS also/RB have/VBP analogues/NNS among/IN the/DT potex-/NN and/IN //IN or/IN carlavirus-encoded/JJ proteins/NNS ./.
@@77530305954/CD Hybridization/NNS signals/NNS were/VBD also/RB detected/VBN with/IN total/JJ DNAs/NNS of/IN Rhizobium/MULTIGENE leguminosarum/MULTIGENE bv/MULTIGENE ./MULTIGENE phaseoli/NN ,/, Rhodobacter/NN capsulatus/NN and/CC Escherichia/NN coli/JJ ,/, but/CC not/RB those/DT of/IN Xanthomonas/NNP campestris/NN pv/CD ./CD campestris/NN and/CC Pseudomonas/NNS putida/NN ./.
@@83875078052/CD The/DT regulation/NN of/IN Myf-5/NEWGENE and/CC MyoD/NEWGENE function/NN by/IN a/DT cAMP-dependent/JJ pathway/NN may/MD partly/RB explain/VB how/RB external/NN signals/NNS generated/VBN by/IN serum/JJ and/CC certain/JJ peptide/MULTIGENE growth/MULTIGENE factors/MULTIGENE can/MD be/VB transduced/VBN to/IN the/DT nucleus/NN and/CC inhibit/VB dominant-acting/JJ factors/NNS that/WDT are/VBP responsible/JJ for/IN myoblast/NN differentiation/NN ./.
@@8530418694/CD Together/RB ,/, our/PRP data/NN suggest/VB that/IN the/DT TR2/MULTIGENE orphan/MULTIGENE receptor/MULTIGENE may/MD be/VB a/DT master/JJ regulator/NN in/IN modulating/JJ the/DT activation/NN of/IN two/JJ key/JJ HREs/CONTEXTGENE ,/, RARE/MULTIGENE beta/MULTIGENE and/CC CRBPIIp/GENE ,/, involved/VBN in/IN the/DT retinoic/JJ acid/NN signal/JJ transduction/NN pathway/NN ./.
@@95451463805/CD CONCLUSIONS/IN :/: These/DT routinely/RB collected/VBN data/NN provided/VBD quantitative/JJ estimates/NNS of/IN changes/NNS in/IN CBZ/MULTIGENE Cl/MULTIGENE //MULTIGENE F/MULTIGENE due/NN to/IN comedication/NN and/CC an/DT age-related/JJ decrease/NN in/IN Cl/NNP //NNP F/NNP The/DT derived/VBN regression/NN equations/NNS reasonably/RB predicted/VBN concentrations/NNS in/IN a/DT separate/JJ validation/NN set/NN ./.
@@78917204033/CD We/PRP show/VBP here/RB that/IN the/DT binding/NN of/IN C1F/GENE in/IN vitro/FW is/VBZ sensitive/JJ to/IN the/DT concentration/NN of/IN calcium/NN ions/NNS ./.
@@28707203553/CD Bisoprolol/NNP was/VBD found/VBN to/IN be/VB an/DT effective/JJ beta-adrenoceptor/MULTIGENE antagonist/MULTIGENE ,/, the/DT pA2/GENE values/NNS determined/VBN against/IN isoprenaline/NN in/IN guinea/NN pig/NN atria/NNS and/CC tracheal/JJ muscle/NN being/VBP 7/CD ./CD 45/CD and/CC 6/CD ./CD 41/CD ,/, respectively/RB ./.
@@104445972170/CD Interestingly/RB ,/, following/IN induction/NN of/IN stress/NN by/IN heat/NN shock/NN ,/, high/JJ salt/NN ,/, or/CC ethanol/NN ,/, conditions/NNS under/IN which/WDT most/JJ mRNA/NN export/NN is/VBZ blocked/VBN ,/, Npl3p/GENE is/VBZ still/RB exported/VBN from/IN the/DT nucleus/NN ./.
@@34517614717/CD After/IN a/DT baseline/NN study/NN ,/, WPW/NNP syndrome/NN was/VBD simulated/JJ by/IN stimulation/NN at/IN seven/JJ different/JJ sites/NNS around/IN the/DT base/NN of/IN the/DT ventricles/NNS ,/, and/CC RNV's/GENE were/VBD obtained/VBN ./.
@@106697369006/CD There/EX was/VBD a/DT 2/CD ./CD 4-fold/CD difference/NN in/IN CAT/NN produced/VBN from/IN these/DT transcripts/NNS in/IN HeLa/DT cells/NNS ,/, which/WDT contain/VBP a/DT greater/RBR natural/JJ abundance/NN of/IN PTB/GENE ./.
@@16976112294/CD We/PRP speculate/VBP that/IN these/DT tumors/NNS may/MD represent/VB congenital/JJ hamartomatous/JJ growths/NNS ./.
@@17482924262/CD We/PRP have/VBP isolated/VBN cDNAs/NNS for/IN a/DT gene/NN coding/JJ for/IN a/DT G/MULTIGENE protein/MULTIGENE alpha/MULTIGENE subunit/MULTIGENE from/IN tomato/NN (/( Lycopersicon/NN esculentum/NN ,/, cv/NN ./NN
@@63241218499/CD The/DT 12/CD ,/CD 000/CD MW/NN (/( 12K/NN )/SYM IE/JJ polypeptide/NN encoded/VBN by/IN IEmRNA-5/GENE is/VBZ translated/VBN from/IN an/DT 88/CD codon/NN open/JJ reading/JJ frame/NN ,/, leaving/VBG a/DT 1200/CD base/NN 3'/CD non-translated/JJ region/NN ./.
@@96570039575/CD Evolutionary/NNP relationships/NNS among/IN putative/JJ RNA-dependent/MULTIGENE RNA/MULTIGENE polymerases/MULTIGENE encoded/VBN by/IN a/DT mitochondrial/MULTIGENE virus-like/MULTIGENE RNA/MULTIGENE in/IN the/DT Dutch/JJ elm/NN disease/NN fungus/NN ,/, Ophiostoma/NNP novo-ulmi/JJ ,/, by/IN other/DT viruses/NNS and/CC virus-like/MULTIGENE RNAs/MULTIGENE and/CC by/IN the/DT Arabidopsis/NN mitochondrial/JJ genome/NN ./.
@@16596851512/CD Two/CD independent/JJ promoters/NNS as/RB well/VBP as/IN 5'/CD untranslated/JJ regions/MULTIGENE regulate/MULTIGENE Dd/MULTIGENE ras/MULTIGENE expression/NN in/IN Dictyostelium/DT ./.
@@10666509476/CD Ischemia-induced/JJ biphasic/JJ arrhythmias/NNS were/VBD suppressed/VBN in/IN both/DT zatebradine/NN and/CC propranolol/NN groups/NNS ./.
@@18849984983/CD All/DT members/NNS are/VBP also/RB capable/JJ of/IN activating/JJ in/IN vivo/NN transcription/NN from/IN promoters/NNS that/WDT contain/VBP a/DT C/MULTIGENE //MULTIGENE EBP-binding/MULTIGENE site/MULTIGENE ./.
@@8334728314/CD Also/RB ,/, except/VB in/IN one/PRP patient/NN who/WP developed/VBD gallstones/NNS following/IN institution/NN of/IN colestipol/NN ,/, saturation/NN of/IN gallbladder/NN bile/NN with/IN cholesterol/NN was/VBD not/RB markedly/RB increased/VBN by/IN this/DT drug/NN alone/RB ./.
@@17519707405/CD Amino/NN acid/NN residues/NNS 147-167/NN of/IN the/DT previously/RB reported/VBN sequence/NN are/VBP replaced/VBN by/IN new/JJ residues/NNS 147/CD to/IN 150/CD ./.
@@66678688737/CD Morphofunctional/JJ status/NN of/IN the/DT formed/VBN elements/NNS of/IN the/DT blood/NN in/IN rats/NNS subjected/VBN to/IN different/JJ variants/NNS of/IN combined/JJ and/CC isolated/VBN exposure/NN to/IN BR-1/GENE benzene/NN ./.
@@36520834323/CD Thus/RB in/IN this/DT region/NN of/IN the/DT vessel/NN pyridinoline/NN represents/VBZ the/DT major/JJ stabilising/JJ crosslink/NN of/IN collagen/NN ./.
@@77146086772/CD No/DT significant/JJ differences/NNS were/VBD identified/VBN between/IN groups/NNS for/IN pH/NN ,/, PaCO2/GENE ,/, intracranial/JJ pressure/NN ,/, heart/NN rate/NN ,/, brain/NN temperature/NN ,/, or/CC glucose/NN levels/NNS ./.
@@105644744853/CD PhoP-PhoQ/NNP homologues/NNS in/IN Pseudomonas/NNS aeruginosa/NN regulate/VB expression/NN of/IN the/DT outer-membrane/MULTIGENE protein/MULTIGENE OprH/NN and/CC polymyxin/MULTIGENE B/MULTIGENE resistance/NN ./.
@@107995953216/CD Thus/RB ,/, both/DT YY1/GENE and/CC CDP/NN appear/VB to/IN be/VB negative/JJ regulators/NNS of/IN the/DT differentiation-induced/MULTIGENE HPV-6/MULTIGENE E1/MULTIGENE promoter/MULTIGENE and/CC thereby/RB the/DT HPV/NN life/NN cycle/NN ./.
@@90654634488/CD DNA/NN strand/NN exchange/NN catalyzed/VBN by/IN Rad51/MULTIGENE protein/MULTIGENE is/VBZ also/RB greatly/RB stimulated/VBN by/IN RPA/NNS ./.
@@97907689992/CD Htra2-beta3/GENE is/VBZ developmentally/RB regulated/VBN and/CC expressed/VBN predominantly/RB in/IN brain/NN ,/, liver/NN testis/NN ,/, and/CC weakly/RB in/IN kidney/NN ./.
@@62304996031/CD It/PRP has/VBZ been/VBN established/VBN that/IN preoperative/JJ irradiation/NN in/IN the/DT form/NN of/IN the/DT fractionation/NN of/IN a/DT single/JJ focal/JJ dose/NN of/IN 6/CD Gy/JJ every/DT other/DT day/NN ,/, the/DT summary/NN dose/NN of/IN 24/CD Gy/JJ within/IN 8-10/CD days/NNS followed/VBN by/IN surgery/NN 1-3/CD days/NNS after/IN irradiation/NN does/VBP not/RB either/DT complicate/VB its/PRP performance/NN or/CC the/DT course/NN of/IN the/DT postoperative/JJ period/NN ,/, and/CC by/IN the/DT short-/JJ and/CC long-term/JJ results/NNS it/PRP is/VBZ no/DT worse/JJ than/IN the/DT routine/JJ dose/NN fractionation/NN ./.
@@25440593469/CD Effects/NNPS of/IN nitrogen/NN (/( PN2/GENE :/: 5/CD and/CC 14/CD MPa/NNS )/SYM and/CC helium/NN (/( PHe/NNP :/: 13/CD and/CC 14/CD MPa/NNS )/SYM were/VBD also/RB tested/VBN ./.
@@89278418887/CD Epidemiological/JJ data/NN are/VBP quite/RB controversial/JJ but/CC sudden/JJ death/NN occurring/VBG during/IN sporting/JJ activity/NN is/VBZ probably/RB not/RB a/DT rare/JJ occurrence/NN ./.
@@2211362844/CD A/DT similar/JJ phenomenon/NN has/VBZ been/VBN reported/VBN in/IN a/DT few/JJ humans/NNS ./.
@@95109255235/CD If/IN the/DT haemoglobin/NN concentration/NN (/( Hb/NN )/SYM was/VBD less/PRP than/IN 12/CD g/NN dL-1/GENE they/PRP were/VBD given/VBP a/DT four/CD week/NN course/NN of/IN ferrous/JJ sulphate/NN ./.
@@104097413270/CD We/PRP have/VBP isolated/VBN three/CD mutant/MULTIGENE alleles/MULTIGENE of/IN CDC4/GENE (/( cdc4-10/GENE ,/, cdc4-11/GENE ,/, and/CC cdc4-16/GENE )/SYM which/WDT suppress/VBP the/DT nuclear/JJ division/NN defect/NN of/IN cdc20-1/NNP cells/NNS ./.
@@8703010461/CD Therefore/RB ,/, we/PRP have/VBP identified/VBN a/DT cis-acting/JJ element/NN ,/, the/DT E1/MULTIGENE E-box/MULTIGENE ,/, located/VBN in/IN the/DT GAP-43/MULTIGENE promoter/MULTIGENE region/MULTIGENE that/WDT modulates/VBZ either/DT positively/RB or/CC negatively/RB the/DT expression/NN of/IN the/DT GAP-43/MULTIGENE gene/MULTIGENE depending/VBG on/IN which/WDT E-box-binding/MULTIGENE proteins/MULTIGENE occupy/VBP this/DT site/NN ./.
@@107481642790/CD Scanning/NN mutations/NNS throughout/IN the/DT AC/MULTIGENE element/MULTIGENE interfered/VBN with/IN induction/NN but/CC allowed/VBN us/PRP to/IN define/VB five/CD overlapping/JJ sites/NNS for/IN regulatory/JJ factors/NNS in/IN AC/NEWGENE and/CC to/IN design/NN probes/NNS binding/JJ just/RB one/PRP or/CC two/JJ factors/NNS ./.
@@86105828586/CD Forty-five/CD patients/NNS with/IN pleural/JJ lesions/NNS identified/VBN on/IN CT/NN scans/NNS were/VBD subsequently/RB examined/VBN by/IN MR/NN imaging/JJ at/IN 0/CD ./CD 5/CD T/NNP ./NNP
@@108268615708/CD The/DT monoclonal/JJ immunoglobulin/MULTIGENE products/MULTIGENE of/IN plasma/NN cell/NN neoplasm/NN can/MD give/VB rise/VB to/IN a/DT variety/NN of/IN manifestations/NNS including/JJ hyperviscosity/NN ,/, amyloidosis/NN ,/, cryoglobulinemia/NN ,/, neuropathy/NN ,/, and/CC renal/JJ failure/NN ./.
@@117164411170/CD ISS/NN and/CC the/DT acute/JJ physiology/NN and/CC chronic/JJ health/NN evaluation/NN (/( APACHE/MULTIGENE II/MULTIGENE )/SYM calculated/VBN on/IN admission/NN ./.
@@29833161047/CD When/WRB the/DT coding/JJ segments/NNS ,/, including/JJ both/DT framework/NN and/CC complementarity-determining/MULTIGENE regions/MULTIGENE ,/, of/IN these/DT genes/NNS and/CC the/DT murine/JJ probe/NN sequences/NNS are/VBP compared/VBN by/IN metric/JJ analysis/NN ,/, it/PRP is/VBZ apparent/JJ that/IN the/DT caiman/NN genes/NNS are/VBP only/RB slightly/RB more/RB related/VBN to/IN each/DT other/DT than/IN to/IN the/DT mammalian/JJ sequence/NN ,/, consistent/JJ with/IN significant/JJ preservation/NN of/IN nucleotide/NN sequence/NN over/RB an/DT extended/VBN period/NN of/IN phylogenetic/JJ time/NN ./.
@@55604285597/CD Behavioral/JJ and/CC electrographic/JJ expression/NN of/IN natural/JJ sleep/NN and/CC wakefulness/NN in/IN reptiles/NNS ./.
@@90400119197/CD In/NN summary/NN ,/, p56/NN (/NN lck/NN )/NN activity/NN stimulates/VBZ G1/NN //NN S/NN transition/NN in/IN immature/JJ thymoblasts/NNS and/CC maintains/VBZ cell/NN viability/NN via/NN transduction/NN of/IN constitutive/JJ activation/NN signals/NNS downstream/RB to/IN components/NNS of/IN the/DT Ras/GENE //GENE Raf/GENE //GENE MAPK/GENE pathway/NN ./.
@@31371059039/CD A/DT prostaglandin/NN analogue/NN given/VBP in/IN early/JJ pregnancy/NN and/CC human/JJ chorionic/JJ gonadotropin/NN given/VBP near/IN the/DT end/NN of/IN the/DT ensuing/JJ follicular/JJ phase/NN were/VBD used/VBN for/IN controlling/VBG the/DT reproductive/JJ cycle/NN ,/, timing/JJ oocyte/NN collection/NN ,/, and/CC synchronizing/JJ the/DT cycles/NNS of/IN oocyte/NN donors/NNS and/CC embryo/NN recipients/NNS ./.
@@98192167054/CD (/( 1992/CD )/SYM Biochemistry/NNP 31/CD ,/, 3351-3358/NN ]/NN ./.
@@8876167355/CD However/RB ,/, an/DT intrinsic/MULTIGENE DNA-binding/MULTIGENE subunit/MULTIGENE for/IN HiNF-D/NNP was/VBD not/RB identified/VBN ./.
@@91384921993/CD Laboratory/NNP exam/NN :/: IDR/NNS of/IN the/DT tuberculin/NN was/VBD high/JJ positive/NN ,/, chest/NN radiography/NN shows/VBZ hilar/JJ bilateral/JJ calcifications/NNS ,/, ORL/NN exam/NN shows/VBZ a/DT tumor/NN at/IN the/DT foot/NN of/IN the/DT epiglottis/NN and/CC anatomopathological/JJ exam/NN shows/VBZ low/RB differentiated/VBN epidermoid/JJ carcinoma/NN ./.
@@1316476537/CD The/DT ORF/MULTIGENE 4/MULTIGENE gene/MULTIGENE was/VBD minimally/RB active/JJ ,/, whereas/IN the/DT ORF/MULTIGENE 62/MULTIGENE gene/MULTIGENE gave/VBD twofold/JJ induction/NN ;/: both/DT genes/NNS ,/, acting/JJ together/RB ,/, gave/VBD fivefold/JJ induction/NN ./.
@@92280421862/CD We/PRP have/VBP separated/VBN a/DT dermatan/NN sulfate/NN proteoglycan/NN ,/, epiphycan/NN ,/, from/IN decorin/NN and/CC biglycan/NN by/IN using/VBG dissociative/JJ extraction/NN of/IN bovine/JJ fetal/JJ epiphyseal/JJ cartilage/NN ,/, followed/VBN by/IN sequential/JJ ion-exchange/NN ,/, gel/NN permeation/NN ,/, hydrophobic/JJ ,/, and/CC Zn2+/NN chelate/JJ chromatographic/JJ steps/NNS ./.
@@12253391863/CD We/PRP suggest/VBP that/IN such/JJ occlusions/NNS occurred/VBN at/IN the/DT time/NN of/IN the/DT infarction/NN ./.
@@98587457923/CD In/NN vitro/FW transcription/NN assays/NNS demonstrate/VBP that/IN the/DT TCA-cycle/NNP intermediate/JJ ,/, fumarate/NN ,/, directly/RB and/CC specifically/RB inhibits/VBZ the/DT formation/NN of/IN the/DT clcA/MULTIGENE transcript/MULTIGENE ./.
@@103773456116/CD Green/NNP fluorescent/JJ protein-tagged/JJ UNC-49B/GENE and/CC UNC-49C/GENE subunits/NNS are/VBP coexpressed/VBN in/IN muscle/NN cells/NNS and/CC are/VBP colocalized/VBN to/IN synaptic/JJ regions/NNS ./.
@@56838095645/CD Effect/NN of/IN thrombotic/JJ and/CC antithrombotic/JJ drugs/NNS on/IN the/DT surface/NN charge/NN characteristics/NNS of/IN canine/JJ blood/NN vessels/NNS :/: in/IN vivo/NN and/CC in/IN vitro/FW studies/NNS ./.
@@106841116421/CD It/PRP has/VBZ also/RB been/VBN shown/VBP that/IN a/DT variety/NN of/IN extracellular/JJ factors/NNS stimulate/VBP a/DT pair/NN of/IN MAPK/MULTIGENE p44/MULTIGENE and/CC MAPK/MULTIGENE p42/MULTIGENE of/IN MAPK/MULTIGENE family/MULTIGENE members/MULTIGENE ./.
@@86494054842/CD Sp1/GENE binds/VBZ two/JJ sites/NNS in/IN the/PDT CD11c/MULTIGENE promoter/MULTIGENE in/IN vivo/NN specifically/RB in/IN myeloid/JJ cells/NNS and/CC cooperates/VBZ with/IN AP1/GENE to/IN activate/VB transcription/NN ./.
@@93745418197/CD Constitutive/JJ protection/NN of/IN E2F/MULTIGENE recognition/MULTIGENE sequences/MULTIGENE in/IN the/DT human/MULTIGENE thymidine/MULTIGENE kinase/MULTIGENE promoter/MULTIGENE during/IN cell/NN cycle/NN progression/NN ./.
@@83701193610/CD These/DT contain/VB a/DT single/JJ 1977-bp/CD exon/NN that/IN encodes/VBZ 900/CD bp/NN of/IN the/DT 5'/CD and/CC 3'/CD untranslated/JJ sequences/NNS in/IN addition/NN to/IN a/DT 1077-bp/JJ open/JJ reading/JJ frame/NN identical/JJ to/IN that/DT found/VB in/IN vascular/MULTIGENE smooth/MULTIGENE muscle/MULTIGENE cell/MULTIGENE AT1a/MULTIGENE receptor/MULTIGENE cDNAs/MULTIGENE ./.
@@22007368752/CD These/DT factors/NNS belong/VBP to/IN a/DT set/NN of/IN genetically/RB distinct/JJ molecules/NNS ,/, including/JJ AP-4/GENE and/CC MLTF/GENE ,/, that/WDT bind/VBP to/IN the/DT CACCTGTC/MULTIGENE motif/MULTIGENE or/CC related/VBN sequences/NNS ./.
@@7539119945/CD Both/DT mutations/NNS completely/RB abolished/VBN binding/NN of/IN the/DT Abl/MULTIGENE SH3/MULTIGENE domain/NN to/IN proline-rich/JJ target/NN proteins/NNS in/IN a/DT filter-binding/JJ assay/NN ./.
@@88584632255/CD We/PRP conclude/VBP that/IN ,/, in/IN AIDS/NN patients/NNS with/IN cryptococcosis/NN ,/, tolerance/NN to/IN ILd-AmB/GENE was/VBD acceptable/JJ when/CC the/DT daily/JJ dosage/NN did/VBD not/RB exceed/VB 1/CD mg/CD //CD kg/CD ,/, but/CC the/DT higher/JJ 1/CD ./CD 5/CD mg/CD //CD kg/CD daily/JJ dosage/NN was/VBD associated/VBN with/IN an/DT unacceptable/JJ rate/NN of/IN nephrotoxicity/NN ./.
@@89060568866/CD These/DT patients/NNS appear/VBP to/IN have/NN slightly/RB better/RBR pulmonary/JJ function/NN and/CC nutritional/JJ status/NN ;/: yet/RB ,/, they/PRP seem/VBP to/IN have/NN a/DT higher/JJ degree/NN of/IN health/NN care/NN utilization/NN ./.
@@82078055041/CD The/DT p53/GENE tumor/NN suppressor/NN gene/NN product/NN ,/, a/DT sequence-specific/MULTIGENE DNA-binding/MULTIGENE protein/MULTIGENE ,/, has/VBZ been/VBN shown/VBP to/RB act/NN as/IN a/DT transcriptional/JJ activator/NN and/CC repressor/NN both/DT in/NN vitro/FW and/CC in/IN vivo/NN ./.
@@80458348036/CD The/DT PCr/NN resynthesis/NN rate/NN (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM and/CC the/DT effective/JJ maximal/JJ rate/NN of/IN mitochondrial/JJ ATP/NN synthesis/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM also/RB improved/VBN ./.
@@87566365971/CD Semidominant/NNP mutations/NNS in/IN the/DT yeast/MULTIGENE Rad51/MULTIGENE protein/MULTIGENE and/CC their/PRP relationships/NNS with/IN the/DT Srs2/MULTIGENE helicase/MULTIGENE ./.
@@30200014519/CD The/DT smallest/JJS of/IN the/DT mini-Mu/MULTIGENE elements/MULTIGENE is/VBZ only/RB 7/CD ./CD 9/CD kilobase/NN pairs/NNS long/JJ ,/, allowing/VBG the/DT cloning/NN of/IN DNA/NN fragments/NNS of/IN up/JJ to/IN 31/CD ./CD 1/CD kilobase/NN pairs/NNS ,/, and/CC the/DT largest/JJS of/IN them/PRP is/VBZ 21/CD ./CD 7/CD kilobase/NN pairs/NNS ,/, requiring/JJ that/IN clones/NNS carry/VBP insertions/NNS of/IN less/PRP than/IN 17/CD ./CD 3/CD kilobase/NN pairs/NNS ./.
@@87030053921/CD The/DT cis-acting/JJ elements/NNS that/WDT control/VBP promoter/NN activity/NN include/VB binding/JJ sites/NNS for/IN transcription/MULTIGENE factors/MULTIGENE Sp1/MULTIGENE and/CC alphaCbf/NN ,/, a/DT 60-kDa/MULTIGENE CCAAT/MULTIGENE box-binding/MULTIGENE protein/MULTIGENE ./.
@@76746495879/CD A/DT single-case/JJ experimental/JJ ABAB/GENE multiple/JJ baseline/NN design/NN was/VBD employed/VBN to/IN test/NN for/IN treatment/NN effectiveness/NN ./.
@@113068451135/CD Histological/JJ examination/NN showed/VBD lichenoid/JJ changes/NNS ,/, acantholytic/JJ blister/NN formation/NN and/CC apoptotic/JJ keratinocytes/NNS ./.
@@114699702518/CD Patients/NNS with/IN type/MULTIGENE III/MULTIGENE SOD/NEWGENE may/MD have/VB visceral/JJ hyperalgesia/NN ;/: a/DT trial/NN of/IN antidepressants/NNS or/CC a/DT therapeutic/JJ trial/NN with/IN botulinum/MULTIGENE toxin/MULTIGENE injection/NN into/IN the/DT ampulla/NN should/MD be/VB considered/VBN prior/NN to/IN more/RB invasive/JJ endoscopic/JJ therapy/NN ./.
@@2061282194/CD The/DT sequence/NN of/IN the/DT pMxL1/GENE plasmid/NN containing/JJ the/DT invertible/JJ region/NN contains/VBZ a/DT perfect/JJ tandem/NN repeat/NN of/IN 19/CD bp/NN in/IN the/DT orientation/NN 1/CD nonexpressed/JJ pilin/NN gene/NN at/IN the/DT middle/NN of/IN the/DT recombination/NN junction/NN site/NN ./.
@@116863781533/CD Considering/VBG that/IN the/DT reactor/NN is/VBZ thoroughly/RB mixed/JJ during/IN each/DT discharge/NN and/CC that/DT LD50/NN =/SYM 0/CD ./CD 9/CD values/NNS are/VBP nearly/RB independent/NN of/IN E/NNP ./NNP coli/JJ concentrations/NNS in/IN the/DT range/NN of/IN 2/CD x/NN 10/NN (/NN 3/NN )/NN </SYM or/CC =/SYM E/NN coli/NN //NN cfu/NN mL/NN (/NN -1/NN )/NN </SYM or/CC =/SYM 3/CD x/NN 10/NN (/NN 6/NN )/NN ,/, we/PRP ascribe/VBP the/DT nonexponential/JJ Pn/NN decay/NN of/IN single-strain/NNP E/NNP ./NNP coli/JJ colonies/NNS to/IN a/DT shielding/NN phenomenon/NN where/CC inactive/JJ cells/NNS protect/VBP the/DT successively/RB smaller/JJR numbers/NNS of/IN viable/JJ cells/NNS in/IN the/DT EHD/NN ./.
@@13712722135/CD Perturbation/NNS of/IN dNTP/NN pools/NNS also/RB affected/VBN the/DT frameshift/JJ fidelity/NN of/IN the/DT replicative/JJ yeast/MULTIGENE DNA/MULTIGENE polymerase/MULTIGENE alpha/MULTIGENE ./.
@@2393001557/CD Although/IN %BF/GENE was/VBD correlated/VBN with/IN all/PDT the/DT BMIs/NNS (/( r/JJ =/SYM 0/CD ./CD 60-0/CD ./CD 82/CD )/SYM ,/, applying/VBG objective/JJ definitions/NNS of/IN obesity/NN based/VBN on/IN BMIs/NNS or/CC %BF/GENE by/IN densitometry/NN often/RB produced/VBD conflicting/JJ results/NNS ./.
@@80079756563/CD The/DT IPL1/MULTIGENE gene/MULTIGENE is/VBZ required/VBN for/IN high-fidelity/NN chromosome/NN segregation/NN in/IN the/DT budding/JJ yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@11064829899/CD Cardiovascular/NNP risk/NN factors/NNS and/CC antihypertensive/JJ treatment/NN ./.
@@114480511326/CD The/DT system/NN ,/, designed/VBN to/IN exploit/NN the/DT relatively/JJ constant/JJ small/JJ intestine/NN transit/NN time/NN ,/, consists/VBZ of/IN a/DT drug-containing/JJ core/NN coated/JJ with/IN a/DT polymeric/JJ matrix/NN formed/VBN by/IN a/DT channeling/VBG agent/NN (/( NaCl/NN ,/, mannitol/NN ,/, and/CC Emdex/NN )/SYM and/CC an/DT inert/JJ polymer/NN (/( Eudragit/NNP RS100/NNP )/SYM ./.
@@96502759622/CD Strengthening/VBG the/DT biological/JJ weapons/NNS convention/NN and/CC implications/NNS on/IN the/DT pharmaceutical/NN and/CC biotechnology/NN industry/NN ./.
@@1004451943/CD Drag/VB reduction/NN in/IN turbulent/JJ flows/NNS by/IN polymers/NNS ./.
@@112786717690/CD Neuron-specific/MULTIGENE Bcl-2/MULTIGENE homology/MULTIGENE 3/MULTIGENE domain-only/MULTIGENE splice/NN variant/NN of/IN Bak/GENE is/VBZ anti-apoptotic/JJ in/IN neurons/NNS ,/, but/CC pro-apoptotic/JJ in/IN non-neuronal/JJ cells/NNS ./.
@@14963482108/CD Caries/NNPS and/CC parodontitis/NN have/NN been/VBN one/PRP of/IN the/DT most/JJ spread/NN diseases/NNS of/IN mankind/NN ./.
@@9829916306/CD Expression/NNS of/IN lacZ/NN from/IN the/DT promoter/NN of/IN the/DT Escherichia/NN coli/JJ spc/NN operon/NN cloned/VBN into/IN vectors/NNS carrying/VBG the/DT W205/GENE trp-lac/JJ fusion/NN ./.
@@80824408062/CD (/( LH/MULTIGENE P/MULTIGENE </SYM 0/CD ./CD 05/CD ,/, LH/MULTIGENE //MULTIGENE FSH/MULTIGENE P/MULTIGENE </SYM 0/CD ./CD 01/CD )/SYM ./.
@@100717618068/CD In/NN addition/NN ,/, mapping/NN of/IN the/DT promoter/NN region/NN and/CC the/DT identification/NN of/IN putative/JJ promoter/NN regulatory/JJ sequences/NNS should/MD give/VB insight/NN into/IN the/DT transcriptional/JJ regulation/NN of/IN UCP2/GENE expression--in/JJ particular/NN by/IN anyone/NN of/IN the/DT above/RB mentioned/VBN factors--in/MULTIGENE vitro/MULTIGENE and/CC in/IN vivo/NN ./.
@@13330472402/CD Here/RB we/PRP show/VBP that/IN epidermal/MULTIGENE growth/MULTIGENE factor/MULTIGENE or/CC platelet-derived/MULTIGENE growth/MULTIGENE factor/MULTIGENE stimulation/NN of/IN intact/JJ human/JJ or/CC murine/JJ cells/NNS leads/VBP to/IN phosphorylation/NN of/IN Nck/MULTIGENE protein/MULTIGENE on/IN tyrosine/NN ,/, serine/NN ,/, and/CC threonine/NN residues/NNS ./.
@@79160032439/CD Similar/JJ to/IN the/DT mouse/NN gene/NN ,/, the/DT 5'/CD flanking/JJ region/NN of/IN human/MULTIGENE CD79/MULTIGENE alpha/MULTIGENE lacks/VBZ a/DT TATA/MULTIGENE box/MULTIGENE ;/: however/RB ,/, unlike/IN mouse/MULTIGENE CD79/MULTIGENE alpha/MULTIGENE ,/, a/DT classical/JJ octamer/NN motif/NN could/MD not/RB be/VB identified/VBN in/IN the/DT human/JJ gene/NN ./.
@@98381221957/CD Here/RB we/PRP report/VBP the/DT full-length/JJ coding/JJ cDNA/NN sequence/NN of/IN the/DT mouse/NN homologue/NN of/IN MPP3/GENE ./.
@@3817836103/CD Bone/NN marrow/NN transplantation-1979/GENE ./.
@@97927029419/CD Expression/NNS of/IN a/DT dominant-negative/JJ mutant/NN of/IN JNK1/GENE also/RB suppressed/VBN glucose/MULTIGENE deprivation-induced/MULTIGENE JNK1/MULTIGENE activation/NN as/RB well/VB as/IN HSP70/MULTIGENE gene/MULTIGENE expression/NN ./.
@@95648601057/CD In/NN contrast/NN ,/, receptor/MULTIGENE //MULTIGENE G/MULTIGENE protein/MULTIGENE coupling/NN appeared/VBD unaffected/JJ by/IN expression/NN of/IN loop/NN 3i/MULTIGENE domains/MULTIGENE derived/VBN from/IN two/JJ receptors/NNS coupled/VBN to/IN G/NN (/NN i/NN //NN o/NN )/NN proteins/NNS (/( M2Ach-muscarinic/NNP and/CC alpha2A-adrenergic/MULTIGENE receptors/MULTIGENE )/SYM ./.
@@113761191236/CD The/DT first/JJ exon/NN (/( exon/NN 1A/CD )/SYM that/WDT corresponded/VBD to/IN the/DT 5'-untranslated/JJ region/NN of/IN the/DT GHR/MULTIGENE 1A/MULTIGENE mRNA/MULTIGENE was/VBD 15/CD ,/CD 250/CD bp/NN upstream/RB from/IN exon/NN 2/CD in/IN the/DT GHR/MULTIGENE gene/MULTIGENE ./.
@@97842453313/CD Cardiac/MULTIGENE myosin-binding/MULTIGENE protein/MULTIGENE C/MULTIGENE (/( MyBP-C/CONTEXTGENE )/SYM :/: identification/NN of/IN protein/MULTIGENE kinase/MULTIGENE A/MULTIGENE and/CC protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE phosphorylation/MULTIGENE sites/MULTIGENE ./.
@@88203241266/CD The/DT limits/NNS of/IN agreement/NN between/IN DBS/NNP and/CC TOF/GENE responses/NNS were/VBD so/RB wide/JJ that/IN they/PRP cannot/MD be/VB used/VBN interchangeably/RB ./.
@@66599826417/CD The/DT analysis/NN of/IN the/DT structure/NN of/IN the/DT sleep/NN period/NN as/IN a/DT whole/NN reveals/VBZ that/IN with/IN increasing/NN of/IN the/DT age/NN the/DT delta-wave/NN stage/NN (/( DS/NN )/SYM of/IN the/DT QS/NN (/( determined/VBN by/IN defined/JJ polygraphic/JJ parameters/NNS )/SYM increases/NNS ,/, while/CC the/DT paradoxical/JJ phase/NN of/IN sleep/NN (/( PS/NN )/SYM decreases/NNS ,/, this/DT change/NN being/NN more/RB pronounced/VBD during/IN the/DT first/JJ six/CD months/NNS than/IN during/IN the/DT second/JJ ones/NNS of/IN the/DT first/JJ year/NN of/IN the/DT life/NN ./.
@@93495015655/CD We/PRP previously/RB showed/VBD that/IN the/DT N-terminal/NN portion/NN common/JJ to/IN various/JJ chimeric/JJ MLL/MULTIGENE products/MULTIGENE ,/, as/RB well/VB as/IN to/IN MLL-LTG9/GENE and/CC MLL-LTG19/GENE ,/, localizes/VBZ in/IN the/DT nuclei/NNS ,/, and/CC therefore/RB suggested/VBN that/IN it/PRP might/MD play/VB an/DT important/JJ role/NN in/IN leukemogenesis/NN ./.
@@4792465165/CD Isolated/JJ calcaneal/JJ tuberculous/JJ osteomyelitis/NN ./.
@@85667733974/CD We/PRP propose/VBP that/IN CTS1/GENE and/CC CTS2/GENE of/IN Ci/NN are/VBP members/NNS of/IN two/JJ distinct/JJ classes/NNS of/IN fungal/JJ chitinases/NNS ,/, an/DT observation/NN not/RB previously/RB reported/VBN for/IN a/DT single/JJ fungus/NN ./.
@@95456387274/CD We/PRP recently/RB characterized/VBD a/DT single/MULTIGENE yeast/MULTIGENE hnRNP/MULTIGENE methyltransferase/MULTIGENE (/( HMT1/GENE )/SYM ./.
@@99360018611/CD Electronic/NNP structure/NN of/IN delta/JJ -plutonium/CD and/CC of/IN single/MULTIGENE Al/MULTIGENE ,/, Ga/NN ,/, and/CC Sc/NN impurities/NNS in/IN delta/JJ -plutonium/CD ./.
@@56833637233/CD Investigation/NNP on/IN the/DT exchange/NN of/IN Ca45/GENE in/IN intact/JJ and/CC burned/VBN rats/NNS by/IN the/DT kinetic/JJ analysis/NN method/NN ./.
@@114330246197/CD Telomerase/WDT is/VBZ a/DT ribonucleoprotein/NN complex/NN that/WDT synthesizes/VBZ telomeric/MULTIGENE DNA/MULTIGENE onto/IN chromosomes/NNS using/VBG its/PRP RNA/NN component/NN as/IN template/NN ./.
@@10451209523/CD OBJECTIVE/IN :/: To/TO determine/VB whether/IN administration/NN of/IN misoprostol/NN prevents/VBZ gastric/JJ hemorrhage/NN in/IN healthy/JJ dogs/NNS treated/VBN with/IN high/JJ doses/NNS of/IN methylprednisolone/NN sodium/NN succinate/NN (/( MPSS/NN )/SYM ./.
@@96552485061/CD The/DT gp330/MULTIGENE //MULTIGENE Megalin/MULTIGENE //MULTIGENE LRP-2/MULTIGENE protein/MULTIGENE belongs/VBZ to/IN the/DT low-density/JJ lipoprotein/NN receptor/NN gene/NN family/NN and/CC is/VBZ believed/VBN to/RB function/NN as/IN an/DT endocytic/JJ receptor/NN for/IN the/DT uptake/NN of/IN lipoproteins/NNS and/CC many/VB other/DT ligands/NNS ./.
@@108504539401/CD Moreover/RB ,/, expression/NN of/IN antisense/NN Ha-Ras/NEWGENE or/CC dominant/JJ negative/JJ Raf-1/GENE abrogated/VBN the/DT mitogenic/JJ effect/NN of/IN TGF-beta1/GENE in/IN TSU-Pr1/NNP ,/, and/CC the/DT TGF-beta1/GENE inhibition/NN of/IN DU145/GENE was/VBD switched/VBN to/IN stimulation/NN by/IN V12Ha-Ras/NNP transfection/NN ./.
@@112227209188/CD We/PRP conclude/VBP that/IN RPMS/NNP acts/NNS as/IN a/DT negative/JJ regulator/NN of/IN EBNA2/GENE and/CC Notch/DT activity/NN through/RB its/PRP interactions/NNS with/IN the/DT CBF1-associated/MULTIGENE corepressor/MULTIGENE complex/MULTIGENE ./.
@@8189533827/CD To/TO study/VB the/DT structure-function/NN of/IN the/DT gene/MULTIGENE 5/MULTIGENE product/MULTIGENE ,/, wild-type/NN and/CC mutant/JJ forms/NNS of/IN NS53/GENE were/VBD produced/VBN by/IN using/VBG a/DT recombinant/JJ baculovirus/NN expression/NN system/NN and/CC a/DT recombinant/JJ vaccinia/NN virus/CONTEXTGENE //CONTEXTGENE T7/CONTEXTGENE (/( vTF7-3/GENE )/SYM expression/NN system/NN ./.
@@48391765201/CD Effect/NN of/IN a/DT high-intensity/JJ SHF/GENE field/NN on/IN the/DT blood/NN coagulation/NN system/NN ./.
@@112072616096/CD Functional/JJ analysis/NN of/IN various/JJ PTP-deficient/NNP DT40/NNP B/NNP cell/NN lines/NNS stably/RB expressing/MULTIGENE wild-type/MULTIGENE chimeric/JJ Fc/MULTIGENE gamma/MULTIGENE RIIB1-PECAM-1/MULTIGENE receptor/MULTIGENE indicated/VBN that/IN cytoplasmic/MULTIGENE Src/MULTIGENE homology/MULTIGENE 2-domain-containing/MULTIGENE phosphatases/MULTIGENE ,/, SHP-1/GENE and/CC SHP-2/GENE ,/, were/VBD both/DT necessary/JJ and/CC sufficient/JJ to/IN deliver/VB inhibitory/JJ negative/JJ regulation/NN upon/IN coligation/NN of/IN BCR/MULTIGENE complex/MULTIGENE with/IN inhibitory/JJ receptor/NN ./.
@@17266312304/CD Epidemiology/NNS and/CC prevention/NN of/IN hospital/NN infections/NNS in/IN the/DT Local/NNP Health/NNP Unit/NN of/IN Sassari/NNP :/: profile/NN of/IN bacterial/JJ resistance/NN and/CC antimicrobial/JJ agents/NNS of/IN large/JJ usage/NN ./.
@@95550468200/CD The/DT results/NNS confirm/VBP that/IN a/DT single/JJ base/NN change/NN in/IN the/DT branchpoint/NN consensus/NN sequence/NN of/IN an/DT intron/NN can/MD cause/NN human/JJ disease/NN although/IN this/DT sequence/NN is/VBZ poorly/RB conserved/VBN in/IN mammals/NNS ./.
@@93977239354/CD Responsibility/NNP matters--this/NN is/VBZ a/DT scientific/JJ council/NN ./.
@@24580803119/CD Prognosis/NNS of/IN asymptomatic/JJ multiple/JJ myeloma/NN ./.
@@92905719251/CD Among/IN 38/CD patients/NNS with/IN inducible/JJ reentrant/JJ VTs/NNS who/WP underwent/VBD electrophysiologic/JJ study/NN (/( EPS/NNS )/SYM ,/, 10/CD VTs/NNS of/IN six/CD patients/NNS were/VBD selected/VBN ./.
@@71918047015/CD The/DT hormonal/JJ response/NN to/IN a/DT standardized/JJ bicycle/NN exercise/NN test/NN was/VBD studied/VBN in/IN 11/CD male/JJ cadets/NNS exposed/VBN to/IN a/DT course/NN of/IN 107/CD h/NN of/IN continuous/JJ activity/NN with/IN less/PRP than/IN 2/CD h/NN sleep/NN ./.
@@118033251669/CD Only/RB one/PRP DC/JJ cardioversion/NN was/VBD required/VBN in/IN the/DT HBS/NNS group/NN ,/, whereas/IN 2/CD DC/JJ in/IN the/DT CBC/NN group/NN and/CC total/JJ 7/CD DC/JJ in/IN the/DT GIK/NN group/NN ./.
@@100508837787/CD Inhibition/NNS of/IN phosphatidylinositol-3/MULTIGENE kinase/MULTIGENE did/VBD not/RB have/VB a/DT significant/JJ effect/NN on/IN p53/GENE conformation/NN but/CC did/VBD have/VBN a/DT weak/JJ but/CC significant/JJ effect/NN on/IN Tpo-enhanced/JJ viability/NN ./.
@@39207009394/CD This/DT suggests/VBZ that/DT alaproclate/NN acutely/RB increases/VBZ the/DT responsiveness/NN of/IN postsynaptic/JJ muscarinic/JJ and/CC alpha/MULTIGENE 1/MULTIGENE adrenoceptors/MULTIGENE ./.
@@11373277824/CD In/NN summary/NN ,/, we/PRP conclude/VBP that/IN the/DT adenoviral/MULTIGENE oncoprotein/MULTIGENE E1A/NN activates/VBZ transcription/NN from/IN the/DT endogenous/JJ AP-2alpha/GENE gene/NN ,/, an/DT effect/NN that/WDT involves/VBZ transcriptional/JJ derepression/NN of/IN the/DT AP-2alpha/NNP promoter/NN by/IN interaction/NN of/IN E1A/NN with/IN the/DT AP-2rep/MULTIGENE corepressor/MULTIGENE CtBP1/MULTIGENE ./.
@@67772296544/CD The/DT subjects/NNS of/IN the/DT study/NN were/VBD 10/CD normal/JJ subjects/NNS and/CC 64/CD patients/NNS with/IN gastroduodenal/JJ disease/NN ./.
@@78717575045/CD Analysis/NNP of/IN the/DT sequence/NN upstream/RB of/IN this/DT initiation/NN codon/NN reveals/VBZ the/DT presence/NN of/IN a/DT promotor/MULTIGENE sequence/MULTIGENE ./.
@@94650352262/CD A/DT putative/JJ inhibitor/NN (/NN s/NN )/NN appears/VBZ to/IN co-elute/NN in/IN the/DT inactive/JJ fraction/NN that/WDT blocked/VBD the/DT L/NN (/NN alpha/NN )/NN activity/NN ./.
@@115923151484/CD PROCEDURE/NNP :/: Cannulas/NNP were/VBD surgically/RB positioned/VBN in/IN the/DT abomasal/JJ body/NN and/CC pyloric/JJ antrum/NN of/IN each/DT calf/NN ./.
@@97172469736/CD Generally/RB ILC/VBZ and/CC ILVF/GENE values/NNS decreased/VBN with/IN increasing/JJ exposure/NN time/NN with/IN rate/NN constants/NNS ranging/VBG from/IN 0/CD ./CD 03/CD to/IN 0/CD ./CD 33/CD day-1/NN (/( wet/NN and/CC lipid/NN weight/NN )/SYM for/IN ILC/NNS and/CC 0/CD ./CD 03/CD to/IN 0/CD ./CD 31/CD day-1/NN for/IN ILVF/GENE ./.
@@113109371575/CD RESULTS/NNS :/: Coronary/NNP mortality/NN during/IN the/DT median/JJ follow-up/JJ time/NN of/IN 17/CD months/NNS was/VBD 6-fold/CD higher/JJ in/IN the/DT highest/JJS tertile/NN for/IN CRP/NN and/CC IL-6/NEWGENE and/CC 3/CD ./CD 5-fold/CD higher/JJ in/IN the/DT highest/JJS tertile/NN for/IN fibrinogen/NN and/CC TNF-alpha/NN than/IN in/IN the/DT respective/JJ combined/JJ lower/JJR tertiles/NNS ./.
@@76891541505/CD Protein/NN phosphorylation/NN appears/VBZ to/IN play/NN a/DT critical/JJ role/NN in/IN uPA/MULTIGENE gene/MULTIGENE expression/NN in/IN these/DT cells/NNS ;/: protein/MULTIGENE kinase/MULTIGENE C-activating/JJ phorbol/NN esters/NNS cooperate/VBP with/IN pp60v-src/GENE to/IN synergistically/RB increase/VBP uPA/MULTIGENE mRNA/MULTIGENE ,/, whereas/IN cyclic/JJ AMP/NN (/( cAMP/NN )/NN -dependent/NN protein/NN kinase-activating/JJ agents/NNS (/( e/FW ./FW g/FW ./FW ,/, 8-bromo/JJ cAMP/NN )/SYM repress/VB uPA/MULTIGENE mRNA/MULTIGENE levels/NNS ./.
@@95027208810/CD Cis-regulation/NNP downstream/RB of/IN cell/NN type/NN specification/NN :/: a/DT single/JJ compact/JJ element/NN controls/VBZ the/DT complex/NN expression/NN of/IN the/DT CyIIa/MULTIGENE gene/MULTIGENE in/IN sea/NN urchin/NN embryos/NNS ./.
@@93703079843/CD One/CD of/IN these/DT ,/, an/DT AACA/MULTIGENE motif/MULTIGENE ,/, has/VBZ been/VBN shown/VBP to/IN be/VB a/DT negative/JJ regulator/NN in/IN non-seed/JJ tissues/NNS and/CC has/VBZ a/DT similarity/NN to/IN the/DT barley/NN gibberellin/MULTIGENE responsive/MULTIGENE element/MULTIGENE recognized/VBN by/IN MYB-like/MULTIGENE DNA/MULTIGENE binding/MULTIGENE proteins/MULTIGENE ./.
@@12848287397/CD Tissue/NEWGENE plasminogen/MULTIGENE activator/MULTIGENE ,/, its/PRP inhibitor/NN and/CC other/DT parameters/NNS of/IN fibrinolysis/NN in/IN blood/NN of/IN patients/NNS operated/VBN for/IN mild/JJ hypertrophy/NN of/IN the/DT prostate/NN ./.
@@87025175807/CD In/NN a/DT screen/NN for/IN genes/NNS with/IN oncogenic/JJ potential/RB expressed/VBN by/IN the/DT murine/JJ B6SUtA1/GENE myeloid/JJ progenitor/NN cell/NN line/NN ,/, we/PRP isolated/VBD a/DT 2/CD ./CD
@@2062933281/CD When/WRB given/VBP the/DT choice/NN between/IN an/DT estrous/JJ female/JJ and/CC a/DT sexually/RB active/JJ male/NN in/IN the/DT AOF/GENE ,/, flutamide/NN females/NNS ,/, as/RB well/VB as/IN controls/NNS ,/, preferred/VBD the/DT male/JJ partner/NN ./.
@@22838732935/CD Since/IN one/PRP group/NN of/IN adolescents/NNS more/RB difficult/JJ to/IN influence/NN are/VBP those/DT whose/WP parents/NNS smoke/NN ,/, parental/JJ involvement/NN in/IN smoking/NN prevention/NN may/MD be/VB a/DT powerful/JJ enhancer/NN ./.
@@13521131977/CD The/DT pulmonary/JJ toxic/JJ events/NNS induced/VBN by/IN acute/JJ nitrogen/NN dioxide/NN (/( NO/DT )/NN 2/NN exposure/NN were/VBD studied/VBN in/IN the/DT rat/NN to/IN develop/VB an/DT inhalation/NN model/NN to/IN investigate/VB therapeutic/JJ measures/NNS ./.
@@76147627525/CD The/DT cryptococcal/JJ antigen/NN test/NN was/VBD positive/JJ at/IN 1/CD :/: 125/CD by/IN latex/NN agglutination/NN ./.
@@99274495167/CD Overexpression/NNS of/IN POG1/GENE inhibits/VBZ alpha-factor-induced/MULTIGENE G1/MULTIGENE arrest/NN and/CC transcriptional/JJ repression/NN of/IN the/DT CLN1/GENE and/CC CLN2/MULTIGENE genes/MULTIGENE ./.
@@75407732330/CD The/DT levels/NNS of/IN NSE/NN and/CC MBP/NN in/IN the/DT IJVB/GENE were/VBD compared/VBN to/IN those/DT in/NN the/DT PVB/GENE ./.
@@85736378549/CD The/DT method/NN has/VBZ been/VBN satisfactorily/RB applied/VBN to/IN the/DT determination/NN of/IN paracetamol/NN in/IN pharmaceutical/JJ formulations/NNS and/CC biological/JJ fluids/NNS ./.
@@24921113148/CD When/WRB considered/VBN with/IN the/DT known/VBP neurotoxic/JJ effects/NNS on/IN children/NNS of/IN "low/NN levels"/NN of/IN exposure/NN to/IN lead/NN ,/, these/DT results/NNS also/RB suggest/VBP that/IN either/DT an/DT excessively/RB narrow/JJ margin/NN of/IN safety/NN or/CC insufficient/JJ safety/NN is/VBZ provided/VBN by/IN present/NN U/NNP ./NNP S/NNP ./. guidelines/NNS ,/, which/WDT classify/VBP an/DT elevated/VBN blood/NN lead/NN concentration/NN as/IN 25/CD micrograms/NN //NN dl/NN or/CC greater/JJR ./.
@@118461871729/CD The/DT GT-foreign-pictures/NNP showed/VBD that/IN the/DT judgment/NN of/IN other/DT subjects/NNS changed/VBN toward/IN hedonic/JJ and/CC permeability/NN directions/NNS ./.
@@19236282545/CD Quantitative/JJ analysis/NN of/IN DNA/NN using/VBG flow/NN cytometry/NN and/CC immunocytochemical/JJ findings/NNS in/IN 16/CD cases/NNS of/IN cardiac/JJ myxomas/NNS ./.
@@86338557657/CD The/DT lacS/MULTIGENE gene/MULTIGENE was/VBD cloned/VBN in/IN an/DT E/NNP ./NNP coli-Streptococcus/NN shuttle/NN vector/NN and/CC was/VBD expressed/VBN both/DT in/NN a/DT lacS/NN deletion/NN derivative/NN of/IN S/NNP ./NNP thermophilus/JJ and/CC in/IN a/DT pNZ63-cured/NEWGENE strain/NN ,/, L/NNP ./NNP lactis/MULTIGENE NZ6091/MULTIGENE ./.
@@87238839740/CD The/DT concentrations/NNS of/IN vitamin/NN A/DT precursors/NNS and/CC vitamin/NN E/NN in/IN the/DT hay/NN were/VBD below/RB currently/RB recommended/VBN dietary/JJ levels/NNS for/IN llamas/NNS ,/, and/CC alfalfa/NN hay/NN appears/VBZ to/IN provide/VB an/DT unreliable/JJ source/NN of/IN vitamins/MULTIGENE A/MULTIGENE and/CC E/NN in/IN this/DT species/NN ./.
@@81445722103/CD ATP/NN by/IN itself/PRP also/RB reduced/VBD polypeptide/NN binding/JJ to/IN Ssb1/GENE //GENE 2p/GENE to/IN a/DT level/NN that/WDT was/VBD intermediate/JJ between/IN that/DT observed/VBD for/IN the/DT Ssa/NNP Hsp70/MULTIGENE proteins/MULTIGENE tested/VBN and/CC BiP/CONTEXTGENE and/CC DnaK/GENE ./.
@@7068496508/CD We/PRP compared/VBD the/DT volume/NN of/IN the/DT pulmonary/JJ extravascular/JJ ,/, extracellular/JJ water/NN space/NN using/VBG sodium/NN and/CC sucrose/MULTIGENE indicators/MULTIGENE in/IN 8/CD normal/JJ and/CC 11/CD edematous/JJ rabbit/NN lungs/NNS by/IN steady-state/JJ techniques/NNS ./.
@@17223196802/CD Analysis/NNP of/IN the/DT deduced/VBN amino/JJ acid/NN sequence/NN suggests/VBZ that/IN CHIP28/MULTIGENE protein/MULTIGENE contains/VBZ six/CD bilayer-spanning/JJ domains/NNS ,/, two/JJ exofacial/JJ potential/JJ N-glycosylation/MULTIGENE sites/MULTIGENE ,/, and/CC intracellular/JJ N/NN and/CC C/NN termini/NNS ./.
@@91999708390/CD Recombinant/JJ soluble/JJ pMCP/NN that/WDT lacked/VBD transmembrane/JJ and/CC cytoplasmic/JJ domains/NNS had/VBP factor/MULTIGENE I/MULTIGENE cofactor/MULTIGENE activity/NN in/IN C3b/NN cleavage/NN ,/, indicating/VBG that/IN it/PRP is/VBZ functionally/RB ,/, as/RB well/VB as/IN structurally/RB homologous/JJ to/IN MCP/JJ ./.
@@75577177443/CD However/RB ,/, division/NN of/IN the/DT chest/NN wall/NN muscles/NNS ,/, usually/RB with/IN diathermy/NN ,/, contributes/VBZ to/IN prolonged/JJ pain/NN and/CC morbidity/NN ./.
@@41405674811/CD Histamine/NNS metabolism/NN in/IN hemorrhagic-hypotensive/JJ shock/NN ./.
@@20697382671/CD A/DT method/NN for/IN establishing/VBG stimulus/NN control/NN of/IN ethanol/NN responding/VBG was/VBD developed/VBN ./.
@@98797664093/CD In/NN PAV-3/GENE ,/, the/DT E1A/MULTIGENE region/MULTIGENE is/VBZ located/VBN between/IN 1/CD ./CD 5/CD and/CC 3/CD ./CD 8/CD map/NN units/NNS ./.
@@10983344817/CD The/DT article/NN deals/VBP with/IN the/DT diagnosing/NN and/CC correction/NN of/IN reversible/JJ ischemia/NN of/IN the/DT intestine/NN ./.
@@111262759138/CD Increased/VBN levels/NNS of/IN anticardiolipin/MULTIGENE immunoglobulin/MULTIGENE G/MULTIGENE may/MD also/RB cause/VB bleeding/NN ./.
@@85730835264/CD This/DT region/NN contains/VBZ a/DT motif/NN with/IN partial/JJ identity/NN with/IN the/DT binding/JJ site/NN for/IN the/DT ubiquitous/JJ transcription/NN factor/NN upstream/RB stimulatory/JJ factor/NN (/( USF/GENE )/SYM ,/, which/WDT binds/VBZ to/IN the/DT human/MULTIGENE insulin/MULTIGENE promoter/MULTIGENE ./.
@@16847914875/CD The/DT cis-acting/JJ element/NN mediating/JJ glucocorticoid/NN inducibility/NN of/IN the/DT chicken/MULTIGENE glutamine/MULTIGENE synthetase/MULTIGENE gene/MULTIGENE has/VBZ been/VBN identified/VBN ./.
@@20554845943/CD Some/DT of/IN the/DT PCR/NN products/NNS contained/VBD mutations/NNS in/IN ATG1/NNP and/DT //DT or/DT ATG2/GENE ./.
@@95449914459/CD The/DT dominant/JJ negative/JJ mutant/NN of/IN SHP-2/GENE was/VBD found/VBN to/IN inhibit/VB the/DT induction/NN of/IN tyrosine/NN phosphorylation/NN and/CC DNA-binding/NN activity/NN of/IN m-Stat5a/JJ ,/, m-Stat5b/JJ ,/, and/CC the/DT carboxyl-terminal/NN deletion/NN variant/NN m-Stat5adelta749/GENE ,/, as/RB well/VB as/IN the/DT transactivation/NN potential/NN of/IN m-Stat5a/JJ and/CC m-Stat5b/JJ ./.
@@4039439661/CD Male/JJ Japanese/JJ quail/NN were/VBD chronically/RB exposed/VBN to/IN 5000/CD ppm/NN manganese/NN (/( Mn/NN )/SYM as/IN particulate/JJ manganese/NN oxide/NN (/( Mn3O4/GENE )/SYM in/IN their/PRP diet/NN from/IN hatching/NN to/IN 75/CD days/NNS of/IN age/NN ./.
@@11934588296/CD Routine/JJ isotope/NN cystography/NN using/VBG 99M/NN Tc/NN sulfur/JJ colloid/NN for/IN detection/NN and/CC follow-up/NN of/IN vesico-ureteral/JJ reflux/NN ./.
@@110084205805/CD The/DT detector/NN has/VBZ the/DT advantage/NN of/IN finding/VBG both/DT ST/MULTIGENE segment/MULTIGENE deviations/NNS and/CC entire/JJ ST-T/MULTIGENE complex/MULTIGENE changes/NNS thereby/RB providing/CC a/DT wider/JJR characterization/NN of/IN the/DT potential/JJ ischemic/JJ events/NNS ./.
@@93411829525/CD We/PRP have/VBP overexpressed/VBN ,/, purified/VBN ,/, characterized/VBN ,/, and/CC crystallized/VBD the/DT BTB/GENE //GENE POZ/GENE domain/NN from/IN PLZF/GENE (/( PLZF-BTB/GENE //GENE POZ/GENE )/SYM ./.
@@88164592948/CD An/DT interaction/NN screen/NN with/IN the/DT repression/NN domain/NN of/IN the/DT orphan/MULTIGENE receptor/MULTIGENE RevErb/NNP identified/VBD N-CoR/IN ,/, the/DT corepressor/NN for/IN thyroid/MULTIGENE hormone/MULTIGENE receptor/MULTIGENE (/( TR/CONTEXTGENE )/SYM and/CC retinoic/NEWGENE acid/NEWGENE receptor/NEWGENE (/( RAR/NN )/SYM ./.
@@78717188462/CD However/RB ,/, inclusion/NN of/IN the/DT neighboring/JJ CGGAAR/MULTIGENE motifs/MULTIGENE from/IN the/DT ICP4/MULTIGENE promoter/MULTIGENE ,/, which/WDT bind/VBP factors/MULTIGENE GABP/MULTIGENE alpha/MULTIGENE and/CC beta/NN ,/, results/VBZ in/IN a/DT strong/JJ synergistic/JJ activation/NN ./.
@@98910659651/CD Furthermore/RB ,/, rhoA-mediated/JJ SRE/NNS activation/NN was/VBD blocked/VBN by/IN dominant/JJ negative/JJ mutants/NNS of/IN PKC-alpha/DT or/CC PKC-epsilon/GENE ./.
@@87811195483/CD The/DT 5'/CD flanking/JJ region/NN of/IN the/DT mouse/MULTIGENE Met-ase-1/MULTIGENE gene/MULTIGENE also/RB shares/VBP considerable/JJ regions/NNS of/IN identity/NN with/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT rat/MULTIGENE Met-ase-1/MULTIGENE gene/MULTIGENE ./.
@@96774055732/CD Pol32Delta/GENE strains/NNS are/VBP weak/JJ antimutators/NNS and/CC are/VBP defective/JJ for/IN damage-induced/JJ mutagenesis/NN ./.
@@98551119250/CD Although/IN we/PRP predicted/VBD that/DT overexpression/NN of/IN the/DT COOH-terminal/MULTIGENE domains/MULTIGENE ,/, which/WDT were/VBD thought/VBP to/IN be/VB involved/VBN in/IN the/DT regulation/NN of/IN SREBP/NN processing/VBG ,/, would/MD result/VB in/IN disruption/NN of/IN the/DT SREBP-dependent/NNP transcriptional/JJ regulation/NN of/IN several/DT genes/NNS ,/, the/DT mRNA/NN levels/NNS for/IN 3-hydroxy-3-methylglutaryl/MULTIGENE coenzyme/MULTIGENE A/MULTIGENE (/( HMG/CONTEXTGENE CoA/CONTEXTGENE )/SYM synthase/NN in/IN these/DT two/JJ cell/NN lines/NNS were/VBD regulated/VBN in/IN a/DT sterol-dependent/JJ manner/NN ./.
@@104986164387/CD Mammalian/NNP M-Ras/GENE and/CC a/DT Caenorhabditis/NNP elegans/NNS orthologue/NN exhibit/NN conserved/VBN structural/JJ features/NNS ,/, and/CC these/DT are/VBP likely/RB to/IN mediate/VB activation/NN of/IN distinctive/JJ signaling/JJ paths/NNS that/WDT function/VBP in/IN parallel/JJ to/IN those/DT downstream/RB of/IN p21/MULTIGENE Ras/MULTIGENE ./.
@@94421721178/CD Both/DT increasing/JJ basal/MULTIGENE FSH/MULTIGENE and/CC age/NN were/VBD associated/VBN significantly/RB with/IN increased/VBN total/JJ gonadotrophin/NN dose/NN ,/, and/CC reduced/VBD number/NN of/IN oocytes/NNS collected/VBN and/CC pregnancy/NN rate/NN ./.
@@91811302479/CD We/PRP have/VBP inactivated/VBN Krox-20/NEWGENE by/IN homologous/JJ recombination/NN in/IN ES/NNP cells/NNS and/CC demonstrated/VBN that/IN the/DT mutation/NN leads/VBP to/IN the/DT deletion/NN of/IN r3/GENE and/CC r5/NN ./NN
@@105414326094/CD Kinase-deficient/NNP erbB/MULTIGENE proteins/MULTIGENE reduced/VBD epidermal/MULTIGENE growth/MULTIGENE factor/MULTIGENE (/( EGF/NN )/NN -induced/NN tyrosine/NN phosphorylation/NN of/IN endogenous/JJ Shc/MULTIGENE proteins/MULTIGENE and/CC also/RB reduced/VBN immediate/JJ and/CC sustained/JJ EGF-induced/MULTIGENE ERK/MULTIGENE MAPK/NN activities/NNS in/IN human/JJ glioblastoma/NN cells/NNS ,/, although/IN basal/MULTIGENE ERK/MULTIGENE MAPK/NN activities/NNS were/VBD unaffected/JJ ./.
@@81123412057/CD L/NNP ./NNP ,/, Greer/NNP ,/, J/NNP ./NNP &/CC Carter/NNP ,/, G/NNP ./NNP
@@8355697344/CD Protein/MULTIGENE tyrosine/MULTIGENE phosphatases/MULTIGENE (/( PTPs/CONTEXTGENE )/SYM ,/, together/RB with/IN protein/MULTIGENE tyrosine/MULTIGENE kinases/MULTIGENE (/( PTKs/GENE )/SYM ,/, are/VBP involved/VBN in/IN the/DT regulation/NN of/IN cell/NN activation/NN ,/, growth/NN ,/, and/CC differentiation/NN ./.
@@27082884512/CD The/DT dichloromethane/NN is/VBZ removed/VBN ,/, mobile/JJ phase/NN solvent/NN is/VBZ added/VBN ,/, and/CC aliquots/NNS are/VBP injected/VBN onto/IN a/DT PRP-1/GENE liquid/JJ chromatographic/JJ column/NN ;/: fluazifop/NN acid/NN is/VBZ separated/VBN from/IN coextracted/VBN compounds/NNS and/CC detected/VBN at/IN an/DT applied/VBN potential/NN of/IN +/SYM 1/CD ./CD 25/CD V/NN ,/, using/VBG an/DT amperometric/JJ electrochemical/JJ detector/NN in/IN the/DT oxidation/NN mode/NN ./.
@@87756748763/CD OBJECTIVES/NNS :/: The/DT aim/NN of/IN the/DT study/NN was/VBD to/IN analyze/VB the/DT clinical/JJ characteristics/NNS ,/, treatment/NN and/CC outcome/NN of/IN 310/CD patients/NNS with/IN hydatidiform/JJ mole/NN ./.
@@39650127756/CD The/DT results/NNS from/IN the/DT first/JJ five/CD years/NNS of/IN follow/VB up/JJ in/IN 1972/CD showed/VBD a/DT 4/CD ./CD 7-fold/CD excess/NN mortality/NN for/IN ischaemic/JJ and/CC other/DT heart/NN diseases/NNS (/( ICD/NN A83-A84/NN )/SYM compared/VBN with/IN a/DT comparable/JJ reference/NN cohort/NN of/IN paper/NN mill/NN workers/NNS ./.
@@77688984639/CD Based/VBN on/IN the/DT estimated/VBN values/NNS of/IN divergence/NN of/IN apobec1/MULTIGENE sequences/MULTIGENE in/IN terms/NNS of/IN the/DT numbers/NNS of/IN synonymous/JJ and/CC non-synonymous/JJ suhstitutions/NNS per/IN site/NN ,/, we/PRP found/VBP that/IN apobec1/GENE is/VBZ a/DT fairly/RB rapidly/RB evolving/JJ protein/NN ./.
@@108577515703/CD In/NN addition/NN ,/, the/DT mouse/NN ortholog/NN (/( Mharp/GENE //GENE Smarcal1/GENE )/SYM was/VBD cloned/VBN ,/, and/CC the/DT Caenorhabditis/NNP elegans/NNS ortholog/NN (/( CEHARP/NNP )/SYM was/VBD identified/VBN in/IN the/DT GenBank/NN database/NN ./.
@@108941495354/CD PNRC/NNP :/: a/DT proline-rich/JJ nuclear/MULTIGENE receptor/MULTIGENE coregulatory/MULTIGENE protein/MULTIGENE that/WDT modulates/VBZ transcriptional/JJ activation/NN of/IN multiple/JJ nuclear/JJ receptors/NNS including/JJ orphan/MULTIGENE receptors/MULTIGENE SF1/MULTIGENE (/( steroidogenic/NEWGENE factor/NEWGENE 1/NEWGENE )/SYM and/CC ERRalpha1/GENE (/( estrogen/MULTIGENE related/MULTIGENE receptor/MULTIGENE alpha-1/MULTIGENE )/SYM ./.
@@86478222841/CD A/DT direct/JJ role/NN for/IN sterol/NN regulatory/JJ element/NN binding/JJ protein/NN in/IN activation/NN of/IN 3-hydroxy-3-methylglutaryl/MULTIGENE coenzyme/MULTIGENE A/MULTIGENE reductase/MULTIGENE gene/MULTIGENE ./.
@@7588633702/CD We/PRP show/VBP that/IN c-Fos/GENE (/( the/DT c-fos/MULTIGENE protooncogene/MULTIGENE product/MULTIGENE )/SYM ,/, which/WDT is/VBZ an/DT intrinsically/RB unstable/JJ nuclear/JJ protein/NN ,/, is/VBZ metabolically/RB highly/RB stabilized/VBN ,/, and/CC greatly/RB enhances/VBZ the/DT transforming/JJ efficiency/NN of/IN NIH/NN 3T3/CD cells/NNS ,/, by/IN Mos/NNS ./.
@@80004975250/CD METHODS--16/GENE volunteered/VBN for/IN spirometry/NN with/IN methacholine/NN provocation/NN test/NN including/JJ a/DT test/NN for/IN small/JJ airways/NNS function/NN by/IN volume/NN of/IN trapped/VBN gas/NN (/( VTG/NN )/SYM ./.
@@85925902746/CD These/DT findings/NNS demonstrate/VBP that/IN haemodialysis/NN patients/NNS with/IN chronic/JJ hepatitis/MULTIGENE C/MULTIGENE respond/NN well/NN to/IN interferon/NN treatment/NN and/CC that/IN a/DT long-term/JJ response/NN is/VBZ achieved/VBN in/IN a/DT high/JJ proportion/NN of/IN patients/NNS ./.
@@97366979708/CD MEKs/GENE and/CC ERKs/GENE inhibited/VBN IL-6/NEWGENE activation/NN of/IN Stat3/GENE harboring/VBG a/DT mutation/NN at/IN serine-727/JJ ,/, the/DT major/JJ site/NN for/IN serine/NN phosphorylation/NN ,/, similar/JJ to/IN inhibition/NN of/IN wild-type/MULTIGENE Stat3/MULTIGENE ,/, and/CC inhibited/VBD Janus/MULTIGENE kinases/MULTIGENE Jak1/MULTIGENE and/CC Jak2/GENE upstream/RB of/IN Stat3/GENE in/IN the/DT Jak-STAT-signaling/JJ pathway/NN ./.
@@94420808102/CD A/DT reciprocal/JJ binding/JJ assay/NN using/VBG IM-9/CD cells/NNS as/IN a/DT source/NN of/IN SHP-1/GENE and/CC SHP-2/GENE revealed/VBN specific/JJ association/NN of/IN SHP-2/GENE (/( but/CC not/RB SHP-1/GENE )/SYM with/IN a/DT glutathione/MULTIGENE S-transferase/MULTIGENE fusion/MULTIGENE incorporating/JJ GHR/NNP cytoplasmic/JJ domain/NN residues/NNS 485-620/JJ ,/, but/CC only/RB if/IN the/DT fusion/NN was/VBD first/RB rendered/VBN tyrosine-phosphorylated/JJ ./.
@@86762668653/CD The/DT mean/JJ values/NNS of/IN protease/NN activity/NN were/VBD significantly/RB higher/JJ in/IN the/DT test/NN groups/NNS than/IN in/IN the/DT control/NN group/NN at/IN baseline/NN ./.
@@86831063315/CD Although/IN IL-2/NEWGENE and/CC IFN-alpha/NNS activated/VBN STAT1/MULTIGENE alpha/MULTIGENE and/CC STAT5/GENE ,/, IL-2/NEWGENE predominantly/RB activated/VBN STAT5/GENE ,/, while/CC IFN-alpha/CONTEXTGENE predominantly/RB activated/VBN STAT1/MULTIGENE alpha/MULTIGENE ./.
@@11084334849/CD The/DT swa2-1/MULTIGENE allele/MULTIGENE recovered/VBN from/IN the/DT original/JJ screen/NN carries/VBZ a/DT point/NN mutation/NN in/IN its/PRP tetratricopeptide/NN repeat/NN (/( TPR/NN )/SYM domain/NN ,/, a/DT motif/NN not/RB found/VB in/IN auxilin/NN but/CC known/VBP in/IN other/DT proteins/NNS to/IN mediate/VB interaction/NN with/IN heat-shock/MULTIGENE proteins/MULTIGENE ./.
@@20239045566/CD The/DT CDC7/MULTIGENE gene/MULTIGENE has/VBZ two/JJ in-frame/NN AUG/NNS codons/NNS as/IN possible/JJ translation/NN start/NN sites/NNS ,/, which/WDT would/MD produce/VB 58-/DT and/CC 56-kDa/MULTIGENE proteins/MULTIGENE ,/, respectively/RB ./.
@@104853539073/CD Natural/NNP Haemophilus/NN influenzae/NNS type/MULTIGENE b/MULTIGENE capsular/JJ polysaccharide/NN antibodies/NNS in/IN 412/CD infants/NNS and/CC children/NNS from/IN West/NN Africa/NN (/( Burkina-Faso/NNP )/SYM and/CC France/NN :/: a/DT cross-sectional/JJ serosurvey/NN ./.
@@13290399267/CD Intermediate/NNP levels/NNS of/IN gene/NN activity/NN were/VBD observed/VBN for/IN TnI/MULTIGENE enhancers/MULTIGENE containing/JJ E-boxes/NNP derived/VBD from/IN the/DT MCK/GENE left/NN E-box/MULTIGENE site/MULTIGENE or/CC from/IN the/DT Ig/MULTIGENE kappa/MULTIGENE E2/MULTIGENE E-box/MULTIGENE ./.
@@79294114149/CD A/DT comparison/NN of/IN the/DT predicted/VBN polypeptide/NN sequence/NN of/IN the/DT Drosophila/MULTIGENE protein/MULTIGENE with/IN the/DT equivalent/JJ subunits/NNS from/IN mouse/NN and/CC yeast/NN suggests/VBZ that/IN they/PRP are/VBP closely/RB related/VBN and/CC defines/VBZ three/CD conserved/VBN regions/NNS which/WDT are/VBP likely/RB to/IN be/VB important/JJ for/IN enzyme/NN activity/NN ./.
@@1188101770/CD Hemolytic/JJ disease/NN of/IN African/JJ newborn/NN ./.
@@104414833821/CD Oligonucleotide/NN probes/NNS corresponding/JJ to/IN wild-type/NN and/CC mutant/MULTIGENE EpRE/MULTIGENE sequences/MULTIGENE were/VBD used/VBN in/IN gel-shift/JJ and/CC super-shift/JJ analyses/NNS to/IN identify/VB proteins/NNS binding/JJ ./.
@@114072899773/CD CONCLUSIONS/IN :/: Ketamine-induced/JJ dissociative/JJ anesthesia/NN produces/VBZ persistently/RB elevated/VBN BIS/GENE index/NN which/WDT is/VBZ different/JJ from/IN thiamylal/NN and/CC those/DT reported/VBN with/IN other/DT conventional/JJ anesthetic/JJ agents/NNS ./.
@@9341192168/CD Osmotic/JJ shock/NN stimulates/VBZ GLUT4/MULTIGENE translocation/MULTIGENE in/IN 3T3L1/CD adipocytes/NNS by/IN a/DT novel/JJ tyrosine/MULTIGENE kinase/MULTIGENE pathway/NN ./.
@@84205711396/CD They/PRP were/VBD called/VBN PACE4/GENE and/CC PC4/GENE ./.
@@55748182016/CD Two/CD Lab/MULTIGENE 8/MULTIGENE computer/NN programmes/NNS for/IN use/NN in/IN the/DT study/NN of/IN the/DT isometric/JJ and/CC isotonic/JJ contractile/JJ characteristics/NNS of/IN skeletal/JJ muscle/NN ./.
@@9355269317/CD The/DT difficulties/NNS to/IN analyse/VB prostaglandins/NNS (/( PG/NN )/SYM by/IN gas-liquid/JJ chromatography/NN are/VBP mainly/RB due/NN to/IN the/DT lack/NN of/IN sensitivity/NN of/IN the/DT gas-chromatograph/JJ itself/PRP (/( higher/JJ than/IN 200/CD ng/NN )/SYM and/CC to/IN the/DT poor/JJ resolution/NN of/IN the/DT packed/JJ columns/NNS ./.
@@91307181511/CD Sequences/NNS needed/VBN for/IN iron-regulated/JJ expression/NN of/IN sid1/GENE were/VBD localized/VBN to/IN a/DT 306/CD bp/NN region/NN mapping/NN 2/CD ./CD 3/CD and/CC 2/CD ./CD 6/CD kb/NN upstream/RB of/IN the/DT ATG/NN ./.
@@13498377203/CD cDNA/NN clones/NNS encoding/VBG Arabidopsis/NN thaliana/NN and/CC Zea/GENE mays/VBZ mitochondrial/MULTIGENE chaperonin/MULTIGENE HSP60/MULTIGENE and/CC gene/NN expression/NN during/IN seed/JJ germination/NN and/CC heat/NN shock/NN ./.
@@74951207383/CD Therefore/RB ,/, a/DT prospective/JJ Phase/NNP II/NNP trial/NN was/VBD conducted/VBN to/IN determine/VB the/DT safety/NN and/CC efficacy/NN of/IN cryosurgery/NN following/IN radiation/NN therapy/NN in/IN men/NNS with/IN local/JJ recurrence/NN ./.
@@98464829806/CD In/NN turn/NN ,/, assembly/NN of/IN this/DT complex/NN mediates/VBZ the/DT enzymatic/JJ activation/NN of/IN the/DT p21-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE 1/MULTIGENE and/CC facilitates/VBZ actin/NN polymerization/NN ./.
@@9464525170/CD Expression/NNS and/CC characterization/NN of/IN recombinant/JJ single-chain/MULTIGENE Fv/MULTIGENE and/CC Fv/MULTIGENE fragments/MULTIGENE derived/VBN from/IN a/DT set/NN of/IN catalytic/JJ antibodies/NNS ./.
@@85837838559/CD Although/IN ANP/NNP induced/VBD systemic/JJ capillary/JJ filtration/NN ,/, in/IN the/DT calf/NN ,/, filtration/NN was/VBD reduced/VBN with/IN ANP/NNP ./.
@@53440977186/CD Factors/NNS influencing/VBG in/IN vitro/FW skin/NN permeability/MULTIGENE factor/MULTIGENE production/NN by/IN Vibrio/NN cholerae/NNS ./.
@@68106945506/CD The/DT decrease/NN in/IN HDL-cholesterol/NN with/IN increasing/JJ VLDL-triglycerides/NNP was/VBD relatively/JJ much/RB larger/JJR than/IN the/DT concomitant/JJ decrease/NN in/IN apo/MULTIGENE A-I/MULTIGENE ./.
@@82470435652/CD Hepatitis/MULTIGENE B/MULTIGENE and/CC liver/NN transplantation/NN ./.
@@95998976039/CD The/DT clinical/JJ and/CC laboratory/NN features/NNS of/IN 72/CD children/NNS with/IN Henoch-Schonlein/NNP purpura/NN (/( HSP/NN )/SYM were/VBD examined/VBN to/IN determine/VB if/IN there/RB were/VBD associations/NNS between/IN the/DT laboratory/NN indices--including/JJ white/JJ blood/NN cell/NN (/( WBC/NN )/SYM counts/NNS ,/, serum/JJ C-reactive/NN protein/NN (/( CRP/NN )/SYM levels/NNS ,/, platelet/NN (/( PLT/NN )/SYM counts--and/VBD the/DT clinical/JJ manifestations/NNS of/IN acute/MULTIGENE HSP/MULTIGENE ./.
@@7647377641/CD The/DT vigilance/MULTIGENE task/MULTIGENE and/CC the/DT measurement/NN of/IN attentional/JJ deficits/NNS ./. pp/NNS ./NNS
@@11037823874/CD CONCLUSIONS/IN :/: LSCC/NN malformation/NN ,/, like/VB other/DT inner/JJ ear/NN malformations/NNS such/JJ as/IN large/JJ vestibular/JJ aqueduct/NN and/CC X-linked/JJ mixed/JJ deafness/NN with/IN perilymph/NN gusher/NN ,/, can/MD be/VB associated/VBN with/IN CHL/DT ,/, SNHL/NNS ,/, or/CC normal/JJ hearing/NN ./.
@@67623213415/CD Nucleotide/NN sequence/NN of/IN DNA/NN controlling/JJ expression/NN of/IN genes/NNS for/IN maltosaccharide/NN utilization/NN in/IN Streptococcus/NN pneumoniae/NNS ./.
@@21196262722/CD Five/CD of/IN 10/CD scars/NNS studied/VBN decreased/VBN at/IN least/RB 50%/CD in/IN linear/JJ dimensions/NNS ./.
@@24766648787/CD Previously/RB ,/, we/PRP reported/VBD the/DT sequence/NN of/IN the/DT gene/NN encoding/VBG human/MULTIGENE K14/MULTIGENE (/( D/NN ./NN
@@7607197205/CD Basal/JJ plasma/NN renin/NEWGENE activity/NN (/( PRA/NN )/SYM was/VBD slightly/RB raised/VBN prior/NN to/IN training/NN (/( P/NN </SYM 0/CD ./CD 07/CD )/SYM compared/VBN to/IN the/DT controls/NNS and/CC post-training/NN ./.
@@19381781461/CD Applications/NNS of/IN three-dimensional/JJ analysis/NN to/IN the/DT auditory/JJ P300/GENE ./.
@@113418284308/CD Linear/NNP eight-/DT or/CC nine-residue/NNP D-peptides/NNP derived/VBD from/IN the/DT pocket-binding/JJ domain/NN of/IN the/DT cyclic/JJ molecules/NNS also/RB bind/VBP specifically/RB ./.
@@97990867536/CD Another/DT tentative/JJ hotspot/NN mutation/NN in/IN the/DT third/JJ patient/NN ,/, a/DT frame/NN shift/NN caused/VBN by/IN a/DT G/NN nucleotide/NN insertion/NN in/IN a/DT monotonous/JJ repeat/NN of/IN six/CD Gs/NNS in/IN HPRT/NEWGENE exon/NN 3/CD ,/, has/VBZ been/VBN reported/VBN previously/RB in/IN three/CD other/DT LN/NN patients/NNS ./.
@@82767624573/CD Effect/NN of/IN single/JJ base/NN substitutions/NNS at/IN glycine-870/JJ codon/NN of/IN gramicidin/MULTIGENE S/MULTIGENE synthetase/MULTIGENE 2/MULTIGENE gene/MULTIGENE on/IN proline/NN activation/NN ./.
@@77610915962/CD Inactivation/NNS of/IN MAP/MULTIGENE kinases/MULTIGENE occurs/VBZ via/NN a/DT specific/MULTIGENE phosphatase/MULTIGENE ,/, MKP-1/GENE ./.
@@92384679198/CD These/DT lesions/NNS may/MD be/VB treated/VBN by/IN propranolol/NN or/CC phentolamine/NN ./.
@@111913652482/CD Susceptibility/NNS to/IN ischemia-induced/JJ arrhythmias/NNS was/VBD lower/JJR in/IN 1-week/JJ diabetics/NNS :/: only/RB 42/CD %/NN of/IN diabetic/JJ hearts/NNS exhibited/VBD ventricular/JJ tachycardia/NN (/( VT/NN )/SYM and/CC 16/CD %/NN had/VBP short/JJ episodes/NNS of/IN ventricular/JJ fibrillation/NN (/( VF/NN )/SYM as/IN compared/VBN to/IN VT/NN 100/NN %/NN and/CC VF/NN 70/NN %/NN (/( including/JJ sustained/JJ VF/NN 36/NN %/NN )/SYM in/IN the/DT non-diabetics/NNS (/( P/CD </CD 0/CD ./CD 05/CD )/SYM ./.
@@61204295945/CD Can/MD thyroglobulin/NN assay/NN really/RB supplant/VB radioiodine/NN scans/NNS in/IN patients/NNS with/IN differentiated/VBN thyroid/JJ cancer/NN ?/.
@@28348438946/CD The/DT bactericidal/JJ activity/NN of/IN six/CD new/JJ rifamycin/NN derivatives--rifabutin/JJ (/( RBU/NNP )/SYM ,/, FCE/NNS 22250/CD (/( F22/GENE )/SYM ,/, rifapentine/NN (/( RPE/NN )/SYM ,/, CGP/NN 29861/CD (/( C29/CD )/SYM ,/, CGP/NN 7040/CD (/( C70/GENE )/SYM and/CC CGP/NN 27557/CD (/( C27/NNP )/SYM and/CC rifampicin/NN (/( RMP/NN )/NN --have/NN been/VBN measured/VBN against/IN log/NN phase/NN and/CC ,/, as/IN a/DT better/JJR test/NN of/IN sterilising/JJ activity/NN ,/, against/IN stationary/JJ phase/NN cultures/NNS of/IN Mycobacterium/NN tuberculosis/NN ,/, H37Rv/GENE ./.
@@96422383318/CD The/DT intron/NN 8/MULTIGENE enhancer/MULTIGENE region/MULTIGENE was/VBD not/RB activated/VBN by/IN GATA-1/GENE together/RB with/IN Sp1/GENE in/IN transactivation/NN experiments/NNS in/IN COS-1/NNP cells/NNS indicating/VBG the/DT involvement/NN of/IN a/DT related/MULTIGENE Sp1/MULTIGENE protein/MULTIGENE or/CC of/IN another/DT unidentified/JJ erythroid/MULTIGENE factor/MULTIGENE ./.
@@107795087392/CD Estrogen/MULTIGENE receptor-related/MULTIGENE receptor/MULTIGENE alpha/MULTIGENE 1/MULTIGENE interacts/VBZ with/IN coactivator/NN and/CC constitutively/RB activates/VBZ the/DT estrogen/MULTIGENE response/MULTIGENE elements/MULTIGENE of/IN the/DT human/MULTIGENE lactoferrin/MULTIGENE gene/MULTIGENE ./.
@@97652855986/CD However/RB ,/, changing/JJ the/DT half-site/NN to/IN the/DT consensus/NN sequence/NN AGGTCA/GENE (/( IRper-1/GENE )/SYM increased/VBN binding/NN of/IN AaEcR/NNP ./NNP AaUSP/NNP 10-fold/JJ over/RB IRhsp-1/GENE and/CC ,/, at/IN the/DT same/JJ time/NN ,/, reduced/VBD the/DT stringency/NN of/IN the/DT spacer/NN length/NN requirement/NN ,/, with/IN IRper-0/NNP to/IN IRper-5/GENE showing/VBG detectable/JJ binding/NN ./.
@@98337408465/CD Pyrrolidine/NNP dithiocarbamate/NN ,/, a/DT potent/JJ transcriptional/JJ inhibitor/NN of/IN the/DT viral/JJ LTR/NN ,/, abrogated/VBN the/DT cytokine/NN responses/NNS in/IN both/DT U1/GENE and/CC ACH-2/GENE cells/NNS ,/, suggesting/VBG a/DT common/JJ TNF-alpha-mediated/JJ transcriptional/JJ mechanism/NN in/IN these/DT cell/NN types/NNS despite/IN their/PRP different/JJ modes/NNS of/IN provirus/NN latency/NN ./.
@@111626666522/CD The/DT glucose/NN //NN insulin/NN stimulation/NN was/VBD inhibited/VBN by/IN the/DT addition/NN of/IN polyunsaturated/JJ fatty/JJ acids/NNS ./.
@@81341153489/CD MSSP-1/GENE produced/VBN in/IN E/NNP ./NNP coli/JJ as/IN a/DT fusion/NN protein/NN with/IN GST/NEWGENE specifically/RB interacted/VBN with/IN single-stranded/JJ TCTTAT/GENE (/( plus/IN myc/NN (/NN H-P/NN )/NN 21/NN )/NN and/CC ACT-ATT/NNP (/( in/IN minus/IN myc/NN (/NN H-P/NN )/NN 21/NN )/NN ,/, the/DT consensus/NN of/IN which/WDT can/MD be/VB referred/VBN to/RB as/IN A/NNP //NNP TCTA/NNP //NNP TA/NNP //NNP TT/NNP ./.
@@99314351736/CD Although/IN both/DT transcripts/NNS share/NN the/DT first/JJ nine/JJ exons/NNS ,/, exon/NN 10/CD of/IN ZIS-2/GENE is/VBZ lacking/VBG in/IN ZIS-1/NNP ,/, and/CC instead/RB ,/, exon/NN 11/CD (/( 10th/CD exon/NN )/SYM of/IN ZIS-1/GENE is/VBZ larger/JJR in/IN size/NN ,/, leading/JJ to/IN the/DT longer/JJR 3'-UTR/CD ./.
@@73452177194/CD Urological/JJ complications/NNS are/VBP frequent/VB during/IN and/CC after/IN the/DT treatment/NN of/IN gynecological/JJ malignancy/NN ./.
@@16478135268/CD Since/IN each/DT transcript/NN appears/VBZ to/IN encode/VB the/DT same/JJ protein/NN ,/, this/DT complexity/NN may/MD reflect/VB the/DT need/NN for/IN lineage-specific/JJ or/CC differentiation-dependent/JJ control/NN of/IN expression/NN ./.
@@86633263931/CD The/DT final/JJ sigma54-dependent/MULTIGENE DmpR/MULTIGENE activator/MULTIGENE regulates/VBZ transcription/NN of/IN the/DT dmp/MULTIGENE operon/MULTIGENE that/IN encodes/VBZ the/DT enzymes/NNS for/IN catabolism/NN of/IN (/( methyl/NN )/NN phenols/NN ./.
@@93694828952/CD Electromobility/NNP shift/NN and/CC cotransfection/NN assays/NNS demonstrated/VBN that/IN HNF1alpha/NNP ,/, but/CC not/RB HNF4/GENE ,/, bound/JJ to/IN its/PRP cognate/MULTIGENE site/MULTIGENE and/CC transactivated/VBN G6Pase/MULTIGENE gene/MULTIGENE expression/NN ./.
@@17078002161/CD Although/IN the/DT N13-N20/NN interpeak/JJ interval/NN remained/VBD stable/JJ because/IN of/IN the/DT parallel/JJ shift/NN of/IN the/DT 2/CD peaks/NNS ,/, the/DT central/JJ conduction/NN time/NN measured/VBN from/IN onset/NN latencies/NNS of/IN N11/NN and/CC N20/NNS significantly/RB increased/VBN ./.
@@2957125749/CD In/NN nine/JJ patients/NNS with/IN renal/JJ failure/NN routine/JJ haemodialysis/NN was/VBD accompanied/VBN by/IN a/DT 30/CD per/IN cent/NN reduction/NN in/IN plasma/NN ANP/NEWGENE concentration/NN ./.
@@85290989785/CD Striking/VBG sequence/NN similarities/NNS (/( 57/CD and/CC 53%/CD )/SYM were/VBD observed/VBN with/IN yeast/NN mitochondrial/JJ proteins/NNS ,/, SMF1/GENE and/CC SMF2/GENE ,/, especially/RB within/IN putative/JJ functional/JJ domains/NNS :/: exon/NN 6/CD encoding/VBG the/DT second/JJ transmembrane/JJ spanning/VBG domain/NN ,/, site/NN of/IN the/DT murine/JJ susceptibility/NN mutation/NN ;/: and/CC exon/NN 11/CD encoding/VBG a/DT conserved/VBN transport/NN motif/NN ./.
@@110699997635/CD The/DT U17/GENE //GENE U16/GENE and/CC the/DT U16+/MULTIGENE gene/MULTIGENE products/MULTIGENE transactivated/VBN the/DT HIV/MULTIGENE LTR/MULTIGENE ./.
@@11128925246/CD BACKGROUND/IN :/: The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN determine/VB and/CC compare/VB interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM levels/NNS in/IN gingival/JJ crevicular/JJ fluid/NN (/( GCF/NN )/SYM and/CC clinical/JJ periodontal/JJ findings/NNS in/IN patients/NNS with/IN rheumatoid/JJ arthritis/NN (/( RA/NN )/SYM and/CC adult/JJ periodontitis/NN (/( AP/NN )/SYM ./.
@@106849674694/CD NKX2/GENE ./GENE 1/GENE is/VBZ a/DT member/NN of/IN the/DT NK2/MULTIGENE family/MULTIGENE of/IN homeodomain-containing/MULTIGENE transcription/MULTIGENE factors/MULTIGENE whose/WP targeted/VBN disruption/NN in/IN mouse/NN results/NNS in/IN the/DT absence/NN of/IN thyroid/JJ tissue/NN and/CC a/DT severely/RB abnormal/JJ lung/NN phenotype/NN ./.
@@70688876840/CD Investigated/VBG the/DT reliability/NN ,/, validity/NN and/CC dimensionality/NN of/IN scores/NNS obtained/VBN by/IN acute/JJ psychiatric/JJ inpatients/NNS (/( N/JJ =/SYM 120/CD )/SYM on/IN the/DT Michigan/NN Alcoholism/DT Screening/NNP Test/NNP adapted/VBD to/IN assess/VB lifetime/NN and/CC current/JJ symptomatology/NN ./.
@@7330677189/CD To/TO minimize/VB reflux/JJ into/IN the/DT blind/JJ loop/NN ,/, a/DT number/NN of/IN technical/JJ steps/NNS are/VBP considered/VBN indispensable/JJ :/: 1/NN )/NN fluted/JJ section/NN of/IN the/DT jejunal/JJ stump/NN ;/: 2/NN )/NN isoperistaltic/JJ construction/NN of/IN the/DT anastomosis/NN and/CC ,/, particularly/RB ,/, 3/NN )/NN the/DT creation/NN of/IN a/DT single/JJ or/CC double/JJ valve/NN system/NN upstream/RB from/IN the/DT anastomosis/NN by/IN spiral/JJ introflexion/NN of/IN the/DT mucosa/NN using/VBG seroserous/JJ stitches/NNS parallel/JJ and/CC perpendicular/JJ to/IN the/DT ileal/JJ lumen/NN ./.
@@92090316839/CD The/DT C-terminal/NN mature/JJ region/NN is/VBZ highly/RB conserved/VBN in/IN other/DT serine/MULTIGENE carboxypeptidases/MULTIGENE ./.
@@22337158881/CD The/DT induction/NN by/IN pseudorabies/NN virus/NN of/IN an/DT IL-6/MULTIGENE construct/MULTIGENE containing/JJ the/DT IL-6/MULTIGENE TATA/MULTIGENE box/MULTIGENE and/CC the/DT RNA/NN start/NN site/NN (/( "initiator"/NN or/CC Inr/MULTIGENE element/MULTIGENE )/SYM but/CC not/RB the/DT MRE/MULTIGENE region/MULTIGENE was/VBD also/RB repressed/VBN by/IN Dex/NN in/IN the/DT presence/NN of/IN wild-type/NNP GR/NNP ./NNP
@@24755061696/CD The/DT mRNA/NN was/VBD converted/VBN to/IN cDNA/NN and/CC amplified/VBN by/IN the/DT polymerase/NN chain/NN reaction/NN technique/NN ./.
@@78541308030/CD The/DT requirement/NN of/IN PilE/NNP in/IN pilus/NN biogenesis/NN was/VBD confirmed/VBN by/IN demonstrating/VBG that/IN chromosomal/MULTIGENE pilE/MULTIGENE insertion/MULTIGENE mutants/MULTIGENE were/VBD pilus-/JJ and/CC twitching-motility/JJ deficient/JJ ./.
@@111629369053/CD The/DT continuing/JJ development/NN of/IN ligands/NNS that/WDT function/VBP as/IN selective/JJ estrogens/NNS or/CC antiestrogens/NNS for/IN ERalpha/GENE or/CC ERbeta/GENE should/MD allow/VB optimized/VBN tissue/NN selectivity/NN of/IN these/DT agents/NNS for/IN menopausal/JJ hormone/NN replacement/NN therapy/NN and/CC the/DT treatment/NN and/CC prevention/NN of/IN breast/NN cancer/NN ./.
@@113400806573/CD Three/CD of/IN the/DT proteins/NNS involved/VBN in/IN checkpoint/NN signaling/JJ ,/, Rad1/GENE ,/, Hus1/GENE ,/, and/CC Rad9/GENE ,/, have/VB been/VBN shown/VBP to/IN interact/VB by/IN immunoprecipitation/NN and/CC yeast/NN two-hybrid/JJ studies/NNS ./.
@@96640331424/CD This/DT distribution/NN implies/VBZ that/IN the/DT polycistronic/JJ precursor/NN is/VBZ imported/VBN into/IN the/DT nucleolus/NN for/IN processing/VBG to/IN the/DT mature/JJ snoRNAs/NNS ,/, and/CC that/IN the/DT import/NN or/CC processing/VBG pathway/NN involves/VBZ coiled/VBN bodies/NNS ./.
@@75082507393/CD There/EX was/VBD also/RB a/DT highly/RB significant/JJ correlation/NN between/IN total/JJ selenium/NN intake/NN and/CC liver/NN selenium/NN concentration/NN (/( r/JJ =/SYM 0/CD ./CD 99/CD ,/, p/NN </SYM 0/CD ./CD 01/CD )/SYM after/IN 1/CD mo/NN of/IN treatment/NN ,/, but/CC this/DT time/NN liver/NN selenium/NN did/VBD not/RB change/VB with/IN time/NN ,/, and/CC the/DT correlation/NN remained/VBN highly/RB significant/JJ throughout/IN the/DT investigation/NN ./.
@@113025666811/CD Instead/RB ,/, affective/JJ flattening/NN was/VBD associated/VBN with/IN both/DT dopamine/MULTIGENE receptor/MULTIGENE sensitivity/NN and/CC psychomotor/JJ slowing/NN ./.
@@72253007051/CD These/DT results/NNS show/NN that/IN the/DT neonate/NN differs/VBZ from/IN the/DT adult/NN in/IN respect/NN of/IN both/PDT the/DT nature/NN of/IN effects/NNS of/IN the/DT drug/NN and/CC sensitivity/NN to/IN it/CD ./CD
@@17029721319/CD Whereas/IN cDNA/NN hybridization/NN to/IN genomic/JJ DNA/NN blots/NNS indicated/VBD a/DT small/MULTIGENE subfamily/MULTIGENE of/IN G0S19/MULTIGENE genes/MULTIGENE ,/, simple/JJ patterns/NNS of/IN bands/NNS indicated/VBN that/WDT most/RB cDNAs/VBZ ,/, including/JJ G0S30/MULTIGENE cDNA/MULTIGENE ,/, corresponded/VBN to/IN single-copy/JJ genes/NNS ./.
@@17311072411/CD Substitutions/NNS introduced/VBN at/IN bases/NNS surrounding/JJ the/DT ICR2/MULTIGENE motif/MULTIGENE yielded/VBD levels/NNS of/IN pRNA/NN replication/NN that/WDT differed/VBD ,/, depending/VBG on/IN the/DT maintenance/NN of/IN a/DT putative/JJ 5'/CD stem-loop/NN structure/NN in/IN the/DT positive/JJ strand/NN of/IN the/DT viral/JJ genome/NN ./.
@@83336434395/CD Pneumoscrotum/GENE is/VBZ a/DT rare/JJ condition/NN that/WDT receives/VBZ little/JJ discussion/NN in/IN standard/JJ texts/NNS of/IN urology/NN ./.
@@13575284472/CD The/DT subunit/NN protein/NN of/IN curli/NN was/VBD highly/RB homologous/JJ at/IN its/PRP amino/JJ terminus/NN to/IN SEF-17/GENE ,/, the/DT subunit/NN protein/NN of/IN thin/JJ ,/, aggregative/JJ fimbriae/NNS of/IN Salmonella/NN enteritidis/NN 27655/CD strain/NN 3b/CD ,/, suggesting/VBG that/IN these/DT fibres/NNS form/NN a/DT novel/JJ class/NN of/IN surface/NN organelles/NNS on/IN enterobacteria/NNS ./.
@@79080123910/CD To/TO examine/VB the/DT possibility/NN that/IN LNNB/GENE performance/NN of/IN the/DT schizophrenic/JJ groups/NNS may/MD have/VB been/VBN related/VBN to/IN neuroleptic/JJ medication/NN ,/, analyses/NNS were/VBD completed/VBN on/IN the/DT relationship/NN between/IN medication/NN levels/NNS and/CC LNNB/GENE scores/NNS ./.
@@109509352225/CD To/TO facilitate/VB manipulation/NN of/IN large/JJ genomic/JJ sequences/NNS ,/, we/PRP developed/VBD a/DT method/NN of/IN converting/JJ Escherichia/NN coli/JJ P1/NEWGENE artificial/JJ chromosomes/NNS (/( PACs/NNS )/SYM into/IN yeast/NN artificial/JJ chromosomes/NNS (/( YACs/NNS )/SYM ./.
@@42390414683/CD The/DT effect/NN of/IN anticonvulsants/NNS on/IN sodium-potassium-activated/MULTIGENE ATPase/MULTIGENE ,/, sodium/NN ,/, and/CC potassim/NN in/IN cortex/NN ./.
@@21387078649/CD We/PRP have/VBP previously/RB identified/VBN ,/, by/IN screening/JJ a/DT lambda/MULTIGENE gt11/MULTIGENE expression/NN library/NN ,/, murine/MULTIGENE protein/MULTIGENE mXBP/MULTIGENE ,/, which/WDT binds/VBZ to/IN a/DT sequence/NN which/WDT overlaps/VBP the/DT 3'/CD end/NN of/IN the/DT murine/MULTIGENE class/MULTIGENE II/MULTIGENE major/JJ histocompatibility/NN complex/NN A/DT alpha/NN gene/NN X/NN box/NN ,/, a/DT conserved/VBN transcription/NN element/NN found/VB upstream/RB of/IN all/DT class/MULTIGENE II/MULTIGENE genes/MULTIGENE ./.
@@1447189272/CD Purification/NN and/CC cloning/NN of/IN a/DT novel/JJ serine/NN protease/NN ,/, RNK-Met-1/GENE ,/, from/IN the/DT granules/NNS of/IN a/DT rat/NN natural/JJ killer/NN cell/NN leukemia/NN ./.
@@7947930897/CD The/DT fibrinogen/NN ,/, serum/JJ proteins/NNS ,/, sodium/MULTIGENE heparin/MULTIGENE and/CC membrane/NN contributed/VBN to/IN Cm/NN by/IN 20%/CD ,/, 14%/JJ ,/, 2%/JJ and/CC 64%/JJ ,/, respectively/RB ./.
@@114080999027/CD Positive/JJ and/CC significant/JJ correlations/NNS were/VBD found/VBN between/IN the/DT weeks/NNS of/IN pregnancy/NN and/CC Se/NEWGENE levels/NNS in/IN kidney/NN (/( r/NN =/NN 0/NN ./NN 433/NN ,/, P/CD =/CD 0/CD ./CD 023/CD )/SYM and/CC heart/NN (/( r/NN =/NN 0/NN ./NN 313/NN ,/, P/CD =/CD 0/CD ./CD 030/CD )/SYM ./.
@@10906999734/CD The/DT measurement/NN of/IN NO/DT in/NN biological/JJ systems/NNS using/VBG chemiluminescence/NN ./.
@@75194817679/CD In/NN female/JJ Sl/NN (/NN pan/NN )/NN //NN Sl/NN (/NN pan/NN )/NN mice/NNS ,/, ovarian/JJ follicle/NN development/NN is/VBZ arrested/VBN at/IN the/DT one/PRP layered/JJ cuboidal/JJ stage/NN as/IN a/DT result/NN of/IN reduced/VBN KL/NN expression/NN in/IN follicle/NN cells/NNS ,/, indicating/VBG a/DT role/NN for/IN c-kit/GENE in/IN oocyte/NN growth/NN ./.
@@22360221534/CD The/DT protooncogene/MULTIGENE c-myb/MULTIGENE encodes/VBZ a/DT nuclear/JJ transcription/NN factor/NN that/WDT binds/VBZ to/IN DNA/NN in/IN a/DT sequence-specific/JJ manner/NN and/CC transactivates/VBZ transcription/NN of/IN several/DT viral/JJ and/CC cellular/JJ genes/NNS ./.
@@79806692052/CD Basal/JJ plasma/NN AVP/NEWGENE levels/NNS and/CC AVP/NN release/NN after/IN postural/JJ change/NN were/VBD assessed/VBN ,/, and/CC plasma/NN NPY/NEWGENE levels/NNS were/VBD measured/VBN in/IN the/DT same/JJ samples/NNS ./.
@@112578701091/CD The/DT present/NN study/NN was/VBD initiated/VBN to/IN explore/VB the/DT potential/NN of/IN a/DT hybrid/JJ biological/JJ reactor/NN ,/, combining/JJ trickling/NN filter/NN (/( TF/NN )/SYM and/CC activated/VBN sludge/NN process/NN (/( ASP/NN )/SYM ,/, to/IN treat/NN wastewater/NN containing/JJ trichloroethylene/NN (/( TCE/NN )/SYM at/IN ambient/JJ temperature/NN at/IN different/JJ hydraulic/JJ retention/NN time/NN (/( HRT/NN )/SYM ./.
@@74942449832/CD In/NN the/DT absence/NN of/IN E1A243/GENE ,/, YY1/GENE represses/VBZ CRE-dependent/GENE transcription/NN of/IN c-fos/GENE by/IN physically/RB interacting/VBG with/IN ATF/MULTIGENE //MULTIGENE CREB/MULTIGENE proteins/MULTIGENE bound/JJ to/IN the/DT -67/CD CRE/NN ./.
@@7651424933/CD Biochemical/NNP analysis/NN shows/VBZ that/IN Ssm1p/GENE is/VBZ a/DT structural/JJ protein/NN that/IN forms/NNS part/NN of/IN the/DT largest/JJS 60S/MULTIGENE ribosomal/MULTIGENE subunit/MULTIGENE ,/, which/WDT does/VBP not/RB exist/VB in/IN a/DT pool/NN of/IN free/JJ proteins/NNS ./.
@@33606674048/CD To/TO evaluate/VB the/DT effect/NN of/IN altitude/NN on/IN adolescent/JJ growth/NN and/CC development/NN ,/, three/CD groups/NNS of/IN healthy/JJ ,/, well-nourished/JJ youth/NN of/IN similar/JJ socioeconomic/JJ status/NN and/CC ethnic/JJ grouping/NN who/WP resided/VBD at/IN sea/NN level/NN (/( n/NN =/SYM 1262/CD subjects/NNS )/SYM ,/, mid-altitude/JJ (/( n/NN =/SYM 1743/CD subjects/NNS )/SYM ,/, and/CC high/JJ altitude/NN (/( n/NN =/SYM 1137/CD subjects/NNS )/SYM were/VBD studied/VBN ./.
@@71696306990/CD It/PRP was/VBD suggested/VBN that/IN the/DT absence/NN of/IN pronounced/VBN differences/NNS between/IN conditions/NNS may/MD have/VB been/VBN due/NN to/IN the/DT complexity/NN of/IN the/DT task/NN or/CC the/DT type/NN of/IN prompts/NNS employed/VBN ./.
@@9572965149/CD A/DT third/JJ ORF/NN ,/, ORF5/NNS ,/, shows/VBZ homology/NN with/IN gene/NN agrB/GENE from/IN Staphylococcus/NN aureus/NN ,/, which/WDT is/VBZ involved/VBN in/IN the/DT mechanism/NN of/IN regulation/NN of/IN the/DT virulence/NN phenotype/NN in/IN this/DT species/NN ./.
@@37389194406/CD Calcifications/NNS in/IN the/DT thoracic/JJ aorta/NN at/IN the/DT level/NN of/IN the/DT 11th/CD and/CC the/DT 12th/CD thoracic/JJ vertebrae/NNS in/IN 592/NNP men/NNS and/CC 333/CD women/NNS were/VBD studied/VBN using/VBG computed/JJ tomography/NN ./.
@@111972881037/CD Most/JJS patients/NNS harboring/VBG metronidazole-/JJ and/CC clarithromycin-resistant/JJ strains/NNS were/VBD eradicated/VBN at/IN an/DT equal/NN rate/NN by/IN each/DT of/IN the/DT three/CD regimens/NNS ./.
@@90486174202/CD Here/RB we/PRP show/VBP that/IN the/DT type/NN of/IN tyrosine/MULTIGENE kinase/MULTIGENE receptor/MULTIGENE stimulated/VBN also/RB participates/VBZ in/IN the/DT nature/NN of/IN the/DT cAMP/NN effect/NN ./.
@@83349893821/CD To/TO begin/VB to/IN examine/VB the/DT mechanism/NN controlling/JJ expression/NN of/IN this/DT gene/NN during/IN the/DT cell-cycle/NN ,/, a/DT mouse/MULTIGENE B-myb/MULTIGENE 5'/CD flanking/JJ sequence/NN was/VBD isolated/VBN from/IN a/DT cosmid/NN library/NN and/CC shown/VBP to/IN promote/VB efficiently/RB the/DT transcription/NN of/IN a/DT luciferase/NN reporter/NN gene/NN when/CC transfected/VBN into/IN NIH3T3/CELL fibroblasts/NNS ./.
@@34365296948/CD The/DT structure/NN of/IN the/DT enhancer/NN was/VBD also/RB probed/VBN by/IN inserting/VBG a/DT pair/NN of/IN complementary/JJ synthetic/JJ oligodeoxynucleotides/NNS which/WDT represented/VBD the/DT region/NN between/IN nt/NN positions/NNS -235/CD and/CC -215/CD into/IN a/DT truncated/JJ template/NN which/WDT lacked/VBD the/DT enhancer/NN ./.
@@114085911969/CD We/PRP investigated/VBD the/DT production/NN of/IN hyaluronan/NN (/( HA/NN )/SYM and/CC its/PRP effect/NN on/IN cell/NN motility/NN in/IN cells/NNS expressing/JJ the/DT v-src/NN mutants/NNS ./.
@@22286152867/CD For/IN 85Sr/CD ,/, larger-than-expected/JJ distribution/NN coefficients/NNS were/VBD obtained/VBN in/IN the/DT desorption/NN experiments/NNS ,/, an/DT indication/NN of/IN the/DT irreversible/JJ formation/NN of/IN metal-oxyhydroxides/NNS during/IN a/DT slow/JJ reaction/NN ./.
@@79990662529/CD The/DT role/NN of/IN HIV/MULTIGENE tat/MULTIGENE ,/, which/WDT is/VBZ the/DT main/JJ enhancing/JJ factor/NN for/IN viral/JJ LTR/NN ,/, in/IN the/DT regulation/NN of/IN IL-2/MULTIGENE gene/MULTIGENE transcription/NN has/VBZ been/VBN studied/VBN following/IN transient/JJ expression/NN of/IN the/DT tat/MULTIGENE gene/MULTIGENE in/IN phorbol/NN ester/NN and/CC calcium/NN ionophore-activated/JJ Jurkat/NN cells/NNS transfected/VBN with/IN IL-2/MULTIGENE promoter-chloramphenicol/MULTIGENE acetyltransferase/MULTIGENE reporter/NN constructs/NNS ./.
@@108052867985/CD In/NN the/DT study/NN on/IN PCI/MULTIGENE mRNA/MULTIGENE expression/NN in/IN the/DT reproductive/JJ organs/NNS ,/, we/PRP first/RB cloned/VBN rat/MULTIGENE PCI/MULTIGENE cDNA/MULTIGENE and/CC then/RB evaluated/VBN the/DT effect/NN of/IN androgen/NN on/IN the/DT PCI/MULTIGENE mRNA/MULTIGENE expression/NN ./.
@@104097247644/CD Activation/NNS of/IN ERK1/GENE //GENE 2/GENE is/VBZ correlated/VBN with/IN induction/NN of/IN the/DT immediate-early/JJ response/NN genes/NNS ./.
@@93674265599/CD We/PRP argue/VBP that/IN the/DT primary/JJ role/NN of/IN hh/NN in/IN controlling/JJ polarity/NN is/VBZ to/IN cause/NN anterior/JJ compartment/NN cells/NNS to/IN reverse/JJ their/PRP interpretation/NN of/IN an/DT underlying/JJ symmetric/JJ polarization/NN ./.
@@14599218236/CD Four/CD ruminally/RB and/CC duodenally/RB cannulated/VBN Hampshire/NNP wethers/NNS were/VBD used/VBN in/IN a/DT 4/CD x/NN 4/CD Latin/JJ square/NN experiment/NN to/IN determine/VB whether/IN linoleoyl/JJ methionine/NN and/CC calcium/NN linoleate/NN would/MD increase/VB duodenal/JJ flow/NN of/IN unsaturated/JJ fatty/JJ acids/NNS (/( C18/IN :/: 2/CD +/SYM cis/MULTIGENE C18/MULTIGENE :/: 1/CD )/SYM ./.
@@77688484163/CD Polypeptides/NNS of/IN the/DT same/JJ apparent/JJ sizes/NNS are/VBP detected/VBN in/IN spores/NNS of/IN a/DT cotE/JJ null/JJ mutant/NN ,/, on/IN which/WDT basis/NN we/PRP infer/VBP that/IN the/DT products/NNS of/IN the/DT cotJ/MULTIGENE operon/MULTIGENE are/VBP required/VBN for/IN the/DT normal/JJ formation/NN of/IN the/DT inner/JJ layers/NNS of/IN the/DT coat/NN or/CC are/VBP themselves/PRP structural/JJ components/NNS of/IN the/DT coat/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@97675753783/CD This/DT domain/NN ,/, although/IN adjacent/JJ to/IN the/DT 5'/CD edge/NN of/IN the/DT SD/MULTIGENE sequence/MULTIGENE ,/, does/VBP not/RB inhibit/VB ribosome/NN binding/JJ as/RB long/RB as/IN the/DT single-stranded/JJ region/NN of/IN domain/NN 3/CD is/VBZ present/VB ./.
@@58934955796/CD Studies/NNS on/IN the/DT intracutaneous/JJ infection/NN of/IN rabbits/NNS by/IN Staphylococcus/NN aureus/NN ./.
@@85242725259/CD Differential/JJ regulation/NN of/IN the/DT alpha/MULTIGENE //MULTIGENE beta/MULTIGENE interferon-stimulated/MULTIGENE Jak/NNP //NNP Stat/NNP pathway/NN by/IN the/DT SH2/MULTIGENE domain-containing/MULTIGENE tyrosine/MULTIGENE phosphatase/MULTIGENE SHPTP1/MULTIGENE ./.
@@98345219819/CD The/DT retrovesical/JJ hydatid/NN cyst/NN is/VBZ a/DT very/RB rare/JJ site/NN ./.
@@98226026248/CD Thus/RB ,/, hypoxia-inducible/JJ nuclear/JJ import/NN and/CC transactivation/NN by/IN recruitment/NN of/IN CBP/NEWGENE can/MD be/VB functionally/RB separated/VBN from/IN one/PRP another/DT and/CC play/NN critical/JJ roles/NNS in/IN signal/JJ transduction/NN by/IN HIF-1alpha/NNP ./.
@@14004015855/CD Western/JJ blot/NN analyses/NNS detect/VBP anti-E-specific/JJ immunoreactivity/NN in/IN affinity-purified/JJ extracts/NNS derived/VBN from/IN the/DT bacterial/JJ expression/NN of/IN a/DT truncated/JJ AMPD3/MULTIGENE cDNA/MULTIGENE ./.
@@25250444197/CD The/DT recovery/NN index/NN (/( T25-T75/NN )/SYM after/IN the/DT infusion/NN stopped/VBN was/VBD similar/JJ in/IN patients/NNS who/WP received/VBD mivacurium/NN and/CC those/DT who/WP received/VBD suxamethonium/NN ./.
@@70735206843/CD During/IN conventional/JJ hemofiltration/NN using/VBG substitution/NN fluid/NN with/IN a/DT Na+/NN concentration/NN of/IN 140/CD mEq/NN //NN L/NN ,/, a/DT decrease/NN in/IN extracellular/JJ fluid/NN volume/NN was/VBD noted/VBN whereas/IN the/DT intracellular/JJ fluid/NN volume/NN was/VBD unaltered/JJ ./.
@@95287687315/CD Cells/NNS respond/VBP to/IN the/DT accumulation/NN of/IN unfolded/JJ proteins/NNS in/IN the/DT endoplasmic/JJ reticulum/NN (/( ER/NN )/SYM by/IN increasing/JJ the/DT transcription/NN of/IN the/DT genes/NNS encoding/VBG ER-resident/GENE chaperone/MULTIGENE proteins/MULTIGENE ./.
@@61933516014/CD The/DT intracoronary/JJ administration/NN of/IN both/DT drugs/NNS markedly/RB reduced/VBN the/DT incidence/NN of/IN VF/NN induced/VBN by/IN the/DT release/NN of/IN a/DT 40-min/JJ coronary/JJ artery/NN occlusion/NN ./.
@@91489351478/CD FN-stimulated/JJ c-Src/GENE PTK/GENE activity/NN was/VBD enhanced/VBN by/IN wild/JJ type/NN FAK/GENE expression/NN ,/, whereas/IN FN-stimulated/JJ activation/NN of/IN ERK2/GENE was/VBD blocked/VBN by/IN expression/NN of/IN the/DT c-Src/GENE binding/MULTIGENE site/MULTIGENE Phe-397/MULTIGENE mutant/MULTIGENE of/IN FAK/GENE ./.
@@26928813367/CD In/NN comparison/NN with/IN normal/JJ pregnant/JJ women/NNS and/CC normal/JJ non-pregnant/JJ women/NNS ,/, women/NNS with/IN PIH/NN showed/VBD an/DT increase/NN in/IN heart/NN rate/NN ,/, suggesting/VBG an/DT increased/VBN peripheral/JJ sympathetic/JJ tone/NN ,/, and/CC an/DT initial/JJ derangement/NN in/IN renal/JJ function/NN as/IN shown/VBP by/IN the/DT increase/NN in/IN serum/JJ uric/JJ acid/NN and/CC reduction/NN in/IN sodium/NN excretion/NN and/CC total/JJ and/CC fractional/JJ calcium/NN excretion/NN at/IN any/DT given/NN level/NN of/IN sodium/NN excretion/NN ./.
@@17826696916/CD However/RB ,/, it/PRP was/VBD synthesized/VBN at/IN both/DT temperatures/NNS after/IN addition/NN of/IN A23187/GENE ./.
@@96367086879/CD The/DT YccA/MULTIGENE protein/MULTIGENE was/VBD found/VBN to/IN be/VB degraded/VBN in/IN an/DT FtsH-dependent/NNP manner/NN in/IN vivo/NN and/CC in/IN vitro/FW ,/, whereas/IN the/DT YccA11/MULTIGENE mutant/MULTIGENE protein/MULTIGENE ,/, lacking/JJ eight/CD amino/JJ acid/NN residues/NNS within/IN the/DT amino-terminal/JJ cytoplasmic/JJ domain/NN ,/, was/VBD refractory/JJ to/IN the/DT degradation/NN ./.
@@115568099424/CD Interestingly/RB ,/, the/DT CYP71D20-encoded/MULTIGENE enzyme/MULTIGENE activity/NN was/VBD capable/JJ of/IN converting/JJ both/DT 5-epi-aristolochene/JJ and/CC 1-deoxycapsidiol/JJ to/IN capsidiol/NN in/IN vitro/FW ,/, consistent/JJ with/IN the/DT notion/NN that/IN this/DT P450/MULTIGENE enzyme/MULTIGENE catalyzes/VBZ both/DT hydroxylations/NNS of/IN its/PRP hydrocarbon/NN substrate/NN ./.
@@107338801176/CD Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@109804166059/CD Parathyroid/JJ hormone/NN regulation/NN of/IN bone/MULTIGENE sialoprotein/MULTIGENE (/( BSP/CONTEXTGENE )/SYM gene/NN transcription/NN is/VBZ mediated/JJ through/RB a/DT pituitary-specific/MULTIGENE transcription/MULTIGENE factor-1/MULTIGENE (/( Pit-1/GENE )/SYM motif/NN in/IN the/DT rat/MULTIGENE BSP/MULTIGENE gene/MULTIGENE promoter/MULTIGENE ./.
@@36079614274/CD Hypoglycemic/NNP action/NN of/IN "he/NN xiang/NN zhuang/NN qi/NN gong"/NN and/CC its/PRP mechanism/NN on/IN diabetes/NN mellitus/MD ./.
@@72375608489/CD While/IN all/DT deletions/NNS within/IN the/DT sequence/NN coding/JJ for/IN the/DT mature/JJ tRNA/NN led/VBN to/IN inactivity/NN of/IN the/DT mutated/MULTIGENE genes/MULTIGENE ,/, substitution/NN of/IN the/DT central/JJ portion/NN by/IN concatenated/JJ Hind/NNP III/NNP linkers/NNS produced/VBD gene/NN units/NNS active/JJ in/IN transcription/NN ./.
@@24812305419/CD Similarly/RB ,/, a/DT human/JJ but/CC not/RB a/DT bovine/MULTIGENE alpha/MULTIGENE transgene/MULTIGENE was/VBD expressed/VBN in/IN placenta/NN in/IN transgenic/JJ mice/NNS ./.
@@18560212452/CD The/DT method/NN has/VBZ been/VBN routinely/RB used/VBN in/IN our/PRP laboratory/NN for/IN 1/CD year/NN and/CC has/VBZ proven/VBP to/IN be/VB a/DT reliable/JJ procedure/NN for/IN the/DT biological/JJ control/NN of/IN occupational/JJ exposure/NN to/IN toluene/NN and/DT //DT or/DT xylene/NN ./.
@@80448026321/CD However/RB ,/, Southern/NNP blot/NN and/CC karyotype/NN analyses/NNS did/VBD not/RB reveal/VB any/DT significant/JJ changes/NNS in/IN copy/NN number/NN or/CC gross/JJ rearrangements/NNS of/IN the/DT p53/MULTIGENE gene/MULTIGENE in/IN any/DT of/IN the/DT p53-/NEWGENE cell/NN lines/NNS ./.
@@90774372774/CD Recognition/NNP mechanisms/NNS of/IN the/DT minus-strand/NN origin/NN of/IN phage/NN f1/GENE by/IN Escherichia/NN coli/JJ RNA/MULTIGENE polymerase/MULTIGENE ./.
@@107449747533/CD Phosphorylation/NNS and/CC spindle/NN pole/NN body/NN localization/NN of/IN the/DT Cdc15p/GENE mitotic/JJ regulatory/MULTIGENE protein/MULTIGENE kinase/MULTIGENE in/IN budding/JJ yeast/NN ./.
@@16116994713/CD Three/CD pyridoxine/NN derivatives/NNS have/VBP been/VBN isolated/VBN from/IN the/DT fresh/JJ stem/NN bark/NN of/IN Albizzia/MULTIGENE julibrissin/MULTIGENE DURAZZ/NNP ./NNP ./.
@@24004577700/CD In/NN Experiment/NN II/NNP ,/, as/IN performing/JJ moderate/JJ supine/JJ cycling/JJ (/( 55%/JJ VO2/GENE max/CONTEXTGENE )/SYM for/IN 50/CD minutes/NNS under/IN several/DT LBNP/NN conditions/NNS in/IN 5/CD sedentary/JJ women/NNS ,/, there/RB were/VBD correspondingly/RB similar/JJ changing/JJ manners/NNS of/IN the/DT cardiovascular/JJ adjustments/NNS to/IN each/DT of/IN the/DT phases/NNS given/NN in/IN Experiment/NN I/NNP ./NNP
@@91936714758/CD The/DT active/JJ state/NN is/VBZ terminated/VBN by/IN hydrolysis/NN of/IN bound/JJ GTP/NN ,/, producing/JJ inactive/JJ ARF-GDP/NNP ./.
@@70406596816/CD All/DT patients/NNS in/IN the/DT control/NN group/NN showed/VBD a/DT significant/JJ improvement/NN in/IN their/PRP PEFR/NN while/CC only/RB 3/CD patients/NNS in/IN the/DT treated/VBN group/NN showed/VBD an/DT improvement/NN ./.
@@34293064132/CD A/DT Golgi/JJ study/NN of/IN the/DT sixth/JJ layer/NN of/IN the/DT cerebral/JJ cortex/NN ./.
@@80343189253/CD The/DT availability/NN of/IN sequence/NN from/IN multiple/JJ species/NN has/VBZ permitted/VBN us/PRP to/IN determine/VB that/IN the/DT UBE/MULTIGENE site/MULTIGENE has/VBZ close/JJ similarity/NN to/IN motifs/NNS that/WDT bind/VBP members/NNS of/IN the/DT NF-1/MULTIGENE family/MULTIGENE of/IN transcription/NN factors/NNS ./.
@@3078268640/CD Finally/RB ,/, the/DT pathophysiological/JJ aspects/NNS of/IN urinary/JJ acidification/NN are/VBP discussed/VBN ,/, focusing/NN on/IN renal/JJ tubular/JJ acidosis/NN models/NNS (/( induced/VBN by/IN maleate/NN and/CC amphotericin/MULTIGENE B/MULTIGENE treatment/NN )/SYM and/CC their/PRP cellular/JJ mechanisms/NNS ,/, as/RB well/VB as/IN the/DT role/NN of/IN adrenal/JJ steroids/NNS in/IN urinary/JJ acidification/NN ./.
@@21620499972/CD To/TO address/VB this/DT issue/NN ,/, the/DT gene/NN for/IN factor/MULTIGENE Y/MULTIGENE has/VBZ been/VBN cloned/VBN molecularly/RB and/CC its/PRP DNA/NN sequence/NN has/VBZ been/VBN determined/VBN ./.
@@60544115883/CD Retention/NNP behavior/NN of/IN steroids/NNS in/IN gas/NN chromatography/NN with/IN a/DT series/NN of/IN combination/NN columns/NNS ./.
@@20167696244/CD We/PRP found/VBP that/IN the/DT relative/JJ strengths/NNS of/IN the/DT promoters/NNS were/VBD similar/JJ in/IN different/JJ contexts/NNS ./.
@@39781324640/CD In/NN MCCP/NN functions/NNS of/IN the/DT source/NN emission/NN ,/, surface/NN reflection/NN ,/, photoacceptor/NN sensitivity/NN are/VBP approximated/VBN by/IN the/DT normal/JJ distribution/NN curves/NNS ./.
@@96608384899/CD Regulation/NN at/IN 37/CD degrees/NNS C/NN ,/, therefore/RB ,/, involves/VBZ the/DT action/NN of/IN three/CD protein/MULTIGENE kinase/MULTIGENE cascades/NNS that/WDT repress/VBP HSF1/GENE through/JJ phosphorylation/NN of/IN serine/NN residues/NNS 303/CD ,/, 307/CD ,/, and/CC 363/CD and/CC may/MD promote/VB growth/VB by/IN suppressing/JJ the/DT heat/NN shock/NN response/NN ./.
@@13462622675/CD A/DT comparative/JJ study/NN of/IN the/DT total/JJ protein/NN profiles/NNS of/IN wild-type/NNP S/NNP ./NNP entomophila/NN UC9/CD and/CC mutant/MULTIGENE UC21/MULTIGENE revealed/VBN that/IN the/DT mutant/RB lacked/VBN an/DT approximately/RB 44-kDa/MULTIGENE protein/MULTIGENE and/CC overexpressed/VBN an/DT approximately/RB 20-kDa/MULTIGENE protein/MULTIGENE ./.
@@113838601234/CD The/DT images/NNS showed/VBD rapid/JJ ,/, predominantly/RB urinary/JJ excretion/NN of/IN 99mTc/MULTIGENE ciprofloxacin/MULTIGENE ,/, with/IN low/JJ to/IN absent/VB brain/NN ,/, lung/NN and/CC bone/NN marrow/NN uptake/NN and/CC low/JJ liver/NN uptake/NN and/CC excretion/NN ./.
@@20410889005/CD To/TO measure/VB the/DT enhancer/NN activity/NN of/IN DR60/NNP ,/, a/DT reporter/NN plasmid/NN was/VBD constructed/VBN that/WDT contained/VBD DR60/NNP cloned/VBN upstream/RB of/IN the/DT reporter/NN chloramphenicol/NN acetyltransferase/MULTIGENE gene/MULTIGENE under/IN the/DT control/NN of/IN the/DT delayed-early/JJ 39K/MULTIGENE promoter/MULTIGENE ./.
@@81894988713/CD Identification/NNP of/IN an/DT immediate-early/NEWGENE gene/NN in/IN the/DT Marek's/NNP disease/NN virus/NN long/JJ internal/JJ repeat/NN region/NN which/WDT encodes/VBZ a/DT unique/JJ 14-kilodalton/JJ polypeptide/NN ./.
@@86764545979/CD Only/RB fully/RB processed/VBN Pra/NN (/( N0/IN and/CC Nb/NN )/SYM and/CC ICP35/GENE (/( ICP35/GENE e/CONTEXTGENE ,/CONTEXTGENE f/CONTEXTGENE )/SYM are/VBP present/VB in/IN B/NNP capsids/NNS ,/, which/WDT are/VBP believed/VBN to/IN be/VB precursors/NNS of/IN mature/JJ virions/NNS ./.
@@27079097705/CD An/DT alternative/JJ method/NN of/IN UKM/GENE is/VBZ proposed/VBN based/VBN on/IN collecting/JJ a/DT small/JJ fraction/NN of/IN spent/VBP dialysate/NN flow/NN for/IN 3/CD consecutive/JJ dialyses/NNS ./.
@@2217253389/CD The/DT decline/NN in/IN the/DT activity/NN of/IN cytochrome/MULTIGENE oxidase/MULTIGENE ,/, peroxidase/NN and/CC in/IN the/DT lipid/NN content/NN of/IN peripheral/JJ neutrophils/NNS was/VBD followed/VBN by/IN a/DT decrease/NN in/IN the/DT phagocytic/JJ activity/NN ./.
@@11108548943/CD MS/NN characteristics/NNS of/IN coumarins/NNS ,/, psoralens/NNS and/CC polymethoxylated/VBN flavones/NNS with/IN different/JJ substitution/NN patterns/NNS were/VBD determined/VBN on/IN the/DT basis/NN of/IN the/DT response/NN obtained/VBN with/IN the/DT APcI/NN interface/NN ./.
@@9445056914/CD We/PRP have/VBP used/VBN mutation-directed/JJ chemical/JJ cross-linking/VBG with/IN bis/NN (/NN sulfosuccinimidyl/NN )/NN suberate/NN (/( BS3/GENE )/SYM to/IN investigate/VB the/DT architecture/NN of/IN the/DT gp41/MULTIGENE oligomer/MULTIGENE ./.
@@30480249233/CD Bacteriologic/NNP culture/NN of/IN pancreatic/JJ tissue/NN was/VBD positive/JJ in/IN 6/CD //CD 8/CD IB/NN and/CC 3/CD //CD 17/CD NIB/GENE rats/NNS (/( p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@808898994/CD The/DT clinico-pathological/JJ data/NN from/IN a/DT patient/NN with/IN irreversible/JJ post-partum/JJ renal/JJ failure/NN (/( IPRF/GENE )/SYM are/VBP presented/VBN ./.
@@37513084420/CD Study/NNP of/IN the/DT energy/NN metabolism/NN of/IN the/DT sensomotor/JJ cortex/NN and/CC hippocampus/NN by/IN the/DT (/( 14C/CD )/NN 2-deoxyglucose/NN method/NN during/IN the/DT development/NN of/IN dissociated/VBN states/NNS ./.
@@24921113463/CD In/NN 76%/NN of/IN 59/CD lead-toxic/JJ children/NNS ,/, bone/NN lead/NN values/NNS measured/VBN by/IN LXRF/GENE were/VBD equal/VB to/IN or/CC greater/JJR than/IN those/DT measured/VBN in/IN normal/JJ and/CC industrially/RB exposed/VBN adults/NNS ./.
@@37792054458/CD Only/RB seven/JJ patients/NNS ,/, five/CD of/IN whom/WP have/VBP metastatic/JJ disease/NN ,/, survive/VB more/RB than/IN 10/CD years/NNS after/IN first/JJ presentation/NN ;/: nine/JJ patients/NNS ,/, one/PRP of/IN whom/WP has/VBZ secondaries/NNS ,/, survive/VB for/IN 5/CD years/NNS or/CC less/PRP ./.
@@113748668768/CD Copyright/NNP 2001/CD Academic/NNP Press/NNP ./.
@@67841232013/CD The/DT 1/CD ./CD 9-kb/CD C/MULTIGENE mu/MULTIGENE RNA/MULTIGENE contains/VBZ the/DT 3'/CD sequence/NN characteristic/NN of/IN secreted/VBN mu/MULTIGENE chain/MULTIGENE ,/, whereas/IN the/DT longer/JJR species/NN bear/NN that/IN of/IN membrane-bound/MULTIGENE mu/MULTIGENE chin/NN ./.
@@76385173384/CD From/IN May/NN 1985/CD to/IN May/NN 1989/CD ,/, 126/CD necropsies/NNS were/VBD performed/VBN at/IN the/DT Sao/NNP Paulo/NNP City/NNP Morgue/NNP on/IN cadavers/NNS of/IN individuals/NNS AIDS/MULTIGENE victims/MULTIGENE whose/WP unnatural/JJ deaths/NNS had/VBP prompted/VBN police/NNS investigations/NNS ./.
@@85756141401/CD Rad6/MULTIGENE mutants/MULTIGENE display/NN a/DT remarkably/RB pleiotropic/JJ phenotype/NN ,/, implicating/VBG the/DT protein/NN in/IN DNA/NN damage-induced/JJ mutagenesis/NN ,/, postreplication/JJ repair/NN ,/, repression/NN of/IN retrotransposition/JJ ,/, and/CC sporulation/NN ./.
@@88824927414/CD The/DT mammalian/JJ homeodomain/MULTIGENE proteins/MULTIGENE encoded/VBN by/IN Hox/MULTIGENE genes/MULTIGENE play/VBP an/DT important/JJ role/NN in/IN embryonic/JJ development/NN by/IN providing/CC positional/JJ queues/NNS which/WDT define/VBP developmental/JJ identities/NNS along/IN the/DT anteroposterior/JJ axis/NN of/IN developing/JJ organisms/NNS ./.
@@27139943399/CD The/DT titer/NN of/IN anti/JJ HSV/MULTIGENE type/MULTIGENE 1/MULTIGENE and/CC anti/JJ HSV/MULTIGENE type/MULTIGENE 2/MULTIGENE antibodies/NNS in/IN the/DT mothers'/NN and/CC cord/NN blood/NN was/VBD determined/VBN and/CC compared/VBN ./.
@@75719537470/CD Negative-staining/VBG ,/, refractile/JJ mycobacteria/NNS in/IN Romanowsky-stained/JJ smears/NNS ./.
@@40378091278/CD The/DT effective/JJ and/CC low/JJ toxic/JJ dose/NN schedules/NNS of/IN KW-2083/GENE should/MD be/VB investigated/VBN further/RB ./.
@@94794985832/CD We/PRP have/VBP isolated/VBN a/DT new/JJ human/MULTIGENE RING-finger/MULTIGENE gene/MULTIGENE (/( RNF4/GENE )/SYM that/IN encodes/VBZ a/DT 190-amino-acid/GENE protein/NN ./.
@@30404039443/CD The/DT PSS/NN gene/NN was/VBD subcloned/JJ into/IN a/DT 1/CD ./CD 1-kb/CD fragment/NN of/IN the/DT yeast/NN DNA/NN on/IN the/DT YEp13/NNP vector/NN ./.
@@2679804929/CD The/DT products/NNS of/IN genes/MULTIGENE ura10/MULTIGENE and/CC ura3/NEWGENE are/VBP proposed/VBN to/IN participate/VB in/IN the/DT channeling/VBG of/IN orotidine/NN monophosphate/NN ./.
@@97951309885/CD Interestingly/RB ,/, an/DT increase/NN of/IN distance/NN per/IN se/FW did/VBD not/RB have/VB a/DT deleterious/JJ effect/NN on/IN translation/NN efficiency/NN ./.
@@23618122749/CD Per/IN kg/NN FFM/NN SMR/NN was/VBD almost/RB restored/VBN to/IN baseline/NN values/NNS for/IN the/DT EX/NN group/NN ,/, whereas/IN the/DT non-exercising/JJ subjects/NNS still/RB showed/VBD depressed/VBN values/NNS (/( EX/NN 3/NN ./NN 7/NN per/IN cent/NN and/CC D/NN +/SYM DE/NNP 15/CD ./CD 8/CD per/IN cent/NN lower/JJR than/IN before/IN treatment/NN ;/: P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@16959059788/CD GLUT5/MULTIGENE mRNA/MULTIGENE is/VBZ expressed/VBN at/IN highest/JJS levels/NNS in/IN small/JJ intestine/NN and/CC at/IN much/RB lower/JJR levels/NNS in/IN kidney/NN ,/, skeletal/JJ muscle/NN ,/, and/CC adipose/JJ tissue/NN ./.
@@91723128543/CD Characterization/NNS of/IN CR1/GENE repeat/NN random/JJ PCR/NN markers/NNS for/IN mapping/VBG the/DT chicken/NN genome/NN ./.
@@91219981563/CD Time-activity/NNP curves/NNS from/IN the/DT gastric/JJ region/NN of/IN interest/NN were/VBD used/VBN ,/, after/IN subjection/NN to/IN appropriate/JJ corrective/JJ procedures/NNS ,/, to/IN calculate/VB the/DT mean/JJ gastric/JJ transit/NN time/NN (/( MTT/MULTIGENE 90/MULTIGENE )/SYM and/CC the/DT fraction/NN of/IN the/DT test/NN meal/NN retained/VBN in/IN the/DT stomach/NN after/IN 90/CD min/NN (/( F90/CD )/SYM ./.
@@81083438369/CD Comparative/JJ analysis/NN with/IN an/DT antiandrogen/NN niftolid/NN and/CC synthetic/JJ GnRH/NEWGENE was/VBD carried/VBN out/RB in/IN 22/CD normal/JJ subjects/NNS ,/, 14/CD patients/NNS with/IN primary/JJ and/CC 20/CD ones/NNS with/IN secondary/JJ hypogonadism/NN ,/, and/CC in/IN 5/CD patients/NNS with/IN clinical/JJ signs/NNS of/IN gonadal/JJ insufficiency/NN and/CC obscure/VB diagnosis/NN in/IN order/NN to/IN elucidate/VB the/DT pituitary/JJ gonadotropin/NN reserves/NNS ./.
@@86172431788/CD We/PRP have/VBP isolated/VBN a/DT novel/JJ protein/NN from/IN Drosophila/NN nuclear/JJ extracts/NNS which/WDT binds/VBZ specifically/RB to/IN a/DT site/NN in/IN this/DT second/JJ region/NN ./.
@@112790869060/CD These/DT data/NN suggest/VB that/IN ADAM-TS12/GENE may/MD play/VB roles/NNS in/IN pulmonary/JJ cells/NNS during/IN fetal/JJ development/NN or/CC in/IN tumor/NN processes/NNS through/RB its/PRP proteolytic/JJ activity/NN or/CC as/IN a/DT molecule/NN potentially/RB involved/VBD in/IN regulation/NN of/IN cell/NN adhesion/NN ./.
@@105214473214/CD Furthermore/RB ,/, overexpression/NN of/IN AML3/GENE //GENE CBFalpha1/GENE could/MD rescue/VB the/DT AML1-ETO/NNP repression/NN ./.
@@77448467648/CD Analysis/NNP of/IN Bcl-2/GENE //GENE Bcl-2/GENE homodimerization/NN using/VBG both/DT in/NN vitro/FW binding/JJ assays/NNS as/RB well/VBP as/IN a/DT yeast/NN two-hybrid/JJ method/NN provided/VBD evidence/NN in/IN support/NN of/IN a/DT head-to-tail/JJ model/NN for/IN Bcl-2/GENE //GENE Bcl-2/GENE homodimerization/NN and/CC revealed/VBN that/IN sequences/NNS within/IN the/DT NH2-terminal/MULTIGENE A/MULTIGENE domain/NN interact/VB with/IN a/DT structure/NN that/WDT requires/VBZ the/DT presence/NN of/IN both/PDT the/DT carboxyl/MULTIGENE B/MULTIGENE and/CC C/MULTIGENE domains/MULTIGENE in/IN combination/NN ./.
@@83170942672/CD The/DT 5'/CD ends/NNS of/IN F3R/GENE late/JJ transcripts/NNS were/VBD located/VBN to/IN an/DT A/DT within/IN the/DT sequence/NN 5'-TAAAG/JJ ,/, 41/CD nt/NN downstream/RB from/IN the/DT early/JJ promoter/NN and/CC 17/CD nt/NN upstream/RB from/IN the/DT initiation/NN codon/NN ./.
@@117265741571/CD These/DT results/NNS were/VBD robust/JJ to/IN changes/NNS in/IN the/DT baseline/NN assumptions/NNS of/IN the/DT model/NN ./.
@@114658441341/CD Lack/NN of/IN association/NN between/IN Kawasaki/NN syndrome/NN and/CC infection/NN with/IN Rickettsia/NN conorii/NN ,/, Rickettsia/NN typhi/NN ,/, Coxiella/NN burnetii/NN or/CC Ehrlichia/NNP phagocytophila/NN group/NN ./.
@@72496607081/CD Determination/NNS of/IN aortic/JJ distensibility/NN and/CC its/PRP variations/NNS in/IN arterial/JJ hypertension/NN ./.
@@9480831754/CD To/TO elucidate/VB the/DT regulatory/JJ mechanism/NN of/IN human/MULTIGENE AM/MULTIGENE gene/MULTIGENE expression/NN ,/, functional/JJ elements/NNS of/IN 5'-flanking/JJ region/NN of/IN AM/MULTIGENE gene/MULTIGENE were/VBD studied/VBN in/IN human/JJ aortic/JJ endothelial/JJ cells/NNS (/( HAEC/NN )/SYM ./.
@@113568538986/CD Members/NNS of/IN the/DT AP-1/MULTIGENE superfamily/MULTIGENE of/IN basic-leucine/MULTIGENE zipper/MULTIGENE factors/MULTIGENE bind/VBP to/IN the/DT StRE/NNP ./.
@@22566782739/CD Finally/RB ,/, a/DT complementary/JJ footprinting/VBG analysis/NN of/IN the/DT upstream/JJ region/NN of/IN the/DT constitutively/RB expressed/VBN HSC82/MULTIGENE gene/MULTIGENE reveals/VBZ the/DT presence/NN of/IN three/CD discrete/JJ protein/NN complexes/NNS ./.
@@10766556580/CD The/DT somatoform/JJ conundrum/NN :/: a/DT question/NN of/IN nosological/JJ valves/NNS ./.
@@64299926231/CD Gonadotropin/NN levels/NNS in/IN mothers/NNS who/WP have/VBP had/VBP two/JJ sets/NNS of/IN DZ/JJ twins/NNS ./.
@@90289424518/CD Human/MULTIGENE granulocyte-macrophage/MULTIGENE colony-stimulating/MULTIGENE factor/MULTIGENE (/( hGM-CSF/GENE )/SYM activates/VBZ a/DT set/NN of/IN genes/NNS such/JJ as/IN c-fos/GENE ,/, jun/CONTEXTGENE ,/, myc/CONTEXTGENE ,/, and/CC early/JJ growth/NN response/NN gene/NN 1/CD (/( egr-1/NEWGENE )/SYM ./.
@@10872851690/CD When/WRB the/DT LCx/NN was/VBD partially/RB occluded/VBN ,/, mild/JJ PM-induced/JJ tachycardia/NN resulted/VBN in/IN decreased/VBN AoP/NN (/( P/NN =/NN 0/NN ./NN 045/NN )/SYM as/RB well/VB as/IN in/IN decreased/VBN SV/NN (/( P/NNP =/NNP 0/NNP ./NNP 048/NNP )/SYM ;/: the/DT LVEDP/NN remained/VBD high/JJ (/( P/CD =/CD 0/CD ./CD 002/CD )/SYM ./.
@@112308892657/CD Two/CD cases/NNS with/IN marked/JJ chronic/JJ arm/NN lymphoedema/NN reported/VBD major/JJ and/CC persistent/JJ improvements/NNS in/IN arm/NN volume/NN for/IN at/IN least/RB 12/CD months/NNS after/IN treatment/NN with/IN HBO2/GENE ./.
@@38632317191/CD The/DT M-3/MULTIGENE subtype/MULTIGENE was/VBD an/DT adverse/JJ prognostic/JJ factor/NN ./.
@@53649515505/CD Histopathology/NNS and/CC pathogenesis/NN of/IN exanthematous/JJ viroses/NNS ./.
@@90606236234/CD The/DT human/MULTIGENE coreceptor/MULTIGENE was/VBD as/RB active/JJ as/IN the/DT simian/NN for/IN SIV/NN entry/NN ./.
@@28394887288/CD Quantitative/JJ assays/NNS in/IN which/WDT the/DT activity/NN of/IN the/DT synthetic/JJ alpha/MULTIGENE s-1/MULTIGENE was/VBD compared/VBN to/IN that/DT of/IN native/RB purified/VBN human/MULTIGENE erythrocyte/MULTIGENE type-1/MULTIGENE Gs/MULTIGENE ,/, indicated/VBN that/IN the/DT two/JJ products/NNS are/VBP equipotent/JJ within/IN a/DT 2-fold/JJ margin/NN of/IN error/NN ./.
@@78995814610/CD The/DT effect/NN of/IN the/DT Ca/NN entry/NN blocker/NN nitrendipine/NN ,/, the/DT antioxidant/JJ superoxide/MULTIGENE dismutase/MULTIGENE (/( SOD/CONTEXTGENE )/SYM ,/, and/CC a/DT combination/NN of/IN nitrendipine/NN and/CC superoxide/MULTIGENE dismutase/MULTIGENE on/IN postischemic/JJ renal/JJ function/NN was/VBD studied/VBN in/IN four/CD groups/NNS (/( n/NN =/SYM 24/CD )/SYM of/IN rats/NNS ./.
@@81335028105/CD European/NNP Community/NNP Huntington's/NNP Disease/NNP Collaborative/NNP Study/NNP Group/NNP ./.
@@14690472246/CD Interestingly/RB ,/, a/DT portion/NN of/IN the/DT tail/NN domain/NN (/( aa/NNS ,/, 1/CD ,/CD 094-1/CD ,/CD 830/CD )/SYM shares/VBP 58%/JJ amino/JJ acid/NN sequence/NN identity/NN with/IN a/DT 723-aa/JJ protein/NN from/IN mouse/NN brain/NN reported/VBN to/IN be/VB a/DT glutamic/MULTIGENE acid/MULTIGENE decarboxylase/MULTIGENE ./.
@@16407782243/CD This/DT accurate/JJ and/CC rapid/JJ method/NN makes/VBP the/DT MLPA/NN test/NN logistically/RB feasible/JJ for/IN large-scale/JJ screening/NN ./.
@@77116672573/CD A/DT multivariate/JJ analysis/NN of/IN risk/NN factors/NNS for/IN relapse/NN examined/VBD age/NN ,/, WBC/NN at/IN diagnosis/NN ,/, blast/NN count/NN at/IN diagnosis/NN ,/, percentage/NN of/IN marrow/NN blasts/NNS ,/, FAB/MULTIGENE subtype/MULTIGENE ,/, the/DT number/NN of/IN remission/NN induction/NN courses/NNS to/IN achieve/VB a/DT remission/NN ,/, maintenance/NN therapy/NN ,/, consolidation/NN therapy/NN ,/, marrow/NN cell/NN dose/NN ,/, donor-recipient/JJ sex/NN ,/, GVHD/NN prophylaxis/NN regimen/NN and/CC isolation/NN and/CC decontamination/NN in/IN laminar/JJ airflow/NN rooms/NNS ./.
@@82533864496/CD We/PRP have/VBP explored/VBN the/DT mechanism/NN of/IN action/NN of/IN the/DT fibronectin/NN splicing/JJ enhancer/NN and/CC found/VB that/IN the/DT SE/MULTIGENE element/MULTIGENE is/VBZ required/VBN for/IN efficient/JJ assembly/NN of/IN early/JJ splicing/JJ complexes/NNS ,/, allowing/VBG a/DT more/RB efficient/JJ interaction/NN of/IN the/DT U2/MULTIGENE snRNP/MULTIGENE with/IN branch/NN site/NN sequences/NNS ./.
@@75763078086/CD Unexpectedly/RB ,/, all/DT ENK-specific/MULTIGENE motifs/MULTIGENE formed/VBD specific/JJ and/CC highly/RB abundant/JJ protein-DNA/JJ complexes/NNS when/CC nuclear/JJ extracts/NNS from/IN the/DT human/JJ tumor/NN cell/NN line/NN (/( HeLa/IN )/SYM ,/, which/WDT does/VBP not/RB express/VB ENK/GENE ,/, were/VBD used/VBN ./.
@@109325278012/CD Subsequently/RB ,/, HD/NEWGENE inhibited/VBD healing/NN because/IN it/PRP significantly/RB delayed/JJ epithelialization/NN and/CC caused/VBN protracted/JJ inflammation/NN ./.
@@103929039525/CD The/DT bovine/JJ papillomavirus/NN E2/MULTIGENE protein/MULTIGENE can/MD inhibit/VB the/DT proliferation/NN of/IN HT-3/NNP cells/NNS ,/, a/DT p53-negative/JJ cervical/JJ carcinoma/NN cell/NN line/NN containing/JJ integrated/JJ human/JJ papillomavirus/NN type/MULTIGENE 30/MULTIGENE DNA/MULTIGENE ./.
@@89016588862/CD Vascular/JJ responses/NNS to/IN reactive/NN hyperemia/NN (/( with/IN flow/NN increase/NN leading/JJ to/IN endothelium-dependent/JJ dilation/NN )/SYM and/CC to/IN sublingual/JJ glyceryl/NN trinitrate/NN (/( GTN/NN ;/: endothelium-independent/JJ dilation/NN )/SYM were/VBD recorded/VBN ./.
@@77969354216/CD We/PRP compared/VBD the/DT inhibitory/JJ effect/NN of/IN naturally/RB occurring/VBG mutant/JJ hTR/NN beta/NN 1/CD ,/, artificially/RB created/VBN hTR/MULTIGENE alpha/MULTIGENE 1/MULTIGENE mutants/MULTIGENE ,/, c-erbA/MULTIGENE alpha/MULTIGENE 2/MULTIGENE and/CC the/DT human/MULTIGENE peroxisome/MULTIGENE proliferator-activated/MULTIGENE receptor/MULTIGENE (/( hPPAR/NN )/SYM on/IN three/CD prototypic/JJ T3-response/MULTIGENE elements/MULTIGENE (/( TREs/CONTEXTGENE )/SYM ,/, TRE-PAL/NNP ,/, DR/NN +/SYM 4/CD and/CC TRE-LAP/GENE ./.
@@2289639346/CD The/DT mean/JJ change/NN in/IN HbA1/NEWGENE ,/, adjusted/VBN for/IN the/DT initial/JJ value/NN ,/, was/VBD -0/CD ./CD 4%/CD in/IN the/DT experimental/JJ and/CC +0/CD ./CD 5%/CD in/IN the/DT control/NN group/NN (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@67554687294/CD Regions/NNS of/IN the/DT translated/VBN open/JJ reading/JJ frames/NNS of/IN cobA/NN and/CC the/DT third/JJ intron/NN of/IN the/DT cob/MULTIGENE gene/MULTIGENE in/IN yeast/NN show/NN high/JJ amino/JJ acid/NN homology/NN ./.
@@112909069069/CD Tumor-like/NNP accumulation/NN on/IN Tl-201/GENE SPECT/NN in/IN subacute/JJ hemorrhagic/JJ cerebral/JJ infarction/NN ./.
@@13169036212/CD RNA/MULTIGENE polymerase/MULTIGENE IIA/MULTIGENE was/VBD recovered/VBN in/IN transcriptionally/RB active/JJ complexes/NNS in/IN reactions/NNS in/IN which/WDT the/DT input/NN enzyme/NN was/VBD RNA/MULTIGENE polymerase/MULTIGENE IIA/MULTIGENE ./.
@@89739177586/CD Isolation/NNS and/CC genomic/JJ structure/NN of/IN a/DT human/JJ homolog/NN of/IN the/DT yeast/NN periodic/JJ tryptophan/NN protein/NN 2/CD (/( PWP2/GENE )/SYM gene/NN mapping/NN to/IN 21q22/CD ./CD 3/CD ./.
@@67026437189/CD In/NN 14/CD of/IN 21/CD infant/NN hearts/NNS (/( 66%/JJ )/SYM with/IN aortic/JJ arch/NN interruption/NN between/IN the/DT left/JJ common/JJ carotid/NN and/CC left/NN subclavian/JJ arteries/NNS (/( type/NN B/NN of/IN Celoria/NNP and/CC Patton/NNP )/SYM ,/, the/DT right/JJ subclavian/JJ artery/NN (/( SA/NNP )/SYM arose/VBD anomalously/RB ./.
@@78445558066/CD They/PRP also/RB reported/VBD that/DT E/MULTIGENE mu/MULTIGENE pim-1/MULTIGENE transgenic/JJ mice/NNS show/VBP greatly/RB accelerated/JJ lymphoma/NN development/NN when/CC infected/VBN with/IN wild-type/NN M-MuLV/IN at/IN birth/NN ./.
@@16790682276/CD Among/IN 953/CD infants/NNS in/IN 22/CD neonatal/JJ care/NN units/NNS studied/VBN ,/, 23%/JJ (/( median/JJ value/NN ,/, range/NN 0-78/JJ )/SYM were/VBD found/VBN to/IN be/VB faecally/RB colonized/VBN with/IN one/PRP of/IN 21/CD distinct/JJ nosocomial/JJ strains/NNS of/IN Escherichia/NN coli/JJ ,/, Klebsiella/NN or/CC Enterobacter/NN spp/NNS ./.
@@10993773829/CD This/DT slope/NN was/VBD further/RB significantly/RB decreased/VBN at/IN 5/CD min/NN ischemia/NN (/( -26/CD ./CD 5/CD +/NN //NN -/NN 8/CD ./CD 8/CD &mgr/NN ;/: m/NN //NN mmHg/NN )/SYM but/CC returned/VBN toward/IN control/NN values/NNS in/IN short-term/JJ hibernating/JJ myocardium/NN at/IN 90/CD min/NN ischemia/NN (/( -17/CD ./CD 2/CD +/NN //NN -/NN 6/CD ./CD 6/CD &mgr/NN ;/: m/NN //NN mmHg/NN )/SYM ./.
@@54242202082/CD Lipid/NN concentration/NN and/CC lipase/NEWGENE activity/NN in/IN the/DT epiphysis/NN of/IN adrenalectomized/JJ rats/NNS consuming/JJ food/NN with/IN different/JJ sodium/NN content/NN ./.
@@95826352740/CD Results/NNS showed/VBN that/IN the/DT mean/JJ bond/NN strength/NN of/IN H/NNP ./NNP T/NNP ./NNP V/NNP ./. specimens/NNS ranged/VBN from/IN 9/CD ./CD 6/CD to/IN 13/CD ./CD 12/CD kg/GENE //GENE cm2/GENE ,/, while/CC the/DT mean/JJ bond/NN strength/NN of/IN R/NNP ./NNP T/NNP ./NNP V/NNP ./. specimens/NNS ranged/VBN from/IN 0/CD ./CD 36/CD to/IN 1/CD ./CD 75/CD kg/GENE //GENE cm2/GENE ./.
@@37216661415/CD Nickel/GENE is/VBZ the/DT most/RB common/JJ cause/NN of/IN allergic/JJ contact/NN dermatitis/NN in/IN Singapore/NN ,/, resulting/JJ in/IN positive/JJ reactions/NNS in/IN patch/NN tests/NNS between/IN 7/CD and/CC 14%/CD ./.
@@95496609500/CD One/CD hundred/JJ replicate/VB data/NN sets/NNS of/IN 100/CD subjects/VBZ each/DT were/VBD simulated/JJ for/IN each/DT missing/JJ data/NN scenario/NN ./.
@@97869496121/CD J/NNP ./NNP
@@22770052924/CD The/DT CT/NN characteristics/NNS are/VBP discussed/VBN and/CC the/DT recent/JJ literature/NN is/VBZ reviewed/VBN ./.
@@13479081967/CD The/DT rationale/NN for/IN continuous/JJ dopaminergic/JJ stimulation/NN in/IN patients/NNS with/IN Parkinson's/NNP disease/NN ./.
@@90884164129/CD Idiopathic/NNP bilateral/JJ recurrent/JJ branch/NN retinal/JJ arterial/JJ occlusion/NN (/( IBRBRAO/NN )/SYM is/VBZ a/DT rare/JJ syndrome/NN characterized/VBN by/IN migraine/JJ headaches/NNS ,/, tinnitus/NN ,/, vertigo/NN ,/, hearing/JJ loss/NN ,/, and/CC recurrent/JJ branch/NN retinal/JJ artery/NN occlusion/NN of/IN unknown/JJ etiology/NN ./.
@@111704762405/CD The/DT extraordinary/JJ stability/NN of/IN peptide--gp96/GENE complexes/NNS and/CC the/DT plasticity/NN of/IN the/DT peptide-binding/JJ pocket/NN support/NN the/DT proposed/VBN relay/NN of/IN diverse/JJ peptides/NNS to/IN MHC/NN and/IN //IN or/IN other/DT molecules/NNS via/NN molecular/JJ recognition/NN ./.
@@28134049707/CD Male-enhanced/JJ antigen/NN gene/NN is/VBZ phylogenetically/RB conserved/VBN and/CC expressed/VBN at/IN late/JJ stages/NNS of/IN spermatogenesis/NN ./.
@@75381223482/CD In/NN this/DT report/NN we/PRP describe/VBP the/DT isolation/NN of/IN a/DT Fab/NNP fragment/NN (/( Fab/NNP A8/NNS )/SYM showing/VBG a/DT high/JJ relative/JJ affinity/NN for/IN the/DT receptor/NN (/( 0/CD ./CD 5/CD nM/NN )/SYM ./.
@@77945569812/CD In/NN the/DT Center/NNP for/IN Human/NNP Genetics/NNP in/IN Leuven/NNP ,/, predictive/JJ DNA-testing/NN for/IN Huntington's/GENE disease/NN is/VBZ available/JJ as/IN a/DT clinical/JJ service/NN since/IN November/NN 1987/CD ,/, initially/RB by/IN DNA-linkage/NNP and/CC since/IN mid/NN 1993/CD by/IN direct/JJ mutation/NN analysis/NN ./.
@@10024498429/CD Electrophoretic/JJ mobility-shift/JJ assays/NNS performed/VBN with/IN the/DT HNF-3/MULTIGENE X/MULTIGENE and/CC Y/MULTIGENE sites/MULTIGENE demonstrated/VBN that/IN both/DT sites/NNS are/VBP capable/JJ of/IN binding/JJ HNF-3alpha/GENE and/CC HNF-3beta/GENE ./.
@@86774434829/CD In/NN a/DT Hoosier/NNP Oncology/NNP Group/NNP randomized/JJ study/NN involving/VBG extensive-disease/MULTIGENE SCLC/MULTIGENE patients/NNS ,/, VIP/NN was/VBD superior/JJ to/IN etoposide/NN //NN cisplatin/NN with/IN regard/NN to/IN median/JJ time/NN to/IN progression/NN (/( 6/CD ./CD 6/CD v/NN 5/CD ./CD 8/CD months/NNS )/SYM ,/, median/JJ survival/NN times/NNS (/( 9/CD ./CD 1/CD v/NN 7/CD ./CD 3/CD months/NNS )/SYM ,/, and/CC 2-/CD and/CC 3-year/CD survival/NN rates/NNS (/( 13%/JJ v/NN 5%/JJ and/CC 5%/JJ v/NN 0%/CD ,/, respectively/RB )/SYM ./.
@@79371064038/CD The/DT v-ets/MULTIGENE oncogene/MULTIGENE of/IN the/DT avian/JJ retrovirus/NN E26/NEWGENE differs/VBZ from/IN its/PRP cellular/JJ progenitor/NN p68c-ets-1/GENE by/IN two/JJ amino/JJ acid/NN substitutions/NNS (/( alanine/NN 285/CD and/CC isoleucine/NN 445/CD in/IN c-ets-1/NNP both/DT substituted/JJ by/IN valine/NN in/IN v-ets/NNS ,/, mutations/MULTIGENE A/MULTIGENE and/CC B/NNP respectively/RB )/SYM and/CC its/PRP carboxy-terminal/JJ end/NN (/( mutation/MULTIGENE C/MULTIGENE )/SYM ./SYM
@@19278451508/CD Since/IN the/DT morphology/NN of/IN the/DT lesions/NNS can/MD mimic/NN that/IN of/IN other/DT cutaneous/JJ disorders/NNS ,/, Bowen's/GENE disease/NN is/VBZ often/RB not/RB recognized/VBN initially/RB ./.
@@84289539590/CD This/DT promoter/NN could/MD direct/VB the/DT constitutive/JJ expression/NN of/IN the/DT reporter/NN beta-galactosidase/NN at/IN high/JJ frequency/NN in/IN transfected/VBN colonies/NNS of/IN transformed/VBN cells/NNS that/WDT express/VBP L-plastin/NNP constitutively/RB ;/: by/IN contrast/NN ,/, this/DT promoter/NN was/VBD virtually/RB inactive/JJ in/IN transfected/VBN colonies/NNS of/IN normal/JJ fibroblasts/NNS and/CC it/PRP exhibited/VBD a/DT low/JJ frequency/NN of/IN constitutive/JJ activation/NN in/IN transfected/VBN colonies/NNS of/IN in/IN vitro/FW SV40-transformed/JJ fibroblasts/NNS which/WDT did/VBD not/RB exhibit/VB L-plastin/GENE expression/NN ./.
@@18844354340/CD This/DT study/NN examines/VBZ the/DT effects/NNS of/IN hypovolemia/NN on/IN the/DT extracellular/JJ ptO2/GENE and/CC ptH/GENE distributions/NNS at/IN multiple/JJ tissue/NN sites/NNS using/VBG a/DT recently/RB developed/VBN multipoint/JJ microelectrode/NN ,/, that/WDT provides/VBZ simultaneous/JJ measurements/NNS of/IN ptO2/GENE and/CC ptH/GENE ./.
@@2645276946/CD Construction/NN of/IN a/DT RIP1/GENE deletion/NN strain/NN and/CC isolation/NN of/IN temperature-sensitive/JJ mutants/NNS ./.
@@86629287026/CD This/DT regulation/NN could/MD not/RB be/VB appreciably/RB modified/JJ by/IN enhanced/JJ expression/NN of/IN STAT/MULTIGENE proteins/MULTIGENE ./.
@@40529194735/CD These/DT data/NN showed/VBD :/: that/DT progesterone/NN secretion/NN is/VBZ pulsatile/JJ throughout/IN the/DT human/JJ luteal/JJ phase/NN ,/, with/IN maximum/JJ frequency/NN in/IN the/DT mid-luteal/JJ phase/NN ;/: that/IN during/IN the/DT mid-luteal/JJ phase/NN most/JJ subjects/NNS had/VBP progesterone/NN levels/VBZ both/DT above/RB and/CC below/RB currently/RB accepted/VBN ovulatory/JJ thresholds/NNS ;/: the/DT use/NN of/IN a/DT single/JJ measurement/NN of/IN progesterone/NN in/IN the/DT mid-luteal/JJ phase/NN is/VBZ not/RB always/RB a/DT reliable/JJ indicator/NN of/IN ovulation/NN ;/: a/DT threshold/NN greater/JJR than/IN 20/CD nmol/NN //NN l/NN may/MD yield/VB an/DT unacceptable/JJ number/NN of/IN false/JJ negative/JJ results/NNS ./.
@@36979715466/CD The/DT selenium/NN level/NN and/CC glutathione/MULTIGENE peroxidase/MULTIGENE activity/NN in/IN the/DT blood/NN ,/, liver/NN ,/, and/CC stomach/NN mucosa/NN were/VBD significantly/RB higher/JJ in/IN the/DT high-selenium/JJ diet/NN group/NN than/IN in/IN the/DT low-selenium/JJ diet/NN group/NN ./.
@@28997923606/CD Oestrogen/NN implant/NN overdose/NN ./.
@@95069591290/CD Identification/NNP and/CC characterization/NN of/IN specific/MULTIGENE DNA-binding/MULTIGENE complexes/MULTIGENE containing/MULTIGENE members/MULTIGENE of/IN the/DT Myc/NNP //NNP Max/NNP //NNP Mad/NNP network/NN of/IN transcriptional/MULTIGENE regulators/MULTIGENE ./.
@@49119255234/CD Electrocardiographic/NNP QRS/NN complexes/NNS and/CC vectorcardiographic/JJ QRS/NN loop/NN ./.
@@73562737204/CD Mucoepidermoid/JJ and/CC acinous/JJ cell/NN carcinomas/NNS of/IN salivary/JJ tissues/NNS ./.
@@117367923437/CD Fifty-six/NNS semen/NN samples/NNS were/VBD included/VBN in/IN this/DT study/NN ;/: 18/CD were/VBD subnormal/JJ (/( G1/GENE )/SYM and/CC 38/CD were/VBD normal/JJ (/( G2/GENE )/SYM based/VBN on/IN World/NNP Health/NNP Organization/NNP criteria/NNS ,/, except/VB for/IN morphology/NN ,/, which/WDT was/VBD evaluated/VBN according/VBG to/IN strict/JJ criteria/NNS ./.
@@19379891322/CD Both/DT groups/NNS then/RB underwent/VBD hypnotic/JJ induction/NN ,/, and/CC completed/VBD the/DT test/NN again/RB (/( R2/NN )/SYM ./.
@@89678709765/CD 327/CD and/CC 736/CD protocols/NNS of/IN postmortem/JJ examinations/NNS from/IN Moscow/NN hospitals/NNS N/MULTIGENE 31/MULTIGENE and/CC 57/CD ,/, respectively/RB ,/, were/VBD evaluated/VBN statistically/RB ./.
@@10780018588/CD We/PRP examine/VBP current/JJ models/NNS of/IN the/DT effects/NNS of/IN aging/NN on/IN mean/JJ response/NN time/NN and/CC show/VB how/RB they/PRP might/MD be/VB reinterpreted/VBN ./.
@@98013337992/CD The/DT full-length/JJ N/MULTIGENE gene/MULTIGENE ,/, encoded/VBN by/IN open/JJ reading/JJ frame/NN 7/CD ,/, was/VBD cloned/VBN from/IN the/DT Canadian/JJ PRRS/NNS virus/NN ,/, PA-8/NNP ./.
@@74404302898/CD All/DT lambs/NNS with/IN B/NNP breeding/JJ had/VBP significantly/RB higher/JJ Hb/NEWGENE levels/NNS at/IN the/DT end/NN of/IN the/DT experiment/NN than/IN did/VBD NB/JJ lambs/NNS ./. b/NN and/CC S/NNP x/NN B/NNP lambs/NNS had/VBP higher/JJ (/( P/NN </SYM ./CD 05/CD )/SYM Hb/NEWGENE levels/NNS than/IN the/DT D/NN x/NN B/NNP lambs/NNS ,/, and/CC B/NNP lambs/NNS had/VBP the/DT highest/JJS (/( P/NN </SYM ./CD 05/CD )/SYM mean/JJ corpuscular/JJ hemoglobin/NN concentrations/NNS ./.
@@115096736230/CD In/NN the/DT stable/JJ transfectants/NNS (/( BM3/NNP cells/NNS )/SYM expressing/MULTIGENE a/MULTIGENE mutant/MULTIGENE bacterial/JJ P450/MULTIGENE AA/MULTIGENE epoxygenase/MULTIGENE ,/, F87V/MULTIGENE BM3/MULTIGENE ,/, which/WDT was/VBD genetically/RB engineered/VBN to/IN metabolize/VB arachidonic/JJ acid/NN only/RB to/IN 14/CD ,/CD 15-EET/CD ,/, AA/NN did/VBD not/RB induce/VB apoptosis/NN and/CC protected/VBN against/IN agonist-induced/JJ apoptosis/NN ./.
@@102069596632/CD Pathol/NNP ./.
@@86259879051/CD In/NN sorted/VBD bone/NN marrow/NN cells/NNS expression/NN of/IN both/DT VpreB/MULTIGENE genes/MULTIGENE was/VBD detected/VBN in/IN pro-B/JJ //JJ pre-BI/JJ and/CC large/JJ pre-BII/JJ cells/NNS ,/, while/CC the/DT RNA/NN steady/JJ state/NN levels/NNS were/VBD at/IN least/RB 100-fold/RB lower/JJR in/IN small/JJ pre-BII/JJ and/CC immature/NNP //NNP mature/NNP B/NNP cells/NNS ./.
@@86642294018/CD Clinical/NNP evaluation/NN of/IN the/DT Allergan/NNP Humphrey/NN 500/CD autorefractor/NN and/CC the/DT Nidek/NNP AR-1000/MULTIGENE autorefractor/MULTIGENE ./.
@@74581717351/CD Fourteen/CD different/JJ species/NN (/( eight/CD Platyhelmintha/NNP ,/, one/PRP Nematoda/NNS and/CC five/CD Crustacea/NNS )/SYM have/VB been/VBN inventorized/VBN ./.
@@87667818759/CD In/NN the/DT same/JJ period/NN we/PRP pointed/VBD out/RB an/DT increase/NN of/IN hematocrit/NN (/( from/IN 29%/CD to/IN 35%/CD )/SYM and/CC of/IN the/DT Hb/NN (/( from/IN 9/CD ./CD 3/CD to/IN 11/CD ./CD 2/CD g/NN //NN dl/NN )/SYM ./.
@@35704556156/CD Rabbits/NNS developed/VBD profound/JJ hypocalcemia/NN ,/, with/IN levels/NNS falling/NN from/IN 15/CD ./CD 5/CD +/NN //NN -/NN 0/CD ./CD 2/CD to/IN 7/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 4/CD mg/NN //NN dl/NN under/IN the/DT influence/NN of/IN TSST-1/GENE ./.
@@53799015516/CD Midge/NNP control/NN in/IN flood/NN channels/NNS ./.
@@99145006508/CD Nuclear/MULTIGENE factor/MULTIGENE kappa/MULTIGENE B/MULTIGENE (/( NF-kappaB/GENE )/SYM is/VBZ an/DT important/JJ transcription/NN factor/NN for/IN the/DT genes/NNS of/IN many/JJ pro-inflammatory/JJ proteins/NNS and/CC is/VBZ strongly/RB activated/VBN by/IN the/DT cytokines/NNS interleukin-1/NEWGENE and/CC tumor/NN necrosis/MULTIGENE factor/MULTIGENE (/( TNF/CONTEXTGENE )/NN alpha/NN under/IN various/JJ pathological/JJ conditions/NNS ./.
@@111762901017/CD Identification/NNP of/IN pulmonary/JJ vein/NN stenosis/NN after/IN radiofrequency/NN ablation/NN for/IN atrial/JJ fibrillation/NN using/VBG MRI/NN ./.
@@10369418709/CD EMSA/NN with/IN crude/JJ nuclear/JJ extracts/NNS demonstrated/VBD that/DT stimulation/NN with/IN CD40L/GENE results/NNS in/IN the/DT induction/NN of/IN NF-kappaB/GENE complexes/NNS that/WDT bind/VBP to/IN each/DT of/IN the/DT three/CD NF-kappaB/MULTIGENE sites/MULTIGENE and/CC are/VBP composed/VBN mainly/RB of/IN p50/GENE and/CC RelB/GENE ,/, but/CC also/RB include/VB c-Rel/GENE and/CC p65/GENE ./.
@@103412197049/CD Furthermore/RB ,/, heparin/MULTIGENE lyase/MULTIGENE treatment/NN of/IN extracts/NNS of/IN cells/NNS expressing/JJ recombinant/JJ YD-repeat/GENE protein/NN releases/VBZ this/DT protein/NN from/IN high/JJ molecular/JJ mass/JJ aggregates/NNS ./.
@@67054566467/CD Absorption/NNS was/VBD rapid/JJ ,/, with/IN a/DT mean/JJ time/NN to/IN peak/NN of/IN 39/CD min/NN ./.
@@32430276426/CD Post-transcriptional/JJ regulation/NN of/IN ribosomal/JJ protein/NN gene/NN expression/NN during/IN development/NN in/IN Dictyostelium/DT discoideum/JJ ./.
@@104024675038/CD Myosin/MULTIGENE light/MULTIGENE chain/MULTIGENE kinase/MULTIGENE functions/NNS downstream/RB of/IN Ras/GENE //GENE ERK/GENE to/IN promote/VB migration/NN of/IN urokinase-type/NN plasminogen/NN activator-stimulated/JJ cells/NNS in/IN an/DT integrin-selective/JJ manner/NN ./.
@@81784901390/CD Thus/RB ,/, we/PRP have/VBP separated/VBN the/DT signal/JJ function/NN from/IN the/DT anchor/NN function/NN of/IN the/DT 6/CD ./CD 7K/CD SA/NEWGENE domain/NN ./.
@@110834321806/CD Studied/NN groups/NNS were/VBD (/( 1/CD )/SYM untreated/JJ control/NN ,/, n/NN =/SYM 12/CD ;/: (/( 2/CD )/SYM FK-1/GENE ,/, n/NN =/SYM 8/CD ;/: (/( 3/CD )/SYM FK-3/GENE ,/, n/NN =/SYM 8/CD ./CD
@@90013131028/CD Prevalence/NNS of/IN sleep-disordered/JJ breathing/JJ (/( SDB/GENE )/SYM is/VBZ reported/VBN to/IN increase/NN in/IN menopausal/JJ women/NNS ./.
@@97129198318/CD In/NN the/DT studies/NNS described/VBN in/IN this/DT report/NN ,/, we/PRP have/VBP investigated/VBN the/DT signaling/JJ pathway/NN (/NN s/NN )/NN that/WDT are/VBP responsible/JJ for/IN CREB/NN activation/NN in/IN normal/JJ T/NN cells/NNS ./.
@@21571416432/CD With/IN only/RB purified/VBN T/NN antigen/NN in/IN the/DT presence/NN of/IN topoisomerase/MULTIGENE I/MULTIGENE to/IN unwind/VB purified/VBN DNA/NN ,/, ori-auxiliary/JJ sequences/NNS strongly/RB facilitated/VBN T-antigen-dependent/MULTIGENE DNA/MULTIGENE conformational/JJ changes/NNS consistent/JJ with/IN melting/JJ the/DT first/JJ 50/CD base/NN pairs/NNS ./.
@@100646048985/CD CPDs/NNS at/IN these/DT three/CD sites/NNS may/MD partially/RB displace/VB TFIIIA/NN ,/, thereby/RB enabling/JJ rapid/JJ repair/NN ./.
@@22498722686/CD This/DT interaction/NN occurs/VBZ over/RB a/DT wide/JJ range/NN of/IN both/DT parameters/NNS ;/: for/IN charge/NN density/NN from/IN at/IN least/RB 10/CD to/IN 800/CD microC/GENE //GENE cm2/GENE and/CC ,/, for/IN charge/NN per/IN phase/NN ,/, from/IN at/IN least/RB 0/CD ./CD 05/CD to/IN 5/CD ./CD 0/CD microC/NN per/IN phase/NN ./.
@@25196793176/CD Inefficacy/NNS of/IN phosphine/NN fumigation/NN against/IN ticks/NNS ./.
@@33840334076/CD Of/IN the/DT 53/CD units/NNS tested/VBN during/IN sinusoidal/JJ motion/NN at/IN 0/CD ./CD 05/CD Hz/NN (/( 9/CD ./CD 1/CD cm/NNS //NNS s/NNS )/SYM ,/, 1/CD (/( 1/CD ./CD 9%/CD )/SYM was/VBD responsive/JJ to/IN the/DT otolith/NN input/NN only/RB ,/, 13/CD (/( 24/CD ./CD 5%/CD )/SYM were/VBD influenced/VBN by/IN the/DT visual/JJ input/NN only/RB and/CC 23/CD (/( 43/CD ./CD 4%/CD )/SYM responded/VBN to/IN both/DT modalities/NNS ./.
@@113454451193/CD In/NNP Cd-spiked/NNP OECD/NNP soil/NN ,/, internal/JJ Cd/NN levels/NNS were/VBD linearly/RB related/VBN to/IN external/NN Cd/NN concentrations/NNS ,/, whereas/IN the/DT springtails/NNS maintained/VBD fixed/JJ internal/JJ levels/NNS of/IN Cu/NN and/CC Zn/NN regardless/RB of/IN spiked/VBN concentrations/NNS ./.
@@13854622001/CD In/NN general/JJ ,/, two/JJ separate/JJ high-performance/JJ liquid/JJ chromatographic/JJ runs/VBP were/VBD performed/VBN ,/, one/PRP for/IN the/DT gamma-aminobutyric/JJ acid/NN determination/NN and/CC one/PRP for/IN the/DT determination/NN of/IN the/DT monoamines/NNS ./.
@@110739192305/CD In/NN addition/NN ,/, 26/CD amino/JJ acid/JJ residues/NNS ,/, K69/CONTEXTGENE ,/, D88/GENE ,/, E94/GENE ,/, D134/GENE ,/, R154/GENE ,/, K169/GENE ,/, H197/GENE ,/, D233/GENE ,/, G235/GENE ,/, G236/GENE ,/, G237/GENE ,/, F238/GENE ,/, E274/GENE ,/, G276/GENE ,/, R277/GENE ,/, Y278/GENE ,/, K294/GENE ,/, Y323/GENE ,/, Y331/GENE ,/, D332/GENE ,/, C360/GENE ,/, D361/GENE ,/, D364/GENE ,/, G387/GENE ,/, Y389/GENE ,/, and/CC F397/CONTEXTGENE (/( mouse/MULTIGENE ODC/MULTIGENE numbering/NN )/SYM ,/, all/DT of/IN which/WDT are/VBP implicated/VBN in/IN the/DT formation/NN of/IN the/DT pyridoxal/NN phosphate-binding/JJ domain/NN and/CC the/DT substrate-binding/JJ domain/NN and/CC in/IN dimer/NN stabilization/NN with/IN the/DT eukaryotic/JJ ODCs/NNS ,/, were/VBD also/RB conserved/VBN in/IN S/NNP ./NNP ruminantium/MULTIGENE LDC/MULTIGENE ./.
@@37179362220/CD Amikacin/GENE was/VBD the/DT most/JJ stable/NN and/CC tobramycin/NN was/VBD the/DT least/RB stable/JJ aminoglycoside/NN under/IN the/DT conditions/NNS tested/VBN ./.
@@112232462419/CD Sequence/NN analysis/NN indicates/VBZ that/IN RBP21/GENE shares/VBP homology/NN with/IN other/DT retinoblastoma-binding/MULTIGENE proteins/MULTIGENE in/IN the/DT pRb-binding/MULTIGENE motif/MULTIGENE LxCxE/NNP at/IN the/DT C-terminal/MULTIGENE region/MULTIGENE ./.
@@82529768170/CD Rinit/GENE reflects/VBZ the/DT Newtonian/JJ resistances/NNS and/CC Rdiff/GENE represents/VBZ the/DT viscoelastic/JJ //JJ inhomogeneous/JJ pressure/NN dissipations/NNS in/IN the/DT system/NN ./.
@@99211799918/CD The/DT role/NN of/IN intraoperative/JJ echocardiography/NN in/IN surgery/NN of/IN the/DT heart/NN and/CC large/JJ vessels/NNS ./.
@@9858619706/CD Recent/JJ studies/NNS have/VBP suggested/VBN that/IN Y319/GENE also/RB positively/RB regulate/VB ZAP-70/NEWGENE function/NN ./.
@@86081266108/CD As/IN the/DT length/NN of/IN the/DT fatty/JJ acid/NN decreased/VBN ,/, the/DT binding/JJ affinity/NN was/VBD reduced/VBN ;/: myristic/JJ acid/NN (/( 14/CD :/: 0/CD )/SYM bound/JJ with/IN a/DT K/NN (/NN d/NN )/NN of/IN 1409/CD +/NN //NN -/NN 423/CD nM/NN ,/, but/CC medium-chain/JJ (/( decanoic/JJ acid/NN ,/, 10/CD :/: 0/CD )/SYM and/CC short-chain/JJ (/( octanoic/JJ acid/NN ,/, 8/CD :/: 0/CD )/SYM lipids/NNS were/VBD not/RB bound/JJ at/IN all/DT ./.
@@21633945409/CD The/DT sacT/MULTIGENE gene/MULTIGENE regulating/JJ the/DT sacPA/MULTIGENE operon/MULTIGENE in/IN Bacillus/NN subtilis/JJ shares/NN strong/JJ homology/NN with/IN transcriptional/MULTIGENE antiterminators/MULTIGENE ./.
@@84972488543/CD The/DT gene/NN encoding/VBG the/DT receptor/NN for/IN macrophage/MULTIGENE colony-stimulating/MULTIGENE factor/MULTIGENE 1/MULTIGENE (/( CSF-1/GENE )/SYM ,/, the/DT c-fms/GENE protooncogene/NN ,/, is/VBZ selectively/RB expressed/VBN in/IN immature/JJ and/CC mature/JJ mononuclear/JJ phagocytes/NNS and/CC trophoblasts/NNS ./.
@@10586107272/CD They/PRP are/VBP subdivided/VBN into/IN two/JJ types/NNS that/WDT activate/VBP transduction/NN pathways/NNS via/NN different/JJ cell/NN surface/NN receptors/NNS ./.
@@72034101670/CD Family/NN visits/NN and/CC involvement/NN in/IN treatment/NN of/IN patients/NNS at/IN a/DT state/NN hospital/NN ./.
@@24630506683/CD The/DT corticosterone/MULTIGENE synthesis/MULTIGENE inhibitor/MULTIGENE metyrapone/NN (/( 75/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./CD )/SYM was/VBD given/VBP to/IN attenuate/VB the/DT rise/NN of/IN corticosterone/NN to/IN a/DT level/JJ typical/JJ of/IN stressed/VBN males/NNS ./.
@@31759423861/CD This/DT effect/NN and/CC the/DT fact/NN that/IN all/DT three/CD doses/NNS were/VBD toxic/JJ to/IN the/DT dams/NNS dictated/VBN that/IN a/DT second/JJ experiment/NN be/VB carried/VBN out/RB at/IN lower/JJR doses/NNS ./.
@@69696386756/CD Both/DT examinations/NNS are/VBP sensitive/MULTIGENE indicators/MULTIGENE of/IN CNS/NN abnormalities/NNS associated/VBN with/IN bacterial/JJ meningeal/JJ infections/NNS and/CC are/VBP important/JJ determinants/NNS of/IN the/DT therapy/NN and/CC ultimate/JJ prognosis/NN of/IN such/JJ complications/NNS ./.
@@104455066140/CD Some/DT of/IN them/PRP produce/VBP gigantic/JJ sperm/NN several/DT times/VBZ the/DT total/JJ male/JJ body/NN length/NN ./.
@@95655844165/CD A/DT cluster/NN of/IN basic/JJ amino/JJ acids/NNS ,/, KKKR/GENE ,/, generated/VBN by/IN joining/NN of/IN the/DT sequences/NNS encoded/VBN by/IN the/DT constitutive/JJ exon/NN 13/CD and/CC the/DT alternative/JJ exon/NN 16/CD ,/, is/VBZ necessary/JJ for/IN the/DT nuclear/JJ targeting/NN of/IN 4/CD ./CD 1H/CD ,/, as/IN demonstrated/VBN by/IN site-directed/JJ mutagenesis/NN analysis/NN ./.
@@2273931875/CD Modulation/NNS of/IN 25-hydroxyvitamin/MULTIGENE D3-24-hydroxylase/MULTIGENE by/IN aminophylline/NN :/: a/DT cytochrome/MULTIGENE P-450/MULTIGENE monooxygenase/MULTIGENE system/NN ./.
@@4318321312/CD Plasma/NN ion/NN changes/NNS in/IN venous/JJ blood/NN incubated/VBN with/IN beta/MULTIGENE receptor/MULTIGENE blockers/NNS and/CC subjected/VBN to/IN tonometry/NN in/IN vitro/FW ./.
@@27439817554/CD Transcripts/NNS characterized/VBN include/VB (/( i/NN )/SYM abundant/JJ monocistronic/JJ L11e/NNP and/CC tricistronic/NNP L1e-L10e-L12e/MULTIGENE transcripts/MULTIGENE ;/: (/( ii/NN )/SYM less/PRP abundant/JJ bicistronic/JJ NAB-L11e/NNP and/CC monocistronic/JJ NAB/MULTIGENE transcripts/MULTIGENE and/CC (/( iii/NN )/SYM a/DT very/RB rare/JJ ORF/NN monocistronic/JJ transcript/NN ./.
@@8816460616/CD These/DT results/NNS indicate/VBP that/DT inhibition/NN of/IN Jun/MULTIGENE kinase/MULTIGENE activation/NN was/VBD sufficient/JJ to/IN inhibit/VB Ras/NNS transformation/NN even/VB in/IN the/DT presence/NN of/IN activated/VBN Erk-2/GENE ./.
@@87614803939/CD Interaction/NNS was/VBD apparently/RB determined/VBN by/IN the/DT N-terminal/NN splice/NN region/NN of/IN RPDE-6/GENE ,/, as/IN the/DT PDE4A/NEWGENE splice/NN variant/MULTIGENE RPDE-39/MULTIGENE ,/, which/WDT differs/VBZ from/IN RPDE-6/NNP at/IN the/DT extreme/JJ N-terminus/NN ,/, failed/VBN to/IN associate/NN with/IN v-Src-SH3/JJ ;/: met26RD1/NN (/( where/CC RD1/GENE is/VBZ rat/NN 'dunc-like'/JJ PDE/NEWGENE )/SYM ,/, which/WDT has/VBZ the/DT N-terminal/NN splice/NN region/NN deleted/VBN ,/, failed/VBN to/IN associate/NN with/IN v-Src-SH3/JJ ,/, and/CC the/DT association/NN of/IN RPDE-6/NNP and/CC v-Src-SH3/NN was/VBD blocked/VBN by/IN a/DT fusion/NN protein/NN formed/VBN from/IN the/DT N-terminal/NN splice/NN region/NN ./.
@@97374536668/CD Plasma/NN was/VBD tested/VBN before/IN and/CC after/IN (/( 14/CD +/NN //NN -/NN 7/CD ./CD 5/CD [/NN SD/NN ]/NN days/NNS )/SYM surgery/NN for/IN IgG/NEWGENE antibodies/NNS to/IN the/DT complex/NN of/IN heparin/MULTIGENE //MULTIGENE platelet/MULTIGENE factor/MULTIGENE 4/MULTIGENE ,/, using/VBG a/DT standardized/JJ ,/, validated/VBN enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/SYM ./.
@@13724561984/CD Necrosis/NNS appears/VBZ 6/CD h/NN after/IN TA/NN infusion/NN ,/, being/VBP 5/CD ./CD 77%/CD in/IN extent/NN after/IN 12/CD h/NN ,/, 14/NN ./NN 9%/NN after/IN 24/CD h/NN and/CC animals/NNS die/NN with/IN an/DT area/NN of/IN 29/CD ./CD 5%/CD necrosis/NN ./.
@@8812020909/CD In/NN a/DT third/JJ experiment/NN ,/, a/DT Chessmaster/GENE gradually/RB increases/VBZ the/DT number/NN of/IN boards/NNS he/PRP can/MD reproduce/VB with/IN higher/JJ than/IN 70%/CD average/JJ accuracy/NN to/IN nine/JJ ,/, replacing/VBG as/RB many/JJ as/IN 160/CD pieces/NNS correctly/RB ./.
@@89718358406/CD In/NNP Group/NNP IV/NN dogs/NNS that/WDT received/VBD alpha-MSH/GENE only/RB during/IN reperfusion/NN ,/, BAEPs/NNS were/VBD increased/VBN approximately/RB 10/CD to/IN 14%/CD more/RB than/IN in/IN Group/NNP II/NNP during/IN the/DT late/JJ reperfusion/NN period/NN ./.
@@97153848037/CD For/IN smaller/JJR vessels/NNS up/JJ to/IN a/DT diameter/NN of/IN 0/CD ./CD 5/CD mm/NN ,/, treatments/NNS at/IN 16/CD and/CC 18/CD J/GENE //GENE cm2/GENE showed/VBD good/JJ results/NNS in/IN 60/CD and/CC 82%/CD respectively/RB ;/: for/IN vessels/NNS up/JJ to/IN 1/CD mm/NN in/IN 27/CD and/CC 33%/CD ./.
@@7635312507/CD Using/VBG mutagenesis/NN ,/, we/PRP have/VBP identified/VBN two/JJ mutations/NNS of/IN the/DT second/JJ actin-binding/NN domain/NN that/WDT can/MD also/RB suppress/VB the/DT act1/MULTIGENE mutations/MULTIGENE of/IN interest/NN ./.
@@105897118755/CD In/NN addition/NN ,/, narZ/NN expression/NN was/VBD induced/VBN approximately/RB 20-fold/JJ intracellularly/RB in/IN Madin-Darby/NNP canine/JJ kidney/NN epithelial/JJ cells/NNS and/CC 16-fold/JJ in/IN intracellular/JJ salts/NNS medium/NN ,/, which/WDT is/VBZ believed/VBN to/IN mimic/NN the/DT intracellular/JJ milieu/NN ./.
@@74992529642/CD As/IN hGM-CSF/MULTIGENE receptor/MULTIGENE (/( hGMR/CONTEXTGENE )/SYM does/VBP not/RB contain/VB a/DT consensus/NN sequence/NN for/IN binding/NN of/IN PI/NN 3-kinase/CD ,/, hGMR/NN must/MD use/VB a/DT distinct/JJ mechanism/NN for/IN its/PRP association/NN with/IN and/CC activation/NN of/IN PI/NN 3-kinase/CD ./.
@@111023674109/CD This/DT study/NN allows/VBZ us/PRP to/IN draw/NN conclusions/NNS about/RB the/DT identity/NN of/IN proteins/NNS required/VBN for/IN the/DT development/NN of/IN the/DT nervous/JJ system/NN in/IN Drosophila/NN and/CC provides/VBZ an/DT example/NN of/IN a/DT molecular/JJ approach/NN to/IN characterize/VB en/NN masse/NN transposon-tagged/MULTIGENE mutations/MULTIGENE identified/VBN in/IN genetic/JJ screens/NNS ./.
@@15515681139/CD Marker/NNS rescue/NN analysis/NN has/VBZ localized/VBN ts8/CD to/IN a/DT 910-bp/CD internal/JJ segment/NN of/IN rpoB/GENE that/IN encodes/VBZ the/DT Rif/NN domain/NN ./.
@@86259001019/CD Pituitary/NNP adenylate/NN cyclase-activating/JJ polypeptide/NN regulates/VBZ prolactin/MULTIGENE promoter/MULTIGENE activity/NN via/NN a/DT protein/MULTIGENE kinase/MULTIGENE A-mediated/JJ pathway/NN that/WDT is/VBZ independent/NN of/IN the/DT transcriptional/JJ pathway/NN employed/VBN by/IN thyrotropin-releasing/JJ hormone/NN ./.
@@79720121431/CD A/DT full-length/JJ cDNA/NN clone/NN isolated/VBN from/IN a/DT rat/NN lung/NN library/NN was/VBD predicted/VBN to/IN encode/VB a/DT 55-kDa/MULTIGENE protein/MULTIGENE containing/JJ at/IN its/PRP amino/JJ terminus/NN a/DT targeting/JJ domain/NN that/WDT binds/VBZ to/IN the/DT ANP-receptor/MULTIGENE kinase-like/MULTIGENE domain/NN and/CC containing/JJ at/IN its/PRP carboxyl/NN terminus/NN a/DT putative/JJ protein-serine/MULTIGENE phosphatase/MULTIGENE domain/NN ./.
@@64546258300/CD It/PRP has/VBZ been/VBN shown/VBP in/IN an/DT animal/NN experiment/NN that/IN alterations/NNS of/IN the/DT renal/JJ vasculature/NN and/CC parenchyma/NN after/IN hemostasis/NN performed/VBN by/IN Infrared-Contact-Coagulation/GENE are/VBP best/JJS shown/VBP by/IN intravital/JJ magnification/NN angiography/NN (/( magnification/NN factor/NN 2/CD ./CD 22/CD )/SYM ./.
@@42823154904/CD Sensitization/NNS to/IN hyperlactatemia/NN induced/VBN by/IN phenformin/NN after/IN subtotal/JJ ablation/NN of/IN the/DT pancreas/NN ./.
@@82459338231/CD Partial/JJ engorgement/NN was/VBD higher/JJ in/IN the/DT treatments/NNS ./.
@@99113289912/CD Nonlocal/JJ approach/NN to/IN scattering/JJ in/IN a/DT one-dimensional/JJ problem/NN ./.
@@85420267792/CD DAF/NN is/VBZ a/DT 70/MULTIGENE kD/MULTIGENE glycoprotein/MULTIGENE containing/MULTIGENE complement/MULTIGENE regulatory/JJ short/JJ consensus/NN repeats/NNS (/( SCRs/NNS )/SYM ;/: its/PRP gene/NN is/VBZ located/VBN in/IN the/DT regulation/NN of/IN complement/NN activation/NN (/( RCA/NN )/SYM gene/NN cluster/NN on/IN chromosome/NN 1/CD and/CC is/VBZ about/RB 40/CD kb/NN in/IN size/NN ./.
@@29679154575/CD In/NN addition/NN ,/, the/DT calbindin-D28K/GENE promoter/NN is/VBZ composed/VBN of/IN a/DT variety/NN of/IN simple/JJ repeated/JJ sequences/NNS ,/, some/DT of/IN which/WDT are/VBP components/NNS of/IN putative/JJ regulatory/JJ signals/NNS ./.
@@83232945662/CD Chicken/NNP sterol/NN carrier/NN protein/NN 2/CD //CD sterol/CD carrier/MULTIGENE protein/MULTIGENE x/MULTIGENE :/: cDNA/NN cloning/NN reveals/VBZ evolutionary/JJ conservation/NN of/IN structure/NN and/CC regulated/VBN expression/NN ./.
@@14026471818/CD DR1/MULTIGENE molecules/MULTIGENE purified/VBN from/IN human/JJ lymphoblastoid/JJ cell/NN lines/NNS could/MD specifically/RB bind/VB to/IN these/DT peptide/NN sequences/NNS expressed/VBN on/IN the/DT phage/NN surface/NN ./.
@@110819621754/CD An/DT anchored/VBN AFLP-/NNP and/CC retrotransposon-based/MULTIGENE map/MULTIGENE of/IN diploid/JJ Avena/NN ./.
@@103335293375/CD Both/DT betaAPP/MULTIGENE mRNA/MULTIGENE and/CC Abeta/IN levels/NNS are/VBP increased/VBN in/IN trisomy/NN 21/CD ./CD
@@112978667238/CD In/NN contrast/NN ,/, neither/DT I/NNP ./NNP argentina/NN nor/CC I/NNP ./NNP theezans/NNS exerted/VBD any/DT effect/NN on/IN BF/GENE or/CC intestinal/JJ propulsion/NN ./.
@@86566728449/CD An/DT apparent/JJ ufo/NN mRNA/NN overexpression/NN was/VBD not/RB found/VB in/IN any/DT of/IN the/DT positive/JJ leukemia/NN cell/NN lines/NNS ,/, but/CC was/VBD identified/VBN in/IN the/DT drug-resistant/NN subclones/NNS of/IN the/DT cervix/NN carcinoma/NN cell/NN line/NN HeLa/DT ./.
@@92347177766/CD Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN Cbl/DT ,/, the/DT 120-kDa/MULTIGENE protein/MULTIGENE product/MULTIGENE of/IN the/DT c-cbl/GENE proto-oncogene/NN ,/, serves/VBP as/IN a/DT substrate/NN of/IN a/DT number/NN of/IN receptor-coupled/MULTIGENE tyrosine/MULTIGENE kinases/MULTIGENE and/CC forms/NNS complexes/NNS with/IN SH3/GENE and/CC SH2/MULTIGENE domain-containing/MULTIGENE proteins/MULTIGENE ,/, pointing/VBG to/IN its/PRP role/NN in/IN signal/JJ transduction/NN ./.
@@79673609762/CD The/DT present/NN data/NN also/RB indicate/VB that/IN patients/NNS with/IN TGBM/GENE nephropathy/NN often/RB have/VB concomitant/JJ IgA/NN nephropathy/NN and/CC mesangial/JJ proliferative/JJ glomerulonephritis/NN ./.
@@111295157017/CD In/NN a/DT prospective/NN ,/, multicentre/JJ trial/NN the/DT efficacy/NN of/IN an/DT Vitex/NN agnus/NN castus/NN L/JJ extract/NN Ze/MULTIGENE 440/MULTIGENE was/VBD investigated/VBN in/IN 50/CD patients/NNS with/IN pre-menstrual/JJ syndrome/NN (/( PMS/NN )/SYM ./.
@@22017707443/CD Among/IN known/VBP flea/NN larvae/NNS ,/, the/DT genus/NN Anomiopsyllus/NNP (/( Anomiopsyllinae/GENE ,/, Anomiopsyllini/GENE )/SYM is/VBZ as/IN distinctive/JJ in/IN larval/JJ form/NN as/IN are/VBP the/DT adults/NNS ./.
@@105687447436/CD Among/IN the/DT remaining/JJ 22/CD sites/NNS ,/, six/CD are/VBP in/IN the/DT promoters/NNS of/IN known/VBP alpha-specific/MULTIGENE genes/MULTIGENE and/CC two/JJ other/DT sites/NNS have/NN an/DT alpha2-Mcm1-dependent/JJ role/NN in/IN determining/JJ the/DT direction/NN of/IN mating/JJ type/NN switching/NN ./.
@@12658871909/CD Acquired/VBN factor/MULTIGENE VIII/MULTIGENE inhibitor/MULTIGENE in/IN non-hemophilic/JJ patients/NNS ./.
@@9851102789/CD Efferent/JJ projections/NNS of/IN the/DT ventral/JJ portion/NN of/IN the/DT putamen/NN to/IN the/DT frontal/JJ ,/, parietal/JJ and/CC temporal/MULTIGENE regions/MULTIGENE of/IN the/DT cat/NN cerebral/JJ cortex/NN ./.
@@84100975266/CD A/DT high/JJ mean/JJ intensity/NN of/IN CLTPA/NNP (/( standardized/JJ multivariate/JJ regression/NN coefficient/NN beta/NN -0/CD ./CD 059/CD ,/, p/NN =/SYM 0/CD ./CD 020/CD )/SYM and/CC a/DT high/JJ maximal/JJ oxygen/NN uptake/NN (/( beta/NN -0/CD ./CD 163/CD ,/, p/NN </SYM 0/CD ./CD 001/CD )/SYM were/VBD associated/VBN with/IN reduced/VBN plasma/NN fibrinogen/NEWGENE when/CC adjusting/VBG for/IN the/DT strongest/JJS covariates/NNS ./.
@@105866262296/CD Demyelinating/VBG diseases/NNS involving/VBG the/DT grey/JJ matter/NN were/VBD very/RB rare/JJ ,/, but/CC we/PRP must/MD consider/VB the/DT presence/NN of/IN symmetrical/JJ thalamic/JJ involvement/NN in/IN patients/NNS with/IN ADEM/NN ./.
@@85893587490/CD One/CD hundred/JJ units/NN //NN kg/NN of/IN recombinant/JJ human/MULTIGENE erythropoietin/MULTIGENE (/( rhEPO/CONTEXTGENE )/SYM was/VBD given/VBP subcutaneously/RB 3/CD times/VBZ a/DT week/NN for/IN 3/CD weeks/NNS ./.
@@39296104582/CD Mild/JJ orbital/JJ discomfort/NN occurred/VBN in/IN some/DT patients/NNS ./.
@@22290727042/CD This/DT growth/NN arrest/NN is/VBZ partly/RB suppressed/VBN on/IN minimal/JJ medium/NN or/CC under/IN conditions/NNS in/IN which/WDT the/DT cells/NNS are/VBP less/PRP dependent/JJ on/IN mitochondrial/JJ metabolism/NN ./.
@@103768773869/CD Removal/NNP of/IN each/DT of/IN three/CD contiguous/JJ segments/NNS from/IN the/DT N-terminal/NN half/NN specifically/RB inhibits/VBZ the/DT formation/NN of/IN 5/NNS ./NNS 8Ss/NNS rRNA/NN ,/, whereas/IN deleting/VBG part/NN of/IN the/DT C-terminal/MULTIGENE region/MULTIGENE of/IN the/DT protein/NN only/RB blocks/NNS the/DT production/NN of/IN 18S/JJ rRNA/NN ./.
@@32981348720/CD This/DT report/NN expands/VBZ on/IN previous/JJ work/NN with/IN interferon/NN alfa-2b/NN (/( Intron/JJ A/DT ;/: Schering-Plough/NNP )/SYM in/IN the/DT treatment/NN of/IN hairy/JJ cell/NN leukemia/NN (/( HCL/NN )/SYM ./.
@@8093642694/CD In/NN addition/NN ,/, a/DT microsatellite/NN repeat/NN polymorphism/NN with/IN a/DT heterozygosity/NN of/IN 71%/JJ at/IN the/PDT RET/MULTIGENE locus/MULTIGENE and/CC a/DT restriction/NN fragment/NN length/NN polymorphism/NN with/IN a/DT heterozygosity/NN of/IN 42%/RB detected/VBN by/IN a/DT lambda/NN clone/NN from/IN the/DT D10S94/MULTIGENE locus/MULTIGENE have/NN been/VBN developed/VBN for/IN high-resolution/JJ genetic/JJ linkage/NN mapping/NN and/CC predictive/JJ diagnostic/JJ testing/NN ./.
@@86214488381/CD We/PRP isolated/VBD a/DT complementary/JJ DNA/NN (/( cDNA/NN )/SYM clone/NN from/IN an/DT RL95-2/GENE expression/NN library/NN that/IN encodes/VBZ the/DT C1/MULTIGENE site-binding/MULTIGENE protein/MULTIGENE ./.
@@8754777234/CD The/DT upTRE/NN binds/VBZ more/RB T3R/MULTIGENE homodimers/MULTIGENE and/CC less/PRP T3R-RXR/MULTIGENE heterodimers/MULTIGENE than/IN the/DT dnTRE/NN ,/, and/CC T3/NN more/RB readily/RB facilitates/VBZ heterodimer/NN binding/JJ to/IN the/DT dn-/NN than/IN to/IN the/DT upTRE/NN ./.
@@30159535808/CD Analysis/NNP of/IN glucocorticoid/NN unresponsive/JJ cell/NN variants/NNS using/VBG a/DT mouse/MULTIGENE glucocorticoid/MULTIGENE receptor/MULTIGENE complementary/JJ DNA/NN clone/NN ./.
@@112541342881/CD Moreover/RB ,/, PTax/NNP expressed/VBD higher/JJ background/NN activities/NNS than/IN PTF/GENE ,/, indicating/VBG that/IN the/DT sequence/NN of/IN the/DT synthetic/JJ regulatory/JJ region/NN can/MD influence/VB background/NN levels/NNS ./.
@@99257772806/CD When/WRB the/DT high/MULTIGENE affinity/MULTIGENE hnRNP/MULTIGENE A1/MULTIGENE binding/MULTIGENE site/MULTIGENE was/VBD inserted/VBN into/IN the/DT beta-globin/NN reporter/NN ,/, Rev/NNP was/VBD able/JJ to/IN increase/NN the/DT cytoplasmic/JJ levels/NNS of/IN unspliced/JJ mRNAs/NNS to/IN 14%/NN ./.
@@28808416711/CD Since/IN the/DT stability/NN of/IN TF1/GENE resides/VBZ in/IN its/PRP primary/JJ structure/NN ,/, we/PRP cloned/VBN a/DT gene/NN coding/JJ for/IN TF1/GENE ,/, and/CC the/DT primary/JJ structure/NN of/IN the/DT beta/MULTIGENE subunit/MULTIGENE was/VBD deduced/VBN from/IN the/DT nucleotide/NN sequence/NN of/IN the/DT gene/NN to/IN compare/NN the/DT sequence/NN with/IN those/DT of/IN beta's/NNS of/IN three/CD major/JJ categories/NNS of/IN F1's/NNS ;/: prokaryotic/JJ membranes/NNS ,/, chloroplasts/NNS ,/, and/CC mitochondria/NNS ./.
@@111525218576/CD Intact/JJ Flag-tagged/JJ protein/NN products/NNS from/IN all/DT six/CD were/VBD produced/VBN from/IN genomic/JJ expression/NN vectors/NNS ,/, although/IN the/DT ORF40/MULTIGENE //MULTIGENE 41/MULTIGENE transcript/MULTIGENE encoding/VBG a/DT primase-helicase/MULTIGENE component/MULTIGENE proved/VBN to/IN be/VB spliced/VBN with/IN a/DT 127-bp/JJ intron/NN ./.
@@26770022323/CD With/IN both/DT wild-type/NN and/CC the/DT mutant/JJ enzymes/NNS ,/, ATP/NN activates/VBZ both/DT [/NN 14C/NN ]/NN Asp/NN in/IN equilibrium/NN N-carbamyl-L-aspartate/JJ (/( C-Asp/GENE )/SYM and/CC the/DT [/NN 32P/NN ]/NN carbamyl/NN phosphate/NN (/( C-P/NN )/SYM in/IN equilibrium/NN Pi/NN exchanges/NNS ./.
@@108968591579/CD The/DT effect/NN of/IN water/NN deprivation/NN for/IN 19/CD h/NN on/IN renal/MULTIGENE Na/MULTIGENE excretion/NN of/IN conscious/JJ adrenalectomized/JJ (/( ADX/NNS )/SYM sheep/NN maintained/VBN on/IN a/DT constant/JJ intravenous/JJ infusion/NN of/IN aldosterone/NN and/CC cortisol/NN (/( ADX-constant/NNP steroid/JJ sheep/NN )/SYM was/VBD investigated/VBN ./.
@@109922992316/CD As/IN in/IN the/PDT other/DT three/CD members/NNS whose/WP gene/NN expression/NN is/VBZ altered/VBN during/IN tumorigenesis/NN ,/, PI12/GENE expression/NN was/VBD found/VBN to/IN be/VB down-regulated/IN in/IN tumor/NN brain/NN tissues/NNS and/CC in/IN two/JJ brain/NN cancer/NN cell/NN lines/NNS :/: U-87/MULTIGENE MG/MULTIGENE and/CC H4/NNP ./NNP
@@37468966756/CD It/PRP is/VBZ suggested/VBN that/IN these/DT results/NNS may/MD raise/NN the/DT interesting/JJ possibility/NN of/IN providing/CC a/DT means/NN of/IN identifying/JJ greater/JJR or/CC lesser/JJ susceptibility/NN to/IN the/DT coronary/JJ effects/NNS of/IN Type/MULTIGENE A/MULTIGENE behavior/NN ./.
@@35727068572/CD Similarly/RB ,/, actuarial/JJ interpretations/NNS for/IN the/DT second/JJ protocols/NNS were/VBD not/RB more/RB frequently/RB selected/VBN by/RB therapists/NNS as/IN more/RB valid/JJ ,/, regardless/RB of/IN treatment/NN condition/NN and/CC elevation/NN of/IN the/DT F/NN and/CC F-K/NN indices/NNS on/IN the/DT first/JJ MMPI/NN profile/NN ./.
@@61500697311/CD All/DT patients/NNS received/VBD VCR/MULTIGENE 1/MULTIGENE ./MULTIGENE 0/MULTIGENE mg/NN //NN m2/NN weekly/JJ for/IN 6/CD weeks/NNS with/IN dose/NN modification/NN for/IN neurotoxicity/NN ./.
@@119115521823/CD In/NN patients/NNS who/WP respond/VBP to/IN quetiapine/NN ,/, therapy/NN should/MD be/VB continued/VBN at/IN the/DT optimal/JJ dose/NN that/WDT maintains/VBZ remission/NN ,/, within/IN the/DT range/NN of/IN 150/CD to/IN 750/CD mg/NN //NN d/NN ./.
@@62084777840/CD The/DT construction/NN of/IN a/DT small/JJ library/NN of/IN mouse/NN repetitive/JJ DNA/NN has/VBZ been/VBN previously/RB reported/VBN (/( Pietras/NNP et/FW al/NNS ./NNS ,/, Nucleic/NNP Acids/NNS Res/NNS ./.
@@99733518213/CD This/DT suggests/VBZ that/IN the/DT DcuS-DcuR/GENE system/NN responds/VBZ to/IN external/NN substrates/NNS ./.
@@40687744747/CD The/DT weak/JJ relationships/NNS between/IN F/NN and/CC Zn/NN to/IN Mg/NN clearly/RB have/VB no/DT significant/JJ effect/NN on/IN the/DT contents/NNS of/IN these/DT elements/NNS in/IN bone/NN ./.
@@27615401869/CD Deletion/NNS analysis/NN showed/VBN that/IN the/DT NF-4FA/GENE ,/, NF-4FB/GENE ,/, and/CC AP-1/MULTIGENE sequences/MULTIGENE are/VBP each/DT necessary/JJ for/IN full/JJ enhancer/NN activity/NN ./.
@@111786961020/CD Serial/JJ US/NN images/NNS were/VBD obtained/VBN before/IN and/CC 20/CD ,/, 30/CD ,/, 40/CD ,/, 50/CD ,/, 60/CD ,/, 90/CD ,/, 120/CD ,/, 150/CD ,/, 180/CD ,/, 240/CD ,/, and/CC 300/CD s/NN after/IN intravenous/JJ injection/NN of/IN 2/CD g/NN of/IN contrast/NN agent/NN using/VBG conventional/JJ and/CC harmonic/NN PD/NN US/NNP ./NNP
@@101961278259/CD The/DT catalytic/JJ site/NN has/VBZ an/DT S1/NN pocket/NN lined/VBN with/IN conserved/VBN hydrophobic/JJ residues/NNS to/IN accommodate/VB the/DT pyroglutamyl/NN residue/NN ./.
@@111161486202/CD Coexpression/NNS studies/NNS indicate/VBP that/DT insulin/NN and/CC PKB/GENE suppress/VB transactivation/NN by/IN C/GENE //GENE EBPbeta/GENE ,/, but/CC not/RB C/NNP //NNP EBPalpha/NNP ,/, and/CC that/DT N-terminal/NN transactivation/NN domains/NNS in/IN C/NNP //NNP EBPbeta/NNP are/VBP required/VBN ./.
@@115609921169/CD Thus/RB ,/, MKK7/GENE is/VBZ an/DT essential/JJ and/CC specific/MULTIGENE regulator/MULTIGENE of/IN stress-induced/JJ SAPK/GENE //GENE JNK/GENE activation/NN in/IN mast/NN cells/NNS and/CC MKK7/GENE negatively/RB regulates/VBZ growth/MULTIGENE factor/MULTIGENE and/CC antigen/NN receptor-driven/JJ proliferation/NN in/IN hematopoietic/JJ cells/NNS ./.
@@46561855079/CD Glucose/NN disappearance/NN rate/NN and/CC changes/NNS in/IN plasma/NN nutrients/NNS after/IN intravenouly/RB injected/VBN glucose/NN in/IN normoglycaemic/JJ and/CC hypoglycaemic/JJ underweight/JJ newborns/NNS ./.
@@106045835142/CD Albumin/NNS dialysis/NN :/: effective/JJ removal/NN of/IN copper/JJ in/IN a/DT patient/NN with/IN fulminant/JJ Wilson/NN disease/NN and/CC successful/JJ bridging/JJ to/IN liver/NN transplantation/NN :/: a/DT new/JJ possibility/NN for/IN the/DT elimination/NN of/IN protein-bound/JJ toxins/NNS ./.
@@95823273050/CD We/PRP have/VBP shown/VBP previously/RB that/IN GH3/NNP cells/NNS transfected/VBN with/IN the/DT rat/MULTIGENE GnRH/MULTIGENE receptor/MULTIGENE cDNA/MULTIGENE (/( GGH3-1'/CONTEXTGENE cells/NNS )/SYM support/NN the/DT expression/NN of/IN a/DT cotransfected/VBN fusion/NN gene/NN composed/VBN of/IN 797/CD base/NN pairs/NNS of/IN rat/MULTIGENE LHbeta/MULTIGENE gene/MULTIGENE 5'-flanking/JJ sequence/NN and/CC the/DT first/JJ 5/CD base/NN pairs/NNS of/IN the/DT 5'-untranslated/JJ region/NN fused/VBN to/IN a/DT luciferase/NN reporter/NN (/( -797/NN //NN +5LHbetaLUC/NN )/SYM and/CC respond/VB to/IN a/DT GnRH/MULTIGENE agonist/MULTIGENE with/IN a/DT 10-fold/JJ stimulation/NN of/IN activity/NN ./.
@@82811532868/CD However/RB ,/, a/DT surprisingly/RB high/JJ degree/NN of/IN conservation/NN of/IN intron/NN sequences/NNS was/VBD observed/VBN between/IN both/DT species/NN ./.
@@101030571603/CD Here/RB we/PRP describe/VBP the/DT optimization/NN and/CC characterization/NN of/IN a/DT 140-residue/JJ fragment/NN ,/, containing/JJ the/DT Runt/GENE domain/NN of/IN AML1/GENE ,/, which/WDT is/VBZ suitable/JJ for/IN structural/JJ studies/NNS ./.
@@80907677555/CD We/PRP present/VBP evidence/NN that/DT DNA/MULTIGENE polymerase/MULTIGENE delta/MULTIGENE of/IN Saccharomyces/NN cerevisiae/NN ,/, an/DT enzyme/NN that/WDT is/VBZ essential/JJ for/IN viability/NN and/CC chromosomal/JJ replication/NN ,/, is/VBZ also/RB required/VBN for/IN base/NN excision/NN repair/NN of/IN exogenous/JJ DNA/NN methylation/NN damage/NN ./.
@@32808079116/CD The/DT behavior/NN of/IN suf12-null/JJ //JJ SUF12+/JJ heterozygotes/NNS indicates/VBZ that/IN suf12/GENE is/VBZ co-dominantly/RB expressed/VBN and/CC suggests/VBZ that/IN suf12/MULTIGENE allele-specific/MULTIGENE suppression/NN may/MD result/VB from/IN functionally/RB distinct/JJ mutant/JJ proteins/NNS rather/RB than/IN variation/NN in/IN residual/JJ wild-type/NNP SUF12+/NEWGENE activity/NN ./.
@@36058954572/CD The/DT 4/CD patients/NNS with/IN carboxyhemoglobin/NN levels/NNS in/IN excess/NN of/IN 10%/NN may/MD represent/VB occult/JJ carbon/NN monoxide/NN poisoning/VBG in/IN this/DT population/NN ./.
@@83807367987/CD The/DT 7-kb/JJ mRNA/NN differs/VBZ by/IN alternative/JJ splicing/JJ such/JJ that/IN it/PRP encodes/VBZ a/DT protein/NN with/IN a/DT distinct/JJ amino/JJ terminus/NN ./.
@@77951047770/CD Risks/NNS of/IN chronicity/NN following/IN acute/MULTIGENE hepatitis/MULTIGENE B/MULTIGENE virus/NN infection/NN :/: a/DT review/NN ./.
@@112231319274/CD Folate/NN metabolism/NN in/IN the/DT human/JJ malaria/NN parasite/NN Plasmodium/NN falciparum/NN is/VBZ an/DT essential/JJ activity/NN for/IN cell/NN growth/NN and/CC replication/NN ,/, and/CC the/DT target/NN of/IN an/DT important/JJ class/NN of/IN therapeutic/JJ agents/NNS in/IN widespread/JJ use/NN ./.
@@15895762182/CD The/DT decay/NN curves/NNS of/IN chlorophyll/NN fluorescence/NN showed/VBD a/DT superposition/NN of/IN three/CD exponentially/RB decaying/JJ components/NNS with/IN time/NN constants/NNS of/IN T1/NN =/SYM 100-200/JJ ps/NNS ,/, T2/NN =/SYM 300-500/JJ ps/NNS and/CC T3/NN =/SYM 2/CD ./CD 0-3/CD ./CD 5/CD ns/CD ./CD
@@117769223014/CD IV/IN ./IN combined/JJ sclerosis/NN and/CC resorption/NN of/IN the/DT skull/NN base/NN (/( 6/CD cases/NNS ,/, 2/MULTIGENE group/MULTIGENE I/MULTIGENE lesions/NNS and/CC 4/MULTIGENE group/MULTIGENE II/MULTIGENE lesions/NNS )/SYM ./.
@@75142954915/CD Tyrosine/NN phosphorylation/NN of/IN cellular/JJ proteins/NNS is/VBZ the/DT earliest/JJS identifiable/JJ event/NN following/IN T-cell/MULTIGENE antigen/MULTIGENE receptor/MULTIGENE (/( TCR/CONTEXTGENE )/SYM stimulation/NN and/CC is/VBZ essential/JJ for/IN activating/JJ downstream/RB signaling/JJ machinery/NN ./.
@@12288821865/CD Generally/RB ,/, a/DT correlation/NN was/VBD observed/VBN between/IN highest/JJS concentrations/NNS of/IN CSF/NN immunoglobulins/NNS and/CC degree/NN of/IN meningeal/JJ inflammatory/JJ response/NN ,/, even/VB if/IN this/DT was/VBD a/DT component/NN of/IN other/DT neurological/JJ diseases/NNS ./.
@@111711182692/CD High-affinity/NNP binding/NN of/IN NF-1/GENE to/IN PSE-B/GENE ,/, but/CC not/RB to/IN PSE-A/GENE ,/, was/VBD confirmed/VBN by/IN competition/NN of/IN DNA-protein/NN interactions/NNS by/IN using/VBG NF-1/MULTIGENE DNA/MULTIGENE elements/MULTIGENE and/CC antibodies/NNS ./.
@@10679649496/CD METHODS/IN :/: TBN/NN measurements/NNS were/VBD performed/VBN in/IN 31/CD female/JJ outpatients/NNS with/IN breast/NN carcinoma/NN who/WP were/VBD undergoing/VBG standard/JJ cyclophosphamide/NN ,/, methotrexate/NN ,/, and/CC 5-fluorouracil/NN (/( CMF/NN )/NN -based/NN chemotherapy/NN (/( median/JJ age/NN ,/, 48/CD years/NNS ;/: range/NN ,/, 26-/DT 77/CD years/NNS )/SYM ./.
@@77054767659/CD While/IN daily/JJ food/NN intake/NN was/VBD almost/RB constant/JJ regardless/RB of/IN the/DT dietary/JJ protein/NN level/NN ,/, water/NN intake/NN and/CC urine/NN volume/NN increased/VBN with/IN increasing/JJ the/DT dietary/JJ protein/NN ./.
@@84395974031/CD This/DT short/JJ communication/NN compares/VBZ a/DT novel/JJ fluorimetric/JJ microplate/MULTIGENE enzyme/MULTIGENE immunoassay/NN (/( FEIA/NNP )/SYM with/IN a/DT commercial/JJ time-resolved/JJ fluoroimmunoassay/NN for/IN the/DT determination/NN of/IN thyrotropin/NN in/IN dried/JJ blood/NN spots/NNS ./.
@@5752315704/NN None/NN of/IN the/DT cystometrograms/NNS showed/VBD uninhibited/JJ detrusor/NN contractions/NNS ./.
@@8550564920/CD CXC/NNP chemokines/NNS bind/VBP to/IN unique/JJ sets/NNS of/IN selectivity/NN determinants/NNS that/WDT can/MD function/VB independently/RB and/CC are/VBP broadly/RB distributed/VBN on/IN multiple/JJ domains/NNS of/IN human/MULTIGENE interleukin-8/MULTIGENE receptor/MULTIGENE B/NNP ./NNP
@@77840785323/CD An/DT explanation/NN explored/VBN for/IN this/DT lack/NN of/IN gene/NN expression/NN was/VBD that/WDT increased/VBD levels/NNS of/IN RAR/MULTIGENE alpha/MULTIGENE or/CC PML/NN might/MD suppress/VB APL/NN cell/NN growth/NN ./.
@@9643546241/CD Transcription/NNS initiation/NN occurred/VBN predominantly/RB at/IN the/DT putative/JJ sigmaA-dependent/MULTIGENE promoter/MULTIGENE in/IN exponentially/RB growing/JJ cells/NNS and/CC was/VBD induced/VBN under/IN stress/NN conditions/NNS ./.
@@91050422821/CD This/DT study/NN indicates/VBZ that/IN the/DT phenotype/NN of/IN myofibrillar/JJ disarray/NN seen/VBP in/IN HCM/NNS patients/NNS which/WDT harbor/VBP either/DT of/IN these/DT two/JJ mutations/NNS may/MD not/RB be/VB directly/RB due/NN to/IN the/DT failure/NN of/IN the/DT mutant/MULTIGENE myosin/MULTIGENE heavy/MULTIGENE chain/MULTIGENE protein/MULTIGENE to/IN assemble/VB and/CC form/NN normal/JJ sarcomeres/NNS ,/, but/CC may/MD rather/RB be/VB a/DT secondary/JJ effect/NN possibly/RB resulting/JJ from/IN the/DT chronic/JJ stress/NN of/IN decreased/VBN beta/MULTIGENE MHC/MULTIGENE function/NN ./.
@@105560331968/CD The/DT RFX/MULTIGENE protein/MULTIGENE family/MULTIGENE includes/VBZ members/NNS from/IN yeast/NN to/IN humans/NNS ,/, which/WDT function/VBP in/IN various/JJ biological/JJ systems/NNS ,/, and/CC share/VB a/DT DNA-binding/NN domain/NN and/CC a/DT conserved/VBN C-terminal/MULTIGENE region/MULTIGENE ./.
@@21353431397/CD In/NN this/DT article/NN we/PRP propose/VBP to/IN find/NN out/RB the/DT percentage/NN of/IN normal/JJ occlusion/NN and/CC the/DT distribution/NN of/IN maloclusions/NNS ,/, according/VBG to/IN the/DT anteroposterior/JJ relationship/NN between/IN the/DT dental/JJ archs/NNS (/( following/IN the/DT ANGLE3/NN classification/NN )/SYM ./.
@@13411192447/CD Some/DT research/NN studies/NNS have/VBP related/VBN this/DT kind/NN of/IN tumors/NNS with/IN prolonged/JJ ingestion/NN of/IN H2/MULTIGENE inhibitors/MULTIGENE and/CC others/NNS antacid/JJ ./.
@@86682012528/CD Detailed/VBN mutagenesis/NN of/IN the/DT element's/MULTIGENE rare-codon/MULTIGENE //MULTIGENE AU-rich/MULTIGENE sequence/MULTIGENE boundary/NN revealed/VBN that/IN the/DT destabilizing/JJ activity/NN of/IN the/DT MATalpha1/GENE IE/NN is/VBZ observed/VBN when/CC the/DT terminal/JJ codon/NN of/IN the/DT element's/NNS rare-codon/JJ interval/NN is/VBZ translated/VBN ./.
@@119154361830/CD The/DT observed/VBN incidence/NN rates/NNS were/VBD compared/VBN to/IN expected/VBN rates/NNS in/IN the/DT general/JJ population/NN ./.
@@1552662146/CD Electromagnetic/JJ blood/NN flow/NN (/( BF/GENE )/SYM probe/NN was/VBD applied/VBN on/IN the/DT left/JJ anterior/JJ descending/JJ artery/NN (/( LAD/NN )/SYM ./.
@@98623433027/CD We/PRP now/RB show/VBP that/IN gp200-MR6/GENE ligation/NN can/MD also/RB mimic/VB IL-4/NEWGENE and/CC have/VB an/DT anti-proliferative/JJ pro-maturational/JJ influence/NN within/IN the/DT immune/JJ system/NN ,/, causing/JJ up-regulation/NN of/IN co-stimulatory/JJ molecules/NNS on/IN B/NNP lymphocytes/NNS ./.
@@10829973635/CD Iodine/NNP deficiency/NN disorders/NNS in/IN Bangladesh/NN ./.
@@47532865134/CD Suppression/NN of/IN food/NN intake/NN in/IN the/DT rat/NN by/IN tung/NN oil/NN ./.
@@94021395899/CD Similarities/NNS between/IN the/DT hIGFBP-1/GENE and/CC phosphoenolpyruvate/MULTIGENE kinase/MULTIGENE (/( PEPCK/CONTEXTGENE )/SYM promoters/NNS ,/, including/JJ regions/NNS conferring/JJ insulin/NN ,/, glucocorticoid/NN ,/, and/CC cyclic/JJ adenosine-monophosphate/JJ responses/NNS ,/, are/VBP consistent/JJ with/IN our/PRP previous/JJ hypothesis/NN that/IN IGFBP-1/GENE is/VBZ involved/VBN in/IN regulation/NN of/IN glucose/NN metabolism/NN ./.
@@14749906016/CD A/DT genomic/JJ clone/NN ,/, pTt21/GENE ,/, containing/MULTIGENE DNA/MULTIGENE apparently/RB transcribed/VBN specifically/RB in/IN Trypanosoma/JJ cruzi/JJ trypomastigotes/NNS ,/, was/VBD obtained/VBN by/IN differentially/RB screening/JJ a/DT genomic/JJ library/NN with/IN trypomastigote/NN and/CC epimastigote/NN cDNA/NN ./.
@@112804951113/CD CONCLUSIONS/IN :/: Using/VBG icodextrin-based/JJ instead/RB of/IN glucose-based/JJ PD/NN fluids/NNS can/MD largely/RB reduce/VB the/DT formation/NN of/IN Amadori/NNP albumin/NN and/CC AGEs/DT ./.
@@21677844468/CD Five/CD healthy/JJ male/JJ subjects/NNS inspired/JJ air/NN for/IN 20/CD min/NN and/CC then/RB 5%/JJ CO2/CD //CD 95%/CD O2/GENE for/IN 30/CD min/NN ,/, of/IN which/WDT the/DT first/JJ 10/CD min/NN was/VBD used/VBN to/IN achieve/VB a/DT steady-state/JJ end-tidal/JJ CO2/NN measurement/NN ./.
@@8088513114/CD Here/RB ,/, we/PRP present/VBP genetic/JJ evidence/NN in/IN Saccharomyces/NN cerevisiae/NN for/IN a/DT functional/JJ interaction/NN between/IN the/DT DEAH/MULTIGENE protein/MULTIGENE Prp16/MULTIGENE ,/, and/CC the/DT U6/NN and/CC U2/GENE spliceosomal/JJ snRNAs/NNS ./.
@@67097006471/CD Within/IN the/DT compartment/NN or/CC dimension/NN of/IN severity/NN of/IN depression/NN a/DT subscale/NN of/IN the/DT Hamilton/NNP Depression/NNP Scale/NNP (/( or/CC the/DT Melancholia/NNP Scale/NNP )/SYM was/VBD shown/VBP to/IN have/NN reached/VBD an/DT instrumental/JJ perfection/NN ,/, e/NN ./NN g/NN ./. as/IN an/DT outcome/NN measure/NN of/IN antidepressant/JJ treatment/NN ./.
@@75502167426/CD Although/IN within/IN normal/JJ limits/NNS ,/, latency/NN was/VBD high/JJ ./.
@@118351098016/CD Since/IN the/DT early/MULTIGENE 1980s/MULTIGENE there/RB has/VBZ been/VBN increasing/JJ awareness/NN of/IN the/DT importance/NN of/IN quantifying/JJ health-related/JJ quality/NN of/IN life/NN (/( HRQL/NNS )/SYM in/IN patients/NNS with/IN chronic/JJ respiratory/JJ disorders/NNS included/VBN in/IN clinical/JJ trials/NNS ./.
@@87567127471/CD Previous/JJ studies/NNS have/VBP suggested/VBN that/IN the/DT 616/CD amino/JJ acid/NN ,/, 70-kDa/MULTIGENE subunit/MULTIGENE of/IN RPA/CONTEXTGENE (/( RPA/MULTIGENE 70/MULTIGENE )/SYM is/VBZ composed/VBN of/IN multiple/JJ structural/MULTIGENE //MULTIGENE functional/MULTIGENE domains/MULTIGENE ./.
@@76238219580/CD One/CD of/IN these/DT factors/NNS ,/, HRF-1/GENE ,/, recognizes/VBZ a/DT cis/MULTIGENE element/MULTIGENE consisting/VBG of/IN an/DT inverted/JJ palindromic/JJ motif/NN ./.
@@67409196509/CD Adult/NN Amblyomma/NN lepidum/NN ticks/NNS fed/VBN as/IN nymphs/NNS on/IN this/DT goat/NN transmitted/VBD heartwater/NN to/IN a/DT Friesian/JJ (/( Bos/NN taurus/NN )/SYM calf/NN ./.
@@10531342196/CD The/DT N-terminal/NN domain/NN of/IN approximately/RB 70/CD kDa/NN exhibits/VBP 11/CD imperfect/JJ amino/JJ acid/NN repeats/NNS that/WDT show/VBP some/DT homology/NN to/IN promastigote/NN surface/NN glycoproteins/NNS of/IN the/DT psa2/MULTIGENE //MULTIGENE gp46/MULTIGENE complex/MULTIGENE ./.
@@79733648141/CD In/NN the/DT present/NN article/NN ,/, the/DT causes/NNS of/IN death/NN or/CC ill-being/JJ as/IN found/VB in/IN 10/CD consecutive/JJ carcinogenicity/NN studies--5/JJ studies/NNS with/IN 2400/CD OFA/NN (/( Sprague-Dawley-derived/JJ )/SYM and/CC Wistar/NN rats/NNS and/CC 5/CD studies/NNS with/IN 2400/CD OF1/GENE and/CC NMRI/NN mice--were/RB re-examined/VBD ./.
@@109937876117/CD Whereas/IN both/DT MAP/NN and/CC MSNA/NNS increase/NN during/IN SHG/NN ,/, the/DT transition/NN from/IN SHG/NN to/IN PHI/NN is/VBZ characterized/VBN by/IN a/DT transient/JJ reduction/NN in/IN MAP/NN but/CC sustained/JJ elevation/NN in/IN MSNA/NNS ,/, facilitating/JJ separation/NN of/IN these/DT factors/NNS in/IN vivo/NN ./.
@@28497592398/CD The/DT SV40/MULTIGENE enhancer/MULTIGENE augmented/VBD replication/NN 1/CD ./CD 5-10/CD fold/NN ./.
@@84586608423/CD Air/NNP lead/VB was/VBD not/RB a/DT significant/JJ explanatory/JJ variable/NN ./.
@@86478847538/CD E3/GENE //GENE 19K/GENE resides/VBZ in/IN the/DT endoplasmic/JJ reticulum/NN where/CC it/PRP binds/VBZ to/IN MHC/MULTIGENE class/MULTIGENE I/MULTIGENE molecules/MULTIGENE ,/, thereby/RB preventing/JJ their/PRP transport/NN to/IN the/DT cell/NN surface/NN ./.
@@61912436009/CD Differential/JJ drawing/JJ size/NN associated/VBN with/IN unilateral/JJ brain/NN damage/NN ./.
@@71252389112/CD The/DT pia/MULTIGENE mater/MULTIGENE at/IN the/DT site/NN of/IN the/DT entry/NN of/IN blood/NN vessels/NNS into/IN the/DT central/JJ nervous/JJ system/NN ./.
@@109281799698/CD The/DT optimum/JJ technique/NN for/IN the/DT pathological/JJ examination/NN of/IN sentinel/NN lymph/NN nodes/NNS (/( SLNs/NN )/SYM is/VBZ still/RB under/IN debate/NN ./.
@@65852779717/CD In/NN a/DT man/NN with/IN myelomonocytic/JJ leukemia/NN ,/, the/DT association/NN of/IN increased/VBN prostatic/JJ acid/NN phosphatase/NN activity/NN in/IN serum/JJ and/CC the/DT presence/NN of/IN typical/JJ bone/NN lesions/NNS on/IN roentgenography/NN suggested/VBD the/DT existence/NN of/IN disseminated/JJ prostatic/JJ carcinoma/NN ./.
@@110062847453/CD The/DT protein-tyrosine/MULTIGENE kinase/MULTIGENE fer/IN associates/VBP with/IN signaling/MULTIGENE complexes/MULTIGENE containing/MULTIGENE insulin/MULTIGENE receptor/MULTIGENE substrate-1/MULTIGENE and/CC phosphatidylinositol/NN 3-kinase/CD ./.
@@82550227646/CD The/DT degree/NN of/IN hypoperfusion/NN was/VBD slightly/RB related/VBN to/IN decrease/NN in/IN FEV1/CONTEXTGENE ./CONTEXTGENE 0%/CONTEXTGENE ,/, V25/GENE and/CC PaO2/GENE and/CC increase/NN in/IN circulating/JJ blood/NN volume/NN and/CC peripheral/JJ red/JJ blood/NN cell/NN counts/NNS ./.
@@88477238820/CD IMPLICATIONS/NNP :/: Given/VBN the/DT small/JJ size/NN of/IN this/DT study/NN and/CC the/DT inconsistency/NN of/IN results/NNS among/IN the/DT few/JJ prospective/JJ studies/NNS of/IN ovarian/JJ cancer/NN conducted/VBN to/IN test/NN these/DT associations/NNS ,/, replications/VBZ of/IN these/DT findings/NNS are/VBP highly/RB desirable/JJ ./.
@@89618731763/CD Abnormal/JJ urinary/MULTIGENE coproporphyrin/MULTIGENE levels/NNS in/IN patients/NNS infected/VBN by/IN hepatitis/MULTIGENE C/MULTIGENE virus/NN with/IN or/CC without/IN human/JJ immunodeficiency/NN virus/NN ./.
@@76444666930/CD Here/RB we/PRP describe/VBP an/DT in/NN vitro/FW assay/NN where/CC the/DT NS3-4A/MULTIGENE polyprotein/MULTIGENE ,/, NS3/GENE ,/, the/DT serine/NN proteinase/NN domain/NN (/( the/DT N-terminal/MULTIGENE 181/MULTIGENE residues/NNS of/IN NS3/GENE )/SYM ,/, and/CC the/PDT NS4A/MULTIGENE cofactor/MULTIGENE were/VBD produced/VBN by/IN cell-free/JJ translation/NN and/CC tested/VBN for/IN trans-processing/NN of/IN radiolabeled/JJ substrates/NNS ./.
@@88698256296/CD Previous/JJ studies/NNS demonstrated/VBN that/IN the/DT flavin-containing/MULTIGENE monooxygenases/MULTIGENE (/( FMO/CONTEXTGENE )/SYM are/VBP expressed/VBN in/IN a/DT tissue-specific/JJ manner/NN ./.
@@112983267382/CD A/DT comparison/NN of/IN the/DT duplicated/VBN Vkappa/MULTIGENE genes/MULTIGENE suggests/VBZ positive/JJ selection/NN on/IN the/DT complementarity-determining/MULTIGENE regions/MULTIGENE of/IN the/DT duplicated/VBN genes/NNS by/IN point/NN mutations/NNS ./.
@@114160122458/CD Concerted/JJ transcriptional/JJ activation/NN of/IN the/DT low/NEWGENE density/NEWGENE lipoprotein/NEWGENE receptor/NEWGENE gene/NN by/IN insulin/NN and/CC luteinizing/JJ hormone/NN in/IN cultured/JJ porcine/JJ granulosa-luteal/JJ cells/NNS :/: possible/JJ convergence/NN of/IN protein/MULTIGENE kinase/MULTIGENE a/DT ,/, phosphatidylinositol/NEWGENE 3-kinase/NEWGENE ,/, and/CC mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE signaling/JJ pathways/NNS ./.
@@62387046035/CD Synthesis/NNS of/IN (/( +/SYM )/NN -lysergic/NN acid/NN diethylamide/JJ tartrate/NN ./.
@@9749019735/CD Stimulation/NNS of/IN macrophage/NN function/NN by/IN killed/VBN Bordetella/NN pertussis/NN cells/NNS did/VBD not/RB show/VB any/DT beneficial/JJ effect/NN as/IN an/DT increased/VBN susceptibility/NN became/VBD apparent/JJ ./.
@@90609719284/CD RESULTS/NNS :/: Among/IN women/NNS ,/, the/DT age-related/JJ decline/NN in/IN BMD/NN at/IN all/DT non-spine/MULTIGENE skeletal/MULTIGENE sites/MULTIGENE was/VBD significantly/RB different/JJ from/IN zero/NN ,/, with/IN the/DT largest/JJS decline/NN seen/VBP at/IN the/DT femoral/JJ neck/NN (/( -/CD ./CD 0038/CD g/GENE //GENE cm2/GENE //GENE y/GENE ,/, p/NN </SYM ./CD 001/CD )/SYM and/CC the/DT smallest/JJS at/IN the/DT trochanter/NN of/IN the/DT hip/NN (/( -/CD ./CD 0023/CD g/GENE //GENE cm2/GENE //GENE y/GENE ,/, p/NN =/SYM ./CD 03/CD )/SYM ./.
@@27279094327/CD A/DT raised/VBN amplitude/NN of/IN the/DT aggregation/NN of/IN plates/NNS and/CC a/DT decrease/NN in/IN the/DT threshold/NN of/IN their/PRP sensitivity/NN to/IN ADP/NN were/VBD established/VBN in/IN the/DT persons/NNS with/IN types/NNS IIa/NN and/CC IIb/MULTIGENE HLP/MULTIGENE and/CC in/IN CHD/NN without/IN HLP/NNS ./.
@@113917936182/CD To/TO determine/VB the/DT genomic/JJ complexity/NN of/IN the/DT deleted/VBN region/NN shared/VBN among/IN tumors/NNS ,/, we/PRP assembled/VBD a/DT physical/JJ map/NN of/IN the/DT I/MULTIGENE Mbp/MULTIGENE SRO/NNS consisting/VBG predominantly/RB of/IN bacteriophage/NN P1-derived/JJ artificial/JJ chromosome/NN (/( PAC/NN )/SYM clones/NNS ./.
@@10212332150/CD Chronotherapeutics/NNP in/IN cardiovascular/JJ disease/NN ./.
@@115409913868/CD In/NN order/NN to/IN quantify/VB these/DT effects/NNS ,/, tests/NNS were/VBD conducted/VBN in/IN the/DT NASA/MULTIGENE MSFC/MULTIGENE Neutral/NNP Buoyancy/NNP Simulator/NNP ,/, in/IN the/DT NASA/MULTIGENE KC-135/MULTIGENE in/IN parabolic/JJ flight/NN ,/, and/CC in/IN space/NN with/IN the/DT EASE/NNP program/NN during/IN the/DT Shuttle/NNP Atlantis/NNP mission/NN 61-B/GENE ./.
@@85581878541/CD Cycles/NNS were/VBD repeated/VBN every/DT 3/CD weeks/NNS ./.
@@47874725162/CD Change/NNP in/IN the/DT makeup/NN of/IN the/DT blood/NN following/IN a/DT short-term/JJ local/JJ action/NN of/IN a/DT permanent/JJ magnetic/JJ field/NN on/IN the/DT human/JJ body/NN ./.
@@24270248501/CD Tolerance/NN to/IN fenfluramine/MULTIGENE anorexia/MULTIGENE :/: fact/NN or/CC fiction/NN ?/. Recent/JJ findings/NNS in/IN this/DT laboratory/NN with/IN regard/NN to/IN tolerance/NN to/IN fenfluramine/MULTIGENE anorexia/MULTIGENE are/VBP reviewed/VBN with/IN respect/NN to/IN generality/NN of/IN the/DT behavioural/JJ phenomenon/NN ./.
@@100267848768/CD Here/RB ,/, we/PRP evidence/VBP that/IN the/DT developmental/JJ functions/NNS of/IN the/DT family/NN of/IN transcription/NN factors/NNS characterized/VBN by/IN the/DT POU/MULTIGENE DNA/MULTIGENE binding/MULTIGENE motif/MULTIGENE exerts/VBZ roles/NNS in/IN mammalian/JJ development/NN ./.
@@8223576301/CD The/DT absence/NN of/IN H4PteGlun/VB bound/JJ to/IN the/DT T/NN protein/NN in/IN our/PRP experimental/JJ conditions/NNS demonstrates/VBZ that/WDT H4PteGlun/VBP is/VBZ not/RB covalently/RB linked/JJ to/IN the/DT T/NN protein/NN ./.
@@96587693223/CD He/NN was/VBD administered/VBN recombinant/JJ IFN/MULTIGENE alpha-2b/MULTIGENE under/IN the/DT diagnosis/NN of/IN chronic/JJ hepatitis/NNP C/NNP ./NNP
@@62941112322/CD 74/CD ,/, 193-197/NN )/NN ./.
@@61519425974/CD Serum/NN ascorbic/JJ acid/NN had/VBP an/DT inverse/JJ and/CC the/DT strongest/JJS association/NN with/IN systolic/JJ blood/NN pressure/NN among/IN the/DT risk/NN factors/NNS including/JJ blood/NN pressure/NN ,/, total/JJ cholesterol/NN ,/, triglyceride/NN ,/, gamma-GTP/NN and/CC obesity/NN ./.
@@16505572252/CD Discrepant/NNP results/NNS with/IN a/DT latex/NN agglutination/NN test/NN in/IN the/DT assessment/NN of/IN cytomegalovirus/NN antibody/NN status/NN of/IN cardiac/JJ transplant/NN donors/NNS ./.
@@26553813332/CD Many/JJ studies/NNS have/VBP pointed/VBN out/RB the/DT possibility/NN of/IN "masked"/JJ organic/JJ factors/NNS in/IN erectile/JJ impotence/NN ,/, detectable/JJ only/RB by/IN means/NN of/IN laboratory/NN investigations/NNS :/: mild/JJ hypogonadism/NN ,/, hyperprolactinemia/NN ,/, occlusions/NNS selectively/RB located/VBN at/IN the/DT site/NN of/IN the/DT sexual/JJ arteries/NNS ,/, venous/JJ incompetence/NN ,/, subclinical/JJ neuropathies/NNS ./.
@@88715678403/CD MSSP/MULTIGENE proteins/MULTIGENE have/VBP been/VBN identified/VBN by/IN their/PRP binding/JJ to/IN an/DT upstream/JJ element/NN of/IN c-myc/NN ./.
@@111410033737/CD Changes/NNS in/IN stimulation/NN levels/NNS over/JJ time/NN in/IN nucleus/NN 22/NN cochlear/JJ implant/NN users/NNS ./.
@@89216675938/CD A/DT given/JJ standard/JJ input/NN function/NN and/CC a/DT given/NN value/NN of/IN distribution/NN volume/NN (/( Vd/NN )/SYM used/VBN for/IN the/DT rCBF/GENE measurement/NN of/IN this/DT method/NN were/VBD calculated/VBN from/IN the/DT dynamic/JJ study/NN by/IN six/CD normal/JJ volunteers/NNS ./.
@@104938763968/CD The/DT solution/NN structure/NN of/IN the/DT adduct/NN derived/VBN from/IN the/DT covalent/JJ bonding/NN of/IN the/DT fjord/NN region/NN (/( +/SYM )/NN -/NN (/NN 11S/NN ,/, 12R/CD ,/, 13R/CD ,/, 14S/NN )/NN stereoisomer/NN of/IN anti/JJ -11/NN ,/NN 12-dihydroxy-13/NN ,/NN 14-epoxy-11/NN ,/NN 12/NN ,/NN 13/NN ,/, 14-tetrahydrobenzo/NN [/NN g/NN ]/NN chrysene/NN ,/, (/( +/SYM )/JJ -/JJ anti/JJ -B/NN [/NN g/NN ]/NN CDE/NN ,/, to/IN the/DT exocyclic/JJ N/NN (/NN 6/NN )/NN amino/NN group/NN of/IN the/DT adenine/NN residue/NN dA6/CD ,/, (/( designated/VBN (/( +/SYM )/JJ -/JJ trans-anti/JJ -/NN (/NN B/NN [/NN g/NN ]/NN C/NN )/NN dA6/NN )/NN ,/, positioned/VBN opposite/NN a/DT thymine/NN residue/NN dT17/CD in/IN the/DT DNA/NN sequence/NN context/NN d/NN (/NN C1-T2-C3-T4-C5-/NN (/NN B/NN [/NN g/NN ]/NN C/NN )/NN A6-C7-T8-T9-C10-C11/NN )/NN ./. d/NN (/NN G12-G13-A14-A15-G16-T17-G18-A19-G20++/NN +-A21-G22/NN )/NN (/( designated/VBN (/( B/NN [/NN g/NN ]/NN C/NN )/NN dA/NN ./. dT/MULTIGENE 11-mer/MULTIGENE duplex/NN )/NN ,/, has/VBZ been/VBN studied/VBN using/VBG structural/JJ information/NN derived/VBN from/IN NMR/NN data/NN in/IN combination/NN with/IN molecular/JJ dynamics/NNS (/( MD/NN )/SYM calculations/NNS ./.
@@20346554411/CD Characterization/NNS of/IN the/DT alpha/MULTIGENE 4/MULTIGENE integrin/MULTIGENE gene/MULTIGENE promoter/MULTIGENE ./.
@@21177995026/CD Uses/NNS of/IN orthoclone/MULTIGENE OKT3/MULTIGENE for/IN prophylaxis/NN of/IN rejection/NN and/CC induction/NN in/IN initial/JJ nonfunction/NN in/IN kidney/NN transplantation/NN ./.
@@48638955210/CD Relationship/NNP between/IN gross/JJ lesions/NNS and/CC Escherichia/NN coli/JJ serotypes/NNS in/IN chronic/JJ respiratory/JJ disease/NN (/( CRD/NN )/SYM of/IN poultry/NN ./.
@@98340707528/CD Furthermore/RB ,/, synergistic/JJ activation/NN of/IN ERK2/GENE occurred/VBN in/IN the/DT absence/NN of/IN changes/NNS in/IN intracellular/JJ Ca2+/NN ,/, and/CC was/VBD not/RB blocked/VBN by/IN inhibition/NN of/IN protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE activity/NN and/CC represents/VBZ a/DT separate/JJ pathway/NN by/IN which/WDT CD19/GENE regulates/VBZ B/NNP cell/NN function/NN ./.
@@8305688967/CD Pancreatic/JJ and/CC biliary/JJ secretion/NN and/CC gastric/JJ emptying/NN rates/NNS of/IN a/DT liquid/JJ test/NN meal/NN (/( LTM/NN )/SYM were/VBD determined/VBN in/IN normal/JJ persons/NNS ,/, in/IN patients/NNS with/IN subtotal/JJ gastrectomy/NN with/IN gastroduodenostomy/NN (/( STG-BI/NNP )/SYM or/CC with/IN gastrojejunostomy/NN (/( STG-BII/NN )/SYM ,/, and/CC in/IN patients/NNS with/IN truncal/JJ vagotomy/NN and/CC pyloroplasty/NN (/( V&P/NNP )/SYM ./.
@@19014053494/CD Analysis/NNP of/IN mRNA/NN expression/NN shows/VBZ that/IN AT-BP1/GENE and/CC AT-BP2/GENE are/VBP expressed/VBN in/IN all/PDT the/DT tissues/NNS examined/VBN ./.
@@25354608843/CD RNA/NN transcripts/NNS that/WDT hybridize/VBP to/IN the/DT introduced/VBN foreign/JJ gene/NN have/NN been/VBN identified/VBN ./.
@@104643106379/CD Transient/JJ tyrosine/NN phosphorylation/NN of/IN Crk/NN in/IN fibroblast/NN growth/NN factor-2-stimulated/NN endothelial/JJ cells/NNS was/VBD dependent/JJ on/IN the/DT juxtamembrane/JJ tyrosine/NN residue/NN 463/CD in/IN FGFR-1/NEWGENE ,/, and/CC a/DT Crk/MULTIGENE SH2/MULTIGENE domain/NN precipitated/VBN FGFR-1/GENE via/NN phosphorylated/VBN Tyr-463/NN ,/, indicating/VBG direct/JJ complex/NN formation/NN between/IN Crk/CONTEXTGENE and/CC FGFR-1/GENE ./.
@@77147587662/CD Blood/NNP pressure/NN also/RB was/VBD increased/VBN by/IN lidocaine/NN (/( 6/CD mg/NN kg-1/NN )/SYM ./.
@@84972808260/CD Multiple/NNP SW16-dependent/NNP cis-acting/JJ elements/MULTIGENE control/MULTIGENE SWI4/MULTIGENE transcription/NN through/RB the/DT cell/NN cycle/NN ./.
@@19711911952/CD We/PRP conclude/VBP that/IN the/DT beta-adrenergic/MULTIGENE agonist/MULTIGENE ,/, isoproterenol/NN ,/, has/VBZ little/JJ influence/NN on/IN vascular/JJ capacitance/NN or/CC liver/NN volume/NN of/IN dogs/NNS ,/, unless/IN the/DT hepatic/JJ outflow/NN resistance/NN is/VBZ elevated/VBN by/IN agents/NNS such/JJ as/IN histamine/NN ./.
@@21151188198/CD This/DT Mr/NNP is/VBZ similar/JJ to/IN those/DT of/IN the/DT purified/VBN smg/MULTIGENE p25A/MULTIGENE GDI/MULTIGENE estimated/VBN by/IN sodium/NN dodecyl/NN sulfate-polyacrylamide/NN gel/NN electrophoresis/NN and/CC sucrose/NN density/NN gradient/NN ultracentrifugation/NN ,/, which/WDT are/VBP about/RB 54/CD ,/CD 000/CD and/CC 65/CD ,/CD 000/CD ,/, respectively/RB ./.
@@82132358756/CD Measurement/NNP of/IN SaO2/NN at/IN moderate/JJ altitude/NN can/MD be/VB helpful/JJ in/IN the/DT care/NN of/IN both/DT healthy/JJ and/CC ill/JJ newborns/NNS or/CC infants/NNS ./.
@@90493047180/CD In/NN co-transfection/JJ studies/NNS ,/, an/DT AP-2/GENE but/CC not/RB an/DT Egr-1/NEWGENE expression/NN vector/NN activated/VBN VPF/GENE //GENE VEGF/GENE transcription/NN ,/, thus/RB indicating/VBG that/IN AP-2/MULTIGENE protein/MULTIGENE is/VBZ functionally/RB important/JJ in/IN TGF/MULTIGENE alpha-induced/MULTIGENE VPF/MULTIGENE //MULTIGENE VEGF/MULTIGENE gene/MULTIGENE expression/NN ./.
@@112073083259/CD Similarly/RB ,/, curcumin/NN (/( diferuloylmethane/NN )/SYM ,/, an/DT anti-inflammatory/JJ agent/NN ,/, suppressed/VBN OSM-stimulated/JJ STAT1/GENE phosphorylation/NN ,/, DNA-binding/NN activity/NN of/IN STAT1/GENE ,/, and/CC c-Jun/MULTIGENE N-terminal/MULTIGENE kinase/MULTIGENE activation/NN without/IN affecting/VBG JAK1/GENE ,/, JAK2/GENE ,/, JAK3/GENE ,/, ERK1/GENE //GENE 2/GENE ,/, and/CC p38/GENE phosphorylation/NN ./.
@@112889301121/CD The/DT reproductive/JJ effects/NNS of/IN the/DT administration/NN of/IN 4-chloro-2-methylphenoxyacetic/JJ acid/NN (/( MCPA/NN )/SYM to/IN rats/NNS were/VBD evaluated/VBN through/RB two/JJ generations/NNS ,/, from/IN prior/NN to/IN mating/JJ ,/, throughout/IN mating/JJ ,/, to/IN gestation/NN and/CC lactation/NN ./.
@@97294817723/CD The/DT rat/MULTIGENE branched-chain-2-oxo-acid/MULTIGENE dehydrogenase/MULTIGENE (/( BCOD/CONTEXTGENE )/SYM kinase/MULTIGENE mRNA/MULTIGENE is/VBZ transcribed/VBN from/IN a/DT TATA-less/NNP promoter/NN that/WDT has/VBZ GC-rich/GENE sequences/NNS and/CC two/JJ putative/JJ Sp1/MULTIGENE binding/MULTIGENE sites/MULTIGENE near/IN the/DT transcription/NN start/NN site/NN ./.
@@104072693842/CD 67/CD 393/CD bp/NN of/IN contiguous/JJ DNA/NN located/VBN between/IN markers/MULTIGENE cdc18/MULTIGENE and/CC cdc14/GENE on/IN the/DT right/JJ arm/NN of/IN fission/NN yeast/MULTIGENE chromosome/MULTIGENE II/MULTIGENE has/VBZ been/VBN sequenced/VBN as/IN part/NN of/IN the/DT European/NNP Union/NNP Schizosaccharomyces/NN pombe/NN genome/NN sequencing/VBG project/NN ./.
@@118951841804/CD The/DT ability/NN of/IN rats/NNS with/IN control/NN or/CC hippocampal/JJ lesions/NNS to/IN learn/VB an/DT object-place/NN ,/, odor-place/JJ ,/, or/CC object-odor/MULTIGENE paired-associate/MULTIGENE task/MULTIGENE was/VBD assessed/VBN in/IN a/DT cheeseboard/NN maze/NN apparatus/NN ./.
@@81895331254/CD Gel/NNP electrophoresis/NN and/CC Western/JJ immunoblot/VB analyses/NNS of/IN intracellular/JJ fractions/NNS derived/VBN from/IN infected/VBN cells/NNS revealed/VBN that/IN large/JJ amounts/NNS of/IN NS53/GENE were/VBD present/VB in/IN the/DT cytosol/NN and/CC in/IN association/NN with/IN the/DT cytoskeletal/JJ matrix/NN ./.
@@81126011503/CD Structural/NNP organization/NN of/IN the/DT gene/NN encoding/VBG the/DT human/MULTIGENE lipocalin/MULTIGENE tear/NN prealbumin/NN and/CC synthesis/NN of/IN the/DT recombinant/JJ protein/NN in/IN Escherichia/NN coli/JJ ./.
@@8767228761/CD Bacterial/JJ meningitis/NN secondary/JJ to/IN abscess/NN of/IN the/DT nasal/JJ septum/NN ./.
@@89717213423/CD On/IN the/DT basis/NN of/IN serological/JJ studies/NNS ,/, the/DT highly/RB conserved/VBN A/DT domain/NN of/IN HspA/GENE was/VBD found/VBN to/IN be/VB the/DT immunodominant/JJ domain/NN ./.
@@105328059570/CD In/NN PC12/NNP cells/NNS ,/, nerve/MULTIGENE growth/MULTIGENE factor/MULTIGENE induces/VBZ neuronal/JJ differentiation/NN and/CC repressed/VBN expression/NN of/IN nrg-1/GENE ./.
@@97652771954/CD The/DT murine/JJ facilitative/JJ glucose/MULTIGENE transporter/MULTIGENE isoform/MULTIGENE 3/MULTIGENE (/( Glut/NN 3/CD )/SYM is/VBZ developmentally/RB regulated/VBN and/CC is/VBZ predominantly/RB expressed/VBN in/IN neurons/NNS and/CC trophoblasts/NNS ./.
@@118723596822/CD It/PRP has/VBZ been/VBN proposed/VBN that/DT insulin/NN resistance/NN (/( IR/JJ )/SYM underlies/VBZ a/DT cluster/NN of/IN cardiovascular/JJ disease/NN (/( CVD/NN )/SYM risk/NN factors/NNS constituting/VBG a/DT "metabolic/JJ syndrome/GENE ./GENE "/GENE CVD/NN is/VBZ a/DT leading/JJ cause/NN of/IN premature/JJ mortality/NN among/IN indigenous/JJ Australians/NNS ./.
@@81018393773/CD To/TO investigate/VB the/DT regulation/NN of/IN expression/NN of/IN the/DT human/MULTIGENE mdr1/MULTIGENE gene/MULTIGENE ,/, the/DT response/NN of/IN the/DT mdr1/MULTIGENE promoter/MULTIGENE to/IN signals/NNS involved/VBN in/IN cell/NN proliferation/NN was/VBD examined/VBN ./.
@@6599629616/CD Increased/VBN urinary/MULTIGENE riboflavin/MULTIGENE excretion/NN resulting/JJ from/IN boric/JJ acid/NN ingestion/NN ./.
@@25322105493/CD The/DT adenovirus/NN E1A/MULTIGENE gene/MULTIGENE encodes/VBZ a/DT protein/NN that/WDT transcriptionally/RB activates/VBZ viral/JJ early/JJ genes/NNS ./.
@@65219996311/CD This/DT compares/VBZ favorably/RB to/IN results/NNS of/IN similarly/RB sized/JJ melanomas/NNS treated/VBN by/IN enucleation/NN ./.
@@33177964000/CD In/NN the/DT control/NN group/NN the/DT histological/JJ picture/NN resembled/VBD osteoarthritis/NN ./.
@@79166892906/CD The/DT isolated/VBN POT1/GENE clones/NNS hybridized/VBN to/IN a/DT 1/CD ./CD 4/CD kb/NN RNA/NN species/NN ,/, which/WDT was/VBD induced/VBN approximately/RB 30-fold/JJ when/CC oleate/NN was/VBD the/DT carbon/NN source/NN ./.
@@85187973043/CD X-linked/JJ liver/NN glycogenosis/NN :/: localization/NN and/CC isolation/NN of/IN a/DT candidate/NN gene/NN ./.
@@75335273649/CD Cell/NNP lines/NNS derived/VBN from/IN the/DT tumors/NNS were/VBD examined/VBN by/IN fluorescent/JJ in/IN situ/NN hybridization/NN for/IN the/DT status/NN of/IN the/DT transferred/VBN human/JJ chromosome/NN and/CC by/IN PCR/NN for/IN marker/NN loss/NN ./.
@@68100709262/CD Other/JJ properties/NNS of/IN Hg-/GENE and/CC Cd-spores/GENE were/VBD similar/JJ to/IN those/DT of/IN control/NN spores/NNS ./.
@@16824842279/CD During/IN coronary/JJ stenosis/NN ,/, on/IN the/DT contrary/NN ,/, intracoronary/JJ procaterol/NN at/IN the/DT same/JJ dose/NN significantly/RB deteriorated/VBD regional/JJ myocardial/JJ dysfunction/NN without/IN changing/JJ LCX/NNS flow/NN ,/, global/JJ hemodynamics/NN and/CC cardiac/JJ lactate/NN metabolism/NN ./.
@@104111396960/CD Accumulation/NNP of/IN the/DT U4/NNP //NNP U6/NNP duplex/NN was/VBD relieved/VBN by/IN overexpression/NN of/IN wild-type/NN Prp44p/GENE ./.
@@87987008286/CD Its/PRP transcription/NN has/VBZ been/VBN shown/VBP to/IN be/VB induced/VBN 40-50-fold/JJ in/IN response/NN to/IN oxygen/NN or/CC heme/NN deficiency/NN ,/, in/IN part/NN through/JJ relief/NN of/IN repression/NN exerted/VBN by/IN Rox1p/GENE and/CC in/IN part/NN by/IN activation/NN mediated/JJ by/IN an/DT upstream/MULTIGENE activation/MULTIGENE sequence/MULTIGENE (/( UAS/CONTEXTGENE )/SYM ./.
@@23267163467/CD Methods/NNS used/VBN include/VB Cobb/NNP angle/NN and/CC a/DT segmental/JJ evaluation/NN (/( T7-T12/GENE )/SYM of/IN each/DT of/IN convex/JJ and/CC concave/JJ rib-vertebra/JJ angles/NNS (/( RVAs/NNS )/SYM ,/, rib-vertebra/JJ angle/NN differences/NNS (/( RVADs/GENE )/SYM ,/, vertebral/JJ rotation/NN ,/, tilt/NN and/CC displacement/NN ./.
@@91193918891/CD The/DT exonic/JJ sequence/NN encodes/VBZ a/DT protein/NN of/IN 495/CD amino/JJ acids/NNS that/WDT is/VBZ nearly/RB identical/JJ to/IN the/DT previously/RB reported/VBN protein/NN sequence/NN of/IN human/MULTIGENE GPT-1/MULTIGENE ./.
@@20702272673/CD Endothelial/JJ cell/NN seeding/NN ./.
@@86362113721/CD EMBO/NNP J/NNP ./NNP
@@94306682597/CD The/DT promoter/NN for/IN HMG-CoA/MULTIGENE synthase/MULTIGENE contains/VBZ two/JJ binding/JJ sites/NNS for/IN the/DT sterol/NN regulatory/MULTIGENE element-binding/MULTIGENE proteins/MULTIGENE (/( SREBPs/CONTEXTGENE )/SYM ./.
@@87219999409/CD U24/GENE has/VBZ two/JJ separate/JJ 12/CD nt/JJ long/JJ complementarities/NNS to/IN a/DT highly/RB conserved/VBN tract/NN of/IN 28S/CD rRNA/NN ./.
@@11062047969/CD Thus/RB ,/, IHHNV/ORG is/VBZ closely/RB related/VBN to/IN densoviruses/NNS of/IN the/DT genus/NN Brevidensovirus/NNP in/IN the/DT family/NN Parvoviridae/NN ,/, and/CC we/PRP therefore/RB propose/VBP to/IN rename/VB this/DT virus/NN Penaeus/NNP stylirostris/NN densovirus/NN (/( PstDNV/NNP )/SYM ./.
@@109545646531/CD We/PRP have/VBP also/RB identified/VBN a/DT functional/JJ domain/NN in/IN the/DT ORF/MULTIGENE 50/MULTIGENE protein/MULTIGENE ,/, an/DT immediate-early/NEWGENE gene/NN product/NN that/WDT is/VBZ mainly/RB encoded/VBN by/IN ORF/NN 50/CD ./CD
@@107131759062/CD Collectively/RB ,/, the/DT results/NNS suggest/VBP that/DT ARF/NN binding/JJ to/IN Mdm2/GENE induces/VBZ a/DT conformational/JJ change/NN that/WDT facilitates/VBZ nucleolar/JJ import/NN of/IN the/DT ARF-Mdm2/MULTIGENE complex/MULTIGENE and/CC p53-dependent/JJ cell/NN cycle/NN arrest/NN ./.
@@1074812553/CD Inhibitor-1/GENE (/( I-1/GENE )/SYM and/CC inhibitor-2/GENE (/( I-2/GENE )/SYM selectively/RB inhibit/VB type/MULTIGENE 1/MULTIGENE protein/MULTIGENE serine/MULTIGENE //MULTIGENE threonine/MULTIGENE phosphatases/MULTIGENE (/( PP1/GENE )/SYM ./.
@@18337162820/CD Deregulation/NN of/IN their/PRP expression/NN may/MD contribute/VB to/IN malignant/JJ transformation/NN associated/VBN with/IN HTLV-1/NN infection/NN ./.
@@81457708056/CD Thus/RB our/PRP observations/NNS establish/VBP a/DT functional/JJ link/NN between/IN the/DT PKC/NEWGENE and/CC retinoid/JJ pathways/NNS ,/, which/WDT are/VBP generally/RB considered/VBN to/IN have/NN antagonistic/JJ activities/NNS on/IN differentiation/NN processes/NNS ./.
@@35592324223/CD A/DT preliminary/JJ study/NN on/IN pyogenic/JJ arthritis/NN ./.
@@91537952226/CD In/NN several/DT studies/VBZ the/DT RDFS/GENE has/VBZ shown/VBP evidence/NN of/IN reliability/NN and/CC validity/NN ./.
@@111577846429/CD We/PRP mapped/VBD the/DT DGCR6/MULTIGENE gene/MULTIGENE to/IN chromosome/NN 22q11/CD within/IN a/DT low/JJ copy/NN repeat/NN ,/, termed/JJ sc11/CD ./CD 1a/CD ,/, and/CC identified/VBD a/DT second/JJ copy/NN of/IN the/DT gene/NN ,/, DGCR6L/GENE ,/, within/IN the/DT duplicate/JJ locus/NN ,/, termed/JJ sc11/CD ./CD 1b/CD ./.
@@37441684409/CD Pharmacological/JJ action/NN of/IN eptazocine/NN (/( l-1/JJ ,/JJ 4-dimethyl-10-hydroxy-2/JJ ,/JJ 3/JJ ,/JJ 4/JJ ,/JJ 5/JJ ,/JJ 6/JJ ,/JJ 7-hexahydro-1/JJ ,/JJ 6-methano-1H-4-benz/JJ azonine/NN )/SYM ./.
@@95101891294/CD We/PRP have/VBP elucidated/VBN the/DT exon-intron/JJ organization/NN of/IN the/DT entire/JJ human/MULTIGENE CD58/MULTIGENE gene/MULTIGENE ,/, including/JJ approximately/RB 2/CD ./CD 5/CD kilobases/NNS (/( kb/NN )/SYM of/IN 5'-flanking/JJ DNA/NN ./.
@@84797426799/CD This/DT may/MD account/NN ,/, at/IN least/RB in/IN part/NN ,/, for/IN the/DT ability/NN of/IN excess/NN wt/NN p53/GENE to/IN inhibit/VB cell/NN proliferation/NN and/CC to/IN interfere/VB with/IN neoplastic/JJ processes/NNS ./.
@@24741103129/CD In/NN addition/NN to/IN the/DT significant/JJ reduction/NN in/IN blood/NN pressure/NN ,/, the/DT angiotensin/MULTIGENE converting/MULTIGENE enzyme/MULTIGENE (/( ACE/CONTEXTGENE )/SYM inhibitor/NN ramipril/NN caused/VBD a/DT significant/JJ regression/NN of/IN pathologic/JJ left/NN ventricular/JJ hypertrophy/NN demonstrated/VBN by/IN magnetic/JJ resonance/NN imaging/JJ and/CC echocardiography/NN ./.
@@88913456426/CD We/PRP show/VBP that/IN the/DT 5'UTR/GENE characteristic/NN of/IN testis-specific/MULTIGENE c-mos/MULTIGENE mRNA/MULTIGENE strongly/RB represses/VBZ translation/NN relative/JJ to/IN the/DT translation/NN of/IN transcripts/NNS that/WDT contain/VBP a/DT 5'UTR/CD derived/VBN from/IN beta-globin/MULTIGENE mRNA/MULTIGENE ,/, and/CC this/DT is/VBZ mainly/RB due/NN to/IN the/DT four/CD uORFs/NNS ./.
@@113537709932/CD In/NN regards/VBZ to/IN the/DT latter/JJ activity/NN ,/, it/PRP has/VBZ been/VBN shown/VBP that/DT S3/NN contains/VBZ vigorous/MULTIGENE N-glycosylase/MULTIGENE activity/NN for/IN the/DT removal/NN of/IN 8-oxoguanine/CD residues/NNS in/IN DNA/NN that/WDT leaves/VBZ baseless/JJ sites/NNS in/IN their/PRP places/NNS ./.
@@63693552333/CD Analysis/NNP of/IN proteins/NNS synthesized/VBN by/IN plasmids/NNS containing/JJ deleted/VBN forms/NNS of/IN the/DT trfA/MULTIGENE region/MULTIGENE indicates/VBZ that/IN the/DT A2/MULTIGENE protein/MULTIGENE is/VBZ the/DT essential/JJ trfA-encoded/JJ replication/NN protein/NN of/IN plasmid/NN RK2/GENE ./.
@@25740168763/CD When/WRB the/DT first/JJ twitch/NN of/IN TOF/GENE spontaneously/RB recovered/VBN to/IN 10%/CD of/IN control/NN value/NN ,/, neostigmine/NN was/VBD injected/VBN (/( 40/CD micrograms/GENE //GENE kg/GENE in/IN adults/NNS ,/, 30/CD micrograms/GENE //GENE kg/GENE in/IN infants/NNS and/CC children/NNS )/SYM ./.
@@8387508582/CD 16/CD ,/, 99-104/NN )/NN ./.
@@115571277392/CD In/NN conclusion/NN ,/, NF-Y/GENE and/CC Sp1/MULTIGENE binding/MULTIGENE sites/MULTIGENE play/VBP a/DT decisive/JJ role/NN in/IN the/DT basal/JJ expression/NN of/IN the/DT rat/MULTIGENE mrp2/MULTIGENE gene/MULTIGENE ,/, while/CC the/DT human/MULTIGENE MRP2/MULTIGENE gene/MULTIGENE is/VBZ regulated/VBN differently/RB ./.
@@75286679016/CD Minor/NNP initiation/NN sites/NNS were/VBD found/VBN at/IN positions/NNS -128/CD ,/, -111/CD ,/, -91/CD ,/, and/CC -74/CD ./.
@@17087745758/CD The/DT DNA/NN sequence/NN conferring/JJ AP-1/GENE activity/NN was/VBD located/VBN in/IN the/DT proximal/JJ promoter/NN region/NN ./.
@@85455023176/CD Thus/RB ,/, SPECT/NN was/VBD not/RB as/RB sensitive/JJ as/IN PET/NN in/IN this/DT activation/MULTIGENE task/MULTIGENE ./.
@@34435664146/CD In/NN both/DT experiments/NNS ,/, average/JJ daily/JJ gain/NN and/CC gain-to-feed/JJ ratio/NN were/VBD similar/JJ for/IN TR/NN and/CC CR/NNP ./NNP
@@113234193724/CD Molecular/NNP cloning/NN ,/, genomic/JJ mapping/NN ,/, and/CC expression/NN of/IN two/JJ secretor/NN blood/NN group/NN alpha/NN (/( 1/CD ,/CD 2/CD )/NN fucosyltransferase/NN genes/NNS differentially/RB regulated/VBN in/IN mouse/NN uterine/NEWGENE epithelium/NN and/CC gastrointestinal/JJ tract/NN ./.
@@23327981929/CD The/DT afferents'/NN phase/NN of/IN response/NN was/VBD unmodified/JJ by/IN electrical/JJ EVS/GENE stimulation/NN ./.
@@113341247591/CD A/DT log-linear/JJ dose-response/NN was/VBD obtained/VBN for/IN the/DT average/JJ increase/NN in/IN FEV1/NN up/JJ to/IN 6/CD h/NN (/( AUC0-6/MULTIGENE h/MULTIGENE )/SYM and/CC peak/NN FEV1/NN across/IN the/DT dose/NN range/NN administered/VBN by/IN Respimat/NNP ./.
@@32084933901/CD The/DT glomerular/JJ filtration/NN rate/NN did/VBD not/RB change/VB but/CC lithium/NN clearance/NN fell/NN by/IN 30%/CD ./.
@@104469988614/CD Adipocyte/NN differentiation/NN of/IN nontransformed/JJ cells/NNS also/RB markedly/RB represses/VBZ the/DT ability/NN of/IN SRF/NN to/IN bind/NN to/IN the/DT junB/GENE SRE/NNS ,/, the/DT c-fos/GENE SRE/NNS ,/, and/CC other/DT SREs/NNP ,/, as/IN determined/VBN by/IN mobility/NN shift/NN and/CC gel/NN supershift/NN assays/NNS ,/, without/IN affecting/VBG the/DT DNA/NN binding/JJ characteristics/NNS of/IN the/DT nuclear/MULTIGENE protein/MULTIGENE SP-1/MULTIGENE ./.
@@76220586522/CD The/DT PEBP2/MULTIGENE alpha/MULTIGENE proteins/MULTIGENE contain/VBP a/DT 128-amino-acid/JJ (/( aa/NNS )/SYM region/NN highly/RB homologous/JJ to/IN the/DT Drosophila/NN melanogaster/NN segmentation/MULTIGENE gene/MULTIGENE runt/NN ./.
@@108395472892/CD Consistent/JJ with/IN our/PRP model/NN ,/, CTCF/GENE binding/NN is/VBZ abolished/VBN by/IN DNA/NN methylation/NN ./.
@@112788703935/CD Analysis/NNP of/IN regulatory/JJ regions/NNS in/IN the/DT promoter/NN of/IN the/DT ctr4/NN (/NN +/NN )/NN copper/JJ transporter/MULTIGENE gene/MULTIGENE in/IN fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN reveals/VBZ the/DT identity/NN of/IN a/DT conserved/VBN copper-signaling/JJ element/NN (/( CuSE/GENE )/SYM ,/, which/WDT is/VBZ recognized/VBN by/IN the/DT transcription/MULTIGENE factor/MULTIGENE Cuf1/MULTIGENE ./.
@@3610594276/CD A/DT study/NN of/IN the/DT comparative/JJ efficacy/NN of/IN diflucortolone/NN valerate/NN 0/CD ./CD 3%/CD ointment/NN and/CC clobetasol/NN propionate/NN 0/CD ./CD 05%/CD ointment/NN ./.
@@78981787872/CD The/DT relative/JJ risk/NN of/IN graft/NN loss/NN after/IN conversion/NN to/IN azathioprine/NN compared/VBN with/IN graft/NN loss/NN after/IN conversion/NN to/IN azathioprine/NN compared/VBN with/IN cyclosporin/NN maintenance/NN was/VBD 0/CD ./CD 71/CD (/( 0/CD ./CD 37-1/CD ./CD 38/CD )/SYM and/CC the/DT relative/JJ risk/NN of/IN patient/NN death/NN was/VBD 0/CD ./CD 57/CD (/( 0/CD ./CD 23-1/CD ./CD 41/CD )/SYM ./.
@@100825702303/CD Therefore/RB ,/, we/PRP have/VBP named/VBN this/DT gene/MULTIGENE UBP43/MULTIGENE ./.
@@112641773460/CD Nucleotide/NN sequence/NN ,/, transcription/NN map/NN ,/, and/CC mutation/NN analysis/NN of/IN the/DT 13q14/MULTIGENE chromosomal/MULTIGENE region/MULTIGENE deleted/VBN in/IN B-cell/NN chronic/JJ lymphocytic/JJ leukemia/NN ./.
@@38367775575/CD Practical/JJ use/NN and/CC interpretation/NN of/IN viral/MULTIGENE hepatitis/MULTIGENE B/MULTIGENE markers/MULTIGENE and/CC hepatic/JJ biopsy/NN in/IN HBs/MULTIGENE Ag/MULTIGENE carriers/MULTIGENE and/CC at/IN the/DT chronic/JJ hepatitis/NN stage/NN ./.
@@104589076851/CD The/DT human/JJ RAD30B/GENE and/CC mouse/MULTIGENE Rad30b/MULTIGENE mRNA/MULTIGENE transcripts/MULTIGENE ,/, like/JJ many/JJ repair/MULTIGENE proteins/MULTIGENE ,/, are/VBP highly/RB expressed/VBN in/IN the/DT testis/NN ./.
@@86344206719/CD HuEpo-R/MULTIGENE Ab/MULTIGENE inhibited/VBD Epo-induced/JJ parental/JJ UT-7/NNP cell/NN growth/NN ,/, but/CC not/RB that/IN of/IN cells/NNS of/IN clone/NN 12/CD ,/, suggesting/VBG that/IN the/DT muEpo-R/NN is/VBZ able/JJ to/IN induce/VB human/JJ UT-7/NNP cell/NN proliferation/NN ./.
@@88066932938/CD In/NN order/NN to/IN determine/VB which/WDT sequences/NNS in/IN the/DT GATA-1/MULTIGENE promoter/MULTIGENE are/VBP crucial/JJ for/IN activation/NN by/IN the/DT ME26/MULTIGENE viral/MULTIGENE protein/MULTIGENE ,/, we/PRP made/VBP deletions/NNS of/IN the/DT promoter/NN ,/, cloned/VBN them/PRP into/IN a/DT luciferase/NEWGENE expression/NN vector/NN and/CC tested/VBN their/PRP activity/NN in/IN mouse/NN fibroblasts/NNS ,/, which/WDT do/VBP not/RB express/VB GATA-1/GENE ./.
@@112242266061/CD The/DT effects/NNS of/IN chlordiazepoxide/NN (/( 2/CD ./CD 5-15/CD ./CD 0mg/CD //CD kg/CD )/SYM ,/, a/DT full/JJ benzodiazepine/MULTIGENE receptor/MULTIGENE agonist/MULTIGENE ,/, and/CC bretazenil/NN (/( 5/CD ./CD 0-30/CD ./CD 0mg/CD //CD kg/CD )/SYM ,/, a/DT partial/JJ benzodiazepine/MULTIGENE receptor/MULTIGENE agonist/MULTIGENE ,/, were/VBD examined/VBN in/IN the/DT murine/RB elevated/VBN plus-maze/NN paradigm/NN ./.
@@78886235831/CD PMEK1/GENE displays/VBP 96/CD and/CC 80%/CD identity/NN respectively/RB with/IN the/DT tobacco/NN NTF3/GENE and/CC Arabidopsis/NN ATMPK1/MULTIGENE kinases/MULTIGENE ,/, and/CC only/RB 50%/CD to/IN the/DT more/RB distantly/RB related/VBN plant/NN MAP/MULTIGENE kinase/MULTIGENE MsERK1/MULTIGENE from/IN alfalfa/NN ./.
@@88876618903/CD IRF-1/GENE acts/NNS as/IN a/DT transcriptional/JJ activator/NN ,/, while/CC IRF-2/GENE acts/NNS as/IN a/DT repressor/NN ./.
@@82291025822/CD We/PRP conclude/VBP that/IN the/DT QLMI/GENE questionnaire/NN has/VBZ good/JJ potential/NN as/IN an/DT instrument/NN for/IN assessing/JJ QL/NN in/IN post-AMI/JJ patients/NNS and/CC that/IN it/PRP can/MD be/VB successfully/RB self-administered/VB ./.
@@9422351592/CD Ca2+/MULTIGENE //MULTIGENE calmodulin-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE II/MULTIGENE (/( CaMK/MULTIGENE II/MULTIGENE )/SYM is/VBZ a/DT multifunctional/MULTIGENE serine/MULTIGENE //MULTIGENE threonine/MULTIGENE protein/MULTIGENE kinase/MULTIGENE that/WDT regulates/VBZ ion/NN channels/NNS ,/, metabolic/JJ enzymes/NNS ,/, cytoskeletal/JJ proteins/NNS ,/, and/CC possibly/RB transcription/NN factors/NNS ./.
@@74911115924/CD We/PRP studied/VBD the/DT GR/NN in/IN DMS-79/NNP cells/NNS derived/VBN from/IN a/DT human/JJ ACTH-secreting/JJ small/JJ cell/NN lung/NN cancer/NN ./.
@@93118085942/CD However/RB ,/, we/PRP were/VBD unable/JJ to/IN identify/VB a/DT p4/MULTIGENE molecule/MULTIGENE ./.
@@99659099963/CD Direct/JJ approach/NN to/IN the/DT study/NN of/IN soliton/NN perturbations/NNS ./.
@@105874601688/CD To/TO define/VB the/DT minimal/JJ VDRE/NN binding/JJ domain/NN for/IN human/MULTIGENE VDR/MULTIGENE (/( hVDR/CONTEXTGENE )/SYM ,/, a/DT series/NN of/IN C-terminally/RB truncated/JJ hVDR/MULTIGENE mutants/MULTIGENE (/( Delta134/GENE ,/, Delta113/GENE ,/, Delta102/GENE ,/, Delta90/GENE ,/, Delta84/GENE ,/, Delta80/GENE ,/, and/CC Delta60/CONTEXTGENE )/SYM was/VBD generated/VBN and/CC expressed/VBN in/IN bacteria/NNS ./.
@@2209243388/CD The/DT urinary/MULTIGENE protein/MULTIGENE ,/, serum/JJ albumin/NN ,/, BUN/NN and/CC SCr/NN all/DT had/VBP very/RB significant/JJ improvement/NN ./.
@@80944988069/CD Most/JJS ,/, however/RB ,/, would/MD tell/VB the/DT spouse/NN the/DT full/JJ truth/NN about/RB both/DT diagnosis/NN and/CC prognosis/NN ./.
@@27978774357/CD The/DT combination/NN PIP/MULTIGENE 64/MULTIGENE micrograms/NNS -/: PEF/MULTIGENE 4/MULTIGENE micrograms/NNS prevents/VBZ the/DT frequent/JJ secondary/JJ regrowth/NN seen/VBP after/IN 6/CD hours/NNS with/IN the/DT antibiotics/NNS used/VBN alone/RB ./.
@@10789821880/CD The/DT second/JJ and/CC third/RB responded/VBN similarly/RB to/IN either/DT a/DT combined/JJ cyclophosphamide/NN +/SYM antilymphocyte/MULTIGENE globulin/MULTIGENE (/( ALG/CONTEXTGENE )/SYM treatment/NN or/CC to/IN ALG/NN administration/NN preceded/VBN by/IN a/DT small/JJ dosage/NN of/IN cyclophosphamide/NN ,/, which/WDT had/VBP proved/VBN ineffective/JJ when/CC administered/VBN alone/RB ./.
@@94215113075/CD These/DT and/CC other/DT comparisons/NNS suggest/VBP that/IN ,/, during/IN evolution/NN ,/, both/PDT the/DT RNA-polymerase/NN specificity/NN of/IN telomerase/MULTIGENE RNA-gene/MULTIGENE promoters/MULTIGENE and/CC ,/, more/RB recently/RB ,/, the/DT position/NN of/IN the/DT template/NN sequence/NN in/IN the/DT telomerase/MULTIGENE RNA/MULTIGENE changed/VBN ./.
@@93729684144/CD Importantly/RB ,/, in/IN HeLa/DT and/CC 293/CD cells/NNS ,/, endogenous/JJ and/CC transfected/VBN I/MULTIGENE kappaB/MULTIGENE alpha/MULTIGENE coimmunoprecipitated/VBN with/IN Myc-tagged/JJ or/CC endogenous/JJ Dlc-1/GENE ./.
@@57509505699/CD Estrus/NNP and/CC copulative/JJ abilities/NNS of/IN androgen-sterilized/JJ rats/NNS ./.
@@49892515293/CD Analysis/NNP of/IN corticosteroids/NNS ./.
@@107125993287/CD Here/RB ,/, we/PRP show/VBP that/IN IRF-1/GENE is/VBZ degraded/VBN via/NN the/DT ubiquitin-proteasome/NN pathway/NN ./.
@@74879086139/CD That/DT sequence/NN strongly/RB promoted/VBD the/DT transcription/NN of/IN the/DT promotorless/JJ chloramphenicol/NN acetyltranferase/NN (/( CAT/NN )/SYM gene/NN in/IN cells/NNS of/IN pancreatic/JJ origin/NN (/( AR-42J/NNP )/SYM but/CC not/RB in/IN cells/NNS of/IN non-pancreatic/JJ origin/NN (/( Rat/NNP 2/CD and/CC IEC/MULTIGENE 6/MULTIGENE )/SYM ./SYM
@@85761311807/CD We/PRP report/VBP the/DT molecular/JJ cloning/NN and/CC functional/JJ characterization/NN of/IN USF2/MULTIGENE isoforms/MULTIGENE ,/, corresponding/JJ to/IN a/DT 44-kDa/MULTIGENE subunit/MULTIGENE ,/, USF2a/NNP ,/, and/CC a/DT new/JJ 38-kDa/MULTIGENE subunit/MULTIGENE ,/, USF2b/NNP ,/, generated/VBN by/IN differential/JJ splicing/JJ ./.
@@81541718131/CD These/DT issues/NNS include/VBP the/DT use/NN of/IN LMWHs/DT in/NN patients/NNS with/IN arterial/JJ thrombosis/NN or/CC myocardial/JJ infarction/NN (/( e/NN ./NN g/NN ./. in/IN conjunction/NN with/IN thrombolytic/JJ treatment/NN )/SYM ,/, and/CC in/IN patients/NNS with/IN pulmonary/JJ embolism/NN ./.
@@85374039054/CD The/DT protein/MULTIGENE kinase/MULTIGENE domains/MULTIGENE of/IN LIMK1/GENE and/CC LIMK2/GENE are/VBP unique/JJ in/IN that/DT they/PRP contain/VBP an/DT unusual/JJ sequence/NN motif/NN Asp-Leu-Asn-Ser-His-Asn/NNP in/IN subdomain/MULTIGENE VIB/MULTIGENE and/CC a/DT highly/RB basic/JJ insert/NN between/IN subdomains/MULTIGENE VII/MULTIGENE and/CC VIII/NNP ./.
@@86263258273/CD In/NN agreement/NN with/IN previous/JJ in/IN vitro/FW data/NN ,/, we/PRP have/VBP shown/VBP that/IN UmuD/GENE and/CC UmuD'/GENE are/VBP able/JJ to/IN form/NN both/DT homodimers/NNS (/( UmuD-UmuD/NNP and/CC UmuD'-UmuD'/NNP )/SYM and/CC a/DT heterodimer/NN (/( UmuD-UmuD'/NNP )/SYM ./.
@@34276134129/CD In/NNP Salmo/NNP gairdneri/NN ,/, no/DT specialized/JJ system/NN of/IN portal/JJ vessels/NNS appears/VBZ to/IN exist/VB between/IN the/DT pineal/JJ organ/NN and/CC other/DT portions/NNS of/IN the/DT brain/NN ./.
@@2945027797/CD Diagnosis/NNP and/CC treatment/NN planning/NN in/IN Class/MULTIGENE II/MULTIGENE ,/, division/NN 2/CD ./CD
@@82790984658/CD Peripheral/MULTIGENE vitreochorioretinal/MULTIGENE dystrophies/NNS in/IN myopia/NN patients/NNS ./.
@@10518956351/CD ESS/MULTIGENE type/MULTIGENE 1/MULTIGENE ,/, with/IN FT3/GENE low/NN and/CC FT4/NN and/CC TSH/NN normal/JJ ,/, is/VBZ the/DT most/RB frequent/VB form/NN ./.
@@5538588580/CD Although/IN Grice's/NN operation/NN has/VBZ been/VBN used/VBN all/DT over/RB the/DT world/NN ,/, no/DT systematic/JJ account/NN of/IN it/PRP has/VBZ been/VBN found/VB in/IN the/DT literature/NN (/( including/JJ publications/NNS dealing/VBG with/IN technique/NN )/SYM ,/, which/WDT presents/VBP it/PRP in/IN terms/NNS related/VBN to/IN the/DT basic/JJ "classical"/JJ principles/NNS on/IN which/WDT the/DT operation/NN was/VBD conceived/VBN ./.
@@82289978206/CD Our/PRP results/NNS indicate/VBP that/DT periseizure/NN lipid/NN accumulation/NN is/VBZ related/VBN to/IN cortical/JJ oxygenation/NN ./.
@@68589672199/CD Serum/NN lactate/MULTIGENE dehydrogenase/MULTIGENE and/CC haptoglobin/NN levels/NNS were/VBD normal/JJ ,/, and/CC total/JJ bilirubin/NN was/VBD only/RB slightly/RB elevated/VBN ./.
@@107022535253/CD During/IN the/DT cloning/NN by/IN reverse/JJ transcriptase-polymerase/JJ chain/NN reaction/NN of/IN the/DT human/JJ HIF-1alpha/NNP subunit/NN ,/, we/PRP isolated/VBD two/JJ cDNA/NN clones/NNS which/WDT corresponded/VBD to/IN alternative/JJ splicing/JJ of/IN the/DT HIF-1alpha/GENE gene/NN ./.
@@115281273783/CD With/IN a/DT GC/NEWGENE content/NN of/IN 45%/VBD the/DT one/PRP segment/NN would/MD correspond/VB to/IN "isochore/NNP H1"/NNP and/CC the/PDT other/DT segment/NN (/( 39%/CD GC/NN in/IN human/JJ ,/, 40%/CD GC/NN in/IN mouse/NN )/SYM to/IN "isochore/NNP L1/NNP //NNP L2"/NNP ./.
@@99871769985/CD Sixty/CD months/NNS after/IN the/DT initial/JJ vaccination/NN ,/, all/DT vaccinees/NNS who/WP received/VBD annual/JJ follow-up/JJ still/RB had/VBP protective/JJ levels/NNS of/IN anti-HAV/NN ./.
@@111936669305/CD This/DT could/MD lead/NN to/IN subsequent/JJ outbreaks/NNS if/IN Babesia/MULTIGENE carrier/MULTIGENE animals/NNS were/VBD to/IN be/VB introduced/VBN into/IN the/DT herd/NN ./.
@@39081964557/CD Shear/JJ bond/NN strength/NN of/IN a/DT composite/JJ resin/NN to/IN an/DT etched/JJ glass/NN ionomer/NN ./.
@@30210503732/CD There/EX were/VBD no/DT interfering/JJ peaks/NNS in/IN the/DT quantitation/NN of/IN sulbactam/NN ./.
@@4145754818/CD Ultrasonic/NN evaluation/NN of/IN renal/JJ calculi/NNS ./.
@@83832873195/CD Since/IN the/DT -172/JJ //JJ -148/JJ element/NN also/RB conferred/VBD estrogen/NN and/CC thyroid/JJ hormone/NN responsiveness/NN ,/, it/PRP can/MD be/VB considered/VBN a/DT composite/JJ hormone/MULTIGENE response/MULTIGENE element/MULTIGENE ./.
@@77917637607/CD Molecular/NNP cloning/NN of/IN an/DT amphibian/NN insulin/MULTIGENE receptor/MULTIGENE substrate/MULTIGENE 1-like/MULTIGENE cDNA/MULTIGENE and/CC involvement/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE in/IN insulin-induced/CD Xenopus/NN oocyte/NN maturation/NN ./.
@@63943477867/CD Hydrallazine/NNP also/RB caused/VBD a/DT slight/JJ increase/NN in/IN plasma/NN renin/NEWGENE activity/NN and/CC urinary/JJ excretion/NN of/IN noradrenaline/NN ./.
@@112875558872/CD The/DT Delta6CCI/NNP virus/NN was/VBD extremely/RB attenuated/VBN in/IN replication/NN capacity/NN yet/RB retained/VBD infectiousness/NN for/IN CEMx174/GENE and/CC MT4/GENE cells/NNS ./.
@@2475717363/CD Tissue/NN necrosis/NN was/VBD evaluated/VBN using/VBG triphenyltetrazolium/NN staining/NN and/CC was/VBD related/VBN to/IN two/JJ major/JJ baseline/MULTIGENE predictors/MULTIGENE of/IN infarct/NN size/NN :/: anatomic/JJ risk/NN zone/NN size/NN and/CC coronary/JJ collateral/JJ flow/NN ./.
@@25754906477/CD Northern/NNP blot/NN analysis/NN revealed/VBD multiple/JJ oIGF-I/MULTIGENE transcripts/MULTIGENE in/IN a/DT broad/JJ band/NN at/IN 800-1/JJ ,/JJ 100/JJ nucleotides/NNS and/CC other/DT transcripts/NNS of/IN higher/JJ molecular/JJ weight/NN in/IN liver/NN ./.
@@2253524008/CD Phenobarbital-induced/JJ alterations/NNS in/IN the/DT metabolism/NN of/IN [/NN 3H/NN ]/NN vitamin/NN D3/GENE by/IN the/DT perfused/VBN rachitic/JJ rat/NN liver/NN in/IN vitro/FW ./.
@@16251319010/CD Therefore/RB ,/, with/IN a/DT biopsy/NN from/IN the/DT stoma/MULTIGENE site/MULTIGENE there/RB is/VBZ a/DT risk/NN of/IN missing/JJ early/JJ rejection/NN ./.
@@102176837000/CD Canalith/GENE repositioning/VBG is/VBZ the/DT mainstay/NN of/IN treatment/NN ./.
@@67262572297/CD Further/RB ,/, the/DT reduction/NN in/IN 5-hydroxytryptophan/NEWGENE (/( 5-HTP/CONTEXTGENE )/SYM accumulation/NN by/IN LSD/NN showed/VBD regional/JJ differences/NNS in/IN inhibition/NN by/IN methiothepin/NN (/( hypothalamus/NN greater/JJR than/IN cortex/NN greater/JJR than/IN striatum/NN )/SYM which/WDT paralleled/VBN the/DT autoreceptor/MULTIGENE antagonist/MULTIGENE activity/NN of/IN methiothepin/NN in/IN vitro/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@98585883855/CD The/DT slower-electrophoretic-mobility/JJ form/NN of/IN p68/GENE was/VBD absent/VB in/IN human/JJ cells/NNS in/IN G1/NN //NN S/NN and/CC appeared/VBN as/IN the/DT cells/NNS entered/VBD G2/NN //NN M/NN ./.
@@21546869054/CD Fragments/NNS containing/JJ the/DT 21-base-pair/JJ repeat/NN region/NN ,/, the/DT enhancer/NN of/IN simian/JJ virus/NN 40/CD or/CC both/DT strongly/RB stimulated/VBN beta-galactosidase/NEWGENE synthesis/NN ,/, and/CC three/CD fragments/NNS from/IN the/DT polyomavirus/NN enhancer/NN region/NN stimulated/VBD moderate/JJ levels/NNS ./.
@@36913163377/CD It/PRP is/VBZ concluded/VBN that/DT contact/NN allergy/NN to/IN K-CG/GENE is/VBZ common/JJ ./.
@@87717877413/CD Characterization/NNS of/IN LRP/NN ,/, a/DT leucine-rich/JJ repeat/NN (/( LRR/NNS )/SYM protein/NN from/IN tomato/NN plants/NNS that/WDT is/VBZ processed/VBN during/IN pathogenesis/NN ./.
@@16532366301/CD We/PRP did/VBD not/RB detect/VB p50/GENE in/IN association/NN with/IN native/JJ glucocorticoid/MULTIGENE receptor/MULTIGENE in/IN L/JJ cells/NNS or/CC with/IN the/DT overexpressed/VBN glucocorticoid/MULTIGENE receptor/MULTIGENE in/IN Chinese/JJ hamster/NN ovary/NN cells/NNS ./.
@@20453667225/CD Hydrophobicity/NNS analysis/NN indicated/VBN that/IN the/DT KlaA/NN and/CC KlaB/MULTIGENE polypeptides/MULTIGENE are/VBP likely/RB to/IN be/VB soluble/JJ ,/, whereas/IN the/DT KlaC/NNP polypeptide/NN was/VBD predicted/VBN to/IN have/NN four/CD potential/JJ membrane-spanning/MULTIGENE domains/MULTIGENE ./.
@@105418655534/CD Therefore/RB ,/, homozygous/JJ co-deletions/NNS of/IN CDKN2A/GENE and/CC CDKN2B/GENE rather/RB than/IN mutations/NNS targeting/JJ individual/JJ transcripts/NNS are/VBP frequently/RB selected/VBN for/IN in/IN these/DT tumors/NNS ./.
@@107971254121/CD To/TO test/VB the/DT hypothesis/NN that/IN progestin-mediated/JJ increases/NNS in/IN resting/JJ core/NN temperature/NN and/CC the/DT core/NN temperature/NN threshold/NN for/IN sweating/NN onset/NN are/VBP counteracted/VBN by/IN estrogen/NN ,/, we/PRP studied/VBD eight/CD women/NNS (/( 24/CD +/NN //NN -/NN 2/CD yr/NN )/SYM at/IN 27/CD degrees/NNS C/MULTIGENE rest/MULTIGENE ,/, during/IN 20/CD min/NN of/IN passive/JJ heating/NN (/( 35/CD degrees/NNS C/NN )/SYM ,/, and/CC during/IN 40/CD min/NN of/IN exercise/NN at/IN 35/CD degrees/NNS C/NNP ./NNP
@@107528079282/CD CONCLUSION/IN :/: Treatment/NNP of/IN sepsis/NN with/IN the/DT platelet-activating/JJ factor/MULTIGENE antagonist/MULTIGENE BB-882/MULTIGENE offers/VBP no/DT advantage/NN over/JJ placebo/NN on/IN survival/NN ,/, hemodynamic/JJ status/NN ,/, respiratory/JJ function/NN ,/, or/CC organ/NN failure/NN scores/NNS ./.
@@10835732642/CD No/DT differences/NNS in/IN total/JJ cholesterol/NN levels/NNS were/VBD observed/VBN between/IN mapuches/NNS and/CC aymaras/NNS ./.
@@4039667570/CD Scintigraphic/NNP visualisation/NN of/IN Walker/NN carcinoma-256/JJ in/IN Sprague-Dawley/NN rats/NNS by/IN means/NN of/IN 99mTc-labelled/GENE monocytes/NNS ./.
@@107949368672/CD The/DT recovery/NN rates/NNS for/IN the/DT MB/CONTEXTGENE //CONTEXTGENE BacT/CONTEXTGENE ,/, MGIT/MULTIGENE 960/MULTIGENE ,/, and/CC solid/JJ media/NN were/VBD 91/CD ./CD 6/CD ,/, 87/CD ./CD 4/CD ,/, and/CC 54/CD ./CD 7%/CD ,/, respectively/RB ,/, for/IN all/DT mycobacteria/NNS ;/: the/DT recovery/NN rates/NNS were/VBD 93/CD ./CD 6/CD ,/, 88/CD ./CD 9/CD ,/, and/CC 63/CD ./CD 4%/CD ,/, respectively/RB ,/, for/IN M/NNP ./NNP tuberculosis/NN complex/NN alone/RB ,/, and/CC 87/CD ./CD 5/CD ,/, 84/CD ./CD 4/CD ,/, and/CC 37/CD ./CD 5%/CD ,/, respectively/RB ,/, for/IN all/DT nontuberculous/JJ mycobacteria/NNS ./.
@@103769914545/CD Ras/NNS is/VBZ not/RB associated/VBN with/IN the/DT tegument/NN ./.
@@77075235199/CD In/NN 293/CD cells/NNS ,/, expression/NN of/IN the/DT NF-kappa/MULTIGENE B/MULTIGENE inhibitor/MULTIGENE ,/, I/MULTIGENE kappa/MULTIGENE B-alpha/IN ,/, reduced/VBD the/DT stimulatory/JJ activity/NN of/IN LMP/NN ./.
@@90322582326/CD Studies/NNS using/VBG HLA-DR-B7-1-LFA-3/GENE triple/JJ transfectants/NNS showed/VBN that/IN the/DT LFA-3-induced/MULTIGENE NF-AT/MULTIGENE DNA/MULTIGENE binding/JJ activity/NN was/VBD negatively/RB regulated/VBN by/IN B7-1/GENE costimulation/NN ./.
@@77429177695/CD Icterus/FW and/CC beta-thalassemia/NN in/IN Congolese/JJ children/NNS in/IN Brazzaville/DT ./.
@@105437275981/CD It/PRP contains/VBZ binding/JJ sites/NNS for/IN several/DT transcription/NN factors/NNS ,/, for/IN example/NN :/: (/( i/NN )/SYM a/DT well-characterized/JJ binding/JJ site/NN for/IN rel/MULTIGENE //MULTIGENE NF-kappaB/MULTIGENE transcription/MULTIGENE factors/MULTIGENE in/IN its/PRP 3'-end/CD (/( the/DT H2TF1/GENE or/CC kappaB1/MULTIGENE element/MULTIGENE )/SYM ,/, (/( ii/NN )/SYM a/DT second/JJ kappaB/MULTIGENE site/MULTIGENE (/( the/DT kappaB2/MULTIGENE element/MULTIGENE )/SYM ,/, which/WDT is/VBZ located/VBN immediately/RB adjacent/JJ 5'/CD to/IN the/DT H2TF1/MULTIGENE element/MULTIGENE and/CC which/WDT is/VBZ recognized/VBN by/IN p65/GENE //GENE relA/GENE in/IN the/DT human/MULTIGENE HLA/MULTIGENE system/NN ,/, and/CC (/( iii/NN )/SYM an/DT AP-1/GENE //GENE ATF/GENE recognition/NN sequence/NN in/IN the/DT 5'/CD end/NN (/( EnA-TRE/NNP )/SYM ./.
@@104165581372/CD PURPOSE/NNS :/: The/DT purposes/NNS of/IN the/DT present/NN study/NN were/VBD to/IN assess/VB the/DT effects/NNS of/IN a/DT 12-wk/JJ laboratory/NN based/VBD aerobic/JJ exercise/NN program/NN on/IN cardiopulmonary/JJ function/NN ,/, CD4/NN cell/NN count/NN ,/, and/CC physician-assessed/JJ health/NN status/NN among/IN symptomatic/JJ pre-AIDS/JJ HIV-infected/JJ individuals/NNS (/( N/JJ =/SYM 28/CD )/SYM and/CC to/IN assess/VB the/DT degree/NN to/IN which/WDT ill/JJ health/NN was/VBD associated/VBN with/IN exercise/NN relapse/NN ./.
@@72029197028/CD Ulcer/NNS appeared/VBN on/IN the/DT angulus/NN of/IN the/DT stomach/NN at/IN the/DT 28th/CD week/NN and/CC resulted/VBN in/IN ulcer/NN scar/NN at/IN the/DT 42nd/CD week/NN ./.
@@30495704988/CD These/DT similarities/NNS suggest/VBP that/IN these/DT E2/MULTIGENE proteins/MULTIGENE are/VBP structurally/RB and/CC evolutionarily/RB related/VBN ./.
@@12804131924/CD Treatment/NNP and/CC staining/NN of/IN smears/NNS and/CC sections/NNS for/IN detection/NN of/IN microorganisms/NNS ./.
@@45794365035/CD Taxonomically/RB significant/JJ colour/NN changes/NNS in/IN Brevibacterium/NNP linens/NNS probably/RB associated/VBN with/IN a/DT carotenoid-like/JJ pigment/NN ./.
@@41382242281/CD The/DT effect/NN of/IN a/DT tissue/NN emulsion/NN ,/, vitamin/NN A/DT and/CC nonspecific/MULTIGENE gamma-globulin/MULTIGENE on/IN the/DT blood/NN clearance/NN in/IN rabbits/NNS ./.
@@78246574452/CD The/DT enhanced/VBN cysteine/NN formation/NN in/IN a/DT pCSK4F/GENE plant/NN responding/VBG to/IN sulfite/NN was/VBD also/RB observed/VBN in/IN leaf/NN discs/NNS ./.
@@19829975750/CD Examination/NN of/IN immediate-early/NEWGENE transcription/NN factor/NN expression/NN during/IN the/DT MDI/NN regimen/NN revealed/VBD that/DT RA/NEWGENE mediated/JJ an/DT elevated/VBN ,/, prolonged/JJ expression/NN of/IN c-Jun/MULTIGENE mRNA/MULTIGENE accompanied/VBN by/IN diminished/JJ expression/NN of/IN c-Fos/GENE and/CC Jun-B/MULTIGENE mRNAs/MULTIGENE ./.
@@19072653282/CD Consistent/JJ with/IN the/DT in/NN vivo/NN result/NN ,/, the/DT pseudorevertant/NN endonucleases/NNS in/IN the/DT crude/JJ cell/NN extract/NN display/NN site-specific/JJ partial/JJ DNA/NN cleavage/NN activity/NN ./.
@@77547136218/CD Six/CD of/IN them/PRP ,/, NUC1/GENE ,/, PRP21/GENE (/( also/RB called/VBN SPP91/GENE )/SYM ,/, CDC6/NEWGENE ,/, CRY2/GENE ,/, the/DT gene/NN encoding/VBG the/DT ribosomal/MULTIGENE protein/MULTIGENE S24/MULTIGENE and/CC the/DT gene/NN coding/JJ for/IN a/DT hypothetical/JJ protein/NN of/IN 599/CD amino/JJ acids/NNS ,/, have/VB been/VBN sequenced/VBN previously/RB ./.
@@109586989400/CD The/DT spacing/NN of/IN the/DT essential/JJ N-terminal/NN domain/NN (/( END/NN )/SYM relative/JJ to/IN the/DT HFD/WDT can/MD be/VB changed/VBN significantly/RB without/IN an/DT apparent/JJ effect/NN on/IN Cse4p/GENE function/NN ./.
@@97106153998/CD Vam7p/GENE ,/, a/DT SNAP-25-like/MULTIGENE molecule/MULTIGENE ,/, and/CC Vam3p/GENE ,/, a/DT syntaxin/MULTIGENE homolog/MULTIGENE ,/, function/NN together/RB in/IN yeast/NN vacuolar/JJ protein/NN trafficking/NN ./.
@@76513986477/CD A/DT potential/JJ binding/JJ site/NN for/IN the/DT dShc/MULTIGENE PTB/MULTIGENE domain/NN is/VBZ located/VBN at/IN Tyr-1228/NN of/IN DER/NN ./.
@@93716226425/CD Chimeras/NNS containing/MULTIGENE IE1/MULTIGENE peptides/MULTIGENE dramatically/RB activated/VBN transcription/NN of/IN the/DT basal/JJ promoter/NN only/RB when/CC lac/NN operator/NN sequences/NNS were/VBD present/VB ./.
@@104600154478/CD After/IN 10/CD months/NNS of/IN treatment/NN with/IN the/DT conjugated/MULTIGENE estrogen/MULTIGENE ,/, both/DT his/PRP height/NN and/CC weight/NN showed/VBD improvement/NN ,/, while/CC his/PRP bone/NN mineral/JJ density/NN and/CC bone/NN age/NN were/VBD increased/VBN ./.
@@26845854305/CD Agranulocytosis/NNP treatment/NN with/IN rhGM-CSF/GENE ./.
@@97652716644/CD This/DT sequence/NN is/VBZ very/RB similar/JJ to/IN the/DT insulin/MULTIGENE response/MULTIGENE sequence/MULTIGENE found/VB in/IN the/DT regulatory/JJ region/NN of/IN other/DT genes/NNS negatively/RB regulated/VBN by/IN insulin/NN such/JJ as/IN those/DT encoding/VBG phosphoenolpyruvate/MULTIGENE carboxykinase/MULTIGENE ,/, tyrosine/MULTIGENE aminotransferase/MULTIGENE ,/, and/CC insulin-like/MULTIGENE growth/MULTIGENE factor-binding/MULTIGENE protein/MULTIGENE 1/CD ./CD
@@88976638857/CD Beyond/IN the/DT Tower/NNP of/IN Babel/NNP :/: a/DT nomenclature/NN for/IN suicidology/NN ./.
@@26200853295/CD Animal/NN experimental/JJ and/CC clinical/JJ applications/NNS of/IN plates/NNS ,/, screws/NNS and/CC spinal/JJ segmental/JJ replacement/NN implants/NNS made/VBP of/IN this/DT composite/JJ material/NN have/NN shown/VBP good/JJ results/NNS so/RB far/RB ./.
@@9267542367/CD Naltrexone/GENE has/VBZ been/VBN recently/RB approved/VBN by/IN the/DT Food/NNP and/CC Drug/NNP Administration/NNP for/IN the/DT treatment/NN of/IN alcohol/NN dependence/NN ./.
@@31150873837/CD The/DT mean/JJ weight/NN and/CC height/NN velocities/NNS were/VBD 148%/CD and/CC 122%/CD of/IN the/DT standard/NN ,/, respectively/RB ./.
@@838463540/CD Albumin/NNS and/CC cyclic/JJ AMP/NEWGENE levels/NNS in/IN peritoneal/JJ fluids/NNS in/IN the/DT child/NN ./.
@@74994216676/CD In/NN the/DT present/NN study/NN ,/, we/PRP transiently/RB expressed/VBD in/IN primary/JJ cultures/NNS of/IN rat/NN hepatocytes/NNS plasmids/NNS consisting/VBG of/IN CYP3A1/GENE 5'-flanking/JJ sequences/NNS fused/VBN to/IN a/DT chloramphenicol/NN acetyltransferase/NN reporter/NN plasmid/NN ./.
@@24731565381/CD A/DT cDNA/NN encoding/VBG a/DT new/JJ human/JJ lymphocyte/NN cell/NN surface/NN molecule/NN has/VBZ been/VBN isolated/VBN and/CC shown/VBP to/IN identify/VB a/DT fourth/NN member/NN of/IN a/DT recently/RB discovered/VBN family/NN of/IN adhesion/NN proteins/NNS ./.
@@112876238717/CD Here/RB we/PRP demonstrate/VBP that/IN the/DT Ras-activated/JJ Raf-MEK-extracellular/JJ signal-regulated/MULTIGENE kinase/MULTIGENE (/( ERK/CONTEXTGENE )/SYM signaling/JJ pathway/NN can/MD specifically/RB control/VB the/DT expression/NN of/IN individual/JJ integrin/MULTIGENE subunits/MULTIGENE in/IN a/DT variety/NN of/IN human/NN and/CC mouse/NN cell/NN lines/NNS ./.
@@96196311972/CD RESULTS/NNS :/: We/PRP isolated/VBD a/DT C/NNP ./NNP elegans/NNS cDNA/NN that/IN encoded/VBN a/DT protein/NN which/WDT was/VBD similar/JJ to/IN ,/, but/CC not/RB exactly/RB homologous/JJ with/IN mammalian/JJ p120/MULTIGENE Ras-GAP/MULTIGENE ./.
@@21232937203/CD Petko/NNP ,/, and/CC S/NNP ./NNP
@@37954884478/CD Among/IN 82/CD superficial/JJ lesions/NNS 34/CD were/VBD classified/VBN as/IN showing/VBG CR/NN and/CC another/DT 23/CD as/IN showing/VBG PR/NNP ,/, with/IN a/DT response/NN rate/NN of/IN 69/CD ./CD 5%/CD ./.
@@91694206786/CD The/DT mammalian/JJ phosphoinositide/MULTIGENE 3-kinases/MULTIGENE (/( PI3Ks/GENE )/SYM p110alpha/GENE ,/, beta/NN ,/, and/CC delta/JJ form/NN heterodimers/NNS with/IN Src/MULTIGENE homology/MULTIGENE 2/MULTIGENE (/( SH2/GENE )/SYM domain-containing/MULTIGENE adaptors/MULTIGENE such/JJ as/IN p85alpha/GENE or/CC p55/CONTEXTGENE (/CONTEXTGENE PIK/CONTEXTGENE )/CONTEXTGENE ./.
@@28954729384/CD Transformed/JJ bacterial/JJ colonies/NNS were/VBD screened/VBN for/IN recombinant/JJ plasmids/NNS containing/MULTIGENE cDNA/MULTIGENE coding/JJ for/IN BiP/NN by/IN hybrid-selected/JJ mRNA/NN translation/NN ./.
@@40710632048/CD Although/IN no/DT differences/NNS were/VBD noted/VBN in/IN the/DT decrease/NN in/IN platelet/NN counts/NNS between/IN the/DT two/JJ groups/NNS ,/, fibrinogen/NEWGENE levels/NNS and/CC alpha/MULTIGENE 2-antiplasmin/MULTIGENE levels/NNS declined/VBN less/PRP drastically/RB in/IN the/DT antithrombin-treated/JJ group/NN ./.
@@79353836907/CD Using/VBG an/DT RNase/NN H-mediated/JJ mapping/NN technique/NN ,/, we/PRP show/VBP that/IN the/DT 64-kDa/MULTIGENE subunit/MULTIGENE of/IN CstF/GENE can/MD be/VB photo/NN cross-linked/VBN to/IN pre-mRNAs/NNS at/IN U-rich/NNP regions/NNS located/VBN downstream/RB of/IN the/DT cleavage/NN site/NN of/IN the/DT simian/JJ virus/NN 40/CD late/JJ and/CC adenovirus/NN L3/MULTIGENE pre-mRNAs/MULTIGENE ./.
@@71819856663/CD Either/CC 20/CD mg/NN mitomycin/GENE //GENE 20/GENE ml/NN distilled/JJ water/NN or/CC 40/CD mg/CD //CD 40/CD ml/NN distilled/JJ water/NN was/VBD locally/RB instilled/VBN into/IN the/DT bladder/NN with/IN a/DT catheter/NN after/IN emptying/NN it/PRP and/CC was/VBD left/NN for/IN about/RB 25-l20/JJ min/NN ./.
@@76047947504/CD Total/JJ cholesterol/NN was/VBD also/RB reduced/VBN at/IN week/NN 12/CD by/IN 17/CD ./CD 0%/CD (/( 20/CD mg/NN //NN day/NN )/SYM and/CC 15/CD ./CD 7%/CD (/( 20-30/CD mg/NN //NN day/NN )/SYM ,/, and/CC at/IN week/NN 52/CD by/IN 20/CD ./CD 4%/CD (/( </SYM or/CC =/SYM 20/CD mg/NN //NN day/NN )/SYM and/CC 19/CD ./CD 2%/CD (/( >/SYM or/CC =/SYM 30/CD mg/NN //NN day/NN )/SYM ./.
@@1873999720/CD Saccharomyces/NN cerevisiae/NN has/VBZ been/VBN used/VBN widely/RB both/DT as/IN a/DT model/NN system/NN for/IN unraveling/VBG the/DT biochemical/NN ,/, genetic/JJ ,/, and/CC molecular/JJ details/NNS of/IN gene/NN expression/NN and/CC the/DT secretion/NN process/NN ,/, and/CC as/IN a/DT host/NN for/IN the/DT production/NN of/IN heterologous/JJ proteins/NNS of/IN biotechnological/JJ interest/NN ./.
@@22295412871/CD Giant/NNP pilomatrix/NN carcinoma/NN :/: report/VB and/CC review/NN of/IN the/DT literature/NN ./.
@@89774013498/CD The/DT RI/MULTIGENE alpha/MULTIGENE gene/MULTIGENE is/VBZ composed/VBN of/IN nine/JJ coding/JJ exons/NNS of/IN varying/JJ lengths/NNS ,/, separated/VBN by/IN introns/NNS ,/, giving/JJ the/DT gene/NN a/DT total/JJ length/NN of/IN at/IN least/RB 21/CD kb/CD ./CD our/PRP recent/JJ cloning/NN of/IN a/DT processed/VBN RI/MULTIGENE alpha/MULTIGENE pseudogene/NN with/IN a/DT 5'-noncoding/JJ region/NN different/JJ from/IN the/DT previously/RB reported/VBN RI/MULTIGENE alpha/MULTIGENE complementary/JJ RNA/NN indicated/VBN that/IN the/DT RI/MULTIGENE alpha/MULTIGENE gene/MULTIGENE may/MD have/VB multiple/JJ leader/NN exons/NNS giving/JJ rise/NN to/IN alternately/RB spliced/VBN messenger/NN RNAs/NNS (/( mRNAs/NNS )/SYM ./.
@@97817615910/CD 1/CD in/IN Ho/MULTIGENE Chi/MULTIGENE Minh/NNP City/NNP was/VBD studied/VBN by/IN culture/NN and/CC latex/NN agglutination/NN of/IN blood/NN ,/, cerebrospinal/JJ fluid/NN ,/, urine/NN and/CC pleural/JJ fluid/NN ./.
@@111253631225/CD Patients/NNS underwent/VBD pretreatment/JJ cystoscopy/NN and/CC detailed/JJ tumor/NN mapping/NN ,/, and/CC were/VBD treated/VBN with/IN 75/MULTIGENE mg/MULTIGENE ./MULTIGENE //CD m/CD ./CD 2/CD cisplatin/NN on/IN day/NN 1/CD and/CC 1/CD gm/CD ./CD //CD m/CD ./CD 2/CD daily/JJ ,/, 5-fluorouracil/GENE on/IN days/NNS 1/CD to/IN 4/CD and/CC definitive/JJ radiotherapy/NN ./.
@@84157126902/CD Genomic/NNP Southern/NNP blot/NN analysis/NN and/CC chromosome/NN mapping/NN showed/VBN that/IN GPRK6/GENE hybridizes/VBZ to/IN two/JJ closely/RB related/VBN genes/NNS located/VBN on/IN chromosomes/NNS 5/CD and/CC 13/CD and/CC are/VBP ,/, therefore/RB ,/, distinct/JJ from/IN the/DT GPRK/GENE located/VBN near/IN the/DT Huntington/NN disease/NN locus/NN on/IN chromosome/NN 4/CD ./CD
@@90946712938/CD Candidate/NNS tumor/NN suppressor/NN genes/NNS ,/, Mts1/GENE (/( p16INK4a/GENE )/SYM and/CC Mts2/GENE (/( p15INK4b/GENE )/SYM ,/, have/VB been/VBN mapped/VBN to/IN this/DT region/NN ,/, but/CC by/IN Southern/NNP blot/NN analysis/NN ,/, no/DT homozygous/JJ deletions/NNS were/VBD detected/VBN in/IN either/DT gene/NN ./.
@@118994891809/CD The/DT effects/NNS of/IN pharmacological/JJ treatment/NN and/CC professional/JJ care/NN and/CC support/NN may/MD improve/VB when/CC dementia/NN is/VBZ detected/VBN in/IN an/DT early/JJ stage/NN ./.
@@68106942357/CD Apo/MULTIGENE A-I/MULTIGENE level/NN was/VBD unrelated/JJ to/IN age/NN ,/, but/CC increased/VBD with/IN ethanol/NN consumption/NN and/CC decreased/VBN with/IN adiposity/NN ./.
@@92008115464/CD The/DT linear/JJ plasmid/NN pDHL1/GENE from/IN Debaryomyces/JJ hansenii/NN encodes/VBZ a/DT protein/NN highly/RB homologous/JJ to/IN the/DT pGKL1-plasmid/MULTIGENE DNA/MULTIGENE polymerase/MULTIGENE ./.
@@87709208753/CD Paradoxically/RB ,/, coexpression/NN of/IN the/DT transcriptionally/RB inactive/JJ ,/, amino-terminally/MULTIGENE deleted/MULTIGENE IDX-1/MULTIGENE mutant/MULTIGENE proteins/MULTIGENE ,/, either/DT with/IN the/DT wild-type/MULTIGENE IDX-1/MULTIGENE or/CC with/IN themselves/PRP ,/, results/VBZ in/IN a/DT marked/JJ enhancement/NN of/IN transactivation/NN of/IN the/DT transcriptional/MULTIGENE TAAT-1/MULTIGENE element/MULTIGENE reporter/NN ./.
@@1692135534/CD However/RB ,/, the/DT rtFc/MULTIGENE gamma/MULTIGENE R/MULTIGENE alpha/MULTIGENE cDNA/MULTIGENE clone/MULTIGENE is/VBZ complementary/JJ to/IN at/IN least/RB two/JJ different-sized/JJ mRNAs/NNS expressed/VBN by/IN CRNK-16/NNP cells/NNS ,/, contrasting/JJ the/DT single/MULTIGENE Fc/MULTIGENE gamma/MULTIGENE R-related/MULTIGENE mRNA/MULTIGENE species/NN expressed/VBN by/IN human/NN and/CC mouse/NN natural/JJ killer/NN cells/NNS ./.
@@95292169484/CD Flap/NN survival/NN depends/VBZ on/IN the/DT development/NN of/IN a/DT small/JJ number/NN of/IN vascular/JJ connections/NNS between/IN vessels/NNS arising/VBG from/IN the/DT pedicle/NN and/CC preexisting/JJ dermal/JJ vessels/NNS ./.
@@27052964408/CD The/DT predicted/VBN molecular/JJ weight/NN of/IN the/DT polyprotein/NN encoded/VBN by/IN ORF1/GENE is/VBZ 33/CD kilodaltons/NNS (/( kDa/NN )/SYM ./.
@@69193476697/CD After/IN a/DT year/NN of/IN planning/NN in/IN the/DT Laboratory/NNP Assistants'/NNP School/NNP in/IN Stockholm/NN :/: new/JJ education/NN for/IN laboratory/NN assistants/NNS is/VBZ now/RB arranged/VBN ./.
@@103640766656/CD These/DT regions/NNS contain/VBP inverted/JJ E-box/NNS palindromic/JJ or/CC direct/JJ repeat/NN motifs/NNS and/CC bind/VB SREBP-1/GENE with/IN different/JJ affinities/NNS ./.
@@33718064301/CD Electronic/NNP data/NN processing/VBG (/( EDP/NN )/SYM latex/NN immunoassay/NN using/VBG anti-human/JJ seminal/JJ acid/MULTIGENE phosphatase/MULTIGENE (/( anti-HSAP/CONTEXTGENE )/SYM immune/JJ serum/NN was/VBD applied/VBN for/IN the/DT species/NN and/CC organ/NN identification/NN of/IN human/JJ seminal/JJ stains/NNS ./.
@@27316113420/CD The/DT author/NN provides/VBZ a/DT rationale/NN for/IN an/DT interactional/JJ view/NN and/CC presents/VBP a/DT case/NN in/IN which/WDT post-surgical/JJ hiccups/NNS were/VBD successfully/RB treated/VBN ,/, using/VBG principles/NNS developed/VBN by/IN the/DT Mental/NNP Research/NNP Institute/NNP ./.
@@78570866588/CD Near/IN a/DT third/RB (/( 31/CD ./CD 6%/CD )/SYM of/IN Insulin/NNP Dependent/NNP and/CC a/DT third/RB (/( 33/CD ./CD 41%/CD )/SYM for/IN Non/MULTIGENE Insulin/MULTIGENE Dependent/NNP were/VBD of/IN D/NN ,/, F/NN ,/, H/NNP White's/NNP Class/NNP ./.
@@82991818275/CD Subretinal/JJ fluid/NN was/VBD punctured/VBN on/IN the/DT poorer/JJR eye/NN in/IN 19/CD eyes/NNS (/( 52/CD ./CD 7%/CD )/SYM and/CC on/IN the/DT better/JJR eye/NN in/IN 7/CD eyes/NNS (/( 19/CD ./CD 4%/CD )/SYM ./.
@@39523877525/CD In/NN each/DT compartment/NN O2/GENE is/VBZ removed/VBN by/IN the/DT tissues/NNS as/IN a/DT chemical/JJ reaction/NN takes/VBP place/NN between/IN O2/GENE and/CC oxyhemoglobin/NN (/( HbO2/GENE )/SYM ./.
@@75962835211/CD Additionally/RB ,/, the/DT enzyme/NN shows/VBZ activity/NN towards/IN triglycerides/NNS such/JJ as/IN olive/JJ oil/NN and/CC tributyrin/NN and/CC towards/IN egg-yolk/NN emulsions/NNS ./.
@@71379276945/CD In/NN the/DT past/NN ,/, immunology/NN in/IN Singapore/NN was/VBD mainly/RB confined/VBN to/IN serology/NN for/IN the/DT diagnosis/NN of/IN certain/JJ infectious/JJ diseases/NNS ./.
@@46531445078/CD General/NNP formulae/NNS for/IN estimating/VBG heritability/NN in/IN a/DT population/NN with/IN related/VBN parents/NNS ./.
@@74746172017/CD Patients/NNS with/IN psychotropic/JJ drugs/NNS showed/VBD significantly/RB higher/JJ PRL/NEWGENE levels/NNS ./.
@@10374632246/CD The/DT potency/NN of/IN the/DT effect/NN of/IN Nim/NNP (/( 0/CD ./CD 5/CD mg/CD ./CD kg-1/CD i/CD ./CD p/CD ./CD )/SYM was/VBD similar/JJ to/IN that/DT of/IN NBP/CONTEXTGENE (/( 10/MULTIGENE mg/MULTIGENE ./MULTIGENE kg-1/MULTIGENE i/MULTIGENE ./MULTIGENE p/MULTIGENE ./MULTIGENE )/SYM ./.
@@112358178457/CD The/DT histamine/MULTIGENE H1/MULTIGENE receptor/MULTIGENE antagonists/NNS (/( antihistamines/NNS )/SYM are/VBP an/DT important/JJ class/NN of/IN medications/NNS used/VBN for/IN the/DT relief/NN of/IN common/JJ symptoms/NNS associated/VBN with/IN hyperhistaminic/JJ conditions/NNS occurring/VBG in/IN children/NNS and/CC adults/NNS ./.
@@61588442498/CD Thalamotomy/NNP aiming/VBG at/IN the/DT CM-Pf/MULTIGENE complex/MULTIGENE and/CC using/VBG stereotactic/JJ gamma/JJ irradiation/NN has/VBZ been/VBN performed/VBN in/IN a/DT series/NN of/IN 52/CD patients/NNS with/IN severe/JJ pain/NN due/NN to/IN malignancy/NN ./.
@@98202055043/CD The/DT zona/NN pellucida/NN (/( ZP/NN )/SYM ,/, the/DT extracellular/JJ glycocalyx/NN that/WDT surrounds/VBZ the/DT oocyte/NN ,/, is/VBZ well/VB known/VBP to/IN mediate/VB homologous/JJ gamete/NN interaction/NN ./.
@@90969583046/CD We/PRP have/VBP characterized/VBN a/DT panel/NN of/IN 6/CD monoclonal/JJ antibodies/NNS raised/VBN against/IN human/MULTIGENE platelet/MULTIGENE talin/MULTIGENE by/IN Western/JJ blotting/NN ,/, immune/JJ precipitation/NN ,/, and/CC immunofluorescence/NN ,/, and/CC shown/VBP that/IN antibodies/MULTIGENE TA205/MULTIGENE and/CC TD77/GENE disrupt/VB actin/NN stress/NN fibers/NNS and/CC focal/JJ adhesions/NNS ,/, and/CC inhibit/VB cell/NN motility/NN when/CC microinjected/VBN into/IN human/JJ fibroblasts/NNS ./.
@@107470533826/CD The/DT cell/NN cycle/NN and/CC transcriptional/JJ defects/NNS caused/VBN by/IN taf17/NN (/NN slm7-1/NN )/NN are/VBP consistent/JJ with/IN the/DT role/NN of/RB TAF/NN (/NN II/NN )/NN s/NN as/IN modulators/NNS of/IN transcriptional/JJ activation/NN and/CC may/MD reflect/VB a/DT role/NN for/IN TAF17/NEWGENE in/IN regulating/JJ activation/NN by/IN SBF/GENE and/CC MBF/GENE ./.
@@104007574282/CD These/DT data/NN will/MD help/NN us/PRP to/IN better/JJR detail/NN the/DT CXCR4/NEWGENE structural/JJ requirements/NNS exhibited/VBN by/IN different/JJ HIV-1/NNP strains/NNS and/CC will/MD direct/VB further/JJ mutagenesis/NN efforts/NNS aimed/VBN at/IN better/JJR defining/VBG the/DT domains/NNS in/IN CXCR4/NEWGENE involved/VBN in/IN the/DT HIV-1/MULTIGENE Env-mediated/MULTIGENE fusion/MULTIGENE process/NN ./.
@@82269563170/CD There/EX was/VBD no/DT apparent/JJ effect/NN of/IN growth/NN temperature/NN on/IN the/DT steady-state/JJ levels/NNS of/IN fad7/MULTIGENE mRNA/MULTIGENE in/IN wild/JJ type/NN plants/NNS ./.
@@114633592802/CD Here/RB ,/, we/PRP show/VBP that/IN the/DT phorbol/NN ester/NN PMA/NN decreases/VBZ both/DT basal/JJ and/CC dexamethasone/JJ //JJ cAMP-induced/JJ expression/NN of/IN a/DT luciferase/MULTIGENE gene/MULTIGENE under/IN the/DT control/NN of/IN the/DT G6Pase/MULTIGENE promoter/MULTIGENE in/IN transiently/RB transfected/VBN H4IIE/NNP hepatoma/NN cells/NNS ./.
@@107912513697/CD They/PRP are/VBP present/VB in/IN many/JJ kinds/NNS of/IN living/VBG things/NNS ,/, but/CC their/PRP functions/NNS ,/, especially/RB those/DT in/NN humans/NNS ,/, are/VBP unclear/JJ ./.
@@75924399631/CD A511/GENE is/VBZ a/DT broad-host-range/NN ,/, virulent/JJ myovirus/NN for/IN Listeria/NN monocytogenes/NNS ./.
@@21512297078/CD Regional/NNP cerebral/JJ blood/NN flow/NN was/VBD measured/VBN using/VBG N-isopropyl-123I-iodoamphetamine/NNP with/IN single-photon/VB emission/NN computed/JJ tomography/NN (/( CT/NN )/SYM in/IN 16/CD aged/VBN patients/NNS with/IN noninsulin-dependent/JJ diabetes/NN mellitus/MD (/( NIDDM/NN ,/, average/JJ age/NN 72/CD ./CD 8/CD years/NNS ,/, average/JJ fasting/JJ plasma/NN glucose/NN 7/NN ./NN 7/NN mmol/NN //NN L/NN )/SYM ,/, and/CC 12/CD nondiabetic/JJ subjects/NNS (/( 71/CD ./CD 6/CD years/NNS ,/, 5/CD ./CD 3/CD mmol/NN //NN L/NN )/SYM ./.
@@105682755722/CD The/DT role/NN of/IN transport/NN by/IN sea/MULTIGENE ice/MULTIGENE from/IN the/DT Kara/NNP Sea/NNP into/IN the/DT Arctic/NNP Ocean/NNP was/VBD assessed/VBN by/IN a/DT small/MULTIGENE subgroup/MULTIGENE at/IN GEOMAR/GENE ./.
@@113890851072/CD Inhibition/NNS of/IN constitutive/JJ NF-kappaB/GENE activity/NN results/NNS in/IN cell/NN death/NN of/IN TT/NN cells/NNS and/CC blocks/NNS focus/NN formation/NN induced/VBN by/IN oncogenic/JJ forms/NNS of/IN RET/DT in/NN NIH/NN 3T3/CD cells/NNS ./.
@@93580692028/CD Codon/VBP optimization/NN for/IN high-level/JJ expression/NN of/IN human/MULTIGENE erythropoietin/MULTIGENE (/( EPO/CONTEXTGENE )/SYM in/IN mammalian/JJ cells/NNS ./.
@@98191103665/CD CD4/NEWGENE lymphocyte/NN and/CC viral/JJ load/NN levels/NNS suggested/VBD an/DT optimal/JJ response/NN to/IN ARV/NN therapy/NN at/IN the/DT time/NN LD/JJ developed/VBN ./.
@@55726625605/CD Central/NNP venous/JJ catheter/NN used/VBN for/IN recording/JJ intracardiac/JJ electrocardiogram/NN ./.
@@86630002011/CD The/DT receptor/NN for/IN hyaluronan/NN mediated/JJ motility/NN (/( RHAMM/NNP )/SYM gene/NN expression/NN is/VBZ markedly/RB elevated/VBN in/IN fibrosarcomas/NNS exposed/VBN to/IN transforming/JJ growth/NN factor-beta1/GENE (/( TGF-beta1/GENE )/SYM ./.
@@80898877205/CD SECONDARY/GENE OUTCOME/NNP MEASURE--Double-blind/GENE caffeine-withdrawal/JJ evaluation/NN ./.
@@80078353066/CD A/DT causal/JJ analysis/NN of/IN secondary/JJ variables/NNS showed/VBN that/IN the/DT formation/NN of/IN FB/GENE memories/NNS was/VBD primarily/RB associated/VBN with/IN the/DT level/NN of/IN importance/NN attached/VBN to/IN the/DT event/NN and/CC level/NN of/IN affective/JJ response/NN to/IN the/DT news/NN ./.
@@48715895216/CD Plastic/JJ solution/NN of/IN elbow/NN joint/JJ ankylosis/NN with/IN a/DT decorticated/JJ cylindrical/JJ flap/NN ./.
@@85266204917/CD This/DT study/NN underlines/VBP the/DT importance/NN of/IN terminal/MULTIGENE SC5b-9/MULTIGENE complement/MULTIGENE complex/MULTIGENE as/IN a/DT suitable/JJ marker/NN in/IN the/DT evaluation/NN of/IN complement/NN activation/NN during/IN cardiopulmonary/JJ bypass/NN ./.
@@102155942883/CD Glucagon/IN also/RB induced/VBN LUC/NN activity/NN very/RB strongly/RB when/CC the/DT CRE1/GENE and/CC CRE2/MULTIGENE sites/MULTIGENE were/VBD combined/JJ ;/: induction/NN of/IN the/DT (/( CRE1/GENE )/NN 3/NN (/NN CRE2/NN )/NN 2SV40-LUC/NN constructs/NNS was/VBD positively/RB modulated/VBN by/IN the/DT pO2/NN ./.
@@53094715465/CD Problems/NNS in/IN the/DT determination/NN of/IN the/DT antigenic/JJ content/NN of/IN influenza/NN vaccines/NNS ./.
@@97944145447/CD The/DT role/NN of/IN protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE signaling/JJ in/IN activated/VBN DRA/NEWGENE transcription/NN ./.
@@38660858048/CD It/PRP is/VBZ concluded/VBN that/IN the/DT unique/JJ suppository/NN formulation/NN of/IN CZX-S/GENE is/VBZ useful/JJ in/IN the/DT treatment/NN of/IN infections/NNS in/IN children/NNS with/IN heavy/JJ psychophysiologic/JJ disorders/NNS and/CC in/IN children/NNS who/WP cannot/MD take/VB oral/JJ drugs/NNS because/IN of/IN severe/JJ vomiting/NN ./.
@@94639919420/CD Training/NNP for/IN audit/NN ./.
@@92524068459/CD Tyrosine/NN 1356/CD forms/VBZ a/DT multisubstrate/MULTIGENE binding/MULTIGENE site/MULTIGENE for/IN the/DT Grb2/GENE and/CC Shc/MULTIGENE adaptor/MULTIGENE proteins/MULTIGENE ,/, the/DT p85/MULTIGENE subunit/MULTIGENE of/IN phosphatidylinositol/NN 3'-kinase/CD ,/, phospholipase/NN Cgamma/NNS ,/, and/CC a/DT phosphatase/NN ,/, SHP2/GENE ./.
@@10330146745/CD In/NN the/DT case/NN of/IN the/DT unspliceable/JJ intron/NN ,/, repression/NN of/IN luciferase/NEWGENE expression/NN likely/RB involved/VBD two/JJ AUF1-binding/MULTIGENE sequences/MULTIGENE ,/, since/IN luciferase/NEWGENE expression/NN was/VBD increased/VBN by/IN deletion/NN of/IN these/DT sites/NNS ./.
@@95922087843/CD Amongst/IN other/DT qualities/NNS ,/, the/DT book's/NNS importance/NN lies/NNS in/IN the/DT fact/NN that/IN it/PRP associates/VBP an/DT elaborate/JJ theoretical/JJ construction/NN with/IN the/DT empirical/JJ data/NN ,/, working/JJ within/IN the/DT possibilities/NNS provided/VBN by/IN late/JJ 19th-century/NN moral/JJ statistics/NN ./.
@@27171333407/CD A/DT method/NN for/IN determining/JJ optimal/JJ development/NN conditions/NNS by/IN summary/NN oxygen/NN consumption/NN ./.
@@95868321798/CD The/DT lines/NNS also/RB differed/VBN in/IN postsynaptic/JJ ,/, but/CC not/RB presynaptic/JJ ,/, 5-HT1A/MULTIGENE receptors/MULTIGENE ./.
@@76072139982/CD This/DT apparently/RB anomalous/JJ structure/NN //NN activity/NN relationship/NN raises/VBP important/JJ issues/NNS for/IN understanding/VBG the/DT evolution/NN of/IN regulatory/JJ peptides/NNS and/CC the/DT mechanisms/NNS that/WDT control/VBP their/PRP expression/NN ./.
@@34493584156/CD Ultrastructural/JJ study/NN of/IN polyarteritis/NN ./.
@@52532745435/CD Osteosarcoma/NNS caused/VBN by/IN 3/NN ,/NN 4-benzopyrene/NN ./.
@@14938641439/CD Dopamine/IN neurons/NNS in/IN subjects/NNS that/WDT received/VBD 6-OHDA/GENE were/VBD protected/VBN by/IN pre-treatment/NN with/IN GBR-12909/CD ./.
@@103929034791/CD E2/GENE point/NN mutants/NNS unable/JJ to/IN inhibit/VB cell/NN growth/NN did/VBD not/RB repress/VB cdc25A/GENE and/CC cdc25B/GENE expression/NN ,/, nor/CC did/VBD the/DT cell/NN cycle/NN inhibitors/NNS hydroxyurea/NN and/CC mimosine/NN ./.
@@110421977731/CD Lys/NN (/NN 193/NN )/NN and/CC Arg/NN (/NN 194/NN )/NN ,/, located/VBN at/IN the/DT COOH-terminal/NN end/NN of/IN HD/NN ,/, are/VBP essential/JJ for/IN dimerization/NN ./.
@@8299896203/CD Regression/NNS line/NN slopes/NNS of/IN IBDQ/GENE scores/NNS were/VBD significantly/RB different/JJ in/IN patients/NNS who/WP deteriorated/VBD from/IN those/DT who/WP remained/VBD stable/JJ (/( [/NN b/NN ]/NN </SYM 0/CD ./CD 15/CD ;/: P/NN </SYM 0/CD ./CD 0001/CD )/SYM ./.
@@84744383779/CD A/DT variety/NN of/IN nuclear/JJ ribonucleoproteins/NNS are/VBP believed/VBN to/IN associate/NN directly/RB with/IN nascent/JJ RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE transcripts/MULTIGENE and/CC remain/VB associated/VBN during/IN subsequent/JJ nuclear/JJ RNA/NN processing/VBG reactions/NNS ,/, including/JJ pre-mRNA/NN polyadenylation/NN and/CC splicing/JJ as/RB well/VB as/IN nucleocytoplasmic/JJ mRNA/NN transport/NN ./.
@@16889727752/CD Inducible/MULTIGENE VT/MULTIGENE was/VBD suppressed/VBN entirely/RB in/IN one/PRP patient/NN ./.
@@96681194402/CD Electrophoretic/JJ mobility/NN shift/NN assays/NNS demonstrated/VBD specific/JJ nuclear/JJ protein/NN binding/JJ to/IN -85/JJ //JJ -64/JJ ,/, and/CC single/JJ point/NN mutations/NNS suggested/VBD important/JJ binding/JJ nucleotides/NNS between/IN -79/CD //CD -68/CD with/IN five/CD critical/JJ bases/NNS between/IN -74/JJ //JJ -70/JJ (/( 5'-CTCCT-3'/JJ )/SYM ./.
@@77999396142/CD The/DT 27-base/JJ element/NN interacts/VBZ with/IN a/DT PDGF-activated/MULTIGENE serine/MULTIGENE //MULTIGENE threonine/MULTIGENE phosphoprotein/MULTIGENE that/WDT is/VBZ detected/VBN only/RB within/IN the/DT nucleus/NN of/IN PDGF-treated/JJ 3T3/CD cells/NNS ./.
@@79879248045/CD The/DT inflation/NN hub/NN of/IN the/DT probe/NN is/VBZ recreated/VBN by/IN modifying/JJ a/DT standard/JJ USCI/NNP Tuohy-Borst/NNP Y/MULTIGENE adaptor/MULTIGENE and/CC attaching/JJ this/DT to/IN the/DT transected/VBN probe/NN hypotube/NN ./.
@@31042457139/CD The/DT 8/CD patients/NNS receiving/JJ Ir192/GENE implant/NN in/IN addition/NN to/IN external/NN radiation/NN showed/VBD improved/VBN (/( p/NN =/SYM 0/CD ./CD 06/CD )/SYM survival/NN compared/VBN to/IN the/DT 9/CD receiving/JJ external/NN only/RB :/: median/JJ 15/CD months/NNS (/( range/NN 1/CD ./CD 5-34/CD +/SYM months/NNS )/SYM versus/IN 7/CD months/NNS (/( range/NN 2/CD ./CD 5-21/CD months/NNS )/SYM ./.
@@108893993827/CD The/DT detection/NN success/NN rate/NN was/VBD determined/VBN for/IN different/JJ markers/NNS using/VBG this/DT MEK/GENE ./.
@@110402195170/CD Binding/NN of/IN NusA/NN to/IN RNA/NN in/IN the/DT presence/NN of/IN alpha/NN or/CC N/NN involves/VBZ an/DT amino-terminal/MULTIGENE S1/MULTIGENE homology/MULTIGENE region/MULTIGENE that/WDT is/VBZ otherwise/RB inactive/JJ in/IN full-length/JJ NusA/NN ./.
@@70649238833/CD Diagnosis/NNP of/IN phenylalanine/MULTIGENE hydroxylase/MULTIGENE deficiency/NN (/( phenylketonuria/NN )/SYM ./.
@@25477783045/CD The/DT unique/JJ nature/NN and/CC arrangement/NN of/IN the/DT ANT1/MULTIGENE transcriptional/MULTIGENE control/MULTIGENE elements/MULTIGENE may/MD account/VB for/IN this/DT differential/JJ expression/NN ./.
@@76542397115/CD Max/NNP was/VBD constantly/RB transcribed/VBN at/IN a/DT relatively/JJ low/JJ level/NN during/IN cell/NN cycle/NN progression/NN ./.
@@106584457061/CD METHODS/IN :/: The/DT former/JJ group/NN included/VBD patients/NNS who/WP had/VBP been/VBN treated/VBN with/IN at/IN least/RB four/CD PGE1/MULTIGENE alpha-ciclodestrina/MULTIGENE ,/, short-term/JJ treatment/NN cycles/NNS per/IN year/NN while/CC the/DT latter/NN was/VBD a/DT historical/JJ reference/NN group/NN managed/VBN without/IN prostaglandins/NNS ./.
@@76518358121/CD However/RB ,/, the/DT relative/JJ binding/JJ affinity/NN for/IN the/DT motifs/NNS is/VBZ different/JJ ./.
@@89271698837/CD In/NN 1993/CD and/CC 1994/CD and/CC infection/NN with/IN body/NN lice/NN was/VBD registered/VBN 41/CD times/NNS in/IN 31/CD patients/NNS at/IN the/DT clinic/NN for/IN homeless/NN of/IN the/DT Community/NNP Health/NNP Service/NNP of/IN Utrecht/NNP ./.
@@98228257566/CD In/NN this/DT paper/NN ,/, we/PRP show/VBP that/IN ,/, like/JJ BAP2/GENE ,/, the/DT expression/NN of/IN the/DT BAP3/MULTIGENE gene/MULTIGENE in/IN S/NNP ./NNP cerevisiae/NN is/VBZ induced/VBN by/IN the/DT addition/NN of/IN branched-chain/JJ amino/JJ acids/NNS to/IN the/DT medium/NN ./.
@@37492264417/CD When/WRB phencyclidine/NN was/VBD administered/VBN alone/RB ,/, overall/JJ response/NN rate/NN decreased/VBN and/CC percent/NN errors/NNS increased/VBN with/IN increasing/JJ doses/NNS ./.
@@74769751947/CD The/DT number/NN of/IN lactotropes/NNS ,/, somatotropes/NNS ,/, thyrotropes/NNS ,/, and/CC gonadotropes/NNS was/VBD not/RB altered/VBN compared/VBN with/IN controls/NNS ,/, indicating/VBG that/IN in/IN the/DT adult/JJ pituitary/NN ,/, POMC/MULTIGENE products/MULTIGENE are/VBP not/RB required/VBN to/IN maintain/VB the/DT distribution/NN of/IN cell/NN types/NNS ./.
@@82267778349/CD A/DT Dictyostelium/DT transformant/NN overexpressing/JJ DdPTPa/GENE does/VBP not/RB develop/VB normally/RB ./.
@@35830014249/CD Using/VBG the/DT balloon-gas/NNS procedure/NN with/IN a/DT single/JJ gas/NN injection/NN ,/, a/DT bubble/NN was/VBD obtained/VBN that/WDT was/VBD large/JJ enough/RB to/IN tamponade/NN a/DT giant/NN tear/NN without/IN prior/NN drainage/NN of/IN subretinal/JJ fluid/NN or/CC vitrectomy/NN ./.
@@18495098856/CD Identification/NNP and/CC nucleotide/NN sequence/NN of/IN Rhizobium/NN meliloti/NN insertion/MULTIGENE sequence/MULTIGENE ISRm3/MULTIGENE :/: similarity/NN between/IN the/DT putative/JJ transposase/NEWGENE encoded/VBN by/IN ISRm3/GENE and/CC those/DT encoded/VBN by/IN Staphylococcus/NN aureus/NN IS256/NNP and/CC Thiobacillus/NN ferrooxidans/VBZ IST2/GENE ./.
@@19096212536/CD Lengthy/NNP and/CC repeated/JJ hemodialyses/NNS were/VBD required/VBN to/IN lower/JJR lithemia/NN to/IN nontoxic/JJ ranges/NNS ./.
@@18637688639/CD The/DT protein/NN encoded/VBN by/IN ORF113/GENE contains/VBZ a/DT transmembrane/JJ domain/NN ./.
@@70622696075/CD When/WRB the/DT l-methadone-sensitive/NN ,/, opioid/MULTIGENE receptor/MULTIGENE is/VBZ blocked/VBN by/IN naloxone/NN or/CC tolerance/NN has/VBZ developed/VBN ,/, than/IN l-methadone/NN can/MD produce/VB behavioral/JJ effects/NNS by/IN a/DT nonopioid/JJ mechanism/NN ./.
@@92476454459/CD Two/CD new/JJ temperature-sensitive/JJ alleles/NNS of/IN SEC3/GENE ,/, 1/CD of/IN 10/CD late-acting/NNP SEC/MULTIGENE genes/MULTIGENE required/VBN for/IN targeting/NN or/CC fusion/NN of/IN post-Golgi/JJ secretory/JJ vesicles/NNS to/IN the/DT plasma/NN membrane/NN in/IN Saccharomyces/NN cerevisiae/NN ,/, were/VBD isolated/VBN in/IN a/DT screen/NN for/IN temperature-sensitive/JJ secretory/JJ mutants/NNS that/WDT are/VBP synthetically/RB lethal/JJ with/IN sec4-8/NN ./.
@@69027226692/CD The/DT hyperacute/JJ phase/NN of/IN posterolateral/JJ myocardial/JJ infarction/NN ./.
@@75595108459/CD Although/IN Micrococcus/NN luteus/NN UV/MULTIGENE endonuclease/MULTIGENE has/VBZ been/VBN reported/VBN to/IN be/VB an/DT 18-kDa/MULTIGENE enzyme/MULTIGENE with/IN possible/JJ homology/NN to/IN the/DT 16-kDa/MULTIGENE endonuclease/MULTIGENE V/MULTIGENE from/IN bacteriophage/NN T4/NN (/( Gordon/NNP ,/, L/NNP ./NNP
@@81563328134/CD Endoscopic/NNP transthoracic/JJ sympathectomy/NN as/IN adjuvant/JJ treatment/NN for/IN critical/JJ upper-limb/JJ ischaemia/NN ./.
@@112783105347/CD Furthermore/RB ,/, this/DT kinase-deficient/JJ mutant/RB inhibited/VBN 2-MeSADP-induced/MULTIGENE caspase-3/MULTIGENE stimulation/NN and/CC the/DT associated/VBN decrease/NN in/IN cell/NN number/NN ./.
@@87988937410/CD Furthermore/RB ,/, freezing/NN in/IN the/DT presence/NN of/IN bovine/MULTIGENE lactalbumin/MULTIGENE resulted/VBN in/IN a/DT good/JJ maintenance/NN of/IN the/DT cellular/JJ viability/NN and/CC of/IN the/DT CCCD/NNP heterogeneity/NN in/IN respect/NN to/IN fresh/JJ cells/NNS ./.
@@20449509292/CD Using/VBG the/DT polymerase/NN chain/NN reaction/NN ,/, we/PRP analyzed/VBD the/PDT U6/MULTIGENE RNA/MULTIGENE genes/MULTIGENE of/IN 52/CD organisms/NNS ./.
@@17107682798/CD Our/PRP results/NNS also/RB indicate/VBP the/DT existence/NN of/IN sequences/NNS downstream/RB of/IN -0/CD ./CD 11/CD kb/NN which/WDT can/MD influence/VB the/DT pattern/NN of/IN tissue-specific/JJ expression/NN of/IN the/PDT HLA-B7/MULTIGENE gene/MULTIGENE and/CC the/DT ability/NN of/IN this/DT gene/NN to/IN respond/NN to/IN gamma/MULTIGENE interferon/MULTIGENE ./.
@@109405571303/CD Additionally/RB ,/, putative/JJ CF1/NNP //NNP USP/NNP and/CC Broad/NNP Complex/MULTIGENE Z2/MULTIGENE transcription/MULTIGENE factor/MULTIGENE elements/MULTIGENE were/VBD found/VBN in/IN the/DT upstream/JJ regions/NNS of/IN MIH/NNS and/CC MO-IH/GENE genes/NNS respectively/RB ./.
@@107396716602/CD By/IN electrophoresis/NN mobility/NN shift/NN assays/NNS using/VBG probes/NNS corresponding/JJ to/IN different/JJ segments/NNS of/IN the/DT putative/JJ human/MULTIGENE c-myb/MULTIGENE intron/NN 1/CD transcription/NN pause/NN region/NN and/CC nuclear/JJ extracts/NNS from/IN myeloid/MULTIGENE leukemia/MULTIGENE HL/MULTIGENE 60/MULTIGENE and/CC fibroblast/NN WI/NN 38/CD cells/NNS ,/, we/PRP detected/VBD a/DT HL-60-specific/MULTIGENE DNA-protein/MULTIGENE complex/MULTIGENE with/IN a/DT 123-bp/JJ fragment/MULTIGENE containing/MULTIGENE binding/MULTIGENE sites/MULTIGENE for/IN the/DT interferon/MULTIGENE regulatory/MULTIGENE factors/MULTIGENE (/( IRFs/NNP )/SYM nuclear/JJ proteins/NNS ./.
@@21247106240/CD This/DT model/NN is/VBZ further/RB supported/VBN by/IN binding/NN of/IN the/DT Fos-Jun/NNP complex/NN at/IN an/DT AP-1/MULTIGENE site/MULTIGENE in/IN the/DT type/MULTIGENE alpha/MULTIGENE I/MULTIGENE collagen/MULTIGENE promoter/MULTIGENE that/WDT is/VBZ contiguous/JJ with/IN ,/, but/CC not/RB overlapping/JJ ,/, the/DT VDRE/NN ./.
@@10833751488/CD Alpha-1/MULTIGENE antitrypsin/MULTIGENE and/CC Indian/JJ childhood/NN cirrhosis/NN ./.
@@82304529439/CD The/DT recombinant/JJ vaccinia/MULTIGENE virus-expressed/MULTIGENE mutant/MULTIGENE P1/MULTIGENE polyproteins/MULTIGENE were/VBD analyzed/VBN for/IN proteolytic/JJ processing/NN defects/NNS in/IN cells/NNS coinfected/VBN with/IN a/DT recombinant/JJ vaccinia/NN virus/NN (/( VVP3/GENE )/SYM that/WDT expresses/VBP the/DT poliovirus/NN 3CD/CD protease/NN and/CC for/IN processing/VBG and/CC assembly/NN defects/NNS by/IN using/VBG a/DT trans/JJ complementation/NN system/NN in/IN which/WDT P1-expressing/JJ recombinant/JJ vaccinia/NN viruses/NNS provide/VBP capsid/NN precursor/NN to/IN a/DT defective/JJ poliovirus/NN genome/NN that/WDT does/VBP not/RB express/VB functional/JJ capsid/NN proteins/NNS (/( D/NN ./NN
@@67132047563/CD The/DT AD/MULTIGENE components/MULTIGENE were/VBD markedly/RB more/RB dependent/JJ on/IN the/DT affective/JJ state/NN of/IN the/DT rat/NN then/RB was/VBD the/DT V1/MULTIGENE component/MULTIGENE ./.
@@59397489693/CD When/WRB the/DT cervical/JJ Pap/NN smear/NN is/VBZ positive/JJ ./.
@@28528943542/CD Causes/NNP of/IN death/NN found/VB in/IN an/DT epidemiological/JJ study/NN of/IN native/JJ chickens/NNS in/IN Thai/JJ villages/NNS ./.
@@76828421962/CD To/TO study/VB the/DT origin/NN of/IN different/JJ fMLF-R/MULTIGENE transcripts/MULTIGENE ,/, the/DT genetic/JJ linkage/NN of/IN chemotactic/JJ receptor/NN genes/NNS ,/, and/CC the/DT regulation/NN of/IN fMLF-R/MULTIGENE gene/MULTIGENE expression/NN ,/, we/PRP determined/VBD the/DT copy/NN number/NN ,/, chromosomal/JJ location/NN ,/, structural/JJ organization/NN ,/, and/CC 5'-flanking/JJ sequence/NN of/IN the/DT human/MULTIGENE fMLF-R/MULTIGENE gene/MULTIGENE ./.
@@92523973161/CD We/PRP had/VBP previously/RB analyzed/VBN repair/NN rates/NNS of/IN cyclobutane/MULTIGENE pyrimidine/MULTIGENE dimers/MULTIGENE at/IN nucleotide/NN resolution/NN along/IN the/DT human/MULTIGENE JUN/MULTIGENE gene/MULTIGENE in/IN normal/JJ fibroblasts/NNS and/CC found/VB very/RB efficient/JJ repair/NN of/IN sequences/NNS near/IN the/DT transcription/NN initiation/NN site/NN but/CC slow/JJ repair/NN along/IN the/DT promoter/NN ./.
@@94642485318/CD A/DT canonical/JJ TATA/MULTIGENE box/MULTIGENE was/VBD not/RB detected/VBN ./.
@@21389922735/CD This/DT multimodality/NN treatment/NN for/IN locally/RB advanced/JJ gynecologic/JJ tumors/NNS appears/VBZ feasible/JJ with/IN modification/NN ,/, and/CC continued/VBD work/NN exploring/VBG this/DT approach/NN is/VBZ encouraged/VBN ./.
@@107131612318/CD Inactivation/NNS of/IN Ulp2/GENE also/RB suppresses/VBZ several/DT ulp1/NN (/NN ts/NN )/NN defects/NNS ,/, and/CC the/DT double/JJ mutant/NN accumulates/VBZ far/RB fewer/DT Smt3-protein/GENE conjugates/NNS than/IN either/DT single/JJ mutant/NN ./.
@@11092809400/CD In/NN addition/NN ,/, our/PRP results/NNS show/VBP that/IN ERKs/GENE and/CC PI3Ks/GENE can/MD synergise/VB to/IN convert/NN ectoderm/NN into/IN mesoderm/NN ./.
@@90771089764/CD During/IN the/DT febrile/JJ period/NN ,/, pleocytosis/NN was/VBD associated/VBN with/IN high/JJ levels/NNS of/IN IgG/CONTEXTGENE ,/, IL-6/NEWGENE ,/, TNF-alpha/CONTEXTGENE ,/, and/CC PGE2/CONTEXTGENE in/IN the/DT cerebrospinal/JJ fluid/NN ./.
@@95297219488/CD Potential/JJ indicators/NNS were/VBD assessed/VBN for/IN the/DT two/JJ classifications/NNS of/IN protein-energy/JJ malnutrition/NN in/IN the/DT guidelines/NNS for/IN integrated/JJ management/NN of/IN childhood/NN illness/NN :/: severe/JJ malnutrition/NN ,/, which/WDT requires/VBZ immediate/JJ referral/NN to/IN hospital/NN ,/, and/CC very/RB low/JJ weight/NN ,/, which/WDT calls/VBZ for/IN feeding/JJ assessment/NN ,/, nutritional/JJ counselling/NN and/CC follow-up/JJ ./.
@@76039567969/CD The/DT experimental/JJ design/NN represents/VBZ a/DT 2/CD x/NN 3/CD factorial/NN arrangement/NN of/IN treatments/NNS with/IN three/CD dietary/JJ levels/NNS of/IN incorporation/NN of/IN RSB/GENE (/( 0/CD ,/, 50/CD ,/, and/CC 100%/CD )/SYM ,/, and/CC chickens/NNS either/DT infected/VBN or/CC uninfected/JJ ./.
@@112785632647/CD Deletion/NNS analyses/NNS implicate/VBP the/DT N-terminal/MULTIGENE 110/MULTIGENE amino/JJ acids/NNS of/IN Grb14/GENE and/CC ankyrin/NN repeats/NNS 10-19/CD of/IN tankyrase/MULTIGENE 2/MULTIGENE in/IN mediating/JJ this/DT interaction/NN ./.
@@12817718658/CD Characterization/NNS of/IN the/DT human/JJ gene/NN encoding/VBG cytokeratin/MULTIGENE 17/MULTIGENE and/CC its/PRP expression/NN pattern/NN ./.
@@55677215047/CD Sensitivities/NNS of/IN thromboplastins/NNS to/IN factor/MULTIGENE VII/MULTIGENE deficiency/NN ./.
@@87641365668/CD In/NN an/DT effort/NN to/IN isolate/MULTIGENE genes/MULTIGENE with/IN down-regulated/DT expression/NN at/IN the/DT mRNA/NN level/NN during/IN oncogenic/JJ transformation/NN of/IN human/JJ mammary/JJ epithelial/JJ cells/NNS (/( MECs/NNS )/SYM ,/, we/PRP performed/VBD subtractive/JJ hybridization/NN between/IN normal/JJ MEC/NN strain/NN 76N/CD and/CC its/PRP radiation-transformed/JJ tumorigenic/JJ derivative/NN 76R-30/JJ ./.
@@78792043427/CD OKT3/GENE prophylaxis/NN improves/VBZ long-term/JJ renal/JJ graft/NN survival/NN in/IN high-risk/JJ patients/NNS as/IN compared/VBN to/IN cyclosporine/NN :/: combined/JJ results/NNS from/IN the/DT prospective/NN ,/, randomized/JJ Belgian/NN and/CC US/NN studies/NNS ./.
@@107670917864/CD Intra-operative/JJ ultrasound/JJ (/( IOUS/GENE )/SYM has/VBZ been/VBN widely/RB used/VBN in/IN an/DT attempt/NN to/IN overcome/VB these/DT difficulties/NNS ,/, but/CC is/VBZ limited/VBN by/IN its/PRP two-dimensional/JJ nature/NN ,/, inter-user/JJ variability/NN ,/, and/CC image/NN obliteration/NN with/IN ablative/JJ or/CC resectional/JJ techniques/NNS ./.
@@93964028832/CD PATIENTS/IN AND/CC METHODS/IN :/: Semen/NNS analyses/NNS were/VBD performed/VBN on/IN 58/CD patients/NNS with/IN stages/NNS I-III/MULTIGENE HD/MULTIGENE before/RB ,/, during/IN ,/, and/CC after/IN chemotherapy/NN and/CC after/IN the/DT sperm/NN count/NN recovered/VBN from/IN the/DT effects/NNS of/IN abdominal/JJ radiotherapy/NN that/WDT was/VBD given/VBP after/IN chemotherapy/NN ./.
@@97337942378/CD We/PRP did/VBD not/RB observe/VB any/DT changes/NNS in/IN Bcl-2/NEWGENE or/CC Bcl-2-related/MULTIGENE proteins/MULTIGENE (/( Bcl-x/CONTEXTGENE ,/, Bax/CONTEXTGENE ,/, and/CC Bad/CONTEXTGENE )/SYM in/IN control/NN or/CC KCREB-transfected/JJ cells/NNS before/IN or/CC after/IN treatment/NN with/IN Tg/NNP ./NNP
@@943842726/CD An/DT evolutionary/RB conserved/VBN element/NN is/VBZ essential/JJ for/IN somite/NN and/CC adjacent/JJ mesenchymal/JJ expression/NN of/IN the/DT Hoxa1/MULTIGENE gene/MULTIGENE ./.
@@18309288612/CD The/DT minus-end-directed/JJ microtubule/NN motors/NNS ,/, the/DT dyneins/NNS ,/, may/MD also/RB constitute/VB a/DT superfamily/NN of/IN force-generating/JJ proteins/NNS with/IN distinct/JJ attachment/NN domains/NNS ./.
@@27135203393/CD Chronic/NN dose/NN effects/NNS of/IN methyl/NN parathion/NN on/IN nuthatches/NNS :/: cholinesterase/NN and/CC ptilochronology/NN ./.
@@94341606855/CD Several/JJ PTPases/GENE were/VBD expressed/VBN abundantly/RB in/IN the/DT 5-FU-treated/JJ bone/NN marrow/NN stem/NN cells/NNS ./.
@@28634924354/CD No/DT significant/JJ differences/NNS between/IN the/DT two/JJ treatment/NN groups/NNS were/VBD found/VBN ,/, but/CC rapid/JJ responders/NNS had/VBP a/DT smaller/RBR mean/JJ initial/JJ platelet-associated/MULTIGENE IgG/MULTIGENE index/NN which/WDT returned/VBD more/RB rapidly/RB and/CC more/RB permanently/RB to/IN normal/JJ than/IN that/DT of/IN slow/JJ responders/NNS ./.
@@920381329/CD Decreased/JJ cardiac/MULTIGENE glycogen/MULTIGENE following/IN phenformin/NN injection/NN in/IN hyperglycemic/JJ ,/, hyperinsulinemic/JJ anaesthetized/JJ rats/NNS ./.
@@102190918047/CD Accordingly/RB ,/, we/PRP designated/VBD this/DT gene/MULTIGENE CTL1/MULTIGENE (/( capping/MULTIGENE enzyme/MULTIGENE RNAtriphosphatase-like/MULTIGENE 1/MULTIGENE )/SYM ./SYM
@@36327394309/CD Cyclosporine/DT treatment/NN for/IN intractable/JJ polymyositis/NN ./.
@@78976964734/CD Erythrocyte/MULTIGENE delta-aminolevulinic/MULTIGENE acid/MULTIGENE dehydratase/MULTIGENE (/( ALAD/CONTEXTGENE )/SYM activity/NN ,/, erythrocyte/MULTIGENE zinc/MULTIGENE protoporphyrin/MULTIGENE (/( ZPP/GENE )/NN //NN heme/NN ratio/NN ,/, and/CC urinary/MULTIGENE coproporphyrin/MULTIGENE (/( UC/CONTEXTGENE )/SYM concentration/NN have/NN been/VBN employed/VBN as/IN biological/JJ indicators/NNS of/IN moderate-to/JJ high-level/JJ lead/NN exposure/NN ,/, corresponding/JJ to/IN blood/NN levels/NNS in/IN excess/NN of/IN 50/CD micrograms/NN //NN dl/NN ,/, in/IN human/JJ subjects/NNS ./.
@@16304548182/CD A/DT 38-bp/JJ poly/NN (/NN dA-dT/NN )/NN region/NN was/VBD found/VBN to/IN be/VB a/DT positive/JJ regulator/NN of/IN Act1/MULTIGENE promoter/MULTIGENE activity/NN ./.
@@107918192269/CD This/DT tendency/NN is/VBZ likely/JJ due/NN to/IN the/DT biased/VBN nucleotide/NN composition/NN of/IN the/DT asparagus/NN genome/NN ,/, rather/RB than/IN to/IN the/DT translational/JJ selection/NN for/IN specific/JJ codons/NNS ./.
@@94635609415/CD PATIENTS/IN AND/CC METHOD/IN :/: Since/IN 1986/CD ,/, 62/CD patients/NNS were/VBD irradiated/JJ stereotactically/RB ./.
@@75122589588/CD Liver/NN transplantation/NN in/IN one/PRP patient/NN resolved/VBD metabolic/JJ complications/NNS but/CC did/VBD not/RB improve/VB PMN/NN count/NN or/CC the/DT infectious/JJ status/NN ,/, while/CC neutropenia/NN was/VBD corrected/VBN by/IN G-CSF/GENE ./.
@@106536935802/CD The/DT RING/NN finger/NN ,/, B2/MULTIGENE box/MULTIGENE ,/, and/CC coiled-coil/MULTIGENE region/MULTIGENE are/VBP required/VBN for/IN oligomerization/NN of/IN KAP-1-RBCC/GENE and/CC KRAB/GENE binding/JJ ,/, as/IN mutations/NNS in/IN these/DT domains/NNS concomitantly/RB abolished/VBN these/DT functions/NNS ./.
@@106062724630/CD Injection/NNP of/IN double-stranded/JJ RNA/NN into/IN C/NNP ./NNP elegans/NNS results/NNS in/IN embryonic/JJ lethality/NN ;/: thus/RB ,/, the/DT SF1/MULTIGENE gene/MULTIGENE is/VBZ essential/JJ not/RB only/RB in/IN yeast/NN but/CC also/RB in/IN at/IN least/RB one/PRP metazoan/JJ ./.
@@99187154581/CD We/PRP suggest/VBP that/DT MotA/NN and/CC AsiA/NN may/MD function/VB like/JJ certain/JJ eukaryotic/JJ TAFs/CONTEXTGENE (/( TATA/MULTIGENE binding/MULTIGENE protein/MULTIGENE (/( TBP/CONTEXTGENE )/SYM associated/VBN factors/NN )/NN whose/WP binding/JJ to/IN TBP/NN results/NNS in/IN transcription/NN from/IN new/JJ core/NN promoter/NN sequences/NNS ./.
@@8154182869/CD The/DT usefulness/NN of/IN the/DT lambda/MULTIGENE PG15/MULTIGENE and/CC the/DT lambda/MULTIGENE AD5/MULTIGENE cloning/NN vectors/NNS was/VBD demonstrated/VBN by/IN constructing/JJ large/JJ Neurospora/NN crassa/NN cDNA/NN libraries/NNS ./.
@@47608265137/CD Manifest/JJ anxiety/NN of/IN Vietnam/NN returnees/NNS and/CC undergraduates/NNS ./.
@@75754389949/CD This/DT action/NN is/VBZ dependent/JJ on/IN helix-loop-helix/JJ factors/NNS bound/JJ to/IN the/DT E1/MULTIGENE element/MULTIGENE ./.
@@110126807689/CD The/DT use/NN of/IN the/DT PLCgamma/GENE inhibitory/JJ peptide/NN ,/, neomycin/NN and/CC the/DT calcium/MULTIGENE chelator/MULTIGENE BAPTA-AM/IN on/IN oocytes/MULTIGENE expressing/MULTIGENE FGFR1/MULTIGENE or/CC the/DT stimulation/NN by/IN PDGF-BB/GENE of/IN oocytes/NNS expressing/JJ PDGFR-FGFR1/GENE mutated/JJ on/IN the/DT PLCgamma/GENE binding/JJ site/NN ,/, prevented/VBN GVBD/NNS and/CC ERK2/GENE phosphorylation/NN ./.
@@93214069137/CD The/DT pheromone/NN response/NN pathway/NN activates/VBZ transcription/NN of/IN Ty5/MULTIGENE retrotransposons/MULTIGENE located/VBN within/IN silent/JJ chromatin/NN of/IN Saccharomyces/NN cerevisiae/NN ./.
@@16945252832/CD Isopenicillin/MULTIGENE N/MULTIGENE isomerase/MULTIGENE (/( epimerase/NN )/SYM has/VBZ been/VBN purified/VBN from/IN Streptomyces/NN clavuligerus/NN ,/, and/CC the/DT amino/JJ acid/NN sequence/NN of/IN the/DT N-terminus/NN has/VBZ been/VBN determined/VBN ./.
@@88164618956/CD Our/PRP analysis/NN suggests/VBZ that/IN Upf1p/GENE is/VBZ a/DT multifunctional/MULTIGENE protein/MULTIGENE with/IN separable/JJ activities/NNS that/WDT can/MD affect/VB mRNA/NN turnover/NN and/CC nonsense/NN suppression/NN ./.
@@109133049204/CD A/DT 2/CD kb/NN transcript/NN was/VBD isolated/VBN from/IN brain/NN that/IN encodes/VBZ a/DT approximately/RB 57/MULTIGENE kDa/MULTIGENE protein/MULTIGENE ;/: the/DT predicted/VBN protein/NN contains/VBZ the/DT known/VBP N-terminal/NN Ets/NNS domain/NN of/IN PE1/GENE and/CC a/DT novel/JJ C-terminal/NN domain/NN with/IN signficant/JJ homology/NN to/IN murine/MULTIGENE ERF/MULTIGENE ./.
@@95731874384/CD Transcriptional/JJ repression/NN mediated/JJ by/IN LysR-type/MULTIGENE regulator/MULTIGENE CatR/GENE bound/JJ at/IN multiple/JJ binding/JJ sites/NNS ./.
@@109828256661/CD We/PRP show/VBP here/RB that/IN this/DT difference/NN is/VBZ due/NN to/IN the/DT presence/NN of/IN a/DT Mot3/MULTIGENE binding/MULTIGENE site/MULTIGENE in/IN OpA/NNP ./.
@@29144223617/CD Computer/NNP analysis/NN included/VBD digital/JJ averaging/NN ,/, followed/VBN by/IN digital/JJ filtering/NN in/IN different/JJ frequency/NN bands/NNS in/IN order/NN to/IN determine/VB the/DT frequency/NN range/NN corresponding/JJ to/IN notches/NNS and/CC slurs/NNS ./.
@@82576666791/CD In/NN the/DT present/NN study/NN ,/, lesions/NNS of/IN the/PDT OPT/MULTIGENE complex/MULTIGENE (/( the/DT thalamic/JJ source/NN of/IN afferents/NNS to/IN IHA/NN and/CC HD/NN )/SYM were/VBD found/VBN to/IN have/NN no/DT effect/NN on/IN color-reversal/JJ learning/JJ performance/NN ./.
@@77982075736/CD The/DT deduced/VBN amino/JJ acid/NN sequences/NNS of/IN each/DT of/IN the/DT W3A1/MULTIGENE ETF/MULTIGENE subunits/MULTIGENE exhibit/VBP only/RB approximately/RB 30%/CD identity/NN with/IN the/DT corresponding/JJ subunits/NNS of/IN the/DT ETF/GENE from/IN human/JJ ,/, rat/NN ,/, and/CC Paracoccus/ORG denitrificans/VBZ ,/, which/WDT as/IN a/DT group/NN are/VBP greater/JJR than/IN 50%/CD identical/JJ ./.
@@110581191117/CD These/DT results/NNS suggest/VBP that/IN XAB1/GENE is/VBZ a/DT novel/JJ cytoplasmic/MULTIGENE GTPase/MULTIGENE involved/VBN in/IN nuclear/JJ localization/NN of/IN XPA/NN ./.
@@69488686723/CD The/DT scores/NNS are/VBP dependent/JJ in/IN part/NN on/IN the/DT reliability/NN of/IN faculty/NN evaluations/NNS ./.
@@92051139545/CD Thus/RB E14/GENE ./GENE 1TG3B1/GENE is/VBZ a/DT useful/JJ ES/NNP cell/NN line/NN for/IN modifying/JJ the/DT mouse/NN genome/NN using/VBG the/DT HPRT/MULTIGENE gene/MULTIGENE as/IN a/DT selection/NN marker/NN and/CC for/IN transmission/NN at/IN a/DT high/JJ frequency/NN into/IN the/DT mouse/NN germ/NN line/NN ./.
@@79165887474/CD This/DT virus/NN is/VBZ not/RB merely/RB a/DT South/JJ African/JJ strain/NN of/IN passion/NN fruit/NN woodiness/NN virus/NN (/( PWV/NN )/SYM :/: the/DT deduced/VBN CP/MULTIGENE sequence/MULTIGENE is/VBZ only/RB distantly/RB related/VBN to/IN CPs/NNS of/IN other/DT sequenced/VBN strains/NNS of/IN PWV/NN ,/, although/IN it/PRP is/VBZ part/NN of/IN a/DT distinct/JJ subgroup/NN of/IN potyviruses/NNS related/VBN to/IN PWV/NN ./.
@@103735237594/CD In/NN serum-free/JJ media/NN ,/, p50E4F/GENE accelerated/JJ E1A-induced/JJ apoptosis/NN ./.
@@19680616200/CD Sci/NNS ./.
@@72349747065/CD Morphological/JJ features/NNS of/IN Jat/NN dentition/NN ./.
@@77316869545/CD The/DT TTG-2/MULTIGENE gene/MULTIGENE has/VBZ been/VBN identified/VBN at/IN the/DT site/NN of/IN chromosomal/JJ translocations/NNS in/IN acute/JJ T-cell/NN leukemia's/NNS (/( T-ALL/NN )/SYM ./.
@@114273293285/CD The/DT validity/NN of/IN the/DT FPS-R/GENE was/VBD further/RB supported/VBN by/IN strong/JJ positive/JJ correlations/NNS with/IN the/DT VAS/NN (/( r/NN =/NN 0/NN ./NN 92/NN ,/, N/NN =/NN 45/NN )/SYM and/CC the/DT CAS/NN (/( r/NN =/NN 0/NN ./NN 84/NN ,/, N/NN =/NN 45/NN )/SYM in/IN this/DT clinical/JJ sample/NN ./.
@@18336377055/CD The/DT abundance/NN of/IN transcripts/NNS from/IN several/DT unrelated/MULTIGENE genes/MULTIGENE is/VBZ decreased/VBN in/IN cdc68-1/NNP mutant/JJ cells/NNS after/IN transfer/NN to/IN the/DT restrictive/JJ temperature/NN ,/, while/CC at/IN least/RB one/PRP transcript/NN ,/, from/IN the/DT HSP82/MULTIGENE gene/MULTIGENE ,/, persists/VBZ in/IN an/DT aberrant/JJ fashion/NN ./.
@@86831082464/CD Collectively/RB ,/, these/DT results/NNS suggest/VBP that/IN components/NNS of/IN the/DT protein/MULTIGENE kinase/MULTIGENE A/MULTIGENE signaling/JJ pathway/NN are/VBP recruited/VBN by/IN mIg/NN to/IN induce/VB junB/GENE transcription/NN ./.
@@91992923753/CD Strikingly/RB ,/, stoichiometric/JJ association/NN of/IN p107/GENE or/CC p130/GENE with/IN either/DT cyclin/NN E-cdk2/NNP or/CC cyclin/NN A-cdk2/NNP negated/VBN the/DT activities/NNS of/IN these/DT kinases/NNS ./.
@@20230973716/CD The/DT human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM Rev/MULTIGENE protein/MULTIGENE is/VBZ a/DT positive/JJ posttranscriptional/MULTIGENE regulator/MULTIGENE of/IN viral/JJ structural/JJ gene/NN expression/NN and/CC essential/JJ for/IN virus/NN replication/NN ./.
@@109157801894/CD Wnt-1/GENE overexpression/NN in/IN mammary/JJ epithelial/JJ cells/NNS induced/VBD cyclin/MULTIGENE D1/MULTIGENE mRNA/MULTIGENE and/CC targeted/VBN overexpression/NN of/IN Wnt-1/GENE in/IN the/DT mammary/JJ gland/NN of/IN transgenic/JJ mice/NNS increased/VBD both/DT ILK/GENE activity/NN and/CC cyclin/MULTIGENE D1/MULTIGENE levels/NNS ./.
@@108154105665/CD The/DT immune/JJ system/NN is/VBZ closely/RB integrated/JJ with/IN the/DT neuroendocrine/JJ system/NN ,/, and/CC infection-induced/JJ increases/NNS in/IN cytokines/NNS such/JJ as/IN IL-1/CONTEXTGENE ,/, IL-6/NEWGENE and/CC TNF/NN have/NN numerous/JJ effects/NNS on/IN the/DT central/JJ nervous/JJ system/NN ./.
@@79227094102/CD Biological/JJ activities/NNS of/IN hematopoietic/MULTIGENE growth/MULTIGENE factors/MULTIGENE that/WDT lead/VBP to/IN future/JJ clinical/JJ application/NN ./.
@@28771246819/CD Mature/NNP and/CC old/JJ B6AF1/GENE and/CC B6D2F1/GENE mice/NNS were/VBD given/VBP acidified/JJ tap/NN water/NN or/CC promethazine/NN HCl/NN (/( a/DT phenothiazine/NN with/IN H1/MULTIGENE receptor/MULTIGENE blocking/JJ activity/NN )/SYM ,/, chlorpheniramine/NN (/( an/DT H1/NN blocker/NN )/SYM or/CC trifluoperazine/NN (/( a/DT phenothiazine/NN with/IN no/DT H1/NN blocking/JJ activity/NN )/SYM in/IN their/PRP drinking/JJ water/NN ,/, and/CC the/DT effects/NNS of/IN these/DT agents/NNS on/IN bone/NN mineral/JJ content/NN were/VBD assessed/VBN by/IN intermittently/RB measuring/JJ the/DT 24-h/JJ whole/JJ body/NN retention/NN of/IN Tc/MULTIGENE 99m/MULTIGENE methylene/NN diphosphonate/NN (/( Tc/MULTIGENE 99m/MULTIGENE MDP/MULTIGENE ,/, an/DT indicator/NN of/IN bone/NN metabolism/NN )/SYM and/CC at/IN the/DT end/NN of/IN the/DT studies/NNS by/IN determining/VBG ash/NN weights/NNS of/IN femur/NN ,/, ilium/NN and/CC sacrum/NN ./.
@@113848801116/CD The/DT mechanism/NN of/IN the/DT induction/NN of/IN 3beta-HSD/MULTIGENE type/MULTIGENE 1/MULTIGENE gene/MULTIGENE expression/NN was/VBD further/RB characterized/VBN in/IN ZR-75-1/NNP human/JJ breast/NN cancer/NN cells/NNS ./.
@@82646508858/CD Analysis/NNP of/IN strains/NNS harboring/VBG an/DT mds1/GENE null/JJ mutation/NN demonstrates/VBZ that/IN MDS1/GENE is/VBZ not/RB essential/JJ during/IN normal/JJ vegetative/JJ growth/NN but/CC appears/VBZ to/IN be/VB required/VBN for/IN meiosis/NN ./.
@@25554182963/CD Insert2/GENE contains/VBZ repetitive/JJ non-Ig-related/MULTIGENE sequences/MULTIGENE and/CC a/DT small/MULTIGENE Ig-related/MULTIGENE sequence/MULTIGENE ./.
@@90092083497/CD The/DT primer/NN is/VBZ generated/VBN by/IN a/DT cleavage/NN that/WDT occurs/VBZ between/IN bases/NNS 11/CD and/CC 12/CD of/IN the/DT Tf1/MULTIGENE mRNA/MULTIGENE ./.
@@21251535461/CD A/DT bacteriological/JJ relapse/NN requiring/JJ treatment/NN occurred/VBN by/IN 5/CD years/NNS in/IN 16/CD ./CD 8%/CD of/IN 113/CD R3/GENE ,/, 5/NN ./NN 2%/NN of/IN 97/CD R5/GENE ,/, and/CC 20/CD ./CD 0%/CD of/IN 115/CD Z5/GENE patients/NNS with/IN organisms/NNS sensitive/JJ to/IN streptomycin/NN and/CC isoniazid/NN initially/RB ./.
@@8230878212/CD Deflunia/NNP was/VBD well/VB tolerated/VBN by/IN 25/CD patients/NNS ,/, very/RB well/VB tolerated/VBN by/IN 2/CD ./CD
@@91441652703/CD In/NN a/DT model/NN of/IN the/DT ternary/JJ complex/NN ,/, the/DT segment/NN of/IN NFAT/GENE nearest/JJS AP-1/GENE is/VBZ the/DT Rel/NN insert/NN region/NN (/( RIR/GENE )/SYM ,/, a/DT feature/NN that/WDT is/VBZ notable/JJ for/IN its/PRP hypervariability/NN in/IN size/NN and/CC in/IN sequence/NN amongst/IN members/NNS of/IN the/DT Rel/MULTIGENE transcription/MULTIGENE factor/MULTIGENE family/MULTIGENE ./.
@@75962878650/CD The/DT nucleotide/NN sequence/NN directly/RB upstream/RB of/IN fimA/NN contains/VBZ two/JJ open/JJ reading/JJ frames/NNS ,/, ORF5/NNS and/CC ORF1/GENE ,/, whose/WP deduced/VBN protein/NN products/NNS are/VBP homologous/JJ to/IN members/NNS of/IN a/DT superfamily/NN of/IN ATP-binding/MULTIGENE cassette/MULTIGENE membrane/NN transport/NN proteins/NNS ,/, including/JJ both/DT prokaryotic/JJ and/CC eukaryotic/JJ uptake/NN and/CC export/NN systems/NNS ./.
@@92944224847/CD The/DT two/JJ cysteine/NN residues/NNS located/VBN in/IN this/DT additional/JJ region/NN may/MD be/VB involved/VBN in/IN the/DT formation/NN of/IN a/DT disulfide/NN bridge/NN associated/VBN with/IN the/DT activation/NN process/NN of/IN the/DT catalytic/JJ activity/NN ./.
@@78658763188/CD The/DT tissue-specific/JJ expression/NN of/IN DP/MULTIGENE family/MULTIGENE members/MULTIGENE suggests/VBZ that/IN the/DT combination/NN of/IN DP/MULTIGENE //MULTIGENE E2F/MULTIGENE heterodimers/MULTIGENE that/WDT constitute/VBP DRTF1/GENE //GENE E2F/GENE is/VBZ influenced/VBN by/IN the/DT phenotype/NN of/IN the/DT cell/NN ./.
@@89433542008/CD Recent/JJ studies/NNS have/VBP suggested/VBN that/IN SHP-1/GENE regulates/VBZ the/DT function/NN of/IN Jak/NN family/MULTIGENE tyrosine/MULTIGENE kinases/MULTIGENE ,/, as/IN shown/VBP by/IN its/PRP constitutive/JJ association/NN with/IN the/DT Tyk2/MULTIGENE kinase/MULTIGENE and/CC the/DT hyperphosphorylation/NN of/IN Jak/NN kinases/NNS in/IN the/DT motheaten/NN cells/NNS that/WDT lack/VBP functional/JJ SHP-1/GENE ./.
@@43152334925/CD Clinico-physiological/JJ experiment/NN ./.
@@11222639108/CD These/DT results/NNS suggested/VBD a/DT critical/JJ role/NN for/IN tyrosine/NN residue/NN 1229/CD in/IN the/DT regulation/NN of/IN L1/NN endocytosis/NN ./.
@@87238831367/CD Blood/NNP GSH-Px/NN activity/NN was/VBD measured/VBN with/IN a/DT spectrophotometer/NN ,/, using/VBG a/DT modification/NN of/IN a/DT previously/RB described/VBN assay/NN ./.
@@51747535420/CD Cleidocranial/JJ dysostosis/NN ./.
@@80754218552/CD The/DT partial/JJ ORF/NN was/VBD found/VBN to/IN be/VB identical/JJ to/IN the/DT C/NN terminus/NN of/IN HrpJ2/GENE ./.
@@91214328006/CD The/DT Ras/MULTIGENE guanine/MULTIGENE nucleotide-binding/MULTIGENE protein/MULTIGENE functions/NNS as/IN a/DT molecular/JJ switch/NN in/IN signalling/JJ downstream/RB of/IN protein-tyrosine/MULTIGENE kinases/MULTIGENE ./.
@@97139909273/CD Isolation/NNS of/IN a/DT novel/JJ TP53/MULTIGENE target/MULTIGENE gene/MULTIGENE from/IN a/DT colon/NN cancer/NN cell/NN line/NN carrying/JJ a/DT highly/RB regulated/VBN wild-type/MULTIGENE TP53/MULTIGENE expression/NN system/NN ./.
@@88513378825/CD Tonsillectomy/NN is/VBZ an/DT effective/JJ means/NN of/IN prophylaxis/NN for/IN upper/JJ respiratory/JJ infection/NN in/IN habitual/JJ angina/NN patients/NNS ./.
@@67169776484/CD All/DT samples/NNS exhibited/VBD a/DT decline/NN in/IN ethanol/NN concentration/NN ,/, with/IN most/JJ losses/NNS falling/NN within/IN the/DT expected/VBN 20/CD to/IN 40/CD mg%/NN range/NN ./.
@@99187155082/CD MotA/NN also/RB binds/VBZ a/DT DNA/NN sequence/NN (/( a/DT MotA/MULTIGENE box/MULTIGENE )/SYM ,/, centered/VBN at/IN position/NN -30/CD ./.
@@99209307626/CD However/RB ,/, C3/MULTIGENE toxin/MULTIGENE alone/RB or/CC in/IN combination/NN with/IN growth/MULTIGENE factors/MULTIGENE did/VBD not/RB stimulate/VB AP-1/GENE :/: Luc/NNP activity/NN and/CC actually/RB antagonized/VBN the/DT synergistic/JJ activation/NN of/IN AP-1/GENE :/: Luc/NNP observed/VBD in/IN response/NN to/IN co-stimulation/NN with/IN growth/MULTIGENE factors/MULTIGENE and/CC Ro-31-8220/GENE ./.
@@100637398173/CD Basal/JJ midexpiratory/RB lower/JJR esophageal/JJ sphincter/NN pressure/NN was/VBD similar/JJ in/IN the/DT study/NN group/NN (/( mean/JJ [/NN SD/NN ]/NN 20/CD ./CD 1/CD [/NN 9/NN ./NN 1/NN ]/NN mmHg/NN )/SYM and/CC controls/NNS (/( 17/CD ./CD 6/CD [/NN 6/NN ./NN 0/NN ]/NN mmHg/NN )/SYM ;/: the/DT pressure/NN did/VBD not/RB change/VB following/IN EVS/GENE or/CC EVL/GENE ./.
@@98068578553/CD An/DT open/JJ reading/JJ frame/NN encoding/VBG a/DT protein/NN which/WDT shows/VBZ significant/JJ similarity/NN to/IN invertases/NNS and/CC resolvases/NNS was/VBD located/VBN immediately/RB upstream/RB of/IN the/DT Pac25I/NNP R-M/NNP operon/NN ./.
@@82897838103/CD Using/VBG site-directed/JJ mutagenesis/NN ,/, we/PRP show/VBP that/IN the/DT RAREoct/GENE contributes/VBZ to/IN the/DT transcriptional/JJ activation/NN of/IN Oct-3/MULTIGENE //MULTIGENE 4/MULTIGENE promoter/MULTIGENE in/IN P19/CD cells/NNS and/CC ,/, most/RB interestingly/RB ,/, mediates/VBZ the/DT RA-induced/JJ repression/NN in/IN RA-differentiated/JJ EC/NN cells/NNS ./.
@@80653656138/CD Binding/NN of/IN U2/MULTIGENE small/MULTIGENE nuclear/MULTIGENE ribonucleoprotein/MULTIGENE (/( snRNP/CONTEXTGENE )/SYM to/IN the/DT pre-mRNA/NN is/VBZ an/DT early/JJ and/CC important/JJ step/NN in/IN spliceosome/NN assembly/NN ./.
@@25729283227/CD Monitoring/NN of/IN rheumatoid/JJ arthritis/NN ./.
@@40384546371/CD Furthermore/RB ,/, the/DT initial/JJ plasma/NN retinol/NN level/NN in/IN conjunction/NN with/IN RBP/NN was/VBD found/VBN to/IN be/VB even/VB lower/JJR in/IN 12/CD patients/NNS (/( 35/CD ./CD 1/CD micrograms/NNS dl-1/GENE ,/, 3/CD ./CD 7/CD mg/NN dl-1/GENE )/SYM who/WP subsequently/RB had/VBP cancer/NN recurrence/NN than/IN in/IN those/DT who/WP remained/VBD free/JJ of/IN apparent/JJ cancer/NN (/( 44/CD ./CD 5/CD micrograms/NNS dl-1/GENE ,/, 4/CD ./CD 6/CD mg/NN dl-1/GENE )/SYM ./.
@@112790388923/CD WRN/MULTIGENE helicase/MULTIGENE resolves/VBZ alternate/MULTIGENE DNA/MULTIGENE structures/NNS including/JJ tetraplex/NN and/CC triplex/JJ DNA/NN ,/, and/CC Holliday/NNP junctions/NNS ./.
@@5554955594/CD Study/NNP on/IN re-establishment/NN of/IN ovulation/NN after/IN termination/NN of/IN sex-steroidal/JJ treatment/NN --compared/JJ with/IN re-appearance/NN of/IN ovulation/NN after/IN abortion/NN and/CC premature/JJ delivery/NN ./.
@@95141593790/CD Most/JJS pituitary/JJ hormone-coding/JJ gene/NN promoters/NNS are/VBP activated/VBN by/IN Ptx1/GENE ./.
@@78763005296/CD The/DT p97-depleted/GENE nuclei/NNS remained/VBN largely/RB competent/JJ for/IN nuclear/JJ protein/NN import/NN ./.
@@106790655395/CD BCR/NN cross-linking/VBG also/RB led/VBN to/IN increased/VBN MAPK-activated/MULTIGENE protein/MULTIGENE kinase-2/MULTIGENE activity/NN ,/, an/DT enzyme/NN that/IN lies/NNS immediately/RB downstream/RB from/IN p38/GENE MAPK/NEWGENE ;/: MAPK-activated/MULTIGENE protein/MULTIGENE kinase-2/MULTIGENE immune/JJ complexes/NNS phosphorylated/VBN a/DT peptide/NN substrate/NN containing/JJ the/DT CREB/MULTIGENE serine/MULTIGENE 133/MULTIGENE phosphoacceptor/MULTIGENE motif/MULTIGENE ./.
@@95565669002/CD It/PRP bound/JJ to/IN vitamin/NN D/MULTIGENE receptor/MULTIGENE (/( VDR/CONTEXTGENE )/SYM but/CC not/RB retinoic/JJ acid/NN Xalpha/NNP receptor/NN (/( RXRalpha/NNP )/SYM in/IN the/DT human/JJ T/NN cell/NN line/NN MT2/NEWGENE cells/NNS ./.
@@50053115307/CD Immunogenicity/NNS of/IN various/JJ mycobacteria/NNS and/CC the/DT corresponding/JJ levels/NNS of/IN cross-protection/NN developed/VBN between/IN species/NN ./.
@@94351169389/CD Isomers/NNS were/VBD differentiated/VBN based/VBN on/IN the/DT MS-MS/NNP data/NN of/IN the/DT trofluoroacetyl-biphenylol/JJ derivatives/NNS ./.
@@83674878379/CD Most/JJS importantly/RB ,/, the/DT addition/NN of/IN purified/VBN 17S/MULTIGENE U2/MULTIGENE snRNPs/MULTIGENE ,/, but/CC not/RB of/IN 12S/MULTIGENE U2/MULTIGENE snRNPs/MULTIGENE ,/, to/IN HeLa/DT splicing/JJ extracts/NNS in/IN which/WDT the/DT endogeneous/JJ U2/MULTIGENE snRNPs/MULTIGENE have/VBP been/VBN functionally/RB neutralized/VBN with/IN anti-PRP9/CD antibodies/NNS fully/RB restores/VBZ the/DT mRNA-splicing/JJ activity/NN of/IN the/DT extracts/NNS ./.
@@6272026068/CD Diuretics/NNS :/: basic/JJ clinical/JJ pharmacology/NN and/CC therapeutic/JJ use/NN ./.
@@86470868871/CD The/DT Cdk2-cyclin-D1/MULTIGENE complex/MULTIGENE did/VBD not/RB phosphorylate/VB any/DT tested/VBN substrates/NNS ,/, such/JJ as/IN H1/MULTIGENE histone/MULTIGENE ,/, pRB/GENE ,/, SV40/MULTIGENE large/MULTIGENE T/MULTIGENE antigen/NN ,/, p53/GENE ,/, E2F-1/GENE or/CC a/DT preparation/NN of/IN nuclear/JJ proteins/NNS from/IN HeLa/DT cells/NNS ;/: in/IN contrast/NN ,/, Cdk2-cyclin-E/GENE and/CC Cdk2-cyclin-A/GENE phosphorylated/VBN these/DT proteins/NNS ./.
@@7671557600/CD The/DT December/NN armed/JJ revolt/NN in/IN Moscow/NN and/CC the/DT paramedical/JJ personnel/NN ./.
@@108694656640/CD In/NN situ/NN hybridization/NN with/IN the/DT antisense/NN RNA/NN probes/NNS further/RB supported/VBN the/DT expression/NN changes/NNS of/IN these/DT six/CD clones/NNS and/CC localized/VBN the/DT changes/NNS in/IN multiple/JJ germ/NN cell/NN stages/NNS as/RB well/VBP as/IN other/DT cell/NN types/NNS (/( Sertoli/NN ,/, interstitial/JJ and/CC peritubular/JJ cells/NNS )/SYM ./.
@@82019328175/CD On/IN physical/JJ examination/NN a/DT mild/JJ symmetrical/JJ polyarthritis/NN of/IN small/JJ and/CC large/JJ joints/NNS was/VBD seen/VBP ./.
@@113966854709/CD The/DT described/VBN results/NNS show/VBP that/DT DTD/NN is/VBZ fast/JJ ,/, simple/JJ ,/, and/CC easy/RB to/IN automate/VB ;/: requires/VBZ only/RB a/DT small/JJ amount/NN of/IN sample/NN (/( approximately/RB 50/CD mg/NN )/SYM ;/: and/CC affords/VBZ quantitative/JJ information/NN about/RB the/DT main/JJ groups/NNS of/IN compounds/NNS present/VBP in/IN cheeses/NNS ./.
@@81509708118/CD With/IN a/DT cutoff/NN level/NN for/IN TSST-1/GENE of/IN less/PRP than/IN 100/CD pg/NN //NN ml/NN ,/, 28/CD samples/NNS obtained/VBN from/IN 12/CD patients/NNS were/VBD positive/JJ for/IN TSST-1/GENE ./.
@@88164538021/CD The/DT elevation/NN of/IN cyclic/JJ AMP/NN (/( cAMP/NN )/SYM levels/NNS in/IN the/DT cell/NN downregulates/VBZ the/DT activity/NN of/IN the/DT Raf-1/MULTIGENE kinase/MULTIGENE ./.
@@17076594590/CD It/PRP is/VBZ ,/, however/RB ,/, extremely/RB homologous/JJ to/IN a/DT third/RB 'non-classical'/NEWGENE gene/NN ,/, HLA-5/GENE ./GENE 4/GENE ,/, and/CC to/IN the/DT chimpanzee/NN gene/NN ,/, Ch28/GENE ./.
@@40662744742/CD Twenty-five/CD patients/NNS (/( 80/CD ,/CD 6%/CD )/SYM with/IN mixed/JJ neoplasms/NNS were/VBD operated/VBN on/IN by/IN total/JJ conservative/JJ parotidectomy/NN (/( T/NNP ./NNP C/NNP ./NNP P/NNP ./NNP )/SYM ,/, 3/CD (/( 9/CD ,/CD 7%/CD )/SYM by/IN S/NN ./NN P/NN ./. and/CC 3/CD (/( 9/CD ,/CD 7%/CD )/SYM by/IN En/NN ./NN
@@118186751685/CD Karger/NNP AG/NN ,/, Basel/NNP
@@117751801617/CD Traditional/JJ surgical/JJ exploration/NN was/VBD followed/VBN by/IN survey/NN with/IN a/DT gamma-detecting/JJ probe/NN ./.
@@74744517362/CD Magnetic/JJ resonance/NN imaging/JJ (/( MRI/NN )/SYM has/VBZ enabled/VBN us/PRP to/IN see/VB the/DT spinal/JJ intramedullary/JJ pathology/NN as/IN differences/NNS in/IN signal/JJ intensity/NN ./.
@@74550422062/CD As/IN high-speed/JJ ,/, volumetric/JJ imaging/NN ,/, computed/JJ tomographic/JJ scan/NN machines/NNS such/JJ as/IN the/DT Dynamic/NNP Spatial/JJ Reconstructor/NN become/VB available/JJ with/IN higher/JJ density/NN resolution/NN ,/, perhaps/RB a/DT single/JJ injection/NN of/IN contrast/NN agent/NN into/IN the/DT right/JJ atrium/NN or/CC even/VB a/DT peripheral/MULTIGENE vein/MULTIGENE may/MD be/VB adequate/JJ to/IN obtain/VB all/PDT these/DT measurements/NNS ./.
@@111391485204/CD We/PRP demonstrate/VBP that/IN the/DT protein/NN is/VBZ a/DT murine/JJ homologue/NN of/IN SAF-A/GENE which/WDT has/VBZ been/VBN shown/VBP to/IN bind/NN selectively/RB to/IN MARs/NNS and/CC is/VBZ responsible/JJ for/IN the/DT satMa-binding/JJ activity/NN in/IN the/DT chromatographic/JJ fractions/NNS ./.
@@8759870717/CD The/DT extent/NN of/IN the/DT fbpA/GENE operator/NN sequence/NN (/( 42/CD bp/NN )/SYM ,/, as/IN defined/VBN by/IN our/PRP footprinting/VBG analysis/NN ,/, would/MD suggest/VB the/DT binding/NN of/IN two/JJ Fur/MULTIGENE repressor/MULTIGENE dimers/MULTIGENE ./.
@@25238008687/CD According/VBG to/IN the/DT published/VBN sequence/NN of/IN the/DT CHS1/MULTIGENE gene/MULTIGENE ,/, this/DT fragment/NN contains/VBZ four/CD repeats/NNS of/IN a/DT TGAAACA/NNP consensus/NN sequence/NN previously/RB identified/VBD in/IN the/DT alpha-factor-inducible/MULTIGENE BAR1/MULTIGENE promoter/MULTIGENE [/NN Kronstad/NN ,/, J/NNP ./NNP
@@37034933501/CD The/DT number/NN of/IN crystalline/JJ deposits/NNS is/VBZ less/PRP in/IN the/DT advanced/JJ atrophic/JJ areas/NNS of/IN the/DT RPE-choriocapillaris/MULTIGENE complex/MULTIGENE ./.
@@54900347/CD Peroxydase/NNP reaction/NN stains/NNS were/VBD negative/JJ ,/, chloroacetate/MULTIGENE esterase/MULTIGENE were/VBD strongly/RB positive/JJ ./.
@@43504104943/CD Genesis/NNP of/IN foam/NN cells/NNS :/: study/NN in/IN rats/NNS after/IN administration/NN of/IN Cloforex/NN ./.
@@76927543632/CD Risk/NN factors/NNS associated/VBN with/IN a/DT high/JJ seroprevalence/NN of/IN hepatitis/MULTIGENE C/MULTIGENE virus/NN infection/NN in/IN Egyptian/JJ blood/NN donors/NNS ./.
@@113011892647/CD In/NN contrast/NN ,/, the/DT ubiquitous/JJ expression/NN of/IN p19/NN (/NN INK4d/NN )/NN has/VBZ not/RB been/VBN previously/RB described/VBN in/IN human/JJ or/CC murine/JJ B-lineage/NNP cells/NNS ./.
@@10933154751/CD These/DT findings/NNS were/VBD reinforced/VBN by/IN an/DT analysis/NN that/WDT was/VBD restricted/VBN to/IN living/VBG donor/NN transplants/NNS without/IN acute/JJ rejection/NN ./.
@@87304702068/CD There/EX is/VBZ general/JJ agreement/NN that/IN the/DT hepatitis/MULTIGENE C/MULTIGENE virus/NN is/VBZ efficiently/RB transmitted/VBN parenterally/RB ,/, while/CC data/NN on/IN viral/JJ transmission/NN from/IN mothers/NNS to/IN babies/NNS or/CC by/IN sexual/JJ or/CC non-sexual/JJ household/NN contact/NN are/VBP conflicting/JJ ./.
@@90799152945/CD Molecular/NNP characterization/NN of/IN a/DT large/JJ Borrelia/NN burgdorferi/NN motility/NN operon/NN which/WDT is/VBZ initiated/VBN by/IN a/DT consensus/NN sigma70/MULTIGENE promoter/MULTIGENE ./.
@@808522873/CD Demographic/NN characteristics/NNS and/CC risk/NN factor/NN data/NN for/IN 76/NN ,/NN 672/NN clients/NNS were/VBD studied/VBN to/IN characterize/VB the/DT distribution/NN of/IN infection/NN with/IN human/JJ immunodeficiency/NN virus/NN (/( HIV/NN )/SYM and/CC the/DT use/NN of/IN counseling/NN and/CC testing/NN facilities/NNS in/IN Houston/NN ,/, Tex/NNP ./.
@@84169773423/CD These/DT CTD/MULTIGENE kinases/MULTIGENE ,/, designated/VBN CTDK1/GENE and/CC CTDK2/GENE ,/, are/VBP fractionated/VBN by/IN chromatography/NN on/IN Mono/NNP Q/NNP ./NNP
@@75196069301/CD Anti-NPROSP-C/NNP also/RB exclusively/RB detected/VBN time-dependent/NN appearances/NNS of/IN 5-10-kDa/JJ proSP-C/NN forms/NNS in/IN lamellar/JJ bodies/NNS and/CC homogenates/NNS ./.
@@90030017741/CD The/DT ubiquitously/RB expressed/VBN E12/MULTIGENE bHLH/MULTIGENE protein/MULTIGENE dimerizes/VBZ with/IN numerous/JJ cell-specific/MULTIGENE bHLH/MULTIGENE factors/MULTIGENE ./.
@@116692811514/CD Epithelial/JJ cytotoxicity/NN of/IN combined/JJ antibiotics/NNS was/VBD additive/JJ ,/, with/IN no/DT evidence/NN of/IN competition/NN or/CC synergism/NN ./.
@@33307114004/CD In/NN vitro/FW antimalarial/JJ activity/NN of/IN neem/NN (/( Azadirachta/NNP indica/NNP A/NNP ./NNP
@@14950697188/CD DIBA/NN was/VBD more/RB sensitive/JJ and/CC had/VBP a/DT better/RBR negative/JJ predictive/JJ value/NN and/CC a/DT lower/JJR false/JJ negative/JJ percentage/NN than/IN DFAT/GENE ./.
@@21199462723/CD Managing/NNP dysphagia/NN in/IN a/DT chronic/JJ care/NN setting/NN :/: an/DT introduction/NN ./.
@@11251171489/CD In/NN none/NN of/IN the/DT 44/MULTIGENE type/MULTIGENE I/MULTIGENE attacks/NNS and/CC 29/MULTIGENE type/MULTIGENE II/MULTIGENE attacks/NNS which/WDT were/VBD recorded/VBN did/VBD circulatory/JJ changes/NNS ;/: the/DT latter/NN were/VBD different/JJ in/IN the/DT two/JJ groups/NNS ./.
@@84038048368/CD By/IN stepwise/JJ linear/JJ multiple/JJ regression/NN analysis/NN ,/, ionized/JJ magnesium/NN was/VBD significantly/RB related/VBN to/IN cyclosporin/NN trough/NN level/NN and/CC total/JJ cholesterol/NN but/CC not/RB to/IN serum/JJ creatinine/NN ,/, time/NN after/IN transplant/NN or/CC the/DT dose/NN of/IN cyclosporin/NN ./.
@@107227378567/CD These/DT findings/NNS indicate/VBP the/DT involvement/NN of/IN Sp1/GENE and/CC an/DT Inr/NN in/IN non-cell-specific/JJ regulation/NN and/CC a/DT Kruppel-like/MULTIGENE transcription/MULTIGENE factor/MULTIGENE and/CC Sp1/GENE in/IN the/DT cell-specific/JJ regulation/NN of/IN the/DT LTC/NN (/NN 4/NN )/NN S/NN gene/NN ./.
@@22274385302/CD Primer/NNS extension/NN analysis/NN and/CC RNA/NN sequencing/VBG demonstrates/VBZ that/IN the/DT transcription/NN start/NN point/NN of/IN rat/MULTIGENE ODC/MULTIGENE mRNA/MULTIGENE is/VBZ located/VBN 303/CD nt/NN upstream/RB from/IN the/PDT A/DT residue/NN in/IN the/DT start/NN codon/NN ./.
@@92378629196/CD In/NN all/DT experimental/JJ eyes/NNS ,/, there/RB was/VBD a/DT marked/JJ reduction/NN ,/, but/CC never/RB a/DT complete/JJ absence/NN of/IN adrenergic/JJ nerves/NNS in/IN the/DT iris/NN ./.
@@109509247832/CD RNA/NN in/IN situ/NN hybridization/NN on/IN brain/NN sections/NNS of/IN normal/JJ human/JJ embryos/NNS revealed/VBD a/DT strong/JJ labeling/NN in/IN restricted/VBN areas/NNS of/IN the/DT cerebral/JJ cortex/NN ./.
@@40269724693/CD Individual/JJ alcohol/NN reaction/NN profiles/NNS ./.
@@11058406896/CD Tobramycin-loaded/JJ SLN/NNS administered/VBN i/CD ./CD v/CD ./. showed/VBD a/DT prolonged/JJ circulation/NN time/NN compared/VBN to/IN the/DT i/CD ./CD v/CD ./. administered/VBN tobramycin/NN solution/NN ./.
@@13474769023/CD Mapping/NN of/IN the/DT mouse/MULTIGENE ornithine/MULTIGENE decarboxylase-related/MULTIGENE sequence/MULTIGENE family/MULTIGENE ./.
@@27523033448/CD Lithium/WDT delays/VBZ the/DT circadian/JJ rhythm/NN of/IN wheel-running/NN in/IN Syrian/JJ hamsters/NNS at/IN plasma/NN concentrations/NNS (/( 0/CD ./CD 59-0/CD ./CD 74/CD mM/NN )/SYM that/IN also/RB cause/VBP toxic/JJ weight/NN loss/NN ./.
@@21754334235/CD The/DT recombinant/NN contains/VBZ the/DT normal/JJ beta/MULTIGENE A-globin/MULTIGENE gene/MULTIGENE ,/, the/DT mutant/JJ gene/NN and/CC Ylp/NN vector/NN sequences/NNS between/IN the/DT two/JJ copies/NNS ./.
@@100865443647/CD The/DT following/JJ data/NN were/VBD recorded/VBN at/IN arrival/NN in/IN the/DT intensive/JJ care/NN unit/NN 6/NN ,/, 12/CD ,/, 24/CD ,/, and/CC 48/CD hours/NNS after/IN termination/NN of/IN CPB/NNP :/: heart/NN rate/NN ,/, blood/NN pressure/NN ,/, left/NN atrial/JJ pressure/NN ,/, central-peripheral/JJ temperature/NN difference/NN ,/, arterial-central/JJ venous/JJ oxygen/NN saturation/NN difference/NN ,/, urine/NN output/NN ,/, serum/JJ creatinine/NN ,/, lactate/NN and/CC neutrophil/JJ elastase/NN levels/NNS ,/, the/DT Doppler/NN echocardiographic/JJ factors/NNS shortening/NN fraction/NN and/CC preejection/JJ period/JJ //JJ left-ventricular/JJ ejection/NN time/NN ,/, and/CC cumulative/JJ doses/NNS of/IN catecholamines/NNS (/( epinephrine/NN )/SYM ,/, enoximone/NN ,/, and/CC furosemide/NN ./.
@@8512868477/CD Deaths/NNP stopped/VBD 11/CD hours/NNS after/IN copper/JJ concentrations/NNS decreased/VBN below/RB 0/CD ./CD 2/CD ppm/NN and/CC signs/NNS of/IN distress/NN stopped/VBN in/IN surviving/JJ pinfish/NN by/IN approximately/RB 6/CD hours/NNS after/IN the/DT last/NN death/NN ./.
@@28488424397/CD A/DT family/NN of/IN RNA/NN molecules/NNS in/IN the/DT 2/CD ./CD 0-2/CD ./CD 2-kilobase/CD range/NN identified/VBN with/IN a/DT probe/NN from/IN this/DT gene/NN was/VBD overexpressed/VBN in/IN the/DT resistant/JJ cells/NNS ./.
@@115669611442/CD Body/NNP weight/NN reduction/NN increases/NNS insulin/NN sensitivity/NN and/CC improves/VBZ both/DT blood/NN glucose/NN and/CC blood/NN pressure/NN control/NN ./.
@@99717903215/CD Several/JJ mutations/NNS disrupted/VBD the/DT endonuclease/NN and/CC helicase/NN activities/NNS ;/: however/RB ,/, only/RB one/PRP amino-terminal-charge/MULTIGENE cluster/MULTIGENE mutant/MULTIGENE protein/MULTIGENE (/( D40A-D42A-D44A/GENE )/SYM completely/RB lost/VBP AAV/MULTIGENE hairpin/MULTIGENE DNA/MULTIGENE binding/JJ activity/NN ./.
@@107153229696/CD Gene/NNP silencing/VBG associated/VBN with/IN repeated/JJ DNA/NN sequences/NNS has/VBZ been/VBN reported/VBN for/IN many/JJ eukaryotes/NNS ,/, including/JJ plants/NNS ./.
@@85063847240/CD In/NN mammalian/JJ cells/NNS ,/, phosphorylation/NN of/IN eIF-2/MULTIGENE alpha/MULTIGENE inhibits/VBZ the/DT activity/NN of/IN eIF-2B/GENE ,/, the/DT GDP-GTP/MULTIGENE exchange/MULTIGENE factor/MULTIGENE for/IN eIF-2/GENE ./.
@@17110415842/CD These/DT clones/NNS overlapped/VBN and/CC contained/VBD the/DT structural/JJ gene/NN encoding/VBG the/DT complete/JJ C5/MULTIGENE alpha-chain/MULTIGENE and/CC 90%/CD of/IN the/DT beta-chain/NN ./.
@@81252582121/CD Although/IN inactive/JJ in/IN cells/NNS under/IN normal/JJ conditions/NNS ,/, the/DT CHOP/MULTIGENE gene/MULTIGENE is/VBZ markedly/RB induced/VBN by/IN a/DT variety/NN of/IN cellular/JJ stresses/NNS ,/, including/JJ nutrient/JJ deprivation/NN and/CC metabolic/JJ perturbations/NNS ./.
@@92119345012/CD DNase/MULTIGENE I/MULTIGENE footprint/NN analysis/NN identified/VBD a/DT protected/VBN region/NN from/IN -37/CD to/IN -53/CD ./.
@@29936301973/CD Fine/NNP analysis/NN at/IN the/DT nucleotide/NN level/NN of/IN the/DT early/JJ events/NNS in/IN the/DT digestion/NN with/IN nuclease/MULTIGENE S1/MULTIGENE shows/VBZ that/IN the/DT enzyme/NN attacks/NNS preferentially/RB the/DT sequence/NN (/( G-A/GENE )/NN 12/NN on/IN the/DT message/NN complementary/JJ strand/NN ./.
@@93588378557/CD Parodoxical/JJ rise/NN in/IN urinary/MULTIGENE albumin/MULTIGENE levels/NNS after/IN treatment/NN of/IN essential/JJ hypertension/NN ./.
@@22019053595/CD These/DT latter/JJ results/NNS showed/VBN that/IN the/DT ABFI/MULTIGENE protein/MULTIGENE ,/, like/VB the/DT RAP1/MULTIGENE protein/MULTIGENE ,/, bound/JJ sequences/NNS required/VBN for/RB positive/JJ as/RB well/VB as/IN negative/JJ regulation/NN of/IN gene/NN expression/NN ./.
@@68648376663/CD Efficacy/NNS of/IN cervical/JJ spine/NN immobilization/NN methods/NNS ./.
@@112519516689/CD BACKGROUND/IN :/: Dermoscopy/GENE is/VBZ a/DT noninvasive/JJ technique/NN that/WDT increases/VBZ the/DT diagnostic/JJ accuracy/NN of/IN pigmented/JJ skin/NN lesions/NNS ,/, particularly/RB improving/JJ the/DT diagnosis/NN of/IN patients/NNS with/IN cutaneous/JJ melanoma/NN in/IN situ/NN (/( CMIS/NNP )/SYM and/CC early/JJ invasive/JJ melanoma/NN ./.
@@92301295864/CD 3600-fold/JJ to/IN apparent/JJ homogeneity/NN with/IN a/DT 41%/JJ yield/NN by/IN affinity/NN chromatography/NN utilizing/VBG DNA-cellulose/NN ;/: the/DT purity/NN of/IN the/DT final/JJ preparation/NN was/VBD assessed/VBN by/IN SDS/NNS //NNS PAGE/NNS ,/, lack/NN of/IN contamination/NN by/IN other/DT nucleases/NNS and/CC production/NN of/IN a/DT monospecific/JJ antibody/NN against/IN the/DT enzyme/NN ./.
@@75164695798/CD Several/JJ Src/MULTIGENE SH3-binding/MULTIGENE proteins/MULTIGENE were/VBD phosphorylated/VBN in/IN Src-transformed/JJ cells/NNS ./.
@@107289454283/CD Patients/NNS enrolled/VBN in/IN the/DT Integrilin/NNP to/IN Minimize/DT Platelet/NN Aggregation/NNS and/CC Coronary/NNP Thrombosis-II/GENE (/( IMPACT-II/GENE )/SYM trial/NN were/VBD analyzed/VBN ./.
@@15825002173/CD The/DT circadian/JJ rhythmicity/NN of/IN sleep/NN was/VBD pronounced/VBN ./.
@@19090274856/CD Sequence/NN analysis/NN reveals/VBZ that/IN the/DT DNA/NN binding/JJ domain/NN of/IN ILF/GENE has/VBZ strong/JJ homology/NN to/IN the/DT recently/RB described/VBN fork/JJ head/JJ DNA/NN binding/JJ domain/NN found/VB in/IN the/DT Drosophila/MULTIGENE homeotic/MULTIGENE protein/MULTIGENE fork/JJ head/JJ and/CC a/DT family/NN of/IN hepatocyte/MULTIGENE nuclear/MULTIGENE factors/MULTIGENE ,/, HNF-3/GENE ./.
@@67180644329/CD Plasma/NN lactoferrin/NEWGENE and/CC the/DT blood/NN count/NN of/IN polynuclear/JJ neutrophils/NNS ./.
@@13964322010/CD Although/IN a/DT wide/JJ range/NN of/IN cognitive/JJ functions/NNS had/VBP been/VBN tested/VBN ,/, all/DT but/CC one/PRP seizure/NN occurred/VBN during/IN assessment/NN of/IN memory/NN performance/NN ./.
@@117424322481/CD Because/IN results/NNS of/IN recent/JJ randomized/JJ trials/NNS indicate/VBP minimal/JJ efficacy/NN of/IN continuing/JJ MAC/NN prophylaxis/NN in/IN patients/NNS who/WP respond/VBP to/IN potent/JJ combination/NN antiretroviral/JJ therapy/NN ,/, the/DT observed/VBN high/JJ incidence/NN of/IN macrolide-resistant/JJ bacterial/JJ colonization/NN of/IN the/DT respiratory/JJ tract/NN in/IN this/DT trial/NN supports/VBP the/DT discontinuation/NN of/IN macrolide/NN prophylaxis/NN in/IN all/DT AIDS/NN patients/NNS whose/WP CD4/NEWGENE counts/NNS have/VBP risen/VBP above/RB 100/CD cells/NN //NN microL/NN ./.
@@37109734382/CD Mean/VB weighted/JJ skin/NN temperature/NN (/( Tsk/NN )/SYM was/VBD lower/JJR (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM following/IN acclimation/NN than/IN before/RB ,/, and/CC acclimation/NN resulted/VBN in/IN a/DT larger/JJR (/( P/NN less/PRP than/IN 0/CD ./CD 02/CD )/SYM Tre-to-Tsk/NNP gradient/NN ./.
@@86214517586/CD Biol/NNP ./.
@@1331501484/CD Here/RB we/PRP show/VBP that/IN short/JJ synthetic/JJ peptides/NNS containing/JJ the/DT pRB-binding/MULTIGENE sequences/MULTIGENE of/IN E1A/NN are/VBP sufficient/JJ for/IN interaction/NN with/IN p107/GENE ,/, cyclin/MULTIGENE A/MULTIGENE ,/, and/CC p130/GENE ./.
@@57928685724/CD Evidence/NN forthe/NN electroosmosis/NN theory/NN of/IN transport/NN in/IN the/DT phloem/NN ./.
@@28335174561/CD Either/CC two/CD or/CC more/RB different/JJ sequences/NNS can/MD promote/VB cleavage/NN ,/, or/CC a/DT single/JJ element/NN exists/VBZ which/WDT is/VBZ long/JJ and/CC diffuse/JJ ./.
@@18741954160/CD Paradoxically/RB ,/, however/RB ,/, the/DT GH/MULTIGENE receptor/MULTIGENE cloned/VBN from/IN liver/NN exhibits/VBP no/DT sequence/NN similarity/NN to/IN receptors/NNS with/IN known/VBP signal/JJ transduction/NN mechanisms/NNS ,/, including/JJ those/DT exhibiting/VBG ligand-activated/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE activity/NN ./.
@@77012667650/CD RESULTS/NNS :/: Closure/NNS time/NN of/IN fistulas/NNS in/IN patients/NNS receiving/JJ TPN/NN +/SYM somatostatin/NN was/VBD significantly/RB shorter/JJR (/( 13/CD ./CD 86/CD +/NN //NN -/NN 1/CD ./CD 84/CD versus/IN 20/CD ./CD 4/CD +/NN //NN -/NN 2/CD ./CD 89/CD days/NNS )/SYM than/IN in/IN those/DT receiving/JJ TPN/NN alone/RB ./.
@@10868488682/CD In/NN the/DT premating/JJ period/NN male/JJ rate/NN of/IN aggression/NN was/VBD not/RB significantly/RB correlated/VBN with/IN testosterone/NN level/NN ./.
@@100022455646/CD Far-infrared/JJ hopping/JJ conductivity/NN in/IN the/DT CuO/NN chains/NN of/IN a/DT single-domain/NN YBa2Cu3O7-/NN delta/NN crystal/NN ./.
@@15231112145/CD Factors/NNS associated/VBN with/IN afterdrop/NN included/VBD age/NN ,/, end-of-surgery/NN temperature/NN (/( both/DT positively/RB )/SYM and/CC body/NN mass/JJ (/( negatively/RB )/SYM ./.
@@45479335027/CD Extracellular/JJ fibril/NN formation/NN by/IN neuroglial/JJ cells/NNS at/IN the/DT vitreoretinal/MULTIGENE junction/MULTIGENE of/IN the/DT human/JJ eye/NN ./.
@@26562575880/CD The/DT site-specific/MULTIGENE DNA/MULTIGENE inversion/NN system/NN Cin/NEWGENE encoded/VBN by/IN the/DT bacteriophage/NN P1/NEWGENE consists/VBZ of/IN a/DT recombinase/NN ,/, two/JJ inverted/JJ crossing-over/NN sites/NNS and/CC a/DT recombinational/JJ enhancer/NN ./.
@@110036698610/CD The/DT product/NN of/IN rat/NN gene/NN 33/CD was/VBD identified/VBN as/IN an/DT ErbB-2-interacting/MULTIGENE protein/MULTIGENE in/IN a/DT two-hybrid/JJ screen/NN employing/VBG the/DT ErbB-2/GENE juxtamembrane/JJ and/CC kinase/MULTIGENE domains/MULTIGENE as/IN bait/NN ./.
@@84212955642/CD Both/DT fusion/NN proteins/NNS form/NN stable/JJ specific/JJ complexes/NNS with/IN a/DT short/JJ DNA/NN duplex/JJ harboring/VBG the/DT CTGT/NN (/NN at/NN )/NN 4ACAG/NN consensus/NN sequence/NN of/IN the/PDT LexA/MULTIGENE repressor/MULTIGENE ./.
@@96112293615/CD The/DT ability/NN to/IN maintain/VB expression/NN of/IN FAS1/GENE in/IN nmt1-451Dino2/NNP Delta/NNP cells/NNS suggests/VBZ the/DT existence/NN of/IN another/DT transcription/NN factor/NN ,/, or/CC factors/NNS ,/, whose/WP expression/NN //NN activity/NN is/VBZ inversely/RB related/VBN to/IN overall/JJ levels/NNS of/IN cellular/JJ protein/NN N-myristoy-lation/GENE ./.
@@112547138619/CD Thus/RB ,/, the/DT interaction/NN of/IN Tat/NN with/IN the/DT components/NNS of/IN this/DT rel/GENE //GENE AP1/GENE cooperative/JJ complex/NN seems/VBZ to/IN induce/VB quantitative/JJ and/CC qualitative/JJ alterations/NNS of/IN this/DT complex/NN as/IN activation/NN progresses/VBZ ,/, resulting/VBG in/IN a/DT decrease/NN of/IN IL-2/MULTIGENE gene/MULTIGENE transcription/NN ./.
@@96501803663/CD The/DT general/JJ recombination/NN at/IN a/DT polarizing/JJ voltage/NN of/IN 300/CD V/NN is/VBZ less/PRP than/IN 2%/JJ for/IN dose-rates/NNS up/JJ to/IN about/RB 100/MULTIGENE mGy/MULTIGENE min-1/NN ./.
@@103295664425/CD The/DT 3'/CD terminus/NN of/IN the/DT genome/NN can/MD be/VB folded/JJ into/IN a/DT tRNA-like/JJ secondary/JJ structure/NN that/WDT has/VBZ a/DT valine/NN anticodon/NN ;/: the/DT tRNA-like/JJ structure/NN lacks/VBZ a/DT pseudoknot/NN in/IN the/DT aminoacyl/NN stem/NN ,/, a/DT feature/JJ common/JJ to/IN both/DT genera/NNS of/IN tetraviruses/NNS ./.
@@91865074846/CD Comprising/VBG a/DT 126-nucleotide/JJ 5'/CD untranscribed/JJ genomic/JJ sequence/NN and/CC a/DT 466-nucleotide/JJ 5'/CD noncoding/JJ cDNA/NN sequence/NN ,/, the/DT 592-nucleotide/NNP 5'/CD CpG/NN island/NN lacked/VBD TATA/NN and/CC CAAT/NN boxes/NNS but/CC displayed/VBD a/DT high/JJ G+C/NN content/NN ,/, was/VBD enriched/VBN for/IN CpG/MULTIGENE dinucleotides/MULTIGENE ,/, and/CC contained/VBD a/DT potential/JJ Sp1-binding/MULTIGENE site/MULTIGENE ,/, i/FW ./FW e/FW ./FW ,/, features/NNS compatible/JJ with/IN a/DT housekeeping/NN gene/NN ./.
@@85515724348/CD Oligodeoxynucleotides/NNP antisense/NN to/IN the/DT predicted/VBN translation/NN initiation/NN regions/NNS of/IN ICP4/NNS and/CC pp38/MULTIGENE mRNAs/MULTIGENE inhibited/VBD proliferation/NN of/IN MSB1/NEWGENE cells/NNS but/CC not/RB MDCC-CU91/GENE (/( CU91/GENE )/SYM reticuloendotheliosis/NN virus-transformed/JJ cells/NNS ./.
@@114031731266/CD A/DT total/NN of/IN 25/CD patients/NNS with/IN malignant/JJ brain/NN tumours/NNS were/VBD investigated/VBN ./.
@@65050142066/CD Other/JJ uncertainties/NNS in/IN the/DT dosimetry/NN at/IN Y-12/GENE and/CC Vinca/NN are/VBP unaltered/JJ ./.
@@90799281136/CD The/DT binding/JJ site/NN for/IN OxyR/GENE overlapped/VBN P1oxyR/GENE ,/, reminiscent/NN of/IN the/DT autoregulatory/JJ loops/NNS controlling/JJ expression/NN of/IN oxyR/NN in/IN enteric/JJ bacteria/NNS and/CC characteristic/NN of/IN the/DT LysR/MULTIGENE superfamily/MULTIGENE in/IN general/NN ./.
@@18282488872/CD Furthermore/RB ,/, the/PDT UvrA/MULTIGENE protein/MULTIGENE interacts/VBZ with/IN the/DT UvrB/MULTIGENE protein/MULTIGENE to/IN modulate/VB its/PRP activities/NNS ,/, both/DT in/NN solution/NN and/CC in/IN association/NN with/IN DNA/NN ,/, where/CC the/DT UvrAB/MULTIGENE complex/MULTIGENE possesses/VBZ a/DT helicase/NN activity/NN ./.
@@104896807656/CD Sputum/MULTIGENE IL-8/MULTIGENE and/CC MPO/NN were/VBD significantly/RB increased/VBN after/IN BPT/NN in/IN both/DT TDI-/NNP and/CC grain/NN dust-asthma/JJ (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@9585509537/CD Crisis/NNP of/IN the/DT therapeutic/JJ community/NN in/IN Great/NNP Britain/NN ./.
@@95732027536/CD Two/CD of/IN these/DT resulted/VBN in/IN increased/VBN levels/NNS of/IN the/DT alpha/MULTIGENE subunit/MULTIGENE ,/, and/CC one/PRP caused/VBN a/DT substitution/NN of/IN glycine/NN for/IN the/DT aspartic/JJ acid/NN residue/NN at/IN position/NN 171/CD ,/, in/IN the/DT N-terminal/NN domain/NN ./.
@@13144576408/CD Analysis/NNP of/IN nucleotide/NN sequence/NN of/IN the/DT rightmost/JJ 43/CD kbp/NN of/IN herpesvirus/NN saimiri/NN (/( HVS/NNS )/SYM L-DNA/NNS :/: general/JJ conservation/NN of/IN genetic/JJ organization/NN between/IN HVS/NNS and/CC Epstein-Barr/NNP virus/NN ./.
@@88955226541/CD Oncogenic/NNP activation/NN of/IN the/DT tyrosine/MULTIGENE kinase/MULTIGENE domain/NN of/IN the/DT human/MULTIGENE trk/MULTIGENE proto-oncogene/MULTIGENE by/IN fusion/NN to/IN a/DT cell/NN adhesion/NN molecule/NN ./.
@@91651188980/CD In/NN unc-4/MULTIGENE mutants/MULTIGENE ,/, VA/NN motor/JJ neurons/NNS assume/VBP the/DT pattern/NN of/IN synaptic/JJ input/NN normally/RB reserved/VBD for/IN their/PRP lineal/JJ sister/JJ cells/NNS ,/, the/DT VB/JJ motor/JJ neurons/NNS ;/: the/DT loss/NN of/IN normal/JJ input/NN to/IN the/DT VAs/NNS produces/VBZ a/DT distinctive/JJ backward/JJ movement/NN defect/NN ./.
@@98671592349/CD With/IN regard/NN to/IN the/DT optimal/JJ threshold/NN values/NNS ,/, sensitivity/NN and/CC specificity/NN were/VBD 100%/CD //CD 97%/CD and/CC 95%/CD //CD 95%/CD with/IN FDG/MULTIGENE PET/MULTIGENE ,/, compared/VBN to/IN 86%/GENE //GENE 92%/GENE and/CC 77%/GENE //GENE 82%/GENE with/IN IS/VBZ ,/, respectively/RB ./.
@@17925802407/CD Among/IN blood/NN donors/NNS in/IN the/DT Republic/NNP of/IN Serbia/NN ,/, regardless/RB the/DT number/NN of/IN blood/NN donations/NNS ,/, the/DT percentage/NN of/IN female/JJ donors/NNS is/VBZ significantly/RB lower/RBR compared/VBN to/IN the/DT percentage/NN of/IN male/JJ blood/NN donors/NNS ./.
@@88248009548/CD The/DT fragments/NNS are/VBP separated/VBN and/CC directly/RB sized/JJ by/IN agarose/NN gel/NN electrophoresis/NN ./.
@@75920722641/CD In/NN Trial/NN 1/CD ,/, eight/CD sows/NNS were/VBD allowed/VBN to/IN farrow/NN naturally/RB (/( d/MULTIGENE 114/MULTIGENE ,/, NF/CONTEXTGENE sows/NNS )/SYM and/CC eight/CD sows/NNS were/VBD induced/VBN to/IN farrow/NN (/( IF/IN sows/NNS )/SYM prematurely/RB by/IN injection/NN of/IN prostaglandin/MULTIGENE F2/MULTIGENE alpha/MULTIGENE on/IN d/MULTIGENE 112/MULTIGENE of/IN gestation/NN ./.
@@115384372885/CD In/NN such/JJ conditions/NNS ,/, the/DT following/JJ kinetic/JJ reactions/NNS have/VBP been/VBN studied/VBN :/: N2/NN (/NN A/NN )/NN +/SYM N2/NN (/NN A/NN )/NN --/NNP >/NNP N2/NN (/NN C/NN ,/NN B/NN ,/NN V'/NN )/NN +/SYM N2/NN (/NN X/NN )/NN ,/, N2/NN (/NN A/NN )/NN +/SYM N2/NN (/NN X/NN ,/NN V/NN >/NN 5/NN )/NN --/NNP >/NNP N2/NN (/NN X/NN )/NN +/SYM N2/NN (/NN B/NN ,/NN V'/NN )/NN in/IN pure/JJ N2/GENE post-discharges/NNS and/CC N2/NN (/NN A/NN )/NN +/SYM CH4/JJ --/JJ >/JJ products/NNS ,/, C/NN +/SYM N/JJ +/SYM M2/CD --/NNP >/NNP CN/NN (/NN B/NN ,/NN V'/NN )/NN +/SYM M2/CD ,/, N2/NN (/NN X/NN ,/NN V/NN >/NN 4/NN )/NN +/SYM CN/NN --/NNP >/NNP N2/NN (/NN X/NN )/NN +/SYM CN/NN (/NN B/NN ,/NN A/NN ,/NN V'/NN )/NN ,/, in/IN N2-1%/NNP CH4/NN post-discharges/NNS ./.
@@81390175661/CD Moreover/RB ,/, the/DT major/JJ site/NN of/IN transcriptional/JJ initiation/NN ,/, which/WDT was/VBD localized/VBN by/IN primer/NN extension/NN 250/CD bp/NN upstream/RB of/IN the/DT 5'/CD end/NN of/IN the/DT Ets-1/MULTIGENE cDNA/MULTIGENE clone/MULTIGENE ,/, was/VBD shown/VBP to/IN be/VB identical/JJ in/IN normal/JJ cells/NNS and/CC tumors/NNS carrying/VBG a/DT provirus/NN in/IN the/DT Tpl-1/MULTIGENE locus/MULTIGENE ./.
@@106013442719/CD In/NN addition/NN ,/, using/VBG biochemical/JJ activity/NN assays/NNS for/IN Rho-like/MULTIGENE GTPases/MULTIGENE ,/, we/PRP show/VBP that/IN the/DT expression/NN of/IN beta1A/GENE ,/, beta1D/GENE ,/, or/CC IL2R-beta1A/GENE in/IN GE11/GENE or/CC GD25/GENE cells/NNS triggers/VBP activation/NN of/IN both/DT RhoA/NN and/CC Rac1/GENE ,/, but/CC not/RB of/IN Cdc42/GENE ./.
@@31460175770/CD The/DT nucleotide/NN sequence/NN of/IN the/DT region/NN upstream/RB from/IN M/NNP ./NNP voltae/NNS ORFtrpA/GENE was/VBD determined/VBN and/CC revealed/VBD the/DT presence/NN of/IN an/DT ORF/NN of/IN 1227/CD nucleotides/NNS (/( ORFtrpB/GENE )/SYM encoding/VBG a/DT 409/CD amino/JJ acid/NN polypeptide/NN of/IN mol/NN ./. wt/CD ./CD
@@77768827744/CD The/DT present/NN study/NN describes/VBZ the/DT cell/NN volume/NN dynamics/NNS in/IN intact/JJ rat/NN hearts/NNS ,/, during/IN ischemia/NN and/CC after/IN reperfusion/NN ./.
@@109951211820/CD Analysis/NNP of/IN Standard/NNP Reference/NNP Material/NNP 1846/CD ,/, Infant/JJ Formula/NN ,/, gave/VBD a/DT mean/JJ value/NN of/IN 0/CD ./CD 95/CD +/NN //NN -/NN 0/CD ./CD 088/CD mg/NN vitamin/NN K/NNP //NNP kg/NNP (/( K/NN or/CC K1/GENE ?/. )/SYM (/( n/NN =/SYM 31/CD )/SYM with/IN a/DT coefficient/NN of/IN variation/NN of/IN 9/CD ./CD 26/CD ./.
@@90305812849/CD When/WRB expressed/VBN in/IN COS-7/NNP cells/NNS ,/, MKP-4/GENE blocks/NNS activation/NN of/IN MAP/MULTIGENE kinases/MULTIGENE with/IN the/DT selectivity/NN ERK/NN >/SYM p38/GENE =/SYM JNK/GENE //GENE SAPK/GENE ./.
@@9770415428/CD Here/RB we/PRP demonstrate/VBP that/IN THOV/MULTIGENE NP/MULTIGENE contains/VBZ a/DT motif/NN (/( KRxxxxxxxxxKTKK/GENE )/SYM at/IN amino/JJ acid/NN positions/NNS 179-193/CD that/WDT represents/VBZ a/DT classical/JJ bipartite/JJ nuclear/JJ localization/NN signal/JJ (/( NLS/NN )/SYM ./.
@@73049059150/CD Autotransfusion/NNS was/VBD performed/VBN as/IN follows/VBZ :/: Heparin-ACD-B-/NNP Heparin-DPD-/NNP Heparin-ACD-B/GENE etc/NN ./.
@@57156135659/CD Sterols/NNS in/IN pollen/NN ./.
@@27748082886/CD The/DT values/NNS were/VBD consistently/RB lower/JJR (/( P/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM during/IN summer/NN (/( 3/CD ./CD 79/CD +/NN //NN -/NN 0/CD ./CD 13/CD micrograms/GENE //GENE 100/GENE ml/NN )/SYM ,/, as/IN compared/VBN to/IN winter/NN (/( 5/CD ./CD 06/CD +/NN //NN -/NN 0/CD ./CD 27/CD )/SYM ./.
@@98377158248/CD We/PRP report/VBP here/RB that/IN ,/, for/IN a/DT constant/JJ amount/NN of/IN transfected/VBN DNA/NN ,/, the/DT level/NN of/IN chloramphenicol/NN acetyltransferase/NN (/( CAT/NN )/SYM mRNA/NN is/VBZ increased/VBN in/IN Vpr-expressing/VBG cells/NNS using/VBG either/DT HIV-1/NNP or/CC a/DT murine/JJ leukemia/NN virus/NN (/( MLV/NN )/SYM SL3-3/GENE LTR-CAT/NN reporter/NN construct/NN ./.
@@87025431631/CD Gap1/NN (/NN IP4BP/NN )/NN ,/, one/PRP of/IN a/DT member/NN of/IN Ras/NEWGENE GTPase-activating/NEWGENE proteins/NEWGENE ,/, has/VBZ been/VBN identified/VBN as/IN a/DT specific/JJ inositol/NN 1/JJ ,/JJ 3/JJ ,/JJ 4/JJ ,/JJ 5-tetrakisphosphate/JJ (/( IP4/NNS )/NN -binding/NN protein/NN (/( Cullen/NN ,/, P/NNP ./NNP
@@92187752397/CD Activity/NN of/IN palgD/NN in/IN the/DT cysB/MULTIGENE mutant/MULTIGENE ,/, in/IN CHA/NNS and/CC in/IN the/DT non-mucoid/JJ strain/NN PAO/NN was/VBD assessed/VBN by/IN the/DT use/NN of/IN a/DT transcriptional/MULTIGENE algD-xylE/MULTIGENE fusion/MULTIGENE ./.
@@100851405426/CD These/DT results/NNS indicate/VBP that/IN ATF-2/GENE plays/VBP a/DT central/JJ role/NN in/IN TGF-beta/NN signaling/JJ by/RB acting/JJ as/IN a/DT common/JJ nuclear/JJ target/NN of/IN both/DT Smad/NN and/CC TAK1/GENE pathways/NNS ./.
@@92463439208/CD Proteinuria/NNS in/IN a/DT young/JJ man/NN ./.
@@55569775596/CD Morphogenesis/NNS of/IN the/DT trochanter/NN produced/VBN by/IN femoral/JJ regeneration/NN in/IN the/DT phasmid/NNP Carausius/NNP morosus/NNP Br/NNP ./NNP
@@27031215117/CD Diagnosis/NNP of/IN primary/JJ sclerosing/JJ cholangitis/NN in/IN a/DT blood/NN donor/NN with/IN elevated/VBN serum/JJ alanine/MULTIGENE aminotransferase/MULTIGENE ./.
@@7559488915/CD Control/NNP experiments/NNS showed/VBN that/IN each/DT fusion/NN protein/NN had/VBP a/DT high/MULTIGENE affinity/MULTIGENE binding/MULTIGENE site/MULTIGENE for/IN estradiol-17/MULTIGENE beta/MULTIGENE and/CC could/MD transactivate/VB an/DT ERE-LacZ/NNP reporter/NN gene/NN in/IN yeast/NN similar/JJ to/IN the/DT wild/JJ type/NN ER/NNP ./NNP
@@106042463097/CD STUDY/NN DESIGN/IN AND/CC METHODS/IN :/: A/DT study/NN was/VBD initiated/VBN to/IN compare/NN the/DT collection/NN of/IN PBPCs/GENE with/IN the/DT new/JJ device/NN ,/, the/DT AutoPBSC/NNP (/( version/NN [/NN V/NN ]/NN 6/NN ./NN 0/NN with/IN AutoPBSC/NNP tubing/NN set/NN )/SYM ,/, and/CC that/IN with/IN the/DT MNC/NN (/( mononuclear/JJ cell/NN )/SYM procedure/NN (/( V4/NNP ./NNP 7/NNP with/IN white/JJ cell/NN tubing/NN set/NN )/SYM ,/, for/IN patients/NNS and/CC healthy/JJ donors/NNS ./.
@@97634707751/CD Collectively/RB ,/, this/DT study/NN emphasizes/VBZ a/DT critical/JJ role/NN of/RB Phox2a/NEWGENE as/NNP well/VB as/IN its/PRP functional/JJ synergism/NN with/IN other/DT transcription/NN factors/NNS (/( e/FW ./FW g/FW ./FW ,/, CREB/CONTEXTGENE ,/, AP2/GENE ,/, and/CC Sp1/GENE )/SYM in/IN transcriptional/JJ activation/NN of/IN the/DT DBH/MULTIGENE gene/MULTIGENE ./.
@@110005211463/CD Studying/VBG intracellular/JJ signaling/JJ pathways/NNS ,/, which/WDT may/MD be/VB involved/VBN in/IN malignant/JJ transformation/NN of/IN Ret-9bp/GENE expressing/JJ NIH3T3/NNP cells/NNS ,/, we/PRP could/MD demonstrate/VB Ret-9bp/GENE dependent/JJ phosphorylation/NN of/IN insulin/MULTIGENE receptor/MULTIGENE substrate-2/MULTIGENE (/( IRS-2/GENE )/SYM with/IN consecutive/JJ activation/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE (/( PI/NN 3-kinase/CD )/SYM and/CC protein/MULTIGENE kinase/MULTIGENE B/MULTIGENE (/( PKB/NNP //NNP AKT/NNP )/SYM ./.
@@10884978704/CD The/DT duration/NN of/IN reactive/NN hyperemia/NN decreased/VBN with/IN aging/NN ,/, but/CC the/DT difference/NN between/IN males/NNS and/CC females/NNS was/VBD not/RB significant/JJ at/IN any/DT age/NN ./.
@@104971176440/CD The/DT P/MULTIGENE mRNA/MULTIGENE also/RB contains/VBZ a/DT third/JJ ORF/NN for/IN the/DT V/MULTIGENE protein/MULTIGENE ,/, although/IN it/PRP is/VBZ unclear/JJ how/RB or/CC whether/IN this/DT ORF/NN is/VBZ accessed/VBN ./.
@@30352189034/CD Identification/NNP of/IN p40x-responsive/MULTIGENE regulatory/MULTIGENE sequences/MULTIGENE within/IN the/DT human/JJ T-cell/NN leukemia/NN virus/NN type/MULTIGENE I/MULTIGENE long/JJ terminal/JJ repeat/NN ./.
@@10229668427/CD A/DT cdc33-1/GENE strain/NN expressing/JJ either/DT stable/JJ Cln3p/GENE (/( Cln3-1p/GENE )/SYM or/CC a/DT hybrid/NN UBI4/MULTIGENE 5'-CLN3/MULTIGENE mRNA/MULTIGENE ,/, whose/WP translation/NN displays/VBP decreased/VBN dependence/NN on/IN eIF4E/GENE ,/, arrested/VBD randomly/RB in/IN the/DT cell/NN cycle/NN ./.
@@21495708278/CD Cutaneous/JJ necrosis/NN associated/VBN with/IN protein/MULTIGENE S/MULTIGENE deficiency/NN ./.
@@72622397099/CD Effects/NNPS of/IN early/JJ monocular/JJ deprivation/NN on/IN development/NN of/IN cortico-geniculate/JJ projections/NNS in/IN the/DT cat/NN ./.
@@80394224927/CD The/DT nerve/MULTIGENE growth/MULTIGENE factor/MULTIGENE beta/MULTIGENE gene/MULTIGENE (/( NGFB/GENE )/SYM belongs/VBZ to/IN a/DT conserved/VBN syntenic/JJ group/NN on/IN human/JJ chromosome/NN 1/CD and/CC mouse/NN Chromosome/NN 3/CD ./CD
@@525976313/CD Studies/NNS on/IN immunoglobulin/NN E/NN :/: the/DT impact/NN of/IN a/DT sojourn/NN with/IN Professor/NNP Dan/NNP H/NNP ./NNP
@@104713835769/CD 272/CD ,/, 1904/NN ]/NN ./.
@@113599076229/CD Several/JJ dozen/NN HIF-1/MULTIGENE targets/MULTIGENE are/VBP known/VBP ,/, including/JJ the/DT gene/NN encoding/VBG vascular/JJ endothelial/JJ growth/MULTIGENE factor/MULTIGENE (/( VEGF/CONTEXTGENE )/SYM ./.
@@3001645554/CD The/DT pet56/GENE and/CC his3/NEWGENE genes/NNS are/VBP transcribed/VBN divergently/RB from/IN initiation/NN sites/NNS that/WDT are/VBP separated/VBN by/IN only/RB 192/CD bp/CD ./CD
@@94698333674/CD To/TO further/RB investigate/VB the/DT nature/NN of/IN the/DT site/NN specificity/NN a/DT set/NN of/IN deletion/NN mutants/NNS of/IN the/DT 160/CD bp/NN sequence/NN were/VBD analysed/VBN ./.
@@74148177265/CD Cataract/NNS extraction/NN in/IN primary/JJ glaucoma/NN ./.
@@62865495413/CD WR-2721/GENE (/( S-2-/CONTEXTGENE (/CONTEXTGENE 3/CONTEXTGENE aminopropylamino/NN )/SYM ethylphosphorothioic/JJ acid/NN )/NN has/VBZ been/VBN investigated/VBN for/IN its/PRP ability/NN to/IN protect/VB gut/JJ ,/, lung/NN ,/, and/CC testis/NN ,/, as/RB well/VB as/IN fibrosarcoma/NN (/( FSa/NN )/SYM tumor/NN nodules/NNS ,/, in/IN the/DT lungs/NNS of/IN mice/NNS from/IN gamma-radiation/NN injury/NN ./.
@@89551896776/CD The/DT 0/CD ./CD 22-kb/CD NheI/MULTIGENE //MULTIGENE BglII/MULTIGENE promoter/MULTIGENE exhibited/VBD PMA/NN inducibility/NN in/IN myeloid/JJ cells/NNS and/CC contained/VBD a/DT PMA-responsive/NNP element/NN recognized/VBN by/IN Sp1/GENE and/CC EGR-1/MULTIGENE transcription/MULTIGENE factors/MULTIGENE ./.
@@99312529800/CD Both/DT mutations/NNS confer/VBP amino/JJ acid/NN substitutions/NNS in/IN the/DT viral/JJ coat/NN protein/NN but/CC differ/VB in/IN their/PRP relative/JJ abilities/NNS to/IN utilize/VB the/DT foreign/JJ scaffolding/NN protein/NN ./.
@@76982198979/CD Cell/NNP adhesion/NN and/CC migration/NN assays/NNS demonstrate/VBP that/DT alpha/MULTIGENE 6/MULTIGENE beta/MULTIGENE 1/MULTIGENE is/VBZ the/DT major/JJ laminin/MULTIGENE receptor/MULTIGENE in/IN undifferentiated/JJ F9/NN cells/NNS as/RB well/VBP as/IN F9-derived/CD PE/NN cells/NNS ./.
@@36261294305/CD Effects/NNPS of/IN a/DT low-energy/JJ laser/NN beam/NN on/IN the/DT cells/NNS of/IN the/DT newt/NN embryo/NN ./.
@@74790048888/CD In/NN electrophoretic/JJ mobility/NN shift/NN assays/NNS ,/, the/DT PERE/NNP formed/VBD three/CD major/JJ complexes/NNS (/( P1/NN ,/, P2/NN and/CC P3/GENE )/SYM with/IN proteins/NNS in/IN nuclear/JJ extracts/NNS from/IN HeLa/DT or/CC 293/CD cells/NNS ./.
@@101963185623/CD CCAAT/GENE displacement/NN protein/NN binds/VBZ to/IN and/CC negatively/RB regulates/VBZ human/JJ papillomavirus/NN type/MULTIGENE 6/MULTIGENE E6/MULTIGENE ,/, E7/CONTEXTGENE ,/, and/CC E1/MULTIGENE promoters/MULTIGENE ./.
@@86103288585/CD SUMMARY/NNP OF/IN REVIEW/NNP :/: We/PRP discuss/VBP the/DT criteria/NNS that/WDT make/VBP such/JJ studies/NNS comparable/JJ ,/, drawing/JJ on/IN the/DT experiences/NNS of/IN recent/JJ studies/NNS performed/VBN around/IN the/DT world/NN ./.
@@112203064077/CD Multiple/NNP copies/NNS of/IN rsmB+/MULTIGENE DNA/MULTIGENE ,/, on/IN the/PDT other/DT hand/NN ,/, stimulate/VB exoenzyme/NN production/NN by/IN relieving/JJ the/DT negative/JJ effects/NNS of/IN a/DT chromosomal/JJ copy/NN of/IN hexA+/NN ./.
@@85526437094/CD Clones/NNS that/WDT expressed/VBD DBD/NN exhibited/VBD a/DT dominant/JJ negative/JJ phenotype/NN and/CC did/VBD not/RB elicit/VB antiviral/JJ activity/NN against/IN vesicular/JJ stomatitis/NN virus/NN (/( VSV/NN )/SYM infection/NN upon/IN IFN/NN treatment/NN ./.
@@96394106338/CD These/DT genes/NNS may/MD represent/VB interesting/JJ targets/NNS for/IN new/JJ therapeutic/JJ strategies/NNS ./.
@@89174496026/CD Leukemia-inhibitory/JJ factor/NN (/( LIF/NN )/SYM is/VBZ a/DT neuropoietin/JJ able/JJ to/IN regulate/VB the/DT differentiation/NN and/CC the/DT survival/NN of/IN many/JJ cell/NN types/NNS ,/, which/WDT include/VBP some/DT neuronal/JJ populations/NNS ./.
@@36224238131/CD Groups/NNS of/IN male/JJ and/CC female/JJ Fischer/NN 344/CD rats/NNS ,/, B6C3F1/GENE mice/NNS ,/, and/CC Hartley/NNP guinea/NN pigs/NNS were/VBD exposed/VBN once/CC for/IN 6/CD hr/NN to/IN mean/JJ concentrations/NNS of/IN 10/CD ./CD 5/CD ,/, 5/CD ./CD 4/CD ,/, 2/CD ./CD 4/CD ,/, 1/CD ./CD 0/CD ,/, or/CC 0/CD (/( control/NN )/SYM ppm/NN of/IN methyl/NN isocyanate/NN (/( MIC/NN )/SYM vapor/NN ./.
@@94318121303/CD Here/RB we/PRP demonstrate/VBP that/DT Hh/NN and/CC Patched/JJ (/( Ptc/NNP )/SYM act/VB through/RB those/DT Ci/MULTIGENE binding/MULTIGENE sites/MULTIGENE to/IN modulate/VB the/DT level/NN of/IN Ci-dependent/NNP transcriptional/JJ activation/NN in/IN S2/NN cells/NNS ./.
@@91530104319/CD The/DT main/JJ advantages/NNS of/IN Multi-MUP/NNP analysis/NN are/VBP :/: (/( 1/CD )/SYM quick/JJ acquisition/NN of/IN many/JJ MUPs/NNS ;/: (/( 2/CD )/SYM simultaneous/JJ collection/NN of/IN several/DT MUPs/NNS at/IN one/PRP recording/JJ site/NN ;/: (/( 3/CD )/SYM possibility/NN to/IN analyze/VB not/RB only/RB low/JJ threshold/NN MUPs/NNS ;/: (/( 4/CD )/SYM less/PRP bias/NN in/IN the/DT selection/NN of/IN MUPs/NNS and/CC (/( 5/CD )/SYM the/DT reproducibility/NN of/IN the/DT results/NNS that/WDT allow/VBP the/DT same/JJ reference/NN values/NNS to/IN be/VB used/VBN in/IN different/JJ laboratories/NNS ./.
@@10560997576/CD CONCLUSION/NN (/NN S/NN )/NN :/: Measuring/VBG urinary/MULTIGENE LH/MULTIGENE levels/NNS is/VBZ an/DT excellent/JJ method/NN for/IN determining/JJ ovulation/NN ./.
@@8902548828/CD Intraperitoneal/JJ administration/NN of/IN L-5-hydroxytryptophan/GENE (/( L-5-HTP/GENE )/SYM at/IN doses/NNS of/IN 25/CD to/IN 100/CD mg/CD //CD kg/CD dramatically/RB increase/VBP defecation/NN in/IN mice/NNS ./.
@@97485139497/CD Copyright/NNP 1998/CD Elsevier/NNP Science/NNP B/NNP ./NNP V/NNP ./.
@@109185969941/CD It/PRP is/VBZ now/RB well/VB accepted/VBN that/IN the/DT p53/GENE C-terminus/NN plays/VBP a/DT central/JJ role/NN in/IN controlling/JJ the/DT activity/NN of/IN the/DT wild-type/MULTIGENE molecule/MULTIGENE ./.
@@115211912852/CD We/PRP have/VBP previously/RB shown/VBP that/IN the/DT adenoviral/MULTIGENE 12S/MULTIGENE E1A/MULTIGENE protein/MULTIGENE modulates/VBZ the/DT phosphorylation/NN status/NN of/IN p130/GENE and/CC p107/GENE without/IN apparent/JJ changes/NNS in/IN the/DT cell/NN cycle/NN dependent/JJ phosphorylation/NN of/IN the/DT retinoblastoma/MULTIGENE protein/MULTIGENE ./.
@@108280226085/CD Endostatin/NNP treatment/NN for/IN 10/CD minutes/NNS or/CC 24/CD hours/NNS induced/VBD tyrosine/NN phosphorylation/NN of/IN Shb/NNP and/CC formation/NN of/IN multiprotein/JJ complexes/NNS ./.
@@78907402675/CD The/DT PSD2/MULTIGENE gene/MULTIGENE was/VBD heterologously/RB expressed/VBN by/IN infection/NN of/IN Sf-9/CD insect/NN cells/NNS with/IN recombinant/JJ baculovirus/NN ,/, resulting/JJ in/IN a/DT 10-fold/JJ increase/NN in/IN PSD/NN activity/NN ./.
@@78621297300/CD In/NN acute-phase/JJ livers/NNS ,/, we/PRP observed/VBD a/DT dramatic/JJ reduction/NN in/IN HNF-3/MULTIGENE alpha/MULTIGENE expression/NN which/WDT correlates/VBP with/IN a/DT decrease/NN in/IN the/DT expression/NN of/IN its/PRP target/NN gene/NN ,/, the/DT TTR/MULTIGENE gene/MULTIGENE ./.
@@118623501750/CD A/DT comparative/JJ study/NN of/IN the/DT effects/NNS of/IN carbamazepine/NN and/CC the/DT NMDA/MULTIGENE receptor/MULTIGENE antagonist/MULTIGENE remacemide/NN on/IN road/NN tracking/JJ and/CC car-following/JJ performance/NN in/IN actual/JJ traffic/NN ./.
@@16470708281/CD All/DT mutant/MULTIGENE JCV/MULTIGENE T/MULTIGENE antigens/NNS bound/JJ to/IN JCV/DT and/CC SV40/NN origins/NNS of/IN DNA/NN replication/NN ./.
@@80017925251/CD The/DT git1/GENE ,/, git3/GENE ,/, git5/GENE ,/, git7/GENE ,/, git8/GENE and/CC git10/MULTIGENE genes/MULTIGENE act/VBP upstream/RB of/IN adenylate/MULTIGENE cyclase/MULTIGENE ,/, presumably/RB encoding/VBG an/DT adenylate/MULTIGENE cyclase/MULTIGENE activation/NN pathway/NN ./.
@@1068158898/CD EMSA/NN showed/VBN that/IN nuclear/JJ proteins/NNS from/IN PC12/CELL but/CC not/RB C6/VB or/CC Rat2/NNP cells/NNS bind/VBP the/DT CRE/NN as/IN a/DT complex/MULTIGENE containing/MULTIGENE activating/MULTIGENE transcription/MULTIGENE factor/MULTIGENE (/( ATF/CONTEXTGENE )/NN -4/NN and/CC CCAAT/MULTIGENE enhancer-binding/MULTIGENE protein/MULTIGENE beta/MULTIGENE ,/, while/CC both/DT PC12/CELL and/CC C6/NN cell/NN nuclear/JJ extracts/NNS were/VBD recruited/VBN by/IN the/DT CCAAT-box/NNP as/IN a/DT complex/MULTIGENE containing/MULTIGENE nuclear/MULTIGENE factor/MULTIGENE Y/NNP ./NNP
@@27962163488/CD The/DT disease/NN ran/VBP an/DT atypical/JJ course/NN ;/: with/IN early/JJ jaundice/NN syndrome/NN ,/, severe/JJ enterorrhagia/NN and/CC late/JJ appearance/NN of/IN roseola/NN ./.
@@104475938807/CD The/DT core/NN enzyme/NN is/VBZ homologous/JJ to/IN those/DT of/IN bacteriophages/NNS T3/NN ,/, T7/NN and/CC SP6/NEWGENE whereas/IN the/DT specificity/MULTIGENE factor/MULTIGENE shows/VBZ similarities/NNS with/IN bacterial/JJ sigma/NN factors/NNS ./.
@@97128595299/CD The/DT binding/NN of/IN NF-ATp/GENE ,/, although/IN not/RB NF-AT4/GENE ,/, to/IN this/DT enhancer/NN also/RB occurs/VBZ along/IN with/IN HTLV-I-mediated/JJ infection/NN of/IN human/JJ peripheral/JJ blood/NN T-cells/NNS ./.
@@76766557606/CD The/DT serum/JJ concentration/NN of/IN iP/NN before/IN dialysis/NN (/( HD/NN )/SYM was/VBD on/IN average/JJ 3/CD ./CD 06/CD (/( +/NN //NN -/NN 0/CD ./CD 81/CD )/SYM mmol/NN //NN l/NN and/CC D/NN was/VBD on/IN average/JJ 55/CD ./CD 6/CD (/( +/NN //NN -/NN 10/CD ./CD 0/CD )/SYM mmol/NN ./.
@@10501448043/CD Since/IN 1968/CD ,/, a/DT steep/JJ decrease/NN in/IN the/DT number/NN of/IN strains/NNS resistant/JJ to/IN three/CD or/CC more/JJ antibiotics/NNS (/( multiple-resistant/JJ )/SYM and/CC in/IN strains/NNS of/IN the/DT 83A/MULTIGENE complex/MULTIGENE was/VBD noticed/VBN ./.
@@111340334556/CD An/DT int6/NEWGENE deletion/NN (/( int6Delta/CD )/SYM mutant/NN was/VBD viable/JJ but/CC grew/VBD slowly/RB in/IN minimal/JJ medium/NN ./.
@@34436094147/CD The/DT role/NN of/IN supercritical/JJ fluid/NN chromatography/NN (/( SFC/NN )/SYM as/IN a/DT viable/JJ technique/NN for/IN analyzing/VBG agricultural/JJ products/NNS has/VBZ been/VBN investigated/VBN using/VBG packed/JJ and/CC capillary/JJ column/NN methodology/NN ./.
@@39368284596/CD Chronic/NN thyroiditis/NN as/IN a/DT risk/NN factor/NN of/IN B-cell/NN lymphoma/NN in/IN the/DT thyroid/JJ gland/NN ./.
@@105367886489/CD After/IN 14/CD d/NN of/IN overfeeding/NN ,/, hepatic/JJ PL/NN profiles/NNS were/VBD identical/JJ in/IN the/DT two/JJ breeds/NNS and/CC similar/JJ to/IN that/DT in/NN control/NN livers/NNS ;/: choline-containing/MULTIGENE PL/MULTIGENE accounted/VBN for/IN 95%/CD of/IN total/JJ PL/NNP ./NNP
@@9328173305/CD Iodine-123/NN was/VBD satisfactorily/RB imaged/VBN only/RB with/IN the/DT MEC/NN and/CC pinhole/NN collimators/NNS ,/, which/WDT in/IN turn/NN yielded/VBN MTF/NN values/NNS comparable/JJ to/IN those/DT measured/VBN for/IN 99mTc/NN ./.
@@90069141846/CD JNK/GENE and/CC p38/GENE are/VBP constitutively/RB present/VB in/IN the/DT nucleus/NN ,/, and/CC DNA-bound/MULTIGENE c-JUN/MULTIGENE and/CC ATF-2/GENE are/VBP stably/RB contacted/VBN by/IN JNK/GENE and/CC p38/GENE ,/, respectively/RB ./.
@@16182562202/CD The/DT mean/JJ minimum/JJ steady-state/JJ concentration/NN after/IN the/DT oral/JJ regimen/NN (/( 23/CD micrograms/CD ./CD l-1/CD )/SYM was/VBD 78%/NN of/IN that/DT after/IN the/DT intramuscular/JJ regime/NN (/( 29/CD micrograms/CD ./CD l-1/CD )/SYM ./.
@@111979263131/CD BACKGROUND/IN :/: Previous/JJ studies/NNS have/VBP indicated/VBN that/IN the/DT 60-/GENE ,/, 30-/GENE ,/, 28-/DT and/CC 12-item/JJ versions/NNS of/IN the/DT General/NNP Health/NNP Questionnaire/NN (/( GHQ/IN )/SYM are/VBP liable/JJ to/IN retest/VB effects/NNS ,/, especially/RB when/CC administered/VBN multiple/JJ times/NNS with/IN short/JJ intervals/NNS ./.
@@33987141568/CD Increasing/VBG the/DT RH/GENE beyond/RB 32%/RB resulted/VBN in/IN solvation/NN of/IN the/DT peroxy/JJ radical/NN ,/, sterically/RB hindering/JJ the/DT radical/NN from/IN entering/VBG the/DT propagation/NN transition/NN state/NN ./.
@@113687871425/CD Promoter/NNS transcriptional/JJ activity/NN was/VBD determined/VBN for/IN a/DT wide/JJ 5'/CD portion/NN of/IN the/DT human/MULTIGENE annexin/MULTIGENE A5/MULTIGENE gene/MULTIGENE ,/, from/IN bp/NN -1275/CD to/IN +79/NN relative/JJ to/IN the/DT most/RB 5'/CD of/IN several/DT discrete/JJ transcription/NN start/NN points/NNS ./.
@@1003258128/CD Depth-controlled/JJ grazing-incidence/JJ diffraction/NN of/IN synchrotron/NN x/NN radiation/NN ./.
@@78657873100/CD Our/PRP results/NNS suggested/VBN that/IN the/DT hexamer/NN and/CC the/DT octamer/NN motifs/NNS may/MD play/VB important/JJ role/NN (/NN s/NN )/NN in/IN regulation/NN of/IN replication-dependent/JJ but/CC not/RB of/IN replication-independent/JJ expression/NN of/IN the/DT wheat/MULTIGENE histone/MULTIGENE H3/MULTIGENE gene/MULTIGENE ./.
@@112741845654/CD These/DT results/NNS indicate/VBP that/IN ATF4/GENE regulates/VBZ basal/JJ and/CC CdCl/NN (/NN 2/NN )/NN -induced/NN expression/NN of/IN the/DT ho-1/MULTIGENE gene/MULTIGENE in/IN a/DT cell-specific/JJ manner/NN and/CC possibly/RB in/IN a/DT complex/NN with/IN Nrf2/GENE ./.
@@1005287854/CD Therefore/RB ,/, high/JJ set-up/NN accuracy/NN and/CC reproducibility/NN are/VBP mandatory/JJ ./.
@@10192432130/CD A/DT list/NN of/IN 12/CD names/NNS for/IN the/DT disease/NN and/CC 37/CD diagnostic/JJ criteria/NNS were/VBD proposed/VBN to/IN a/DT Consensus/NNP Panel/NNP of/IN 12/CD Italian/JJ experts/NNS who/WP ranked/VBD them/PRP in/IN order/NN so/RB as/IN to/IN identify/VB a/DT core/NN set/NN of/IN criteria/NNS ./.
@@111480429481/CD As/IN well/NN ,/, mixtures/NNS of/IN (/( LA/NN )/NN (/NN 12/NN )/NN with/IN the/DT longer/JJR chain/NN PEs/NNS exhibit/VBP unusual/JJ biomodal/JJ enthalpy/NN variations/NNS ,/, suggesting/VBG peptide/NN immiscibility/NN in/IN thicker/JJR gel/NN state/NN bilayers/NNS ./.
@@18081366692/CD The/DT effects/NNS of/IN contrast/NN media/NN on/IN coagulation/MULTIGENE factor/MULTIGENE XII/MULTIGENE ./.
@@113906848028/CD Evidence/NN from/IN a/DT Northern/NNP hybridization/NN indicated/VBD that/DT jadM/NN expression/NN is/VBZ correlated/VBN with/IN jadomycin/NNP B/NNP synthesis/NN ./.
@@74878116734/CD Two/CD experiments/NNS investigating/VBG the/DT effects/NNS of/IN short-term/JJ spaceflight/NN on/IN cancellous/JJ bone/NN turnover/NN were/VBD carried/VBN out/RB :/: Physiological/NNP Systems/NNPS Experiment-1/GENE (/( PSE-1/GENE )/SYM (/( a/DT 4-d/JJ orbital/JJ spaceflight/NN )/SYM and/CC PSE-2/GENE (/( a/DT 10-d/JJ flight/NN )/SYM ./.
@@113915312916/CD Mutation/NN of/IN the/DT NF-kappaB/MULTIGENE site/MULTIGENE in/IN the/DT Mdr1b/MULTIGENE promoter/MULTIGENE prevents/VBZ its/PRP induction/NN by/IN TNF-alpha/NN ./.
@@97545713795/CD A/DT 5/CD ./CD 0-kb/CD transcript/NN detected/VBN by/IN the/DT differential/JJ display/NN amplicon/MULTIGENE 3G1/MULTIGENE was/VBD found/VBN to/IN correlate/NN strongly/RB with/IN RAG1/MULTIGENE mRNA/MULTIGENE expression/NN in/IN various/JJ human/JJ cell/NN lines/NNS ./.
@@9560325383/CD Post-translational/JJ modifications/NNS such/JJ as/IN glycosylation/NN and/CC phosphorylation/NN could/MD be/VB excluded/VBN as/IN potential/JJ explanations/NNS for/IN the/DT protein/NN heterogeneity/NN ./.
@@75484255403/CD In/NN 4/CD spinalized/VBN cats/NNS ,/, the/DT effects/NNS of/IN afferent/JJ inputs/NNS from/IN hindlimb/NN cutaneous/JJ nerves/NNS (/( sural/JJ cutaneous/JJ nerve/NN :/: Sur/FW )/SYM on/IN mono-and/JJ poly-synaptic/JJ reflex/NN recorded/VBN from/IN tail/NN muscle/NN motoneurons/NNS were/VBD studied/VBN before/IN and/CC after/IN spinal/JJ lesioning/VBG at/IN S2-3/GENE level/NN ./.
@@87639534992/CD One/CD unit/NN encodes/VBZ traA/CONTEXTGENE ,/, traF/GENE ,/, and/CC traB/GENE ,/, while/CC the/DT second/JJ encodes/NNS traC/NN ,/, traD/NN ,/, and/CC traG/NN ./.
@@73270975578/CD In/NN PB/NN mice/NNS ,/, there/RB was/VBD only/RB a/DT small/JJ deficit/NN in/IN the/DT number/NN of/IN the/DT hippocampal/JJ pyramidal/JJ neurons/NNS compared/VBN to/IN controls/NNS (/( 15%/JJ ,/, p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ,/, and/CC no/DT deficit/NN in/IN the/DT granule/NN cells/NNS ./.
@@65353846325/CD In/NN the/DT Arithmetic/NNP subtest/NN one/PRP of/IN the/DT items/NNS would/MD not/RB meet/VB the/DT difficulty/NN grading/JJ shown/VBP while/CC the/DT last/JJ two/JJ items/NNS offer/VBP very/RB little/JJ possibility/NN of/IN success/NN for/IN all/DT subjects/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@18787552488/CD In/NN the/DT ileum/NN ,/, enterotoxin/NN increased/VBD the/DT luminal/JJ disappearance/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM and/CC peripheral/JJ blood/NN appearance/NN (/( P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM of/IN chloroquine/NN ./.
@@111607426850/CD Both/DT Z/NN and/CC R/NN expression/NN resulted/VBN in/IN PML/NN dispersion/NN in/IN EBV-positive/NNP cells/NNS ./.
@@107925837584/CD Regulation/NN of/IN pituitary/JJ vasopressin/MULTIGENE V1b/MULTIGENE receptors/MULTIGENE plays/VBP a/DT critical/JJ role/NN in/IN regulating/JJ pituitary/JJ adrenocorticotropic/JJ hormone/NN (/( ACTH/NN )/SYM secretion/NN during/IN adaptation/NN to/IN stress/NN ./.
@@99167869081/CD Measurements/NNS included/VBD bone/NN mineral/JJ density/NN of/IN the/DT lumbar/JJ spine/NN and/CC proximal/JJ femur/NN (/( by/IN dual-energy/JJ X-ray/NN absorptiometry/NN )/SYM and/CC biochemical/JJ markers/NNS of/IN bone/NN remodeling/NN (/( serum/JJ bone-specific/MULTIGENE alkaline/MULTIGENE phosphatase/MULTIGENE by/IN immunoassay/NN and/CC urine/NN deoxypyridinoline/NN by/IN high-pressure/JJ liquid/JJ chromatography/NN )/SYM ./.
@@84229755617/CD The/DT obvious/JJ functional/JJ necessity/NN for/IN editing/VBG in/IN kinetoplastid/NN mitochondria/NNS is/VBZ the/DT formation/NN of/IN translatable/JJ mRNAs/NNS ./.
@@87026336186/CD The/DT mechanism/NN involves/VBZ Gbetagamma/GENE subunit-mediated/JJ increases/NNS in/IN tyrosine/NN phosphorylation/NN of/IN the/PDT Shc/DT adapter/NN protein/NN ,/, Shc*Grb2/MULTIGENE complex/MULTIGENE formation/NN ,/, and/CC recruitment/NN of/IN Ras/MULTIGENE guanine/MULTIGENE nucleotide/MULTIGENE exchange/MULTIGENE factor/MULTIGENE activity/NN ./.
@@28727869549/CD The/DT Hagen-Poiseuille/GENE equation/NN is/VBZ used/VBN to/IN assess/VB the/DT effects/NNS of/IN attached/VBN parasites/NNS in/IN the/DT foregut/NN of/IN Leishmania-infected/JJ sandflies/NNS on/IN blood/NN flow/NN ./.
@@3023067834/CD Translation/NNP of/IN specific/JJ cellular/JJ genes/NNS from/IN the/DT chimeric/JJ viral-cellular/MULTIGENE transcripts/MULTIGENE seems/VBZ to/IN be/VB unlikely/JJ ./.
@@79887312491/CD Recently/RB ,/, a/DT protein/NN designated/VBN GF14/GENE has/VBZ been/VBN isolated/VBN that/WDT is/VBZ associated/VBN with/IN the/DT GBF/MULTIGENE protein/MULTIGENE complex/MULTIGENE ./.
@@76107357519/CD Diltiazem/GENE caused/VBN significant/JJ decrease/NN in/IN the/DT ventricular/JJ response/NN without/IN conversion/NN to/IN sinus/NN rhythm/NN ./.
@@35139894194/CD Although/IN not/RB common/JJ ,/, the/DT disorder/NN is/VBZ the/DT most/RB frequently/RB diagnosed/VBN disturbance/NN of/IN porphyrin/NN metabolism/NN in/IN many/JJ countries/NNS ,/, and/CC further/JJ insight/NN into/IN its/PRP unusual/JJ pathogenesis/NN may/MD clarify/VB the/DT hepatotoxic/JJ effects/NNS of/IN the/DT 4/CD etiologic/JJ agents/NNS ./.
@@94601719310/CD Resistance/NNP to/IN thyroid/JJ hormone/NN :/: implications/NNS for/IN neurodevelopmental/JJ research/NN on/IN the/DT effects/NNS of/IN thyroid/MULTIGENE hormone/MULTIGENE disruptors/MULTIGENE ./.
@@107793139672/CD We/PRP conclude/VBP that/IN ,/, both/DT in/NN atrial/JJ myocytes/NNS and/CC in/IN Xenopus/JJ oocytes/NNS ,/, beta-adrenergic/JJ stimulation/NN potentiates/VBZ the/DT ACh-evoked/JJ GIRK/GENE channels/NNS via/NN a/DT pathway/NN that/WDT involves/VBZ PKA-catalyzed/JJ phosphorylation/NN downstream/RB from/IN beta/NN (/NN 2/NN )/NN AR/NN ./.
@@95823437598/CD We/PRP established/VBD the/DT radiosensitive/JJ cell/NN line/NN SX9/CD from/IN mammary/JJ carcinoma/NN cell/NN line/NN FM3A/CELL ./.
@@81286296713/CD CRS/NN function/NN in/IN a/DT 5'/GENE LTR-linked/MULTIGENE gene/MULTIGENE expression/NN assay/NN correlates/VBP with/IN the/DT ability/NN of/IN both/DT p60CRS/GENE and/CC p40CRS/GENE to/IN interact/VB with/IN 5'/CD LTR/NN RNA/NN in/IN vitro/FW ./.
@@93343302531/CD Null/NNP mutations/NNS in/IN daf-3/NNP suppress/VB mutations/NNS in/IN genes/NNS encoding/VBG this/DT TGF-beta/NEWGENE signal/JJ ,/, its/PRP receptors/NNS ,/, and/CC associated/VBD Smad/NN signal/JJ transduction/NN proteins/NNS ./. daf-3/GENE encodes/VBZ a/DT Smad/NN protein/NN that/WDT is/VBZ most/RB closely/RB related/VBN to/IN mammalian/JJ DPC4/GENE ,/, and/CC is/VBZ expressed/VBN throughout/IN development/NN in/IN many/NN of/IN the/DT tissues/NNS that/WDT are/VBP remodeled/VBN during/IN dauer/NN development/NN ./.
@@75596399136/CD In/NN addition/NN ,/, the/DT R206S/MULTIGENE HSF/MULTIGENE substitution/NN exhibits/VBP constitutive/JJ transcriptional/JJ activation/NN from/IN a/DT consensus/NN HSE/CONTEXTGENE (/( HSE2/GENE )/SYM ./.
@@11030066860/CD The/DT major/JJ neurological/JJ manifestations/NNS of/IN brain/NN injury/NN in/IN these/DT babies/NNS are/VBP spastic/JJ motor/JJ deficits/NNS ./.
@@386251319/CD The/DT IDF/GENE standard/JJ method/NN for/IN the/DT detection/NN of/IN penicillin/NN in/IN milk/NN is/VBZ not/RB suitable/JJ for/IN the/DT detection/NN of/IN sulphonamide/NN residues/NNS in/IN milk/NN ./.
@@7802355823/CD Comparative/JJ study/NN of/IN the/DT differential/JJ white/JJ blood/NN cell/NN count/NN using/VBG three/CD automated/JJ analyzers/NNS :/: Coulter/NN STKS/GENE ,/, Sysmex/NN NE/NN 8000/CD and/CC Technicon/VB H-1/NN ./.
@@84972691238/CD This/DT sequence/NN similarity/NN raises/VBP the/DT possibility/NN that/IN GCN1/GENE interacts/VBZ with/IN ribosomes/NNS or/CC tRNA/NN molecules/NNS and/CC functions/NNS in/IN conjunction/NN with/IN GCN2/GENE in/IN monitoring/VBG uncharged/JJ tRNA/NN levels/NNS during/IN the/DT process/NN of/IN translation/NN elongation/NN ./.
@@94633807517/CD Moreover/RB ,/, xTAK1KN/GENE could/MD block/VB the/DT expression/NN of/IN ventral/JJ mesoderm/NN marker/NN genes/NNS induced/VBN by/IN Smad1/GENE or/CC 5/NN ./NN
@@2445751729/CD The/DT first/RB involved/VBN measurements/NNS of/IN the/DT steady/JJ state/NN levels/NNS of/IN mRNAs/NNS for/IN subunit/NN 5/CD of/IN cytochrome/MULTIGENE oxidase/MULTIGENE and/CC the/DT beta/MULTIGENE subunit/MULTIGENE of/IN F1/MULTIGENE ATPase/MULTIGENE in/IN wild/JJ type/NN and/CC in/IN a/DT hem2/MULTIGENE mutant/MULTIGENE ./.
@@733447190/CD In/NN 2/CD subjects/VBZ the/DT phytomitogen/NN reactivity/NN of/IN the/DT lymphocytes/NNS was/VBD improved/VBN after/IN treatment/NN ./.
@@68153686589/CD The/DT osmotic/JJ diuretic/JJ mannitol/NN was/VBD administered/VBN to/IN 21/CD patients/NNS ./.
@@75902683313/CD A/DT 2/CD ./CD 4-kb/CD MAPKAPK-2/MULTIGENE message/MULTIGENE is/VBZ expressed/VBN throughout/IN development/NN ,/, while/CC two/RB shorter/JJR transcripts/NNS of/IN 2/CD ./CD 3/CD and/CC 1/CD ./CD 8/CD kb/NN appear/VB to/IN be/VB specifically/RB expressed/VBN in/IN the/DT germline/NN ./.
@@91214241901/CD Here/RB we/PRP characterize/VBP an/DT S/NNP ./NNP cerevisiae/NN Swi3/MULTIGENE homolog/MULTIGENE (/( Swh3/GENE )/SYM and/CC present/VB evidence/NN that/IN it/PRP associates/VBP in/IN a/DT complex/NN with/IN a/DT Snf2/MULTIGENE homolog/MULTIGENE ,/, Sthl/NNP ./.
@@90181333768/CD Phylogenetic/JJ analysis/NN gave/VBD evidence/NN for/IN a/DT close/JJ evolutionary/JJ relationship/NN between/IN PhHV-1/GENE and/CC members/NNS of/IN the/DT Varicellovirus/NNP genus/NN of/IN the/DT alpha-Herpesvirinae/NN and/CC canid/NN herpesvirus/NN in/IN particular/NN ./.
@@86043381124/CD Both/DT EWS-FLI-1/GENE and/CC FLI-1/MULTIGENE proteins/MULTIGENE function/NN as/IN transcription/NN factors/NNS that/WDT bind/VBP specifically/RB to/IN ets/NN sequences/NNS (/( the/DT ets/NN boxes/NNS )/SYM present/VB in/IN promoter/NN elements/NNS ./.
@@73793349880/CD Changes/NNS in/IN immunologic/JJ reactivity/NN in/IN subjects/NNS receiving/JJ transfer/MULTIGENE factor/MULTIGENE could/MD not/RB be/VB distinguished/VBN from/IN those/DT in/NN subjects/NNS receiving/JJ placebo/NN ./.
@@64281166227/CD Transitory/JJ subclinical/JJ and/CC permanent/JJ hypothyroidism/NN in/IN the/DT course/NN of/IN subacute/JJ thyroiditis/NN (/( de/FW Quervain/NN )/SYM ./.
@@105972234460/CD Transient/JJ ,/, high-level/NNP Ras-expression/GENE induces/VBZ transcriptional/JJ activation/NN of/IN p21/GENE mediated/JJ by/IN a/DT GC-rich/NNP region/NN in/IN p21/MULTIGENE promoter/MULTIGENE -83-54/JJ bp/NN relative/JJ to/IN the/DT transcription/MULTIGENE initiation/MULTIGENE site/MULTIGENE containing/MULTIGENE binding/MULTIGENE sites/MULTIGENE for/IN Sp1-family/MULTIGENE transcription/MULTIGENE factors/MULTIGENE ./.
@@13325891963/CD The/DT MICs/NNS of/IN this/DT compound/NN against/IN 90%/CD of/IN these/DT organisms/NNS ,/, except/VB for/IN methicillin-resistant/NNP S/NNP ./NNP aureus/NN ,/, ranged/VBN from/IN less/PRP than/IN or/CC equal/NN to/IN 0/CD ./CD 006/CD to/IN 3/CD ./CD 13/CD micrograms/NN //NN ml/NN ./.
@@68513273029/CD Five/CD patients/NNS with/IN type/MULTIGENE III/MULTIGENE musculoskeletal/JJ infection/NN from/IN nongonococcal/JJ Neisseria/NN species/NN were/VBD examined/VBN during/IN a/DT 13-month/CD period/NN ./.
@@37807044461/CD A/DT large/JJ increase/NN of/IN serum/JJ ketones/NNS occurred/VBN under/IN all/DT conditions/NNS ,/, and/CC the/DT exercise/NN respiratory/JJ quotient/NN suggested/VBD some/DT increase/NN of/IN fat/JJ utilization/NN ,/, WW/NN (/( 0/CD ./CD 85/CD )/SYM through/RB CW/JJ (/( 0/CD ./CD 84/CD )/SYM to/IN CC/NN (/( 0/CD ./CD 83/CD )/SYM ./.
@@92248112812/CD The/DT current/JJ study/NN demonstrates/VBZ that/IN T3-activated/JJ transcription/NN of/IN the/DT NADPH/NN :/: cytochrome/MULTIGENE P450/MULTIGENE oxidoreductase/MULTIGENE (/( P450R/GENE )/SYM gene/NN is/VBZ dependent/JJ on/IN the/DT thyroid/JJ hormonal/JJ status/NN of/IN the/DT animal/NN ,/, with/IN both/DT transcriptional/JJ and/CC post-transcriptional/JJ pathways/NNS being/VBP important/JJ in/IN regulating/JJ the/DT cellular/JJ P450R/MULTIGENE mRNA/MULTIGENE level/NN ./.
@@14686251883/CD From/IN this/DT library/NN ,/, LEU2/NEWGENE and/CC HIS3/NEWGENE cDNAs/NNS were/VBD recovered/VBN at/IN a/DT frequency/NN of/IN about/RB 1/CD in/IN 10/NN (/NN 4/NN )/NN and/CC in/IN 12/CD out/RB of/IN 13/CD cases/VBZ these/DT were/VBD expressed/VBN in/IN a/DT galactose-dependent/JJ manner/NN ./.
@@87260241533/CD However/RB ,/, as/IN determined/VBN by/IN PCR/NN with/IN primers/NNS specific/JJ for/IN the/DT 26-kDa/MULTIGENE product/MULTIGENE ,/, the/DT majority/NN of/IN cats/NNS at/IN 2/CD and/CC 4/CD weeks/NNS p/CD ./CD t/CD ./. had/VBP gastric/JJ fluid/NN samples/NNS which/WDT were/VBD positive/JJ for/IN H/NNP ./NNP pylori/NNS and/CC three/CD of/IN three/CD cats/NNS at/IN 2/CD weeks/NNS p/CD ./CD t/CD ./. had/VBP dental/JJ plaque/NN which/WDT was/VBD positive/JJ for/IN H/NNP ./NNP pylori/NNS ./.
@@24973407411/CD Functional/JJ rearranged/JJ antibody/NN genes/NNS were/VBD detected/VBN with/IN JH/NNP and/CC VH/MULTIGENE heavy/MULTIGENE chain/MULTIGENE probes/NNS and/CC with/IN Jk/NNP and/CC Vk/MULTIGENE light/MULTIGENE chain/MULTIGENE probes/NNS ./.
@@19994597633/CD A/NNP ./NNP
@@63545946156/CD Sweet/JJ oranges/NNS ,/, mandarin/NN ,/, grapefruit/NN ,/, lemon/NN ,/, and/CC lime/NN are/VBP generally/RB used/VBN for/IN processing/VBG ./.
@@15869012176/CD Drug-drug/NNP interactions/NNS are/VBP most/RB likely/RB to/IN occur/VB in/IN patients/NNS receiving/JJ multiple/JJ medications/NNS and/CC with/IN drugs/NNS that/WDT have/VBP a/DT narrow/JJ therapeutic/JJ window/NN ./.
@@93637592353/CD Protein/MULTIGENE phosphatases/MULTIGENE play/VBP a/DT critical/JJ role/NN in/IN the/DT regulation/NN of/IN the/DT eukaryotic/JJ cell/NN cycle/NN and/CC signal/JJ transduction/NN ./.
@@92613972453/CD Gag/MULTIGENE protein/MULTIGENE sequence/MULTIGENE motifs/MULTIGENE of/IN the/DT NC/NEWGENE domain/NN of/IN primate/NN foamy/JJ viruses/NNS assumed/VBN to/IN be/VB involved/VBN in/IN genome/NN encapsidation/NN are/VBP not/RB conserved/VBN in/IN FeFV/NNP ./.
@@88876676597/CD The/DT requirement/NN of/IN Tyr-19/CD dephosphorylation/NN for/IN spindle/NN assembly/NN is/VBZ also/RB observed/VBN under/IN conditions/NNS in/IN which/WDT spindle/VBP formation/NN is/VBZ independent/NN of/IN mitosis/NN ,/, suggesting/VBG that/IN the/DT involvement/NN of/IN Cdc28/MULTIGENE //MULTIGENE Clb/MULTIGENE kinase/MULTIGENE in/IN SPB/NNP separation/NN is/VBZ direct/JJ ./.
@@90460135982/CD The/DT neuroprotective/JJ efficacy/NN of/IN the/DT selective/JJ N-type/NN voltage-sensitive/JJ calcium/NN channel/NN blocker/NN ,/, SNX-111/GENE ,/, was/VBD evaluated/VBN in/IN spontaneously/RB hypertensive/JJ rats/NNS subjected/VBN to/IN 60/CD min/NN of/IN focal/JJ cerebral/JJ ischemia/NN by/IN permanent/JJ ligation/NN of/IN the/DT right/JJ common/JJ carotid/JJ artery/NN and/CC temporary/JJ occlusion/NN of/IN the/DT right/JJ middle/JJ cerebral/JJ artery/NN ./.
@@110461533018/CD Further/RB ,/, Tax-mediated/JJ apoptosis/NN was/VBD effectively/RB prevented/VBN by/IN ectopic/JJ expression/NN of/IN the/DT p300/MULTIGENE coactivator/MULTIGENE ./.
@@1008043680/CD Comparison/NNS of/IN frequencies/NNS of/IN atrial/JJ fibrillation/NN after/IN coronary/JJ artery/NN bypass/NN grafting/NN with/IN and/CC without/IN the/DT use/NN of/IN cardiopulmonary/JJ bypass/NN ./.
@@110530097155/CD Aspirin/NNP causes/VBZ peptic/JJ ulcers/NNS predominately/RB by/IN reducing/JJ gastric/JJ mucosal/JJ cyclooxygenase/NN (/( COX/NN )/SYM activity/NN and/CC prostaglandin/NN synthesis/NN ./.
@@105981017620/CD The/DT mEmBP-1/MULTIGENE protein/MULTIGENE can/MD activate/VB transcription/NN from/IN a/DT truncated/JJ promoter/MULTIGENE containing/MULTIGENE a/MULTIGENE pentamer/MULTIGENE of/IN the/DT O2/MULTIGENE site/MULTIGENE in/IN yeast/NN cells/NNS ;/: however/RB ,/, it/PRP inhibited/VBD regulated/VBN transcription/NN of/IN a/DT 22/CD kDa/NN zein/NN promoter/NN in/IN a/DT transient/JJ expression/NN assay/NN using/VBG cultured/JJ maize/NN endosperm/NN cells/NNS ./.
@@100754155144/CD Partial/JJ sequencing/VBG of/IN the/DT region/NN downstream/RB of/IN ORF-Pto/NNP revealed/VBD homology/NN to/IN the/DT ru/MULTIGENE //MULTIGENE AB/MULTIGENE genes/MULTIGENE ,/, involved/VBN in/IN UV/NN resistance/NN ,/, from/IN plasmid/NN pPSR1/GENE ./.
@@10961585780/CD The/DT manifestations/NNS often/RB include/VBP a/DT moderate/JJ thrombocytopenia/NN and/CC ,/, less/PRP commonly/RB ,/, hemolysis/NN ./.
@@40021314663/CD During/IN a/DT disease/NN remission/NN there/RB was/VBD an/DT increase/NN in/IN GAG/NNP secretion/NN with/IN urine/NN ,/, linked/JJ with/IN hyperheparinuria/NN (/( 13/NN ./NN 1-fold/NN ,/, P/NN less/PRP than/IN 0/CD ./CD 001/CD )/SYM ./.
@@34175884117/CD Liquid/NNP chromatographic/JJ method/NN for/IN determination/NN of/IN citreoviridin/NN in/IN corn/NN and/CC rice/NN ./.
@@80958754146/CD Effects/NNPS of/IN moderate/JJ hypercapnia/NN on/IN hypothermia/NN induced/VBN by/IN cold/JJ He-O2/GENE in/IN rats/NNS ./.
@@77046897655/CD Solitary/NNP thyroid/JJ nodule/NN ./.
@@108659404463/CD The/DT antioxidant/JJ agent/NN pyrrolidine/NN dithiocarbamate/NN (/( PDTC/NN )/SYM has/VBZ been/VBN shown/VBP to/IN protect/VB endothelial/JJ cells/NNS (/( EC/NN )/SYM from/IN pro-inflammatory-induced/JJ and/CC pro-oxidant-induced/MULTIGENE NF-kappaB/MULTIGENE activation/NN ./.
@@104480369436/CD The/DT interaction/NN of/IN zf4-6/JJ with/IN full-length/JJ 5/MULTIGENE S/MULTIGENE RNA/MULTIGENE was/VBD far/RB more/RB sensitive/JJ to/IN non-specific/JJ competitor/NN concentration/NN than/IN was/VBD the/DT zf4-7/JJ :/: 5/MULTIGENE S/MULTIGENE RNA/MULTIGENE interaction/NN ,/, suggesting/VBG that/DT finger/NN seven/NN contributes/VBZ to/IN both/DT affinity/NN and/CC specificity/NN in/IN this/DT protein/NN :/: RNA/NN interaction/NN ./.
@@118041005504/CD It/PRP was/VBD found/VBN that/IN the/DT disappearance/NN of/IN BOD5/GENE and/CC NH3-N/GENE could/MD be/VB approximated/VBN using/VBG first-order/JJ kinetics/NN ,/, but/CC the/DT kinetics/NN of/IN TP/NN removal/NN were/VBD unclear/JJ ./.
@@28181223517/CD A/DT great/JJ deal/NN of/IN information/NN is/VBZ available/JJ on/IN the/DT morphology/NN of/IN the/DT claustrum/NN in/IN various/JJ animal/NN species/NN ,/, as/RB well/VB as/IN on/IN its/PRP neuronal/JJ distribution/NN and/CC relationships/NNS with/IN the/DT cerebral/JJ cortex/NN and/CC other/DT nuclei/NNS ./.
@@106923741051/CD These/DT results/NNS suggest/VBP that/IN the/DT M/NNP ./NNP jannaschii/NN as/RB well/VB as/IN related/VBN archaeal/JJ 20S/CD proteasomes/NNS require/VBP a/DT nucleotidase/MULTIGENE complex/MULTIGENE such/JJ as/IN PAN/NNP to/IN mediate/VB the/DT energy-dependent/JJ hydrolysis/NN of/IN folded-substrate/MULTIGENE proteins/MULTIGENE and/CC that/IN the/DT N-terminal/MULTIGENE 73/MULTIGENE amino/JJ acid/NN residues/NNS of/IN PAN/NNP are/VBP not/RB absolutely/RB required/VBN for/IN this/DT reaction/NN ./.
@@83871552280/CD This/DT stimulatory/JJ effect/NN could/MD also/RB be/VB elicited/VBN by/IN c-Jun/GENE ,/, which/WDT interacts/VBZ with/IN topo/NNP II/NNP ,/, but/CC not/RB by/IN c-Fos/GENE ,/, which/WDT does/VBP not/RB bind/VB topo/NNP II/NNP in/IN our/PRP in/IN vitro/FW assay/NN ./.
@@74943066607/CD Here/RB we/PRP examine/VBP the/DT potential/NN for/IN VP16/MULTIGENE protein-protein/MULTIGENE interactions/NNS specific/JJ to/IN virus-infected/JJ cells/NNS and/CC show/VB that/DT VP16/NN copurifies/VBZ in/IN a/DT highly/RB enriched/VBN fraction/NN with/IN a/DT single/JJ major/JJ polypeptide/NN which/WDT we/PRP identify/VBP as/IN the/DT virus-encoded/JJ structural/MULTIGENE protein/MULTIGENE VP22/MULTIGENE ./.
@@415124819/CD Abstracts/NNP ./.
@@97776009763/CD A/DT simple/JJ analytical/JJ method/NN for/IN l-menthol/NN by/IN high-performance/JJ liquid/JJ chromatography/NN with/IN a/DT polarized/JJ photometric/JJ detector/NN was/VBD established/VBN ./.
@@111870161028/CD Multistage/NNP models/NNS and/CC the/DT A-bomb/NN survivor/NN data/NN :/: implications/NNS for/IN carcinogenic/JJ mechanisms/NNS ?/.
@@9050689790/CD The/DT best/JJS endometrial/JJ ablation/NN was/VBD seen/VBP when/CC SnET2/GENE was/VBD given/VBP by/IN intrauterine/JJ administration/NN with/IN light/NN treatment/NN at/IN 150/CD J/NNP //NNP cm/NNP 24/CD hours/NNS later/JJR ./.
@@75606627452/CD After/IN recovery/NN ,/, a/DT hypertonic/JJ saline/JJ challenge/NN was/VBD performed/VBN ./.
@@21155726777/CD We/PRP also/RB discovered/VBD a/DT V/MULTIGENE lambda/MULTIGENE pseudogene/NN ,/, called/VBN psi/MULTIGENE V/MULTIGENE lambda/MULTIGENE 1/MULTIGENE ,/, 3/CD kb/NN upstream/RB of/IN the/DT U266/MULTIGENE lambda/MULTIGENE gene/MULTIGENE ./.
@@10079179/CD These/DT results/NNS indicate/VBP that/IN cynomolgus/JJ monkeys/NNS are/VBP either/DT less/PRP sensitive/JJ or/CC respond/VB differently/RB than/IN rhesus/NN monkeys/NNS to/IN some/DT of/IN the/DT pharmacological/JJ effects/NNS of/IN norcocaine/NN ./.
@@12353471870/CD Experimental/JJ cardiotoxicity/NN of/IN adriamycin/NN ./.
@@23103502960/CD The/DT present/NN study/NN examined/VBD the/DT effect/NN of/IN intensity/NN ,/, rate/NN ,/, and/CC polarity/NN on/IN the/DT spectral/JJ content/NN of/IN ABRs/NNS of/IN 15/CD normal-hearing/JJ subjects/NNS ./.
@@88089242626/CD Its/PRP hydropathy/NN profile/NN predicts/VBZ seven/JJ transmembrane/JJ spans/NNS and/CC a/DT hydrophilic/JJ amino/JJ terminus/NN of/IN approximately/RB 100/CD residues/NNS ,/, and/CC it/PRP suggests/VBZ the/DT presence/NN of/IN an/DT amphiphilic/JJ alpha-helix/NN (/( L-61/GENE to/IN F-97/CD )/SYM in/IN close/JJ proximity/NN to/IN the/DT first/JJ strongly/RB hydrophobic/JJ segment/NN of/IN ProW/NNP ./.
@@106534004668/CD The/DT applicability/NN of/IN laparoscopic/JJ donor/NN nephrectomy/NN (/( LDN/GENE )/SYM has/VBZ not/RB been/VBN assessed/VBN in/IN the/DT obese/JJ donor/NN ./.
@@104881481916/CD ERK/MULTIGENE MAP/MULTIGENE kinase/MULTIGENE links/NNS cytokine/NN signals/NNS to/IN activation/NN of/IN latent/JJ HIV-1/NNP infection/NN by/IN stimulating/JJ a/DT cooperative/JJ interaction/NN of/IN AP-1/GENE and/CC NF-kappaB/GENE ./.
@@15848128418/CD Neural-specific/NN expression/NN ,/, genomic/JJ structure/NN ,/, and/CC chromosomal/JJ localization/NN of/IN the/DT gene/NN encoding/VBG the/DT zinc-finger/MULTIGENE transcription/MULTIGENE factor/MULTIGENE NGFI-C/GENE ./.
@@33668649283/CD The/DT skin/NN site/NN ,/, 6-cm-distal/GENE and/CC -proximal/CD subcutaneous/JJ segments/NNS of/IN the/DT catheter/NN ,/, exudates/NNS ,/, and/CC blood/NN were/VBD cultured/JJ ./.
@@53056715463/CD A/DT brief/JJ discussion/NN of/IN color/NN deficiencies/NNS ./.
@@104883378017/CD A/DT human/JJ nuclear-localized/JJ chaperone/NN that/WDT regulates/VBZ dimerization/NN ,/, DNA/NN binding/JJ ,/, and/CC transcriptional/JJ activity/NN of/IN bZIP/MULTIGENE proteins/MULTIGENE ./.
@@93253228778/CD The/DT inhibition/NN by/IN cytosolic/JJ Ca2+/NN was/VBD caused/VBN by/IN a/DT decrease/NN in/IN cooperativity/NN and/CC by/IN a/DT shift/NN in/IN EC50/NN toward/IN higher/JJ InsP3/NN concentrations/NNS ./.
@@78362187938/CD Some/DT studies/NNS of/IN exercise/NN have/NN associated/VBD beta-endorphin/NEWGENE release/NN with/IN increased/VBN exertion/NN levels/NNS ,/, but/CC other/DT evidence/NN suggests/VBZ that/DT acidosis/NN may/MD stimulate/VB the/DT release/NN of/IN beta-endorphin/NN ./.
@@1170438054/CD The/DT event/NN rate/NN in/IN patients/NNS with/IN chronic/JJ Irr-rMFP/GENE or/CC Un-nrMFP/GENE was/VBD markedly/RB higher/JJ than/IN it/PRP was/VBD in/IN those/DT with/IN Rev-rMFP/NNP or/CC Sta-nrMFP/NNP ./.
@@21131749335/CD Krox-24/GENE is/VBZ therefore/RB a/DT sequence-specific/MULTIGENE transcriptional/MULTIGENE activator/MULTIGENE ./.
@@84289076479/CD In/NN wandering/JJ stage/NN larvae/NNS ,/, the/DT OBP/MULTIGENE transcript/MULTIGENE appeared/VBN to/IN be/VB at/IN least/RB 250-fold/JJ less/PRP abundant/JJ than/IN ribosomal/JJ RNA/NN ./.
@@83942554766/CD A/DT sheep/NN testicular/JJ cDNA/NN library/NN constructed/VBN in/IN pcDNA1/NNP vector/NN was/VBD screened/VBN with/IN a/DT probe/NN generated/VBN by/IN polymerase/NN chain/NN reaction/NN (/( PCR/NN )/SYM and/CC corresponding/JJ to/IN a/DT 1/CD ./CD 6/CD kb/NN fragment/NN of/IN the/DT rat/NN luteinizing/JJ hormone/MULTIGENE receptor/MULTIGENE cDNA/MULTIGENE ./.
@@1071715543/CD Plethysmographic/NNP technique/NN and/CC indirect/JJ blood/NN pressure/NN recordings/NNS were/VBD used/VBN ./.
@@83716508333/CD Dissipation/NNS of/IN claudication/NN pain/NN after/IN walking/NN :/: implications/NNS for/IN endurance/NN training/NN ./.
@@114249921299/CD This/DT is/VBZ necessary/JJ if/IN psychiatric/JJ diagnoses/NNS are/VBP ultimately/RB going/JJ to/IN be/VB refined/VBN and/CC validated/VBN against/IN biological/JJ criteria/NNS ./.
@@97225086532/CD Furthermore/RB ,/, we/PRP demonstrated/VBD that/IN Galpha11/GENE Q209L/GENE stimulated/VBN Src/MULTIGENE family/MULTIGENE kinase/MULTIGENE activity/NN and/CC induced/VBN tyrosine/NN phosphorylation/NN of/IN several/DT proteins/NNS in/IN HEK-293/CD cells/NNS ./.
@@10388670255/CD The/DT percentages/NNS of/IN recovery/NN decreased/VBN with/IN storage/NN time/NN ,/, although/IN the/DT addition/NN of/IN dispersant/NN (/( Tris-Tween/NNP 80/CD )/SYM before/IN storage/NN appeared/VBN to/IN partially/RB prevent/VB adhesion/NN ./.
@@119085291819/CD The/DT results/NNS are/VBP given/VBP as/IN :/: flux/NN ,/, number/NN of/IN stars/NNS per/IN CM3/NNP ,/, charge/NN of/IN the/DT ions/NNS ,/, comparison/NN with/IN other/DT detectors/NNS (/( plastics/NNS ,/, AgCl/NNP crystals/NNS ,/, LiF/GENE )/SYM ,/, energy/NN loss/NN ,/, hit/JJ region/NN in/IN the/DT biological/JJ objects/NNS ./.
@@10146207115/CD Ultrasonography/NNS provides/VBZ excellent/JJ intraoperative/JJ evaluation/NN of/IN spinal/JJ cord/NN injury/NN ./.
@@76073424186/CD This/DT paper/NN summarises/VBZ the/DT experimental/JJ evidence/NN upon/IN which/WDT the/DT clinical/JJ trials/NNS of/IN aldose/MULTIGENE reductase/MULTIGENE inhibitors/MULTIGENE in/IN diabetic/JJ patients/NNS have/VBP been/VBN initiated/VBN and/CC the/DT results/NNS of/IN published/VBN drug/NN trials/NNS in/IN these/DT patients/NNS ./.
@@80354993293/CD At/NN least/RB some/DT of/IN the/DT difference/NN in/IN stability/NN of/IN the/DT two/JJ kinds/NNS of/IN complexes/NNS was/VBD due/NN to/IN the/DT fact/NN that/IN the/DT dissociation/NN rate/NN of/IN the/PDT A/DT stem/NN substrate/NN from/IN the/DT protein-DNA/JJ complexes/NNS was/VBD approximately/RB fourfold/RB faster/RBR than/IN that/DT of/IN the/DT complete/JJ TR/NNP ./NNP
@@15457979793/CD Disruption/NNS mutations/NNS have/VBP been/VBN constructed/VBN in/IN the/DT SLK1/MULTIGENE gene/MULTIGENE ./. slk1/GENE null/JJ mutants/NNS cannot/MD grow/VB at/IN 37/CD degrees/NNS C/NN ,/, but/CC many/JJ cells/NNS can/MD grow/VB at/IN 30/CD ,/, 24/CD ,/, and/CC 17/CD degrees/NNS C/NNP ./NNP
@@113526719649/CD As/IN an/DT application/NN of/IN reverse/JJ genetics/NN ,/, we/PRP introduced/VBD one/PRP nucleotide/NN change/NN (/( UCU/NNP to/IN ACU/NNP )/SYM to/IN immediate/JJ downstream/RB of/IN the/DT RNA-editing/MULTIGENE site/MULTIGENE of/IN the/DT V/MULTIGENE gene/MULTIGENE in/IN the/DT full-length/JJ hPIV2/MULTIGENE cDNA/MULTIGENE and/CC were/VBD able/JJ to/IN obtain/VB infectious/JJ viruses/NNS [/NN rPIV2V/NN (/NN -/NN )/NN ]/NN from/IN the/DT cDNA/NN ./.
@@20938883150/CD ARPIA/GENE has/VBZ been/VBN implemented/VBN by/IN using/VBG a/DT relational/JJ DBMS/NN ,/, very/RB cheap/JJ and/CC highly/RB diffused/VBN on/IN personal/JJ computers/NNS ./.
@@110622748594/CD Combined/VBN intravenous/JJ and/CC intra-arterial/JJ recombinant/JJ tissue/NEWGENE plasminogen/MULTIGENE activator/MULTIGENE in/IN acute/JJ ischemic/JJ stroke/NN ./.
@@60895755918/CD Stimulation/NNS with/IN MCh/NNS produced/VBD a/DT Ca-dependent/NNP transient/JJ elevation/NN of/IN cGMP/NN level/NN from/IN 10/CD to/IN 80/CD fmol/NN //NN gland/NN ,/, peaking/VBG at/IN 1-2/CD min/NN but/CC returning/VBG to/IN the/DT basal/JJ level/NN by/IN 5/CD min/NN ./.
@@60887225910/CD Courses/NNS were/VBD repeated/JJ monthly/NN upon/IN recovery/NN of/IN myelosuppression/NN ./.
@@88771031895/CD To/TO study/VB the/DT regulation/NN of/IN mdr2/GENE expression/NN ,/, the/DT promoter/NN of/IN the/DT mdr2/MULTIGENE gene/MULTIGENE has/VBZ been/VBN isolated/VBN from/IN a/DT murine/JJ vinblastine-resistant/JJ cell/NN line/NN ,/, J7/CELL ./CELL V2-1/CELL ,/, and/CC characterized/VBD ./.
@@116041521496/CD The/DT MABP/NN and/CC MCBFV/NNP signals/NNS were/VBD bandpass/NN filtered/JJ in/IN the/DT very/RB low-frequency/JJ range/NN (/( VLF/NN ,/, 0/CD ./CD 015-0/CD ./CD 07/CD Hz/NN )/SYM ,/, low-frequency/JJ range/NN (/( LF/NN ,/, 0/CD ./CD 07-0/CD ./CD 15/CD Hz/NN )/SYM and/CC high-frequency/JJ range/NN (/( HF/NN ,/, 0/CD ./CD 15-0/CD ./CD 40/CD Hz/NN )/SYM before/IN applying/VBG CCF/NNP for/IN the/DT purpose/NN of/IN studying/VBG the/DT effect/NN of/IN different/JJ bandwidths/NNS on/IN the/DT resulting/JJ mean/JJ CCFs/NNP ./.
@@6443146243/CD Delayed/JJ hypersensitivity/NN in/IN man/NN :/: effects/NNS of/IN systemic/JJ anticoagulation/NN ./.
@@105675249730/CD The/DT elm1/MULTIGENE kinase/MULTIGENE functions/NNS in/IN a/DT mitotic/JJ signaling/JJ network/NN in/IN budding/JJ yeast/NN ./.
@@11015197835/CD We/PRP have/VBP mutated/JJ to/IN cysteine/NN ,/, one/PRP at/IN a/DT time/NN ,/, 21/CD consecutive/JJ residues/NNS in/IN the/DT fourth/NN TMS/NN (/( TM4/NNS )/SYM ./.
@@89950541045/CD D/NN ./NN melanogaster/NN HeT-A/GENE coding/JJ sequences/NNS have/VBP a/DT polymorphic/JJ region/NN with/IN insertions/NNS //NNS deletions/NNS of/IN 1-31/CD codons/NNS and/CC many/JJ nucleotide/NN changes/NNS ./.
@@21265042727/CD Although/IN no/DT Rh-antibodies/NNS were/VBD demonstrable/JJ ,/, a/DT similar/JJ mechanism/NN can/MD be/VB postulated/VBN for/IN the/DT Rh-system/NNP ./.
@@77537969891/CD The/DT predicted/VBN amino/JJ acid/NN sequence/NN contains/VBZ regions/NNS identical/JJ to/IN the/DT sequences/NNS of/IN peptides/NNS derived/VBN from/IN bovine/MULTIGENE liver/MULTIGENE eIF-2B/MULTIGENE alpha/MULTIGENE subunit/MULTIGENE ./.
@@105875769021/CD These/DT REPs/NNS ,/, or/CC clusters/NNS of/IN paralogous/JJ loci/NNS ,/, are/VBP 15-100/JJ kb/NN and/CC harbor/VB at/IN least/RB four/CD ESTs/NNS and/CC an/DT expressed/VBN SH3GL/GENE pseudogene/NN ./.
@@104735897935/CD The/DT N/JJ terminus/NN of/IN beta/NN (/( 95/CD kDa/NN )/SYM corresponds/VBZ to/IN alpha/NN with/IN the/DT integrase/NEWGENE domain/NN attached/VBN to/IN the/DT C/NN terminus/NN (/( 32/CD kDa/NN )/SYM ./.
@@109381029038/CD Eukaryotic/MULTIGENE translation/MULTIGENE initiation/MULTIGENE factor/MULTIGENE 4GI/GENE is/VBZ a/DT cellular/JJ target/NN for/IN NS1/MULTIGENE protein/MULTIGENE ,/, a/DT translational/JJ activator/NN of/IN influenza/NN virus/NN ./.
@@92714006854/CD Various/JJ assays/NNS demonstrate/VBP promoter/NN activity/NN in/IN this/DT sequence/NN that/WDT reproduces/VBZ the/DT normal/JJ control/NN of/IN E2F2/GENE expression/NN during/IN a/DT growth/NN stimulation/NN ./.
@@112830109456/CD This/DT activation/NN was/VBD then/RB blocked/VBN by/IN CGS/MULTIGENE 12066A/MULTIGENE ./.
@@112406004949/CD A/DT complete/JJ drug/NN history/NN was/VBD compiled/VBN ,/, specifying/VBG the/DT amount/NN and/CC duration/NN of/IN VGB/NN medication/NN ./.
@@93680571704/CD Thus/RB ,/, unlike/IN other/DT proteins/NNS reported/VBN to/IN inhibit/VB SRF/NN activity/NN ,/, the/DT repressor/NN activity/NN associated/VBN with/IN the/DT GC-rich/NNP element/NN does/VBP not/RB appear/VB to/IN function/NN through/RB direct/JJ inhibition/NN of/IN SRF/NN binding/JJ ./.
@@106425243752/CD The/DT concomitant/JJ interaction/NN of/IN mSTI1/GENE with/IN hsp70/GENE and/CC hsp90/GENE at/IN its/PRP N-/DT and/CC C-termini/NNS respectively/RB is/VBZ mediated/JJ by/IN the/DT tetratricopeptide/NN repeat/NN (/( TPR/NN )/SYM motifs/NNS in/IN these/DT regions/NNS ./.
@@21028316679/CD The/DT 5'/CD regions/NNS of/IN these/DT two/JJ soybean/NN actin/MULTIGENE genes/MULTIGENE contain/VBP many/JJ unusual/JJ features/NNS including/JJ (/( CT/NN )/SYM repeats/NNS and/CC long/JJ stretches/NNS of/IN pyrimidine-rich/JJ DNA/NN ./.
@@107419473391/CD A/DT new/JJ technique/NN to/IN create/VB an/DT artificial/JJ stenosis/NN in/IN the/DT native/JJ LAD/NEWGENE using/VBG a/DT hemoclip/NN ./.
@@10908462736/CD The/DT effectiveness/NN of/IN NRT/NN appears/VBZ to/IN be/VB largely/RB independent/NN of/IN the/DT intensity/NN of/IN additional/JJ support/NN provided/VBN to/IN the/DT smoker/NN ./.
@@95358354257/CD ROCK-I/NNP ,/, Kinectin/NNP ,/, and/CC mDia2/GENE can/MD bind/VB the/DT wild/JJ type/NN forms/NNS of/IN both/DT RhoA/NN and/CC Cdc42/GENE in/IN a/DT GTP-dependent/NNP manner/NN in/IN vitro/FW ./.
@@104337299338/CD A/NNP ./NNP ,/, Bowers/NNP ,/, K/NNP ./NNP E/NNP ,/, and/CC Matthews/NNP ,/, C/NNP ./NNP
@@62375181584/CD The/DT customary/JJ coupling/NN reagent/NN sulfanilic/JJ acid/NN has/VBZ been/VBN replaced/VBN by/IN 1/JJ ,/JJ 3-dimethylbarbituric/JJ acid/NN ;/: CNCl/GENE is/VBZ produced/VBN in/IN the/DT flow/NN through/JJ system/NN directly/RB from/IN KCN/DT and/CC chloramine/NN T/NNP ./NNP
@@21244331999/CD Of/IN 848/CD patients/NNS ,/, 819/CD cases/NNS with/IN complete/JJ description/NN of/IN patient's/VBZ background/NN were/VBD evaluable/JJ :/: Group/NNP A/DT (/( surgery/NN +/SYM MMC/NN +/SYM 5-FU/JJ :/: chemotherapy/NN )/SYM 253/CD cases/NNS ,/, group/NN B/NNP (/( surgery/NN +/SYM MMC/NN +/SYM 5-FU/JJ +/SYM OK-432/GENE or/CC PSK/GENE :/: immunochemotherapy/NN )/SYM 282/CD and/CC group/NN C/NN (/( surgery/NN alone/RB )/SYM 284/CD ./.
@@7532371032/CD A--A/NN natural/JJ hydrostatic/JJ phenomenon/NN ,/, at/IN the/DT level/NN of/IN the/DT ends/NNS of/IN the/DT plantar/JJ arcs/NNS ,/, diffuses/VBZ body/NN weight/NN ,/, as/IN PAIN/NN plays/VBP the/DT role/NN of/IN outsentry/NN (/( fig/CD ./CD --1/CD )/SYM (/( 5/CD )/SYM ;/: B--Plantar/JJ perforating/JJ ulceration/NN (/( PPU/NNS )/SYM is/VBZ caused/VBN by/IN a/DT combination/NN of/IN INSENSITIVITY/NNP and/CC TRAUMATIS/NNP (/( 1/CD )/SYM ;/: C--The/NNP patient/NN reposing/JJ ,/, as/IN body/NN weight/NN (/( traumatism/NN )/SYM effects/NNS disappear/VBP ,/, cicatrization/NN process/NN can/MD be/VB easily/RB observed/VBN ;/: D--PNEUMATIC/NNP INSOLE/NNP ,/, being/VBP elastic/JJ ,/, diffuses/VBZ localized/VBN compression/NN at/IN the/DT ends/NNS of/IN the/DT plantar/JJ arcs/NNS ,/, reduces/VBZ attrition/NN ,/, makes/VBP easier/JJR blood/NN circulation/NN ,/, as/RB well/VB as/IN cure/NN and/CC prophylaxis/NN of/IN PPU/NNS (/( fig/CD ./CD --6/CD )/SYM (/( 3/CD )/SYM ./.
@@19289237442/CD Equine/NN amnion/NN and/CC live/VB yeast/NN cell/NN derivative/NN were/VBD evaluated/VBN as/IN a/DT biological/JJ dressing/NN and/CC as/IN a/DT topical/JJ wound/JJ medicament/NN respectively/RB ,/, in/IN the/DT treatment/NN of/IN granulating/JJ wounds/NNS of/IN the/DT distal/JJ portion/NN of/IN the/DT limbs/NNS of/IN horses/NNS ./.
@@93680263914/CD Osteocalcin/IN (/( OC/NN )/SYM is/VBZ a/DT matrix/MULTIGENE calcium-binding/MULTIGENE protein/MULTIGENE expressed/VBN in/IN osteoblasts/NNS and/CC odontoblasts/NNS undergoing/VBG mineralization/NN ./.
@@114162601285/CD A/DT computerized/JJ method/NN of/IN determining/JJ the/DT focal/JJ point/NN of/IN electrical/JJ activity/NN in/IN the/DT pallidum/NN of/IN parkinsonian/JJ patients/NNS was/VBD developed/VBN using/VBG on-line/JJ quantitative/JJ physiological/JJ data/NN analysis/NN ./.
@@115328564589/CD Third/NNP ,/, consistent/JJ with/IN these/DT data/NN ,/, N-acetylcysteine/NNP reduced/VBD the/DT stimulatory/JJ effect/NN of/IN HGF/NEWGENE on/IN stress/MULTIGENE kinase/MULTIGENE activities/NNS ,/, while/CC p42/GENE //GENE 44/GENE mitogen/NN activated/VBN kinase/NN (/( MAPK/NEWGENE )/SYM was/VBD unmodified/JJ ,/, suggesting/VBG an/DT involvement/NN of/IN c-Jun-N-terminal/MULTIGENE kinase/MULTIGENE (/( JNK/GENE )/SYM and/CC p38/GENE MAPK/NEWGENE in/IN HIF-1/NNP activation/NN ./.
@@93118109769/CD (/( iv/NN )/SYM The/DT accumulation/NN of/IN cyclin/MULTIGENE D3/MULTIGENE protein/MULTIGENE in/IN Vero/NNP cells/NNS infected/VBN with/IN an/DT alpha0/GENE deletion/NN mutant/NN was/VBD reduced/VBN relative/JJ to/IN that/IN of/IN cells/NNS infected/VBN with/IN wild-type/NN virus/NN or/CC a/DT recombinant/JJ virus/NN in/IN which/WDT the/DT deleted/VBN alpha0/MULTIGENE sequences/MULTIGENE were/VBD restored/VBN ./.
@@10611228345/CD The/DT DAP5/GENE //GENE p86/GENE apoptotic/JJ form/NN was/VBD more/RB potent/JJ than/IN DAP5/GENE //GENE p97/GENE in/IN these/DT functional/JJ assays/NNS ./.
@@8902988452/CD Factor/MULTIGENE V/MULTIGENE Leiden/NN is/VBZ a/DT genetic/JJ disorder/NN associated/VBN with/IN an/DT increased/VBN risk/NN of/IN venous/JJ thrombosis/NN ./.
@@75143016007/CD The/DT interferon-induced/MULTIGENE RNA-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( PKR/CONTEXTGENE )/SYM is/VBZ considered/VBN to/IN play/NN an/DT important/JJ role/NN in/IN the/DT cellular/JJ defense/NN against/IN viral/JJ infection/NN and/CC ,/, in/IN addition/NN ,/, has/VBZ been/VBN suggested/VBN to/IN be/VB a/DT tumor/NN suppressor/NN gene/NN because/IN of/IN its/PRP growth-suppressive/JJ properties/NNS ./.
@@85221757691/CD Egd1p/GENE is/VBZ homologous/JJ to/IN human/MULTIGENE BTF3b/MULTIGENE ,/, recently/RB identified/VBN as/IN the/DT beta/MULTIGENE subunit/MULTIGENE of/IN the/DT heterodimeric/MULTIGENE nascent-polypeptide-associated/MULTIGENE complex/MULTIGENE (/( NAC/CONTEXTGENE )/SYM involved/VBN in/IN ensuring/VBG signal-sequence-specific/MULTIGENE protein/MULTIGENE sorting/NN and/CC translocation/NN [/NN Wiedmann/NN et/FW al/NNS ./NNS ,/, Nature/NNP 370/CD (/( 1994/CD )/SYM 434-440/NN ]/NN ./.
@@11150439988/CD Energy/NNP expenditure/NN was/VBD obtained/VBN using/VBG a/DT primed/JJ ,/, 3-hour/JJ infusion/NN of/IN NaH/NN (/NN 13/NN )/NN CO/NN (/NN 3'/NN )/NN ,/, breath/NN (/( 13/CD )/NN CO/NN (/NN 2/NN )/NN enrichment/NN determination/NN by/IN isotope/NN ratio/NN mass/JJ spectroscopy/NN ,/, and/CC the/DT application/NN of/IN a/DT standard/JJ regression/NN equation/NN ./.
@@76291964764/CD We/PRP have/VBP found/VBN that/IN the/DT expression/NN of/IN GTPase-deficient/NNP mutants/NNS of/IN alpha/MULTIGENE 12/MULTIGENE (/( alpha/NN 12Q229L/CD )/SYM or/CC alpha/MULTIGENE 13/MULTIGENE (/( alpha/NN 13Q226L/CD )/SYM leads/VBP to/IN robust/JJ activation/NN of/IN the/DT Jun/MULTIGENE kinase/MULTIGENE //MULTIGENE stress-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( JNK/GENE //GENE SAPK/GENE )/SYM pathway/NN ./.
@@16263722216/CD Tissues/NNPS and/CC exudates/NNS contain/VB sufficient/JJ thymidine/NN for/IN growth/NN of/IN anaerobic/JJ bacteria/NNS in/IN the/DT presence/NN of/IN inhibitory/JJ levels/NNS of/IN trimethoprim-sulfamethoxazole/NN ./.
@@999006066/CD Two/CD of/IN these/DT motifs/NNS are/VBP part/NN of/IN a/DT highly/RB conserved/VBN and/CC inducible/JJ dyad/NN symmetry/NN element/NN shown/VBP previously/RB to/IN control/NN a/DT remote/JJ IL-2/MULTIGENE enhancer/MULTIGENE and/CC the/DT CD18/MULTIGENE promoter/MULTIGENE ./.
@@78593718914/CD Specific/JJ binding/NN was/VBD not/RB observed/VBN with/IN either/DT the/DT orthologous/JJ rat/NN or/CC mouse/NN fragments/NNS using/VBG human/NN or/CC rodent/NN extracts/NNS ./.
@@88965904720/CD Spliced/JJ exons/NNS of/IN adenovirus/NN late/JJ RNAs/NNS colocalize/VBP with/IN snRNP/NN in/IN a/DT specific/JJ nuclear/JJ domain/NN ./.
@@85242299926/CD Degradation/NNS of/IN the/DT soybean/NN ribulose-1/MULTIGENE ,/MULTIGENE 5-bisphosphate/MULTIGENE carboxylase/MULTIGENE small-subunit/MULTIGENE mRNA/MULTIGENE ,/, SRS4/GENE ,/, initiates/VBP with/IN endonucleolytic/JJ cleavage/NN ./.
@@63942286195/CD Results/NNS of/IN a/DT controlled/VBN study/NN ./.
@@88474038819/CD How/WRB many/JJ embryos/NNS to/IN transfer/NN in/IN patients/NNS undergoing/VBG IVF/NN ?/.
@@35592874226/CD Legionella/NN ,/, microbial/JJ ecology/NN ,/, and/CC inconspicuous/JJ consumption/NN ./.
@@87695689379/CD The/DT structure/NN of/IN these/DT genes/NNS suggests/VBZ a/DT common/JJ ancestor/NN for/IN all/DT viperid/MULTIGENE PLA2/MULTIGENE genes/MULTIGENE ./.
@@7112320613/CD CSF/MULTIGENE adenosine/MULTIGENE deaminase/MULTIGENE activity/NN (/( ADA/NN )/SYM was/VBD measured/VBN at/IN the/DT same/JJ time/NN ./.
@@30072815424/CD The/DT Dox-A2/MULTIGENE locus/MULTIGENE is/VBZ within/IN 3/CD ./CD 4/CD to/IN 4/CD ./CD 4/CD kb/NN of/IN the/DT Df/NN (/NN 2L/NN )/NN OD15/NN breakpoint/NN ,/, placing/VBG four/CD of/IN the/DT vital/MULTIGENE loci/MULTIGENE within/IN a/DT maximum/NN of/IN 15/CD ./CD 5/CD kb/CD ./CD
@@9061698158/CD 99Tcm-DMP-HSA/GENE showed/VBD an/DT almost/RB identical/JJ behaviour/NN to/IN in/IN vitro/FW labelled/JJ red/JJ blood/NN cells/NNS (/( RBCs/NNS )/SYM ,/, which/WDT are/VBP generally/RB considered/VBN the/DT reference/NN standard/JJ for/IN blood/NN pool/NN agents/NNS ./.
@@5977155851/CD One-third/NN of/IN the/DT men/NNS with/IN azoospermia/NN and/CC with/IN sperm/NN density/NN of/IN less/PRP than/IN 10/CD million/NN had/VBP marked/JJ FSH/JJ elevation/NN and/CC our/PRP experience/NN confirms/VBZ the/DT work/NN of/IN others/NNS that/WDT this/DT indicates/VBZ a/DT poor/JJ prognosis/NN ./.
@@30332837413/CD The/DT previously/RB described/VBN four/CD sets/NNS of/IN 13-/CD to/IN 18-base-pair/CD interspersed/JJ repeat/NN elements/NNS between/IN -55/NN and/CC -580/JJ provide/VB most/RB of/IN the/DT high/JJ basal/JJ transcriptional/JJ strength/NN ,/, whereas/IN the/DT arrangement/NN of/IN further/RB upstream/RB tandemly/RB repeated/JJ NF1-binding/MULTIGENE sites/MULTIGENE may/MD contribute/VB significantly/RB to/IN the/DT expanded/JJ biological/JJ host/NN range/NN for/IN expression/NN of/IN SCMV/MULTIGENE IE94/MULTIGENE compared/VBN with/IN HCMV/MULTIGENE IE68/MULTIGENE ./.
@@241151336/CD These/DT characteristics/NNS of/IN N22/GENE //GENE P22/GENE indicate/VB that/IN it/PRP is/VBZ a/DT localized/VBN synaptically/RB dependent/JJ event/NN conforming/VBG to/IN a/DT transverse/JJ dipole/NN with/IN dorsal/JJ negativity/NN and/CC a/DT simultaneous/JJ anterior/JJ positivity/NN ./.
@@17110485599/CD Heterozygous/JJ mutation/NN in/IN the/DT G+5/GENE position/NN of/IN intron/NN 33/CD of/IN the/DT pro-alpha/JJ 2/NN (/NN I/NN )/NN gene/NN (/( COL1A2/GENE )/SYM that/IN causes/NNS aberrant/JJ RNA/NN splicing/JJ and/CC lethal/JJ osteogenesis/NN imperfecta/NN ./.
@@37741114448/CD Evidence/NN that/IN opiate/JJ addiction/NN is/VBZ in/IN part/NN an/DT immune/JJ response/NN ./.
@@96327347466/CD These/DT widely/RB expressed/VBN proteins/NNS share/VBP a/DT C-terminal/MULTIGENE region/MULTIGENE that/WDT bears/VBP significant/JJ sequence/NN homology/NN to/IN a/DT group/NN of/IN GDP/MULTIGENE //MULTIGENE GTP/MULTIGENE exchange/MULTIGENE proteins/MULTIGENE for/IN the/DT Rab3/MULTIGENE family/MULTIGENE of/IN small/MULTIGENE GTP/MULTIGENE binding/MULTIGENE proteins/MULTIGENE ./.
@@9385949520/CD On/IN cessation/NN of/IN steroid/JJ therapy/NN the/DT patient/NN was/VBD noted/VBN to/IN have/NN radiologic/JJ manifestations/NNS of/IN hypertrophic/JJ osteoarthropathy/NN (/( HOA/GENE )/SYM as/RB well/VB as/IN clinical/JJ and/CC laboratory/NN features/NNS of/IN rheumatoid/JJ arthritis/NN (/( RA/NN )/SYM ./.
@@79329436723/CD Specifically/RB ,/, this/DT study/NN determined/VBD the/DT influence/NN of/IN :/: (/( 1/CD )/SYM an/DT awareness/NN strategy/NN ,/, (/( 2/CD )/SYM a/DT non-awareness/NN strategy/NN ,/, (/( 3/CD )/SYM a/DT Five-Step/GENE Approach/NNP strategy/NN and/CC (/( 4/CD )/SYM a/DT control/NN condition/NN ./.
@@79081878429/CD ISIS/MULTIGENE 5/MULTIGENE possibilities/NNS ./.
@@93120255124/CD These/DT effects/NNS were/VBD abrogated/VBN by/IN co-expression/NN of/IN kinase-deficient/JJ PKC/MULTIGENE zeta/MULTIGENE and/CC inhibition/NN of/IN phosphatidylinositol/NN 3-kinase/CD p85alpha-p110/JJ by/IN wortmannin/NN ,/, LY294002/GENE and/CC a/DT dominant-negative/JJ mutant/NN of/IN p85alpha/GENE ./.
@@38835414544/CD The/DT H2/MULTIGENE receptor/MULTIGENE antagonists/NNS and/CC sucralfate/NN cost/NN about/RB the/DT same/JJ and/CC have/NN few/JJ side/JJ effects/NNS ./.
@@94417462528/CD A/DT cDNA/NN clone/NN was/VBD identified/VBN encoding/VBG a/DT second/JJ GHS-R-related/MULTIGENE gene/MULTIGENE (/( GPR39/CONTEXTGENE )/SYM ./.
@@101011595280/CD A/DT mutation/NN linked/JJ to/IN the/DT SOC1/MULTIGENE gene/MULTIGENE ,/, previously/RB defined/VBN by/IN recessive/JJ mutations/NNS that/WDT suppress/VBP cbp1/MULTIGENE ts/MULTIGENE alleles/MULTIGENE and/CC stabilize/VB many/JJ mitochondrial/JJ mRNAs/NNS ,/, was/VBD also/RB isolated/VBN ./.
@@1618243342/CD Intravenous/JJ amine/MULTIGENE pressor/MULTIGENE tests/NNS in/IN healthy/JJ volunteers/NNS ./.
@@80713562426/CD During/IN transcript/NN elongation/NN ,/, the/DT sizes/NNS of/IN the/DT DNA/NN footprint/NN and/CC the/DT single-stranded/JJ transcription/NN bubble/NN vary/VB markedly/RB among/IN transcription/NN complexes/NNS halted/VBN at/IN different/JJ template/NN positions/NNS ./.
@@86377113801/CD Furthermore/RB ,/, we/PRP showed/VBD that/IN the/DT IL-6/MULTIGENE //MULTIGENE interferon/MULTIGENE gamma/MULTIGENE (/( IFN/MULTIGENE gamma/MULTIGENE )/SYM response/MULTIGENE element/MULTIGENE in/IN the/DT IRF-1/MULTIGENE promoter/MULTIGENE (/( IR/GENE //GENE IRF-1/GENE )/SYM ,/, which/WDT contains/VBZ a/DT Stat-binding/MULTIGENE site/MULTIGENE and/CC an/DT adjacent/JJ CRE-like/MULTIGENE site/MULTIGENE ,/, also/RB makes/VBP IL-6-induced/JJ binding/JJ complexes/NNS similar/JJ to/IN JRE-IL6-BCs/NNP ./.
@@63411391771/CD Blood/NNP glucose/NN and/CC plasma/NN insulin/NN were/VBD measured/VBN at/IN zero/NN time/NN and/CC then/RB at/IN 15/CD ,/, 30/CD ,/, 60/CD ,/, 90/CD and/CC 120/CD min/NN after/IN ingestion/NN of/IN 25/CD g/NN glucose/NN ,/, fructose/NN or/CC lactose/NN ,/, or/CC 30/CD g/NN honey/NN ,/, 50/CD g/NN white/NEWGENE bread/NN ,/, 125/CD g/NN white/NEWGENE rice/NN or/CC potatoes/NNS ,/, 150/CD g/NN apples/NNS or/CC 260/CD g/NN carrots/NNS ./.
@@110532639430/CD A/DT total/NN of/IN 1060/CD clones/NNS were/VBD randomly/RB selected/VBN for/IN sequencing/VBG of/IN one/PRP end/NN ./.
@@18543398283/CD The/DT 5'/GENE region/NN shows/VBZ strong/JJ sequence/NN similarity/NN to/IN Escherichia/NN coli/JJ consensus/NN promoters/NNS and/CC ribosome-binding/MULTIGENE sequences/MULTIGENE and/CC allows/VBZ high/JJ levels/NNS of/IN expression/NN in/IN E/NNP ./NNP coli/JJ ./.
@@80448006228/CD This/DT DNA/MULTIGENE containing/MULTIGENE promoter/MULTIGENE activity/NN has/VBZ been/VBN sequenced/VBN in/IN its/PRP entirety/NN and/CC found/VB to/IN contain/VB multiple/JJ putative/JJ regulatory/JJ sites/NNS ./.
@@102070872846/CD MEF/GENE and/CC AML1B/GENE synergistically/RB transactivated/VBN an/DT interleukin/MULTIGENE 3/MULTIGENE promoter/MULTIGENE reporter/NN gene/NN construct/NN ,/, yet/RB the/DT activating/JJ activity/NN of/IN MEF/GENE was/VBD abolished/VBN when/CC MEF/GENE was/VBD coexpressed/VBN with/IN AML1/NNP //NNP ETO/NNP ./.
@@93434269855/CD Alanine/NN substitution/NN mutations/NNS in/IN the/DT Zta/GENE activation/NN domain/NN which/WDT eliminate/VBP the/DT ability/NN of/IN Zta/NNP to/IN stimulate/VB the/DT D-A/GENE complex/NN were/VBD examined/VBN ./.
@@94202349379/CD MpB/GENE GroEL/NN has/VBZ extensive/JJ sequence/NN similarity/NN (/( 92%/CD )/SYM with/IN Escherichia/NN coli/JJ GroEL/NN and/CC other/DT members/NNS of/IN the/DT chaperonin-60/MULTIGENE family/MULTIGENE ./.
@@85762458674/CD GRP78/GENE ,/, a/DT molecular/JJ chaperone/NN expressed/VBN in/IN the/DT endoplasmic/JJ reticulum/NN ,/, is/VBZ a/DT "glucose-regulated/JJ protein"/NN induced/VBN by/IN stress/NN responses/NNS that/WDT deplete/VBP glucose/NN or/CC intracisternal/JJ calcium/NN or/CC otherwise/RB disrupt/VB glycoprotein/NN trafficking/NN ./.
@@2849100465/CD A/DT highly/RB hydrophobic/JJ sequence/NN located/VBN near/IN the/DT carboxyl-terminal/NN extremity/NN of/IN the/DT molecule/NN most/RB likely/RB constitutes/VBZ the/DT anchor/NN to/IN the/DT plasma/NN membrane/NN ./.
@@94367959393/CD Protein/MULTIGENE C/MULTIGENE deficiency/NN or/CC protein/MULTIGENE S/MULTIGENE deficiency/NN was/VBD the/DT only/RB identified/VBN risk/NN factor/NN for/IN 5/CD ./CD 4%/CD (/( 2/CD patients/NNS )/SYM and/CC 13/CD ./CD 5%/CD (/( 5/CD patients/NNS )/SYM ,/, respectively/RB ,/, of/IN these/DT 37/CD children/NNS ./.
@@20887817402/CD The/DT results/NNS showed/VBD that/DT fog/NN ,/, up/JJ to/IN a/DT level/NN of/IN base/NN plus/IN fog/NEWGENE of/IN 0/CD ./CD 6/CD optical/JJ density/NN units/NNS ,/, had/VBP no/DT influence/NN on/IN the/DT diagnostic/JJ accuracy/NN in/IN the/DT absence/NN of/IN any/DT compensation/NN ./.
@@61086105932/CD Theories/NNS proffered/VBN to/IN account/NN for/IN the/DT modality/NN shift/NN effect/NN are/VBP critically/RB evaluated/VBN ./.
@@90583782967/CD Conversely/RB ,/, activated/VBN glucocorticoid/MULTIGENE receptors/MULTIGENE suppressed/VBD the/DT transactivation/NN function/NN of/IN p53/GENE ,/, while/CC transrepression/NN by/IN p53/GENE was/VBD largely/RB unaffected/JJ ./.
@@85757543786/CD Molecular/NNP cloning/NN ,/, expression/NN pattern/NN ,/, and/CC chromosomal/JJ localization/NN of/IN human/JJ CDKN2D/GENE //GENE INK4d/GENE ,/, an/DT inhibitor/NN of/IN cyclin/MULTIGENE D-dependent/MULTIGENE kinases/MULTIGENE ./.
@@1167591279/CD She/PRP drank/VBD alcohol/NN once/CC or/CC twice/RB a/DT week/NN and/CC regularly/RB took/VBD an/DT analgesic/JJ preparation/NN ,/, containing/MULTIGENE aspirin/MULTIGENE and/CC acetaminophen/NN ,/, for/IN alleviation/NN of/IN headaches/NNS ./.
@@8756597912/CD Mutants/NNS lacking/VBG the/DT 3'/CD stem-loop/NN exhibited/VBD a/DT 75%/JJ reduction/NN in/IN the/DT level/NN of/IN psaB/MULTIGENE mRNA/MULTIGENE ./.
@@74162049395/CD In/NN the/DT intact/JJ animal/NN ,/, postextrasystolic/JJ potentiation/NN depended/VBN on/IN the/DT basic/JJ pacing/NN interval/NN ,/, t0/GENE ,/, and/CC the/DT timing/NN of/IN the/DT extrasystole/NN ,/, t1/GENE :/: when/CC t0/CD was/VBD held/VBP constant/JJ and/CC t1/GENE was/VBD increased/VBN ,/, potentiation/NN decreased/VBD ;/: when/CC t1/GENE was/VBD held/VBP constant/JJ and/CC t0/CD was/VBD increased/VBN ,/, potentiation/NN increased/VBD ./.
@@13393916234/CD We/PRP have/VBP cloned/VBN and/CC characterized/VBD a/DT 55-kb/JJ region/NN of/IN DNA/NN surrounding/JJ HRAS1/GENE ./.
@@16754246017/CD The/DT most/RB striking/JJ difference/NN in/IN the/DT birch/NN NAD/NN (/NN P/NN )/NN H-NR/NN sequence/NN in/IN comparison/NN to/IN NADH-NR/GENE sequences/NNS was/VBD found/VBN at/IN the/DT putative/JJ pyridine/MULTIGENE nucleotide/MULTIGENE binding/MULTIGENE site/MULTIGENE ./.
@@107499328402/CD Paxillin/NNP acts/NNS as/IN an/DT adaptor/MULTIGENE molecule/MULTIGENE in/IN integrin/NEWGENE signaling/JJ ./.
@@95197572434/CD Two/CD rare/JJ novel/JJ mutations/NNS ,/, D811N/NNP in/IN exon/NN 20/CD and/CC R835C/GENE in/IN exon/NN 21/CD ,/, were/VBD identified/VBN in/IN the/DT first/JJ nucleotide-binding/JJ fold/NN (/( NBF/GENE )/SYM ,/, a/DT functionally/RB important/JJ region/NN of/IN SUR1/GENE ,/, in/IN one/PRP patient/NN each/DT ,/, both/DT heterozygotes/NNS ./.
@@111037924398/CD Overexpression/NNS of/IN c-Myc/GENE in/IN serum-starved/JJ human/NN or/CC mouse/NN embryonic/JJ cells/NNS leads/VBP to/IN apoptosis/NN which/WDT is/VBZ significantly/RB reduced/VBN in/IN the/DT presence/NN of/IN growth/NN factor-containing/NN serum/NN ./. c-Myc-induced/GENE apoptosis/NN appears/VBZ to/IN be/VB deficient/JJ in/RB bax-null/JJ as/IN compared/VBN with/IN bax-wild-type/JJ mouse/NN embryonic/JJ fibroblasts/NNS ./.
@@28400343531/CD Accurate/JJ evaluation/NN of/IN the/DT treatment/NN results/NNS in/IN unresectable/JJ lung/NN cancer/NN patients/NNS must/MD take/VB the/DT strong/JJ prognostic/JJ factors/NNS into/IN account/NN ./.
@@26003063254/CD Specifically/RB ,/, they/PRP were/VBD performed/VBN to/IN determine/VB whether/IN detection/NN of/IN envelope/NN phase/NN disparity/NN was/VBD consistent/JJ with/IN processing/VBG within/IN a/DT single/JJ channel/NN in/IN which/WDT the/DT AM/NN tones/NNS were/VBD simply/RB added/VBN ./.
@@110698973024/CD These/DT results/NNS suggested/VBN that/IN BACH1t/NNP recruits/NNS BACH1/GENE to/IN the/DT nucleus/NN through/RB BTB/GENE domain-mediated/JJ interaction/NN ./.
@@99151187514/CD Unilateral/JJ naris/NN occlusion/NN and/CC the/DT rat/NN accessory/JJ olfactory/MULTIGENE bulb/MULTIGENE ./.
@@1005949659/CD Acoustic/NNP transmission/NN spectra/NNS in/IN the/DT Penrose/NNP lattice/NN ./.
@@7490278132/CD The/DT latter/JJ domain/NN appears/VBZ to/IN be/VB involved/VBN in/IN targeting/JJ Num1p/GENE to/IN the/DT mother/NN cell/NN cortex/NN ./.
@@4995885295/CD Carbohydrate/NNS metabolism/NN and/CC the/DT semen/NN profile/NN :/: glucose/NN ,/, insulin/NN ,/, and/CC sperm/NN studies/NNS ./.
@@84961843335/CD The/DT active/JJ open/JJ reading/JJ frame/NN in/IN the/DT clone/NN maps/NNS at/IN 27/CD min/NN on/IN the/DT E/NNP ./NNP coli/JJ chromosome/NN and/CC is/VBZ identical/JJ in/IN sequence/NN to/IN a/DT wild/JJ type/NN counterpart/NN ./.
@@94490189402/CD Childhood/NNP misbehavior/NN and/CC the/DT risk/NN of/IN injecting/JJ drug/NN use/NN ./.
@@13630803858/CD Visual/JJ acuity/NN may/MD be/VB decreased/VBN by/IN transient/JJ changes/NNS in/IN refractive/JJ error/NN caused/VBN by/IN sulfonamides/NNS ,/, the/DT antifungal/JJ agent/NN metronidazole/NN ,/, thiazide/NN diuretics/NNS ,/, and/CC carbonic/JJ anhydrase/MULTIGENE inhibitors/MULTIGENE ./.
@@83006056631/CD Transcriptional/JJ analysis/NN of/IN a/DT series/NN of/IN deletion/NN mutants/NNS of/IN the/DT gene/NN in/IN the/DT nuclear/JJ extracts/NNS prepared/VBN from/IN the/DT middle/JJ silk/NN gland/NN of/IN 2-day-old/NN fifth/JJ instar/NN larvae/NNS revealed/VBD the/DT presence/NN of/IN multiple/JJ cis-regulatory/MULTIGENE elements/MULTIGENE located/VBD both/DT upstream/RB and/CC downstream/RB of/IN the/DT initiation/NN site/NN ./.
@@79354473284/CD This/DT study/NN provides/VBZ direct/JJ evidence/NN that/IN USF/GENE ,/, a/DT member/NN of/IN the/DT basic/JJ helix-loop-helix/JJ leucine/MULTIGENE zipper/MULTIGENE family/MULTIGENE ,/, binds/VBZ to/IN MLE1/GENE ,/, HF-1a/GENE ,/, and/CC PRE/MULTIGENE B/MULTIGENE sites/MULTIGENE and/CC suggests/VBZ that/IN it/PRP is/VBZ a/DT component/NN of/IN protein/NN complexes/NNS that/WDT may/MD coordinately/RB control/VB the/DT expression/NN of/IN MLC-2v/NEWGENE and/CC alpha-myosin/MULTIGENE heavy-chain/MULTIGENE genes/MULTIGENE ./.
@@74258387278/CD We/PRP report/VBP a/DT case/NN of/IN pheochromocytoma/NN manifesting/VBG during/IN the/DT third/JJ trimester/NN of/IN pregnancy/NN ./.
@@18260438144/CD The/DT pp90rsk-protein/MULTIGENE kinase/MULTIGENE activity/NN (/( referred/VBN to/RB as/IN rsk-kinase/JJ )/SYM is/VBZ also/RB not/RB related/VBN to/IN cofactor-dependent/JJ signal/JJ transducing/JJ protein/MULTIGENE kinases/MULTIGENE such/JJ as/IN the/DT cyclic/JJ AMP-dependent/MULTIGENE protein/MULTIGENE kinases/MULTIGENE ,/, members/NNS of/IN the/DT protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE family/MULTIGENE ,/, or/CC other/DT Ca2/NN (/NN +/NN )/NN -dependent/NN protein/NN kinases/NEWGENE ./.
@@77218785320/CD The/DT beta/MULTIGENE subunit/MULTIGENE of/IN the/DT Fc/MULTIGENE epsilon/MULTIGENE R1/MULTIGENE is/VBZ a/DT 33-kDa/MULTIGENE tyrosine/MULTIGENE phosphoprotein/MULTIGENE ,/, but/CC the/DT p33/MULTIGENE Grb2-binding/MULTIGENE protein/MULTIGENE described/VBN in/IN the/DT present/NN report/NN is/VBZ not/RB the/DT Fc/MULTIGENE epsilon/MULTIGENE R1/MULTIGENE beta/MULTIGENE chain/MULTIGENE and/CC its/PRP identity/NN is/VBZ unknown/JJ ./.
@@104385403400/CD We/PRP also/RB identify/VBP several/DT regulatory/JJ domain/NN mutants/NNS in/IN which/WDT Cd/NN (/NN 2+/NN )/NN tolerance/NN of/IN the/DT mutant/JJ strain/NN and/CC transport/NN activity/NN of/IN the/DT protein/NN are/VBP dissociated/VBN ./.
@@79829647352/CD ATX/NNP ,/, like/JJ PC-1/GENE ,/, was/VBD found/VBN to/IN hydrolyze/VB the/DT type/MULTIGENE I/MULTIGENE phosphodiesterase/MULTIGENE substrate/NN p-nitrophenyl/JJ thymidine-5'-monophosphate/NN ./.
@@80578331794/CD The/DT two/JJ ParA/MULTIGENE proteins/MULTIGENE that/WDT are/VBP produced/VBN as/IN a/DT result/NN of/IN independent/JJ translation/NN initiation/NN at/IN two/JJ different/JJ start/NN codons/NNS within/IN the/DT same/JJ open/JJ reading/JJ frame/NN were/VBD overexpressed/VBN in/IN Escherichia/NN coli/JJ and/CC partially/RB purified/VBN ./.
@@85093339075/CD A/DT 36-kDa/MULTIGENE protein/MULTIGENE that/WDT was/VBD localized/VBN to/IN the/DT membrane/NN fraction/NN was/VBD detected/VBN in/IN minicells/NNS containing/JJ plasmids/NNS with/IN the/DT ftsN/MULTIGENE gene/MULTIGENE ,/, confirming/VBG that/IN FtsN/NNP was/VBD a/DT membrane/NN protein/NN ./.
@@16748176550/CD Mutations/NNS in/IN the/DT yeast/MULTIGENE RNA14/MULTIGENE and/CC RNA15/MULTIGENE genes/MULTIGENE result/NN in/IN an/DT abnormal/JJ mRNA/NN decay/NN rate/NN ;/: sequence/NN analysis/NN reveals/VBZ an/DT RNA-binding/NN domain/NN in/IN the/DT RNA15/MULTIGENE protein/MULTIGENE ./.
@@102711714004/CD Online/NNP LATCH/CELL demonstrates/VBZ a/DT shift/NN in/IN identification/NN of/IN the/DT library/NN as/IN an/DT isolated/VBN unit/NN to/IN an/DT interactive/JJ resource/NN center/NN ./.
@@13743985583/CD The/DT initial/JJ translation/NN protein/NN encoded/VBN by/IN the/DT cDNA/NN is/VBZ 53/GENE ,/GENE 932/GENE kDa/NN and/CC possesses/VBZ a/DT hydrophilic/JJ amino/JJ acid/NN composition/NN with/IN glutamic/JJ acid/NN comprising/VBG 22%/NN of/IN the/DT total/JJ amino/JJ acid/NN residues/NNS ./.
@@18953702516/CD With/IN stepwise/JJ reductions/NNS in/IN flow/NN ,/, the/DT peak/NN (/( S/NNP )/SYM and/CC trough/NN (/( D/NN )/SYM points/NNS of/IN the/DT maximum/JJ shifted-frequency/JJ envelope/NN fell/NN in/IN parallel/JJ in/IN a/DT linear/JJ fashion/NN until/IN D/NN reached/VBD zero/NN ./.
@@81445046102/CD Kinetic/JJ coupling/NN and/CC requirement/NN for/IN ATP/NN hydrolysis/NN ./.
@@113937917809/CD Northern/NNP blot/NN analysis/NN of/IN RNAs/NNS from/IN a/DT number/NN of/IN mouse/NN tissues/NNS reveals/VBZ that/IN Atp6i/GENE is/VBZ expressed/VBN predominantly/RB in/IN osteoclasts/NNS ,/, and/CC this/DT predominant/JJ expression/NN was/VBD confirmed/VBN by/IN reverse-transcription/NN polymerase/NN chain/NN reaction/NN (/( RT-PCR/NN )/SYM assay/NN and/CC immunohistochemical/JJ analysis/NN ./.
@@76782421716/CD We/PRP found/VBP a/DT direct/JJ correlation/NN between/IN the/DT levels/NNS of/IN transcription/NN of/IN the/DT acc/NN genes/NNS and/CC the/DT rate/NN of/IN cellular/JJ growth/NN ./.
@@15188338623/CD A/DT lambda/MULTIGENE gt10/MULTIGENE cDNA/MULTIGENE library/NN was/VBD constructed/VBN from/IN poly/NN (/NN A+/NN )/NN RNA/NN of/IN young/JJ green/JJ leaves/NNS of/IN spinach/NN ./.
@@37717499289/CD MICs/NNS of/IN four/CD antifungal/JJ agents/NNS (/( 5-fluorocytosine/NNP ,/, miconazole/NN ,/, ketoconazole/NN ,/, and/CC amphotericin/MULTIGENE B/MULTIGENE )/SYM for/IN 84/CD clinical/JJ isolates/NNS of/IN various/JJ Candida/NN species/NN were/VBD then/RB determined/VBN with/IN both/DT media/NN in/IN agar/NN dilution/NN and/CC microtiter/NN broth/NN dilution/NN systems/NNS ./.
@@54966195567/CD Foreign/NNP profiles/NNS in/IN air/NN pollution/NN control/NN activities/NNS ./.
@@83310645779/CD Release/NNP of/IN this/DT selective/JJ pressure/NN ,/, however/RB ,/, gave/VBD way/NN to/IN homologous/JJ resolution/NN of/IN the/DT cointegrate/NN structures/NNS ./.
@@78352147812/CD Therefore/RB the/DT prevalences/NNS of/IN total/JJ diabetes/NN and/CC GDM/NN were/VBD 1/CD ./CD 19%/CD and/CC 0/CD ./CD 56%/CD ,/, respectively/RB ./.
@@93120325826/CD These/DT introns/NNS contain/VBP only/RB single/MULTIGENE snoRNA/MULTIGENE genes/MULTIGENE and/CC their/PRP processing/NN involves/VBZ exonucleolytic/JJ release/NN of/IN the/DT snoRNA/NN from/IN debranched/JJ intron/NN lariats/NNS ./.
@@11003807838/CD Symptoms/NNS ,/, however/RB ,/, appear/VB to/IN correlate/NN poorly/RB with/IN oesophagitis/NN ;/: hence/RB ,/, severe/JJ symptoms/NNS do/VBP not/RB indicate/VB there/RB is/VBZ greater/RBR oesophageal/JJ damage/NN ./.
@@80977326577/CD Activation/NNS of/IN the/DT aboral/JJ ectoderm-specific/MULTIGENE Spec2a/MULTIGENE gene/MULTIGENE in/IN blastula-stage/MULTIGENE sea/MULTIGENE urchin/NN embryos/NNS requires/VBZ an/DT upstream/RB regulatory/JJ region/NN that/WDT is/VBZ part/NN of/IN a/DT repetitive/JJ sequence/NN element/NN (/( RSR/NNS )/SYM associated/VBN with/IN all/DT Spec1/MULTIGENE //MULTIGENE Spec2/MULTIGENE genes/MULTIGENE ./.
@@13281978452/CD These/DT findings/NNS suggest/VBP that/IN the/DT MAP/MULTIGENE kinase/MULTIGENE activator/MULTIGENE //MULTIGENE MAP/MULTIGENE kinase/MULTIGENE system/NN may/MD be/VB the/DT downstream/JJ components/NNS of/IN ras/NEWGENE signal/JJ transduction/NN pathways/NNS ./.
@@105903682/CD The/DT present/NN research/NN evaluated/VBD the/DT possibility/NN that/DT polyethylene/NN glycol/NN 400/CD (/( PEG/MULTIGENE 400/MULTIGENE )/SYM might/MD be/VB efficacious/JJ ,/, toxic/JJ ,/, or/CC both/DT ./.
@@89199868877/CD Keeping/VBG in/IN mind/NN the/DT limited/VBN range/NN of/IN age/NN and/CC dosages/NNS ,/, advantages/NNS and/CC disadvantages/NNS of/IN the/DT drug/NN are/VBP discussed/VBN ,/, comparing/VBG the/DT experimental/JJ results/NNS with/IN those/DT derived/VBN from/IN the/DT literature/NN ./.
@@113276989384/CD Here/RB we/PRP show/VBP that/DT PKC/NN and/CC p44/GENE //GENE p42MAPK/GENE signalings/NNS are/VBP required/VBN for/IN the/DT HBx-induced/MULTIGENE Sp1-mediated/MULTIGENE IGF-II/MULTIGENE P4/MULTIGENE transcriptional/JJ activity/NN since/IN (/( i/NN )/SYM PKC/NN activation/NN by/IN PMA/NN or/CC PKC/NN expression/NN vector/NN increases/NNS Sp1/GENE phosphorylation/NN and/CC P4/NN activity/NN in/IN HBx-transfected/JJ HepG2/NNP cells/NNS ;/: (/( ii/NN )/SYM PKC/NN inhibition/NN by/IN PKC/MULTIGENE inhibitor/MULTIGENE Go6976/MULTIGENE reduces/VBZ Sp1/GENE phosphorylation/NN ,/, P4/NN activity/NN ,/, and/CC IGF-II/MULTIGENE mRNA/MULTIGENE in/IN HBx-transfected/JJ HepG2/NNP cells/NNS ;/: and/CC (/( iii/NN )/SYM the/DT inhibition/NN of/IN MEK/GENE activation/NN by/IN U0126/GENE reduces/VBZ Sp1/GENE phosphorylation/NN ,/, P4/NN activity/NN and/CC IGF-II/MULTIGENE mRNA/MULTIGENE in/IN HBx-transfected/JJ HepG2/NNP cells/NNS ./.
@@24187017383/CD We/PRP evaluated/VBD the/DT likelihood/NN of/IN tissues/NNS to/IN be/VB positive/JJ for/IN carcinoembryonic/NN antigen/NN and/CC the/DT intensity/NN of/IN carcinoembryonic/NN antigen/NN staining/NN in/IN specimens/NNS of/IN villous/JJ adenomas/NNS ,/, mixed/JJ polypoid/NN villous/NN adenomas/NNS ,/, polypoid/JJ adenomas/NNS ,/, and/CC diverticulitis/NN using/VBG the/DT peroxidase-antiperoxidase/NN technique/NN ./.
@@87984437412/CD Serine/NN 528/CD is/VBZ phosphorylated/VBN in/IN vivo/NN in/IN several/DT cell/NN lines/NNS ,/, and/CC substitution/NN of/IN serine/NN 528/CD to/IN alanine/NN (/( S528A/NNP )/SYM resulted/VBN in/IN an/DT increased/VBN ability/NN of/IN Myb/NNP to/IN transactivate/VB a/DT synthetic/JJ promoter/NN containing/JJ five/CD copies/NNS of/IN the/DT mim-1A/GENE Myb-responsive/NNP element/NN and/CC a/DT minimal/JJ herpes/NN tk/MULTIGENE promoter/MULTIGENE ./.
@@54661775551/CD Teratogenic/NNP effects/NNS of/IN actinomycin/NN D/NN in/IN rats/NNS ./.
@@79009157883/CD To/TO determine/VB whether/IN food/NN and/DT //DT or/DT water/NN in/IN the/DT gastrointestinal/JJ tract/NN affects/VBP restitution/NN of/IN blood/NN volume/NN and/CC plasma/NN protein/NN after/IN hemorrhage/NN ,/, fed/VBN and/CC 24-h-fasted/JJ awake/JJ rats/NNS received/VBD a/DT 20/CD ml/CD ./CD kg-1/CD x/NN 3/CD min-1/NN hemorrhage/NN ,/, and/CC restitution/NN of/IN blood/NN volume/NN was/VBD measured/VBN by/IN Evans/NN blue/JJ dye/NN and/CC dilution/NN of/IN hematocrit/NN ./.
@@111034723302/CD Children/NNS with/IN ADD/NNS showed/VBD an/DT attenuated/VBN frontal/JJ CNV-1/GENE amplitude/NN and/CC a/DT trend/NN towards/IN increased/VBN CNV-1/GENE and/CC CNV-2/GENE occipital/JJ amplitudes/NNS ./.
@@17423412325/CD This/DT study/NN confirms/VBZ ,/, although/IN individual/JJ reaction/NN is/VBZ remarkably/RB different/JJ ,/, transportation/NN as/IN a/DT potent/JJ stressor/NN for/IN Beagle/NN dogs/NNS ./.
@@93729687958/CD Sequence/NN analysis/NN identified/VBD some/DT of/IN these/DT cDNA/NN clones/NNS as/IN Dlc-1/GENE ,/, a/DT sequence/NN encoding/VBG a/DT small/NN ,/, 9-kDa/MULTIGENE human/MULTIGENE homolog/MULTIGENE of/IN the/DT outer-arm/JJ dynein/MULTIGENE light-chain/MULTIGENE protein/MULTIGENE ./.
@@24743563131/CD The/DT ratio/NN of/IN radioactivity/NN in/IN tumour/NN compared/VBN with/IN normal/JJ tissue/NN (/( T/NN :/: N/JJ ratio/NN )/SYM was/VBD determined/VBN after/IN simultaneously/RB injecting/JJ microspheres/NNS into/IN the/DT portal/JJ and/CC arterial/JJ circulation/NN of/IN each/DT animal/NN ./.
@@92486397717/CD Five/CD cell/NN strains/NNS of/IN human/JJ dermal/JJ fibroblasts/NNS were/VBD each/DT treated/VBN with/IN three/CD samples/NNS of/IN burn/NN blister/NN fluid/NN and/CC the/DT effect/NN compared/VBN with/IN the/DT rate/NN of/IN contraction/NN of/IN free/JJ floating/JJ fibroblast/NN populated/VBD collagen/NN lattices/NNS (/( FPCL/NN )/SYM ./.
@@37009525476/CD Infants/NNS of/IN this/DT sample/NN had/VBP monocular/JJ PL/NN visual/NN acuities/NNS similar/JJ to/IN those/DT established/VBN by/IN McDonald/NNP et/FW al/NNS ./NNS in/IN a/DT laboratory/NN setting/NN ./.
@@19179628982/CD The/DT cDNA/NN segment/NN is/VBZ flanked/VBN by/IN the/DT immunoglobulin/MULTIGENE gene/MULTIGENE recombination/NN signal/JJ sequences/NNS so/RB that/IN the/DT cDNA/NN segment/NN can/MD invert/VB and/CC the/DT human/MULTIGENE IL-2R/MULTIGENE L/MULTIGENE chain/MULTIGENE is/VBZ subsequently/RB expressed/VBN under/IN the/DT control/NN of/IN the/DT SV40/MULTIGENE promoter/MULTIGENE ./.
@@1895555503/CD Evaluation/NN of/IN left/NN ventricular/JJ function/NN using/VBG gated/JJ planar/JJ myocardial/JJ imaging/NN with/IN Tc-99m-MIBI/GENE ./.
@@81519808120/CD Panlobular/JJ emphysema/NN ./.
@@110036415236/CD Mutating/VBG the/DT Fcp1p-binding/VBG motif/NN KEFGK/GENE in/IN the/DT RAP74/CONTEXTGENE (/( Tfg1p/GENE )/SYM subunit/NN of/IN TFIIF/NN to/IN EEFGE/NNP led/VBD to/IN both/DT synthetic/JJ phenotypes/NNS in/IN certain/JJ fcp1/MULTIGENE tfg1/MULTIGENE double/JJ mutants/NNS and/CC a/DT reduced/VBN ability/NN of/IN Fcp1p/GENE to/IN activate/VB transcription/NN when/CC it/PRP is/VBZ artificially/RB tethered/JJ to/IN a/DT promoter/NN ./.
@@91507747754/CD Anesthesia/NNS was/VBD maintained/VBN with/IN isoflurane/NN (/( ISO/NN )/NN //NN N2O/NN //NN O2/GENE inhalation/NN ./.
@@112784883163/CD The/DT v-Src/NN SH3/GENE domain/NN facilitates/VBZ a/DT cell/NN adhesion-independent/JJ association/NN with/IN focal/JJ adhesion/MULTIGENE kinase/MULTIGENE ./.
@@12436288792/CD In/NN both/DT cases/NNS ,/, at/IN the/DT end/NN of/IN exposure/NN the/DT same/JJ level/NN of/IN blood/NN carboxyhemoglobin/NEWGENE (/( COHb/CONTEXTGENE )/SYM (/( about/RB 50%/CD )/SYM was/VBD reached/VBN ./.
@@82032604591/CD We/PRP conclude/VBP that/IN the/DT SIMV/GENE is/VBZ useful/JJ in/IN weaning/NN neonates/NNS from/IN the/DT ventilator/NN ./.
@@90069363714/CD Identification/NNP of/IN the/DT region/NN in/IN actin-binding/MULTIGENE protein/MULTIGENE that/WDT binds/VBZ to/IN the/DT cytoplasmic/JJ domain/NN of/IN glycoprotein/NN IBalpha/NNP ./.
@@94765203041/CD Simple/JJ models/NNS of/IN bimolecular/JJ interaction/NN did/VBD not/RB fully/RB account/VB for/IN the/DT kinetic/JJ profiles/NNS obtained/VBN with/IN the/DT parental/JJ antibodies/NNS and/CC the/DT hybrids/NNS ,/, and/CC this/DT complexity/NN suggested/VBD the/DT existence/NN of/IN a/DT conformational/JJ heterogeneity/NN in/IN these/DT molecules/NNS ./.
@@3395249431/CD Histopathological/JJ examination/NN revealed/VBD dose-related/JJ proliferation/NN of/IN type/MULTIGENE II/MULTIGENE pneumocytes/NNS in/IN dams/NNS and/CC proliferation/NN of/IN interstitial/JJ cells/NNS and/CC delayed/JJ septal/JJ //JJ capillary/JJ development/NN in/IN neonates/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@91153575631/CD Little/NN is/NNS known/VBP about/RB the/DT mechanism/NN ,/, but/CC the/DT availability/NN of/IN rapid/JJ facile/JJ assays/NNS for/IN monitoring/VBG immunoglobulin/MULTIGENE hypermutation/MULTIGENE would/MD greatly/RB aid/VB the/DT development/NN of/IN culture/NN systems/NNS for/IN hypermutating/JJ B/NNP cells/NNS as/RB well/VBP as/IN the/DT screening/NN for/IN individuals/NNS deficient/JJ in/IN the/DT process/NN ./.
@@93652724063/CD Xenopus/NN Ran-binding/MULTIGENE protein/MULTIGENE 1/MULTIGENE :/: molecular/JJ interactions/NNS and/CC effects/NNS on/IN nuclear/JJ assembly/NN in/IN Xenopus/NN egg/NN extracts/NNS ./.
@@10745563557/CD Thus/RB ,/, both/PDT the/DT hyperplasia/NN and/CC thrombotic/JJ complications/NNS which/WDT often/RB follow/VB stenting/NN might/MD be/VB minimized/VBN by/IN employing/VBG gold/JJ stents/NNS ,/, which/WDT have/VBP a/DT greater/JJR capacity/NN than/IN steel/NN in/IN supporting/JJ a/DT functional/JJ neo-endothelium/NN ./.
@@114282761302/CD The/DT Van/NNP der/NNP Hoeve's/NNP syndrome/NN lesions/NNS as/IN poorly/RB mineralized/JJ ,/, with/IN low/JJ calcium/NN salt/JJ and/CC apparent/JJ increase/NN of/IN phosphates/NNS ./.
@@1500662078/CD Native/NNP human/MULTIGENE fibrinogen/MULTIGENE was/VBD brought/VBP to/IN coagulation/NN by/IN adding/JJ thrombin/NN ./.
@@88876476597/CD Fission/NNS yeast/NN mal2+/GENE is/VBZ required/VBN for/IN chromosome/NN segregation/NN ./.
@@13981407995/CD Surprisingly/RB ,/, the/DT Xenopus/NNP U7/MULTIGENE gene/MULTIGENE contains/VBZ two/JJ adjacent/JJ octamer-binding/MULTIGENE motifs/MULTIGENE located/VBN only/RB 12/CD and/CC 24/CD bp/NN upstream/RB from/IN the/DT PSE/NN ,/, instead/RB of/IN the/DT usual/JJ location/NN around/IN 150-200/JJ bp/NN upstream/RB ./.
@@91695937552/CD Insulin/NNS regulation/NN of/IN mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE kinase/MULTIGENE (/( MEK/GENE )/SYM ,/, mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE and/CC casein/MULTIGENE kinase/MULTIGENE in/IN the/DT cell/NN nucleus/NN :/: a/DT possible/JJ role/NN in/IN the/DT regulation/NN of/IN gene/NN expression/NN ./.
@@10082554822/CD Functional/JJ domains/NNS of/IN c-myc/MULTIGENE promoter/MULTIGENE binding/MULTIGENE protein/MULTIGENE 1/MULTIGENE involved/VBN in/IN transcriptional/JJ repression/NN and/CC cell/NN growth/NN regulation/NN ./.
@@75377363954/CD Our/PRP results/NNS indicate/VBP that/DT interaction/NN between/IN Jak2/GENE and/CC PRLR/NN requires/VBZ a/DT proline-rich/JJ sequence/NN in/IN the/DT membrane/NN proximal/JJ region/NN of/IN the/DT receptor/NN ,/, which/WDT is/VBZ conserved/VBN among/IN the/DT different/JJ members/NNS of/IN the/DT cytokine/MULTIGENE receptor/MULTIGENE superfamily/MULTIGENE ./.
@@93609939203/CD Mouse/MULTIGENE mast/MULTIGENE cell/MULTIGENE protease/MULTIGENE 9/MULTIGENE ,/, a/DT novel/JJ member/NN of/IN the/DT chromosome/MULTIGENE 14/MULTIGENE family/MULTIGENE of/IN serine/NN proteases/NNS that/WDT is/VBZ selectively/RB expressed/VBN in/IN uterine/JJ mast/NN cells/NNS ./.
@@72142309122/CD Inhibition/NNS of/IN Fusarium/NN moniliforme/NN var/NN ./. subglutinans/NNS ,/, the/DT causal/JJ agent/NN of/IN pine/NN pitch/NN canker/NN ,/, by/IN the/DT soil/NN bacterium/NN Arthrobacter/NN sp/NN ./NN
@@86571356114/CD We/PRP conclude/VBP from/IN these/DT studies/NNS that/WDT CKII/DT may/MD act/NN as/IN a/DT positive/JJ regulator/NN of/IN myogenesis/NN by/IN preventing/JJ E/MULTIGENE protein/MULTIGENE homodimers/MULTIGENE from/IN binding/JJ to/IN muscle/NN gene/NN regulatory/JJ elements/NNS ./.
@@86260651344/CD We/PRP have/VBP cloned/VBN and/CC sequenced/VBN a/DT 3574-bp/JJ Bacillus/NN subtilis/JJ (/( Bs/IN )/SYM DNA/NN fragment/NN located/VBN between/IN the/DT nrdA/NN and/CC citB/MULTIGENE genes/MULTIGENE at/IN about/RB 169/CD degrees/NNS on/IN the/DT chromosome/NN ./.
@@2536160942/CD At/NN the/DT basal/JJ unstimulated/JJ condition/NN ,/, Ren1d/NEWGENE 5'/CD flanking/JJ sequence/NN in/IN the/DT sense/NN orientation/NN inhibited/VBD basal/JJ CAT/NN expression/NN from/IN the/DT TK/MULTIGENE promoter/MULTIGENE of/IN pUTKAT1/GENE ,/, whereas/IN the/DT same/JJ sequence/NN in/IN the/DT antisense/NN orientation/NN did/VBD not/RB ./.
@@18458999078/CD The/DT adeno-associated/JJ virus/NN (/( AAV/IN )/SYM rep/MULTIGENE gene/MULTIGENE encodes/VBZ four/CD proteins/NNS (/( Rep78/GENE ,/, Rep68/GENE ,/, Rep52/GENE ,/, and/CC Rep40/CONTEXTGENE )/SYM required/VBN for/IN AAV/MULTIGENE DNA/MULTIGENE replication/NN and/CC AAV/MULTIGENE gene/MULTIGENE regulation/NN ./.
@@10585311412/CD Patients/NNS with/IN types/NNS I/PRP and/CC III/NNP MPGN/NN did/VBD not/RB differ/VB in/IN age/NN at/IN apparent/JJ onset/NN ,/, age/NN at/IN diagnosis/NN ,/, or/CC interval/NN from/IN apparent/JJ onset/NN of/IN symptoms/NNS to/IN diagnosis/NN (/( biopsy/NN )/SYM ./.
@@63163471044/CD The/DT dnaQ-lacZ/JJ and/CC the/DT rnh-lacZ/RB fused/VBN genes/NNS were/VBD constructed/VBN and/CC hybrid/JJ proteins/NNS with/IN beta-galactosidase/NEWGENE activity/NN were/VBD produced/VBN ./.
@@16304552942/CD We/PRP identified/VBD a/DT protein/NN ,/, termed/JJ NFIL-1/MULTIGENE beta/MULTIGENE A/MULTIGENE (/( NF/MULTIGENE beta/MULTIGENE A/MULTIGENE )/SYM ,/, that/WDT binds/VBZ to/IN a/DT highly/RB conserved/VBN 12-bp/JJ DNA/NN sequence/NN (/( -49/CD to/IN -38/CD )/SYM located/VBN upstream/RB of/IN the/DT TATA/MULTIGENE box/MULTIGENE motif/MULTIGENE in/IN both/PDT the/DT human/JJ and/CC murine/MULTIGENE IL-1/MULTIGENE beta/MULTIGENE genes/MULTIGENE ./.
@@85761313136/CD The/DT preferential/JJ heterodimerization/NN of/IN USF/MULTIGENE subunits/MULTIGENE was/VBD reproduced/VBN ex/NN vivo/NN ,/, while/CC the/DT in/NN vitro/FW association/NN of/IN cotranslated/VBN subunits/NNS ,/, or/CC recombinant/JJ USF/MULTIGENE proteins/MULTIGENE ,/, appeared/VBN to/IN be/VB random/JJ ./.
@@10101744104/CD In/NN all/DT trials/NNS ,/, antigen/NN challenge/NN followed/VBN 1/CD h/NN after/IN the/DT last/NN treatment/NN ./.
@@25555194284/CD Since/IN considerable/JJ variations/NNS in/IN length/NN and/CC primary/JJ sequence/NN in/IN the/DT CDR3/GENE (/( complementarity/MULTIGENE determining/MULTIGENE region/MULTIGENE )/SYM peptides/NNS of/IN all/PDT the/DT H-chains/NNS are/VBP evident/JJ ,/, conservation/NN of/IN the/DT D-region/NN structure/NN does/VBP not/RB appear/VB to/IN be/VB necessary/JJ for/IN effective/JJ hapten/NN binding/JJ ./.
@@19880417309/CD The/DT sequence/NN of/IN four/CD clones/NNS was/VBD sufficient/JJ to/IN construct/NN a/DT 3018-bp/JJ BAL/MULTIGENE cDNA/MULTIGENE structure/NN ./.
@@95684459515/CD New-onset/NNP angina/NN preceding/JJ acute/JJ myocardial/JJ infarction/NN is/VBZ associated/VBN with/IN improved/VBN contractile/JJ recovery/NN after/IN thrombolysis/NN ./.
@@76933727627/CD This/DT agent/NN ,/, isolated/VBN from/IN the/DT fungus/NN Streptomyces/NN tsukubaensis/NN ,/, has/VBZ a/DT mechanism/NN of/IN action/NN similar/JJ to/IN that/DT of/IN cyclosporine/NN ./.
@@97040066244/CD Arnt3/MULTIGENE mRNA/MULTIGENE was/VBD expressed/VBN in/IN brain/NN ,/, skeletal/JJ muscle/NN ,/, 13/NN ./NN 5-day/NN embryos/NNS ,/, and/CC P19/CD cells/NNS treated/VBN with/IN retinoic/JJ acid/NN ./.
@@83255049519/CD Neither/CC RD19/GENE nor/CC RD21/MULTIGENE mRNA/MULTIGENE synthesis/NN was/VBD responsive/JJ to/IN cold/JJ or/CC to/IN heat/NN stress/NN ./.
@@36015334265/CD Diagnostic/NNP importance/NN of/IN determining/JJ the/DT complement/NN constituents/NNS in/IN children/NNS with/IN autoimmune/JJ thyroiditis/NN ./.
@@78543249403/CD Because/IN of/IN the/DT functional/JJ conservation/NN of/IN cell/NN cycle/NN control/JJ elements/NNS ,/, the/DT expression/NN of/IN a/DT vertebrate/MULTIGENE wee1/MULTIGENE or/CC mik1/MULTIGENE homolog/MULTIGENE would/MD be/VB expected/VBN to/IN rescue/NN such/JJ lethal/JJ mutations/NNS in/IN yeast/NN ./.
@@78810779371/CD Supplementary/NNP Phase/NN Contraste/JJ RSE/GENE (/( "Rapid/GENE Sequential/NNP Excitation"/GENE )/SYM sequences/NNS were/VBD carried/VBN out/RB in/IN 29/CD patients/NNS ./.
@@94737559432/CD PATIENTS/IN AND/CC METHODS/IN :/: Between/IN January/NN 1992/CD and/CC June/NN 1994/CD at/IN St/NN ./NN
@@30019523722/CD It/PRP is/VBZ concluded/VBN that/IN in/IN patients/NNS with/IN first-attack/JJ genital/JJ herpes/NN ,/, the/DT type/NN of/IN HSV/NN is/VBZ the/DT most/RB important/JJ determinant/NN of/IN subsequent/JJ recurrences/NNS and/CC that/IN intravenous/JJ acyclovir/NN has/VBZ little/JJ effect/NN on/IN subsequent/JJ recurrences/NNS ./.
@@77307955950/CD The/DT amino/JJ acid/NN sequences/NNS of/IN the/DT known/VBP largest/JJS subunits/NNS of/IN DdRPs/NNP from/IN different/JJ species/NN contain/VB highly/RB conserved/VBN regions/NNS ./.
@@85348488127/CD All/DT three/CD NR/MULTIGENE isoforms/MULTIGENE are/VBP expressed/VBN in/IN cv/CD ./CD
@@87331238108/CD Facioscapulohumeral/JJ muscular/JJ dystrophy/NN (/( FSHD/GENE )/SYM is/VBZ an/DT autosomal/JJ dominant/NN ,/, neuromuscular/JJ disorder/NN characterized/VBN by/IN progressive/JJ weakness/NN of/IN muscles/NNS in/IN the/DT face/NN ,/, shoulder/NN and/CC upper/JJ arm/NN ./.
@@35811605978/CD Significantly/RB lower/JJR heart/NN rate/NN reactivity/NN and/CC significantly/RB less/PRP pronounced/VBN left/NN temporal/JJ artery/NN pulse/NN amplitude/NN responses/NNS were/VBD found/VBN in/IN non-medicated/JJ TH/NN subjects/NNS than/IN in/IN controls/NNS ./.
@@86579186807/CD MATERIALS/NNP AND/CC METHODS/IN :/: Coronal/NNP 3D/NNP GRE/NNP imaging/VBG was/VBD used/VBN to/IN study/NN the/DT volar/JJ ,/, middle/JJ ,/, and/CC dorsal/JJ portions/NNS of/IN the/DT SLL/NN in/IN 14/CD patients/NNS with/IN an/DT arthroscopically/RB normal/JJ SLL/NN and/CC in/IN five/CD cadaveric/JJ wrists/NNS that/WDT had/VBP a/DT normal/NN SLL/NN proved/VBN with/IN dissection/NN ./.
@@95287588250/CD Rex-1/GENE ,/, a/DT gene/NN encoding/VBG a/DT transcription/NN factor/NN expressed/VBN in/IN the/DT early/JJ embryo/NN ,/, is/VBZ regulated/VBN via/NN Oct-3/GENE //GENE 4/GENE and/CC Oct-6/GENE binding/JJ to/IN an/DT octamer/NN site/NN and/CC a/DT novel/JJ protein/NN ,/, Rox-1/GENE ,/, binding/JJ to/IN an/DT adjacent/JJ site/NN ./.
@@67620252158/CD The/DT 13/NNS ,/NNS 14-dihydro-15-keto-metabolites/NNS of/IN PGE2/NN and/CC PGF2/MULTIGENE alpha/MULTIGENE had/VBP no/DT statistically/RB significant/JJ antiarrhythmic/JJ effect/NN ./.
@@40846075441/CD The/DT imino/JJ proton/NN of/IN T3/NN in/IN the/DT O6meG/MULTIGENE ./MULTIGENE T/MULTIGENE 12-mer/MULTIGENE and/CC G3/GENE in/IN the/DT O6meG/MULTIGENE ./MULTIGENE N/MULTIGENE 12-mer/MULTIGENE helix/NN ,/, which/WDT are/VBP associated/VBN with/IN the/DT modification/NN site/NN ,/, resonate/VB at/IN unusually/RB high/JJ field/NN (/( 8/CD ./CD 5/CD to/IN 9/CD ./CD 0/CD ppm/NN )/SYM compared/VBN to/IN imino/JJ protons/NNS in/IN Watson-Crick/NNP base/NN pairs/NNS (/( 12/CD ./CD 5/CD to/IN 14/CD ./CD 5/CD ppm/NN )/SYM ./.
@@87973628162/CD Update/NNP :/: diphtheria/NN epidemic/JJ in/IN the/DT newly/RB independent/JJ states/NNS of/IN the/DT former/JJ USSR/NN ,/, January/NN 1995-March/GENE 1996/CD ./.
@@33543414044/CD The/DT glomerular/JJ filtration/NN rate/NN and/CC effective/JJ renal/JJ plasma/NN flow/NN were/VBD determined/VBN by/IN a/DT standard/JJ clearance/NN method/NN ,/, employing/VBG continuous/JJ infusion/NN of/IN inulin/NN and/CC para-aminohippuric/JJ acid/NN ./.
@@76426337855/CD A/DT TATA-less/NNP promoter/MULTIGENE containing/MULTIGENE binding/MULTIGENE sites/MULTIGENE for/IN ubiquitous/JJ transcription/NN factors/NNS mediates/VBZ cell/NN type-specific/JJ regulation/NN of/IN the/DT gene/NN for/IN transcription/MULTIGENE enhancer/MULTIGENE factor-1/MULTIGENE (/( TEF-1/GENE )/SYM ./.
@@35076893804/CD Chimeric/NNP phage-plasmid/JJ expression/NN vectors/NNS were/VBD constructed/VBN from/IN pUC18/GENE //GENE 19/GENE plasmids/NNS by/IN cloning/VBG a/DT single-stranded/JJ DNA/NN (/( ssDNA/NN )/SYM origin/NN of/IN replication/NN from/IN bacteriophage/NN f1/GENE and/CC inserting/VBG a/DT bacteriophage/NN T7/MULTIGENE promoter/MULTIGENE within/IN the/DT beta-galactosidase/MULTIGENE gene/MULTIGENE ./.
@@104469104874/CD Analysis/NNP of/IN the/DT E2F1/MULTIGENE gene/MULTIGENE promoter/MULTIGENE showed/VBN that/IN the/DT -146/NN to/IN -54/CD region/NN was/VBD required/VBN for/IN E2-responsiveness/NNP in/IN transient/JJ transfection/NN assays/NNS ,/, and/CC subsequent/JJ deletion/NN //NN mutation/NN analysis/NN showed/VBN that/IN a/DT single/JJ upstream/RB GC-rich/NNP and/CC two/JJ downstream/MULTIGENE CCAAT-binding/MULTIGENE sites/MULTIGENE were/VBD required/VBN for/IN transactivation/NN by/IN E2/NNP ./NNP
@@82293308210/CD Most/JJS smokers/NNS would/MD prefer/VB to/IN quit/NN smoking/NN on/IN their/PRP own/VB ./.
@@20930335868/CD Effect/NN of/IN separate/JJ and/CC combined/JJ effects/NNS of/IN plutonium-239/NN ,/, hexachlorobutadiene/NN and/CC tributyl/NN phosphate/NN on/IN the/DT thymus/NN gland/NN of/IN rats/NNS ./.
@@90833454563/CD However/RB ,/, the/DT range/NN of/IN values/NNS observed/VBN is/VBZ suggestive/JJ of/IN the/DT need/NN to/IN investigate/VB districts/NNS with/IN contrasting/JJ values/NNS of/IN SYPLR/GENE with/IN respect/NN to/IN the/DT inter-relationships/NNS between/IN sociodemographic/JJ characteristics/NNS ,/, duration/NN of/IN symptoms/NNS ,/, clinical/JJ presentation/NN and/CC treatment/NN efficacy/NN ./.
@@100842945657/CD Because/IN there/RB is/VBZ great/JJ need/NN for/IN iron/NN in/IN the/DT EPO-stimulated/JJ erythroid/MULTIGENE progenitors/MULTIGENE ,/, it/PRP is/VBZ essential/JJ that/IN serum/JJ ferritin/NEWGENE and/CC transferrin/NN saturation/NN levels/NNS should/MD be/VB maintained/VBN over/RB 300/CD microg/NN //NN liter/NN and/CC 30%/CD ,/, respectively/RB ./.
@@22694263524/CD IST/NN is/VBZ not/RB the/DT RNA/NN target/NN (/( TAR/JJ )/SYM for/IN Tat/NN trans-activation/NN ;/: however/RB ,/, because/IN it/PRP relies/VBZ entirely/RB on/IN cellular/JJ factors/NNS for/IN activity/NN ,/, IST/NN may/MD serve/VB to/IN provide/VB abundant/JJ RNA/NN targets/NNS for/IN Tat/NN trans-activation/NN without/IN a/DT requirement/NN for/IN full-length/JJ viral/JJ mRNA/NN expression/NN ./.
@@86320154779/CD Immunocytochemical/JJ analysis/NN demonstrated/VBD the/DT presence/NN of/IN DREF/GENE polypeptide/NN in/IN nuclei/NNS after/IN the/DT eighth/JJ nuclear/JJ division/NN cycle/NN ,/, suggesting/VBG that/IN nuclear/JJ accumulation/NN of/IN DREF/GENE is/VBZ important/JJ for/IN the/DT coordinate/JJ zygotic/JJ expression/NN of/IN DNA/MULTIGENE replication-related/MULTIGENE genes/MULTIGENE carrying/VBG DRE/MULTIGENE sequences/MULTIGENE ./.
@@75981061435/CD Mean/VB growth/NN changes/NNS in/IN this/DT Class/MULTIGENE II/MULTIGENE sample/NN were/VBD comparable/JJ to/IN those/DT previously/RB reported/VBN for/IN male/JJ subjects/NNS with/IN Class/MULTIGENE I/MULTIGENE malocclusions/NNS over/RB the/DT same/JJ age/NN period/NN ,/, suggesting/VBG a/DT similarity/NN in/IN postpubertal/JJ development/NN between/IN these/DT two/JJ groups/NNS ./.
@@94051955355/CD Large/JJ genomic/JJ constructs/NNS integrate/VBP at/IN the/DT endogenous/JJ locus/NN by/IN homologous/JJ recombination/NN ,/, but/CC cDNA-derived/MULTIGENE sequences/MULTIGENE lacking/JJ long/JJ stretches/NNS of/IN contiguous/JJ genomic/JJ DNA/NN (/( due/NN to/IN intron/NN excision/NN )/SYM typically/RB integrate/VB into/IN chromosomal/JJ DNA/NN by/IN nonhomologous/JJ recombination/NN ./.
@@30537133462/CD DNA/NN sequencing/VBG of/IN the/DT DPM1/MULTIGENE gene/MULTIGENE revealed/VBD an/DT open/JJ reading/JJ frame/NN of/IN 801/CD bases/NNS ./.
@@93694531839/CD Unlike/IN most/RB other/DT members/NNS of/IN the/DT Bcl-2/MULTIGENE family/MULTIGENE ,/, BAD/GENE (/( Bcl-xL/MULTIGENE //MULTIGENE Bcl-2/MULTIGENE associated/MULTIGENE death/MULTIGENE promoter/MULTIGENE )/SYM ,/, a/DT death/MULTIGENE enhancer/MULTIGENE ,/, has/VBZ no/DT C-terminal/NN transmembrane/JJ domain/NN for/IN targeting/JJ to/IN the/DT outer/JJ mitochondrial/JJ membrane/NN and/CC nuclear/JJ envelope/NN ./.
@@95372952232/CD Analysis/NNP of/IN promoter/NN and/CC androgen/MULTIGENE regulatory/MULTIGENE sequences/MULTIGENE required/VBN for/IN optimal/JJ transcription/NN of/IN the/DT rat/MULTIGENE androgen-binding/MULTIGENE protein/MULTIGENE gene/MULTIGENE ./.
@@24360053099/CD These/DT results/NNS suggest/VBP that/IN the/DT negative/JJ inotropic/JJ action/NN of/IN nicorandil/NN is/VBZ caused/VBN by/IN inhibition/NN of/IN Ca/NN influx/NN and/CC intracellular/JJ mobilization/NN of/IN Ca/NNP ./NNP
@@13183103538/CD Plasma/NN membranes/NNS of/IN cultured/JJ cells/NNS contain/VBP high/JJ affinity/NN receptors/NNS for/IN high/JJ density/NN lipoprotein/NN (/( HDL/NN )/SYM that/WDT appear/VBP to/IN mediate/VB removal/NN of/IN excess/NN intracellular/JJ cholesterol/NN ./.
@@106536934623/CD We/PRP have/VBP addressed/VBN these/DT issues/NNS by/IN reconstituting/JJ and/CC characterizing/VBG the/DT KRAB/GENE :/: KAP-1-RBCC/GENE interaction/NN using/VBG purified/VBN components/NNS ./.
@@113808371221/CD Interventions/NNS aimed/VBN at/IN these/DT specific/JJ mediators/NNS and/CC processes/NNS may/MD be/VB successful/JJ in/IN reducing/JJ the/DT very/RB significant/JJ human/JJ and/CC economic/JJ costs/NNS of/IN vascular/JJ access/NN dysfunction/NN ./.
@@105928249874/CD Despite/IN the/DT high/JJ frequency/NN of/IN natural/JJ infection/NN ,/, the/DT seropositive/JJ rates/NNS of/IN JEV/GENE antibody/NN still/RB correlated/VBD well/VB with/IN the/DT dose/NN of/IN vaccine/NN received/VBN ,/, i/FW ./FW e/FW ./FW ,/, 67%/JJ (/( 1122/CD //CD 1664/CD )/SYM ,/, 66%/JJ (/( 65/CD //CD 97/CD )/SYM ,/, 33%/JJ (/( 4/CD //CD 12/CD )/SYM and/CC 40%/CD (/( 19/CD //CD 47/CD )/SYM for/IN children/NNS receiving/JJ 3/CD ,/, 2/CD ,/, 1/CD ,/, and/CC 0/CD dose/NN of/IN JE/NN vaccines/NNS ,/, respectively/RB (/( P/NN </SYM 0/CD ./CD 0001/CD Chi-square/NN for/IN trend/NN test/NN )/SYM ./.
@@27492153442/CD Isolated/JJ proteinuria/NN (/( i/CD ./CD e/CD ./. without/IN hematuria/NN and/DT //DT or/DT pyuria/NN )/SYM is/VBZ a/DT frequent/JJ finding/NN ./.
@@91740496749/CD Concomitantly/RB ,/, p34CDC2/MULTIGENE histone/MULTIGENE H1/MULTIGENE kinase/MULTIGENE activity/NN increases/NNS in/IN the/DT former/NN ,/, but/CC not/RB in/IN the/DT latter/JJ cell/NN lines/NNS ,/, hence/RB suggesting/VBG a/DT role/NN for/IN this/DT protein/NN in/IN radiation-induced/JJ cell/NN death/NN ./.
@@104881484711/CD These/DT studies/NNS suggest/VBP that/IN MAPK/NEWGENE acts/NNS by/IN stimulating/MULTIGENE AP-1/MULTIGENE and/CC a/DT subsequent/JJ physical/JJ and/CC functional/JJ interaction/NN of/IN AP-1/GENE with/IN NF-kappaB/GENE ,/, resulting/VBG in/IN a/DT complex/NN that/WDT synergistically/RB transactivates/VBZ the/DT HIV-1/MULTIGENE LTR/MULTIGENE ./.
@@26291098732/CD Although/IN the/DT fertility/NN decline/NN in/IN the/DT black/JJ population/NN in/IN the/DT Mississippi/MULTIGENE Delta/MULTIGENE between/IN the/DT late/JJ 1870's/CD and/CC early/JJ 1930's/CD closely/RB paralleled/VBN that/IN of/IN the/DT national/JJ black/JJ population/NN ,/, it/PRP rose/VBD much/JJ more/RB dramatically/RB in/IN the/DT 1940's/CD and/CC 1950's/CD to/IN almost/RB 1880/CD levels/NNS ./.
@@32090199952/CD During/IN a/DT 28-week/CD promotion/NN bioassay/NN ,/, groups/NNS of/IN 30/CD male/JJ CD-1/GENE mice/NNS were/VBD treated/VBN once/CC with/IN 50/CD microliter/NN of/IN either/DT DMBA/NN (/( 1/CD ./CD 0/CD mg/NN //NN ml/NN )/SYM or/CC acetone/NN ,/, rested/VBN for/IN 2/CD weeks/NNS ,/, and/CC then/RB treated/VBN twice/RB per/IN week/NN with/IN test/NN material/NN for/IN the/DT remaining/JJ 25/CD weeks/NNS ./.
@@76513409932/CD Retransformation/NNS of/IN uvsH77/MULTIGENE mutants/MULTIGENE with/IN the/DT rescued/VBN cosmids/NNS from/IN the/DT MMS-resistant/NNP transformants/NNS resulted/VBN in/IN restoration/NN of/IN both/DT UV/NN and/CC MMS/NNP resistance/NN to/IN wild-type/NN levels/NNS ./.
@@105493547937/CD Similar/JJ mechanisms/NNS leading/VBG to/IN deregulation/NN of/IN Tcf/MULTIGENE target/MULTIGENE gene/MULTIGENE activity/NN are/VBP likely/RB to/IN be/VB involved/VBN in/IN melanoma/NN and/CC other/DT forms/NNS of/IN cancer/NN ./.
@@93087381240/CD In/NN the/DT United/NNP States/NNPS high-MW/JJ HES/MULTIGENE 480/MULTIGENE which/WDT is/VBZ difficult/JJ to/IN degrade/VB is/VBZ most/RB frequently/RB used/VBN and/CC results/NNS in/IN a/DT larger/JJR in/IN vivo/MULTIGENE MW/MULTIGENE and/CC subsequent/JJ decrease/NN in/IN factor/MULTIGENE VIII/MULTIGENE //MULTIGENE von/MULTIGENE Willebrand/NN factor/NN levels/NNS ./.
@@65247618275/CD However/RB ,/, there/RB was/VBD a/DT difference/NN in/IN the/DT quality/NN of/IN immunity/NN :/: fever/NN and/CC body/NN weight/NN loss/NN were/VBD seen/VBP in/IN hamsters/NNS vaccinated/VBN with/IN the/DT killed-toxoplasma/JJ vaccine/NN after/IN they/PRP were/VBD challenge/NN exposed/VBN with/IN T-1/GENE strain/NN ,/, whereas/IN these/DT changes/NNS were/VBD rarely/RB seen/VBP in/IN hamsters/NNS given/VBP the/DT live-toxoplasma/JJ vaccine/NN and/CC then/JJ challenge/NN exposed/VBN with/IN RH/GENE strain/NN ./.
@@89169608055/CD We/PRP analyzed/VBD serial/JJ biopsy/NN specimens/NNS from/IN eight/CD patients/NNS with/IN FL/NN for/IN secondary/JJ alterations/NNS of/IN the/DT rearranged/JJ bcl-2/MULTIGENE gene/MULTIGENE in/IN the/DT breakpoint/NN and/CC open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM regions/NNS ./.
@@15572172163/CD Eight/CD of/IN 14/CD infectious/JJ or/CC inflammatory/JJ lesions/NNS could/MD be/VB detected/VBN in/IN the/DT early/JJ scan/NN (/( 4-6/CD h/NN p/CD ./CD i/CD ./CD )/SYM ./.
@@92714176350/CD In/NN the/DT adult/JJ mouse/NN ,/, ERR/MULTIGENE alpha/MULTIGENE is/VBZ most/RB highly/RB expressed/VBN in/IN kidney/NN ,/, heart/NN ,/, and/CC brown/JJ adipocytes/NNS ,/, tissues/NNS which/WDT preferentially/RB metabolize/VB fatty/JJ acids/NNS ./.
@@67022571860/CD Antithrombin/MULTIGENE III/MULTIGENE in/IN hip/NN surgery/NN ./.
@@80125668303/CD The/DT pentafluorobenzyl/NN derivative/NN of/IN clonidine/NN yields/VBZ an/DT intense/JJ ion/NN fragment/NN at/IN m/MULTIGENE //MULTIGENE z/MULTIGENE 354/MULTIGENE ,/, and/CC the/DT lower/JJR limit/NN of/IN detection/NN is/VBZ 0/CD ./CD 025/CD ng/NN //NN ml/NN for/IN a/DT 1-ml/JJ plasma/NN sample/NN ./.
@@109305261398/CD We/PRP recently/RB reported/VBD the/DT molecular/JJ cloning/NN of/IN a/DT PL/MULTIGENE scramblase/MULTIGENE of/IN human/JJ (/( HuPLSCR1/GENE )/SYM and/CC mouse/NN origin/NN ,/, respectively/RB ./.
@@76238445533/CD However/RB ,/, unlike/IN Bcl-2/GENE and/CC the/DT E1B/MULTIGENE 19K/MULTIGENE proteins/MULTIGENE ,/, which/WDT completely/RB block/VB apoptosis/NN but/CC not/RB p53-dependent/JJ growth/NN arrest/NN ,/, H-ras/GENE expression/NN permitted/VBD DNA/NN synthesis/NN and/CC cell/NN proliferation/NN in/IN the/DT presence/NN of/IN high/JJ levels/NNS of/IN wild-type/MULTIGENE p53/MULTIGENE ./.
@@91153957250/CD Of/IN these/DT proteins/NNS ,/, five/CD have/VB previously/RB been/VBN shown/VBP to/IN be/VB phosphorylated/VBN during/IN mitosis/NN (/( epithelial-microtubule/RB associated/VBN protein-115/CONTEXTGENE ,/, Oct91/GENE ,/, Elongation/NNS factor/NN 1gamma/CD ,/, BRG1/GENE and/CC Ribosomal/JJ protein/NN L18A/GENE )/SYM ,/, five/CD are/VBP related/VBN to/IN proteins/NNS postulated/VBN to/IN have/NN roles/NNS in/IN mitosis/NN (/( epithelial-microtubule/RB associated/VBN protein-115/CONTEXTGENE ,/, Schizosaccharomyces/NN pombe/NN Cdc5/GENE ,/, innercentrosome/MULTIGENE protein/MULTIGENE ,/, BRG1/GENE and/CC the/DT RNA/MULTIGENE helicase/MULTIGENE WM6/MULTIGENE )/SYM ,/, and/CC nine/JJ are/VBP related/VBN to/IN transcription/NN factors/NNS (/( BRG1/GENE ,/, negative/JJ co-factor/NN 2alpha/CD ,/, Oct91/GENE ,/, S/NNP ./NNP pombe/NN Cdc5/GENE ,/, HoxD1/GENE ,/, Sox3/GENE ,/, Vent2/GENE ,/, and/CC two/JJ isoforms/NNS of/IN Xbr1b/NNP )/SYM ./.
@@29283763635/CD For/IN the/DT present/NN work/NN we/PRP used/VBD water/VBP saturated/JJ with/IN a/DT 50/CD //CD 50/CD mixture/NN of/IN H2/NN and/CC O2/GENE gases/NNS ,/, for/IN which/WDT the/DT heat/NN defect/NN is/VBZ calculated/VBN to/IN be/VB -2/CD ./CD 1%/CD ./.
@@11902511814/CD Caution/NN should/MD be/VB exercised/VBN in/IN the/DT use/NN of/IN these/DT dyes/NNS for/IN lymphograms/NNS ./.
@@93546849966/CD In/NN addition/NN ,/, mutation/NN of/IN the/DT Sp1/MULTIGENE site/MULTIGENE also/RB significantly/RB reduced/VBN promoter/NN activity/NN ./.
@@85196218488/CD This/DT conclusion/NN is/VBZ based/VBN on/IN the/DT observations/NNS of/IN the/DT immunologic/JJ changes/NNS that/WDT characterize/VBP the/DT acute/JJ stages/NNS of/RB illness/NN as/RB well/VB as/IN on/IN the/DT demonstrated/VBN association/NN with/IN toxin-producing/JJ bacteria/NNS in/IN the/DT pharynx/NN and/CC gastrointestinal/JJ tract/NN ./.
@@115738916847/CD RESULTS/NNS :/: Sixty/CD per/IN cent/NN of/IN African/JJ Americans/NNS exposed/VBN in/IN 26/CD community/NN outbreaks/NNS were/VBD TST/NEWGENE positive/RB compared/VBD to/IN only/RB 40%/CD of/IN whites/NNS following/IN comparable/JJ exposures/NNS ./.
@@92823291649/CD To/TO address/VB mechanisms/NNS that/WDT define/VBP interactions/NNS of/IN Site/MULTIGENE II/MULTIGENE regulatory/MULTIGENE factors/MULTIGENE with/IN this/DT cell/NN cycle/NN control/NN element/NN ,/, we/PRP have/VBP investigated/VBN these/DT determinants/NNS of/IN transcriptional/JJ regulation/NN at/IN the/DT G1/NN //NN S/NN phase/NN transition/NN in/IN FDC-P1/NNP hematopoietic/JJ progenitor/NN cells/NNS ./.
@@83489197747/CD Botulinum/MULTIGENE toxin/MULTIGENE :/: preferred/VBN treatment/NN for/IN hemifacial/JJ spasm/NN ./.
@@106146761333/CD Objective/JJ :/: To/TO evaluate/VB endometrial/JJ thickness/NN and/CC the/DT incidence/NN of/IN uterine/JJ bleeding/NN in/IN postmenopausal/JJ women/NNS using/VBG either/DT tibolone/MULTIGENE 2/MULTIGENE ./MULTIGENE 5/MULTIGENE mg/NN or/CC continuous/JJ combined/JJ 2/CD mg/NN estradiol/NN and/CC 1/CD mg/NN norethisterone/NN acetate/NN (/( E+NETA/NNP )/SYM daily/JJ as/IN hormone/NN replacement/NN therapy/NN ./.
@@11305311134/CD Nerve/NN stimulation/NN (/( 1/CD ./CD 5-12/CD cycles/NNS //NNS s/NNS )/SYM produced/VBN frequency-dependent/JJ reductions/NNS in/IN CBF/NN ,/, a/DT decrease/NN of/IN 50/CD percent/NN occurring/VBG with/IN the/DT highest/JJS frequency/NN ./.
@@94677078960/CD Sibling/NN aggregation/NN of/IN low-/DT and/CC high-density/JJ lipoprotein/NN cholesterol/NN and/CC apolipoproteins/MULTIGENE B/MULTIGENE and/CC A-I/NNS levels/NNS in/IN black/JJ and/CC white/JJ children/NNS :/: the/DT Bogalusa/NNP Heart/NNP Study/NNP ./.
@@75258437774/CD Dilutions/NNS of/IN H-2b/NNP or/CC H-2d/MULTIGENE NP/MULTIGENE peptides/MULTIGENE indicated/VBN that/IN 3-4/CD logs/NNS less/PRP H-2b/NNP NP/NN peptide/NN was/VBD required/VBN to/IN sensitize/VB syngeneic/JJ target/NN cells/NNS for/IN CTL-specific/NNP lysis/NN ,/, suggesting/VBG that/IN the/DT differing/JJ affinities/NNS of/IN H-2b/NNP and/CC H-2d/NEWGENE major/JJ histocompatibility/MULTIGENE complex/MULTIGENE molecules/MULTIGENE for/IN their/PRP peptides/NNS likely/JJ account/NN for/IN the/DT total/JJ removal/NN of/IN NP/MULTIGENE CTL/MULTIGENE in/IN the/DT H-2b/NNP mice/NNS but/CC only/RB partial/JJ removal/NN in/IN H-2d/NEWGENE mice/NNS made/VBP to/IN express/NN thymic/JJ NP/NNP ./NNP
@@106815887698/CD EMSA/NN showed/VBN that/IN nuclear/JJ proteins/NNS from/IN PC12/CELL but/CC not/RB C6/VB or/CC Rat2/NNP cells/NNS bind/VBP the/DT CRE/NN as/IN a/DT complex/MULTIGENE containing/MULTIGENE activating/MULTIGENE transcription/MULTIGENE factor/MULTIGENE (/( ATF/CONTEXTGENE )/NN -4/NN and/CC CCAAT/MULTIGENE enhancer-binding/MULTIGENE protein/MULTIGENE beta/MULTIGENE ,/, while/CC both/DT PC12/CELL and/CC C6/NN cell/NN nuclear/JJ extracts/NNS were/VBD recruited/VBN by/IN the/DT CCAAT-box/NNP as/IN a/DT complex/MULTIGENE containing/MULTIGENE nuclear/MULTIGENE factor/MULTIGENE Y/NNP ./NNP
@@22578992898/CD Auditory-visual/JJ interaction/NN in/IN the/DT generation/NN of/IN saccades/NNS in/IN man/NN ./.
@@110126712971/CD In/NN addition/NN ,/, a/DT noncanonical/NNP C/MULTIGENE //MULTIGENE EBP-binding/MULTIGENE site/MULTIGENE within/IN the/DT Gadd45gamma/MULTIGENE promoter/MULTIGENE where/CC C/GENE //GENE EBPbeta/GENE and/CC C/GENE //GENE EBPdelta/GENE could/MD bind/VB ,/, was/VBD identified/VBN by/IN electrophoretic/JJ mobility/NN shift/NN assay/NN (/( EMSA/NN )/SYM and/CC reporter/NN gene/NN analysis/NN ./.
@@83966678753/CD BCR-ABL/GENE and/CC v-abl/MULTIGENE oncogenes/MULTIGENE induce/VBP distinct/JJ patterns/NNS of/IN thymic/JJ lymphoma/NN involving/VBG different/JJ lymphocyte/NN subsets/NNS ./.
@@80025647852/CD DNA/NN sequence/NN analysis/NN has/VBZ confirmed/VBN that/IN this/DT mutation/NN affects/VBP the/DT C-terminal/MULTIGENE region/MULTIGENE of/IN the/DT alpha/MULTIGENE subunit/MULTIGENE ,/, changing/JJ a/DT leucine/NN residue/NN at/IN position/NN 290/CD to/IN a/DT histidine/NN (/( rpoAL290H/GENE )/SYM ./.
@@7011446791/CD Biometric/NN analysis/NN of/IN intraocular/JJ lens/NN power/NN required/VBN to/IN produce/NN emmetropia/NN :/: results/NNS of/IN 450/CD implants/NNS ./.
@@10563605384/CD There/EX was/VBD a/DT trend/NN toward/IN an/DT association/NN between/IN IENF/GENE and/CC sural/JJ nerve/NN unmyelinated/JJ fiber/NN densities/NNS (/( r/JJ =/SYM 0/CD ./CD 32/CD ,/, p/NN =/SYM 0/CD ./CD 054/CD )/SYM ./.
@@90117451634/CD CDNA/NNP cloning/NN of/IN chick/NN brain/NN alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic/MULTIGENE acid/MULTIGENE receptors/MULTIGENE reveals/VBZ conservation/NN of/IN structure/NN ,/, function/NN and/CC post-transcriptional/JJ processes/NNS with/IN mammalian/JJ receptors/NNS ./.
@@12808071233/CD The/DT apparent/JJ Kd/NN of/IN the/DT MetRS/NNP //NNP CAU/NNP operator/NN complex/NN is/VBZ one/PRP order/NN magnitude/NN higher/JJ than/IN that/DT of/IN the/DT ThrRS/NNP //NNP CGU/NNP operator/NN complex/NN ./.
@@84739676830/CD Bipolarity/NNS in/IN Jungian/NNP type/NN theory/NN and/CC the/DT Myers-Briggs/NNP Type/MULTIGENE Indicator/MULTIGENE ./.
@@112509425694/CD Deletional/JJ analyses/NNS of/IN VDR/NN indicated/VBN that/IN GRIP1/GENE and/CC RAC3/GENE required/VBN an/DT intact/JJ VDR/NEWGENE activation/NN function/NN (/( AF-2/GENE )/SYM domain/NN for/IN efficient/JJ interaction/NN as/RB well/VB as/IN additional/JJ but/CC distinct/JJ regions/NNS of/IN the/DT VDR/NN ./.
@@97654111732/CD Sequence/NN comparisons/NNS strongly/RB suggest/VBP that/IN the/DT S27a/NNP and/CC the/DT ubiquitin/NEWGENE coding/JJ sequences/NNS found/VBP in/IN the/DT genome/NN of/IN CP/NN Rit/GENE were/VBD both/DT derived/VBN from/IN a/DT bovine/MULTIGENE mRNA/MULTIGENE encoding/VBG a/DT hybrid/JJ protein/NN with/IN the/DT structure/NN NH2-ubiquitin-S27a-COOH/NNP ./.
@@83808965542/CD Kinetics/NNS of/IN the/DT inhibition/NN indicated/VBN that/IN this/DT polymerase/NN domain/NN can/MD inhibit/VB viral/JJ replication/NN only/RB during/IN the/DT preinitiation/JJ stage/NN ./.
@@90798174646/CD The/DT reduced/VBN NO/DT production/NN in/IN these/DT cells/NNS was/VBD associated/VBN with/IN low/JJ levels/NNS of/IN mRNA/NN of/IN inducible/JJ NO/DT synthetase/NN ./.
@@8378115406/CD A/DT diagnosis/NN of/IN MS/NN was/VBD made/VBP based/VBN on/IN subtle/JJ neurologic/JJ signs/NNS ,/, spinal/JJ fluid/NN gamma/MULTIGENE globulin/MULTIGENE elevations/NNS ,/, and/CC abnormalities/NNS in/IN neuropsychological/JJ testing/NN ./.
@@97636076059/CD We/PRP found/VBP that/IN virulent/JJ Ngo/NNP strains/NNS induce/VBP phosphorylation/NN and/CC activation/NN of/IN JNK/GENE but/CC not/RB of/IN p38/MULTIGENE kinase/MULTIGENE ./.
@@28201288232/CD In/NN terms/NNS of/IN sequence/NN repetitions/NNS ,/, seven/JJ tandemly/RB repeated/JJ copies/NNS of/IN the/DT hexanucleotide/NN ATTGTT/NNP and/CC three/CD flanking/JJ regions/NNS of/IN dyad/NN symmetry/NN were/VBD detected/VBN ,/, all/DT in/NN ORF/MULTIGENE T3C/MULTIGENE ./.
@@87565569611/CD The/DT cDNA/NN encoded/VBN a/DT mature/JJ protein/NN of/IN 240/CD amino/JJ acids/NNS ,/, including/JJ a/DT 29-amino/CD acid/NN signal/JJ sequence/NN ./.
@@86470866252/CD Cdk2/GENE formed/VBN a/DT complex/NN with/IN cyclin/MULTIGENE D1/MULTIGENE in/IN this/DT system/NN ./.
@@79837129323/CD However/RB ,/, when/CC domain/NN I/PRP and/CC domain/NN II/NNP were/VBD linked/JJ on/IN the/DT same/JJ plasmid/NN ,/, high/JJ levels/NNS of/IN replication/NN were/VBD observed/VBN ./.
@@7755827725/CD Biological/JJ properties/NNS of/IN sumithion/NN ./.
@@76483386029/CD These/DT results/NNS suggest/VBP that/IN different/JJ models/NNS of/IN intestinal/JJ ischemia/NN have/NN different/JJ cytokine/NN profiles/NNS and/CC that/IN the/DT early/MULTIGENE TNF/MULTIGENE response/NN associated/VBN with/IN SMA/NN occlusion/NN model/NN is/VBZ primarily/RB due/NN to/IN the/DT laparotomy/NN ./.
@@80653313550/CD An/DT in/NN vitro/MULTIGENE binding/MULTIGENE site/MULTIGENE selection/NN procedure/NN was/VBD used/VBN to/IN determine/VB DNA/NN sequences/NNS preferentially/RB bound/JJ by/IN wild-type/MULTIGENE HLF/MULTIGENE and/CC chimeric/JJ E2A-HLF/MULTIGENE proteins/MULTIGENE isolated/VBN from/IN various/JJ t/NN (/NN 17/NN ;/: 19/NN )/NN -bearing/NN leukemias/NNS ./.
@@10882462703/CD The/DT science/NN of/IN tissue/NN engineering/JJ ./.
@@87602867181/CD The/DT structural/JJ similarity/NN between/IN Vav/GENE and/CC other/DT guanine/MULTIGENE nucleotide/MULTIGENE exchange/MULTIGENE factors/MULTIGENE for/IN small/MULTIGENE GTP-binding/MULTIGENE proteins/MULTIGENE ,/, together/RB with/IN the/DT recent/JJ identification/NN of/IN biochemical/JJ routes/NNS specific/JJ for/IN members/NNS of/IN the/DT Ras/NNS and/CC Rho/MULTIGENE family/MULTIGENE of/IN GTPases/NNS ,/, prompted/VBD us/PRP to/IN explore/VB whether/IN MAPK/NEWGENE or/CC JNK/GENE are/VBP downstream/JJ components/NNS of/IN the/DT Vav/GENE signaling/JJ pathways/NNS ./.
@@81237878342/CD The/DT inferred/VBN amino/JJ acid/NN sequence/NN of/IN the/DT cyanobacterial/JJ HemB/MULTIGENE protein/MULTIGENE indicates/VBZ a/DT significant/JJ difference/NN in/IN the/DT metal/NN cofactor/NN requirement/NN from/IN the/DT higher-plant/JJ enzymes/NNS ,/, which/WDT was/VBD confirmed/VBN by/IN overexpression/NN and/CC biochemical/JJ analysis/NN ./.
@@65791524399/CD Besides/IN ,/, it/PRP was/VBD considered/VBN that/IN the/DT NPF/NN was/VBD a/DT useful/JJ tool/NN for/IN activation/NN of/IN velopharyngeal/JJ activity/NN by/IN way/NN of/IN visual/JJ feed-back/NN control/NN ./.
@@15889633872/CD Using/VBG these/DT antibodies/NNS ,/, we/PRP were/VBD able/JJ to/IN define/VB the/DT conditions/NNS to/IN completely/RB solubilize/VB the/PDT Cdc25/MULTIGENE protein/MULTIGENE ./.
@@78761343849/CD Here/RB ,/, we/PRP report/VBP the/DT characterization/NN of/IN an/DT alternatively/RB processed/VBN form/NN of/IN AFAP-110/GENE that/IN encodes/VBZ an/DT additional/JJ 258/CD base/NN pair/NN (/( bp/NN )/SYM of/IN open/JJ reading/JJ frame/NN ./.
@@98563979792/CD Dry/NNP matter/NN intake/NN ,/, apparent/JJ nutrient/JJ digestibilities/NNS ,/, serum/JJ chemistry/NN profiles/NNS ,/, sphingolipid/NN concentrations/NNS ,/, and/CC persistency/NN of/IN FB1/GENE in/IN tissues/NNS were/VBD evaluated/VBN ./.
@@61618235982/CD 2/CD Silastic/NN capsules/NNS ,/, each/DT containing/JJ 22-23/JJ mg/NN of/IN ethinyl/NN estradiol/NN ,/, were/VBD inserted/VBN subcutaneously/RB in/IN 5/CD men/NNS with/IN benign/JJ prostatic/JJ hypertrophy/NN ./.
@@115174453809/CD Sixty-one/NN cases/NNS of/IN cholera/NN ,/, all/DT caused/VBN by/IN V/NNP ./NNP cholerae/NNS O1/GENE ,/, were/VBD reported/VBN ./.
@@97505409737/CD Multiple/NNP chemical/JJ sensitivity/NN (/( MCS/NNS )/SYM is/VBZ a/DT syndrome/NN in/IN which/WDT multiple/JJ symptoms/NNS reportedly/RB occur/VBP with/IN low-level/JJ chemical/JJ exposure/NN ./.
@@90774382980/CD The/DT minimum/JJ and/CC essential/JJ subunits/NNS for/IN RNA/NN synthesis/NN have/NN not/RB yet/RB been/VBN identified/VBN ./.
@@14044012690/CD Behind/IN the/DT ATPase/MULTIGENE cluster/MULTIGENE ,/, two/JJ open/JJ reading/JJ frames/NNS were/VBD detected/VBN that/WDT are/VBP not/RB homologous/JJ to/IN any/DT known/VBP chloroplast/NN gene/NN ./.
@@63642654427/CD Induced/MULTIGENE gamma-ray/MULTIGENE spectroscopy/NN ./.
@@118594001747/CD We/PRP compared/VBD the/DT efficacy/NN and/CC costs/NNS of/IN valacyclovir/NN in/IN preventing/JJ HSV/NN reactivation/NN among/IN HSV/NN seropositive/JJ autologous/JJ progenitor/NN cell/NN transplantation/NN (/( APCT/NNP )/SYM patients/NNS with/IN historical/JJ controls/NNS in/IN whom/WP intravenous/JJ acyclovir/NN or/CC no/DT HSV/NN prophylaxis/NN were/VBD used/VBN ./.
@@88937797627/CD Frozen/NN //NN thawed/NN extensor/NN digitorum/NN longus/NN muscle/NN tendon/NN units/NNS had/VBP significantly/RB lower/JJR values/NNS for/IN load/NN to/IN failure/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, energy/NN absorbed/VBD to/IN failure/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, and/CC strain/NN at/IN failure/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, and/CC they/PRP tended/VBD to/IN fail/NN at/IN a/DT different/JJ anatomic/JJ location/NN (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM (/( broadly/RB at/IN the/DT fascia-muscle/JJ interface/NN as/IN compared/VBN with/IN horizontally/RB at/IN the/DT musculotendinous/JJ junction/NN )/SYM than/IN fresh/JJ units/NNS ./.
@@103506383387/CD Latexin/NNP ,/, a/DT carboxypeptidase/MULTIGENE A/MULTIGENE inhibitor/MULTIGENE ,/, is/VBZ expressed/VBN in/IN a/DT cell/NN type-specific/JJ manner/NN in/IN both/DT central/JJ and/CC peripheral/JJ nervous/JJ systems/NNS in/IN the/DT rat/NN ./.
@@66026004977/CD The/DT Sarns/NNP 51F/GENE cavoatrial/JJ cannula/NN decompressed/VBN the/DT venous/JJ system/NN as/RB efficiently/RB as/IN the/DT double/JJ caval/JJ cannulas/NNS ./.
@@91550155586/CD We/PRP show/VBP here/RB that/IN the/DT protein/MULTIGENE kinase/MULTIGENE MEKK1/MULTIGENE can/MD induce/VB reporter/NN gene/NN expression/NN from/IN the/DT atrial/JJ natriuretic/JJ factor/NN (/( ANF/NN )/SYM promoter/NN ,/, a/DT genetic/JJ marker/NN that/WDT is/VBZ activated/VBN during/IN in/IN vivo/NN hypertrophy/NN ./.
@@11301861132/CD The/DT other/DT hypoglycaemic/JJ patient/NN showed/VBD an/DT exaggerated/JJ insulin/NN release/NN in/IN response/NN to/IN tolbutamide/NN ./.
@@988930648/CD In/NN addition/NN ,/, the/DT regulation/NN of/IN Glvr-1/MULTIGENE gene/MULTIGENE expression/NN also/RB has/VBZ potential/JJ applications/NNS to/IN gene/NN therapy/NN ,/, since/IN retroviral/MULTIGENE vectors/MULTIGENE carrying/VBG gibbon/NN ape/NN leukemia/NN virus/NN envelope/NN proteins/NNS are/VBP used/VBN for/IN gene/NN delivery/NN into/IN different/JJ cell/NN types/NNS ./.
@@7682207619/CD The/DT motor/JJ unit/NN viewed/VBN from/IN above/RB ./. pp/NNS ./NNS
@@105235201007/CD Thus/RB ,/, the/DT nematode/JJ genes/NNS could/MD be/VB the/DT homologs/NNS of/IN Hh/MULTIGENE molecules/MULTIGENE in/IN other/DT phyla/NNS ./.
@@98408229830/CD The/DT method/NN also/RB eliminates/VBZ tagging/NN of/IN venous/JJ spins/NNS and/CC concern/NN about/RB asymmetric/JJ magnetization/NN transfer/NN effects/NNS ./.
@@100867255520/CD MDS1/GENE //GENE EVI1/GENE ,/, located/VBN on/IN chromosome/MULTIGENE 3/MULTIGENE band/MULTIGENE q26/MULTIGENE ,/, encodes/VBZ a/DT zinc-finger/MULTIGENE DNA-binding/MULTIGENE transcription/MULTIGENE activator/MULTIGENE not/RB detected/VBD in/IN normal/JJ hematopoietic/JJ cells/NNS but/CC expressed/VBN in/IN several/DT normal/JJ tissues/NNS ./.
@@93609567212/CD We/PRP have/VBP now/RB shown/VBP that/IN in/IN vivo/NN phosphorylation/NN of/IN 14-3-3/NEWGENE zeta/NN at/IN the/DT CKIalpha/NNP site/NN (/( Thr-233/NN )/SYM negatively/RB regulates/VBZ its/PRP binding/JJ to/IN c-Raf/GENE ,/, and/CC may/MD be/VB important/JJ in/IN Raf-mediated/JJ signal/JJ transduction/NN ./.
@@19319669604/CD Fusion/NNS of/IN ubiquitin/NN to/IN pADPRP/NN increased/VBD the/DT yield/NN of/IN pADPRP/NN approximately/RB 10-fold/RB compared/VBN to/IN that/DT of/IN the/DT unfused/JJ enzyme/NN ./.
@@93766269428/CD Radiation/NN decreased/VBD the/DT levels/NNS of/IN T4/NN and/CC T3/MULTIGENE 6/MULTIGENE h/MULTIGENE and/CC 72/CD h/NN in/IN group/NN C/NN ,/, in/IN group/NN A/DT at/IN 72/CD h/NN ,/, in/IN group/NN B/NNP at/IN 24/CD h/NN postexposure/RB ./.
@@113903953672/CD Reciprocally/RB ,/, HMGI-C/GENE expression/NN also/RB coordinately/RB enhances/VBZ PIAS3-mediated/JJ repression/NN of/IN STAT3-dependent/GENE transactivation/NN ./.
@@89626141234/CD The/DT determination/NN of/IN immunoglobulin/MULTIGENE E/MULTIGENE (/( IgE/CONTEXTGENE )/SYM antibodies/NNS by/IN one/PRP of/IN several/DT laboratory/NN tests/NNS ,/, by/IN skin-prick/JJ tests/NNS or/CC by/IN appropriate/JJ challenge/NN procedures/NNS is/VBZ useful/JJ either/DT to/IN identify/VB atopic/JJ individuals/NNS or/CC as/IN outcome/MULTIGENE predictors/MULTIGENE in/IN wheezy/JJ children/NNS ./.
@@90926759169/CD A/DT P22/MULTIGENE R17/MULTIGENE derivative/NN with/IN an/DT OcRNA/MULTIGENE site/MULTIGENE (/( P22/GENE R17/NNP [/NN A/NN (/NN -10/NN )/NN U/NN ]/NN )/NN develops/VBZ lytically/RB following/IN infection/NN of/IN these/DT strains/NNS ./.
@@18994091132/CD Determinants/NNS of/IN recurrent/JJ ischaemia/NN and/CC revascularisation/NN procedures/NNS after/IN thrombolysis/NN with/IN recombinant/JJ tissue/NEWGENE plasminogen/MULTIGENE activator/MULTIGENE in/IN primary/JJ coronary/JJ occlusion/NN ./.
@@17404375522/CD The/DT major/JJ 49-kDa/CD core/NN protein/NN in/IN the/DT liver/MULTIGENE HSPG/MULTIGENE preparation/NN was/VBD found/VBN to/IN be/VB reactive/VBN to/IN an/DT antibody/NN that/WDT specifically/RB recognizes/VBZ the/DT cytoplasmic/JJ domain/NN of/IN fibroglycan/NN ./.
@@111775385961/CD Tumor/NNP cell/NN lines/NNS transduced/VBN at/IN an/DT MOI/NN of/IN 8/CD for/IN 3/CD days/NNS led/VBN to/IN >/SYM 90%/NN gene/NN transfer/NN efficiency/NN ./.
@@94734839308/CD It/PRP may/MD also/RB be/VB suggested/VBN that/IN particular/JJ care/NN should/MD be/VB taken/VBP when/CC such/JJ a/DT trans-dominant/NNP Rev/MULTIGENE mutant/MULTIGENE is/VBZ considered/VBN to/IN be/VB used/VBN as/IN a/DT genetic/JJ therapy/NN against/IN HIV-I/NNP infection/NN ,/, in/IN individuals/NNS infected/VBN with/IN both/DT HIV-I/NNP and/CC HTLV-1/NN ./.
@@110501686390/CD These/DT results/NNS provide/VBP direct/JJ evidence/NN for/IN differential/JJ susceptibility/NN to/IN endonuclease-mediated/JJ mRNA/NN decay/NN resulting/JJ from/IN the/DT differential/JJ affinity/NN of/IN a/DT RNA-binding/MULTIGENE protein/MULTIGENE for/IN cis-acting/JJ stability/NN determinants/NNS ./.
@@111395674958/CD LH/MULTIGENE //MULTIGENE CG/MULTIGENE receptor/MULTIGENE activation/NN of/IN ARNO/ORG is/VBZ not/RB mediated/JJ by/IN activation/NN of/IN phosphatidylinositol/NEWGENE 3-kinase/NEWGENE (/( PI/NN 3-kinase/CD )/SYM or/CC by/IN G/MULTIGENE protein/MULTIGENE beta/MULTIGENE gamma/MULTIGENE subunits/MULTIGENE ./.
@@103580809165/CD Modulation/NNS of/IN human/MULTIGENE heat/MULTIGENE shock/MULTIGENE factor/MULTIGENE trimerization/NN by/IN the/DT linker/NN domain/NN ./.
@@82676588243/CD A/DT much/JJ less/PRP expensive/JJ solution/NN than/IN UW/NN ,/, containing/JJ only/RB K/NN (/NN +/NN )/NN -lactobionate/NN ,/, KH2PO4/NN ,/, MgSO4/IN and/CC raffinose/NN ,/, can/MD be/VB used/VBN successfully/RB for/IN preservation/NN of/IN rat/NN hepatocytes/NNS for/IN 24/CD hr/NN for/IN drug/NN transport/NN studies/NNS ./.
@@88983655832/CD Rss1p/GENE encodes/VBZ a/DT novel/JJ essential/JJ protein/NN of/IN 538/CD amino/JJ acids/NNS ,/, which/WDT contains/VBZ an/DT extended/VBN predicted/VBN coiled-coil/NN domain/NN and/CC is/VBZ located/VBN both/DT at/IN nuclear/JJ pore/NN complexes/NNS (/( NPCs/NNS )/SYM and/CC in/IN the/DT cytoplasm/NN ./.
@@2989786113/CD In/NN the/DT absence/NN of/IN enhancer/NN sequences/NNS ,/, the/DT adenovirus/NN E1A/MULTIGENE gene/MULTIGENE can/MD not/RB stimulate/VB CATase/NN synthesis/NN ./.
@@9006022824/CD To/TO characterize/VB the/DT gene/NN products/NNS ,/, the/DT cvaA/MULTIGENE gene/MULTIGENE was/VBD subcloned/JJ and/CC expressed/VBN under/IN the/DT control/NN of/IN T7/MULTIGENE RNA/MULTIGENE polymerase/MULTIGENE promoter/MULTIGENE ./.
@@5651365624/CD Delayed/JJ mortality/NN of/IN mice/NNS following/IN inhalation/NN of/IN acute/JJ doses/NNS of/IN CH2O/CONTEXTGENE ,/, SO2Cl2/GENE ,/, and/CC Br2/GENE ./.
@@108546994766/CD Three/CD FGF-AS/NNP cDNAs/NNS were/VBD isolated/VBN ;/: the/DT full-length/JJ FGF-AS/GENE mRNA/NN and/CC two/JJ alternative/JJ splice/NN variants/NNS lacking/JJ exon/NN 2/CD or/CC exons/NNS 2/CD and/CC 3/CD of/IN the/DT FGF-AS/NNP sequence/NN ./.
@@112271821984/CD The/DT authors/NNS did/VBD not/RB detect/VB any/DT significant/JJ correlations/NNS between/IN parameters/NNS of/IN the/DT lipids/NNS of/IN bone/NN marrow/NN and/CC leptin/NEWGENE levels/NNS in/IN serum/NN and/CC bone/NN marrow/NN ./.
@@30345708965/CD We/PRP inserted/VBD genes/NNS or/CC gene/NN segments/NNS ,/, that/DT code/NN for/IN the/DT bacterial/JJ chloramphenicol/NN acetyltransferase/NN ,/, the/DT bacterial/JJ gene/NN conferring/JJ resistance/NN against/IN hygromycin/NN ,/, and/CC the/DT ORF/MULTIGENE E7/MULTIGENE of/IN the/DT human/JJ papillomavirus/NN type/NN 18/CD into/IN these/DT vectors/NNS ./.
@@109354888186/CD Troglitazone/NNP also/RB induced/VBD an/DT endogenous/JJ PPARgamma/NN target/NN gene/NN in/IN T24/DT cells/NNS ,/, adipocyte-type/JJ fatty/JJ acid/NN binding/JJ protein/NN (/( A-FABP/GENE )/SYM ,/, the/DT expression/NN of/IN which/WDT correlates/VBP with/IN bladder/NN cancer/NN differentiation/NN ./.
@@32439203934/CD The/DT temporal/JJ and/CC static/JJ plasma/NN concentration-effect/NN relationships/NNS were/VBD evaluated/VBN by/IN pharmacodynamic/JJ modeling/NN and/CC linear/JJ regression/NN ./.
@@2342062995/CD Bertioga/NNP (/( Guama/NNP group/NN )/SYM and/CC Anhembi/NNP (/( Bunyamwera/NNP group/NN )/SYM ,/, two/JJ new/JJ arboviruses/NNS isolated/VBN in/IN Sao/NNP Paulo/NNP ,/, Brazil/NN ./.
@@84156374229/CD The/DT ADP-ribosylation/MULTIGENE factor/MULTIGENE (/( ARF/CONTEXTGENE )/SYM family/NN is/VBZ one/PRP of/IN four/CD subfamilies/NNS of/IN the/DT RAS/MULTIGENE superfamily/MULTIGENE of/IN low/JJ molecular/JJ weight/NN GTP-binding/MULTIGENE proteins/MULTIGENE (/( G/MULTIGENE proteins/MULTIGENE )/SYM ./.
@@14095811471/CD We/PRP found/VBP that/IN both/PDT the/DT E26/NEWGENE virus-encoded/JJ v-ets/NNS and/CC the/DT myeloid/MULTIGENE //MULTIGENE B-cell-specific/MULTIGENE factor/MULTIGENE PU/MULTIGENE ./MULTIGENE 1/MULTIGENE bind/VB efficiently/RB to/IN this/DT site/NN in/IN vitro/FW ./.
@@64375799759/CD Cimetidine/MULTIGENE 800/MULTIGENE mg/NN given/VBP at/IN night/NN is/VBZ as/RB effective/JJ as/IN 400/CD mg/NN twice/RB daily/JJ ;/: the/DT single/JJ dose/NN regimen/NN may/MD improve/VB patient/NN compliance/NN ,/, thus/RB facilitating/JJ treatment/NN ./.
@@86494255229/CD A/DT developmentally/RB modulated/VBN chromatin/NN structure/NN at/IN the/DT mouse/MULTIGENE immunoglobulin/MULTIGENE kappa/MULTIGENE 3'/CD enhancer/NN ./.
@@10999301837/CD Quantitative/JJ evaluation/NN of/IN magneto-optical/JJ parameters/NNS is/VBZ necessary/JJ in/IN order/NN to/IN apply/VB scanning/JJ near-field/NN optical/JJ microscope/NN (/( SNOM/NNP )/SYM technology/NN to/IN the/DT study/NN of/IN magnetism/NN on/IN the/DT mesoscopic/JJ scale/NN ./.
@@92089307779/CD Identification/NNP of/IN five/CD new/JJ genes/NNS ,/, closely/RB related/VBN to/IN the/DT interleukin-1beta/MULTIGENE converting/MULTIGENE enzyme/MULTIGENE gene/MULTIGENE ,/, that/WDT do/VBP not/RB encode/VB functional/JJ proteases/NNS ./.
@@233482984/CD Colorectal/JJ polyps/NNS should/MD be/VB removed/VBN endoscopically/RB whenever/CC possible/JJ ./.
@@73102067178/CD The/DT architecture/NN of/IN microvasculature/NN in/IN these/DT two/JJ regions/NNS was/VBD also/RB examined/VBN by/IN scanning/JJ electron/NN microscopy/NN ,/, using/VBG the/DT resin/NN casting/JJ method/NN ./.
@@32498408971/CD Baseline/NN measurements/NNS of/IN forced/JJ expiratory/JJ volume/NN in/IN 1/CD s/NN (/( FEV1/NN )/SYM ,/, specific/JJ airway/NN conductance/NN (/( SGaw/NNS )/SYM and/CC the/DT provocative/JJ dose/NN of/IN carbachol/NN causing/JJ a/DT 35%/JJ reduction/NN in/IN SGaw/CONTEXTGENE (/( PD35/GENE )/SYM ,/, and/CC a/DT 20%/CD reduction/NN in/IN FEV1/NN (/( PD20/NN )/SYM were/VBD established/VBN on/IN entry/NN while/CC each/DT subject/NN was/VBD still/JJ smoking/NN ./.
@@114239912677/CD Thus/RB ,/, the/DT screen/NN for/IN toxic/JJ p53/MULTIGENE mutants/MULTIGENE in/IN yeast/NN can/MD identify/VB novel/JJ p53/MULTIGENE variants/MULTIGENE that/WDT may/MD be/VB useful/JJ in/IN dissecting/JJ p53/GENE regulated/VBN cellular/JJ responses/NNS and/CC in/IN developing/JJ p53-based/JJ cancer/NN therapies/NNS ./.
@@112447331074/CD Cases/NNS of/IN lung/NN cancer/NN with/IN intramedullary/JJ metastasis/NN are/VBP rare/JJ ,/, especially/RB those/DT diagnosed/VBN before/IN death/NN ./.
@@95725116962/CD The/DT new/JJ algorithm/NN ,/, called/VBN RBI-MAP/GENE ,/, is/VBZ based/VBN on/IN the/DT rescaled/VBN block/NN iterative/JJ EM/NN (/( RBI-EM/NNP )/SYM algorithm/NN ./.
@@71063234564/CD These/DT results/NNS suggested/VBD the/DT possibility/NN that/IN the/DT fetus/NN played/VBD some/DT role/NN in/IN the/DT production/NN of/IN E3-16-G/GENE in/IN early/JJ pregnancy/NN ./.
@@108960089454/CD PARTICIPANTS/NNP :/: Convenience/NNP sample/NN of/IN ambulatory/JJ outpatients/NNS with/IN hereditary/JJ motor/JJ and/CC sensory/JJ neuropathy/NN ,/, type/MULTIGENE I/MULTIGENE (/( n/NN =/SYM 9/CD )/SYM ,/, myotonic/JJ muscular/JJ dystrophy/NN (/( n/NN =/SYM 10/CD )/SYM ,/, and/CC able-bodied/JJ controls/NNS (/( n/NN =/SYM 11/CD )/SYM ./.
@@14437452061/CD Respiratory/NNP interaction/NN after/IN spinal/JJ anesthesia/NN and/CC sedation/NN with/IN midazolam/NN ./.
@@28059456660/CD The/DT percentages/NNS of/IN formed/VBN cysts/NNS and/CC growth/NN rates/NNS were/VBD monthly/RB estimated/VBN and/CC analyzed/VBN rhythmometrically/RB by/IN cosinor/NN for/IN 5/CD clonal/JJ cultures/NNS of/IN Scripsiella/NNP trochoidea/NN Stein/NN grown/VBP for/IN 2/CD years/NNS under/IN laboratory/NN conditions/NNS ,/, rended/VBD as/RB constant/JJ as/IN possible/JJ from/IN the/DT view/NN point/NN of/IN environmental/JJ temperature/NN (/( 24/CD +/NN //NN -/NN 1/CD degree/NN C/NN )/SYM ,/, lighting/JJ (/( 25/MULTIGENE microEin/MULTIGENE m-2/MULTIGENE s-1/MULTIGENE )/SYM ,/, and/CC artificial/JJ seawater/NN ./.
@@3504654190/CD Antenatal/JJ diagnosis/NN of/IN haematological/JJ disorders--'1978'/CD ./.
@@95922199549/CD The/DT results/NNS point/NN to/IN the/DT effectiveness/NN of/IN the/DT educational/JJ intervention/NN ./.
@@86215427670/CD The/DT novel/JJ protein/MULTIGENE kinases/MULTIGENE ,/, c-Jun/MULTIGENE NH2-terminal/MULTIGENE kinases/MULTIGENE (/( JNKs/GENE )/NN //NN stress-activated/NN protein/NN kinases/NEWGENE ,/, are/VBP also/RB activated/VBN by/IN TNF-alpha/NN ,/, IL-1/NEWGENE ,/, and/CC CD28/GENE costimulation/NN ./.
@@113570633037/CD Descriptions/NNS of/IN this/DT locus/NN would/MD allow/VB comparison/NN with/IN functionally/RB relevant/JJ molecular/JJ genetic/JJ features/NNS of/IN other/DT species'/JJ homologous/JJ loci/NNS including/JJ the/DT single-copy/JJ equid/NN LH/MULTIGENE //MULTIGENE CGbeta/MULTIGENE gene/MULTIGENE and/CC the/DT primate/NN LHbeta-CGbeta/MULTIGENE gene/MULTIGENE cluster/MULTIGENE locus/MULTIGENE ./.
@@108671998922/CD In/NN contrast/NN to/IN the/DT morphological/JJ criteria/NNS ,/, the/DT few/JJ data/NN available/JJ from/IN recent/JJ studies/NNS at/IN the/DT genetic/JJ level/NN have/NN suggested/VBN that/IN EPVs/NNP infecting/JJ different/JJ insect/NN orders/NNS are/VBP phylogenetically/RB distant/JJ ./.
@@39803866906/CD To/TO assess/VB the/DT effects/NNS of/IN alveolar/JJ hypoxia/NN and/CC angiotensin/NN II/NN infusion/NN on/IN distribution/NN of/IN blood/NN flow/NN to/IN the/DT lung/NN we/PRP performed/VBD perfusion/NN lung/NN scans/NNS on/IN anesthetized/JJ mechanically/RB ventilated/VBN lambs/NNS ./.
@@27122463391/CD Its/PRP clinical/JJ and/CC histopathologic/JJ characteristics/NNS ./.
@@92184361329/CD Both/DT promoters/NNS lack/NN a/DT TATA/MULTIGENE box/MULTIGENE ,/, and/CC Pint/GENE belongs/VBZ to/IN the/DT MED-1/GENE class/NN of/IN promoters/NNS ,/, which/WDT initiate/VBP transcription/NN at/IN multiple/JJ sites/NNS ./.
@@88089273680/CD A/DT 1/CD ./CD 5-kb/CD HindIII/NN genomic/JJ fragment/NN carrying/JJ the/DT vspA/MULTIGENE gene/MULTIGENE from/IN M/NNP ./NNP bovis/MULTIGENE PG45/MULTIGENE was/VBD cloned/VBN and/CC sequenced/VBN ./.
@@41969861555/CD Cerebrospinal/JJ fluid/NN transferrin/MULTIGENE II/MULTIGENE studies/NNS in/IN ischemic/JJ disorders/NNS of/IN the/DT central/JJ nervous/JJ system/NN ./.
@@110036528199/CD These/DT results/NNS suggest/VBP that/IN Cdc42p/GENE is/VBZ in/IN fact/NN required/VBN for/IN pheromone/NN response/NN and/CC that/DT interaction/NN with/IN the/DT PAK/NN Ste20p/GENE is/VBZ critical/JJ for/IN that/DT role/NN ./.
@@1168466542/CD C/NNP ./NNP elegans/NNS embryogenesis/NN begins/VBZ with/IN a/DT stereotyped/JJ sequence/NN of/IN asymmetric/JJ cell/NN divisions/NNS that/WDT are/VBP largely/RB responsible/JJ for/IN establishing/VBG the/DT nematode/JJ body/NN plan/NN ./.
@@15426675110/CD The/DT gene/NN encoding/VBG IFN-gamma/NN was/VBD previously/RB found/VB to/IN contain/VB an/DT intronic/JJ enhancer/NN element/NN that/WDT was/VBD not/RB tissue-specific/JJ in/IN its/PRP activity/NN ,/, despite/IN the/DT restricted/VBN expression/NN of/IN the/DT intact/JJ IFN-gamma-encoding/MULTIGENE gene/MULTIGENE ./.
@@90493066449/CD The/DT HBP/MULTIGENE gene/MULTIGENE is/VBZ composed/VBN of/IN eight/CD exons/NNS covering/VBG 19/CD ./CD 5/CD kb/NN on/IN the/DT short/JJ arm/NN of/IN chromosome/NN 4/CD ./CD
@@72637457106/CD Bilateral/JJ Charnley/NN arthroplasty/NN as/IN a/DT single/JJ procedure/NN ./.
@@216283526/CD It/PRP is/VBZ likely/RB that/IN the/DT sequence/NN similarities/NNS reflect/VBP a/DT common/JJ molecular/JJ architecture/NN of/IN the/DT two/JJ heme/NN binding/JJ sites/NNS and/CC of/IN a/DT copper/JJ binding/JJ site/NN in/IN these/DT enzymes/NNS ./.
@@109267768040/CD Five/CD of/IN the/DT PDP1/MULTIGENE isoforms/MULTIGENE differ/VBP by/IN the/DT substitution/NN or/CC insertion/NN of/IN amino/JJ acids/NNS at/IN or/CC near/IN the/DT N-terminal/NN of/IN the/DT protein/NN ./.
@@105610955249/CD However/RB ,/, reoperation/NN for/IN bulky/JJ cervical/JJ disease/NN (/( group/NN 3/CD )/SYM rarely/RB results/VBZ in/IN normal/JJ calcitonin/NEWGENE levels/NNS and/CC is/VBZ associated/VBN with/IN a/DT high/JJ incidence/NN of/IN permanent/JJ hypoparathyroidism/NN ./.
@@116871803637/CD In/NN the/DT long/JJ term/NN ,/, questions/NNS still/RB remain/VBP about/RB whether/IN pre-dialysis/JJ rHu/MULTIGENE EPO/MULTIGENE either/DT speeds/NNS up/JJ or/CC delays/VBZ the/DT onset/NN of/IN dialysis/NN ./.
@@97744036488/CD T/NNP ./NNP ,/, Mahasneh/NNP ,/, A/NNP ./NNP ,/, and/CC Cote/NNP ,/, G/NNP ./NNP
@@15693445862/CD In/NN both/DT cities/NNS ,/, HTLV-I/GENE //GENE II/GENE prevalence/NN increased/VBN significantly/RB with/IN age/NN ,/, and/CC the/DT New/NNP Orleans/NN age-/JJ and/CC sex-adjusted/JJ HTLV-I/GENE //GENE II/GENE prevalence/NN was/VBD significantly/RB higher/JJ than/IN that/DT of/IN Baltimore/NN (/( P/NN less/PRP than/IN ./CD 001/CD )/SYM ./.
@@94685154128/CD As/IN well/NN ,/, further/JJ deletion/NN of/IN the/DT promoter/NN region/NN to/IN nucleotide/NN -110/NN ,/, which/WDT contains/VBZ only/RB one/PRP SF-1/MULTIGENE binding/MULTIGENE site/MULTIGENE ,/, still/RB retained/VBN the/DT ability/NN to/IN respond/NN to/IN exogenous/JJ SF-1/GENE ./.
@@107662464201/CD Integrin/MULTIGENE adhesion/MULTIGENE receptors/MULTIGENE transduce/VBP signals/VBZ that/DT control/NN complex/NN cell/NN functions/NNS which/WDT require/VBP the/DT regulation/NN of/IN gene/NN expression/NN ,/, such/JJ as/IN proliferation/NN ,/, differentiation/NN and/CC survival/NN ./.
@@5165455413/CD Structural/NNP characteristics/NNS of/IN the/DT erythrocyte/NN membrane/NN ,/, peroxidation/NN processes/NNS and/CC antioxidant/JJ function/NN in/IN children/NNS with/IN diffuse/JJ glomerulonephritis/NN ./.
@@94699339300/CD In/NN the/DT tissues/NNS tested/VBN ,/, except/VB brain/NN ,/, the/DT message/NN for/IN CLIP-170/GENE was/VBD more/RB abundant/JJ than/IN that/DT for/IN Restin/NNP ./.
@@23947079703/CD Promoter/NNS elements/NNS include/VBP an/DT atypical/JJ TATA/MULTIGENE box/MULTIGENE (/( GTTA/CONTEXTGENE )/SYM ,/, one/PRP CCAAT/MULTIGENE box/MULTIGENE much/JJ further/RB from/IN the/DT initiation/NN site/NN ,/, three/CD reverse/JJ compliments/NNS of/IN CCAAT/NNP (/( ATTGG/NNP )/SYM ,/, and/CC two/JJ pyrimidine-rich/JJ nucleotide/NN stretches/NNS ./.
@@76093727514/CD M/NNP ./NNP M/NNP ./NNP C/NNP ./. was/VBD used/VBN for/IN 2/CD ./CD 5/CD minutes/NNS in/IN 44/CD cases/NNS (/( 20/CD HR/JJ patients/NNS ,/, 24/CD LR/NN patients/NNS )/SYM ,/, and/CC for/IN 5/CD minutes/NNS in/IN 66/CD cases/NNS (/( 46/CD HR/JJ patients/NNS ,/, 20/CD LR/NN patients/NNS )/SYM ./.
@@75378514849/CD Transcription/NNS of/IN the/DT vascular/MULTIGENE cell/MULTIGENE adhesion/MULTIGENE molecule/MULTIGENE 1/MULTIGENE (/( VCAM-1/NEWGENE )/SYM gene/NN in/IN endothelial/JJ cells/NNS is/VBZ induced/VBN by/IN lipopolysaccharide/NN and/CC the/DT inflammatory/JJ cytokines/NNS interleukin-1/MULTIGENE beta/MULTIGENE and/CC tumor/NEWGENE necrosis/MULTIGENE factor/MULTIGENE alpha/MULTIGENE (/( TNF-alpha/CONTEXTGENE )/SYM ./.
@@105593643895/CD In/NN HCMV/NN (/NN Towne/NN )/NN -infected/NN HF/NN cells/NNS at/IN 24/CD to/IN 48/CD h/NN ,/, IE2/GENE also/RB accumulated/VBN in/IN newly/RB formed/VBN viral/JJ DNA/NN replication/NN compartments/NNS containing/JJ the/DT polymerase/NN processivity/NN factor/NN (/( UL44/GENE )/SYM ,/, the/DT single-stranded/JJ DNA/NN binding/JJ protein/NN (/( SSB/NN ;/: UL57/NNP )/SYM ,/, the/DT UL112-113/GENE accessory/JJ protein/NN ,/, and/CC newly/RB incorporated/VBN bromodeoxyuridine/NN (/( BrdU/NN )/SYM ./.
@@36370374315/CD A/DT preoperative/JJ teaching/JJ booklet/NN for/IN pediatric/JJ patients/NNS ./.
@@105560635934/CD These/DT kinases/NNS belong/VBP to/IN a/DT new/JJ subfamily/NN related/VBN to/IN the/DT Trk/MULTIGENE subfamily/MULTIGENE ./.
@@11207288886/CD Substitutions/NNS in/IN the/DT YFV/MULTIGENE Ag-binding/MULTIGENE region/MULTIGENE (/( ABR/CONTEXTGENE )/SYM occur/VB at/IN four/CD of/IN the/DT eight/CD highly/RB conserved/VBN residues/NNS that/WDT are/VBP essential/JJ for/IN binding/NN of/IN peptide-Ag/JJ in/IN the/DT class/MULTIGENE Ia/MULTIGENE molecules/MULTIGENE ./.
@@105484342833/CD Furthermore/RB ,/, the/DT striking/JJ ability/NN of/IN polyoma/NN middle/JJ T/NN antigens/NNS to/IN promote/VB retinoic/JJ acid-induced/JJ differentiation/NN appears/VBZ to/IN utilize/VB ERK/NN ,/, but/CC not/RB JNK/GENE //GENE SPK/GENE or/CC p38/GENE signaling/JJ ./.
@@118026011668/CD This/DT paper/NN reports/VBZ the/DT results/NNS of/IN a/DT laboratory/NN study/NN on/IN aldicarb/NN and/CC its/PRP main/JJ metabolites/NNS ,/, aldicarb/NN sulfone/NN and/CC aldicarb/NN sulfoxide/NN ./.
@@21431862329/CD In/NN comparison/NN with/IN the/DT 16/CD introns/NNS reported/VBN in/IN AHA3/GENE ,/, AHA2/GENE is/VBZ missing/JJ one/PRP intron/NN in/IN the/DT 5'-untranslated/JJ region/NN and/CC a/DT second/JJ intron/NN in/IN the/DT C-terminal/NN coding/JJ region/NN ./.
@@93881985315/CD The/DT data/NN provide/VB evidence/NN both/DT for/IN a/DT signal/JJ transduction/NN pathway/NN independent/NN of/IN JNK/GENE ,/, ERK/CONTEXTGENE ,/, and/CC p38/MULTIGENE MAP/MULTIGENE kinase/MULTIGENE to/IN be/VB involved/VBN in/IN the/DT induction/NN of/IN rhoB/GENE by/IN genotoxic/JJ stress/NN ,/, and/CC furthermore/RB ,/, indicate/VB autoregulation/NN of/IN rhoB/GENE ./.
@@21207077580/CD Gel-mobility-shift/NNP assays/NNS confirmed/VBN that/IN the/DT Raji/JJ nuclear/JJ proteins/NNS that/WDT bound/JJ to/IN W/NN and/CC V/MULTIGENE elements/MULTIGENE were/VBD competed/VBN with/IN by/IN an/DT HLA-DRA/NNP X-box/NNS oligonucleotide/NN ./.
@@32200773908/CD The/DT median/JJ survival/NN is/VBZ not/RB reached/VBN with/IN a/DT median/JJ follow-up/JJ time/NN of/IN 9/CD ./CD 6/CD years/NNS ./.
@@107793291982/CD Slap/GENE negatively/RB regulates/VBZ Src/IN mitogenic/JJ function/NN but/CC does/VBP not/RB revert/VB Src-induced/JJ cell/NN morphology/NN changes/NNS ./.
@@10533066195/CD Twelve/CD patients/NNS without/IN abnormalities/NNS in/IN the/DT PTT/NN are/VBP assumed/VBN to/IN harbor/NN missense/JJ mutations/NNS ,/, probably/RB in/IN TSC2/NEWGENE ./.
@@109823915838/CD These/DT include/VB NPF/GENE repeats/NNS ,/, a/DT leucine/NN heptad/NN repeat/NN enriched/VBN in/IN charged/VBN residues/NNS ,/, and/CC a/DT proline-rich/NNP SH3-like/NNP and/DT //DT or/DT WW/MULTIGENE domain-binding/MULTIGENE site/MULTIGENE in/IN the/DT N-terminal/NN domain/NN ,/, which/WDT is/VBZ followed/VBN by/IN a/DT membrane/NN core/NN containing/JJ four/CD putative/JJ transmembrane/JJ spans/NNS and/CC three/CD amphiphilic/JJ segments/NNS that/WDT are/VBP the/DT most/RB highly/RB conserved/VBN structural/JJ elements/NNS ./.
@@24176697520/CD At/NN maximum/JJ photosensitivity/NN the/DT inhibitory/JJ amino/JJ acids/NNS gamma-aminobutyric/JJ acid/NN and/CC taurine/NN were/VBD lower/JJR ,/, and/CC those/DT of/IN asparagine/NN (/( metabolite/NN of/IN the/DT excitatory/JJ amino/JJ acid/NN aspartate/NN )/SYM were/VBD higher/JJ ,/, than/IN when/CC the/DT animals/NNS were/VBD not/RB photosensitive/JJ ./.
@@104288116401/CD Cat-1/GENE is/VBZ identical/JJ to/IN the/DT recently/RB identified/VBN binding/JJ partner/NN for/IN the/DT beta-adrenergic/MULTIGENE receptor/MULTIGENE kinase/MULTIGENE (/( betaARK/GENE or/CC GRK-2/GENE )/SYM ,/, which/WDT was/VBD shown/VBP to/IN have/NN Arf-GAP/GENE activity/NN ./.
@@108649895793/CD RESULTS/NNS :/: The/DT introduction/NN of/IN the/DT PAIP/GENE resulted/VBN in/IN a/DT significant/JJ (/( p/CD </CD 0/CD ./CD 001/CD )/SYM reduction/NN in/IN contaminating/JJ WBCs/NNS (/( median/JJ ,/, 30/CD ,/CD 000/CD )/SYM from/IN the/DT numbers/NNS seen/VBP with/IN FIP/NN (/( median/JJ ,/, 2/CD ,/CD 300/CD ,/CD 000/CD )/SYM while/CC maintaining/VBG the/DT separation/NN efficacy/NN (/( 47%/JJ )/SYM and/CC separation/NN time/NN ./.
@@96751549630/CD We/PRP then/RB studied/VBD four/CD unrelated/JJ Japanese/JJ families/NNS with/IN GSD-Ib/NNP ,/, and/CC found/VB three/CD novel/JJ mutations/NNS :/: a/DT four-base/JJ deletion/JJ //JJ two-base/JJ insertion/NN ,/, a/DT point/NN mutation/NN within/IN a/DT consensus/NN splicing/JJ donor/NN site/NN ,/, and/CC a/DT missense/JJ mutation/NN (/( W118R/GENE )/SYM ./.
@@18701948976/CD Human/NNP immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM IN/IN ,/, expressed/VBN in/IN Escherichia/NN coli/JJ ,/, was/VBD purified/VBN to/IN near/IN homogeneity/NN ./.
@@114388385178/CD The/DT other/DT inhibitor/NN was/VBD a/DT single/JJ TAR/JJ decoy/NN ,/, driven/VBP by/IN the/DT U6/MULTIGENE small/MULTIGENE nuclear/MULTIGENE RNA/MULTIGENE promoter/MULTIGENE (/( U6-P/CONTEXTGENE )/SYM ./.
@@87101512824/CD 5/NN )/NN We've/NN noticed/VBN that/IN the/DT mean/JJ value/NN of/IN the/DT cost/NN for/IN episode/NN of/IN pnx/NN s/CD ./CD in/IN class/NN A/NN was/VBD more/RB than/IN 15%/RB compared/VBN to/IN class/NN B/NN and/CC the/DT cost/NN for/IN patient/NN in/IN class/NN A/NN was/VBD nearly/RB double/JJ than/IN in/IN class/NN B/NNP ./NNP
@@107673383052/CD Hailey-Hailey/GENE disease/NN is/VBZ caused/VBN by/IN mutations/NNS in/IN ATP2C1/NNP encoding/VBG a/DT novel/JJ Ca/NN (/NN 2+/NN )/NN pump/NN ./.
@@93964278969/CD Thus/RB ,/, the/DT absence/NN of/IN residual/JJ infarct-zone/MULTIGENE viability/MULTIGENE discriminates/NNS patients/NNS who/WP develop/VBP progressive/JJ left/NN ventricular/JJ dilation/NN after/IN reperfused/JJ AMI/NN from/IN those/DT who/WP maintain/VBP normal/JJ left/NN ventricular/JJ geometry/NN ./.
@@93432108268/CD Furthermore/RB ,/, deletion/NN and/CC mutation/NN analyses/NNS of/IN the/DT VCAM-1/MULTIGENE promoter/MULTIGENE performed/VBN with/IN chloramphenicol/NN acetyltransferase/MULTIGENE constructs/MULTIGENE revealed/VBN that/IN Tax/NNP was/VBD trans/JJ activating/JJ the/DT VCAM-1/MULTIGENE promoter/MULTIGENE via/NN two/JJ NF-kappaB/MULTIGENE sites/MULTIGENE present/VBP at/IN bp/NN -72/CD and/CC -57/CD in/IN the/DT VCAM-1/MULTIGENE gene/MULTIGENE promoter/MULTIGENE ,/, with/IN both/DT of/IN them/PRP being/VBP required/VBN for/IN the/DT Tax-induced/JJ expression/NN of/IN this/DT adhesion/NN molecule/NN ./.
@@86018069380/CD These/DT data/NN suggest/VB that/IN RPF-1/GENE is/VBZ likely/RB to/IN be/VB involved/VBN in/IN early/JJ steps/NNS in/IN the/DT differentiation/NN of/IN amacrine/NN and/CC ganglion/NN cells/NNS ./.
@@39357975217/CD The/DT data/NN indicate/VB that/IN the/DT five/CD different/JJ (/( and/CC partially/RB overlapping/JJ )/SYM sry/MULTIGENE messenger/MULTIGENE RNAs/MULTIGENE detectable/JJ in/IN early/JJ embryos/NNS are/VBP initiated/VBN at/IN three/CD separate/JJ sites/NNS ,/, each/DT directly/RB upstream/RB from/IN one/PRP of/IN the/DT three/CD protein-coding/MULTIGENE regions/MULTIGENE ,/, designated/VBN (/( in/IN 5'/CD to/IN 3'/CD order/NN )/SYM beta/NN ,/, alpha/NN and/CC delta/JJ ./.
@@10841601648/CD Paper/NNP alert/VB ./.
@@8570242468/CD Recurrence/NNS of/IN bladder/NN tumors/NNS among/IN the/DT original/JJ 9/CD cases/NNS has/VBZ occurred/VBN only/RB among/IN the/DT 5/CD whose/WP properdin/NEWGENE levels/NNS remained/VBN below/RB the/DT median/NN ./.
@@113913031607/CD CONCLUSIONS/IN :/: The/DT methodology/NN of/IN LHR/NNS measurement/NN significantly/RB influences/VBZ the/DT clinical/JJ contribution/NN of/IN Tl-201/NN lung/NN uptake/NN evaluation/NN ./.
@@78288118625/CD This/DT failure/NN to/IN execute/VB regulated/VBN G1/NN //NN S/NN arrest/NN is/VBZ correlated/VBN with/IN enhanced/VBN thermosensitivity/NN of/IN colony-forming/JJ ability/NN ./.
@@96327092918/CD One/CD cDNA/NN clone/NN designated/VBN NCoA-62/GENE ,/, encoded/VBN a/DT 62/CD ,/, 000-Da/JJ protein/NN that/WDT is/VBZ highly/RB related/VBN to/IN BX42/GENE ,/, a/DT Drosophila/NN melanogaster/NN nuclear/JJ protein/NN involved/VBN in/IN ecdysone-stimulated/JJ gene/NN expression/NN ./.
@@29706405915/CD Atomic/NNP absorption/NN spectrophotometry/NN applied/VBN to/IN bacterially/RB expressed/VBN E1A/MULTIGENE proteins/MULTIGENE revealed/VBN that/IN the/DT 289-amino/GENE acid/NN protein/NN binds/VBZ one/PRP zinc/NN ion/NN ,/, whereas/IN the/DT 243-amino/JJ acid/NN protein/NN binds/VBZ no/DT zinc/NN ./.
@@115602929328/CD Using/VBG the/DT presented/VBN categorical/JJ structure/NN as/IN domain/NN model/NN a/DT prototype/MULTIGENE DSS/MULTIGENE for/IN dipslide/NN urine/NN cultures/NNS has/VBZ been/VBN developed/VBN ./.
@@98910856584/CD Nip7p-depleted/JJ cells/NNS exhibited/VBD the/DT same/JJ defects/NNS as/IN Nop8p-depleted/JJ cells/NNS ,/, except/VB that/IN they/PRP accumulated/VBD 27S/CD precursors/NNS ./.
@@89361285817/CD Discordance/NNS on/IN the/DT cost/NN dimension/NN correlated/VBN negatively/RB with/IN G/MULTIGENE Hb/MULTIGENE ,/, suggesting/VBG better/RBR glycemic/JJ control/NN with/IN greater/JJR disagreement/NN ./.
@@112636221097/CD RESULTS/NNS :/: A/DT significant/JJ correlation/NN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM was/VBD observed/VBN for/IN mean/JJ wall/NN thickness/NN and/CC vessel/NN wall/NN area/NN between/IN MRI/NN and/CC histopathology/NN (/( r/JJ =/SYM 0/CD ./CD 87/CD and/CC r/JJ =/SYM 0/CD ./CD 85/CD ,/, respectively/RB )/SYM ./.
@@111796878135/CD In/NN this/DT paper/NN the/DT tyrosine/NN dephosphorylating/JJ enzymes/NNS ,/, the/DT protein-tyrosine/MULTIGENE phosphatases/MULTIGENE (/( PTPs/CONTEXTGENE )/SYM ,/, are/VBP studied/VBN which/WDT can/MD be/VB grouped/VBN into/IN two/JJ subfamilies/NNS ,/, the/DT soluble/MULTIGENE PTPs/MULTIGENE and/CC the/DT receptor/MULTIGENE PTPs/MULTIGENE (/( RPTPs/GENE )/SYM ./.
@@80286714882/CD We/PRP report/VBP here/RB that/DT microinjection/NN of/IN an/DT anti-CBP/NN antiserum/NN into/IN fibroblasts/NNS can/MD inhibit/VB transcription/NN from/IN a/DT cAMP/MULTIGENE responsive/MULTIGENE promoter/MULTIGENE ./.
@@17845891016/CD Relatively/RB little/NN is/NNS known/VBP regarding/IN the/DT role/NN of/IN 5-HT2/MULTIGENE receptor/MULTIGENE activity/NN in/IN male/JJ rat/NN sexual/JJ behavior/NN ./.
@@92861152930/CD S2F/GENE ,/, a/DT leaf-specific/JJ trans-acting/JJ factor/NN ,/, binds/VBZ to/IN a/DT novel/JJ cis-acting/JJ element/NN and/CC differentially/RB activates/VBZ the/DT RPL21/MULTIGENE gene/MULTIGENE ./.
@@95358519498/CD Among/IN three/CD isoforms/NNS ,/, the/DT beta/MULTIGENE isoform/MULTIGENE has/VBZ the/DT greatest/JJS Vmax/NN value/NN for/IN the/DT PtdIns/NN (/NN 4/NN )/NN P/NN kinase/NN activity/NN and/CC the/DT gamma/MULTIGENE isoform/MULTIGENE is/VBZ most/RB markedly/RB stimulated/VBN by/IN phosphatidic/JJ acid/NN ./.
@@92120596752/CD The/DT overall/JJ results/NNS of/IN this/DT paper/NN are/VBP consistent/JJ with/IN the/DT conclusion/NN that/IN the/DT carboxyl-terminal/MULTIGENE LBD/MULTIGENE is/VBZ not/RB sufficient/JJ for/IN mediating/JJ PR/NNP dimerization/NN and/CC that/IN multiple/JJ regions/NNS ,/, including/JJ the/DT hinge/NN and/CC amino-terminal/MULTIGENE sequences/MULTIGENE ,/, contribute/VB either/DT directly/RB or/CC indirectly/RB to/IN homodimerization/NN of/IN PR/NNP ./NNP
@@7501016314/CD A/DT water-vapour/JJ giga-maser/NN in/IN the/DT active/JJ galaxy/NN TXFS2226-184/GENE ./.
@@78765622008/CD A/DT potential/JJ outcome/NN of/IN these/DT biochemical/JJ effects/NNS may/MD include/VB the/DT limited/VBN responsiveness/NN of/IN infected/VBN T/NN cells/NNS to/IN antigenic/JJ stimulation/NN observed/VBN during/IN HIV-1/NNP infection/NN ./.
@@83885106437/CD Analysis/NNP by/IN cell/NN surface/NN immunofluorescence/NN showed/VBN that/IN the/DT UL28/MULTIGENE gene/MULTIGENE is/VBZ not/RB required/VBN for/IN expression/NN of/IN viral/JJ glycoproteins/NNS on/IN the/DT surface/NN of/IN infected/VBN cells/NNS ./.
@@107362239352/CD Based/VBN on/IN these/DT data/NN ,/, we/PRP conclude/VBP that/DT transcription/NN of/IN prgX/NN is/VBZ initiated/VBN from/IN the/DT Qa/MULTIGENE promoter/MULTIGENE in/IN prgQ/NN ,/, and/CC PrgX/GENE autoregulates/VBZ its/PRP transcription/NN either/DT by/IN mediating/JJ transcriptional/JJ readthrough/NN or/CC increasing/JJ mRNA/NN stability/NN ./.
@@69389489929/CD Secretory/MULTIGENE IgA/MULTIGENE and/CC serum/JJ immunoglobulins/NNS as/IN indices/NNS of/IN the/DT local/JJ immunity/NN of/IN the/DT intestinal/JJ mucosa/NN in/IN acute/JJ leukemias/NNS ./.
@@78469422541/CD Digitalis/NN glycosides/NNS or/CC beta-receptor/NN antagonists/NNS are/VBP not/RB helpful/JJ in/IN the/DT therapy/NN of/IN this/DT form/NN of/IN atrial/JJ fibrillation/NN whereas/IN class/MULTIGENE I/MULTIGENE antiarrhythmic/JJ drugs/NNS have/VBP been/VBN shown/VBP to/IN be/VB more/RB effective/JJ ./.
@@111124179349/CD Our/PRP data/NN show/NN that/IN multiple/JJ MLSN1/MULTIGENE transcripts/MULTIGENE ,/, both/DT constitutively/RB expressed/VBN and/CC inducible/JJ ,/, are/VBP present/VB in/IN cultured/JJ pigmented/JJ melanoma/NN cells/NNS ,/, and/CC suggest/VB that/IN MLSN1/GENE expression/NN can/MD be/VB regulated/VBN at/IN the/DT level/NN of/IN both/DT transcription/NN and/CC mRNA/NN processing/VBG ./.
@@74785252611/CD Both/DT classes/NNS of/IN MHBst/MULTIGENE proteins/MULTIGENE were/VBD found/VBN to/IN form/NN dimers/NNS ;/: an/DT which/WDT is/VBZ involved/VBN in/IN mediating/JJ the/DT dimerization/NN ./.
@@13187391952/CD After/IN the/DT first/JJ 28/CD patients/NNS vincristine/NN was/VBD replaced/VBN by/IN teniposide/NN (/( VM-26/IN )/SYM due/NN to/IN neurotoxicity/NN ./.
@@86320093323/CD The/DT specificity/NN of/IN action/NN of/IN C/MULTIGENE //MULTIGENE EBP/MULTIGENE family/MULTIGENE members/MULTIGENE may/MD be/VB derived/VBN from/IN the/DT characteristics/NNS of/IN each/DT factor/NN ,/, including/JJ the/DT expression/NN profiles/NNS ,/, the/DT DNA/NN binding/JJ affinities/NNS ,/, the/DT cofactors/NNS ,/, and/CC so/RB on/IN ,/, in/IN addition/NN to/IN the/DT DNA/NN binding/JJ specificities/NNS ./.
@@88497785700/CD We/PRP have/VBP performed/VBN toeprinting/JJ analyses/NNS on/IN repA/MULTIGENE mRNA/MULTIGENE of/IN plasmid/NN R1/GENE ,/, both/DT free/JJ and/CC in/IN duplex/JJ with/IN the/DT antisense/NN RNA/NN ,/, CopA/GENE ./.
@@103596731918/CD The/DT yeast/MULTIGENE LPD1/MULTIGENE gene/MULTIGENE encoding/VBG lipoamide/MULTIGENE dehydrogenase/MULTIGENE is/VBZ subject/NN to/IN the/DT general/JJ control/NN of/IN amino/JJ acid/NN biosynthesis/NN mediated/JJ by/IN the/PDT GCN4/MULTIGENE transcription/MULTIGENE factor/MULTIGENE ./.
@@40322687006/CD Either/CC a/DT UV/NN detector/NN set/NN at/IN 268/CD nm/NN or/CC an/DT electrochemical/JJ (/( EC/NN )/SYM detector/NN set/NN at/IN a/DT potential/NN of/IN +0/CD ./CD 9/CD V/NN (/( versus/IN Ag/MULTIGENE //MULTIGENE AgCl/MULTIGENE //MULTIGENE 3/MULTIGENE M/MULTIGENE NaCl/NN )/SYM was/VBD used/VBN to/IN monitor/NN the/DT drug/NN ./.
@@85726162435/CD Apparent/JJ loss/NN of/IN differentiation/NN markers/NNS characterizes/VBZ advanced/JJ malignant/JJ neoplasms/NNS ./.
@@93311199295/CD The/DT most/RB common/JJ grade/NN 3/CD toxicity/NN was/VBD neutropenia/NN ,/, thrombocytopenia/NN ,/, and/CC parasthesias/NNS (/( observed/VBN in/IN </SYM 10%/CD of/IN cycles/NNS )/SYM ./.
@@79121237890/CD Mitogen-induced/JJ lymphocyte/NN proliferation/NN was/VBD diminished/VBN ./.
@@92035857572/CD A/DT striking/JJ feature/NN of/IN the/DT recombinant/JJ H19/MULTIGENE allele/MULTIGENE is/VBZ the/DT occurrence/NN of/IN a/DT parental/JJ imprint/NN set/NN on/IN the/DT neo/JJ replacement/NN cassette/NN ./.
@@105437306700/CD The/DT yeast/MULTIGENE C-type/MULTIGENE cyclin/MULTIGENE Ume3p/NNP //NNP Srb11p/NNP and/CC its/PRP cyclin-dependent/MULTIGENE kinase/MULTIGENE (/( Cdk/CONTEXTGENE )/SYM Ume5p/GENE are/VBP required/VBN for/IN the/DT full/JJ repression/NN of/IN genes/NNS involved/VBN in/IN the/DT stress/NN response/NN or/CC meiosis/NN ./.
@@109037333660/CD Coimmunoprecipitation/NNS experiments/NNS performed/VBN in/IN transfected/VBN cells/NNS showed/VBD that/DT BCMA/NN associates/VBP with/IN TNFR-associated/MULTIGENE factor/MULTIGENE (/( TRAF/GENE )/SYM 1/CD ,/, TRAF2/GENE ,/, and/CC TRAF3/MULTIGENE adaptor/MULTIGENE proteins/MULTIGENE ./.
@@10496388329/CD Except/IN for/IN nonperfusion/NN of/IN neurosensory/JJ retinal/JJ vessels/NNS at/IN a/DT light/NN dose/NN of/IN 150/CD J/GENE //GENE cm2/GENE ,/, no/DT other/DT adverse/JJ events/NNS were/VBD of/IN concern/NN ./.
@@22922722949/CD Interlimb/NNP coordination/NN during/IN fictive/JJ locomotion/NN in/IN the/DT thalamic/JJ cat/NN ./.
@@93676761048/CD Restriction/NNS enzyme/NN mapping/NN ,/, subcloning/NN ,/, and/CC DNA/NN sequencing/VBG analysis/NN of/IN recombinant/JJ phage/NN lambda/NN and/CC P1/NEWGENE clones/NNS revealed/VBN that/IN exons/NNS encoding/VBG the/DT 1/CD ./CD 9-kb/CD mouse/MULTIGENE TS/MULTIGENE mRNA/MULTIGENE are/VBP dispersed/VBN over/RB >/SYM 150/CD kb/NN genomic/JJ DNA/NN ./.
@@16448212754/CD However/RB ,/, butyrate/NN was/VBD at/IN least/RB 2-fold/JJ more/RB effective/JJ in/IN stimulating/JJ CAT/NN activity/NN of/IN fusion/MULTIGENE genes/MULTIGENE containing/MULTIGENE upstream/MULTIGENE sequences/MULTIGENE (/( -834/JJ to/IN -576/JJ )/SYM than/IN those/DT containing/JJ proximal/JJ sequences/NNS (/( -456/CD to/IN -172/CD )/SYM ,/, suggesting/VBG two/JJ regions/NNS in/IN the/DT PSG1-I/MULTIGENE gene/MULTIGENE that/WDT mediate/VBP the/DT butyrate/NN response/NN ./.
@@49678245272/CD Effects/NNPS of/IN temperature/NN and/CC moulting/JJ cycle/NN on/IN melanin/NN synthesis/NN in/IN the/DT newt/NN ,/, Triturus/NN cristatus/NN ./.
@@111340334114/CD The/DT murine/MULTIGENE int-6/MULTIGENE locus/MULTIGENE ,/, identified/VBN as/IN a/DT frequent/JJ integration/MULTIGENE site/MULTIGENE of/IN mouse/NN mammary/JJ tumor/NN viruses/NNS ,/, encodes/VBZ the/DT 48-kDa/MULTIGENE eIF3e/MULTIGENE subunit/MULTIGENE of/IN translation/MULTIGENE initiation/MULTIGENE factor/MULTIGENE eIF3/MULTIGENE ./.
@@24277973097/CD In/NN 30/CD dogs/VBZ the/DT left/NN limb/NN (/( tail/NN )/SYM of/IN the/DT pancreas/NN was/VBD removed/VBN but/CC left/NN in/IN the/DT abdominal/JJ cavity/NN after/IN cessation/NN of/IN blood/NN flow/NN to/IN produce/NN warm/JJ ischemia/NN for/IN 30/CD ,/, 60/CD ,/, and/CC 120/CD min/NN (/( 10/CD dogs/NNS at/IN each/DT time/NN point/NN )/SYM ,/, and/CC then/RB was/VBD flushed/VBN with/IN cold/JJ Ringers'/NNP lactate/NN and/CC transplanted/VBN to/IN the/DT iliac/JJ vessels/NNS ./.
@@10545248325/CD The/DT core/NN of/IN this/DT enhancer/NN contains/VBZ two/JJ evolutionarily/RB conserved/VBN binding/JJ sites/NNS for/IN the/DT homeodomain/MULTIGENE protein/MULTIGENE Tinman/MULTIGENE (/( Tin/NNP )/SYM ,/, expressed/VBN in/IN developing/JJ cardiac/NN ,/, somatic/JJ ,/, and/CC visceral/JJ muscle/NN lineages/NNS ./.
@@92944225224/CD The/DT por/NEWGENE gene/NN has/VBZ been/VBN expressed/VBN ,/, for/IN the/DT first/JJ time/NN ,/, in/IN anaerobically/RB grown/VBP Escherichia/NN coli/JJ behind/RB the/DT isopropyl-beta-D-thiogalactopyranoside-inducible/JJ tac/NN promoter/NN ,/, resulting/JJ in/IN the/DT production/NN of/IN POR/NN in/IN its/PRP active/JJ form/NN ./.
@@10784393603/CD Marrow/NN dysplasia/NN is/VBZ a/DT major/JJ characteristic/NN of/IN patients/NNS with/IN myelodysplastic/JJ syndrome/NN (/( MDS/NN )/SYM ,/, along/IN with/IN marrow/NN blastosis/NN ,/, cytopenia/NN and/CC cytogenetic/JJ anomalies/NNS ./.
@@88321467039/CD Proximal/JJ CBD/NN was/VBD inversely/RB correlated/VBN with/IN bone/MULTIGENE alkaline/MULTIGENE phosphatase/MULTIGENE (/( r/JJ =/SYM -0/CD ./CD 71/CD ,/, p/NN </SYM 0/CD ./CD 01/CD )/SYM and/CC intact/JJ PTH/NN (/( r/JJ =/SYM -0/CD ./CD 59/CD ,/, p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@110277244619/CD Recombinant/NNP BRI1-KD/NNP autophosphorylated/VBN on/IN serine/NN (/( Ser/NN )/SYM and/CC threonine/NN (/( Thr/NN )/SYM residues/NNS with/IN p-Ser/JJ predominating/VBG ./.
@@10823961915/CD The/DT C/NN terminus/NN of/IN TRBP/NN binds/VBZ to/IN CBP/GENE //GENE p300/GENE and/CC DRIP130/GENE ,/, a/DT component/NN of/IN the/DT DRIP/MULTIGENE //MULTIGENE TRAP/MULTIGENE //MULTIGENE ARC/MULTIGENE complex/MULTIGENE ,/, which/WDT suggests/VBZ that/DT TRBP/NN may/MD activate/VB transcription/NN by/IN means/NN of/IN such/JJ interactions/NNS ./.
@@105645935531/CD FISH/ORG using/VBG a/DT whole/JJ chromosome/NN 4/CD paint/NN demonstrated/VBD multiple/JJ rearrangements/NNS involving/VBG chromosome/NN 4/CD in/IN MCF-7/MULTIGENE AdVp3000/MULTIGENE and/CC MCF-7/MULTIGENE MX/MULTIGENE ,/, while/CC S1-M1-80/GENE contained/VBD only/RB a/DT simple/JJ reciprocal/JJ translocation/NN ./.
@@7876192791/CD In/NNP ICE/MULTIGENE gamma/MULTIGENE ,/, most/RB of/IN the/DT propeptide/NN (/( amino/JJ acids/NNS 20-112/CD )/SYM is/VBZ deleted/VBN ,/, which/WDT suggests/VBZ that/IN it/PRP may/MD function/VB as/IN a/DT catalyst/NN for/IN ICE/NNP autoprocessing/NN in/IN vivo/NN ./.
@@118427288051/CD Schistosoma/ORG mansoni/NN schistosomiasis/NN Schistosomosis/GENE are/VBP parasitic/JJ diseases/NNS caused/VBN by/IN blood/NN flukes/NNS of/IN the/DT Schistosoma/ORG genus/NN ./.
@@10181397122/CD They/PRP contrast/NN trends/NNS in/IN fertility/NN ,/, life/NN expectancy/NN ratios/NNS ,/, and/CC gender/NN differences/NNS in/IN these/DT countries/NNS with/IN the/DT Hispanic/NN population/NN of/IN the/DT United/NNP States/NNPS ./.
@@30623701616/CD These/DT results/NNS imply/VBP that/IN the/DT GCN3/MULTIGENE product/MULTIGENE can/MD promote/VB either/DT repression/NN or/CC activation/NN of/IN GCN4/NEWGENE expression/NN depending/VBG on/IN amino/JJ acid/NN availability/NN ./.
@@78878597718/CD Twenty-two/CD consecutive/JJ patients/NNS with/IN ischaemic/JJ ulcers/NNS had/VBP tcPO2/GENE measured/VBN and/CC the/DT ankle/JJ //JJ brachial/JJ (/( ABI/NNS )/SYM and/CC toe/JJ //JJ brachial/JJ (/( TBI/NN )/SYM indices/NNS calculated/VBN ./.
@@10445945291/CD John/NN leonard/NN dawson/NN ./.
@@1007220572/CD In/NN order/NN to/IN better/JJR characterize/VB the/DT distribution/NN of/IN ML/NN and/CC MAP/NN estimates/NNS under/IN these/DT conditions/NNS ,/, we/PRP derive/VBP a/DT point/NN approximation/NN to/IN density/NN values/NNS of/IN the/DT conditional/JJ distribution/NN of/IN such/JJ estimates/NNS ./.
@@75436848079/CD We/PRP conclude/VBP that/DT cAMP/NN ,/, acting/JJ through/JJ PKA/NN ,/, is/VBZ an/DT essential/JJ regulator/NN of/IN basal/MULTIGENE CFTR/MULTIGENE gene/MULTIGENE expression/NN and/CC may/MD mediate/VB an/DT induction/NN of/IN CFTR/NN in/IN responsive/JJ cell/NN types/NNS ./.
@@110079492153/CD We/PRP have/VBP demonstrated/VBN that/IN the/DT activity/NN of/IN ILK/GENE is/VBZ constitutively/RB elevated/VBN in/IN PTEN/NNP mutant/JJ cells/NNS ./.
@@79717096552/CD A/DT normal/JJ systemic/JJ response/NN was/VBD obtained/VBN after/IN IF/IN ,/, indicating/VBG that/IN rhG-CSF/GENE retains/VBZ activity/NN in/IN the/DT solid/JJ state/NN ./.
@@112388821587/CD In/NN Saccharomyces/NN cerevisiae/NN ,/, eIF6/GENE is/VBZ encoded/VBN by/IN a/DT single-copy/JJ essential/JJ gene/NN ./.
@@111550968074/CD METHODS/IN :/: Thyroid/NN status/NN was/VBD measured/VBN at/IN baseline/NN (/( 1990-93/CD )/SYM ,/, through/JJ assessment/NN of/IN serum/JJ antibodies/NNS to/IN thyroid/MULTIGENE peroxidase/MULTIGENE (/( TPO-Abs/CONTEXTGENE ,/, positive/JJ :/: >/SYM 10/CD IU/NNS //NNS ml/NNS )/SYM ,/, serum/JJ TSH/NN levels/NNS ,/, and/CC when/CC TSH/NN was/VBD abnormal/JJ (/( </SYM 0/CD ./CD 4/CD or/CC >/SYM 4/CD ./CD 0/CD mU/NN //NN l/NN )/SYM ,/, serum/JJ thyroxin/NN levels/NNS (/( T4/NN )/SYM ./.
@@60903698235/CD Two/CD hundred/JJ forty-three/CD patients/NNS have/VBP received/VBN WR-2721/GENE in/IN Phase/NN I-II/NNS studies/NNS ./.
@@85348482198/CD All/DT three/CD NR/MULTIGENE isoforms/MULTIGENE are/VBP expressed/VBN in/IN cv/CD ./CD
@@80637917033/CD These/DT results/NNS demonstrate/VBP that/IN a/DT diverse/JJ set/NN of/IN carboxyl-terminal/MULTIGENE sequence/MULTIGENE motifs/MULTIGENE and/CC posttranslational/JJ modifications/NNS lead/VBP to/IN functional/JJ Ras/MULTIGENE proteins/MULTIGENE in/IN yeast/NN ./.
@@90887373899/CD Epithelial/JJ and/CC corneal/JJ thickness/NN measurements/NNS by/IN in/IN vivo/NN confocal/JJ microscopy/NN through/JJ focusing/NN (/( CMTF/GENE )/SYM ./.
@@88037107736/CD Five-year/JJ survivals/NNS amounted/VBN to/IN 100%/CD ,/, 86/CD ./CD 2%/CD ,/, 59/CD ./CD 4%/CD ,/, 29/CD ./CD 8%/CD ,/, and/CC 20%/CD for/IN stages/NNS I/PRP ,/, II/NNP ,/, III/NNP ,/, IVA/NNS and/CC IVB/GENE respectively/RB ./.
@@715753215/CD In/NN biopsies/NNS CK-MB/GENE fraction/NN of/IN total/JJ myocardial/JJ CPK/NN was/VBD 37%/JJ ,/, the/DT total-CPK/GENE activity/NN of/IN human/JJ skeletal/JJ muscles/NNS still/RB shows/VBZ a/DT 5%/JJ fraction/NN of/IN CK-MB/GENE ./.
@@113497962309/CD Measurements/NNS were/VBD obtained/VBN :/: (/( i/NN )/SYM just/RB after/IN the/DT traumatic/JJ exposure/NN (/( D0/NN )/SYM ;/: (/( ii/NN )/SYM 3/CD days/NNS after/IN this/DT first/JJ measurement/NN (/( D3/GENE )/SYM ;/: and/CC (/( iii/NN )/SYM 30/CD days/NNS after/IN (/( D30/GENE )/SYM ./.
@@118118251679/CD The/DT results/NNS of/IN our/PRP ten-fold/JJ cross-validation/NN experiments/NNS show/VBP that/IN ,/, on/IN the/DT average/NN ,/, the/DT system/NN increases/VBZ the/DT specificity/NN from/IN 0/CD ./CD 19/CD (/( 0/CD ./CD 35/CD )/SYM to/IN 0/CD ./CD 69/CD (/( 0/CD ./CD 74/CD )/SYM at/IN a/DT sensitivity/NN level/NN of/IN 1/CD ./CD 0/CD (/( 0/CD ./CD 95/CD )/SYM ./.
@@82013528723/CD In/NN the/DT case/NN of/IN congenital/JJ protein/MULTIGENE C/MULTIGENE deficiency/NN ,/, vitamin/NN K/NN antagonists/NNS must/MD be/VB started/VBN cautiously/RB due/NN to/IN the/DT risk/NN of/IN skin/NN necrosis/NN ./.
@@83567929675/CD HTLV-1/MULTIGENE gene/MULTIGENE expression/NN by/IN defective/JJ proviruses/NNS in/IN an/DT infected/VBN T-cell/NN line/NN ./.
@@82886228216/CD The/DT structural/JJ analysis/NN also/RB demonstrated/VBD that/IN the/DT heterogeneity/NN of/IN the/DT HDC/MULTIGENE mRNA/MULTIGENE is/VBZ caused/VBN by/IN an/DT insertion/NN of/IN the/DT seventh/JJ intron/NN sequence/NN and/CC alternative/JJ use/NN of/IN the/DT splicing/JJ acceptor/NN site/NN at/IN the/DT 12th/NEWGENE exon/NN ./.
@@93469351416/CD Thus/RB ,/, ZNF74/GENE sublocalization/NN in/IN nuclear/JJ domains/NNS enriched/VBN in/IN pre-mRNA/JJ maturating/JJ factors/NNS ,/, its/PRP RNA/NN binding/JJ activity/NN ,/, and/CC its/PRP direct/JJ phosphodependent/NN interaction/NN with/IN the/DT pol/MULTIGENE IIo/MULTIGENE ,/, a/DT form/NN of/IN the/DT RNA/MULTIGENE polymerase/MULTIGENE functionally/RB associated/VBD with/IN pre-/MULTIGENE mRNA/MULTIGENE processing/VBG ,/, suggest/VB a/DT role/NN for/IN this/DT member/NN of/IN the/DT KRAB/MULTIGENE multifinger/MULTIGENE protein/MULTIGENE family/MULTIGENE in/IN RNA/NN processing/VBG ./.
@@112484631083/CD The/DT blood/NN levels/NNS of/IN lactate/NN ,/, pyruvate/NN and/CC amino/JJ acids/NNS were/VBD not/RB elevated/VBN ./.
@@86664046081/CD Isolation/NNS of/IN a/DT near/IN full-length/JJ cDNA/NN from/IN a/DT human/JJ fetal/JJ brain/NN cDNA/NN library/NN revealed/VBD a/DT protein/MULTIGENE serine-threonine/MULTIGENE phosphatase/MULTIGENE with/IN a/DT tetratricopeptide/MULTIGENE motif/MULTIGENE ,/, almost/RB identical/JJ to/IN human/MULTIGENE PPP5C/MULTIGENE (/( PP5/CONTEXTGENE )/SYM and/CC highly/RB homologous/JJ to/IN rat/MULTIGENE PPT/MULTIGENE ./.
@@18518763260/CD This/DT element/NN was/VBD used/VBN to/IN screen/NN an/DT EMBL3/GENE mouse/NN genomic/JJ library/NN ./.
@@23864857230/CD The/DT nucleotide/NN sequence/NN consists/VBZ of/IN 48/CD bp/NN of/IN 5'-end/CD non-coding/JJ region/NN ,/, 1695/CD bp/NN of/IN coding/JJ region/NN and/CC 212/CD bp/NN of/IN 3'-end/CD non-coding/JJ region/NN including/JJ a/DT 20/CD bp/NN poly/NN (/NN A/NN )/NN tail/NN ./.
@@28799513782/CD Effects/NNPS of/IN a/DT new/JJ antihypertensive/JJ agent/NN ,/, SGB-1534/GENE ,/, on/IN rat/NN platelet/NN aggregation/NN ./.
@@90883713854/CD Plasma/NN levels/NNS of/IN protein/MULTIGENE C/MULTIGENE ,/, protein/MULTIGENE S/MULTIGENE ,/, and/CC antithrombin/MULTIGENE III/MULTIGENE in/IN patients/NNS with/IN subarachnoid/JJ haemorrhage/NN ./.
@@82226188193/CD Two/CD BASIC/DT computer/NN programs/NNS using/VBG logit/NN transformation/NN for/IN the/DT analysis/NN of/IN S-shaped/JJ curves/NNS are/VBP presented/VBN ./.
@@7863992212/CD Among/IN 9/MULTIGENE group/MULTIGENE I/MULTIGENE patients/NNS with/IN a/DT positive/JJ result/NN on/IN head-up/JJ tilt-table/JJ testing/NN and/CC no/DT evidence/NN of/IN structural/JJ heart/NN disease/NN (/( mean/JJ follow-up/JJ 4/CD ./CD 3/CD years/NNS )/SYM ,/, 7/CD are/VBP without/IN further/JJ episodes/NNS of/IN syncope/NN ;/: 3/CD have/VB discontinued/VBN medication/NN and/CC 5/CD have/VB resumed/VBN at/IN least/RB limited/VBN exercise/NN ./.
@@77769793602/CD In/NN contrast/NN ,/, COUP-TF/GENE alone/RB had/VBP no/DT effect/NN on/IN repCRS2-dependent/JJ reporter/NN gene/NN activity/NN ./.
@@22064302824/CD Pups/NNS placed/VBN into/IN the/DT novel/JJ environment/NN with/IN their/PRP mothers/NNS exhibited/VBD an/DT intermediate/JJ level/NN of/IN DA/NN turnover/NN ./.
@@77807197752/CD With/IN this/DT bisected/VBN diastolic/JJ driving/NN ,/, the/DT abnormal/JJ echo/NN disappeared/VBN completely/RB ./.
@@75685763151/CD This/DT report/NN focused/VBN on/IN the/DT relationship/NN between/IN Type/MULTIGENE A/MULTIGENE behavior/NN and/CC eight/CD basic/JJ emotion/NN dimensions/NNS ./.
@@14066308973/CD Using/VBG either/DT a/DT p50-/NEWGENE or/CC p65-selected/MULTIGENE kappa/MULTIGENE B/MULTIGENE motif/MULTIGENE ,/, which/WDT displayed/VBD differential/JJ binding/NN with/IN respect/NN to/IN the/PDT other/DT protein/NN ,/, little/JJ to/IN no/DT binding/NN was/VBD observed/VBN with/IN the/DT heterodimeric/MULTIGENE NF-kappa/MULTIGENE B/MULTIGENE complex/MULTIGENE ./.
@@98409434894/CD We/PRP have/VBP isolated/VBN a/DT novel/JJ human/MULTIGENE cyclin/MULTIGENE ,/, cyclin/MULTIGENE E2/MULTIGENE ,/, that/WDT contains/VBZ significant/JJ homology/NN to/IN cyclin/NN E/NNP ./NNP
@@89527968908/CD He/NN is/VBZ well/VB ,/, five/CD years/NNS after/IN relapse/NN ./.
@@89778446/CD The/DT concentration/NN of/IN alpha/MULTIGENE 2-macroglobulin/MULTIGENE ,/, alpha/MULTIGENE 1-antitrypsin/MULTIGENE ,/, plasminogen/NN ,/, C3-complement/GENE ,/, fibrinogen/NEWGENE degradation/NN products/NNS (/( FDP/NN )/SYM and/CC fibrinolytic/JJ activity/NN ,/, were/VBD studied/VBN in/IN the/DT aqueous/JJ humour/NN and/CC serum/JJ from/IN nine/JJ patients/NNS with/IN Fuchs'/NN endothelial/JJ dystrophy/NN ,/, 17/CD patients/NNS with/IN uncomplicated/JJ senile/JJ cataract/NN and/CC in/IN the/DT secondary/JJ aqueous/JJ from/IN six/CD cataract/NN patients/NNS ./.
@@64799762681/CD Significant/JJ clinical/JJ differences/NNS between/IN the/DT patients/NNS treated/VBN with/IN and/CC without/IN AMB/GENE were/VBD longer/JJR survival/NN time/NN following/IN diagnosis/NN of/IN illness/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM and/CC more/RB frequent/VB cranial/JJ nerve/NN signs/NNS in/IN the/DT treated/VBN patients/NNS (/( P/NN =/SYM 0/CD ./CD 089/CD )/SYM ./.
@@95738844448/CD However/RB ,/, mandibular/JJ position/NN (/( S-N-B/GENE and/CC S-N-Pog/GENE )/SYM was/VBD found/VBN to/IN be/VB significantly/RB more/RB retrusive/JJ in/IN Class/MULTIGENE II/MULTIGENE when/CC compared/VBN with/IN Class/MULTIGENE I/MULTIGENE subjects/NNS ./.
@@35262794204/CD State-approved/NN schools/NNS of/IN nursing/JJ R/NNP ./NNP N/NNP ./.
@@96709439567/CD B/MULTIGENE cell/MULTIGENE antigen/MULTIGENE receptor/MULTIGENE (/( BCR/CONTEXTGENE )/NN -mediated/NN formation/NN of/IN a/DT SHP-2-pp120/MULTIGENE complex/MULTIGENE and/CC its/PRP inhibition/NN by/IN Fc/MULTIGENE gamma/MULTIGENE RIIB1-BCR/NNP coligation/NN ./.
@@84500158408/CD The/DT method/NN involves/VBZ preliminary/JJ isolation/NN of/IN oxiracetam/NN and/CC internal/JJ standard/NN from/IN plasma/NN by/IN solid-phase/JJ extraction/NN prior/NN to/IN the/DT formation/NN of/IN their/PRP n-propyl/JJ carbamate/NN derivatives/NNS ./.
@@92444309851/CD The/DT alternative/JJ splice/NN sites/NNS for/IN the/DT smallest/JJS adducin/MULTIGENE isoform/MULTIGENE ,/, beta-3/GENE ,/, are/VBP alternative/JJ donor/NN and/CC acceptor/NN sites/NNS within/IN exons/NNS 7/CD and/CC 12/CD ./CD
@@18571432454/CD The/DT patient/NN was/VBD a/DT 78-year-old/JJ male/NN in/IN whom/WP skin/VBP lesions/NNS preceded/VBD the/DT diagnosis/NN of/IN myelofibrosis/NN ./.
@@25046036325/CD Isolation/NNS of/IN Weeksella/NNP virosa/NN (/( formerly/RB CDC/MULTIGENE group/MULTIGENE IIf/MULTIGENE )/SYM from/IN a/DT vaginal/JJ sample/NN ./.
@@20221887069/CD Biochemical/NNP analysis/NN demonstrates/VBZ that/IN the/DT BJ1/MULTIGENE protein/MULTIGENE is/VBZ associated/VBN with/IN nucleosomes/NNS and/CC is/VBZ released/VBN from/IN chromatin/NN by/IN agents/NNS which/WDT intercalate/VBP into/IN DNA/NN ,/, as/IN previously/RB shown/VBP for/IN the/DT high/JJ mobility/NN group/NN proteins/NNS (/( HMGs/NNP )/SYM ./.
@@110307444874/CD Overexpression/NNS of/IN Trdpm1/GENE in/IN a/DT dpm1/NN (/NN +/NN )/NN :/: :/: his7/NN //NN dpm1/NN (/NN +/NN )/NN S/NNP ./NNP pombe/NNP diploid/RB resulted/VBD in/IN a/DT 4-fold/JJ increase/NN in/IN specific/MULTIGENE DPM/MULTIGENE synthase/MULTIGENE activity/NN ./.
@@36687362848/CD The/DT average/JJ deviations/NNS in/IN the/DT X-ray/NN counts/NNS of/IN the/DT constant/MULTIGENE elements/MULTIGENE from/IN the/DT series/NN means/NN were/VBD used/VBN to/IN correct/VB the/DT recorded/VBN count/NN of/IN the/DT variable/JJ element/NN in/IN each/DT block/NN ./.
@@93740828758/CD The/DT proposed/VBN mechanism/NN of/IN effect/NN states/NNS that/WDT mono/NN (/NN 2-ethylhexyl/NN )/NN phthalate/NN (/( MEHP/NN )/SYM ,/, the/DT primary/JJ hydrolysis/NN product/NN of/IN DEHP/NN ,/, mimics/VBP the/DT inducing/JJ prostaglandins/NNS (/( PG/NN )/SYM PGD/CONTEXTGENE (/CONTEXTGENE 2/CONTEXTGENE )/CONTEXTGENE ,/, 9alpha/GENE ,/GENE 11betaPGF2/GENE ,/, and/CC PGF2alpha/CONTEXTGENE ,/, and/CC thromboxanes/NNS in/IN the/DT lungs/NNS ,/, thereby/RB increasing/JJ the/DT risk/NN of/IN inducing/JJ inflammation/NN in/IN the/DT airways/NNS ,/, which/WDT is/VBZ a/DT characteristic/NN of/IN asthma/NN ./.
@@32347903924/CD Effect/NN of/IN the/DT methods/NNS of/IN cutaneous/JJ administration/NN of/IN methyl/NN isobutyl/NN ketone/NN on/IN its/PRP toxicity/NN ./.
@@10698937386/CD TIP30/GENE has/VBZ an/DT intrinsic/MULTIGENE kinase/MULTIGENE activity/NN required/VBN for/IN up-regulation/NN of/IN a/DT subset/NN of/IN apoptotic/JJ genes/NNS ./.
@@75545417438/CD The/DT optimal/JJ care/NN of/IN CHF/NN patient/NN includes/VBZ the/DT recognition/NN and/CC management/NN of/IN these/DT electrolyte/NN disturbances/NNS ./.
@@94868909452/CD However/RB ,/, laparoscopy/NN failed/VBD to/IN establish/VB inoperability/NN in/IN any/DT cases/NNS of/IN carcinoma/NN spread/NN to/IN areas/NNS not/RB accessible/JJ to/IN laparoscopic/JJ visualization/NN ./.
@@95045144660/CD Randomised/JJ comparison/NN of/IN addition/NN of/IN autologous/JJ bone-marrow/NN transplantation/NN to/IN intensive/JJ chemotherapy/NN for/IN acute/JJ myeloid/JJ leukaemia/NN in/IN first/JJ remission/NN :/: results/NNS of/IN MRC/MULTIGENE AML/MULTIGENE 10/MULTIGENE trial/NN ./.
@@94341858102/CD The/DT organization/NN of/IN SPP1/MULTIGENE genes/MULTIGENE involved/VBN in/IN the/DT replication/NN ,/, DNA/NN packaging/NN and/CC phage/NN assembly/NN proteins/NNS resembles/VBZ the/DT organization/NN of/IN genes/NNS of/IN equivalent/JJ regions/NNS of/IN different/JJ E/NNP ./NNP coli/JJ double-stranded/JJ DNA/NN phages/NNS ./.
@@80542812668/CD The/DT retention/NN index/NN of/IN 201Tl/GENE SPECT/NN is/VBZ a/DT useful/JJ indicator/NN of/IN metastatic/JJ potential/NN ,/, thereby/RB facilitating/JJ the/DT prediction/NN of/IN prognosis/NN ,/, and/CC provides/VBZ insight/NN into/IN the/DT relationship/NN between/IN 201Tl/CD uptake/NN and/CC malignancy/NN ./.
@@81137361743/CD The/DT gene/NN organization/NN of/IN CRSV/MULTIGENE RNA-1/MULTIGENE is/VBZ similar/JJ to/IN those/DT of/IN red/JJ clover/NN necrotic/JJ mosaic/NN (/( RCNMV/NNP )/SYM and/CC sweet/JJ clover/NN necrotic/JJ mosaic/NN (/( SCNMV/NNP )/SYM dianthoviruses/NNS with/IN the/DT exception/NN that/IN CRSV/MULTIGENE RNA-1/MULTIGENE contains/VBZ the/DT additional/JJ 3'-terminal/JJ ORF/NN ./.
@@16572493183/CD All/DT anti-I/JJ and/CC anti-i/MULTIGENE CA/MULTIGENE were/VBD shown/VBP to/IN express/NN VH4/MULTIGENE heavy/MULTIGENE chains/MULTIGENE ,/, and/CC 14/CD of/IN 17/CD CA/NN expressed/VBD a/DT previously/RB described/VBN VH4/GENE second/JJ hypervariable/JJ region/NN determinant/NN ,/, termed/JJ VH4-HV2a/NNP ./.
@@7477226444/CD The/DT data/NN indicate/VB a/DT three-phase/JJ reaction/NN after/IN B1/GENE injection/NN :/: Phase/NN 1--shortly/JJ after/IN injection/NN there/RB is/VBZ a/DT drop/NN of/IN all/DT parameters/NNS lasting/JJ for/IN 30/CD sec/NN ./.
@@7798217311/CD A/DT secondary/JJ phosphorylation/NN of/IN CREB341/GENE at/IN Ser129/NN is/VBZ required/VBN for/IN the/DT cAMP-mediated/JJ control/NN of/IN gene/NN expression/NN ./.
@@10967531799/CD After/IN declamping/NN of/IN the/DT aorta/NN ,/, there/RB were/VBD also/RB severe/JJ edema/NN ,/, local/JJ fibre/NN necrosis/NN ,/, and/CC adhesion/NN of/IN leucocytes/NNS ,/, whereas/IN muscle/NN fibre/NN areas/NNS became/VBD 3/CD ,/CD 935/CD ./CD 18/CD &mgr/NN ;/: 531/CD &mgr/NN ;/: m/NN (/NN 2/NN )/NN for/IN type/MULTIGENE I/MULTIGENE and/CC 5/CD ,/CD 804/CD +/NN //NN -/NN 1/CD ,/CD 075/CD &mgr/NN ;/: m/NN (/NN 2/NN )/NN for/IN type/NN II/NNS ./NNS
@@105236747097/CD RNase/MULTIGENE MRP/MULTIGENE is/VBZ a/DT ribonucleoprotein/MULTIGENE endoribonuclease/MULTIGENE that/WDT has/VBZ been/VBN shown/VBP to/IN have/NN roles/NNS in/IN both/DT mitochondrial/JJ DNA/NN replication/NN and/CC nuclear/JJ 5/CD ./CD 8S/CD rRNA/NN processing/VBG ./.
@@112904154786/CD In/NN the/DT present/NN study/NN ,/, we/PRP have/VBP determined/VBN the/DT ICBP90/MULTIGENE gene/MULTIGENE structure/NN by/IN screening/NN of/IN a/DT human/JJ placenta/NN genomic/JJ library/NN and/CC PCR/NN analysis/NN ./.
@@30690463782/CD The/DT method/NN is/VBZ accurate/JJ ,/, with/IN good/JJ precision/NN and/CC adequate/JJ sensitivity/NN ./.
@@2555703217/CD Tyrosine/MULTIGENE kinase/MULTIGENE oncogenes/MULTIGENE abrogate/VBP interleukin-3/NEWGENE dependence/NN of/IN murine/JJ myeloid/JJ cells/NNS through/RB signaling/JJ pathways/NNS involving/VBG c-myc/NN :/: conditional/JJ regulation/NN of/IN c-myc/NN transcription/NN by/IN temperature-sensitive/JJ v-abl/NN ./.
@@83365437293/CD In/JJ mice/NNS ,/, three/CD major/JJ families/NNS of/IN L1/MULTIGENE elements/MULTIGENE ,/, termed/JJ "A/NN ,/NN "/NN "F/NN ,/NN "/NN and/CC "V/NN ,/NN "/NN have/NN been/VBN defined/VBN on/IN the/DT basis/NN of/IN the/DT sequence/NN found/VB at/IN the/DT 5'/CD terminus/NN ./.
@@83558571362/CD ST/NN elevation/NN occurs/VBZ in/IN 5/CD patients/NNS (/( 55/CD ./CD 5%/CD )/SYM of/IN subgroup/MULTIGENE A/MULTIGENE and/CC in/IN no/DT patient/NN of/IN the/DT subgroup/NN B/NNP ./NNP
@@82973767445/CD Co-transfection/NNS of/IN expression/NN vectors/NNS for/IN CCAAT/MULTIGENE //MULTIGENE enhancer/MULTIGENE binding/MULTIGENE protein/MULTIGENE (/( C/CONTEXTGENE //CONTEXTGENE EBP/CONTEXTGENE )/SYM alpha/NN and/CC C/MULTIGENE //MULTIGENE EBP/MULTIGENE beta/MULTIGENE trans-activated/VBD the/DT rat/NN uncoupling/JJ protein/NN gene/NN promoter/NN due/NN to/IN sequences/NNS in/IN the/DT 5'/CD proximal/JJ region/NN ./.
@@31467846398/CD Of/IN 49/CD receptors/NNS which/WDT fired/VBD in/IN phase/NN with/IN ventilation/NN ,/, 13/CD behaved/VBN like/JJ mammalian/JJ rapidly/RB adapting/JJ pulmonary/JJ stretch/JJ receptors/NNS ,/, 19/CD like/JJ mammalian/JJ slowly/RB adapting/JJ pulmonary/JJ stretch/NN receptors/NNS (/( PSR/NN )/SYM ,/, and/CC 17/CD like/JJ avian/JJ intrapulmonary/JJ CO2-sensitive/MULTIGENE chemoreceptors/MULTIGENE (/( IPC/CONTEXTGENE )/SYM ./.
@@104111397448/CD Our/PRP results/NNS ,/, when/CC combined/JJ with/IN previously/RB published/VBN in/IN vitro/FW results/NNS ,/, support/NN a/DT direct/JJ role/NN for/IN Prp44p/GENE in/IN unwinding/NN of/IN the/DT U4/NNP //NNP U6/NNP helix/NN ./.
@@80494444238/CD Tryptic/JJ cleavage/NN and/CC peptide/NN sequence/NN analysis/NN demonstrated/VBN that/IN the/DT 98-kD/MULTIGENE protein/MULTIGENE is/VBZ identical/JJ to/IN a/DT recently/RB cloned/VBN protein/NN ,/, special/JJ A-T-rich/GENE binding/JJ protein/NN 1/CD (/( SATB1/GENE )/SYM ,/, that/WDT binds/VBZ selectively/RB to/IN nuclear/MULTIGENE matrix/MULTIGENE //MULTIGENE scaffold-associated/MULTIGENE regions/MULTIGENE of/IN DNA/NN (/( MARs/NNP //NNP SARs/NNP )/SYM ./.
@@105749925486/CD Conversely/RB ,/, E1A/NN binding/JJ to/IN only/RB p300/GENE //GENE CBP/GENE results/NNS in/IN an/DT increase/NN in/IN PARP/MULTIGENE enzyme/MULTIGENE activity/NN and/CC consequently/RB in/IN cell/NN death/NN susceptibility/NN to/IN irradiation/NN ,/, which/WDT is/VBZ effectively/RB counteracted/VBN by/IN the/DT PARP/NN chemical/JJ inhibitor/NN 3-aminobenzamide/JJ ./.
@@95531341868/CD The/DT N-syndecan-dependent/NNP neurite/NN outgrowth/NN is/VBZ inhibited/VBN by/IN the/DT tyrosine/NEWGENE kinase/NEWGENE inhibitors/NNS herbimycin/NN A/DT and/CC PP1/GENE ./.
@@19927422608/CD We/PRP reviewed/VBD the/DT records/NNS of/IN 151/CD patients/NNS with/IN optic/JJ neuritis/NN examined/VBN over/RB an/DT eight-year/JJ period/NN ./.
@@18705002476/CD Contributions/NNS from/IN pairs/NNS of/IN source/NN and/CC target/NN volume/NN elements/NNS are/VBP summed/VBN for/IN the/DT S/NNP values/NNS between/IN the/DT tumor/NN and/CC itself/PRP ,/, between/IN the/DT remaining/JJ healthy/JJ host/NN organ/NN and/CC itself/PRP ,/, and/CC between/IN the/DT tumor/NN and/CC the/DT remaining/JJ healthy/JJ host/NN organ/NN ,/, with/IN the/DT reciprocity/NN theorem/NN assumed/VBN for/IN the/DT last/NN ./.
@@94789764821/CD Transfection/NNS studies/NNS also/RB showed/VBD that/IN 3'-deletion/GENE of/IN sequences/NNS downstream/RB of/IN the/DT transcriptional/JJ start/NN site/NN (/( +1/CD //CD +47/CD )/SYM markedly/RB reduced/VBN OSM/GENE -fold/CD induction/NN ./.
@@113954692036/CD Indeed/RB ,/, mutation/NN of/IN two/NN of/IN these/DT motifs/NNS ,/, known/VBP to/IN be/VB important/JJ to/IN regulation/NN of/IN sid1/GENE ,/, altered/VBD the/DT differential/JJ regulation/NN of/IN sid2/GENE by/IN iron/NN ./.
@@104685851094/CD Like/IN DNA/NN binding/JJ ,/, transcriptional/JJ enhancement/NN required/VBN amino-terminally/RB located/VBN basic/JJ amino/JJ acid/NN residues/NNS but/CC not/RB the/DT carboxyl-terminal/NN portion/NN of/IN Hap46/GENE known/VBP to/IN participate/VB in/IN hsp70/NEWGENE interaction/NN ./.
@@94683866050/CD Pet-1/GENE can/MD bind/VB specifically/RB to/IN a/DT PEA3/MULTIGENE ETS/MULTIGENE DNA-binding/MULTIGENE motif/MULTIGENE and/CC can/MD modulate/VB transcription/NN of/IN synthetic/JJ promoter/NN constructs/NNS in/IN a/DT sequence-specific/JJ manner/NN ./.
@@10601410426/CD In/NN conclusion/NN ,/, our/PRP data/NN do/NN not/RB support/VB a/DT role/NN for/IN IVIg/NNS in/IN the/DT remyelination/NN of/IN stable/JJ multiple/JJ sclerosis/NN lesions/NNS as/IN measured/VBN by/IN central/JJ conduction/NN time/NN ./.
@@48285875196/CD Isolation/NNS of/IN tha/NN avian/JJ reticuloendothelial/JJ virus/NN (/( strain/NN T/NN )/SYM ./SYM
@@76425381123/CD To/TO explore/VB the/DT mechanism/NN of/IN RSK/GENE activation/NN ,/, a/DT cloned/VBN human/MULTIGENE RSK/MULTIGENE cDNA/MULTIGENE (/( RSK3/GENE )/SYM was/VBD used/VBN to/IN generate/VB and/CC characterize/VB several/DT site-directed/MULTIGENE RSK/MULTIGENE mutants/MULTIGENE ;/: K91A/GENE (/( N-Lys/GENE ,/, NH2-terminal/MULTIGENE ATP-binding/MULTIGENE mutant/MULTIGENE )/SYM ,/, K444A/NNP (/( C-Lys/CONTEXTGENE ,/, COOH-terminal/MULTIGENE ATP-binding/MULTIGENE mutant/MULTIGENE )/SYM ,/, N/NNP //NNP C-Lys/NNP (/( double/JJ ATP-binding/MULTIGENE mutant/MULTIGENE )/SYM T570A/NNP (/( C-Thr/NNP ,/, mutant/NN of/IN the/DT putative/JJ MAPK/MULTIGENE phosphorylation/MULTIGENE site/MULTIGENE in/IN subdomain/MULTIGENE VIII/MULTIGENE of/IN the/DT C-domain/NN )/SYM ,/, S218A/NNP (/( N-Ser/NNP ,/, mutant/NN of/IN the/DT corresponding/JJ NH2-terminal/NN residue/NN )/SYM ./.
@@111131993379/CD Since/IN MEK/GENE acts/NNS as/IN a/DT cytoplasmic/MULTIGENE anchor/MULTIGENE for/IN the/DT ERKs/GENE ,/, the/DT lack/NN of/IN a/DT MEK/GENE interaction/NN resulted/VBN in/IN the/DT aberrant/JJ nuclear/JJ localization/NN of/IN ERK2-Delta19-25/MULTIGENE mutants/MULTIGENE in/IN serum-starved/JJ cells/NNS ./.
@@5417525538/CD When/WRB two/JJ determinations/NNS were/VBD performed/VBN on/IN 12/CD samples/NNS of/IN plasma/NN taken/VBP from/IN normal/JJ adults/NNS in/IN October/NN ,/, the/DT values/NNS were/VBD 22/CD ./CD 6/CD +/NN //NN -/NN 4/CD ./CD 8/CD and/CC 21/CD ./CD 0/CD +/NN //NN -/NN 3/CD ./CD 6/CD (/( mean/JJ +/NN //NN -/NN SD/NN )/SYM ng/NN //NN ml/NN ,/, respectively/RB ./.
@@70386843751/CD Based/VBN on/IN peptide/NN map/NEWGENE similarities/NNS ,/, partial/JJ amino-terminal/MULTIGENE sequence/MULTIGENE data/NN ,/, and/CC common/JJ genetic/JJ origin/NN ,/, it/PRP is/VBZ suggested/VBN that/IN p60/GENE and/CC p62/GENE have/VB identical/JJ amino/JJ acid/NN sequences/NNS carboxy-terminal/JJ to/IN the/DT p60/MULTIGENE initiator/MULTIGENE methionine/NN (/( residue/NN 21/CD of/IN p62/GENE )/SYM ./.
@@106468634721/CD Overexpression/NNS of/IN ICBP90/CD in/IN COS-1-transfected/CD cells/NNS induced/VBD an/DT enhanced/VBN expression/NN of/IN endogenous/JJ topoisomerase/MULTIGENE IIalpha/MULTIGENE ./.
@@10400032266/CD The/DT latter/JJ method/NN adds/VBZ clamping/NN of/IN the/DT inferior/JJ vena/NN cava/NN ,/, which/WDT results/VBZ in/IN hypotension/NN ,/, requiring/JJ invasive/JJ anesthetic/JJ management/NN ./.
@@76571622247/CD We/PRP conclude/VBP that/DT transcription/NN activation/NN by/IN LEF-1/GENE in/IN vitro/FW is/VBZ a/DT chromatin-dependent/JJ process/NN that/WDT requires/VBZ a/DT functional/JJ trans-activation/NN domain/NN in/IN addition/NN to/IN the/DT HMG/NN domain/NN ./.
@@79073283996/CD 313/CD ,/, 98-102/NN )/NN ./.
@@85744145842/CD These/DT primers/NNS yielded/VBD a/DT PCR/NN product/NN of/IN a/DT characteristic/JJ length/NN within/IN most/RB Xanthomonas/NNP species/NN and/CC pathovars/NNS tested/VBN ./.
@@90646592968/CD We/PRP have/VBP thus/RB identified/VBN the/DT first/JJ mammalian/JJ homolog/NN of/IN yeast/MULTIGENE UPF1/MULTIGENE ,/, a/DT protein/NN that/WDT regulates/VBZ levels/NNS of/IN nonsense/NN mRNA/NN ,/, and/CC we/PRP tentatively/RB name/VBP this/DT protein/MULTIGENE human/MULTIGENE HUPF1/MULTIGENE (/( for/IN human/JJ homolog/NN of/IN UPF1/GENE )/SYM ./.
@@75014588027/CD Of/IN the/DT three/CD known/VBP C/VBG //VBG EBP/VBG family/NN inhibitors/NNS ,/, Ig/GENE //GENE EBP/GENE ,/, LIP/GENE and/CC CHOP-10/GENE ,/, only/RB Ig/GENE //GENE EBP/GENE is/VBZ ubiquitously/RB expressed/VBN ./.
@@10391277574/CD BACKGROUND/IN :/: The/DT MAZE-III/NN is/VBZ the/DT surgical/JJ treatment/NN of/IN choice/JJ for/IN medically/RB refractory/JJ atrial/JJ fibrillation/NN ./.
@@37465084415/CD Failures/NNS of/IN colorimetric/JJ additivity/NN under/IN these/DT experimental/JJ conditions/NNS are/VBP discussed/VBN ./.
@@112204861222/CD 0%/NN )/NN and/CC IL-12/GENE (/( 42/CD ./CD 6%/CD vs/IN ./IN
@@116852846215/CD [/NN Diabetologia/NN (/( 2001/CD )/SYM 44/CD [/NN Suppl/NN 3/NN ]/NN :/: B/NNP 37-B/GENE 44/NN ]/NN
@@40507714726/CD The/DT Cox/NN proportional/JJ hazards/NNS model/NN was/VBD applied/VBN to/IN the/DT data/NN in/IN order/NN to/IN determine/VB the/DT prognostic/JJ factors/NNS for/IN long-term/JJ survival/NN ./.
@@77210747675/CD Atopic/NN dermatitis/NN is/VBZ an/DT "itch/NN which/WDT rashes/NNS and/CC not/RB a/DT rash/NN which/WDT itches"/VBP and/CC therefore/RB ,/, any/DT patient/NN treatment/NN program/NN should/MD address/VB the/DT multiplicity/NN of/IN potential/JJ trigger/NN factors/NNS that/WDT provoke/VBP this/DT itching/NN ./.
@@91449588375/CD This/DT protein/NN can/MD bind/NN to/IN a/DT region/NN of/IN the/DT promoter/NN of/IN an/DT Arabidopsis/NN light-harvesting/JJ chlorophyll/MULTIGENE a/MULTIGENE //MULTIGENE b/MULTIGENE protein/MULTIGENE gene/MULTIGENE ,/, Lhcb1*3/GENE ,/, which/WDT is/VBZ necessary/JJ for/IN its/PRP regulation/NN by/IN phytochrome/NN ./.
@@111606888518/CD The/DT metabolic/JJ events/NNS occurring/VBG at/IN or/CC near/IN that/DT structure/NN and/CC involving/VBG cyclin/MULTIGENE D3/MULTIGENE cause/VBG the/DT translocation/NN of/IN ICP0/NNS to/IN the/DT cytoplasm/NN ./.
@@76780519509/CD The/DT PDGFR/MULTIGENE mutants/MULTIGENE that/WDT failed/VBD to/IN associate/NN with/IN PLC/MULTIGENE gamma/MULTIGENE were/VBD not/RB able/JJ to/IN mediate/VB the/DT PDGF-dependent/NNP production/NN of/IN inositol/NN phosphates/NNS ./.
@@26672593338/CD There/EX were/VBD 3/CD //CD 32/CD (/( 9/CD ./CD 4/CD per/IN cent/NN )/SYM adverse/JJ reactions/NNS (/( ADRs/NNS )/SYM ,/, and/CC one/PRP case/NN each/DT of/IN nausea/NN ,/, dizziness/NN and/CC increased/VBN menstrual/JJ flow/NN ./.
@@102088654695/CD Moreover/RB ,/, when/CC added/VBD to/IN the/DT osteoclast/NN cultures/NNS ,/, mrIhh-N/JJ markedly/RB stimulated/VBN the/DT formation/NN of/IN resorption/NN pits/NNS on/IN dentine/NN slices/NNS ./.
@@99440669939/CD II/NNS ./NNS
@@78442017817/CD Sex/NN selection/NN via/NN albumin/NN columns/NNS :/: 20/CD years/NNS of/IN results/NNS ./.
@@85156192204/CD Tl-201/GENE uptake/NN ratio/NN of/IN the/DT right/JJ ventricle/NN ,/, which/WDT represents/VBZ the/DT ratio/NN of/IN total/JJ counts/NNS of/IN the/DT right/JJ ventricle/NN to/IN counts/NNS of/IN the/DT administered/VBN dose/NN of/IN Tl-201/GENE ,/, was/VBD higher/JJ in/IN COPD/NN ,/, especially/RB in/IN pulmonary/JJ emphysema/NN and/CC B/NNP type/NN COPD/NN by/IN Burrows/NNS classification/NN than/IN in/IN controls/NNS ./.
@@31381903854/CD Substantial/JJ amounts/NNS of/IN liposomal/JJ ampicillin/NN were/VBD recovered/VBN from/IN isolated/VBN Kupffer/NN cells/NNS ,/, the/DT target/NN cells/NNS of/IN L/NNP ./NNP monocytogenes/NNS after/IN intravenous/JJ inoculation/NN ./.
@@82656021212/CD Val--/NNP >/NNP Ala/NNP mutations/NNS selectively/RB alter/VBP helix-helix/JJ packing/NN in/IN the/DT transmembrane/JJ segment/NN of/IN phage/NN M13/GENE coat/NN protein/NN ./.
@@4537808049/CD The/DT preferential/JJ serum/JJ IgA/NEWGENE response/NN observed/VBN in/IN the/DT patient/NN population/NN suggests/VBZ that/IN bronchial/RB associated/VBN lymphoid/JJ tissue/NN in/IN the/DT diseased/JJ lung/NN is/VBZ an/DT important/JJ source/NN of/IN circulating/JJ IgA/NEWGENE ./.
@@77502172775/CD Indium-111/GENE OncoScint/NNP CR/GENE //GENE OV/GENE and/CC F-18/MULTIGENE FDG/MULTIGENE in/IN colorectal/JJ and/CC ovarian/JJ carcinoma/NN recurrences/NNS ./.
@@35434854213/CD Possible/JJ pathogenetic/JJ mechanisms/NNS of/IN hemopoietic/JJ changes/NNS in/IN response/NN to/IN space/NN flight/NN effects/NNS are/VBP described/VBN ./.
@@84289405522/CD One/CD such/JJ mutant/JJ also/RB affects/VBP the/DT overlapping/JJ -10/CD hexamer/NN of/IN PR/NNP and/CC results/NNS in/IN reduced/VBN occupancy/NN by/IN both/DT MerR/NN and/CC RNA/MULTIGENE polymerase/MULTIGENE ,/, likely/RB as/IN a/DT result/NN of/IN inefficient/JJ transcriptional/JJ initiation/NN of/IN merR/MULTIGENE mRNA/MULTIGENE ./.
@@1159741488/CD All/DT groups/NNS were/VBD tested/VBN in/IN a/DT Hebb-Williams/NNP maze/NN at/IN 100/CD approximately/RB 10/CD days/NNS of/IN age/NN ./.
@@69861682658/CD Complete/JJ sequences/NNS were/VBD obtained/VBN for/IN the/DT three/CD large/JJ thrombic/JJ peptides/NNS ,/, and/CC these/DT were/VBD aligned/VBN by/IN using/VBG peptides/NNS from/IN the/DT V8/MULTIGENE protease/MULTIGENE digest/NN ./.
@@83863191468/CD Mutation/NN of/IN the/DT presumptive/RB phosphorylated/VBN tyrosine/NN and/CC threonine/NN residues/NNS of/IN Mpk1p/GENE individually/RB to/IN phenylalanine/NN and/CC alanine/NN ,/, respectively/RB ,/, severely/RB impaired/VBN Mpk1p/GENE function/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@95733742880/CD Using/VBG Southern/NNP blot/NN analysis/NN and/CC restriction/NN mapping/NN of/IN genomic/JJ YAC/NN (/( yeast/NN artificial/JJ chromosome/NN )/SYM and/CC cosmid/NN clones/NNS ,/, we/PRP located/VBD the/DT human/JJ RIL/NN gene/NN 240-260/JJ kb/NN telomeric/JJ to/IN the/DT IRF1/MULTIGENE gene/MULTIGENE and/CC characterized/VBN its/PRP genomic/JJ structure/NN ./.
@@62913698174/CD In/NN 49/CD patients/NNS in/IN whom/WP gated/JJ equilibrium/NN ventriculography/NN and/CC cardiac/JJ catheterization/NN were/VBD performed/VBN within/IN a/DT 6/CD day/NN interval/NN ,/, total/JJ and/CC fractional/JJ portions/NNS of/IN global/JJ and/CC regional/JJ right/JJ ventricular/JJ ejection/NN fraction/NN (/( RVEF/NN )/SYM were/VBD correlated/VBN with/IN pulmonary/JJ arterial/JJ systolic/JJ pressure/NN ./.
@@70613501018/CD (/( 1980/CD )/SYM :/: Science/NNP 210/CD ,/, 77-72/NN )/NN that/IN stimulating/JJ the/DT crossed/JJ olivocochlear/JJ bundle/NN (/( COCB/GENE )/SYM can/MD change/VB the/DT magnitude/NN of/IN the/DT distortion/NN product/NN (/( f2-f1/GENE )/SYM in/IN the/DT ear-canal/JJ sound/NN pressure/NN ./.
@@117603981595/CD METHODS/IN :/: 302/CD consecutive/JJ patients/NNS with/IN BS/NN and/CC 438/CD patients/NNS with/IN other/DT rheumatological/JJ conditions/NNS were/VBD surveyed/VBN for/IN the/DT presence/NN or/CC absence/NN of/IN the/DT features/NNS of/IN BS/NN by/IN means/NN of/IN a/DT standard/JJ form/NN which/WDT had/VBP been/VBN prepared/VBN according/VBG to/IN ISG/NNS criteria/NNS ./.
@@12994899571/CD In/NN general/JJ ,/, however/RB ,/, this/DT study/NN provided/VBD little/JJ evidence/NN of/IN any/DT effect/NN of/IN supplementation/NN to/IN athletic/JJ performance/NN for/IN athletes/NNS consuming/JJ the/DT dietary/JJ RDIs/GENE ./.
@@105638362835/CD In/NN contrast/NN ,/, AP-2/GENE binding/JJ activity/NN was/VBD significantly/RB greater/JJR in/IN T47D/DT cells/NNS ,/, and/CC Western/JJ blots/NNS confirmed/VBN increased/VBN AP-2/MULTIGENE protein/MULTIGENE levels/NNS in/IN these/DT cells/NNS ./.
@@95291561920/CD Deletion/NNS of/IN the/DT last/JJ two/JJ Ser/NN residues/NNS ,/, including/JJ one/PRP PKC/NEWGENE consensus/NN site/NN in/IN the/DT receptor/NN tail/NN ,/, prevented/VBN only/JJ phorbol/NN 12-myristate/JJ 13-acetate-induced/JJ desensitization/NN by/IN 30%/CD ./.
@@94753789169/CD Competitive/JJ reverse/JJ transcription-polymerase/JJ chain/NN reaction/NN and/CC HPLC/NN analysis/NN showed/VBN that/IN RUSH-1alpha/GENE is/VBZ the/DT progesterone-dependent/JJ splice/NN variant/NN ./.
@@84603468432/CD This/DT was/VBD performed/VBN in/IN a/DT double/JJ blinded/JJ ,/, randomized/JJ ,/, placebo-controlled/JJ study/NN ./.
@@97049277554/CD E2F-6/GENE shares/VBP significant/JJ homology/NN with/IN E2Fs/NNP 1-5/CD ,/, especially/RB within/IN the/DT DNA/NN binding/JJ ,/, heterodimerization/NN and/CC marked/JJ box/MULTIGENE domains/MULTIGENE ./.
@@109079718463/CD Pharmacoeconomic/NN assessment/NN of/IN HMG-CoA/MULTIGENE reductase/MULTIGENE inhibitor/MULTIGENE therapy/NN :/: an/DT analysis/NN based/VBN on/IN the/DT CURVES/NNS study/NN ./.
@@78806501594/CD A/DT quantitative/JJ analysis/NN of/IN the/DT diffraction/NN intensity/NN as/IN function/NN of/IN the/DT accumulated/VBN electron/NN dose/NN suggests/VBZ the/DT possibility/NN of/IN recording/JJ up/NN to/IN 250/CD diffraction/NN patterns/NNS with/IN 3/CD ./CD 5/CD A/DT resolution/NN from/IN a/DT single/MULTIGENE crotoxin/MULTIGENE complex/MULTIGENE crystal/NN 128/CD A/DT thick/NN ./.
@@79371084482/CD Consequently/RB functional/JJ mRNAs/NNS can/MD be/VB produced/VBN by/IN endogenous/JJ RNA/NN polymerase/NEWGENE I/NNP ./NNP
@@80750708519/CD Essential/JJ features/NNS of/IN this/DT model/NN are/VBP bending/NN of/IN the/DT DNA/NN double/JJ helix/NN and/CC contact/NN of/IN operator/NN sites/NNS with/IN repressor/NN domains/NNS bearing/JJ sequence/NN homologies/NNS with/IN the/DT helix-turn-helix/NN (/( HTH/NNS )/SYM motifs/NNS of/IN other/DT DNA-binding/MULTIGENE proteins/MULTIGENE ./.
@@36669574330/CD Organisms/NNS were/VBD recovered/VBN from/IN the/DT conjunctiva/NN for/IN several/DT weeks/NNS ,/, and/CC persistent/JJ genital/JJ and/CC gastrointestinal/JJ infection/NN also/RB resulted/VBD from/IN the/DT ocular/JJ infection/NN in/IN some/DT cats/NNS ./.
@@34343476208/CD Mean/VB rCBF/GENE increased/VBN in/IN some/DT patients/NNS 4-8/JJ weeks/NNS after/IN surgery/NN on/IN the/DT ipsilateral/JJ side/NN ./.
@@76828422716/CD The/DT first/JJ exon/NN encodes/VBZ 66/CD bp/NN of/IN the/DT 5'-untranslated/JJ sequence/NN ,/, while/CC exon/NN 2/CD encodes/VBZ the/DT coding/JJ and/CC 3'-untranslated/JJ sequences/NNS ./.
@@34635371744/CD Clinical/NNP method/NN for/IN the/DT treatment/NN of/IN Class/MULTIGENE II/MULTIGENE occlusal/JJ anomalies/NNS with/IN open/JJ bite/NN ./.
@@105916338421/CD A/DT key/NN event/NN in/IN this/DT process/NN is/VBZ the/DT selective/JJ recognition/NN of/IN the/DT target/NN membrane/NN by/IN the/DT vesicle/NN and/CC the/DT current/JJ view/NN is/VBZ that/DT SNARE/MULTIGENE protein/MULTIGENE interactions/NNS likely/RB play/VBP a/DT central/JJ role/NN in/IN vesicle-target/JJ recognition/NN and/CC or/CC membrane/NN fusion/NN ./.
@@87579438042/CD This/DT site/NN acts/NNS as/IN a/DT negative/JJ element/NN when/CC transferred/VBN to/IN the/DT thymidine/MULTIGENE kinase/MULTIGENE promoter/MULTIGENE ,/, but/CC does/VBP not/RB confer/VB inducibility/NN ./.
@@10950415415/CD CONCLUSION/IN :/: Vitrectomy/GENE for/IN vitreous/JJ hemorrhage/NN in/IN Terson/NN syndrome/NN is/VBZ a/DT safe/JJ and/CC effective/JJ procedure/NN ,/, offering/VBG a/DT rapid/JJ and/CC prolonged/JJ improvement/NN in/IN vision/NN ./.
@@106878553864/CD Mouse/MULTIGENE growth/MULTIGENE hormone/MULTIGENE transcription/MULTIGENE factor/MULTIGENE Zn-16/MULTIGENE :/: unique/JJ bipartite/JJ structure/NN containing/JJ tandemly/RB repeated/JJ zinc/NN finger/NN domains/NNS not/RB reported/VBN in/IN rat/MULTIGENE Zn-15/MULTIGENE ./.
@@74634657354/CD Early/JJ infection/NN was/VBD detected/VBN in/IN one/PRP of/IN 50/CD control/NN women/NNS who/WP gave/VBD birth/NN to/IN a/DT healthy/JJ infant/NN ./.
@@14067032709/CD By/IN screening/JJ a/DT Y1/MULTIGENE cell/MULTIGENE cDNA/MULTIGENE library/NN with/IN the/DT DNA-binding/MULTIGENE region/MULTIGENE of/IN the/DT H-2RIIBP/MULTIGENE nuclear/MULTIGENE hormone/MULTIGENE receptor/MULTIGENE cDNA/MULTIGENE ,/, we/PRP isolated/VBD a/DT cDNA/NN that/WDT is/VBZ selectively/RB expressed/VBN in/IN steroidogenic/JJ cells/NNS ./.
@@74668317437/CD Pentachlorophenol/CHEM accelerates/VBZ the/DT onset/NN of/IN HCB/NN porphyria/NN ,/, in/IN other/DT words/NNS it/PRP increases/VBZ the/DT total/JJ urinary/MULTIGENE porphyrin/MULTIGENE excretion/NN and/CC causes/VBZ an/DT earlier/JJR disturbance/NN of/IN the/DT porphyrin/NN pattern/NN ./.
@@112080179840/CD A/DT cDNA/NN clone/NN encoding/VBG C2H2-type/MULTIGENE zinc/MULTIGENE finger/MULTIGENE protein/MULTIGENE ,/, SCOF-1/GENE ,/, was/VBD isolated/VBN from/IN soybean/NN ./.
@@63762276176/CD EGV/NN had/VBP no/DT detectable/JJ effect/NN on/IN PP/NN secretion/NN under/IN basal/JJ or/CC stimulated/VBN conditions/NNS ./.
@@15524579684/CD Intrapocket/NNP chemotherapy/NN in/IN adult/JJ periodontitis/NN using/VBG a/DT new/JJ controlled-release/NN insert/NN containing/MULTIGENE ofloxacin/MULTIGENE (/( PT-01/GENE )/SYM ./.
@@106946051738/CD Linearized/JJ overall/JJ infection/NN rates/NNS (/( events/GENE //GENE 100/GENE patient-days/NNS )/SYM were/VBD 2/CD ./CD 05/CD +/NN //NN -/NN 0/CD ./CD 33/CD (/( heart-lung/NN )/SYM and/CC 2/CD ./CD 34/CD +/NN //NN -/NN 0/CD ./CD 34/CD (/( double-lung/JJ ;/: P/NN =/SYM NS/NNP )/SYM at/IN 3/CD months/NNS ./.
@@116055988805/CD Hepatitis/MULTIGENE B/MULTIGENE and/CC C/NN seroprevalence/NN rates/NNS among/IN high-risk/JJ adolescents/NNS are/VBP lower/JJR in/IN El/NNP Paso/NNP than/IN in/IN other/DT similar/JJ US/NN populations/NNS ,/, presenting/VBG an/DT ideal/JJ climate/NN for/IN prevention/NN programs/NNS ./.
@@105422814784/CD The/DT results/NNS suggest/VBP that/IN the/DT presence/NN or/CC absence/NN per/IN se/FW of/IN keratan/NN sulfate/NN on/IN native/JJ G1-G2/GENE does/VBP not/RB affect/VB the/DT activity/NN of/IN atrolysin/MULTIGENE C/MULTIGENE toward/IN the/DT two/JJ sites/NNS ./.
@@73868647226/CD Charcoal-facilitated/JJ dialysis/NN ./.
@@14525849269/CD Pseudomonas/NNS aeruginosa/NN exotoxin/MULTIGENE A/MULTIGENE :/: its/PRP role/NN in/IN retardation/NN of/IN wound/JJ healing/NN :/: the/DT 1992/CD Lindberg/NNP Award/NNP ./.
@@35313174205/CD This/DT means/NN that/IN the/DT loss/NN of/IN recessives/NNS must/MD be/VB calculated/VBN by/IN using/VBG a/DT hypergeometric/JJ and/CC not/RB a/DT binomial/JJ model/NN as/IN Fisher/NN did/VBD ./.
@@105615462412/CD We/PRP have/VBP cloned/VBN a/DT novel/JJ 100-kDa/JJ mammalian/JJ protein/NN ,/, which/WDT was/VBD recognized/VBN by/IN an/DT anti-peptide/NN antibody/NN against/IN an/DT epitope-containing/JJ nuclear/JJ localization/NN signal/NN of/IN NF-kappaB/MULTIGENE p65/MULTIGENE subunit/MULTIGENE ./.
@@7813466445/CD The/DT U14/MULTIGENE genes/MULTIGENE of/RB mouse/NN as/RB well/VB as/IN rat/NN ,/, hamster/NN ,/, human/JJ ,/, Xenopus/NN and/CC trout/NN are/VBP encoded/VBN within/IN introns/NNS of/IN the/DT constitutively/RB expressed/VBN 70-kDa-cognate-heat-shock/MULTIGENE protein/MULTIGENE gene/MULTIGENE (/( hsc70/GENE )/SYM ./.
@@22422222884/CD Presidential/JJ address/NN 1990--coming/NN in/IN from/IN the/DT cold/NN ./.
@@92094063304/CD However/RB ,/, we/PRP could/MD not/RB find/VB the/DT homologous/JJ regions/NNS with/IN guanine/MULTIGENE nucleotide/MULTIGENE exchange/MULTIGENE factors/MULTIGENE or/CC GTPase-activating/NEWGENE proteins/NEWGENE in/IN the/DT c-cbl/GENE gene/NN ./.
@@10224758164/CD The/DT control/NN group/NN included/VBN 8/CD afterbirth/NN samples/NNS from/IN physiological/JJ full-term/JJ pregnancies/NNS ./.
@@77937832408/CD Scalp/NN flaps/NN can/MD be/VB expanded/JJ just/RB to/IN the/DT point/NN of/IN becoming/VBG noticeable/JJ over/RB 4/CD to/IN 6/CD weeks/NNS followed/VBN by/IN scalp/NN flap/NN transposition/NN and/CC easy/JJ closure/NN of/IN the/DT donor/NN site/NN ./.
@@25470793196/CD The/DT negative/JJ calcium/NN balance/NN with/IN hyperparathyroidemia/NN occurred/VBN after/IN continuous/JJ oral/JJ administration/NN of/IN Cd/NN and/CC developed/VBN via/NN increased/VBD urinary/JJ excretion/NN of/IN calcium/NN ./.
@@80772368042/CD Wild/NNP type/NN and/CC mutant/MULTIGENE Epo/MULTIGENE cDNAs/MULTIGENE were/VBD transiently/RB expressed/VBN at/IN high/JJ levels/NNS in/IN COS1/GENE and/CC COS7/GENE cells/NNS ./.
@@100261465467/CD The/DT inhibition/NN by/IN the/DT RIalpha/GENE subunit/NN is/VBZ reversed/VBN by/IN addition/NN of/IN nanomolar/JJ concentrations/NNS of/IN cAMP/NN (/( Ka/NN =/SYM 40/CD nM/NN )/SYM ,/, thus/RB demonstrating/VBG that/IN PrKX/GENE is/VBZ a/DT novel/NN ,/, type/MULTIGENE I/MULTIGENE cAMP-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE that/WDT is/VBZ activated/VBN at/IN lower/JJR cAMP/NN concentrations/NNS than/IN the/DT holoenzyme/NN with/IN the/DT Calpha/NNS subunit/NN of/IN cAMP-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE ./.
@@88905376384/CD This/DT technique/NN was/VBD employed/VBN in/IN 12/CD patients/NNS with/IN a/DT unicameral/JJ bone/NN cyst/NN ./.
@@106395851086/CD Studies/NNS of/IN MPO/MULTIGENE gene/MULTIGENE regulation/NN can/MD help/VB to/IN elucidate/VB the/DT mechanism/NN of/IN normal/JJ and/CC abnormal/JJ myeloid/JJ differentiation/NN ./.
@@67946662248/CD The/DT sympathetic/JJ neuroeffector/NN influence/NN on/IN the/DT myocardium/NN with/IN ATCI/GENE depends/VBZ to/IN a/DT large/JJ measure/NN on/IN the/DT intensity/NN of/IN the/DT neurotransmitter/NN biosynthesis/NN and/CC function/NN of/IN cardiomyocyte/MULTIGENE adrenoreceptors/MULTIGENE ./.
@@76103247515/CD Oncological/JJ ,/, clinical/JJ and/CC psychological/JJ aspects/NNS are/VBP evaluated/VBN according/VBG to/IN experience/NN accumulated/VBN in/IN recent/JJ years/NNS ,/, with/IN immediate/JJ and/CC delayed/JJ reconstruction/NN ,/, carried/VBD out/RB in/IN the/DT most/RB diverse/JJ specialized/JJ centers/NNS ./.
@@110297009022/CD Moreover/RB ,/, an/DT in/NN vitro/FW pull-down/JJ assay/NN showed/VBN that/IN Os/NNS ;/: CycH/NN ;/: 1/CD specifically/RB bound/JJ to/IN R2/GENE but/CC not/RB to/IN other/DT rice/NN CDKs/GENE ./.
@@103312769709/CD All/DT of/IN the/DT elements/NNS exhibited/VBD a/DT uniform/JJ structure/NN ./.
@@26474038738/CD Vivid/MULTIGENE visual/MULTIGENE hallucinations/NNS without/IN other/DT psychopathology/NN have/NN been/VBN reported/VBN for/IN several/DT hundred/JJ years/NNS ./.
@@91974085839/CD Sequencing/NN of/IN the/DT facB/MULTIGENE gene/MULTIGENE revealed/VBN that/IN it/PRP encodes/VBZ a/DT protein/NN that/WDT contains/VBZ an/DT N-terminal/NN GAL4-like/NNP Zn/NN (/NN II/NN )/NN 2Cys6/NN (/( or/CC C6/NN zinc/NN )/SYM binuclear/JJ cluster/NN for/IN DNA/NN binding/JJ ,/, leucine/MULTIGENE zipper-like/MULTIGENE heptad/NN repeat/NN motifs/NNS and/CC central/NN and/CC C-terminal/MULTIGENE acidic/MULTIGENE alpha-helical/MULTIGENE regions/MULTIGENE ,/, consistent/JJ with/IN a/DT function/NN as/IN a/DT DNA-binding/MULTIGENE transcriptional/MULTIGENE activator/MULTIGENE ./.
@@81259491126/CD The/DT previously/RB described/VBN enhanced/VBN translation/NN of/IN spinach/NN L12/MULTIGENE mRNA/MULTIGENE from/IN its/PRP two/JJ tandem/NN AUG/NNS codons/NNS and/CC the/DT two/JJ functional/JJ rpl12/MULTIGENE genes/MULTIGENE in/IN Arabidopsis/NN probably/RB provide/VB two/JJ mechanisms/NNS for/IN generating/JJ the/DT four/CD copies/NNS of/IN L12/NNP //NNP chloroplast/NNP ribosome/NN ,/, qualitatively/RB different/JJ from/IN those/DT attempted/VBN in/IN eubacteria/NNS ./.
@@113567166322/CD An/DT 18-kb/JJ genomic/JJ clone/NN including/JJ sequences/NNS encoding/VBG for/IN the/DT two/JJ GHS-R/MULTIGENE variants/MULTIGENE was/VBD isolated/VBN ./.
@@16344646115/CD We/PRP report/VBP a/DT patient/JJ developing/JJ factor/MULTIGENE VII/MULTIGENE inhibitor/MULTIGENE possibly/RB as/IN a/DT reaction/NN to/IN penicillin/NN administration/NN ;/: it/PRP gave/VBD rise/NN to/IN fatal/JJ haemorrhage/NN ./.
@@93717312084/CD Both/DT inserts/NNS are/VBP larger/JJR than/IN their/PRP homologues/NNS in/IN eIF-2alpha/MULTIGENE kinases/MULTIGENE ./.
@@16953224239/CD Wnt-1/GENE (/( int-1/GENE )/SYM is/VBZ a/DT cellular/JJ oncogene/NN often/RB activated/VBN by/IN insertion/NN of/IN proviral/JJ DNA/NN of/IN the/DT mouse/NN mammary/JJ tumor/NN virus/NN ./.
@@65715876337/CD Effects/NNPS of/IN ketamine/NN on/IN the/DT circulatory/JJ functions/NNS and/CC body/NN tissue/NN oxygenation/NN in/IN dogs/NNS under/IN normal/JJ and/CC hypovolemic/JJ conditions/NNS ./.
@@99271932732/CD To/TO date/VB ,/, two/JJ such/JJ proteins/NNS ,/, PLZF/GENE and/CC LAZ-3/GENE //GENE BCL-6/GENE ,/, have/VB been/VBN implicated/VBN in/IN oncogenesis/NN ./.
@@86216643515/CD Polymerization/NN of/IN neurofilament/MULTIGENE L/MULTIGENE protein/MULTIGENE in/IN vitro/FW was/VBD inhibited/VBN by/IN phosphorylation/NN of/IN neurofilament/MULTIGENE L/MULTIGENE protein/MULTIGENE by/IN PKN/GENE ./.
@@77670117518/CD Repair/NNS of/IN this/DT insertion/NN by/IN homologous/JJ recombination/NN restores/VBZ the/DT activity/NN of/IN the/DT hprt/MULTIGENE locus/MULTIGENE ,/, thus/RB confirming/VBG the/DT site/NN of/IN mutation/NN ./.
@@84216877661/CD Ten/CD selenocysteine/NN residues/NNS (/( deduced/VBN )/SYM are/VBP present/VB ./.
@@95364407255/CD Recent/JJ studies/NNS have/VBP revealed/VBN unconventional/JJ myosin/MULTIGENE V/MULTIGENE to/IN be/VB an/DT important/JJ actin-based/JJ molecular/JJ motor/RB involved/VBN in/IN vesicular/JJ movement/NN ./.
@@75255968648/CD When/WRB expressed/VBN in/IN and/CC purified/VBN from/IN Escherichia/NN coli/JJ ,/, both/DT full-length/JJ Fpr3/GENE and/CC its/PRP isolated/VBN COOH-terminal/NN domain/NN exhibit/NN readily/RB detectable/JJ PPIase/NN activity/NN ./.
@@6234369123/CD Hepatitis-B/GENE vaccination/NN in/IN the/DT elderly/NN ./.
@@11946731847/CD No/DT evidence/NN of/IN either/DT positive/JJ or/CC negative/JJ chemography/NN was/VBD found/VBN ./.
@@74579317346/CD A/DT third/JJ series/NN of/IN mice/NNS were/VBD given/VBP a/DT single/JJ injection/NN of/IN 5-OH-DA/JJ ,/, sacrificed/VBN ,/, and/CC prepared/VBD for/IN ultrastructural/JJ study/NN ./.
@@20680854404/CD We/PRP also/RB present/VBP evidence/NN for/IN a/DT negative/JJ regulatory/JJ element/NN in/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT Mlu/NN I/MULTIGENE upstream/MULTIGENE activation/MULTIGENE sequence/MULTIGENE ./.
@@89033397737/CD This/DT is/VBZ the/DT first/JJ determination/NN of/IN the/DT complete/JJ secondary/JJ structure/NN of/IN an/DT RNA/NN spliced/VBN in/IN a/DT spliceosome/NN ./.
@@22955212952/CD No/DT causal/JJ relations/NNS may/MD be/VB inferred/VBN from/IN the/DT correlation/NN between/IN the/DT level/NN of/IN trapezius/NN activity/NN and/CC complaints/NNS ,/, though/CC it/PRP indicates/VBZ that/IN individual/JJ ,/, inexpedient/JJ muscle/NN activity/NN patterns/NNS may/MD constitute/VB an/DT important/JJ risk/NN factor/NN for/IN development/NN of/IN musculo-skeletal/JJ complaints/NNS ./.
@@89805338760/CD Finally/RB ,/, the/DT C-terminal/MULTIGENE region/MULTIGENE of/IN ENBP1/GENE shows/VBZ strong/JJ homology/NN to/IN a/DT protein/NN from/IN rat/NN that/WDT is/VBZ specifically/RB expressed/VBN in/IN testis/NN tissue/NN ./.
@@117371584400/CD Modality-specific/NNP areas/NNS (/( e/FW ./FW g/FW ./FW ,/, right/JJ Wernicke/NN ,/, left/NN fusiform/JJ gyrus/NN ,/, Broca/NN BA44/GENE ,/, supramarginal/JJ gyrus/NN )/SYM ,/, appear/VB to/IN cope/NN with/IN the/DT computations/NNS relevant/JJ to/IN making/VBG contact/NN with/IN these/DT more/RB abstract/JJ dimensions/NNS ./.
@@7491791421/CD The/DT promoter/NN mutation/NN is/VBZ complemented/VBN in/IN trans/JJ by/IN E1A/MULTIGENE products/MULTIGENE of/IN the/DT heterologous/JJ helper/NN adenovirus/NN type/NN 5/CD (/( Ad5/DT )/SYM ./.
@@105644798161/CD Deletion/NNS of/IN fdsR/NN revealed/VBD a/DT dual/JJ regulatory/JJ effect/NN of/IN FdsR/GENE on/IN the/DT fds/MULTIGENE operon/MULTIGENE by/RB acting/JJ as/IN transcriptional/JJ activator/NN in/IN the/DT presence/NN of/IN formate/NN or/CC as/IN repressor/NN in/IN the/DT absence/NN of/IN formate/NN ./.
@@86977288677/CD The/DT predictive/JJ value/NN of/IN a/DT positive/JJ flag/NN was/VBD 77/CD ./CD 7%/CD ./.
@@22831482933/CD Significance/NN of/IN cytokine/NN production/NN and/CC adhesion/NN molecules/NNS in/IN malarial/JJ immunopathology/NN ./.
@@92774729235/CD Myocardial/JJ interstitial/JJ edema/NN is/VBZ more/RB likely/RB a/DT potential/JJ mechanism/NN of/IN diastolic/JJ dysfunction/NN after/IN DC/JJ shocks/NNS ./.
@@105487221683/CD All/DT loci/NNS have/NN a/DT similar/JJ organization/NN ,/, except/VB for/IN H1/NNP ./NNP 8/NNP that/WDT harbors/VBP two/JJ TcP2beta/MULTIGENE genes/MULTIGENE arranged/VBN in/IN tandem/NN and/CC separated/VBN by/IN a/DT short/JJ repetitive/JJ sequence/NN ,/, named/VBN SIRE/NNP (/( short/JJ interspersed/JJ repetitive/JJ element/NN )/SYM ,/, which/WDT is/VBZ also/RB found/VB upstream/RB of/IN the/DT first/JJ gene/NN of/IN the/DT tandem/NN and/CC downstream/RB of/IN the/DT second/NN ./.
@@25902783234/CD 5/CD ./CD
@@106138166687/CD Statins/GENE :/: lower/JJR lipids/NNS and/CC better/JJR bones/NNS ?/. Although/IN statins/NNS are/VBP widely/RB used/VBN as/IN cholesterol-lowering/JJ drugs/NNS ,/, a/DT recent/JJ study/NN suggests/VBZ that/IN these/DT compounds/NNS have/NN anabolic/JJ effects/NNS on/IN bone/NN and/CC could/MD be/VB developed/VBN into/IN new/JJ treatments/NNS for/IN common/JJ metabolic/JJ bone/NN diseases/NNS such/JJ as/IN osteoporosis/NN
@@103645237547/CD Campomelic/NNP dysplasia/MULTIGENE translocation/MULTIGENE breakpoints/NNS are/VBP scattered/JJ over/RB 1/CD Mb/NN proximal/JJ to/IN SOX9/NEWGENE :/: evidence/NN for/IN an/DT extended/VBN control/NN region/NN ./.
@@113245164228/CD It/PRP was/VBD found/VBN that/IN intrathecal/JJ administration/NN (/( i/CD ./CD t/CD ./CD )/SYM of/IN D2/NN receptor/NN agonist/NN LY171555/NN or/CC D1/NN //NN D2/NN receptor/NN agonist/NN apomorphine/NN increased/VBD pain/NN threshold/NN and/CC had/VBP a/DT potentiating/JJ effect/NN on/IN AA/NNS ./NNS
@@76185487530/CD The/DT Babcock/NNP Surgical/NNP Clinic/NNP ./.
@@74013181426/CD However/RB ,/, at/IN lower/JJR temperature/NN the/DT positive/JJ staircase/NN was/VBD not/RB clear/JJ and/CC rather/RB negative/JJ staircase/NN appeared/VBN (/( 1--3/GENE Hz/NN )/SYM ./.
@@79272677900/CD Internal/NNP biliary/JJ drainage/NN ,/, unlike/IN external/NN drainage/NN ,/, does/VBP not/RB suppress/VB the/DT regeneration/NN of/IN cholestatic/JJ rat/NN liver/NN after/IN partial/JJ hepatectomy/NN ./.
@@106372309541/CD Induced/JJ expression/NN of/IN c-myc/NN is/VBZ likely/RB to/IN contribute/VB to/IN the/DT proliferation/NN of/IN Stat1-null/NNP cells/NNS in/IN response/NN to/IN IFNs/NNS ./.
@@98920174541/CD Further/JJ experiments/NNS will/MD be/VB required/VBN to/IN highlight/NN the/DT in/NN vivo/NN role/NN of/IN ELE1/GENE in/IN nuclear/JJ receptor/NN functioning/NN ./.
@@32191076268/CD The/DT incidence/NN of/IN early/JJ neonatal/JJ convulsions/NNS for/IN inborn/JJ babies/NNS was/VBD 3/GENE ./GENE 0/GENE //GENE 1000/GENE live/VB births/NNS ./.
@@77318989654/CD In/NN vitro/FW studies/NNS with/IN blood/NN cells/NNS incubated/VBN with/IN acetate/NN or/CC bicarbonate/NN ions/NNS in/IN concentrations/NNS ,/, which/WDT are/VBP observed/VBN in/IN vivo/NN during/IN hemodialysis/NN ,/, suggest/VB that/IN probably/RB these/DT ions/NNS do/NN not/RB directly/RB affect/VB superoxide/NN anions/NNS generation/NN ,/, erythrocyte/MULTIGENE SOD-1/MULTIGENE and/CC catalase/NN activities/NNS and/CC erythrocyte/NN membrane/NN lipid/NN peroxidation/NN ./.
@@113096779719/CD A/DT comprehensive/JJ neuropsychological/JJ battery/NN was/VBD administered/VBN to/IN 48/CD veterans/NNS with/IN Gulf/NNP War/NNP Illness/NNS (/( GWI/NNP )/SYM characterized/VBN by/IN severe/JJ fatigue/NN (/( GV-F/GENE )/SYM and/CC 39/CD healthy/JJ veterans/NNS (/( GV-H/NNP )/SYM ./.
@@24000703062/CD Comparison/NNS of/IN propofol/NN and/CC thiopentone/NN as/IN anaesthetic/JJ agents/NNS for/IN electroconvulsive/JJ therapy/NN ./.
@@31502963857/CD It/PRP is/VBZ suggested/VBN that/IN the/DT use/NN of/IN endogenous/JJ creatinine/NN clearance/NN to/IN estimate/NN the/DT glomerular/JJ filtration/NN rate/NN (/( GFR/NN )/SYM requires/VBZ caution/NN and/CC the/DT recognition/NN of/IN the/DT limitations/NNS of/IN the/DT method/NN ,/, and/CC that/IN simpler/JJR techniques/NNS (/( serum/JJ creatinine/NN or/CC estimated/VBN endogenous/JJ creatinine/NN clearance/NN )/SYM are/VBP preferable/JJ in/IN routine/JJ practice/NN ./.
@@9243587736/CD PURPOSE/NNS //NNS OBJECTIVES/NNS :/: To/TO examine/VB the/DT question/NN of/IN whether/IN an/DT early/JJ first/JJ full-term/JJ pregnancy/NN (/( FFTP/NN )/SYM protects/VBZ against/IN breast/NN cancer/NN and/CC whether/IN interruption/NN of/IN the/DT pregnancy/NN with/IN an/DT induced/VBN abortion/NN increases/NNS breast/NN cancer/NN risk/NN ./.
@@115115445341/CD The/DT loop/NN domain/NN of/IN heat/MULTIGENE shock/MULTIGENE transcription/MULTIGENE factor/MULTIGENE 1/MULTIGENE dictates/VBP DNA-binding/VBG specificity/NN and/CC responses/NNS to/IN heat/NN stress/NN ./.
@@75593565382/CD The/DT hypBFCDE/MULTIGENE operon/MULTIGENE from/IN Rhizobium/NN leguminosarum/NN biovar/NN viciae/NNS is/VBZ expressed/VBN from/IN an/DT Fnr-type/MULTIGENE promoter/MULTIGENE that/IN escapes/NNS mutagenesis/NN of/IN the/DT fnrN/MULTIGENE gene/MULTIGENE ./.
@@110272941247/CD This/DT interaction/NN inhibits/VBZ the/DT histone/MULTIGENE acetyltransferase/MULTIGENE activity/NN of/IN p300/GENE ,/, resulting/VBG in/IN drastic/JJ reduction/NN of/IN nucleosomal/JJ histone/NN acetylation/NN and/CC alteration/NN of/IN chromatin/NN structure/NN ./.
@@91110595850/CD Unlike/IN the/DT MAR-binding/JJ domain/NN ,/, the/DT homeodomain/JJ when/CC isolated/VBN binds/VBZ poorly/RB and/CC with/IN low/JJ specificity/NN to/IN DNA/NN ./.
@@113845761235/CD In/NN addition/NN ,/, severe/JJ vision/NN loss/NN can/MD be/VB seen/VBP with/IN interferon/NN alfa-2b-associated/JJ retinopathy/NN ./.
@@92638569450/CD Here/RB ,/, we/PRP report/VBP theoretical/JJ models/NNS for/IN the/DT Gla/NN and/CC EGF-1/GENE modules/NNS of/IN human/MULTIGENE PS/MULTIGENE constructed/VBN using/VBG prothrombin/NN and/CC factor/MULTIGENE X/MULTIGENE experimental/JJ structures/NNS ./.
@@19250922548/CD Previous/JJ investigators/NNS have/VBP suggested/VBN that/IN subretinal/JJ blood/NN damages/VBZ the/DT retina/NN in/IN part/NN because/IN of/IN its/PRP solid/JJ fibrin/NN meshwork/NN ./.
@@110500846375/CD High/NNP expression/NN of/IN the/DT peroxisome/MULTIGENE proliferator-activated/MULTIGENE receptor/MULTIGENE alpha/MULTIGENE (/( PPARalpha/CONTEXTGENE )/SYM differentiates/VBZ brown/JJ fat/NN from/IN white/JJ ,/, and/CC is/VBZ related/VBN to/IN its/PRP high/JJ capacity/NN of/IN lipid/NN oxidation/NN ./.
@@98521093914/CD In/NN vitro/FW translation/NN and/CC in/IN vivo/NN polysome/NN profile/NN analysis/NN indicated/VBN that/IN transcripts/MULTIGENE C/MULTIGENE and/CC E/NN were/VBD translated/VBN with/IN similar/JJ translational/JJ efficiencies/NNS that/WDT are/VBP substantially/RB greater/JJR than/IN that/DT of/IN transcript/MULTIGENE D/MULTIGENE ,/, suggesting/VBG that/IN 5'-untranslated/JJ regions/NNS play/VBP a/DT role/NN in/IN translational/JJ control/NN ./.
@@76780066826/CD RNase/NN protection/NN analyses/NNS indicate/VBP that/IN either/DT 61-kDa/MULTIGENE CaM/MULTIGENE PDE/MULTIGENE mRNA/MULTIGENE or/CC structurally/RB related/VBN transcripts/NNS encoding/VBG different/JJ CaM/MULTIGENE PDE/MULTIGENE isoforms/MULTIGENE are/VBP expressed/VBN in/IN a/DT tissue-specific/JJ manner/NN ./.
@@23484083001/CD Attitudes/NNS were/VBD found/VBN to/IN be/VB multidimensional/JJ ,/, with/IN similar/JJ dimensions/NNS being/VBP identified/VBN in/IN both/DT samples/NNS ./.
@@31599035099/CD The/DT 5'/CD end/NN of/IN the/DT coding/JJ region/NN was/VBD located/VBN precisely/RB by/IN comparing/VBG the/DT deduced/VBN amino/JJ acid/NN sequence/NN to/IN the/DT actual/JJ N-terminal/NN amino/JJ acid/NN sequence/NN of/IN IHF/NN ./.
@@99336413945/CD The/DT missing/JJ 5'/CD sequences/NNS were/VBD obtained/VBN by/IN 5'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS and/CC by/IN analysis/NN of/IN an/DT NHE5/GENE genomic/JJ clone/NN ,/, and/CC the/DT missing/JJ 3'/CD sequences/NNS were/VBD obtained/VBN by/IN 3'-rapid/JJ amplification/NN of/IN cDNA/NN ends/NNS ./.
@@98641415424/CD We/PRP showed/VBD that/IN Stat3/GENE and/CC Stat3beta/GENE were/VBD affinity/NN purified/VBN using/VBG phosphopeptides/MULTIGENE containing/MULTIGENE Y704/MULTIGENE and/CC Y744/GENE but/CC not/RB by/IN nonphosphorylated/JJ peptide/NN analogues/NNS or/CC by/IN phosphopeptides/MULTIGENE containing/MULTIGENE Y729/MULTIGENE and/CC Y764/GENE ./.
@@27610083458/CD Brain/NN cholinesterase/NN activity/NN of/IN nestling/JJ great/JJ egrets/NNS ,/, snowy/JJ egrets/NNS and/CC black-crowned/JJ night-herons/NNS ./. inhibition/NN of/IN brain/NN cholinesterase/NN (/( ChE/NN )/SYM activity/NN in/IN birds/NNS is/VBZ often/RB used/VBN to/IN diagnose/VB exposure/NN or/CC death/NN from/IN organophosphorus/NN or/CC carbamate/NN pesticides/NNS ./.
@@29877773709/CD Three/CD cases/NNS of/IN primary/JJ signet-ring/NN cell/NN carcinoma/NN of/IN the/DT rectum/NN are/VBP described/VBN ./.
@@84290197405/CD Furthermore/RB ,/, competitor/NN containing/JJ the/DT YY1/GENE consensus/NN sequence/NN competed/VBN for/IN protein/MULTIGENE B/MULTIGENE binding/JJ ,/, whereas/IN competitor/NN containing/JJ a/DT perfect/JJ yeast/MULTIGENE ABF-1/MULTIGENE consensus/NN sequence/NN did/VBD not/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@109185722469/CD VaI/NN and/CC VaII/GENE co-immunoprecipitated/JJ with/IN ErbB2/GENE ,/, but/CC not/RB with/IN ErbB1/GENE ,/, ErbB3/GENE ,/, or/CC ErbB4/GENE ./.
@@20089822619/CD ELISA/NN was/VBD found/VBN to/IN make/NN a/DT contribution/NN to/IN the/DT diagnosis/NN of/IN tuberculosis/NN similar/JJ to/IN that/DT of/IN sputum/NN smear/NN ./.
@@24235338644/CD The/DT levels/NNS of/IN both/DT MAP1-specific/NNP and/CC MAP2-specific/MULTIGENE mRNAs/MULTIGENE decline/NN in/IN the/DT postnatal/JJ developing/JJ brain/NN ;/: the/DT level/NN of/IN MAP1-specific/MULTIGENE mRNA/MULTIGENE also/RB increases/VBZ slightly/RB in/IN rat/NN PC12/NNP cells/NNS upon/IN exposure/NN to/IN nerve/MULTIGENE growth/MULTIGENE factor/MULTIGENE ./.
@@38302554509/CD This/DT is/VBZ based/VBN on/IN partitioning/VBG an/DT underlying/JJ multivariate/JJ normal/JJ distribution/NN ./.
@@17482872138/CD Human/MULTIGENE SRF-related/MULTIGENE proteins/MULTIGENE :/: DNA-binding/NN properties/NNS and/CC potential/JJ regulatory/JJ targets/NNS ./.
@@23241021179/CD Comparison/NNS of/IN transmembrane/JJ and/CC cytoplasmic/JJ domains/NNS to/IN a/DT third/JJ cell-surface/NN proteoglycan/NN ,/, 48K5/GENE from/IN human/JJ lung/NN fibroblasts/NNS (/( Marynen/NNP ,/, P/NNP ./NNP ,/, Zhang/NNP ,/, J/NNP ./NNP ,/, Cassiman/NNP ,/, J/NNP ./NNP ,/, Vanden/NNP Berghe/NNP ,/, H/NNP ./NNP ,/, and/CC David/NN ,/, C/NNP ./NNP
@@18500962761/CD Heterodimers/NNS of/IN myogenin/NN and/CC E12/GENE (/( or/CC MyoD/IN and/CC E12/GENE )/SYM specifically/RB bound/VBD a/DT restriction/NN fragment/NN extending/VBG from/IN -200/CD to/IN -103/NN relative/JJ to/IN the/DT start/NN of/IN cardiac/MULTIGENE alpha-actin/MULTIGENE transcription/NN ./.
@@21748611906/CD Regulation/NN of/IN irgA/NN by/IN iron/NN in/IN V/NNP ./NNP cholerae/NNS occurs/VBZ at/IN the/DT transcriptional/JJ level/NN ,/, and/CC there/RB is/VBZ an/DT interrupted/VBN dyad/NN symmetric/JJ sequence/NN in/IN the/DT vicinity/NN of/IN the/DT promoter/NN that/WDT is/VBZ homologous/JJ to/IN Fur/MULTIGENE binding/MULTIGENE sites/MULTIGENE of/IN E/NNP ./NNP coli/JJ ./.
@@24760303132/CD To/TO study/VB the/DT retinal/JJ surface/NN in/IN the/DT human/JJ eye/NN in/IN normal/JJ and/CC diseased/JJ states/NNS we/PRP used/VBD laser/VBP scanning/JJ tomography/NN ./.
@@113256851174/CD Intravenous/JJ L-carnitine/NNS treatment/NN increased/VBD plasma/NN carnitine/NN concentrations/NNS ,/, improved/VBN patient-assessed/JJ fatigue/NN ,/, and/CC may/MD prevent/VB the/DT decline/NN in/IN peak/NN exercise/NN capacity/NN in/IN hemodialysis/NN patients/NNS ./.
@@98050529773/CD Dose/NNS of/IN 20/CD ig/NN were/VBD administered/VBN within/IN a/DT scheme/NN from/IN 0/CD ./CD 1/CD to/IN 6/CD months/NNS in/IN order/NN to/IN study/NN its/PRP immunogenicity/NN ,/, which/WDT was/VBD evaluated/VBN at/IN 2/CD ,/, 7/CD ,/, and/CC 12/CD months/NNS after/IN the/DT first/JJ dose/NN ./.
@@7666538269/CD Initiation/NN of/IN translation/NN of/IN the/DT human/MULTIGENE hepatitis/MULTIGENE C/MULTIGENE virus/NN (/( HCV/NN )/SYM RNA/NN genome/NN occurs/VBZ by/IN internal/JJ ribosome/NN entry/NN into/IN the/DT 5'/CD noncoding/JJ region/NN (/( 5'NCR/CD )/SYM in/IN a/DT cap-independent/JJ manner/NN ./.
@@17590522352/CD Appl/NNP ./.
@@1376711987/CD These/DT observations/NNS have/NN led/VBD us/PRP to/IN conclude/VB that/IN an/DT elevated/VBN VIII-ratio/GENE is/VBZ a/DT very/RB sensitive/MULTIGENE indicator/MULTIGENE of/IN intravascular/JJ coagulation/NN ./.
@@9576230277/CD The/DT effect/NN of/IN nitric/JJ oxide/MULTIGENE synthase/MULTIGENE inhibitor/MULTIGENE on/IN reperfusion/NN injury/NN of/IN the/DT brain/NN under/IN hypothermic/JJ circulatory/JJ arrest/NN ./.
@@81341085112/CD The/DT c-myc/NN and/CC skeletal/MULTIGENE alpha-actin/MULTIGENE gene/MULTIGENE promoters/MULTIGENE contain/VBP YY1/MULTIGENE binding/MULTIGENE sites/MULTIGENE thought/VBP to/IN act/NN either/DT as/IN positive/JJ or/CC negative/JJ cis-acting/JJ elements/NNS ./.
@@1930882550/CD Sixteen/CD other/DT normal/JJ subjects/NNS with/IN 2/CD g/NN of/IN Metyrapone/GENE are/VBP best/JJS responses/NNS ./.
@@90275066100/CD cDNA/NN cloning/NN ,/, expression/NN analysis/NN ,/, and/CC chromosomal/JJ localization/NN of/IN a/DT gene/NN with/IN high/JJ homology/NN to/IN wheat/NN eIF-/NN (/NN iso/NN )/NN 4F/NN and/CC mammalian/JJ eIF-4G/NEWGENE ./.
@@84100428373/CD Creutzfeldt-Jakob/NNP disease/NN and/CC lyophilised/JJ dura/NN mater/JJ grafts/NNS :/: report/VB of/IN two/JJ cases/NNS ./.
@@35531492510/CD We/PRP used/VBD oligonucleotide-directed/JJ mutagenesis/NN to/IN alter/VB a/DT site/NN in/IN MucA/NN homologous/JJ to/IN the/DT Ala-Gly/JJ cleavage/NN site/NN of/IN LexA/DT ./.
@@76403099514/CD The/DT C-terminal/MULTIGENE peptide/MULTIGENE sequences/MULTIGENE of/IN the/DT human/JJ lymphocyte-specific/JJ high/JJ mobility/NN group/NN (/( HMG/NN )/NN -box/NN transcription/NN factor/NN TCF-1/GENE are/VBP determined/VBN by/IN alternative/JJ splice/NN mechanisms/NNS affecting/VBG the/DT exons/NNS VIII/NNP to/IN X/NNP ./NNP
@@81785721624/CD Five/CD concensus/NN poly/NN A/DT addition/NN sites/NNS are/VBP located/VBN in/IN the/DT 350/CD base/NN pairs/NNS immediately/RB following/IN the/DT protein/MULTIGENE IX/MULTIGENE coding/JJ region/NN ./.
@@24237733091/CD Colorimetric/NNP method/NN of/IN determining/MULTIGENE glycerin/MULTIGENE in/IN the/DT blood/NN ./.
@@76731544511/CD The/DT tyrosine-phosphorylated/JJ state/NN of/IN CAK/MULTIGENE beta/MULTIGENE was/VBD not/RB reduced/VBN on/IN trypsinization/NN ,/, nor/CC enhanced/VBD in/IN response/NN to/IN plating/NN 3Y1/CD cells/NNS onto/IN fibronectin/NN ./.
@@91856451001/CD Comparison/NNS of/IN Tc-99m/GENE sestamibi/NN perfusion/NN imaging/JJ and/CC echocardiography/NN using/VBG an/DT arbutamine/NN infusion/NN for/IN the/DT detection/NN of/IN coronary/JJ artery/NN disease/NN ./.
@@14594473666/CD These/DT sequences/NNS were/VBD then/RB used/VBN to/IN clone/NN the/DT full-length/JJ genes/NNS from/IN a/DT yeast/NN genomic/JJ library/NN ./.
@@30975096884/CD This/DT gave/VBD rise/NN to/IN RNA/NN molecules/NNS with/IN 3'-untranslated/JJ regions/NNS of/IN roughly/RB 375/CD ,/, 655/CD ,/, and/CC 945/CD base/NN pairs/NNS ./.
@@29794263693/CD Organ/NN transplantation/NN in/IN Denmark/NN ./.
@@113186085138/CD Transfection/NNS of/IN EGFP-tagged/NNP DENTT/MULTIGENE NLS/MULTIGENE deletion/NN constructs/NNS lacking/JJ the/DT bipartite/JJ NLS-1/GENE were/VBD excluded/VBN from/IN the/DT nucleolus/NN ./.
@@25906153236/CD We/PRP conclude/VBP that/IN at/IN steady/JJ state/NN the/DT timing/NN of/IN a/DT light/NN meal/NN is/VBZ unlikely/JJ to/IN alter/VB in/IN any/DT clinically/RB important/JJ manner/NN the/DT pharmacokinetics/NN of/IN nifedipine/NN released/VBN from/IN 'biphasic'/NN tablets/NNS ./.
@@74679757357/CD Family/NNP planning/NN continues/VBZ to/IN play/NN a/DT minor/JJ role/NN ,/, and/CC only/RB 25/CD ./CD 3/CD per/IN cent/NN of/IN all/DT patients/NNS reviewed/VBN took/VBD to/IN oral/JJ contraceptives/NNS for/IN shorter/JJR or/CC longer/JJR periods/NNS of/IN time/NN ./. -/: The/DT percentages/NNS of/IN primiparae/NNS and/CC secundiparae/NNS in/IN all/DT births/NNS as/RB well/VBP as/IN the/DT high/JJ percentage/NN of/IN multigravidity/NN are/VBP parameters/NNS by/IN which/WDT the/DT approach/NN to/IN reproduction/NN differs/VBZ substantively/RB from/IN behaviour/NN patterns/NNS in/IN Europe/NN ./.
@@76284561351/CD The/DT double-stranded/JJ RNA/NN binding/JJ domain/NN (/( dsRBD/NN )/SYM is/VBZ an/DT approximately/RB 65/CD amino/JJ acid/NN motif/NN that/WDT is/VBZ found/VBN in/IN a/DT variety/NN of/IN proteins/NNS that/WDT interact/VBP with/IN double-stranded/JJ (/( ds/NNS )/SYM RNA/NN ,/, such/JJ as/IN Escherichia/NN coli/JJ RNase/MULTIGENE III/MULTIGENE and/CC the/DT dsRNA-dependent/MULTIGENE kinase/MULTIGENE ,/, PKR/CONTEXTGENE ./.
@@119007701813/CD Sexually/RB conditioned/JJ incentives/NNS :/: Attenuation/NNS of/IN motivational/JJ impact/NN during/IN dopamine/MULTIGENE receptor/MULTIGENE antagonism/NN ./.
@@4397164959/CD Ophthalmosonographic/NNP evaluation/NN of/IN blood/NN flow/NN velocity/NN in/IN arteriocavernous/JJ fistula/NN ./.
@@14205791452/CD Of/IN the/DT serum/JJ neutralizing/JJ (/( SN/RB )/SYM antibody/NN negative/JJ calves/NNS 89/CD ./CD 7%/CD (/( 26/CD //CD 29/CD )/SYM and/CC 92/CD ./CD 8%/CD (/( 90/CD //CD 97/CD )/SYM developed/VBN SN/MULTIGENE antibody/MULTIGENE 1/MULTIGENE month/NN after/IN intranasal/JJ and/CC intramuscular/JJ vaccination/NN ,/, respectively/RB ./.
@@80574218769/CD Direct/JJ binding/NN and/CC competition/NN assays/NNS using/VBG 30-mer/NN oligonucleotide/NN probes/NNS representing/VBG the/DT individual/JJ CBF1/MULTIGENE binding/MULTIGENE sites/MULTIGENE indicated/VBN that/IN CBF1/GENE bound/JJ less/PRP efficiently/RB to/IN the/DT CD23/MULTIGENE promoter/MULTIGENE and/CC the/DT EBV/MULTIGENE LMP-1/MULTIGENE promoter/MULTIGENE sites/MULTIGENE than/IN to/IN the/DT Cp/MULTIGENE site/MULTIGENE ./.
@@27438428360/CD The/DT present/NN study/NN investigates/VBZ whether/IN prostaglandins/NNS "cytoprotect"/VBG the/DT gastric/JJ mucosa/NN against/IN hemorrhage-induced/JJ stress/NN ulceration/NN by/IN assessing/JJ the/DT influence/NN of/IN 16/MULTIGENE ,/MULTIGENE 16-dimethyl/MULTIGENE prostaglandin/MULTIGENE E2/MULTIGENE (/( 16/CONTEXTGENE ,/CONTEXTGENE 16-dm/CONTEXTGENE PGE2/CONTEXTGENE )/SYM on/IN gross/JJ and/CC microscopic/JJ lesion/NN formation/NN ,/, intramucosal/JJ tissue/NN pH/NN ,/, H+/NN back-diffusion/NN ,/, and/CC mucosal/JJ blood/NN flow/NN in/IN rat/NN gastric/JJ mucosa/NN exposed/VBN to/IN luminal/JJ acid/NN (/( 100/CD mM/NN HCl/NN )/SYM during/IN hemorrhagic/JJ shock/NN (/( 13/CD ml/NN //NN kg/NN for/IN 20/CD min/NN )/SYM ./.
@@19243159006/CD In/NN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ,/, copper/JJ levels/NNS exert/VBP some/DT control/NN over/RB the/DT level/NN of/IN SOD1/GENE expression/NN ./.
@@33984334094/CD The/DT state/NN of/IN the/DT liver/NN in/IN generalized/JJ forms/NNS of/IN meningococcal/JJ infection/NN ./.
@@111961998110/CD Human/NNP homologue/NN of/IN yeast/MULTIGENE Rad23/MULTIGENE protein/MULTIGENE A/MULTIGENE interacts/VBZ with/IN p300/GENE //GENE cyclic/GENE AMP-responsive/NNP element/NN binding/JJ (/( CREB/NN )/NN -binding/NN protein/NN to/IN down-regulate/DT transcriptional/JJ activity/NN of/IN p53/GENE ./.
@@71109996914/CD They/PRP consisted/VBP of/IN behavioural/JJ disorders/NNS ,/, tetraparesis/NN ,/, incontinence/NN and/CC oculomotor/JJ paralysis/NN ./.
@@95921687428/CD Structural/NNP features/NNS of/IN the/DT minimal/JJ DNA/NN binding/JJ domain/NN (/( M98-F219/CD )/SYM of/IN human/MULTIGENE nucleotide/MULTIGENE excision/MULTIGENE repair/MULTIGENE protein/MULTIGENE XPA/MULTIGENE ./.
@@58192495752/CD Mining/NNP the/DT diagnostic/JJ iron/NN ore/NN ./.
@@17974671216/CD RU486/IN and/CC ONO/MULTIGENE 802/MULTIGENE in/IN combination/NN have/NN been/VBN shown/VBP to/IN be/VB effective/JJ in/IN early/JJ termination/NN of/IN pregnancy/NN ./.
@@1386210639/CD We/PRP report/VBP the/DT successful/JJ use/NN of/IN electroconvulsive/JJ therapy/NN for/IN treatment/NN of/IN severe/JJ depression/NN in/IN a/DT young/JJ man/NN with/IN adult/JJ GM2/GENE gangliosidosis/NN ./.
@@108910931156/CD The/DT transmembrane/JJ topology/NN of/IN Na/NN (/NN +/NN )/NN //NN H/NN (/NN +/NN )/NN exchanger/MULTIGENE NHE3/MULTIGENE has/VBZ been/VBN studied/VBN using/VBG in/IN vitro/FW transcription/NN //NN translation/NN of/IN two/JJ types/NNS of/IN fusion/NN vectors/NNS designed/VBN to/IN test/NN membrane/NN insertion/NN properties/NNS of/IN cDNA/NN sequences/NNS encoding/VBG putative/JJ NHE3/GENE membrane/NN spanning/VBG domains/NNS (/( msds/NNS )/SYM ./.
@@11062067641/CD Stress-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE 1/MULTIGENE (/( SAPK1/GENE )/SYM ,/, also/RB called/VBN c-Jun/MULTIGENE N-terminal/MULTIGENE kinase/MULTIGENE (/( JNK/GENE )/SYM ,/, becomes/VBZ activated/VBN in/IN vivo/NN in/IN response/NN to/IN pro-inflammatory/JJ cytokines/NNS or/CC cellular/JJ stresses/NNS ./.
@@96238305014/CD The/DT therapeutic/JJ use/NN of/IN botulinum/MULTIGENE toxin/MULTIGENE (/( Botox/GENE )/SYM is/VBZ increasing/JJ in/IN popularity/NN ./.
@@111593636435/CD Methylation/NNS at/IN both/DT cytosine/NN residues/NNS in/IN the/DT E2F/MULTIGENE element/MULTIGENE (/( (/( m/NN )/NN CG/NN (/NN m/NN )/NN CG/NN )/NN generated/VBD a/DT new/JJ methylcytosine-specific/MULTIGENE DNA-protein/MULTIGENE complex/MULTIGENE ./.
@@10575642396/NNS Skin/VBP pH/NN changes/NNS associated/VBN with/IN iontophoresis/NN ./.
@@115807572665/CD METHODS/IN :/: We/PRP retrospectively/RB selected/VBD 13/CD TFCD/NN patients/NNS who/WP underwent/VBD surgery/NN for/IN intractable/JJ epilepsy/NN with/IN the/DT aim/NN of/IN removing/JJ the/DT magnetic/JJ resonance/NN (/( MR/NN )/NN -detectable/NN lesion/NN and/IN //IN or/IN the/DT epileptogenic/JJ zone/NN defined/VBN by/IN stereoelectroencephalographic/JJ recordings/NNS ./.
@@20020513989/CD Isoform/MULTIGENE C/MULTIGENE beta/MULTIGENE 2/MULTIGENE ,/, an/DT unusual/JJ form/NN of/IN the/DT bovine/JJ catalytic/JJ subunit/NN of/IN cAMP-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE ./.
@@91519255653/CD The/DT C-LIP/GENE also/RB was/VBD compared/VBN with/IN transcather/NN arterial/JJ embolization/NN (/( TAE/NN ;/: C-LIP/GENE followed/VBN by/IN gelatin/NN sponge/NN )/SYM and/CC percutaneous/JJ ethanol/NN injection/NN therapy/NN (/( PEIT/NNP )/SYM ./.
@@12522232934/CD The/DT authors/NNS found/VBP that/WDT except/VBP for/IN fear/NN and/CC pugnacity/NN all/DT husband-wife/JJ trait/NN correlations/NNS were/VBD positive/JJ ,/, in/IN contrast/NN to/IN Winch's/NNP principle/NN of/IN type/MULTIGENE I/MULTIGENE complementarity/NN ./.
@@40026674666/CD In/NN metastasis-free/JJ patients/NNS ,/, the/DT best/JJS results/NNS were/VBD obtained/VBN with/IN tumor/NN diameters/NNS under/IN 2/CD cm/NN regardless/RB of/IN their/PRP localization/NN in/IN lung/NN tissue/NN and/CC with/IN 2--4/CD ./CD 9/CD cm/NN tumors/NNS embedded/VBN in/IN lung/NN parenchyma/NN ./.
@@32685553964/CD In/NN vitro/FW assessment/NN of/IN the/DT biocompatibility/NN of/IN dental/JJ materials--the/JJ millipore/NN filter/NN method/NN ./.
@@33125147822/CD The/DT N3/GENE wave/NN of/IN the/DT SSEP's/NNP ,/, which/WDT has/VBZ been/VBN found/VB to/IN correlate/NN best/JJS with/IN neurological/JJ recovery/NN ,/, returned/VBN to/IN 65%/JJ +/NN //NN -/NN 48%/NN of/IN the/DT preischemia/NN amplitude/NN in/IN the/DT insulin-treated/JJ animals/NNS ,/, compared/VBN to/IN 40%/CD +/NN //NN -/NN 34%/JJ in/IN the/DT fasted/VBN group/NN and/CC 26%/JJ +/NN //NN -/NN 24%/JJ in/IN the/DT control/NN animals/NNS ./.
@@18903622512/CD Out/IN of/IN 40/CD patients/NNS ,/, who/WP initially/RB did/VBD not/RB show/VB eye/NN complications/NNS due/NN to/IN leprosy/NN ,/, 37/CD patients/NNS were/VBD essentially/RB the/DT same/JJ 10/CD years/NNS later/JJR ./.
@@51541325403/CD The/DT value/NN of/IN different/JJ sources/NNS of/IN nitrogen/NN in/IN diets/NNS for/IN the/DT early-weaned/JJ calf/NN ./.
@@113934636126/CD Data/NNP were/VBD obtained/VBN from/IN 2/CD undergraduate/NN student/NN samples/NNS ,/, a/DT self-report/NN group/NN (/( n/NN =/SYM 132/CD )/SYM who/WP provided/VBD NEO-PI-R/NN self-ratings/NNS on/IN 2/CD occasions/NNS separated/VBN by/IN a/DT 7-/CD to/IN 14-day/NN interval/NN and/CC an/DT informant/NN group/NN (/( n/NN =/SYM 109/CD )/SYM who/WP provided/VBD ratings/NNS of/IN well-known/JJ friends/NNS or/CC relatives/NNS on/IN 2/CD occasions/NNS separated/VBN by/IN a/DT 6/CD month/NN interval/NN ./.
@@74900796547/CD These/DT are/VBP two/JJ regions/NNS of/IN known/VBP conserved/VBN synteny/NN ,/, providing/CC further/JJ evidence/NN that/IN the/DT human/JJ STEP/NN is/VBZ a/DT true/JJ homolog/NN of/IN the/DT murine/MULTIGENE STEP/MULTIGENE gene/MULTIGENE ./.
@@109545256321/CD However/RB ,/, the/DT presence/NN of/IN Tax/MULTIGENE I/MULTIGENE increased/VBD the/DT extent/NN and/CC altered/VBD the/DT profile/NN of/IN proteins/MULTIGENE binding/MULTIGENE TRE-2/MULTIGENE in/IN vivo/NN ./.
@@103674609015/CD The/DT FCMS/NNP conditions/NNS were/VBD as/IN follows/VBZ :/: 2/MULTIGENE kW/MULTIGENE maximum/JJ electrical/JJ power/NN consumption/NN ,/, 800/MULTIGENE V/MULTIGENE maximum/JJ capacitor/NN voltage/NN ,/, 720/CD microseconds/NNS pulsewidth/NN (/( 180/CD microseconds/NNS rise/NN time/NN )/SYM ,/, and/CC 5-30/CD Hz/NN frequency/NN ./.
@@90796389339/CD The/DT 3ASubE/CD cells/NNS expressing/MULTIGENE CXCR2/MULTIGENE with/IN mutation/NN of/IN Ser-346/NN ,/, -347/NN ,/, and/CC -348/CD to/IN alanine/NN ,/, or/CC with/IN mutation/NN of/IN only/RB one/PRP serine/NN in/IN this/DT domain/NN ,/, continue/VB to/IN be/VB phosphorylated/VBN in/IN response/NN to/IN ligand/NN and/CC are/VBP 60-70%/RB desensitized/VBN following/IN the/DT initial/JJ ligand/NN challenge/NN ./.
@@94269582582/CD The/DT study/NN goals/NNS were/VBD to/IN isolate/NN a/DT full-length/JJ clone/NN encoding/VBG CO-Ag/NNP from/IN a/DT bovine/JJ corneal/JJ cDNA/NN library/NN and/CC to/IN express/NN this/DT clone/NN in/IN Escherichia/NN coli/JJ (/( E/NNP ./NNP coli/JJ )/SYM ./.
@@2182618461/CD The/DT promoter/NN activity/NN was/VBD measured/VBN by/IN a/DT transient/JJ expression/NN of/IN a/DT chloramphenicol/NN acetyltransferase/NN (/( CAT/NN )/SYM gene/NN connected/VBN with/IN various/JJ 5'-deletion/CD mutants/NNS of/IN the/DT 5'-flanking/JJ region/NN ./.
@@78295547808/CD To/TO further/RB our/PRP knowledge/NN about/RB the/DT systemic/JJ humoral/JJ immune/JJ system/NN response/NN to/IN weak/JJ hapten-syngeneic/JJ or/CC allogeneic/JJ protein/NN conjugates/NNS (/( corrosion/NN and/CC wear/NN products/NNS of/IN metallic/JJ orthopedic/JJ devices/NNS )/SYM ,/, a/DT sensitive/JJ enzyme-linked/JJ immunosorbent/JJ assay/NN (/( ELISA/NN )/SYM method/NN for/IN testing/NN for/IN antibody/NN (/( humoral/JJ immunity/NN )/SYM to/IN metals/NNS was/VBD developed/VBN ./.
@@83550621063/CD Single-photon/NNP emission/NN computed/JJ tomography/NN (/( SPECT/NN )/SYM with/IN 99mTc-hexamethylpropyleneamine/NNP oxime/NN (/( HMPAO/GENE )/SYM was/VBD used/VBN to/IN investigate/VB changes/NNS in/IN cerebral/JJ blood/NN flow/NN in/IN seven/JJ patients/NNS with/IN cortical/JJ visual/JJ impairment/NN ./.
@@73494167197/CD 100/CD more/RB than/IN in/IN the/DT summer/NN coat/NN )/NN ./.
@@10321158185/CD Post/NNP and/CC core/NN fabrication/NN for/IN divergent/JJ canals/NNS with/IN a/DT cast/JJ post/NN and/CC core/NN and/CC a/DT prefabricated/JJ dowel/NN ./.
@@94857909449/CD Alison/NN Bell/NNP Memorial/NNP Award/NNP ./.
@@20722382681/CD Menetrier/NNP disease/NN in/IN a/DT child/NN ./.
@@66250582085/CD The/DT population/NN of/IN between/IN 75/GENE ,/GENE 000/GENE and/CC 100/CD ,/CD 000/CD was/VBD largely/RB unstable/JJ ,/, and/CC cost/NN per/IN capita/NNS was/VBD $0/CD ./CD 95/CD to/IN $1/CD ./CD 21/CD ./.
@@63183226781/CD This/DT is/VBZ consistent/JJ with/IN a/DT model/NN proposing/VBG that/DT SSV/NN was/VBD generated/VBN by/IN recombination/NN between/IN proviral/JJ DNA/NN of/IN a/DT simian/JJ sarcoma/NN associated/VBD virus/NN and/CC proto-sis/NN and/CC that/IN introns/NNS were/VBD spliced/VBN out/RB subsequently/RB from/IN a/DT fused/VBN viral-sis/MULTIGENE messenger/MULTIGENE RNA/MULTIGENE ./.
@@32808071743/CD Mutations/NNS at/IN the/DT suf12/MULTIGENE locus/MULTIGENE were/VBD isolated/VBN in/IN Saccharomyces/NN cerevisiae/NN as/IN extragenic/JJ suppressors/NNS of/IN +1/NN frameshift/JJ mutations/NNS in/IN glycine/NN (/( GGX/NNP )/SYM and/CC proline/NN (/( CCX/NNP )/SYM codons/NNS ,/, as/RB well/VB as/IN UGA/DT and/CC UAG/NN nonsense/NN mutations/NNS ./.
@@43712795006/CD Absence/NNS of/IN action/NN potentials/NNS in/IN frog/NN slow/JJ muscle/NN fibres/NNS paralysed/VBN by/IN botulinum/MULTIGENE toxin/MULTIGENE ./.
@@83201206904/CD Pronounced/JJ microangiopathy/NN characterized/VBN by/IN avascular/JJ fields/NNS ,/, enlarged/JJ and/CC tortuous/JJ capillaries/NNS and/CC increased/VBN transcapillary/JJ diffusion/NN of/IN sodium/MULTIGENE fluorescein/MULTIGENE ,/, was/VBD clearly/RB demonstrable/JJ in/IN the/DT area/NN of/IN the/DT nodules/NNS ./.
@@10918164738/CD Logistic/JJ regression/NN analysis/NN revealed/VBN that/IN physicians/NNS were/VBD 3/CD ./CD 6/CD times/NNS more/RB likely/RB to/IN detect/VB thin/JJ lesions/NNS (/( </SYM //CD =/CD 0/CD ./CD 75/CD mm/NN )/SYM compared/VBN with/IN nonphysician/NN detectors/NNS (/( 95%/CD confidence/NN interval/NN [/NN 95%/NN CI/NN ]/NN ,/, 2/CD ./CD 1/CD ,/, 6/CD ./CD 5/CD ;/: P/NN =/SYM 0/CD ./CD 0001/CD )/SYM ./.
@@1000956514/CD GW/MULTIGENE Gamma/MULTIGENE approximation/NN for/IN electron/NN self-energies/NNS in/IN semiconductors/NNS and/CC insulators/NNS ./.
@@68763176671/CD Relationships/NNS with/IN the/DT acquired/VBN immune/JJ deficiency/NN syndrome/NN ./.
@@104268787551/CD The/DT results/NNS of/IN the/DT ISIS-2/GENE trial/NN and/CC the/DT data/NN from/IN the/DT Antiplatelet/NNP Trialists'/NNP Collaboration/NNS indicated/VBD that/DT aspirin/NN is/VBZ mandatory/JJ in/IN patients/NNS with/IN acute/JJ myocardial/JJ infarction/NN and/CC for/IN secondary/JJ prevention/NN ./.
@@107250175327/CD This/DT paper/NN reviews/VBP the/DT middleware-based/JJ approach/NN adopted/VBN by/IN CEN/MULTIGENE ENV/MULTIGENE 12967-1/CD and/CC the/DT specialisation/NN necessary/JJ for/IN the/DT healthcare/NN record/NN based/VBN on/IN CEN/MULTIGENE ENV/MULTIGENE 12265/CD 'Electronic/NNP Healthcare/NNP Record/NNP Architecture'/NNP ./.
@@109053498139/CD Double/NNP mutant/JJ analysis/NN suggests/VBZ that/IN Rad54p/GENE and/CC Mus81p/GENE act/VB in/IN one/PRP pathway/NN for/IN the/DT repair/NN of/IN ,/, or/CC tolerance/NN to/IN ,/, UV-induced/MULTIGENE DNA/MULTIGENE damage/NN ./.
@@33098924680/CD Contrary/JJ to/IN the/DT observation/NN made/VBP with/IN other/DT S/NNP ./NNP pombe/NN genes/NNS transcribed/VBN in/IN the/DT budding/JJ yeast/NN ,/, the/DT heterologous/JJ actin/MULTIGENE gene/MULTIGENE transcript/MULTIGENE is/VBZ initiated/VBN 39/CD nucleotides/NNS upstream/RB of/IN the/DT initiation/NN start/NN site/NN used/VBN in/IN the/DT homologous/JJ yeast/NN ./.
@@97246545581/CD Furthermore/RB ,/, early-/JJ and/CC late-firing/JJ origins/NNS differ/VBP not/RB in/IN the/DT timing/NN of/IN their/PRP recruitment/NN of/IN an/DT Mcm/MULTIGENE protein/MULTIGENE ,/, but/CC in/IN the/DT timing/NN of/IN RPA's/GENE recruitment/NN ./.
@@986800191/CD All/DT Cu/NN values/NNS obtained/VBN from/IN the/DT organs/NNS investigated/VBN had/VBP reached/VBN a/DT saturation/NN level/NN at/IN 8/CD mug/NN Cu/NNS //NNS g/NNS diet/NN with/IN the/DT exception/NN of/IN the/DT values/NNS for/IN body/MULTIGENE Cu/MULTIGENE found/VB in/IN the/DT dams/NNS that/WDT were/VBD killed/VBN on/IN the/DT day/NN of/IN delivery/NN ./.
@@14829127012/CD The/DT CEM/NN receives/VBZ registration/NN updates/NNS via/NN an/DT HL7/NN message/NN and/CC evaluates/VBZ data/NN dependencies/NNS in/IN rules/NNS via/NN an/DT interface/NN to/IN the/DT relational/JJ database/NN ./.
@@72515647083/CD Since/IN only/JJ 58%/NN of/IN our/PRP sample/NN could/MD be/VB adequately/RB classified/VBN with/IN one/PRP diagnosis/NN ,/, we/PRP expect/VBP that/IN the/DT ASDC/NNP nosology/NN will/MD need/VB to/IN evolve/VB further/RB ./.
@@83885433388/CD Furthermore/RB ,/, a/DT mutant/JJ receptor/NN (/( Y977F/GENE //GENE Y989F/GENE [/NN PLC/NN gamma-binding/JJ sites/NN ]/NN )/SYM could/MD fully/RB activate/VB Ras/NNS ,/, and/CC the/DT direct/JJ activation/NN of/IN protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE and/CC calcium/NN mobilization/NN had/VBP almost/RB no/DT effect/NN on/IN the/DT GDP/NNP //NNP GTP/NNP state/NN of/IN Ras/NNS in/IN this/DT cell/NN line/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@28152293513/CD The/DT treatments/NNS were/VBD 60/CD mg/NN t/CD ./CD i/CD ./CD d/CD ./. and/CC 120/CD mg/NN t/CD ./CD i/CD ./CD d/CD ./. during/IN 14/CD days'/NN treatment/NN ,/, with/IN the/DT last/NN dose/NN pulsed/JJ with/IN 1/CD ./CD 85/CD MBq/NN [/NN 14C/NN ]/NN diltiazem/NN ./.
@@98585939152/CD We/PRP have/VBP identified/VBN amino/JJ acid/NN sequences/NNS in/IN mammalian/JJ and/CC Xenopus/NN NeuroD1/GENE //GENE BETA2/GENE that/WDT are/VBP necessary/JJ for/IN insulin/MULTIGENE gene/MULTIGENE expression/NN and/CC ectopic/JJ neurogenesis/NN ./.
@@118448121727/CD For/IN the/DT 2/CD ./CD 5/CD to/IN 4/CD ng/NN //NN mL/NN model/NN ,/, the/DT AUC/NN of/IN the/DT ANN/NNP ROC/NN curve/NN was/VBD significantly/RB higher/JJ than/IN the/DT AUCs/NNS for/IN percentage/NN of/IN free/JJ PSA/NEWGENE (/( P/NN =/CD ./CD 0239/CD )/SYM ,/, PSA-TZ/NNP (/( P/NN =/CD ./CD 0204/CD )/SYM ,/, and/CC PSA/NN density/NN and/CC total/JJ prostate/NN volume/NN (/( P/NN </SYM ./CD 01/CD for/IN both/DT )/SYM ./.
@@100015413/CD Mechanisms/NNPS of/IN visible-light/JJ emission/NN from/IN electro-oxidized/JJ porous/JJ silicon/NN ./.
@@5905945816/CD Ovarian/JJ allotransplantation/NN in/IN human/NN ./.
@@28509711736/CD A/DT 17-mer/CD oligodeoxynucleotide/NN ,/, corresponding/JJ to/IN a/DT region/NN of/IN the/DT VtHb/NNP amino/JJ acid/NN sequence/NN was/VBD used/VBN as/IN a/DT hybridization/NN probe/NN to/IN screen/NN a/DT Vitreoscilla/JJ genomic/JJ library/NN constructed/VBN in/IN broad-host-range/JJ cosmid/NN vector/NN pVK102/GENE ./.
@@89379895700/CD The/DT results/NNS suggest/VBP that/IN ,/, although/IN both/PDT the/PDT N-/DT and/CC C-terminal/MULTIGENE regions/MULTIGENE of/IN talin/NN bind/NN actin/NEWGENE ,/, the/DT properties/NNS of/IN these/DT two/JJ regions/NNS of/IN the/DT protein/NN are/VBP distinct/JJ ./.
@@110272809271/CD Cam/MULTIGENE kinase/MULTIGENE II/MULTIGENE induces/VBZ in/IN vivo/NN phosphorylation/NN of/IN Smad2/GENE and/CC Smad4/GENE and/CC ,/, to/IN a/DT lesser/JJ extent/NN ,/, Smad3/GENE ./.
@@82944593836/CD The/DT predicted/VBN amino/JJ acid/NN sequence/NN of/IN the/DT SAP-1/MULTIGENE cDNA/MULTIGENE showed/VBN that/IN mature/JJ SAP-1/GENE consisted/VB of/IN 1093/CD amino/JJ acids/NNS and/CC a/DT transmembrane-type/MULTIGENE PTP/MULTIGENE ,/, which/WDT possessed/VBD a/DT single/JJ PTP-conserved/JJ domain/NN in/IN the/DT cytoplasmic/JJ region/NN ./.
@@111975493399/CD RESULTS/NNS :/: During/IN the/DT stabilization/NN period/NN ,/, PaCO2/GENE (/( mean/JJ +/NN //NN -/NN SD/NN )/SYM was/VBD 33/CD +/NN //NN -/NN 5/CD mm/NN Hg/NNP ,/NNP and/NNP arrhythmias/NNS were/VBD not/RB detected/VBN ./.
@@112545043022/CD However/RB ,/, the/DT promoter/NN region/NN contains/VBZ several/DT potential/JJ cis-regulatory/MULTIGENE elements/MULTIGENE such/JJ as/IN Sp1/GENE ,/, early/MULTIGENE growth/MULTIGENE response-1/MULTIGENE ,/, activator/MULTIGENE protein-2/MULTIGENE ,/, MyoD/CONTEXTGENE ,/, p300/GENE ,/, nuclear/JJ factor-kappaB/CONTEXTGENE ,/, myeloid/MULTIGENE zinc/MULTIGENE finger/MULTIGENE protein-1/MULTIGENE ,/, caudal-related/MULTIGENE homeobox/MULTIGENE (/( Cdx/CONTEXTGENE )/SYM gene/MULTIGENE A/MULTIGENE ,/, and/CC Cdx/MULTIGENE protein-2/MULTIGENE binding/MULTIGENE sites/MULTIGENE ./.
@@110735392755/CD Functional/JJ analysis/NN of/IN the/DT mutant/MULTIGENE desmin/MULTIGENE in/IN SW13/NNP (/( vim-/JJ )/SYM cells/NNS showed/VBD aggregation/NN of/IN abnormal/JJ coarse/JJ clumps/NNS of/IN desmin/NN positive/JJ material/NN dispersed/VBN throughout/IN the/DT cytoplasm/NN ./.
@@13981063818/CD Cleavage/NNS by/IN the/DT intron-encoded/JJ enzyme/NN (/( I-CreI/GENE )/SYM occurs/VBZ 5/CD bp/NN and/CC 1/CD bp/NN 3'/CD to/IN the/DT intron/NN insertion/MULTIGENE site/MULTIGENE (/( in/IN the/DT 3'-exon/NN )/SYM in/IN the/DT top/JJ (/( //NN )/SYM and/CC bottom/NN (/( ,/, )/SYM strands/NNS ,/, respectively/RB ,/, resulting/JJ in/IN 4-nt/JJ single-stranded/JJ overhangs/NNS with/IN 3'-OH/JJ termini/NNS ./.
@@90997028696/CD Based/VBN on/IN the/DT sequence/NN of/IN the/DT conRTRE/NN ,/, we/PRP located/VBD a/DT putative/JJ RTRE/GENE ,/, referred/VBN to/RB as/IN P2-RE/NNP ,/, in/IN the/DT 5'/CD promoter-flanking/MULTIGENE region/MULTIGENE of/IN the/DT mouse/MULTIGENE protamine/MULTIGENE 2/MULTIGENE gene/MULTIGENE ,/, which/WDT is/VBZ induced/VBN during/IN the/DT same/JJ stage/NN of/RB spermatogenesis/NN as/IN RTR/NN ./.
@@96422275337/CD Osteoadherin/GENE is/VBZ a/DT recently/RB described/VBN bone/NN proteoglycan/NN containing/JJ keratan/NN sulfate/NN ./.
@@13098153275/CD Possibly/RB ,/, the/DT scr1-1/MULTIGENE mutation/MULTIGENE does/VBP not/RB affect/VB signal/JJ recognition/NN or/CC translational/JJ arrest/NN but/CC instead/RB results/VBZ in/IN maintenance/NN of/IN translational/JJ arrest/NN of/IN AEP/NEWGENE synthesis/NN ./.
@@30165065963/CD A/DT recombinant/JJ vector/NN ,/, p410+/GENE ,/, was/VBD constructed/VBN which/WDT carried/VBD the/DT BamHI-K/MULTIGENE fragment/MULTIGENE (/( nucleotides/NNS 107565/CD to/IN 112625/CD of/IN the/DT B95-8/CD strain/NN ,/, encoding/VBG the/DT EBV-associated/MULTIGENE nuclear/MULTIGENE antigen/MULTIGENE EBNA-1/MULTIGENE )/SYM ,/, the/DT cis-acting/JJ sequence/NN from/IN the/DT BamHI-C/MULTIGENE fragment/MULTIGENE ,/, and/CC a/DT dominant/JJ selectable/JJ marker/NN gene/NN encoding/VBG G-418/GENE resistance/NN in/IN animal/NN cells/NNS ./.
@@113115636214/CD When/WRB this/DT CCAAT/MULTIGENE box/MULTIGENE was/VBD inserted/VBN into/IN a/DT heterologous/JJ promoter/NN construct/NN ,/, OA/NN induction/NN was/VBD dependent/JJ on/IN an/DT intact/JJ CCAAT/MULTIGENE box/MULTIGENE ./.
@@1398272016/CD Radioimmunoassays/NNS of/IN pregnenolone/NN ,/, progesterone/NN ,/, dehydroepiandrosterone/NN (/( DHA/NN )/SYM 16/CD alpha-hydroxy-DHA/JJ ,/, estriol/NN ,/, and/CC cortisol/NN were/VBD performed/VBN on/IN a/DT total/NN of/IN 0/CD ;/: 1/CD ml/NN ;/: of/IN fetal/JJ plasma/NN ,/, collected/VBN during/IN the/DT course/NN of/IN normal/JJ vaginal/JJ delivery/NN ./.
@@77775186183/CD DNA/NN sequencing/VBG and/CC Southern/NNP blot/NN analyses/NNS established/VBN that/IN the/DT cDNA/NN clones/NNS are/VBP derived/VBN from/IN two/JJ different/JJ genes/NNS ./.
@@2745444395/CD The/DT transcription/NN initiation/NN site/NN was/VBD determined/VBN by/IN S1/MULTIGENE nuclease/MULTIGENE mapping/NN ./.
@@18967772913/CD Ivermectin/GENE uptake/NN and/CC distribution/NN in/IN the/DT plasma/NN and/CC tissue/NN of/IN Sudanese/JJ and/CC Mexican/JJ patients/NNS infected/VBN with/IN Onchocerca/NN volvulus/NN ./.
@@64152996215/CD Total/JJ cumulative/JJ doses/NNS of/IN doxorubicin/NN ranged/VBN from/IN 145/CD to/IN 625/CD mg/CD ./CD //CD m/CD ./CD 2/CD ./.
@@91757088420/CD Using/VBG PRL-R/NEWGENE tagged/VBD both/DT in/NN the/DT N-terminal/NN or/CC C-terminal/MULTIGENE regions/MULTIGENE of/IN the/DT mature/JJ receptor/NN excludes/VBZ the/DT possibility/NN of/IN a/DT cleaved/VBN fragment/NN which/WDT could/MD have/VB been/VBN subsequently/RB imported/VBN into/IN the/DT nucleus/NN ./.
@@110513703001/CD Response/NNP was/VBD extremely/RB poor/JJ in/IN African/JJ Americans/NNS and/CC those/DT with/JJ HCV/MULTIGENE genotype/MULTIGENE 1/CD ./CD
@@107217047320/CD Analysis/NNP of/IN the/DT 5'/CD end/NN of/IN the/DT mouse/MULTIGENE Elavl1/MULTIGENE (/( mHuA/CONTEXTGENE )/SYM gene/NN reveals/VBZ a/DT transcriptional/JJ regulatory/JJ element/NN and/CC evidence/NN for/IN conserved/VBN genomic/JJ organization/NN ./. mHuA/CONTEXTGENE (/( Elavl1/GENE )/SYM belongs/VBZ to/IN a/DT highly/RB conserved/VBN family/NN of/IN genes/NNS encoding/VBG RNA-binding/MULTIGENE proteins/MULTIGENE and/CC has/VBZ been/VBN linked/JJ to/IN cell/NN growth/NN and/CC proliferation/NN through/RB its/PRP regulation/NN of/IN mRNA/NN stability/NN ./.
@@115530912459/CD The/DT results/NNS indicate/VBP that/IN a/DT more/RB differentiated/VBN diagnosis/NN of/IN the/DT molar/JJ relationship/NN will/MD allow/VB for/IN a/DT more/RB causally/RB directed/VBN correction/NN of/IN Class/MULTIGENE II/MULTIGENE molar/JJ relationship/NN ./.
@@10678144494/CD After/IN i/CD ./CD v/CD ./.
@@93356081385/CD Splice-junction/NNP elements/NNS and/CC intronic/JJ sequences/NNS regulate/VBP alternative/JJ splicing/JJ of/IN the/DT Drosophila/MULTIGENE myosin/MULTIGENE heavy/MULTIGENE chain/MULTIGENE gene/MULTIGENE transcript/MULTIGENE ./.
@@99275852595/CD Competitionsupershift/NNP EMSA/NN assays/NNS revealed/VBN that/IN multiple/JJ proteins/NNS were/VBD involved/VBN in/IN bandshift/NN complex/NN formation/NN with/IN KCS/NNP ,/, one/PRP of/IN which/WDT was/VBD identified/VBN as/IN factor/MULTIGENE Sp1/MULTIGENE ./.
@@79138918233/CD Some/DT of/IN these/DT targets/NNS were/VBD reported/VBN to/IN code/NN for/IN molecules/NNS involved/VBN in/IN cell-cell/JJ interactions/NNS ,/, whereas/IN no/DT relationship/NN has/VBZ yet/RB been/VBN demonstrated/VBN between/IN Hox/MULTIGENE genes/MULTIGENE and/CC other/DT transcription/NN factors/NNS involved/VBN in/IN determining/VBG and/IN //IN or/IN maintaining/VBG tissue/NN specificity/NN ./.
@@60968632875/CD Upstream/MULTIGENE activation/MULTIGENE sites/MULTIGENE of/IN the/DT CYC1/MULTIGENE gene/MULTIGENE of/IN Saccharomyces/NN cerevisiae/NN are/VBP active/JJ when/CC inverted/JJ but/CC not/RB when/CC placed/VBN downstream/RB of/IN the/DT "TATA/NN box"/NN ./.
@@80830113132/CD The/DT relative/JJ R-/DT and/CC L-brain/NNP weights/NNS were/VBD found/VBN to/IN be/VB inversely/RB related/VBN to/IN the/DT relative/JJ R-L/NNP brain/NN weight/NN only/RB in/IN the/DT RH/GENE female/JJ cats/NNS with/IN R-L/NNP brain/NN weight/NN smaller/JJR than/IN zero/NN (/( testosterone/NN in/IN males/NNS ,/, estrogen/NN in/IN females/NNS )/SYM ./.
@@73965457247/CD Chemotherapy/NNS was/VBD administered/VBN without/IN altering/VBG the/DT course/NN of/IN the/DT disorder/NN ./.
@@88058248786/CD Furthermore/RB ,/, the/DT use/NN of/IN zero-loss/NN filtering/JJ in/IN combination/NN with/IN exit/NN wavefront/NN reconstruction/NN is/VBZ considerably/RB more/RB effective/JJ at/IN removing/JJ the/DT effects/NNS of/IN multiple/JJ elastic/JJ and/CC inelastic/JJ scattering/NN and/CC microscope/NN objective/JJ lens/NN aberrations/NNS than/IN either/DT technique/NN by/IN itself/PRP ./.
@@87092459626/CD Our/PRP studies/NNS also/RB excluded/VBN the/DT possibility/NN that/IN the/DT phosphorylation/NN of/IN Ser-2/NEWGENE ,/, Ser-123/CONTEXTGENE ,/, or/CC Ser-210/CONTEXTGENE ,/, had/VBP roles/NNS in/IN the/DT trans-suppression/JJ activity/NN of/IN the/DT large/JJ HDAg/NN ,/, in/IN the/DT assembly/NN of/IN empty/JJ virus-like/JJ HDAg/NN particle/NN ,/, and/CC in/IN the/DT nuclear/JJ transport/NN of/IN HDAgs/NNS ./.
@@87050568681/CD Workplace/NN violence--nurses/NNS at/IN risk/NN ./.
@@44288004226/CD Effect/NN of/IN noise/NN on/IN CO-induced/JJ increases/NNS of/IN LAP/NN and/CC GPT/NEWGENE activity/NN in/IN the/DT plasma/NN of/IN rats/NNS ./.
@@75929466801/CD It/PRP contains/VBZ three/CD putative/JJ TATA/NN boxes/NNS far/RB upstream/RB of/IN the/DT main/JJ start/NN sites/NNS region/NN ,/, one/PRP AP-1/MULTIGENE box/MULTIGENE ,/, one/PRP AP-2/MULTIGENE box/MULTIGENE ,/, one/PRP Malt/NNP box/NN ,/, one/PRP GAGA/MULTIGENE box/MULTIGENE ,/, one/PRP half/NN serum-responsive/JJ element/NN ,/, and/CC putative/JJ binding/JJ sites/NNS for/IN Sp1/GENE (/( five/CD )/SYM ,/, GC-rich/NNP binding/JJ factor/NN (/( five/CD )/SYM ,/, CTF-NF1/GENE (/( one/PRP )/SYM ,/, Myb/NNP (/( one/PRP )/SYM ,/, p53/GENE (/( two/JJ )/SYM ,/, Ets-1/GENE (/( one/PRP )/SYM ,/, NF-IL6/GENE (/( two/JJ )/SYM ,/, MyoD/IN (/( two/JJ )/SYM ,/, Zeste/JJ (/( one/PRP )/SYM ,/, and/CC hepatocyte/MULTIGENE nuclear/MULTIGENE factor-5/MULTIGENE (/( one/PRP )/SYM ./.
@@6286443323/CD Postoperative/JJ serum/JJ ACTH/NEWGENE levels/NNS were/VBD normal/JJ ./.
@@106561612175/CD MBI/NNP and/CC MMBI/NN showed/VBD similar/JJ Cmax/JJ values/NNS ,/, but/CC the/DT former/RB disappeared/VBN slower/JJR in/IN the/DT serum/NN than/IN the/DT latter/JJ and/CC resulted/VBN in/IN its/PRP larger/JJR AUC/NN values/NNS ./.
@@82428617276/CD Both/DT 4/JJ ,/JJ 8-DiMeIQx/JJ and/CC A/DT alpha/MULTIGENE C/MULTIGENE were/VBD found/VBN at/IN </SYM 1/CD p/CD ./CD p/CD ./CD b/CD ./.
@@86059311762/CD Epitope/NNS mapping/NN revealed/VBN that/IN these/DT three/CD clones/NNS appear/VBP to/IN recognize/VB an/DT identical/JJ epitope/NN domain/NN present/NN on/IN the/DT C-terminal/MULTIGENE RNP/MULTIGENE motif/MULTIGENE of/IN the/DT U1A/MULTIGENE protein/MULTIGENE ./.
@@118475801733/CD Emphysematous/JJ cholecystitis/NN :/: sonographic/JJ findings/NNS ./.
@@91397212422/NNS Cyclin/MULTIGENE G2/MULTIGENE is/VBZ highly/RB expressed/VBN in/IN the/DT immune/JJ system/NN where/CC immunologic/JJ tolerance/NN subjects/VBZ self-reactive/JJ lymphocytes/NNS to/IN negative/JJ selection/NN and/CC clonal/JJ deletion/NN via/NN apoptosis/NN ./.
@@103595754335/CD Nevertheless/RB ,/, they/PRP are/VBP functionally/RB distinct/JJ in/IN that/DT FcalphaRI/GENE binds/VBZ human/MULTIGENE IgA/MULTIGENE (/( hIgA/CONTEXTGENE )/SYM but/CC not/RB bovine/MULTIGENE IgG2/MULTIGENE (/( bIgG2/GENE )/SYM ,/, whereas/IN bFcgamma2R/GENE binds/VBZ bIgG2/GENE but/CC not/RB hIgA/VB ./.
@@90456366559/CD CD3/GENE cross-linking/VBG induced/VBN tyrosine/NN phosphorylation/NN of/IN Sam68/NEWGENE in/IN uninfected/JJ T/NN cells/NNS ./.
@@106568029386/CD Another/DT long/JJ insertion/NN in/IN the/DT cathepsin/MULTIGENE X/MULTIGENE amino/JJ acid/NN sequence/NN forms/VBZ a/DT beta-hairpin/NN pointing/VBG away/RB from/IN the/DT active/JJ site/NN ./.
@@83702758330/CD One/CD chimpanzee/NN reliably/RB selected/VBD the/DT larger/JJR numeral/NN 4/CD during/IN testing/NN with/IN a/DT nonadjacent/JJ pair/NN (/( 2-4/CD )/SYM ,/, and/CC 2/CD chimps/NNS showed/VBD no/DT preference/NN ./.
@@106373374192/CD We/PRP determined/VBD how/RB DNA/NN repair/NN is/VBZ affected/VBN by/IN TFA1/GENE conditional/JJ mutations/NNS ./.
@@104409236850/CD Analysis/NNP of/IN cell/NN cycle/NN proteins/NNS showed/VBN that/IN 24/CD h/NN of/IN lovastatin/NN treatment/NN in/IN the/DT control/NN cells/NNS caused/VBD an/DT elevation/NN in/IN the/DT levels/NNS of/IN the/DT cyclin-dependent/JJ kinase/NN inhibitor/NN p27/NN (/NN kip1/NN )/NN ,/, inhibition/NN of/IN both/DT cyclin/NN E-/NNP and/CC cyclin/MULTIGENE A-dependent/MULTIGENE kinase/MULTIGENE activity/NN ,/, and/CC decreased/VBD levels/NNS of/IN hyperphosphorylated/JJ retinoblastoma/MULTIGENE protein/MULTIGENE (/( pRb/CONTEXTGENE )/SYM ./.
@@63958042006/CD Urease/NEWGENE activity/NN of/IN 97%/CD of/IN these/DT organisms/NNS became/VBD evident/JJ within/IN 30/CD min/NN ./.
@@30656218338/CD Structure/NNS and/CC regulation/NN of/IN a/DT nuclear/JJ gene/NN in/IN Saccharomyces/NN cerevisiae/NN that/WDT specifies/VBZ MRP13/GENE ,/, a/DT protein/NN of/IN the/DT small/JJ subunit/NN of/IN the/DT mitochondrial/JJ ribosome/NN ./.
@@15425657332/CD Nuclear-encoded/JJ chloroplast/NN ribosomal/MULTIGENE protein/MULTIGENE L12/MULTIGENE of/IN Nicotiana/ORG tabacum/NN :/: characterization/NN of/IN mature/JJ protein/NN and/CC isolation/NN and/CC sequence/NN analysis/NN of/IN cDNA/NN clones/NNS encoding/VBG its/PRP cytoplasmic/JJ precursor/NN ./.
@@77970773163/CD The/DT amino-terminal/JJ DNA-binding/NN domain/NN of/IN Pip/NNP exhibits/VBP a/DT high/JJ degree/NN of/IN homology/NN to/IN the/DT DNA-binding/MULTIGENE domains/MULTIGENE of/IN members/NNS of/IN the/DT interferon/MULTIGENE regulatory/MULTIGENE factor/MULTIGENE (/( IRF/GENE )/SYM family/NN ,/, which/WDT includes/VBZ IRF-1/GENE ,/, IRF-2/GENE ,/, ICSBP/CONTEXTGENE ,/, and/CC ISGF3/MULTIGENE gamma/MULTIGENE ./.
@@63705534358/CD Resting/VBG plasma/NN norepinephrine/NN (/( NE/NN )/SYM and/CC epinephrine/NN (/( E/NN )/SYM levels/NNS were/VBD lower/JJR during/IN active/JJ therapy/NN than/IN 2/CD wk/NN after/IN withdrawal/NN (/( guanfacine/NN and/CC control/NN :/: plasma/NN NE/NEWGENE ,/, 0/NN ./NN 27/NN +/NN //NN -/NN 0/CD ./CD 03/CD //CD 0/CD ./CD 64/CD +/NN //NN -/NN 0/CD ./CD 13/CD ng/NN //NN ml/NN ;/: plasma/NN E/NN ,/, 0/NN ./NN 09/NN +/NN //NN -/NN 0/CD ./CD 02/CD //CD 0/CD ./CD 17/CD +/NN //NN -/NN 0/CD ./CD 05/CD ng/NN //NN ml/NN )/SYM ./.
@@10422291960/CD A/DT diagnosis/NN of/IN IgA/MULTIGENE lambda/MULTIGENE multiple/JJ myeloma/NN with/IN peritoneal/JJ involvement/NN was/VBD made/VBP ./.
@@1064124454/CD After/IN 90/NN d/NN a/DT subsurface/NN ,/, radiolucent/JJ caries-like/JJ lesion/NN was/VBD observed/VBN in/IN two/JJ specimens/NNS only/RB ./.
@@106254386168/CD In/NN all/DT tissues/NNS examined/VBD only/JJ transcripts/NNS positive/JJ for/IN insert/NN 3/CD ,/, an/DT 18/CD bp/NN insertion/NN in/IN repeat/NN 21/CD ,/, were/VBD amplified/VBN ,/, even/VB under/IN conditions/NNS in/IN which/WDT a/DT 30%/CD level/NN of/IN insert/NN 3/CD negative/JJ transcript/NN could/MD be/VB easily/RB detected/VBN in/IN artificially/RB prepared/VBN control/NN samples/NNS ./.
@@8432328391/CD The/DT background/NN processes/NNS depending/VBG on/IN the/DT etiological/JJ factor/NN and/CC the/DT character/NN of/IN lesion/NN of/IN the/DT epithelium/NN are/VBP divided/VBN into/IN dyshormonal/JJ ,/, inflammatory/JJ ,/, and/CC posttraumatic/JJ ./.
@@107815521501/CD Purple/NNP photosynthetic/JJ bacteria/NNS are/VBP capable/JJ of/IN generating/JJ cellular/JJ energy/NN from/IN several/DT sources/NNS ,/, including/JJ photosynthesis/NN ,/, respiration/NN ,/, and/CC H/NN (/NN 2/NN )/NN oxidation/NN ./.
@@90689899020/CD Effect/NN of/IN Azadirachta/NNP indica/NN hydroalcoholic/JJ leaf/NN extract/NN on/IN the/DT cardiovascular/JJ system/NN ./.
@@60925886084/CD Hepatitis/MULTIGENE B/MULTIGENE virus/NN and/CC hepatoma/NN ./.
@@79381377905/CD All/DT groups/NNS were/VBD challenged/VBN subsequently/RB with/IN naloxone/NN (/( 0/CD ./CD 4/CD mg/CD //CD kg/CD )/SYM in/IN the/DT distinctive/JJ environment/NN and/CC then/RB observed/VBN for/IN signs/NNS of/IN opiate/JJ withdrawal/NN ./.
@@100510305388/CD No/DT difference/NN in/IN percentage/NN of/IN males/NNS in/IN semen/NN production/NN was/VBD noted/VBN between/IN strains/NNS ,/, CP/NEWGENE levels/NNS ,/, or/CC feeding/JJ regimens/NNS ./.
@@86494406495/CD The/DT heterogeneity/NN of/IN bovine/MULTIGENE IgG2--VIII/MULTIGENE ./.
@@1177481614/CD Erythromycin/IN and/CC clindamycin/NN resistance/NN in/IN Corynebacterium/NN diphtheriae/NNS from/IN skin/NN lesions/NNS ./.
@@3875231473/CD MRI/NN disclosed/VBN one/PRP or/CC more/RB of/IN the/DT following/NN abnormalities/NNS in/IN 24/CD (/( 63%/JJ )/SYM of/IN 38/CD treated/VBN kidneys/NNS :/: (/( 1/CD )/SYM loss/NN of/IN corticomedullary/JJ differentiation/NN ,/, (/( 2/CD )/SYM perirenal/JJ fluid/NN ,/, (/( 3/CD )/SYM subcapsular/JJ hematoma/NN ,/, (/( 4/CD )/SYM hemorrhage/NN into/IN a/DT renal/MULTIGENE cyst/MULTIGENE ,/, and/CC (/( 5/CD )/SYM unexplained/JJ abnormalities/NNS ./.
@@13213373212/CD As/IN was/VBD observed/VBN previously/RB for/IN MATa/NNP cna1/MULTIGENE cna2/MULTIGENE double/JJ mutants/NNS ,/, MATa/NNP cnb1/MULTIGENE mutants/MULTIGENE were/VBD defective/JJ in/IN their/PRP ability/NN to/IN recover/VB from/IN alpha-factor-induced/JJ growth/NN arrest/NN ./.
@@83906659254/CD Lithium/DT phthalocyanine/NN (/( LiPc/GENE )/SYM is/VBZ a/DT prototype/NN of/IN another/DT generation/NN of/IN synthetic/JJ ,/, metallic-organic/JJ ,/, paramagnetic/JJ crystallites/NNS that/WDT appear/VBP very/RB useful/JJ for/IN in/IN vitro/FW and/CC in/IN vivo/NN electron/NN paramagnetic/JJ resonance/NN oximetry/NN ./.
@@107326699087/CD In/NN transient/JJ assays/NNS ,/, using/VBG rice/NN suspension-cultured/JJ cells/NNS transformed/VBN by/IN particle/NN bombardment/NN ,/, we/PRP showed/VBD previously/RB that/IN Oshox1/GENE can/MD transcriptionally/RB repress/VB the/DT activity/NN of/IN reporter/NN gene/NN constructs/NNS with/IN upstream/RB HD-Zip/GENE binding/JJ sites/NNS ./.
@@98193774470/CD A/DT mutation/NN in/IN the/DT 5'/CD C2U4/GENE repeat/NN causes/NNS underaccumulation/NN of/IN snR13F/GENE ,/, whereas/IN mutations/NNS in/IN the/DT 3'/CD C2U4/GENE repeat/NN cause/VBG the/DT accumulation/NN of/IN two/JJ novel/JJ RNAs/NNS that/WDT migrate/VBP in/IN the/DT 500-nt/JJ range/NN ./.
@@109079712661/CD Atorvastatin/GENE was/VBD the/DT most/RB cost-effective/JJ HMG-CoA/MULTIGENE reductase/MULTIGENE inhibitor/MULTIGENE ./.
@@103815705763/CD Slp1/GENE represses/VBZ transcription/NN via/NN this/DT binding/JJ site/NN in/IN yeast/NN cells/NNS ,/, consistent/JJ with/IN its/PRP role/NN as/IN a/DT direct/JJ repressor/NN of/IN ftz/NN stripes/NNS in/IN interstripe/NN regions/NNS during/IN late/JJ stages/NNS of/IN embryogenesis/NN ./.
@@75630728414/CD Comparisons/NNS of/IN rrnB/GENE P1-lacZ/GENE expression/NN at/IN different/JJ ppGpp/NN levels/NNS is/VBZ interpreted/VBN for/IN the/DT rpoD/NN (/NN P504L/NN )/NN mutant/JJ as/IN resulting/VBG from/IN a/DT hypersensitivity/NN to/IN ppGpp/NN ./.
@@17149028430/CD In/NN addition/NN to/IN targeting/JJ partially/RB assembled/VBN Ti/MULTIGENE alpha-beta/MULTIGENE CD3/MULTIGENE gamma/MULTIGENE delta/MULTIGENE epsilon/MULTIGENE TCR/MULTIGENE complexes/NNS to/IN the/DT cell/NN surface/NN ,/, CD3/MULTIGENE zeta/MULTIGENE appears/VBZ to/IN be/VB essential/JJ for/IN interleukin-2/NEWGENE production/NN after/IN TCR/NNP stimulation/NN with/IN antigen/MULTIGENE //MULTIGENE major/MULTIGENE histocompatibility/MULTIGENE complex/MULTIGENE ./.
@@25312036685/CD Quantitative/JJ predictions/NNS are/VBP confirmed/VBN for/IN the/DT positive/JJ responses/NNS ,/, but/CC not/RB for/IN the/DT negatives/NNS ,/, suggesting/VBG that/IN the/DT SSTS/GENE model/NN is/VBZ incorrect/JJ ./.
@@54724855559/CD Bimodal/JJ cochlear/JJ response/NN curves/NNS in/IN rodents/NNS ./.
@@96366702405/CD Structure/NNS of/IN the/DT gene/NN encoding/VBG the/DT human/MULTIGENE cyclin-dependent/MULTIGENE kinase/MULTIGENE inhibitor/MULTIGENE p18/MULTIGENE and/CC mutational/JJ analysis/NN in/IN breast/NN cancer/NN ./.
@@86610079885/CD Human/MULTIGENE MN/MULTIGENE //MULTIGENE CA9/MULTIGENE gene/MULTIGENE ,/, a/DT novel/JJ member/NN of/IN the/DT carbonic/JJ anhydrase/MULTIGENE family/MULTIGENE :/: structure/NN and/CC exon/NN to/IN protein/NN domain/NN relationships/NNS ./.
@@107064753444/CD However/RB ,/, when/CC ,/, where/CC and/CC how/RB the/DT DSPP/NN is/VBZ cleaved/VBN into/IN DSP/NNP and/CC DPP/NN is/VBZ not/RB clear/JJ ./.
@@68630879215/CD Low-dose/NNP D/NN (/( 0/CD ./CD 4-0/CD ./CD 8/CD mg/NN )/SYM and/CC DB/GENE (/( 1/CD ./CD 0-5/CD ./CD 0/CD mg/NN )/SYM did/VBD not/RB significantly/RB alter/VB any/DT parameter/NN from/IN control/NN ./.
@@8312243645/CD We/PRP have/VBP investigated/VBN the/DT influence/NN of/IN NaFe3+EDTA/GENE ,/, and/CC of/IN increasing/JJ dietary/JJ levels/NNS of/IN Na2EDTA/NNP ,/, on/IN Zn/NN ,/, Cu/NN and/CC Ca/NN metabolism/NN in/IN rats/NNS fed/VBN on/IN Zn-sufficient/NNP and/CC Zn-deficient/NNP soya-bean-isolate-based/JJ diets/NNS ./.
@@84640568868/CD Further/JJ evidence/NN for/IN a/DT clustered/VBN organization/NN of/IN FAX-ZFP/NEWGENE transcription/NN units/NNS is/VBZ provided/VBN by/IN Southern/NNP blot/NN analysis/NN of/IN large/JJ genomic/JJ restriction/NN fragments/NNS separated/VBN by/IN transverse/JJ field/NN gel/NN electrophoresis/NN ,/, and/CC by/IN in/IN situ/NN hybridization/NN on/IN intact/JJ chromosomes/NNS ./.
@@105422374216/CD Here/RB ,/, we/PRP show/VBP that/IN aortic/JJ explants/NNS isolated/VBN from/IN PPARalpha-null/NNP mice/NNS display/NN an/DT exacerbated/VBN response/NN to/IN inflammatory/JJ stimuli/NNS ,/, such/JJ as/IN lipopolysaccharide/NN (/( LPS/NN )/SYM ,/, as/IN demonstrated/VBN by/IN increased/JJ IL-6/NEWGENE secretion/NN ./.
@@43359654938/CD Metastasis/NNS of/IN colon/NN carcinoma/NN to/IN the/DT lip/NN ./.
@@79537857934/CD During/IN heat/NN exposure/NN ,/, chicks/NNS that/WDT had/VBP been/VBN subjected/VBN to/IN early/JJ 60%/CD restriction/NN with/IN non-metyrapone-treated/JJ food/NN had/VBP lower/JJR H/NNS //NNS L/NNS ratios/NNS and/CC improved/VBN resistance/NN to/IN marble/NN spleen/NN disease/NN infection/NN ./.
@@21605028797/CD No/DT recombination/NN signal/JJ sequences/NNS have/VBP been/VBN found/VB contiguous/JJ to/IN the/DT recombination/NN point/NN ./.
@@22092378138/CD Abnormal/JJ intrapulmonary/JJ shunting/NN (/( IPS/NNS )/SYM ,/, which/WDT was/VBD proved/VBN in/IN 4/CD cases/NNS by/IN whole-body/NN radionuclide/NN scanning/JJ with/IN 99mTc-MAA/NN ,/, is/VBZ suggested/VBN as/IN the/DT major/JJ cause/NN of/IN cyanosis/NN in/IN liver/NN cirrhosis/NN ./.
@@75194476861/CD Organization/NNP of/IN the/DT bovine/MULTIGENE gene/MULTIGENE encoding/VBG the/DT endothelial/JJ nitric/JJ oxide/MULTIGENE synthase/MULTIGENE ./.
@@30269152099/CD The/DT 5'-nontranslated/JJ sequences/NNS and/CC parts/NNS of/IN the/DT coding/JJ sequences/NNS of/IN various/JJ yeast/NN genes/NNS have/VBP been/VBN cloned/VBN into/IN representative/JJ lacZ/MULTIGENE fusion/MULTIGENE vectors/MULTIGENE ./.
@@98409322259/CD In/NN this/DT study/NN we/PRP provide/VBP evidence/VBP that/IN B-Myb/GENE is/VBZ a/DT direct/JJ physiological/JJ target/NN for/IN cyclin/NN A/NNP //NNP Cdk2/NNP ./.
@@107217049162/CD Thus/RB ,/, while/CC the/DT genomic/JJ organization/NN of/IN mHuA/NN is/VBZ similar/JJ to/IN the/DT neural-restricted/MULTIGENE members/MULTIGENE of/IN the/DT Elav/MULTIGENE family/MULTIGENE ,/, the/DT promoter/NN element/NN differs/VBZ substantially/RB both/DT by/IN sequence/NN analysis/NN and/CC transcriptional/JJ activity/NN in/IN non-neural/JJ cell/NN types/NNS ./.
@@3963860417/CD A/DT total/NN of/IN 90/CD patients/NNS were/VBD randomly/RB allocated/VBN either/DT to/IN an/DT MY-1/GENE treated/VBN or/CC an/DT untreated/JJ group/NN ./.
@@17748222377/CD Using/VBG an/DT image-processing/NN computer/NN ,/, regional/MULTIGENE LV/MULTIGENE time-density/JJ curves/NNS were/VBD constructed/VBN for/IN one/PRP cardiac/JJ cycle/NN ./.
@@75342867115/CD A/DT chicken/MULTIGENE paxillin/MULTIGENE cDNA/MULTIGENE was/VBD also/RB cloned/VBN and/CC is/VBZ predicted/VBN to/IN encode/VB a/DT protein/NN approximately/RB 90%/NN identical/JJ to/IN human/JJ paxil-lin/NN ./.
@@36022611174/CD In/NN the/DT normal/NN ,/, basal/JJ (/( unstimulated/JJ )/SYM condition/NN there/RB were/VBD no/DT significant/JJ correlations/NNS (/( p/NN greater/JJR than/IN 0/CD ./CD 05/CD )/SYM between/IN the/DT systolic/JJ blood/NN pressure/NN and/CC dopamine/NN (/( r/JJ =/SYM 0/CD ./CD 09/CD )/SYM ,/, norepinephrine/NN (/( r/JJ =/SYM 0/CD ./CD 26/CD )/SYM ,/, or/CC epinephrine/NN (/( r/JJ =/SYM 0/CD ./CD 27/CD )/SYM ,/, nor/CC were/VBD there/RB significant/JJ correlations/NNS between/IN melatonin/NN and/CC dopamine/NN (/( r/JJ =/SYM -0/CD ./CD 01/CD )/SYM ,/, norepinephrine/NN (/( r/JJ =/SYM -0/CD ./CD 26/CD )/SYM ,/, or/CC growth/NN hormone/NN (/( r/JJ =/SYM 0/CD ./CD 17/CD )/SYM ./.
@@112187396561/CD Transition/NN between/IN P-/NN and/CC H-BPPV/GENE was/VBD found/VBN in/IN 6/CD cases/NNS ./.
@@10647633117/CD The/DT study/NN suggests/VBZ the/DT presence/NN of/IN an/DT anatomical/JJ sphincter/NN at/IN the/DT RSJ/GENE which/WDT seems/VBZ to/IN regulate/VB the/DT passage/NN of/IN stools/NNS from/IN the/DT sigmoid/JJ colon/NN to/IN the/DT rectum/NN ./.
@@90058368970/CD No/DT correlation/NN between/IN the/DT age/NN of/IN the/DT horses/NNS and/CC the/DT antibody/NN level/NN could/MD be/VB found/VB ./.
@@79784067971/CD In/NN the/DT ISO/NN group/NN ,/, at/IN pre-DEX/JJ ,/, CBF/NN increased/VBD from/IN 86/CD +/NN //NN -/NN 8/CD to/IN 166/CD +/NN //NN -/NN 19/MULTIGENE mL/MULTIGENE ./MULTIGENE min-1/MULTIGENE ./MULTIGENE 100/MULTIGENE g-1/MULTIGENE in/IN response/NN to/IN hypercapnia/NN (/( PCO2/GENE approximately/RB 90/CD mmHg/NN )/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@106186456771/CD Maximum/NNP induction/NN of/IN AP-1/GENE was/VBD reached/VBN at/IN a/DT concentration/NN of/IN 250/CD nmol/NN //NN L/NN of/IN CalC/NNP ./.
@@78988409179/CD Pregnancy/NNS screening/JJ by/IN uterine/JJ artery/NN Doppler/NN velocimetry--which/JJ criterion/NN performs/VBZ best/JJS ?/. OBJECTIVE/IN :/: To/TO test/VB whether/IN repeating/JJ Doppler/NN studies/NNS of/IN the/DT uteroplacental/JJ circulation/NN late/RB in/IN gestation/NN will/MD improve/VB the/DT test's/NNS power/NN for/IN predicting/JJ pregnancy-induced/JJ hypertension/NN and/CC fetal/JJ growth/NN restriction/NN (/( FGR/GENE )/SYM ,/, and/CC whether/IN analysis/NN based/VBN on/IN a/DT combination/NN of/IN quantitative/JJ and/CC qualitative/JJ assessments/NNS of/IN the/DT uterine/JJ arterial/JJ waveforms/NNS will/MD yield/VB better/JJR results/NNS than/IN analysis/NN based/VBN on/IN either/DT alone/RB ./.
@@10852460660/CD The/DT relationships/NNS among/IN blood/NN concentrations/NNS of/IN thyroid/JJ hormones/NNS and/CC selenium/NN ,/, zinc/NN ,/, retinol/NN ,/, and/CC alpha-tocopherol/NN were/VBD studied/VBN in/IN 44/CD healthy/JJ Northern/NNP Italian/JJ oldest-old/JJ subjects/NNS (/( age/NN range/NN ,/, 90-107/CD yr/NN )/SYM ,/, selected/VBN by/IN the/DT criteria/NNS of/IN the/DT SENIEUR/GENE protocol/NN ./.
@@40750214892/CD [/NN 14C/NN ]/NN -beta-phenethylamine/NN ,/, its/PRP distribution/NN after/IN administration/NN by/IN various/JJ routes/NNS to/IN cats/NNS ,/, and/CC the/DT effects/NNS of/IN monoamine/MULTIGENE oxidase/MULTIGENE inhibitors/MULTIGENE ./.
@@33063404966/CD The/DT intrapancreatic/JJ spread/NN of/IN the/DT carcinoma/NN correlated/VBN with/IN portal/JJ invasion/NN of/IN carcinoma/NN ,/, hardness/NN of/IN the/DT body/NN and/CC tail/NN ,/, obstruction/NN of/IN main/JJ pancreatic/JJ duct/NN and/CC irregular/JJ pancreaticogram/NN ./.
@@52741285443/CD The/DT content/NN of/IN glucosamine/NN and/CC galactosamine/NN in/IN tartar/NN ./.
@@75596403706/CD The/DT two/JJ bases/NNS immediately/RB flanking/JJ the/DT 5'/CD end/NN of/IN the/DT element/NN proved/VBN to/IN be/VB very/RB important/JJ to/IN its/PRP function/NN as/IN a/DT UAS/MULTIGENE element/MULTIGENE as/IN did/VBD the/DT two/JJ bases/NNS immediately/RB 3'/CD of/IN the/DT bHLH/GENE core/NN motif/NN ./.
@@80812938059/CD 2/CD ./CD
@@21762093714/CD Moreover/RB ,/, radiolabeled/JJ EFI/GENE ,/, NF-Y/GENE ,/, or/CC CBF/MULTIGENE DNAs/MULTIGENE give/VBP rise/NN to/IN identical/JJ gel/NN retardation/NN patterns/NNS in/IN extracts/NNS from/IN a/DT variety/NN of/IN different/JJ cell/NN types/NNS ./.
@@17592822357/CD Issues/NNS of/IN distribution/NN of/IN kinetic/JJ energy/NN of/IN traumatizing/JJ object/NN in/IN direct/JJ contact/NN interaction/NN with/IN head/JJ during/IN impact/NN are/VBP discussed/VBN from/IN position/NN of/IN biomechanics/NN ./.
@@7014626792/CD Urine/NNS antibodies/NNS could/MD not/RB be/VB demonstrated/VBN in/IN any/DT other/DT cases/NNS ./.
@@81882583738/CD Glutamyl-tRNA/MULTIGENE synthetase/MULTIGENE and/CC prolyl-tRNA/MULTIGENE synthetase/MULTIGENE belong/VB to/IN different/JJ classes/NNS of/IN aminoacyl-tRNA/MULTIGENE synthetases/MULTIGENE that/WDT are/VBP thought/VBP to/IN have/NN evolved/VBN along/IN independent/JJ evolutionary/JJ pathways/NNS ./.
@@13344936507/CD This/DT soluble/JJ form/NN of/IN the/DT HGFr/NNP (/( sHGFr/NN )/SYM bound/JJ HGF/NEWGENE with/IN an/DT affinity/NN similar/JJ to/IN that/DT of/IN the/DT authentic/NN ,/, membrane-associated/MULTIGENE receptor/MULTIGENE ./.
@@38712981836/CD Single/NNP photon/NN emission/NN computerized/JJ tomography/NN (/( SPECT/NN )/SYM ,/, by/IN providing/CC three-dimensional/JJ representation/NN of/IN myocardial/JJ Tl-201/GENE ,/, offers/VBP promise/VB for/IN improved/VBN localization/NN of/IN CAD/NN ./.
@@9339900470/CD Functional/JJ analysis/NN of/IN promoter/NN activity/NN of/IN the/DT 5'-flanking/JJ region/NN of/IN cyclin/MULTIGENE D2/MULTIGENE suggested/VBN that/IN the/DT region/NN -/: 1/CD ,/CD 100/CD to/IN -/: 805/CD including/JJ C/CONTEXTGENE //CONTEXTGENE EBP/CONTEXTGENE ,/, PEA3/GENE ,/, AP2/GENE ,/, NF-Y/GENE ,/, c-Myc/GENE ,/, and/CC Sp1/GENE may/MD have/VB a/DT major/JJ positive/JJ regulatory/JJ activity/NN for/IN expression/NN of/IN cyclin/NN D2/NNP ./NNP
@@2196748343/CD Technetium-99m/GENE stannous/JJ pyrophosphate/NN myocardial/JJ scintigrams/NNS were/VBD obtained/VBN in/IN 138/CD clinically/RB stable/JJ patients/NNS 32/CD ./CD 7/CD +/NN //NN -/NN 47/CD ./CD 3/CD weeks/NNS (/( range/NN 6/CD to/IN 260/CD )/SYM after/IN acute/JJ myocardial/JJ infarction/NN ./.
@@111854751027/CD By/IN Caveman/NNP ./.
@@86316674545/CD Identification/NNP of/IN this/DT region/NN as/IN the/DT E/NNP ./NNP coli/JJ tmk/MULTIGENE gene/MULTIGENE was/VBD confirmed/VBN by/IN functional/JJ complementation/NN of/IN a/DT yeast/MULTIGENE dTMP/MULTIGENE kinase/MULTIGENE temperature-sensitive/JJ mutant/JJ and/CC by/IN in/IN vitro/MULTIGENE enzyme/MULTIGENE assay/NN of/IN the/DT thymidylate/MULTIGENE kinase/MULTIGENE activity/NN in/IN cell/NN extracts/NNS of/IN E/NNP ./NNP coli/JJ by/IN use/NN of/IN tmk-overproducing/JJ plasmids/NNS ./.
@@9037728995/CD Wherever/WRB the/DT site/NN of/IN the/DT conditioning/JJ stimulation/NN ,/, these/DT modifications/NNS disappeared/VBN after/IN ischaemia/NN of/IN the/DT leg/NN ./.
@@26769453350/CD 62/CD :/: 2491-2499/CD ,/, 1987/NN )/NN ./.
@@10933728763/CD These/DT results/NNS further/JJ support/NN an/DT important/JJ role/NN for/IN CBF2/GENE in/IN mediating/JJ EBNA2/GENE transactivation/NN ;/: they/PRP identify/VBP the/DT hnRNP/MULTIGENE protein/MULTIGENE AUF1/MULTIGENE as/IN a/DT major/JJ component/NN of/IN CBF2/GENE and/CC are/VBP also/RB the/DT first/JJ evidence/NN of/IN a/DT cis-acting/JJ sequence/NN other/DT than/IN a/DT CBF1/MULTIGENE binding/MULTIGENE element/MULTIGENE that/WDT is/VBZ able/JJ to/IN confer/VB responsiveness/NN to/IN EBNA2/GENE ./.
@@48840605221/CD The/DT Twentieth/NNP Anniversary/NNP of/IN the/DT Pomeranian/NNP Medical/NNP Academy/NNP ./.
@@9778191609/CD We/PRP have/VBP developed/VBN a/DT new/JJ method/NN for/IN estimation/NN of/IN regional/MULTIGENE CBF/MULTIGENE (/( rCBF/GENE )/SYM and/CC cerebrovascular/JJ reserve/NN capacity/NN on/IN a/DT pixel-by-pixel/JJ basis/NN by/IN means/NN of/IN dynamic/JJ magnetic/JJ resonance/NN imaging/JJ (/( MRI/NN )/SYM ./.
@@106410373799/CD AF154055/GENE ./.
@@33462107416/CD The/DT epidermal/MULTIGENE growth/MULTIGENE factor/MULTIGENE (/( EGF/CONTEXTGENE )/SYM receptor/NN ,/, which/WDT exhibits/VBP intrinsic/MULTIGENE protein/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE activity/NN ,/, undergoes/VBZ a/DT rapid/NN ,/, intramolecular/JJ self-phosphorylation/NN reaction/NN following/IN EGF/NEWGENE activation/NN ./.
@@36794079181/CD These/DT results/NNS suggest/VBP that/IN N-nitroso/GENE compounds/NNS can/MD be/VB formed/VBN in/IN vivo/NN in/IN the/DT infected/VBN bladder/NN ,/, which/WDT could/MD explain/VB the/DT association/NN between/IN urinary-tract/NN infections/NNS and/CC increased/VBN risk/NN for/IN bladder/NN cancer/NN ./.
@@97503259736/CD The/DT effects/NNS of/IN high/JJ intensity/NN light/JJ emissions/NNS ,/, produced/VBN by/IN a/DT novel/JJ pulsed/JJ power/NN energization/NN technique/NN (/( PPET/NNP )/SYM ,/, on/IN the/DT survival/NN of/IN bacterial/JJ populations/NNS of/IN verocytotoxigenic/JJ Escherichia/NN coli/JJ (/( serotype/NN 0157/CD :/: H7/IN )/SYM and/CC Listeria/NN monocytogenes/NNS (/( serotype/NN 4b/CD )/SYM were/VBD investigated/VBN ./.
@@94094163074/CD Bilateral/JJ basal/JJ arteries/NNS were/VBD measured/VBN by/IN the/DT transtemporal/JJ approach/NN with/IN a/DT 2/CD MHz/NN pulsed/JJ Doppler/NN instrument/NN (/( TC-2/MULTIGENE 64B/MULTIGENE EME/GENE )/SYM ./.
@@7874060460/CD TDEYA/NNP at/IN doses/NNS of/IN 200/CD to/IN 500/CD mg/CD //CD kg/CD significantly/RB suppressed/VBN xanthine/MULTIGENE oxidase/MULTIGENE (/( XO/CONTEXTGENE )/SYM activity/NN in/IN the/DT stomach/NN tissue/NN following/IN its/PRP oral/JJ administration/NN ./.
@@111614551652/CD Southern/NNP blot/NN analysis/NN of/IN genomic/JJ DNA/NN from/IN somatic/JJ cell/NN hybrids/NNS showed/VBN that/IN endothelial-TACC-related/MULTIGENE cDNA/MULTIGENE maps/NNS to/IN chromosome/NN 10/CD ./CD
@@91591117130/CD We/PRP have/VBP tested/VBN this/DT proposal/NN by/IN carrying/JJ out/RB circular/JJ dichroism/NN (/( CD/NN )/SYM and/CC NMR/NN experiments/NNS on/IN the/DT Skn/NN domain/NN and/CC five/CD truncated/JJ proteins/NNS ./.
@@86282544624/CD We/PRP show/VBP here/RB that/IN these/DT Jun/GENE //GENE eb1/GENE chimeras/NNS are/VBP potent/JJ transactivators/NNS of/IN AP1/MULTIGENE sites/MULTIGENE and/CC that/IN they/PRP can/MD cooperate/VB with/IN c-Ha-Ras/GENE to/IN induce/VB foci/NNS ./.
@@72180084620/CD Visual/JJ response/NN properties/NNS of/IN neurons/NNS in/IN four/CD extrastriate/MULTIGENE visual/MULTIGENE areas/NNS of/IN the/DT owl/NN monkey/NN (/( Aotus/NN trivirgatus/NN )/SYM :/: a/DT quantitative/JJ comparison/NN of/IN medial/JJ ,/, dorsomedial/JJ ,/, dorsolateral/JJ ,/, and/CC middle/JJ temporal/JJ areas/NNS ./.
@@78362286031/CD An/DT interatrial/JJ communication/NN mitigates/VBZ the/DT impairment/NN of/IN LV/NN function/NN after/IN an/DT acute/JJ and/CC sustained/JJ drop/NN of/IN intrathoracic/JJ pressure/NN ./.
@@33711394057/CD The/DT former/JJ group/NN did/VBD excrete/VB less/PRP dry/JJ fecal/JJ material/NN compared/VBN to/IN both/PDT other/DT groups/NNS ./.
@@91214356610/CD Domains/MULTIGENE I/MULTIGENE and/CC II/NNP of/IN B"/GENE are/VBP buried/VBN upon/IN assembly/NN of/IN the/DT TFIIIB-DNA/MULTIGENE complex/MULTIGENE ,/, as/IN determined/VBN by/IN protein/NN footprinting/VBG ./.
@@80577621891/CD We/PRP have/VBP found/VBN a/DT satisfactory/JJ reproducibility/NN in/IN vitro/FW (/( T1/NN :/: 1/CD ./CD 9%/CD ;/: T2/GENE :/: 6/CD ./CD 2%/CD )/SYM ,/, while/CC the/DT reproducibility/NN was/VBD less/PRP satisfactory/JJ in/IN vivo/NN (/( T1/NN :/: 16/CD ./CD 4%/CD ;/: T2/GENE :/: 13/CD ./CD 4%/CD )/SYM ./.
@@71958807023/CD This/DT test/NN should/MD provide/VB another/DT practical/JJ means/NN to/IN study/NN leprosy/NN ./.
@@77528869261/CD The/DT smallest/JJS active/JJ FecR/GENE derivative/NN contained/VBN 59/CD amino/JJ acid/NN residues/NNS as/IN compared/VBN to/IN the/DT 317/CD residues/NNS of/IN wild-type/NN FecR/GENE ./.
@@52843105452/CD The/DT non-role/NN of/IN fluoride/NN in/IN the/DT control/NN of/IN plasma/NN calcium/NN in/IN the/DT parathyroidectomized/VBN rat/NN ./.
@@76664151128/CD The/DT nucleotide/NN sequence/NN of/IN the/DT chloroplast/NN (/( cp/NN )/SYM DNA/NN from/IN maize/NN (/( Zea/GENE mays/VBZ )/SYM has/VBZ been/VBN completed/VBN ./.
@@87945478777/CD Although/IN basal/JJ vessels/NNS may/MD constrict/VB distal/JJ parenchymal/JJ vessels/NNS tend/VBP to/IN dilate/VB after/IN SAH/NN ./.
@@75927061486/CD Exchange/NNP of/IN the/DT LPL/NN and/CC HL/NN lids/NNS resulted/VBN in/IN a/DT reversal/NN of/IN the/DT phospholipase/MULTIGENE //MULTIGENE neutral/MULTIGENE lipase/MULTIGENE ratio/NN ,/, establishing/VBG the/DT important/JJ role/NN of/IN this/DT region/NN in/IN mediating/JJ substrate/NN specificity/NN ./.
@@63360456126/CD Frog/NN type/NN I/NN (/( Ft/NN I/NN )/SYM and/CC frog/NN type/NN II/NN (/( Ft/NN II/NN )/SYM slowly/RB adapting/JJ (/( SA/NNP )/SYM units/NNS produced/VBD spikes/NNS only/RB at/IN the/DT indentation/NN phase/NN ,/, and/CC the/DT threshold/NN response/NN phase/NN (/( TRP/NN )/SYM ,/, i/FW ./FW e/FW ./FW ./. the/DT phase/NN of/IN the/DT first/JJ spike/NN was/VBD for/IN ca/NN ./NN
@@54744662436/CD A/DT new/JJ hemagglutination/NN test/NN for/IN the/DT on-slide/JJ assay/NN of/IN rheumatoid/MULTIGENE factor/MULTIGENE ./.
@@92236677453/CD Through/IN transient/JJ transfection/NN of/IN NIH3T3/NNP fibroblast/NN cells/NNS and/CC gel/NN mobility/NN shift/NN assays/NNS ,/, the/DT functional/JJ binding/JJ site/NN was/VBD localized/VBN to/IN a/DT short/JJ region/NN (/( -318/CD to/IN -303/CD bp/NN from/IN the/DT transcription/NN start/NN site/NN )/SYM which/WDT has/VBZ a/DT CTCCC/MULTIGENE sequence/MULTIGENE ./.
@@96504039625/CD The/DT DHEAS/NN levels/NNS in/IN all/DT stages/NNS of/IN decreased/VBN BMD/NN were/VBD significantly/RB lower/JJR than/IN those/DT in/NN the/DT group/NN with/IN normal/JJ BMD/NN ./.
@@15960076120/CD Most/JJS apneic/JJ events/NNS occurred/VBN during/IN Stages/NNS I/PRP and/CC II/NNP ,/, and/CC REM/NN ,/, but/CC this/DT proportion/NN was/VBD less/PRP during/IN the/DT gamma/MULTIGENE OH/MULTIGENE study/NN (/( 77/CD ./CD 9/CD +/NN //NN -/NN 8/CD ./CD 9%/CD )/SYM than/IN during/IN the/DT control/NN studies/NNS (/( 92/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 9/CD and/CC 95/CD ./CD 9/CD +/NN //NN -/NN 2/CD ./CD 2%/CD )/SYM ,/, apneas/NNS occurring/VBG even/VB during/IN SWS/NN with/IN gamma/JJ OH/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@114043121268/CD 10/CD ./CD 0/CD +/NN //NN -/NN 2/CD ./CD 0/CD pmol/GENE //GENE 24/GENE h/NN ,/, P/NN </SYM 0/NN ./NN 01/NN )/NN and/CC remained/VBN elevated/VBN ./.
@@91404749082/CD Is/VBZ leishmaniasis/NN endemic/JJ on/IN the/DT island/NN of/IN Minorca/NNP (/( Spain/NN )/SYM ?/. A/DT human/MULTIGENE visceral/MULTIGENE case/NN after/IN living/JJ 13/CD years/NNS in/IN Minorca/NNP ./.
@@93330186113/CD Interferon/MULTIGENE Regulatory/MULTIGENE Factor/MULTIGENE (/( IRF/GENE )/NN -1/NN has/VBZ been/VBN characterized/VBN as/IN an/DT important/JJ growth/NN regulatory/JJ and/CC immunomodulatory/JJ transcription/NN factor/NN ./.
@@82048244370/CD A/DT genomic/JJ clone/NN for/IN the/DT cyc07/MULTIGENE gene/MULTIGENE ,/, which/WDT is/VBZ expressed/VBN specifically/RB at/IN the/DT S/NNP phase/NN during/IN the/DT cell/NN cycle/NN in/IN synchronous/JJ cultures/NNS of/IN periwinkle/NN (/( Catharanthus/NNP roseus/NN )/SYM cells/NNS ,/, was/VBD isolated/VBN ./.
@@82943868274/CD BACKGROUND/IN :/: To/TO determine/VB the/DT predictors/NNS of/IN desipramine-refractory/JJ depression/NN ,/, the/DT authors/NNS examined/VBD the/DT outcome/NN in/IN patients/NNS with/IN major/JJ depression/NN who/WP were/VBD admitted/VBN to/IN a/DT general/JJ hospital/NN and/CC treated/VBN with/IN desipramine/NN adjusted/VBN to/IN an/DT adequate/JJ blood/NN level/NN ./.
@@92388609635/CD It/PRP is/VBZ present/VB in/IN the/DT nucleus/NN of/IN the/DT cells/NNS in/IN which/WDT it/PRP is/VBZ expressed/VBN and/CC can/MD phosphorylate/VB and/CC activate/VB the/DT cyclic/JJ AMP/MULTIGENE response/MULTIGENE element/MULTIGENE binding/MULTIGENE proteins/MULTIGENE CREB/MULTIGENE and/CC CREM/MULTIGENE tau/MULTIGENE in/IN a/DT manner/NN analogous/JJ to/IN protein/MULTIGENE kinase/MULTIGENE A/NNP ./NNP
@@118305444091/CD Herceptin/NNP ,/, which/WDT recognizes/VBZ the/DT HER-2/GENE //GENE neu/GENE antigen/NN and/CC has/VBZ similar/JJ size/NN (/( 10/CD nm/NN )/SYM to/IN G6-/NN (/NN 1B4M-Gd/NN )/NN (/NN 256/NN )/NN ,/, accumulated/VBN and/CC internalized/VBN in/IN the/DT WIBC-9/CD tumors/NNS more/RB quickly/RB than/IN in/IN the/DT control/MULTIGENE MC-5/MULTIGENE tumors/NNS that/WDT progress/VBP with/IN normal/JJ angiogenesis/NN ./.
@@82606353387/CD This/DT intron/NN occupies/VBZ a/DT conserved/VBN position/NN corresponding/JJ to/IN that/DT of/IN intron/NN 1/CD in/IN the/DT transit/NN peptide/NN region/NN of/IN chloroplast/NN GAPDH/MULTIGENE genes/MULTIGENE (/( GapA/GENE and/CC GapB/GENE )/SYM of/IN higher/JJ plants/NNS ./.
@@17715931627/CD We/PRP conclude/VBP that/DT TA/NN caused/VBD a/DT specific/JJ decrease/NN in/IN AGD/NNS on/IN GD/MULTIGENE 20/MULTIGENE that/WDT was/VBD largely/RB reversed/VBN by/IN PCD/NN 23/CD ./CD
@@95051359468/CD Peripheral/MULTIGENE visual/MULTIGENE stimuli/NNS and/CC monoaural/JJ auditory/JJ stimuli/NNS were/VBD used/VBN as/IN targets/NNS ./.
@@107829897791/CD The/DT interaction/NN does/VBP not/RB depend/VB on/IN the/DT presence/NN of/IN the/DT correct/JJ amino-terminal/MULTIGENE DNA/MULTIGENE binding/JJ domain/NN or/CC the/DT amino/JJ acid/NN sequences/NNS between/IN the/DT DNA/NN binding/JJ domain/NN and/CC the/DT last/NN ten/CD amino/JJ acids/NNS ./.
@@39980719517/CD Electrochemical/NNP detection/NN of/IN depressed/VBN circulating/JJ levels/NNS of/IN vitamin/NN K1/GENE in/IN osteoporosis/NN ./.
@@94278444985/CD Conversely/RB ,/, the/DT inactive/JJ dAK/MULTIGENE subunit/MULTIGENE is/VBZ progressively/RB activated/VBN by/IN 1/NN )/NN association/NN with/IN a/DT dGK/GENE or/CC dCK/MULTIGENE subunit/MULTIGENE and/CC 2/NN )/NN the/DT conformationally/RB driven/VBP heterotropic/JJ affect/NN of/IN dGuo/NN or/CC dCyd/NN bound/JJ to/IN the/DT opposing/JJ subunit/NN ./.
@@1048808732/CD Mutation/NN of/IN TTF-1-binding/MULTIGENE sites/MULTIGENE (/( TBE/NNP )/SYM 1/CD ,/, 3/CD ,/, and/CC 4/CD in/IN combination/NN markedly/RB decreased/VBD transcriptional/JJ activity/NN of/IN SP-A/MULTIGENE promoter-chloramphenicol/MULTIGENE acetyltransferase/MULTIGENE constructs/MULTIGENE containing/MULTIGENE SP-A/MULTIGENE gene/MULTIGENE sequences/MULTIGENE from/IN -256/CD to/IN +45/CD ./.
@@8749428736/CD Unrecognized/JJ amnionitis/NN and/CC prematurity/NN :/: a/DT preliminary/JJ report/NN ./.
@@84112766741/CD A/DT patient/NN matches/VBZ a/DT PIC/NNP patient/NN if/IN both/DT have/NN the/DT same/JJ mechanism/NN of/IN injury/NN ,/, the/DT same/JJ coding/NN of/IN Revised/NNP Trauma/NN Score/NN variables/NNS (/( Glascow/NNP Coma/NNP Scale/NNP score/NN ,/, systolic/JJ blood/NN pressure/NN ,/, respiratory/JJ rate/NN )/SYM ,/, the/DT same/RB coded/VBN age/NN per/IN A/DT Severity/NN Characterization/NNS of/IN Trauma/NN )/NN (/( ASCOT/NNP )/SYM ,/, and/CC if/IN they/PRP differ/VBP by/IN no/DT more/RB than/IN 0/CD ./CD 5/CD for/IN A/DT ,/, B/NNP ,/, and/CC C/NN (/( the/DT ASCOT/NN components/NN for/IN serious/JJ injuries/NNS )/SYM ./.
@@88082756474/CD Although/IN the/DT RAD23/GENE equivalents/NNS are/VBP well/VB conserved/VBN during/IN evolution/NN ,/, the/DT mammalian/JJ genes/NNS did/VBD not/RB express/VB the/DT UV-inducible/NNP phenotype/NN of/IN their/PRP yeast/NN counterpart/NN ./.
@@57740625714/CD Measurement/NNP of/IN gastric/JJ acid/NN secretion/NN by/IN conductivity/NN ./.
@@26865887919/CD Routine/JJ clinical/JJ analysis/NN revealed/VBN lower/JJR hematocrit/NN and/CC hemoglobin/NN ,/, and/CC elevated/VBD BUN/NN and/CC alkaline/MULTIGENE phosphatase/MULTIGENE in/IN the/DT treated/VBN group/NN ./.
@@83170922462/CD The/DT C-terminal/MULTIGENE region/MULTIGENE of/IN the/DT 150-kDa/MULTIGENE protein/MULTIGENE contains/VBZ an/DT NTP-binding/MULTIGENE helicase/MULTIGENE motif/MULTIGENE and/CC the/DT readthrough/NN region/NN ,/, an/DT RNA/MULTIGENE polymerase/MULTIGENE motif/MULTIGENE ,/, indicating/VBG that/IN these/DT two/JJ overlapping/JJ proteins/NNS may/MD form/VB an/DT RNA/NN replication/NN complex/NN similar/JJ to/IN those/DT of/IN tobamo-/JJ and/CC tobraviruses/NNS ./.
@@14646067172/CD Comparable/JJ amounts/NNS of/IN alpha/MULTIGENE 5/MULTIGENE beta/MULTIGENE 1/MULTIGENE integrin/MULTIGENE were/VBD isolated/VBN from/IN these/DT cells/NNS by/IN chromatography/NN of/IN detergent/JJ extracts/NNS on/IN a/DT fibronectin/MULTIGENE cell-binding/MULTIGENE fragment/MULTIGENE affinity/NN column/NN and/CC elution/NN with/IN EDTA/NN ./.
@@67958328585/CD In/NN the/DT course/NN of/IN Hepatitis/MULTIGENE A/MULTIGENE HBs-/MULTIGENE and/CC HBe-antigen/NNP as/NNP well/VB as/IN HBc/NN (/NN IgM/NN and/CC IgG/NN )/NN -/NN ,/, HBs-/NNP and/CC HBe-antibodies/NNS can/MD be/VB detected/VBN ./.
@@97653728293/CD The/DT high/JJ density/NN of/IN tegumental/JJ spines/NNS on/IN posterior/JJ half/NN of/IN the/DT body/NN and/CC the/DT distribution/NN of/IN type/MULTIGENE II/MULTIGENE papillae/NNS on/IN dorsal/JJ surface/NN are/VBP considered/VBN to/IN be/VB characteristic/NN of/IN C/NNP ./NNP armatus/NN ./.
@@83212275104/CD It/PRP could/MD be/VB detected/VBN exclusively/RB in/IN the/DT culture/NN medium/NN of/IN cDNA-transfected/JJ COS/NN cells/NNS ./.
@@87558987855/CD Two/CD classes/NNS of/IN Xanthomonas/NNP pathogens/NNS evading/JJ Bs2/GENE host/NN resistance/NN and/CC displaying/VBG reduced/VBN fitness/NN were/VBD found/VBN to/IN be/VB specifically/RB mutated/JJ in/IN avrBs2/NNP ./.
@@31333606625/CD Our/PRP findings/NNS suggest/VBP that/IN the/DT mtr/MULTIGENE product/MULTIGENE causes/VBZ both/DT transcription/NN attenuation/NN and/CC inhibition/NN of/IN translation/NN of/IN trpE/MULTIGENE mRNA/MULTIGENE ./.
@@665336941/CD At/NN the/DT same/JJ time/NN we/PRP obtained/VBD easily/RB understandable/JJ EEG-information/GENE which/WDT has/VBZ never/RB previously/RB been/VBN available/JJ to/IN us/CD ./CD
@@11937701845/CD Air/NNP ion/NN action/NN on/IN bacteria/NNS ./.
@@103471974674/CD Induction/NNS of/IN the/DT urokinase/MULTIGENE promoter/MULTIGENE by/IN HGF/GENE //GENE SF/GENE via/NN the/DT Met/MULTIGENE receptor/MULTIGENE was/VBD blocked/VBN by/IN co-expression/NN of/IN a/DT dominant-negative/JJ Grb2/GENE and/CC Sos1/GENE expression/NN construct/NN ./.
@@8296434419/CD The/DT Harleco/NN apparatus/NN is/VBZ a/DT simple/NN ,/, useful/JJ ,/, cost-effective/JJ adjunct/NN to/IN the/DT diagnosis/NN and/CC treatment/NN of/IN this/DT life-threatening/JJ condition/NN ./.
@@71794127252/CD The/DT average/JJ annual/JJ cost/NN per/IN head/NN of/IN population/NN was/VBD US+0/MULTIGENE X/MULTIGENE 46/CD ./CD
@@13108791570/CD A/DT patient/JJ suffering/JJ from/IN heparin-associated/JJ thrombocytopenia/NN (/( HAT/GENE )/SYM ,/, recurrent/JJ arteriothromboses/NNS ,/, and/CC acute/JJ renal/JJ failure/NN after/IN treatment/NN with/IN standard/JJ heparin/NN is/VBZ described/VBN ./.
@@36886764354/CD However/RB ,/, conversions/NNS of/IN 12/CD mm/NN or/CC more/RB from/IN a/DT documented/VBN negative/JJ result/NN indicated/VBN spread/VB of/IN infection/NN ./.
@@92356182203/CD In/NN a/DT series/NN of/IN patients/NNS with/IN neuroinfection/NN ,/, Lyme/NNP disease/NN ,/, Guillain/NNP Barre/NN syndrome/NN ,/, demyelinization/NN ,/, partial/JJ or/CC generalized/JJ ,/, epilepsy/NN ,/, we/PRP have/VBP investigated/VBN antiphospholipid/NN antibodies/NNS of/IN IgG/NN and/CC IgM/NEWGENE subtypes/NNS ,/, together/RB with/IN anticoagulant/JJ factors/NNS ,/, member/NN of/IN thrombocytes/NNS ,/, sedimentation/NN rate/NN of/IN erythrocytes/NNS ./.
@@78143237274/CD Inclusion/NNS in/IN this/DT family/NN of/IN proteins/NNS suggests/VBZ that/IN FliQ/GENE and/CC FliR/GENE may/MD participate/VB in/IN an/DT export/NN pathway/NN required/VBN for/IN flagellum/NN assembly/NN ./.
@@14437484199/CD For/IN pressure/NN greater/JJR than/IN 121/CD atm/NEWGENE abs/NNS ,/, an/DT increased/VBN excitability/NN of/IN the/DT tadpoles/NNS made/VBP it/PRP difficult/JJ to/IN distinguish/VB the/DT righting/JJ reflex/NN from/IN involuntary/JJ movements/NNS ./.
@@70971826881/CD The/DT duration/NN and/CC the/DT amplitude/NN of/IN the/DT negative/JJ potential/NN were/VBD greatest/JJS for/IN completely/RB regenerating/JJ ears/NNS with/IN overgrowth/NN ,/, smaller/JJR for/IN partially/RB regenerating/JJ ears/NNS ,/, and/CC smallest/JJS for/IN the/DT nonregenerating/JJ ears/NNS ./.
@@103991369847/CD Ozagrel/NNP ,/, ifenprodil/NN ,/, cinnarizine/NN and/CC dilazep/NN were/VBD more/RB effective/JJ than/IN pentoxifylline/NN in/IN increasing/JJ rCBF/GENE at/IN the/DT HPC/NN ./.
@@105919331273/CD Scapulae/NNP with/IN a/DT Type/NN I/NN configuration/NN were/VBD found/VBN to/IN have/NN low/JJ values/NNS for/IN the/DT coraco-glenoid/JJ angle/NN and/CC coracoid/JJ overlap/NN ,/, which/WDT are/VBP known/VBP to/IN be/VB associated/VBN with/IN a/DT short/JJ coraco-humeral/JJ distance/NN ./.
@@34237327735/CD Addition/NN of/IN sucralfate/NN or/CC De-Nol/CHEM resulted/VBD in/IN increments/NNS of/IN gastric/JJ HCO3/NN secretion/NN ,/, reaching/VBG about/RB 45%/JJ and/CC 59%/CD ,/, respectively/RB ,/, of/IN the/DT maximal/JJ HCO3/NN response/NN to/IN 16/MULTIGENE ,/MULTIGENE 16-dimethyl/MULTIGENE PGE2/MULTIGENE (/( dmPGE2/GENE )/SYM ./.
@@26935932825/CD The/DT encoded/VBN protein/NN has/VBZ a/DT leader/NN sequence/NN of/IN 27/CD amino/JJ acids/NNS ./.
@@31855402823/CD Factors/NNS involved/VBN in/IN specific/JJ transcription/NN by/IN mammalian/JJ RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE :/: purification/NN ,/, genetic/JJ specificity/NN ,/, and/CC TATA/MULTIGENE box-promoter/MULTIGENE interactions/NNS of/IN TFIID/NN ./.
@@28331013528/CD Aplastic/JJ crisis/NN in/IN sickle/JJ cell/NN disorders/NNS :/: bone/NN marrow/NN necrosis/NN and/CC human/JJ parvovirus/NN infection/NN ./.
@@25112075641/CD K/NNP ./NNP
@@111187123269/CD This/DT sensitivity/NN analysis/NN showed/VBN that/IN the/DT practical/JJ limits/NNS of/IN the/DT accuracy/NN of/IN the/DT used/VBN screening/JJ test/NN jeopardize/VB the/DT estimation/NN of/IN the/DT true/JJ herd/NN prevalence/NN within/IN reasonable/JJ confidence/NN limits/NNS ,/, because/IN the/DT within-herd/JJ PTB/NN true/JJ prevalence/NN was/VBD low/CD ./CD For/CD this/DT reason/NN we/PRP augmented/VBD the/DT herd/NN specificity/NN for/IN herds/NNS with/IN larger/RBR adult/JJ herd/NN size/NN (/( >/SYM 5/CD )/SYM ./.
@@41721664684/CD Poliomyelitis/GENE from/IN a/DT vaccine/NN ./.
@@13244049422/CD HNF-3/MULTIGENE beta/MULTIGENE amino-terminal/MULTIGENE sequences/MULTIGENE defined/VBN by/IN conserved/VBN region/MULTIGENE IV/MULTIGENE also/RB contributed/VBD to/IN transactivation/NN ,/, but/CC region/MULTIGENE IV/MULTIGENE activity/NN required/VBD the/DT participation/NN of/IN the/DT region/MULTIGENE II-III/MULTIGENE domain/NN ./.
@@105612513863/CD PURPOSE/NNS :/: To/TO evaluate/VB the/DT disease-free/NN survival/NN (/( DFS/NN )/SYM and/CC overall/JJ survival/NN (/( OS/NNS )/SYM ,/, prognostic/JJ factors/NNS ,/, and/CC treatment-related/JJ mortality/NN of/IN women/NNS with/IN stage/NN IIIB/GENE inflammatory/JJ breast/NN cancer/NN (/( IBC/NN )/SYM treated/VBN with/IN combined/JJ modality/NN therapy/NN (/( CMT/NN )/SYM and/CC high-dose/JJ chemotherapy/NN (/( HDCT/IN )/SYM with/IN autologous/JJ stem-cell/NN transplantation/NN ./.
@@80028577996/CD CONCLUSIONS/IN :/: These/DT findings/NNS indicate/VBP a/DT physical/JJ barrier/NN of/IN oesophageal/JJ surfactant/JJ which/WDT could/MD offer/VB some/DT degree/NN of/IN protection/NN against/IN gastro-oesophageal/JJ reflux/JJ but/CC one/PRP which/WDT is/VBZ particularly/RB prone/RB to/IN attack/NN by/IN bile/NN ./.
@@95685499517/CD In/NN this/DT study/NN ,/, the/DT effect/NN of/IN acute/JJ administration/NN of/IN various/JJ doses/NNS of/IN malathion/NN via/NN oral/JJ and/CC dermal/JJ routes/NNS to/IN mice/NNS and/CC rats/NNS on/IN serum/JJ levels/NNS of/IN histamine/NN was/VBD evaluated/VBN ./.
@@9234713299/CD In/NN this/DT study/NN ,/, we/PRP tested/VBD this/DT notion/NN by/IN using/VBG ligation-mediated/JJ PCR/NN to/IN assess/VB the/DT formation/NN of/IN recombination-activating/JJ gene/NN (/( RAG/NN )/NN -dependent/NN double-strand/NN breaks/NNS (/( DSBs/NNS )/SYM at/IN RSSs/GENE 3'/CD of/IN Ddelta3/GENE and/CC 5'/GENE of/IN Jdelta1/GENE ./.
@@79117367888/CD At/NN the/DT MTD/NN (/( 8/CD mg/CD //CD m2/CD //CD day/CD )/SYM ,/, the/DT dose-limiting/JJ toxicity/NN of/IN this/DT agent/NN is/VBZ myelosuppression/NN ./.
@@74367023447/CD All/DT control/NN persons/NNS had/VBP a/DT normal/JJ reaction/NN to/IN DNFB/GENE ./.
@@43119514921/CD Therapeutic/JJ action/NN of/IN a/DT new/JJ antibiotic-corticoid/JJ association/NN used/VBN for/IN instillations/NNS in/IN otology/NN ./.
@@97634465530/CD Small/MULTIGENE GTPases/MULTIGENE of/IN the/DT Ypt/MULTIGENE //MULTIGENE Rab/MULTIGENE family/MULTIGENE are/VBP involved/VBN in/IN the/DT regulation/NN of/IN vesicular/JJ transport/NN ./.
@@103735076502/CD SRFDelta5/GENE acts/NNS as/IN a/DT naturally/RB occurring/VBG dominant/JJ negative/JJ regulatory/JJ mutant/NN that/IN blocks/NNS SRF-dependent/MULTIGENE skeletal/MULTIGENE alpha-actin/MULTIGENE ,/, cardiac/MULTIGENE alpha-actin/MULTIGENE ,/, smooth/MULTIGENE alpha-actin/MULTIGENE ,/, SM22alpha/CONTEXTGENE ,/, and/CC SRF/MULTIGENE promoter-luciferase/MULTIGENE reporter/NN activities/NNS ./.
@@53628665503/CD Renin/DT secretion/NN in/IN essential/JJ and/CC accelerated/JJ hypertension/NN ./.
@@37916454477/CD These/DT findings/NNS suggest/VBP that/IN there/RB may/MD be/VB a/DT relationship/NN between/IN the/DT pathogenesis/NN of/IN MAL/NN ,/, narcolepsy/NN ,/, and/CC OSA/NN ./.
@@89949689873/CD An/DT N-terminal/MULTIGENE arm/MULTIGENE from/IN each/DT subunit/NN wraps/NNS around/IN the/DT dinucleotide-binding/JJ domain/NN of/IN an/DT adjacent/JJ subunit/NN ,/, covering/VBG the/DT adenine/NN ring/NN of/IN NADP/NN ./.
@@15097981540/CD At/NN rest/NN AFF/GENE was/VBD significantly/RB higher/JJ in/IN UT/NN (/( 29%/CD )/SYM as/IN compared/VBN to/IN AT/IN (/( 25%/JJ )/SYM and/CC UEA/NNP (/( 25%/JJ )/SYM ./.
@@90896535230/CD Recombinant/JJ plasmids/NNS containing/JJ the/DT entire/JJ 322/CD nt/NN 5'/CD UTR/NNS of/IN exon/NN 1/CD and/CC a/DT 1630/CD nt/NN segment/NN of/IN 5'/CD flanking/JJ sequence/NN stimulated/VBD luciferase/NEWGENE activity/NN nearly/RB 70/CD times/NNS higher/JJ than/IN a/DT promoterless/JJ control/NN plasmid/NN ./.
@@71097889731/CD In/NN concept/NN II/MULTIGENE 62/MULTIGENE patients/NNS were/VBD treated/VBN with/IN selective/JJ vagotomy/NN and/CC pyloroplasty/NN ./.
@@44469234974/CD Abnormal/JJ characteristics/NNS and/CC verticillation/NN in/IN Platynothrus/NNP peltifer/NN ./.
@@3017225872/CD Next/JJ ,/, with/IN carcinoma/NN presenting/VBG a/DT leather/NN bottle/NN (/( linitis/NN plastica/NN type/NN )/SYM of/IN the/DT stomach/NN itself/PRP ,/, the/DT II/NN c/NN portion/NN of/IN the/DT stomach/NN consisted/VB of/IN fundic/JJ glands/NNS (/( undifferentiated/JJ carcinoma/NN )/SYM shall/MD become/VB the/DT primary/JJ focus/NN supporting/JJ Nakamura's/NNP theory/NN ./.
@@62252792818/CD The/DT abluminal/JJ surface/NN is/VBZ often/RB almost/RB entirely/RB encircled/VBN by/IN a/DT thick/JJ layer/NN of/IN fibrillary/JJ connective/JJ tissue/NN ./.
@@91533488992/CD Thus/RB ,/, an/DT increase/NN in/IN plasma/NN TBG/NN and/CC a/DT shift/NN from/IN adrenal/JJ androgen/NN and/CC mineralocorticoid/JJ steroid/JJ secretion/NN towards/IN cortisol/NN secretion/NN may/MD be/VB endocrine/MULTIGENE markers/MULTIGENE for/IN progression/NN of/IN the/DT disease/NN in/IN patients/NNS with/IN HIV-infection/NN ./.
@@75640046362/CD By/IN 150/CD minutes/NNS after/IN Cr2O3/GENE inhalation/NN ,/, FEV1/NN ./NN 0/NN had/VBP decreased/VBN by/IN 32%/NN ./.
@@101011986784/CD A/DT deletion/NN mutation/NN analysis/NN of/IN the/DT recombinant/JJ protein/NN has/VBZ shown/VBP that/IN the/DT N-terminal/MULTIGENE region/MULTIGENE and/CC the/DT two/JJ leucine/MULTIGENE zippers/MULTIGENE are/VBP necessary/JJ for/IN the/DT binding/NN ./.
@@10827265400/CD The/DT influence/NN of/IN a/DT mobile/JJ pupil/NN on/IN the/DT response/NN in/IN the/DT DC-ERG/GENE is/VBZ demonstrated/VBN ./.
@@7999887989/CD On/IN the/DT basis/NN of/IN a/DT global/JJ assessment/NN patients/NNS showed/VBD a/DT highly/RB significant/JJ preference/NN for/IN imipramine/NN compared/VBD with/JJ placebo/NN as/IN adjunctive/JJ therapy/NN ./.
@@37791829411/CD The/DT growing/JJ drug/NN problem/NN is/VBZ also/RB reflected/VBN in/IN the/DT increasing/JJ number/NN of/IN cases/NNS of/IN hepatitis/MULTIGENE B/MULTIGENE and/CC of/IN drug-related/JJ deaths/NNS ./.
@@8869358709/CD Many/JJ human/JJ viruses/NNS are/VBP able/JJ to/IN develop/VB suitable/JJ strategies/NNS for/IN modifying/JJ apoptosis/NN in/IN virus-infected/JJ cells/NNS and/CC in/IN virus-primed/JJ T/NN cells/NNS ./.
@@7964459516/CD This/DT motif/NN is/VBZ similar/JJ to/IN but/CC distinct/JJ from/IN the/DT LIM/NN domain/NN and/CC the/DT RING/NN finger/NN family/NN ,/, and/CC is/VBZ reminiscent/NN of/IN known/VBP metal-binding/MULTIGENE regions/MULTIGENE ./.
@@80172909407/CD The/DT femoroarterial/JJ coronary/JJ sinus/NN difference/NN in/IN lactate/NN turned/VBD negative/JJ ,/, and/CC pH/NN ,/, PCO2/GENE and/CC potassium/NN differences/NNS increased/VBN in/IN group/NN 2/CD during/IN pacing/NN ./.
@@13800623049/CD T/NN antigen/NN contains/VBZ four/CD H-2Db-restricted/MULTIGENE cytotoxic/MULTIGENE T/MULTIGENE lymphocyte/NN (/( CTL/NN )/SYM recognition/NN epitopes/NNS that/WDT are/VBP targets/NNS for/IN CTL/NN clones/NNS Y-1/CONTEXTGENE ,/, Y-2/GENE ,/, Y-3/GENE ,/, and/CC Y-5/GENE ./.
@@19853012598/CD Combined/VBN therapy/NN with/IN MK-801/GENE and/CC nimodipine/NN for/IN protection/NN of/IN ischemic/JJ brain/NN damage/NN ./.
@@76229327543/CD Histopathological/JJ features/NNS of/IN relapsed/VBN leprosy/NN ./.
@@25999953250/CD Intracellular/JJ activity/NN studies/NNS indicated/VBN that/IN ,/, at/IN ten/CD times/NNS MBC/NN ,/, only/JJ penicillin/NN had/VBP any/DT significant/JJ activity/NN against/IN intracellular/JJ staphylococci/NNS ,/, reducing/JJ survival/NN by/IN 28%/NN ./.
@@105215097175/CD Regulators/NNS of/IN G/MULTIGENE protein/MULTIGENE signaling/JJ (/( RGS/GENE )/SYM proteins/NNS that/WDT contain/VBP DEP/NN (/( disheveled/JJ ,/, EGL-10/GENE ,/, pleckstrin/NN )/SYM and/CC GGL/CONTEXTGENE (/( G/MULTIGENE protein/MULTIGENE gamma/MULTIGENE subunit-like/MULTIGENE )/SYM domains/NNS form/NN a/DT subfamily/NN that/WDT includes/VBZ the/DT mammalian/JJ RGS/MULTIGENE proteins/MULTIGENE RGS6/MULTIGENE ,/, RGS7/GENE ,/, RGS9/GENE ,/, and/CC RGS11/GENE ./.
@@90060077332/CD The/DT results/NNS demonstrate/VBP (/( i/NN )/SYM that/IN the/DT selenocysteine-specific/VBD UGA/DT codon/NN is/VBZ readily/RB suppressed/VBN under/IN conditions/NNS where/CC the/DT homologous/JJ SelB/MULTIGENE protein/MULTIGENE is/VBZ absent/VB and/CC (/( ii/NN )/SYM that/IN apart/RB from/IN the/DT specificity/NN of/IN the/DT SelB-mRNA/NNP interaction/NN ,/, a/DT structural/JJ compatibility/NN of/IN the/DT quaternary/JJ complex/NN with/IN the/DT ribosome/NN is/VBZ required/VBN ./.
@@96495376570/CD Genomic/NN and/CC cDNA/NN clones/NNS homologous/JJ to/IN the/DT yeast/MULTIGENE GCN2/MULTIGENE eIF-2alpha/MULTIGENE kinase/MULTIGENE (/( yGCN2/GENE )/SYM were/VBD isolated/VBN from/IN Drosophila/NN melanogaster/NN ./.
@@78223337341/CD Chem/NNP ./.
@@89547254782/CD Later/RB in/IN development/NN ,/, Tbx6/GENE expression/NN is/VBZ restricted/VBN to/IN presomitic/JJ ,/, paraxial/JJ mesoderm/NN and/CC to/IN the/DT tail/NN bud/NN ,/, which/WDT replaces/VBZ the/DT streak/NN as/IN the/DT source/NN of/IN mesoderm/NN ./.
@@86435787149/CD RAS2val19/CD ,/, a/DT dominant/RB activated/VBN form/NN of/IN Saccharomyces/NN cerevisiae/NN Ras2/GENE ,/, stimulates/VBZ both/DT filamentous/JJ growth/NN and/CC expression/NN of/IN a/DT transcriptional/JJ reporter/NN FG/NN (/NN TyA/NN )/NN :/: :/: lacZ/NN but/CC does/VBP not/RB induce/VB the/DT mating/JJ pathway/NN reporter/NN FUS1/GENE :/: :/: lacZ/NN ./.
@@23836934026/CD The/DT eluent/NN from/IN the/DT column/NN was/VBD mixed/JJ with/IN the/DT chemiluminescent/JJ solution/NN containing/MULTIGENE lucigenin/MULTIGENE and/CC Triton/NN X-100/NNS and/CC a/DT 0/CD ./CD 28/CD M/NN KOH/NN solution/NN by/IN pumps/NNS and/CC monitored/VBN by/IN a/DT chemiluminescence/NN detector/NN ./.
@@84846897433/CD Prevalence/NNS of/IN rheumatoid/JJ arthritis/NN and/CC rheumatoid/MULTIGENE factor/MULTIGENE in/IN women/NNS :/: evidence/NN for/IN a/DT secular/JJ decline/NN ./.
@@77303376799/CD The/DT Ng/GENE //GENE RC3/GENE and/CC PKC-gamma/MULTIGENE genes/MULTIGENE have/VBP a/DT similar/JJ expression/NN pattern/NN in/IN the/DT brain/NN during/IN development/NN ./.
@@114795011850/CD RESULTS/NNS :/: In/NN vivo/NN ,/, there/RB was/VBD a/DT wide/JJ distribution/NN with/IN the/DT coefficient/NN of/IN variation/NN (/( SD/NN //NN mean/NN x/NN 100%/CD )/SYM for/IN different/JJ valve/NN sizes/NNS ranging/VBG from/IN 21%/JJ to/IN 39%/CD in/IN the/DT St/NNP Jude/NNP Medical/NNP valve/NN and/CC from/IN 25%/JJ to/IN 33%/JJ in/IN the/DT Omnicarbon/NNP valve/NN ./.
@@119103441822/CD CONCLUSIONS/IN :/: This/DT retrospective/JJ uncontrolled/JJ study/NN shows/VBZ that/IN in/IN patients/NNS with/IN type/MULTIGENE 1/MULTIGENE HRS/MULTIGENE ,/, terlipressin-induced/RB improved/VBN renal/JJ function/NN is/VBZ associated/VBN with/IN an/DT increase/NN in/IN survival/NN ./.
@@75825926287/CD HRES/NNS has/VBZ been/VBN found/VB to/IN be/VB clinically/RB useful/JJ in/IN assessing/JJ histologic/JJ damage/NN following/IN pneumatic/JJ dilatation/NN and/CC in/IN localizing/JJ the/DT LES/NN during/IN the/DT administration/NN of/IN intrasphincter/NN botulinum/NN toxin/NN injection/NN in/IN the/DT treatment/NN of/IN achalasia/NN ./.
@@48133945185/CD Evaluation/NN of/RB 1/NN ,/NN 10-phenanthroline/NN as/IN a/DT reagent/NN for/IN sialic/JJ acid/NN determinations/NNS ./.
@@44878354982/CD On/IN parents/NNS ./.
@@57829435720/CD Relationship/NNP of/IN mast/NN cells/NNS to/IN sarcoidosis/NN granuloma/NN of/IN the/DT skin/NN ./.
@@23905385290/CD In/NN 6/CD of/IN 24/CD infants/NNS studied/VBN (/( 27th-40th/JJ weeks/NNS of/IN gestation/NN )/SYM ,/, acquired/VBN and/CC congenital/JJ structural/JJ anomalies/NNS of/IN the/DT airways/NNS were/VBD detected/VBN with/IN an/DT ultrathin/JJ flexible/JJ fiberscope/NN (/( Olympus/NN PF18/MULTIGENE S/MULTIGENE ,/, 1/CD ./CD 8/CD mm/NN )/SYM ./.
@@93469538428/CD The/DT cellular/JJ rate/NN of/IN anticoagulant/JJ heparan/NN sulfate/NN proteoglycan/NN (/( HSPGact/NNP )/SYM generation/NN is/VBZ determined/VBN by/IN the/DT level/NN of/IN a/DT kinetically/RB limiting/JJ microsomal/JJ activity/NN ,/, HSact/NNP conversion/NN activity/NN ,/, which/WDT is/VBZ predominantly/RB composed/VBN of/IN the/DT long/JJ sought/VBP heparan/NN sulfate/MULTIGENE D-glucosaminyl/MULTIGENE 3-O-sulfotransferase/MULTIGENE (/( 3-OST/CONTEXTGENE )/SYM (/( Shworak/NNP ,/, N/NNP ./NNP
@@108540045881/CD Basal/MULTIGENE FVR/MULTIGENE was/VBD reduced/VBN by/IN approximately/RB 18%/JJ by/IN ERT/NN and/CC HRT/NN ,/, but/CC FVR/NNS responses/NNS to/IN noradrenaline/NN ,/, angiotensin/MULTIGENE II/MULTIGENE ,/, acetylcholine/NN and/CC nitroprusside/NN were/VBD unaffected/JJ ./.
@@106715207807/CD Molecular/NNP cloning/NN of/IN a/DT novel/JJ human/MULTIGENE I-mfa/MULTIGENE domain-containing/MULTIGENE protein/MULTIGENE that/WDT differently/RB regulates/VBZ human/JJ T-cell/NN leukemia/NN virus/NN type/MULTIGENE I/MULTIGENE and/CC HIV-1/NNP expression/NN ./.
@@41762684839/CD Aluminium/NNP resin/NN for/IN the/DT treatment/NN of/IN the/DT hyperkalamia/NN of/IN renal/JJ failure/NN ./.
@@82659558242/CD Strategic/NNP change/NN in/IN the/DT NHS/NN ./.
@@96494262632/CD Interestingly/RB ,/, PKA/NEWGENE activity/NN is/VBZ dispensable/JJ in/IN a/DT strain/NN lacking/JJ Msn2p/GENE and/CC Msn4p/GENE activity/NN ./.
@@112375985774/CD The/DT homologous/JJ active-site/NN framework/NN of/IN these/DT enzymes/NNS with/IN distinct/JJ structures/NNS suggests/VBZ convergent/JJ evolution/NN of/IN a/DT common/JJ catalytic/JJ mechanism/NN ./.
@@104195215660/CD In/NN addition/NN to/IN its/PRP elongation/NN activity/NN ,/, ELL/NNS contains/VBZ a/DT novel/JJ type/NN of/IN RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE interaction/NN domain/NN that/WDT is/VBZ capable/JJ of/IN repressing/JJ polymerase/NN activity/NN in/IN promoter-specific/JJ transcription/NN ./.
@@32920823978/CD In/NN contrast/NN ,/, we/PRP observed/VBD high/JJ concentrations/NNS in/IN 29/CD of/IN 75/CD patients/NNS with/IN tumors/NNS of/IN the/DT central/JJ nervous/JJ system/NN ,/, especially/RB in/IN meningioma/NN (/( 6/CD //CD 9/CD )/SYM ,/, glioblastoma/NN (/( 9/CD //CD 23/CD )/SYM ,/, and/CC neurinoma/NN (/( 5/CD //CD 5/CD )/SYM ./.
@@8276234326/CD We/PRP present/VBP evidence/NN that/IN YY1/GENE ,/, a/DT ubiquitously/RB expressed/VBN DNA-binding/MULTIGENE protein/MULTIGENE ,/, regulates/VBZ the/DT activity/NN of/IN the/DT c-fos/MULTIGENE promoter/MULTIGENE primarily/RB through/RB an/DT effect/NN on/IN DNA/NN structure/NN ./.
@@110940725808/CD DNase/MULTIGENE I/MULTIGENE genomic/JJ footprinting/VBG revealed/VBN that/IN the/DT c-Myb/MULTIGENE site/MULTIGENE is/VBZ occupied/VBN in/IN a/DT tissue-specific/JJ fashion/NN in/IN vivo/NN ./.
@@79712823715/CD Regulators/NNS responsible/JJ for/IN the/DT pervasive/JJ ,/, nonsex-specific/JJ alternative/JJ pre-mRNA/NN splicing/JJ characteristic/NN of/IN metazoans/NNS are/VBP almost/RB entirely/RB unknown/JJ or/CC uncertain/JJ ./.
@@96513214981/CD Cystatin/MULTIGENE A/MULTIGENE ,/, a/DT cysteine/MULTIGENE proteinase/MULTIGENE inhibitor/MULTIGENE ,/, is/VBZ one/PRP of/IN the/DT precursor/NN proteins/NNS of/IN cornified/JJ cell/NN envelope/NN of/IN keratinocytes/NNS and/CC is/VBZ expressed/VBN during/IN the/DT late/JJ stage/NN of/IN keratinocyte/NN differentiation/NN ./.
@@34840754175/CD Emergency/NNP treatment/NN of/IN facial/JJ and/CC maxillary/JJ //JJ mandibular/JJ injuries/NNS ./.
@@29733043691/CD A/DT rare/JJ chronic/JJ course/NN of/IN Budd-Chiari/NNP syndrome/NN associated/VBN with/IN thrombosis/NN of/IN the/DT portal/JJ vein/NN was/VBD observed/VBN in/IN a/DT 30-year-old/CD male/JJ patient/NN suffering/JJ from/IN postmyocarditic/JJ cardiosclerosis/NN ./.
@@21880963623/CD The/DT contribution/NN that/IN alternative/JJ splicing/JJ events/NNS in/IN c-myb/NEWGENE expression/NN may/MD make/VB on/IN c-myb/NEWGENE function/NN remains/VBP to/IN be/VB elucidated/VBN ./.
@@106606045783/CD In/NN vivo/NN ,/, CARbeta/NNP //NNP RXRalpha/NNP activated/VBN transcription/NN from/IN an/DT HD-PPRE/NNP luciferase/NEWGENE reporter/NN construct/NN ./.
@@114689585771/CD We/PRP report/VBP the/DT results/NNS of/IN a/DT detailed/JJ policy/NN analysis/NN comparing/VBG 2/CD CJD-related/JJ decisions/NNS :/: a/DT 1995/CD recall/NN of/IN blood/NN from/IN a/DT donor/NN with/IN classic/JJ CJD/NN and/CC the/DT 1999/CD decision/NN to/IN defer/VB donations/NNS from/IN individuals/NNS with/IN a/DT 6-month/CD travel/NN history/NN to/IN the/DT UK/NN between/IN 1980/CD and/CC 1996/CD due/NN to/IN concerns/NNS related/VBN to/IN variant/NN CJD/NN ./.
@@89956149275/CD Identification/NNP of/IN a/DT cis-acting/JJ element/NN in/IN the/DT class/MULTIGENE I/MULTIGENE major/JJ histocompatibility/MULTIGENE complex/MULTIGENE gene/MULTIGENE promoter/MULTIGENE responsive/JJ to/IN activation/NN by/IN retroviral/MULTIGENE sequences/MULTIGENE ./.
@@104164294835/CD DESIGN/IN :/: Comparison/NNS of/IN number/NN of/IN women/NNS with/IN PKU/NN aged/VBD 15-44/JJ years/NNS on/IN the/PDT NSW/NN PKU/NN database/NN (/( observed/VBN number/NN )/SYM with/IN expected/VBN number/NN derived/VBN from/IN population/NN data/NN ./.
@@22544181678/CD Most/JJS strains/NNS (/( 95%/CD )/SYM of/IN S/NNP ./NNP lugdunensis/NN produced/VBD a/DT delta/MULTIGENE hemolysin/MULTIGENE like/JJ that/WDT seen/VBP with/IN nine/JJ other/DT species/NN of/IN CNS/NN ./.
@@73724337213/CD Longitudinal/JJ force-length/JJ relationships/NNS of/IN guinea/NN pig/NN ureter/NN were/VBD studied/VBN in/IN vitro/FW in/IN animals/NNS 3/CD weeks/NNS ,/, 3/CD months/NNS ,/, and/CC 3/CD years/NNS of/IN age/NN ./.
@@105184963828/CD Aggregation/NNS of/IN vHnf1-deficient/JJ embryonic/JJ stem/NN cells/NNS with/IN wild-type/JJ tetraploid/JJ embryos/NNS ,/, which/WDT contribute/VBP exclusively/RB to/IN extraembryonic/JJ tissues/NNS ,/, rescues/VBP periimplantation/VBG lethality/NN and/CC allows/VBZ development/NN to/IN progress/NN to/IN early/JJ organogenesis/NN ./.
@@2459309845/CD Endogenous/JJ release/NN of/IN neuronal/MULTIGENE serotonin/MULTIGENE and/CC 5-hydroxyindoleacetic/JJ acid/NN in/IN the/DT caudate-putamen/NNS of/IN the/DT rat/NN as/IN revealed/VBN by/IN intracerebral/JJ dialysis/NN coupled/VBN to/IN high-performance/JJ liquid/JJ chromatography/NN with/IN fluorimetric/JJ detection/NN ./.
@@88288579226/CD The/DT use/NN of/IN primary/JJ GE/JJ cells/NNS thus/RB provides/VBZ a/DT convenient/JJ in/IN vitro/FW system/NN for/IN further/JJ study/NN of/IN the/DT endocrine/NN ,/, paracrine/JJ ,/, and/CC autocrine/MULTIGENE factors/MULTIGENE regulating/JJ endometrial/JJ gene/NN expression/NN during/IN pregnancy/NN ./.
@@93745411011/CD We/PRP found/VBP 14/MULTIGENE protein/MULTIGENE binding/MULTIGENE sites/MULTIGENE that/WDT were/VBD occupied/VBN in/IN vivo/NN ./.
@@13807161999/CD The/DT pulpal/JJ tissues/NNS of/IN the/DT permanent/JJ mandibular/JJ molars/NNS were/VBD amputated/VBN and/CC then/RB dressed/VBN with/IN calcium/NN hydrate/NN ./.
@@82391648223/CD CPAP/NN reduced/VBD isotime/NN (/( defined/VBN as/IN the/DT last/JJ common/JJ minute/NN of/IN exercise/NN )/SYM VO2/GENE and/CC dyspnea/NN in/IN those/DT patients/NNS with/IN more/RB severe/JJ lung/NN disease/NN ,/, but/CC these/DT values/NNS tended/VBN to/IN increase/NN slightly/RB in/IN the/DT patients/NNS with/IN only/RB mild/JJ lung/NN disease/NN ./.
@@79151447893/CD High-frequency/NNP electrical/JJ stimulation/NN in/IN the/DT hippocampus/NN leads/VBP to/IN an/DT increase/NN in/IN synaptic/JJ efficacy/NN that/IN lasts/NNS for/IN many/JJ hours/NNS ./.
@@36807914347/CD The/DT histologic/JJ grade/NN for/IN the/DT same/JJ anatomic/JJ site/NN varied/VBN among/IN hearts/NNS and/CC among/IN different/JJ anatomic/JJ sites/NNS in/IN the/DT same/JJ heart/NN ./.
@@10330396253/CD The/DT RanQ69L/CD preincubation/NN leads/VBP to/IN accumulation/NN of/IN CRM1/GENE at/IN the/DT cytoplasmic/JJ periphery/NN of/IN the/DT nuclear/JJ pore/NN complex/NN (/( NPC/NN )/SYM in/IN association/NN with/IN the/DT p62/MULTIGENE complex/MULTIGENE and/CC Can/GENE //GENE Nup214/GENE ./.
@@19399062570/CD This/DT generalization/NN of/IN MFP/NN involves/VBZ defining/VBG an/DT appropriate/JJ high-resolution/JJ cost/NN function/NN ,/, parametrizing/JJ the/DT search/NN space/NN of/IN the/DT environment/NN and/CC source/NN ,/, constructing/JJ solutions/NNS of/IN the/DT wave/NN equation/NN ,/, and/CC utilizing/VBG a/DT nonlinear/JJ optimization/NN method/NN to/IN search/NN the/DT parameter/NN landscape/NN for/IN the/DT global/JJ minimum/NN of/IN the/DT cost/NN function/NN ./.
@@113711607236/CD This/DT domain/NN without/IN the/DT canonical/JJ anticodon/NN loop/NN or/CC the/DT tyrosine/NN anticodon/NN acts/NNS as/IN an/DT anchor/NN for/IN TyrRS/NEWGENE interaction/NN leading/JJ to/IN a/DT better/JJR efficiency/NN of/IN tyrosylation/NN ./.
@@33058758826/CD Static/NN orthoses/NNS for/IN the/DT management/NN of/IN microstomia/NN ./.
@@64732196276/CD Value/NNP of/IN urine/NN glucose/NN tests/NNS in/IN the/DT management/NN of/IN type/NN II/NNP diabetes/NN mellitus/MD ./.
@@10627834327/CD Two/CD US/NN commercial/JJ cultivars/NNS (/( Tehama/NNP and/CC Vina/NNP )/SYM ,/, three/CD European/JJ commercial/JJ cultivars/NNS (/( Esterhazy/NNP ,/, 139/CD ,/, G120/GENE )/SYM and/CC five/CD New/NNP Zealand/NNP selections/NNS (/( Rex/NNP ,/, Dublin's/NNP Glory/NN ,/, Meyric/NNP ,/, McKinster/NNP ,/, Stanley/NNP )/SYM were/VBD evaluated/VBN ./.
@@94366579392/CD This/DT review/NN seeks/VBZ to/IN summarize/VB the/DT disease/NN ,/, to/IN propose/VB pathways/NNS of/IN carcinogenesis/NN and/CC to/IN suggest/VB ways/NNS in/IN which/WDT the/DT "traditional"/NN risk/NN factors/NNS may/MD be/VB interpreted/VBN on/IN the/DT basis/NN of/IN evolving/JJ knowledge/NN ./.
@@15676492168/CD Twenty-eight/CD (/( 7/CD ./CD 0%/CD )/SYM infants/NNS without/IN periventricular/JJ hemorrhage/NN were/VBD revealed/VBN as/IN having/VBG spastic/JJ cerebral/JJ palsy/NN by/IN neurodevelopmental/JJ evaluation/NN in/IN later/JJR infancy/NN ./.
@@64149902683/CD The/DT statistical/JJ analysis/NN of/IN data/NN of/IN TRH/NN test/NN on/IN a/DT sample/NN of/IN 57/CD healthy/JJ volunteers/NNS has/VBZ permitted/VBN an/DT evaluation/NN of/IN the/DT upper/JJ limits/NNS of/IN the/DT normal/JJ thyrotropin/NEWGENE response/NN ;/: the/DT secretory/JJ area/NN (/( As/IN )/SYM was/VBD shown/VBP to/IN be/VB more/RB discriminating/JJ ./.
@@83851315841/CD The/DT alpha/JJ 2A-adrenergic/JJ receptor/NN (/( alpha/NN 2AAR/GENE )/SYM is/VBZ coupled/VBN to/IN a/DT variety/NN of/IN effectors/NNS via/NN pertussis/NN toxin-sensitive/JJ GTP-binding/MULTIGENE proteins/MULTIGENE ./.
@@90356128994/CD Cardiac/MULTIGENE endothelin/MULTIGENE release/NN and/CC infarct/NN size/NN ,/, myocardial/JJ blood/NN flow/NN ,/, and/CC ventricular/JJ function/NN in/IN canine/JJ infarction/NN and/CC reperfusion/NN ./.
@@98065169777/CD This/DT association/NN was/VBD independently/RB significant/JJ for/IN patients/NNS treated/VBN primarily/RB (/( not/RB for/IN recurrence/NN )/SYM ./.
@@24640971931/CD The/DT effects/NNS of/IN L655/NNP ,/NNP 240/NNP ,/, a/DT selective/JJ thromboxane/NN and/CC prostaglandin/MULTIGENE endoperoxide/MULTIGENE antagonist/MULTIGENE ,/, on/IN ischemia-/JJ and/CC reperfusion-induced/JJ cardiac/JJ arrhythmias/NNS ./.
@@87042407314/CD However/RB ,/, in/IN TF-1/NNP cells/NNS grown/VBP on/IN GM-CSF/NNP before/IN starvation/NN ,/, CREB/NN phosphorylation/NN was/VBD observed/VBN 10/CD minutes/NNS after/IN PIXY321/GENE stimulation/NN ./.
@@104475976224/CD The/DT Cr/GENE ./GENE psbA-4/GENE ORF/NN contains/VBZ an/DT H-N-H/NNP motif/NN ,/, and/CC possibly/RB a/DT GIY-YIG/NNP motif/NN ./.
@@82516224757/CD The/DT promoter/NN and/CC upstream/JJ region/NN of/IN the/DT Brassica/NNP napus/NN 2S/CD storage/NN protein/MULTIGENE napA/MULTIGENE gene/MULTIGENE were/VBD studied/VBN to/IN identify/VB cis-acting/JJ sequences/NNS involved/VBN in/IN developmental/JJ seed-specific/JJ expression/NN ./.
@@9452421991/CD Antibodies/NNS raised/VBN against/IN GST/MULTIGENE mSH2-B/MULTIGENE identified/VBN a/DT cellular/JJ protein/NN of/IN 92/CD kDa/NN that/WDT was/VBD not/RB found/VB to/IN be/VB phosphorylated/VBN on/IN Tyr/NN ./.
@@35776709527/CD The/DT diagnosis/NN of/IN metachromatic/JJ leukodystrophy/NN (/( MLD/NNP )/SYM was/VBD confirmed/VBN by/IN the/DT finding/NN of/IN low/JJ arylsulfatase/MULTIGENE A/MULTIGENE (/( ASA/CONTEXTGENE )/SYM levels/NNS in/IN cultured/JJ fibroblasts/NNS in/IN both/DT sisters/NNS ./.
@@54141865536/CD Once/RB more/RB Hong/NNP Kong/NNP influenza/NN in/IN the/DT Netherlands/NN ./.
@@81952336469/CD In/NN addition/NN ,/, this/DT kinase/NN is/VBZ well/NN conserved/VBN evolutionarily/RB ,/, ubiquitously/RB expressed/VBN ,/, and/CC its/PRP genes/NNS map/NEWGENE to/IN a/DT position/NN on/IN human/JJ chromosome/NN 1/CD frequently/RB deleted/VBN in/IN the/DT late/JJ stages/NNS of/IN tumorigenesis/NN ./.
@@93533044547/CD Deletions/NNS in/IN each/DT of/IN these/DT regions/NNS abolish/VBP membrane/NN localization/NN of/IN Tiam1/GENE and/CC membrane/NN ruffling/JJ ,/, suggesting/VBG that/IN they/PRP function/NN cooperatively/RB ./.
@@104551839448/CD In/NN contrast/NN ,/, the/DT xtRNA/NN (/NN Sec/NN )/NN gene/NN needs/NN the/DT binding/NN of/IN the/DT seven/JJ Staf/NNP zinc/NN fingers/NNS ,/, but/CC not/RB Oct-1/GENE ,/, for/IN optimal/JJ transcriptional/JJ capacity/NN ./.
@@77388398865/CD During/IN IC/NN breaths/NNS and/CC following/IN EC/NN and/CC VC/NN breaths/NNS at/IN rest/NN ,/, end-tidal/JJ CO2/NN pressure/NN (/( PET/GENE ,/GENE CO2/GENE )/SYM fell/NN by/IN 7/CD ./CD 5/CD ,/, 8/CD ./CD 5/CD and/CC 9/CD ./CD 5/CD mmHg/NN ,/, respectively/RB ./.
@@71809012304/CD It/PRP is/VBZ postulated/VBN that/WDT altered/VBD blood/NN flow/NN ,/, mediated/JJ through/RB the/DT well-known/JJ prostaglandin/MULTIGENE synthetase/MULTIGENE inhibitory/JJ effects/NNS of/IN ibuprofen/NN ,/, resulted/VBN in/IN tubular/JJ necrosis/NN ./.
@@81635284520/CD Mitochondrial/MULTIGENE Mas70p/MULTIGENE signal/MULTIGENE anchor/MULTIGENE sequence/MULTIGENE ./.
@@81395439049/CD Genetic/NNP and/CC phenotypic/JJ analysis/NN indicates/VBZ that/IN NHP6A/GENE and/CC NHP6B/GENE function/NN downstream/RB of/IN SLT2/GENE ./.
@@28077803503/CD The/DT use/NN of/IN an/DT appropriate/JJ solution/NN of/IN methylene/NN blue/JJ (/( 0/CD ./CD 2%/CD in/IN 0/CD ./CD 9/CD M/NN NaCl/NN for/IN 15/CD min/NN )/SYM permits/VBP the/DT staining/NN of/IN premalignant/JJ areas/NNS and/CC CIS/NN ,/, and/CC their/PRP early/JJ diagnosis/NN ./.
@@98082169781/CD BACKGROUND/IN :/: Studies/NNS in/IN lean/JJ men/NNS show/VBP poor/JJ regulation/NN of/IN energy/NN (/( EB/NN )/SYM and/CC fat/JJ balance/NN (/( FB/GENE )/SYM during/IN manipulation/NN of/IN dietary/JJ ratios/NNS of/IN fat/JJ to/IN carbohydrate/NN ./.
@@103841297368/CD TCR/MULTIGENE alpha/MULTIGENE (/( TCRA/NN )/SYM expression/NN was/VBD examined/VBN in/IN RNA/NN samples/NNS from/IN PBMC/NN and/CC isolated/VBN populations/NNS of/IN CD4+/DT ,/, CD8+/NN ,/, and/CC DN/NN T/NN cells/NNS from/IN 15/CD healthy/JJ individuals/NNS ./.
@@19959517937/CD The/DT long/JJ terminal/JJ repeat/NN (/( LTR/NN )/SYM of/IN the/DT human/JJ immunodeficiency/NN virus/NN (/( HIV/NN )/SYM contains/VBZ three/CD binding/JJ sites/NNS for/IN the/DT transcriptional/MULTIGENE factor/MULTIGENE Sp1/MULTIGENE ./.
@@92584398378/CD The/DT used/VBN expression/NN system/NN could/MD allow/VB to/IN produce/NN mutated/JJ forms/NNS of/IN SsEF-2/GENE obtained/VBN by/IN mutagenesis/NN of/IN the/DT corresponding/JJ gene/NN ./.
@@114355178629/CD Ileal/JJ digestibilities/NNS of/IN DM/NN ,/, OM/NN ,/, CP/NN ,/, total/JJ dietary/JJ fiber/NN (/( TDF/GENE )/SYM ,/, fat/JJ and/CC gross/JJ energy/NN (/( GE/JJ )/SYM were/VBD lower/JJR (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM for/IN dogs/NNS fed/VBD diets/NNS containing/JJ supplemental/JJ fiber/NN compared/VBN with/IN dogs/NNS fed/VBD the/DT control/NN diet/NN ./.
@@98435724195/CD This/DT model/NN is/VBZ supported/VBN by/IN experiments/NNS showing/VBG that/IN Cdr2/GENE associates/VBP with/IN the/DT N-terminal/NN regulatory/JJ domain/NN of/IN Wee1/GENE in/IN cell/NN lysates/NNS and/CC phosphorylates/VBZ Wee1/GENE in/IN vitro/FW ./.
@@39332324591/CD Greek/JJ classicism/NN in/IN living/JJ structure/NN ?/. Some/DT deductive/JJ pathways/NNS in/IN animal/NN morphology/NN ./.
@@75342978635/CD We/PRP linked/VBD a/DT 4/CD ./CD 1-kilobase/CD pair/NN HindIII/MULTIGENE DNA/MULTIGENE fragment/MULTIGENE from/IN the/DT region/NN upstream/RB of/IN the/DT human/MULTIGENE AP/MULTIGENE endonuclease/MULTIGENE gene/MULTIGENE (/( APE/CONTEXTGENE )/SYM to/IN the/DT chloramphenicol/NN acetyltransferase/NN (/( CAT/NN )/SYM gene/NN ./.
@@918965131/CD It/PRP was/VBD concluded/VBN that/IN patients/NNS with/IN acute/JJ respiratory/JJ failure/NN requiring/JJ artificial/JJ ventilation/NN have/NN two/JJ componenents/NNS of/IN the/DT pulmonary/JJ shunt/NN ,/, one/PRP parallel/JJ with/IN and/CC the/PDT other/DT inversely/RB related/VBN with/IN the/DT PAO2/GENE ./.
@@90858426525/CD Recent/JJ studies/NNS have/VBP demonstrated/VBN that/IN the/DT U1/MULTIGENE snRNP/MULTIGENE is/VBZ recruited/VBN to/IN the/DT 5'/CD splice/NN site/NN by/IN protein/NN //NN protein/NN interactions/NNS involving/VBG the/DT SR/MULTIGENE domains/MULTIGENE of/IN the/DT U1-70K/MULTIGENE protein/MULTIGENE and/CC SF2/GENE //GENE ASF/GENE ./.
@@92255066935/CD The/DT control/NN group/NN revealed/VBN significantly/RB higher/JJ levels/NNS of/IN coagulation/MULTIGENE factors/MULTIGENE II/MULTIGENE ,/, V/NN and/CC VIII/NNP ,/, compared/VBN to/IN the/DT index/NN group/NN ./.
@@9741391464/CD Whereas/IN ,/, in/IN the/DT single-chambered/JJ body/MULTIGENE box/MULTIGENE ,/, PenH/NN units/NNS (/( Enhanced/NNP Pause/NN )/SYM reflect/VB "effort/NN of/IN breathing/GENE ./GENE "/GENE This/DT is/VBZ measured/VBN as/IN the/DT pause/NN between/IN inspiration/NN and/CC expiration/NN ./.
@@105189567951/CD These/DT thyroid/JJ hormone/NN changes/NNS may/MD be/VB mediated/JJ in/IN part/NN by/IN cytokines/NNS or/CC other/DT inflammatory/JJ mediators/NNS ,/, acting/JJ at/IN the/DT level/NN of/IN the/DT hypothalamus/NN and/CC pituitary/JJ gland/NN ,/, the/DT thyroid/JJ gland/NN ,/, and/CC the/DT hepatic/JJ deiodinase/NEWGENE system/NN ./.
@@112739952168/CD Compared/VBN with/IN normal/JJ control/JJ subjects/NNS ,/, all/DT 74/CD TOF/GENE patients/NNS had/VBP decreased/VBN systolic/JJ and/CC diastolic/JJ myocardial/JJ velocities/NNS and/CC a/DT longer/RBR isovolumic/JJ relaxation/NN time/NN ./.
@@86928854445/CD The/DT ability/NN of/IN A20/NEWGENE to/IN block/NN NF-kappaB/GENE activation/NN was/VBD mapped/VBN to/IN its/PRP C-terminal/NN zinc/NN finger/NN domain/NN ./.
@@113555767761/CD The/DT cyclins/NNS bind/VBP to/IN and/CC activate/VB the/DT CDK/NN ,/, which/WDT leads/VBP to/IN phosphorylation/NN (/( and/CC then/JJ inhibition/NN )/SYM of/IN the/DT tumor/NN suppressor/NN protein/NN ,/, pRb/NN ./. pRb/NN controls/NNS commitment/NN to/IN progress/NN from/IN the/DT G1/GENE to/IN S/NNP phase/NN ,/, at/IN least/RB in/IN part/NN by/IN repressing/JJ the/DT activity/NN of/IN the/DT E2F/MULTIGENE transcription/MULTIGENE factors/MULTIGENE known/VBP to/IN promote/VB cell/NN proliferation/NN ./.
@@106066641286/CD Snail/NN family/NN proteins/NNS are/VBP zinc/MULTIGENE finger/MULTIGENE transcriptional/MULTIGENE regulators/MULTIGENE first/RB identified/VBN in/IN Drosophila/NN which/WDT play/VBP critical/JJ roles/NNS in/IN cell/NN fate/NN determination/NN ./.
@@102051769067/CD When/WRB tethered/JJ to/IN a/DT heterologous/JJ DNA-binding/NN domain/NN ,/, PSU1/GENE can/MD activate/VB transcription/NN on/IN its/PRP own/VB ./.
@@85504762261/CD The/DT promoter/NN of/IN the/DT first/JJ gene/NN ,/, epiF/GENE ,/, responded/VBN to/IN the/DT activator/NN protein/NN EpiQ/GENE and/CC contained/VBD a/DT palindromic/JJ sequence/NN similar/JJ to/IN the/DT EpiQ/MULTIGENE binding/MULTIGENE site/MULTIGENE of/IN the/DT epiA/MULTIGENE promoter/MULTIGENE ,/, which/WDT is/VBZ also/RB activated/VBN by/IN EpiQ/NNP ./.
@@91633327022/CD We/PRP have/VBP used/VBN a/DT site-directed/JJ mutagenesis/NN approach/NN to/IN examine/VB how/RB the/DT Xaa/NNP and/CC hydroxy/JJ (/( Ser/NNP //NNP Thr/NNP )/SYM amino/JJ acid/NN residues/NNS in/IN sequons/NNS influence/NN core-glycosylation/JJ efficiency/NN ./.
@@13312922828/CD Lastly/RB ,/, there/RB are/VBP multiple/JJ instances/NNS in/IN which/WDT short/JJ oligonucleotide/NN direct/JJ repeats/NNS flank/NN a/DT region/NN absent/VB from/IN either/DT variola/NN or/CC vaccinia/NN virus/NN ./.
@@11863441752/CD The/DT attainment/NN of/IN sexual/JJ maturity/NN in/IN terms/NNS of/IN secondary/JJ sexual/JJ characteristics/NNS ,/, the/DT production/NN of/IN spermatozoa/NNS in/IN the/DT male/NN ,/, and/CC the/DT cyclical/JJ female/JJ pattern/NN with/IN release/NN of/IN ova/NNS are/VBP end-points/NNS of/IN the/DT developmental/JJ process/NN ./.
@@84218238054/CD CONCLUSIONS/IN :/: Free/NNP protein/MULTIGENE S/MULTIGENE deficiency/NN is/VBZ common/JJ among/IN hospitalized/VBN patients/NNS ,/, even/VB in/IN the/DT absence/NN of/IN a/DT recognized/VBN predisposing/JJ condition/NN ./.
@@74820696572/CD She/PRP had/VBP been/VBN receiving/JJ MTX/MULTIGENE 7/MULTIGENE ./MULTIGENE 5/MULTIGENE mg/NN //NN week/NN for/IN 2/CD ./CD 5/CD months/NNS because/IN of/IN her/PRP vasculitis/NN symptoms/NNS ./.
@@114698538765/CD We/PRP interpret/VBP these/DT data/NN as/IN further/JJ evidence/NN that/DT interaction/NN with/IN a/DT small/MULTIGENE GTPase/MULTIGENE is/VBZ the/DT main/JJ regulatory/JJ function/NN of/IN the/DT C1/NN domain/NN in/IN yeast/NN ./.
@@90757398478/CD Type/MULTIGENE IV/MULTIGENE splice/NN pattern/NN ,/, containing/JJ exon/NN U3/GENE and/CC S/NNP was/VBD found/VBN both/DT in/NN kidney/NN and/CC ovary/NN ./.
@@86789598660/CD Sestamibi/NNP scintigraphy/NN ,/, performed/VBN in/IN 70/CD patients/NNS ,/, was/VBD less/PRP sensitive/JJ than/IN ultrasonography/NN (/( 80%/CD )/SYM ./.
@@84810048438/CD Neither/CC clone/NN encoded/VBN the/DT cognate/MULTIGENE endonuclease/MULTIGENE ./.
@@22024962819/CD Clinical/NNP nutrition/NN of/IN adult/JJ horses/NNS ./.
@@107226611527/CD To/TO determine/VB if/IN CYC2/GENE is/VBZ found/VBN in/IN a/DT complex/NN with/IN previously/RB identified/VBN trypanosome/MULTIGENE cdc2-related/MULTIGENE kinases/MULTIGENE (/( CRKs/CONTEXTGENE )/SYM ,/, the/DT CYC2/MULTIGENE gene/MULTIGENE was/VBD fused/VBN to/IN the/DT TY/NNP epitope/NN tag/NN ,/, integrated/JJ into/IN the/DT trypanosome/NN genome/NN ,/, and/CC expressed/VBD under/IN inducible/JJ control/NN ./.
@@107421147521/CD Dll3/GENE is/VBZ mutated/JJ in/IN the/DT X-ray-induced/MULTIGENE mouse/MULTIGENE mutant/MULTIGENE pudgy/JJ (/( pu/NN )/SYM ,/, causing/JJ a/DT variety/NN of/IN vertebrocostal/JJ defects/NNS similar/JJ to/IN SD/NEWGENE phenotypes/NNS ./.
@@63086077478/CD The/DT junctions/NNS between/IN viral/JJ and/CC cellular/JJ sequences/NNS were/VBD determined/VBN by/IN DNA/NN sequence/NN analysis/NN to/IN be/VB 517/CD nucleotides/NNS into/IN the/DT p30/MULTIGENE sequence/MULTIGENE and/CC 1/CD ,/CD 920/CD nucleotides/NNS into/IN the/DT polymerase/MULTIGENE sequence/MULTIGENE ./.
@@104064592725/CD In/NN this/DT study/NN we/PRP describe/VBP that/IN platelet-derived/MULTIGENE growth/MULTIGENE factor/MULTIGENE (/( PDGF/NN )/SYM ,/, 12-O-tetradecanoyl-phorbol-acetate/JJ (/( TPA/NN )/SYM ,/, and/CC forskolin/MULTIGENE induced/MULTIGENE CREB/MULTIGENE (/( cAMP-responsive/MULTIGENE element-binding/MULTIGENE protein/MULTIGENE )/SYM Ser-133/NN phosphorylation/NN with/IN comparable/JJ magnitude/NN and/CC kinetics/NN in/IN NIH/NN 3T3/CD cells/NNS ./.
@@883912291/CD On/IN the/PDT other/DT hand/NN factor/MULTIGENE IX/MULTIGENE activity/NN is/VBZ decreased/VBN in/IN coumarin/NN treatment/NN with/IN factor/MULTIGENE IX/MULTIGENE antigen/NN remaining/JJ normal/NN ./.
@@83907479190/CD In/NN this/DT report/NN ,/, we/PRP focus/VBP on/IN the/DT genetics/NN of/IN the/DT region/NN of/IN the/DT 17/CD hep/NN syn/JJ gB/MULTIGENE gene/MULTIGENE that/WDT conferred/VBD both/PDT the/DT syncytial/JJ and/CC pathogenic/JJ phenotypes/NNS to/IN 17/CD syn+/NN ./.
@@19682247403/CD The/DT coding/JJ sequence/NN for/IN a/DT 260-amino-acid/JJ residue/NN polypeptide/NN was/VBD interrupted/VBN by/IN a/DT single/JJ short/JJ intron/NN of/IN 60/CD base/NN pairs/NNS (/( bp/NN )/SYM ,/, and/CC about/RB 70%/CD of/IN the/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN the/DT Drosophila/MULTIGENE PCNA/MULTIGENE was/VBD identical/JJ to/IN the/DT rat/NN and/CC human/MULTIGENE PCNA/MULTIGENE polypeptides/MULTIGENE ,/, with/IN conserved/VBN unique/JJ repeats/NNS of/IN leucine/NN in/IN the/DT C-terminal/MULTIGENE region/MULTIGENE ./.
@@82371126152/CD No/DT homology/NN was/VBD found/VBN between/IN the/DT 36K/MULTIGENE protein/MULTIGENE and/CC known/VBP structures/NNS of/IN proteins/NNS ./.
@@39049524555/CD Nursing/NNP education--the/JJ computer/NN obligation/NN ./.
@@68512801318/CD Plasma/NN fibrinogen/NEWGENE was/VBD measured/VBN by/IN the/DT turbidimetric/JJ method/NN in/IN timol/JJ turbidimetric/JJ units/NNS ./.
@@89981158947/CD SUMMARY/NNP BACKGROUND/IN DATA/NNP :/: Melanoma/NNS care/NN has/VBZ not/RB changed/VBN significantly/RB in/IN the/DT last/NN 20/CD years/NNS ,/, and/CC the/DT controversy/NN of/IN elective/JJ lymph/NN node/NN dissections/NNS in/IN this/DT disease/NN continues/VBZ to/IN be/VB discussed/VBN ./.
@@40387024705/CD The/DT results/NNS indicate/VBP that/IN :/: 1/NN )/NN the/DT initial/JJ response/NN to/IN tethering/VBG varies/VBZ according/VBG to/IN previous/JJ penning/NN and/CC handling/VBG experience/NN ,/, 2/NN )/NN although/IN the/DT circadian/JJ rhythm/NN of/IN cortisol/NN was/VBD either/DT altered/VBN or/CC disrupted/VBN during/IN estrus/NN ,/, such/JJ disruptions/NNS were/VBD not/RB influenced/VBN by/IN type/NN of/IN penning/NN and/CC 3/NN )/NN tether/NN stalls/NNS may/MD chronically/RB increase/VB cortisol/NN concentrations/NNS in/IN gilts/NNS ./.
@@116394851506/CD This/DT unique/JJ work/NN needs/NN to/IN be/VB edited/VBN critically/RB and/CC afterwards/RB translated/VBN into/IN Urdu/NN and/CC other/DT languages/NNS for/IN the/DT benefit/NN of/IN the/DT present/NN day/NN students/NNS and/CC scholars/NNS ./.
@@105600144067/CD Macroscopic/GENE researches/VBZ on/IN heart/NN vascularization/NN have/NN indicated/VBN that/IN the/DT angioarchitecture/NN of/IN the/DT conducting/JJ system/NN differs/VBZ from/IN that/DT of/IN the/DT normal/JJ myocardium/NN ./.
@@76547407577/CD Key/NNP areas/NNS of/IN the/DT selection/NN process/NN including/JJ medical/JJ and/CC surgical/JJ alternatives/NNS to/IN transplantation/NN ,/, the/DT composition/NN of/IN the/DT transplant/NN work-up/NN ,/, specific/JJ inclusion/NN criteria/NNS as/RB well/VBP as/IN specific/JJ psychosocial/JJ factors/NNS and/CC specific/JJ disease/NN etiologies/NNS and/CC co-morbidities/NNS that/WDT might/MD represent/VB contraindications/NNS were/VB extensively/RB reviewed/VBN ./.
@@115803015421/CD The/DT diagnosis/NN of/IN HCV/NN arthritis/NN in/IN patients/NNS with/IN positive/JJ rheumatoid/MULTIGENE factor/MULTIGENE and/CC chronic/JJ inflammatory/JJ polyarthritis/NN may/MD be/VB difficult/JJ ./.
@@14581708150/CD Adapromine/NN was/VBD established/VBN to/IN evoke/VB a/DT decrease/NN of/IN the/DT amplitude/NN of/IN the/DT dominant/JJ peak/NN and/CC dominant/JJ theta-activity/NN in/IN power/NN spectra/NNS of/IN the/DT EEG/NN in/IN the/DT cortex/NN and/CC hippocamp/NN ,/, with/IN an/DT increase/NN of/IN rapid/JJ wave/NN activity/NN in/IN the/DT beta/MULTIGENE 2/MULTIGENE range/NN in/IN the/DT right/JJ cortex/NN and/CC hippocamp/NN ./.
@@39119658408/CD Although/IN no/DT statistical/JJ significance/NN was/VBD achieved/VBN ,/, it/PRP is/VBZ remarkable/JJ that/IN there/RB was/VBD a/DT clear/JJ trend/NN for/IN the/DT superiority/NN of/IN Galphimia/MULTIGENE D6/MULTIGENE while/CC the/DT Galphimia/NNP dilution/NN 10/NN (/NN -6/NN )/NN was/VBD about/RB equally/RB effective/JJ compared/VBN with/IN placebo/NN ./.
@@27650013465/CD Definite/JJ JPsA/NN (/( 24/CD patients/NNS )/SYM was/VBD defined/VBN as/IN arthritis/NN associated/VBN ,/, but/CC not/RB necessarily/RB coincident/JJ ,/, with/IN a/DT typical/JJ psoriatic/JJ rash/NN ,/, or/CC arthritis/NN plus/IN at/IN least/RB 3/CD of/IN 4/CD minor/JJ criteria/NNS :/: dactylitis/NN ,/, nail/NN pitting/NN ,/, psoriasis-like/JJ rash/NN ,/, or/CC family/NN history/NN of/IN psoriasis/NN ./.
@@93284763796/CD Hprp3p/GENE is/VBZ a/DT 77/MULTIGENE kDa/MULTIGENE protein/MULTIGENE ,/, which/WDT is/VBZ homologous/JJ to/IN the/DT Saccharomyces/NN cerevisiae/NN splicing/JJ factor/NN Prp3p/GENE ./.
@@85343674888/CD PTP-S3/GENE differs/VBZ from/IN PTP-S4/GENE in/IN having/VBG a/DT deletion/NN of/IN 19/CD amino/JJ acids/NNS corresponding/JJ to/IN exon/NN E1/NNP ./NNP
@@72347557061/CD For/IN monocytes/NNS ,/, as/IN measured/VBN on/IN the/DT Hematrak/NNP ,/, it/PRP was/VBD 13/CD ./CD 4%/CD ./.
@@8062958045/CD Absorption/NNS varied/VBN between/IN 65/CD and/CC 95/CD per/IN cent/NN ,/, with/IN a/DT mean/JJ absorption/NN of/IN 80/CD per/IN cent/NN ,/, in/IN both/DT pregnant/JJ and/CC non-pregnant/JJ subjects/NNS ./.
@@89709794325/CD In/NN contrast/NN ,/, extracts/VBZ of/IN the/DT mutant/JJ virions/NNS catalyze/VBP the/DT wild-type/NN level/NN of/IN transcription/NN from/IN an/DT exogenous/JJ template/NN containing/JJ an/DT early/JJ promoter/NN ./.
@@50682715351/CD Influence/NNS of/IN diet/NN on/IN urinary/JJ VMA/NN excretion/NN ./.
@@7516597951/CD We/PRP also/RB examined/VBD the/DT effect/NN of/IN proteolytic/JJ processing/NN in/IN the/DT MVE/JJ nonstructural/JJ polyprotein/NN segment/NN mediated/JJ by/IN the/DT viral/MULTIGENE proteinase/MULTIGENE NS3/MULTIGENE on/IN antigen/NN processing/VBG and/CC presentation/NN of/IN the/DT MVE/JJ H-2Kk-restricted/JJ T/NN cell/NN determinant/NN ./.
@@10820904622/CD BACKGROUND/IN :/: Hepatic/JJ encephalopathy/NN is/VBZ a/DT neuropsychiatric/JJ syndrome/NN associated/VBN with/IN acute/JJ liver/NN failure/NN ,/, chronic/JJ parenchymal/JJ liver/NN disease/NN or/CC portal/JJ systemic/JJ anastomosis/NN ./.
@@101939504223/CD METHODS/IN :/: Between/IN August/NN 1991/CD and/CC June/NN 1994/CD ,/, 198/CD men/NNS with/IN clinical/JJ T2/GENE or/CC T3/NN classified/VBN (/( TNM/NN )/SYM prostate/NN carcinoma/NN (/( bone/NN scan/NN negative/JJ )/SYM who/WP were/VBD at/IN high/JJ risk/NN of/IN lymph/NN node/NN involvement/NN underwent/VBD a/DT 111In-capromab/JJ pendetide/NN scan/NN prior/NN to/IN staging/JJ lymphadenectomy/NN ./.
@@71744376996/CD Organisms/NNS were/VBD not/RB observed/VBN in/IN the/DT 5/CD bobcats/NNS trapped/VBN in/IN 2/CD other/DT counties/NNS ./.
@@75266092963/CD However/RB ,/, expression/NN of/IN sigma/NN 3/CD from/IN S4/NN (/( 3'UTR/CD //CD S1/CD )/SYM ,/, which/WDT included/VBD the/PDT PKR/MULTIGENE activator/MULTIGENE sequence/MULTIGENE from/IN S1/NN within/IN the/DT 3'-UTR/CD of/IN S4/NN ,/, was/VBD comparable/JJ to/IN that/DT from/IN wild-type/NNP S4/NNP ./NNP
@@78247266647/CD Each/DT type/NN was/VBD divided/VBN into/IN two/JJ subgroups/NNS on/IN the/DT basis/NN of/IN whether/IN the/DT body/NN and/CC tail/NN of/IN the/DT pancreas/NN showed/VBD intense/JJ fatty/JJ replacement/NN (/( type/NN a/DT =/SYM negative/JJ for/IN intense/JJ fatty/JJ replacement/NN ,/, type/MULTIGENE b/MULTIGENE =/SYM positive/JJ for/IN intense/JJ fatty/JJ replacement/NN )/SYM ./.
@@15477751593/CD These/DT data/NN support/NN a/DT possible/JJ biological/JJ significance/NN of/IN the/DT frameshift/NN to/IN occur/VB at/IN this/DT position/NN of/IN the/DT large/JJ overlap/NN by/IN including/JJ the/DT putative/JJ RNA/MULTIGENE template-binding/MULTIGENE site/MULTIGENE of/IN the/DT PLRV/MULTIGENE replicase/MULTIGENE in/IN the/DT ORF2a/GENE //GENE ORF2b/GENE transframe/NN protein/NN ./.
@@65938626295/CD Hepatitis/MULTIGENE B/MULTIGENE vaccine/NN ./.
@@24582343123/CD A/DT new/JJ method/NN for/IN the/DT quantitative/JJ analysis/NN of/IN sleep/NN spindles/NNS during/IN continuous/JJ overnight/JJ EEG/NN recordings/NNS ./.
@@89805222814/CD The/DT cDNA/NN of/IN cpm7/GENE encodes/VBZ a/DT closely/RB related/VBN protein/NN of/IN 36/CD ./CD 8/CD kDa/NN ./.
@@11337859634/CD The/DT COD/NN and/CC color/NN removals/NNS were/VBD both/DT more/RB than/IN 90%/NN when/CC FeCl3/GENE was/VBD used/VBN as/IN the/DT coagulation/NN (/( dosages/NNS of/IN two-step/JJ coagulation/NN were/VBD 0/CD ./CD 031/CD and/CC 0/CD ./CD 012/CD mol/NN //NN L/NN respectively/RB )/SYM after/IN a/DT ferrous/JJ hydrogen/NN peroxide/NN oxidation/NN pretreatment/JJ at/IN a/DT H2O2/NN dosage/NN of/IN 0/CD ./CD 06/CD mol/NN //NN L/NN ./.
@@86282608080/CD Utilizing/JJ transient/JJ transfection/NN studies/NNS in/IN HepG2/NNP cells/NNS ,/, we/PRP have/VBP shown/VBP that/DT deletion/NN of/IN the/DT factor/MULTIGENE VIII/MULTIGENE promoter/MULTIGENE sequences/MULTIGENE distal/JJ to/IN nucleotide/NN -44/CD results/NNS in/IN a/DT significant/JJ but/CC small/JJ increase/NN in/IN promoter/NN activity/NN ./.
@@30980183819/CD Clinical/NNP findings/NNS were/VBD :/: height/NN 183/CD cm/NN ,/, weight/NN 62/CD kg/NN ,/, increased/VBN length/NN of/IN lower/JJR limbs/NNS ,/, P2-A2/GENE pilosity/NN and/CC micropenis/NN ./.
@@105593244280/CD Moreover/RB ,/, a/DT recombinant/JJ Ad/MULTIGENE expressing/MULTIGENE Ad5/MULTIGENE E4orf6/NNP //NNP 7/NNP induced/VBD apoptosis/NN in/IN rat/NN cells/NNS when/CC coinfected/VBN with/IN wild-type/NN p53-expressing/JJ Ad/JJ ./JJ
@@28976513603/CD Hyperthyroidism/NNS is/VBZ one/PRP of/IN the/DT numerous/JJ causes/NNS of/IN infertility/NN and/CC recurrent/JJ abortion/NN ./.
@@84250504625/CD An/DT extensive/JJ inverted/JJ repeat/NN is/VBZ present/VB 3'/CD of/IN rpeA/NN ;/: inverted/JJ repeats/NNS are/VBP found/VB downstream/RB of/IN all/DT PE/MULTIGENE operons/MULTIGENE sequenced/VBN to/IN date/NN ,/, although/IN the/DT sequence/NN is/VBZ not/RB conserved/VBN ./.
@@93120877698/CD Recent/JJ studies/NNS have/VBP shown/VBP that/IN the/DT Src/MULTIGENE homology-2/MULTIGENE (/( SH2/GENE )/SYM domain-containing/MULTIGENE protein-tyrosine/MULTIGENE phosphatase/MULTIGENE ,/, SHP-2/GENE ,/, associates/VBP with/IN the/DT cytoplasmic/JJ domain/NN of/RB PECAM-1/GENE as/IN it/PRP becomes/VBZ tyrosine-phosphorylated/JJ during/IN platelet/NN aggregation/NN :/: a/DT process/NN that/WDT can/MD be/VB mimicked/VBN in/IN part/NN by/IN small/JJ synthetic/JJ phosphopeptides/NEWGENE corresponding/JJ to/IN the/DT cytoplasmic/JJ domain/NN of/IN PECAM-1/GENE encompassing/VBG tyrosine/NN residues/NNS Tyr-663/NN or/CC Tyr-686/NN ./.
@@21031402704/CD All/DT 8/CD (/( 100%/CD )/SYM patients/NNS with/IN fulminant/JJ hepatic/JJ failure/NN who/WP received/VBD grafts/NNS survived/VBN ,/, including/JJ 3/CD who/WP received/VBD ABO-incompatible/NNP grafts/NNS ,/, though/CC 2/CD of/IN these/DT subsequently/RB required/VBN retransplantation/NN ./.
@@42139174859/CD High/NNP dosages/NNS of/IN D-penicillamine/NN in/IN pulmonary/JJ fibroses/NNS ./.
@@111225883577/CD MAIN/NNP OUTCOME/NNP MEASURES/NNS :/: Percentage/NN change/NN in/IN the/DT apnea-hypopnea/JJ index/NN (/( AHI/NNS ;/: apnea/NN events/NNS +/SYM hypopnea/NN events/NNS per/IN hour/NN of/IN sleep/NN )/SYM and/CC odds/NNS of/IN developing/JJ moderate-to-severe/JJ SDB/GENE (/( defined/VBN by/IN an/DT AHI/NNS >/SYM or/CC =/CD 15/CD events/NNS per/IN hour/NN of/IN sleep/NN )/SYM ,/, with/IN respect/NN to/IN change/NN in/IN weight/NN ./.
@@103327337282/CD The/DT paramyxovirus/NN fusion/NN (/( F/NN )/SYM protein/NN mediates/VBZ membrane/NN fusion/NN ./.
@@106878553183/CD Expression/NNS in/IN early/JJ postnatal/JJ pituitary/JJ and/CC in/IN pre-somatotrophic/JJ cells/NNS suggests/VBZ that/IN Zn-16/GENE could/MD play/VB a/DT role/NN in/IN pituitary/JJ development/NN prior/NN to/IN somatotroph/NN differentiation/NN ./.
@@109061765798/CD The/DT repetitive/JJ ETn/NN (/( early/JJ transposon/NN )/SYM family/NN of/IN sequences/NNS represents/VBZ an/DT active/JJ "mobile/JJ mutagen"/NN in/IN the/DT mouse/NN genome/NN ./.
@@90656905287/CD Ume6p/GENE ,/, which/WDT also/RB controls/VBZ the/DT expression/NN of/IN early/JJ meiotic/JJ genes/NNS ,/, represses/VBZ CAR1/GENE expression/NN through/RB a/DT sequence/NN called/VBN URS/NN ,/, as/IN a/DT function/NN of/IN nitrogen/NN availability/NN ./.
@@51145156478/CD Slowed/JJ lysosomal/MULTIGENE enzyme/MULTIGENE release/NN and/CC its/PRP normalization/NN by/IN drugs/NNS in/IN adjuvant-induced/JJ polyarthritis/NN ./.
@@35553184221/CD The/DT pharmacology/NN of/IN carnitine/NN ./.
@@58268185760/CD I/NNP ./NNP
@@50156785311/CD Nitrogen-hydrogen/NNP tautomerism/NN in/IN porphyrins/NNS and/CC chlorins/NNS ./.
@@99887679339/CD Interspecific/NNP mouse/NN back-cross/NN analysis/NN identified/VBD the/DT loci/NNS for/IN mouse/NN 3Ost/NEWGENE genes/NNS and/CC syntenic/JJ assignments/NNS of/IN corresponding/JJ human/JJ isologs/NNS were/VBD confirmed/VBN by/IN the/DT identification/NN of/IN mapped/VBN sequence-tagged/MULTIGENE site/MULTIGENE markers/MULTIGENE ./.
@@93939661532/CD Two/CD closely/RB related/VBN IgH/MULTIGENE constant/MULTIGENE region/MULTIGENE genes/MULTIGENE ,/, CHA/NNS and/CC CHB/NNP ,/, have/VB been/VBN sequenced/VBN completely/RB ./.
@@22807774217/CD The/DT uteroglobin/MULTIGENE promoter/MULTIGENE contains/VBZ a/DT noncanonical/JJ estrogen/MULTIGENE responsive/MULTIGENE element/MULTIGENE ./.
@@78358268050/CD Fraction/NNP 2/CD contains/VBZ 1/NN ,/NN 25/NN (/NN OH/NN )/NN 2-vitamin/NN D3/GENE ,/, vitamin/NN D3/GENE ,/, 25/CONTEXTGENE (/CONTEXTGENE OH/CONTEXTGENE )/CONTEXTGENE -vitamin/CONTEXTGENE D3/GENE and/CC 1/NN ,/NN 24/NN ,/NN 25/NN (/NN OH/NN )/NN 3-vitamin/NN D3/NN ./NN
@@10496553330/CD The/DT healing/NN rate/NN in/IN HIV-positive/NN patients/NNS was/VBD 66/CD percent/NN after/IN 14/CD weeks/NNS and/CC 100/CD percent/NN after/IN 32/CD weeks/NNS ;/: the/DT corresponding/JJ figures/NNS for/IN patients/NNS with/IN acquired/VBN immunodeficiency/NN syndrome/NN were/VBD 0/CD and/CC 50/CD percent/NN ./.
@@64391351224/CD Regional/MULTIGENE CBF/MULTIGENE was/VBD determined/VBN by/IN clearance/NN of/IN xenon/NN 133/CD in/IN 67/CD patients/NNS undergoing/VBG coronary/JJ bypass/NN grafting/NN procedures/NNS ./.
@@28383197072/CD RVEF/GENE and/CC LVEF/NN both/DT increased/VBN by/IN about/RB 14%/JJ (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD and/CC p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@19821902593/CD Early/JJ cirrhosis/NN ,/, an/DT early/JJ modality/NN of/IN the/DT evolution/NN of/IN acute/JJ hepatitis/NN ./.
@@15316325251/CD Among/IN the/DT few/JJ proteins/NNS of/IN the/DT eukaryotic/JJ nucleolus/NN that/WDT have/VBP been/VBN characterized/VBN ,/, four/CD proteins/NNS ,/, nucleolin/NN ,/, fibrillarin/NN ,/, SSB1/GENE and/CC NSR1/GENE ,/, possess/VB a/DT common/JJ structural/JJ motif/NN ,/, the/DT GAR/NN domain/NN ,/, which/WDT is/VBZ rich/JJ in/IN glycine/NN and/CC arginine/NN residues/NNS ./.
@@72378174218/CD Cross/NN reactivity/NN in/IN theophylline/MULTIGENE RIA/MULTIGENE kit/MULTIGENE decreased/VBN ./.
@@79589159049/CD In/NN particular/JJ ,/, changes/VBZ in/IN intracellular/JJ Ca2+/NN have/NN the/DT potential/NN to/IN either/DT inhibit/VB or/CC augment/VB the/DT ability/NN of/IN cAMP/NN to/IN stimulate/VB transcription/NN ,/, depending/VBG on/IN the/DT presence/NN of/IN specific/JJ forms/NNS of/IN Ca2+/MULTIGENE //MULTIGENE calmodulin-dependent/MULTIGENE protein/MULTIGENE kinases/MULTIGENE ./.
@@75164663627/CD In/NN contrast/NN ,/, injection/NN of/IN a/DT plasmid/NN encoding/VBG simian/JJ virus/NN 40/MULTIGENE small/MULTIGENE t/MULTIGENE antigen/NN ,/, which/WDT interacts/VBZ with/IN PP2A/NNS to/IN inhibit/VB its/PRP activity/NN towards/IN several/DT phosphoprotein/MULTIGENE substrates/MULTIGENE ,/, had/VBP no/DT effect/NN on/IN the/DT phosphorylation/NN state/NN of/IN CREB/NN in/IN stimulated/VBN or/CC unstimulated/JJ NIH/NN 3T3/CD cells/NNS ./.
@@1396247452/CD Eight/CD hours/NNS after/IN the/DT administration/NN of/IN colchicine/NN ,/, the/DT serum/JJ ceruloplasmin/NEWGENE level/NN began/VBD to/IN rise/NN again/RB in/IN female/JJ rats/NNS ,/, but/CC not/RB in/IN male/JJ rats/NNS ./.
@@9753149741/CD Primary/JJ amenorrhoea/NN in/IN a/DT phenotypically/RB female/JJ individual/NN with/IN a/DT karyotype/MULTIGENE 46/MULTIGENE ,/, xy/CONTEXTGENE and/CC bilateral/JJ gonadoblastoma/NN ./.
@@33718946349/CD Vimentin/NEWGENE positivity/NN was/VBD noted/VBN in/IN the/DT undifferentiated/JJ and/CC fibroblastic/MULTIGENE components/MULTIGENE ./.
@@62080248292/CD This/DT fraction/NN is/VBZ resistant/JJ to/IN digestions/NNS by/IN DNase/MULTIGENE I/MULTIGENE and/CC RNase/MULTIGENE T1/MULTIGENE and/CC disappears/VBZ completely/RB upon/IN alkali/NN hydrolysis/NN ./.
@@939885546/CD SCID/NN V/NN (/NN D/NN )/NN J/NN recombination/NN can/MD be/VB partly/RB rescued/VBN in/IN T-lymphocytes/NNS by/IN either/DT DNA-damaging/JJ agents/NNS (/( gamma-irradiation/NN and/CC bieomycin/NN )/SYM or/CC a/DT null/JJ mutation/NN of/IN the/DT p53/MULTIGENE gene/MULTIGENE ,/, possibly/RB because/IN of/IN transiently/RB elevated/VBN DNA/NN repair/NN activity/NN in/IN response/NN to/IN DNA/NN damage/NN or/CC to/IN delayed/JJ apoptosis/NN in/IN the/DT absence/NN of/IN p53/GENE ./.
@@93937064621/CD Thus/RB ,/, Fis/NNS acts/NNS as/IN an/DT accessory/JJ transcriptional/JJ activator/NN at/IN the/DT mar/VB promoter/NN ./.
@@27476533916/CD A/DT larval/JJ albumin-like/MULTIGENE protein/MULTIGENE was/VBD not/RB detectable/JJ by/IN silver/NEWGENE staining/NN in/IN serum/NN of/IN tadpoles/NNS before/IN the/DT beginning/NN of/IN metamorphosis/NN at/IN stage/NN 48/CD ./CD
@@36071094269/CD All/PDT these/DT processes/NNS were/VBD fully/RB developed/VBN during/IN the/DT last/NN month/NN of/IN pregnancy/NN ,/, offering/VBG the/DT same/JJ picture/NN as/IN the/DT controls/NNS ./.
@@93434339323/CD It/PRP has/VBZ been/VBN previously/RB shown/VBP that/IN genes/NNS transcribed/VBN by/IN RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE (/( RNAP/MULTIGENE II/MULTIGENE )/SYM are/VBP subject/NN to/IN position/NN effect/NN variegation/NN when/CC located/VBN near/IN yeast/NN telomeres/NNS ./.
@@115951709386/CD Alignment/NNS of/IN different/JJ cDNAs/NNS of/IN the/DT NR5A2/GENE (/( hB1F/GENE )/SYM gene/NN with/IN the/DT genomic/JJ sequence/NN facilitated/VBN the/DT delineation/NN of/IN its/PRP structural/JJ organization/NN ,/, which/WDT spans/VBZ over/RB 150/CD kb/NN and/CC consists/VBZ of/IN eight/CD exons/NNS interrupted/VBN by/IN seven/JJ introns/NNS ./.
@@98816928362/CD Conventionally/RB ,/, four/CD nominal/JJ allotypic/JJ variants/NNS ,/, b4/CD ,/, b5/NN ,/, b6/GENE and/CC b9/GENE have/VB been/VBN shown/VBP to/IN be/VB co-dominantly/RB expressed/VBN at/IN the/DT Ckappa1/MULTIGENE gene/MULTIGENE locus/MULTIGENE ./.
@@83950143849/CD Genetic/NNP interactions/NNS between/IN BCK2/GENE and/CC other/DT pathway/MULTIGENE components/MULTIGENE suggested/VBN that/IN BCK2/GENE functions/NNS on/IN a/DT common/JJ pathway/NN branch/NN with/IN PPZ1/GENE and/CC PPZ2/GENE ./.
@@6657559718/CD Trial/NN 3/CD broiler/NN chickens/NNS were/VBD maintained/VBN on/IN control/NN feed/JJ until/IN they/PRP reached/VBD 3/CD weeks/NNS of/IN age/NN at/IN which/WDT time/VBP they/PRP were/VBD taken/VBP off/RB of/IN feed/JJ for/IN 2/CD ./CD 5/CD hr/NN and/CC then/RB placed/VBN on/IN either/DT control/JJ feed/JJ or/CC feed/JJ containing/JJ 4/CD ./CD 0/CD ppm/NN ochratoxin/MULTIGENE A/MULTIGENE ,/, and/CC heart/NN rate/NN and/CC blood/NN pressure/NN were/VBD measured/VBN every/DT half/NN hour/NN through/RB 7/CD hr/NN ./NN
@@25436799416/CD We/PRP also/RB provide/VBP evidence/NN that/IN neither/DT the/DT lambda/MULTIGENE O/MULTIGENE and/CC P/MULTIGENE initiators/MULTIGENE nor/CC the/DT E/NNP ./NNP coli/JJ DnaJ/NEWGENE and/CC DnaK/MULTIGENE heat/MULTIGENE shock/MULTIGENE proteins/MULTIGENE play/VBP a/DT direct/JJ role/NN in/IN the/DT propagation/NN of/IN lambda/NN replication/NN forks/NNS in/IN vitro/FW ./.
@@86919628675/CD Limited/NNP role/NN for/IN PCR-based/JJ diagnosis/NN of/IN Whipple's/NNP disease/NN from/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS ./.
@@19274212549/CD Neuro-otological/JJ examinations/NNS revealed/VBD spontaneous/JJ downbeat/JJ nystagmus/NN ,/, bilateral/JJ gaze/NN nystagmus/NN and/CC rebound/JJ nystagmus/NN ./.
@@12088117303/CD Study/NNP of/IN the/DT physico-chemical/JJ state/NN of/IN plutonium-239/GENE in/IN a/DT citrate/NN solution-blood/JJ system/NN ./.
@@81517874271/CD Insertion/NNS of/IN short/JJ oligonucleotides/NNS encoding/VBG the/DT basic/JJ amino/JJ acid/NN motifs/NNS 726-GRKRKSP-732/GENE from/IN IE175/GENE and/CC 500-VRPRKRR-506/JJ from/IN IE110/NNP into/IN deleted/VBN cytoplasmic/JJ forms/NNS of/IN the/DT two/JJ proteins/NNS restored/VBD the/DT karyophilic/JJ phenotype/NN and/CC confirmed/VBN that/IN these/DT motifs/NNS are/VBP both/DT necessary/JJ and/CC sufficient/JJ for/IN proper/JJ nuclear/JJ localization/NN ./.
@@83969135510/CD This/DT negative/JJ element/NN may/MD ,/, at/IN least/RB in/IN part/NN ,/, be/VB responsible/JJ for/IN the/DT cell/NN type-specific/JJ expression/NN of/IN the/DT DGK/MULTIGENE gene/MULTIGENE ./.
@@69736646763/CD A/DT case/NN of/IN anterior/JJ cleavage/NN syndrome/NN in/IN a/DT 27-year-old/CD female/JJ patient/NN is/VBZ described/VBN ./.
@@111794006596/CD Responses/NNS of/IN single-unit/NN carotid/JJ body/MULTIGENE chemoreceptors/MULTIGENE in/IN adult/JJ rats/NNS ./.
@@7828824241/CD Mutations/NNS that/WDT alter/VBP photoreceptor/NN cell/NN structure/NN and/CC development/NN were/VBD isolated/VBN that/DT fail/NN to/IN complement/NN these/DT deletions/NNS ./.
@@21355364321/CD In/NN that/DT case/NN ,/, the/DT ratio/NN of/IN brush/NN abrasion/NN was/VBD 0/CD ./CD 268/CD ,/, compressive/JJ and/CC transverse/JJ strength/NN ,/, 124/CD ./CD 3/CD and/CC 86/CD ./CD 3/CD MPa/NNS respectively/RB ,/, hardness/NN ,/, 43/CD ./CD 2/CD Hk/NNP ,/, water/NN absorption/NN 14/CD ./CD 2/CD micrograms/GENE //GENE mm3/GENE and/CC thermal/JJ expansion/NN coefficient/NN ,/, 47/CD ./CD 4/CD x/NN 10/NN (/NN -6/NN )/NN //NN degrees/NN C/NNP ./NNP
@@105493545247/CD A/DT proportion/NN of/IN APC/MULTIGENE wild-type/MULTIGENE colon/NN carcinomas/NNS and/CC melanomas/NNS also/RB contains/VBZ constitutive/JJ nuclear/MULTIGENE Tcf-4/MULTIGENE //MULTIGENE beta-catenin/MULTIGENE complexes/NNS as/IN a/DT result/NN of/IN dominant/JJ mutations/NNS in/IN the/DT N/JJ terminus/NN of/IN beta-catenin/NN that/WDT render/VBP it/PRP insensitive/JJ to/IN downregulation/NN by/IN APC/CONTEXTGENE ,/, GSK3/MULTIGENE beta/MULTIGENE ,/, and/CC Axin/CONTEXTGENE //CONTEXTGENE Conductin/CONTEXTGENE ./.
@@117102331554/CD Hydrogels/NNS for/IN tissue/NN engineering/JJ ./.
@@10490604787/CD Here/RB ,/, we/PRP demonstrate/VBP that/IN kinase-dead/JJ but/CC not/RB wild-type/VB forms/NNS of/IN Fyn/VB ,/, Lck/IN ,/, and/CC ZAP-70/NEWGENE block/NN 70Z/MULTIGENE Cbl-mediated/MULTIGENE NFAT/MULTIGENE activation/NN ./.
@@16825422281/CD In/NN a/DT country/NN where/CC general/JJ HIV/NN prevalence/NN is/VBZ low/JJ ,/, the/DT strategy/NN is/VBZ cost-effective/JJ for/IN location/NN and/CC counselling/NN of/IN unknowingly/RB seropositive/JJ individuals/NNS ./.
@@10612773180/CD CONCLUSIONS/IN :/: Serum/NN levels/NNS of/IN S-100beta/GENE are/VBP reliable/JJ markers/NNS for/IN adverse/JJ neurologic/JJ outcomes/NNS after/IN cardiac/JJ surgery/NN ./.
@@8381528341/CD If/IN ,/, however/RB ,/, the/DT mean/JJ temperature/NN rise/NN was/VBD higher/JJ (/( 0/CD ./CD 57/CD degrees/NNS C/NN or/CC 0/CD ./CD 69/CD degrees/NNS C/NN )/SYM ,/, such/JJ a/DT selection/NN practically/RB resulted/VBD in/IN the/DT disappearance/NN of/IN 'passable'/NN qualifications/NNS in/IN the/DT triplet/NN groups/NNS and/CC a/DT great/JJ predominance/NN of/IN 'to/MD be/VB rejected'/VBN qualifications/NNS in/IN the/DT large/JJ groups/NNS ./.
@@85545402552/CD These/DT regions/NNS overlap/NN with/IN the/DT HIT/MULTIGENE protein/MULTIGENE similarity/NN regions/NNS ./.
@@80843395013/CD This/DT alternatively/RB spliced/VBN transcript/NN contained/VBD an/DT open/JJ reading/JJ frame/NN extending/VBG from/IN the/DT upstream/MULTIGENE J/MULTIGENE alpha/MULTIGENE 11-2/MULTIGENE region/MULTIGENE to/IN 82/CD nucleotides/NNS downstream/RB of/IN the/DT beginning/NN of/IN the/DT TCR/MULTIGENE C/MULTIGENE alpha/MULTIGENE region/MULTIGENE ,/, and/CC potentially/RB encoded/VBN a/DT 36/CD amino/JJ acid/NN polypeptide/NN ./.
@@32231237376/CD Critical/NNP evaluation/NN of/IN various/JJ methods/NNS of/IN determining/NN markers/NN of/IN fetal/JJ maturity/NN in/IN amniotic/JJ fluid/NN ./.
@@10429740284/CD This/DT review/NN summarizes/VBZ the/DT clinical/JJ evidence/NN to/IN support/NN current/JJ therapies/NNS in/IN irritable/JJ bowel/NN syndrome/NN (/( IBS/NNS )/SYM ./.
@@84911248453/CD The/DT technical/JJ construction/NN of/IN the/DT mouth/NN protectors/NNS is/VBZ illustrated/VBN ,/, as/IN is/VBZ the/DT need/NN for/IN instrumentation/NN and/CC its/PRP costs/NNS and/CC the/DT materials/NNS required/VBN to/IN manufacture/NN these/DT mouth/NN protectors/NNS ./.
@@89169286090/CD The/DT same/JJ ligands/NNS also/RB exhibit/VBP a/DT similar/JJ inhibitory/JJ effect/NN on/IN PDGF-BB-dependent/NNP [/NN 3H/NN ]/NN thymidine/NN incorporation/NN in/IN PAE/NN cells/NNS expressing/JJ the/DT PDGF/MULTIGENE beta-receptors/MULTIGENE ./.
@@102260293304/CD In/NN epithelial/JJ cells/NNS ,/, the/DT PH/NN domain/NN of/IN Akt/GENE //GENE PKB/GENE localised/VBN to/IN sites/NNS of/IN cell-cell/JJ and/CC cell-matrix/JJ contact/NN ,/, distinct/JJ from/IN focal/JJ contacts/NNS ,/, even/VB in/IN the/DT absence/NN of/IN serum/NN ./.
@@76584713524/CD The/DT plant/NN hormone/MULTIGENE auxin/MULTIGENE transcriptionally/RB activates/VBZ early/JJ genes/NNS ./.
@@33001183991/CD Oxygen/NN delivery/NN and/CC base/NN excess/NN decreased/VBN significantly/RB and/CC four/CD pigs/NNS died/VBN ./.
@@111455623518/CD The/DT P69/CD cell/NN line/NN was/VBD derived/VBN by/IN immortalization/NN of/IN human/JJ primary/JJ prostate/NN epithelial/JJ cells/NNS with/IN simian/MULTIGENE virus-40/MULTIGENE T/MULTIGENE antigen/NN and/CC is/VBZ rarely/RB tumorigenic/JJ ./.
@@71126546917/CD It/PRP was/VBD also/RB found/VB that/WDT there/RB is/VBZ no/DT significant/JJ difference/NN between/IN the/DT prevalence/NN of/IN nasal/JJ carriage/NN of/IN S/NNP ./NNP aureus/NN amongst/IN the/DT hospital/NN staff/NN and/CC the/DT patients/NNS ./.
@@88164384062/CD Quantitative/JJ analysis/NN of/IN plasmid/NN loss/NN rates/NNS in/IN cdc28-1N/JJ strains/NNS carrying/VBG plasmids/NNS with/IN multiple/JJ replication/NN origins/NNS suggests/VBZ that/IN a/DT defect/NN in/IN initiating/JJ DNA/NN replication/NN probably/RB causes/VBZ this/DT plasmid/NN loss/MULTIGENE phenotype/MULTIGENE ./.
@@2547706967/CD The/DT application/NN of/IN ISH/NN and/CC IHC/NNS did/VBD not/RB change/VB significantly/RB the/DT routine/JJ histologic/JJ classification/NN of/IN pneumonias/NNS into/IN CMV-IP/GENE and/CC IIP/GENE ./.
@@71349246942/CD The/DT most/RB common/JJ types/NNS of/IN malformations/NNS were/VBD eye/NN defects/NNS and/CC open/JJ coeloms/NNS ./.
@@114161442860/CD Our/PRP findings/NNS further/RB our/PRP understanding/NN of/IN how/RB ZBP-89/GENE modulates/VBZ cell/NN proliferation/NN and/CC reveals/VBZ a/DT novel/JJ mechanism/NN by/IN which/WDT the/DT p53/MULTIGENE protein/MULTIGENE is/VBZ stabilized/VBN ./.
@@116977602603/CD This/DT study/NN investigated/VBN whether/IN boron/NN would/MD enhance/VB the/DT ability/NN of/IN 17beta-estradiol/JJ (/( E2/GENE )/SYM or/CC parathyroid/JJ hormone/NN (/( PTH/NN )/SYM to/IN improve/VB bone/NN quality/NN in/IN ovariectomized/JJ OVX/JJ rats/NNS ./.
@@11543317361/CD The/DT absorbed/VBN dose/NN was/VBD measured/VBN by/IN combination/NN of/IN two/JJ integrating/JJ detectors/NNS :/: thermo-/JJ luminescent/JJ dosemeter/NN of/IN Mg2SiO4/GENE :/: Tb/NN (/( TDMS/NNP )/SYM and/CC plastic/JJ nuclear/JJ track/NN detector/NN (/( PNTD/NNP )/SYM ./.
@@10453371302/CD Weight/NN and/CC height/NN z-scores/NNS were/VBD significantly/RB associated/VBN with/IN BMD/NN z-scores/NNS ./.
@@10393197977/CD DDP1/GENE also/RB localizes/VBZ to/IN heterochromatin/NN in/IN interphase/NN nuclei/NNS of/IN larval/JJ neuroblasts/NNS ./.
@@84060044824/CD Moreover/RB ,/, in/IN transient/JJ transfection/NN assays/NNS ,/, PU/NEWGENE ./NEWGENE 1/NEWGENE alone/RB activated/VBN reporter/NN constructs/NNS containing/JJ the/DT JB/MULTIGENE cis-element/MULTIGENE ,/, and/CC the/DT activation/NN was/VBD shown/VBP to/IN be/VB dependent/JJ on/IN a/DT glutamine-rich/JJ sequence/NN in/IN the/DT amino-terminal/JJ portion/NN of/IN PU/NEWGENE ./NEWGENE 1/NEWGENE ./.
@@85103208474/CD It/PRP is/VBZ reported/VBN that/IN ,/, at/IN present/NN ,/, most/RB of/IN the/DT MRSAs/NNS spreading/JJ in/IN Japan/NN are/VBP acceleratedly/RB acquiring/JJ resistance/NN to/IN many/JJ drugs/NNS ,/, and/CC especially/RB ,/, they/PRP are/VBP developing/JJ high/JJ resistance/NN against/IN beta-lactams/NNS ./.
@@110144654430/CD The/DT mean/JJ day/NN of/IN diagnosis/NN of/IN periventricular/JJ echodensities/NNS was/VBD 3/CD +/NN //NN -/NN 2/CD days/NNS (/( range/NN 1-11/CD days/NNS )/SYM ,/, and/CC of/IN cystic/JJ PVL/MULTIGENE 21/MULTIGENE +/NN //NN -/NN 8/CD days/NNS (/( range/NN 2-47/JJ days/NNS )/SYM ./.
@@75907448630/CD The/DT integrity/NN of/IN the/DT cDNA/NN sequence/NN was/VBD confirmed/VBN by/IN analysis/NN of/IN several/DT overlapping/JJ genomic/JJ clones/NNS that/WDT span/VBP the/DT GAR1/MULTIGENE gene/MULTIGENE ./.
@@6027025873/CD In/NN one/PRP patient/NN with/IN severe/JJ diarrhea/NN the/DT estriol/NN concentration/NN in/IN serum/NN was/VBD low/JJ until/IN the/DT intestinal/JJ function/NN normalised/VBN and/CC the/DT estriol/NN concentration/NN went/VBD up/JJ exactly/RB when/CC the/DT diarrhea/NN stopped/VBN ./.
@@110940723715/CD We/PRP conclude/VBP that/IN c-Myb/GENE regulates/VBZ the/DT RAG-2/MULTIGENE promoter/MULTIGENE in/IN T/NN cells/NNS by/IN binding/JJ to/IN this/DT consensus/NN c-Myb/MULTIGENE binding/MULTIGENE site/MULTIGENE ./.
@@98131105622/CD The/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN CBP90/CD had/VBP no/DT significant/JJ similarity/NN to/IN any/DT other/DT protein/NN ,/, but/CC it/PRP had/VBP a/DT proline-rich/JJ domain/NN at/IN the/DT C-terminal/MULTIGENE region/MULTIGENE ./.
@@38886217302/CD The/DT structural/JJ gene/NN for/IN hydrogenase/NEWGENE encodes/VBZ a/DT protein/NN product/NN of/IN molecular/JJ mass/JJ 45820/CD Da/NNP ./NNP
@@89862288933/CD Children/NNS born/JJ from/IN chronic/JJ alcoholic/JJ mothers/NNS have/VBP shown/VBP behavioral/JJ teratogenic/JJ effects/NNS more/RB frequently/RB than/IN morphological/JJ malformations/NNS ./.
@@104963033940/CD CONCLUSIONS/IN :/: These/DT results/NNS show/NN that/IN once/CC daily/JJ oral/JJ valganciclovir/NN can/MD produce/VB exposures/NNS of/IN ganciclovir/NN (/( AUC24/GENE )/SYM exceeding/VBG those/DT attained/VBN using/VBG intravenous/JJ ganciclovir/NN 10/CD mg/CD //CD kg/CD ./.
@@10650104466/CD Copyright/NNP 2000/CD The/DT Royal/NNP College/NNP of/IN Radiologists/NNS ./.
@@4656815080/CD A/DT rise/NN of/IN hemoglobin/NN concentration/NN accompanied/VBN by/IN an/DT increase/NN of/IN the/DT total/JJ iron/NN in/IN the/DT blood/NN serum/NN of/IN white/NEWGENE mice/NNS was/VBD found/VBN under/IN oxygen/NN pressure/NN of/IN 4/CD atm/NN for/IN an/DT hour/NN (/( preconvulsive/JJ state/NN )/SYM and/CC 6/CD atm/NN (/( convulsive/JJ state/NN )/SYM ./.
@@102097593837/CD Antithrombin/MULTIGENE III/MULTIGENE prevents/VBZ 60/CD min/NN warm/JJ intestinal/JJ ischemia/NN reperfusion/NN injury/NN in/IN rats/NNS ./.
@@92338116490/CD This/DT regulation/NN requires/VBZ two/JJ HMG-box/MULTIGENE proteins/MULTIGENE :/: the/DT ubiquitous/JJ Ste11/MULTIGENE transcription/MULTIGENE factor/MULTIGENE and/CC the/DT M/NN cell-controlling/JJ protein/NN Mat1-Mc/GENE ./.
@@92438405105/CD Two/CD related/VBN studies/NNS conducted/VBN over/RB a/DT five/CD week/NN period/NN measured/VBN and/CC typed/VBN HLA-DQA1/GENE from/IN accumulated/VBN DNA/NN on/IN autopsy/NN room/NN and/CC Forensic/NNP DNA/NNP Laboratory/NNP structures/NNS ./.
@@90006329084/CD In/NN the/DT p51/MULTIGENE subunit/MULTIGENE ,/, the/DT Cys181/NN side-chain/NN is/VBZ oriented/VBN in/IN a/DT similar/JJ direction/NN to/IN the/DT Tyr181/NN side-chain/NN in/IN the/DT wild-type/MULTIGENE complex/MULTIGENE ./.
@@82068489677/CD The/DT pyrR/NN and/CC pyrP/MULTIGENE genes/MULTIGENE encoded/VBN polypeptides/NNS with/IN calculated/VBN molecular/JJ masses/NNS of/IN 19/CD ./CD 9/CD and/CC 45/CD ./CD 2/CD kDa/NN ,/, respectively/RB ./.
@@12761051922/CD In/NN contrast/NN ,/, the/DT insulin/NN response/NN had/VBP returned/VBN to/IN the/DT non-pregnant/JJ value/NN by/IN the/DT second/JJ day/NN of/IN the/DT puerperium/NN ./.
@@88237098806/CD Therapy/NNP with/IN dietary/JJ modification/NN and/CC triglyceride/NN lowering/JJ drugs/NNS resulted/VBN in/IN resolution/NN of/IN symptoms/NNS and/CC parotid/JJ swelling/NN in/IN one/PRP patient/NN ./.
@@30084052662/CD Further/JJ outbreaks/NNS of/IN ocular/JJ disease/NN in/IN farmed/JJ red/JJ deer/NN calves/NNS caused/VBN by/IN HVC-1/GENE were/VBD investigated/VBN ./.
@@98130638687/CD Expression/NNS of/IN a/DT novel/JJ murine/MULTIGENE phospholipase/MULTIGENE D/MULTIGENE homolog/MULTIGENE coincides/VBZ with/IN late/JJ neuronal/JJ development/NN in/IN the/DT forebrain/NN ./.
@@106443577994/CD These/DT results/NNS suggest/VBP that/IN VP1/GENE was/VBD efficiently/RB transported/VBN to/IN the/DT nucleus/NN and/CC localized/VBN in/IN the/DT discrete/JJ subnuclear/JJ regions/NNS ,/, possibly/RB with/IN VP2/GENE and/CC VP3/GENE ./.
@@88187189188/CD Moreover/RB ,/, following/IN a/DT single/JJ intravenous/JJ injection/NN of/IN the/DT bicistronic/JJ vector/NN complexed/VBN to/IN cationic/JJ liposomes/NNS into/IN recipient/JJ mice/NNS ,/, delivery/NN of/IN MDR1/GENE and/CC GC/MULTIGENE cDNAs/MULTIGENE was/VBD achieved/VBN in/IN all/PDT the/DT organs/NNS we/PRP tested/VBD ./.
@@112688871101/CD To/TO avoid/VB misinterpretations/NNS ,/, special/JJ reference/NN values/NNS should/MD be/VB applied/VBN for/IN preadolescents/NNS ,/, at/IN least/RB with/IN regard/NN to/IN FVC/NN and/CC FEV1/NN ./.
@@22418925494/CD Utilization/NN of/IN alternative/JJ polyadenylation/NN signals/NNS was/VBD previously/RB shown/VBP to/IN generate/VB two/JJ sialophorin/MULTIGENE mRNAs/MULTIGENE of/IN 1/CD ./CD 9/CD and/CC 4/CD ./CD 3/CD kb/NN ,/, which/WDT differ/VBP in/IN the/DT length/NN of/IN their/PRP 3'/CD untranslated/JJ regions/NNS ./.
@@81199951799/CD Moreover/RB ,/, we/PRP observed/VBD that/IN the/DT function/NN of/IN T3R-RXR/MULTIGENE heterodimers/MULTIGENE on/IN response/MULTIGENE elements/MULTIGENE composed/VBN of/IN two/JJ half-sites/NNS in/IN a/DT directly/RB repeated/JJ orientation/NN spaced/VBN by/IN 4/CD nucleotides/NNS is/VBZ determined/VBN in/IN major/JJ parts/NNS by/IN the/DT 5'-flanking/JJ sequence/NN of/IN the/DT upstream/JJ half-site/NN ./.
@@178800281/CD Magnetotherapy/NNS of/IN hepatitis/NN A/NN and/CC B/NNP in/IN children/NNS ./.
@@91221983474/CD Point/NNP mutations/NNS of/IN the/DT five/CD tyrosine/NN residues/NNS in/IN the/DT cytoplasmic/JJ domain/NN of/IN the/DT receptor/NN were/VBD subsequently/RB used/VBN to/IN confirm/VB our/PRP conclusions/NNS ./.
@@67723702094/CD Volume/NN of/IN distribution/NN of/IN total/JJ DMDZ/NNP (/( range/NN ,/, 1/CD ./CD 33/CD to/IN 6/CD ./CD 30/CD l/NN //NN kg/NN )/SYM and/CC of/IN unbound/JJ DMDZ/NNP after/IN correction/NN for/IN protein/NN binding/JJ (/( range/NN ,/, 43/CD to/IN 243/CD l/NN //NN kg/NN )/SYM was/VBD larger/JJR in/IN women/NNS than/IN in/IN men/NNS of/IN all/DT ages/NNS ,/, and/CC in/IN the/DT elderly/NN as/IN opposed/VBN to/IN the/DT young/NN ./.
@@11685047124/CD Finally/RB ,/, a/DT chromogenic/JJ method/NN was/VBD used/VBN ,/, based/VBN on/IN thrombin/NN inhibition/NN and/CC the/DT substrate/MULTIGENE S-2238/MULTIGENE ./.
@@98298362344/CD It/PRP is/VBZ now/RB well/VB established/VBN that/DT progression/NN through/RB the/DT eukaryotic/JJ cell/NN cycle/NN is/VBZ controlled/VBN by/IN oscillations/NNS in/IN the/DT activity/NN of/IN cyclin-/JJ dependent/MULTIGENE kinases/MULTIGENE (/( CDKs/GENE )/SYM ./.
@@80110173653/CD No/DT drop/NN in/IN oxygen/NN saturation/NN (/( SaO2/GENE )/SYM or/CC visual/JJ evidence/NN of/IN transient/JJ electroencephalographic/JJ (/( EEG/NN )/SYM arousals/NNS can/MD be/VB found/VB at/IN repeat/NN polysomnography/NN ./.
@@80346806653/CD The/DT mechanism/NN whereby/RB zeta/NN PKC/NEWGENE regulates/VBZ NF-kappa/MULTIGENE B/MULTIGENE most/RB probably/RB involves/VBZ the/DT activation/NN of/IN a/DT putative/JJ I/MULTIGENE kappa/MULTIGENE B/MULTIGENE kinase/MULTIGENE of/IN molecular/JJ mass/JJ approximately/RB 50/CD kDa/NN ,/, which/WDT phosphorylates/VBZ and/CC inactivates/VBZ I/MULTIGENE kappa/MULTIGENE B/NNP ./NNP
@@27900097267/CD Sequencing/NN analysis/NN revealed/VBN that/IN the/DT 0/GENE ./GENE 54-/GENE and/CC 0/NN ./NN 4-kb/NN fragments/NNS are/VBP identical/JJ except/VB for/IN 150/CD nucleotides/NNS missing/JJ at/IN the/DT 5'/CD region/NN of/IN the/DT 0/CD ./CD 4-kb/CD fragment/NN ./.
@@91701591492/CD Instead/RB ,/, they/PRP contained/VBD dendritic/JJ cells/NNS that/WDT express/VBP melanogenic/JJ marker/NN proteins/NNS such/JJ as/IN tyrosinase/NN and/CC tyrosinase-related/MULTIGENE protein/MULTIGENE 1/CD ./CD
@@62586997133/CD A/DT double-blind/JJ trial/NN of/IN half-strength/NNP Polybactrin/MULTIGENE Soluble/MULTIGENE GU/MULTIGENE bladder/NN irrigation/NN in/IN cystoscopy/NN ./.
@@114656557845/CD In/NN the/DT next/JJ week/NN ,/, the/DT beta-adrenergic/MULTIGENE antagonist/MULTIGENE atenolol/NN was/VBD added/VBN at/IN an/DT initial/JJ dose/NN of/IN 25/CD mg/NN //NN day/NN and/CC titrated/VBN to/IN 50/CD mg/NN //NN day/NN within/IN 1/CD week/NN ./.
@@111806882169/CD To/TO assess/VB the/DT maximum/JJ oxygen/NN uptake/NN (/( V'O2/NN max/NN )/SYM of/IN Hong/NNP Kong/NNP Chinese/JJ children/NNS and/CC to/IN explore/VB its/PRP association/NN with/IN respiratory/JJ illnesses/NNS ,/, we/PRP conducted/VBD the/DT Multistage/NNP Fitness/NNP Test/NNP (/( MFT/NN )/SYM ,/, a/DT 20-m/NN shuttle/NN run/NN test/NN ,/, in/IN 1/CD ,/CD 427/CD schoolchildren/NNS aged/VBN between/IN 8-12/CD years/NNS ./.
@@85157762444/CD A/DT second/JJ hydrophobic/JJ domain/NN ,/, bordered/VBN by/IN two/JJ hydrophilic/JJ regions/NNS strongly/RB suggests/VBZ a/DT transmembrane/JJ region/NN ./.
@@7592658505/CD The/DT insulin-induced/MULTIGENE DNA-binding/MULTIGENE complex/MULTIGENE was/VBD identified/VBN as/IN the/DT p50/MULTIGENE //MULTIGENE p65/MULTIGENE heterodimer/MULTIGENE ./.
@@18822402499/CD It/PRP is/VBZ concluded/VBN that/DT attention/NN to/IN these/DT issues/NNS can/MD substantially/RB improve/VB the/DT quality/NN of/IN research/NN on/IN AIDS/NN related/VBD behaviors/NNS on/IN Black/NNP communities/NNS ./.
@@79920277979/CD 2/CD patients/NNS (/( 11%/JJ )/SYM had/VBP significant/JJ morbidity/NN 502/CD and/CC 529/CD days/NNS respectively/RB after/IN transplantation/NN ./.
@@62419006040/CD This/DT study/NN was/VBD undertaken/VBP to/IN assess/VB the/DT effects/NNS of/IN hypothermia/NN and/CC chemical/JJ cardioplegia/NN on/IN the/DT functional/JJ recovery/NN of/IN hypertrophied/JJ non-failing/JJ rat/NN hearts/NNS subjected/VBN to/IN an/DT extended/VBN period/NN of/IN global/JJ ischaemia/NN ./.
@@84423845811/CD The/DT SCH9/MULTIGENE protein/MULTIGENE kinase/MULTIGENE mRNA/MULTIGENE contains/VBZ a/DT long/JJ 5'/CD leader/NN with/IN a/DT small/JJ open/JJ reading/JJ frame/NN ./.
@@94202753033/CD In/NN addition/NN ,/, the/DT affinities/NNS of/IN CBF2/GENE for/IN binding/JJ to/IN the/DT LMP-1/GENE ,/, LMP-2/GENE ,/, and/CC CD23/MULTIGENE promoters/MULTIGENE were/VBD also/RB measured/VBN ./.
@@100075645/CD Multilayer-relaxation/NNP geometry/NN and/CC electronic/JJ structure/NN of/IN a/DT W/NN (/NN 111/NN )/NN surface/NN ./.
@@43698848257/CD Conditions/NNS influencing/VBG inhibitors/NNS of/IN the/DT colony-stimulating/MULTIGENE factor/MULTIGENE (/( CSF/CONTEXTGENE )/SYM ./.
@@92004989155/CD Spatial/JJ zones/NNS for/IN muscle/NN coactivation/NN and/CC the/DT control/NN of/IN postural/JJ stability/NN ./.
@@76754494796/CD In/NN one/PRP glioblastoma/NN cell/NN line/NN ,/, a/DT Shc-associated/MULTIGENE p190/MULTIGENE was/VBD identified/VBN as/IN the/DT activated/VBN PDGFR/NN ./.
@@76351409457/CD The/DT expression/NN of/IN the/DT gene/NN encoding/VBG the/DT enzyme/NN (/( CYP19/GENE )/SYM is/VBZ regulated/VBN ,/, in/IN part/NN ,/, by/IN tissue-specific/MULTIGENE promoters/MULTIGENE through/RB the/DT use/NN of/IN alternative-splicing/JJ mechanisms/NNS ./.
@@86571503828/CD The/DT role/NN of/IN negative/JJ regulators/NNS such/JJ as/IN NCE3/GENE ,/, as/RB well/VB as/IN the/DT previously/RB described/VBN SIN5/MULTIGENE gene/MULTIGENE ,/, in/IN determining/VBG the/DT promoter/NN specificity/NN of/IN homologous/JJ activators/NNS is/VBZ discussed/VBN ./.
@@104064644299/CD By/IN contrast/NN ,/, mTRAP100/GENE coprecipitates/NNS in/IN vivo/NN with/IN another/DT component/NN of/IN the/DT TRAP/MULTIGENE complex/MULTIGENE (/( TRAP220/NEWGENE )/SYM ,/, which/WDT directly/RB contacts/VBZ TR/NN and/CC the/DT vitamin/NN D/MULTIGENE receptor/MULTIGENE in/IN a/DT ligand-dependent/JJ manner/NN ./.
@@75887778864/CD These/DT observations/NNS lead/NN to/IN the/DT proposal/NN that/IN the/DT RNAP/MULTIGENE II/MULTIGENE CTD/MULTIGENE might/MD be/VB an/DT in/NN vivo/MULTIGENE target/MULTIGENE for/IN the/DT activated/VBN p42mapk/GENE and/CC p44mapk/MULTIGENE MAP/MULTIGENE kinases/MULTIGENE ./.
@@69500046724/CD Study/NNP on/IN distribution/NN of/IN metal/NN in/IN the/DT teeth/NNS treated/VBN by/IN iontophoresis/NN with/IN transparent/JJ specimens/NNS ./.
@@76238218186/CD Regulation/NN of/IN Gax/MULTIGENE homeobox/MULTIGENE gene/MULTIGENE transcription/NN by/IN a/DT combination/NN of/IN positive/JJ factors/NNS including/JJ myocyte-specific/MULTIGENE enhancer/MULTIGENE factor/MULTIGENE 2/CD ./CD
@@115951761776/CD The/DT genomic/JJ structure/NN of/IN the/DT human/MULTIGENE SPEC1/MULTIGENE gene/MULTIGENE reveals/VBZ complex/NN splicing/JJ and/CC close/JJ promoter/NN proximity/NN to/IN the/DT AF1q/MULTIGENE translocation/MULTIGENE gene/MULTIGENE ./.
@@111607328811/CD Quantitative/JJ PCR/NN studies/NNS indicated/VBD that/DT synthesis/NN and/CC transport/NN of/IN vector/NN DNA/NN into/IN the/DT nucleus/NN were/VBD similar/JJ for/IN macrophages/NNS infected/VBN with/IN the/DT clone/NN 239/CD and/CC 316/CD pseudotypes/NNS ,/, suggesting/VBG that/IN the/DT restriction/NN for/IN SIVmac239/GENE infection/NN is/VBZ after/IN reverse/JJ transcription/NN and/CC nuclear/JJ import/NN of/IN viral/JJ DNA/NN ./.
@@39878577404/CD The/DT various/JJ muscles/NNS of/IN the/DT pelvic/JJ floor/NN region/NN could/MD be/VB reflexly/NEWGENE activated/VBN either/DT individually/RB or/CC as/IN a/DT mass/JJ unit/NN depending/VBG on/IN the/DT intensity/NN of/IN stimulation/NN ./.
@@10466306305/CD ECG-gated/JJ myocardial/JJ Technetium-99m/GENE sestamibi/NN SPECT/NN is/VBZ a/DT useful/JJ technique/NN to/IN measure/NN myocardial/JJ perfusion/NN and/CC function/NN simultaneously/RB ./.
@@10952828772/CD This/DT suggests/VBZ that/IN cardiovascular/JJ magnetic/JJ resonance/NN is/VBZ the/DT preferred/VBN technique/NN for/IN volume/NN and/CC ejection/NN fraction/NN estimation/NN in/IN heart/NN failure/NN patients/NNS ,/, because/IN of/IN its/PRP 3D/JJ approach/NN for/IN non-symmetric/JJ ventricles/NNS and/CC superior/JJ image/NN quality/NN ./.
@@74612267353/CD No/DT symptoms/NNS other/DT than/IN hot/JJ flush/NN showed/VBD such/JJ significant/JJ correlation/NN with/IN plasma/NN epinephrine/NN or/CC norepinephrine/NN levels/NNS ./.
@@10555079373/CD Ti/NN exhibited/VBD a/DT feather-like/JJ morphology/NN ./.
@@98910612711/CD To/TO search/VB for/IN transcriptional/MULTIGENE regulators/MULTIGENE ,/, we/PRP used/VBD a/DT fragment/NN of/IN the/DT SpHE/MULTIGENE promoter/MULTIGENE containing/JJ several/DT individual/JJ elements/NNS instead/RB of/IN the/DT conventional/JJ bait/NN that/WDT contains/VBZ a/DT multimerized/JJ cis/MULTIGENE element/MULTIGENE ./.
@@81839153573/CD The/DT gene/NN encoding/VBG the/DT 105-kDa/MULTIGENE protein/MULTIGENE (/( p105/GENE )/SYM precursor/NN of/IN the/DT p50/MULTIGENE subunit/MULTIGENE of/IN transcription/MULTIGENE factor/MULTIGENE NF-kappa/MULTIGENE B/MULTIGENE also/RB encodes/VBZ a/DT p70/MULTIGENE I/MULTIGENE kappa/MULTIGENE B/MULTIGENE protein/MULTIGENE ,/, I/MULTIGENE kappa/MULTIGENE B/MULTIGENE gamma/MULTIGENE ,/, which/WDT is/VBZ identical/JJ to/IN the/DT C-terminal/MULTIGENE 607/MULTIGENE amino/JJ acids/NNS of/IN p105/GENE ./.
@@12867321928/CD Though/IN hepatomegaly/NN and/CC mild/JJ elevation/NN of/IN enzymes/NNS can/MD be/VB observed/VBN in/IN a/DT significant/JJ proportion/NN of/IN patients/NNS ,/, involvement/NN of/IN liver/NN leading/JJ to/IN acute/JJ hepatitis/NN or/CC liver/NN cell/NN necrosis/NN is/VBZ a/DT relatively/JJ uncommon/JJ complication/NN in/IN P/NNP ./NNP falciparum/NN malaria/NN ./.
@@90157998981/CD Serotonin/MULTIGENE receptors/MULTIGENE in/IN suicide/NN victims/NNS with/IN major/JJ depression/NN ./.
@@17573419170/CD The/DT volume/NN fraction/NN (/( Vv/NN )/SYM and/CC number/GENE //GENE mm2/GENE (/( Na/NN )/SYM of/IN all/DT capillaries/NNS (/( perfused/VBN and/CC nonperfused/JJ )/SYM in/IN a/DT given/NN area/NN of/IN brain/NN were/VBD determined/VBN after/IN staining/NN for/IN alkaline/MULTIGENE phosphatase/MULTIGENE ./.
@@82288054389/CD A/DT second/JJ important/JJ molecule/NN in/IN TCR/NEWGENE signal/JJ transduction/NN is/VBZ the/DT guanine/MULTIGENE nucleotide/MULTIGENE binding/MULTIGENE protein/MULTIGENE ,/, p21ras/VBZ ,/, which/WDT is/VBZ coupled/VBN to/IN the/DT TCR/NEWGENE by/IN a/DT protein/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE dependent/JJ mechanism/NN ./.
@@115248157707/CD Local/JJ control/NN rates/NNS were/VBD 91%/CD for/IN metastatic/JJ lung/NN cancer/NN ,/, 89%/NN for/IN primary/JJ lung/NN cancer/NN and/CC 85%/JJ for/IN T1/CONTEXTGENE ,/, 2N0M0/GENE cases/NNS ./.
@@3042403755/CD Here/RB the/DT conventional/JJ tests/NNS clearly/RB pointed/VBN to/IN the/DT presence/NN of/IN retrocochlear/JJ disease/NN ./.
@@97270451934/CD A/DT further/JJ mechanism/NN increasing/JJ specific/JJ activation/NN was/VBD cooperation/NN of/IN receptors/NNS at/IN multiple/JJ and/CC weak/JJ HREs/NNS ,/, which/WDT was/VBD accentuated/VBN in/IN the/DT presence/NN of/IN both/PDT the/DT AR/MULTIGENE N/MULTIGENE terminus/NN and/CC ligand/NN binding/JJ domain/NN ./.
@@47465595535/CD Estimation/NNS of/IN renin/NN secretion/NN rate/NN and/CC renal/JJ plasma/NN flow/NN from/IN peripheral/JJ and/CC renal/MULTIGENE vein/MULTIGENE renin/MULTIGENE levels/NNS ./.
@@82816348263/CD Other/JJ parameters/NNS of/IN iron/NN metabolism/NN ,/, including/JJ ferritin/NEWGENE ,/, were/VBD not/RB found/VB to/IN contribute/VB to/IN the/DT risk/NN ./.
@@1825027975/CD PAS1/GENE ,/, a/DT yeast/NN gene/NN required/VBN for/IN peroxisome/NN biogenesis/NN ,/, encodes/VBZ a/DT member/NN of/IN a/DT novel/JJ family/NN of/IN putative/JJ ATPases/NNS ./.
@@97537758940/CD However/RB ,/, ICK1/GENE was/VBD induced/VBN by/IN ABA/NN ,/, and/CC along/IN with/IN ICK1/GENE induction/NN there/RB was/VBD a/DT decrease/NN in/IN Cdc2-like/MULTIGENE histone/MULTIGENE H1/MULTIGENE kinase/MULTIGENE activity/NN ./.
@@10797586611/CD The/DT models/NNS were/VBD tested/VBN by/IN studying/VBG their/PRP response/NN to/IN disturbances/NNS of/IN the/DT afferent/JJ signal/NN from/IN the/DT bladder/NN ./.
@@77494613474/CD Functional/JJ analysis/NN of/IN the/DT sGTH/MULTIGENE alpha/MULTIGENE subunit/MULTIGENE promoter/MULTIGENE by/IN the/DT transient/JJ transfection/NN of/IN several/DT sGTH/MULTIGENE alpha/MULTIGENE //MULTIGENE CAT/MULTIGENE chimeric/JJ plasmids/NNS into/IN rainbow/NN trout/NN pituitary/JJ cells/NNS suggests/VBZ that/IN its/PRP pituitary-specific/JJ expression/NN is/VBZ GSE-dependent/GENE ./.
@@91214523557/CD Domain/NNS switch/NN experiments/NNS reveal/VBP that/DT C/MULTIGENE //MULTIGENE EBP/MULTIGENE beta/MULTIGENE proteins/MULTIGENE containing/JJ either/DT the/DT leucine/MULTIGENE zipper/MULTIGENE or/CC the/DT activation/NN domain/NN of/IN C/MULTIGENE //MULTIGENE EBP/MULTIGENE alpha/MULTIGENE are/VBP unable/JJ to/IN stimulate/VB the/DT 2D5/MULTIGENE promoter/MULTIGENE yet/RB are/VBP fully/RB capable/JJ of/IN transactivating/JJ an/DT artificial/JJ promoter/NN bearing/JJ a/DT high-affinity/JJ C/MULTIGENE //MULTIGENE EBP/MULTIGENE site/MULTIGENE ./.
@@103238637243/CD In/NN addition/NN ,/, we/PRP demonstrate/VBP that/IN the/DT production/NN of/IN active/JJ recombinant/JJ telomerase/NEWGENE requires/VBZ a/DT factor/NN in/IN rabbit/NN reticulocyte/NN lysate/NN that/WDT promotes/VBZ ribonucleoprotein/NN assembly/NN ./.
@@70726356841/CD A/DT simple/JJ method/NN for/IN measuring/JJ urinary/JJ iron/NN following/IN the/DT administration/NN of/IN desferrioxamine/NN (/( DF/NN )/SYM is/VBZ described/VBN ./.
@@112123278535/CD Recent/JJ studies/NNS using/VBG isolated/VBN rat/NN adipocytes/NNS and/CC chemically/RB synthesized/VBN PIG/NN compounds/NNS point/NN to/IN IRS1/GENE //GENE 3/GENE tyrosine/NN phosphorylation/NN by/IN p59Lyn/MULTIGENE kinase/MULTIGENE as/IN the/DT site/NN of/IN cross-talk/NN ,/, the/DT negative/JJ regulation/NN of/IN which/WDT by/IN interaction/NN with/IN caveolin/NN is/VBZ apparently/RB abrogated/VBN by/IN PIG/NN ./.
@@9139892331/CD Thus/RB ,/, the/DT P/NNP ./NNP aeruginosa/NN orfX/NN and/CC vfr/MULTIGENE promoters/MULTIGENE are/VBP arranged/VBN in/IN a/DT back-to-back/JJ orientation/NN rather/RB than/IN the/DT face-to-face/JJ orientation/NN of/IN the/DT dorf/NN and/CC crp/MULTIGENE promoters/MULTIGENE ./.
@@114507769484/CD A/DT rare/JJ case/NN of/IN primary/MULTIGENE group/MULTIGENE A/MULTIGENE streptococcal/JJ peritonitis/NN ./.
@@32612233957/CD Fourteen/CD patients/NNS were/VBD in/IN the/DT multifocal/JJ disease/NN group/NN ;/: 13/CD were/VBD detected/VBN by/IN SPECT/NN and/CC 10/CD by/IN TCT/NN ./.
@@75009538899/CD High/NNP ADR1/MULTIGENE gene/MULTIGENE dosage/NN increased/VBD the/DT transcription/NN of/IN genes/NNS encoding/VBG peroxisomal/JJ proteins/NNS as/IN compared/VBN to/IN one/PRP copy/NN of/IN the/DT ADR1/MULTIGENE gene/MULTIGENE ./.
@@25666133260/CD The/DT 65-bp/JJ sequence/NN contains/VBZ the/DT octameric/JJ cAMP-responsive/MULTIGENE enhancer/MULTIGENE (/( CRE/CONTEXTGENE )/SYM TGACGTCA/NNP (/( nucleotides/NNS -48/CD to/IN -41/CD )/SYM ./.
@@82341668217/CD The/DT bioavailability/NN of/IN etodolac/NN from/IN capsules/NNS exposed/VBN to/IN stressed/VBN conditions/NNS was/VBD compared/VBN in/IN both/DT dogs/NNS and/CC humans/NNS to/IN capsules/NNS stored/VBN at/IN RT/JJ conditions/NNS ./.
@@106533592443/CD Scmh1/GENE maps/NNS to/IN 4D1-D2/CD ./CD 1/CD in/IN mice/NNS ./.
@@78697217851/CD In/NN this/DT paper/NN ,/, an/DT analysis/NN of/IN the/DT dynamics/NNS in/IN the/DT closing/JJ phase/NN of/IN the/DT occluder/NN of/IN a/DT mechanical/JJ monoleaflet/NN heart/NN valve/NN prosthesis/NN is/VBZ presented/VBN ./.
@@108269466654/CD Investigation/NNP of/IN the/DT structural/JJ basis/NN of/IN the/DT interaction/NN between/IN human/JJ Igs/NNS and/CC gp120/GENE shows/VBZ that/IN the/DT viral/MULTIGENE gp120/MULTIGENE SAg/MULTIGENE can/MD interact/VB only/RB with/IN a/DT subset/NN of/IN human/JJ V/NN (/NN H/NN )/NN 3+/NN Igs/NNS ./.
@@106540326682/CD JPEG/MULTIGENE 53/MULTIGENE ,/, resulting/VBG in/IN a/DT compression/NN ratio/NN of/IN 1/CD :/: 21/CD ,/, does/VBP not/RB compromise/VB the/DT diagnostic/JJ performance/NN in/IN general/NN ./.
@@16907286188/CD The/DT presence/NN of/IN the/DT corresponding/JJ mature/JJ mRNA/NN transcripts/NNS (/( 3/CD ./CD 2-3/CD ./CD 5/CD kilobase/NN pairs/NNS (/( kb/NN ]/NN in/IN human/JJ fibroblasts/NNS was/VBD shown/VBP by/IN Northern/NNP blot/NN hybridization/NN ,/, S1/MULTIGENE nuclease/MULTIGENE protection/NN assay/NN ,/, and/CC the/DT polymerase/NN chain/NN reaction/NN ./.
@@4837165197/CD In/NN case/NN of/IN a/DT pathologically/RB convoluted/JJ internal/JJ carotid/JJ the/DT common/JJ carotid/JJ artery/NN was/VBD resected/VBN with/IN an/DT end-to-end/JJ anastomosis/NN ./.
@@92263459180/CD However/RB ,/, mean/JJ food/NN intake/NN in/IN the/DT 40%/CD group/NN was/VBD half/NN that/IN of/IN the/DT ACT/NNP group/NN (/( p/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC significantly/RB less/PRP (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM than/IN the/DT SEP/NN group/NN ,/, which/WDT consumed/VBD amounts/NNS equivalent/JJ to/IN 65%/NN of/IN daily/JJ requirement/NN ./.
@@10394116262/CD Wrist/NN measurement/NN of/IN blood/NN pressure/NN :/: some/DT critical/JJ remarks/NNS to/IN oscillometry/NN ./.
@@112122497333/CD The/DT effects/NNS of/IN the/DT transfected/VBN receptors/NNS were/VBD associated/VBN with/IN antagonism/NN of/IN activator/NN protein/NN 1/CD (/( AP-1/GENE )/SYM activity/NN ./.
@@111062161235/CD In/NN the/DT COPD/NN patients/NNS ,/, the/DT variability/NN of/IN Delta-inst/MULTIGENE Rrs/MULTIGENE (/( 30%/CD )/SYM was/VBD greater/JJR than/IN that/DT of/IN FOT/MULTIGENE Rrs/MULTIGENE (/( 21%/JJ )/SYM ./.
@@70374796809/CD The/DT "cracked-tooth"/JJ syndrome/NN ./.
@@103530739413/CD Regression/NNS analyses/NNS identified/VBN 7/CD risk/NN and/CC 7/MULTIGENE protective/MULTIGENE factors/MULTIGENE with/IN minimal/JJ overlap/NN ./.
@@75338589469/CD However/RB ,/, multiple/JJ alanine/NN substitutions/NNS or/CC proline/NN (/( helix-destabilizing/JJ )/SYM substitutions/NNS disrupted/VBD both/DT oligomerization/NN and/CC transport/NN of/IN GP64/MULTIGENE EFP/MULTIGENE ./.
@@79584464475/CD The/DT hepatocyte/MULTIGENE nuclear/MULTIGENE factor-3/MULTIGENE (/( HNF-3/GENE )/NN //NN orkhead/NN (/( fkh/NN )/SYM proteins/NNS consist/VBP of/IN an/DT extensive/JJ family/NN of/IN tissue-specific/JJ and/CC developmental/JJ gene/MULTIGENE regulators/MULTIGENE which/WDT share/VBP homology/NN within/IN the/DT winged/JJ helix/NN DNA/NN binding/JJ motif/NN ./.
@@77700335562/CD Nucleotide/NN sequences/NNS of/IN the/DT clones/NNS revealed/VBN that/IN one/PRP clone/NN ,/, cap3/GENE ,/, contained/VBD an/DT open/JJ reading/JJ frame/NN (/( ORF/NN )/SYM that/WDT would/MD code/VB for/IN a/DT 26-amino/JJ acid/NN ,/, cysteine-rich/JJ peptide/NN with/IN significant/JJ homology/NN to/IN Neurospora/NN crassa/NN copper/JJ metallothionein/NN ./.
@@34783546510/CD In/NN treated/VBD herds/NNS ,/, cows/NNS more/RB than/IN 40/MULTIGENE d/MULTIGENE postpartum/JJ with/IN a/DT corpus/NN luteum/NN received/VBD prostaglandin/MULTIGENE F2/MULTIGENE alpha/MULTIGENE ./.
@@2174105392/CD Immunohistochemical/JJ analysis/NN of/IN several/DT rat/NN organs/NNS also/RB showed/VBD staining/NN in/IN epithelial/JJ cells/NNS ./.
@@87607764598/CD CONCLUSION/IN :/: Twice/RB daily/JJ treatment/NN with/IN inhaled/JJ fluticasone/MULTIGENE propionate/MULTIGENE 50/MULTIGENE micrograms/NNS or/CC 100/CD micrograms/NNS was/VBD significantly/RB more/RB effective/JJ than/IN theophylline/NN in/IN the/DT treatment/NN of/IN mild-to-moderate/JJ asthma/NN ./.
@@839378939/CD The/DT elevated/VBN Viso/MULTIGENE V/MULTIGENE in/IN the/DT RDS/NNS group/NN suggests/VBZ an/DT increase/NN in/IN small/JJ airway/NN resistance/NN secondary/JJ to/IN the/DT disease/NN or/CC to/IN its/PRP therapy/NN ./.
@@97634468507/CD The/DT GEF/GENE and/CC GAP/NNP activities/NNS for/IN Ypt1p/GENE localize/VB to/IN particulate/JJ cellular/JJ fractions/NNS ./.
@@88167927046/CD DNA-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( DNA-PK/CONTEXTGENE )/SYM consists/VBZ of/IN a/DT heterodimeric/MULTIGENE protein/MULTIGENE (/( Ku/NNP )/SYM and/CC a/DT large/JJ catalytic/JJ subunit/NN (/( DNA-PKcs/DT )/SYM ./.
@@90583232794/CD Our/PRP results/NNS demonstrate/VBP that/IN cis/MULTIGENE elements/MULTIGENE positioned/VBN between/IN the/DT alpha/MULTIGENE 3/MULTIGENE and/CC beta/MULTIGENE 4/MULTIGENE coding/JJ regions/NNS are/VBP important/JJ for/IN establishing/VBG part/NN of/IN the/DT restricted/VBN CNS/NN patterns/NNS of/IN beta/MULTIGENE 4/MULTIGENE ,/, alpha/MULTIGENE 3/MULTIGENE ,/, and/CC alpha/MULTIGENE 5/MULTIGENE gene/MULTIGENE transcription/NN ./.
@@106128056784/CD However/RB ,/, no/DT genetic/JJ alteration/NN was/VBD detected/VBN in/IN any/DT of/IN the/DT cancers/NNS examined/VBN ./.
@@94357899803/CD Although/IN RAD17/GENE ,/, RAD24/GENE and/CC MEC3/GENE are/VBP not/RB required/VBN for/IN cell/NN cycle/NN arrest/NN when/CC S/NNP phase/NN is/VBZ inhibited/VBN by/IN hydroxyurea/NN (/( HU/NN )/SYM ,/, they/PRP do/VBP contribute/VB to/IN the/DT viability/NN of/IN yeast/NN cells/NNS grown/VBP in/IN the/DT presence/NN of/IN HU/NN ,/, possibly/RB because/IN they/PRP are/VBP required/VBN for/IN the/DT repair/NN of/IN HU-induced/MULTIGENE DNA/MULTIGENE damage/NN ./.
@@108079037235/CD D5/NN //NN D1/NN (/NN CT/NN )/NN or/CC D5/NN //NN D1D/NN (/NN CT/NN )/NN tail/NN substitution/NN mutants/NNS displayed/VBD a/DT rank/JJ order/NN of/IN potency/NN and/CC agonist/NN affinities/NNS virtually/RB mimicking/VBG wild-type/NN (/( wt/NN )/SYM D1/MULTIGENE receptors/MULTIGENE ,/, as/IN indexed/VBN by/IN both/DT ligand/NN binding/JJ and/CC dopamine-stimulated/JJ cAMP/NN accumulation/NN assays/NNS ,/, and/CC ,/, similar/JJ to/IN wt/NN D1/MULTIGENE receptors/MULTIGENE ,/, did/VBD not/RB exhibit/VB receptor/NN constitutive/JJ activity/NN or/CC responsiveness/NN to/IN inverse/JJ agonists/NNS ./.
@@17715932372/CD When/WRB examined/VBN as/IN adults/NNS (/( 8/CD weeks/NNS old/JJ )/SYM ,/, the/DT external/NN genitalia/NNS of/IN TA-exposed/JJ offspring/NN were/VBD normal/JJ ./.
@@26578833336/CD Doppler/NN echo/NN in/IN evaluating/VBG arteriovenous/JJ fistulae/NNS for/IN dialysis/NN ./.
@@965137598/CD GTPase/NN activating/JJ specificity/NN of/IN RGS12/GENE and/CC binding/JJ specificity/NN of/IN an/DT alternatively/RB spliced/VBN PDZ/CONTEXTGENE (/( PSD-95/GENE //GENE Dlg/GENE //GENE ZO-1/GENE )/SYM domain/NN ./.
@@110899119093/CD The/DT non-homologous/JJ sequences/NNS in/IN the/DT 5'/CD untranslated/JJ regions/NNS might/MD be/VB acquired/VBN at/IN or/CC after/IN transcription/NN during/IN retrotransposition/NN of/IN the/DT ATLN/MULTIGENE elements/MULTIGENE ./.
@@99208821741/CD Chem/NNP ./.
@@105969559145/CD Twelve/CD out/RB of/IN 43/CD renal/JJ failure/NN patients/NNS had/VBP troponin/MULTIGENE I/MULTIGENE 0/CD ./CD 13-0/CD ./CD 9/CD microg/NN //NN l/NN using/VBG Axsym/NNP method/NN and/CC 4/CD had/VBP levels/NNS of/IN 0/CD ./CD 07-0/CD ./CD 13/CD microg/NN //NN l/NN using/VBG Immuno/NNP 1/CD ./CD
@@53594645496/CD Pitfalls/NNS in/IN the/DT use/NN of/IN chromosome/NN aberration/NN analysis/NN for/IN biological/JJ radiation/NN dosimetry/NN ./.
@@15245492147/CD Both/DT GH/NEWGENE deficiency/NN and/CC impaired/VBN spinal/JJ growth/NN may/MD result/VB in/IN short/JJ stature/NN ,/, whereas/IN the/DT occurrence/NN of/IN early/JJ puberty/NN in/IN association/NN with/IN GH/NEWGENE deficiency/NN reduces/VBZ the/DT time/NN available/JJ for/IN GH/NN therapy/NN ./.
@@85956587283/CD The/DT DNA/NN sequences/NNS upstream/RB of/IN these/DT termini/NNS exhibit/NN homology/NN to/IN plant/NN mitochondrial-processing/JJ sites/NNS ,/, therefore/RB the/DT proximal/JJ 5'/CD ends/NNS are/VBP most/RB probably/RB generated/VBN by/IN RNA/NN processing/VBG ./.
@@61380155958/CD Brief/NNP report/VB ./.
@@86807064858/CD After/IN 6/CD h/NN of/IN reperfusion/NN ,/, PO2/GENE //GENE FlO2/GENE ratio/NN was/VBD significantly/RB better/RBR after/IN Combined/VBN Therapy/NNP (/( 372/CD +/NN //NN -/NN 52/CD mm/NN Hg/NN )/SYM than/IN in/IN the/DT Recipient/NNS Instilled/JJ (/( 117/CD +/NN //NN -/NN 47/CD mm/NN Hg/NN )/SYM and/CC Control/NNP groups/NNS (/( 87/CD +/NN //NN -/NN 26/CD mm/NN Hg/NN )/SYM ,/, with/IN intermediate/JJ values/NNS in/IN Donor/NN Aerosol/NN dogs/NNS (/( 232/CD +/NN //NN -/NN 64/CD mm/NN Hg/NN )/SYM ./.
@@89439343148/CD But/CC ,/, as/IN Theriault/GENE explains/VBZ ,/, improvements/NNS in/IN assessing/JJ exposure/NN have/NN not/RB yet/RB translated/VBN into/IN clear/JJ and/CC consistent/JJ findings/NNS ./.
@@102071151197/CD Concomitantly/RB ,/, the/DT total/JJ cellular/JJ level/NN of/IN p21/GENE increased/VBN severalfold/JJ via/NN a/DT posttranscriptional/JJ mechanism/NN ./.
@@89172705849/CD BACKGROUND/IN :/: The/DT Bazett-corrected/JJ QT/NN (/( QTc/NN )/SYM interval/NN during/IN exercise/NN has/VBZ been/VBN used/VBN as/IN a/DT marker/NN for/IN ischemic/JJ disease/NN ,/, arrhythmogenic/JJ substrate/NN and/CC the/DT long/MULTIGENE QT/MULTIGENE syndrome/NN ./.
@@81784465285/CD The/DT data/NN suggest/VB that/IN ICP10/GENE constitutively/RB increases/VBZ ras/NEWGENE activity/NN ,/, and/CC its/PRP TM/MULTIGENE segment/MULTIGENE plays/VBP a/DT critical/JJ role/NN in/IN transformation-related/JJ signaling/JJ pathways/NNS ./.
@@111639321008/CD Behavioural/JJ tests/NNS with/IN 192/CD specimen/NN of/IN the/DT roman/NN garden/NN snail/NN Helix/NNP pomatia/NNP L/NNP ./NNP were/VBD performed/VBN in/IN order/NN to/IN clarify/VB whether/IN the/DT thermopreferendum/NN of/IN this/DT pulmonate/NN is/VBZ influenced/VBN not/RB only/RB by/IN the/DT temperature/NN of/IN the/DT substratum/NN but/CC also/RB by/IN air/NN temperature/NN ./.
@@82763368257/CD In/NN a/DT retrospective/JJ analysis/NN of/IN first-time/JJ total/JJ colonoscopies/NNS in/IN 685/CD patients/NNS ,/, we/PRP investigated/VBD the/DT relationship/NN between/IN hyperplastic/JJ and/CC adenomatous/JJ polyps/NNS ./.
@@14203637429/CD The/DT TIMP/NN (/NN -59/NN //NN -53/NN )/NN AP1/NN site/NN is/VBZ a/DT promiscuous/JJ motif/NN that/WDT binds/VBZ c-Fos/MULTIGENE //MULTIGENE c-Jun/MULTIGENE AP1/MULTIGENE translated/VBN in/IN vitro/FW and/CC is/VBZ an/DT effective/JJ competitor/NN for/IN binding/NN of/IN nuclear/MULTIGENE AP1/MULTIGENE factors/MULTIGENE to/IN the/DT consensus/NN TRE/NEWGENE ,/, but/CC in/IN addition/NN it/PRP binds/VBZ factors/NNS that/WDT do/VBP not/RB associate/VB with/IN the/DT consensus/NN TRE/NEWGENE ./.
@@111524511196/CD These/DT data/NN indicate/VB that/IN the/DT SmSmad2/GENE responds/VBZ to/IN the/DT TGF-beta/NN signals/NNS by/IN interaction/NN with/IN receptor/MULTIGENE I/MULTIGENE ,/, which/WDT phosphorylates/VBZ it/PRP ,/, whereupon/CC it/PRP translocates/VBZ into/IN the/DT nucleus/NN presumably/RB to/IN regulate/VB target/NN gene/NN transcription/NN and/CC consequently/RB elicit/VB a/DT specific/MULTIGENE TGF-beta/MULTIGENE effect/NN ./.
@@92784753706/CD Hence/RB ,/, scs32/GENE only/RB partially/RB suppressed/VBN the/DT ts/MULTIGENE phenotype/MULTIGENE and/CC was/VBD unable/JJ to/IN suppress/VB the/DT Ino-phenotype/NNP of/IN rpo26-31/GENE ./.
@@17080989136/CD Using/VBG avidin-biotin/MULTIGENE complex/MULTIGENE DNA/MULTIGENE binding/JJ assays/NNS ,/, a/DT series/NN of/IN overlapping/JJ alpha/MULTIGENE promoter/MULTIGENE DNA/MULTIGENE sequences/MULTIGENE between/IN -170/CD to/IN 29/CD basepairs/NNS were/VBD tested/VBN ,/, but/CC each/DT failed/VBN to/IN bind/NN GR/NEWGENE ,/, whereas/IN a/DT control/NN GRE/NNP avidly/RB bound/JJ receptor/NN ./.
@@87029364540/CD An/DT expression/NN library/NN was/VBD constructed/VBN by/IN inserting/VBG 5'/CD portion-enriched/JJ cDNAs/NNS from/IN phytohemagglutinin-stimulated/JJ peripheral/JJ blood/NN mononuclear/JJ cells/NNS into/IN upstream/RB of/IN signal/MULTIGENE sequence-deleted/MULTIGENE CD4/MULTIGENE cDNA/MULTIGENE in/IN an/DT Epstein-Barr/NNP virus/NN shuttle/NN vector/NN ./.
@@75902832326/CD The/DT finding/NN that/IN the/DT chimeric/JJ TdT/NEWGENE :/: :/: Pol/MULTIGENE beta/MULTIGENE protein/MULTIGENE possessed/VBD significant/JJ template-dependent/MULTIGENE polymerase/MULTIGENE activity/NN suggests/VBZ that/IN aa/NNS 1-60/NN of/IN Pol/MULTIGENE beta/MULTIGENE are/VBP involved/VBN in/IN template/NN utilization/NN during/IN the/DT polymerization/NN reaction/NN ,/, as/IN suggested/VBN by/IN the/DT previous/JJ finding/NN that/IN the/DT 8-kDa/JJ N-terminal/NN domain/NN of/IN Pol/MULTIGENE beta/MULTIGENE possesses/VBZ ssDNA-binding/JJ activity/NN [/NN Kumar/NN et/FW al/NNS ./NNS ,/, J/NNP ./NNP
@@136835597/CD When/WRB extracorporeal/JJ CO2/NN removal/NN approximated/VBN CO2/NN production/NN (/( VCO2/GENE )/SYM ,/, alveolar/JJ ventilation/NN almost/RB ceased/VBD ./.
@@86324635967/CD This/DT result/NN supports/VBP the/DT argument/NN that/IN the/DT beta'/MULTIGENE subunit/MULTIGENE plays/VBP an/DT essential/JJ role/NN in/IN determining/JJ the/DT progress/NN of/IN transcription/NN elongation/NN ./.
@@7135256943/CD Because/IN decreases/NNS in/IN the/DT disfluency/NN rates/NNS of/IN stutterers/NNS were/VBD observed/VBN during/IN the/DT presentation/NN of/IN all/DT three/CD stimulus/NN words/NNS ,/, the/DT data/NN failed/VBN to/IN support/NN the/DT operant/JJ model/NN ./.
@@65941052927/CD The/DT calculated/VBN values/NNS of/IN lambda/MULTIGENE tb/MULTIGENE at/IN 37/CD degrees/NNS C/NN and/CC 50/CD per/IN cent/NN haematocrit/NN were/VBD 0/CD ./CD 650/CD for/IN the/DT pulp/NN ,/, 0/CD ./CD 674/CD for/IN the/DT tongue/NN ,/, 0/CD ./CD 828/CD for/IN the/DT submandibular/JJ gland/NN and/CC 0/CD ./CD 881/CD for/IN the/DT gingiva/NN of/IN the/DT dog/NN ./. lambda/MULTIGENE cp/MULTIGENE increased/VBN and/CC lambda/NN tp/MD decreased/VBN as/IN the/DT temperature/NN was/VBD reduced/VBN from/IN 37/CD to/IN 4/CD degrees/NNS C/NNP ./NNP
@@81126118801/CD The/DT sequence/NN has/VBZ a/DT 1092-bp/CD open/JJ reading/JJ frame/NN encoding/VBG a/DT protein/NN of/IN 364/CD amino/JJ acids/NNS ./.
@@104264506451/CD Bacterial/JJ recovery/NN of/IN SA/NNP from/IN the/DT liver/NN //NN spleen/NN and/CC the/DT cecal/JJ tonsil/NN in/IN contact/NN poults/NNS and/CC SG/NN from/IN contact/NN chicks/NNS treated/VBN with/IN ILK/GENE was/VBD dramatically/RB reduced/VBN when/CC compared/VBN to/IN non-treated/NN contact/NN poults/NNS and/CC chicks/NNS ./.
@@58069365746/CD Absorption/NNS of/IN electrolytes/NNS from/IN the/DT colon/NN in/IN cases/NNS of/IN ulcerative/JJ colitis/NN and/CC in/IN control/NN subjects/NNS ./.
@@77838227756/CD OBJECTIVE/IN :/: To/TO investigate/VB the/DT incidence/NN and/CC presentation/NN of/IN acute/JJ pernicious/JJ or/CC fulminating/JJ beriberi/NN in/IN a/DT general/JJ district/NN hospital/NN ./.
@@115308292815/CD This/DT article/NN reports/VBZ the/DT design/NN and/CC development/NN of/IN an/DT ECG/MULTIGENE simulator/MULTIGENE intended/VBN for/IN use/NN in/IN the/DT testing/NN ,/, calibration/NN and/CC maintenance/NN of/IN electrocardiographic/JJ equipment/NN ./.
@@34593854161/CD Allergy/NNS and/CC Tourette's/NNP syndrome/NN ./.
@@85840355733/CD Gel/NNP mobility/NN shift/NN assays/NNS indicated/VBN that/IN at/IN least/RB four/CD nuclear/JJ proteins/NNS with/IN distinct/JJ biochemical/JJ and/CC binding/JJ properties/NNS possess/VBP the/DT ability/NN to/IN bind/NN the/DT 3/MULTIGENE beta/MULTIGENE I-A/MULTIGENE element/MULTIGENE to/IN produce/NN four/CD DNA-protein/NN complexes/NNS (/( R1/GENE to/IN R4/DT )/SYM ./.
@@2228272864/CD Workers/NNS with/IN "sensitivity"/NN to/IN toluene/NN diisocyanate/NN (/( TDI/NN )/SYM studied/VBN in/IN depth/NN in/IN an/DT attempt/NN to/IN determine/VB mechanisms/NNS of/IN bronchial/JJ hyperreactivity/NN ./.
@@13465343636/CD Characterization/NNS of/IN the/DT regulon/NN controlled/VBN by/IN the/DT leucine-responsive/JJ regulatory/JJ protein/NN in/IN Escherichia/NN coli/JJ ./.
@@10215803158/CD Calcinosis/NNS cutis/NN following/IN intravenous/JJ infusion/NN of/IN calcium/NN gluconate/NN ./.
@@11525640200/CD Inhibition/NNS of/IN JNK1/GENE and/CC ERK/MULTIGENE kinase/MULTIGENE activities/NNS either/DT by/IN expression/NN of/IN the/DT dominant/JJ negative/JJ mutant/MULTIGENE JNK1/MULTIGENE or/CC by/IN treatment/NN with/IN a/DT selective/JJ chemical/JJ inhibitor/NN of/IN ERK/NN (/( PD098059/CD )/SYM substantially/RB abrogates/VBZ the/DT UV/NN induction/NN of/IN the/DT GADD45/MULTIGENE promoter/MULTIGENE ./.
@@110294596737/CD Transforming/JJ growth/NN factor-beta1/GENE (/( TGF-beta1/GENE )/SYM can/MD act/VB as/IN a/DT tumor/NN suppressor/NN or/CC a/DT tumor/NN promoter/NN depending/VBG on/IN the/DT characteristics/NNS of/IN the/DT malignant/JJ cell/NN ./.
@@10822117623/CD Nor/CC is/VBZ such/JJ adjustment/NN possible/JJ unless/IN one/PRP posits/VBZ a/DT model/NN that/WDT relates/VBZ the/DT missing/JJ observations/NNS to/IN other/DT observed/VBN information/NN for/IN each/DT subject-models/NNS that/WDT are/VBP inherently/RB untestable/JJ ./.
@@110130797284/CD Multiple/NNP transcription/NN start/NN sites/NNS were/VBD revealed/VBN by/IN primer/NN extension/NN analysis/NN of/IN the/DT mouse/NN gene/NN ,/, and/CC transfection/NN constructs/NNS containing/JJ the/DT prospective/JJ promoter/NN generated/VBD transcriptional/JJ activity/NN comparable/JJ to/IN that/DT of/IN the/DT SV40/MULTIGENE promoter/MULTIGENE ./.
@@118607234642/CD A/DT mail/NN survey/NN of/IN Georgia/MULTIGENE members/MULTIGENE of/IN the/DT American/NNP College/NNP of/IN Obstetricians/NNPS and/CC Gynecologists/NN was/VBD conducted/VBN ./.
@@115325568242/CD Subacute/JJ diencephalic/JJ angioencephalopathy/NN (/( SDAE/GENE )/SYM is/VBZ a/DT rare/JJ and/CC fatal/JJ disease/NN of/IN unknown/JJ etiology/NN that/WDT involves/VBZ the/DT thalami/NNS bilaterally/RB ./.
@@81646806469/CD We/PRP estimate/VBP that/IN the/DT protease/NN activity/NN is/VBZ at/IN least/RB 35-fold/RB greater/JJR in/IN mature/NNP B/NNP cells/NNS than/IN in/IN pre-B/NNP cells/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@11112700590/CD Plectin/NNP and/CC desmoplakin/NN have/NN GSR-containing/MULTIGENE domains/MULTIGENE at/IN their/PRP C-termini/NNS and/CC we/PRP further/RB demonstrate/VBP that/IN the/DT GSR-containing/JJ domain/NN of/IN plectin/NN ,/, but/CC not/RB desmoplakin/NN ,/, can/MD bind/VB to/IN MTs/NNS in/IN vivo/NN ./.
@@8668190808/CD Vacuolar/JJ membrane/NN vesicles/NNS from/IN hum1/MULTIGENE mutants/MULTIGENE lack/NN all/DT Ca2+/NNP //NNP H+/NNP antiport/NN activity/NN ,/, demonstrating/VBG that/IN Hum1p/GENE catalyzes/VBZ the/DT exchange/NN of/IN Ca2+/NN for/IN H+/NN across/IN the/DT yeast/NN vacuolar/JJ membrane/NN ./.
@@20242522635/CD During/IN the/DT years/NNS 1980-87/CD a/DT total/NN of/IN 287/CD persons/NNS received/VBD disability/NN pensions/NNS in/IN the/DT municipality/NN of/IN Nordreisa/NNP in/IN northern/JJ Norway/NN ./.
@@39353759482/CD This/DT article/NN will/MD briefly/NN review/NN the/DT published/VBN data/NN on/IN the/DT morphology/NN ,/, function/NN ,/, and/CC biochemistry/NN of/IN the/DT normal/JJ renal/JJ medulla/NN and/CC the/DT pathology/NN associated/VBN with/IN RPN/GENE ,/, together/RB with/IN the/DT secondary/JJ changes/NNS which/WDT give/VBP rise/NN to/IN cortical/JJ degeneration/NN or/CC epithelial/JJ carcinoma/NN ./.
@@38404803010/CD Novel/JJ multigene/JJ families/NNS encoding/VBG highly/RB repetitive/JJ peptide/NN sequences/NNS ./.
@@89854152560/CD The/DT STAT-1/GENE signaling/JJ pathway/NN provides/VBZ at/IN least/RB one/PRP mechanism/NN for/IN activation/NN of/IN the/DT CAEV/MULTIGENE LTR/MULTIGENE by/IN IFN-gamma/NN in/IN monocytes/NNS ./.
@@8285710589/CD A/DT single/JJ 1/CD ./CD 8-kb/CD transcript/NN mRNA/NN was/VBD detected/VBN by/IN Northern/NNP (/( RNA/NN )/SYM blot/NN analysis/NN ,/, and/CC its/PRP 5'/CD end/NN maps/NNS to/IN a/DT position/NN 51/CD bp/NN upstream/RB from/IN the/DT site/NN of/IN initiation/NN of/IN protein/NN synthesis/NN ./.
@@85056058470/CD Patient/NN characteristics/NNS associated/VBN with/IN deep/JJ wounds/NNS as/RB well/VBP as/IN patient/NN and/CC wound/JJ characteristics/NNS predictive/JJ of/IN the/DT extent/NN of/IN healing/NN and/CC time/NN required/VBN for/IN healing/NN were/VBD identified/VBN ./.
@@85054956022/CD The/DT retention/NN of/IN 75SeHCAT/GENE was/VBD low/JJ ./.
@@86484086585/CD When/WRB the/DT PHT/NN and/CC CSA/NN groups/NNS were/VBD compared/VBN ,/, Hyp/NEWGENE levels/NNS were/VBD significantly/RB higher/JJ in/IN the/DT PHT-GO+/NNP group/NN than/IN in/IN the/DT CSA-GO+/NNP group/NN ./.
@@103932512183/CD Sequence/NN of/IN 10q24/MULTIGENE locus/MULTIGENE surrounding/JJ the/DT HOX11/MULTIGENE oncogene/MULTIGENE reveals/VBZ a/DT new/JJ gene/MULTIGENE HUG1/MULTIGENE expressed/VBN in/IN a/DT T-ALL/NN cell/NN line/NN ./.
@@79691151128/CD Using/VBG in/IN organello/NN footprint/NN analysis/NN ,/, we/PRP demonstrate/VBP that/IN within/IN human/JJ placental/JJ mitochondria/NNS there/RB is/VBZ a/DT high/JJ level/NN of/IN protein-DNA/JJ binding/NN at/IN regularly/RB phased/JJ intervals/NNS throughout/IN a/DT 500-bp/JJ region/NN encompassing/VBG the/DT D-loop/NN DNA/NN origins/NNS and/CC two/JJ promoter/NN regions/NNS ./.
@@62872311292/CD In/NN addition/NN ,/, TRP1/NEWGENE RI/NNP Circle/NNP DNA/NN is/VBZ organized/VBN into/IN nucleosomes/NNS whose/WP size/NN and/CC spacing/JJ are/VBP indistinguishable/JJ from/IN that/DT of/IN bulk/NN yeast/MULTIGENE chromatin/MULTIGENE ./.
@@95070328135/CD Surprisingly/RB ,/, the/DT CSF1R/CD //CD IRDelta960/CD was/VBD as/RB effective/JJ as/IN the/DT CSF1R/GENE //GENE IR/GENE in/IN mediating/JJ CSF-1/GENE protection/NN of/IN cells/NNS from/IN staurosporine-induced/JJ apoptosis/NN ./.
@@111796685143/CD Therefore/RB ,/, we/PRP suggested/VBD that/IN both/DT proteins/NNS might/MD belong/VB to/IN the/DT PLTP/MULTIGENE family/MULTIGENE ./.
@@17333588041/CD These/DT tumors/NNS were/VBD classified/VBN into/IN three/CD broad/JJ groups/NNS :/: I/PRP ,/, cystadenoma/NN ;/: II/NNP ,/, cystadenocarcinoma/NN ;/: and/CC III/NNP ,/, adenocarcinoma/NN with/IN mucin/NN production/NN or/CC an/DT associated/VBN cyst/NEWGENE ./.
@@16539182255/CD They/PRP were/VBD almost/RB regularly/RB excited/VBN by/IN pressure/NN to/IN the/DT ipsilateral/JJ cornea/NN or/CC to/IN both/DT corneas/NNS at/IN a/DT strength/NN well/NN above/RB the/DT human/JJ corneal/JJ pain/NN threshold/NN ./.
@@31812767767/CD 26/CD micrograms/NNS PAF/NEWGENE or/CC placebo/NN was/VBD sprayed/VBN into/IN each/DT nasal/JJ cavity/NN 8/CD h/NN and/CC 1/CD h/NN before/IN a/DT nasal/JJ allergen/NN challenge/NN ./.
@@9121430948/CD In/NN contrast/NN ,/, Y239/MULTIGENE //MULTIGENE 240F/MULTIGENE Shc/MULTIGENE ,/, but/CC not/RB Y317F/MULTIGENE Shc/MULTIGENE ,/, reduced/VBD the/DT EGF-induced/MULTIGENE c-myc/MULTIGENE message/MULTIGENE ./.
@@110756784857/CD The/DT wavenumbers/NNS corresponding/JJ to/IN the/DT normal/JJ modes/NNS of/IN vibration/NN were/VBD calculated/VBN using/VBG the/DT DFT/CONTEXTGENE (/( B3LYP/GENE //GENE 6-31G**/GENE )/SYM approximation/NN and/CC their/PRP agreement/NN with/IN the/DT measured/VBN values/NNS improved/VBN after/IN scaling/NN of/IN the/DT associated/VBN force/NN field/NN ./.
@@67123146478/CD A/DT total/JJ number/NN of/IN 1628/CD cases/NNS were/VBD collected/VBN from/IN 135/CD medical/JJ institutions/NNS ./.
@@24666653627/CD The/DT small/MULTIGENE IGF-binding/MULTIGENE protein/MULTIGENE is/VBZ abundant/JJ in/IN human/JJ amniotic/JJ fluid/NN ./.
@@29348915344/CD By/IN adapting/JJ a/DT method/NN for/IN DNA-footprinting/JJ using/VBG impure/JJ extracts/NNS of/IN ner/JJ overproducing/JJ cells/NNS ,/, we/PRP were/VBD able/JJ to/IN determine/VB that/IN the/DT ner-binding/MULTIGENE sites/MULTIGENE are/VBP located/VBN between/IN nucleotides/NNS 1026/CD and/CC 1058/CD from/IN the/DT Mu/NN left/NN end/NN ./.
@@36012754264/CD After/IN dopamine/NN infusion/NN in/IN women/NNS with/IN polycystic/JJ ovary/NN syndrome/NN and/CC in/IN matched/JJ controls/NNS ,/, steady/JJ state/NN levels/NNS of/IN plasma/NN dopamine/NN ,/, norepinephrine/NN ,/, and/CC the/DT ratio/NN of/IN dopamine/NN //NN norepinephrine/NN were/VBD similar/JJ in/IN the/DT two/JJ groups/NNS ./.
@@48207915190/CD Delta-aminolevulinic/NNP acid/NN in/IN physiological/JJ conditions/NNS and/CC some/DT diseases/NNS in/IN children/NNS ./.
@@85242352890/CD Cloning/VBG and/CC sequencing/VBG revealed/VBN that/DT dMax/NN contains/VBZ a/DT deletion/NN spanning/VBG the/DT basic/JJ region/NN and/CC helix/NN 1/CD and/CC the/DT loop/NN of/IN the/DT helix-loop-helix/JJ region/NN ,/, presumably/RB as/IN a/DT result/NN of/IN alternative/JJ splicing/JJ of/IN max/JJ RNA/NN ./.
@@86518531134/CD Mesial/JJ temporal/JJ sclerosis/NN was/VBD characterized/VBN by/IN severe/JJ neuronal/JJ loss/NN accompanied/VBN by/IN gliosis/NN occurring/VBG in/IN the/DT CA1/NNP //NNP prosubiculum/NNP (/( 27/CD patients/NNS ,/, 100%/CD )/SYM ,/, focally/RB in/IN the/DT dentate/NN gyrus/NN (/( 12/CD patients/NNS ,/, 44%/JJ )/SYM ,/, and/CC in/IN the/DT CA4/MULTIGENE region/MULTIGENE (/( 11/CD patients/NNS ,/, 41%/JJ )/SYM ./.
@@10647859464/CD To/TO quantify/VB any/DT mechanical/JJ inhibitory/JJ effect/NN of/IN nasal/JJ intermittent/JJ positive/JJ pressure/NN ventilation/NN (/( IPPV/NN )/SYM on/IN inspiratory/JJ activity/NN of/IN the/DT diaphragm/NN we/PRP ventilated/VBD five/CD conscious/RB relaxed/VBN subjects/NNS on/IN two/JJ occasions/NNS at/IN respiratory/JJ rates/NNS similar/JJ to/IN quiet/JJ breathing/JJ (/( QB/NNP )/SYM and/CC at/IN three/CD levels/NNS of/IN applied/VBN pressure/NN (/( Pappl/NNP )/NN --6/NN ,/, 9/CD and/CC 12/CD cmH2O/NN ,/, each/DT during/IN hypocapnia/NN (/( P/NN (/NN CO2/NN )/SYM allowed/VBN to/IN decrease/NN )/NN and/CC eucapnia/NN (/( CO2/NN added/VBN to/IN inspired/JJ gas/NN )/SYM ./.
@@84287229048/CD In/NN the/DT multivariate/JJ analysis/NN ,/, six/CD variables/NNS were/VBD independently/RB correlated/VBN with/IN survival/NN :/: blood/NN urea/NN nitrogen/NN level/NN ,/, serum/JJ aspartate/MULTIGENE aminotransferase/MULTIGENE level/NN ,/, community-acquired/JJ vs/IN ./IN hospital-acquired/JJ peritonitis/NN ,/, age/NN ,/, Child-Pugh/NNP score/NN and/CC ileus/NN ./.
@@34504381674/CD X2/GENE test/NN ,/, with/IN Yates/NNP correction/NN if/IN need/NN ,/, was/VBD used/VBN as/IN statistical/JJ ./. method/NN ./.
@@86039211892/CD Carboxy-terminal/JJ Spc110p/GENE truncations/NNS lacking/VBG the/DT calmodulin/MULTIGENE binding/MULTIGENE site/MULTIGENE can/MD support/VB growth/VB and/CC are/VBP also/RB phosphorylated/VBN in/IN a/DT cell/NN cycle-specific/JJ manner/NN ./.
@@35776704240/CD The/DT study/NN disclosed/VBD generalized/JJ atrophy/NN and/CC diffuse/JJ symmetric/JJ white/JJ matter/NN hypodensities/NNS ./.
@@92784416727/CD Biol/NNP ./.
@@11764062732/CD The/DT Penn/NNP State/NNP Worry/NN Questionnaire/NN for/IN Children/NNS (/( PSWQ-C/NN )/SYM is/VBZ a/DT 14-item/JJ self-report/NN questionnaire/NN that/WDT intends/VBZ to/IN measure/NN the/DT tendency/NN of/IN children/NNS to/IN engage/VB in/IN excessive/JJ ,/, generalized/JJ ,/, and/CC uncontrollable/JJ worry/NN (/( Chorpita/NNP et/FW al/NNS ./NNS ,/, Behav/NNP ./.
@@105313421908/CD In/NN contrast/NN to/IN previously/RB characterized/VBN proteophosphoglycans/NNS ,/, the/DT ppg1/MULTIGENE gene/MULTIGENE product/MULTIGENE is/VBZ predominantly/RB membrane-associated/JJ and/CC it/PRP is/VBZ expressed/VBN on/IN the/DT promastigote/NN cell/NN surface/NN ./.
@@63254159957/CD The/DT greatest/JJS difference/NN between/IN the/DT Ad7/JJ and/CC Ad5/MULTIGENE DBPs/MULTIGENE is/VBZ the/DT absence/NN ,/, in/IN the/DT Ad7/MULTIGENE protein/MULTIGENE ,/, of/IN 12/CD amino/JJ acids/NNS located/VBN between/IN the/DT two/JJ functional/JJ domains/NNS in/IN the/PDT Ad5/MULTIGENE protein/MULTIGENE (/( amino/JJ acids/NNS 151-162/CD )/SYM ./.
@@117822188117/CD Compared/VBN to/IN white-on-white/JJ (/( W-W/NNP )/SYM perimetry/NN ,/, SWAP/GENE is/VBZ limited/VBN clinically/RB by/IN :/: greater/JJR variability/NN associated/VBN with/IN the/DT estimation/NN of/IN threshold/NN ,/, ocular/JJ media/NN absorption/NN ,/, increased/VBN examination/NN duration/NN and/CC an/DT additional/JJ learning/JJ effect/NN ./.
@@12068961854/CD Characteristics/NNS of/IN anesthesia/NN and/CC resuscitation/NN in/IN emergency/NN lung/NN surgery/NN ./.
@@91101765336/CD Northern/NNP and/CC RT-PCR/NN analysis/NN of/IN Ube3a/GENE expression/NN in/IN mouse/NN tissues/NNS from/IN animals/NNS with/IN segmental/JJ ,/, paternal/JJ uniparental/JJ disomy/NN failed/VBN to/IN detect/VB substantially/RB reduced/VBN or/CC absent/VB expression/NN compared/VBN to/IN control/JJ animals/NNS ,/, failing/VBG to/IN provide/VB any/DT evidence/NN for/IN maternal-specific/JJ expression/NN from/IN this/DT locus/NN ./.
@@42818564900/CD Age/NNP and/CC sex/NN structure/NN of/IN the/DT natural/JJ population/NN of/IN Ornithodoros/NN tatarovski/NNP Ol/NNP ./NNP
@@72950337152/CD Over/IN a/DT period/NN of/IN 15/CD days/NNS 16%/NN of/IN the/DT dose/NN administered/VBN was/VBD excreted/VBN with/IN faeces/NNS and/CC 0/CD ./CD 9%/CD in/IN the/DT urine/NN ./.
@@107477826745/CD Proteolysis/NNS of/IN Mbp1/GENE and/CC Swi4/MULTIGENE DNA-protein/MULTIGENE complexes/NNS has/VBZ revealed/VBN the/DT extent/NN of/IN these/DT sequences/NNS ,/, and/CC C-terminally/RB extended/VBN molecules/NNS with/IN substantially/RB enhanced/VBN DNA/NN binding/JJ activity/NN compared/VBN to/IN the/DT core/NN domains/NNS alone/RB have/VBP been/VBN produced/VBN ./.
@@825775482/CD The/DT fourth/NN dose/NN produced/VBD favorable/JJ results/NNS (/( 66/CD ./CD 7%/CD )/SYM in/IN individuals/NNS with/IN HB/NEWGENE antibodies/NNS between/IN 10/CD and/CC 100/CD IU/NNS //NNS ml/NNS and/CC unfavorable/JJ ones/NNS (/( 3/CD ./CD 8%/CD )/SYM where/CC the/DT HB/NEWGENE antibodies/NNS were/VBD below/RB 10/CD IU/NNS //NNS ml/NNS ./.
@@8286035600/CD Employing/VBG this/DT sequence/NN information/NN from/IN c11/GENE //GENE 1/GENE ,/, the/DT c11/MULTIGENE //MULTIGENE 1-specific/MULTIGENE cDNA/MULTIGENE was/VBD generated/VBN from/IN poly/NN (/NN A/NN )/NN +RNA/NN of/IN bovine/JJ PMNLs/NNS by/IN reverse/JJ transcription/NN and/CC a/DT combination/NN of/IN polymerase/NN chain/NN reaction/NN (/( PCR/NN )/SYM methods/NNS ./.
@@98194214114/CD Cyclophilins/GENE are/VBP cis-trans-peptidyl-prolyl/MULTIGENE isomerases/MULTIGENE that/WDT bind/VBP to/IN and/CC are/VBP inhibited/VBN by/IN the/DT immunosuppressant/NN cyclosporin/MULTIGENE A/MULTIGENE (/( CsA/CONTEXTGENE )/SYM ./.
@@86235547003/CD The/DT 17-kDa/MULTIGENE protein/MULTIGENE is/VBZ required/VBN for/IN the/DT systemic/JJ infection/NN of/IN plants/NNS ./.
@@79665651421/CD The/DT defined/VBN length/NN of/IN the/DT mRNA/NN ,/, 1/GENE ,/GENE 838/GENE nucleotides/NNS ,/, was/VBD in/IN agreement/NN with/IN that/DT of/IN a/DT 1/CD ./CD 9-kb/CD RNA/NN expressed/VBN throughout/IN the/DT replication/NN cycle/NN ,/, starting/JJ at/IN the/DT early/JJ stages/NNS of/IN infection/NN ./.
@@117862488212/CD Consumption/NN of/IN 4%/JJ sucrose/NN was/VBD not/RB affected/VBN by/IN excitotoxic/JJ lesions/NNS of/IN the/DT PPTg/GENE ,/, but/CC PPTg/GENE lesioned/JJ rats/NNS consumed/VBN significantly/RB more/RB 12%/JJ and/CC 20%/CD sucrose/NN than/IN sham/NN controls/NNS ./.
@@36180394300/CD The/DT presence/NN in/IN such/JJ patients/NNS of/IN antibodies/NNS to/IN adrenaline/NN and/CC noradrenaline/NN is/VBZ indicative/NN of/IN considerable/JJ disruption/NN of/IN catecholamine/NN biotransformation/NN ./.
@@28344789024/CD Low/NNP molecular/JJ weight/NN heparins/NNS have/VBP stimulated/VBN much/JJ interest/NN because/IN of/IN their/PRP supposedly/RB more/RB selective/JJ action/NN on/IN Xa/MULTIGENE factor/MULTIGENE ./.
@@114066427708/CD In/NN all/DT of/IN these/DT cases/NNS ,/, expression/NN of/IN the/DT implicated/VBN genes/NNS was/VBD absent/VB ./.
@@11729171575/CD Letter/NNP :/: Lactose/NNP tolerance/NN tests/NNS as/IN a/DT predictor/NN of/IN milk/NN tolerance/NN ./.
@@974178385/CD Anastrozole/CHEM is/VBZ the/DT first/JJ aromatase/MULTIGENE inhibitor/MULTIGENE to/IN show/NN a/DT significant/JJ survival/NN advantage/NN over/JJ megestrol/NN acetate/NN in/IN post-menopausal/JJ women/NNS with/IN advanced/JJ breast/NN cancer/NN ./.
@@21539777407/CD These/DT genes/NNS are/VBP expressed/VBN within/IN a/DT few/JJ hours/NNS of/IN the/DT initiation/NN of/IN development/NN ;/: their/PRP mRNAs/NNS accumulate/VBP to/IN a/DT peak/NN at/IN 12/CD hr/NN and/CC persist/VB until/IN culmination/NN ./.
@@9152656686/CD Fourteen/CD patients/NNS with/IN New/NNP York/NNP Heart/NNP Association/NNP class/MULTIGENE II/MULTIGENE congestive/JJ heart/NN failure/NN were/VBD enrolled/VBN in/IN a/DT double-blind/JJ ,/, cross-over/JJ study/NN ./.
@@117035583062/CD Doxorubicin/GENE (/( DOX/CONTEXTGENE )/SYM is/VBZ commonly/RB used/VBN for/IN the/DT treatment/NN of/IN hematological/JJ and/CC solid/JJ tumors/NNS ./.
@@76731286857/CD The/DT third/JJ domain/NN had/VBP the/DT motif/NN of/IN a/DT cAMP/MULTIGENE response/MULTIGENE element/MULTIGENE (/( CRE/CONTEXTGENE )/SYM ./.
@@37091916945/CD It/PRP was/VBD found/VBN that/IN the/DT primary/MULTIGENE visual/MULTIGENE cortex/NN of/IN the/DT rat/NN is/VBZ asymmetrical/JJ in/IN volume/NN ,/, and/CC that/IN the/DT asymmetry/NN reflects/VBZ side/JJ differences/NNS in/IN the/DT number/NN of/IN neurons/NNS ./.
@@88967958853/CD Using/VBG Spurr's/NNP resin/NN as/IN a/DT mounting/JJ medium/NN ,/, we/PRP could/MD observe/VB thick/JJ specimens/NNS with/IN oil/NN immersion/NN objective/JJ lens/NN without/IN the/DT use/NN of/IN coverslips/NNS ,/, then/RB avoid/VB air/NN bubbles/NNS near/IN the/DT specimen/NN ./.
@@86264936163/CD Mutations/NNS within/IN conserved/VBN region/NN 2/CD (/( CR2/GENE )/SYM of/IN E1A/NN that/WDT inhibit/VBP the/DT binding/NN of/IN E1A/NN to/IN the/DT retinoblastoma/MULTIGENE gene/MULTIGENE product/MULTIGENE (/( pRb/CONTEXTGENE )/SYM further/RB enhanced/VBN the/DT stimulation/NN of/IN transcription/NN from/IN the/DT PEPCK/MULTIGENE promoter/MULTIGENE by/IN 2/CD 3-fold/CD compared/VBN with/IN wild/JJ type/NN E1A/NN ./.
@@67970634676/CD Factor/MULTIGENE VIII/MULTIGENE procoagulant/JJ activity/NN ,/, antigen/NN concentration/NN and/CC von/NNP Willebrand/NN activity/NN as/IN ristocetin/MULTIGENE cofactor/MULTIGENE were/VBD determined/VBN several/DT times/NNS in/IN 10/CD patients/NNS with/IN DIC/NN ./.
@@78621624352/CD In/NN the/DT presence/NN of/IN inositol/NN and/CC choline/NN (/( repressing/JJ )/SYM ,/, the/DT product/NN of/IN the/DT OPI1/MULTIGENE gene/MULTIGENE represses/VBZ transcription/NN dictated/VBN by/IN the/DT UASINO/MULTIGENE element/MULTIGENE ./.
@@110345474217/CD In/NN vitro/FW ,/, Arix/NNP and/CC NBPhox/NNP form/NN DNA-independent/MULTIGENE multimers/MULTIGENE and/CC exhibit/VB cooperative/JJ binding/NN to/IN the/DT DB1/MULTIGENE regulatory/MULTIGENE element/MULTIGENE ,/, which/WDT contains/VBZ two/JJ homeodomain/MULTIGENE recognition/MULTIGENE sites/MULTIGENE ./.
@@89401327593/CD These/DT findings/NNS suggest/VBP that/DT fodrin/NN proteolysis/NN in/IN vivo/NN may/MD reflect/VB the/DT activity/NN of/IN multiple/JJ ICE/MULTIGENE //MULTIGENE Ced-3/MULTIGENE proteases/MULTIGENE whose/WP partial/JJ sensitivity/NN to/IN DEVD-CHO/GENE reflects/VBZ a/DT limited/VBN contribution/NN from/IN CPP32/GENE ,/, or/CC an/DT ICE/MULTIGENE //MULTIGENE Ced-3/MULTIGENE protease/MULTIGENE less/PRP sensitive/JJ than/IN CPP32/GENE to/IN DEVD-CHO/GENE inhibition/NN ./.
@@74900793515/CD Molecular/NNP cloning/NN of/IN the/DT human/JJ homolog/NN of/IN a/DT striatum-enriched/JJ phosphatase/NN (/( STEP/NN )/SYM gene/NN and/CC chromosomal/JJ mapping/NN of/IN the/DT human/JJ and/CC murine/MULTIGENE loci/MULTIGENE ./.
@@85432758528/CD According/VBG to/IN the/DT investigation/NN ,/, the/DT recent/JJ burst/NN of/IN pseudoterranovosis/NN in/IN this/DT area/NN can/MD be/VB attributed/VBN to/IN the/DT increased/VBN presence/NN of/IN sea/NN lions/NNS ,/, which/WDT proliferate/VBP in/IN the/DT Arctic/NN region/NN ,/, then/RB migrate/VB to/IN the/DT northern/JJ Japan/NNP Sea/NNP and/CC eat/VB the/DT intermediate/JJ host/NN fish/NN ./.
@@110278338749/CD Flow/NNP cytomery/NN was/VBD used/VBN for/IN cell/NN cycle/NN analysis/NN ./.
@@67506084652/CD Mutations/NNS in/IN seven/JJ other/DT lts/MULTIGENE genes/MULTIGENE do/VBP not/RB result/VB in/IN the/DT mak-/MULTIGENE phenotype/MULTIGENE ./.
@@14573803073/CD The/DT tramtrack/NN (/( ttk/NN )/SYM gene/NN of/IN Drosophila/NN encodes/VBZ 69-kDa/CD and/CC 88-kDa/MULTIGENE proteins/MULTIGENE through/RB alternative/JJ splicing/JJ of/IN the/DT primary/MULTIGENE ttk/MULTIGENE transcript/MULTIGENE ./.
@@26146683285/CD The/DT lowest/JJS detectable/JJ concentration/NN was/VBD 1/CD ./CD 0/CD ng/NN //NN ml/NN in/IN the/DT serum/NN ./.
@@23349721585/CD The/DT examination/NN was/VBD focused/VBN on/IN assessment/NN of/IN different/JJ types/NNS of/IN drusen/NNS ,/, on/IN evaluation/NN of/IN the/DT development/NN and/CC incidence/NN of/IN risk/NN factors/NNS leading/JJ to/IN complications/NNS and/CC loss/NN of/IN central/MULTIGENE vision/MULTIGENE ./.
@@89016354686/CD In/NN spite/NN of/IN much/JJ effort/NN ,/, no/DT one/PRP has/VBZ succeeded/VBN in/IN isolating/JJ and/CC characterizing/VBG the/DT enzyme/NN (/NN s/NN )/NN responsible/JJ for/IN synthesis/NN of/IN cellulose/NN ,/, the/DT major/JJ cell/NN wall/NN polymer/NN of/IN plants/NNS ./.
@@94358069390/CD Clinical/NNP value/NN of/IN the/DT estimation/NN of/IN growth/NN kinetics/NN of/IN primary/JJ ovarian/JJ cancer/NN recurrences/NNS by/IN CA125/NN doubling/JJ time/NN ./.
@@91460719086/CD Dystonic/NNP movement/NN of/IN the/DT left/JJ upper/JJ limb/NN in/IN a/DT case/NN of/IN the/DT right/JJ pontine/JJ hemorrhage/NN ./.
@@109463035066/CD TNF-alpha/NN induced/VBD a/DT dose-/NN and/CC time-dependent/NN increase/NN in/IN cyclooxygenase-2/GENE (/( COX-2/GENE )/SYM expression/NN and/CC PGE2/NN formation/NN in/IN human/JJ NCI-H292/NNP epithelial/JJ cells/NNS ./.
@@30661313777/CD After/IN a/DT survey/NN of/IN the/DT anatomical/JJ and/CC physiological/JJ basis/NN of/IN operative/JJ treatment/NN of/IN behaviour/NN disorders/NNS by/IN stereotactic/JJ lesions/NNS in/IN the/DT amygdala/NN and/CC the/DT posterior/JJ medial/JJ hypothalamus/NN the/DT author/NN describes/VBZ his/PRP own/VB experiences/NNS with/IN 603/CD operations/NNS for/IN control/NN of/IN conservatively/RB untreatable/JJ aggressiveness/NN ./.
@@105624957509/CD Although/IN most/JJ SFV/MULTIGENE genes/MULTIGENE have/VBP homologs/NNS encoded/VBN by/IN other/DT Chordopoxvirinae/NN ,/, the/DT SFV/NN genome/NN lacks/VBZ a/DT key/NN gene/NN required/VBN for/IN the/DT production/NN of/IN extracellular/JJ enveloped/JJ virus/NN ./.
@@82815369180/CD Interleukin-6/GENE may/MD possibly/RB potentiate/VB metastasis/NN of/IN cardiac/JJ myxoma/NN ./.
@@25386564886/CD We/PRP have/VBP determined/VBN that/IN several/DT E1/MULTIGENE mutants/MULTIGENE mapping/NN in/IN both/PDT the/DT M/NN and/CC R/MULTIGENE regions/MULTIGENE and/CC a/DT single/JJ mutant/NN of/IN the/DT upstream/RB regulatory/JJ region/NN have/NN a/DT higher/JJ transforming/JJ activity/NN on/IN mouse/NN C127/NNP cells/NNS than/IN the/DT wild-type/NN genome/NN does/VBP ./.
@@59852755859/CD Antimicrobial/JJ substance/NN isolated/VBN from/IN an/DT acorn/NN extract/NN ./.
@@84063528370/CD Army/NNP veterans/NNS given/VBP yellow/JJ fever/NN vaccine/NN contaminated/VBN with/IN hepatitis/MULTIGENE B/MULTIGENE virus/NN in/IN 1942/CD and/CC controls/NNS and/CC (/( b/NN )/SYM a/DT case-control/NN study/NN comparing/VBG veterans/NNS with/IN hepatocellular/JJ carcinoma/NN in/IN Veterans/NNP Affairs/NNP hospitals/NNS with/IN matched/JJ controls/NNS with/IN respect/NN to/IN receipt/NN of/IN contaminated/VBN vaccine/NN in/IN 1942/CD ./.
@@15732703039/CD The/DT IA4/GENE mAb/NEWGENE was/VBD identified/VBN among/IN a/DT series/NN of/IN antibodies/NNS raised/VBN in/IN BALB/NN //NN c/NN mice/NNS after/IN immunization/NN against/IN a/DT HLA/MULTIGENE class/MULTIGENE I-deficient/MULTIGENE ,/, lymphokine-activated/JJ killer/NN (/( LAK/NN )/NN -susceptible/NN EBV-B/GENE lymphocyte/NN line/NN ./.
@@86422825906/CD This/DT is/VBZ the/DT first/JJ description/NN ,/, to/IN our/PRP knowledge/NN ,/, of/IN regulatory/JJ elements/NNS that/WDT control/VBP expression/NN of/IN a/DT gene/NN encoding/VBG a/DT B7/JJ costimulatory/JJ molecule/NN ./.
@@106120446969/CD Particularly/RB striking/JJ was/VBD the/DT conservation/NN of/IN an/DT AP-4/MULTIGENE binding/MULTIGENE site/MULTIGENE within/IN 100/CD nucleotides/NNS upstream/RB of/IN the/DT transcription/NN initiation/NN site/NN in/IN both/DT Aal-rpL34/GENE and/CC Aal-rpL8/MULTIGENE genes/MULTIGENE ./.
@@80637663566/CD We/PRP find/VBP that/DT beta/MULTIGENE II/MULTIGENE PKC/NEWGENE phosphorylates/VBZ nuclear/JJ envelope/NN lamin/MULTIGENE B/MULTIGENE at/IN 10-20/CD times/VBZ the/DT rate/NN of/IN alpha/NN PKC/NEWGENE ,/, whereas/IN both/DT kinases/MULTIGENE phosphorylate/MULTIGENE soluble/MULTIGENE lamin/MULTIGENE B/MULTIGENE at/IN similar/JJ rates/NNS ./.
@@63098556092/CD Gel/NNP route/NN preparation/NN of/IN low/JJ fusing/JJ dental/JJ porcelain/NN frit/NN ./.
@@103699656781/CD The/DT Aa-Pri2/MULTIGENE gene/MULTIGENE ,/, specifically/RB expressed/VBN during/IN basidiocarp/NN differentiation/NN of/IN the/DT mushroom/NN Agrocybe/NNP aegerita/NN ,/, was/VBD cloned/VBN ./.
@@9199413697/CD Even/RB when/CC the/DT inoculum/NN size/NN was/VBD reduced/VBN sixfold/RB (/( i/FW ./FW e/FW ./FW ,/, 6/CD x/NN 10/NN (/NN 6/NN )/SYM CFU/NN //NN mouse/NN )/NN ,/, 50%/CD of/IN the/DT RB6-8C5-treated/NEWGENE animals/NNS died/VBN within/IN 6/CD days/NNS ./.
@@77749253765/CD YAC/NN and/CC cosmid/NN contigs/NNS spanning/VBG the/DT BRCA1/MULTIGENE region/MULTIGENE were/VBD used/VBN to/IN select/VB cDNA/NN clones/NNS from/IN pools/NNS of/IN cDNAs/NNS derived/VBN from/IN human/JJ placenta/NN ,/, HeLa/IN cells/NNS ,/, activated/VBN T/NN cells/NNS ,/, and/CC fetal/JJ head/NN ./.
@@86226688680/CD These/DT results/NNS illuminate/VBP a/DT hitherto/RB unanticipated/JJ function/NN of/IN U6/MULTIGENE RNA/MULTIGENE :/: the/DT modulation/NN of/IN a/DT phosphorylation-dephosphorylation/NN cycle/NN of/IN C1/MULTIGENE hnRNP/MULTIGENE protein/MULTIGENE that/WDT influences/VBZ the/DT binding/JJ affinity/NN of/IN this/DT protein/NN for/IN pre-mRNA/NN ./.
@@94188714336/CD The/DT interaction/NN between/IN DDB/NNP and/CC E2F1/GENE can/MD also/RB be/VB detected/VBN by/IN coimmunoprecipitation/NN experiments/NNS ./.
@@85520931284/CD Differentiation/NNS was/VBD not/RB observed/VBN after/IN cellular/JJ expression/NN of/IN GTPase-deficient/NNP forms/NNS of/IN alpha/MULTIGENE i2/MULTIGENE or/CC alpha/MULTIGENE 0/MULTIGENE ,/, indicating/VBG selectivity/NN for/IN the/PDT Gq/MULTIGENE family/MULTIGENE of/IN G/MULTIGENE proteins/MULTIGENE ./.
@@6173860454/CD In/NN most/JJ cases/NNS of/IN acute/JJ transmural/JJ infarction/NN ,/, the/DT reciprocal/JJ ST/MULTIGENE segment/MULTIGENE depressions/NNS observed/VBN in/IN contralateral/JJ leads/VBP are/VBP less/PRP marked/JJ than/IN the/DT primary/MULTIGENE ST/MULTIGENE segment/MULTIGENE elevations/NNS ./.
@@4841774699/CD This/DT expression/NN assumes/VBZ :/: (/( 1/CD )/SYM a/DT laminar/JJ flow/NN regimen/NN during/IN expiration/NN ,/, and/CC (/( 2/CD )/SYM a/DT constant/MULTIGENE CT/MULTIGENE value/NN over/RB the/DT range/NN of/IN VT/NNP ./NNP
@@95453329623/CD Mutation/NN of/IN the/DT central/JJ Tyr497/CD to/IN Phe/NN blocks/NNS the/DT tyrosine/NN phosphorylation/NN of/IN the/DT insulin/MULTIGENE receptor/MULTIGENE substrate/MULTIGENE 1/MULTIGENE (/( IRS1/GENE )/SYM and/CC diminishes/VBZ proliferation/NN in/IN response/NN to/IN IL-4/NEWGENE ./.
@@105570725161/CD ULKs/GENE and/CC UNC-51/GENE share/VB a/DT typical/JJ domain/NN structure/NN of/IN an/DT amino-terminal/MULTIGENE kinase/MULTIGENE domain/NN ,/, a/DT central/JJ proline/NN //NN serine/NN rich/JJ (/( PS/NN )/SYM domain/NN ,/, and/CC a/DT carboxy-terminal/JJ (/( C/NN )/SYM domain/NN ./.
@@17320332307/CD The/DT pathophysiology/NN and/CC clinical/JJ management/NN of/IN acute/JJ brain/NN injury/NN in/IN infancy/NN and/CC childhood/NN are/VBP presented/VBN using/VBG acute/JJ traumatic/JJ brain/NN injury/NN as/IN a/DT model/NN ./.
@@116426878087/CD Comparison/NNS of/IN German/JJ language/NN versions/NNS of/IN the/DT QWB-SA/GENE and/CC SF-36/GENE evaluating/VBG outcomes/NNS for/IN patients/NNS with/IN prostate/NN disease/NN ./.
@@97952138332/CD RBP56/MULTIGENE protein/MULTIGENE turned/VBN out/RB to/IN be/VB hTAFII68/GENE which/WDT was/VBD isolated/VBN as/IN a/DT TATA-binding/MULTIGENE protein/MULTIGENE associated/MULTIGENE factor/MULTIGENE (/( TAF/GENE )/SYM from/IN a/DT sub-population/NN of/IN TFIID/NEWGENE complexes/NNS (/( Bertolotti/NNP A/NNP ./NNP ,/, Lutz/NNP ,/, Y/NNP ./NNP ,/, Heard/NNP ,/, D/NNP ./NNP J/NNP ./NNP ,/, Chambon/NNP ,/, P/NNP ./NNP ,/, Tora/NNP ,/, L/NNP ./NNP ,/, 1996/CD ./. hTAFII68/GENE ,/, a/DT novel/JJ RNA/MULTIGENE //MULTIGENE ssDNA-binding/MULTIGENE protein/MULTIGENE with/IN homology/NN to/IN the/DT proto-oncoproteins/NNP TLS/NNP //NNP FUS/NNP and/CC EWS/NN is/VBZ associated/VBN with/IN both/DT TFIID/NN and/CC RNA/NN polymerase/NEWGENE II/NNS ./NNS
@@60962465921/CD Effect/NN of/IN acute/JJ and/CC chronic/JJ psychogenic/JJ stress/NN on/IN corticoadrenal/JJ and/CC pituitary-thyroid/JJ hormones/NNS in/IN male/JJ rats/NNS ./.
@@16566755076/CD Capnography/GENE curves/NNS of/IN 40/CD HVS/NNS patients/NNS ,/, 40/CD non-HVS/JJ patients/NNS with/IN psycho-somatic/JJ complaints/NNS and/CC 26/CD healthy/JJ controls/NNS were/VBD analyzed/VBN ./.
@@1463272076/CD The/DT majority/NN of/IN tumors/NNS occurred/VBN in/IN the/DT nasal/JJ cavities/NNS ,/, although/IN significant/JJ incidences/NNS were/VBD also/RB found/VB in/IN the/DT larynx/NN ,/, trachea/NN and/CC stem/NN bronchi/NNS ./.
@@105518168342/CD Human/MULTIGENE LTBP-1/MULTIGENE is/NNS known/VBP to/IN exist/VB in/IN different/JJ forms/NNS ./.
@@1396601711/CD In/NN contrast/NN ,/, the/DT lumenal/JJ domains/NNS of/IN Sec12p/GENE ,/, Stl1p/GENE and/CC Stl2p/GENE are/VBP very/RB different/JJ in/IN size/NN and/CC do/VB not/RB show/VB any/DT appreciable/JJ homology/NN ./.
@@112301459197/CD Our/PRP results/NNS suggest/VBP that/IN the/DT central/JJ role/NN of/IN the/DT Notch-CBF1/NNP //NNP RBP-Jkappa/NNP signaling/JJ pathway/NN in/IN cell/NN fate/NN decisions/NNS renders/VBZ it/PRP susceptible/JJ to/IN pathways/NNS of/IN viral/JJ replication/NN and/CC oncogenic/JJ conversion/NN ./.
@@57996861427/CD The/DT possibility/NN of/IN selective/JJ chemotherapy/NN of/IN progressive/JJ recurring/JJ ovarian/JJ carcinoma/NN with/IN the/DT aid/NN of/IN cytodiagnosis/NN and/CC incorporation/NN of/IN tagged/JJ idoxuridine/NN ./.
@@891370677/CD Well-visualised/JJ arteriograms/NNS of/IN the/DT limbs/NNS can/MD be/VB obtained/VBN by/IN xeroradiography/NN after/IN rapid/JJ manual/JJ injection/NN of/IN contrast-medium/JJ into/IN an/DT arm/NN vein/NN ,/, as/IN demonstrated/VBN in/IN 28/CD patients/NNS ./.
@@15600214854/CD To/TO determine/VB the/DT genetic/JJ basis/NN for/IN the/DT differences/NNS between/IN the/DT cardiac/NN and/CC brain/NN AE3/MULTIGENE variants/MULTIGENE ,/, we/PRP isolated/VBD and/CC characterized/VBD the/DT rat/NN gene/NN ./.
@@24065707411/CD All/DT ABFI-binding/MULTIGENE sites/MULTIGENE ,/, regardless/RB of/IN origin/NN ,/, provided/VBN weak/JJ UAS/NN function/NN in/IN vivo/NN when/CC examined/VBN in/IN test/NN plasmids/NNS ./.
@@18650102461/CD Patterns/NNS of/IN connections/NNS underlying/JJ cross-modality/JJ integration/NN were/VBD studied/VBN by/IN injecting/JJ distinguishable/JJ ,/, retrograde/JJ tracers/NNS (/( Fluoro-Gold/NNP and/CC diamidino/NN yellow/JJ )/SYM in/IN pairwise/JJ manner/NN into/IN different/JJ sensory/JJ representations/NNS (/( visual/JJ ,/, somatosensory/JJ ,/, and/CC auditory/JJ )/SYM in/IN the/DT cerebral/JJ cortex/NN of/IN the/DT rat/NN ./.
@@75573878227/CD In/NN this/DT study/NN we/PRP have/VBP investigated/VBN the/DT role/NN of/IN C/MULTIGENE //MULTIGENE EBP/MULTIGENE beta/MULTIGENE in/IN initiating/JJ the/DT adipogenic/JJ program/NN by/IN overexpressing/JJ C/MULTIGENE //MULTIGENE EBP/MULTIGENE beta/MULTIGENE in/IN multipotential/JJ NIH-3T3/GENE fibroblasts/NNS ./.
@@13309751960/CD Peripheral/JJ polyneuropathy/NN associated/VBN with/IN multiple/JJ myeloma/NN ./.
@@11120441958/CD As/IN hypothesized/VBN ,/, believers/NNS showed/VBD relatively/JJ higher/JJ right/JJ hemispheric/JJ activation/NN and/CC reduced/VBN hemispheric/JJ asymmetry/NN of/IN functional/JJ complexity/NN ./.
@@26479187455/CD In/NN the/DT whole/JJ group/NN ,/, basal/MULTIGENE GH/MULTIGENE and/CC somatomedin-C/NN levels/NNS decreased/VBN from/IN a/DT mean/JJ (/( +/NN //NN -/NN standard/JJ error/NN of/IN the/DT mean/JJ )/SYM of/IN 52/CD ./CD 3/CD +/NN //NN -/NN 12/CD ./CD 7/CD to/IN 11/CD ./CD 1/CD +/NN //NN -/NN 6/CD ./CD 3/CD ng/NN //NN ml/NN and/CC from/IN 7/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 7/CD to/IN 2/CD ./CD 5/CD +/NN //NN -/NN 0/CD ./CD 5/CD U/NNS //NNS ml/NNS ,/, respectively/RB ./.
@@80857828064/CD We/PRP describe/VBP 49/CD cases/NNS with/IN papillary/JJ tumor/NN </SYM 1/CD cm/NN ./NN
@@77303375252/CD Structure/NNS and/CC regulation/NN of/IN the/DT gene/NN encoding/VBG the/DT neuron-specific/MULTIGENE protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE substrate/MULTIGENE neurogranin/MULTIGENE (/( RC3/MULTIGENE protein/MULTIGENE )/SYM ./.
@@367605478/CD In/NN group/NN I/PRP ,/, Paw/CONTEXTGENE ,/, delta/MULTIGENE V/MULTIGENE ,/, PaO2/GENE ,/, Vinj/GENE and/CC VT/NN significantly/RB decreased/VBD whereas/IN operating/JJ pressure/NN and/CC E/NN significantly/RB increased/VBD when/CC the/DT internal/JJ diameter/NN of/IN the/DT injector/NN cannula/NN was/VBD reduced/VBN ./.
@@92910779252/CD Transient/JJ hyperammonaemia/NN in/IN an/DT adult/JJ German/JJ shepherd/NN dog/NN ./.
@@101711738831/CD Because/IN of/IN concerns/NNS regarding/IN blood/NN transfusion-related/JJ communicable/JJ disease/NN (/( eg/NN ,/, acquired/VBN immune/JJ deficiency/NN syndrome/NN and/CC non-A/CONTEXTGENE ,/, non-B/GENE hepatitis/NN )/SYM ,/, there/RB has/VBZ been/VBN increasing/JJ research/NN effort/NN into/IN postoperative/JJ hemorrhage/NN related/VBN to/IN cardiopulmonary/JJ bypass/NN with/IN extracorporeal/JJ circulation/NN ./.
@@91548222478/CD Inhibition/NNS of/IN the/DT Raf-1/MULTIGENE kinase/MULTIGENE by/IN cyclic/JJ AMP/NN agonists/NNS causes/NNS apoptosis/NN of/IN v-abl-transformed/JJ cells/NNS ./.
@@18378424657/CD CREB/NN was/VBD identified/VBN as/IN one/PRP of/IN the/DT protein/NN components/NNS in/IN several/DT of/IN the/DT gel/NN shift/NN complexes/NNS formed/VBN with/IN the/DT variant/NN CRE/NN ./.
@@82411395417/CD About/IN 20%/CD of/IN single-stranded/JJ DNA/NN binding/NN was/VBD observed/VBN in/IN the/DT presence/NN of/IN MgdTDP/NNP ,/, but/CC none/NN was/VBD detectable/JJ in/IN the/DT absence/NN of/IN nucleotides/NNS ./.
@@89447553351/CD Biol/NNP ./.
@@98226907629/CD Mammalian/JJ sperm/NN motility/NN is/VBZ regulated/VBN by/IN a/DT cascade/NN of/IN cAMP-dependent/MULTIGENE protein/MULTIGENE phosphorylation/NN events/NNS mediated/JJ by/IN protein/MULTIGENE kinase/MULTIGENE A/NNP ./NNP
@@78985897878/CD The/DT "tobacco/NN issue"/NN ./.
@@17255479370/CD Diltiazem/GENE resulted/VBN in/IN a/DT significant/JJ increase/NN in/IN epicardial/JJ diameter/NN (/( +10%/CD ;/: p/NN =/SYM 0/CD ./CD 001/CD )/SYM and/CC in/IN coronary/JJ blood/NN flow/NN (/( CBF/NN )/SYM (/( +30%/CD ;/: p/NN =/SYM 0/CD ./CD 0001/CD )/SYM ./.
@@88014038783/CD Myelomatous/JJ pleural/JJ effusion/NN as/IN presentation/NN form/NN of/IN multiple/JJ myeloma/NN ./.
@@97032766514/CD These/DT results/NNS establish/VBP that/IN hydroquinones/NNS lead/VBP to/IN mutagenicity/NN and/CC carcinogenicity/NN ./.
@@61515185973/CD Glutamic/NN acid/NN in/IN a/DT dose/NN of/IN 1/CD //CD 100/CD of/IN the/DT LD50/NN was/VBD injected/VBN in/IN the/DT form/NN of/IN sodium/NN salt/JJ into/IN male/JJ and/CC female/JJ Wistar/NN rats/NNS for/IN 7/CD days/NNS after/IN 8-/CD and/CC 12-day/NN injections/NNS of/IN dexazone/NN ./.
@@106603045238/CD Members/NNS of/IN the/DT JAK/MULTIGENE //MULTIGENE Tyk/MULTIGENE family/MULTIGENE of/IN tyrosine/MULTIGENE kinases/MULTIGENE mediate/VBP phosphorylation/NN of/IN STAT3/GENE at/IN Tyr705/NN during/IN CNTF/NN signaling/JJ ;/: however/RB ,/, the/DT kinase/NN responsible/JJ for/IN phosphorylation/NN at/IN STAT3/GENE Tyr727/NN appears/VBZ to/IN depend/VB on/IN both/PDT the/DT extracellular/JJ stimulus/NN and/CC the/DT cellular/JJ context/NN ./.
@@82086181468/CD Also/RB ,/, HR21ap/GENE as/RB well/VB as/IN HR21Xap/GENE are/VBP specific/JJ in/IN their/PRP inhibition/NN of/IN Sp1/GENE binding/JJ ./.
@@90604447073/CD This/DT promoter/NN segment/NN could/MD drive/VB expression/NN of/IN a/DT luciferase/NEWGENE reporter/NN gene/NN ,/, could/MD confer/VB correct/JJ transcriptional/JJ initiation/NN to/IN the/DT reporter/NN and/CC could/MD confer/VB the/DT EGF-responsiveness/NNP previously/RB observed/VBD in/IN the/DT native/JJ gene/NN ./.
@@88072885156/CD Isolation/NNS and/CC identification/NN of/IN genes/MULTIGENE activating/MULTIGENE UAS2-dependent/MULTIGENE ADH2/MULTIGENE expression/NN in/IN Saccharomyces/NN cerevisiae/NN ./.
@@72603898339/CD Methisergide/NNP (/( 0/CD ./CD 5/CD mg/CD //CD kg/CD ,/, i/CD ./CD p/CD ./CD )/SYM ,/, a/DT blocker/NN of/IN serotonin/MULTIGENE receptors/MULTIGENE ,/, prevented/VBD the/DT development/NN of/IN the/DT antinociceptive/JJ effect/NN of/IN serotonin/NN ./.
@@87943393436/CD Although/IN the/DT binding/NN of/IN IE2/MULTIGENE 86/MULTIGENE to/IN nonphosphorylated/JJ full-length/JJ CREB/NN or/CC deltaCREB/GENE is/VBZ minimal/JJ ,/, IE2/MULTIGENE 86/MULTIGENE does/VBP form/NN complexes/NNS with/IN p300/GENE and/CC the/DT CREB-binding/MULTIGENE protein/MULTIGENE (/( CBP/CONTEXTGENE )/SYM ,/, which/WDT in/IN turn/NN bind/NN to/IN CREB/NN and/CC can/MD serve/VB as/IN adaptor/MULTIGENE proteins/MULTIGENE for/IN CREB/NEWGENE function/NN ./.
@@14007752021/CD These/DT results/NNS demonstrate/VBP that/IN endogenous/JJ N-methylation/NNS of/IN salsolinol/NN into/IN N-methylsalsolinol/CHEM occurs/VBZ in/IN the/DT brain/NN in/IN vivo/NN ./.
@@83451913749/CD The/DT peptide/NN sequence/NN contains/VBZ a/DT region/NN of/IN 80/CD amino/JJ acids/NNS that/WDT shows/VBZ similarity/NN to/IN bcl-2/GENE and/CC to/IN the/DT recently/RB described/VBN bcl-2-related/MULTIGENE gene/MULTIGENE ,/, MCL1/GENE ./.
@@72593257098/CD Survival/NNP was/VBD calculated/VBN both/DT from/IN the/DT date/NN of/IN onset/NN and/CC from/IN the/DT date/NN of/IN diagnosis/NN ./.
@@113096782967/CD Reverse/VB transcription-PCR/NN analysis/NN of/IN mRNA/NN from/IN patients/NNS shows/VBZ that/IN each/DT of/IN these/DT five/CD mutations/NNS results/NNS in/IN aberrant/JJ splicing/JJ ./.
@@35568348129/CD Acute/JJ inhalation/NN toxicity/NN of/IN T-2/MULTIGENE mycotoxin/MULTIGENE in/IN mice/NNS ./.
@@99458389940/CD Envelope-function/NNP matching/JJ conditions/NNS for/IN GaAs/NN //NN (/NN Al/NN ,/NN Ga/NN )/NN As/NN heterojunctions/NNS ./.
@@3426233592/CD Disrupted/JJ vaccines/NNS and/CC whole-virus/NN vaccines/NNS containing/MULTIGENE type/MULTIGENE B/MULTIGENE antigen/NN only/RB did/VBD not/RB cause/VB significant/JJ reactivity/NN ./.
@@92104787010/CD The/DT ubiquitously/RB expressed/VBN hypoxia-inducible/JJ factor-1/GENE (/( HIF-1/GENE )/SYM is/VBZ involved/VBN in/IN expression/NN of/IN a/DT large/JJ number/NN of/IN oxygen-regulated/MULTIGENE genes/MULTIGENE ./.
@@7730336674/CD Because/IN ATF-1/GENE and/CC CREM/GENE are/VBP known/VBP to/IN bind/NN to/IN cAMP/MULTIGENE response/MULTIGENE elements/MULTIGENE (/( CRE/CONTEXTGENE )/SYM ,/, this/DT functional/JJ sequence/NN was/VBD named/VBN the/DT kappa/NN E3'-CRE/GENE ./.
@@19066922535/CD INTERVENTIONS/NNP :/: Patients/NNS received/VBD rt-PA/NN ,/, heparin/NN ,/, and/CC aspirin/NN ./.
@@42891564905/CD The/DT incidence/NN of/IN tumours/NNS in/IN young/JJ chickens/NNS ./.
@@83099537902/CD These/DT results/NNS demonstrate/VBP that/DT dopamine/MULTIGENE receptor/MULTIGENE stimulation/NN by/IN different/JJ dopamine/NN agonists/NNS produces/VBZ a/DT different/JJ pattern/NN of/IN effects/NNS on/IN the/DT characteristics/NNS of/IN the/DT reaction/NN time/NN response/NN ./.
@@605291849/CD In/NN the/DT matched/JJ control/NN group/NN the/DT acquisition-rate/NN of/IN both/DT symptomatic/JJ and/CC asymptomatic/JJ 0acteriuria/NN was/VBD over/RB 12%/JJ ,/, a/DT figure/NN similar/JJ to/IN the/DT percentage/NN of/IN women/NNS present/VBP in/IN the/DT practice/NN population/NN during/IN one/PRP year/NN with/IN transient/JJ ,/, symptomatic/JJ ,/, and/CC persistent/JJ A/NN ./NN B/NN ./.
@@98378244790/CD We/PRP identified/VBD telSMN/MULTIGENE mutations/MULTIGENE in/IN 11/CD of/IN these/DT unrelated/MULTIGENE SMA-like/MULTIGENE individuals/NNS who/WP carry/VBP a/DT single/JJ copy/NN of/IN telSMN/NN :/: these/DT include/VB two/JJ frameshift/JJ mutations/NNS (/( 800ins11/GENE and/CC 542delGT/GENE )/SYM and/CC three/CD missense/JJ mutations/NNS (/( A2G/NN ,/, S262I/NNP ,/, and/CC T274I/NNP )/SYM ./.
@@93673921189/CD The/DT presence/NN of/IN an/DT additional/JJ sequence/NN of/IN nucleotides/NNS 145-165/JJ from/IN the/DT 3'/CD end/NN of/IN RNA3/GENE enhanced/VBN template/NN recognition/NN by/IN RdRp/NNS in/IN vitro/FW and/CC accumulation/NN of/IN RNA3/GENE in/IN vivo/NN to/IN wild-type/NN levels/NNS ./.
@@114697374697/CD At/NN visit/MULTIGENE 5/MULTIGENE ,/, the/DT isokinetic/JJ test/NN showed/VBD impaired/VBN muscle/NN function/NN recovery/NN from/IN 23%/JJ to/IN 32%/JJ ,/, while/CC the/DT manual/JJ test/NN showed/VBD almost/RB full/JJ recovery/NN ./.
@@92347366674/CD In/NN situ/NN hybridization/NN analysis/NN in/IN adult/JJ rat/NN tissue/NN reveals/VBZ good/JJ correlation/NN with/IN this/DT pattern/NN and/CC indicates/VBZ that/DT drm/MULTIGENE mRNA/MULTIGENE is/VBZ most/RB highly/RB expressed/VBN in/IN nondividing/JJ and/CC terminally/RB differentiated/VBN cells/NNS ,/, such/JJ as/IN neurons/NNS ,/, type/NN 1/CD lung/NN cells/NNS ,/, and/CC goblet/NN cells/NNS ./.
@@98826389876/CD Folded/NNP tissue/NN and/CC crimped/JJ collagen/NN fibers/NNS in/IN the/DT tunica/NN albuginea/NN permit/NN its/PRP expansion/NN during/IN erection/NN ./.
@@17650958334/CD 12-O-Tetradecanoylphorbol/JJ 13-acetate/NN was/VBD found/VBN to/IN inhibit/VB rapidly/RB and/CC potently/RB the/DT expression/NN of/IN mRNAs/NNS coding/JJ for/IN the/DT myogenic/JJ regulators/MULTIGENE CMD1/MULTIGENE and/CC myogenin/NN ./.
@@85420279126/CD The/DT XS2/MULTIGENE gene/MULTIGENE down-regulates/VBZ but/CC does/VBP not/RB abolish/VB expression/NN of/IN LU/MULTIGENE genes/MULTIGENE and/CC does/VBP not/RB affect/VB expression/NN of/IN CD44/NEWGENE ./.
@@98932628107/CD Additionally/RB ,/, a/DT variety/NN of/IN regulatory/JJ schemes/NNS contribute/VBP temporal/JJ and/IN //IN or/IN spatial/JJ restriction/NN to/IN TGF-beta/NEWGENE responses/NNS ./.
@@9038202904/CD These/DT data/NN support/NN the/DT idea/NN that/IN the/DT repression/NN activity/NN of/IN NRSF/GENE //GENE REST/GENE depends/VBZ upon/IN the/DT species/NN of/IN promoter/NN to/IN which/WDT it/PRP is/VBZ linked/JJ and/CC upon/IN the/DT proteins/NNS that/WDT bind/VBP to/IN those/DT promoters/NNS ./.
@@94420315681/CD This/DT information/NN ,/, together/RB with/IN estimation/NN of/IN the/DT size/NN of/IN the/DT deglycosylated/JJ A/DT subunit/NN relative/JJ to/IN a/DT series/NN of/IN C-terminal/NN truncated/JJ TSHR/MULTIGENE ectodomain/MULTIGENE variants/MULTIGENE ,/, places/NNS cleavage/NN Site/NNP 1/CD in/IN the/DT vicinity/NN of/IN ,/, or/CC closely/RB upstream/RB to/IN ,/, residue/NN 317/CD ./.
@@118210987137/CD MAIN/NNP OUTCOME/NNP MEASURE/NN (/NN S/NN )/NN :/: Serum/NN levels/NNS of/IN FSH/JJ ,/, LH/NN ,/, and/CC inhibin/MULTIGENE A/MULTIGENE and/CC B/NNP ./NNP
@@76786023834/CD We/PRP generated/VBD transformed/VBN B/NNP lymphoblast/NN cell/NN lines/NNS from/IN controls/NNS ,/, from/IN four/CD patients/NNS with/IN p47-phox-deficient/JJ chronic/JJ granulomatous/JJ disease/NN ,/, and/CC from/IN three/CD parents/NNS ./.
@@39294865436/CD In/NN a/DT blind/RB controlled/VBN trial/NN ,/, 15/CD patients/NNS with/IN COCM/CONTEXTGENE (/( NYHA/MULTIGENE II-III/MULTIGENE )/SYM with/IN sinus/NN rhythm/NN and/CC a/DT left/JJ ventricular/JJ ejection/NN fraction/NN (/( LV-EF/GENE )/SYM of/IN 34/CD ./CD 5/CD +/NN //NN -/NN 2/CD ./CD 6%/CD received/VBN consecutively/RB D/NN (/( 0/CD ./CD 25-0/CD ./CD 5/CD mg/NN //NN d/NN )/SYM ,/, placebo/NN (/( PLAC/NN )/SYM ,/, P/NN (/( slow/JJ releases/NNS =/SYM SR/NN )/SYM (/( 80/CD mg/NN //NN d/NN SR/NN )/SYM and/CC both/DT drugs/NNS combined/JJ in/IN respective/JJ doses/NNS ./.
@@96493155245/CD Examination/NN of/IN nuclear/JJ magnetic/JJ resonance/NN (/( NMR/NN )/SYM spectra/NNS of/IN a/DT series/NN of/IN N-terminally/RB truncated/JJ MIP-1/MULTIGENE beta/MULTIGENE variants/MULTIGENE reveals/VBZ that/IN these/DT proteins/NNS possess/VBP a/DT range/NN of/IN ability/NN to/IN dimerize/VB ./.
@@6149158581/CD Vitrectomy/NN in/IN ocular/JJ traumatology/NN ./.
@@95449872363/CD We/PRP further/RB demonstrate/VBP that/IN RU486-PR-B/GENE interacts/VBZ physically/RB with/IN NCoR/GENE in/IN vitro/FW ./.
@@16519188975/CD We/PRP have/VBP isolated/VBN and/CC sequenced/VBN two/JJ overlapping/JJ cDNA/NN fragments/NNS which/WDT could/MD encode/VB the/DT complete/JJ amino/JJ acid/NN sequence/NN of/IN rat/MULTIGENE testis/MULTIGENE fructose-6-phosphate/MULTIGENE ,/MULTIGENE 2-kinase/MULTIGENE :/: fructose-2/NNP ,/NNP 6-bisphosphatase/NNP ./.
@@12793526925/CD One/CD site/NN ,/, PAL/NN ,/, occurs/VBZ within/IN the/DT 10/CD bp/NN sequence/MULTIGENE GGGGAGGAGG/MULTIGENE ./.
@@98527529841/CD We/PRP emphasize/VBP that/IN ANCA-associated/JJ vasculitis/NN is/VBZ another/DT important/JJ complication/NN of/IN RA/NN ./NN
@@84457292274/CD Replacement/NN of/IN the/DT spacer/NN sequence/NN between/IN the/DT two/JJ ARMs/NNS with/IN a/DT shorter/JJR stretch/NN of/IN sequence/NN also/RB reduced/VBD RNA/NN binding/JJ in/IN vitro/FW ./.
@@83771992367/CD It/PRP is/VBZ possible/JJ that/IN the/DT patch/NN determines/VBZ the/DT proper/JJ conformation/NN of/IN the/DT site/NN and/CC thereby/RB contributes/VBZ to/IN recognition/NN indirectly/RB ./.
@@112962886717/CD In/NN addition/NN ,/, another/DT derivative/NN of/IN pCMVJS21/GENE (/( pCMVJS21DeltaGP/GENE )/SYM in/IN which/WDT the/DT gag/NN ,/, pol/JJ (/( and/CC orf-x/JJ )/SYM coding/JJ sequences/NNS were/VBD deleted/VBN also/RB gave/VBD transformed/VBN foci/NNS ./.
@@95085115545/CD In/NN ferrets/NNS naturally/RB infected/VBN with/IN H/NNP ./NNP mustelae/NNS ,/, a/DT single/JJ dose/NN (/( 50/CD mg/CD //CD kg/CD ,/, per/IN os/NN )/SYM of/IN fluorofamide/NN completely/RB inhibited/VBD bacterial/JJ urease/NEWGENE ./.
@@9332514592/CD Petrous/JJ meningioma/NN en/NN plaque/NN presenting/VBG as/IN a/DT right/JJ middle/JJ ear/NN tumor/NN ./.
@@95965429553/CD We/PRP show/VBP that/IN the/DT surfaces/NNS of/IN tracheal/JJ cartilage/NN matrix/NN are/VBP collagen-rich/JJ and/CC surround/VB a/DT proteoglycan-rich/JJ core/NN ./.
@@9622779591/CD Haemodilution/NNP in/IN cardiopulmonary/JJ bypass/NN using/VBG a/DT gelatine/NN derivative/NN for/IN priming/NN ./.
@@22463626453/CD The/DT Jenkins/NNP Activity/NNP Survey/NNP and/CC the/DT CPI-revised/JJ :/: further/JJ evidence/NN of/IN adaptive/JJ and/CC maladaptive/JJ type/MULTIGENE A/MULTIGENE traits/NNS ./.
@@28313986298/CD Irmiere/NNP ,/, and/CC W/NN ./NN
@@79651527602/CD Segments/NNS with/IN more/RB reduced/VBN BMIPP/GENE uptake/NN than/IN MIBI/DT uptake/NN (/( mismatching/VBG )/SYM showed/VBD either/DT normal/JJ wall/NN motion/NN or/CC demonstrated/VBN inotropic/JJ reserve/NN during/IN dobutamine/NN stimulation/NN ./.
@@30102817683/CD Two/CD copies/NNS of/IN the/DT 72-bp/JJ repeat/NN provided/VBD efficient/JJ activation/NN of/IN gene/NN expression/NN ./.
@@102338859755/CD Consistent/JJ with/IN this/DT prediction/NN ,/, transfections/NNS into/IN the/DT hematopoietic/JJ cell/NN line/NN Jurkat/NN showed/VBD a/DT 9/CD ./CD 0-/CD and/CC 2/CD ./CD 5-fold/CD activation/NN of/IN the/DT mim-1/MULTIGENE promoter/MULTIGENE by/IN the/DT p32/GENE and/CC p30/MULTIGENE isoforms/MULTIGENE ,/, respectively/RB ./.
@@93117966051/CD In/NN our/PRP previous/JJ studies/NNS ,/, transcriptional/JJ activation/NN was/VBD shown/VBP to/IN correlate/NN with/IN IEP86/NEWGENE binding/JJ to/IN both/PDT the/DT TATA-box/MULTIGENE binding/MULTIGENE protein/MULTIGENE (/( TBP/CONTEXTGENE )/SYM and/CC the/DT transcription/NN factor/NN bound/JJ upstream/RB ./.
@@40041683581/CD Two/CD siblings/NNS with/IN hemolytic/JJ anemia/NN caused/VBN by/IN triosephosphate/MULTIGENE isomerase/MULTIGENE deficiency/NN developed/VBD a/DT progressive/JJ neurological/JJ syndrome/NN featuring/VBG dystonic/JJ movements/NNS ,/, tremor/NN ,/, pyramidal/JJ tract/NN signs/NNS ,/, and/CC evidence/NN of/IN spinal/JJ motor/JJ neuron/NN involvement/NN ./.
@@13092443918/CD The/DT target/NN contained/VBN between/IN positions/NNS -403/CD and/CC -125/CD acts/NNS independently/RB of/IN orientation/NN ,/, in/IN different/JJ cell/NN types/NNS and/CC species/NN ,/, and/CC in/IN the/DT context/NN of/IN a/DT heterologous/JJ promoter/NN ./.
@@63190717092/CD Female/JJ subjects/NNS ,/, including/JJ both/DT normal/JJ subjects/NNS and/CC idiopathic/JJ calcium/MULTIGENE stone-formers/MULTIGENE ,/, have/VB higher/JJ urinary/JJ cyclic/JJ AMP/NEWGENE levels/NNS than/IN their/PRP male/JJ counterparts/NNS ,/, and/CC this/DT difference/NN is/VBZ significant/JJ when/CC urinary/JJ cyclic/JJ AMP/NN is/VBZ expressed/VBN in/IN the/DT units/NNS mumol/NN //NN g/NN of/IN creatinine/NN ./.
@@37282308433/CD He/NN visited/VBD our/PRP hospital/NN and/CC left/NN solitary/JJ renal/MULTIGENE cyst/MULTIGENE was/VBD suspected/VBN ./.
@@89550228910/CD The/DT effect/NN of/IN maternal/JJ ingestion/NN of/IN the/DT reduced/VBN energy/NN sweetener/NN erythritol/NN was/VBD investigated/VBN in/IN KBL/NNP :/: JW/NN strain/NN pregnant/JJ rabbits/NNS ./.
@@78676044597/CD Our/PRP results/NNS concluded/VBN that/IN 1/NN )/NN the/DT two/JJ inhibin/MULTIGENE //MULTIGENE activin/MULTIGENE beta/MULTIGENE B-subunit/MULTIGENE mRNAs/MULTIGENE were/VBD transcribed/VBN from/IN different/JJ initiation/NN sites/NNS ;/: 2/NN )/NN both/DT promoters/NNS may/MD be/VB controlled/VBN by/IN up-stream/NN negative/JJ regulatory/JJ elements/NNS ;/: and/CC 3/NN )/NN neither/DT of/IN these/DT promoters/NNS is/VBZ responsive/JJ to/IN cAMP/NN and/DT //DT or/DT phorbol/NN esters/NNS under/IN the/DT conditions/NNS employed/VBN ./.
@@114597943382/CD TE-671/NNP cells/NNS that/WDT were/VBD transfected/VBN with/IN cAMP/MULTIGENE response/MULTIGENE element/MULTIGENE mutant/MULTIGENE constructs/MULTIGENE demonstrated/VBD a/DT diminished/VBN basal/JJ activity/NN of/IN the/DT GnRH-II/MULTIGENE promoter/MULTIGENE ./.
@@78350885787/CD The/DT HSD3B1/GENE and/CC HSD3B2/MULTIGENE genes/MULTIGENE encoding/VBG the/DT types/NNS I/PRP and/CC II/MULTIGENE 3/MULTIGENE beta-HSD/MULTIGENE isoenzymes/MULTIGENE ,/, respectively/RB ,/, have/VB been/VBN previously/RB assigned/VBN by/IN in/IN situ/NN hybridization/NN to/IN the/DT chromosome/MULTIGENE 1p13/MULTIGENE ./MULTIGENE 1/MULTIGENE region/MULTIGENE ./.
@@98230149801/CD Effect/NN of/IN enteral/JJ nutritional/JJ products/NNS differing/JJ in/IN carbohydrate/NN and/CC fat/JJ on/IN indices/NNS of/IN carbohydrate/NN and/CC lipid/NN metabolism/NN in/IN patients/NNS with/IN NIDDM/NN ./.
@@86357719441/CD A/DT study/NN was/VBD performed/VBN to/IN compare/NN the/DT ONLINE/NNP and/CC EMIT/NN II/NN immunoassays/NNS with/IN gas/NN chromatographic/NN //NN mass/NN spectrometric/JJ (/( GC/NN //NN MS/NN )/SYM analysis/NN of/IN methaqualone/NN metabolites/NNS on/IN urine/NN using/VBG samples/NNS obtained/VBN from/IN a/DT clinical/JJ study/NN ./.
@@74882473494/CD Functional/JJ analysis/NN of/IN aryl/MULTIGENE hydrocarbon/MULTIGENE receptor/MULTIGENE nuclear/MULTIGENE translocator/MULTIGENE interactions/NNS with/IN aryl/MULTIGENE hydrocarbon/MULTIGENE receptor/MULTIGENE in/IN the/DT yeast/NN two-hybrid/JJ system/NN ./.
@@76511415745/CD The/DT 5'-terminus/NN of/IN the/DT p-gvpF-M/MULTIGENE mRNA/MULTIGENE was/VBD located/VBN 169/CD nucleotides/NNS upstream/RB of/IN p-gvpF/GENE within/IN p-gvpE/NN ./.
@@78621413945/CD Alternatively/RB ,/, loss-of-function/NN alleles/NNS of/IN genes/NNS that/WDT inhibit/VBP cAPK/GENE lead/VB to/IN the/DT inability/NN to/IN undergo/VB sexual/JJ differentiation/NN ./.
@@86417056098/CD These/DT different/JJ observations/NNS exclude/VBP a/DT heterozygosity/NN of/IN the/PDT A/DT --/JJ >/JJ G/MULTIGENE mutation/MULTIGENE at/IN codon/NN beta/MULTIGENE 77/MULTIGENE ,/, as/RB well/VB as/IN a/DT deletion/NN comparable/JJ to/IN that/IN of/IN Hbs/NNS Lepore/WDT or/CC Kenya/NN ,/, or/CC a/DT beta-globin/MULTIGENE gene/MULTIGENE duplication/NN ,/, and/CC point/NN to/IN a/DT nontraditional/JJ inheritance/NN of/IN Hb/NN Costa/NNP Rica/NNP ./.
@@111131796482/CD Remarkably/RB ,/, a/DT construct/NN corresponding/JJ to/IN residues/NNS 631/CD to/IN 970/CD ,/, which/WDT contains/VBZ only/RB the/DT LXXLL/MULTIGENE motifs/MULTIGENE and/CC the/DT AD1/MULTIGENE region/MULTIGENE of/IN SRC1/GENE ,/, retained/VBN strong/JJ coactivator/NN activity/NN in/IN our/PRP assays/NNS ./.
@@90427554793/CD The/DT alternative/JJ sigma/NN factor/NN sigmaB/GENE in/IN Staphylococcus/NN aureus/NN :/: regulation/NN of/IN the/DT sigB/MULTIGENE operon/MULTIGENE in/IN response/NN to/IN growth/NN phase/NN and/CC heat/NN shock/NN ./.
@@16120851316/CD The/DT serum/JJ erythropoietin/NN (/( EPO/NN )/SYM concentrations/NNS of/IN 15/CD male/JJ triathletes/NNS (/( 26/CD ./CD 3/CD U/CD ./CD ml-1/CD )/SYM were/VBD significantly/RB lower/JJR than/IN those/DT of/IN 45/CD male/JJ distance/NN runners/NNS (/( 31/CD ./CD 6/CD U/CD ./CD ml-1/CD ;/: P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@61100267953/CD Endorphins/GENE at/IN the/DT approach/NN of/IN death/NN ./.
@@19018598787/CD UDP-Gal/NN :/: Gal/MULTIGENE beta/MULTIGENE 1----4GlcNAc/MULTIGENE alpha/MULTIGENE 1----3-galactosyltransferase/MULTIGENE is/VBZ a/DT terminal/MULTIGENE glycosyltransferase/MULTIGENE that/WDT is/VBZ widely/RB expressed/VBN in/IN a/DT variety/NN of/IN mammalian/JJ species/NN ,/, with/IN the/DT notable/JJ exception/NN of/IN man/NN ,/, apes/NNS ,/, and/CC Old/NNP World/NNP monkeys/NNS ./.
@@2480419583/CD The/DT underlying/JJ cirrhosis/NN was/VBD alcoholic/JJ in/IN 11/CD (/( 53/CD ./CD 3%/CD )/SYM ,/, cryptogenic/JJ in/IN 5/CD (/( 23/CD ./CD 8%/CD )/SYM ,/, and/CC hepatitis/MULTIGENE B/MULTIGENE chronic/JJ infection/NN related/VBN in/IN 5/CD (/( 23/CD ./CD 8%/CD )/SYM ./.
@@86607488634/CD The/DT model/NN captures/VBP the/DT essence/NN of/IN predator-prey/JJ dynamics/NNS to/IN provide/VB reasonable/JJ predictions/NNS of/IN population/NN patterns/NNS ./.
@@103808907526/CD Forty-eight/NNS sequences/NNS ,/, 30/CD not/RB previously/RB identified/VBN as/IN IR-responsive/NNP ,/, were/VBD significantly/RB regulated/VBN by/IN IR/NNP ./NNP
@@10959676779/CD The/DT bases/NNS of/IN this/DT comparison/NN are/VBP reviewed/VBN and/CC discussed/VBN ./.
@@115761581461/CD In/NN the/DT TVD-patients/NNS decreases/NNS in/IN skin/NN blood/NN flow/NN were/VBD similar/RB compared/VBN with/IN the/DT healthy/JJ controls/NNS ./.
@@29674969078/CD The/DT cpc-1-encoded/JJ transcript/NN contains/VBZ three/CD open/JJ reading/JJ frames/NNS ,/, two/NN of/IN which/WDT are/VBP located/VBN in/IN the/DT 720-nucleotide/JJ leader/NN segment/NN preceding/JJ the/DT cpc-1/GENE coding/JJ region/NN ./.
@@95709527634/CD The/DT complete/JJ exon-intron/JJ organization/NN of/IN the/DT murine/MULTIGENE gene/MULTIGENE encoding/VBG M-protein/NNS ,/, a/DT structural/JJ protein/NN of/IN sarcomeric/JJ myofibrils/NNS ,/, was/VBD determined/VBN ./.
@@108608466954/CD Functional/JJ studies/NNS which/WDT introduced/VBD a/DT mutation/NN in/IN the/DT AP2/GENE core/NN binding/JJ region/NN as/RB well/VB as/IN cotransfection/NN experiments/NNS using/VBG an/DT AP2/GENE expression/NN vector/NN revealed/VBN that/IN AP2/GENE exerts/VBZ a/DT repressive/JJ role/NN on/IN the/DT HGF/MULTIGENE gene/MULTIGENE promoter/MULTIGENE activity/NN ./.
@@59332285822/CD Pigmentary/NNP rhythms/NNS as/IN indicators/NNS of/IN neurosecretion/NN ./.
@@94215167507/CD Deadenylation/NNS and/CC decay/NN of/IN beta-globin/MULTIGENE mRNA/MULTIGENE in/IN K562/NNP cells/NNS is/VBZ extraordinarily/RB slow/RB compared/VBN with/IN NIH/NN 3T3/CD cells/NNS ,/, suggesting/VBG that/IN the/DT increased/VBN stability/NN gained/VBN by/IN beta-globin/MULTIGENE mRNA/MULTIGENE in/IN K562/NNP cells/NNS is/VBZ mainly/RB controlled/VBN at/IN the/DT deadenylation/NN step/NN ./.
@@108460697674/CD Role/NN of/IN NH/NN (/NN 2/NN )/NN -/NN and/CC COOH-terminal/MULTIGENE domains/MULTIGENE of/IN the/DT P/MULTIGENE protein/MULTIGENE of/IN human/JJ parainfluenza/NN virus/NN type/NN 3/CD in/IN transcription/NN and/CC replication/NN ./.
@@77917719718/CD Otte/NNP ,/, Mol/JJ ./.
@@76090792178/CD Transactivation/NNS of/IN the/DT HIV-1/MULTIGENE LTR/MULTIGENE by/IN T3R/MULTIGENE alpha/MULTIGENE and/CC several/DT receptor/NN mutants/NNS revealed/VBN that/IN the/DT 50-amino-acid/JJ N-terminal/MULTIGENE A/MULTIGENE //MULTIGENE B/MULTIGENE region/MULTIGENE of/IN T3R/MULTIGENE alpha/MULTIGENE ,/, known/VBP to/IN interact/VB with/IN the/DT basal/MULTIGENE transcription/MULTIGENE factor/MULTIGENE TFIIB/MULTIGENE ,/, is/VBZ critical/JJ for/IN activation/NN of/IN both/DT Tat-dependent/NNP and/CC Tat-independent/MULTIGENE responsive/MULTIGENE sequences/MULTIGENE of/IN the/DT LTR/NN ./.
@@107125129134/CD Ste18p/GENE was/VBD targeted/VBN to/IN the/DT plasma/NN membrane/NN even/VB in/IN the/DT absence/NN of/IN prenylation/NN or/CC thioacylation/NN ./.
@@29862793703/CD 81/CD milk/NN samples/NNS collected/VBN from/IN 35/CD donors/NNS 3/CD days/NNS to/IN 7/CD months/NNS after/IN delivery/NN were/VBD examined/VBN for/IN the/DT occurrence/NN of/IN cytomegalovirus/NN (/( CMV/NN )/SYM ./.
@@86554979501/CD A/DT novel/JJ gene/NN designated/VBD cmr/NN ,/, which/WDT mapped/VBD to/IN 18/CD ./CD 8/CD min/NN of/IN the/DT Escherichia/NN coli/JJ K-12/GENE genome/NN ,/, was/VBD shown/VBP to/IN mediate/VB resistance/NN to/IN chloramphenicol/NN when/CC it/PRP was/VBD expressed/VBN from/IN a/DT multicopy/JJ vector/NN ./.
@@95982054101/CD Neither/CC the/DT reaction/NN of/IN monosaccharides/NNS nor/CC the/DT disaccharides/NNS with/IN beta-alanine/NN resulted/VBN in/IN the/DT formation/NN of/IN maltol/NN ./.
@@8689033003/CD Amikacin/NN was/VBD used/VBN in/IN the/DT treatment/NN of/IN 56/CD serious/JJ gram-negative/JJ infections/NNS in/IN 54/CD patients/NNS of/IN whom/WP 47/CD survived/VBN ./.
@@63881896190/CD Transplantation/NNP of/IN kidneys/NNS of/IN juvenile/JJ donors/NNS in/IN adult/JJ recipients/NNS ./.
@@36285324307/CD The/DT role/NN of/IN saliva/NN in/IN sour/JJ taste/NN perception/NN was/VBD investigated/VBN in/IN a/DT series/NN of/IN 4/CD experiments/NNS ./.
@@26033743261/CD Ventral/JJ rhinotomy/NN is/VBZ no/DT more/RB difficult/JJ than/IN dorsal/JJ rhinotomy/NN ,/, has/VBZ less/PRP patient/NN morbidity/NN and/CC fewer/DT postoperative/JJ complications/NNS ,/, and/CC is/VBZ more/RB cosmetically/RB acceptable/JJ ./.
@@39666874612/CD The/DT financial/JJ impact/NN of/IN childhood/NN asthma/NN has/VBZ not/RB been/VBN assessed/VBN since/IN Vance/NNP and/CC Taylor/NN reported/VBD their/PRP data/NN in/IN Annals/NNS of/IN Allergy/NNS 13/CD years/NNS ago/RB ./.
@@93793019332/CD 447/CD microns/NNS for/IN A/NNP ./NNP microcephalum/NN and/CC 350/CD microns/NNS for/IN A/NNP ./NNP wedli/NN )/NN ,/, and/CC fewer/DT testes/NNS per/IN proglottis/NN (/( 44-73/JJ vs/IN ./IN
@@34076764104/CD Primary/JJ infection/NN is/VBZ usually/RB managed/VBN conservatively/RB ./.
@@95701334453/CD In/NN addition/NN to/IN DNA-protein/JJ interactions/NNS ,/, protein-protein/JJ interactions/NNS with/IN partner/NN proteins/NNS often/RB play/VBP major/JJ roles/NNS in/IN targeting/MULTIGENE ETS-domain/MULTIGENE proteins/MULTIGENE to/IN specific/JJ promoters/NNS ./.
@@14066301479/CD Alignment/NNS of/IN the/DT selected/VBN sequences/NNS allowed/VBN us/PRP to/IN predict/VB a/DT consensus/NN sequence/NN for/IN binding/NN of/IN the/DT individual/JJ homodimeric/MULTIGENE Rel-related/MULTIGENE proteins/MULTIGENE ,/, and/CC DNA-protein/CONTEXTGENE binding/JJ analysis/NN of/IN the/DT selected/VBN DNA/NN sequences/NNS revealed/VBD sequence/NN specificity/NN of/IN the/DT proteins/NNS ./.
@@8683018663/CD In/NN diethyl/JJ ether/NN solution/NN the/DT main/JJ peak/NN is/VBZ that/IN of/IN 2-benzylidenamio-1-phenylpropane/JJ ,/, which/WDT has/VBZ a/DT retention/NN time/NN of/IN 23/CD ,/CD 2/CD minutes/NNS under/IN the/DT condition/NN delineated/VBN ./.
@@78244647798/CD On-line/NNP angioscopic/JJ images/NNS of/IN tissue/NN flaps/NN floating/JJ in/IN the/DT lumen/NN ,/, recent/JJ or/CC structured/JJ thrombi/NNS ,/, artery/NN wall/NN dissections/NNS ,/, plaque/NN ruptures/NNS ,/, deep/JJ fissurations/NNS and/CC sub-intimal/JJ haemorrhages/NNS demonstrate/VBP ,/, in/IN live/VB colour/NN ,/, the/DT pathophysiological/JJ mechanisms/NNS of/IN coronary/JJ artery/NN stenosis/NN ./.
@@92798896447/CD Area/NNP under/IN the/DT drug/NN concentration-time/NN curves/NNS (/( AUC0-24/NNS hr/NN )/SYM for/IN MTX/NN were/VBD 2379/CD and/CC 3534/CD ng*hr/GENE //GENE ml/GENE from/IN PG-2/GENE ./GENE 5%/GENE Azone/NNP and/CC PG-7/NNP ./NNP 5%/NNP Azone/NNP systems/NNS respectively/RB ./.
@@21337317871/CD From/IN S3/NN (/( CBF/NN :/: 79-60%/GENE )/SYM to/IN S5/NNS (/( CBF/NN :/: 39-0%/CD )/SYM ,/, %WTh/CONTEXTGENE ,/, 1/GENE //GENE TPC/GENE and/CC 1/CD //CD T/CD were/VBD significantly/RB decreased/VBN from/IN those/DT of/IN the/DT control/NN levels/NNS (/( all/DT p/NN less/PRP than/IN 0/CD ./CD 01/CD )/SYM ./.
@@7822329885/CD One/CD complex/NN appears/VBZ to/IN be/VB ubiquitous/JJ but/CC enriched/VBN in/IN lymphoid/JJ cells/NNS and/CC represents/VBZ the/DT binding/NN of/IN a/DT potentially/RB novel/JJ factor/NN with/IN an/DT apparent/JJ molecular/JJ mass/NN of/IN approximately/RB 50/CD kDa/NN ./.
@@91993483650/CD With/IN a/DT view/NN to/IN identifying/JJ other/DT important/JJ U14/GENE interactions/NNS ,/, a/DT stem-loop/NN domain/NN required/VBN for/IN activity/NN of/IN Saccharomyces/NN cerevisiae/NN U14/MULTIGENE RNAs/MULTIGENE (/( the/DT Y/NN domain/NN )/SYM was/VBD first/RB subjected/VBN to/IN detailed/JJ mutational/JJ analysis/NN ./.
@@78520378877/CD The/DT newly/RB devised/VBN DCT/NNS method/NN yields/NNS reliable/JJ data/NN in/IN measuring/JJ TBF/GENE ./.
@@43643694479/CD Pre-beta-1/MULTIGENE lipoprotein/MULTIGENE and/CC early/JJ detection/NN of/IN risk/NN factors/NNS for/IN coronary/JJ heart/NN disease/NN ./.
@@40334025707/CD We/PRP conclude/VBP that/IN androgenic/JJ hormones/NNS reduce/VBP HDL-cholesterol/VBG concentrations/NNS and/CC the/DT HDL2-cholesterol/NNP subfraction/NN ,/, possibly/RB by/IN enhancing/JJ hepatic/JJ triglyceride/MULTIGENE lipase/MULTIGENE activity/NN ./.
@@30675053781/CD Thus/RB ,/, prostacyclin/NN enhanced/VBD the/DT autoregulative/JJ property/NN of/IN the/DT inner/JJ ear/NN vessels/NNS ./.
@@74785235801/CD In/NN addition/NN to/IN the/DT nine/JJ and/CC 51/CD terminal/JJ amino/JJ acid/NN forms/NNS already/RB known/VBP ,/, we/PRP identified/VBD a/DT third/RB with/IN 43/CD terminal/JJ amino/JJ acids/NNS predicted/VBN to/IN encode/VB a/DT novel/JJ RET/MULTIGENE protein/MULTIGENE isoform/MULTIGENE ./.
@@88102789417/CD Here/RB we/PRP demonstrate/VBP that/IN another/DT cellular/JJ protein/NN linked/JJ to/IN BCR/GENE //GENE ABL/GENE through/RB the/DT CRKL-SH2/GENE domain/NN is/VBZ p130/NN (/NN CAS/NN )/NN ./. p130/NN (/NN CAS/NN )/NN was/VBD found/VBN to/IN be/VB tyrosine/NN phosphorylated/VBN and/CC associated/VBN with/IN CRKL/NNP in/IN BCR/NNP //NNP ABL/NNP expressing/JJ cell/NN lines/NNS and/CC in/IN samples/NNS obtained/VBN from/IN CML/NN and/CC ALL/NN patients/NNS ,/, but/CC not/RB in/IN samples/NNS from/IN controls/NNS ./.
@@85206468490/CD Embryo/NN coculture/VB system/NN may/MD contribute/VB to/IN understand/VB the/DT mechanisms/NNS underlying/JJ the/DT decrease/NN of/IN fertility/NN with/IN aging/NN ./.
@@91682185645/CD METHODS/IN :/: The/DT responses/NNS of/IN a/DT 31-year-old/JJ woman/NN with/IN complex/MULTIGENE regional/MULTIGENE pain/NN syndrome/MULTIGENE type/MULTIGENE I/MULTIGENE (/( reflex/NN sympathetic/JJ dystrophy/NN )/SYM to/IN a/DT thermal/JJ grill/NN were/VBD evaluated/VBN before/IN and/CC after/IN stellate/JJ ganglion/NN block/NN ./.
@@399921921/CD Ultrastructure/NNS of/IN the/DT tumor/NN in/IN 1/CD patient/NN in/IN whom/WP transurethral/JJ resection/NN was/VBD performed/VBN 2/CD weeks/NNS after/IN alum/NN irrigation/NN revealed/VBN well/VB preserved/VBN nuclear/MULTIGENE chromatin/MULTIGENE ,/, thus/RB ,/, suggesting/VBG that/IN whatever/WDT changes/NNS occur/VBP after/IN alum/NN irrigation/NN are/VBP short-lived/JJ ./.
@@80241398023/CD In/NN addition/NN ,/, we/PRP sought/VBP to/IN test/NN the/DT hypothesis/NN that/IN ,/, when/CC equal/VB volumes/NNS are/VBP administered/VBN intrathecally/RB ,/, significant/JJ differences/NNS exist/VBP in/IN the/DT potential/NN to/IN three/CD commonly/RB used/VBN anesthetic/JJ solutions/NNS to/IN induce/VB sensory/JJ impairment/NN ./.
@@87493948964/CD In/NN vitro/FW interaction/NN studies/NNS ,/, using/VBG proteins/NNS fused/VBN to/IN glutathione-S-transferase/NN ,/, showed/VBD that/IN RBP-J/MULTIGENE kappa/MULTIGENE and/CC Su/NN (/NN H/NN )/NN bind/VB directly/RB to/IN the/DT RAM23/MULTIGENE regions/MULTIGENE of/IN mouse/MULTIGENE Notch1/MULTIGENE and/CC Drosophila/NN Notch/IN ,/, respectively/RB ./.
@@79169833802/CD It/PRP is/VBZ concluded/VBN that/DT CT/NN should/MD be/VB routinely/RB employed/VBN in/IN patients/NNS with/IN N1-N3/GENE neck/NN disease/NN to/IN determine/VB the/DT proper/JJ electron-energy/JJ prescription/NN ./.
@@64435506245/CD The/DT management/NN of/IN the/DT "chronic"/NN patient/NN ./.
@@16278285304/CD In/NN agreement/NN with/IN this/DT southern/JJ blotting/NN of/IN mouse/NN DNA/NN with/IN SmN/GENE probes/NNS reveals/VBZ bands/NNS ,/, additional/JJ to/IN those/DT derived/VBN from/IN the/DT pseudogene/NN ,/, which/WDT are/VBP characteristic/NN of/IN an/DT intron-containing/MULTIGENE SmN/MULTIGENE gene/MULTIGENE ./.
@@22470816748/CD Interestingly/RB ,/, disruption/NN of/IN the/DT VPS34/MULTIGENE locus/MULTIGENE resulted/VBN in/IN a/DT temperature-sensitive/JJ growth/NN defect/NN ,/, indicating/VBG that/IN the/DT VPS34/MULTIGENE gene/MULTIGENE is/VBZ essential/JJ for/IN vegetative/JJ growth/NN only/RB at/IN elevated/VBN growth/NN temperatures/NNS ./.
@@111564135422/CD Derivation/NNS and/CC initial/JJ characterization/NN of/IN a/DT mouse/NN mammary/JJ tumor/NN cell/NN line/NN carrying/JJ the/DT polyomavirus/NN middle/JJ T/NN antigen/NN :/: utility/NN in/IN the/DT development/NN of/IN novel/JJ cancer/NN therapeutics/NN ./.
@@17178333294/CD Regulation/NN of/IN the/DT alpha/MULTIGENE inhibin/MULTIGENE gene/MULTIGENE by/IN cyclic/JJ adenosine/NN 3'/CD ,/CD 5'-monophosphate/CD after/IN transfection/NN into/IN rat/NN granulosa/NN cells/NNS ./.
@@10962881786/CD Multiparity/GENE had/VBP a/DT protective/JJ effect/NN with/IN 0/CD ./CD 66/CD less/PRP risk/NN (/( 95%/CD CI/NN 0/CD ./CD 44-0/CD ./CD 99/CD )/SYM ./.
@@98030819772/CD Renal/JJ pathology/NN and/CC long-term/JJ outcome/NN in/IN childhood/NN SLE/NN ./.
@@20160533736/CD Amino/NN acid/NN sequence/NN comparisons/NNS of/IN the/DT E74A/MULTIGENE protein/MULTIGENE reveal/VB a/DT highly/RB conserved/VBN C-terminal/MULTIGENE region/MULTIGENE that/WDT is/VBZ rich/JJ in/IN basic/JJ amino/JJ acid/NN residues/NNS and/CC which/WDT has/VBZ been/VBN proposed/VBN to/IN possess/VB sequence-specific/MULTIGENE DNA/MULTIGENE binding/JJ activity/NN ./.
@@50959885368/CD Conservative/NNP treatment/NN of/IN central/JJ nervous/JJ system/NN injuries/NNS ./.
@@2631566176/CD Alkoxymetgyl-3/GENE ,/GENE 4-dimethylpyridinium/GENE chlorides/NNS were/VBD synthetized/VBN by/IN reacting/VBG 3/JJ ,/JJ 4-dimethylpyridine/JJ with/IN chloromethyl/JJ alkyl/NN ethers/NNS ,/, while/CC 1-ethyloxymethyl-3-alkylthiomethylimidazolium/JJ chlorides/NNS were/VBD obtained/VBN in/IN reactions/NNS of/IN 1-ethyloxymethylimidazol/JJ with/IN chloromethyl/JJ alkyl/NN sulfides/NNS ./.
@@90805179027/CD Thirty-five/CD patients/NNS were/VBD included/VBN ./.
@@176742439/CD Polyglactin/MULTIGENE 910/MULTIGENE suture/NN absorption/NN and/CC the/DT role/NN of/IN cellular/JJ enzymes/NNS ./.
@@86478027444/CD A/DT human/MULTIGENE cytoplasmic/MULTIGENE signaling/MULTIGENE protein/MULTIGENE has/VBZ been/VBN cloned/VBN that/WDT possesses/VBZ the/DT same/JJ structural/JJ arrangement/NN of/IN SH3-SH2-SH3/MULTIGENE domains/MULTIGENE as/IN Grb2/GENE ./.
@@112218457507/CD The/DT Genescan/NNP program/NN predicted/VBD an/DT open/JJ reading/JJ frame/NN of/IN a/DT novel/NN ,/, intron-less/JJ gene/NN adjacent/JJ to/IN the/DT B236/GENE spot/NN that/IN encodes/VBZ a/DT putative/JJ 493-amino/CD acid/NN protein/NN containing/JJ the/DT SNAG/MULTIGENE repressor/MULTIGENE motif/MULTIGENE in/IN the/DT NH2-terminal/MULTIGENE region/MULTIGENE and/CC five/CD C2H2-type/MULTIGENE zinc/MULTIGENE finger/MULTIGENE motifs/MULTIGENE in/IN the/DT COOH-terminal/NN half/NN ./.
@@16572467850/CD The/DT transcription/NN initiation/NN site/NN was/VBD determined/VBN to/IN occur/VB 66/CD bp/NN upstream/RB of/IN the/DT initiating/JJ Met/NNP ./.
@@96210625086/CD The/DT importance/NN of/IN these/DT sites/NNS for/IN transcriptional/JJ activation/NN was/VBD studied/VBN by/IN site-directed/JJ mutagenesis/NN followed/VBN by/IN promoter/NN function/NN analysis/NN of/IN the/DT mutants/NNS with/IN a/DT chloramphenicol/NN acetyltransferase/NN reporter/NN system/NN ./.
@@78352734403/CD After/IN selection/NN and/CC conversion/NN to/IN adipocytes/NNS ,/, the/DT level/NN of/IN EGFR/NN expression/NN was/VBD retained/VBN in/IN infectant/JJ adipocytes/NNS (/( 150/CD ,/CD 000/CD and/CC 250/CD ,/CD 000/CD //CD cell/CD ,/, respectively/RB )/SYM ,/, but/CC not/RB in/IN the/DT parental/JJ 3T3-L1/CD adipocytes/NNS (/( </SYM 5000/GENE //GENE cell/GENE )/SYM ./.
@@81941399435/CD CONCLUSIONS/IN :/: Serum/NN prolactin/NEWGENE concentrations/NNS show/VBP age/NN related/VBD variations/NNS in/IN presumably/RB fertile/JJ men/NNS ./.
@@83097268285/CD To/TO gain/VB further/JJ insight/NN into/IN the/DT pathogenesis/NN of/IN the/DT adult/JJ respiratory/JJ distress/NN syndrome/NN (/( ARDS/NNS )/SYM ,/, the/DT authors/NNS studied/VBD possible/JJ relationships/NNS among/IN the/DT activation/NN status/NN of/IN circulating/JJ polymorphonuclear/JJ neutrophils/NNS (/( PMN/NN )/SYM ,/, cytokine/NN levels/NNS ,/, and/CC the/DT severity/NN of/IN lung/NN injury/NN in/IN 31/CD patients/NNS :/: 15/CD with/IN ARDS/NNS ,/, 9/CD with/IN severe/JJ pneumonia/NN uncomplicated/JJ by/IN ARDS/NNS ,/, and/CC 7/CD mechanically/RB ventilated/VBN patients/NNS with/IN neither/DT ARDS/NNS nor/CC pneumonia/NN ./.
@@77907194978/CD There/EX is/VBZ a/DT national/JJ effort/NN to/IN begin/VB to/IN ask/VB all/DT female/JJ patients/NNS about/JJ family/NN violence/NN ./.
@@75996538279/CD In/NN addition/NN ,/, we/PRP found/VBP differences/NNS in/IN the/DT binding/NN of/IN nuclear/JJ factors/NNS from/IN shoots/NNS versus/IN from/IN roots/NNS ,/, in/IN agreement/NN with/IN the/DT different/JJ activities/NNS of/IN the/DT promoter/NN in/IN these/DT two/JJ organs/NNS ./.
@@58927125793/CD (/( 3/CD )/SYM ./.
@@13840407550/CD Interestingly/RB ,/, this/DT activation/NN occurred/VBN only/RB when/CC the/DT regions/NNS were/VBD cloned/VBN in/IN the/DT same/JJ relative/JJ orientation/NN in/IN which/WDT they/PRP exist/VBP on/IN wild-type/MULTIGENE pCF10/MULTIGENE ./.
@@17481942339/CD When/WRB both/DT lesions/NNS were/VBD complete/JJ lateral/JJ hemisections/NNS in/IN weanling/NN operates/VBZ ,/, little/JJ behavioral/JJ recovery/NN was/VBD observed/VBN ,/, similar/JJ to/IN complete/JJ spinal/JJ cord/NN transection/NN (/( N/JJ =/SYM 3/CD )/SYM ./SYM
@@15270206654/CD Exon-intron/NNP junctions/NNS in/IN the/DT human/NN and/CC rat/MULTIGENE AdoMet/MULTIGENE decarboxylase/MULTIGENE genes/MULTIGENE were/VBD in/IN identical/JJ positions/NNS except/VBP that/IN exons/NNS 6/CD and/CC 7/CD of/IN the/DT human/JJ gene/NN formed/VBD a/DT single/JJ exon/NN in/IN the/DT rat/NN gene/NN ./.
@@67559866519/CD Multiresistant/NNP strains/NNS isolated/VBN from/IN humans/NNS in/IN enteral/JJ toxico-infections/NNS kill/NN orally/RB infected/VBD mice/NNS more/RB frequently/RB than/IN strains/NNS isolated/VBN in/IN hospital/NN infections/NNS ./.
@@60128275871/CD Pharmacodynamic/NN studies/NNS on/IN the/DT cardiovascular/JJ system/NN of/IN spontaneously/RB hypertensive/JJ rats/NNS ./.
@@117144291557/CD Is/VBZ clopidogrel/NN superior/JJ to/IN aspirin/NN in/IN secondary/JJ prevention/NN of/IN vascular/JJ disease/NN ?/. The/DT cornerstone/NN in/IN clinical/JJ evidence/NN of/IN the/DT relative/JJ efficacy/NN of/IN thienopyridines/NNS (/( clopidogrel/NN ,/, ticlopidine/NN )/SYM versus/IN aspirin/NN in/IN the/DT secondary/JJ prevention/NN of/IN vascular/JJ disease/NN is/VBZ the/DT Clopidogrel/NNP versus/IN Aspirin/NNP in/IN Patients/NNS at/IN Risk/NN of/IN Ischaemic/NNP Events/NNS trial/NN ./.
@@94250369206/CD In/NN addition/NN ,/, a/DT catalytically/RB inactive/JJ version/NN of/IN the/PDT Src/MULTIGENE family/MULTIGENE member/MULTIGENE ,/, Lck/CONTEXTGENE (/( lymphoid/MULTIGENE cell/MULTIGENE kinase/MULTIGENE )/SYM ,/, was/VBD expressed/VBN ,/, purified/VBN ,/, and/CC evaluated/VBD as/IN a/DT Csk/NNP substrate/NN ./.
@@3004982984/CD The/DT N-terminal/MULTIGENE sequence/MULTIGENE of/IN one/PRP hydrophilic/JJ peptide/NN of/IN the/DT FeS/MULTIGENE protein/MULTIGENE has/VBZ been/VBN also/RB obtained/VBN confirming/VBG the/DT fbcF/GENE reading/JJ frame/NN ./.
@@96984576525/CD The/DT mutant/JJ protein/NN is/VBZ present/VB at/IN levels/NNS slightly/RB greater/JJR than/IN wild-type/NN ,/, but/CC exhibits/VBP the/DT same/JJ tissue/NN distribution/NN as/IN wild-type/MULTIGENE protein/MULTIGENE ,/, and/CC has/VBZ approximately/RB normal/JJ affinity/NN for/IN known/VBP target/NN sequences/NNS (/( though/CC no/DT DNA/NN targets/NNS identified/VBN to/IN date/NN require/VB the/DT first/JJ cut/JJ repeat/NN for/IN binding/JJ )/SYM ./.
@@30168833999/CD 13/CD men/NNS with/IN a/DT history/NN of/IN recurrent/JJ genital/JJ herpes/NN simplex/JJ virus/NN type/NN 2/CD (/( HSV-2/GENE )/SYM infection/NN were/VBD followed/VBN daily/JJ for/IN 4/CD weeks/NNS with/IN samples/NNS taken/VBP from/IN the/DT urethra/NN for/IN virus/NN isolation/NN ./.
@@93807075841/CD Furthermore/RB ,/, DNA-bound/NNP LAZ3/GENE //GENE BCL6/GENE recruits/NNS SMRT/GENE in/IN vivo/NN ,/, and/CC both/DT overexpressed/VBN proteins/NNS completely/RB colocalize/VBP in/IN nuclear/JJ dots/NNS ./.
@@104912139240/CD Serum/NN concentrations/NNS of/IN bone/NN specific/NN alkaline/NN phosphatase/NN (/( BALP/NN )/SYM and/CC osteocalcin/NN (/( bone/NN Gla/NN protein/NN ,/, BGP/NN )/SYM ,/, urinary/JJ levels/NNS of/IN pyridinoline/NN (/( Pyr/NN )/SYM and/CC deoxypyridinoline/NN (/( Dpyr/NNP )/SYM and/CC computed/JJ tomography/NN (/( CT/NN )/SYM measurements/NNS of/IN the/DT cross-sectional/JJ areas/NNS of/IN the/DT vertebrae/NNS and/CC the/DT femurs/NNS ,/, the/DT apparent/JJ density/NN of/IN cancellous/JJ bone/NN in/IN the/DT vertebrae/NNS ,/, and/CC the/DT volume/NN and/CC the/DT material/NN density/NN of/IN cortical/JJ bone/NN in/IN the/DT femurs/NNS were/VBD determined/VBN in/IN 126/CD boys/NNS and/CC 143/CD girls/NNS ,/, ages/VBZ 7-18/JJ years/NNS ./.
@@6014013620/CD Such/JJ an/DT hemoglobin/NN solution/NN was/VBD shown/VBP to/IN exhibit/NN a/DT high/JJ affinity/NN for/IN oxygen/NN and/CC a/DT low/JJ Bohr/JJ effect/NN (/( assessed/VBN from/IN the/DT delta/JJ log/NN Po2/MULTIGENE //MULTIGENE delta/MULTIGENE pH/MULTIGENE ratio/NN )/SYM ./.
@@30210884118/CD The/DT latent/JJ periods/NNS from/IN the/DT antral/JJ exclusion/NN to/IN the/DT occurrence/NN of/IN anastomotic/JJ ulcers/NNS after/IN a/DT subtotal/JJ gastrectomy/NN with/IN Billroth's/NNP type/MULTIGENE II/MULTIGENE reconstruction/NN varied/VBN from/IN a/DT few/JJ days/NNS to/IN 19/CD years/NNS ,/, with/IN an/DT average/NN of/IN 2/CD ./CD 8/CD years/NNS ./.
@@86831085985/CD Consistent/JJ with/IN this/DT interpretation/NN ,/, recombinant/JJ CREB/NEWGENE and/CC activating/MULTIGENE transcription/MULTIGENE factor/MULTIGENE proteins/MULTIGENE bound/VBD the/DT junB/MULTIGENE CRE-like/MULTIGENE site/MULTIGENE ,/, but/CC did/VBD not/RB interact/VB with/IN a/DT mutant/MULTIGENE CRE-like/MULTIGENE site/MULTIGENE ./.
@@77205723166/CD However/RB ,/, a/DT clear/JJ difference/NN exists/VBZ between/IN myoblasts/NNS and/CC 10T1/CD //CD 2/CD cells/NNS (/( and/CC other/DT non-muscle/JJ cell/NN types/NNS )/SYM in/IN the/DT chromatin/NN structure/NN of/IN the/DT chromosomal/MULTIGENE myoD/MULTIGENE core/NN enhancer/NN ,/, suggesting/VBG that/IN the/DT myoD/MULTIGENE enhancer/MULTIGENE is/VBZ repressed/VBN by/IN epigenetic/JJ mechanisms/NNS in/IN 10T1/CD //CD 2/CD cells/NNS ./.
@@60278416145/CD Nuclear/NNP spin/NEWGENE of/IN 249Bk/CD from/IN the/DT hyperfine/JJ structure/NN in/IN its/PRP emission/NN spectrum/NN ./.
@@100228807047/CD Mammalian/JJ Ras/NEWGENE GTPase-activating/JJ protein/NN (/( GAP/NNP )/SYM ,/, p120/MULTIGENE Ras-GAP/MULTIGENE ,/, has/VBZ been/VBN implicated/VBN as/IN both/PDT a/DT downregulator/NN and/CC effector/NN of/IN Ras/MULTIGENE proteins/MULTIGENE ,/, but/CC its/PRP precise/JJ role/NN in/IN Ras-mediated/JJ signal/JJ transduction/NN pathways/NNS is/VBZ unclear/JJ ./.
@@118881831784/CD A/DT further/JJ analysis/NN has/VBZ been/VBN performed/VBN using/VBG the/DT series/NN of/IN maximum/JJ intensity/NN for/IN fixed/JJ duration/NN (/( 1/CD ,/, 3/CD ,/, 6/CD ,/, 12/CD ,/, 24/CD hrs/NN )/SYM and/CC annual/JJ daily/JJ maxima/NNS ./.
@@108912662979/CD ACE-2/GENE has/VBZ a/DT hydrophobic/MULTIGENE C/MULTIGENE terminus/NN of/IN H/NN type/NN ./.
@@103642021995/CD The/DT coexpression/NN of/IN full-length/JJ expression/NN constructs/NNS for/IN both/DT DBP/NN and/CC hepatic/JJ leukemia/MULTIGENE factor/MULTIGENE resulted/VBN in/IN a/DT dramatic/JJ increase/NN in/IN activation/NN mediated/JJ by/IN the/DT GAL4-DBP/MULTIGENE fusion/MULTIGENE proteins/MULTIGENE ,/, suggesting/VBG the/DT involvement/NN of/IN a/DT regulated/MULTIGENE coactivator/MULTIGENE in/IN this/DT process/NN ./.
@@107216985500/CD These/DT data/NN indicate/VB that/DT expansion/NN of/IN the/DT dodecamer/NN repeat/NN located/VBN in/IN the/DT proximal/JJ promoter/NN of/IN CSTB/GENE severely/RB disrupts/VBZ the/DT function/NN of/IN the/DT promoter/NN and/CC thereby/RB reduces/VBZ transcription/NN of/IN CSTB/GENE ./.
@@8183805747/CD Rheumatoid/MULTIGENE factor/MULTIGENE and/CC antinuclear/JJ antibody/NN tests/NNS were/VBD frequently/RB positive/JJ ,/, and/CC reactions/NNS to/IN gold/NN therapy/NN were/VBD more/RB frequent/VB than/IN in/IN other/DT rheumatoid/JJ populations/NNS ./.
@@94070319838/CD Moreover/RB ,/, moderate/JJ overexpression/NN of/IN Chk1/GENE suppresses/VBZ the/DT phenotypes/NNS of/IN cut5/GENE and/CC crb2/MULTIGENE mutants/MULTIGENE ./.
@@95625581187/CD Solution/NNP structure/NN of/IN the/DT IRF-2/GENE DNA-binding/NN domain/NN :/: a/DT novel/JJ subgroup/NN of/IN the/DT winged/JJ helix-turn-helix/NN family/NN ./.
@@108012448179/CD Vancomycin/GENE data/NN were/VBD analyzed/VBN according/VBG to/IN a/DT one-compartment/JJ open/JJ model/NN with/IN use/NN of/IN NONMEM/DT population/NN pharmacokinetic/JJ software/NN ./.
@@8245125224/CD Addition/NN of/IN phalloidin-stabilized/JJ F-actin/NN nuclei/NNS and/CC phalloidin/NN restored/VBN L266D/NNP actin's/NNS ability/NN to/IN polymerize/VB at/IN 4/CD degrees/NNS C/NNP ./NNP
@@111223812167/CD Addition/NN of/IN synthetic/JJ tyrosine-phosphorylated/JJ peptides/NNS derived/VBN from/IN betac/JJ cytoplasmic/JJ tyrosines/NNS prior/NN to/IN GM-CSF/NNP stimulation/NN inhibited/VBD the/DT in/NN vitro/FW activation/NN of/IN STAT5/GENE ./.
@@115455947610/CD Thus/RB ,/, while/CC the/DT folds/NNS of/IN all/DT Myb/MULTIGENE domains/MULTIGENE resemble/VBP each/DT other/DT closely/RB ,/, the/DT function/NN of/IN each/DT Myb/GENE domain/NN depends/VBZ on/IN the/DT amino/JJ acid/NN residues/NNS that/WDT are/VBP located/VBN on/IN the/DT surface/NN of/IN each/DT protein/NN ./.
@@22374314584/CD The/DT Ets-1/MULTIGENE binding/MULTIGENE site/MULTIGENE was/VBD localized/VBN to/IN a/DT 17-base/JJ pair/NN (/( bp/NN )/SYM region/NN from/IN the/DT 3'/CD end/NN of/IN T/MULTIGENE alpha/MULTIGENE 2/CD ./CD
@@97904999732/CD Northern/NNP blot/NN analyses/NNS show/VBP that/IN the/DT hBub1/MULTIGENE mRNA/MULTIGENE level/NN is/VBZ abundantly/RB expressed/VBN in/IN tissues/NNS or/CC cells/NNS with/IN a/DT high/JJ mitotic/JJ index/NN ./.
@@105942398883/CD A/DT novel/JJ pleckstrin/MULTIGENE homology-related/MULTIGENE gene/MULTIGENE family/MULTIGENE defined/VBN by/IN Ipl/GENE //GENE Tssc3/GENE ,/, TDAG51/GENE ,/, and/CC Tih1/GENE :/: tissue-specific/JJ expression/NN ,/, chromosomal/JJ location/NN ,/, and/CC parental/JJ imprinting/NN ./.
@@10607900386/CD Sak/MULTIGENE kinase/MULTIGENE gene/MULTIGENE structure/NN and/CC transcriptional/JJ regulation/NN ./.
@@30291115021/CD Two/CD mutants/NNS ,/, each/DT representative/NN of/IN a/DT separate/JJ pet/NN complementation/NN group/NN ,/, have/VB been/VBN analyzed/VBN ./.
@@23947188670/CD The/DT cloned/VBN genes/NNS were/VBD identified/VBN in/IN genetic/JJ libraries/NNS by/IN hybridization/NN screening/JJ using/VBG four/CD deoxyoligonucleotide/NN probes/NNS which/WDT corresponded/VBD to/IN the/DT partial/JJ amino/JJ acid/NN sequence/NN of/IN the/DT purified/VBN enzyme/NN ./.
@@11097040930/CD The/DT objectives/NNS of/IN the/DT present/NN study/NN were/VBD to/IN evaluate/VB the/DT effects/NNS of/IN adding/JJ Equex/NN to/IN a/DT TRIS-extender/NNP ,/, diluting/JJ the/DT semen/NN in/IN 1/CD or/CC 2/CD steps/NNS ,/, freezing/NN according/VBG to/IN 2/CD methods/NNS ,/, thawing/NN at/IN 2/CD rates/NNS ,/, and/CC the/DT interactions/NNS between/IN these/DT treatments/NNS ,/, on/IN the/DT post-thaw/NN survival/NN of/IN dog/NN spermatozoa/NNS at/IN 38/CD degrees/NNS C/NNP ./NNP
@@86692741088/CD Stylohyoid/NN chain/NN ossification/NN :/: choice/NN of/IN the/DT surgical/JJ approach/NN ./.
@@84545919116/CD The/DT region/NN that/WDT imparts/VBZ inducibility/NN by/IN IL-1/NEWGENE or/CC TNF/NN (/( positions/NNS -165/CD to/IN -58/NN )/SYM contains/VBZ potential/JJ binding/JJ sites/NNS for/IN IRF-1/GENE and/CC -2/NN ,/, AP-1/GENE ,/, and/CC NF-IL-6/CONTEXTGENE ./.
@@90582505037/CD To/TO avoid/VB complications/NNS ,/, accurate/JJ quantitative/JJ analysis/NN of/IN NO/DT and/CC NO2/GENE is/VBZ necessary/JJ during/IN this/DT therapy/NN ./.
@@96455769614/CD RNA/NN of/IN GBV-C/GENE was/VBD detected/VBN in/IN 14/CD (/( 18%/JJ )/SYM patients/NNS before/IN BMT/NN ./.
@@102233385865/CD In/NN addition/NN ,/, we/PRP also/RB constructed/VBD and/CC expressed/VBN chimeric/JJ fusion/NN protein/NN that/WDT contains/VBZ HIV-2/MULTIGENE gag/MULTIGENE with/IN V3/MULTIGENE domains/MULTIGENE of/IN HIV-1IIIB/GENE ,/, HIV-1MN/GENE ,/, HIV-1SF2/GENE and/CC HIV-1RF/GENE ./.
@@87507029801/CD Study/NNP groups/NNS were/VBD control/NN ,/, and/CC those/DT treated/VBN with/IN the/DT alpha1-adrenoceptor-subtype/JJ blockers/NNS WB4101/GENE (/( 0/CD ./CD 5/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM or/CC chloroethylclonidine/NN (/( 1/CD ./CD 9/CD mg/CD //CD kg/CD i/CD ./CD v/CD ./CD )/SYM ./.
@@75047126895/CD These/DT observations/NNS link/NN actin/NN plaque/NN assembly/NN to/IN increased/VBN cell/NN substrate/NN adhesion/NN ./.
@@79571067696/CD These/DT mutations/NNS are/VBP localized/VBN in/IN the/DT same/JJ region/NN where/CC the/DT HSV/MULTIGENE transactivator/MULTIGENE VP16/MULTIGENE binds/VBZ ,/, but/CC did/VBD not/RB coincide/VB with/IN the/DT VP16/NN contacts/NNS ./.
@@64528273249/CD Statokinesimetric/GENE recording/JJ in/IN Huntington/NN choreas/NNS ./.
@@61651329881/CD An/DT experiment/NN was/VBD carried/VBN on/IN 133/CD grown/VBP up/JJ fowls/NNS and/CC broilers/NNS from/IN 4/CD industrial/JJ farms/NNS ,/, vaccinated/VBN with/IN spray/NN lento/NN and/CC mesogenic/JJ vaccines/NNS for/IN straining/JJ the/DT immunity/NN against/IN pseodopest/JJS through/RB RIHA/GENE and/CC provoking/JJ pseudoplague/NN with/IN a/DT pathogenic/JJ virus/NN ./.
@@110500844314/CD This/DT -2485/JJ //JJ -2458/JJ element/NN bound/JJ PPARalpha/NEWGENE and/CC PPARgamma/NN from/IN brown/JJ fat/JJ nuclei/NNS ./.
@@67406976506/CD The/DT results/NNS showed/VBN that/IN the/DT sensitivity/NN of/IN the/DT 3/CD given/NN guinea/NN pig/NN strains/NNS was/VBD comparable/JJ ./.
@@84032458365/CD Plasma/NN thromboxane/MULTIGENE B2/MULTIGENE levels/NNS in/IN the/DT older/JJR group/NN were/VBD about/RB double/VB those/DT in/NN younger/JJR piglets/NNS ./.
@@86764958964/CD However/RB ,/, one/PRP 3'/CD splice/NN site/NN ,/, located/VBN at/IN nucleotide/NN (/( nt/NN )/SYM 3225/CD ,/, is/VBZ used/VBN for/IN the/DT processing/NN of/IN most/RB BPV-1/MULTIGENE pre-mRNAs/MULTIGENE in/IN BPV-1-transformed/NNP C127/NNP cells/NNS and/CC at/IN early/RB to/IN intermediate/JJ times/NNS in/IN productively/RB infected/VBN warts/NNS ./.
@@43871034954/CD Particles/NNS resembling/VBG microbodies/NNS in/IN normal/JJ and/CC neoplastic/JJ perianal/JJ glands/NNS of/IN dogs/NNS ./.
@@10564495337/CD In/NN addition/NN ,/, all/DT three/CD Opa/MULTIGENE proteins/MULTIGENE of/IN C751/GENE bind/NN equally/RB well/VB to/IN HeLa/DT cells/NNS transfected/VBN with/IN cDNA/NN encoding/VBG the/DT carcinoembryonic/JJ antigen/NN [/NN CEA/NN (/( CD66e/NNP )/NN ]/NN subgroup/NN of/IN the/DT CD66/MULTIGENE family/MULTIGENE ,/, but/CC show/VB distinct/JJ tropism/NN for/IN CGM1-/NNP (/( CD66d/NNP )/SYM and/CC NCA/NN (/( CD66c/NNP )/NN -expressing/NN cells/NNS ./.
@@26344901694/CD The/DT differential/JJ diagnosis/NN of/IN both/DT affections/NNS is/VBZ based/VBN on/IN the/DT clinical/JJ course/NN ,/, sialography/NN and/CC CT/NN examination/NN which/WDT along/IN with/IN modern/JJ ATB/NN treatment/NN significantly/RB modify/VB hitherto/RB used/VBN surgical/JJ therapy/NN ./.
@@78184167797/CD The/DT pre-/JJ and/CC postoperative/JJ haemoglobin/NN concentrations/NNS in/IN the/DT autologous/JJ group/NN were/VBD lower/JJR by/IN 15/CD and/CC 10/CD g/NN //NN L/NN ,/, respectively/RB ,/, after/IN primary/MULTIGENE THR/MULTIGENE and/CC by/IN 10/CD g/NN //NN L/NN in/IN both/DT instances/NNS after/IN revision/NN THR/NNP ./.
@@95841804497/CD The/DT same/JJ IL-4-inducible/NNP reporter/NN gene/NN is/VBZ also/RB synergistically/RB activated/VBN by/IN the/DT endogenous/JJ Stat6/GENE and/CC NF-kappaB/MULTIGENE proteins/MULTIGENE in/IN IL-4-stimulated/JJ I/CD ./CD 29mu/CD B/NNP lymphoma/NN cells/NNS ./.
@@9952378966/CD The/DT odds/NNS ratio/NN for/IN CHD/NN was/VBD 1/CD ./CD 21/CD (/( 95%/CD confidence/NN interval/NN ,/, 0/CD ./CD 84-1/CD ./CD 75/CD )/SYM given/VBP a/DT positive/JJ serostatus/NN of/IN specific/MULTIGENE IgG/MULTIGENE antibodies/NNS after/IN adjustment/NN for/IN covariates/NNS ./.
@@108556908881/CD Taken/VBN together/RB ,/, these/DT results/NNS indicate/VBP that/DT MAP/MULTIGENE kinase/MULTIGENE stimulates/VBZ the/DT hPL-B/MULTIGENE enhancer/MULTIGENE by/IN an/DT NF-IL-6-dependent/NNP pathway/NN ./.
@@104280913299/CD This/DT report/NN presents/VBP state-specific/NN MMRs/NN for/IN 1987-1996/CD ,/, focusing/NN on/IN persistent/JJ disparities/NNS in/IN maternal/JJ mortality/NN between/IN black/JJ and/CC white/JJ women/NNS ./.
@@75886039682/CD The/DT results/NNS indicate/VBP considerable/JJ flexibility/NN in/IN the/DT spacing/NN between/IN DH/MULTIGENE regulatory/MULTIGENE sites/MULTIGENE ./.
@@118706461761/CD The/DT utility/NN of/IN such/JJ analyses/NNS in/IN the/DT design/NN of/IN ceramic/JJ //JJ substrate/JJ bilayer/JJ systems/NNS for/IN optimal/JJ resistance/NN to/IN lifetime-threatening/JJ damage/NN is/VBZ discussed/VBN ./.
@@2231479247/CD Each/DT parent/NN interacted/VBN with/IN their/PRP 4-/CD or/CC 5-year-old/CD son/NN or/CC daughter/JJ in/IN each/DT of/IN two/JJ conversations--unstructured/JJ (/( social/JJ conversation/NN )/SYM and/CC structured/JJ (/( task/NN activity/NN )/SYM ./.
@@76665237147/CD Investigation/NNP of/IN the/DT control/NN of/IN coronavirus/NN subgenomic/JJ mRNA/NN transcription/NN by/IN using/VBG T7-generated/JJ negative-sense/JJ RNA/NN transcripts/NNS ./.
@@21851403255/CD The/DT Saccharomyces/NN cerevisiae/NN 14DM/GENE gene/NN ,/, encoding/VBG cytochrome/MULTIGENE P450/MULTIGENE lanosterol/NN 14/CD alpha-demethylase/NN (/( 14DM/CD )/SYM ,/, was/VBD overexpressed/VBN in/IN various/JJ S/NNP ./NNP cerevisiae/NN strains/NNS under/IN the/DT control/NN of/IN three/CD strong/JJ heterologous/JJ yeast/NN transcription/NN promoters/NNS (/( pADC1/GENE ,/, pGPD/CONTEXTGENE ,/, pPHO5/GENE )/SYM and/CC under/IN the/DT control/NN of/IN its/PRP own/VB promoter/NN ./.
@@106287506658/CD Previously/RB ,/, we/PRP showed/VBD that/IN the/DT APRE/GENE is/VBZ a/DT cytokine/NN [/NN tumor/NN necrosis/NN factor-alpha/NN (/( TNFalpha/NN )/JJ ]/JJ -/JJ inducible/MULTIGENE enhancer/MULTIGENE by/IN binding/JJ the/DT heterodimeric/JJ nuclear/JJ factor-kappaB/CONTEXTGENE (/( NF-kappaB/GENE )/SYM complex/NN Rel/NEWGENE A/DT x/NN NF-kappaB1/GENE ./.
@@17678996047/CD Marked/JJ thrombocytopenia/NN ,/, depletion/NN of/IN serum/JJ fibrinogen/NEWGENE and/CC prolonged/JJ prothrombin/NN and/CC activated/VBN partial/JJ thromboplastin/NEWGENE time/NN ,/, were/VBD recorded/VBN at/IN 5/CD to/IN 10/CD and/CC 30/CD to/IN 40/CD minutes/NNS after/IN intravenous/JJ envenomation/NN ./.
@@82238233763/CD Stroop/NN interference/NN :/: aging/NN effects/NNS assessed/VBN with/IN the/DT Stroop/NN Color-Word/NNP Test/NNP ./.
@@111503154463/CD A/DT novel/JJ approach/NN was/VBD developed/VBN for/IN identifying/JJ transcription/NN factor/NN activities/NNS associated/VBN with/IN NGF-activated/JJ ,/, but/CC not/RB EGF-activated/JJ ,/, signaling/JJ ,/, using/VBG random/JJ oligonucleotide/NN clones/NNS from/IN a/DT DNA/NN recognition/NN library/NN to/IN isolate/MULTIGENE specific/MULTIGENE DNA/MULTIGENE binding/MULTIGENE proteins/MULTIGENE from/IN PC12/GENE nuclear/JJ extracts/NNS ./.
@@88040127530/CD The/DT partial/JJ categories/NNS of/IN the/DT SIP/NN that/WDT were/VBD more/RB affected/VBN were/VBD work/NN ,/, recreation/NN and/CC pastimes/NNS ,/, home/JJ management/NN ,/, and/CC sleep/NN and/CC rest/NN ./.
@@349354182/CD Patients/NNS with/IN Parkinson's/NNP disease/NN showed/VBD a/DT relatively/JJ high/JJ incidence/NN to/IN psychoses/NNS during/IN drug/NN treatment/NN (/( 51/CD ./CD 47%/CD )/SYM ./.
@@107067362097/CD Thus/RB ,/, patients/NNS with/IN metastatic/JJ melanoma/NN are/VBP not/RB tolerant/JJ to/IN gp100/MULTIGENE Ag/MULTIGENE based/VBN on/IN the/DT detection/NN of/IN CD8+/NN T/NN cells/NNS specific/JJ for/IN multiple/JJ HLA-A*0201-restricted/GENE ,/, gp100-derived/JJ epitopes/NNS ./.
@@20119242622/CD Despite/IN the/DT small/JJ number/NN of/IN patients/NNS ,/, on/IN the/DT basis/NN of/IN this/DT report/NN ,/, we/PRP can/MD confirm/VB that/IN 1/CD ./CD 5/CD MU/NNS //NNS day/NNS of/IN alpha-IFN/NN is/VBZ an/DT adequate/JJ treatment/NN for/IN patients/NNS with/IN hairy/JJ cell/NN leukemia/NN ./.
@@37131874390/CD Overall/RB ,/, lesions/NNS infiltrating/JJ the/DT deep/JJ lamina/NN propria/NN do/NN not/RB exhibit/VB a/DT reduced/VBN frequency/NN of/IN occurrence/NN compared/VBN to/IN lesions/NNS infiltrating/JJ the/DT skeletal/JJ muscle/NN ;/: however/RB ,/, carcinomas/NNS affecting/VBG other/DT oral/JJ sites/NNS showed/VBD a/DT reduced/VBN frequency/NN of/IN deeply/RB infiltrating/JJ lesions/NNS in/IN comparison/NN to/IN more/RB superficial/JJ lesions/NNS ./.
@@76245818290/CD All/DT subjects/NNS were/VBD submitted/VBN to/IN ECG/NN and/CC arterial/JJ blood/NN pressure/NN determination/NN and/CC were/VBD assayed/VBN for/IN TSH/NN ,/, thyroid/JJ hormone/NN ,/, PRL/NN ,/, glucose/NN ,/, creatinine/NN ,/, nitrogen/NN ,/, glutamine/MULTIGENE transaminase/MULTIGENE ,/, cholesterol/NN and/CC triglycerides/NNS plasma/NN levels/NNS before/IN therapy/NN (/( T0/NN )/SYM ,/, after/IN 30/CD treatment/NN days/NNS (/( T30/GENE )/SYM and/CC after/IN a/DT 15/CD days/NNS washout/NN (/( T45/GENE )/SYM ./.
@@37206154394/CD This/DT may/MD explain/VB in/IN part/NN a/DT secular/JJ trend/NN towards/IN reduced/VBN birthweight/NN for/IN gestation/NN in/IN preterm/JJ infants/NNS ./.
@@111570355756/CD The/DT utilities/NNS measured/VBN in/IN our/PRP study/NN can/MD be/VB applied/VBN directly/RB to/IN quality-of-life/NN determinations/NNS in/IN clinical/JJ trials/NNS of/IN adjuvant/JJ IFN/MULTIGENE alpha-2b/MULTIGENE to/IN measure/NN the/DT net/JJ benefit/NN of/IN therapy/NN ./.
@@57799535719/CD Effect/NN of/IN castration/NN on/IN pituitary/JJ and/CC serum/JJ LH/NN and/CC FSH/JJ in/IN testosterone-sterilized/JJ rats/NNS ./.
@@29412374153/CD In/NN the/DT former/JJ instance/NN ,/, in/IN addition/NN to/IN serum/JJ calcium/NN and/CC phosphorous/JJ ion/NN concentrations/NNS ,/, tissue/NN pH/NN ,/, blood/NN supply/NN ,/, hormones/NNS ,/, i/FW ./FW e/FW ./FW ,/, vitamin/NN D/NN ,/, vitamin/NN A/DT ,/, and/CC various/JJ enzymes/NNS (/( e/FW ./FW g/FW ./FW ,/, alkaline/MULTIGENE phosphatase/MULTIGENE and/CC pyrophosphatase/NN )/SYM may/MD all/DT play/NN significant/JJ ,/, ancillary/JJ ,/, time-dependent/NN ,/, but/CC as/IN yet/RB undetermined/JJ roles/NNS ./.
@@97873231689/CD PURPOSE/NNS :/: The/DT role/NN interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM in/IN the/DT treatment/NN of/IN congenital/JJ thrombocytopenias/NNS is/VBZ unknown/JJ ./.
@@14600545256/CD Truncated/JJ ICSBP/NEWGENE lacking/JJ the/DT first/JJ 33/CD amino-terminal/JJ amino/JJ acids/NNS fails/VBZ to/IN bind/NN to/IN the/DT ICS/NNP ,/, indicating/VBG that/IN at/IN least/JJ part/NN of/IN the/DT DNA/NN binding/JJ domain/NN is/VBZ located/VBN within/IN the/DT well/NN conserved/VBN amino/JJ terminus/NN ./.
@@79291654737/CD DNA/NN sequence/NN and/CC functions/NNS of/IN the/DT actVI/MULTIGENE region/MULTIGENE of/IN the/DT actinorhodin/NN biosynthetic/JJ gene/NN cluster/NN of/IN Streptomyces/NN coelicolor/NN A3/NN (/NN 2/NN )/NN ./.
@@68649556235/CD Leads/VBZ from/IN the/DT MMWR/GENE ./.
@@114840281367/CD At/NN cross/NN purposes/NNS ./.
@@111272008421/CD Using/VBG a/DT natural/JJ dominant/JJ negative/NN for/IN AP-1/GENE transcriptional/JJ activity/NN in/IN ROS/NN 17/CD //CD 2/CD ./CD 8/CD cells/NNS ,/, we/PRP then/RB showed/VBD that/IN AP-1/MULTIGENE transcription/MULTIGENE factors/MULTIGENE mediated/JJ TGF-beta1-/NNP and/CC BMP-2-regulated/JJ expression/NN of/IN the/DT (/( alpha1/GENE )/SYM collagen/MULTIGENE I/MULTIGENE gene/MULTIGENE as/RB well/VB as/IN TGF-beta1-regulated/JJ expression/NN of/IN the/DT parathyroid/JJ hormone/NN (/( PTH/NN )/NN //NN PTH-related/NN peptide/NN (/( PTHrP/NN )/SYM receptor/NN ./.
@@107717099007/CD The/DT physicians/NNS in/IN charge/NN of/IN all/DT patients/NNS with/IN evidence/NN of/IN acute/MULTIGENE Q/MULTIGENE fever/NN (/( seroconversion/NN and/DT //DT or/DT presence/NN of/IN IgM/NN )/SYM or/CC chronic/JJ Q/JJ fever/NN (/( prolonged/JJ disease/NN and/DT //DT or/DT IgG/NEWGENE antibody/NN titer/NN to/IN phase/NN I/PRP of/IN Coxiella/NN burnetii/NN >/SYM or/CC =/SYM 800/CD )/SYM were/VBD asked/VBN to/IN complete/VB a/DT questionnaire/NN ,/, which/WDT was/VBD computerized/JJ ./.
@@106299387891/CD Furthermore/RB ,/, the/DT wide/JJ distribution/NN of/IN the/DT GFP-POLO/NNP protein/NN to/IN all/DT compartments/NNS of/IN the/DT mitotic/JJ apparatus/NN provides/VBZ a/DT valuable/NN tool/NN for/IN future/JJ studies/NNS on/IN cell/NN cycle/NN during/IN development/NN ./.
@@27082883378/CD Liquid/NNP chromatography/NN with/IN amperometric/JJ detection/NN (/( LC/GENE //GENE AD/GENE )/SYM is/VBZ used/VBN to/IN determine/VB fluazifop/NN acid/NN produced/VBN from/IN the/DT metabolism/NN or/CC base/NN hydrolysis/NN of/IN fluazifop-butyl/JJ in/IN soybeans/NNS and/CC soybean/NN oil/NN ./.
@@10820829621/CD Flavonoids/NNS from/IN Brosimum/NNP acutifolium/NN ./.
@@10940562136/CD Sequence/NN analysis/NN reveals/VBZ that/IN the/DT newly/RB discovered/VBN oasA2/MULTIGENE gene/MULTIGENE represents/VBZ a/DT pseudogene/NN that/WDT is/VBZ still/RB transcribed/VBN ,/, but/CC is/VBZ not/RB functionally/RB translated/VBN ./.
@@93665179374/CD Our/PRP findings/NNS provide/VBP the/DT first/JJ evidence/NN that/IN the/DT function/NN of/IN WT1/GENE can/MD be/VB modulated/VBN by/IN its/PRP phosphorylation/NN in/IN vivo/NN ./.
@@82249074999/CD Genomic/NNP Southern/NNP blot/NN analysis/NN of/IN rat/NN EFIA/NNP (/( gene/NN encoding/VBG enhancer/MULTIGENE factor/MULTIGENE I/MULTIGENE subunit/MULTIGENE A/MULTIGENE )/SYM reveals/VBZ a/DT complex/NN band/NN pattern/NN when/CC cDNA/NN subfragment/NN probes/NNS are/VBP used/VBN ./.
@@6165759868/CD To/TO study/VB the/DT sensitivity/NN of/IN some/DT central/JJ brain/NN structures/NNS to/IN the/DT action/NN of/IN an/DT electromagnetic/JJ field/NN of/IN decimeter/NN waves/NNS (/( EMF/NN of/IN DW/JJ )/SYM a/DT dynamic/JJ investigation/NN of/IN single/JJ unit/NN activity/NN was/VBD undertaken/VBP ./.
@@15636358228/CD Overproduction/NNS ,/, purification/NN and/CC characterization/NN of/IN M/MULTIGENE ./MULTIGENE HinfI/MULTIGENE methyltransferase/MULTIGENE and/CC its/PRP deletion/NN mutant/JJ ./.
@@10705783523/CD In/NN all/PDT other/DT cases/NNS ,/, vestibular/JJ neurectomy/NN or/CC chemical/JJ vestibular/JJ labyrinthectomy/NN ,/, by/IN means/NN of/IN intratympanic/JJ low/JJ concentration/NN gentamicin/NN (/( 20/CD mg/NN //NN mL/NN )/SYM ,/, are/VBP indicated/VBN ./.
@@78593019206/CD This/DT region/NN constitutes/VBZ the/DT DNA-binding/NN domain/NN with/IN basic-helix-loop-helix/JJ and/CC leucine-zipper/MULTIGENE motifs/MULTIGENE ,/, features/NNS common/JJ to/IN the/DT myc-related/MULTIGENE transcription/MULTIGENE factor/MULTIGENE family/MULTIGENE ./.
@@92713975214/CD Consistent/JJ with/IN this/DT model/NN ,/, a/DT synthetic/JJ construct/NN containing/JJ three/CD tandem/NN copies/NNS of/IN the/DT native/JJ LDL/MULTIGENE receptor/MULTIGENE SREBP/MULTIGENE site/MULTIGENE linked/JJ to/IN a/DT single/MULTIGENE Sp1/MULTIGENE site/MULTIGENE was/VBD also/RB significantly/RB activated/VBN in/IN a/DT buttonhead-independent/JJ fashion/NN ./.
@@3584426927/CD Heat-labile-like/MULTIGENE enterotoxin/MULTIGENE (/( LT/CONTEXTGENE )/SYM was/VBD produced/VBN by/IN 26/CD of/IN 42/CD stool/NN isolates/NNS (/( 62%/JJ )/SYM ,/, while/CC only/RB 1/CD of/IN the/DT 42/CD isolates/NNS (/( 2%/JJ )/SYM produced/VBN enterotoxinlike/NN activity/NN in/IN suckling/JJ mice/NNS ;/: 65%/NN of/IN the/DT cytotoxin-producing/JJ strains/NNS also/RB produced/VBN an/DT LT-like/NNP material/NN ./.
@@115545661429/CD The/DT hatcher/NN incubators/NNS of/IN both/DT companies/NNS were/VBD also/RB persistently/RB contaminated/VBN with/IN Salmonella/NN livingstone/NN and/CC Salmonella/NN thomasville/NN in/IN company/NN A/DT and/CC with/IN Salmonella/NN senftenberg/NN in/IN company/NN B/NNP ./NNP
@@8663120735/CD Oncogenic/GENE Raf-1/GENE activates/VBZ p70/MULTIGENE S6/MULTIGENE kinase/MULTIGENE via/NN a/DT mitogen-activated/MULTIGENE protein/MULTIGENE kinase-independent/JJ pathway/NN ./.
@@80643518048/CD Long-latency/NNP :/: locked/VBN units/NNS responded/VBN to/IN shocks/NNS with/IN little/JJ jitter/NN and/CC long/JJ latency/NN (/( 4-11/CD ms/NN )/SYM ./.
@@76291039148/CD CCAAT/MULTIGENE //MULTIGENE enhancer-binding/MULTIGENE protein/MULTIGENE isoforms/MULTIGENE beta/MULTIGENE and/CC delta/JJ are/VBP expressed/VBN in/IN mammary/JJ epithelial/JJ cells/NNS and/CC bind/VB to/IN multiple/JJ sites/NNS in/IN the/DT beta-casein/MULTIGENE gene/MULTIGENE promoter/MULTIGENE ./.
@@94275444751/CD The/DT pel/NN gene/NN from/IN an/DT Amycolata/NNP sp/NN ./NN encoding/VBG a/DT pectate/MULTIGENE lyase/MULTIGENE (/( EC/NN 4/CD ./CD 2/CD ./CD 2/CD ./CD 2/CD )/SYM was/VBD isolated/VBN by/IN activity/NN screening/JJ a/DT genomic/JJ DNA/NN library/NN in/IN Streptomyces/NN lividans/VBZ TK24/DT ./.
@@100656844057/CD On/IN the/PDT other/DT hand/NN ,/, subjects/VBZ with/IN air/NN trapping/JJ (/( residual/JJ volume/NN (/( RV/NN )/NN //NN total/NN lung/NN capacity/NN (/( TLC/NN )/SYM >/SYM 37%/NN )/NN disclosed/VBN not/RB only/RB a/DT higher/JJ n/NN (/NN mit/NN )/NN (/( 0/CD ./CD 63+/CD //CD -0/CD ./CD 17/CD versus/IN 0/CD ./CD 43+/CD //CD -0/CD ./CD 07/CD mt/NN x/NN microm/NN (/NN -2/NN )/SYM ,/, p/NN </NN 0/NN ./NN 05/NN )/NN but/CC shorter/JJR sarcomeres/NNS (/( L/NN (/NN sar/NN )/NN )/NN than/IN subjects/NNS without/IN this/DT functional/JJ abnormality/NN (/( 2/NN ./NN 08+/NN //NN -0/NN ./NN 16/NN to/IN 2/CD ./CD 27+/CD //CD -0/CD ./CD 15/CD microm/NN ,/, p/NN </NN 0/NN ./NN 05/NN )/SYM ./.
@@88124905401/CD The/DT high/JJ sequence/NN homology/NN ,/, similar/JJ genomic/JJ structure/NN ,/, and/CC identical/JJ chromosomal/JJ loci/NNS of/IN hKID/NN ,/, MIP/JJ ,/, and/CC AQP-2/GENE suggest/VB a/DT MIP/MULTIGENE family/MULTIGENE gene/MULTIGENE cluster/MULTIGENE at/IN chromosome/NN locus/NN 12q13/CD ./.
@@103756405917/CD As/IN is/VBZ deduced/VBN from/IN the/DT nucleotide/NN sequence/NN of/IN the/DT cDNA/NN ,/, CBS-1/GENE contains/VBZ an/DT open/JJ reading/JJ frame/NN consisting/VBG of/IN 182/CD amino/JJ acids/NNS ,/, with/IN a/DT molecular/JJ weight/NN of/IN 19/CD ./CD 5kDa/CD ./.
@@94875909454/CD The/DT mean/JJ duration/NN of/IN pain/NN relief/NN was/VBD 4-6/CD weeks/NNS ./.
@@10810083251/CD The/DT serine-threonine/MULTIGENE kinase/MULTIGENE gene/MULTIGENE is/VBZ likely/RB functional/JJ ,/, whereas/IN the/DT zinc/NN finger/NN motif/NN is/VBZ likely/RB nonfunctional/JJ ./.
@@108092336893/CD Modeling/NNP also/RB revealed/VBD a/DT very/RB hydrophobic/JJ surface/NN due/NN to/IN the/DT absence/NN of/IN H12/GENE ,/, exposing/VBG residues/NNS from/IN H3/GENE ,/, loop/NN 3-4/CD ,/, H4/NNS ,/, and/CC H11/GENE ./.
@@84088419097/CD Genetic/NNP abnormalities/NNS that/WDT could/MD lead/VB to/IN mutagenesis/NN include/VB chromosomal/JJ abnormalities/NNS and/CC single-gene/MULTIGENE mutations/MULTIGENE ./.
@@84717967089/CD Based/VBN on/IN these/DT results/NNS ,/, a/DT new/JJ model/NN for/IN the/DT regulation/NN of/IN nif/MULTIGENE //MULTIGENE fix/MULTIGENE gene/MULTIGENE expression/NN in/IN A/NNP ./NNP caulinodans/NNS is/VBZ proposed/VBN ./.
@@86266988255/CD However/RB ,/, a/DT >/SYM 10-fold/JJ increase/NN in/IN ERK3/NEWGENE activity/NN in/IN each/DT PKC/NEWGENE beta/NN transfectant/NN was/VBD shown/VBP by/IN immunoprecipitation/NN with/IN anti-ERK3/JJ monoclonal/JJ antibody/NN followed/VBN by/IN either/DT immune/MULTIGENE complex/MULTIGENE kinase/MULTIGENE assay/NN or/CC by/IN in/IN gel/NN kinase/NN assay/NN ./.
@@70075919330/CD The/DT residue/NN functions/NNS ,/, R/NN (/NN t/NN )/NN ,/, for/IN C-11/GENE CPZ/NN and/CC In-113m/GENE transferrin/NN were/VBD plotted/VBN against/IN time/NN for/IN selected/VBN areas/NNS of/IN interest/NN ,/, and/CC the/DT CPZ/NN area-weighted/JJ extraction/NN ,/, E/NN (/NN t/NN )/NN ,/, was/VBD computed/JJ for/IN the/DT same/JJ areas/NNS every/DT 250/CD msec/NN using/VBG the/DT formula/NN :/: E/NN (/NN t/NN )/NN =/SYM [/NN RT/NN (/NN t/NN )/NN -/: RR/NN (/NN t/NN )/NN ]/NN //NN [/NN 1/NN -/: RR/NN (/NN t/NN )/NN ]/NN ,/, where/CC RT/JJ and/CC RR/NN are/VBP the/DT normalized/VBN residue/NN functions/NNS for/IN CPZ/NN and/CC transferrin/NN ,/, respectively/RB ./.
@@10699684510/CD Furthermore/RB ,/, Zelen's/GENE method/NN is/VBZ used/VBN to/IN balance/NN the/DT number/NN of/IN patients/NNS allocated/VBN to/IN the/DT two/JJ groups/NNS within/IN each/DT institution/NN (/( M/NNP ./NNP
@@100879932036/CD In/NN contrast/NN ,/, deletion/NN of/IN the/DT upstream/JJ portion/NN of/IN the/DT delta/MULTIGENE promoter/MULTIGENE led/VBN to/IN a/DT 10/CD fold/NN decrease/NN in/IN expression/NN ./.
@@10770065373/CD The/DT clinical/JJ stage/NN was/VBD I/PRP (/( T1N0M0/NNP )/SYM ,/, and/CC S2/NN sleeve/NN segmentectomy/NN with/IN lymph/NN node/NN dissection/NN (/( R/NN 2/NN b/NN )/SYM was/VBD performed/VBN ./.
@@80784734861/CD Expression/NNS of/IN ME31B/MULTIGENE cDNA/MULTIGENE in/IN S/NNP ./NNP pombe/NN suppresses/VBZ the/DT ste13/MULTIGENE mutation/MULTIGENE ./.
@@107919011978/CD Transduction/NNS of/IN the/DT human/JJ leukemic/JJ cell/NN line/NN K562/CELL showed/VBD that/IN viral/MULTIGENE MRP1-PG13/MULTIGENE supernatants/MULTIGENE routinely/RB transfer/VBP the/DT MRP1/MULTIGENE gene/MULTIGENE to/IN approximately/JJ 35%/NN of/IN target/NN K562/NNP cells/NNS ,/, of/IN which/WDT at/IN least/RB one/PRP third/RB are/VBP capable/JJ of/IN proliferating/JJ in/IN the/DT presence/NN of/IN otherwise/RB toxic/JJ concentrations/NNS of/IN etoposide/NN ./.
@@88248841659/CD The/DT cytogenetic/JJ expression/NN of/IN the/DT folate/NN sensitive/JJ fragile/JJ site/NN ,/, FRAXE/GENE ,/, is/VBZ due/NN to/IN the/DT expansion/NN of/IN a/DT GCC/NN repeat/NN in/IN proximal/JJ Xq28/GENE of/IN the/DT human/JJ X/NN chromosome/NN and/CC is/VBZ associated/VBN with/IN a/DT mild/JJ form/NN of/IN mental/JJ handicap/NN ./.
@@72744827126/CD 33/CD out/RB of/IN 90/CD neurons/NNS of/IN the/DT cat/NN medial/JJ geniculate/JJ body/NN revealed/VBD the/DT selectivity/NN of/IN their/PRP afterdischarges/NNS to/IN movement/NN of/IN sound/NN when/CC velocity/NN of/IN the/DT movement/NN changed/VBN from/IN 30/CD to/IN 180/CD deg/NNS //NNS s/NNS ./.
@@26315056917/CD Ampicillin/GENE (/( AMP/CONTEXTGENE )/SYM alone/RB or/CC with/IN an/DT aminoglycoside/NN (/( AMI/NN )/SYM was/VBD the/DT treatment/NN in/IN 9/CD and/CC 16/CD cases/NNS ,/, respectively/RB ./.
@@40397441960/CD These/DT results/NNS were/VBD compared/VBN with/IN those/DT obtained/VBN in/IN -D/CD mothers/NNS and/CC pups/NNS ,/, after/IN giving/JJ the/DT mothers/NNS an/DT oral/JJ supplement/NN (/( 10/CD i/CD ./CD u/CD ./. vitamin/NN D3/GENE //GENE day/GENE )/SYM during/IN the/DT period/NN of/IN lactation/NN (/( 20/CD days/NNS )/SYM ./.
@@89872253157/CD The/DT most/RB common/JJ risk/NN factor/NN reported/VBN for/IN both/DT recent/JJ and/CC all/PDT other/DT hepatitis/MULTIGENE C/MULTIGENE cases/NNS was/VBD a/DT history/NN of/IN injecting/JJ drug/NN use/NN ,/, although/IN the/DT proportion/NN of/IN cases/NNS with/IN that/DT history/NN was/VBD different/JJ in/IN NT/NN from/IN ACT/NNP and/CC Queensland/NN ./.
@@25562649025/CD This/DT TC-II/GENE enhanson/NN ,/, which/WDT is/VBZ identical/JJ to/IN the/DT kappa/MULTIGENE B/MULTIGENE motif/MULTIGENE from/IN the/DT kappa/MULTIGENE chain/MULTIGENE enhancer/MULTIGENE ,/, was/VBD active/JJ in/IN both/DT lymphoid/JJ and/CC non-lymphoid/JJ cells/NNS ,/, which/WDT contrasts/VBZ with/IN the/DT previously/RB reported/VBN lymphoid/JJ cell/NN specificity/NN of/IN the/DT kappa/MULTIGENE B/MULTIGENE motif/MULTIGENE ./.
@@10487921776/CD ATF1/GENE transcription/NN is/VBZ negatively/RB regulated/VBN by/IN unsaturated/JJ fatty/JJ acids/NNS and/CC oxygen/NN ./.
@@77485027707/CD Rats/NNP treated/VBD with/IN 8-OH-DPAT/NN were/VBD not/RB impaired/VBN in/IN their/PRP ability/NN to/IN learn/VB a/DT visual/JJ discrimination/NN in/IN a/DT water/NN maze/NN ./.
@@63316846120/CD An/DT immunologic/JJ test/NN using/VBG stomach/NN and/CC tumor/NN antigens/NNS for/IN screening/NN of/IN those/DT at/IN high/JJ risk/NN for/IN stomach/NN cancer/NN is/VBZ suggested/VBN ./.
@@104570759729/CD Independent/MULTIGENE protrudor/MULTIGENE muscle/NN stimulation/NN increased/VBN VI/NNP ,/NNP max/NNP (/( peak/NN increase/NN 61/CD %/NN ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ,/, did/VBD not/RB change/VB Pcrit/NNP ,/, and/CC decreased/VBD Rn/NN (/( peak/NN decrease/NN of/IN 41/CD %/NN ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@83496327343/CD Sequence/NN comparison/NN indicates/VBZ that/IN exons/NNS 5'/GENE //GENE L/GENE and/CC L/GENE //GENE N/GENE in/IN PSG12/GENE and/CC PSG12/MULTIGENE psi/MULTIGENE are/VBP 99%/NN identical/JJ ,/, except/VB that/IN the/DT L/NNP //NNP N/NNP exon/NN in/IN the/DT PSG12/MULTIGENE psi/MULTIGENE gene/MULTIGENE contains/VBZ a/DT stop/NN codon/NN ./.
@@79371129084/CD The/DT individual/JJ subunits/NNS of/IN Ku/NNP have/NN been/VBN difficult/JJ to/IN isolate/NN from/IN human/JJ cells/NNS without/IN denaturation/NN and/CC attempts/NNS to/IN produce/NN functional/JJ recombinant/JJ Ku/NNP have/VB been/VBN largely/RB unsuccessful/JJ ./.
@@9294189255/CD Role/NN of/IN the/DT infectious-disease/JJ specialist/NN of/IN a/DT polyclinic/NN in/IN reducing/JJ the/DT incidence/NN of/IN communicable/JJ diseases/NNS ./.
@@92410929201/CD CONCLUSIONS/IN :/: Valproate/NN appears/VBZ to/IN inhibit/VB the/DT glucuronidation/NN of/IN carbamazepine-10/JJ ,/JJ 11-trans-diol/JJ ,/, and/CC probably/RB also/RB inhibits/VBZ the/DT conversion/NN of/IN carbamazepine-10/NN ,/NN 11-epoxide/NN to/IN this/DT trans-diol/NN derivative/NN ,/, rather/RB than/IN simply/RB inhibiting/JJ the/DT latter/JJ reaction/NN only/RB ./.
@@76659483479/CD IgE/NEWGENE levels/NNS showed/VBD higher/JJ values/NNS compared/VBN to/IN normal/JJ individuals/NNS and/CC IgE/NEWGENE levels/NNS were/VBD higher/JJ in/IN children/NNS groups/NNS than/IN in/IN adults/NNS regardless/RB of/IN the/DT intensity/NN of/IN infection/NN ./.
@@68498426641/CD Penicillin-G/NN degradation/NN products/NNS inhibit/VBP in/IN vitro/FW granulopoiesis/NN ./.
@@78535245391/CD Removal/NNP of/IN the/DT GST/NEWGENE domain/NN from/IN GST-Tax/GENE by/IN thrombin/NN restores/VBZ Tax's/GENE ability/NN to/IN assemble/VB a/DT ternary/JJ Tax-CREB-21-bp-repeat/NNP complex/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 400/CD WORDS/NN )/NN
@@106113207581/CD Saccharomyces/NN cerevisiae/NN contains/VBZ a/DT genetically/RB and/CC biochemically/RB proven/VBP CAK/MULTIGENE gene/MULTIGENE ,/, CAK1/GENE ,/, that/IN encodes/VBZ a/DT monomeric/JJ 44-kDa/MULTIGENE Cak1p/MULTIGENE protein/MULTIGENE unrelated/JJ to/IN Cdk7/GENE ./.
@@21930335342/CD R/NNP ./NNP
@@89058192134/CD The/DT majority/NN of/IN the/DT cases/NNS with/IN 0-I/JJ or/CC 0-III/MULTIGENE components/MULTIGENE were/VBD sm/CD ./CD cancer/NN ./.
@@78804426640/CD The/DT major/JJ PKC/MULTIGENE beta/MULTIGENE transcription/MULTIGENE initiation/MULTIGENE site/MULTIGENE was/VBD identified/VBN by/IN primer/NN extension/NN and/CC S1/MULTIGENE nuclease/MULTIGENE protection/NN ./.
@@91474206555/CD TAR/JJ and/CC Sp1-independent/NNP transactivation/NN of/IN HIV/NN long/JJ terminal/JJ repeat/NN by/IN the/DT Tat/MULTIGENE protein/MULTIGENE in/IN the/DT presence/NN of/IN human/JJ cytomegalovirus/NN IE1/GENE //GENE IE2/GENE ./.
@@100739403044/CD Ectopic/GENE expression/NN of/IN d-axin/RB inhibited/VBN Wingless/NEWGENE signaling/NN ./.
@@102182008078/CD In/NN 11/CD eyes/NNS that/WDT had/VBP been/VBN selected/VBN at/IN random/JJ 10/CD micrograms/NNS of/IN recombinant/JJ tissue/NEWGENE plasminogen/MULTIGENE activator/MULTIGENE were/VBD injected/VBN midvitreally/RB 24/CD hrs/NN later/JJR ./.
@@7910716636/CD Our/PRP study/NN cohorts/NNS consisted/VBP of/IN 15/CD patients/NNS who/WP received/VBD SC/NN rIL-2/NN at/IN doses/NNS of/IN 4/CD ./CD 8-14/CD ./CD 4/CD million/NN IU/NNS //NNS m2/NNS //NNS day/NNS on/IN 5/CD days/NNS per/IN week/NN for/IN a/DT total/NN of/IN 8/CD weeks/NNS ,/, 20/CD patients/NNS who/WP received/VBD rIFN-alpha/NN 2b/NN at/IN 3/CD ./CD 0-6/CD ./CD 0/CD million/NN U/NNS //NNS m2/NNS //NNS day/NNS thrice/RB weekly/JJ for/IN a/DT total/NN of/IN 6/CD weeks/NNS ,/, and/CC 72/CD patients/NNS who/WP were/VBD given/VBP SC/NN rIFN-alpha/NN 2b/NN at/IN 6/CD ./CD 0/CD million/NN U/NNS //NNS m2/NNS //NNS day/NNS thrice/RB weekly/JJ plus/IN SC/NN rIL-2/NN at/IN 14/CD ./CD 4-18/CD ./CD 0/CD million/NN IU/NNS //NNS m2/NNS //NNS day/NNS on/IN days/NNS 1/CD and/CC 2/CD ,/, followed/VBN by/IN 4/CD ./CD 8/CD million/JJ IU/NNS //NNS m2/NNS //NNS day/NNS ,/, 5/CD days/NNS per/IN week/NN for/IN 6/CD consecutive/JJ weeks/NNS ./.
@@75094509168/CD This/DT specific/JJ methylation/NN pattern/NN caused/VBD inactivation/NN of/IN the/DT HSV/MULTIGENE tk/MULTIGENE gene/MULTIGENE ,/, while/CC methylation/NN of/IN the/DT cytosine/NN residues/NNS within/IN the/DT nucleotide/NN sequence/NN from/IN +811/NN to/IN +1309/CD had/VBP no/DT effect/NN on/IN HSV/MULTIGENE tk/MULTIGENE gene/MULTIGENE activity/NN ./.
@@8118528091/CD Personal/JJ satisfaction/NN in/IN nursing/JJ :/: an/DT encounter/NN with/IN extremely/RB hostile/JJ patients/NNS ./.
@@23175542962/CD Determination/NNS of/IN three-dimensional/JJ imaging/NN properties/NNS of/IN a/DT light/NN microscope/NN system/NN ./.
@@78762103694/CD Mutation/NN of/IN the/DT P450BM-3/GENE Barbie/NNP box/NN significantly/RB increased/VBD the/DT expression/NN of/IN both/DT P450BM-3/GENE and/CC Bm3P1/GENE (/( another/DT small/JJ gene/NN located/VBN upstream/RB of/IN the/DT P450BM-3/MULTIGENE gene/MULTIGENE that/IN encodes/VBZ a/DT second/JJ putative/JJ regulatory/JJ protein/NN )/SYM in/IN response/NN to/IN pentobarbital/NN induction/NN but/CC left/NN the/DT basal/JJ levels/NNS unaffected/JJ ./.
@@111582951835/CD This/DT function/NN requires/VBZ not/RB only/RB the/DT kinase/NN domain/NN of/IN Csk/GENE ,/, but/CC also/RB its/PRP Src/MULTIGENE homology/MULTIGENE 3/MULTIGENE (/( SH3/GENE )/SYM and/CC SH2/MULTIGENE regions/MULTIGENE ./.
@@75797049547/CD To/TO accomplish/VB this/DT ,/, actin/MULTIGENE cables/MULTIGENE and/CC patches/NNS are/VBP redistributed/VBN during/IN the/DT cell/NN cycle/NN to/IN direct/JJ secretory/JJ components/NNS to/IN appropriate/JJ sites/NNS for/IN cell/NN growth/NN ./.
@@75926478739/CD Association/NNP of/IN human/MULTIGENE Pur/MULTIGENE alpha/MULTIGENE with/IN the/DT retinoblastoma/MULTIGENE protein/MULTIGENE ,/, Rb/NN ,/, regulates/VBZ binding/JJ to/IN the/DT single-stranded/JJ DNA/MULTIGENE Pur/MULTIGENE alpha/MULTIGENE recognition/MULTIGENE element/MULTIGENE ./.
@@104717433804/CD A/DT cDNA/NN encoding/VBG a/DT putative/JJ RNA/NN and/DT //DT or/DT DNA/MULTIGENE helicase/MULTIGENE has/VBZ been/VBN isolated/VBN from/IN Arabidopsis/NN thaliana/NN cDNA/NN libraries/NNS ./.
@@111815162826/CD By/IN analyzing/VBG 5'-deletion/CD insulin/MULTIGENE promoter-reporter/MULTIGENE constructs/MULTIGENE in/IN transient/JJ transfections/NNS of/IN clonal/JJ INS-1/GENE beta-cells/NNS ,/, we/PRP located/VBD activating/JJ Hh-responsive/NNP regions/NNS within/IN the/DT rat/MULTIGENE insulin/MULTIGENE I/MULTIGENE promoter/MULTIGENE that/WDT include/VBP the/DT glucose-response/JJ elements/NNS Far/NNP (/( E2/GENE )/SYM and/CC Flat/JJ (/( A2/GENE //GENE A3/GENE )/SYM ./.
@@37852124296/CD Human/NNP and/CC Chinese/MULTIGENE hamster/MULTIGENE S14/MULTIGENE protein/MULTIGENE sequences/MULTIGENE deduced/VBN from/IN the/DT cDNAs/NNS are/VBP identical/JJ ./.
@@91688791483/CD In/NN AcMNPV-infected/JJ Sf9/CD cells/NNS ,/, late/JJ transcription/NN initiation/NN is/VBZ detected/VBN from/IN only/RB two/JJ upstream/MULTIGENE TAAG/MULTIGENE sites/MULTIGENE and/CC not/RB from/IN three/CD downstream/MULTIGENE TAAG/MULTIGENE sites/MULTIGENE ./.
@@92976981167/CD These/DT transcripts/NNS contain/VBP the/DT 5'/CD ends/NNS of/IN mature/NNP UbCRBP/MULTIGENE mRNAs/MULTIGENE ;/: extend/VB through/RB UbCRBP/NNP ,/, across/IN the/DT intergenic/JJ region/NN ,/, and/CC a/DT significant/JJ distance/NN 3'/CD into/IN the/DT enolase/MULTIGENE gene/MULTIGENE ./.
@@79606087949/CD Courses/NNS were/VBD repeated/VBN every/DT four/CD weeks/NNS ./.
@@103040905800/CD Medicare/NN SNF/GENE benefits/NNS revised--again/JJ ./.
@@89597782115/CD There/EX were/VBD no/DT significant/JJ differences/NNS in/IN graft/NN survival/NN between/IN groups/NNS with/IN early/JJ graft/NN function/NN (/( EGF/NN )/SYM and/CC DGF/GENE ,/, either/DT in/NN first/JJ transplantations/NNS or/CC retransplantations/NNS ./.
@@107728564261/CD Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@113454359229/CD One/CD of/IN the/DT conserved/VBN RNA/MULTIGENE subdomains/MULTIGENE ,/, designated/VBN P3/GENE ,/, has/VBZ previously/RB been/VBN shown/VBP to/IN be/VB required/VBN for/IN nucleolar/JJ localization/NN ./.
@@92873529486/CD Consistent/JJ with/IN effects/NNS on/IN STAT/GENE activation/NN ,/, altered/VBN SHP-1/GENE expression/NN also/RB affected/VBD EGF-induced/JJ activation/NN of/IN the/DT mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE pathway/NN ;/: expression/NN of/IN SHP-1-/NN (/NN Cys/NN --/NNP >/NNP Ser/NN )/NN inhibited/VBD activity/NN of/IN MEK/GENE by/IN approximately/RB 25%/JJ ,/, whereas/IN expression/NN of/IN SHP-1/GENE resulted/VBN in/IN a/DT approximately/RB 25%/JJ increase/NN ./.
@@114137609685/CD Myasthenia/GENE gravis/MD is/VBZ an/DT autoimmune/JJ disease/NN resulting/JJ from/IN the/DT production/NN of/IN antibodies/NNS against/IN the/DT ACh/NN receptors/NNS of/IN the/DT neuromuscular/JJ synapse/NN ./.
@@98449214145/CD Raf/WDT is/VBZ a/DT key/JJ serine-threonine/MULTIGENE protein/MULTIGENE kinase/MULTIGENE which/WDT participates/VBZ in/IN the/DT transmission/NN of/IN growth/NN ,/, anti-apoptotic/NN and/CC differentiation/NN messages/NNS ./.
@@75790237482/CD During/IN the/DT dose-finding/NN ,/, two/JJ patients/NNS were/VBD temporarily/RB withdrawn/VBP from/IN medication/NN and/CC one/PRP patient/NN was/VBD excluded/VBN because/IN of/IN elevated/VBN levels/NNS of/IN liver/NN enzymes/NNS ./.
@@110597778005/CD Terminal/NNP deoxynucleotidyl/NN transferase-mediated/JJ nick/NN end/NN labeling/VBG assays/NNS revealed/VBN that/IN hormonal/JJ activation/NN of/IN the/DT PAX3/MULTIGENE repressors/MULTIGENE induced/VBD extensive/JJ apoptosis/NN that/WDT correlated/VBD with/IN down-regulation/NN of/IN BCL-X/NN (/NN L/NN )/NN expression/NN ./.
@@118041001670/CD It/PRP was/VBD found/VBN that/IN the/DT disappearance/NN of/IN BOD5/GENE and/CC NH3-N/GENE could/MD be/VB approximated/VBN using/VBG first-order/JJ kinetics/NN ,/, but/CC the/DT kinetics/NN of/IN TP/NN removal/NN were/VBD unclear/JJ ./.
@@75601379906/CD Differential/JJ sensitivity/NN of/IN the/DT MMPI-2/NN depression/NN scales/NNS and/CC subscales/NNS ./.
@@259754933/CD The/DT two/JJ most/RB recent/JJ patients/NNS (/( 35/CD and/CC 132/CD days/NNS )/SYM received/VBN only/RB oral/JJ dipyridamole/NN (/( 75/CD mg/NN X/NN 3/CD //CD day/CD )/SYM and/CC aspirin/NN (/( 80/CD mg/NN //NN day/NN )/SYM after/IN the/DT early/JJ recovery/NN period/NN (/( four-six/JJ days/NNS )/SYM ,/, resulting/VBG in/IN normal/JJ prothrombin/NEWGENE and/CC partial/JJ thromboplastin/NEWGENE times/NNS ./.
@@85694439920/CD The/DT purpose/NN of/IN the/DT study/NN reported/VBN here/RB was/VBD to/IN investigate/VB whether/IN differences/NNS in/IN T1/NN and/CC T2/GENE between/IN tumors/NNS are/VBP mainly/RB a/DT consequence/NN of/IN differences/NNS in/IN the/DT fractional/JJ volume/NN of/IN the/DT extracellular/JJ compartment/NN ./.
@@32338623923/CD Neuromyelitis/NNP optica/NN (/( Devic's/NNP syndrome/NN )/SYM :/: not/RB always/RB multiple/JJ sclerosis/NN ./.
@@91930729815/CD Cytological/JJ data/NN suggest/VB that/IN the/DT transgenes/NNS associate/NN with/IN a/DT nucleolus/NN ./.
@@8626290676/CD Aeromonas/NNS salmonicida/NN possesses/VBZ two/JJ genes/NNS encoding/VBG homologs/NNS of/IN the/DT major/JJ outer/JJ membrane/NN protein/NN ,/, OmpA/GENE ./.
@@18863682505/CD PO2/NN measurements/NNS using/VBG a/DT double/JJ barrelled/JJ recess/NN type/NN microelectrodes/NNS were/VBD measured/VBN in/IN the/DT optic/JJ nerve/NN head/NN of/IN miniature/NN pigs/NNS in/IN normoxia/NN and/CC hyperoxia/NN ./.
@@90943156911/CD In/NN this/DT study/NN ,/, we/PRP have/VBP examined/VBN the/DT regulation/NN of/IN B-Myb/NEWGENE activity/NN by/IN cyclin-Cdks/NNS ./.
@@77614347884/CD Since/IN AP-1/GENE is/VBZ an/DT important/JJ mediator/NN of/IN tumor/NN promoter/NN action/NN ,/, these/DT findings/NNS may/MD explain/VB the/DT anti-tumor-promoting/JJ activity/NN of/IN phenolic/JJ antioxidants/NNS ./.
@@77456859583/CD Interestingly/RB ,/, virions/NNS also/RB contained/VBN smaller/JJR proteins/NNS that/WDT reacted/VBD with/IN antibodies/NNS specific/JJ for/IN the/DT accessory/JJ proteins/NNS as/RB well/VBP as/IN SN/RB and/CC CAT/MULTIGENE fusion/MULTIGENE partners/NNS ./.
@@55526425590/CD Propagation/NNS and/CC hormone/NN production/NN by/IN human/JJ normal/JJ and/CC malignant/JJ trophoblast/NN in/IN rats/NNS ./.
@@74942937802/CD These/DT results/NNS demonstrate/VBP that/IN tip/NN acts/NNS at/IN an/DT early/JJ stage/NN of/IN the/DT T-cell/NN signal/JJ transduction/NN cascade/NN by/IN associating/JJ with/IN Lck/DT and/CC downregulating/JJ Lck-mediated/JJ activation/NN ./.
@@21791882789/CD The/DT electrically/RB induced/VBN motile/JJ responses/NNS were/VBD not/RB suppressed/VBN in/IN the/DT presence/NN of/IN dinitrophenol/NN or/CC cytochalasin/NN B/NNP ./NNP
@@40172954684/CD For/IN comparison/NN conventional/JJ heparin/NN was/VBD used/VBN during/IN 18/CD dialyses/NNS in/IN the/DT same/JJ patients/NNS ./.
@@93462381846/CD F-box/MULTIGENE proteins/MULTIGENE are/VBP receptors/NNS that/WDT recruit/VBP phosphorylated/VBN substrates/NNS to/IN the/DT SCF/MULTIGENE ubiquitin-ligase/MULTIGENE complex/MULTIGENE ./.
@@79548917286/CD ERV1/GENE is/VBZ involved/VBN in/IN the/DT cell-division/JJ cycle/NN and/CC the/DT maintenance/NN of/IN mitochondrial/JJ genomes/NNS in/IN Saccharomyces/NN cerevisiae/NN ./.
@@92337724009/CD This/DT protein/NN ,/, designated/VBN p532/GENE based/VBN on/IN its/PRP predicted/VBN molecular/JJ weight/NN (/( EMBO/NNP J/NN 15/CD :/: 5738/CD ,/, 1996/CD )/SYM ,/, contains/VBZ multiple/JJ structural/JJ domains/NNS including/JJ two/JJ regions/NNS of/IN seven/JJ internal/JJ repeats/NNS highly/RB related/VBN to/IN the/DT cell/NN cycle/MULTIGENE regulator/MULTIGENE RCC1/MULTIGENE ,/, a/DT guanine/MULTIGENE nucleotide/MULTIGENE exchange/MULTIGENE factor/MULTIGENE for/IN the/DT small/MULTIGENE GTP-binding/MULTIGENE protein/MULTIGENE Ran/MULTIGENE ,/, seven/JJ beta-repeat/MULTIGENE domains/MULTIGENE characteristic/NN of/IN the/DT beta/MULTIGENE subunit/MULTIGENE of/IN heterotrimeric/JJ G/MULTIGENE proteins/MULTIGENE ,/, three/CD putative/JJ SH3/MULTIGENE binding/MULTIGENE sites/MULTIGENE ,/, a/DT putative/JJ leucine-zipper/JJ and/CC a/DT carboxy-terminal/JJ HECT/GENE domain/NN characteristic/NN of/IN E3/MULTIGENE ubiquitin-protein/MULTIGENE ligases/MULTIGENE ./.
@@38387976363/CD Northern/NNP blotting/NN with/IN a/DT unique/JJ 17-mer/CD oligonucleotide/NN demonstrated/VBD the/DT absence/NN of/IN the/DT mutant/JJ sequence/NN in/IN the/DT mRNA/NN from/IN which/WDT the/DT cDNA/NN library/NN giving/JJ rise/NN to/IN the/DT mutant/JJ cDNA/NN was/VBD constructed/VBN ./.
@@106772145906/CD For/IN wild/JJ type/NN MutT/NNP and/CC its/PRP E53D/GENE and/CC E44D/MULTIGENE mutants/MULTIGENE ,/, plots/VBZ of/IN log/NN (/NN k/NN (/NN cat/NN )/NN )/NN versus/IN pH/NN exhibited/VBD a/DT limiting/JJ slope/NN of/IN 1/CD on/IN the/DT ascending/JJ limb/NN and/CC then/RB a/DT hump/NN ,/, i/FW ./FW e/FW ./FW ,/, a/DT sharply/RB defined/VBN maximum/JJ near/IN pH/NN 8/CD followed/VBN by/IN a/DT plateau/NN ,/, yielding/JJ apparent/JJ pK/NN (/NN a/NN )/NN values/NNS of/IN 7/CD ./CD 6/CD +/NN //NN -/NN 0/CD ./CD 3/CD and/CC 8/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 4/CD for/IN an/DT essential/JJ base/NN and/CC a/DT nonessential/JJ acid/NN catalyst/NN ,/, respectively/RB ,/, in/IN the/DT active/JJ quaternary/JJ MutT-Mg/NN (/NN 2+/NN )/NN -dGTP-Mg/NN (/NN 2+/NN )/NN complex/NN ./.
@@74400855148/CD Arm/NEWGENE function/NN tests/NNS ./.
@@10125354111/CD Groups/NNS dicker/VBP for/IN price/NN breaks/NNS as/IN anesthetic/JJ gas/NN goes/VBP multi-source/JJ ./.
@@31091473822/CD Research/NNP on/IN ethylene/NN glycol/NN and/CC diethylene/NN glycol/NN for/IN carcinogenic/JJ effects/NNS ./.
@@9091149042/CD Diallylnitrosamine/NNP (/( DAN/IN )/SYM ,/, one/PRP of/IN the/DT few/JJ nitrosamines/NNS tested/VBN thus/RB far/RB that/WDT has/VBZ not/RB induced/VBN neoplasms/NNS in/IN rats/NNS ,/, caused/VBD a/DT high/JJ incidence/NN of/IN respiratory/JJ tract/NN tumors/NNS in/IN Syrian/JJ golden/JJ hamsters/NNS treated/VBD sc/NN with/IN single/JJ or/CC weekly/JJ doses/NNS of/IN the/DT compound/NN ./.
@@76815397617/CD Cytogenetic/JJ studies/NNS were/VBD performed/VBN in/IN lymphocytes/NNS from/IN hospital/NN workers/NNS exposed/VBN to/IN low/JJ doses/NNS of/IN radiation/NN (/( 1/CD ./CD 6-42/CD ./CD 71/CD mSv/NN )/SYM ./.
@@117912921650/CD According/VBG to/IN the/DT laboratory/NN results/NNS ,/, the/DT application/NN of/IN neural/JJ network/NN can/MD solve/VB the/DT problem/NN successfully/RB ./.
@@91149724028/CD Upon/IN induction/NN of/IN SOS/NN ,/, viability/NN increased/VBD 2-6-fold/JJ ./.
@@19846658911/CD Processing/NNP ,/, secretion/NN ,/, and/CC immunoreactivity/NN of/IN carboxy/JJ terminally/RB truncated/JJ dengue-2/GENE virus/NN envelope/NN proteins/NNS expressed/VBN in/IN insect/NN cells/NNS by/IN recombinant/JJ baculoviruses/NNS ./.
@@105432707218/CD Despite/IN i/CD ./CD v/CD ./. steroid/JJ therapy/NN ,/, [/NN NOexh/NN ]/NN remained/VBD elevated/VBN throughout/IN recovery/NN (/( 37/CD ./CD 9+/CD //CD -4/CD ./CD 8/CD ppb/NN ,/, p/GENE </GENE 0/GENE ./GENE 001/GENE )/SYM until/IN discharge/NN (/( 40/CD ./CD 9+/CD //CD -4/CD ./CD 3/CD ppb/NN ,/, p/GENE </GENE 0/GENE ./GENE 001/GENE )/SYM ./.
@@25462343194/CD Similarly/RB ,/, supraventricular/JJ tachycaydia/NN following/IN resuscitative/JJ efforts/NNS appeared/VBN to/IN be/VB associated/VBN with/IN a/DT negative/JJ outcome/NN ./.
@@11025367854/CD Abnormalities/NNS of/IN plasma/NN cholecystokinin/NEWGENE were/VBD observed/VBN only/RB in/IN patients/NNS with/IN delayed/JJ gastric/JJ emptying/NN ./.
@@65169776309/CD Reaction/NN of/IN human/JJ organism/NN to/IN exercise/NN ./.
@@18086022414/CD In/NN sixteen/CD patients/NNS with/IN moderate/JJ essential/JJ hypertension/NN the/DT effects/NNS of/IN 10-day/NN nifedipine/NN treatment/NN on/IN serum/JJ uric/JJ acid/NN and/CC renal/JJ excretion/NN of/IN uric/JJ acid/NN were/VBD evaluated/VBN ./.
@@93955259800/CD We/PRP now/RB demonstrate/VBP that/IN CCAAT/MULTIGENE //MULTIGENE enhancer-binding/MULTIGENE protein/MULTIGENE (/( C/CONTEXTGENE //CONTEXTGENE EBP/CONTEXTGENE )/SYM delta/NN is/VBZ a/DT major/JJ component/NN of/IN a/DT PGE2-stimulated/MULTIGENE DNA-protein/MULTIGENE complex/MULTIGENE involving/VBG HS3D/GENE and/CC find/VB that/IN C/GENE //GENE EBPdelta/GENE transactivates/VBZ IGF-I/MULTIGENE promoter/MULTIGENE 1/MULTIGENE through/RB this/DT site/NN ./.
@@21633821715/CD To/TO characterize/VB the/DT O7-LPS/MULTIGENE region/MULTIGENE ,/, the/DT recombinant/JJ cosmids/NNS pJHCV31/GENE and/CC pJHCV32/GENE were/VBD mutagenized/VBN by/IN transposon/NN mutagenesis/NN with/IN Tn3HoHo1/GENE ,/, which/WDT carries/VBZ a/DT promoterless/MULTIGENE lac/MULTIGENE operon/MULTIGENE and/CC can/MD therefore/RB generate/VB lacZ/MULTIGENE transcriptional/MULTIGENE fusions/MULTIGENE with/IN target/NN DNA/NN sequences/NNS ./.
@@97338541317/CD The/DT only/RB abundant/JJ viral/JJ transcript/NN expressed/VBN during/IN latency/NN is/VBZ the/DT latency-related/JJ (/( LR/NN )/SYM RNA/NN ./.
@@10210918374/CD The/DT influence/NN of/IN adrenergic/JJ nerves/NNS of/IN the/DT response/NN of/IN blood/NN vessels/NNS in/IN the/DT rabbit/NN ear/NN to/IN 2--phenylalanine-8-lysine/MULTIGENE vasopressin/MULTIGENE (/( Octapressin/CONTEXTGENE )/SYM ./.
@@10635209452/CD Following/VBG conditioning/JJ ,/, a/DT single/JJ coat/NN of/IN adhesive/NN was/VBD applied/VBN and/CC light-cured/JJ ./.
@@110297044770/CD In/NN transient/JJ analysis/NN using/VBG particle/NN bombardment/NN of/IN tobacco/NN leaf/NN sections/NNS ,/, a/DT tetramer/NN of/IN the/DT distB/GENE ABRE/NNP (/( abscisic/JJ acid-responsive/JJ element/NN )/SYM mediated/JJ transactivation/NN by/IN ABI3/GENE and/CC ABI3-dependent/GENE response/NN to/IN ABA/NN ,/, whereas/IN a/DT tetramer/NN of/IN the/DT composite/JJ RY/MULTIGENE //MULTIGENE G/MULTIGENE complex/MULTIGENE ,/, containing/MULTIGENE RY/MULTIGENE repeats/NNS and/CC a/DT G-box/NN ,/, mediated/JJ only/RB ABA-independent/NNP transactivation/NN by/IN ABI3/GENE ./.
@@7753027540/CD The/DT gene/NN pairs/NNS psbB-psbT/JJ and/CC psbH-psbN/JJ are/VBP cotranscribed/VBN from/IN opposite/NN strands/NNS ./.
@@103934221160/CD About/IN 20/CD kb/NN upstream/RB of/IN LAMB2/GENE we/PRP found/VBP a/DT gene/NN encoding/VBG a/DT transcribed/VBN ,/, non-processed/NNP LAMB2-like/NNP pseudogene/NN (/( LAMB2L/NNP )/SYM ./.
@@8710371542/CD Site/MULTIGENE S-II/MULTIGENE also/RB spans/VBZ a/DT 23/CD bp/NN sequence/NN containing/JJ two/JJ tandem/NN consensus/NN binding/JJ sites/NNS with/IN three/CD base/NN pair/NN mismatches/NNS in/IN each/DT and/CC a/DT one/PRP base/NN pair/NN deletion/NN ./.
@@105440374986/CD FZD4/GENE is/VBZ homologous/JJ to/IN FZD9/CD and/CC FZD10/NNP ,/, and/CC overall/JJ amino/JJ acid/NN identity/NN is/VBZ as/IN follows/VBZ :/: FZD4/GENE vs/NNP FZD9/CD ,/, 51/CD ./CD 6%/CD ;/: FZD4/GENE vs/NNP FZD10/GENE ,/, 51/NN ./NN 2%/NN ;/: FZD9/CD vs/NNP FZD10/NNP ,/, 65/CD ./CD 7%/CD ./.
@@115593663676/CD E2F1-mediated/JJ transcriptional/JJ inhibition/NN of/IN the/DT plasminogen/MULTIGENE activator/MULTIGENE inhibitor/MULTIGENE type/MULTIGENE 1/MULTIGENE gene/MULTIGENE ./.
@@25453578318/CD The/DT mustard/NN chloroplast/NN gene/MULTIGENE rps16/MULTIGENE is/VBZ split/JJ by/IN an/DT 887/CD bp/NN group/NN II/NNP (/( or/CC III/NNP )/SYM intron/NN ./.
@@20055472616/CD Armed/NNP with/IN a/DT clear/JJ understanding/NN of/IN the/DT pathophysiologic/JJ pathways/NNS that/WDT may/MD cause/VB and/WDT //WDT or/WDT contribute/VBP to/IN the/DT development/NN of/IN unconjugated/JJ hyperbilirubinemia/NN and/CC the/DT associated/VBN jaundice/NN ,/, the/DT practitioner/NN will/MD be/VB successful/JJ in/IN helping/JJ the/DT family/NN understand/VB their/PRP child's/NNS illness/NN ./.
@@112439809870/CD Twenty-five/CD patients/NNS also/RB received/VBN PET/NEWGENE examinations/NNS during/IN the/DT staging/JJ procedures/NNS ./.
@@35711354233/CD Reward/VB value/NN of/IN prosodic/JJ features/NNS of/IN language/NN for/IN autistic/JJ ,/, mentally/RB retarded/VBN ,/, and/CC normal/JJ children/NNS ./.
@@24613687889/CD In/NN this/DT report/NN we/PRP describe/VBP for/IN the/DT first/JJ time/NN the/DT complete/JJ primary/JJ structure/NN of/IN type/NN X/NN collagen/NEWGENE ,/, based/VBN on/IN cloning/NN and/CC sequencing/VBG of/IN cDNA/NN and/CC genomic/JJ DNA/NN ./.
@@85329678502/CD An/DT infectious/JJ origin/NN should/MD always/RB be/VB excluded/VBN since/IN specific/JJ etiologic/JJ therapy/NN may/MD be/VB implemented/VBN ./.
@@106989748417/CD We/PRP have/VBP mapped/VBN the/DT human/MULTIGENE STAG3/MULTIGENE gene/MULTIGENE to/IN the/DT 7q22/MULTIGENE region/MULTIGENE of/IN chromosome/NN 7/CD ;/: six/CD human/MULTIGENE STAG3-related/MULTIGENE genes/MULTIGENE have/VBP also/RB been/VBN mapped/VBN :/: two/JJ at/IN 7q22/GENE near/IN the/DT functional/JJ gene/NN ,/, one/PRP at/IN 7q11/CD ./CD 22/CD ,/, and/CC three/CD at/IN 7q11/CD ./CD 23/CD ,/, two/NN of/IN them/PRP flanking/JJ the/DT breakpoints/NNS commonly/RB associated/VBN with/IN the/DT Williams-Beuren/NNP syndrome/NN (/( WBS/NNS )/SYM deletion/NN ./.
@@106662223937/CD Surprisingly/RB ,/, 3/CD full-length/JJ murine/MULTIGENE survivin/MULTIGENE cDNA/MULTIGENE clones/NNS were/VBD isolated/VBN ,/, predicting/JJ the/DT existence/NN of/IN 3/CD distinct/JJ survivin/MULTIGENE proteins/MULTIGENE ./.
@@9325278218/CD A/DT data/NN base/NN homology/NN search/NN revealed/VBN that/IN the/DT predicted/VBN ER1/GENE amino/JJ acid/NN sequence/NN contains/VBZ three/CD regions/NNS of/IN similarity/NN to/IN the/DT rat/NN and/CC human/JJ proteins/NNS encoded/VBN by/IN the/DT metastasis-associated/MULTIGENE gene/MULTIGENE ,/, mta1/GENE ,/, and/CC two/JJ regions/NNS of/IN similarity/NN to/IN the/DT Caenorhabditis/NNP elegans/NNS sequence/NN that/WDT is/VBZ similar/JJ to/IN mta1/GENE ./.
@@16416282244/CD The/DT modalities/NNS for/IN using/VBG reference/NN values/NNS for/IN individual/JJ subjects/NNS as/RB well/VBP as/IN for/IN groups/NNS are/VBP then/RB discussed/VBN and/CC the/DT main/JJ points/NNS of/IN research/NN which/WDT must/MD be/VB faced/VBN in/IN the/DT near/IN future/JJ regarding/IN reference/NN values/NNS are/VBP highlighted/VBN ./.
@@104775839562/CD Cross-linking/VBG the/DT B/MULTIGENE cell/MULTIGENE Ag/MULTIGENE receptor/MULTIGENE (/( BCR/CONTEXTGENE )/SYM to/IN surface/NN Fc/MULTIGENE receptors/MULTIGENE for/IN IgG/CONTEXTGENE (/( Fc/MULTIGENE gamma/MULTIGENE R/MULTIGENE )/SYM inhibits/VBZ G1-to-S/GENE progression/NN ;/: the/DT mechanism/NN by/IN which/WDT this/DT occurs/VBZ is/VBZ not/RB completely/RB known/VBP ./.
@@94992543220/CD The/DT DSF/GENE regimen/NN appears/VBZ to/IN have/NN significant/JJ activity/NN in/IN patients/NNS who/WP have/VBP metastatic/JJ pancreatic/JJ islet-cell/NN carcinoma/NN ,/, and/CC patient/NN tolerance/NN of/IN the/DT regimen/NN is/VBZ excellent/JJ ,/, thus/RB warranting/JJ further/JJ investigation/NN ./.
@@78589861141/CD A/DT comparative/JJ study/NN by/IN holographic/JJ interferometry/NN of/IN ten/CD porcine/JJ bioprosthetic/JJ valves/NNS (/( seven/JJ Carpentier-Edwards/JJ SAV/GENE ,/, two/JJ BioImplant/NNP and/CC one/PRP Valcor/NNP )/SYM with/IN five/CD human/JJ aortic/JJ valves/NNS before/IN and/CC after/IN glutaraldehyde/NN treatment/NN is/VBZ presented/VBN ./.
@@112076091876/CD In/NN contrast/NN ,/, the/DT failure/NN of/IN the/DT QKTT/MULTIGENE motif/MULTIGENE and/CC TGN46/NNP cytoplasmic/JJ tail/NN to/IN induce/VB steady-state/JJ ER/NN localization/NN of/IN vesicular/JJ stomatitis/NN virus/NN glycoprotein/NN (/( VSVG/NN )/SYM chimeras/NNS in/IN HeLa/DT and/CC NRK/NN cells/NNS indicates/VBZ that/IN significant/JJ differences/NNS in/IN early/JJ secretory/JJ trafficking/NN also/RB exist/VB ./.
@@26915578902/CD The/DT incidence/NN of/IN fetal/JJ breathing/JJ movements/NNS (/( 06/CD ./CD 00-10/CD ./CD 00/CD h/NN )/SYM decreased/VBN with/IN increasing/JJ gestational/JJ age/NN while/CC fetal/JJ arterial/JJ concentrations/NNS of/IN plasma/NN PGE/NN increased/VBN significantly/RB over/RB the/DT same/JJ period/NN of/IN gestation/NN ./.
@@106497384407/CD Two/CD episodes/NNS of/IN peritonitis/NN occurred/VBN while/CC the/DT patient/NN received/VBD CAPD/NN (/( 1/CD episode/NN //NN 3/NN ./NN 5/NN patient-months/NNS )/SYM ./.
@@1832152233/CD Potential/JJ translational/JJ start/NN signals/NNS are/VBP upstream/RB of/IN ORF1/GENE and/CC ORF2/GENE ./.
@@90578401387/CD The/DT recombinant/JJ protein/NN was/VBD purified/VBN to/IN homogeneity/NN by/IN (/( NH4/DT )/NN 2SO4-precipitation/NN and/CC affinity/NN chromatography/NN on/IN 5'/CD AMP-Sepharose/NNP ./.
@@107131558944/CD Here/RB we/PRP show/VBP that/IN IIIa/MULTIGENE pre-mRNA/MULTIGENE splicing/JJ is/VBZ activated/VBN more/RB than/IN 200-fold/JJ in/IN nuclear/JJ extracts/NNS prepared/VBN from/IN late/JJ adenovirus-infected/JJ cells/NNS (/( Ad-NE/JJ )/SYM compared/VBN to/IN uninfected/JJ HeLa/DT cell/NN nuclear/JJ extracts/NNS (/( HeLa-NE/NNP )/SYM ./.
@@20942212694/CD Diuresis/NNS was/VBD induced/VBN by/IN scheduled/JJ drinking/NN of/IN tea/NN (/( 150/CD ml/NN //NN h/NN )/SYM ./.
@@96623395715/CD In/NN these/DT cells/NNS ,/, ras-induced/JJ transition/NN is/VBZ accompanied/VBN by/IN a/DT strong/JJ induction/NN of/IN AP-1-binding/JJ activity/NN along/IN with/IN increased/VBN expression/NN of/IN CD44/MULTIGENE mRNA/MULTIGENE and/CC protein/NN ./.
@@96661145916/CD Structural/NNP analysis/NN of/IN the/DT 5'-regulatory/MULTIGENE region/MULTIGENE reveals/VBZ that/IN the/DT c-met/MULTIGENE promoter/MULTIGENE lacks/VBZ TATA/NN or/CC CAAT/MULTIGENE elements/MULTIGENE but/CC has/VBZ an/DT extremely/RB high/JJ G-C/NEWGENE content/NN and/CC multiple/JJ Sp1/MULTIGENE binding/MULTIGENE sites/MULTIGENE ./.
@@114600351337/CD In/NN the/DT last/NN case/NN ,/, both/DT hydroxychloroquine/NN ,/, carbamazepine/NN and/CC fluvoxamine/NN had/VBP a/DT common/JJ imputability/NN which/WDT was/VBD plausible/JJ ./.
@@22509196724/CD Perceptions/NNS of/IN illness/NN intrusiveness/NN were/VBD significantly/RB higher/JJ when/CC both/DT muscle/MULTIGENE cramp/MULTIGENE and/CC headache/NN symptoms/NNS occurred/VBN during/IN one/PRP or/CC more/JJ assessment/NN intervals/NNS as/IN compared/VBN to/IN when/CC muscle/NN cramps/NNS or/CC headaches/NNS ,/, only/RB ,/, occurred/VBN ./.
@@85526704603/CD Abp1/GENE preferentially/RB binds/VBZ to/IN multiple/JJ sites/NNS in/IN ARS/NNS 3002/CD and/CC to/IN the/DT DNA/NN polymer/NN poly/NN [/NN d/NN (/NN A/NN ./NN T/NN )/NN ]/NN ./.
@@92347433659/CD Neither/CC of/IN these/DT proteins/NNS ,/, individually/RB or/CC as/IN a/DT pair/NN ,/, can/MD bind/VB the/DT alpha-globin/NN 3'UTR/CD unless/IN they/PRP are/VBP complexed/VBN with/IN the/DT remaining/JJ non-poly/NN (/NN C/NN )/NN binding/JJ proteins/NNS of/IN the/DT alpha-complex/NN ./.
@@90606221833/CD This/DT is/VBZ the/DT first/JJ report/NN that/IN an/DT in/NN vitro-synthesized/MULTIGENE alphavirus/MULTIGENE RNA/MULTIGENE lacking/JJ a/DT poly/NN (/NN A/NN )/NN tail/NN can/MD initiate/VB infection/NN and/CC produce/VB 3'/CD polyadenylated/JJ viral/JJ genome/NN in/IN vivo/NN ./.
@@11701431543/CD Groups/NNS of/IN ten/CD dependent/JJ and/CC ten/CD saline/JJ mice/NNS were/VBD singly/RB tested/VBN in/IN both/DT light/NN and/CC dark/JJ conditions/NNS in/IN each/DT of/IN five/CD covered/VBN cylinders/NNS (/( 2-23/JJ in/IN high/JJ )/SYM ./.
@@97269917903/CD Mapping/NN of/IN the/DT DNA/NN binding/JJ domain/NN of/IN the/DT copper-responsive/JJ transcription/MULTIGENE factor/MULTIGENE Mac1/MULTIGENE from/IN Saccharomyces/NN cerevisiae/NN ./.
@@27652147597/CD Hence/RB follows/VBZ Kurti's/GENE demand/NN to/IN mete/VB out/RB appropriate/JJ importance/NN to/IN the/DT arguments/NNS ./.
@@67828694806/CD Nitrogen/NN balance/NN was/VBD compared/VBN ,/, and/CC metabolic/JJ complications/NNS were/VBD monitored/VBN by/IN evaluating/VBG BUN/NN ,/, serum/JJ creatinine/NN ,/, creatinine/NN clearance/NN ,/, serum/JJ CO2/NN ,/, SGOT/NN ,/, SGPT/NN ,/, serum/JJ LDH/NEWGENE ,/, and/CC serum/JJ alkaline/MULTIGENE phosphatase/MULTIGENE ./.
@@60953728558/CD The/DT drug/NN was/VBD given/VBP in/IN a/DT daily/JJ oral/JJ dose/NN of/IN 0/CD ./CD 5/CD g/GENE //GENE m2/GENE ,/, 3/CD ./CD 5/CD h/NN prior/NN to/IN each/DT radiation/NN treatment/NN ./.
@@92656422801/CD Because/IN the/DT biosynthetic/JJ pathway/NN to/IN the/DT vacuole/NN intersects/VBZ with/IN the/DT endocytic/JJ pathway/NN ,/, internalization/NN of/IN a/DT bulk/NN membrane/NN endocytic/JJ marker/NN FM/NNP 4-64/NN was/VBD assayed/VBN in/IN the/DT sop/MULTIGENE mutants/MULTIGENE ./.
@@104723141748/CD RESULTS/NNS :/: 256/CD Periods/NNS of/IN TTP/NN or/CC PUNP/GENE were/VBD reported/VBN by/IN men/NNS and/CC 174/CD by/IN women/NNS ./.
@@90461869003/CD The/DT protector/NN doubled/VBD the/DT estimated/VBN fall/NN distance/NN for/IN fracture/NN of/IN the/DT trochanter/NN ./.
@@92364419194/CD The/DT remaining/JJ 80/CD patients/NNS underwent/VBD recordings/NNS of/IN ECG/NN ,/, beat-to-beat/JJ arterial/JJ oxygen/NN saturation/NN (/( SaO2/GENE )/SYM ,/, and/CC respiration/NN during/IN both/DT spontaneous/JJ and/CC controlled/VBN breathing/JJ ./.
@@974787345/CD The/DT SH2-containing/JJ adapter/NN protein/MULTIGENE GRB10/MULTIGENE interacts/VBZ with/IN BCR-ABL/GENE ./.
@@29195303628/CD Controlled/JJ versus/IN uncontrolled/JJ reperfusion/NN of/IN ischemic/JJ myocardium/NN after/IN experimental/JJ coronary/JJ artery/NN occlusion/NN was/VBD studied/VBN to/IN determine/VB the/DT effect/NN on/IN regional/JJ ventricular/JJ wall/NN motion/NN and/CC associated/VBN biochemical/JJ alterations/NNS ./.
@@106799228913/CD No/DT somatic/JJ mutations/NNS were/VBD found/VBN in/IN any/DT of/IN the/DT samples/NNS ,/, suggesting/VBG that/IN ING1/GENE is/VBZ not/RB a/DT tumor/NN suppressor/NN gene/NN target/NN in/IN head/NN and/CC neck/NN cancer/NN ./.
@@105804384259/CD In/NN electrophoretic/JJ mobility/NN shift/NN assay/NN (/( EMSA/NN )/SYM ,/, this/DT GLUT4/MULTIGENE repressor/MULTIGENE element/MULTIGENE (/( G4RE/GENE )/SYM generated/VBN specific/JJ bands/NNS with/IN nuclear/JJ extracts/NNS from/IN preadipocytes/NNS ,/, but/CC not/RB from/IN adipocytes/NNS ./.
@@96674822320/CD The/DT report/NN highlights/VBP the/DT possible/JJ contribution/NN of/IN stress/MULTIGENE factors/MULTIGENE in/IN the/DT context/NN of/IN therapy/NN resistant/JJ periodontal/JJ disease/NN ,/, and/CC the/DT results/NNS seem/VBP to/IN be/VB understandable/JJ within/IN the/DT context/NN of/IN a/DT stress/NN system/NN disorder/NN perspective/NN ./.
@@19680433598/CD Four/CD putative/JJ positive/JJ cDNA/NN clones/NNS were/VBD isolated/VBN ,/, and/CC the/DT largest/JJS insert/NN (/( pASB-1/GENE )/SYM was/VBD sequenced/VBN in/IN both/DT orientations/NNS ./.
@@19902666592/CD DNA-protein/MULTIGENE UV/MULTIGENE cross-linking/VBG studies/NNS indicated/VBN that/IN UHF-1/GENE has/VBZ an/DT electrophoretic/JJ mobility/NN on/IN sodium/NN dodecyl/NN sulfate-acrylamide/JJ gels/NNS of/IN approximately/RB 85/CD kDa/NN and/CC suggested/VBN that/IN additional/JJ proteins/NNS ,/, specific/JJ to/IN each/DT promoter/NN ,/, bind/NN to/IN each/DT site/NN ./.
@@106509392492/CD In/NN myometrial/JJ SMC/NN ,/, both/DT isoforms/NNS of/IN the/DT progesterone/MULTIGENE receptor/MULTIGENE ,/, PR-B/GENE and/CC PR-A/GENE ,/, caused/VBD a/DT ligand-dependent/JJ activation/NN of/IN PGDH-2368/GENE //GENE luc3/GENE ./.
@@86188641646/CD Further/JJ analysis/NN of/IN this/DT domain/NN by/IN in/IN vitro/FW mutagenesis/NN pointed/VBN to/IN a/DT core/NN of/IN hydrophobic/NN and/CC acidic/NN residues/NNS as/IN critical/JJ for/IN the/DT activity/NN ./.
@@65419326331/CD Methods/NNS of/IN clinical/JJ and/CC experimental/JJ algesimetry/NN are/VBP described/VBN that/WDT have/VBP been/VBN used/VBN to/IN evaluate/VB effects/NNS of/IN peripherally/RB and/CC centrally/RB acting/JJ analgesics/NNS ./.
@@70443896817/CD Facts/NNP on/IN the/DT Economic/NNP Recovery/NNP Tax/NN Act/NN of/IN 1981/CD for/IN speech-language/NN pathologists/NNS and/CC audiologists/NNS ./.
@@93156784731/CD However/RB ,/, Cbf5p/GENE was/VBD found/VBN to/IN be/VB nucleolar/JJ and/CC is/VBZ highly/RB homologous/JJ to/IN the/DT rat/NN nucleolar/JJ protein/MULTIGENE NAP57/MULTIGENE ,/, which/WDT coimmunoprecipitates/NNS with/IN Nopp140/NEWGENE and/CC which/WDT is/VBZ postulated/VBN to/IN be/VB involved/VBN in/IN nucleolar-cytoplasmic/JJ shuttling/VBG (/( U/NNP ./NNP
@@95829537131/CD RESULTS/NNS :/: Horses/NNS with/IN colic/JJ had/VBP significantly/RB higher/JJ fibrinogen/NN concentration/NN ,/, greater/JJR alpha/NN 2AP/CD and/CC protein/MULTIGENE C/MULTIGENE activities/NNS ,/, and/CC longer/JJR PT/NN and/CC APTT/NN than/IN did/VBD healthy/JJ horses/NNS ./.
@@61112835933/CD Trial/NN treatment/NN of/IN schizophrenia/NN with/IN des-Tyr-gamma-endorphin/NN ./.
@@77522231003/CD The/DT Myc/MULTIGENE LZ/MULTIGENE was/VBD found/VBN to/IN prevent/VB homodimeric/JJ interactions/NNS ,/, thus/RB explaining/VBG Myc/NN inability/NN to/IN homodimerize/VB efficiently/RB ./.
@@96459425389/CD A/DT major/JJ pool/NN of/IN Dsg-plakoglobin/NNP complexes/NNS sedimented/VBN at/IN 8S/CD and/CC exhibited/VBD a/DT 1/CD :/: 1/CD stoichiometry/NN ./.
@@112360561067/CD Conclusion/NNS :/: The/DT Lp/NN (/NN a/NN )/NN levels/NNS in/IN these/DT children/NNS were/VBD the/DT lower/RBR ever/RB reported/VBN ./.
@@82689122403/CD In/NN vitro/FW translation/NN experiments/NNS show/VBP that/IN human/MULTIGENE cDNA/MULTIGENE derived/MULTIGENE RNA/MULTIGENE translates/VBZ into/IN a/DT protein/NN with/IN a/DT mobility/NN of/IN 44-46/JJ kD/NN on/IN SDS/NN polyacrylamide/NN gels/NNS ./.
@@25459035530/CD Antibodies/NNS raised/VBN to/IN the/DT expressed/VBN NS3/GENE by/IN immunization/NN of/IN mice/NNS detected/VBD both/DT NS3/GENE and/CC NS3A/GENE in/IN BTV-10-infected/JJ BHK/NN cells/NNS but/CC not/RB in/IN purified/VBN BTV-10/GENE virus/NN particles/NNS ./.
@@33320221913/CD There/EX is/VBZ a/DT cysteine/MULTIGENE clustering/MULTIGENE region/MULTIGENE in/IN an/DT N-terminal/MULTIGENE region/MULTIGENE of/IN the/DT c-raf/NN (/NN -1/NN )/NN product/NN deduced/VBN from/IN the/DT nucleotide/NN sequence/NN ,/, and/CC this/DT cysteine/MULTIGENE clustering/MULTIGENE region/MULTIGENE was/VBD found/VBN to/IN be/VB highly/RB homologous/JJ to/IN that/DT present/NN in/IN an/DT N-terminal/MULTIGENE region/MULTIGENE of/IN protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE ,/, although/IN ,/, in/IN the/DT latter/JJ cysteine/MULTIGENE clusters/MULTIGENE are/VBP present/VB in/IN duplicate/NN ./.
@@88165073818/CD In/NN transient/JJ cotransfections/NNS E1A/NN could/MD induce/VB the/DT activity/NN of/IN the/DT p53/MULTIGENE promoter/MULTIGENE to/IN a/DT high/JJ level/NN ;/: 12S/CD E1A/NN was/VBD threefold/RB as/RB efficient/JJ as/IN 13S/CD E1A/NN in/IN this/DT activity/NN ,/, and/CC YY1/GENE bound/JJ to/IN the/DT composite/JJ element/NN was/VBD shown/VBP to/IN mediate/VB 55%/NN of/IN this/DT induction/NN ./.
@@15778196545/CD Two/CD variant/MULTIGENE PRP-precursor/MULTIGENE alleles/MULTIGENE occur/VBP which/WDT slightly/RB differ/VB in/IN the/DT number/NN of/IN repeats/NNS in/IN domain/NN C/NNP ./NNP
@@78717217036/CD The/DT first/JJ open/JJ reading/JJ frame/NN of/IN the/DT blueberry/NN scorch/NN carlavirus/NN (/( BBScV/NNP )/SYM genome/NN encodes/VBZ a/DT putative/JJ replication-associated/MULTIGENE protein/MULTIGENE of/IN 223/CD kDa/NN (/( p223/GENE )/SYM ./.
@@17629145609/CD Hence/RB ,/, the/DT uPA/MULTIGENE promoter/MULTIGENE contains/VBZ multiple/JJ weak/JJ cis-acting/JJ elements/NNS distributed/VBN over/RB 7/CD ./CD 0/CD kb/NN 5'/CD to/IN the/DT translation/NN start/NN site/NN ./.
@@21054974381/CD An/DT evolutionary/JJ comparison/NN of/IN amino/JJ acid/NN sequences/NNS of/IN 34/MULTIGENE HSP70/MULTIGENE proteins/MULTIGENE from/IN 17/CD species/NN suggests/VBZ that/IN BiP/MULTIGENE genes/MULTIGENE share/VBP a/DT common/JJ ancestor/NN ,/, which/WDT diverged/VBN from/IN other/DT HSP70/MULTIGENE genes/MULTIGENE near/IN the/DT time/NN when/CC eukaryotes/NNS first/RB appeared/VBN ./.
@@107343127292/CD To/TO understand/VB whether/IN Shc/DT localization/NN in/IN membrane/NN rafts/NNS is/VBZ sufficient/JJ to/IN regulate/VB Shc/NEWGENE function/NN ,/, we/PRP constructed/VBD a/DT Shc/DT chimera/NN containing/JJ the/DT Ras/NNS membrane/NN localization/NN motif/NN at/IN the/DT C-terminus/NN ./.
@@75184602728/CD On/IN the/PDT other/DT hand/NN ,/, cells/NNS containing/MULTIGENE a/MULTIGENE PTP1C/MULTIGENE in/IN which/WDT the/DT catalytic/JJ site/NN had/VBP been/VBN inactivated/VBN through/JJ mutagenesis/NN ,/, stably/RB phosphorylated/VBN the/DT phosphatase/NN ./.
@@9115909068/CD Haemodynamic/NN responses/NNS to/IN antagonism/NN of/IN bocurarine/NN block/NN with/IN atropine-neostigmine/JJ mixture/NN in/IN children/NNS ./.
@@40251784175/CD Retrospective/JJ analyses/NNS of/IN this/DT death/NN revealed/VBD a/DT significant/JJ decrease/NN of/IN the/DT left/JJ ventricular/JJ (/( LV/JJ )/SYM end-diastolic/JJ volume/NN index/NN (/( EDVI/NNS )/SYM of/IN 21/CD ml/GENE //GENE m2/GENE (/( 36%/NN of/IN normal/JJ )/SYM ./.
@@109582717943/CD METHODS/IN AND/CC RESULTS/NNS :/: We/PRP prospectively/RB compared/VBD the/DT automated/JJ measurements/NNS of/IN left/NN ventricular/JJ ejection/NN fraction/NN (/( LVEF/NN )/SYM and/CC volumes/NNS from/IN rest-injected/JJ gated/MULTIGENE Technetium/MULTIGENE 99m/MULTIGENE (/( Tc99m/GENE )/SYM perfusion/NN SPECT/NN with/IN equilibrium/NN radionuclide/NN angiocardiography/NN (/( ERNA/NNP )/SYM in/IN 62/NNP patients/NNS and/CC the/DT assessment/NN of/IN regional/JJ function/NN with/IN echocardiography/NN in/IN 22/CD patients/NNS ./.
@@2556269234/CD The/DT DNA/NN helix/NN at/IN the/DT tandemly/RB repeated/JJ ,/, 13mer/MULTIGENE sequence/MULTIGENE is/VBZ thermodynamically/RB unstable/JJ ,/, as/IN evidenced/VBN by/IN hypersensitivity/NN to/IN single-strand-specific/MULTIGENE nuclease/MULTIGENE in/IN a/DT negatively/RB supercoiled/VBN plasmid/NN ,/, and/CC demonstrated/VBD by/IN stable/JJ DNA/NN unwinding/JJ seen/VBP after/IN two-dimensional/JJ gel/NN electrophoresis/NN of/IN topoisomers/NNS ./.
@@15695817924/CD Here/RB ,/, we/PRP present/VBP evidence/VBP for/IN a/DT model/NN in/IN which/WDT mRNA/NN sequences/NNS up/JJ to/IN around/IN 100/CD nucleotides/NNS downstream/RB from/IN the/DT start/NN codon/NN of/IN 21K/CD fold/NN back/NN and/CC base-pair/NN to/IN the/DT 21K/MULTIGENE translation/MULTIGENE initiation/MULTIGENE region/MULTIGENE ,/, thereby/RB decreasing/JJ the/DT translation/NN initiation/NN frequency/NN ./.
@@113316137431/CD Consistent/JJ effects/NNS on/IN pVHL/NEWGENE function/NN were/VBD observed/VBN for/IN all/DT mutations/NNS within/IN each/DT subclass/NN ./.
@@80845929663/CD In/NN HeLa/DT x/NN fibroblast/NN cell/NN hybrids/NNS its/PRP expression/NN correlates/VBP with/IN tumorigenicity/NN ./.
@@79619577632/CD Furthermore/RB ,/, our/PRP data/NN also/RB show/VB that/IN ,/, in/IN addition/NN to/IN TEF-1/GENE ,/, another/DT HF-1a-related/MULTIGENE factor/MULTIGENE may/MD be/VB recognized/VBN by/IN the/DT alpha-MHC/MULTIGENE gene/MULTIGENE EM/MULTIGENE element/MULTIGENE ./.
@@71065346904/CD In/NN this/DT way/NN it/PRP is/VBZ possible/JJ to/IN simulate/VB the/DT growth/NN function/NN of/IN the/DT embryofetal/JJ curve/NN of/IN the/DT length'/NN increase/NN of/IN man/NN and/CC the/DT curve/NN of/IN the/DT mass'/NN increase/NN of/IN rat/NN ./.
@@84238318376/CD The/DT use/NN of/IN this/DT model/NN for/IN investigating/VBG pathophysiologically/RB significant/JJ issues/NNS in/IN denervating/JJ diseases/NNS is/VBZ illustrated/VBN with/IN five/CD different/JJ sets/NNS of/IN parameters/NNS ./.
@@90291049923/CD The/DT 14/NN ./NN 1/NN (/NN IGLL1/NN )/NN gene/NN is/VBZ expressed/VBN in/IN a/DT lineage-/JJ and/CC stage-restricted/JJ manner/NN ./.
@@31909143886/CD Determined/VBN as/IN migration/NN differentials/NNS ,/, chemotactic/JJ and/CC chemokinetic/JJ responsiveness/NN tended/VBN to/IN be/VB higher/JJ in/IN the/DT neutropenic/JJ group/NN ./.
@@97038162587/CD IA-CT/NNP with/IN cisplatin/MULTIGENE 50/MULTIGENE mg/NN and/CC doxorubicin/MULTIGENE 30/MULTIGENE mg/NN was/VBD administered/VBN by/IN one/PRP shot/JJ method/NN in/IN bilateral/JJ internal/JJ iliac/JJ arteries/NNS ./.
@@40661949515/CD Greater/NNP attenuation/NN of/IN the/DT N1-P2/GENE and/CC baseline-P2/GENE amplitude/NN of/IN the/DT probe/NN EPs/NNS was/VBD observed/VBN when/CC the/DT probe/NN stimulus/NN was/VBD presented/VBN to/IN the/DT right/JJ ear/NN and/CC the/DT verbal/JJ material/NN presented/VBN to/IN the/DT left/NN ear/NN than/IN when/CC the/DT opposite/NN stimulation/NN arrangement/NN was/VBD used/VBN ./.
@@2259334343/CD The/DT upstream/JJ promoter/NN is/VBZ located/VBN within/IN the/DT coding/JJ sequence/NN of/IN a/DT divergent/JJ gene/MULTIGENE expressing/MULTIGENE a/MULTIGENE protein/MULTIGENE of/IN Mr/NNP 39/CD kDa/NN of/IN unknown/JJ function/NN ./.
@@75697707469/CD METHODS/IN :/: All/PDT these/DT 30/CD non-responders/NNS received/VBD an/DT extra/JJ dose/NN of/IN the/DT same/JJ vaccine/NN 2/CD months/NNS after/IN primary/JJ immunization/NN and/CC a/DT booster/NN dose/NN with/IN a/DT yeast-derived/MULTIGENE vaccine/MULTIGENE 6/MULTIGENE years/NNS later/JJR ./.
@@117877201644/CD In/NN sterilized/VBD milk/NN there/RB was/VBD a/DT slight/JJ decrease/NN of/IN linoleic/JJ acid/NN (/( C18/IN :/: 2n6/CD ;/: -0/CD ./CD 7%/CD vs/IN ./IN fresh/JJ ;/: P/NN =/SYM 0/CD ./CD 006/CD )/SYM and/CC arachidonic/JJ acid/NN (/( C20/NN :/: 4n6/CD ;/: -2/CD ./CD 5%/CD ;/: P/NN =/SYM 0/CD ./CD 045/CD )/SYM ./.
@@22177412855/CD The/DT interrelation/NN of/IN the/DT levels/NNS of/IN glucocorticoids/NNS and/CC insulin/NN in/IN the/DT blood/NN of/IN irradiated/JJ animals/NNS ./.
@@115529228667/CD CYP2C19/MULTIGENE genotype/MULTIGENE was/VBD determined/VBN by/IN the/DT polymerase/NN chain/NN reaction-restriction/JJ fragment/NN length/NN polymorphism/NN method/NN ./.
@@102070494998/CD The/DT results/NNS demonstrate/VBP that/IN the/DT Glc7/MULTIGENE phosphatase/MULTIGENE and/CC its/PRP Gac1/MULTIGENE regulatory/MULTIGENE subunit/MULTIGENE play/NN positive/JJ roles/NNS in/IN HSF/NEWGENE activation/NN of/IN CUP1/GENE transcription/NN ./.
@@25987453249/CD Most/JJS of/IN them/PRP were/VBD situated/VBN at/IN Sylvius/NN fissure/NN (/( 13/CD cases/NNS )/SYM ./.
@@76514006220/CD This/DT inhibition/NN can/MD be/VB overcome/VB by/IN mutating/JJ either/DT the/DT exon's/NNS 5'/CD or/CC 3'/CD splice/NN site/NN to/IN make/NN it/PRP correspond/VBP more/RB closely/RB to/IN the/DT relevant/JJ consensus/NN sequence/NN ./.
@@101011984832/CD A/DT database/NN search/NN has/VBZ revealed/VBN as/IN the/DT most/RB significative/JJ homology/NN a/DT match/NN with/IN the/DT human/JJ mitochondrial/JJ transcription/NN termination/NN factor/NN (/( mTERF/GENE )/SYM ,/, a/DT protein/NN that/WDT also/RB binds/VBZ DNA/NN as/IN a/DT monomer/NN and/CC contains/VBZ three/CD leucine/MULTIGENE zippers/MULTIGENE forming/JJ intramolecular/JJ interactions/NNS ./.
@@91214764813/CD PRH75/GENE ,/, a/DT new/JJ nucleus-localized/JJ member/NN of/IN the/DT DEAD-box/MULTIGENE protein/MULTIGENE family/MULTIGENE from/IN higher/JJ plants/NNS ./.
@@82897935524/CD Furthermore/RB ,/, the/DT negative/JJ transcriptional/JJ effect/NN of/IN COUP-TFs/GENE is/VBZ dominant/JJ over/RB the/DT activating/JJ effect/NN of/IN the/DT Oct4/GENE embryonic/JJ stem/NN cell-specific/MULTIGENE enhancer/MULTIGENE ./.
@@105854804614/CD Point/NNP mutations/NNS in/IN the/DT third/RB SH3/GENE domain/NN abolished/VBD the/DT vinexin-Sos/NNS interaction/NN ./.
@@74785147548/CD We/PRP have/VBP isolated/VBN a/DT new/JJ ,/, larger/JJR rat/MULTIGENE B-myc/MULTIGENE genomic/JJ clone/NN ./.
@@90137606891/CD Cholesterol/NN side-chain/NN cleavage/NN cytochrome/MULTIGENE P450/MULTIGENE (/( CYP11A/GENE ;/: P450scc/IN )/SYM gene/NN expression/NN is/VBZ regulated/VBN by/IN gonadotropins/NNS via/NN cAMP/NN in/IN the/DT ovary/NN and/CC by/IN ACTH/NN via/NN cAMP/NN in/IN adrenal/JJ cortical/JJ cells/NNS ./.
@@32838813967/CD Stable/NN patients/NNS have/VBP mucous/JJ hypersecretion/NN and/CC little/JJ evidence/NN of/IN acute/JJ inflammation/NN ./.
@@70841988316/CD Selenium/GENE status/NN of/IN thoroughbreds/NNS in/IN the/DT United/NNP Kingdom/NNP ./.
@@13777641988/CD The/DT carcinoma/NN was/VBD restricted/VBN within/IN the/DT epithelium/NN in/IN one/PRP ,/, the/DT mucosal/JJ layer/NN in/IN five/CD ,/, and/CC the/DT submucosal/JJ layer/NN in/IN two/NN ./.
@@68174104979/CD During/IN the/DT last/NN 6/CD months/NNS of/IN the/DT study/NN a/DT striking/JJ change/NN in/IN epidemiology/NN concerning/VBG hepatitis/MULTIGENE A/MULTIGENE was/VBD seen/VBP ,/, apparently/RB caused/VBN by/IN a/DT steep/JJ increase/NN in/IN the/DT incidence/NN of/IN this/DT type/NN of/IN hepatitis/NN among/IN drug/NN addicts/NNS ./.
@@10693246899/CD In/NN two-field/JJ nodal/JJ dissection/NN ,/, two/JJ components/NNS are/VBP included/VBN with/IN (/( modern/JJ two-field/JJ )/SYM or/CC without/IN (/( traditional/JJ two-field/JJ )/SYM nodal/JJ dissection/NN around/IN both/DT recurrent/JJ laryngeal/JJ nerve/MULTIGENE chains/MULTIGENE in/IN the/DT upper/JJ mediastinum/NN ./.
@@91320113199/CD Comparison/NNS of/IN the/DT p50/MULTIGENE sequence/MULTIGENE to/IN other/DT cloned/VBN proteins/NNS revealed/VBN 89%/CD homology/NN with/IN a/DT glycosaminoglycan-binding/MULTIGENE protein/MULTIGENE and/CC 54%/JJ homology/NN with/IN Drosophila/MULTIGENE cell/MULTIGENE cycle/MULTIGENE control/MULTIGENE protein/MULTIGENE (/( cdc/NN )/SYM 37/CD ./CD
@@49424146804/CD The/DT metabolism/NN and/CC pharmacology/NN of/IN 5-fluorouracil/GENE ./.
@@98892028835/CD Structure-function/NNS analysis/NN of/IN the/DT Z-DNA-binding/VBG domain/NN Zalpha/GENE of/IN dsRNA/MULTIGENE adenosine/MULTIGENE deaminase/MULTIGENE type/MULTIGENE I/MULTIGENE reveals/VBZ similarity/NN to/IN the/DT (/( alpha/NN +/SYM beta/NN )/SYM family/NN of/IN helix-turn-helix/NN proteins/NNS ./.
@@84193384401/CD L/NNP ./NNP ,/, Stange/NNP ,/, G/NNP ./NNP ,/, Markovich/NNP ,/, D/NN ./NN ,/, Biber/NNP ,/, J/NNP ./NNP ,/, Testar/JJ ,/, X/NNP ./NNP ,/, Zorzano/NNP ,/, A/NNP ./NNP ,/, Palacin/NNP ,/, M/NNP ./NNP ,/, and/CC Murer/NNP ,/, H/NNP ./NNP
@@77080581497/CD The/DT GRE/NNP at/IN nucleotide/NN 7640/CD is/VBZ a/DT composite/JJ GRE/NNP (/( cGRE/NN )/SYM containing/JJ an/DT overlapping/JJ activator/MULTIGENE protein-1/MULTIGENE (/( AP-1/GENE )/SYM motif/NN for/IN the/DT c-jun/MULTIGENE homodimer/MULTIGENE and/CC c-jun/MULTIGENE //MULTIGENE c-fos/MULTIGENE heterodimer/MULTIGENE ./.
@@88281422198/CD Feline/NNP leukemia/NN viruses/NNS (/( FeLVs/NNS )/SYM ,/, which/WDT are/VBP replication-competent/JJ oncoretroviruses/NNS of/IN the/DT domestic/JJ cat/NN species/NN ,/, are/VBP contagiously/RB transmitted/VBN in/IN natural/JJ environments/NNS ./.
@@75927903971/CD Altogether/RB our/PRP data/NN indicate/VB that/DT PEDF/NN belongs/VBZ to/IN the/DT subgroup/NN of/IN noninhibitory/JJ serpins/NNS and/CC that/IN its/PRP N-terminal/MULTIGENE region/MULTIGENE confers/VBZ a/DT neurite-promoting/JJ activity/NN to/IN the/DT protein/NN ./.
@@107601328119/CD Our/PRP data/NN suggest/VB that/IN ,/, at/IN least/RB at/IN high/JJ temperature/NN ,/, a/DT critical/JJ minimal/JJ level/NN of/IN Ypt/NNP protein/NN prenylation/NN is/VBZ required/VBN for/IN maintaining/VBG vesicle/NN polarization/NN ./.
@@13759138255/CD We/PRP have/VBP constructed/VBN ,/, using/VBG synthetic/JJ DNA/NN oligonucleotides/NNS ,/, a/DT U14/MULTIGENE snRNA/MULTIGENE gene/MULTIGENE which/WDT has/VBZ been/VBN positioned/VBN behind/RB a/DT T7/MULTIGENE RNA/MULTIGENE polymerase/MULTIGENE promoter/MULTIGENE site/MULTIGENE and/CC then/RB inserted/VBN into/IN a/DT plasmid/NN ./.
@@83193968924/CD On/IN T2/GENE weighted/JJ images/NNS ,/, low/JJ intensity/NN areas/NNS in/IN the/DT thalamus/NN ,/, the/DT striatum/NN ,/, the/DT anterior/JJ limb/NN of/IN the/DT internal/JJ capsule/NN ,/, the/DT tegmentum/NN of/IN midbrain/NN ,/, high/JJ intensity/NN areas/NNS in/IN middle/JJ cerebellar/JJ peduncle/NN ,/, the/DT posterior/JJ limb/NN of/IN the/DT internal/JJ capsule/NN ,/, the/DT lateral/JJ part/NN of/IN the/DT cerebral/JJ peduncle/NN ,/, and/CC the/DT cerebral/JJ white/JJ matter/NN were/VBD noted/VBN ./.
@@86474513022/CD Northern/NNP blot/NN hybridization/NN demonstrated/VBN that/IN HEP-COP/NNP was/VBD expressed/VBN in/IN a/DT wide/JJ range/NN of/IN human/JJ adult/JJ and/CC fetal/JJ tissues/NNS ./.
@@84126627681/CD We/PRP have/VBP isolated/VBN a/DT cosmid/NN containing/MULTIGENE DNA/MULTIGENE that/WDT corresponds/VBZ to/IN the/DT site/NN of/IN transposon/NN insertion/NN in/IN 257DH4/NNP and/CC have/VB localized/VBN Tn5/IN on/IN an/DT 8/CD ./CD 0/CD kb/NN EcoRI/MULTIGENE fragment/MULTIGENE ./.
@@82886334112/CD A/DT complementary/JJ DNA/NN was/VBD isolated/VBN from/IN Caenorhabditis/NNP elegans/NNS that/WDT encoded/VBN a/DT polypeptide/NN of/IN 1438/CD amino/JJ acid/JJ residues/NNS ,/, CeGAP/GENE ,/, which/WDT contains/VBZ a/DT domain/NN with/IN sequence/NN similarity/NN to/IN the/DT COOH-terminal/MULTIGENE segment/MULTIGENE (/( GTPase-activating/JJ protein/NN region/NN )/SYM of/IN Bcr/NNP and/CC other/DT known/VBP GTPase-activating/JJ proteins/NNS of/IN the/DT Rho/MULTIGENE subfamily/MULTIGENE ./.
@@14084742024/CD PaO2/GENE threshold/NN was/VBD determined/VBN through/RB an/DT indwelling/JJ O2/GENE sensor/NN catheter/NN ./.
@@7572447472/CD The/DT results/NNS of/IN a/DT quantitative/JJ study/NN of/IN vasculosyncytial/JJ membranes/NNS in/IN 123/CD placentas/NNS are/VBP presented/VBN ./.
@@82835314154/CD The/DT Stryker/NN frame/NN modification/NN to/IN the/DT standard/JJ Dornier/NNP HM3/NN lithotriptor/NN allows/VBZ for/IN improved/VBN visualization/NN and/CC easier/JJR localization/NN of/IN distal/JJ ureteral/JJ calculi/NNS compared/VBN to/IN the/DT standard/JJ gantry/NN ./.
@@10553959370/CD The/DT Ishasha/NNP samples/NNS show/VBP a/DT range/NN encompassing/VBG three/CD trophic/JJ levels/NNS ./.
@@10657238733/CD Transfection/NNS experiments/NNS demonstrated/VBN that/IN the/DT 5'-flanking/JJ region/NN (/( -1894/CD to/IN +37/CD )/SYM of/IN the/DT mStaf/MULTIGENE gene/MULTIGENE drives/NNS transcription/NN in/IN mouse/NN NMuMG/NNP cells/NNS and/CC that/IN a/DT construct/MULTIGENE containing/MULTIGENE a/MULTIGENE fragment/MULTIGENE from/IN -387/CD to/IN +37/CD showed/VBD the/DT highest/JJS transcriptional/JJ activity/NN ./.
@@93610078906/CD A/DT DNase/MULTIGENE I-hypersensitive/MULTIGENE site/MULTIGENE has/VBZ also/RB been/VBN mapped/VBN in/IN the/DT 258-base/JJ pair/NN enhancer/NN region/NN ./.
@@93687608990/CD Human/MULTIGENE PDK1/MULTIGENE is/VBZ homologous/JJ to/IN the/DT Drosophila/MULTIGENE protein/MULTIGENE kinase/MULTIGENE DSTPK61/MULTIGENE ,/, which/WDT has/VBZ been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN sex/NN differentiation/NN ,/, oogenesis/NN and/CC spermatogenesis/NN ./.
@@97676872419/CD Phylogenetic/JJ position/NN of/IN the/DT Phacotaceae/NNP within/IN the/DT Chlamydophyceaeas/NNP revealed/VBD by/IN analysis/NN of/IN 18S/MULTIGENE rDNA/MULTIGENE and/CC rbcL/MULTIGENE sequences/MULTIGENE ./.
@@86047088581/CD Additional/JJ studies/NNS with/IN new/JJ and/CC reprocessed/VBN regenerated/VBN cellulose/NN dialyzers/NNS comparing/VBG 450/CD and/CC 220/CD mL/NN //NN min/NN blood/NN flow/NN rates/NNS at/IN 10/CD minutes/NNS showed/VBD no/DT change/NN in/IN BTG/NN ./.
@@94307301879/CD S/NNP ./NNP ,/, and/CC Walter/NN ,/, P/NNP ./NNP
@@95149626166/CD M-66/NNP identified/VBD the/DT 14-kDa/MULTIGENE protein/MULTIGENE in/IN another/DT MMTV/NN bearing/JJ T-cell/NN lymphoma/NN ,/, EL-4/DT ./.
@@76775737608/CD A/DT significant/JJ correlation/NN between/IN a/DT number/NN of/IN functional/JJ parameters/NNS of/IN gastric/JJ secretion/NN ,/, incretion/NN and/CC histological/JJ changes/NNS of/IN gastric/JJ mucosa/NN was/VBD found/VBN in/IN patients/NNS with/IN chronic/JJ gastritis/NN ./.
@@111600966266/CD These/DT mutations/NNS ,/, when/CC placed/VBD in/IN a/DT wild-type/NN fliF/GENE background/NN ,/, had/VBP no/DT mutant/JJ phenotype/NN ./.
@@80302399699/CD 65/CD ,/, 3829-3838/CD ,/, 1991/NN )/NN ,/, a/DT truncated/JJ form/NN of/IN the/DT IE/JJ polypeptide/NN lacking/JJ IE/JJ amino/JJ acid/NN residues/NNS 1-322/CD (/( and/CC ,/, therefore/RB lacks/VBZ the/DT deduced/VBN transcriptional/JJ activation/NN domain/NN )/SYM ,/, fails/VBZ to/IN transactivate/VB the/DT EHV-1/MULTIGENE tk/MULTIGENE promoter/MULTIGENE ,/, but/CC retains/VBZ the/DT ability/NN to/IN down-regulate/PDT the/DT EHV-1/GENE IE/JJ promoter/NN ./.
@@85090518473/CD Seven/CD out/RB of/IN 34/CD patients/NNS died/VBN ,/, giving/JJ a/DT mortality/NN rate/NN of/IN 21%/NN ./.
@@23471023000/CD The/DT pseudolymphoma/NN syndrome/NN is/VBZ a/DT reversible/JJ reactive/NN condition/NN consisting/VBG of/IN fever/NN ,/, lymphadenopathy/NN and/CC generalized/JJ rash/NN ./.
@@80700049907/CD Large/JJ interpatient/JJ variation/NN in/IN peak/NN PCZ/NNP plasma/NN levels/NNS (/( 91-3215/CD ng/NN //NN ml/NN )/SYM was/VBD seen/VBP ,/, with/IN the/DT plasma/NN half-life/NN (/( t1/MULTIGENE //MULTIGENE 2/MULTIGENE alpha/MULTIGENE )/SYM being/VBP approximately/RB 57/CD min/NN in/IN patients/NNS given/VBP 135-180/JJ mg/NN //NN m2/NN PCZ/NNP ./.
@@24849943138/CD Intravenous/JJ gamma/JJ globulins/NNS ./.
@@92578875766/CD G-CSF/GENE was/VBD started/VBN on/IN day/NN 3/CD of/IN each/DT cycle/NN (/( 5/CD microg/NN //NN kg/NN //NN day/NN )/SYM and/CC was/VBD stopped/VBN the/DT day/NN before/IN the/DT last/NN apheresis/NN or/CC when/CC absolute/JJ neutrophil/JJ count/NN was/VBD above/RB 0/CD ./CD 5/CD x/NN 10/NN (/NN 9/NN )/NN //NN l/NN ./.
@@62592206057/CD Experiment/NN 3/CD showed/VBD that/IN the/DT long-term/JJ analgesic/JJ reaction/NN could/MD also/RB be/VB reduced/VBN by/IN administration/NN of/IN naltrexone/NN prior/NN to/IN reexposure/NN to/IN shock/NN ./.
@@77624312951/CD The/DT protein/NN expressed/VBN from/IN the/DT cloned/VBN cDNA/NN is/VBZ secreted/VBN into/IN the/DT culture/NN medium/NN and/CC yields/NNS of/IN up/JJ to/IN 40/CD mg/NN per/IN litre/NN have/NN been/VBN obtained/VBN ./.
@@90458055957/CD Acetoin-dependent/GENE expression/NN of/IN the/DT acoABCD/MULTIGENE operon/MULTIGENE could/MD be/VB restored/VBN in/IN the/DT E/NNP ./NNP coli/JJ acoK/MULTIGENE mutants/MULTIGENE by/IN supplying/VBG a/DT plasmid/NN carrying/JJ an/DT intact/JJ acoK/GENE ,/, suggesting/VBG a/DT transactivating/JJ function/NN of/IN the/DT gene/NN product/NN ./.
@@11145887429/CD Activation/NNS of/IN transcription/NN through/RB the/DT AP-1/MULTIGENE site/MULTIGENE in/IN Jurkat/NN cells/NNS by/IN JunD/GENE and/IN //IN or/IN Fra-2/GENE was/VBD weak/JJ ./. c-Jun/GENE ,/, JunB/GENE ,/, and/CC c-Fos/GENE activation/NN was/VBD greater/JJR ,/, although/IN the/DT level/NN was/VBD still/RB less/PRP than/IN that/DT with/IN Tax/NNP ./.
@@117788041626/CD Frequency/NNP of/IN seeing/VBG curves/NNS were/VBD examined/VBN for/IN the/DT method/NN most/RB similar/JJ to/IN FDT/NN ./.
@@84572919839/CD Estradiol/CHEM is/NNS known/VBP to/IN induce/VB expression/NN of/IN certain/JJ proto-oncogenes/NNS ,/, and/CC this/DT led/VBN us/PRP to/IN examine/VB potential/JJ regulatory/JJ regions/NNS of/IN the/DT cellular/JJ c-fos/MULTIGENE oncogene/MULTIGENE ./.
@@94726164636/CD Also/RB ,/, the/DT deduced/VBN amino/JJ acids/NNS of/IN the/DT antigenic/JJ regions/MULTIGENE A/MULTIGENE ,/, B/NNP and/CC C/NN of/IN VP7/NN were/VBD nearly/RB conserved/VBN within/IN the/DT phylogenetic/JJ lineages/NNS ./.
@@107622542752/CD The/DT MMA/NN ,/, DMA/NN ,/, and/CC TMA/MULTIGENE methyltransferases/MULTIGENE are/VBP not/RB homologs/NNS ;/: however/RB ,/, like/VB the/DT MMA/MULTIGENE methyltransferase/MULTIGENE gene/MULTIGENE ,/, the/DT genes/NNS encoding/VBG the/DT DMA/NN and/CC TMA/MULTIGENE methyltransferases/MULTIGENE each/DT contain/VB a/DT single/JJ in-frame/NN amber/JJ codon/NN ./.
@@108057374093/CD Mutational/JJ analysis/NN of/IN mammalian/JJ translation/NN initiation/NN factor/NN 5/CD (/( eIF5/GENE )/SYM :/: role/NN of/IN interaction/NN between/IN the/DT beta/MULTIGENE subunit/MULTIGENE of/IN eIF2/GENE and/CC eIF5/GENE in/IN eIF5/NEWGENE function/NN in/IN vitro/FW and/CC in/IN vivo/NN ./.
@@86053022044/CD DNA/NN methylation/NN ,/, especially/RB of/IN either/DT one/PRP or/CC both/DT of/IN the/DT deoxyadenosines/NNS at/IN the/DT two/NN GATC/MULTIGENE motifs/MULTIGENE (/( one/PRP in/IN the/DT first/JJ exon/NN and/CC the/PDT other/DT in/NN the/DT first/JJ intron/NN of/IN the/DT rice/NN CatA/MULTIGENE gene/MULTIGENE )/SYM ,/, appeared/VBN to/IN be/VB responsible/JJ for/IN the/DT CatA/MULTIGENE promoter/MULTIGENE activity/NN identified/VBN in/IN the/DT transient/JJ assay/NN ./.
@@95902944324/CD Genetic/NNP studies/NNS in/IN Drosophila/NN have/NN led/VBN to/IN the/DT identification/NN of/IN several/DT components/NNS of/IN the/PDT Notch/DT pathway/NN ./.
@@22087622834/CD The/DT grandfather/NN and/CC the/DT granddaughter/NN both/DT had/VBP microtia/NN and/CC meatal/JJ atresia/NN ,/, whereas/IN the/DT daughter/JJ had/VBP a/DT normal/JJ outer/JJ ear/NN except/VB for/IN a/DT narrow/JJ meatus/NN and/CC auricular/JJ appendages/NNS ./.
@@99208962994/CD No/DT significant/JJ differences/NNS between/IN the/DT substituted/JJ and/CC wild/JJ type/NN peptides/NNS were/VBD observed/VBN ,/, suggesting/VBG that/IN this/DT substitution/NN in/IN the/DT intact/JJ protein/NN may/MD cause/VB disruption/NN of/IN global/JJ rather/RB than/IN local/JJ structures/NNS ./.
@@106425319349/CD Competition/NN experiments/NNS demonstrate/VBP a/DT negative/JJ allosteric/JJ relationship/NN between/IN these/DT RGD/MULTIGENE recognition/MULTIGENE sites/MULTIGENE ./.
@@71604918772/CD The/DT favourable/NN effect/NN of/IN thymic/JJ shielding/NN was/VBD also/RB reflected/VBN in/IN a/DT significant/JJ increase/NN of/IN LD50/GENE //GENE 30/GENE ,/, and/CC the/DT dose/NN reduction/NN factor/NN was/VBD equal/VB to/IN 2/CD ./CD
@@7933076544/CD As/IN shown/VBP previously/RB ,/, EBNA2/GENE transactivates/VBZ the/DT promoters/NNS of/IN the/DT viral/JJ latent/JJ membrane/NN proteins/NNS ./.
@@24082481409/CD Likewise/RB ,/, whether/IN or/CC not/RB the/DT hypotensive/JJ action/NN of/IN converting/MULTIGENE enzyme/MULTIGENE inhibitors/MULTIGENE is/VBZ age-related/VBG is/VBZ as/IN yet/RB unknown/JJ ./.
@@85296546852/CD The/DT B/NNP ./NNP germanica/MULTIGENE cyclophilin/MULTIGENE amino/JJ acid/NN sequence/NN shares/VBP 83%/JJ identity/NN with/IN the/DT cytosolic/JJ cyclophilin/MULTIGENE isoform/MULTIGENE from/IN Drosophila/NN melanogaster/NN (/( Cyp-1/GENE )/SYM ./.
@@93824987726/CD First/RB ,/, two/JJ MCTs/GENE using/VBG a/DT long/JJ electrode/NN ,/, 3/CD cm/NN in/IN size/NN ,/, were/VBD performed/VBN in/IN the/DT central/JJ area/NN of/IN the/DT tumor/NN ,/, and/CC eight/CD MCTs/GENE by/IN a/DT short/JJ electrode/NN ,/, 2/CD cm/NN in/IN size/NN ,/, were/VBD done/VBP in/IN the/DT peripheral/JJ and/CC surrounding/JJ area/NN of/IN the/DT tumor/NN ./.
@@1002221016/CD Factors/NNS influencing/VBG direct-immersion/JJ (/( DI/JJ )/NN -SPME/NN process/NN were/VBD also/RB checked/VBN and/CC chosen/VBP experimentally/RB ./.
@@16154932073/CD Argatroban/NNP may/MD be/VB more/RB effective/JJ under/IN low/JJ HC/MULTIGENE II/MULTIGENE conditions/NNS because/IN of/IN its/PRP potent/JJ inhibition/NN of/IN thrombin/NEWGENE activity/NN at/IN sites/NNS of/IN vascular/JJ wall/NN damage/NN ./.
@@10423193280/CD CONCLUSION/IN :/: These/DT results/NNS suggest/VBP that/IN vibration-induced/JJ neural/JJ involvement/NN can/MD be/VB considered/VBN neither/DT pure/JJ digital/JJ neuropathy/NN ,/, nor/CC definite/JJ CTS/NN ,/, as/IN previously/RB described/VBN ./.
@@6487290703/CD Salivary/NNP estradiol/NN 17/CD beta/NN (/( E2-17/MULTIGENE beta/MULTIGENE )/SYM and/CC progesterone/NN (/( P/NN )/SYM were/VBD determined/VBN by/IN using/VBG radioimmunoassay/NN techniques/NNS in/IN 30/CD pregnant/JJ females/NNS in/IN the/DT first/NN ,/, second/JJ and/CC third/JJ trimesters/NNS as/RB well/VBP as/IN in/IN 10/CD non-pregnant/JJ controls/NNS during/IN the/DT luteal/JJ phase/NN of/IN the/DT menstrual/JJ cycle/NN ./.
@@83343044552/CD Triton-disrupted/JJ cells/NNS retained/VBD capacity/NN for/IN activation/NN of/IN the/DT pathway/NN by/IN both/DT peptide/MULTIGENE growth/MULTIGENE factors/MULTIGENE and/CC by/IN addition/NN of/IN GTP-loaded/JJ p21/MULTIGENE rasVal12/MULTIGENE ./.
@@21993119724/CD In/NN vitro/FW transcription/NN extracts/NNS from/IN ret1-1/NNP cells/NNS terminate/VBP less/PRP efficiently/RB at/IN weak/JJ transcription/NN termination/NN signals/NNS than/IN those/DT from/IN RET1/NEWGENE cells/NNS ,/, using/VBG a/DT variety/NN of/IN tRNA/NN templates/NNS ./.
@@83966575913/CD Liu/NNP ,/, B/NNP ./NNP
@@93714316521/CD Strain/NNS CFN037/CELL is/VBZ an/DT R/NNP ./NNP etli/NN mutant/RB induced/VBD by/IN a/DT single/JJ Tn5mob/NNP insertion/NN in/IN the/DT promoter/NN region/NN of/IN the/DT thiCOGE/MULTIGENE gene/MULTIGENE cluster/MULTIGENE ./.
@@1826003325/CD The/DT gene/NN is/VBZ 1/CD ,/CD 139/CD base/NN pairs/NNS (/( bp/NN )/SYM long/JJ ,/, and/CC ,/, like/VB other/DT members/NNS of/IN the/DT SIG/MULTIGENE family/MULTIGENE ,/, the/DT beta/MULTIGENE TG/MULTIGENE gene/MULTIGENE is/VBZ divided/VBN into/IN 3/CD exons/NNS ./.
@@87945471637/CD The/DT rCBF/GENE and/CC vasomotion/NN were/VBD recorded/VBN by/IN laser-doppler/JJ fluxmetry/NN ./.
@@90823359035/CD None/NN of/IN these/DT organic/JJ manifestations/NNS was/VBD discovered/VBN by/IN scintigraphic/JJ means/NN ./.
@@71949051462/CD TCZ/GENE provides/VBZ quick/JJ ,/, inexpensive/JJ ,/, noninvasive/JJ indication/NN of/IN tissue/NN necrosis/NN ,/, moderate-to-severe/JJ intracranial/JJ hemorrhage/NN ,/, and/CC delayed/JJ brain/NN maturation/NN ./.
@@113132492201/CD A/DT novel/JJ myeloid-restricted/JJ zebrafish/NN CCAAT/MULTIGENE //MULTIGENE enhancer-binding/MULTIGENE protein/MULTIGENE with/IN a/DT potent/JJ transcriptional/JJ activation/NN domain/NN ./.
@@8614410463/CD The/DT alpha/NN T3-1/GENE cell/NN line/NN ,/, a/DT GnRH-responsive/JJ gonadotroph/NN cell/NN line/NN developed/VBN by/IN targeted/JJ oncogenesis/NN in/IN transgenic/JJ mice/NNS ,/, was/VBD used/VBN to/IN study/NN regulation/NN of/IN the/DT glycoprotein/MULTIGENE hormone/MULTIGENE alpha-subunit/MULTIGENE by/IN activin/NN ./.
@@100250503470/CD The/DT therapy/NN with/IN a/DT H2-receptor/MULTIGENE antagonist/MULTIGENE is/VBZ less/PRP effective/JJ than/IN the/DT triple/JJ therapies/NNS with/IN omeprazole/NN or/CC lansoprazole/NN ./.
@@91396659935/CD Finally/RB ,/, we/PRP show/VBP that/IN PhLP/JJ complexes/NNS ,/, at/IN least/RB partially/RB ,/, with/IN Gbetagamma/NNP in/IN vivo/NN ./.
@@106016063201/CD The/DT rhabdomyosarcoma/MULTIGENE R1H/MULTIGENE growing/JJ on/IN the/DT right/JJ flank/NN of/IN male/JJ WAG/NNP //NNP Rij/NNP rats/NNS was/VBD clamped/VBN for/IN 2/CD or/CC 4/CD h/NN at/IN 20/CD degrees/NNS C/NN or/CC 37/CD degrees/NNS C/NNP ./NNP
@@101956979239/CD However/RB ,/, F-SRC-1/MULTIGENE mutant/MULTIGENE lacking/JJ CBP-interacting/GENE domain/NN still/RB preserved/VBD enhancing/JJ activity/NN ./.
@@69289746706/CD The/DT electrocardiogram/NN ./.
@@79728312107/CD PAI-1/GENE levels/NNS increased/VBN significantly/RB in/IN patients/NNS who/WP received/VBD iohexol/NN but/CC not/RB in/IN those/DT who/WP received/VBD ioxaglate/NN ./.
@@69576335509/CD Development/NNP of/IN basophilic/JJ leukemia/NN with/IN trisomy/NN 8/CD and/CC atypical/JJ erythroblastosis/NN in/IN a/DT patient/NN with/IN a/DT history/NN of/IN aplastic/JJ anemia/MULTIGENE 22/MULTIGENE years/NNS earlier/JJR ./.
@@91320577796/CD A/DT polypeptide/NN encoded/VBN by/IN the/DT NTS/MULTIGENE 16/MULTIGENE open/JJ reading/JJ frame/NN has/VBZ sequence/NN similarity/NN to/IN the/DT catalytic/JJ domain/NN of/IN several/DT receptor/MULTIGENE protein/MULTIGENE kinases/MULTIGENE from/IN plants/NNS including/JJ the/DT S-receptor/MULTIGENE kinases/MULTIGENE implicated/VBN in/IN the/DT rejection/NN of/IN self-pollen/JJ in/IN Brassica/NNP species/NN and/CC the/DT Pto/GENE gene/NN product/NN of/IN tomato/NN which/WDT confers/VBZ resistance/NN to/IN a/DT bacterial/JJ pathogen/NN ./.
@@24736196237/CD Spontaneous/JJ sensitization/NN to/IN cross-reacting/VBG chemicals/NNS in/IN a/DT proportion/NN of/IN control/NN animals/NNS is/VBZ strongly/RB suggested/VBN ,/, somewhat/RB akin/JJ to/IN spontaneous/JJ sensitization/NN in/IN patients/NNS with/IN anaphylactoid/JJ reactions/NNS to/IN neuromuscular/JJ blockers/NNS on/IN first/JJ exposure/NN ,/, and/CC in/IN whom/WP IgE/NN antibodies/NNS are/VBP detected/VBN ./.
@@10856805663/CD Improving/VBG fissure/NN sealant/NN quality/NN :/: mechanical/JJ preparation/NN and/CC filling/JJ level/NN ./.
@@85983596716/CD Do/VBP overall/JJ treatment/NN time/NN ,/, field/NN size/NN ,/, and/CC treatment/NN energy/NN influence/NN local/JJ control/NN of/IN T1-T2/GENE squamous/JJ cell/NN carcinomas/NNS of/IN the/DT glottic/JJ larynx/NN ?/. PURPOSE/NNS :/: To/TO evaluate/VB treatment/NN and/CC patient/NN related/VBD prognostic/JJ factors/NNS that/WDT may/MD influence/VB local/JJ control/NN in/IN the/DT treatment/NN of/IN T1-T2/GENE squamous/JJ cell/NN carcinoma/NN of/IN the/DT glottic/JJ larynx/NN ./.
@@8246984688/CD These/DT results/NNS demonstrate/VBP the/DT existence/NN of/IN different/JJ PI/NN 3-kinase/GENE isoforms/NNS and/CC define/VB a/DT family/NN of/IN genes/NNS encoding/VBG distinct/JJ PI/NN 3-kinase/CD catalytic/JJ subunits/NNS that/WDT can/MD associate/VB with/IN p85/GENE ./.
@@90429115721/CD Cognate/MULTIGENE promoter/MULTIGENE elements/MULTIGENE implicated/VBN in/IN glucocorticoid-/JJ and/CC cAMP-mediated/JJ regulation/NN as/RB well/VB as/IN in/IN liver-/DT ,/, myeloid-/JJ ,/, and/CC lymphocyte-specific/JJ expression/NN are/VBP located/VBN within/IN the/DT 5'/CD flanking/JJ sequence/NN ./.
@@7290034444/CD Residues/NNS removed/VBN from/IN transcripts/NNS by/IN splicing/JJ were/VBD identified/VBN ./.
@@77973464376/CD An/DT outbreak/NN of/IN hepatitis/MULTIGENE A/MULTIGENE among/IN homosexual/JJ men/NNS in/IN Amsterdam/NN ,/, 1991-1993/CD ./.
@@70804966863/CD The/DT differential/JJ investigation/NN of/IN lipoproteins/NNS ,/, however/RB ,/, showed/VBD that/IN the/DT high-density/JJ lipoprotein/NN (/( HDL/NN )/SYM fractions/NNS are/VBP absolutely/RB or/CC relatively/RB decreased/VBN with/IN respect/NN to/IN low-density/JJ lipoproteins/NNS (/( LDL/NN )/SYM in/IN cerebral/JJ infarcts/NNS and/CC in/IN transient/JJ ischaemic/JJ attacks/NNS ./.
@@53573905490/CD Auto-/NNP and/CC isotopy/NN of/IN the/DT conjunctiva/NN ./.
@@946397800/CD Prazosin/GENE alone/RB was/VBD effective/JJ in/IN volume/NN responsive/JJ patients/NNS at/IN a/DT dose/NN of/IN 5/CD +/NN //NN -/NN 1/CD ./CD 0/CD mg/NN daily/JJ ./.
@@53725115509/CD Diethylene/NNP benzene/NN ./.
@@10991648825/CD Coexisting/JJ vertical/JJ and/CC horizontal/JJ one/PRP and/CC a/DT half/NN syndromes/NNS ./.
@@17023611808/CD Recently/RB ,/, studies/VBZ of/IN agents/NNS that/WDT disrupt/VBP collagen/NEWGENE synthesis/NN and/CC deposition/NN have/NN yielded/VBD several/DT new/JJ angiogenesis/NN inhibitors/NNS ./.
@@30258628939/CD A/DT single/JJ exon/NN encodes/VBZ the/DT carboxyl-terminal/MULTIGENE 26/MULTIGENE amino/JJ acids/NNS of/IN the/DT ssd/MULTIGENE chain/MULTIGENE and/CC the/DT 3'/CD untranslated/JJ region/NN of/IN its/PRP mRNA/NN ,/, ending/NN with/IN a/DT poly/NN (/NN A/NN )/NN -addition/NN site/NN ./.
@@100986014444/CD Mutational/JJ analysis/NN of/IN the/DT -84/JJ //JJ -55/JJ DNA/NN showed/VBN that/IN JEG-3/MULTIGENE nuclear/MULTIGENE proteins/MULTIGENE bound/JJ to/IN a/DT site/NN containing/JJ ,/, but/CC not/RB identical/JJ to/IN ,/, the/DT SF-1/MULTIGENE sequence/MULTIGENE ./.
@@93252843789/CD The/DT sequenced/VBN cDNA/NN predicts/VBZ a/DT 704-amino/JJ acid/NN protein/NN 80%/NN identical/JJ to/IN human/MULTIGENE progelatinase/MULTIGENE B/NNP ./NNP
@@96272855964/CD RESULT/NN (/NN S/NN )/NN :/: In/NN patients/NNS with/IN elevated/VBN FSH/NEWGENE levels/NNS on/IN cycle/NN day/NN 3/CD ,/, a/DT low/JJ oocyte/NN yield/NN was/VBD achieved/VBN (/( 7/CD versus/IN 11/CD )/SYM and/CC a/DT high/JJ number/NN of/IN ampules/NNS of/IN hMG/NN was/VBD necessary/JJ (/( 56/CD versus/IN 33/CD )/SYM ./.
@@112741841815/CD Nrf2/GENE regulates/VBZ expression/NN of/IN genes/NNS encoding/VBG enzymes/NNS with/IN antioxidant/JJ (/( e/NN ./NN g/NN ./. heme/NN oxygenase-1/GENE (/( HO-1/GENE )/NN )/NN or/CC xenobiotic/NN detoxification/NN (/( e/NN ./NN g/NN ./.
@@64598316261/CD Cardiovascular/NNP and/CC adrenal/JJ medullo-sympathetic/JJ reactions/NNS to/IN acute/JJ tobacco/NN poisoning/VBG ./.
@@28096513506/CD This/DT in/NN turn/NN will/MD further/RB enhance/VB the/DT role/NN of/IN meta-analysis/NN in/IN helping/JJ clinicians/NNS and/CC policy/NN makers/NNS answer/NN clinical/JJ questions/NNS ./.
@@92184599356/CD Serum/NN response/MULTIGENE factor/MULTIGENE (/( SRF/CONTEXTGENE )/SYM ,/, a/DT member/NN of/IN an/DT ancient/JJ family/NN of/IN DNA-binding/MULTIGENE proteins/MULTIGENE ,/, is/VBZ generally/RB assumed/VBN to/IN be/VB a/DT ubiquitous/JJ transcription/NN factor/NN involved/VBN in/IN regulating/JJ growth/MULTIGENE factor-responsive/MULTIGENE genes/MULTIGENE ./.
@@33153593999/CD Proctoscopy/NNP and/CC roentgenographic/JJ studies/NNS may/MD be/VB an/DT important/JJ part/NN of/IN evaluation/NN ,/, especially/RB in/IN patients/NNS who/WP present/VBP with/IN perianal/JJ suppuration/NN ,/, masses/NNS ,/, or/CC anal/JJ fissures/NNS ./.
@@99168096106/CD Human/MULTIGENE MGP/MULTIGENE is/VBZ a/DT 10-kD/JJ skeletal/JJ extracellular/JJ matrix/NN (/( ECM/NN )/SYM protein/NN that/WDT consists/VBZ of/IN an/DT 84-aa/JJ mature/JJ protein/NN and/CC a/DT 19-aa/CD transmembrane/JJ signal/JJ peptide/NN ./.
@@98193915245/CD By/IN directly/RB interacting/VBG with/IN both/DT Arfs/NNP and/CC tyrosine/MULTIGENE kinases/MULTIGENE involved/VBN in/IN regulating/JJ cell/NN growth/NN and/CC cytoskeletal/JJ organization/NN ,/, ASAP1/GENE could/MD coordinate/VB membrane/NN remodeling/NN events/NNS with/IN these/DT processes/NNS ./.
@@75656726142/NN In/NN cells/NNS limited/VBN for/IN His/NN ,/, increased/VBN expression/NN of/IN arg-2/NEWGENE and/CC cpc-1/GENE ,/, and/CC decreased/VBD expression/NN of/IN cox-5/JJ ,/, also/RB had/VBP translational/JJ and/CC transcriptional/JJ components/NNS ./.
@@18537962451/CD Review/NNP :/: deterioration/NN of/IN glucose/NN tolerance/NN with/IN age/NN :/: the/DT role/NN of/IN insulin/NN resistance/NN ./.
@@462747744/CD Resistance/NNP pattern/NN of/IN Mycobacterium/NN tuberculosis/NN (/( H/NN 37/NN Rv/NN )/SYM to/IN a/DT new/JJ antibiotic/NN ,/, lividomycin/NN ./.
@@90251226270/CD Subsequent/JJ experiments/NNS showed/VBN that/IN motoric/JJ tasks/NNS rather/RB than/IN cognitive/JJ aspects/NNS of/IN the/DT COWA/MULTIGENE task/MULTIGENE were/VBD critical/JJ in/IN potentiating/JJ finger-tapping/NN performance/NN ./.
@@9172641562/CD Mutational/JJ studies/NNS provide/VBP evidence/NN to/IN this/DT end/NN and/CC indicate/VB that/IN the/DT side/JJ chains/NNS of/IN subdomain/MULTIGENE 4/MULTIGENE ./MULTIGENE 2/MULTIGENE make/VB specific/JJ contacts/NNS with/IN the/DT nucleotides/NNS at/IN -35/CD ./.
@@113030277262/CD These/DT data/NN reveal/VB a/DT complex/NN network/NN of/IN interactions/NNS between/IN GTPases/NNS in/IN the/DT ARF/MULTIGENE family/MULTIGENE and/CC their/PRP effectors/NNS and/CC reveal/VB a/DT potential/NN for/IN cross-talk/NN not/RB demonstrated/VBD previously/RB ./.
@@46401555071/CD Sex/NN ratio/NN at/IN birth/NN ./.
@@1075075566/CD I/NNP ./NNP
@@25186916377/CD Using/VBG mutated/MULTIGENE IL2R/MULTIGENE alpha/MULTIGENE promoter/MULTIGENE constructs/MULTIGENE in/IN transient/JJ transfection/NN and/CC DNA/NN binding/JJ assays/NNS ,/, we/PRP now/RB demonstrate/VBP that/IN sequences/NNS located/VBN immediately/RB upstream/RB and/CC downstream/RB of/IN the/DT kappa/MULTIGENE B/MULTIGENE enhancer/MULTIGENE also/RB contribute/VB to/IN the/DT regulation/NN of/IN IL2R/MULTIGENE alpha/MULTIGENE gene/MULTIGENE expression/NN ./.
@@20447851614/CD A/DT single/JJ case/NN of/IN an/DT adenocarcinoma/NN ,/, arising/VBG in/IN a/DT retroperitoneal/JJ enterogenous/JJ cyst/NN and/CC which/WDT presented/VBD as/IN a/DT left/JJ renal/MULTIGENE cyst/MULTIGENE ,/, is/VBZ reported/VBN ./.
@@83617543708/CD On/IN the/PDT other/DT hand/NN ,/, the/DT structures/NNS of/IN the/DT b-Zip/JJ domain/NN are/VBP well/VB conserved/VBN among/IN these/DT Maf-related/MULTIGENE proteins/MULTIGENE ./.
@@69940356772/CD On/IN line/NN calculation/NN of/IN steroid/JJ concentrations/NNS by/IN radioimmunoassay/NN ./.
@@27452801951/CD At/NN each/DT level/NN of/IN PaO2/GENE we/PRP obtained/VBD simultaneous/JJ measures/NNS of/IN arterial/JJ and/CC venous/JJ blood/NN gases/NNS ,/, venous/JJ lactate/NN concentration/NN ,/, and/CC changes/NNS in/IN the/DT relative/JJ concentrations/NNS of/IN inorganic/JJ phosphate/NN ,/, phosphocreatine/NN ,/, and/CC ATP/NN measured/VBN with/IN 31P/CD magnetic/JJ resonance/NN spectroscopy/NN ./.
@@86226984878/CD Truncated/JJ mammalian/JJ Notch1/GENE activates/VBZ CBF1/MULTIGENE //MULTIGENE RBPJk-repressed/MULTIGENE genes/MULTIGENE by/IN a/DT mechanism/NN resembling/VBG that/IN of/IN Epstein-Barr/NNP virus/NN EBNA2/GENE ./.
@@95882281898/CD Immunohistochemically/RB ,/, anticytokeratin/MULTIGENE 19/MULTIGENE antibody/NN revealed/VBD strong/JJ staining/NN in/IN both/DT epithelial/JJ and/CC sarcomatous/JJ MPM/NNS tissues/NNS ./.
@@93236129286/CD Lack/NN of/IN controlled/VBN prospective/JJ studies/NNS of/IN sleep/NN electroencephalograms/NNS (/( EEG/NN )/SYM ,/, and/CC the/DT use/NN of/IN medication/NN ,/, in/IN children/NNS with/IN developmental/JJ dysphasia/NN ,/, may/MD deny/VB appropriate/JJ treatment/NN strategies/NNS to/IN children/NNS with/IN severe/JJ developmental/JJ speech/NN and/CC language/NN disorders/NNS ./.
@@112287001055/CD The/DT position/NN of/IN the/DT analyst/NN as/IN expert/JJ :/: yesterday/NN and/CC today/NN ./.
@@30238878262/CD Nuclease/NN footprinting/VBG revealed/VBN that/IN purified/VBN glucocorticoid/MULTIGENE receptor/MULTIGENE bound/JJ at/IN multiple/JJ discrete/JJ sites/NNS within/IN and/CC at/IN the/DT borders/NN of/IN the/DT tandemly/RB repeated/JJ sequence/NN motif/NN that/WDT defines/VBZ Sa/NN ./NN
@@42637484892/CD A/DT medical-geographical/JJ review/NN ./.
@@8184923512/CD Topical/JJ L-NNA/NN attenuated/VBN the/DT hypercapnic/JJ increase/NN of/IN CoBF/GENE by/IN 52/NN +/NN //NN -/NN 6%/JJ and/CC CeBF/GENE by/IN 29/CD +/NN //NN -/NN 5%/JJ after/IN 45-min/JJ exposure/NN ./.
@@74964003009/CD In/NN contrast/NN with/IN the/DT previously/RB reported/VBN HMGR1/MULTIGENE mRNA/MULTIGENE (/( HMGR1S/MULTIGENE mRNA/MULTIGENE )/SYM ,/, which/WDT is/VBZ detected/VBN at/IN high/JJ levels/NNS in/IN all/DT tissues/NNS of/IN the/DT plant/NN ,/, HMGR1L/MULTIGENE mRNA/MULTIGENE is/VBZ present/VB at/IN relatively/JJ low/JJ levels/NNS and/CC its/PRP expression/NN is/VBZ restricted/VBN mostly/RB to/IN seedlings/NNS ,/, roots/NNS and/CC inflorescences/NNS ./.
@@91221683752/CD This/DT study/NN provides/VBZ a/DT direct/JJ demonstration/NN of/IN a/DT role/NN for/IN G/NN betagamma/NN in/IN mediating/JJ the/DT agonist-stimulated/JJ translocation/NN of/IN GRK2/GENE and/CC GRK3/GENE in/IN an/DT intact/JJ cellular/JJ system/NN and/CC demonstrates/VBZ isoform/NN specificity/NN in/IN the/DT interaction/NN of/IN these/DT components/NNS ./.
@@2642406829/CD The/DT sequences/NNS following/IN the/DT X/NNP ./NNP borealis/NN oocyte/NN and/CC somatic/JJ 5S/MULTIGENE genes/MULTIGENE are/VBP identical/JJ in/IN 12/CD of/IN the/DT first/JJ 14/CD residues/NNS and/CC contain/VB two/JJ or/CC more/JJ T/NN clusters/NNS ,/, as/IN does/VBP the/DT corresponding/JJ region/NN of/IN X/NNP ./NNP laevis/MULTIGENE oocyte/MULTIGENE 5S/MULTIGENE DNA/MULTIGENE ./.
@@93946509348/CD The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN find/NN out/RB whether/IN it/PRP was/VBD possible/JJ to/IN detect/VB normal/JJ lymph/NN nodes/NNS by/IN high-resolution/JJ mediastinal/JJ US/NNP ./NNP
@@110002033080/CD While/IN mutations/NNS in/IN K-Rev/NNP that/WDT inactivate/VBP any/DT one/PRP of/IN these/DT properties/NNS also/RB blocked/VBN K-Rev-dependent/MULTIGENE nuclear/MULTIGENE RNA/MULTIGENE export/NN ,/, several/DT K-Rev/NNP mutants/NNS were/VBD comparable/JJ to/IN wild/JJ type/NN when/CC assayed/VBN for/IN any/DT of/IN these/DT individual/JJ activities/NNS yet/RB nevertheless/RB defective/JJ for/IN RNA/NN export/NN ./.
@@31332506041/CD A/DT randomized/JJ ,/, prospective/JJ study/NN was/VBD conducted/VBN to/IN compare/NN ovarian/JJ stimulation/NN with/IN human/JJ menopausal/JJ gonadotropin/NN (/( hMG/NN )/SYM and/CC human/JJ follicle-stimulating/JJ hormone/NN (/( hFSH/GENE )/SYM in/IN an/DT in/NN vitro/FW fertilization/NN and/CC embryo/NN transfer/NN (/( IVF-ET/NNS )/SYM program/NN ./.
@@109284774576/CD This/DT study/NN demonstrated/VBN that/IN the/DT PFA-100/GENE analyzer/NN can/MD accurately/RB assess/VB vWF-dependent/JJ platelet/NN function/NN and/CC detect/VB other/DT platelet/NN defects/NNS under/IN high/JJ shear/NN stress/NN in/IN complex/NN patient/NN populations/NNS ./.
@@117667471605/CD We/PRP conducted/VBD a/DT clinical/JJ and/CC pathologic/JJ review/NN of/IN nine/JJ patients/NNS with/IN immature/JJ ovarian/JJ teratoma/NN ./.
@@37437021487/CD Approximately/RB 60%/CD of/IN cell/NN bodies/NNS of/IN primary/JJ neurons/NNS innervating/VBG the/DT intra/CD and/CC perioral/JJ structures/NNS through/RB the/DT inferior/JJ alveolar/NN ,/, lingual/JJ ,/, mental/JJ ,/, and/CC buccal/JJ nerves/NNS were/VBD in/IN the/DT range/NN between/IN 300/CD and/CC 600/CD micron/NN 2/CD in/IN cross-sectional/JJ area/NN :/: mean/JJ +/NN //NN -/NN SD/MULTIGENE 509/MULTIGENE +/NN //NN -/NN 243/CD micron/NN 2/CD ,/, 420/CD +/NN //NN -/NN 181/CD micron/NN 2/CD ,/, 469/CD +/NN //NN -/NN 200/CD micron/NN 2/CD ,/, and/CC 444/CD +/NN //NN -/NN 186/CD micron/NN 2/CD ,/, respectively/RB ./.
@@24523139321/CD ASL-8123/GENE demonstrated/VBN weak/JJ competitive/JJ beta-adrenoreceptor/NN blocking/JJ activity/NN in/IN isolated/VBN guinea/NN pig/NN right/JJ atria/NNS with/IN a/DT pA2/GENE of/IN 3/CD ./CD 73/CD +/NN //NN -/NN 0/CD ./CD 07/CD ;/: no/DT agonist-like/JJ activity/NN was/VBD observed/VBN in/IN this/DT tissue/NN at/IN concentrations/NNS of/IN ASL-8123/GENE from/IN 3/CD X/NN 10/NN (/NN -5/NN )/NN to/IN 1/CD X/NNP 10/NN (/NN -2/NN )/NN M/NNP ./NNP
@@75793287896/CD As/IN with/IN the/DT heterologous/JJ DNA/NN binding/JJ domain/NN ,/, MZF-1/GENE represses/VBZ reporter/NN gene/NN expression/NN in/IN nonhematopoietic/JJ cell/NN lines/NNS and/CC activates/VBZ expression/NN in/IN hematopoietic/JJ cell/NN lines/NNS ./.
@@16151822999/CD The/DT present/NN study/NN highlights/VBP the/DT improvement/NN in/IN sputum/MULTIGENE amoxycillin/MULTIGENE (/( amoxy/NN )/SYM levels/NNS when/CC a/DT combination/NN tablet/NN ,/, amoxy/NN 500/CD mg/NN plus/IN bromhexeine/MULTIGENE 8/MULTIGENE mg/NN ,/, is/VBZ administered/VBN as/IN compared/VBN to/IN plain/JJ amoxy/NN 500/CD mg/NN ./NN
@@1429714917/CD Clin/VBP ./.
@@32287853917/CD Recovery/NNP was/VBD characterized/VBN by/IN rapid/JJ improvement/NN such/JJ that/IN all/DT measured/VBN parameters/NNS normalized/VBN by/IN 1/CD week/NN ,/, except/VB for/IN cross-sectional/JJ cardiac/JJ area/NN which/WDT remained/VBD dilated/JJ up/NN to/IN 4/CD weeks/NNS (/( 14/CD +/NN //NN -/NN 3/CD cm2/NN ,/, p/NN less/PRP than/IN 0/CD ./CD 05/CD versus/IN control/NN )/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@66584456411/CD Harmful/JJ effects/NNS in/IN animals/NNS and/CC man/NN may/MD result/VB from/IN both/DT deficient/JJ or/CC excessive/JJ amounts/NNS of/IN intake/NN ./.
@@78804497065/CD In/NN the/DT course/NN of/IN a/DT study/NN of/IN low/JJ dose/NN X-rays/NNS effects/NNS ,/, we/PRP found/VBP that/IN male/JJ ICR/MULTIGENE white/MULTIGENE Swiss/JJ mice/NNS showed/VBD remarkable/JJ suppression/NN of/IN mounting/JJ behavior/NN after/IN whole/JJ body/NN irradiation/NN by/IN 5/CD to/IN 15/CD cGy/NN X-rays/NNS ./.
@@29007601475/CD Three/CD sequence/NN elements/NNS are/VBP shown/VBP to/IN be/VB required/VBN for/IN accurate/JJ and/CC efficient/JJ transcription/NN termination/NN by/IN RNA/MULTIGENE polymerase/MULTIGENE I/MULTIGENE (/( pol/MULTIGENE I/MULTIGENE )/SYM assayed/VBN both/DT in/NN a/DT cell-free/JJ transcription/NN system/NN and/CC in/IN vivo/NN after/IN transfection/NN of/IN rDNA/MULTIGENE minigene/MULTIGENE constructs/MULTIGENE into/IN 3T6/CD cells/NNS ./.
@@110827158317/CD Simultaneous/JJ determination/NN of/IN theophylline/NN and/CC its/PRP metabolites/NNS by/IN HPLC/MULTIGENE A/MULTIGENE high/JJ performance/NN liquid/JJ chromatography/NN (/( HPLC/NN )/SYM method/NN has/VBZ been/VBN developed/VBN for/IN the/DT simultaneous/JJ determination/NN of/IN theophylline/NN and/CC its/PRP metabolites/NNS ,/, with/IN caffeine/NN and/CC its/PRP metabolites/NNS ./.
@@110543415072/CD RESULTS/NNS :/: Glaucoma/NNS suspects/NNS were/VBD divided/VBN into/IN two/JJ groups/NNS according/VBG to/IN their/PRP SWAP/GENE results/NNS :/: high/JJ risk/NN (/( with/IN SWAP/GENE abnormalities/NNS )/SYM and/CC low/JJ risk/NN (/( with/IN normal/JJ SWAP/GENE result/NN )/SYM ./.
@@35683115684/CD Encompassing/VBG tamponade/NN and/CC pericardiocentesis/NN data/NN ,/, left/NN ventricular/JJ stroke/NN work/NN index/NN showed/VBD positive/JJ correlation/NN with/IN TMFP1/GENE (/( r/JJ =/SYM ./CD 59/CD )/SYM and/CC TMFP2/GENE (/( r/JJ =/SYM ./CD 52/CD )/SYM but/CC not/RB with/IN TMFP3/GENE ./.
@@91650359357/CD Serum/NN alkaline/MULTIGENE phosphatase/MULTIGENE activity/NN ,/, bone/NN mass/JJ measurements/NNS ,/, dual/JJ energy/NN x-ray/NN absortiometric/JJ analysis/NN of/IN mineral/JJ density/NN ,/, and/CC mechanical/JJ testing/NN values/NNS in/IN vertebrae/NNS and/CC femora/NNS of/IN the/DT -D/CD Sal/NNP animals/NNS did/VBD not/RB significantly/RB differ/VB from/IN those/DT in/NNP +D/NNP Sal/NNP animals/NNS ./.
@@92026697748/CD We/PRP have/VBP developed/VBN a/DT rAAV-mediated/MULTIGENE gene/MULTIGENE transfer/NN system/NN for/IN the/DT rat/MULTIGENE preproinsulin/MULTIGENE II/MULTIGENE gene/MULTIGENE ./.
@@99491787014/CD We/PRP used/VBD expression/NN cloning/NN to/IN identify/VB interleukin-6/NEWGENE (/( IL-6/NEWGENE )/SYM as/IN one/PRP factor/NN that/WDT suppressed/VBD growth/NN of/IN a/DT pre-B-cell/MULTIGENE variant/MULTIGENE line/NN ,/, 1A9-M/CELL ./.
@@28403763537/CD (/( anti-IIa/JJ )/SYM and/CC Holmer/NNP et/FW al/NNS ./NNS
@@14182722029/CD Using/VBG 5/CD ng/NN //NN mL/NN as/IN the/DT cutoff/NN ,/, the/DT sensitivity/NN of/IN CEA/NN was/VBD 68%/JJ ./.
@@95219096605/CD APETALA3/MULTIGENE transcripts/MULTIGENE are/VBP first/RB detected/VBN in/IN a/DT meristematic/JJ region/NN that/WDT will/MD give/VB rise/VB to/IN the/DT petal/NN and/CC stamen/NN primordia/NNS ,/, and/CC expression/NN is/VBZ maintained/VBN in/IN this/DT region/NN during/IN subsequent/JJ development/NN of/IN these/DT organs/NNS ./.
@@77214227693/CD Primer/NNS extension/NN experiments/NNS showed/VBN that/IN there/RB are/VBP two/JJ transcription/NN initiation/NN sites/NNS 16/CD bp/NN apart/RB in/IN the/DT mouse/MULTIGENE type/MULTIGENE 2/MULTIGENE receptor/MULTIGENE gene/MULTIGENE ./.
@@87803391418/CD In/NN a/DT randomized/JJ single-blind/JJ 3/CD x/NN 3/CD Latin-square/NNP study/NN with/IN corrections/NNS for/IN any/DT carryover/NN effects/NNS ,/, 27/CD males/NNS and/CC 30/CD females/NNS consumed/VBD supplements/NNS containing/JJ glucose/NN or/CC resistant/JJ starch/NN (/( RS/NN )/SYM from/IN raw/JJ high-amylose/JJ cornstarch/NN (/( RS2/GENE )/SYM or/CC from/IN retrograded/VBN high-amylose/JJ cornstarch/NN (/( RS3/GENE )/SYM ./.
@@4308894916/CD Biliary-enteric/NNP fistulas/NNS ./.
@@106065155928/CD Both/DT domains/NNS were/VBD required/VBN for/IN specific/JJ DNA/NN binding/JJ to/IN the/DT beta-retinoic/MULTIGENE acid/MULTIGENE receptor/MULTIGENE element/MULTIGENE ,/, producing/JJ a/DT DNase/MULTIGENE I/MULTIGENE footprint/NN covering/VBG predominantly/RB one/PRP strand/NN ./.
@@85472058531/CD The/DT results/NNS indicate/VBP that/IN the/DT bradycardic/JJ agents/NNS alinidine/NN and/CC zatebradine/NN do/NN not/RB exert/VB antiarrhythmic/JJ efficacy/NN against/IN SVT/NN induced/VBN during/IN subacute/JJ myocardial/JJ infarction/NN in/IN conscious/JJ dogs/NNS ./.
@@86472647231/CD Ligation/NNS of/IN CD40/NEWGENE rescues/VBP Ramos-Burkitt/NNP lymphoma/NN B/NNP cells/NNS from/IN calcium/NN ionophore-/NN and/CC antigen/NN receptor-triggered/JJ apoptosis/NN by/IN inhibiting/JJ activation/NN of/IN the/DT cysteine/NN protease/NN CPP32/GENE //GENE Yama/GENE and/CC cleavage/NN of/IN its/PRP substrate/MULTIGENE PARP/MULTIGENE ./.
@@103189186643/CD Further/RB ,/, mutational/JJ analysis/NN of/IN NS5A/GENE assigned/VBN the/DT SH3-binding/MULTIGENE region/MULTIGENE to/IN a/DT proline-rich/JJ motif/NN that/WDT is/VBZ highly/RB conserved/VBN among/IN HCV/NN genotypes/NNS ./.
@@81531468128/CD Dotarizine/NNP produced/VBD arterial/JJ dilation/NN in/IN both/DT systemic/JJ and/CC pulmonary/JJ circulation/NN :/: the/DT total/JJ peripheral/JJ resistance/NN dropped/VBN ,/, and/CC femoral/JJ artery/NN flow/NN rose/VBD ;/: aortic/JJ and/CC pulmonary/JJ artery/NN mean/JJ and/CC diastolic/JJ pressures/NNS declined/VBN ,/, and/CC systolic/JJ pressures/NNS remained/VBN almost/RB stable/JJ ./.
@@94746489435/CD We/PRP analyzed/VBD the/DT P-SAECG/NNP in/IN the/DT time/NN and/CC frequency/NN domain/NN in/IN 23/CD patients/NNS with/IN Paf/NEWGENE and/CC 19/CD controls/NNS ./.
@@14184942031/CD Rolandic/NNP spikes/NNS and/CC cognitive/JJ function/NN ./.
@@10901133728/CD Methyllevamisole/NNP was/VBD used/VBN as/IN the/DT internal/JJ standard/NN ./.
@@86395617114/CD Adduction/NNS of/IN the/DT human/MULTIGENE N-ras/MULTIGENE codon/NN 61/CD sequence/NN with/IN (/( -/: )/NN -/NN (/NN 7S/NN ,/NN 8R/NN ,/NN 9R/NN ,/NN 10S/NN )/NN -7/NN ,/NN 8-dihydroxy-9/NN ,/NN 10-epoxy-7/NN ,/NN 8/NN ,/NN 9/NN ,/NN 10-tetrahydrobenzo/NN [/NN a/NN ]/NN pyrene/NN :/: structural/JJ refinement/NN of/IN the/DT intercalated/JJ SRSR/NN (/NN 61/NN ,/NN 2/NN )/NN (/( -/: )/NN -/NN (/NN 7S/NN ,/NN 8R/NN ,/NN 9S/NN ,/NN 10R/NN )/NN -N6-/NN [/NN 10-/NN (/NN 7/NN ,/NN 8/NN ,/NN 9/NN ,/NN 10-/NN tetrahydrobenzo/NN [/NN a/NN ]/NN pyrenyl/NN )/NN ]/NN -2'-deoxyadenosyl/NN adduct/NN from/IN 1H/CD NMR/NN ./.
@@57185005665/CD Histological/JJ observations/NNS on/IN the/DT decidua/NN in/IN the/DT second/JJ half/NN of/IN pregnancy/NN ./.
@@63194216112/CD The/DT effect/NN of/IN desipramine/NN probably/RB represents/VBZ inhibition/NN of/IN neuronal/JJ uptake/NN and/CC that/IN of/IN amitriptyline/NN and/CC mianserin/NN blockade/NN of/IN neuronal/JJ uptake/NN and/CC prejunctional/JJ alpha/MULTIGENE 2-adrenoreceptors/MULTIGENE ./.
@@99613269952/CD Scaling/NN of/IN fluctuations/NNS in/IN one-dimensional/JJ interface/NN and/CC hopping/JJ models/NNS ./.
@@8816443495/CD Thus/RB ,/, the/DT multidomained/VBN ROK/MULTIGENE alpha/MULTIGENE appears/VBZ to/IN be/VB involved/VBN in/IN reorganization/NN of/IN the/DT cytoskeleton/NN ,/, with/IN the/DT N/NN and/CC C/NN termini/NNS acting/JJ as/IN positive/JJ and/CC negative/JJ regulators/NNS ,/, respectively/RB ,/, of/IN the/DT kinase/NN domain/NN whose/WP activity/NN is/VBZ crucial/JJ for/IN formation/NN of/IN stress/NN fibers/NNS and/CC focal/JJ adhesion/NN complexes/NNS ./.
@@10973400809/CD RESULTS/NNS :/: No/DT significant/JJ deformation/NN in/IN vertebral/JJ artery/NN flow/NN was/VBD noted/VBN in/IN the/DT flexion-distraction/NNP Stage/NNP I/PRP injuries/NNS within/IN the/DT physiologic/JJ range/NN of/IN cervical/JJ flexion/NN ./.
@@35377275275/CD The/DT poly/NN (/NN A/NN )/NN segment/NN of/IN the/DT RNA/NN was/VBD selectively/RB cross-linked/VBN to/IN the/DT 72/JJ ,/JJ 000-molecular-weight/JJ protein/NN (/( 72K/MULTIGENE protein/MULTIGENE )/SYM ./.
@@1774063983/CD Interspecific/NNP backcross/NN analysis/NN using/VBG progeny/NN derived/VBN from/IN matings/NNS of/IN (/( C57BL/MULTIGENE //MULTIGENE 6J/MULTIGENE x/MULTIGENE Mus/NNS spretus/NN )/SYM F1/NN x/NN C57BL/IN //IN 6J/IN mice/NNS indicates/VBZ that/IN the/DT thrombospondin/MULTIGENE gene/MULTIGENE is/VBZ tightly/RB linked/JJ to/IN the/DT Fshb/NNP ,/, Actcl/NNP ,/, Ltk/NNP ,/, and/CC B2M/MULTIGENE loci/MULTIGENE on/IN murine/JJ chromosome/NN 2/CD ./CD
@@21823232337/CD However/RB ,/, primary/JJ transcripts/NNS of/IN a/DT variant/NN tRNA/NN (/NN Val/NN )/NN (/NN UAC/NN )/NN gene/NN are/VBP processing/VBG deficient/JJ under/IN standard/JJ growth/NN conditions/NNS (/( 30/CD degrees/NNS C/NN )/SYM ,/, due/NN to/IN a/DT slightly/RB altered/VBN 5'/CD flanking/JJ region/NN ./.
@@10972688806/CD On/IN long-term/JJ follow-up/NN ,/, there/RB was/VBD no/DT significant/JJ difference/NN in/IN the/DT incidence/NN of/IN hospitalizations/NNS (/( 1/CD per/IN 2/CD ./CD 1/CD vs/IN ./IN
@@104299469734/CD Furthermore/RB ,/, addition/NN of/IN B-Myb-glutathionine/MULTIGENE S-transferase/MULTIGENE fusion/MULTIGENE protein/MULTIGENE inhibited/VBD complex/NN formation/NN ./.
@@4099274707/CD Neomycin/GENE is/VBZ fairly/RB effective/JJ against/IN staphylococci/NNS ,/, less/PRP effective/JJ against/IN streptococci/NNS ,/, and/CC fairly/RB effective/JJ against/IN gram-negative/JJ intestinal/JJ organisms/NNS ./.
@@82747748133/CD In/NN addition/NN ,/, REP21/GENE plants/NNS were/VBD resistant/JJ to/IN an/DT unusually/RB broad/JJ range/NN of/IN tobamoviruses/NNS including/JJ tomato/NN mosaic/NN virus/NN ,/, tobacco/NN mild/JJ green/JJ mosaic/NN virus/NN ,/, TMV-U5/GENE ,/, green/JJ tomato/NN atypical/JJ mosaic/NN virus/NN ,/, and/CC ribgrass/NN mosaic/NN virus/NN ./.
@@110058314268/CD Three/CD cDNAs/NNS encoding/VBG basic/MULTIGENE leucine/MULTIGENE zipper/MULTIGENE (/( bZIP/GENE )/NN -type/NN ABRE-binding/GENE proteins/NNS were/VBD isolated/VBN by/IN using/VBG the/DT yeast/NN one-hybrid/JJ system/NN and/CC were/VBD designated/VBN AREB1/GENE ,/, AREB2/GENE ,/, and/CC AREB3/GENE (/( ABA-responsive/GENE element/NN binding/JJ protein/NN )/SYM ./.
@@1285807362/CD The/DT mean/JJ (/( +/NN //NN -/NN SD/NN )/SYM PaO2/NN increased/VBN from/IN 80/CD ./CD 8/CD +/NN //NN -/NN 26/CD ./CD 9/CD mmHg/NN before/IN to/IN 89/NN ./NN 8/NN +/NN //NN -/NN 27/CD ./CD 3/CD mmHg/NN after/IN the/DT infusion/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM and/CC the/DT PaCO2/NN decreased/VBN from/IN 42/CD ./CD 4/CD +/NN //NN -/NN 8/CD ./CD 3/CD to/IN 39/CD ./CD 6/CD +/NN //NN -/NN 7/CD ./CD 9/CD mmHg/NN (/( P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@19250922588/CD Twenty-four/CD hours/NNS later/JJR ,/, the/DT animals/NNS were/VBD randomized/JJ to/IN subretinal/JJ treatment/NN with/IN 2/CD ./CD 5/CD micrograms/NNS of/IN tissue/NEWGENE plasminogen/MULTIGENE activator/MULTIGENE or/CC a/DT similar/JJ volume/NN of/IN physiologic/JJ saline/NN ./.
@@45067385001/CD Junctions/NNS between/IN cells/NNS of/IN the/DT human/JJ enamel/NN organ/NN ./.
@@84406888703/CD These/DT studies/NNS demonstrate/VBP that/IN both/DT G/MULTIGENE alpha/MULTIGENE i/MULTIGENE genes/MULTIGENE are/VBP dynamically/RB regulated/VBN in/IN LLC-PK1/NNP cells/NNS by/IN both/DT growth/NN ,/, differentiation/NN ,/, and/CC hormone/NN signals/NNS ./.
@@2844767921/CD The/DT Nostoc/NN petBD/MULTIGENE genes/MULTIGENE are/VBP not/RB closely/RB linked/JJ to/IN the/DT psbB/MULTIGENE gene/MULTIGENE (/( encoding/VBG the/DT 51-kDa/JJ photosystem/NN II/NNP polypeptide/NN )/SYM and/CC do/VB not/RB contain/VB introns/NNS as/IN do/NN the/DT closely/RB related/VBN chloroplast/NN genes/NNS ./.
@@97394019717/CD OBJECTIVE/IN :/: The/DT purpose/NN of/IN this/DT article/NN is/VBZ to/IN review/NN balance/NN instruments/NNS developed/VBN within/IN the/DT past/JJ 10/CD years/NNS that/WDT can/MD be/VB used/VBN in/IN the/DT clinic/NN or/CC home/JJ environment/NN ./.
@@100514884574/CD Mutations/NNS of/IN the/DT AP-1/MULTIGENE site/MULTIGENE of/IN the/DT TIMP-1/MULTIGENE promoter/MULTIGENE that/WDT prevented/VBD formation/NN of/IN HMAP-1/GENE caused/VBN a/DT 70%/CD loss/NN of/IN activity/NN in/IN transfected/VBN activated/VBN HSCs/NNS ./.
@@31929503890/CD Sera/NNS from/IN euthyroid/JJ post-menopausal/JJ or/CC pregnant/JJ women/NNS yielded/VBD TSH/NN levels/NNS within/IN the/DT normal/JJ range/NN ./.
@@15329142470/CD Expense/NN limits/VBZ the/DT use/NN of/IN hepatitis/MULTIGENE B/MULTIGENE vaccines/NNS ,/, but/CC low-dose/JJ intradermal/JJ immunization/NN has/VBZ been/VBN evaluated/VBN as/IN a/DT cost-saving/JJ strategy/NN in/IN numerous/JJ studies/NNS ./.
@@110079492866/CD It/PRP is/VBZ now/RB estimated/VBN that/IN inactivation/NN mutants/NNS of/IN PTEN/GENE exist/VB in/IN 60%/CD of/IN all/DT forms/NNS of/IN solid/JJ tumors/NNS ./.
@@50122205308/CD Ten-year/JJ experience/NN with/IN one-stage/NN proctocolectomy/NN and/CC anal/JJ ileostomy/NN ./.
@@10997863832/CD In/NN the/DT TLE/NNS patients/NNS the/DT NAA/NN :/: Cr/NN ratios/NNS were/VBD reduced/VBN in/IN the/DT seizure/NN focus/NN ,/, while/CC in/IN the/DT FLE/NNP patients/NNS they/PRP were/VBD not/RB always/RB reduced/VBN in/IN the/DT seizure/NN focus/NN ./.
@@106509584255/CD Element/MULTIGENE B/MULTIGENE (/( -249/NN //NN -229/NN )/SYM shows/VBZ more/RB than/IN 80%/NN homology/NN to/IN a/DT consensus/NN c-myb/MULTIGENE element/MULTIGENE ,/, but/CC formed/VBD two/JJ specific/JJ complexes/NNS that/WDT differed/VBD from/IN that/DT of/IN c-myb/NN in/IN the/DT electrophoretic/JJ mobility/NN shift/NN assay/NN ./.
@@10864641349/CD These/DT results/NNS demonstrate/VBP that/IN N-glycans/NNPS flanking/JJ the/DT receptor-binding/MULTIGENE site/MULTIGENE of/IN the/DT HA/MULTIGENE molecule/MULTIGENE are/VBP potent/JJ regulators/NNS of/IN influenza/NN virus/NN growth/NN ,/, with/IN the/DT glycan/NN at/IN Asn149/CD being/VBP dominant/JJ and/CC that/IN at/IN Asn123/NN being/VBP less/PRP effective/JJ ./.
@@1076480276/CD These/DT data/NN show/NN that/IN the/DT alpha-helix/NN domain/NN of/IN p57/NN (/NN Kip2/NN )/NN ,/, which/WDT is/VBZ conserved/VBN in/IN the/DT Cip/MULTIGENE //MULTIGENE Kip/MULTIGENE proteins/MULTIGENE ,/, is/VBZ implicated/VBN in/IN protein-protein/JJ interaction/NN and/CC confers/VBZ a/DT specific/JJ regulatory/JJ mechanism/NN ,/, outside/RB of/IN their/PRP Cdk-inhibitory/JJ activity/NN ,/, by/IN which/WDT the/DT p57/NN (/NN Kip2/NN )/NN family/NN members/NNS positively/RB act/VBP on/IN myogenic/JJ differentiation/NN ./.
@@66074276358/CD Three/CD experiments/NNS contrasted/VBD the/DT effects/NNS of/IN 6-hydroxydopamine-induced/CD lesions/NNS of/IN the/DT ventral/JJ noradrenergic/JJ and/CC dorsal/JJ noradrenergic/JJ projections/NNS ,/, predominantly/RB to/IN hypothalamus/NN and/CC cortex/NN ,/, respectively/RB ,/, upon/IN body/NN weight/NN changes/NNS and/CC food-related/JJ behaviour/NN in/IN the/DT rat/NN ./.
@@94179283664/CD Replacement/NN of/IN residues/NNS in/IN positions/NNS +3/CD (/( His128Asn/NNP )/SYM and/CC +2/NN (/( Gln155Lys/NN )/SYM of/IN the/DT reading/JJ helices/NNS of/IN fingers/NNS 2/CD and/CC 3/CD ,/, respectively/RB ,/, prevented/VBN binding/JJ ./.
@@20942578401/CD Diagnostic/NNP value/NN of/IN adenosine/MULTIGENE deaminase/MULTIGENE activity/NN in/IN tuberculous/JJ effusions/NNS ./.
@@1093845384/CD Modern/NNP studies/NNS ,/, conducted/VBN with/IN Delta-9-THC/GENE ,/, in/IN healthy/JJ voluntaries/NNS ,/, again/RB suggest/VB the/DT comparison/NN or/CC even/VB the/DT identity/NN of/IN the/DT modifications/NNS caused/VBN by/IN cannabis/NN with/IN sleep/NN and/CC dream/NN ./.
@@23005413930/CD To/TO determine/VB the/DT effects/NNS on/IN the/DT pulmonary/JJ barrier/NN of/IN several/DT surface/NN active/JJ agents/NNS ,/, a/DT series/NN of/IN metered/JJ dose/NN inhalers/NNS (/( MDIs/NN )/SYM was/VBD prepared/VBN and/CC used/VBN to/IN dose/NN aerosolized/JJ surfactant/NN to/IN the/DT airways/NNS of/IN isolated/VBN perfused/VBN rat/NN lungs/NNS ./.
@@91518063277/CD These/DT data/NN provide/VB evidence/NN that/IN the/DT 2/NN ./NN 0-kb/NN LAT/NN is/VBZ an/DT intron/NN of/IN the/DT mLAT/MULTIGENE pre-mRNA/MULTIGENE with/IN a/DT unique/JJ branch/NN point/NN ./.
@@113036386312/CD With/IN NEU/NEWGENE overexpression/NN ,/, nodal/JJ control/NN decreased/VBN from/IN 72%/JJ to/IN 34%/JJ (/( p/NN =/SYM ./CD 008/CD )/SYM ./.
@@27739303470/CD The/DT solitary/JJ kidney/NN :/: a/DT model/NN of/IN chronic/JJ hyperfiltration/NN in/IN humans/NNS ./.
@@92442821972/CD Mutagenesis/NNS of/IN the/DT pecT/MULTIGENE regulatory/MULTIGENE region/MULTIGENE revealed/VBD the/DT presence/NN of/IN two/JJ sites/NNS in/IN which/WDT insertions/NNS reproduced/VBD the/DT pec-1/MULTIGENE phenotype/MULTIGENE ./.
@@97139965342/CD Overexpression/NNS of/IN MDR1/GENE has/VBZ been/VBN demonstrated/VBN in/IN many/JJ cancers/NNS ,/, both/DT in/NN patient/NN tumors/NNS and/CC in/IN cell/NN lines/NNS selected/VBN with/IN a/DT variety/NN of/IN chemotherapeutic/JJ agents/NNS ./.
@@71956158083/CD The/DT number/NN of/IN muricidal/JJ rats/NNS increased/VBN with/IN increase/NN in/IN the/DT duration/NN of/IN Cd/NN administration/NN in/IN association/NN with/IN greater/JJR accumulation/NN of/IN Cd/NN in/IN the/DT olfactory/MULTIGENE bulb/MULTIGENE than/IN in/IN any/DT other/DT region/NN of/IN the/DT brain/NN ./.
@@98237755204/CD These/DT studies/NNS support/NN the/DT view/NN that/DT HMG/MULTIGENE I/MULTIGENE (/MULTIGENE Y/MULTIGENE )/MULTIGENE is/VBZ an/DT important/JJ cofactor/NN for/IN HLA-DRA/GENE gene/NN activation/NN by/IN Oct-2A/NEWGENE and/CC provide/VB insights/NNS into/IN its/PRP mechanism/NN of/IN action/NN ./.
@@98499614021/CD Down-regulation/NNS of/IN IRS-1/GENE is/VBZ linked/JJ to/IN its/PRP serine/NN phosphorylation/NN dependent/JJ on/IN PI/NN 3-kinase/CD activity/NN and/CC appears/VBZ required/VBN for/IN differentiation/NN to/IN occur/VB ,/, as/IN IRS-1/GENE is/VBZ not/RB modified/JJ and/CC continues/VBZ to/IN accumulate/VB in/IN a/DT nondifferentiating/JJ myoblast/NN cell/NN line/NN ./.
@@65977094318/CD As/IN pleural/JJ thickening/NN is/NNS seen/VBP commonly/RB in/IN asbestosis/NN and/CC may/MD influence/VB lung/NN volumes/NNS and/CC the/DT ratio/NN of/IN transfer/MULTIGENE factor/MULTIGENE to/IN effective/JJ alveolar/JJ volume/NN ,/, the/DT results/NNS of/IN these/DT measurements/NNS were/VBD compared/VBN only/RB in/IN the/DT cases/NNS showing/VBG absent/VB or/CC minimal/JJ pleural/JJ thickening/NN ./.
@@74737428106/CD The/DT protein/MULTIGENE ELT-1/MULTIGENE ,/, encoded/VBN by/IN a/DT single-copy/JJ gene/NN homologous/JJ to/IN the/DT GATA/MULTIGENE family/MULTIGENE of/IN vertebrate/MULTIGENE transcription/MULTIGENE factors/MULTIGENE ,/, is/VBZ potentially/RB capable/JJ of/IN interacting/VBG with/IN this/DT element/NN ./.
@@49419515250/CD Dr/NN ./NN
@@111941838336/CD The/DT increase/NN in/IN number/NN of/IN terminal/JJ hairs/NNS ,/, which/WDT are/VBP defined/VBN as/IN hairs/NNS more/RB than/IN 60/CD microm/NN in/IN diameter/NN ,/, in/IN the/DT designated/VBN area/NN (/( 0/CD ./CD 5/CD cm/NN square/NN =/SYM 0/CD ./CD 25/CD cm2/NN area/NN )/SYM of/IN the/DT procyanidin/NNP B-2/NNP group/NN subjects/NNS after/IN the/DT 6-month/CD trial/NN was/VBD significantly/RB greater/JJR than/IN that/DT of/IN the/DT placebo/NN control/NN group/NN subjects/NNS (/( procyanidin/MULTIGENE B-2/MULTIGENE ,/, 1/CD ./CD 99/CD +/NN //NN -/NN 2/CD ./CD 58/CD (/( mean/JJ +/NN //NN -/NN SD/NN )/NN //NN 0/NN ./NN 25/NN cm2/NN ;/: placebo/NN ,/, -0/NN ./NN 82/NN +/NN //NN -/NN 3/CD ./CD 40/CD (/( mean/JJ +/NN //NN -/NN SD/NN )/NN //NN 0/NN ./NN 25/NN cm2/NN ;/: P/NN </SYM 0/CD ./CD 02/CD ,/, two-sample/JJ t/NN test/NN )/NN ./.
@@11727073239/CD CONCLUSION/IN :/: The/DT training/NN of/IN novices/NNS using/VBG MIST-VR/NN yields/VBZ quantifiable/JJ changes/NNS in/IN skill/NN that/WDT are/VBP transferable/JJ to/IN a/DT simple/JJ real/JJ task/NN and/CC are/VBP similar/JJ to/IN the/DT results/NNS achieved/VBN with/IN conventional/JJ training/NN ./.
@@92941396200/CD Within/IN a/DT 135-bp/JJ core/NN homology/NN region/NN ,/, the/DT human/MULTIGENE HS12/MULTIGENE enhancers/MULTIGENE are/VBP approximately/RB 90%/NN identical/JJ to/IN the/DT murine/MULTIGENE homolog/MULTIGENE and/CC include/VB several/DT motifs/NNS previously/RB demonstrated/VBN to/IN be/VB important/JJ for/IN function/NN of/IN the/DT murine/MULTIGENE enhancer/MULTIGENE ;/: additional/JJ segments/NNS of/IN high/JJ sequence/NN conservation/NN suggest/VB the/DT possibility/NN of/IN previously/RB unrecognized/JJ functional/JJ motifs/NNS ./.
@@90181226684/CD The/DT detection/NN of/IN ORF-1/MULTIGENE sequences/MULTIGENE in/IN human/JJ tumors/NNS ,/, while/CC not/RB proof/VB per/IN se/FW ,/, is/VBZ a/DT prerequisite/NN for/IN establishing/VBG its/PRP role/NN in/IN tumor/NN development/NN ./.
@@79841056780/CD Moreover/RB ,/, by/IN complementation/NN of/IN the/DT WA/MULTIGENE fyuA/MULTIGENE mutant/MULTIGENE by/IN the/DT cloned/VBN fyuA/MULTIGENE gene/MULTIGENE ,/, yersiniabactin/NN uptake/NN and/CC mouse/NN virulence/NN were/VBD restored/VBN ./.
@@4765725147/CD Roentgenographically/RB ,/, the/DT lesion/NN was/VBD usually/RB a/DT well-defined/JJ and/CC benign/JJ appearing/NN one/PRP ,/, either/DT purely/RB lytic/JJ (/( 3/CD cases/NNS )/SYM or/CC with/IN central/JJ radiodensity/NN (/( 2/CD cases/NNS )/SYM ./.
@@28322935894/CD The/DT use/NN of/IN CRF-41/GENE in/IN the/DT differential/JJ diagnosis/NN of/IN Cushing's/NNP syndrome/NN and/CC obesity/NN ./.
@@87986432327/CD A/DT novel/JJ phosphotyrosine-binding/JJ domain/NN in/IN the/DT N-terminal/MULTIGENE transforming/MULTIGENE region/MULTIGENE of/IN Cbl/DT interacts/VBZ directly/RB and/CC selectively/RB with/IN ZAP-70/NEWGENE in/NN T/NN cells/NNS ./.
@@26417625746/CD Ischemic/NNP heart/NN disease/NN evaluated/VBN by/IN exercise/NN stress/MULTIGENE thallium-201/MULTIGENE myocardial/JJ scintigraphy/NN :/: a/DT comparison/NN of/IN SPECT/NN and/CC bull's/NNS eye/NN display/NN ./.
@@27767423861/CD Heart/NNP rate/NN (/( HR/NN )/SYM ,/, rectal/JJ temperature/NN (/( Tre/NN )/SYM ,/, blood/NN pressure/NN ,/, temperature/NN and/CC relative/JJ humidity/NN changes/NNS inside/IN clothing/NN were/VBD measured/VBN on/IN 18/CD professional/JJ firemen/NNS (/( mean/JJ age/NN 29/CD ./CD 4/CD +/NN //NN -/NN 7/CD ./CD 4/CD yr/NN ,/, VO2/NN max/JJ 41/CD ./CD 4/CD +/SYM 8/CD ./CD 8/CD ml/NN kg-1/NN min-1/NN )/SYM wearing/JJ fire/NN fighter's/NNS uniforms/NNS (/( SU/JJ )/SYM or/CC aluminized/VBN ,/, fire/NN resistant/JJ ,/, impermeable/JJ clothing/NN with/IN self/NN contained/VBD breathing/JJ apparatus/NN (/( FE/NN )/SYM ./.
@@76160568532/CD Both/DT mu/NN and/CC gamma/MULTIGENE 2b/MULTIGENE heavy/MULTIGENE chain/MULTIGENE genes/MULTIGENE cause/VBG this/DT feedback/NN inhibition/NN of/IN heavy/JJ chain/NN gene/NN rearrangement/NN ./.
@@79798271061/CD KRN2391/GENE and/CC cromakalim/NN produced/VBD a/DT dose-dependent/NN increase/NN in/IN aortic/JJ and/CC coronary/JJ blood/NN flow/NN ./.
@@20281252642/CD The/DT prevalence/NN of/IN opportunistic/JJ infection/NN among/IN surviving/JJ AIDS/NN patients/NNS and/CC the/DT probability/NN of/IN being/VBP in/IN tumour/NN response/NN following/IN cancer/NN therapy/NN conditional/JJ on/IN being/VBP alive/JJ are/VBP two/JJ examples/NNS of/IN such/JJ functions/NNS ./.
@@12019771849/CD The/DT interpretation/NN of/IN antibiotic/JJ disc/NN sensitivities/NNS ./.
@@114133107811/CD RANTES/VBZ (/( regulated/VBN upon/IN activation/NN ,/, normally/RB T-cell/NN expressed/VBN and/CC presumably/RB secreted/VBN )/SYM is/VBZ a/DT CC/NN chemokine/NN which/WDT recruits/NNS and/CC activates/VBZ monocytes/NNS ,/, lymphocytes/NNS ,/, and/CC eosinophils/NNS ,/, all/DT cell/NN types/NNS present/VBP in/IN the/DT lung/NN inflammatory/JJ infiltrate/NN induced/VBN by/IN RSV/NN infection/NN ./.
@@82180568184/CD The/DT ultrastructure/NN of/IN retinal/JJ vessels/NNS was/VBD examined/VBN in/IN three/CD eyes/NNS from/IN diabetic/JJ patients/NNS and/CC two/JJ eyes/NNS from/IN control/NN subjects/NNS ./.
@@107361618402/CD Enzyme/MULTIGENE I/MULTIGENE of/IN the/DT phosphoenolpyruvate/NN :/: sugar/NN phosphotransferase/NN system/NN ./.
@@9708399691/CD Rainbow/NNP trout/NN were/VBD obtained/VBN from/IN a/DT commercial/JJ trout/NN farm/NN ,/, kept/VBP in/IN running/JJ water/NN and/CC feeding/JJ in/IN experimental/JJ pellets/NNS for/IN 4/CD to/IN 8/CD weeks/NNS ./.
@@8191768163/CD The/DT effect/NN of/IN hydrostatic/JJ pressure/NN on/IN the/DT swimming/JJ activity/NN of/IN three/CD hyponeustonic/JJ crustacea/NNS ,/, Anomalocera/NNP patersoni/NN ,/, Pontella/JJ mediterranea/NN ,/, Labidocera/NNP wollastoni/NN ./.
@@17802353328/CD The/DT EPO/NEWGENE levels/NNS were/VBD distinctly/RB increased/VBN before/IN transfusion/NN ;/: they/PRP did/VBD not/RB significantly/RB change/VB just/RB after/IN transfusion/NN ,/, but/CC subsequently/RB decreased/VBN ./.
@@109649953238/CD Taken/VBN together/RB ,/, they/PRP uphold/VBP the/DT emerging/JJ concern/NN that/IN women/NNS with/IN ER/NN (/NN +/NN )/NN cancers/NNS may/MD not/RB benefit/VB significantly/RB from/IN endocrine/JJ treatment/NN if/IN the/DT tumors/NNS also/RB overexpress/VBP HER-2/GENE ./.
@@68383886629/CD Because/IN of/IN a/DT rapid/JJ development/NN of/IN the/DT connective/JJ tissue/NN scars/NNS ,/, however/RB ,/, at/IN the/DT place/NN of/IN the/DT destroyed/VBN glandular/JJ parenchyma/NN areas/NNS ,/, there/RB is/VBZ no/DT normalization/NN of/IN the/DT organ's/NNS structure/NN and/CC function/NN by/IN the/DT 42d/CD day/NN ./.
@@68036344219/CD In/NN silicosis/NN ,/, significant/JJ relationships/NNS between/IN patients/NNS and/CC sons/NNS were/VBD not/RB seen/VBP with/IN respect/NN to/IN arterial/JJ blood/NN gas/NN determinations/NNS and/CC ventilatory/JJ responses/NNS except/VBP for/IN Paco2/GENE of/IN patients/NNS and/CC hypercapnic/JJ ventilatory/JJ responses/NNS of/IN sons/NNS ./.
@@1719684312/CD The/DT above/RB results/VBZ mean/JJ that/IN the/DT increase/NN in/IN alpha-adrenergic/NN receptors/NN makes/VBP the/DT prostate/NN ,/, which/WDT has/VBZ been/VBN already/RB hypertrophied/JJ ,/, less/PRP elastic/JJ ,/, inhibiting/JJ external/NN urinary/JJ sphincter/NN function/NN ./.
@@103932513625/CD The/DT PAC/MULTIGENE clone/MULTIGENE with/IN an/DT insert/NN size/NN of/IN 120kb/CD was/VBD isolated/VBN and/CC mapped/VBN by/IN restriction/NN analysis/NN ./.
@@90065555667/CD MAIN/NNP OUTCOME/NNP MEASURES/NNS :/: Systemic/JJ and/CC pulmonary/JJ hemodynamics/NN ,/, arterial/JJ blood/NN gas/NN determination/NN ,/, bronchoalveolar/JJ lavage/NN protein/NN and/CC neutrophil/JJ content/NN ,/, neutrophil/JJ oxidant/JJ burst/NN ,/, lung/MULTIGENE myeloperoxidase/MULTIGENE content/NN ,/, and/CC scanning/JJ electron/NN micrographic/JJ studies/NNS ./.
@@46460455077/CD Benign/NNP intramural/JJ tumors/NNS of/IN the/DT esophagus/NN ./.
@@92347277592/CD Gal4-Eed/MULTIGENE fusion/MULTIGENE protein/MULTIGENE represses/VBZ transcription/NN of/IN a/DT reporter/NN gene/NN driven/VBP by/IN a/DT promoter/NN that/WDT contains/VBZ Gal4-binding/VBG DNA/NN elements/NNS ./.
@@17668763103/CD A/DT method/NN is/VBZ described/VBN for/IN detecting/JJ targeted/VBN events/NNS at/IN the/DT mu/MULTIGENE heavy/MULTIGENE chain/MULTIGENE gene/MULTIGENE which/WDT relies/VBZ on/IN co-conversion/NN (/( or/CC co-exchange/JJ )/SYM of/IN a/DT point/NN mutation/NN with/IN a/DT selectable/JJ marker/NN contained/VBN on/IN a/DT replacement/NN vector/NN ./.
@@92569736518/CD For/IN E2/GENE ,/, each/DT cat/NN was/VBD given/VBP either/DT 5/CD (/( group/NN [/NN G/NN ]/NN 1/CD )/SYM or/CC 10/CD (/( G2/GENE )/SYM mg/NN of/IN itraconazole/NN //NN kg/NN (/( capsules/NNS )/SYM twice/RB daily/JJ for/IN 6/CD weeks/NNS ./.
@@35616229846/CD As/IN a/DT last/NN resort/NN ,/, it/PRP may/MD be/VB possible/JJ to/IN maintain/VB a/DT patient/NN on/IN dialysis/NN in/IN reasonable/JJ health/NN with/IN a/DT DiaTAP/GENE button/NN graft/NN complex/NN infected/VBN with/IN Staphylococcus/NN epidermidis/NN and/CC intermittent/JJ positive/JJ blood/NN cultures/NNS using/VBG long/JJ term/NN vancomycin/NN therapy/NN ./.
@@101979853178/CD Using/VBG an/DT RNase/MULTIGENE H/MULTIGENE protection/NN assay/NN and/CC specific/JJ blocking/JJ oligonucleotides/NNS ,/, we/PRP find/VBP that/DT recognition/NN of/IN the/DT 5'/CD splice-site/NN (/( 5'ss/CD )/SYM and/CC branchpoint/NN sequence/NN (/( BPS/GENE )/SYM elements/NNS by/IN U11/GENE and/CC U12/MULTIGENE snRNPs/MULTIGENE ,/, respectively/RB ,/, displays/VBP strong/JJ cooperativity/NN ,/, requiring/JJ both/DT sites/NNS in/IN the/DT pre-mRNA/NN substrate/NN for/IN efficient/JJ complex/NN formation/NN ./.
@@103901586278/CD Point/NNP mutations/NNS of/IN the/DT site/NN that/WDT suppressed/VBD Pit-1/GENE binding/JJ in/IN vitro/FW restored/VBN full/JJ tiGH/MULTIGENE promoter/MULTIGENE activity/NN ./.
@@116920046219/CD A/DT review/NN of/IN the/DT literature/NN identified/VBN 8/CD comprehensive/JJ clinical/JJ studies/NNS ,/, all/DT of/IN which/WDT failed/VBD to/IN document/NN any/DT relationship/NN between/IN NF1/GENE and/CC intracranial/JJ aneurysms/NNS ./.
@@3013477525/CD In/NN order/NN to/IN study/NN the/DT influence/NN of/IN iron/NN overload/NN on/IN the/DT polymorphonuclear/JJ leucocyte/NN (/( PMN/NN )/SYM metabolism/NN of/IN patients/NNS on/IN chronic/JJ hemodialysis/NN ,/, generation/NN of/IN superoxide/NN anion/NN (/( O2-/NN )/SYM by/IN PMN/NN in/IN whole/JJ blood/NN was/VBD compared/VBN in/IN two/JJ groups/NNS of/IN hemodialyzed/JJ patients/NNS :/: group/NN A/DT consisted/VB of/IN twenty-one/CD individuals/NNS with/IN serum/JJ ferritin/NEWGENE levels/NNS above/RB 1000/CD ng/NN //NN ml/NN and/CC group/NN B/NNP of/IN nineteen/JJ individuals/NNS with/IN serum/JJ ferritin/NEWGENE levels/NNS below/RB 1000/CD ng/NN //NN ml/NN ./.
@@72998577169/CD LD50/NN values/NNS of/IN terms/NNS of/IN KP/NN were/VBD 84/CD mg/CD //CD kg/CD in/IN male/JJ rats/NNS and/CC 122/CD mg/CD //CD kg/CD in/IN female/JJ rats/NNS when/CC KP-CMC/GENE was/VBD administered/VBN intrarectally/RB ,/, and/CC 117/CD mg/CD //CD kg/CD in/IN male/JJ and/CC 92/CD mg/CD //CD kg/CD in/IN female/JJ when/CC KP-T10/GENE was/VBD administered/VBN intrarectally/CD ./CD ,/, while/CC peroral/JJ administration/NN of/IN KP-CMC/NNP showed/VBD LD50/NN values/NNS of/IN 68/CD mg/CD //CD kg/CD in/IN males/NNS and/CC 78/CD mg/CD //CD kg/CD in/IN females/NNS in/IN terms/NNS of/IN KP/NNP ./NNP
@@45484832896/CD Blood/NNP platelets/NNS ,/, coagulation/MULTIGENE factors/MULTIGENE and/CC morphologic/JJ organ/NN changes/NNS following/IN scadling/VBG shock/NN in/IN rhesus/NN monkeys/NNS ./.
@@13702818804/CD Sequencing/NN revealed/VBN one/PRP large/JJ open/JJ reading/JJ frame/NN encoding/VBG a/DT 39-kDa/MULTIGENE protein/MULTIGENE ./.
@@81191493277/CD Tumor/NEWGENE necrosis/MULTIGENE factor-alpha/MULTIGENE (/( TNF/MULTIGENE alpha/MULTIGENE )/SYM is/VBZ one/PRP of/IN several/DT autocrine/MULTIGENE //MULTIGENE paracrine/MULTIGENE factors/MULTIGENE known/VBP to/IN exert/VB potent/JJ inhibitory/JJ effects/NNS on/IN bone/NN ./.
@@118061321675/CD The/DT TB/NN incidence/NN in/IN the/DT "AIRIN"/NN area/NN ,/, where/CC about/RB 20%/CD TB/NN patients/NNS are/VBP homeless/JJ ,/, shows/VBZ highest/JJS rate/NN of/IN above/RB 1/CD ,/CD 000/CD //CD 100/CD ,/CD 000/CD ./.
@@104071842351/CD For/IN functional/JJ studies/NNS ,/, two/JJ promoter/NN regions/NNS were/VBD cloned/VBN upstream/RB of/IN the/DT reporter/NN gene/NN ,/, chloramphenicol/NN acetyl/MULTIGENE transferase/MULTIGENE (/( CAT/CONTEXTGENE )/SYM :/: (/( i/NN )/SYM phbetaE-B/GENE -/: the/DT plasmid/NN that/WDT contains/VBZ the/DT human/JJ (/( h/NN )/SYM promoter/NN region/NN (/( -2832/CD to/IN +101/NN )/SYM including/JJ URE/GENE ,/, and/CC (/( ii/NN )/SYM prhbetaE-B/GENE -/: the/DT plasmid/NN that/WDT contains/VBZ the/DT rhesus/NN (/( rh/NN )/SYM promoter/NN region/NN excluding/JJ URE/GENE as/IN it/PRP lacks/VBZ a/DT 270/CD bp/NN region/NN of/IN the/DT hbetaAPP/MULTIGENE promoter/MULTIGENE (/( -2435/JJ to/IN -2165/JJ )/SYM ./.
@@90201697786/CD SIM1/GENE and/CC SIM2/GENE do/VB not/RB form/VB homodimers/NNS ,/, and/CC they/PRP do/VBP not/RB interact/VB with/IN AHR/NN ./.
@@64416245074/CD Our/PRP results/NNS indicate/VBP that/IN serum/JJ BGP/NEWGENE is/VBZ a/DT valuable/NN measurement/NN of/IN bone/NN metabolism/NN ./.
@@40621287775/CD National/NNP Institutes/NNS of/IN Health/NNP Consensus/NNP Development/NNP Conference/NNP Statement/GENE ./.
@@82206218189/CD Reviewing/VBG manuscripts/NNS :/: developing/JJ an/DT efficient/JJ system/NN ./.
@@77207105012/CD The/DT Oct/NN and/CC HMG2/MULTIGENE proteins/MULTIGENE also/RB interact/VBP in/IN vivo/NN ./.
@@10194225137/CD Voluntary/NNP wheel/NN running/NN did/VBD not/RB significantly/RB increase/VB estimated/VBN alanine/NN or/CC pyruvate/NN Gneo/NNP or/CC absolute/JJ glycerol/NN Ra/NN ./NN
@@27050723377/CD End/NN points/NNS measured/VBN were/VBD perioperative/JJ (/( 30-day/CD )/SYM myocardial/JJ infarction/NN (/( MI/NN )/SYM rate/NN and/CC death/NN ./.
@@79837443803/CD Surprisingly/RB ,/, nuclear/JJ forms/NNS of/IN IE110/NNP were/VBD found/VBN to/IN move/NN a/DT cytoplasmic/JJ form/NN of/IN IE175/GENE into/IN nuclear/JJ punctate/JJ structures/NNS ,/, and/CC a/DT cytoplasmic/JJ form/NN of/IN IE110/NNP was/VBD able/JJ to/IN retain/VB nuclear/JJ forms/NNS of/IN IE175/GENE in/IN cytoplasmic/JJ punctate/JJ structures/NNS ./.
@@103254132310/CD The/DT enhanced/VBN binding/NN of/IN c-Abl/GENE to/IN DNA/NN containing/JJ 5-methylcytosine/NNP residues/NNS may/MD result/VB from/IN an/DT increased/VBN propensity/NN of/IN the/DT double/JJ helix/NN to/IN denature/VB locally/RB coupled/VBN with/IN a/DT protein-induced/JJ reduction/NN in/IN the/DT base/JJ stacking/JJ interaction/NN ./.
@@19237666709/CD Sequence/NN analysis/NN revealed/VBN that/IN in/IN addition/NN to/IN the/DT non-spliced/JJ variant/NN ,/, multiple/JJ mRNA/NN species/NN were/VBD generated/VBN by/IN alternative/JJ splicing/JJ resulting/VBG in/IN the/DT exclusion/NN of/IN 92/CD ,/, 166/CD ,/, 170/CD ,/, 174/CD and/CC 263/CD nucleotides/NNS (/( nt/NN )/SYM ,/, respectively/RB ,/, from/IN exon/NN 1/CD ./CD
@@103643195899/CD Cp/NN is/VBZ normally/RB the/DT main/JJ promoter/NN for/IN EBNA/MULTIGENE mRNA/MULTIGENE initiation/NN ,/, so/IN it/PRP appears/VBZ that/IN EBNA3C/GENE contributes/VBZ to/IN a/DT negative/JJ autoregulatory/JJ control/NN loop/NN ./.
@@7935418350/CD Using/VBG a/DT v-erbA/NEWGENE probe/NN ,/, we/PRP obtained/VBD a/DT cDNA/NN which/WDT encodes/VBZ a/DT novel/JJ 445-amino-acid/JJ protein/NN ,/, RLD-1/GENE ,/, that/WDT contains/VBZ the/DT characteristic/JJ domains/NNS of/IN nuclear/JJ receptors/NNS ./.
@@107543124030/CD The/DT solubility/NN of/IN all/PDT the/DT mutated/MULTIGENE proteins/MULTIGENE was/VBD remarkably/RB reduced/VBN ./.
@@79607961035/CD Peter/NNP Elfer/GENE explores/VBZ the/DT implications/NNS of/IN the/DT ruling/NN ./.
@@104881295467/CD Synthesis/NNS of/IN antisense/NN RNA/NN and/CC S/NNP phase-dependent/JJ binding/NN of/IN E2F/GENE complexes/NNS in/IN intron/NN 1/CD ./CD
@@111149244736/CD ORFA/NN and/CC ccdA/NN were/VBD constitutively/RB cotranscribed/VBN as/IN determined/VBN by/IN primer/NN extension/NN analysis/NN ./.
@@24026783066/CD Commercially/RB available/JJ formulations/NNS of/IN 2/CD ./CD 5%/CD and/CC 5%/CD lambdacyhalothrin/NN can/MD be/VB diluted/VBN either/DT with/JJ water/NN for/IN ULV/NN cold/JJ aerosol/NN space-spraying/JJ or/CC with/IN diesel/NN //NN kerosene/NN for/IN thermal/JJ fogging/JJ at/IN recommended/VBN application/NN rates/NNS of/IN 0/CD ./CD 5-1/CD g/NN ai/NN //NN ha/NN for/IN mosquito/NN control/NN and/CC 2/CD g/NN ai/NN //NN ha/NN for/IN housefly/NN control/NN ./.
@@19588212580/CD Confocal/JJ fluorescence/NN microscopy/NN in/IN modern/JJ cell/NN biology/NN ./.
@@112975454990/CD Stable/NN transfection/NN of/IN human/MULTIGENE CHOP/MULTIGENE cDNA/MULTIGENE into/IN mammary/JJ carcinoma/NN cells/NNS demonstrated/VBD that/DT CHOP/NN functioned/VBN not/RB as/IN a/DT mediator/NN of/IN hGH-stimulated/JJ mitogenesis/NN but/CC rather/RB enhanced/VBN the/DT protection/NN from/IN apoptosis/NN afforded/VBN by/IN hGH/GENE in/IN a/DT p38/GENE MAPK-dependent/NNP manner/NN ./.
@@79798107973/CD All/PDT other/DT ejaculate/VB parameters/NNS (/( density/NN ,/, motility/NN ,/, swelling/NN test/NN ,/, penetration/NN test/NN )/SYM remained/VBN unchanged/JJ ,/, and/CC there/RB was/VBD only/RB one/PRP post-therapeutic/JJ pregnancy/NN ./.
@@64921886285/CD Other/JJ than/IN d/MULTIGENE 7/MULTIGENE ,/, there/RB was/VBD no/DT significant/JJ effect/NN on/IN the/DT number/NN of/IN implants/NNS ./.
@@37322526253/CD However/RB ,/, further/JJ analyses/NNS of/IN the/DT data/NN indicate/VB that/IN increasing/JJ VO2/GENE AT/IN (/( r/JJ =/SYM -0/CD ./CD 63/CD ,/, P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM rather/RB than/IN VO2max/NN (/( r/JJ =/SYM -0/NN ./NN 15/NN )/SYM could/MD result/VB in/IN improving/JJ the/DT 10/CD ,/CD 000/CD m/NN race/NN performance/NN to/IN a/DT larger/JJR extent/NN ,/, and/CC that/IN the/DT absolute/JJ amount/NN of/IN change/NN (/( delta/JJ )/SYM in/IN the/DT 10/CD ,/CD 000/CD m/NN run/NN time/NN is/VBZ best/RBS accounted/VBN for/IN by/IN a/DT combination/NN of/IN delta/MULTIGENE VO2/MULTIGENE AT/IN and/CC delta/MULTIGENE 5/MULTIGENE ,/MULTIGENE 000/MULTIGENE m/MULTIGENE run/NN time/NN ./.
@@118227906461/CD For/IN instance/NN ,/, a/DT total/JJ SIP/GENE score/NN of/IN an/DT individual/JJ patient/NN of/IN 28/CD ./CD 3%/CD (/( which/WDT is/NNS taken/VBP as/IN an/DT example/NN ,/, being/VBP the/DT mean/JJ score/NN in/IN the/DT study/NN population/NN )/SYM should/MD decrease/VB by/IN at/IN least/RB 9/CD ./CD 26%/CD or/CC approximately/RB 13/CD items/NNS ,/, before/IN any/DT improvement/NN beyond/RB reproducibility/NN noise/NN can/MD be/VB detected/VBN ./.
@@76764927603/CD We/PRP conclude/VBP that/IN ,/, in/IN comparison/NN to/IN reports/NNS from/IN other/DT regions/NNS ,/, Scandinavian/JJ renal/JJ transplant/NN recipients/NNS are/VBP at/IN high/JJ risk/NN of/IN dying/NN of/IN IHD/NN ./.
@@8100057713/CD Double-staining/VBG confirmed/VBN that/IN there/RB were/VBD separate/JJ populations/NNS of/IN CD68-positive/NNP macrophages/NNS and/CC XIIIa-positive/GENE dendrocytes/VBZ ./.
@@112353351063/CD Managing/NNP HIV/NN ./.
@@96714642531/CD Deleting/JJ SNF1/GENE repressed/VBN meiosis/NN at/IN the/DT same/JJ three/CD steps/NNS that/WDT were/VBD inhibited/VBN by/IN glucose/NN ,/, suggesting/VBG that/IN glucose/NN blocks/NNS meiosis/NN by/IN inhibiting/MULTIGENE Snf1/MULTIGENE ./.
@@81528007407/CD Gel/NNP shift/NN analysis/NN indicates/VBZ that/IN the/DT full-length/JJ ERM/MULTIGENE protein/MULTIGENE is/VBZ able/JJ to/IN bind/NN specifically/RB to/IN an/DT oligonucleotide/NN containing/JJ the/DT consensus/NN nucleotide/NN core/NN sequence/NN GGAA/NNP recognized/VBD by/IN the/DT Ets/NNS proteins/NNS ./.
@@87116318692/CD Treatment/NNP is/VBZ instituted/VBN with/IN prednisone/NN and/CC cyclophosphamide/NN ./.
@@78011807778/CD This/DT paper/NN describes/VBZ the/DT advantages/NNS and/CC limitations/NNS of/IN the/DT main/JJ study/NN approaches/NNS used/VBN ./.
@@45430365023/CD Directives/NNS concerning/VBG medical/JJ care/NN ./.
@@16255272213/CD Whole/JJ blood/NN serotonin/NN levels/NNS were/VBD investigated/VBN in/IN a/DT control/NN group/NN (/( n/NN =/SYM 35/CD )/SYM and/CC in/IN a/DT group/NN of/IN chronic/JJ renal/JJ failure/NN patients/NNS (/( n/NN =/SYM 127/CD )/SYM on/IN various/JJ treatment/NN regimen/NN i/CD ./CD e/CD ./. conservative/JJ treatment/NN (/( n/NN =/SYM 39/CD )/SYM ,/, maintenance/NN haemodialysis/NN (/( n/NN =/SYM 35/CD )/SYM and/CC after/IN renal/JJ transplantation/NN (/( n/NN =/SYM 53/CD )/SYM ./.
@@6271296071/CD These/DT responses/NNS were/VBD compared/VBN with/IN others/NNS in/IN the/DT same/JJ subjects/NNS under/IN the/DT same/JJ conditions/NNS and/CC it/PRP was/VBD concluded/VBN that/IN the/DT antihypertensive/JJ effect/NN of/IN labetalol/NN is/VBZ explained/VBN by/IN concurrent/JJ blockade/NN of/IN alpha-and/MULTIGENE beta-adrenoceptors/MULTIGENE ./.
@@62908598126/CD Of/IN 115/MULTIGENE hepatitis/MULTIGENE B/MULTIGENE patients/NNS seen/VBP at/IN 12/CD months/NNS ,/, 6%/JJ had/VBP chronic/JJ hepatitis/MULTIGENE Bs/MULTIGENE antigenaemia/NN ,/, 60%/NN had/VBP developed/VBN anti-HBs/NN antibodies/NNS ,/, and/CC 7/CD ./CD 3%/CD still/RB had/VBP abnormal/JJ liver/NN function/NN ./.
@@23476556032/CD In/NN the/DT artificial/JJ lung/NN ,/, like/JJ in/IN the/DT natural/JJ lung/NN and/CC peripheral/JJ tissues/NNS ,/, gas/NN exchanges/NNS depend/VBP on/IN several/DT parameters/NNS :/: blood/NN inlet/NN conditions/NNS ,/, blood/NN flow/NN rate/NN ,/, temperature/NN ,/, composition/NN of/IN the/DT gas/NN mixture/NN used/VBN for/IN ventilation/NN ,/, blood/NN tissue/NN perfusion/NN ,/, O2/NN consumption/NN ,/, etc/NN ./.
@@88847577522/CD Confirmatory/JJ statistics/NN included/VBD item/NN 2/CD of/IN the/DT Clinical/NNP Global/NNP Impression/NNS (/( CGI/IN )/SYM ,/, the/DT total/JJ score/NN of/IN the/DT Sandoz/NNP Clinical/NNP Assessment/NNP Geriatric/NN (/( SCAG/NN )/SYM scale/NN ,/, the/DT subscale/NN 'need/NN for/IN help'/NN of/IN the/DT nurse's/NNS rating/NN of/IN geriatric/JJ patients/NNS (/( Beurteilungsskala/NNP fur/NN geriatrische/NNP Patienten/NNP ;/: BGP/NN )/SYM and/CC the/DT total/JJ score/NN of/IN the/DT Short/JJ Cognitive/NNP Performance/NNP Test/NNP (/( Syndrom-Kurztest/NNP ;/: SKT/NN )/SYM ./.
@@86150127461/CD Cotransfection/NNS with/IN the/DT ie1/MULTIGENE gene/MULTIGENE resulted/VBN in/IN a/DT dramatic/JJ increase/NN in/IN the/DT amount/NN of/IN the/DT two/JJ enzymes/NNS expressed/VBN in/IN the/DT transfected/VBN cells/NNS ./.
@@79812466798/CD Our/PRP previous/JJ study/NN suggested/VBD that/DT pertussis/NN toxin/NN (/( IAP/NN )/NN -sensitive/NN GTP-binding/NN protein/NN (/NN s/NN )/NN (/( G-protein/NN )/SYM is/VBZ involved/VBN in/IN the/DT process/NN of/IN differentiation/NN by/IN hormones/NN //NN IBMX/NN ,/, accompanied/VBN by/IN c-fos/GENE induction/NN ./.
@@9847371495/CD Jembrana/NNP disease/NN virus/NN (/( JDV/GENE )/SYM is/VBZ a/DT newly/RB identified/VBN bovine/JJ lentivirus/NN that/WDT is/VBZ closely/RB related/VBN to/IN the/DT bovine/JJ immunodeficiency/NN virus/NN (/( BIV/GENE )/SYM ./.
@@10965905750/CD Insulin/MULTIGENE receptor/MULTIGENE substrate-1-mediated/JJ enhancement/NN of/IN growth/MULTIGENE hormone-induced/MULTIGENE mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE activation/NN ./.
@@75539422563/CD The/DT pea/NN rps10/GENE intron/NN is/VBZ homologous/JJ to/IN introns/NNS in/IN rrn26/GENE and/CC cox3/GENE in/IN the/DT Marchantia/NNP mitochondrial/JJ genome/NN ,/, while/CC the/DT Marchantia/MULTIGENE rps10/MULTIGENE gene/MULTIGENE lacks/VBZ an/DT intron/NN ./.
@@93532552900/CD Rip1p/GENE is/VBZ inessential/JJ ,/, associated/VBN with/IN nuclear/JJ pore/NN complexes/NNS ,/, and/CC structurally/RB related/VBN to/IN the/DT FG-nucleoporin/MULTIGENE family/MULTIGENE of/IN pore/NN proteins/NNS ./.
@@1373374382/CD Homodimers/NNS of/IN the/DT three/CD proteins/NNS specifically/RB recognize/VBP the/DT G-box/MULTIGENE motif/MULTIGENE ,/, with/IN GBF1/GENE and/CC GBF3/GENE binding/JJ symmetrically/RB to/IN this/DT palindromic/JJ sequence/NN ./.
@@25551774020/CD First/RB ,/, a/DT pet54/GENE :/: :/: LEU2/NEWGENE cytoductant/NN bearing/JJ the/DT 'short'/JJ mitochondrial/JJ genome/NN that/WDT lacks/VBZ both/DT COX1/GENE introns/NNS aI5/MULTIGENE alpha/MULTIGENE and/CC aI5/MULTIGENE beta/MULTIGENE is/VBZ defective/JJ only/RB in/IN COX3/MULTIGENE gene/MULTIGENE expression/NN and/CC not/RB in/IN COX1/MULTIGENE mRNA/MULTIGENE splicing/JJ or/CC mRNA/NN translation/NN ./.
@@89790896251/CD Stable/NN transfection/NN of/IN the/DT BL/NNP cell/NN line/NN Raji/IN with/IN constructs/NNS containing/JJ core/NN promoter/NN mutations/NNS confirmed/VBN that/IN the/DT proximal/JJ Sp1/MULTIGENE site/MULTIGENE and/CC the/DT TATA/MULTIGENE box/MULTIGENE are/VBP essential/JJ for/IN the/DT activation/NN of/IN promoter/MULTIGENE P1/MULTIGENE by/IN the/DT Ig/MULTIGENE kappa/MULTIGENE enhancers/MULTIGENE ./.
@@8038678035/CD Patients/NNS were/VBD subclassified/VBN into/IN age-matched/JJ groups/NNS of/IN primary/JJ untreated/JJ cancer/NN (/( 21/CD )/SYM ,/, recurrent/JJ cancer/NN (/( 18/CD )/SYM ,/, and/CC "cured"/JJ patients/NNS who/WP had/VBP been/VBN free/JJ of/IN disease/NN for/IN at/IN least/RB 9/CD months/NNS (/( 16/CD )/SYM ./.
@@27874303480/CD Histiocytic/JJ panniculitis/NN was/VBD observed/VBN in/IN biopsy/NN specimens/NNS with/IN cytophagocytosis/NN ./.
@@75823165394/CD With/IN each/DT of/IN the/DT three/CD pairs/NNS of/IN isolates/NNS (/( case/NN and/CC suspicious/JJ case/NN )/SYM ,/, identical/JJ IS6110/VBZ banding/JJ patterns/NNS were/VBD found/VBN suggesting/VBG identical/JJ MTB/GENE strains/NNS ./.
@@85515779742/CD Retroviral/JJ replication/NN requires/VBZ that/IN a/DT portion/NN of/IN the/DT primary/JJ transcripts/NNS generated/VBN from/IN proviral/JJ DNA/NN be/VB spliced/VBN to/RB serve/NN as/IN mRNA/NN for/IN the/DT envelope/NN protein/NN and/CC in/IN Rous/NN sarcoma/NN virus/NN as/IN src/MULTIGENE mRNA/MULTIGENE ./.
@@110152001759/CD (/( 1995/CD )/SYM J/NNP ./NNP
@@33405489306/CD In/NN the/DT chicken/NN liver/NN ,/, levels/VBZ of/IN chicken/MULTIGENE MT/MULTIGENE mRNA/MULTIGENE were/VBD rapidly/RB induced/VBN by/IN metals/NNS (/( Cd2+/NN ,/, Zn2+/NN ,/, Cu2+/NN )/SYM ,/, glucocorticoids/NNS and/CC lipopolysaccharide/NN ./.
@@92116059170/CD Tendon/VBP also/RB shows/VBZ a/DT degree/NN of/IN extensibility/NN ./.
@@88927578532/CD Molecular/NNP cloning/NN of/IN Elk-3/GENE ,/, a/DT new/JJ member/NN of/IN the/DT Ets/NNS family/NN expressed/VBN during/IN mouse/NN embryogenesis/NN and/CC analysis/NN of/IN its/PRP transcriptional/JJ repression/NN activity/NN ./.
@@27620063463/CD Cord/NN swelling/NN was/VBD observed/VBN in/IN 2/CD patients/NNS who/WP developed/VBD complete/JJ lesions/NNS ./.
@@95796029287/CD These/DT modifications/NNS may/MD improve/VB the/DT interlaboratory/JJ reproducibility/NN of/IN CD34/GENE determinations/NNS due/NN to/IN the/DT reduction/NN in/IN sample/NN handling/VBG and/CC calculation/NN of/IN results/NNS ./.
@@56936025652/CD Evaluation/NN of/IN automatic/JJ blood/NN cell/NN counters/NNS ./.
@@90573255758/CD The/DT region/NN of/IN plasmid/NN pCM2/GENE encoding/VBG the/DT pathogenicity/NN locus/MULTIGENE pat-1/MULTIGENE was/VBD mapped/VBN by/IN deletion/NN analysis/NN and/CC complementation/NN studies/NNS to/IN a/DT 1/CD ./CD 5-kb/CD Bg/MULTIGENE //MULTIGENE II/MULTIGENE //MULTIGENE SmaI/MULTIGENE DNA/MULTIGENE fragment/MULTIGENE ./.
@@59921575862/CD The/DT pathogenicity/NN of/IN Achromobacter/NN puntatum/NN for/IN cold/JJ blooded/JJ and/CC warm/JJ blooded/JJ animals/NNS ./.
@@115226586410/CD This/DT plus/NN the/DT reduced/VBN phosphorylation/NN of/IN p27/GENE by/IN MAPK/NEWGENE enhanced/VBD the/DT stability/NN of/IN p27/GENE that/WDT associated/VBD with/IN nuclear/MULTIGENE Cdk2/MULTIGENE at/IN high/JJ stoichiometry/NN and/CC inhibited/VBN its/PRP kinase/NN activity/NN ./.
@@93251354827/CD The/DT Trx-CT/MULTIGENE fusion/MULTIGENE protein/MULTIGENE was/VBD produced/VBN less/PRP efficiently/RB (/( 20%/CD of/IN total/JJ soluble/JJ cellular/JJ protein/NN )/SYM ./.
@@25919698550/CD The/DT elements/NNS responsible/JJ for/IN glucocorticoid/NN stimulation/NN of/IN ADH/MULTIGENE gene/MULTIGENE transcription/NN appear/VB to/IN reside/VB outside/RB of/IN this/DT region/NN ./.
@@107302922409/CD Early/JJ treatment/NN mechanics/NN of/IN the/DT Class/NN II/NN division/NN 2/CD malocclusion/NN ./.
@@108733883060/CD With/IN the/DT human/MULTIGENE Rhotekin/MULTIGENE cDNA/MULTIGENE as/IN a/DT probe/NN ,/, Northern/NNP hybridization/NN revealed/VBN that/IN a/DT 4/NN ./NN 0-kb/NN transcript/NN was/VBD expressed/VBN at/IN a/DT high/JJ level/NN in/IN prostate/NN and/CC at/IN a/DT middle/JJ level/NN in/IN 13/CD of/IN 16/CD tissues/NNS examined/VBN ,/, but/CC it/PRP cannot/MD be/VB detected/VBN in/IN liver/NN and/CC lung/NN tissues/NNS ./.
@@81065122975/CD When/WRB the/DT promoter/NN region/NN was/VBD linked/JJ with/IN a/DT heterologous/JJ reporter/NN gene/NN ,/, we/PRP found/VBP that/IN the/DT promoter/NN region/NN is/VBZ inducible/JJ by/IN both/DT interferons/NNS (/( interferon-alpha/NN and/CC -gamma/CD )/SYM and/CC interferon/MULTIGENE regulatory/MULTIGENE factor/MULTIGENE 1/CD ./CD
@@79935592757/CD A/DT recent/JJ index/NN (/( Fluorosis/NNS Risk/NNP Index/NNP )/SYM developed/VBN by/IN Pendrys/GENE (/( 1990/CD )/SYM is/VBZ also/RB included/VBN in/IN this/DT review/NN ./.
@@85005245425/CD However/RB ,/, study/NN of/IN the/DT productive/MULTIGENE gamma/MULTIGENE gene/MULTIGENE showed/VBN that/IN the/DT skipped/VBN variable/JJ exon/NN was/VBD bounded/VBN by/IN normal/JJ splicing/JJ signals/NNS and/CC that/IN the/DT adjacent/JJ intron/NN organization/NN was/VBD not/RB altered/VBN ./.
@@118820541550/CD Because/IN a/DT close/JJ correlation/NN between/IN regional/JJ decreases/NNS in/IN FMZ/NEWGENE binding/JJ and/CC spiking/JJ activity/NN was/VBD recently/RB demonstrated/VBN in/IN neocortical/JJ epilepsies/NNS ,/, abnormal/JJ peri-lesional/NNP FMZ/NEWGENE binding/NN may/MD bear/VB some/DT relation/NN to/IN the/DT mechanisms/NNS of/IN epileptogenesis/NN in/IN symptomatic/JJ epilepsies/NNS ./.
@@47530735133/CD Choice/NN of/IN vessel/NN ./.
@@70848146868/CD Preparation/NN of/IN a/DT stable/JJ phospholipid/NN reagent/NN for/IN coagulation/NN assays/NNS ./.
@@99006799909/CD Wave/NNP cybernetics/NNS :/: A/DT simple/JJ model/NN of/IN wave-controlled/JJ nonlinear/JJ and/CC nonlocal/JJ cooperative/JJ phenomena/NNS ./.
@@100361914150/CD The/DT microphthalmia-TFE/JJ (/( MiT/NNP )/SYM subfamily/NN of/IN basic/JJ helix-loop-helix/JJ leucine/MULTIGENE zipper/MULTIGENE (/( bHLH-ZIP/GENE )/SYM transcription/NN factors/NNS ,/, including/JJ TFE3/GENE ,/, TFEB/GENE ,/, TFEC/GENE ,/, and/CC Mitf/GENE ,/, has/VBZ been/VBN implicated/VBN in/IN the/DT regulation/NN of/IN tissue-specific/MULTIGENE gene/MULTIGENE expression/NN in/IN several/DT cell/NN lineages/NNS ./.
@@27724952599/CD Asthma/NNS was/VBD significantly/RB more/RB often/RB associated/VBN with/IN ASA/NN group/NN (/( 91%/CD )/SYM vs/NNP 46%/JJ at/IN AT/IN and/CC in/IN only/RB 16%/JJ at/IN INTR/GENE group/NN ./.
@@117631766827/CD Moreover/RB ,/, a/DT severe/JJ decrease/NN of/IN antithrombin/NEWGENE activity/NN became/VBD evident/JJ during/IN both/DT experiments/NNS (/( eg/NN ,/, in/IN experiment/NN 2/CD from/IN 95/CD ./CD 6/CD +/NN //NN -/NN 4/CD ./CD 8/CD to/IN 59/CD ./CD 2/CD +/NN //NN -/NN 6/CD ./CD 6%/CD )/SYM ./.
@@105499121823/CD This/DT report/NN describes/VBZ a/DT patient/NN with/IN a/DT previous/JJ inferior/JJ acute/JJ myocardial/JJ infarction/NN who/WP developed/VBD right/JJ ventricular/JJ infarction/NN with/IN significant/JJ anterior/JJ lead/NN ST/NN segment/NN elevation/NN (/( V1-V4/NNP )/SYM caused/VBN by/IN the/DT loss/NN of/IN two/JJ large/JJ right/JJ ventricular/JJ branches/NNS during/IN a/DT coronary/JJ angioplasty/NN of/IN the/DT right/JJ coronary/JJ artery/NN ./.
@@23990532526/CD Sprague-Dawley/JJ newborn/JJ rats/NNS (/( n/NN =/SYM 85/CD )/SYM breathed/VBN 100%/CD oxygen/NN (/( O2/GENE )/SYM or/CC room/NN air/NN (/( RA/NN )/SYM during/IN the/DT first/JJ 8/CD days/NNS of/IN life/NN ,/, and/CC then/RB RA/NN ./NN
@@64264938686/CD Following/VBG 20/CD min/NN of/IN steady/JJ state/NN anaesthesia/NN during/IN which/WDT measurements/NNS of/IN IOP/NN ,/, arterial/JJ pressure/NN ,/, heart/NN rate/NN ,/, FIO2/GENE ,/, FE'CO2/GENE and/CC CVP/NN were/VBD recorded/VBN ,/, one/PRP group/NN of/IN patients/NNS received/VBD atracurium/NN 0/CD ./CD 45/CD mg/NN kg-1/NN and/CC the/PDT other/DT pancuronium/NN 0/CD ./CD 1/CD mg/NN kg-1/NN ./.
@@94420244258/CD P/NNP ./NNP ,/, Peyron/NNP ,/, J/NNP ./NNP
@@114026741261/CD Newcastle/NN disease/NN antibody/NN titre/NN is/VBZ dependent/JJ on/IN serum/JJ calcium/NN concentration/NN ./.
@@118420371717/CD Based/VBN on/IN analytic/JJ precisions/NNS ,/, a/DT +/JJ //JJ -/JJ 2%/JJ urine-plasma/JJ difference/NN was/VBD set/NN as/IN the/DT cut-off/JJ value/NN ./.
@@15689609365/CD A/DT possible/JJ mechanism/NN is/VBZ that/WDT elevated/VBD alveolar/JJ pressure/NN and/CC decreased/VBN cardiac/JJ output/NN eliminate/VB blood/NN flow/NN from/IN corner/NN vessels/NNS in/IN nondependent/MULTIGENE high/MULTIGENE VA/MULTIGENE //MULTIGENE Q/MULTIGENE regions/MULTIGENE ./.
@@10831972471/CD RESULTS/NNS :/: Soluble/MULTIGENE CD23/MULTIGENE levels/NNS were/VBD significantly/RB higher/JJ in/IN women/NNS with/IN endometriosis/NN before/IN treatment/NN than/IN in/IN ten/CD normal/JJ controls/NNS ./.
@@93812614042/CD CONCLUSIONS/IN :/: We/PRP obtained/VBD normal/JJ EPO/NEWGENE levels/NNS for/IN mothers/NNS and/CC newborns/NNS for/IN our/PRP area/NN ,/, similarly/RB to/IN the/DT previously/RB described/VBN ones/NNS ./.
@@18508932442/CD Naturally/RB acquired/VBN antibodies/NNS were/VBD demonstrated/VBN in/IN some/DT rabbits/NNS kept/VBP on/IN commercial/JJ farms/NNS ./.
@@72523467085/CD A/DT surgical/JJ technique/NN for/IN correcting/VBG this/DT problem/NN is/VBZ described/VBN ./.
@@73779545564/CD The/DT following/NN aspects/NNS were/VBD assessed/VBN :/: (/( 1/CD )/SYM The/DT effect/NN on/IN the/DT cardiovascular/JJ system/NN in/IN terms/NNS of/IN brachial/JJ arterial/JJ pressure/NN ,/, pulse/NN rate/NN ,/, and/CC oxygen/NN consumption/NN (/( VO2/NN )/SYM during/IN exercise/NN in/IN 5/CD health/NN volunteers/NNS ;/: (/( 2/CD )/SYM emg/NN activity/NN of/IN the/DT tibialis/NN anterior/JJ and/CC gastrocnemius/NN muscles/NNS during/IN exercise/NN in/IN the/DT same/JJ 5/CD volunteers/NNS ;/: and/CC (/( 3/CD )/SYM postexercise/JJ ankle/NN pressure/NN changes/NNS in/IN 10/CD subjects/NNS with/IN angiographically/RB proven/VBP occlusive/JJ arterial/JJ diseases/NNS of/IN the/DT lower/JJR extremities/NNS ./.
@@59951405866/CD On/IN the/DT amount/NN and/CC significance/NN of/IN the/DT effective/JJ glucose/NN level/NN in/IN tumors/NNS ./.
@@108572621707/CD The/DT protein/NN encoded/VBN by/IN the/DT fruA/MULTIGENE transcript/MULTIGENE is/VBZ well/VB conserved/VBN with/IN the/DT D/NN ./NN melanogaster/NN type/MULTIGENE A/MULTIGENE protein/MULTIGENE ,/, particularly/RB the/DT BTB/GENE protein-protein-binding/JJ domain/NN ,/, which/WDT is/VBZ encoded/VBN by/IN exons/NNS I/PRP and/CC II/NNP and/CC is/VBZ 100%/CD conserved/VBN ./.
@@97129151082/CD The/DT activity/NN of/IN the/DT minimal/JJ promoter/NN was/VBD found/VBN to/IN be/VB controlled/VBN by/IN a/DT combination/NN of/IN the/DT activities/NNS of/IN the/DT transcription/MULTIGENE factors/MULTIGENE Sp1/MULTIGENE ,/, Sp3/GENE ,/, and/CC NF-Y/CONTEXTGENE ./.
@@111930457305/CD A/DT picture/NN is/VBZ emerging/JJ showing/NN a/DT gradient/NN of/IN function/NN among/IN p53/GENE ,/, p73/GENE ,/, p63/GENE ranging/VBG from/IN tumor/NN suppression/NN to/IN development/NN ./.
@@119208961838/CD In/NN this/DT study/NN we/PRP wanted/VBD to/IN assess/VB the/DT DR/NN using/VBG the/DT 'combined/VBN test'/NN in/IN an/DT unselected/JJ population/NN of/IN self-referred/JJ pregnant/JJ women/NNS at/IN a/DT false-positive/JJ rate/NN (/( FPR/NNS )/SYM of/IN about/RB 5%/CD ./CD
@@30761243800/CD The/DT bile/NN acid/NN sequestrants/NNS (/( cholestyramine/NN and/CC colestipol/NN )/SYM ,/, nicotinic/JJ acid/NN ,/, fenofibrate/NN and/CC inhibitors/NNS of/IN hydroxymethylglutaryl/MULTIGENE coenzyme/MULTIGENE A/MULTIGENE (/( HMG/CONTEXTGENE CoA/CONTEXTGENE )/SYM reductase/NN (/( e/NN ./NN g/NN ./. lovastatin/NN or/CC simvastatin/NN )/SYM are/VBP the/DT most/RB effective/JJ drugs/NNS for/IN use/NN in/IN patients/NNS with/IN primary/JJ hypercholesterolaemia/NN ;/: these/DT agents/NNS reduce/VBP plasma/NN concentrations/NNS of/IN total/NN and/CC LDL-cholesterol/NN by/IN 15/CD to/IN 45%/NN ./.
@@13265575514/CD Cloning/VBG and/CC primary/JJ structure/NN of/IN neurocan/NN ,/, a/DT developmentally/RB regulated/VBN ,/, aggregating/JJ chondroitin/NN sulfate/NN proteoglycan/NN of/IN brain/NN ./.
@@93891989344/CD During/IN the/DT aftermath/NN of/IN excitation/NN of/IN the/DT skin/NN sympathetic/JJ nerve/NN by/IN mental/JJ arithmetics/NNS ,/, 3/MULTIGENE //MULTIGENE 12/MULTIGENE A/MULTIGENE delta/MULTIGENE units/NNS were/VBD turned/VBN to/IN the/DT active/JJ state/NN with/IN decreased/VBN mechanical/JJ threshold/NN ./.
@@103760659364/CD Both/DT filters/NNS equally/RB contributed/VBN to/IN elevation/NN of/IN iliac/JJ venous/JJ pressure/NN (/( median/JJ ,/, 9/CD ./CD 3/CD and/CC 7/CD ./CD 2/CD mm/NN Hg/NN [/NN n/NN =/SYM 9/NN ]/NN with/IN the/DT spring/NN filter/NN and/CC RF02/GENE filter/NN ,/, respectively/RB )/SYM ./.
@@57898701560/CD Phosphate/MULTIGENE glucose/MULTIGENE dehydrogenase/MULTIGENE deficiency/NN causing/JJ hyperbilirubinemia/NN in/IN the/DT newborn/NN ./.
@@90018288962/CD A/DT total/NN of/IN 1459/CD men/NNS aged/VBN 48/CD to/IN 84/CD years/NNS ,/, who/WP were/VBD diagnosed/VBN for/IN the/DT first/JJ time/NN by/RB physicians/NNS as/IN having/VBG BPH/NN in/IN 1994/CD and/CC who/WP had/VBP not/RB received/VBN treatment/NN ,/, participated/VBN in/IN the/DT study/NN ./.
@@39351174592/CD Selective/JJ effect/NN of/IN pulmonary/JJ oedema/NN on/IN prostaglandin/MULTIGENE E2/MULTIGENE pharmacokinetics/NN in/IN rat/NN lung/NN ./.
@@11921126293/CD As/IN measured/VBN by/IN the/DT PDQ-39/CONTEXTGENE ,/, STN-DBS/GENE significantly/RB improves/VBZ important/JJ aspects/NNS of/IN QoL/NN in/IN patients/NNS with/IN advanced/JJ PD/NNP ./NNP
@@11274368877/CD Deletion/NNS of/IN the/DT potential/JJ initiator/MULTIGENE element/MULTIGENE does/VBP not/RB affect/VB repression/NN of/IN the/DT p21/MULTIGENE promoter/MULTIGENE by/IN c-Myc/GENE ./.
@@61475045968/CD Two/CD patients/NNS withdrew/VBD from/IN therapy/NN ,/, one/PRP for/IN personal/JJ reasons/NNS and/CC one/PRP because/IN a/DT paraspinal/JJ mass/RB developed/VBN ./.
@@107132394913/CD CONCLUSION/IN :/: A/DT valve-like/JJ mechanism/NN formed/VBN by/IN the/DT capsulorhexis/NN rim/NN partially/RB adhered/VBD to/IN the/DT IOL/NN optic/NN can/MD occur/VB postoperatively/RB ./.
@@78718919098/CD SUP46/GENE is/VBZ implicated/VBN in/IN translation/NN fidelity/NN and/CC encodes/VBZ the/DT ribosomal/MULTIGENE protein/MULTIGENE S13/MULTIGENE ./.
@@11042204324/CD The/DT present/NN study/NN shows/VBZ that/DT phosphatidylinositol/NN 3-kinase-dependent/MULTIGENE p38/MULTIGENE kinase/MULTIGENE activation/NN regulates/VBZ Akt/GENE phosphorylation/NN and/CC activity/NN in/IN human/JJ neutrophils/NNS ./.
@@110698254198/CD There/EX were/VBD 122/CD cases/NNS of/IN tuberculosis/NN over/RB an/DT average/JJ 10/CD ./CD 3/CD yr/NN of/IN follow-up/JJ (/( crude/JJ annual/JJ incidence/NN ,/, 76/GENE ./GENE 2/GENE //GENE 100/GENE ,/GENE 000/GENE )/SYM ./.
@@1930470125/CD To/TO lower/JJR the/DT current/JJ high/JJ incidence/NN of/IN NANB-induced/JJ PTH/NN ,/, in/IN 1986/CD ,/, the/DT American/NNP Association/NNP of/IN Blood/NNP Banks/NNP (/( AABB/GENE )/SYM recommended/VBN testing/NN for/IN these/DT PTH-associated/JJ "surrogate"/NN markers/NNS on/IN all/DT donated/VBN units/NNS of/IN blood/NN ./.
@@107130836698/CD As/IN assessed/VBN by/IN a/DT genetic/JJ assay/NN that/IN measures/NNS AAI-dependent/MULTIGENE DNA/MULTIGENE binding/JJ ,/, TraM/NN inhibited/VBD TraR/GENE function/NN before/IN and/CC after/IN the/DT transcription/NN factor/NN had/VBP bound/JJ to/IN its/PRP DNA/NN recognition/NN site/NN ./.
@@92231228531/CD The/DT gray/JJ matter/NN NAA/GENE //GENE mI/GENE ratio/NN clearly/RB separated/VBD the/DT two/JJ groups/NNS ./.
@@1010638110/CD The/DT feed/JJ consumed/VBN which/WDT was/VBD lowered/VBN by/IN 25%/JJ initially/RB ,/, did/VBD not/RB alter/VB later/JJR ./.
@@75408661975/CD As/IN expected/VBN ,/, the/DT insulin/NN effect/NN to/IN increase/NN ras/MULTIGENE GTP/MULTIGENE formation/NN and/CC MAP/MULTIGENE kinase/MULTIGENE activity/NN was/VBD negligible/JJ in/IN A/NNP //NNP K1018/NNP cells/NNS but/CC normal/JJ ,/, or/CC supernormal/JJ ,/, in/IN Y/NNP //NNP F2/NNP cells/NNS ./.
@@82547385672/CD Using/VBG a/DT series/NN of/IN mutant/JJ T/NN antigens/NNS expressed/VBN by/IN recombinant/JJ baculoviruses/NNS in/IN Sf9/CD cells/NNS ,/, we/PRP find/VBP that/IN the/DT origin/NN unwinding/JJ activities/NNS of/IN both/DT TS677--/NNP >/NNP A/NNP and/CC TS677/CD ,/CD 679--/CD >/CD A/CD are/VBP inhibited/VBN by/IN the/DT T-antigen/MULTIGENE kinase/MULTIGENE ,/, as/IN is/VBZ wild-type/VBG T/NN antigen/NN ./.
@@18856133195/CD Information/NNP on/IN conserved/VBN noncoding/JJ sequences/NNS will/MD help/VB in/IN studies/NNS on/IN the/DT regulation/NN of/IN the/DT pro/NN alpha/NN 1/NN (/NN II/NN )/NN collagen/NEWGENE gene/NN ./.
@@65178166848/CD HA/NN resulted/VBN in/IN decreased/VBN (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM Tre/NN (/( 0/CD ./CD 4/CD degrees/NNS C/NN )/SYM and/CC HR/NN (/( 17/CD b/NN X/NN min-1/NEWGENE )/SYM ,/, and/CC increased/VBD (/( p/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM Msw/NNP (/( 16/CD g/NN X/NN m-2/GENE X/NN h-1/NEWGENE )/SYM during/IN the/DT saline/JJ experiments/NNS ./.
@@98132599790/CD Our/PRP findings/NNS demonstrate/VBP a/DT dose-dependent/NN blockade/NN of/IN the/DT mechanical/JJ sensitivity/NN caused/VBN by/IN a/DT mild/JJ thermal/JJ injury/NN by/IN both/DT GBP/NN and/CC IBG/NN ./.
@@93216577805/CD In/NN this/DT study/NN we/PRP have/VBP introduced/VBN mutations/NNS into/IN the/DT corresponding/JJ elements/NNS of/IN two/JJ cox3/MULTIGENE promoters/MULTIGENE and/CC show/VB that/IN while/CC the/DT core/NN element/NN is/VBZ essential/JJ for/IN cox3/MULTIGENE promoter/MULTIGENE activity/NN ,/, upstream/JJ element/NN mutations/NNS have/VBP little/JJ or/CC no/DT effect/NN ./.
@@6652146383/CD The/DT method/NN described/VBN may/MD prove/VB useful/JJ in/IN studying/VBG the/DT physiology/NN of/IN the/DT nasal/JJ cycle/NN ./.
@@70188105528/CD Plasma/NN renin/NEWGENE concentration/NN is/VBZ significantly/RB higher/JJ in/IN the/DT subcapsular/JJ venous/JJ outflow/NN ,/, which/WDT drains/VBZ the/DT superficial/JJ cortex/NN ,/, than/IN in/IN the/DT deep/JJ venous/JJ outflow/NN ,/, which/WDT drains/VBZ the/DT inner/JJ half/NN of/IN the/DT cortex/NN and/CC medulla/NN of/IN the/DT cat/NN kidney/NN ./.
@@105214476568/CD The/DT factor/NN designated/VBN B/NNP formed/VBD a/DT complex/NN centered/VBN on/IN the/DT sequence/MULTIGENE TGTGGT/MULTIGENE ,/, a/DT core/NN motif/NN recognized/VBN by/IN members/NNS of/IN the/DT AML/MULTIGENE //MULTIGENE CBFalpha/MULTIGENE transcription/MULTIGENE factor/MULTIGENE family/MULTIGENE ./.
@@76424905455/CD A/DT new/JJ vector/NN ,/, pHBK280/GENE ,/, was/VBD designed/VBN to/IN facilitate/VB this/DT analysis/NN ./.
@@8798443414/CD The/DT DNA/NN binding/NN and/CC multimerization/NN activities/NNS of/IN c-Myb/GENE appear/VB to/IN be/VB unaffected/JJ by/IN the/DT S528A/NNP substitution/NN ,/, suggesting/VBG that/DT phosphorylation/NN of/IN serine/NN 528/CD may/MD mediate/VB its/PRP effect/NN on/IN the/DT transcription/NN transactivating/JJ activity/NN of/IN c-Myb/GENE by/IN regulating/JJ interactions/NNS with/IN other/DT proteins/NNS ./.
@@110513645079/CD RESULTS/NNS :/: Twenty-two/CD (/( 26%/JJ )/SYM patients/NNS had/VBP PHG/GENE before/IN (/( group/NN A/DT )/SYM and/CC 64/CD (/( 74%/JJ )/SYM developed/VBN PHG/GENE after/IN variceal/JJ eradication/NN (/( group/NN B/NNP )/SYM ./SYM
@@10550139368/CD PATIENTS/IN AND/CC METHODS/IN :/: Immediately/RB before/IN radical/JJ prostatectomy/NN ,/, bone/NN marrow/NN aspirates/NNS from/IN both/DT sides/NNS of/IN the/DT iliac/JJ crest/NN were/VBD taken/VBP from/IN 287/CD patients/NNS ./.
@@91763409875/CD Transcription/NNS of/IN these/DT genes/NNS was/VBD also/RB elevated/VBN in/IN gut/NN and/CC lung/NN during/IN freezing/NN ,/, but/CC mRNA/NN levels/NNS in/IN these/DT tissues/NNS were/VBD lower/JJR than/IN in/IN liver/NN ./.
@@37460537170/CD Findings/NNS of/IN positive/JJ potentials/NNS showed/VBN that/IN N1/NN originated/VBN in/IN the/DT area/NN of/IN ventral/JJ gray/JJ matter/NN through/RB the/DT ventro-lateral/JJ column/NN and/CC N2/NN through/RB the/DT dorsal/JJ column/NN ./.
@@96713135225/CD Chem/NNP ./NNP ,/, 270/CD :/: 7117-7124/JJ ,/, 1995/CD ;/: and/CC MT/NN Hartsough/NNP et/FW al/NNS ./NNS ,/, J/NNP ./NNP
@@111607328757/CD Vector/NNP stocks/NNS containing/JJ envelope/NN proteins/NNS from/IN three/CD different/JJ SIVmac/ORG clones/NNS ,/, namely/RB ,/, SIVmac239/GENE (/( T-lymphocyte/NN tropic/JJ [/NN T-tropic/NN ]/NN )/SYM ,/, SIVmac316/GENE (/( macrophage/NN tropic/JJ [/NN M-tropic/NN ]/NN )/SYM ,/, and/CC SIVmac1A11/GENE (/( dualtropic/JJ )/SYM ,/, were/VBD tested/VBN ./.
@@116065381874/CD A/DT twelfth/JJ insertion/NN disrupts/VBZ two/JJ genes/NNS ,/, Nrk/GENE ,/, a/DT "neurospecific"/NN receptor/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE ,/, and/CC Tpp/GENE ,/, which/WDT encodes/VBZ a/DT neuropeptidase/NN ./.
@@1544305512/CD The/DT Southern/NNP technique/NN allowed/VBD a/DT further/JJ localization/NN of/IN the/DT region/NN of/IN most/RB extensive/JJ transcription/NN to/IN a/DT 1/CD ./CD 8/CD kb/NN HindIII-EcoRI/MULTIGENE fragment/MULTIGENE ./.
@@72806549442/CD In/NN literature/NN ,/, the/DT HBE/NN has/VBZ been/VBN displayed/VBN by/IN application/NN of/IN the/DT averaging/VBG method/NN ./.
@@19038419674/CD One/CD of/IN its/PRP lysine/NN residues/NNS is/VBZ modified/JJ by/IN spermidine/NN to/IN form/NN hypusine/NN ,/, a/DT posttranslational/JJ modification/NN unique/JJ to/IN eIF-5A/GENE ./.
@@1681762110/CD Patulin/GENE is/VBZ extracted/VBN from/IN apple/NN butter/NN samples/NNS with/IN ethyl/NN acetate/NN and/CC the/DT extract/NN is/VBZ cleaned/VBN up/JJ on/IN a/DT silica/NN gel/NN column/NN ,/, using/VBG benzene-ethyl/JJ acetate/NN (/( 75+25/CD )/SYM as/IN the/DT eluant/NN ./.
@@1007389973/CD The/DT lowest/JJS culture/NN failure/NN rate/NN of/IN 0/CD ./CD 2/CD per/IN cent/NN was/VBD found/VBN after/IN EAF/GENE compared/VBN with/IN 0/CD ./CD 9/CD per/IN cent/NN among/IN CVS/NN ./.
@@53225585470/CD Homograft/NNS response/NN and/CC hemagglutinin/NN production/NN by/IN sensitized/RB thymectomized/VBN irradiated/JJ adult/JJ mice/NNS ./.
@@34203246652/CD Pregnant/NNP rats/NNS were/VBD exposed/VBN to/IN one/PRP of/IN the/DT following/NN :/: (/( 1/CD )/SYM 10%/CD O2/GENE in/IN N2/GENE or/CC 100%/NN O2/GENE for/IN 2/CD days/NNS beginning/NN at/IN day/NN 7/CD ,/, 11/CD ,/, 14/CD ,/, or/CC 18/CD of/IN pregnancy/NN ;/: (/( 2/CD )/SYM 10%/CD O2/GENE in/IN N2/GENE or/CC 100%/NN O2/GENE for/IN 10/CD h/NN //NN day/NN beginning/NN at/IN day/NN 7/CD ;/: or/CC (/( 3/CD )/SYM 14-11%/JJ O2/GENE in/IN N2/NNP continuously/RB beginning/JJ at/IN day/NN 14/CD till/NN day/NN 21/CD when/CC they/PRP were/VBD sacrificed/VBN ./.
@@90307819848/CD Most/JJS kinases/NNS are/VBP not/RB significantly/RB inhibited/VBN by/IN roscovitine/NN ./. cdc2/MULTIGENE //MULTIGENE cyclin/MULTIGENE B/MULTIGENE ,/, cdk2/MULTIGENE //MULTIGENE cyclin/MULTIGENE A/MULTIGENE ,/, cdk2/MULTIGENE //MULTIGENE cyclin/MULTIGENE E/MULTIGENE and/CC cdk5/GENE //GENE p35/GENE only/RB are/VBP substantially/RB inhibited/VBN (/( IC50/NN values/NNS of/IN 0/CD ./CD 65/CD ,/, 0/CD ./CD 7/CD ,/, 0/CD ./CD 7/CD and/CC 0/CD ./CD 2/CD microM/NN ,/, respectively/RB )/SYM ./. cdk4/MULTIGENE //MULTIGENE cyclin/MULTIGENE D1/MULTIGENE and/CC cdk6/MULTIGENE //MULTIGENE cyclin/MULTIGENE D2/MULTIGENE are/VBP very/RB poorly/RB inhibited/VBN by/IN roscovitine/NN (/( IC50/NN >/SYM 100/CD microM/NN )/SYM ./.
@@10617232439/CD Serum/NN HBV-DNA/NNS ,/, viral/JJ serology/NN ,/, and/CC liver/NN enzymes/NNS were/VBD measured/VBN sequentially/RB ;/: liver/NN histology/NN was/VBD taken/VBP before/IN and/CC during/IN treatment/NN in/IN 12/CD patients/NNS ./.
@@103853957038/CD The/DT high/JJ density/NN lipoprotein/NN (/( HDL/NN )/SYM receptor/NN mediates/VBZ the/DT uptake/NN of/IN cholesterol/NN and/CC cholesteryl/NN esters/NNS ,/, substrates/NNS for/IN steroidogenesis/NN ,/, from/IN an/DT HDL/NN particle/NN in/IN the/DT adrenal/JJ gland/NN and/CC gonads/NNS ./.
@@26348723308/CD Retrograde/JJ filling/NN consists/VBZ in/IN sealing/JJ endodontics/NN system/NN directly/RB at/IN the/DT apical/JJ zone/NN after/IN surgical/JJ approach/NN ./.
@@98298439816/CD The/DT hematopoietic/MULTIGENE colony-stimulating/MULTIGENE factors/MULTIGENE (/( CSF/CONTEXTGENE )/SYM have/VB been/VBN introduced/VBN into/IN clinical/JJ practice/NN as/IN additional/JJ supportive/JJ measures/NNS that/WDT can/MD reduce/VB the/DT incidence/NN of/IN infectious/JJ complications/NNS in/IN patients/NNS with/IN cancer/NN and/CC neutropenia/NN ./.
@@115226263766/CD Furthermore/RB ,/, hormonal/JJ regulation/NN of/IN G/NN (/NN 1/NN )/NN gene/NN transcription/NN can/MD occur/VB even/VB without/IN additional/JJ activation/NN of/IN the/DT Mek-Erk1/GENE //GENE 2/GENE pathway/NN by/IN estrogen/MULTIGENE receptors/MULTIGENE ./.
@@25656833217/CD A/DT critical/JJ heart/NN rate/NN and/IN //IN or/IN appropriate/JJ sympathetic/JJ state/NN was/VBD found/VBN to/IN provoke/VB all/DT instances/NNS of/IN reentrant/JJ or/CC automatic/JJ atrial/JJ tachycardia/NN and/CC atypical/JJ junctional/JJ tachycardia/NN ./.
@@38144938223/CD Chlorambucil/GENE and/CC interferon/NN for/IN low/JJ grade/NN non-Hodgkin's/JJ lymphoma/NN ./.
@@95807003068/CD The/DT DNA/NN binding/JJ activities/NNS of/IN the/DT three/CD repressor/NN preparations/NNS were/VBD studied/VBN using/VBG fragments/NNS containing/JJ CIRs/GENE (/( CIR3-CIR6/GENE )/SYM from/IN the/DT essential/JJ early/JJ region/NN as/IN templates/NNS for/IN DNase/MULTIGENE I/MULTIGENE footprinting/VBG ./.
@@83601128322/CD XII/NNS ./.
@@105214438486/CD This/DT effect/NN required/VBN (/( i/NN )/SYM IR/JJ activation/NN since/IN it/PRP was/VBD abrogated/VBN by/IN IR/MULTIGENE mutation/MULTIGENE at/IN tyrosines/NNS 1162/CD and/CC 1163/CD and/CC (/( ii/NN )/SYM NF-kappaB/GENE activation/NN since/IN it/PRP was/VBD abolished/VBN by/IN overexpression/NN of/IN dominant-negative/JJ IkappaB-alpha/NN (/NN A32/NN //NN 36/NN )/NN and/CC mimicked/VBN by/IN overexpression/NN of/IN the/DT NF-kappaB/MULTIGENE c-Rel/MULTIGENE subunit/MULTIGENE ./.
@@107481944968/CD Synaptic/JJ targeting/NN of/IN the/DT postsynaptic/JJ density/MULTIGENE protein/MULTIGENE PSD-95/MULTIGENE mediated/JJ by/IN a/DT tyrosine-based/JJ trafficking/NN signal/JJ ./.
@@105517962978/CD Regulation/NN of/IN HIV-1/NNP transcription/NN ./.
@@96680989358/CD We/PRP isolated/VBD the/DT human/MULTIGENE FGF-BP/MULTIGENE promoter/MULTIGENE and/CC determined/VBN by/IN deletion/NN analysis/NN that/DT TPA/MULTIGENE regulatory/MULTIGENE elements/MULTIGENE were/VBD all/DT contained/VBN in/IN the/DT first/JJ 118/CD base/NN pairs/NNS upstream/RB of/IN the/DT transcription/NN start/NN site/NN ./.
@@50818145359/CD Derivatives/NNS of/IN boswellic/JJ acids/NNS ./.
@@11518868766/CD Testing/NN was/VBD associated/VBN with/IN a/DT history/NN of/IN nonsexual/JJ risk/NN behavior/NN ,/, increased/VBN knowledge/NN of/IN the/DT hepatitis/NN C/NN virus/NN ,/, and/CC healthcare/NN provider/NN communication/NN ./.
@@24687951101/CD Serum/NN prostatic/JJ acid/MULTIGENE phosphatase/MULTIGENE levels/NNS showed/VBD a/DT significantly/RB weaker/JJR correlation/NN with/IN cancer/NN volume/NN (/( r/JJ equals/VBP 0/CD ./CD 51/CD )/SYM and/CC every/DT other/DT pathological/JJ parameter/NN ./.
@@103645237806/CD With/IN exon/NN trapping/JJ ,/, we/PRP could/MD isolate/VB five/CD potential/JJ exons/NNS from/IN the/DT YAC/NN 946E12/GENE that/WDT spans/VBZ the/DT region/NN ,/, four/CD of/IN which/WDT could/MD be/VB placed/VBN in/IN the/DT contig/NN in/IN the/DT vicinity/NN of/IN the/DT breakpoints/NNS ./.
@@112823944189/CD No/DT preferential/JJ VH/NNP //NNP VL-chains/NNP correlated/VBD with/IN any/DT of/IN the/DT 12/CD different/JJ antigen/NN reactivities/NNS ,/, even/VB for/IN mAbs/NNS with/IN nearly/RB identical/JJ cross-reactivities/NNS ./.
@@17652669031/CD In/NN Xenopus/JJ laevis/NNS ,/, the/DT gene/NN encoding/VBG the/DT elongation/NN factor/NN 1-alpha/JJ variant/MULTIGENE EF-1/MULTIGENE alpha/MULTIGENE O/MULTIGENE ,/, where/CC O/NN stands/NNS for/IN oocyte/NN ,/, is/VBZ expressed/VBN in/IN oocytes/NNS and/CC early/JJ embryos/NNS ./.
@@98805132798/CD Both/DT proteins/NNS were/VBD shown/VBP to/IN be/VB constitutively/RB associated/VBN with/IN tubulin/NN ./.
@@108014824967/CD We/PRP also/RB show/VBP that/IN p65/GENE binds/VBZ to/IN these/DT targets/NNS with/IN almost/JJ equal/NN affinity/NN and/CC that/IN different/JJ residues/NNS have/VBP variable/JJ roles/NNS in/IN binding/JJ different/JJ kappaB/MULTIGENE targets/MULTIGENE ./.
@@105236404388/CD Although/IN the/PDT Src/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE induces/VBZ constitutive/JJ Stat3/GENE phosphorylation/NN on/IN tyrosine/NN ,/, activation/NN of/IN Stat3-mediated/GENE gene/NN regulation/NN requires/VBZ both/DT tyrosine/NN and/CC serine/NN phosphorylation/NN of/IN Stat3/GENE ./.
@@107739514645/CD IgM/NN and/CC IgG/NEWGENE anti/JJ A/DT and/CC anti/JJ B/NNP antibody/NN status/NN of/IN 100/CD antenatal/JJ O/NN group/NN mothers/NNS (/( who/WP had/VBP non/FW O/NN group/NN husbands/NNS )/SYM were/VBD studied/VBN ./.
@@94884865139/CD A/DT triple-mutant/MULTIGENE TBP/MULTIGENE (/( R231E/CONTEXTGENE +/SYM R235E/NN +/SYM R239S/CD )/SYM had/VBP greatly/RB reduced/VBN activity/NN for/IN yeast/MULTIGENE U6/MULTIGENE snRNA/MULTIGENE gene/MULTIGENE transcription/NN while/CC remaining/JJ active/NN for/IN Pol/MULTIGENE II/MULTIGENE basal/JJ transcription/NN ./.
@@93929799345/CD AIDS-related/JJ disseminated/JJ histoplasmosis/NN in/IN San/NNP Francisco/NN ,/, California/NN ./.
@@71056356899/CD Samples/NNS obtained/VBN from/IN normal/JJ volunteers/NNS and/CC from/IN the/DT great/JJ majority/NN of/IN the/DT patients/NNS ,/, excluding/JJ those/DT with/JJ asthma/NN ,/, had/VBP no/DT effect/NN on/IN ciliary/JJ beating/NN ./.
@@97907717326/CD Gng3lg/MULTIGENE transcripts/MULTIGENE are/VBP expressed/VBN in/IN a/DT variety/NN of/IN tissues/NNS including/JJ both/DT brain/NN and/CC testes/NNS ./.
@@91993286214/CD Interdigitated/JJ residues/NNS within/IN a/DT small/JJ region/NN of/IN VP16/NN interact/VB with/IN Oct-1/GENE ,/, HCF/CONTEXTGENE ,/, and/CC DNA/NN ./.
@@105518484934/CD In/NN an/DT earlier/JJR study/NN (/( Kimura/NNP ,/, Y/NNP ./NNP ,/, Kurzydlowski/NNP ,/, K/NNP ./NNP ,/, Tada/NNP ,/, M/NNP ./NNP ,/, and/CC MacLennan/NNP ,/, D/NN ./NN
@@101921348210/CD 25-OH-D3/NN did/VBD not/RB adversely/RB affect/VB animal/NN health/NN at/IN the/DT proposed/VBN use/NN level/NN of/IN 99/CD micrograms/GENE //GENE kg/GENE feed/JJ when/CC replacing/VBG vitamin/NN D3/GENE in/IN turkey/NN rations/NNS ./.
@@79411747906/CD Laser/NNP therapy/NN of/IN penile/JJ carcinoma/NN ./.
@@33524394041/CD Vocal/NN cord/NN abduction/NN rehabilitation/NN by/IN nervous/JJ selective/JJ anastomosis/NN ./.
@@57494385704/CD Dissociative/NNP anesthetics/NNS 2-/NN (/NN o-chlorophenyl/NN )/NN -2-methyl-amino/NN cyclohexane/NN HCL/NN (/( CI-581/GENE )/SYM ./.
@@19041542421/CD If/IN this/DT is/VBZ the/DT case/NN ,/, identification/NN and/CC characterization/NN of/IN transcripts/NNS from/IN the/DT Ig/MULTIGENE loci/MULTIGENE should/MD permit/VB a/DT better/JJR understanding/NN of/IN the/DT gene/NN rearrangement/NN process/NN ./.
@@30221297053/CD The/DT nucleosomal/JJ arrays/NNS detected/VBN by/IN MPE/NNS X/NN Fe/NN (/NN II/NN )/NN were/VBD characterized/VBN by/IN a/DT considerable/JJ loss/NN of/IN detail/NN and/CC significantly/RB enhanced/VBN accessibility/NN ,/, the/DT extent/NN of/IN which/WDT probably/RB reflected/VBN the/DT relative/JJ transcription/NN rate/NN of/IN each/DT gene/NN ./.
@@109180596291/CD Deletion/NNS of/IN the/DT RVH/NEWGENE domain/NN resulted/VBN in/IN loss/NN of/IN Ca/NN (/NN 2+/NN )/NN -dependent/NN activation/NN ./.
@@76939678001/CD The/DT presence/NN of/IN the/DT RV/NN 5'/NN (/NN +/NN )/NN SL/NN sequence/NN had/VBP the/DT primary/JJ enhancing/JJ effect/NN on/IN translation/NN ./.
@@96141065257/CD Three/CD high/JJ mobility/NN group-like/JJ sequences/NNS within/IN a/DT 48-base/JJ pair/NN enhancer/NN of/IN the/DT Col2a1/MULTIGENE gene/MULTIGENE are/VBP required/VBN for/IN cartilage-specific/JJ expression/NN in/IN vivo/NN ./.
@@91898969145/CD The/DT findings/NNS suggest/VBP that/IN ERP/NN effects/NNS of/IN distinct/JJ memory/NN processes/NNS are/VBP differentially/RB influenced/VBN by/IN the/DT encoding/VBG instructions/NNS ./.
@@105160722018/CD Duch/NNP ,/, and/CC F/NN ./NN
@@21762322788/CD Risk/NN factors/NNS influencing/VBG lymph/NN nodes/NNS metastasis/NN in/IN lung/NN cancer/NN with/IN stage/NN I/PRP ,/, II/NNP or/CC IIIA/NNS ./.
@@94439728337/CD Our/PRP results/NNS establish/VBP GKLF/GENE as/IN a/DT sequence-specific/MULTIGENE transcription/MULTIGENE factor/MULTIGENE likely/RB involved/VBD in/IN regulation/NN of/IN expression/NN of/IN endogenous/JJ genes/NNS ./.
@@112788197652/CD Sequence/NN comparison/NN and/CC binding/JJ studies/NNS of/IN the/DT 18-bp/JJ MOK2-binding/MULTIGENE sites/MULTIGENE present/VBP in/IN intron/NN 2/CD of/IN human/JJ ,/, bovine/JJ ,/, and/CC mouse/MULTIGENE IRBP/MULTIGENE genes/MULTIGENE show/VBP that/IN the/DT 3'-half/JJ sequence/NN is/VBZ the/DT essential/JJ core/NN element/NN for/IN MOK2/GENE binding/JJ ./.
@@77117302578/CD Carnitine/MULTIGENE palmitoyltransferase/MULTIGENE (/( CPT/CONTEXTGENE )/SYM II/NNP deficiency/NN is/VBZ the/DT most/RB common/JJ inherited/JJ disorder/NN of/IN lipid/NN metabolism/NN affecting/VBG skeletal/JJ muscle/NN ./.
@@94990311417/CD The/DT intercistronic/JJ gene/NN junctions/NNS of/IN vesicular/JJ stomatitis/NN virus/NN (/( VSV/NN )/SYM contain/VB conserved/VBN sequence/NN elements/NNS that/WDT are/VBP important/JJ for/IN polyadenylation/NN and/CC transcription/NN termination/NN of/IN upstream/JJ transcript/NN as/RB well/VB as/IN reinitiation/NN of/IN transcription/NN of/IN downstream/JJ transcript/NN ./.
@@72025257027/CD Each/DT trial/NN consisted/VB of/IN light/NN and/CC buzzer/NN for/IN five/CD seconds/NNS as/IN conditioned/JJ stimuli/NNS and/CC electric/JJ shock/NN for/IN five/CD seconds/NNS as/IN an/DT unconditioned/JJ stimulus/NN ./.
@@8622645483/CD Conversely/RB ,/, when/CC VDR/NN is/VBZ overexpressed/VBN ,/, vitamin/NN D3/GENE attenuates/VBZ 9-cis/MULTIGENE RA/MULTIGENE induction/NN from/IN an/DT RXR-responsive/NNP element/NN ./.
@@118840142438/CD Rigorous/JJ treatment/NN protocols/NNS for/IN diet/NN delivery/NN and/CC EEN-related/MULTIGENE GI/MULTIGENE adverse/JJ effects/NNS were/VBD applied/VBN ./.
@@87098318690/CD Furthermore/RB ,/, the/DT potency/NN of/IN Dacarbacine/NNP in/IN the/DT treatment/NN of/IN carcinoid/NN tumors/NNS seems/VBZ to/IN be/VB underestimated/VBN up/JJ to/IN now/RB ./.
@@5944665834/CD The/DT induction/NN of/IN seizures/NNS in/IN "Papio/NN papio"/NN following/IN allylglycine/NN alone/RB or/CC in/IN combination/NN with/IN intermittent/JJ photic/JJ stimulation/NN ./.
@@106662386776/CD Thus/RB ,/, the/DT induction/NN of/IN E2F/GENE binding/JJ to/IN the/DT E2F-1/MULTIGENE promoter/MULTIGENE by/IN the/DT E4-6/MULTIGENE //MULTIGENE 7/MULTIGENE protein/MULTIGENE observed/VBN in/IN vitro/FW correlates/VBP with/IN transactivation/NN of/IN E2F-1/MULTIGENE promoter/MULTIGENE activity/NN in/IN vivo/NN ./.
@@78904856471/CD With/IN steady/JJ illumination/NN ,/, outer/JJ retinal/JJ (/( photoreceptor/NN )/SYM QO2/GENE decreased/VBN to/IN 1/CD ./CD 4/CD +/NN //NN -/NN 0/CD ./CD 9/CD ml/NN O2/NN //NN (/NN 100/NN g/NN ./NN min/NN )/NN ,/, but/CC inner/JJ retinal/JJ QO2/GENE remained/VBN unchanged/JJ at/IN 3/CD ./CD 7/CD +/NN //NN -/NN 1/CD ./CD 5/CD ml/NN O2/NN //NN (/NN 100/NN g/NN ./NN min/NN )/NN (/( 5/CD cats/NNS )/SYM ./.
@@79999825621/CD Cumulated/JJ maximum/JJ lod/NN scores/NNS between/IN FRDA/GENE and/CC D9S5/GENE and/CC between/IN FRDA/GENE and/CC D9S15/GENE are/VBP above/RB 36/CD and/CC 61/CD ,/, respectively/RB ,/, at/IN a/DT recombination/NN fraction/NN of/IN 0/CD ,/, indicating/VBG that/IN recombination/NN events/NNS needed/VBN to/IN orient/VB the/DT search/NN of/IN the/DT gene/NN are/VBP very/RB difficult/JJ to/IN identify/VB and/CC ascertain/VB ./.
@@97591808690/CD BACKGROUND/IN :/: Fluoroquinolones/GENE (/( FQ/CONTEXTGENE )/SYM are/VBP contraindicated/VBN in/IN children/NNS because/IN of/IN the/DT risk/NN of/IN cartilage/NN damage/NN ./.
@@83378415474/CD In/NN infected/VBD mammalian/JJ cells/NNS ,/, the/DT ARV/MULTIGENE G/MULTIGENE and/CC GNS/MULTIGENE genes/MULTIGENE are/VBP transcribed/VBN primarily/RB as/IN a/DT polycistronic/JJ mRNA/NN which/WDT appears/VBZ to/IN extend/VB from/IN the/DT consensus/NN sequence/NN (/( AACAG/NNP )/SYM at/IN the/DT start/NN of/IN the/DT G/MULTIGENE gene/MULTIGENE to/IN the/DT next/RB recognized/VBN polyadenylation/NN signal/JJ (/( CATG/NN [/NN A/NN ]/NN 7/NN )/SYM located/VBN 697/CD nucleotides/NNS downstream/RB of/IN the/DT GNS/MULTIGENE protein/MULTIGENE termination/NN codon/NN ./.
@@1423738874/CD On/IN the/PDT other/DT hand/NN ,/, total/JJ pinealectomy/NN in/IN these/DT already/RB sympathectomized/VBN blinded/JJ rabbits/NNS always/RB resulted/VBN in/IN a/DT substantial/JJ deceleration/NN of/IN the/DT rhythms/NNS (/( mean/JJ delta/MULTIGENE tau/MULTIGENE =/SYM +0/CD ./CD 23/CD h/NN )/SYM ./SYM
@@111337415236/CD NiCl/NN (/NN 2/NN )/NN -induced/NN MCP-1/GENE synthesis/NN required/VBD activation/NN of/IN NF-kappaB/GENE since/IN mutation/NN of/IN NF-kappaB-binding/MULTIGENE sites/MULTIGENE in/IN the/DT promoter/NN resulted/VBN in/IN complete/JJ loss/NN of/IN inducible/MULTIGENE promoter/MULTIGENE activity/NN ./.
@@80158508012/CD A/DT more/RB complete/JJ analysis/NN of/IN dose/NN response/NN ,/, time/NN and/CC mode/NN of/IN Ga/NN administration/NN (/( preinjury/NN or/CC postinjury/RB )/SYM ,/, and/CC availability/NN of/IN Ga/NN across/IN the/DT blood-brain/JJ barrier/NN is/VBZ needed/VBN to/IN further/RB evaluate/VB the/DT efficacy/NN of/IN this/DT compound/NN ./.
@@103395667002/CD Spc42p/GENE also/RB was/VBD identified/VBN as/IN a/DT component/NN of/IN a/DT cytoplasmic/MULTIGENE SPB/MULTIGENE subcomplex/MULTIGENE containing/JJ Spc94p/GENE //GENE Nud1p/GENE ,/, Cnm67p/GENE ,/, and/CC Spc42p/GENE ./.
@@59473771348/CD The/DT 3-hour/JJ test/NN iodine/NN (/( I-132/GENE )/SYM uptake/NN by/IN the/DT thyroid/NN in/IN children/NNS with/IN growth/NN deficiency/NN ./.
@@106921675990/CD However/RB ,/, such/JJ a/DT mechanism/NN was/VBD not/RB detected/VBN in/IN preliminary/JJ observations/NNS on/IN M/NNP ./NNP synoviae/NNS ./.
@@93384143846/CD Ea/NN value/NN was/VBD calculated/VBN as/IN the/DT ratio/NN of/IN the/DT steady-state/JJ end-systolic/JJ aortic/JJ pressure/NN (/( ESAP/GENE )/SYM to/IN stroke/NN volume/NN (/( thermodilution/NN )/SYM ./.
@@93882719754/CD The/DT mobility/NN shift/NN of/IN both/DT of/IN these/DT proteins/NNS is/VBZ abolished/VBN by/IN treatment/NN with/IN inhibitors/NNS of/IN PKC/NN or/CC mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE //MULTIGENE extracellular/MULTIGENE signal-related/MULTIGENE kinase/MULTIGENE kinase/MULTIGENE ./.
@@83099128287/CD Amiodarone/IN ,/, seldom/RB used/VBN as/IN first-line/NN treatment/NN ,/, appears/VBZ to/IN be/VB the/DT most/RB effective/JJ drug/NN ./.
@@111802553144/CD This/DT supports/VBP previous/JJ arguments/NNS for/IN the/DT improbability/NN of/IN biological/JJ effects/NNS at/IN UHF/GENE frequencies/NNS unless/IN a/DT mechanism/NN can/MD be/VB found/VB for/IN accumulating/JJ energy/NN over/JJ time/NN and/CC space/NN and/CC focussing/NN it/CD ./CD
@@111893148754/CD These/DT results/NNS indicate/VBP that/IN BACM/GENE has/VBZ antiplaque/NN and/CC stronger/JJR antidegradation/NN effects/NNS than/IN GLCM/NNP ./.
@@79250229572/CD Expression/NNS is/VBZ exclusively/RB limited/VBN to/IN the/DT CNS/NN at/IN this/DT and/CC later/JJR stages/NNS ./.
@@88184368796/CD However/RB ,/, in/IN a/DT multivariate/JJ analysis/NN considering/VBG age/NN ,/, gender/NN ,/, and/CC a/DT previous/JJ history/NN of/IN cardiovascular/JJ diseases/NNS ,/, female/JJ gender/NN was/VBD not/RB independently/RB associated/VBN with/IN death/NN ./.
@@25745514669/CD Antihistamines/GENE in/IN asthma/NN ./.
@@9484463379/CD Cloning/VBG and/CC expression/NN of/IN two/JJ genes/NNS encoding/VBG auxin-binding/MULTIGENE proteins/MULTIGENE from/IN tobacco/NN ./.
@@30356583798/CD During/IN pentobarbital/NN anesthesia/NN ,/, the/DT basal/MULTIGENE VO2/MULTIGENE was/VBD 5/CD ./CD 26/CD ml/NN //NN kg/NN //NN min/NN and/CC was/VBD increased/VBN by/IN epinephrine/NN in/IN a/DT dose/NN dependent/JJ manner/NN at/IN plasma/NN concentrations/NNS between/IN 3/CD ./CD 9/CD ng/NN //NN ml/NN (/( VO2/NN =/SYM 5/CD ./CD 68/CD ml/NN //NN kg/NN //NN min/NN )/SYM and/CC 36/CD ./CD 5/CD ng/NN //NN ml/NN (/( VO2/NN =/SYM 6/CD ./CD 47/CD ml/NN //NN kg/NN //NN min/NN )/SYM ./.
@@1279696250/CD Previous/JJ studies/NNS have/VBP shown/VBP [/NN Hisanaga/NN ,/, S/NNP ./NNP ,/, Kusubata/NNP ,/, M/NNP ./NNP ,/, Okumura/NNP ,/, E/NNP ./NNP &/CC Kishimoto/NNP ,/, T/NNP ./NNP
@@39780456125/CD These/DT findings/NNS suggest/VBP that/IN both/DT in/NN the/DT early/JJ stages/NNS (/( 0T/GENE ,/, 0N/CD )/SYM and/CC in/IN more/RB severe/JJ stages/NNS of/IN VWF/NEWGENE (/( stages/NNS 1-2/CD )/SYM cold/RB induced/VBN hyperreactivity/NN in/IN the/DT digital/JJ vessels/NNS and/CC Raynaud's/NNP syndrome/NN are/VBP vascular/JJ disorders/NNS of/IN functional/JJ origin/NN occurring/VBG without/IN any/DT prethrombotic/JJ alterations/NNS ./.
@@81675558140/CD Response/NNP to/IN treatment/NN was/VBD better/JJR in/IN patients/NNS with/IN less/PRP pretreatment/JJ (/( one-two/JJ prior/NN treatments/NNS )/SYM than/IN in/IN heavily/RB pretreated/VBN ones/NNS (/( more/RB than/IN three/CD )/SYM and/CC this/DT relation/NN was/VBD found/VBN to/IN be/VB statistically/RB significant/JJ (/( p/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@21950255066/CD Regulation/NN of/IN yeast/NN LEU2/NEWGENE ./.
@@112109881049/CD Can/MD survival/NN be/VB prolonged/JJ for/IN patients/NNS with/IN hormone-resistant/JJ prostate/NN cancer/NN ?/.
@@116052071499/CD Treatment/NNP of/IN ischemic/JJ heart/NN disease/NN in/IN the/DT elderly/JJ
@@1379150497/CD Thus/RB ,/, cibenzoline/NN is/VBZ an/DT effective/JJ antiarrhythmic/JJ agent/NN with/IN a/DT favourable/JJ pharmacokinetic/JJ profile/NN that/WDT may/MD be/VB considered/VBN with/IN other/DT class/MULTIGENE I/MULTIGENE drugs/NNS in/IN patients/NNS requiring/JJ therapy/NN for/IN high/JJ risk/NN arrhythmias/NNS ./.
@@85304328605/CD Using/VBG a/DT series/NN of/IN mutant/JJ proteins/NNS ,/, we/PRP have/VBP characterized/VBN domains/NNS responsible/JJ for/IN activation/NN or/CC repression/NN ./.
@@93546442034/CD Their/PRP biosynthesis/NN proceeds/NNS via/NN linear/JJ precursors/NNS that/WDT become/VBP branched/JJ by/IN beta1/MULTIGENE ,/MULTIGENE 6-GlcNAc/MULTIGENE transferases/MULTIGENE (/( IGnT6/CONTEXTGENE ,/, GlcNAc/NN to/IN Gal/NNP )/SYM ./.
@@85550761432/CD Liposomal/JJ Amphotericin-B/NN failed/VBN in/IN 6/CD //CD 7/CD patients/NNS with/IN culture-proven/JJ mycosis/NN who/WP died/VBD from/IN infection/NN with/IN Aspergillus/NNS (/( n/NN =/SYM 2/CD )/SYM and/CC Candida/NN (/( n/NN =/SYM 4/CD )/SYM ,/, respectively/RB ./.
@@18225813840/CD In/NN all/DT instances/NNS the/DT apparent/JJ alcohol/NN responses/NNS were/VBD very/RB small/JJ and/CC never/RB exceeded/VBN a/DT reading/NN of/IN 1/CD microgram/GENE //GENE 100ml/GENE for/IN breath/NN samples/NNS more/RB than/IN 10min/CD post-exposure/JJ ./.
@@109358806424/CD Viruses/NNS were/VBD isolated/VBN from/IN 9/CD lungs/NNS :/: 7/CD with/IN PI-3V/GENE ,/, 1/CD with/IN NCP/MULTIGENE BVDV/MULTIGENE type/MULTIGENE 1/MULTIGENE ,/, and/CC 1/CD with/IN both/DT BVHV-1/GENE and/CC BVDV/NN ./.
@@25493436264/CD In/NN consequence/NN ,/, the/DT gpI/NN derived/VBN from/IN cells/NNS infected/VBN with/IN mO74/CD showed/VBD antigenic/JJ characteristics/NNS similar/JJ to/IN those/DT of/IN gpI/NN from/IN VZV-infected/JJ cells/NNS as/IN determined/VBN from/IN the/DT immunoprecipitation/NN pattern/NN ,/, although/IN the/DT molecular/JJ weight/NN of/IN each/DT polypeptide/NN was/VBD different/JJ ,/, and/CC antibody/NN produced/VBN in/IN rabbits/NNS infected/VBN with/IN recombinant/JJ virus/NN had/VBP a/DT high/JJ neutralizing/JJ activity/NN ,/, when/CC the/DT reaction/NN was/VBD performed/VBN with/IN complement/NN ./.
@@2000093903/CD Landsberg/NNP (/( La-O/NNP )/SYM and/CC cv/CD ./CD
@@106238047540/CD As/IN an/DT alternative/JJ approach/NN to/IN this/DT question/NN ,/, we/PRP have/VBP studied/VBN the/DT effects/NNS of/IN ectopically/RB expressed/VBN SHIP/GENE ,/, SHP-1/GENE ,/, or/CC SHP-2/GENE SH2-containing/JJ decoy/NN proteins/NNS on/IN Fc/MULTIGENE gamma/MULTIGENE RIIB1/MULTIGENE signaling/JJ ./.
@@105126993885/CD This/DT machinery/NN involves/VBZ a/DT secondary/JJ structure/NN ,/, SECIS/MULTIGENE element/MULTIGENE ,/, in/IN the/DT selenoprotein-encoding/MULTIGENE mRNA/MULTIGENE ,/, directing/VBG selenocysteine/NN insertion/NN at/IN the/DT position/NN of/IN an/DT opal/NN (/( UGA/IN )/SYM codon/NN ,/, normally/RB conferring/JJ termination/NN of/IN translation/NN ./.
@@88977216598/CD Infection/NN with/IN Neisseria/MULTIGENE meningitidis/MULTIGENE group/MULTIGENE B/MULTIGENE has/VBZ been/VBN difficult/JJ to/IN detect/VB ,/, partly/RB because/IN this/DT bacterial/JJ group's/NNS polysaccharide/NN is/VBZ a/DT weak/JJ immunogen/NN ./.
@@90012133170/CD The/DT relatively/JJ high/JJ level/NN transcription/NN from/IN this/DT gene/NN shows/VBZ that/IN the/DT polymorphic/JJ chromosome/NN ends/NNS of/IN P/NNP ./NNP falciparum/NN ,/, which/WDT have/VBP been/VBN proposed/VBN to/IN be/VB transcriptionally/RB silent/JJ ,/, can/MD be/VB active/JJ expression/NN sites/NNS for/IN var/NN genes/NNS ./.
@@103596644471/CD To/TO identify/VB these/DT sites/NNS ,/, Cdk2-phosphorylated/MULTIGENE MARCKS/MULTIGENE was/VBD digested/VBN with/IN lysyl/MULTIGENE endoprotease/MULTIGENE and/CC analysed/VBN by/IN electrospray/NN MS/NNP ./NNP
@@114804901366/CD Even/RB if/IN the/DT electrocardiographic/JJ signs/NNS are/VBP subdued/VBN ,/, the/DT underlying/JJ blockade/NN of/IN I/NN (/NN Kr/NN )/NN current/NN may/MD precipitate/VB the/DT occurrence/NN of/IN arrhythmia/NN ./.
@@21238758143/CD To/TO identify/VB structural/JJ features/NNS of/IN residues/NNS flanking/JJ the/DT c-region/GENE that/DT influence/NN the/DT fidelity/NN and/CC efficiency/NN of/IN signal/MULTIGENE peptidase/MULTIGENE cleavage/NN as/RB well/VB as/IN co-translational/JJ translocation/NN ,/, we/PRP introduced/VBD six/CD amino/JJ acid/NN substitutions/NNS into/IN the/DT COOH/NNP terminus/NN of/IN the/DT hydrophobic/JJ core/NN and/CC seven/JJ substitutions/NNS at/IN the/DT NH2/GENE terminus/NN of/IN the/DT mature/JJ region/NN (/( the/DT +1/NN position/NN )/SYM of/IN a/DT model/JJ eukaryotic/JJ preprotein-human/JJ pre/NN (/NN delta/NN pro/NN )/NN apoA-II/NN ./.
@@118445911724/CD We/PRP also/RB studied/VBD a/DT new/JJ parameter/NN :/: the/DT angle/NN to/IN maximal/JJ peak/NN torque/NN (/( APT/NN )/SYM ./.
@@50219125314/CD Photopic/NNP spectral/JJ sensitivity/NN determined/VBN electroretinographically/RB for/IN the/DT pigeon/NN eye/NN ./.
@@77588379829/CD The/DT emerging/JJ complexity/NN of/IN the/DT 5'/CD regulatory/JJ region/NN of/IN the/DT GH/MULTIGENE receptor/MULTIGENE gene/MULTIGENE was/VBD emphasised/VBN by/IN the/DT observation/NN that/IN probes/NNS derived/VBN from/IN exon/NN 1B/GENE and/CC the/DT distal/JJ 3'/CD intron/NN boundary/NN do/NN not/RB hybridise/VB with/IN previously/RB cloned/VBN genomic/JJ sequences/NNS that/WDT span/VBP the/DT liver-specific/MULTIGENE P1/MULTIGENE promoter/MULTIGENE and/CC exon/NN 2/CD ./CD
@@13743923563/CD The/DT hydrophobicity/NN plot/NN of/IN NHE-3/GENE is/VBZ very/RB similar/JJ to/IN that/DT of/IN NHE-1/GENE and/CC NHE-2/GENE ./.
@@76121747520/CD Subhuman/NNP primates/NNS appear/VBP to/IN be/VB more/RB sensitive/JJ to/IN reproductive/JJ and/CC other/DT adverse/JJ effects/NNS of/IN PCBs/NNS than/IN humans/NNS ./.
@@18080494159/CD CT/NEWGENE abnormalities/NNS noted/VBN in/IN term/NN babies/NNS included/VBD hemorrhage/NN (/( subarachnoid/JJ 5/CD ./CD 8%/CD ,/, intracerebral/JJ 11/CD ./CD 6%/CD )/SYM ,/, hypodensity/NN (/( mild/JJ 23/CD ./CD 2%/CD ,/, moderate/JJ 11/CD ./CD 6%/CD severe/JJ 5/CD ./CD 8%/CD )/SYM ;/: hypodensity/NN with/IN hemorrhage/NN 5/CD ./CD 8%/CD and/CC cerebral/JJ atrophy/NN 5/CD ./CD 8%/CD ./.
@@826766768/CD Repeated/VBN administration/NN of/IN GRg2/GENE 20/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./. significantly/RB improved/VBN the/DT CYP-induced/JJ recognitional/JJ deficits/NNS by/IN increasing/JJ the/DT CYP-decreased/JJ rate/NN from/IN 55/CD ./CD 8/CD +/NN //NN -/NN 9/CD ./CD 6/CD to/IN 80/CD ./CD 8/CD +/NN //NN -/NN 4/CD ./CD 2/CD in/IN d/NN 3/CD learning/JJ acquisition/NN (/( F/NN (/NN 1/NN ,/NN 14/NN )/SYM =/SYM 5/CD ./CD 6/CD ,/, p/NN </SYM 0/NN ./NN 05/NN )/NN ,/, from/IN 53/CD ./CD 4/CD +/NN //NN -/NN 8/CD ./CD 4/CD to/IN 60/CD ./CD 0/CD +/NN //NN -/NN 8/CD ./CD 2/CD in/IN 48/CD h/NN memory/NN acquisition/NN (/( F/NN (/NN 1/NN ,/NN 14/NN )/SYM =/SYM 7/CD ./CD 5/CD ,/, p/NN </SYM 0/NN ./NN 05/NN )/NN and/CC from/IN 55/CD ./CD 0/CD +/NN //NN -/NN 5/CD ./CD 5/CD to/IN 88/CD ./CD 3/CD +/NN //NN -/NN 2/CD ./CD 5/CD in/IN 24/CD h/NN memory/NN retention/NN (/( F/NN (/NN 1/NN ,/NN 12/NN )/SYM 27/CD ./CD 5/CD ,/, p/NN </SYM 0/NN ./NN 01/NN )/NN as/RB well/VB as/IN from/IN 60/NN ./NN 0/NN +/NN //NN -/NN 6/CD ./CD 8/CD to/IN 85/CD ./CD 6/CD +/NN //NN -/NN 6/CD ./CD 9/CD in/IN 48/CD h/NN memory/NN retrieval/NN (/( F/NN (/NN 1/NN ,/NN 12/NN )/SYM =/SYM 5/CD ./CD 2/CD ,/, p/NN </SYM 0/NN ./NN 05/NN )/NN ,/, respectively/RB ./.
@@97065655207/CD Anesthesia/NNS with/IN M/GENE //GENE K/GENE was/VBD reversed/VBN after/IN 41/CD ./CD 6/CD min/NN of/IN immobilization/NN with/IN atipamezole/NN ./.
@@29491703651/CD This/DT study/NN reports/VBZ the/DT effects/NNS of/IN a/DT preparation/NN with/IN 50/CD micrograms/NNS ethinyl/NN estradiol/NN and/CC 2/CD mg/NN cyproterone/NN acetate/NN on/IN gonadotropins/NNS ,/, prolactin/NN ,/, testosterone/NN ,/, sex/NN hormone/MULTIGENE binding/MULTIGENE globulin/MULTIGENE (/( SHBG/CONTEXTGENE )/SYM ,/, androstenedione/NN ,/, and/CC calculated/VBD free/JJ testosterone/NN index/NN before/IN and/CC after/IN six/CD months/NNS of/IN treatment/NN ./.
@@33838974075/CD Lithium-carbonate/JJ action/NN during/IN radiation/NN therapy/NN has/VBZ been/VBN studied/VBN ,/, valuing/JJ the/DT positive/JJ effect/NN on/IN leukopoiesis/NN and/CC the/DT consequent/RB better/RBR clinical/JJ conditions/NNS of/IN the/DT patients/NNS in/IN course/NN of/IN treatment/NN ./.
@@32866115936/CD Yang/NNP and/CC H/NNP ./NNP
@@91872773690/CD Type/MULTIGENE I/MULTIGENE position-vestibular-pause/JJ (/( PVP/MULTIGENE I/MULTIGENE )/SYM and/CC vestibular-only/JJ (/( V/MULTIGENE I/MULTIGENE )/SYM neurons/NNS ,/, as/RB well/VB as/IN a/DT smaller/JJR number/NN of/IN other/DT type/MULTIGENE I/MULTIGENE and/CC type/MULTIGENE II/MULTIGENE eye-plus-vestibular/JJ neurons/NNS were/VBD studied/VBN ./.
@@106289716063/CD The/DT collection/NN of/IN mutants/NNS displaying/VBG TGN/JJ sorting/JJ defects/NNS includes/VBZ members/NNS with/IN mutations/NNS in/IN previously/RB identified/VBN vacuolar/JJ protein/NN sorting/JJ genes/NNS (/( VPS/NN )/SYM ,/, including/JJ the/DT dynamin/MULTIGENE family/MULTIGENE member/MULTIGENE VPS1/MULTIGENE ./.
@@84649245090/CD A/DT rat/NN cDNA/NN that/IN encodes/VBZ eIF-5/NEWGENE has/VBZ been/VBN isolated/VBN and/CC expressed/VBN in/IN Escherichia/NN coli/JJ to/IN yield/NN a/DT catalytically/RB active/JJ eIF-5/MULTIGENE protein/MULTIGENE ./.
@@93896668412/CD Thus/RB ,/, Hex/NEWGENE expression/NN marks/VBZ the/DT earliest/JJS unequivocal/JJ molecular/JJ anteroposterior/JJ asymmetry/NN in/IN the/DT mouse/NN embryo/NN and/CC indicates/VBZ that/IN the/DT anteroposterior/JJ axis/NN of/IN the/DT embryo/NN develops/VBZ from/IN conversion/NN of/IN a/DT proximodistal/JJ asymmetry/NN established/VBN in/IN the/DT primitive/JJ endoderm/NN lineage/NN ./.
@@30239708578/CD The/DT 96-bp/CD insert/NN contained/VBD a/DT termination/NN signal/JJ which/WDT caused/VBD the/DT premature/JJ termination/NN of/IN the/DT protein/NN ,/, leading/JJ to/IN the/DT generation/NN of/IN a/DT p53/MULTIGENE product/MULTIGENE 9/MULTIGENE amino/JJ acids/NNS shorter/JJR than/IN usual/JJ ./.
@@108238371290/CD The/DT data/NN are/VBP compatible/JJ with/IN the/DT idea/NN that/IN YLL031c/GENE transfers/VBZ the/DT ethanolaminephosphate/NN to/IN the/DT inner/JJ alpha1-2-linked/JJ mannose/NN ,/, i/NN ./NN e/NN ./. the/DT group/NN that/WDT links/VBZ the/DT GPI/MULTIGENE lipid/MULTIGENE anchor/MULTIGENE to/IN proteins/NNS ,/, whereas/IN Mcd4p/GENE and/CC Gpi7p/GENE transfer/NN ethanolaminephosphate/NN onto/IN the/DT alpha1-4-/JJ and/CC alpha1-6-linked/JJ mannoses/NNS of/IN the/DT GPI/MULTIGENE anchor/MULTIGENE ,/, respectively/RB ./.
@@111827461024/CD An/DT additional/JJ 9/CD patients/NNS achieved/VBD normal/JJ levels/NNS with/IN adjunctive/JJ drug/NN therapy/NN ./.
@@87385108723/CD The/DT relative/JJ tumor/NN FDG-uptake/NNP (/( Q-MRGlu/NNP )/SYM (/( tumor/JJ //JJ contralateral/JJ cortex/NN )/SYM of/IN all/DT meningiomas/NNS was/VBD calculated/VBN with/IN 0/CD ./CD 73/CD +/NN //NN -/NN 0/CD ./CD 37/CD (/( 0/CD ./CD 24-1/CD ./CD 79/CD )/SYM ./.
@@85301052050/CD The/DT minimal/JJ region/NN of/IN overlap/NN of/IN Langer-Giedion/NNP syndrome/NN deletions/NNS ,/, previously/RB identified/VBN by/IN analysis/NN of/IN 15/CD patients/NNS ,/, was/VBD placed/VBN on/IN the/DT map/NN by/IN analysis/NN of/IN 2/CD patients/NNS whose/WP deletions/NNS define/VBP the/DT endpoints/NNS ./.
@@104448136300/CD For/IN symptomatic/JJ relief/NN and/CC inhibition/NN of/IN the/DT growth/NN of/IN the/DT metastases/NNS interferon-a/NN and/CC somatostatin/NEWGENE analogues/NNS can/MD be/VB employed/VBN ./.
@@25751743228/CD We/PRP have/VBP therefore/RB evaluated/VBN the/DT efficacy/NN and/CC safety/NN of/IN doxazosin/NN ,/, a/DT new/JJ orally/RB active/JJ selective/JJ alpha/MULTIGENE 1/MULTIGENE blocker/NN ,/, in/IN patients/NNS with/IN systemic/JJ hypertension/NN with/IN concomitant/JJ airflow/NN limitation/NN ./.
@@31171477289/CD A/DT complementary/JJ study/NN ,/, showing/VBG a/DT good/JJ agreement/NN between/IN surface/NN and/CC oesophageal/JJ EMGd/GENE seems/VBZ to/IN confirm/VB that/DT surface/NN EMGd/GENE is/VBZ a/DT useful/JJ and/CC promising/JJ tool/NN for/IN clinical/JJ investigation/NN ./.
@@79435567372/CD Of/IN 419/CD persons/NNS surveyed/VBN ,/, 207/CD (/( 49/CD ./CD 4%/CD )/SYM were/VBD antigen-positive/NN with/IN the/DT Og4C3/GENE assay/NN ./.
@@6090458600/CD The/DT PEPCK/MULTIGENE promoter/MULTIGENE fragment/MULTIGENE was/VBD introduced/VBN either/DT in/NN the/DT proper/JJ orientation/NN for/IN transcription/NN of/IN the/DT TK/MULTIGENE gene/MULTIGENE or/CC in/IN the/DT opposite/NN orientation/NN ./.
@@22911444728/CD Very/RB good/JJ accuracy/NN (/( r/JJ greater/JJR than/IN 0/CD ./CD 9/CD )/SYM was/VBD found/VBN when/CC except/VB comparing/VBG H*2/GENE with/IN the/PDT other/DT machine/NN and/CC the/DT reference/NN methods/NNS ,/, except/VB for/IN MCHCH/NN and/CC basophil/NN count/NN ./.
@@77688369575/CD Primer/NNS extension/NN experiments/NNS revealed/VBD a/DT strong/JJ transcription/NN initiation/NN site/NN 102/CD bp/NN upstream/RB of/IN the/DT translational/JJ start/NN site/NN ./.
@@96140659756/CD Elimination/NN of/IN the/DT inducible/JJ response/NN requires/VBZ simultaneous/JJ mutation/NN of/IN both/DT sequences/NNS ,/, however/RB ,/, in/IN the/DT presence/NN of/IN an/DT intact/JJ EpRE/NNP the/DT upstream/MULTIGENE AP-1/MULTIGENE site/MULTIGENE is/VBZ irrelevant/JJ to/IN induction/NN ./.
@@110038057319/CD Studies/NNS suggest/VBP that/IN the/DT DGOR/GENE without/IN acid/NN reflux/NN may/MD result/VB in/IN symptoms/NNS but/CC unless/IN acid/NN reflux/NN is/VBZ present/VB simultaneously/RB ,/, it/PRP does/VBP not/RB cause/VB oesophagitis/NN ./.
@@75285317406/CD In/NN viral/JJ infections/NNS ,/, G-CSF/GENE was/VBD correlated/VBN with/IN mononuclear/JJ cells/NNS (/( rs/NNS =/SYM 0/CD ./CD 41/CD ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ,/, white/JJ blood/NN cell/NN counts/NNS (/( rs/NNS =/SYM 0/CD ./CD 56/CD ,/, P/NN </SYM 0/CD ./CD 01/CD )/SYM ,/, neutrophils/NNS (/( rs/NNS =/SYM 0/CD ./CD 41/CD ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM and/CC CRP/NN (/( rs/NNS =/SYM 0/CD ./CD 47/CD ,/, P/NN </SYM 0/CD ./CD 05/CD )/SYM ./.
@@68912706690/CD The/DT effect/NN of/IN emotional-painful/JJ stress/NN (/( EPS/NNS )/SYM on/IN myocardial/JJ extensibility/NN and/CC contractility/NN was/VBD studied/VBN on/IN an/DT isolated/VBN rat/NN atrium/NN ./.
@@95219132127/CD We/PRP also/RB recovered/VBD mutations/NNS in/IN the/DT 60A/MULTIGENE gene/MULTIGENE which/WDT encodes/VBZ another/DT TGF-beta-related/MULTIGENE factor/MULTIGENE in/IN Drosophila/NN ./.
@@90905926064/CD Although/IN methods/NNS to/IN align/VB the/DT control/NN and/CC activation/MULTIGENE fMR/MULTIGENE images/NNS may/MD correct/VB for/IN some/DT of/IN this/DT motional/JJ error/NN ,/, they/PRP will/MD be/VB incomplete/JJ in/IN correcting/VBG for/IN those/DT that/WDT depend/VBP on/IN spatial/JJ orientation/NN ./.
@@50206605312/CD Factors/NNS affecting/VBG the/DT inhibition/NN of/IN phagocytosis/NN by/IN chlorpromazine/NN ./.
@@93828508420/CD BACKGROUND/IN :/: Checkpoint/NN pathways/NNS prevent/VBP cell-cycle/VBG progression/NN in/IN the/DT event/NN of/IN DNA/NN lesions/NNS ./.
@@37724714447/CD There/EX were/VBD 18/CD patients/NNS with/IN Group/NNP II/NN (/NN a/NN )/NN tumors/NNS ;/: although/IN tumor/NN biopsy/NN was/VBD attempted/VBN on/IN eight/CD of/IN these/DT ,/, pathological/JJ diagnosis/NN at/IN the/DT time/NN of/IN surgery/NN was/VBD made/VBP in/IN only/RB one/PRP case/NN ./.
@@105056946306/CD Interleukin-12/GENE (/( IL-12/GENE )/SYM is/VBZ a/DT cytokine/NN produced/VBN by/IN peripheral/JJ blood/NN mononuclear/JJ cells/NNS (/( PBMC/NN )/SYM that/IN causes/NNS interferon-gamma/NN (/( IFN-gamma/NN )/SYM production/NN and/CC enhancement/NN of/IN cell-mediated/JJ cytotoxicity/NN ./.
@@8101171614/CD Instead/RB ,/, the/DT results/NNS support/NN the/DT idea/NN that/DT Pc/MULTIGENE group/MULTIGENE products/MULTIGENE provide/VBP stable/JJ memory/NN or/CC imprinting/NN of/IN boundaries/NNS which/WDT are/VBP initially/RB specified/VBN by/IN gap/NN and/CC pair-rule/JJ regulators/NNS ./.
@@85301498219/CD Comparison/NNS of/IN promoters/NNS repressed/VBN by/IN c-myc/NN reveals/VBZ a/DT weak/JJ consensus/NN sequence/NN of/IN the/DT initiator/NN (/( Inr/NN )/SYM element/NN :/: TCA/NN (/NN +1/NN )/NN YYYNY/NN ./.
@@73761657216/CD Ecthyma/NNP ,/, a/DT known/VBP disease/NN ,/, of/IN which/WDT little/NN is/NNS known/VBP ./.
@@92334877449/CD Future/NNP analysis/NN of/IN long-term/JJ outcome/NN measures/NNS of/IN performance/NN with/IN the/DT implant/NN will/MD confirm/VB or/CC dispute/VB the/DT benefit/NN of/IN ear/NN selection/NN using/VBG the/DT Prom-EABR/GENE ./.
@@95372957460/CD Furthermore/RB ,/, a/DT minor/JJ start/NN site/NN was/VBD localized/VBN 179/CD bp/NN upstream/RB of/IN the/DT major/JJ site/NN using/VBG reverse/JJ transcriptase-polymerase/JJ chain/NN reaction/NN with/IN various/JJ P1/MULTIGENE primers/MULTIGENE (/( primer/NN walking/NN )/SYM ,/, primer/NN extension/NN ,/, and/CC cDNA/NN cloning/NN ./.
@@550402300/CD Ten/CD out-patients/NNS with/IN pustulosis/NN palmaris/JJ et/FW plantaris/JJ were/VBD examined/VBN with/IN direct/JJ immunofluorescence/NN (/( IF/IN )/SYM technique/NN for/IN deposition/NN of/IN fibrinogen/NN ,/, fibrin/NN or/CC its/PRP degradation/NN products/NNS (/( FR-antigen/NNP )/SYM in/IN affected/VBN and/CC unaffected/JJ skin/NN ,/, together/RB with/IN heparin-precipitable/JJ fraction/NN (/( HPF/NN )/SYM ,/, cryoglobulin/NN and/CC total/JJ plasma/NN fibrinogen/NEWGENE in/IN the/DT blood/NN ./.
@@82058278178/CD CONCLUSIONS/IN :/: Translocation/NNS of/IN bacteria/NNS or/CC endotoxin/NN from/IN the/DT gastrointestinal/JJ tract/NN into/IN the/DT bloodstream/NN has/VBZ been/VBN noted/VBN in/IN animal/NN experiments/NNS ;/: however/RB ,/, translocation/NN was/VBD not/RB detected/VBN in/IN our/PRP patients/NNS with/IN hemorrhagic/JJ shock/NN ./.
@@13252215486/CD Nocodazole/NNP arrest/NN of/IN DU249/NNP cells/NNS was/VBD exploited/VBN for/IN the/DT detection/NN of/IN an/DT M-phase-activated/MULTIGENE MBP/MULTIGENE kinase/MULTIGENE that/WDT was/VBD resolved/VBN from/IN p41/MULTIGENE MAP/MULTIGENE kinase/MULTIGENE by/IN phenyl-Superose/JJ chromatography/NN ./.
@@109189486944/CD This/DT compound/NN is/VBZ the/DT main/JJ bioactive/JJ metabolite/NN of/IN trimebutine/MULTIGENE II/MULTIGENE (/( Debridat/NN ,/, CAS/IN 39133-31-8/CD )/SYM ,/, an/DT antispasmodic/JJ widely/RB used/VBN for/IN intestinal/JJ diseases/NNS since/IN 1969/CD ./.
@@1113908985/CD There/EX was/VBD a/DT slight/JJ increase/NN in/IN total/JJ transferrin/MULTIGENE 2/MULTIGENE hr/NN after/IN 1/CD tablet/NN and/CC values/NNS remained/VBD high/JJ throughout/IN the/DT experiment/NN ./.
@@92924993734/CD These/DT repressor/NN sites/NNS are/VBP pyrimidine/NN rich/JJ and/CC bind/VB avidly/RB to/IN the/DT polypyrimidine/NN tract/NN binding/JJ protein/NN (/( PTB/GENE )/SYM in/IN HeLa/DT nuclear/JJ extracts/NNS as/IN determined/VBN by/IN UV/NN crosslinking/NN //NN competition/NN assays/NNS ./.
@@103220223590/CD Rep63A/GENE (/( 513/CD amino/JJ acids/NNS [/NN aa/NN ]/NN )/SYM ,/, encoded/VBN by/IN the/DT largest/JJS ORF/NN ,/, displayed/VBN strong/JJ similarity/NN (/( 40%/CD identity/NN )/SYM to/IN the/DT replication/NN proteins/NNS from/IN plasmids/NNS pAMbeta1/GENE ,/, pIP501/GENE ,/, and/CC pSM19035/GENE ,/, indicating/VBG that/IN the/DT pAW63/MULTIGENE replicon/MULTIGENE belongs/VBZ to/IN the/DT pAMbeta1/MULTIGENE family/MULTIGENE of/IN gram-positive/JJ theta-replicating/JJ plasmids/NNS ./.
@@76100523845/CD Finally/RB ,/, we/PRP show/VBP that/IN complexes/NNS similar/JJ to/IN the/DT C25/GENE ,/, C30/GENE and/CC C35/GENE complexes/NNS are/VBP formed/VBN by/IN rat/NN cortex/NN nuclear/JJ extracts/NNS and/CC the/DT SAA/MULTIGENE element/MULTIGENE in/IN EMSA/NN experiments/NNS ,/, suggesting/VBG the/DT relevance/NN of/IN our/PRP in/IN vitro/FW observations/NNS to/IN the/DT in/NN vivo/NN functioning/NN of/IN the/DT rat/MULTIGENE APP/MULTIGENE promoter/MULTIGENE ./.
@@21487998416/CD The/DT nmr/MULTIGENE gene/MULTIGENE is/VBZ the/DT major/JJ negative/JJ regulatory/JJ gene/NN in/IN the/DT nitrogen/NN control/NN circuit/NN of/IN Neurospora/NN crassa/NN ,/, which/WDT ,/, together/RB with/IN positive/JJ regulatory/JJ genes/NNS ,/, governs/VBZ the/DT expression/NN of/IN multiple/JJ unlinked/MULTIGENE structural/MULTIGENE genes/MULTIGENE of/IN the/DT circuit/NN ./.
@@62817862102/CD At/NN least/RB one/PRP clone/NN ,/, lambda/NN HHG/NN 41/CD ,/, contains/VBZ ,/, in/IN addition/NN to/IN the/DT histone/MULTIGENE genes/MULTIGENE ,/, a/DT region/NN that/WDT hybridizes/VBZ with/IN a/DT cytoplasmic/JJ RNA/NN approximately/RB 330/CD nucleotides/NNS in/IN length/NN ./.
@@11028944856/CD Both/PDT the/DT Cmax/NN and/CC AUC/NN values/NNS were/VBD almost/RB doubled/VBN with/IN doubling/JJ the/DT dose/NN ./.
@@19619962586/CD Adult/NN H/NN ,/, but/CC not/RB R/NN ,/, manifested/VBD the/DT burrowing/JJ preference/NN whenever/CC offered/VBD the/DT opportunity/NN ./.
@@11164663658/CD Thromboplastin/NN time/NN ,/, partial/JJ thromboplastin/NEWGENE time/NN ,/, thrombin/NN time/NN ,/, heat-dependent/MULTIGENE fibrin/MULTIGENE ,/, clot/NN retraction/NN ,/, and/CC clotting/JJ factors/MULTIGENE II/MULTIGENE ,/, V/NN ,/, VIII/NNP ,/, IX/CD ,/, X/NN ,/, and/CC the/DT platelet/NN count/NN were/VBD determined/VBN ./.
@@88675194439/CD The/DT elevations/NNS achieved/VBN by/IN LDEE/GENE given/VBP s/CD ./CD c/CD ./. were/VBD higher/JJ than/IN those/DT achieved/VBN after/IN i/CD ./CD p/CD ./. administration/NN and/CC lasted/VBN for/IN longer/JJR periods/NNS ./.
@@91214338525/CD We/PRP show/VBP that/IN Rlm1/GENE and/CC Smp1/GENE have/VB MEF2-related/JJ DNA-binding/NN specificities/NNS :/: Rlm1/GENE binds/VBZ with/IN the/DT same/JJ specificity/NN as/IN MEF2/GENE ,/, CTA/CONTEXTGENE (/CONTEXTGENE T/CONTEXTGENE //CONTEXTGENE A/CONTEXTGENE )/CONTEXTGENE 4TAG/CONTEXTGENE ,/, while/CC SMP1/GENE binds/VBZ a/DT more/RB extended/VBN consensus/NN sequence/NN ,/, ACTACTA/NN (/NN T/NN //NN A/NN )/NN 4TAG/NN ./.
@@4039307492/CD On/IN d/MULTIGENE 112/MULTIGENE ,/, progesterone/NN was/VBD higher/JJ (/( P/NN less/PRP than/IN ./CD 05/CD )/SYM in/IN hysterectomized/JJ heifers/NNS than/IN in/IN other/DT treatment/NN groups/NNS ./.
@@84993768276/CD Multizone/GENE PRK/GENE has/VBZ been/VBN suggested/VBN to/IN increase/NN the/DT predictability/NN of/IN higher/JJ myopic/JJ corrections/NNS ./.
@@67826126553/CD A/DT convenient/JJ measure/NN of/IN this/DT impairment/NN may/MD be/VB obtained/VBN using/VBG the/DT ratio/NN of/IN urine/NN volume/NN (/( V/NN )/SYM divided/VBN by/IN lithium/NN clearance/NN (/( CLi/NNS )/SYM ./.
@@10724436549/CD Depleted/JJ and/CC enriched/VBN U3O8/GENE standard/JJ reference/NN materials/NNS were/VBD used/VBN to/IN calibrate/VB the/DT system/NN ./.
@@93644402293/CD Our/PRP study/NN reveals/VBZ that/IN the/DT modular/JJ structure/NN of/IN the/DT FSH/MULTIGENE receptor/MULTIGENE gene/MULTIGENE generates/VBZ motifs/NNS that/WDT allows/VBZ coupling/NN to/IN different/JJ effectors/NNS ./.
@@84407206601/CD Constructs/NNS containing/JJ the/DT full-length/JJ PfCPK/MULTIGENE cDNA/MULTIGENE have/NN been/VBN expressed/VBN in/IN Escherichia/NN coli/JJ at/IN a/DT high/JJ level/NN to/IN generate/VB a/DT 60-kDa/JJ recombinant/JJ protein/NN ./.
@@10425094281/CD The/DT in/NN vitro/FW relaxivity/NN of/IN the/DT complex/NN is/VBZ 16/CD ./CD 24/CD s/NN (/NN -1/NN )/NN mM/NN (/NN -1/NN )/NN ./.
@@95456382261/CD The/DT possible/JJ roles/NNS of/IN HRMT1L1/GENE and/CC HRMT1L2/GENE in/IN human/JJ disease/NN are/VBP currently/RB unknown/JJ ./.
@@78831686138/CD Mutations/NNS in/IN UPF1/NEWGENE lead/NN to/IN the/DT selective/JJ stabilization/NN of/IN mRNAs/NNS containing/JJ early/JJ nonsense/NN mutations/NNS without/IN affecting/VBG the/DT decay/NN rates/NNS of/IN most/RB other/DT mRNAs/NNS ./.
@@93716124442/CD Acad/NN ./.
@@10355536216/CD The/DT median/JJ age/NN was/VBD 33/CD years/NNS (/( range/NN 17-56/JJ years/NNS )/SYM ./.
@@61192625939/CD The/DT roll-over/NN test/NN to/IN predict/VB toxemia/NN in/IN pregnancy/NN ./.
@@10459809304/CD A/DT reduced/VBN matrix/NN distribution/NN and/CC enhanced/VBN cell/NN density/NN were/VBD observed/VBN as/IN the/DT biofilm/NN aged/VBN ./.
@@97699105048/CD The/DT activation/NN and/CC injury/NN of/IN endothelial/JJ cells/NNS induced/VBN by/IN TNF/NN and/CC other/DT proinflammatory/JJ cytokines/NNS may/MD underlie/VB the/DT local/JJ effects/NNS of/IN these/DT mediators/NNS in/IN vivo/NN ./.
@@47290635122/CD Compensative/NNP justice/NN and/CC moral/JJ investment/NN among/IN Japanese/JJ ,/, Chinese/JJ ,/, and/CC Koreans/NNS ./.
@@105126999647/CD High-level/JJ expression/NN in/IN Escherichia/NN coli/NN of/IN selenocysteine-containing/MULTIGENE rat/MULTIGENE thioredoxin/MULTIGENE reductase/MULTIGENE utilizing/VBG gene/NN fusions/NNS with/IN engineered/VBN bacterial-type/MULTIGENE SECIS/MULTIGENE elements/MULTIGENE and/CC co-expression/NN with/IN the/DT selA/CONTEXTGENE ,/, selB/GENE and/CC selC/MULTIGENE genes/MULTIGENE ./.
@@90155435998/CD One/CD possible/JJ solution/NN is/VBZ a/DT thin/JJ radial/JJ forearm/NN free/JJ flap/NN ./.
@@22597952704/CD Assuming/VBG O2/GENE consumption/NN of/IN the/DT isolated/VBN skin/NN to/IN be/VB same/JJ as/IN in/IN situ/NN ,/, calculations/NNS showed/VBN that/IN when/CC water/NN PO2/NN was/VBD high/JJ (/( 150/CD mm/NN Hg/NN )/SYM ,/, about/RB 40%/CD of/IN total/JJ cutaneous/JJ O2/GENE uptake/NN was/VBD consumed/VBN by/IN the/DT skin/NN ./.
@@61650685992/CD Then/RB ,/, pure/JJ pancreatic/JJ juice/NN was/VBD infused/VBN into/IN the/DT duodenum/NN ./.
@@76754452334/CD These/DT clones/NNS were/VBD found/VBN to/IN share/NN a/DT common/JJ domain/NN encoded/VBN by/IN p/NN (/NN CA/NN )/NN n/NN repeats/NNS ;/: a/DT simple/JJ sequence/NN length/NN polymorphism/NN (/( SSLP/NN )/SYM ./.
@@90578419306/CD Derepression/NNS of/IN gene/NN expression/NN mediated/JJ by/IN the/DT 5'/CD upstream/JJ region/NN of/IN the/DT isocitrate/MULTIGENE lyase/MULTIGENE gene/MULTIGENE of/IN Candida/NN tropicalis/NN is/VBZ controlled/VBN by/IN two/JJ distinct/JJ regulatory/JJ pathways/NNS in/IN Saccharomyces/NN cerevisiae/NN ./.
@@7775428456/CD The/DT other/DT two/JJ clones/NNS ,/, Ash-m/NNP and/CC -s/CD ,/, had/VBP nucleotide/NN sequences/NNS identical/JJ with/IN Ash-l/NNP cDNA/NN in/IN the/DT amino-terminal/MULTIGENE region/MULTIGENE ./.
@@20261447550/CD Temporal/JJ control/NN of/IN GUS/GENE expression/NN was/VBD found/VBN to/IN involve/VB two/JJ negative/JJ regulatory/JJ sequences/NNS ,/, NRS1/GENE (/( -391/CD to/IN -295/CD )/SYM and/CC NRS2/GENE (/( -518/JJ to/IN -418/JJ )/SYM ,/, as/RB well/VB as/IN the/DT positive/JJ domain/NN UAS1/GENE ./.
@@90675778047/CD In/NN untransformed/JJ cells/NNS ,/, three/CD major/JJ proteins/NNS coprecipitated/VBN with/IN CRKL/NNP ,/, identified/VBN as/IN C3G/GENE ,/, SOS/CONTEXTGENE and/CC c-ABL/GENE ./.
@@59429535833/CD I/NNP ./NNP
@@104870407253/CD Immunohistochemical/JJ staining/NN with/IN MIB-1/GENE and/CC p53/GENE antibodies/NNS showed/VBD low/JJ (/( </SYM 1%/JJ )/SYM and/CC negative/JJ reaction/NN ./.
@@81494849272/CD These/DT results/NNS indicate/VBP that/IN both/DT PKC/MULTIGENE alpha/MULTIGENE (/( calcium/NN dependent/JJ )/SYM and/CC PKC/MULTIGENE delta/MULTIGENE (/( calcium/NN independent/JJ )/SYM may/MD mediate/VB the/DT transcription/NN of/IN TPA-inducible/GENE genes/NNS through/RB both/DT AP-1/GENE and/CC non-AP-1/MULTIGENE sequences/MULTIGENE ./.
@@37461074414/CD One/CD hundred/JJ and/CC four/CD (/( 14/CD per/IN cent/NN )/SYM second/JJ primary/JJ tumours/NNS were/VBD reported/VBN ./.
@@107358483230/CD RegA/NN is/VBZ a/DT positive/JJ yet/RB nonessential/JJ regulator/NN of/IN tol-oprL/JJ expression/NN ./.
@@23557656825/CD The/DT patient/NN was/VBD treated/VBN with/IN benzathine/NN penicillin/NN ,/, 2/NN ,/NN 400/NN ,/NN 000/NN U/NN weekly/JJ for/IN three/CD weeks/NNS ./.
@@109810941559/CD Recent/JJ target/MULTIGENE BP/MULTIGENE goals/NNS promulgated/VBN by/IN the/DT Sixth/NNP Report/NNP from/IN the/DT Joint/NNP National/NNP Committee/NNP (/( JNC/MULTIGENE VI/MULTIGENE )/SYM are/VBP based/VBN on/IN the/DT premise/NN that/IN the/DT intensity/NN of/IN treatment/NN directly/RB corresponds/VBZ to/IN the/DT magnitude/NN of/IN pretreatment/JJ risk/NN ./.
@@78905995515/CD We/PRP have/VBP screened/VBN the/DT mouse/NN cDNA/NN library/NN of/IN an/DT MIN6/NNP cell/NN line/NN ,/, derived/VBN from/IN pancreatic/JJ beta/JJ cells/NNS ,/, for/IN its/PRP novel/JJ isoform/NN and/CC have/VB identified/VBN a/DT cDNA/NN encoding/VBG a/DT 593-amino/CD acid/NN protein/NN having/VBG 63/CD ,/, 53/CD ,/, and/CC 30%/CD identity/NN with/IN munc-18/GENE //GENE n-Sec1/GENE //GENE rbSec1/GENE ,/, Caenorhabditis/ORG elegans/NNS unc18/JJ ,/, and/CC Saccharomyces/NN cerevisiae/NN Sec1p/GENE ,/, respectively/RB ./.
@@10592791418/CD Comparison/NNS of/IN immunoassay/NN kits/NNS for/IN detection/NN of/IN staphylococcal/JJ enterotoxins/NNS produced/VBN by/IN Staphylococcus/NN aureus/NN ./.
@@8383217669/CD The/DT C-terminal/NN approximately/RB 50/CD amino/JJ acids/NNS of/IN Bel-1/GENE are/VBP shown/VBP to/IN be/VB essential/JJ for/IN Bel-1/GENE activity/NN but/CC can/MD be/VB effectively/RB substituted/JJ by/IN the/DT C-terminal/NN activation/NN domain/NN of/IN VP16/NN ./.
@@105139225184/CD Our/PRP study/NN also/RB demonstrated/VBD significant/JJ increases/NNS in/IN the/DT number/NN of/IN larger/RBR myelinated/JJ fibers/NNS crossing/VBG the/DT repair/MULTIGENE site/MULTIGENE in/IN comparison/NN with/IN the/DT neonatal/JJ and/CC adult/JJ groups/NNS (/( p/NN </SYM 0/CD ./CD 04/CD )/SYM ./.
@@77156028688/CD We/PRP suggest/VBP that/IN this/DT gene/NN cluster/NN codes/NNS for/IN (/( parts/NNS of/IN )/SYM a/DT multisubunit/MULTIGENE cytochrome/MULTIGENE c/MULTIGENE haem/NN lyase/NN ./.
@@75216017401/CD Hematopoietic/MULTIGENE growth/MULTIGENE factors/MULTIGENE are/VBP being/VBP used/VBN to/IN accelerate/VB the/DT recovery/NN of/IN myelopoiesis/NN following/IN high-dose/JJ chemotherapy/NN in/IN cancer/NN patients/NNS ./.
@@34529204159/CD Man/NN and/CC insect/NN ,/, past/JJ ,/, present/VB ,/, future/JJ ./.
@@13485901971/CD In/NN a/DT retrospective/JJ analysis/NN of/IN data/NN from/IN 35/CD cases/NNS with/IN malignant/JJ lymphoma/NN from/IN a/DT cohort/NN of/IN 2017/CD HIV-infected/JJ patients/NNS ,/, the/DT stage/NN of/IN HIV-disease/NNP ,/, the/DT CD4/NEWGENE counts/NNS at/IN the/DT time/NN of/IN diagnosis/NN ,/, and/CC the/DT use/NN of/IN antineoplastic/JJ agents/NNS or/CC radiotherapy/NN were/VBD correlated/VBN with/IN outcome/NN ./.
@@59307974022/CD Further/RB studies/VBZ on/IN a/DT "new"/JJ human/MULTIGENE isoprecipitin/MULTIGENE system/NN (/( Australia/NN antigen/NN )/SYM ./.
@@83739727438/CD SvO2/GENE can/MD be/VB determined/VBN in/IN vitro/FW and/CC in/IN vivo/NN ./.
@@11458841332/CD A/DT clinical/JJ ,/, serological/JJ and/CC prognostic/JJ study/NN ./.
@@10670358486/CD Dermatology/NN is/VBZ no/DT exception/NN ./.
@@112827611119/CD Oral/NNP supplementation/NN of/IN L-arginine/NN significantly/RB increased/VBD plasma/NN L-citrulline/IN ,/, which/WDT indicated/VBD enhancement/NN of/IN NO/DT production/NN ./.
@@105363699416/CD The/DT relative/JJ importance/NN of/IN these/DT two/JJ mechanisms/NNS differed/VBN in/IN a/DT response/MULTIGENE element-specific/MULTIGENE manner/NN ./.
@@92294209183/CD Re-evaluation/NNS of/IN the/DT biopsy/NN specimen/NN from/IN the/DT right/JJ hip/NN taken/VBP at/IN the/DT time/NN of/IN the/DT initial/JJ operation/NN showed/VBD areas/NNS of/IN chondrosarcoma/NN arising/VBG in/IN the/DT background/NN of/IN synovial/JJ chondromatosis/NN ./.
@@107440264062/CD Invertases/GENE are/VBP responsible/JJ for/IN the/DT breakdown/NN of/IN sucrose/NN to/IN fructose/NN and/CC glucose/NN ./.
@@106025021765/CD Like/IN the/DT Tob/MULTIGENE protein/MULTIGENE ,/, Tob2/GENE inhibited/VBN cell/NN cycle/NN progression/NN from/IN the/DT G0/GENE //GENE G1/GENE to/IN S/NNP phases/NNS ./.
@@31107943824/CD In/NN overdoses/NNS up/JJ to/IN 2/CD g/NN fluvoxamine/NN no/DT lasting/JJ toxic/JJ effects/NNS were/VBD observed/VBN ./.
@@72264407056/CD The/DT hemodynamics/NN of/IN isoproterenol-induced/JJ cardiac/JJ failure/NN in/IN the/DT rat/NN ./.
@@79691325369/CD One/CD class/NN of/IN plasmids/NNS contained/VBD tRNA/NN (/NN His/NN )/NN genes/NNS and/CC conferred/VBN efficient/JJ suppression/NN only/RB when/CC cells/NNS were/VBD starved/JJ for/IN histidine/NN ;/: these/DT plasmids/NNS suppressed/VBD a/DT gcn2/GENE deletion/NN much/JJ less/PRP efficiently/RB than/IN they/PRP suppressed/VBD gcn2-507/JJ ./.
@@18272034678/CD Like/IN many/JJ eukaryotic/MULTIGENE transcription/MULTIGENE factors/MULTIGENE ,/, these/DT proteins/NNS bind/VBP to/RB DNA/NN as/IN dimers/NNS ./.
@@91871363760/CD SSeCKS/NNP (/( pronounced/VBN essex/NN )/SYM encodes/VBZ a/DT major/JJ protein/MULTIGENE kinase/MULTIGENE C/MULTIGENE substrate/NEWGENE ,/, the/DT expression/NN of/IN which/WDT is/VBZ down-regulated/IN in/IN src-/JJ and/CC ras-transformed/JJ rodent/NN fibroblasts/NNS but/CC not/RB in/IN raf-transformed/JJ rodent/NN fibroblasts/NNS (/( X/NNP ./NNP
@@78264128103/CD A/DT new/JJ hypothesis/NN on/IN mechanisms/NNS for/IN inhibiting/JJ catalytic/JJ subunits/NNS by/IN gamma-subunits/NNS and/CC activation/NN of/IN a/DT holoenzyme/NN by/IN transducin/NN ./.
@@85087786560/CD Yeast/NN mutants/NNS lacking/JJ a/DT functional/JJ NOP1/MULTIGENE gene/MULTIGENE can/MD be/VB complemented/VBN by/IN human/MULTIGENE fibrillarin/MULTIGENE but/CC are/VBP temperature/NN sensitive/JJ for/IN growth/NN and/CC impaired/VBN in/IN pre-rRNA/NN processing/VBG ./.
@@89975326611/CD Specific/MULTIGENE IgG/MULTIGENE ,/, specific/MULTIGENE IgE/MULTIGENE and/CC total/JJ IgE/NN immunoglobulins/NNS against/IN Toxocara/NNP canis/JJ excretory/JJ //JJ secretory/JJ antigens/NNS (/( TES/NNS )/SYM were/VBD detected/VBN by/IN using/VBG ELISA/NN technique/NN ./.
@@17055416416/CD 2/CD :/: 121-133/JJ ,/, 1988/NN )/NN ./.
@@85653301903/CD We/PRP propose/VBP that/IN epigenetic/JJ features/NNS of/IN tissue-specific/JJ control/NN and/CC of/IN the/DT control/NN of/IN allelic/JJ expression/NN are/VBP intricately/RB linked/JJ ./.
@@80671239912/CD According/VBG to/IN the/DT results/NNS of/IN assays/NNS obtained/VBN with/IN the/DT use/NN of/IN assay/NN systems/NNS ORTHO/NNP ELISA/NN and/CC ABBOTT/MULTIGENE HCV/MULTIGENE EIA/NN (/( USA/NN )/SYM ,/, the/DT detection/NN rate/NN of/IN anti-HCV-C100-3/GENE among/IN primary/JJ blood/NN donors/NNS in/IN Moscow/NN was/VBD 1/CD ./CD 37%/CD and/CC was/VBD not/RB different/JJ from/IN that/DT among/IN HBsAg/MULTIGENE carriers/MULTIGENE (/( 1/CD ./CD 8%/CD )/SYM and/CC among/IN donors/NNS with/IN anti-HCV-C100-3/GENE in/IN the/DT blood/NN (/( 1/CD ./CD 6%/CD )/SYM (/( p/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@90056098969/CD Control/NNP examination/NN was/VBD performed/VBN at/IN the/DT end/NN of/IN each/DT period/NN ./.
@@13388678568/CD Comparison/NNS of/IN data/NN obtained/VBN with/IN the/DT results/NNS of/IN chronic/JJ treatment/NN with/IN the/DT opioid/MULTIGENE antagonist/MULTIGENE permits/VBP to/IN conclude/VB that/IN the/DT chronic/JJ blockade/NN increases/VBZ the/DT fatiguability/NN to/IN a/DT great/JJ extent/NN than/IN chronic/JJ activation/NN of/IN opioid/JJ system/NN ./.
@@30349563748/CD By/IN contrast/NN ,/, their/PRP basal/JJ adrenal/JJ androgen/NN levels/NNS were/VBD significantly/RB decreased/VBN compared/VBN to/IN those/DT in/NN normal/JJ subjects/NNS on/IN both/PDT the/DT day/NN on/IN and/CC the/DT day/NN off/JJ prednisone/NN (/( P/NN less/PRP than/IN 0/CD ./CD 05/CD )/SYM ./.
@@10378989252/CD The/DT aim/NN of/IN this/DT study/NN was/VBD to/IN investigate/VB the/DT spontaneous/JJ reports/NNS of/IN suspected/VBN adverse/JJ drug/NN reactions/NNS ,/, observed/VBN in/IN elderly/JJ patients/NNS (/( over/RB 65/CD years/NNS of/IN age/NN )/SYM in/IN Sicily/NN (/( Italy/NN )/SYM during/IN the/DT period/NN from/IN 1/CD January/NN 1995/CD to/IN 31/CD December/NN 1997/CD ./.
@@52859785457/CD Second/JJ report/NN of/IN the/DT Norwegian/NNP Cancer/NNP Society/NNP ./.
@@26891363361/CD These/DT adverse/JJ effects/NNS usually/RB abate/VBP with/IN time/NN ./.
@@74618488044/CD The/DT mean/JJ values/NNS of/IN the/DT concentrations/NNS of/IN the/DT components/NNS due/NN to/IN tobacco/NN smoke/NN are/VBP :/: CO/NN =/SYM 1/CD ./CD 1/CD ppm/NN ,/, NO/DT =/SYM 32/CD ppb/NN ,/, NO2/NN =/SYM 24/CD ppb/NN ,/, nicotine/NN =/SYM 0/CD ./CD 9/CD micrograms/GENE //GENE m3/GENE ,/, particulate/JJ matter/NN =/SYM 133/CD micrograms/GENE //GENE m3/GENE ./.
@@25518866067/CD Restriction/NNS maps/NNS of/IN the/DT cloned/VBN plasmids/NNS revealed/VBN that/IN their/PRP chromosomal/JJ inserts/NNS consisted/VBP of/IN overlapping/JJ fragments/NNS ./.
@@17159757473/CD Opposite/IN effects/NNS of/IN CYP1/GENE are/VBP observed/VBN in/IN aerobic/JJ ,/, heme-sufficient/JJ cells/NNS ./.
@@93624991671/CD The/DT Fis/MULTIGENE protein/MULTIGENE regulates/VBZ site-specific/MULTIGENE DNA/MULTIGENE inversion/NN catalyzed/VBN by/IN a/DT family/NN of/IN DNA/MULTIGENE invertases/MULTIGENE when/CC bound/JJ to/IN a/DT cis-acting/JJ recombinational/JJ enhancer/NN ./.
@@10785668609/CD How/WRB plants/NNS respond/VBP to/IN attack/NN by/IN the/DT range/NN of/IN herbivores/NNS and/CC pathogens/NNS that/WDT confront/VBP them/PRP in/IN the/DT field/NN is/VBZ the/DT subject/NN of/IN considerable/JJ research/NN by/IN both/DT molecular/JJ biologists/NNS and/CC ecologists/NNS ./.
@@84744565199/CD Transient/JJ transfection/NN analysis/NN with/IN these/DT mutations/NNS revealed/VBN that/IN only/RB a/DT 10-bp/JJ region/NN ,/, containing/JJ precisely/RB the/DT Ets/NNS and/CC proximal/JJ LyF-1/MULTIGENE binding/MULTIGENE sites/MULTIGENE ,/, was/VBD needed/VBN for/IN D'/NNS activity/NN ./.
@@18989282348/CD DNA/NN hybridization/NN analysis/NN revealed/VBN that/IN both/DT pigmented/JJ and/CC nonpigmented/JJ cells/NNS of/IN Y/NNP ./NNP pestis/NN possess/VB a/DT DNA/NN locus/NN homologous/JJ to/IN the/DT Escherichia/NN coli/JJ fur/MULTIGENE gene/MULTIGENE ./.
@@96184753938/CD A/DT large/JJ deletion/NN in/IN the/DT CTD-binding/MULTIGENE motif/MULTIGENE blocks/NNS down-regulation/NN but/CC does/VBP not/RB affect/VB the/DT essential/JJ function/NN of/IN Nrd1/GENE ./.
@@26479183319/CD Application/NNP of/IN different/JJ criteria/NNS of/IN cure/NN revealed/VBN that/IN 19/CD patients/NNS (/( 66%/JJ )/SYM had/VBP basal/MULTIGENE GH/MULTIGENE levels/NNS below/RB 5/CD ng/NN //NN ml/NN ,/, 17/CD patients/NNS (/( 59%/CD )/SYM had/VBP normal/JJ somatomedin-C/JJ values/NNS ,/, 16/CD patients/NNS (/( 55%/JJ )/SYM had/VBP complete/JJ GH/NN suppression/NN (/( less/PRP than/IN 1/CD ng/NN //NN ml/NN )/SYM during/IN OGTT/NN ,/, and/CC 13/CD patients/NNS (/( 45%/JJ )/SYM met/VBP the/DT above-mentioned/JJ criteria/NNS with/IN disappearance/NN of/IN the/DT paradoxical/JJ GH/NN response/NN to/IN TRH/NNP //NNP GnRH/NNP test/NN ./.
@@115299144999/CD NF-kappaB/GENE is/VBZ involved/VBN in/IN the/DT regulation/NN of/IN CD154/GENE (/( CD40/MULTIGENE ligand/MULTIGENE )/SYM expression/NN in/IN primary/JJ human/JJ T/NN cells/NNS ./.
@@75958578815/CD The/DT peak/NN velocities/NNS of/IN the/DT atrial/JJ systolic/JJ waves/NNS of/IN the/DT transmitral/JJ and/CC pulmonary/JJ venous/JJ flow/NN velocities/NNS (/( A/DT and/CC PVA/NN ,/, respectively/RB )/SYM and/CC first/JJ systolic/JJ wave/NN (/( PVS1/NN )/SYM of/IN pulmonary/JJ venous/JJ flow/NN ,/, durations/NNS of/IN both/DT atrial/JJ systolic/JJ waves/NNS ,/, and/CC amplitude/NN of/IN interatrial/JJ septal/JJ motion/NN during/IN atrial/JJ systole/NN increased/VBN significantly/RB ten/CD days/NNS after/IN cardioversion/NN compared/VBN with/IN those/DT measured/VBN within/IN a/DT day/NN of/IN cardioversion/NN in/IN all/DT patients/NNS except/VBP the/DT 5/CD patients/NNS with/IN dilated/JJ cardiomyopathy/NN ./.
@@19974656793/CD Radiation-induced/JJ changes/NNS in/IN the/DT area/NN of/IN alveoli/NNS and/CC septa/NNS as/RB well/VBP as/IN collagen/NEWGENE content/NN were/VBD seen/VBP 11/CD weeks/NNS after/IN irradiation/NN ./.
@@82705809869/CD A/DT favourable/NN response/NN was/VBD achieved/VBN with/IN a/DT combination/NN of/IN amphotericin/MULTIGENE B/MULTIGENE and/CC cotrimoxazole/NN ./.
@@97315133264/CD Taken/VBN together/RB ,/, these/DT results/NNS suggest/VBP that/IN the/DT cooperation/NN of/IN transcription/MULTIGENE factors/MULTIGENE NF-kappaB/MULTIGENE and/CC AP-1/GENE is/VBZ essential/JJ for/IN transactivation/NN of/IN IL-8/MULTIGENE gene/MULTIGENE by/IN HTLV-I/MULTIGENE Tax/MULTIGENE ./.
@@10656154471/CD Five/CD women/NNS (/( 15/CD ./CD 6%/CD )/SYM met/VBP criteria/NNS for/IN PMS/NN ./.
@@92273327915/CD In/NN summary/NN ,/, DDC/NN express/NN receptors/NNS for/IN a/DT broad/JJ panel/NN of/IN cytokines/NNS ,/, even/VB receptors/NNS for/IN cytokines/NNS whose/WP effects/NNS on/IN DC/JJ are/VBP still/RB unknown/JJ (/( i/CD ./CD e/CD ./.
@@88250874886/CD DNA/NN sequence/NN analysis/NN of/IN a/DT 3213/CD bp/NN BamHI-ClaI/MULTIGENE fragment/MULTIGENE revealed/VBN that/IN three/CD open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM were/VBD encoded/VBN in/IN the/DT same/JJ orientation/NN ./.
@@94206712472/CD CONCLUSIONS/IN :/: The/DT myocardial/JJ uptake/NN of/IN 99mTc/GENE sestamibi/NN in/IN normal/JJ subjects/NNS and/CC patients/NNS with/IN coronary/JJ artery/NN disease/NN is/VBZ comparable/JJ after/IN exercise/NN ,/, dipyridamole/NN ,/, and/CC adenosine/NN stress/NN ./.
@@28330218325/CD The/DT results/NNS suggest/VBP that/IN the/DT organization/NN of/IN functional/JJ units/NNS of/IN the/DT 72-bp/JJ repeat/NN required/VBN for/IN transcriptional/JJ enhancement/NN of/IN the/DT early/JJ promoter/NN is/VBZ different/JJ from/IN that/DT required/VBD for/IN late/JJ promoter/NN function/NN ./.
@@94479737724/CD Consistent/JJ with/IN previous/JJ reports/NNS ,/, addition/NN of/IN a/DT myristoylation/NN signal/JJ to/IN mSos1/GENE (/( MyrSos1/GENE )/SYM rendered/VBN it/PRP transforming/JJ for/IN NIH/NN 3T3/CD cells/NNS and/CC deletion/NN of/IN the/DT mSos/MULTIGENE C/MULTIGENE terminus/NN (/( MyrSos1-deltaC/NNP )/SYM did/VBD not/RB interfere/VB with/IN this/DT activity/NN ./.
@@92347207259/CD Although/IN neither/DT constitutively/RB activated/VBN MEK/GENE (/( MEK-2E/GENE )/SYM nor/CC v-Src/NN was/VBD sufficient/JJ individually/RB to/IN differentiate/VB the/DT H19-7/CD cells/NNS ,/, coexpression/NN of/IN constitutively/RB activated/VBN MEK/GENE and/CC v-Src/NN induced/VBD neurite/NN outgrowth/NN ./.
@@78160259534/CD Comparison/NNS of/IN the/DT deduced/VBN amino/JJ acid/NN sequence/NN of/IN gamma-kafirin/JJ with/IN the/DT published/VBN sequences/NNS of/IN gamma-prolamins/NNS of/IN maize/NN ,/, and/CC Coix/ORG revealed/VBD highly/RB conserved/VBN domains/NNS ./.
@@69311249033/CD Setting/VBG takes/VBP place/NN through/JJ complex/NN formation/NN of/IN (/( NH4Mg/NNP PO4/GENE ./GENE 6H2O/GENE )/NN n/NN ,/, excess/JJ reactants/NNS ,/, and/CC water/NN ./.
@@99493129945/CD Airflow/NN through/RB the/DT dust/NN trap/NN was/VBD controlled/VBN with/IN a/DT vacuum/NN pump/NN ./.
@@63854746185/CD Climatic/JJ treatment/NN of/IN children/NNS with/IN respiratory/JJ allergy/NN ./.
@@111606569172/CD Inactivity/NNS of/IN the/DT human/JJ cytomegalovirus/NN (/( HCMV/NN )/SYM major/JJ immediate-early/JJ regulatory/JJ region/NN (/( MIERR/GENE )/SYM ,/, which/WDT is/VBZ composed/VBN of/IN promoter/NN ,/, enhancer/NN ,/, unique/JJ region/NN ,/, and/CC modulator/NN ,/, is/VBZ linked/JJ to/IN lack/NN of/IN HCMV/NN replication/NN in/IN latently/RB infected/VBN cells/NNS and/CC in/IN other/DT nonpermissive/JJ cell/NN types/NNS ,/, including/JJ human/JJ embryonal/JJ NTera2/GENE carcinoma/NN (/( NT2/NNP )/SYM cells/NNS ./.
@@40637322949/CD In/JJ controls/NNS ,/, most/RB of/IN the/DT output/NN from/IN the/DT conduit/NN occurred/VBN during/IN type/MULTIGENE I/MULTIGENE activity/NN (/( 73/CD +/NN //NN -/NN 14%/JJ )/SYM ./.
@@110622579029/CD Thus/RB ,/, the/DT class/NN C-Vps/GENE complex/NN directs/VBZ multiple/JJ reactions/NNS during/IN the/DT docking/JJ and/CC fusion/NN of/IN vesicles/NNS with/IN the/DT vacuole/NN ,/, each/DT of/IN which/WDT contributes/VBZ to/IN the/DT overall/JJ specificity/NN and/CC efficiency/NN of/IN this/DT transport/NN process/NN ./.
@@8533472725/CD The/DT predicted/VBN protein/NN products/NNS of/IN ORFs/NNS N2417/GENE and/CC N2403/GENE present/VB similarities/NNS with/IN domains/NNS from/IN proteins/NNS of/IN other/DT organisms/NNS :/: the/DT Candida/NN maltosa/NN cycloheximide-resistance/JJ protein/NN ,/, the/DT human/MULTIGENE interleukin/MULTIGENE enhancer-binding/MULTIGENE factor/MULTIGENE (/( ILF-2/GENE )/SYM ./.
@@107084248479/CD Manganese/NNP ions/NNS were/VBD found/VBN to/IN be/VB essential/JJ for/IN autophosphorylation/NN of/IN BGLF4/GENE ,/, and/CC magnesium/NN can/MD stimulate/VB the/DT activity/NN ./.
@@98171902425/CD However/RB ,/, the/DT use/NN of/IN cyclosporin/MULTIGENE A/MULTIGENE is/VBZ associated/VBN with/IN an/DT increased/VBN prevalence/NN of/IN hypertension/NN in/IN kidney/NN transplant/NN recipients/NNS ./.
@@87691324312/CD The/DT human/MULTIGENE MSH-2/MULTIGENE gene/MULTIGENE product/MULTIGENE is/VBZ a/DT member/NN of/IN a/DT highly/RB conserved/VBN family/NN of/IN proteins/NNS which/WDT are/VBP involved/VBN in/IN post-replication/JJ mismatch/NN repair/NN ./. hMSH-2/GENE is/VBZ homologous/JJ to/IN Escherichia/NN coli/JJ (/( E/NNP ./NNP coli/JJ )/SYM MutS/NNP and/CC Sacchromyces/NNP cerevisiae/NN MSH-1/GENE and/CC MSH-2/MULTIGENE proteins/MULTIGENE ,/, which/WDT recognise/VBP heteroduplex/JJ DNA/NN at/IN the/DT sites/NNS of/IN all/DT single/JJ base/NN mismatches/NNS and/CC deletions/NNS or/CC insertions/NNS up/JJ to/IN 4/CD base/NN pairs/NNS ./. hMSH-2/GENE is/VBZ one/PRP of/IN the/DT hereditary/JJ non-polyposis/NN colorectal/JJ cancer/NN (/( HNPCC/IN )/SYM tumor/NN suppressor/NN genes/NNS ,/, and/CC maps/NNS to/IN human/JJ chromosome/NN 2p16/GENE ./.
@@21185252129/CD In/NN addition/NN ,/, the/DT -119/CD to/IN -81/CD fragment/NN of/IN the/DT CCK/MULTIGENE promoter/MULTIGENE contains/VBZ a/DT transcriptional/JJ enhancer/NN that/WDT potentiates/VBZ the/DT transcription/NN from/IN the/DT herpes/NN simplex/JJ virus/NN thymidine/MULTIGENE kinase/MULTIGENE promoter/MULTIGENE in/IN a/DT position-/JJ and/CC orientation-independent/JJ manner/NN ./.
@@15518984744/CD This/DT vector/NN transfected/VBN into/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN directs/VBZ expression/NN of/IN a/DT secreted/VBN mature/JJ protein/NN at/IN levels/NNS up/JJ to/IN 200/CD mg/NN of/IN LAPP/NNP //NNP liter/NNP of/IN culture/NN medium/NN ./.
@@89798288924/CD Such/JJ multisensory/JJ interactions/NNS can/MD be/VB significant/JJ for/IN behavior/NN ./.
@@95010931453/CD Activation/NNS of/IN the/DT mitogen/NN activated/VBN protein/NN (/( MAP/NN )/SYM kinase/NN is/VBZ a/DT primary/JJ consequence/NN of/IN Ras/NEWGENE activation/NN and/CC plays/VBP a/DT key/NN role/NN in/IN mediating/JJ Ras/NEWGENE signal/JJ transduction/NN ./.
@@88367408435/CD Neither/CC CES1/GENE nor/CC CES4/GENE is/VBZ essential/JJ for/IN cell/NN growth/NN ,/, and/CC a/DT double/JJ deletion/NN mutant/NN is/VBZ viable/JJ ./.
@@95287926008/CD Alternative/JJ splicing/JJ of/IN fibroblast/MULTIGENE growth/MULTIGENE factor/MULTIGENE receptor/MULTIGENE 2/MULTIGENE (/( FGF-R2/GENE )/SYM is/VBZ an/DT example/NN of/IN highly/RB regulated/VBN alternative/JJ splicing/JJ in/IN which/WDT exons/NNS IIIb/NNS and/CC IIIc/NNS are/VBP utilized/VBN in/IN a/DT mutually/RB exclusive/JJ manner/NN in/IN different/JJ cell/NN types/NNS ./.
@@9316937432/CD This/DT newly/RB described/VBN organism/NN was/VBD difficult/JJ to/IN identify/VB due/NN to/IN discrepancies/NNS between/IN the/DT Vitek/NNP and/CC API/MULTIGENE 20E/MULTIGENE identification/NN systems/NNS ./.
@@73694587211/CD This/DT relatively/JJ simple/JJ and/CC easily/RB performed/VBN technique/NN of/IN measuring/JJ deep/JJ muscle/NN temperature/NN appears/VBZ to/IN be/VB a/DT useful/JJ adjunct/NN in/IN choosing/VBG the/DT amputation/NN level/NN ./.
@@78647099852/CD METHODS/IN :/: Ten/CD influenza/NN A/DT (/( H3N2/GENE )/SYM viruses/NNS isolated/VBN during/IN the/DT outbreaks/NNS were/VBD examined/VBN for/IN resistance/NN to/IN amantadine/NN and/CC rimantadine/NN by/IN means/NN of/IN an/DT enzyme/NN immunoassay/NN and/CC by/IN sequencing/VBG of/IN the/DT viral/JJ nucleic/JJ acid/NN that/IN encodes/VBZ the/DT transmembrane/JJ domain/NN of/IN the/DT M2/MULTIGENE protein/MULTIGENE ./.
@@1141447044/CD An/DT anatomical/JJ and/CC histochemical/JJ study/NN has/VBZ been/VBN undertaken/VBP and/CC as/IN a/DT result/NN emphasis/NN is/NNS given/VBP to/IN recent/JJ hypotheses/NNS that/WDT suggest/VBP there/RB are/VBP similarities/NNS with/IN Type/MULTIGENE IV/MULTIGENE glycogen/MULTIGENE storage/NN disease/NN (/( Andersen's/NNP disease/NN )/SYM which/WDT ,/, although/IN clinically/RB distinct/JJ ,/, has/VBZ the/DT same/JJ enzyme/NN defect/NN ./.
@@79451341617/CD Ten/CD volunteers/NNS were/VBD tested/VBN at/IN 18/CD ,/CD 000/CD ft/NN (/( 5/CD ,/CD 486/CD m/NN )/SYM ,/, and/CC through/RB 12/CD ,/CD 000/CD ,/, 8/CD ,/CD 000/CD ,/, and/CC 5/CD ,/CD 000/CD ft/NN (/( 3/GENE ,/GENE 657/GENE ,/, 2/CD ,/CD 438/CD ,/, and/CC 1/CD ,/CD 524/CD m/NN )/SYM with/IN directional/JJ sounds/NNS recorded/VBD via/NN a/DT dummy/JJ head/JJ microphone/NN and/CC presented/VBN binaurally/RB ./.
@@111455662716/CD Because/IN the/DT high-density/JJ lipoprotein/NN receptor/NN (/( HDL-R/GENE )/SYM is/VBZ a/DT key/NN element/NN in/IN cholesterol/NN homeostasis/NN and/CC a/DT potential/JJ therapeutic/JJ target/NN for/IN hypercholesterolemic/JJ drugs/NNS ,/, an/DT understanding/NN of/IN HDL-R/GENE regulation/NN is/VBZ essential/JJ ./.
@@117436121761/CD Patients/NNS with/IN CF/NN and/CC meconium/NN ileus/NN presented/VBD a/DT poor/JJ nutritional/JJ status/NN at/IN diagnosis/NN and/CC a/DT lower/JJR survival/NN rate/NN compared/VBN to/IN the/DT general/MULTIGENE CF/MULTIGENE population/NN ./.
@@91217741387/CD A/DT role/NN for/IN the/DT small/MULTIGENE GTPase/MULTIGENE Rac/MULTIGENE in/IN polyomavirus/NN middle-T/NN antigen-mediated/JJ activation/NN of/IN the/DT serum/JJ response/MULTIGENE element/MULTIGENE and/CC in/IN cell/NN transformation/NN ./.
@@113906638122/CD Finally/RB ,/, profiling/VBG of/IN a/DT gcn4Delta/MULTIGENE mutant/MULTIGENE uncovered/VBN an/DT alternative/JJ induction/NN pathway/NN operating/JJ at/IN many/JJ Gcn4p/MULTIGENE target/MULTIGENE genes/MULTIGENE in/IN histidine-starved/JJ cells/NNS ./.
@@93499679303/CD Our/PRP results/NNS suggest/VBP that/IN the/DT pattern/NN of/IN blood/NN supply/NN is/VBZ relevant/JJ to/IN the/DT structural/JJ organisation/NN of/IN mature/JJ lamellar/JJ bone/NN around/IN the/DT implant/NN ./.
@@35914644253/CD Thus/RB ,/, a/DT negative/JJ test/NN is/VBZ compatible/JJ with/IN low/JJ disease/NN activity/NN and/DT //DT or/DT efficacy/NN of/IN calcium/MULTIGENE antagonist/MULTIGENE treatment/NN ./.
@@109319606607/CD The/DT loss/NN of/IN avirulence/NN activity/NN because/IN of/IN mutations/NNS in/IN the/DT acidic/JJ transcriptional/JJ activation/NN domain/NN was/VBD restored/VBN by/IN addition/NN of/IN the/DT activation/NN domain/NN from/IN the/DT herpes/NN simplex/JJ viral/MULTIGENE protein/MULTIGENE VP16/MULTIGENE ./.
@@14382879785/CD Nonreplicating/VBG vaccinia/NN vector/NN efficiently/RB expresses/VBP recombinant/JJ genes/NNS ./.
@@105874612525/CD By/IN an/DT induced-fit/JJ mechanism/NN ,/, contacts/VBZ with/IN the/DT anticodon/NN can/MD activate/VB formation/NN of/IN a/DT robust/JJ transition/NN state/NN at/IN a/DT site/NN over/RB 70/CD A/DT away/RB ./.
@@27611503459/CD The/DT effect/NN of/IN zinc/NN deficiency/NN on/IN trace/NN metals/NNS in/IN the/DT liver/NN ,/, spleen/NN ,/, kidney/NN ,/, pancreas/NN and/CC duodenum/NN was/VBD investigated/VBN in/IN the/DT control/NN and/CC zinc-deficient/JJ rats/NNS at/IN 17/CD days/NNS and/CC 20/CD days/NNS of/IN pregnancy/NN ./.
@@94479942271/CD Several/JJ studies/NNS have/VBP characterized/VBN the/DT upstream/RB regulatory/JJ region/NN of/IN c-fos/GENE ,/, and/CC identified/VBD cis-acting/JJ elements/NNS termed/VBD the/DT cyclic/JJ AMP/NN (/( cAMP/NN )/SYM response/MULTIGENE elements/MULTIGENE (/( CREs/CONTEXTGENE )/SYM that/WDT are/VBP critical/JJ for/IN c-fos/GENE transcription/NN in/IN response/NN to/IN a/DT variety/NN of/IN extracellular/JJ stimuli/NNS ./.
@@85520967572/CD Using/VBG a/DT high-copy/JJ suppression/NN strategy/NN ,/, we/PRP have/VBP identified/VBN a/DT yeast/NN gene/NN (/( UBS1/GENE )/SYM whose/WP elevated/VBN expression/NN suppresses/VBZ the/DT conditional/JJ cell/NN cycle/NN defects/NNS associated/VBN with/IN cdc34/MULTIGENE mutations/MULTIGENE ./.
@@98713539860/CD However/RB ,/, there/RB has/VBZ not/RB been/VBN any/DT evidence/NN of/IN A/NNP ./NNP salmonicida/JJ infections/NNS ,/, specifically/RB furunculosis/NN ,/, associated/VBN with/IN the/DT fish/NN in/IN this/DT loch/NN ./.
@@27526297590/CD Dynamic/NNP and/CC static/JJ scintigrams/NNS ,/, using/VBG 99mtechnetium/GENE methylene/NN diphosphonate/NN ,/, were/VBD obtained/VBN at/IN zero/NN ,/, six/CD ,/, and/CC 12/CD weeks/NNS after/IN fracture/NN ./.
@@64947666286/CD The/DT persistent/JJ fetal/JJ dispersion/NN of/IN nodal/JJ and/CC Hiss/NNP bundle/NN fragments/NNS within/IN the/DT ventricular/JJ septum/NN is/VBZ proposed/VBN as/IN a/DT possible/JJ explanation/NN ./.
@@105853115457/CD Residual/JJ urinary/JJ abnormalities/NNS were/VBD significantly/RB more/RB frequent/VB in/IN patients/NNS with/IN type/MULTIGENE III/MULTIGENE than/IN type/MULTIGENE I/MULTIGENE MPGN/NN ./.
@@1084413650/CD A/DT range/NN of/IN normal/JJ ventricular/JJ measurements/NNS for/IN the/DT EMI/NNP scan/NN is/VBZ suggested/VBN ./.
@@21139013407/CD Inspired/VBN CO2/NN causing/JJ changes/NNS from/IN hypo-/JJ to/IN normocapnia/NN has/VBZ previously/RB been/VBN shown/VBP to/IN improve/VB arterial/JJ O2/GENE tension/NN (/( PaO2/GENE )/SYM and/CC to/IN reduce/VB alveolar-arterial/JJ O2/GENE difference/NN ./.
@@107245195391/CD Most/JJS likely/RB they/PRP might/MD represent/VB regulatory/JJ RNAs/NNS or/CC transcribed/VBN transposable/JJ elements/NNS ./.
@@86493868656/CD A/DT new/JJ UASH/NNP consensus/NN sequence/NN derived/VBN from/IN this/DT mutational/JJ analysis/NN closely/RB matches/VBZ a/DT consensus/NN Abf1/MULTIGENE binding/MULTIGENE site/MULTIGENE ./.
@@94420244119/CD A/DT hybridoma/MULTIGENE clone/MULTIGENE (/( 7H1/GENE )/SYM resulting/VBG from/IN the/DT fusion/NN between/IN CEMLAI/NNP //NNP NP/NNP and/CC human/JJ embryonic/JJ fibroblasts/NNS MRC5/NNP cells/NNS produced/VBN very/RB large/JJ amounts/NNS of/IN P47/NEWGENE that/WDT was/VBD purified/VBN using/VBG Jacalin/MULTIGENE lectin/MULTIGENE (/( specific/JJ for/IN O-glycans/NNPS )/SYM and/CC microsequenced/VBN ./.
@@96221213575/CD The/DT use/NN of/IN antibodies/NNS to/IN the/DT polypyrimidine/NN tract/NN binding/JJ protein/NN (/( PTB/GENE )/SYM to/IN analyze/VB the/DT protein/NN components/NNS that/WDT assemble/VBP on/IN alternatively/RB spliced/VBN pre-mRNAs/VBZ that/DT use/NN distant/JJ branch/NN points/NNS ./.
@@80156727488/CD In/NN control/JJ patients/NNS ,/, baseline/NN images/NNS presented/VBD Type/MULTIGENE I/MULTIGENE in/IN 25/CD ,/, Type/MULTIGENE II/MULTIGENE in/IN 7/CD ,/, and/CC the/DT Type/MULTIGENE III/MULTIGENE &/CC IV/NN in/IN 0/CD ,/, and/CC the/DT Type/NN after/IN loading/NN was/VBD the/DT same/JJ as/IN the/DT Type/NN at/IN baseline/NN ./.
@@83556805296/CD 2-AP/CD induced/VBN marked/JJ ,/, steady/JJ rises/NNS in/IN mRNA/NN accumulation/NN from/IN both/DT transfected/VBN and/CC chromosomally/RB integrated/JJ HIV-1/MULTIGENE constructs/MULTIGENE but/CC no/DT increases/NNS from/IN an/DT endogenous/JJ gene/NN encoding/VBG gamma-actin/NN or/CC glucose/MULTIGENE 6-phosphate/MULTIGENE dehydrogenase/MULTIGENE ./.
@@3042778922/CD The/DT gene/NN is/VBZ essential/JJ for/IN yeast/NN vegetative/JJ growth/NN ./.
@@95432279495/CD Group/NNP A/DT (/( 68/NN ./NN 7+/NN //NN -2/NN ./NN 7/NN years/NNS )/SYM consisted/VB of/IN patients/NNS with/IN 0/CD or/CC 1/CD risk/NN factors/NNS ;/: B/NNP (/( 68/CD ./CD 3+/CD //CD -4/CD ./CD 2/CD years/NNS )/SYM those/DT with/IN 2/CD risk/NN factors/NNS ;/: and/CC C/NN (/( 69/CD ./CD 2+/CD //CD -3/CD ./CD 6/CD years/NNS )/SYM those/DT with/IN 3/CD or/CC more/JJ risk/NN factors/NNS ./.
@@81985244953/CD 50/CD kDa/NN and/CC 130-170/JJ kDa/NN were/VBD detected/VBN ./.
@@91546219108/CD These/DT results/NNS suggest/VBP that/IN dietary/JJ safflower/NN phospholipids/NNS may/MD be/VB a/DT valuable/NN ingredient/NN to/IN layers/NNS for/IN reducing/JJ liver/NN triglycerides/NNS and/CC serum/JJ cholesterol/NN without/IN any/DT adverse/JJ effects/NNS ./.
@@75595243244/CD Several/JJ different/JJ oncogenes/NNS and/CC growth/MULTIGENE factors/MULTIGENE promote/VBP G1/GENE phase/NN progression/NN ./.
@@96322175948/CD The/DT opioid/MULTIGENE antagonist/MULTIGENE naltrexone/NN (/( 0/CD ./CD 01-1/CD ./CD 0/CD mg/CD //CD kg/CD )/SYM antagonized/VBN the/DT discriminative/JJ stimulus/NN effects/NNS of/IN heroin/NN ,/, but/CC naltrexone/NN at/IN doses/NNS up/JJ to/IN 10/CD mg/CD //CD kg/CD had/VBP no/DT effect/NN on/IN the/DT discriminative/JJ stimulus/NN effects/NNS of/IN cocaine/NN ./.
@@76306875846/CD The/DT objective/NN of/IN our/PRP study/NN was/VBD to/IN evaluate/VB the/DT age/NN ,/, sex/NN ,/, clinical/JJ conditions/NNS ,/, family/NN history/NN ,/, site/NN ,/, catheter/NN association/NN ,/, means/NN of/IN radiologic/JJ evaluation/NN ,/, development/NN of/IN pulmonary/JJ involvement/NN ,/, prevalence/NN of/IN antithrombin/MULTIGENE III/MULTIGENE ,/, protein/MULTIGENE C/MULTIGENE and/CC protein/MULTIGENE S/MULTIGENE deficiencies/NNS ,/, and/CC lupus/NN anticoagulants/NNS in/IN children/NNS who/WP suffered/VBD a/DT thrombotic/JJ event/NN ./.
@@77303289516/CD Vascular/JJ endothelial/JJ cells/NNS undergo/VBP profound/JJ changes/NNS upon/IN cellular/JJ activation/NN including/JJ expression/NN of/IN a/DT spectrum/NN of/IN cell/NN activation-associated/MULTIGENE genes/MULTIGENE ./.
@@75887505168/CD Cloning/VBG ,/, sequencing/VBG and/CC expression/NN of/IN the/DT 3-phosphoglycerate/MULTIGENE kinase/MULTIGENE gene/MULTIGENE of/IN Pyrococcus/ORG woesei/NN in/IN Escherichia/NN coli/NN and/CC characterization/NN of/IN the/DT protein/NN ./.
@@9771967271/CD Furthermore/RB ,/, LB1/MULTIGENE gene/MULTIGENE mapped/VBN to/IN chromosome/NN 13q14/CD ,/, a/DT region/NN that/WDT has/VBZ been/VBN involved/VBN as/IN a/DT chromosomal/JJ breakpoint/NN in/IN DLBL/NN ./.
@@104908223702/CD These/DT results/NNS show/NN that/DT targeting/NN of/IN Ras-GAP/GENE could/MD represent/VB a/DT novel/JJ anticancer/JJ approach/NN ./.
@@88780372890/CD The/DT gene/NN ccpA/GENE encoding/VBG the/DT catabolite/NN control/NN protein/NN CcpA/GENE of/IN Staphylococcus/NN xylosus/NN has/VBZ been/VBN cloned/VBN and/CC characterized/VBN ./.
@@107560948953/CD A/DT total/NN of/IN 194/MULTIGENE STSs/MULTIGENE map/MULTIGENE to/IN this/DT interval/NN of/IN 3/CD Mb/NN ,/, giving/JJ an/DT average/JJ marker/NN resolution/NN of/IN approximately/RB one/PRP per/IN 15/CD kb/CD ./CD
@@8350398846/CD We/PRP suggest/VBP that/IN the/DT ER/NN lumenal/JJ variable/JJ domain/NN of/IN gp19K/GENE has/VBZ a/DT specific/JJ tertiary/JJ structure/NN that/WDT is/VBZ important/JJ for/IN binding/JJ to/IN the/DT polymorphic/JJ alpha/MULTIGENE 1/MULTIGENE and/CC alpha/MULTIGENE 2/MULTIGENE domains/MULTIGENE of/IN class/MULTIGENE I/MULTIGENE heavy/JJ (/( alpha/NN )/SYM chains/NNS ./.
@@83357108315/CD The/DT influence/NN of/IN a/DT high/JJ ionic/JJ strength/NN on/IN the/DT resolution/NN was/VBD clearly/RB shown/VBP ./.
@@11474361360/CD The/DT American/NNP Burkitt/NNP Lymphoma/NNP Registry/NNP :/: a/DT progress/NN report/NN ./.
@@24890324760/CD Immunoglobulin/MULTIGENE light/MULTIGENE chain/MULTIGENE (/( IgL/CONTEXTGENE )/SYM diversity/NN is/VBZ generated/VBN in/IN the/DT chicken/NN by/IN recombination/NN between/IN the/DT single/JJ functional/JJ variable/JJ (/( VL/JJ )/SYM and/CC joining/VBG (/( JL/NNS )/SYM gene/NN segments/NNS and/CC subsequent/JJ somatic/JJ diversification/NN of/IN the/DT rearranged/JJ VL/MULTIGENE region/MULTIGENE ./.
@@114313483746/CD Interactions/NNS between/IN the/DT checkpoint/NN abrogator/MULTIGENE UCN-01/MULTIGENE and/CC several/DT pharmacological/JJ inhibitors/NNS of/IN the/DT mitogen-activated/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( MAPK/CONTEXTGENE )/SYM kinase/NN (/( MEK/GENE )/NN //NN MAPK/NN pathway/NN have/NN been/VBN examined/VBN in/IN a/DT variety/NN of/IN human/JJ leukemia/NN cell/NN lines/NNS ./.
@@22203049090/CD Our/PRP study/NN shows/VBZ that/IN the/DT area/NN of/IN Alcoy/GENE is/VBZ a/DT medium/NN MS/NN risk/NN region/NN according/VBG to/IN the/DT thesis/NN of/IN Kurzke/NNP ,/, although/IN high/JJ MS/NN areas/NNS may/MD be/VB found/VB ,/, thus/RB confirming/VBG that/DT MS/NN distribution/NN in/IN southern/JJ Europe/NN is/VBZ not/RB uniform/JJ ./.
@@15378459574/CD Using/VBG bovine/JJ and/CC murine/MULTIGENE c-myb/MULTIGENE clones/NNS ,/, no/DT change/NN in/IN the/DT rate/NN of/IN c-myb/MULTIGENE gene/MULTIGENE transcription/NN or/CC mRNA/NN stability/NN was/VBD detected/VBN during/IN the/DT cell/NN cycle/NN ./.
@@98755413443/CD The/DT orbitofrontal/NN ,/, cingulate/JJ ,/, and/CC anteromedial/JJ part/NN of/IN the/DT dorsal/JJ premotor/JJ areas/NNS were/VBD preferentially/RB activated/VBN by/IN the/DT self-initiated/JJ hand/NN movement/NN task/NN (/( SELF/GENE )/SYM ./.
@@79782297969/CD An/DT unusual/JJ complication/NN in/IN an/DT unsuitable/JJ patient/NN ./.
@@7959011114/CD C/MULTIGENE //MULTIGENE EBP/MULTIGENE alpha/MULTIGENE also/RB activates/VBZ the/DT promoter/NN of/IN the/DT rat/MULTIGENE class-I/MULTIGENE ADH/MULTIGENE gene/MULTIGENE in/IN a/DT sequence-specific/JJ manner/NN [/NN Potter/NN et/FW al/NNS ./NNS ,/, Arch/NNP ./.
@@92116755372/CD Surveillance/NN for/IN preeclampsia/NN was/VBD conducted/VBN by/IN personnel/NN unaware/JJ of/IN treatment-group/JJ assignments/NNS ,/, using/VBG standardized/JJ measurements/NNS of/IN blood/NN pressure/NN and/CC urinary/MULTIGENE protein/MULTIGENE excretion/NN at/IN uniformly/RB scheduled/VBN prenatal/JJ visits/NNS ,/, protocols/NNS for/IN monitoring/VBG these/DT measurements/NNS during/IN the/DT hospitalization/NN for/IN delivery/NN ,/, and/CC reviews/VBP of/IN medical/JJ records/NNS of/IN unscheduled/JJ outpatient/NN visits/NNS and/CC all/DT hospitalizations/NNS ./.
@@91603612159/CD The/DT 30-day/CD mortality/NN in/IN the/DT CPB/NNP group/NN and/CC the/DT non-CPB/GENE group/NN were/VBD 20%/CD and/CC 4/CD ./CD 6%/CD ,/, respectively/RB which/WDT was/VBD not/RB statistically/RB significant/JJ (/( p/NN =/SYM 0/CD ./CD 06/CD )/SYM ./.
@@79267751787/CD We/PRP show/VBP that/IN the/DT en/NN stripes/NNS expand/VBP anteriorly/RB in/IN slp/MULTIGENE mutant/MULTIGENE embryos/NNS and/CC that/DT slp/NN activity/NN is/VBZ an/DT absolute/JJ requirement/NN for/IN maintenance/NN of/IN wg/NEWGENE expression/NN at/IN the/DT same/JJ time/NN that/DT wg/NEWGENE transcription/NN is/VBZ dependent/JJ on/IN hh/CD ./CD
@@10895851723/CD Bailey/NNP Instruments/NNPS and/CC Owen/NNP Mumford/NNP filaments/NNS were/VBD the/DT most/RB accurate/JJ with/IN 100%/CD buckling/NN within/IN +/CD //CD -1/CD ./CD 0/CD g/NN of/IN 10/CD g/CD ./CD
@@104545574880/CD In/NN the/DT budding/JJ yeast/NN ,/, Saccharomyces/NN cerevisiae/NN ,/, replicators/NNS can/MD function/VB outside/RB the/DT chromosome/NN as/IN autonomously/RB replicating/JJ sequence/NN (/( ARS/NNS )/SYM elements/NNS ;/: however/RB ,/, within/IN chromosome/MULTIGENE III/MULTIGENE ,/, certain/JJ ARSs/NNP near/IN the/DT transcriptionally/RB silent/JJ HML/MULTIGENE locus/MULTIGENE show/NN no/DT replication/NN origin/NN activity/NN ./.
@@82454569946/CD These/DT cells/NNS produce/NN a/DT low/JJ level/NN of/IN IL-5/NEWGENE when/CC stimulated/VBN with/IN PMA/NN alone/RB ;/: however/RB ,/, N6/NNS ,/, O2-dibutyryl/NNP cAMP/NN (/( Bt2cAMP/IN )/SYM ,/, in/IN combination/NN with/IN PMA/NN ,/, augmented/VBN by/IN more/RB than/IN tenfold/RB the/DT IL-5/NEWGENE production/NN at/IN the/DT mRNA/NN and/CC the/DT protein/NN levels/NNS ./.
@@29281126837/CD Molecular/NNP cloning/NN of/IN the/DT cDNA/NN for/IN the/DT human/MULTIGENE U2/MULTIGENE snRNA-specific/JJ A'/NNS protein/NN ./.
@@111819951734/CD Analysis/NNP of/IN the/DT genome/NN sequence/NN revealed/VBN 26/MULTIGENE ,/MULTIGENE 588/MULTIGENE protein-encoding/MULTIGENE transcripts/MULTIGENE for/IN which/WDT there/RB was/VBD strong/JJ corroborating/VBG evidence/NN and/CC an/DT additional/JJ approximately/RB 12/CD ,/CD 000/CD computationally/RB derived/VBN genes/NNS with/IN mouse/NN matches/NNS or/CC other/DT weak/JJ supporting/VBG evidence/NN ./.
@@10523647836/CD Thus/RB ,/, CHOP/NN not/RB only/RB is/VBZ a/DT negative/JJ or/CC a/DT positive/JJ regulator/NN of/IN C/MULTIGENE //MULTIGENE EBP/MULTIGENE target/MULTIGENE genes/MULTIGENE but/CC also/RB ,/, when/CC tethered/JJ to/IN AP-1/MULTIGENE factors/MULTIGENE ,/, can/MD activate/VB AP-1/MULTIGENE target/MULTIGENE genes/MULTIGENE ./.
@@75107247396/CD The/DT lymph/NN nodes/NNS from/IN two/NN of/IN the/DT patients/NNS with/IN rheumatoid/JJ arthritis/NN contained/VBD numerous/JJ sarcoid/JJ like/JJ granulomata/NNS ,/, further/RB indicating/VBG a/DT possible/JJ association/NN between/IN sarcoidosis/NN and/CC rheumatoid/JJ arthritis/NN ./.
@@61134435937/CD Separation/NN of/IN malaria-infected/JJ erythrocytes/NNS from/IN whole/JJ blood/NN :/: use/NN of/IN a/DT selective/JJ high-gradient/JJ magnetic/JJ separation/NN technique/NN ./.
@@72533352499/CD Effects/NNPS of/IN prostaglandin/MULTIGENE inhibitors/MULTIGENE on/IN the/DT onset/NN of/IN proteinuria/NN and/CC stroke/NN in/IN stroke-prone/JJ spontaneously/RB hypertensive/JJ rats/NNS ./.
@@77434727700/CD Female/JJ patients/NNS with/IN breast/NN cancer/NN diagnosed/VBN between/IN 1982/CD and/CC 1991/CD at/IN Roswell/NNP Park/NNP Cancer/NNP Institute/NNP (/( RPCI/GENE )/SYM in/IN Buffalo/NN ,/, New/NNP York/NN ,/, who/WP provided/VBD information/NN on/IN their/PRP cigarette/NN smoking/NN history/NN at/IN the/DT time/NN of/IN their/PRP diagnosis/NN were/VBD included/VBN ./.
@@75106358084/CD One/CD antibody/NN ,/, mAb1C2/GENE ,/, and/CC a/DT synthetic/JJ peptide/NN comprising/VBG its/PRP epitope/NN selectively/RB inhibited/VBD in/IN vitro/FW transcription/NN from/IN TATA-containing/JJ ,/, but/CC not/RB from/IN TATA-less/NNP promoters/NNS ,/, irrespective/JJ of/IN whether/IN they/PRP were/VBD transcribed/VBN by/IN Pol/MULTIGENE II/MULTIGENE or/CC Pol/MULTIGENE III/MULTIGENE ./.
@@105749829096/CD Supershift/NNP EMSAs/NNS identified/VBN that/IN upstream/RB stimulatory/JJ factor-1/GENE and/CC -2/NN (/( USF-1/GENE and/CC -2/NN )/SYM were/VBD part/NN of/IN these/DT complexes/NNS ./.
@@2582918575/CD After/IN hepatitis/MULTIGENE B/MULTIGENE vaccine/NN immunization/NN ,/, serum/JJ antibody/NN response/NN was/VBD of/IN primary/JJ type/NN in/IN 33/CD cases/NNS with/IN anti-HBs/NN less/PRP than/IN 2/CD ./CD 1/CD S/NN //NN N/NN (/( S/NN //NN N/NN Ratio/NNS Unit/NN )/SYM at/IN T0/NN ,/, the/DT anti-HBs/NN positive/JJ rate/NN was/VBD 39/CD ./CD 4%/CD ,/, 84/CD ./CD 8%/CD ,/, 96/CD ./CD 7%/CD and/CC 96/CD ./CD 7%/CD in/IN T1/CONTEXTGENE ,/, T2/GENE ,/, T0/CONTEXTGENE and/CC T12/GENE respectively/RB ./.
@@51623425406/CD Abdominal/JJ tumors/NNS in/IN childhood/NN ./.
@@75657972268/CD Deletion/NNS or/CC inactivation/NN of/IN CRY1/GENE leads/VBP to/IN 5-/CD to/IN 10-fold-increased/CD levels/NNS of/IN CRY2/MULTIGENE mRNA/MULTIGENE ./.
@@100973992/CD Effect/NN of/IN indomethacin/NN on/IN coronary/JJ circulation/NN :/: effect/NN on/IN ECG/NN tracing/JJ ./.
@@1816655442/CD Review/NNP of/IN the/DT literature/NN and/CC report/NN of/IN a/DT case/NN of/IN a/DT dermoid/NN cyst/NN ./.
@@40482454723/CD Treatment/NNP with/IN oxyphenylbutazone/NN and/CC hydrocortisone/NN failed/VBN to/IN inhibit/VB the/DT raised/VBN serum/JJ CPN/NEWGENE levels/NNS ./.
@@85526708587/CD Identification/NNP ,/, purification/NN ,/, and/CC molecular/JJ cloning/NN of/IN autonomously/RB replicating/JJ sequence-binding/MULTIGENE protein/MULTIGENE 1/MULTIGENE from/IN fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN ./.
@@39393178439/CD A/DT comparison/NN among/IN the/DT 5'/CD flanking/JJ regions/NNS encompassing/VBG the/DT presumptive/JJ HS/MULTIGENE promoter/MULTIGENE of/IN the/DT soybean/NN HS-protein/MULTIGENE genes/MULTIGENE demonstrated/VBD this/DT region/NN to/IN be/VB extremely/RB homologous/JJ ./.
@@90799289581/CD M/NNP ./NNP leprae/NNS OxyR/GENE was/VBD overproduced/VBN and/CC purified/VBN ,/, and/CC its/PRP binding/JJ to/IN the/DT oxyR-ahpC/JJ intergenic/JJ region/NN of/IN M/NNP ./NNP leprae/NNS was/VBD demonstrated/VBN ./.
@@105624565438/CD Regulatory/NNP regions/NNS in/IN the/DT promoter/NN and/CC third/JJ intron/NN of/IN the/DT growth/MULTIGENE hormone/MULTIGENE gene/MULTIGENE in/IN rainbow/NN trout/NN ,/, Oncorhynchus/NN mykiss/NN walbaum/NN ./.
@@103951997957/CD This/DT scFv/NN was/VBD therefore/RB used/VBN as/IN control/NN in/IN experiments/NNS where/CC another/DT anti-Ras/NNS scFv/CONTEXTGENE (/( Y259/MULTIGENE scFv/MULTIGENE ,/, derived/VBN from/IN the/DT neutralizing/JJ anti-Ras/NNS mAb/NEWGENE Y13-259/CD )/SYM blocked/VBN the/DT Ras/NEWGENE pathway/NN in/IN vitro/FW and/CC led/VBN to/IN tumor/NN regression/NN in/IN a/DT nude/JJ mouse/NN model/NN [/NN Cochet/NN ,/, O/NNP ./NNP ,/, Kenigsberg/NNP ,/, M/NNP ./NNP ,/, Delumeau/NNP ,/, I/NNP ./NNP ,/, Virone-Oddos/NNP ,/, A/NNP ./NNP ,/, Multon/NNP ,/, M/NN ./NN C/NN ./NN ,/, Fridman/NNP ,/, W/NNP ./NNP H/NNP ./NNP ,/, Schweighoffer/NNP ,/, F/NN ./NN ,/, Teillaud/NNP ,/, J/NNP ./NNP L/NNP ./NNP ,/, Tocque/NNP ,/, B/NNP ./NNP ,/, 1998/CD ./.
@@47914209445/CD Proceedings/NNP :/: Barrels/NNP and/CC somatotopy/NN in/IN S/MULTIGENE I/MULTIGENE neocortex/NN of/IN the/DT brush-tailed/JJ possum/NN ./.
@@85976365464/CD The/DT T-box/MULTIGENE motif/MULTIGENE is/VBZ present/VB in/IN a/DT family/NN of/IN genes/NNS whose/WP structural/JJ features/NNS and/CC expression/NN patterns/NNS support/VBP their/PRP involvement/NN in/IN developmental/JJ gene/NN regulation/NN ./.
@@80706549355/CD KAR1/GENE encodes/VBZ an/DT essential/JJ component/NN of/IN the/DT yeast/NN spindle/NN pole/NN body/NN (/( SPB/GENE )/SYM that/WDT is/VBZ required/VBN for/IN karyogamy/NN and/CC SPB/GENE duplication/NN ./.
@@14545183954/CD To/TO study/VB the/DT significance/NN of/IN these/DT domains/NNS and/CC the/DT overall/JJ evolutionary/JJ conservation/NN of/IN the/DT gene/NN ,/, the/DT homolog/NN from/IN Drosophila/NN melanogaster/NN was/VBD isolated/VBN by/IN low/JJ stringency/NN hybridizations/NNS using/VBG two/JJ flanking/JJ probes/NNS of/IN the/DT human/MULTIGENE ERCC3/MULTIGENE cDNA/MULTIGENE ./.
@@112797204863/CD SELECTION/GENE CRITERIA/NNP :/: Randomised/RB controlled/VBN trials/NNS of/IN cabergoline/NN versus/IN placebo/NN in/IN patients/NNS with/IN a/DT clinical/JJ diagnosis/NN of/IN idiopathic/JJ Parkinson's/NNP disease/NN and/CC long-term/JJ complications/NNS of/IN levodopa/NN therapy/NN ./.
@@21627544922/CD PAO/NN blocks/NNS turnover/NN of/IN the/DT phosphoryl/NN group/NN of/IN pp15/GENE ,/, causing/JJ its/PRP accumulation/NN ,/, and/CC thereby/RB appears/VBZ to/IN interrupt/VB signal/JJ transmission/NN from/IN the/DT receptor/NN to/IN the/DT glucose-transport/JJ system/NN ./.
@@90220402306/CD Because/IN L-plastin/GENE expression/NN in/IN tissue-specifically/RB regulated/VBN in/IN both/DT humans/NNS and/CC rodents/NNS ,/, it/PRP is/VBZ likely/RB that/IN similar/JJ mechanisms/NNS regulate/VBP L-plastin/MULTIGENE gene/MULTIGENE expression/NN in/IN human/NN and/CC rodent/NN cells/NNS and/CC that/IN they/PRP could/MD be/VB identified/VBN by/IN comparing/VBG the/DT function/NN and/CC nucleotide/NN sequences/NNS of/IN the/DT human/JJ and/CC murine/MULTIGENE L-plastin/MULTIGENE gene/MULTIGENE promoters/MULTIGENE ./.
@@76709437869/CD We/PRP studied/VBD 120/CD male/JJ and/CC 42/CD female/JJ patients/NNS with/IN early/MULTIGENE CAD/MULTIGENE who/WP were/VBD unrelated/JJ to/IN each/DT other/DT but/CC were/VBD from/IN families/NNS in/IN which/WDT at/IN least/RB one/PRP other/DT sibling/NN had/VBP early/MULTIGENE CAD/MULTIGENE ./.
@@86167438590/CD On/IN the/DT trail/NN of/IN Dr/NN ./NN
@@4326159512/CD Such/JJ marked/JJ differences/NNS are/VBP found/VB occasionally/RB in/IN the/DT literature/NN :/: heterophile/NN antibodies/NNS against/IN bovine/MULTIGENE gammaglobulin/MULTIGENE are/VBP regarded/VBN as/IN responsible/JJ for/IN the/DT interference/NN in/IN the/DT Sephadex/NN system/NN of/IN RIST/NN ./.
@@106832445725/CD Second/JJ ,/, when/CC the/DT NBF1+R/MULTIGENE protein/MULTIGENE ,/, the/DT NBF2/MULTIGENE protein/MULTIGENE ,/, and/CC a/DT mixture/NN of/IN the/DT two/JJ proteins/NNS were/VBD folded/JJ separately/RB and/CC analyzed/VBN by/IN molecular/JJ sieve/NN chomatography/NN ,/, the/DT mixture/NN was/VBD found/VBN to/IN elute/VB prior/NN to/IN either/DT NBF1+R/GENE or/CC NBF2/GENE ./.
@@95350827677/CD The/DT addition/NN of/IN a/DT Paf-containing/VBG extract/NN does/VBP not/RB lead/VB to/IN significant/JJ protein/NN binding/JJ to/IN these/DT two/JJ hly/NN target/NN sequences/NNS in/IN the/DT absence/NN of/IN PrfA/DT but/CC converts/VBP the/DT complex/NN (/( CIII/GENE )/SYM consisting/VBG of/IN PrfA/DT and/CC the/DT 109/CD bp/NN hly/NN DNA/NN fragment/NN to/IN a/DT slower/RBR migrating/JJ PrfA-Paf-DNA/MULTIGENE complex/MULTIGENE (/( CI/NN )/SYM ./.
@@96700349704/CD We/PRP demonstrate/VBP that/IN Ddc1p/GENE interacts/VBZ physically/RB in/IN vivo/NN with/IN Mec3p/GENE ,/, and/CC this/DT interaction/NN requires/VBZ Rad17p/GENE ./.
@@29586603663/CD Our/PRP data/NN ,/, however/RB ,/, did/VBD not/RB suggest/VB the/DT existence/NN of/IN a/DT conversion/NN factor/NN for/IN LDF/NN signal/JJ to/IN absolute/JJ flow/NN values/NNS from/IN experiment/NN to/IN experiment/NN ./.
@@57197463608/CD Children/NNS with/IN defective/MULTIGENE vision/MULTIGENE ./.
@@3325081435/CD Bullous/JJ keratopathy/NN was/VBD usually/RB aphakic/JJ in/IN origin/NN in/IN 1982/CD ,/, but/CC after/IN 1983/CD pseudophakic/JJ bullous/JJ keratopathy/NN (/( PBK/NN )/SYM was/VBD the/DT most/RB common/JJ cause/NN of/IN bullous/JJ keratopathy/NN ./.
@@14763762094/CD Assay/NNS of/IN urea/NN by/IN immobilized/JJ urease/NN coupled/VBN to/IN a/DT differential/JJ pH-meter/NN ./.
@@15427303204/CD Because/IN single-chamber/CD rate-adaptive/JJ atrial/JJ pacing/NN leaves/VBZ the/DT patient/NN exposed/VBN to/IN the/DT risk/NN of/IN future/JJ development/NN of/IN AV/JJ block/NN and/CC DDD/NN pacing/NN does/VBP not/RB provide/VB chronotropic/JJ support/NN ,/, it/PRP is/VBZ likely/RB that/IN the/DT new/JJ rate-adaptive/JJ dual-chamber/JJ (/( DDDR/NN )/SYM devices/NNS will/MD be/VB used/VBN in/IN a/DT significant/JJ number/NN of/IN these/DT patients/NN ./NN (/NN ABSTRACT/NN TRUNCATED/VBD AT/IN 250/CD WORDS/NN )/NN
@@2510242622/CD Among/IN 100/CD cases/NNS of/IN post-transfusion/JJ hepatitis/NN ,/, 10/CD are/VBP due/NN to/IN the/DT hepatitis/MULTIGENE B/MULTIGENE virus/NN (/( despite/IN systematic/JJ search/NN for/IN HBs/MULTIGENE Ag/MULTIGENE )/SYM ,/, 89/CD are/VBP due/NN to/IN one/PRP of/IN the/DT non-A/JJ non-B/GENE viruses/NNS (/( not/RB detectable/JJ by/IN specific/JJ serological/JJ tests/NNS )/SYM and/CC 1/CD to/IN several/DT viruses/NNS ,/, specially/RB CMV/NN ./.
@@77371183688/CD The/DT MPS1/GENE open/JJ reading/JJ frame/NN has/VBZ been/VBN fused/VBN to/IN those/DT that/WDT encode/VBP the/PDT LexA/MULTIGENE protein/MULTIGENE or/CC the/DT GST/MULTIGENE protein/MULTIGENE and/CC both/DT of/IN these/DT constructs/NNS function/NN in/IN yeast/NN ./.
@@83494992660/CD Sex/NN of/IN calf/NN (/( variate/MULTIGENE 2/MULTIGENE )/SYM was/VBD associated/VBN most/RB closely/RB with/IN width/NN of/IN muzzle/NN and/CC head/JJ ./.
@@35523634219/CD Postglucose/MULTIGENE serum/MULTIGENE insulin/MULTIGENE levels/NNS showed/VBD no/DT significant/JJ correlations/NNS with/IN systolic/JJ or/CC diastolic/JJ blood/NN pressure/NN levels/NNS in/IN men/NNS ,/, but/CC in/IN female/JJ diabetic/NN and/CC non-diabetic/NN subjects/VBZ significant/JJ correlations/NNS were/VBD found/VBN in/IN particular/JJ with/IN systolic/JJ blood/NN pressure/NN level/NN ./.
@@27456664843/CD Endometrial/JJ biopsies/NNS and/CC plasma/NN oestradiol/NN (/( E2/GENE )/SYM and/CC progesterone/NN (/( P4/NN )/SYM levels/NNS in/IN 23/CD patients/NNS were/VBD evaluated/VBN during/IN 26/CD replacement/NN therapy/NN cycles/NNS for/IN premature/JJ ovarian/JJ failure/NN ./.
@@28991773605/CD We/PRP propose/VBP that/IN the/DT technique/NN of/IN low-frequency/JJ kindling/NN is/VBZ a/DT useful/JJ experimental/JJ model/NN in/IN assessing/JJ the/DT effects/NNS of/IN antipsychotic/JJ or/CC antiepileptic/JJ drugs/NNS on/IN the/DT excitability/NN of/IN the/DT limbic/JJ regions/NNS ./.
@@63215054996/CD A/DT promoter/NN sequence/NN (/( Goldberg-Hogness/NNP or/CC TATA/MULTIGENE box/MULTIGENE )/SYM is/VBZ situated/VBN 28/CD base/NN pairs/NNS upstream/RB from/IN the/DT point/NN of/IN initiation/NN of/IN transcription/NN which/WDT was/VBD found/VBN by/IN S1/MULTIGENE nuclease/MULTIGENE mapping/NN and/CC by/IN oligonucleotide-primed/JJ reverse/JJ transcription/NN of/IN rat/MULTIGENE PTH/MULTIGENE mRNA/MULTIGENE ./.
@@93533434370/CD RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE inhibition/NN increased/VBD the/DT binding/NN of/IN ARE/VBP (/( AUBP/NN activity/NN )/SYM and/CC poly/NN (/NN U/NN )/NN -Sepharose/NN by/IN cytoplasmic/MULTIGENE hnRNP/MULTIGENE A1/MULTIGENE ,/, while/CC nuclear/MULTIGENE hnRNP/MULTIGENE A1/MULTIGENE binding/NN was/VBD unaffected/JJ ./.
@@40135764675/CD The/DT present/NN investigation/NN has/VBZ revealed/VBN that/IN the/DT distribution/NN of/IN the/DT main/JJ fatty/JJ acids/NNS in/IN Leptospira/NN phospholipids/NNS is/VBZ similar/JJ to/IN their/PRP distribution/NN in/IN Leptospira/JJ neutral/JJ lipids/NNS with/IN the/DT exception/NN of/IN unsaturated/JJ fatty/JJ acid/NN with/IN 14/CD carbon/NN atoms/NNS ,/, occurring/VBG mainly/RB in/IN phospholipids/NNS ./.
@@22705872915/CD The/DT endodontal/JJ treatment/NN need/NN has/VBZ been/VBN forming/JJ a/DT clinical/JJ order/NN of/IN magnitude/NN ./.
@@89703525023/CD These/DT data/NN do/NN not/RB support/VB the/DT use/NN of/IN LDD/DT to/IN reduce/VB risk/NN of/IN progression/NN to/IN MSOF/GENE in/IN sepsis/NN ./.
@@109283374914/CD Partial/JJ correction/NN of/IN anemia/NN with/IN recombinant/JJ human/MULTIGENE erythropoietin/MULTIGENE likely/RB reduces/VBZ left/NN ventricular/JJ mass/NN and/CC volume/NN ./.
@@54134285535/CD The/DT distribution/NN of/IN body/NN fluids/NNS following/IN hemorrhage/NN and/CC resuscitation/NN in/IN combat/NN casualties/NNS ./.
@@10224293742/CD Receptor/MULTIGENE protein/MULTIGENE tyrosine/MULTIGENE phosphatases/MULTIGENE (/( RPTPs/GENE )/SYM comprise/VB a/DT family/NN of/IN proteins/VBZ that/DT feature/JJ intracellular/JJ phosphatase/MULTIGENE domains/MULTIGENE and/CC an/DT ectodomain/NN with/IN putative/JJ ligand-binding/MULTIGENE motifs/MULTIGENE ./.
@@100872134962/CD Analysis/NNP of/IN the/DT protein/NN sequences/NNS of/IN these/DT two/JJ replicases/NNS ,/, together/RB with/IN previously/RB characterized/VBN H/NNP ./NNP pylori/NNS plasmid/NN replication/NN proteins/NNS ,/, supports/VBP the/DT formation/NN of/IN a/DT distinct/JJ class/NN of/IN H/NNP ./NNP pylori/NNS plasmid/NN proteins/NNS ./.
@@21224544337/CD Hence/RB ,/, the/DT replacement/NN of/IN Phe-62/NN with/IN Ser/NN specifically/RB affects/VBP a/DT determinant/NN on/IN the/DT lambda/MULTIGENE I/MULTIGENE light/MULTIGENE chain/MULTIGENE that/WDT is/VBZ necessary/JJ for/IN the/DT intracellular/JJ transport/NN of/IN this/DT molecule/NN ./.
@@83673889859/CD Cerebro-oculo-facioskeletal/JJ syndrome/NN (/( Pena-Shokeir/NNP syndrome/MULTIGENE II/MULTIGENE )/SYM ./.
@@65883066345/CD The/DT rational/JJ for/IN the/DT prophylactic/JJ treatment/NN ,/, the/DT therapy/NN of/IN the/DT meningopathy/NN and/CC AIL-/NNP AIEOP/NNP protocols/NNS are/VBP exposed/VBN ./.
@@98379455469/CD Immunolocalization/NNS of/IN Sop1p/GENE revealed/VBN a/DT cytoplasmic/JJ distribution/NN and/CC cell/NN fractionation/NN studies/NNS showed/VBN that/IN a/DT significant/JJ fraction/NN of/IN Sop1p/GENE was/VBD recovered/VBN in/IN a/DT sedimentable/JJ fraction/NN of/IN the/DT cytosolic/JJ material/NN ./.
@@94189056271/CD These/DT results/NNS indicate/VBP that/IN in/IN addition/NN to/IN Grb2-mediated/JJ activation/NN of/IN Ras/NNS ,/, PLC-gamma1-mediated/JJ DAG/NN production/NN is/VBZ required/VBN for/IN EGF-/NNP and/CC PDGF-induced/MULTIGENE S-phase/MULTIGENE entry/NN and/CC gene/NN expression/NN ,/, possibly/RB through/JJ activation/NN of/IN PKC/NN ./.
@@22547495729/CD For/IN this/DT ,/, cDNAs/NNS containing/JJ the/DT 60K/NN ,/, 87K/NN ,/, 110K/NN and/CC 170K/MULTIGENE protein/MULTIGENE coding/JJ sequences/NNS were/VBD each/DT provided/VBN with/IN an/DT ATG/NN start/NN codon/NN and/CC the/DT cDNA/NN containing/JJ the/DT 60K/NN coding/JJ sequence/NN with/IN a/DT TAA/MULTIGENE stop/MULTIGENE codon/NN immediately/RB downstream/RB of/IN the/DT coding/JJ sequence/NN ./.
@@91608819028/CD As/IN opposed/VBN to/IN in/IN vitro/FW co-precipitation/JJ studies/NNS ,/, the/DT yeast/NN two-hybrid/JJ screen/NN reveals/VBZ in/IN vivo/MULTIGENE protein-protein/MULTIGENE interactions/NNS ./.
@@89933933330/CD Differential/JJ signaling/JJ and/CC immediate-early/NEWGENE gene/NN activation/NN by/IN four/CD splice/NN variants/NNS of/IN the/DT human/JJ pituitary/JJ adenylate/NN cyclase-activating/JJ polypeptide/NN receptor/NN (/( hPACAP-R/JJ )/SYM ./.
@@108932436255/CD Transcriptional/JJ regulation/NN of/IN the/DT mouse/NN cytosolic/JJ chaperonin/NEWGENE subunit/NN gene/NN Ccta/NN //NN t-complex/NN polypeptide/NN 1/CD by/IN selenocysteine/MULTIGENE tRNA/MULTIGENE gene/MULTIGENE transcription/MULTIGENE activating/MULTIGENE factor/MULTIGENE family/MULTIGENE zinc/MULTIGENE finger/MULTIGENE proteins/MULTIGENE ./.
@@113923061252/CD Online/NNP teaching/JJ :/: design/NN and/CC techniques/NNS ./.
@@111110517710/CD It/PRP was/VBD subsequently/RB shown/VBP that/IN Tip60/GENE had/VBP histone/MULTIGENE acetyltransferase/MULTIGENE (/( HAT/GENE )/SYM activity/NN ./.
@@107217148554/CD Electrophoretic/JJ mobility/NN shift/NN assays/NNS revealed/VBN that/IN Sp1/GENE binds/VBZ to/IN two/JJ different/JJ regions/NNS in/IN the/DT proximal/JJ promoter/NN ,/, a/DT typical/JJ Sp1/MULTIGENE site/MULTIGENE located/VBN at/IN (/( -38/CD ;/: -33/CD )/SYM and/CC a/DT G/MULTIGENE //MULTIGENE C-rich/MULTIGENE region/MULTIGENE between/IN (/( -67/CD ;/: -62/CD )/SYM ./.
@@23748863030/CD The/DT Community/NNP Adjustment/NNP Scale/NNP provided/VBD outcome/NN data/NN related/VBN to/IN the/DT subjects'/JJ degree/NN of/IN productivity/NN ,/, ability/NN to/IN maintain/VB close/JJ relationships/NNS ,/, and/CC presence/NN //NN absence/NN of/IN symptomatology/NN an/DT average/NN of/IN 32/CD years/NNS after/IN initial/JJ admission/NN ./.
@@92424999202/CD Volunteers/NNPS were/VBD irradiated/JJ on/IN their/PRP backs/NNS with/IN suberythemal/JJ UV/NN daily/JJ for/IN 5/CD d/NN after/IN application/NN of/IN the/DT sunscreens/NNS and/CC their/PRP base/NN lotion/NN to/IN different/JJ sites/NNS ./.
@@69484936721/CD Range/NN ,/, variations/NNS and/CC neoplastic/JJ potential/NN ./.
@@89581378916/CD Lipid/NN hydroperoxide/NN levels/NNS in/IN plasma/NN and/CC LDL/NN remained/VBD unchanged/JJ throughout/IN the/DT study/NN ./.
@@117229933319/CD Paul/NNP Monagle/GENE addresses/VBP the/DT epidemiology/NN of/IN neonatal/JJ thrombosis/NN outside/RB of/IN the/DT central/JJ nervous/JJ system/NN in/IN both/DT arterial/JJ and/CC venous/JJ locations/NNS ,/, and/CC those/DT that/WDT occur/VBP in/IN utero/NN ./.
@@118904381786/CD Patients/NNS subsequently/RB returned/VBN to/IN the/DT clinic/NN every/DT 3/CD days/NNS to/IN have/NN the/DT wounds/NNS checked/VBN and/CC dressings/NNS changed/VBN ./.
@@93881996316/CD In/NN an/DT effort/NN to/IN separate/JJ domains/NNS of/IN FadR/GENE required/VBN for/IN DNA/NN binding/JJ ,/, dimerization/NN ,/, and/CC ligand/NN binding/JJ ,/, chimeric/JJ protein/NN fusions/NNS between/IN the/DT DNA/NN binding/JJ domain/NN of/IN LexA/DT and/CC different/JJ regions/NNS of/IN FadR/GENE were/VBD constructed/VBN ./.
@@108218369182/CD These/DT natural/JJ antisense/NN S/MULTIGENE transcripts/MULTIGENE co-exist/MULTIGENE with/IN several/DT less/PRP abundant/JJ sense/NN S/MULTIGENE transcripts/MULTIGENE ./.
@@99353779933/CD Genoa/NNP ,/, Italy/NN ,/, 24-28/CD August/NN 1997/CD ./.
@@86268091311/CD Significantly/RB ,/, pPKR/NN is/VBZ capable/JJ of/IN specifically/RB phosphorylating/JJ Ser51/NN in/IN a/DT synthetic/JJ eIF-2alpha/JJ peptide/NN ,/, a/DT key/NN characteristic/NN of/IN the/DT eIF-2alpha/MULTIGENE kinase/MULTIGENE family/MULTIGENE ./.
@@117287711574/CD They/PRP have/VBP not/RB been/VBN previously/RB reported/VBN as/IN a/DT reaction/NN to/IN i/CD ./CD v/CD ./. contrast/NN material/NN ./.
@@76490989866/CD Our/PRP evidence/NN derives/VBZ from/IN three/CD principal/JJ observations/NNS :/: 1/NN )/NN a/DT transfection/NN construct/NN containing/JJ only/RB 122/CD nucleotides/NNS (/( nt/NN )/SYM of/IN promoter/NN 1/CD and/CC 328/CD nt/NN of/IN the/DT 5'-UTR/CD retained/VBN full/JJ PGE2-stimulated/JJ reporter/NN expression/NN ;/: 2/NN )/NN maximal/JJ PGE2-driven/NNP reporter/NN expression/NN required/VBD the/DT presence/NN of/IN nt/NN 196/CD to/IN 328/CD of/IN exon/NN 1/CD when/CC tested/VBN within/IN the/DT context/NN of/IN IGF-I/MULTIGENE promoter/MULTIGENE 1/MULTIGENE ;/: 3/NN )/NN cotransfection/NN of/IN IGF-I/MULTIGENE promoter-luciferase-reporter/MULTIGENE constructs/MULTIGENE with/IN a/DT plasmid/NN encoding/VBG the/DT alpha-isoform/NN of/IN the/DT catalytic/JJ subunit/NN of/IN murine/MULTIGENE cAMP-dependent/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( PKA/CONTEXTGENE )/SYM produced/VBN results/NNS comparable/JJ to/IN those/DT seen/VBP with/IN PGE2/NN treatment/NN ,/, whereas/IN cotransfection/NN with/IN a/DT plasmid/NN encoding/VBG a/DT mutant/JJ regulatory/JJ subunit/NN of/IN PKA/NN that/WDT cannot/MD bind/VB cAMP/NN blocked/VBD PGE2-induced/JJ reporter/NN expression/NN ./.
@@99380979934/CD Bound-exciton/NNP transfer/NN and/CC photoluminescence/NN undulation/NN spectra/NNS for/IN acceptors/NNS in/IN ZnTe/NNP ./.
@@93171315187/CD The/DT available/JJ data/NN suggest/VB that/IN the/DT NF/MULTIGENE kappa/MULTIGENE B2/MULTIGENE nucleoprotein/MULTIGENE complex/MULTIGENE may/MD cooperate/VB with/IN DNA-bound/MULTIGENE STAT6/MULTIGENE to/IN achieve/VB IL-4-dependent/NNP activation/NN of/IN the/DT human/MULTIGENE IgE/MULTIGENE germline/MULTIGENE gene/MULTIGENE ./.
@@92388609592/CD These/DT cells/NNS fail/NN to/IN generate/VB the/DT signals/NNS to/IN phosphorylate/VB CREB/NN and/CC produce/VB significantly/RB less/PRP of/IN the/DT cytokine/MULTIGENE Interleukin-2/MULTIGENE (/( IL-2/NEWGENE )/SYM in/IN response/NN to/IN agents/NNS that/WDT either/DT increase/NN intracellular/JJ Ca2+/NN and/WDT //WDT or/WDT activate/VBP protein/MULTIGENE kinase/MULTIGENE C/NNP ./NNP
@@79590151583/CD Our/PRP results/NNS show/VBP that/IN the/DT ORF/NN of/IN hAMPK/GENE encodes/VBZ 552/CD amino/JJ acids/NNS (/( aa/NNS )/SYM (/( 62/CD ./CD 250/CD kDa/NN )/SYM and/CC is/VBZ highly/RB conserved/VBN with/IN rAMPK/GENE with/IN identities/NNS of/IN 97/CD ./CD 3/CD and/CC 90%/CD at/IN the/DT aa/NNS and/CC nt/JJ levels/NNS ,/, respectively/RB ./.
@@14461322062/CD One/CD air/NN embolism/NN occurred/VBN ;/: this/DT was/VBD the/DT only/RB filter-/JJ or/CC retrieval-related/JJ complication/NN ./.
@@86768584484/CD Here/RB ,/, the/DT cloning/NN and/CC characterization/NN of/IN S-RNase/MULTIGENE genes/MULTIGENE from/IN two/JJ species/NN of/IN Rosaceae/NNP ,/, apple/NN (/( Malus/NNP x/NN domestica/NN )/SYM and/CC Japanese/JJ pear/NN (/( Pyrus/NNP serotina/NN )/SYM is/VBZ described/VBN and/CC these/DT sequences/NNS are/VBP compared/VBN with/IN those/DT of/IN other/DT T2-type/MULTIGENE RNases/MULTIGENE ./.
@@66585866412/CD Angionephroscintigraphy/NNP in/IN the/DT diagnosis/NN of/IN diseases/NNS of/IN the/DT kidney/NN ./.
@@12728168592/CD The/DT study/NN of/IN calcium/NN metabolism/NN in/IN ten/CD thalassaemic/JJ children/NNS comperatively/RB with/IN controls/NNS after/IN oral/JJ administration/NN of/IN 47Ca/GENE has/VBZ shown/VBP diminished/VBN intestinal/JJ absorption/NN ./.
@@92590526308/CD Supershift/NNP assays/NNS ,/, using/VBG Jun/NN and/CC Fos/MULTIGENE family/MULTIGENE member-specific/JJ antibodies/NNS ,/, showed/VBD that/IN protein/NN complexes/NNS formed/VBN by/IN AtT-20/NNP cell/NN nuclear/JJ extracts/NNS bound/JJ to/IN the/DT c-jun/MULTIGENE AP-1/MULTIGENE site/MULTIGENE were/VBD comprised/VBN of/IN Jun/MULTIGENE family/MULTIGENE members/MULTIGENE ,/, JunD/GENE ,/, JunB/GENE ,/, and/CC cJun/NN ./.
@@85958368572/CD Curing/VBG shrinkage/NN and/CC volumetric/JJ changes/NNS of/IN resin-modified/JJ glass/NN ionomer/NN restorative/JJ materials/NNS ./.
@@106112429450/CD Consistent/JJ with/IN this/DT finding/NN ,/, wild-type/GENE SAGA/GENE inhibits/VBZ TBP/NEWGENE binding/JJ to/IN the/DT HIS3/NEWGENE promoter/NN in/IN vitro/FW ,/, while/CC SAGA/NNP lacking/JJ Spt3/GENE or/CC Spt8/GENE is/VBZ not/RB inhibitory/JJ ./.
@@64936553076/CD Variable/NN FHR/NN decelerations/NNS or/CC bradycardias/NNS were/VBD encountered/VBN on/IN 95/CD nonstress/JJ tests/NNS (/( 18/CD ./CD 8%/CD )/SYM in/IN 80/CD (/( 33/NN ./NN 5%/NN )/SYM postdate/VB patients/NNS ./.
@@105024341708/CD Twelve/CD patients/NNS had/VBP stage/NN IBG3/GENE ,/, 14/CD had/VBP ICG1/GENE ,/, 9/CD had/VBP ICG2/GENE ,/, and/CC 3/CD had/VBP ICG3/GENE disease/NN ./.
@@24055893071/CD Information/NNP about/RB immunologic/JJ drug/NN interactions/NNS is/VBZ needed/VBN by/IN pharmacists/NNS to/IN make/NN rational/JJ drug-use/JJ decisions/NNS ./.
@@17511635968/CD The/DT authors/NNS evaluated/VBD the/DT potential/NN for/IN thrombotic/JJ complications/NNS arising/VBG from/IN implantation/NN of/IN a/DT ventricular/JJ assist/NN device/NN (/( Sarns/GENE //GENE 3M-VAD/GENE )/SYM in/IN four/CD calves/NNS ./.
@@12474751887/CD A/DT late/JJ diagnosis/NN of/IN retinoblastoma/NN is/VBZ an/DT unquestionable/JJ fact/NN that/WDT allows/VBZ its/PRP growth/NN and/CC leads/VBP to/IN a/DT deterioration/NN in/IN the/DT outlook/NN ./.
@@114638344497/CD Through/IN deletion/NN mutagenesis/NN ,/, we/PRP identify/VBP amino/JJ acids/NNS 2003/CD to/IN 2212/CD of/IN CBP/NN ,/, which/WDT we/PRP call/VBP carboxy-terminal/JJ region/NN 2/CD (/( CR2/GENE )/SYM ,/, as/IN the/DT minimal/JJ region/NN for/IN Tax/NEWGENE interaction/NN ./.
@@26664041150/CD The/DT galactose/MULTIGENE transporter/MULTIGENE shows/VBZ both/DT sequence/NN and/CC structural/JJ homology/NN with/IN a/DT superfamily/NN of/IN sugar/NN transporters/NNS which/WDT includes/VBZ the/DT human/JJ HepG2-erythrocyte/JJ and/CC fetal/JJ muscle/MULTIGENE glucose/MULTIGENE transporters/MULTIGENE ,/, the/DT rat/NN brain/NN and/CC liver/MULTIGENE glucose/MULTIGENE transporters/MULTIGENE ,/, the/DT Escherichia/NN coli/JJ xylose/NN and/CC arabinose/MULTIGENE permeases/MULTIGENE ,/, and/CC the/DT S/NNP ./NNP cerevisiae/NN glucose/NN ,/, maltose/NN ,/, and/CC galactose/MULTIGENE transporters/MULTIGENE ./.
@@66347126372/CD Our/PRP results/NNS demonstrate/VBP the/DT importance/NN of/IN phosphate/NN and/CC calcium/NN in/IN influencing/VBG the/DT secretion/NN of/IN PTH/NN and/CC CT/NN in/IN uremia/NN ./.
@@109540932932/CD A/DT degenerate/JJ DNA/NN transposon/NN ,/, Pat/NNP ,/, was/VBD identified/VBN in/IN the/DT genomes/NNS of/IN various/JJ wild-type/NN strains/NNS of/IN the/DT filamentous/JJ fungus/NN Podospora/JJ anserina/NN ./.
@@79757638483/CD The/DT importance/NN of/IN hepatitis/MULTIGENE C/MULTIGENE virus/NN (/( HCV/NN )/SYM infection/NN as/IN a/DT cause/NN of/IN chronic/JJ liver/NN disease/NN has/VBZ become/VBN clear/JJ with/IN the/DT introduction/NN of/IN serologic/JJ detection/NN methods/NNS ./.
@@60702045890/CD XXI/NNS ./.
@@108250004988/CD The/DT gene/NN amplification/NN model/NN of/IN Coquelle/NNP et/FW al/NNS ./NNS
@@110239342024/CD 1111/NN )/NN ;/: L/CD //CD H/CD >/CD 0/CD ./CD 61/CD (/( chi/NN (/NN 2/NN )/NN =/NN 10/NN ./NN 8/NN ;/: P/NN :/: </SYM 0/NN ./NN 1111/NN )/NN and/CC a/DT restrictive/JJ filling/JJ pattern/NN (/( chi/NN (/NN 2/NN )/NN =/NN 3/NN ./NN 6/NN ;/: P/NN :/: </SYM 0/NN ./NN 09/NN )/NN were/VBD independent/MULTIGENE predictors/MULTIGENE of/IN events/NNS ./.
@@111380098650/CD In/NN addition/NN ,/, we/PRP identified/VBD two/JJ mutations/NNS ,/, Delta/MULTIGENE M1281/MULTIGENE and/CC IVS51+5G--/GENE >/GENE A/GENE ,/, in/IN a/DT German/MULTIGENE USH1/MULTIGENE patient/NN ./.
@@98047795767/CD We/PRP propose/VBP that/IN two/JJ pathways/NNS regulate/VBP Stat5/GENE serine/NN phosphorylation/NN ,/, one/PRP that/WDT is/VBZ prolactin-activated/JJ and/CC PD98059-resistant/CD and/CC one/PRP that/WDT is/VBZ constitutively/RB active/JJ and/CC PD98059-sensitive/CD and/CC preferentially/RB targets/VBZ Stat5a/GENE ./.
@@73758643857/CD The/DT authors/NNS conclude/VBP that/DT nonspecificity/NN of/IN low/JJ platelet/NN MAO/NN as/IN a/DT possible/JJ correlate/NN of/IN bipolar/JJ affective/JJ disorder/NN ,/, as/RB well/VB as/IN schizophrenia/NN ,/, increases/VBZ the/DT burden/NN of/IN proof/NN necessary/JJ before/IN findings/NNS of/IN low/JJ platelet/NN MAO/NN can/MD be/VB accepted/VBN as/IN primary/NN ./.
@@31254206218/CD Biol/NNP ./.
@@64017492372/CD The/DT effect/NN of/IN lithium/NN on/IN the/DT osmoregulation/NN of/IN arginine/MULTIGENE vasopressin/MULTIGENE secretion/NN ./.
@@11319461168/CD Effect/NN of/IN ingestion/NN of/IN Norbiogest/NNP during/IN the/DT quiescent/JJ period/NN of/IN the/DT genital/JJ organs/NNS ./.
@@18331854362/CD The/DT Thr161Val/NEWGENE mutation/NN causes/VBZ a/DT lethal/JJ phenotype/NN in/IN the/DT fission/NN yeast/NN Schizosaccharomyces/NN pombe/NN ,/, while/CC replacement/NN of/IN Thr161/NN with/IN glutamic/JJ acid/NN ,/, potentially/RB mimicking/VBG phosphorylation/NN ,/, causes/NNS uncoordination/NN of/IN mitosis/NN and/CC multiple/JJ cytokinesis/NN ./.
@@31119463829/CD No/DT effect/NN was/VBD found/VBN on/IN grooming/NN behavior/NN ./.
@@34463324153/CD Nitrofurazone/NNP significantly/RB reduced/VBD the/DT rise/NN in/IN LH/NN induced/VBN by/IN LHRH/NN ./.
@@25067403154/CD Fourth/NNP ,/, sometime/RB between/IN 4/CD and/CC 24/CD hours/NNS of/IN recovery/NN is/VBZ necessary/JJ to/IN reverse/NN the/DT effect/NN of/IN chronic/JJ hypoxia/NN on/IN cerebral/JJ blood/NN flow/NN ./.
@@103802323929/CD OBJECTIVE/IN :/: To/TO perform/VB a/DT cost-effectiveness/NN analysis/NN (/( CEA/NN )/SYM between/IN a/DT standard/JJ antiemetic/JJ regimen-chlorpromazine/JJ +/SYM dexamethasone/NN (/( CPM-DEX/NNP )/JJ -/JJ and/CC a/DT 5-HT3/MULTIGENE receptor/MULTIGENE antagonist-tropisetron/JJ (/( TROP/NN )/NN --in/NN the/DT control/NN of/IN acute/JJ emesis/NN induced/VBN by/IN highly/RB emetogenic/JJ chemotherapy/NN in/IN children/NNS ,/, considering/VBG two/JJ analytic/JJ perspectives/NNS :/: hospital/NN and/CC patients/NNS ./.
@@12414377617/CD The/DT patients/NNS were/VBD divided/VBN into/IN 4/CD groups/NNS receiving/JJ NLA/MULTIGENE II/MULTIGENE with/IN or/CC without/IN nalorphine/NN ,/, morphine/NN or/CC Micoren/NNP ./.
@@89679631548/CD The/DT promoter/NN segment/NN was/VBD inactive/JJ when/CC introduced/VBN into/IN the/DT rat/NN glioma/NN cell/NN line/NN C6B4/CELL ,/, the/DT rat/NN submandibular/JJ cell/NN line/NN RSMT-A5/CELL ,/, and/CC the/DT rat/NN pancreatic/JJ beta/NN cell/NN line/NN RIN-5AH/NNP ,/, all/DT of/IN which/WDT do/VBP not/RB express/VB the/DT endogenous/JJ alpha2c-AR/MULTIGENE gene/MULTIGENE ./.
@@84572055073/CD Internal/NNP amino/JJ acid/NN sequence/NN has/VBZ now/RB been/VBN obtained/VBN from/IN this/DT protein/NN which/WDT shares/VBP 50-100%/JJ sequence/NN identity/NN with/IN sequences/NNS encoded/VBN by/IN mammalian/JJ G/MULTIGENE alpha/MULTIGENE 11/MULTIGENE and/CC G/MULTIGENE alpha/MULTIGENE q/MULTIGENE cDNAs/MULTIGENE ./.
@@19709842591/CD Following/VBG treatment/NN ,/, serum/JJ estradiol/NN levels/NNS were/VBD higher/JJ in/IN groups/NNS E/NN +/SYM T/NN and/CC E/NN than/IN in/IN group/NN C/NNP ./NNP
@@10674484491/CD These/DT data/NN suggest/VB that/IN combined/JJ lesions/NNS of/IN cholinergic/JJ and/CC serotonergic/JJ neurons/NNS in/IN the/DT rat/NN brain/NN do/NN not/RB alter/VB olfactory/JJ perception/NN or/CC olfactory/JJ short-term/JJ memory/NN ./.
@@21439612749/CD Both/DT antidepressants/NNS elevated/VBD the/DT pain/NN threshold/NN acutely/RB ,/, while/CC pretreatment/JJ with/IN pCPA/NN largely/RB blocked/VBD the/DT analgesia/NN ./.
@@91399108701/CD Sequence/NN analysis/NN of/IN cloned/VBN PCR/NN products/NNS confirmed/VBD the/DT presence/NN of/IN two/JJ different/JJ nifV-like/MULTIGENE DNA/MULTIGENE fragments/MULTIGENE ,/, which/WDT were/VBD subsequently/RB used/VBN as/IN nifV-/JJ and/CC leuA-specific/JJ probes/NNS ,/, respectively/RB ,/, to/IN clone/MULTIGENE XbaI/MULTIGENE fragments/MULTIGENE of/IN 2/CD ./CD 1/CD kbp/NN (/( pOST4/GENE )/SYM and/CC 2/CD ./CD 6/CD kbp/NN (/( pOST2/GENE )/SYM ./.
@@104389249088/CD The/DT B/MULTIGENE cell/MULTIGENE antigen/MULTIGENE receptor/MULTIGENE activates/VBZ the/DT Akt/GENE (/( protein/NN kinase/NN B/NNP )/NN //NN glycogen/NN synthase/NN kinase-3/CD signaling/JJ pathway/NN via/NN phosphatidylinositol/NN 3-kinase/CD ./.
@@97702419759/CD A/DT technique/NN for/IN thermal/JJ imaging/NN of/IN the/DT animal/NN and/CC human/JJ brain/NN cortex/NN using/VBG an/DT infrared/JJ optical/JJ system/NN is/VBZ described/VBN ./.
@@100745208897/CD Identification/NNP and/CC characterization/NN of/IN IS2404/GENE and/CC IS2606/GENE :/: two/JJ distinct/JJ repeated/JJ sequences/NNS for/IN detection/NN of/IN Mycobacterium/NN ulcerans/VBZ by/IN PCR/NN ./.
@@8648726170/CD Cloning/NN of/IN individual/JJ ZI/MULTIGENE domains/MULTIGENE upstream/RB of/IN a/DT minimal/JJ promoter/NN demonstrated/VBN that/IN the/DT ZIA/NN ,/, ZIC/NNP ,/, and/CC ZID/MULTIGENE domains/MULTIGENE ,/, but/CC not/RB the/DT ZIB/GENE domain/NN ,/, are/VBP TPA/NEWGENE responsive/JJ ./.
@@20600522666/CD These/DT data/NN suggest/VB that/IN the/DT levels/NNS of/IN oxygen/NN free/JJ radicals/NNS were/VBD increased/VBN in/IN hepatocytes/NNS and/CC mitochondria/NNS ./.
@@80781672549/CD OBJECTIVE--To/NNP assess/VB the/DT risk/NN of/IN hepatitis/MULTIGENE A/MULTIGENE in/NN international/JJ travelers/NNS and/CC to/IN recommend/VB preventive/JJ measures/NNS ./.
@@114699261348/CD Breast/NN cancer/NN risk/NN assessment/NN :/: who/WP holds/VBP the/DT magic/JJ crystal/NN ball/NN ?/.
@@111671111010/CD Significantly/RB higher/JJ lung/NN function/NN parameters/NNS were/VBD obtained/VBN in/IN extubated/VBN recipients/NNS of/IN LPD/NN preserved/VBD grafts/NNS 2/CD weeks/NNS after/IN TX/NNP ./NNP
@@105644722172/CD These/DT mutants/NNS all/DT failed/VBN to/IN interact/VB with/IN the/DT TraR/MULTIGENE fusion/MULTIGENE in/IN the/DT two-hybrid/JJ system/NN ./.
@@105942392515/CD Tih1/GENE maps/NNS to/IN distal/JJ mouse/NN Chr/NN 1/CD and/CC human/JJ Chr/NN 1q31/CD ,/, chromosomal/JJ regions/NNS that/WDT have/VBP not/RB shown/VBP evidence/NN for/IN imprinting/NN and/CC ,/, in/IN contrast/NN to/IN Ipl/GENE ,/, Tih1/GENE is/VBZ expressed/VBN equally/RB from/IN both/DT parental/JJ alleles/NNS ./.
@@25733039247/CD The/DT decrease/NN in/IN left/NN ventricular/JJ (/( LV/JJ )/SYM stroke/NN volume/NN during/IN positive/JJ end-expiratory/JJ pressure/NN (/( PEEP/NN )/SYM has/VBZ been/VBN attributed/VBN to/IN reduced/VBN LV/NEWGENE filling/JJ and/CC a/DT decreased/VBN contractile/JJ state/NN ./.
@@77404877687/CD To/TO establish/VB a/DT possible/JJ association/NN between/IN familial/JJ dysfibrinogenemia/NN and/CC thrombophilia/NN ,/, data/NN on/IN cases/NNS with/IN both/DT affections/NNS were/VBD collected/VBN in/IN a/DT study/NN within/IN the/DT framework/NN of/IN the/DT SSC/NN Subcommittee/NNP on/IN Fibrinogen/NNS of/IN the/DT International/NNP Society/NNP on/IN Thrombosis/NNS and/CC Haemostasis/NNS ./.
@@12814722249/CD Rabbit/MULTIGENE skeletal/MULTIGENE muscle/MULTIGENE glycogenin/MULTIGENE ./.
@@94847819288/CD Furthermore/RB ,/, direct/JJ association/NN with/IN D3/GENE phosphatidylinositides/NNS seems/VBZ to/IN be/VB essential/JJ for/IN activation/NN of/IN PKB/NNP //NNP Akt/NNP ./.
@@87986109999/CD PIP2/NEWGENE ,/, when/CC incorporated/VBD into/IN phosphatidylcholine/NN carrier/NN vesicles/NNS ,/, binds/VBZ tightly/RB to/IN the/DT guanine/NN nucleotide-depleted/JJ form/NN of/IN Cdc42Hs/GENE and/CC weakly/RB to/IN the/DT GDP-bound/NNP form/NN of/IN the/DT GTP-binding/MULTIGENE protein/MULTIGENE but/CC does/VBP not/RB bind/VB to/IN GTP-bound/NNP Cdc42Hs/GENE ,/, similar/JJ to/IN what/WP was/VBD observed/VBN for/IN the/DT Dbl/MULTIGENE oncoprotein/MULTIGENE ./.
@@28902003596/CD Somatostatin-producing/JJ endocrine/JJ pancreatic/JJ tumor/NN in/IN Recklinghausen's/NNP neurofibromatosis/NN ./.
@@88245855885/CD We/PRP have/VBP cloned/VBN a/DT novel/JJ protein/MULTIGENE kinase/MULTIGENE ,/, termed/JJ hematopoietic/MULTIGENE progenitor/MULTIGENE kinase/MULTIGENE 1/MULTIGENE (/( HPK1/GENE )/SYM ,/, that/WDT is/VBZ expressed/VBN predominantly/RB in/IN hematopoietic/JJ cells/NNS ,/, including/JJ early/JJ progenitor/NN cells/NNS ./.
@@110142153041/CD By/IN progressive/JJ 5'-deletion/CD studies/NNS ,/, we/PRP have/VBP identified/VBN a/DT 248-bp/JJ DNA/NN fragment/NN (/( -1018/JJ to/IN -771/CD ,/, relative/JJ to/IN the/DT translation/NN start/NN site/NN )/SYM at/IN the/DT 5'-flanking/JJ region/NN of/IN the/DT human/MULTIGENE GnRHR/MULTIGENE gene/MULTIGENE that/WDT is/VBZ responsible/JJ for/IN the/DT GnRHa-mediated/JJ down-regulation/NN of/IN human/MULTIGENE GnRHR/MULTIGENE promoter/MULTIGENE activity/NN ./.
@@50497116436/CD Working/NNP session/NN report/NN :/: in/IN vivo-in/MULTIGENE vitro/MULTIGENE screening/JJ ./.
@@113172561159/CD Nearly/RB all/DT isolates/NNS of/IN S/NNP ./NNP intermedius/JJ and/CC most/JJ isolates/NNS of/IN S/NNP ./NNP constellatus/NN ,/, but/CC only/RB 19%/CD of/IN those/DT of/IN S/NNP ./NNP anginosus/NN ,/, were/VBD associated/VBN with/IN abscess/NN ./.
@@108365425398/CD Up/IN to/IN 95%/NN of/IN the/DT total/JJ UV/NN exposure/NN received/VBN is/VBZ in/IN the/DT UV-A/GENE waveband/NN (/( 320-400/JJ nm/NN )/SYM ./.
@@118903547587/CD Genetics/NNP Institute/NNP has/VBZ developed/VBN and/CC launched/VBN oprelvekin/NN (/( rhIL-11/GENE ;/: Neumega/GENE )/SYM ,/, a/DT recombinant/JJ form/NN of/IN human/MULTIGENE IL-11/MULTIGENE ./.
@@90289988992/CD In/NN order/NN to/IN provide/VB adequate/JJ local/JJ control/NN without/IN compromising/JJ cosmetic/JJ outcome/NN ,/, the/DT amount/NN of/IN breast/NN tissue/NN that/WDT must/MD be/VB excised/VBN in/IN BCT/DT needs/NN to/IN be/VB individualized/JJ ./.
@@14211453354/CD Fractionation/NNS of/IN crude/JJ nuclear/JJ extracts/NNS by/IN heparin-agarose/NN chromatography/NN indicates/VBZ that/IN PCAT-1/GENE is/VBZ more/RB prevalent/JJ in/IN extracts/NNS prepared/VBN from/IN salt-stressed/JJ leaf/NN tissue/NN ./.
@@9175729124/CD Possibility/NNS of/IN a/DT TSH-Screening/VBG method/NN for/IN detection/NN of/IN hypothyroidism/NN in/IN the/DT newborn/NN ./.
@@36923315053/CD The/DT effect/NN of/IN a/DT beta-adrenoceptor/MULTIGENE antagonist/MULTIGENE ,/, pindolol/NN ,/, on/IN uterine/JJ smooth/JJ muscle/NN in/IN term/NN pregnant/JJ women/NNS was/VBD studied/VBN in/IN vitro/FW and/CC in/IN vivo/NN (/( in/IN hypertensive/JJ women/NNS )/SYM ./.
@@116862398188/CD The/DT 5'/CD flanking/JJ sequence/NN of/IN the/DT 3B/MULTIGENE gene/MULTIGENE is/VBZ extremely/RB A/DT +/SYM T/NN rich/JJ but/CC contains/VBZ five/CD G/NNP //NNP C/NNP rich/JJ stretches/NNS ,/, each/DT approximately/RB 7bp/NN long/JJ ,/, which/WDT have/VBP strong/JJ sequence/NN similarity/NN to/IN the/DT G/NN boxes/NNS found/VBP upstream/RB of/IN other/DT developmentally/RB regulated/VBN Dictyostelium/MULTIGENE genes/MULTIGENE ./.
@@98439442305/CD A-tracts/NNS functioned/VBN best/JJS when/CC positioned/VBN close/JJ to/IN the/DT -35/CD hexamer/NN rather/RB than/IN one/PRP helical/JJ turn/NN farther/RBR upstream/RB ,/, similar/JJ to/IN the/DT positioning/VBG optimal/JJ for/IN UP/IN element/NN function/NN ./.
@@108885707680/CD The/DT total/JJ alkaloids/NNS contained/VBN in/IN the/DT peel/NN of/IN Atzimba/NNP ,/, Lopez/NNP ,/, Marciana/NNP ,/, Montsama/NNP ,/, Murca/NNP ,/, and/CC Puebla/GENE was/VBD lower/JJR than/IN the/DT limits/NNS recommended/VBN for/IN food/NN safety/NN ./.
@@77023789135/CD Scratching/VBG during/IN sleep/NN in/IN children/NNS with/IN atopic/JJ dermatitis/NN is/VBZ associated/VBN with/IN increased/VBN VO2/GENE ./.
@@3311281680/CD High/NNP levels/NNS of/IN serum/JJ calcitonin/NEWGENE were/VBD found/VBN in/IN patients/NNS with/IN chronic/JJ renal/JJ failure/NN ./.
@@7506253996/CD This/DT enhancer/NN activates/VBZ both/PDT the/DT K19/NEWGENE and/CC TK/MULTIGENE basal/MULTIGENE promoters/MULTIGENE in/IN HeLa/DT cells/NNS ./.
@@79853057975/CD The/DT treatment/NN of/IN hydronephrosis/NN in/IN children/NNS ./.
@@4639735069/CD Platelet/NN number/NN and/CC life/NN span/NN were/VBD determined/VBN in/IN the/DT last/NN trimester/NN of/IN pregnancy/NN in/IN 22/CD women/NNS who/WP were/VBD delivered/VBN of/IN small-for-gestational/JJ age/NN (/( SGA/JJ )/SYM infants/NNS and/CC in/IN 21/CD women/NNS with/IN infants/NNS having/VBG normal/JJ birth/NN weights/NNS ./.
@@3114188595/CD Significant/JJ treatment-related/JJ problems/NNS appeared/VBN during/IN the/DT second/JJ decade/NN in/IN 5/CD patients/NNS ,/, including/JJ one/PRP chest/NN wall/NN sarcoma/NN ;/: all/DT of/IN these/DT patients/NNS had/VBP received/VBN at/IN least/RB 60/CD Gy/JJ to/IN breast/NN and/CC regional/MULTIGENE nodal/MULTIGENE areas/NNS ./.
@@10334888197/CD In/NN reperfusion/NN B/NNP ,/, only/RB the/DT diabetic/JJ group/NN demonstrated/VBD a/DT significant/JJ increase/NN in/IN IL-8/NEWGENE concentrations/NNS at/IN 1/CD and/CC 15/CD min/NN compared/VBN to/IN nondiabetics/NNS ./.
@@76010782239/CD Subjects/NNS with/IN a/DT short/JJ postexposure/JJ time/NN and/CC a/DT dioxin/NN burden/NN >/SYM 0/CD ./CD 6/CD pg/GENE //GENE m3/GENE had/VBP a/DT significantly/RB higher/JJ risk/NN of/IN hypoergy/NN than/IN unexposed/JJ subjects/NNS (/( hypoergy/NN I/PRP :/: OR/NN =/SYM 9/CD ./CD 51/CD ,/, 95%/CD CI/NN =/SYM 1/CD ./CD 96-42/CD ./CD 02/CD ;/: hypoergy/NN II/NNP :/: OR/NN =/SYM 2/CD ./CD 92/CD ,/, 95%/CD CI/NN =/SYM 1/CD ./CD 14-7/CD ./CD 5/CD )/SYM ./.
@@93967228151/CD The/DT gene/NN (/( ApxII/NN )/SYM encoding/VBG both/DT chloroplastic/JJ ascorbate/MULTIGENE peroxidase/MULTIGENE isoenzymes/MULTIGENE was/VBD isolated/VBN and/CC the/DT organization/NN of/IN the/DT gene/NN was/VBD determined/VBN ./.
@@75924679351/CD The/DT mechanism/NN of/IN peroxisome/NN proliferation/NN is/VBZ poorly/RB understood/VBP ./.
@@66091662440/CD The/DT method/NN involved/VBD deproteinizing/JJ samples/NNS with/IN two/JJ volumes/NNS of/IN acetonitrile/NN followed/VBN by/IN injection/NN of/IN 5/CD microliters/NNS of/IN deproteinized/MULTIGENE supernatant/MULTIGENE onto/IN a/DT C18/JJ reversed-phase/JJ column/NN ./.
@@92303076096/CD FOG/GENE is/VBZ coexpressed/VBN with/IN GATA-1/GENE during/IN embryonic/JJ development/NN and/CC in/IN erythroid/JJ and/CC megakaryocytic/JJ cells/NNS ./.
@@113675235671/CD However/RB ,/, C4B/MULTIGENE proteins/MULTIGENE encoded/VBN by/IN monomodular/JJ short/JJ genes/NNS may/MD have/VB relatively/JJ higher/JJ concentrations/NNS than/IN those/DT from/IN long/MULTIGENE C4A/MULTIGENE genes/MULTIGENE ./.
@@100701585498/CD Independent/NNP splicing/JJ events/NNS involve/VBP three/CD previously/RB described/VBN cassette/NN exons/NNS ,/, which/WDT are/VBP predicted/VBN to/IN encode/VB most/RB of/IN the/DT second/JJ transmembrane/JJ domain/NN ./.
@@77457262106/CD As/IN it/PRP had/VBP been/VBN previously/RB reported/VBN that/IN the/DT 18-bp/JJ palindrome/NN contains/VBZ sufficient/JJ nucleotide/NN sequence/NN information/NN for/IN E1/GENE binding/JJ ,/, we/PRP speculate/VBP that/IN a/DT minimal/JJ E1/MULTIGENE recognition/MULTIGENE motif/MULTIGENE is/VBZ presented/VBN in/IN each/DT half/NN site/NN ./.
@@90435348999/CD Clinically/RB meaningful/JJ decreases/NNS due/NN to/IN alkalinization/NN alone/RB within/IN 30/CD minutes/NNS are/VBP unlikely/JJ ./.
@@39407334602/CD Using/VBG this/DT method/NN ,/, we/PRP measured/VBD absorption/NN of/IN low/JJ doses/NNS of/IN vitamin/NN A/DT ,/, which/WDT may/MD provide/VB a/DT more/RB physiological/JJ approach/NN to/IN assessment/NN of/IN fat/JJ malabsorption/NN ./.
@@95822671513/CD To/TO explore/VB the/DT function/NN of/IN human/JJ SINA-homologous/JJ (/( Siah/NNP )/SYM proteins/NNS ,/, expression/NN plasmids/NNS encoding/VBG Siah-1A/GENE were/VBD transiently/RB transfected/VBN into/IN 293/CD epithelial/JJ cells/NNS and/CC GM701/NNP fibroblast/NN cells/NNS ,/, resulting/VBG in/IN growth/NN arrest/NN without/IN induction/NN of/IN apoptosis/NN ./.
@@17587502350/CD Airway/NN pressure/NN and/CC air/NN flow/NN were/VBD measured/VBN at/IN the/DT endotracheal/JJ tube/NN in/IN 13/CD children/NNS on/IN a/DT variety/NN of/IN ventilators/NNS ./.
@@118791088320/CD MAIN/NNP OUTCOME/NNP MEASURE/NNP :/: A/DT positive/JJ test/NN result/NN for/IN gonococcal/JJ or/CC chlamydial/JJ infection/NN by/IN the/DT ligase/MULTIGENE chain/MULTIGENE reaction/NN assay/NN ;/: secondary/JJ outcome/NN measure/NN was/VBD a/DT positive/JJ test/NN result/NN for/IN human/JJ immunodeficiency/NN virus/NN (/( HIV/NN )/SYM ./.
@@105614603344/CD The/DT GPI/MULTIGENE anchor/MULTIGENE moiety/NN is/VBZ either/DT absent/JJ or/CC present/NN at/IN a/DT very/RB low/JJ level/NN in/IN the/DT polypeptide/NN expressed/VBN from/IN the/DT cDNA/NN that/WDT contained/VBD both/PDT the/DT signal/JJ peptide/NN and/CC GPI/MULTIGENE signal/MULTIGENE sequences/MULTIGENE ./.
@@103447364830/CD CDK4/MULTIGENE kinase/MULTIGENE activities/NNS were/VBD unaffected/JJ ,/, as/IN were/VBD the/DT levels/NNS of/IN the/DT CDK/MULTIGENE inhibitor/MULTIGENE p21Cip1/MULTIGENE present/VB in/IN cyclin/MULTIGENE E/MULTIGENE immunocomplexes/NNS ./.
@@100686747558/CD We/PRP also/RB identified/VBD an/DT alternative/RB spliced/VBN form/NN of/IN Lyp/GENE RNA/NN ,/, Lyp2/GENE ./.
@@92325935292/CD With/IN regard/NN to/IN the/DT characteristic/JJ expression/NN pattern/NN of/IN DJ/MULTIGENE protein/MULTIGENE and/CC its/PRP conspicuous/JJ repeat/NN units/NNS possible/JJ functional/JJ roles/NNS are/VBP discussed/VBN ./.
@@10819046913/CD Fibrin/GENE cloaking/NN along/IN the/DT catheter/NN was/VBD found/VBN in/IN 20/CD patients/NNS studied/VBN by/IN pull-out/NN arteriography/NN and/CC was/VBD unassociated/JJ with/IN clinical/JJ symptoms/NNS ./.
@@19019508610/CD Sequence/NN requirements/NNS for/IN premature/JJ transcription/NN arrest/NN within/IN the/DT first/JJ intron/NN of/IN the/DT mouse/MULTIGENE c-fos/MULTIGENE gene/MULTIGENE ./.
@@85667519434/CD However/RB ,/, it/PRP remains/VBP an/DT open/JJ question/NN whether/IN vertebrate/MULTIGENE Hox/MULTIGENE genes/MULTIGENE expressed/VBN under/IN the/DT control/NN of/IN Drosophila/MULTIGENE regulatory/MULTIGENE sequences/MULTIGENE can/MD substitute/VB the/DT function/NN of/IN Drosophila/MULTIGENE Hox/MULTIGENE genes/MULTIGENE ./.
@@34946494186/CD This/DT brief/JJ hypercapnic/JJ challenge/NN induced/VBD a/DT rapid/JJ increase/NN in/IN CBF/NN in/IN the/DT absence/NN of/IN any/DT change/NN in/IN MABP/NN ./.
@@30010846986/CD The/DT sequence/NN was/VBD determined/VBN for/IN a/DT 4024-base/JJ pair/NN (/( bp/NN )/SYM segment/NN that/WDT extends/VBZ from/IN 149/CD bp/NN 5'/CD to/IN the/DT cap/NN site/NN of/IN alpha/MULTIGENE 1/MULTIGENE to/IN 207/CD bp/NN 3'/CD to/IN psi/MULTIGENE alpha/MULTIGENE ./.
@@87039088709/CD Collectively/RB ,/, our/PRP findings/NNS demonstrate/VBP that/IN SF-1/GENE plays/VBP a/DT key/NN role/NN in/IN controlling/JJ the/DT basal/JJ and/CC cAMP-stimulated/JJ expression/NN of/IN the/DT StAR/MULTIGENE gene/MULTIGENE ./.
@@113689016217/CD In/NN contrast/NN the/DT human/NN and/CC mouse/MULTIGENE BCNT/MULTIGENE proteins/MULTIGENE contain/VBP one/PRP repeat/NN unit/NN and/CC lack/VB the/DT RTE-1-derived/JJ portion/NN ./.
@@98520054476/CD Competition/NN with/IN a/DT putative/JJ MADS/MULTIGENE box/MULTIGENE consensus/NN binding/JJ site/NN from/IN the/DT promoter/NN of/IN the/DT coordinately/RB regulated/VBN opaque-phase-specific/MULTIGENE gene/MULTIGENE PEP1/MULTIGENE (/( SAP1/GENE )/SYM and/CC the/DT human/MULTIGENE MADS/MULTIGENE box/MULTIGENE consensus/NN binding/JJ site/NN for/IN serum/JJ response/MULTIGENE factor/MULTIGENE demonstrated/VBN that/IN one/PRP of/IN the/DT three/CD complexes/NNS formed/VBN was/VBD specific/JJ to/IN the/DT OP4/MULTIGENE sequence/MULTIGENE ./.
@@115426771419/CD This/DT article/NN comparatively/RB evaluates/VBZ five/CD Generic/NNP Systems/NNPS that/WDT describe/VBP the/DT basic/JJ alternatives/NNS to/IN composting/JJ facility/NN design/NN and/CC control/NN ./.
@@111196115111/CD ORFK10/GENE ./GENE 5/GENE encodes/VBZ a/DT protein/NN ,/, latency-associated/MULTIGENE nuclear/MULTIGENE antigen/MULTIGENE 2/MULTIGENE (/( LANA2/GENE )/SYM ,/, which/WDT is/VBZ expressed/VBN in/IN KSHV-infected/JJ hematopoietic/JJ tissues/NNS ,/, including/JJ PEL/NN and/CC CD/NN but/CC not/RB KS/VB lesions/NNS ./.
@@86012834313/CD In/NN view/NN of/IN the/DT presence/NN of/IN SECIS/MULTIGENE elements/MULTIGENE in/IN the/DT open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM of/IN bacterial/JJ selenoproteins/NNS ,/, we/PRP examine/VBP the/DT effects/NNS in/IN the/DT type/MULTIGENE 1/MULTIGENE deiodinase/MULTIGENE of/IN extending/VBG the/DT ORF/NN into/IN the/DT SECIS/MULTIGENE element/MULTIGENE ,/, and/CC find/VB that/IN this/DT dramatically/RB inhibits/VBZ SECIS/GENE function/NN ./.
@@1003737835/CD The/DT dorsal/JJ nerves/NNS of/IN the/DT penis/NN were/VBD anesthetized/JJ bilaterally/RB with/IN lidocaine/NN ./.
@@107884769608/CD Antibodies/NNS raised/VBN against/IN a/DT C-terminal/NN portion/NN of/IN Sec31A/MULTIGENE co-precipitate/MULTIGENE Sec13/MULTIGENE and/CC inhibit/VB ER-Golgi/NNP transport/NN of/IN temperature-arrested/JJ vesicular/JJ stomatitis/MULTIGENE G/MULTIGENE protein/MULTIGENE in/IN a/DT semi-intact/JJ cell/NN assay/NN ./.
@@33407746972/CD Dosimetric/NNP estimates/NNS for/IN these/DT organs/NNS were/VBD 2/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 1/CD and/CC 2/CD ./CD 3/CD +/NN //NN -/NN 1/CD ./CD 4/CD rad/NN (/( ./CD 02/CD +/NN //NN -/NN ./MULTIGENE 01/MULTIGENE Gy/MULTIGENE )/SYM ,/, respectively/RB ,/, with/IN a/DT whole-body/NN estimate/NN of/IN 0/CD ./CD 28/CD rad/NN (/( ./MULTIGENE 003/MULTIGENE Gy/MULTIGENE )/SYM ./.
@@99879619988/CD Its/PRP early/JJ lesions/NNS were/VBD characterized/VBN by/IN angiomatosis/NN ,/, vasculopathy/NN ,/, and/CC proliferation/NN of/IN synoviocytes/NNS and/CC fibroblasts/NNS ./.
@@93171311176/CD Ig/MULTIGENE heavy/MULTIGENE chain/MULTIGENE class/NN switching/NN is/VBZ directed/VBN by/IN cytokines/NNS inducing/JJ transcription/NN from/IN unrearranged/JJ CH/MULTIGENE genes/MULTIGENE ./.
@@98953235734/CD Conserved/JJ and/CC distinct/JJ roles/NNS of/IN kreisler/NN in/IN regulation/NN of/IN the/DT paralogous/JJ Hoxa3/GENE and/CC Hoxb3/MULTIGENE genes/MULTIGENE ./.
@@97186719702/CD The/DT Abbreviated/NN Injury/NNP Scale/NNP (/( AIS/NNS )/SYM ,/, Injury/NNP Severity/NNP Scale/NNP and/CC TRISS/NNP methodology/NN comprise/VB a/DT mathematically/RB sound/NN system/NN for/IN the/DT analysis/NN of/IN injuries/NNS and/CC injured/JJ patients/NNS ./.
@@14996162366/CD The/DT mean/JJ blood/NN flow/NN in/IN the/DT penile/JJ foreskin/NN was/VBD estimated/VBN to/IN be/VB 15/CD ml/CD //CD min/CD //CD 100/CD g/NN and/CC it/PRP increased/VBD to/IN 150-200%/JJ after/IN the/DT induction/NN of/IN anesthesia/NN ,/, and/CC then/RB decreased/VBN to/IN 72%/JJ at/IN the/DT tip/NN of/IN the/DT created/VBN parameatal/JJ foreskin/MULTIGENE flap/MULTIGENE ./.
@@15479429739/CD A/DT 32P-labeled/JJ LAP/NN DNA-binding/NN and/CC dimerization/NN domain/NN "zipper/NN probe"/NN was/VBD used/VBN to/IN isolate/MULTIGENE a/MULTIGENE clone/MULTIGENE that/IN encodes/VBZ a/DT new/JJ C/MULTIGENE //MULTIGENE EBP-homologous/MULTIGENE protein/MULTIGENE :/: CHOP-10/GENE ./.
@@64823186281/CD Thrombocyte/NN function/NN was/VBD impaired/VBN in/IN all/DT patients/NNS ,/, characterized/VBN by/IN a/DT diminished/JJ platelet/NN shape/NN change/NN ./.
@@109337327977/CD The/DT genome/NN of/IN the/DT human/JJ herpesvirus/NN 8/CD (/( HHV-8/NN )/SYM contains/VBZ a/DT cluster/NN of/IN open/JJ reading/JJ frames/NNS (/( ORFs/NNS )/SYM encoding/VBG proteins/NNS with/IN homology/NN to/IN the/DT cellular/JJ transcription/NN factors/NNS of/IN the/DT interferon/MULTIGENE regulatory/MULTIGENE factor/MULTIGENE (/( IRF/GENE )/SYM family/NN ./.
@@17441199865/CD The/DT constraints/NNS of/IN primase/MULTIGENE recognition/MULTIGENE sequences/MULTIGENE ,/, nucleotide/NN substrate/NN requirements/NNS ,/, and/CC the/DT effects/NNS of/IN additional/JJ proteins/NNS on/IN oligoribonucleotide/NN synthesis/NN by/IN the/DT 63-kDa/MULTIGENE gene/MULTIGENE 4/MULTIGENE protein/MULTIGENE have/NN been/VBN examined/VBN using/VBG templates/NNS of/IN defined/VBN sequence/NN ./.
@@64634296269/CD Resting/VBG VE/NN in/IN the/DT luteal/JJ phase/NN was/VBD 7/CD ./CD 8%/CD greater/JJR than/IN that/DT in/NN the/DT follicular/JJ phase/NN ./.
@@91082079057/CD However/RB ,/, its/PRP participation/NN in/IN gagging/NN induced/VBN by/IN oropharyngeal/JJ irritation/NN is/VBZ unclear/JJ ./.
@@11555669468/CD Experience/NN with/IN xylene-free/JJ sections/NNS since/IN 1995/CD at/IN the/DT Vrinnevi/GENE Hospital/NNP is/VBZ favorable/JJ ./.
@@110581327330/CD Among/IN the/DT total/JJ CDSs/GENE ,/, 8/CD ./CD 8%/CD match/NN sequences/NNS of/IN proteins/NNS found/VBP only/RB in/IN Bacillus/NN subtilis/JJ and/CC 66/CD ./CD 7%/CD are/VBP widely/RB conserved/VBN in/IN comparison/NN with/IN the/DT proteins/NNS of/IN various/JJ organisms/NNS ,/, including/JJ B/NNP ./NNP subtilis/NNP ./.
@@107805186541/CD The/DT effects/NNS of/IN these/DT mutations/NNS on/IN protein/NN function/NN require/VB further/JJ examination/NN ./.
@@6328504965/CD USA/NN 80/CD ,/, 802-806/NN ]/NN was/VBD used/VBN to/IN isolate/NN a/DT genomic/JJ clone/MULTIGENE lambda/MULTIGENE PGK-1/MULTIGENE containing/JJ a/DT portion/NN of/IN an/DT autosomal/JJ locus/NN for/IN phosphoglycerate/MULTIGENE kinase/MULTIGENE (/( PGK/GENE )/SYM ./.
@@27814952275/CD Changes/NNS in/IN xanthine/MULTIGENE oxidase/MULTIGENE activity/NN in/IN patients/NNS with/IN circulatory/JJ failure/NN ./.
@@98785429565/CD Consistent/JJ with/IN these/DT findings/NNS ,/, relatively/JJ weak/JJ transcriptional/JJ silencing/VBG by/IN the/DT native/JJ VDR/NEWGENE was/VBD observed/VBN using/VBG the/DT osteopontin/NN VDRE/NN ./.
@@79141924556/CD HER2/NEWGENE overexpressing/JJ cells/NNS showed/VBD a/DT single/JJ prominent/JJ DNase/MULTIGENE I/MULTIGENE hypersensitive/JJ site/NN near/IN a/DT conserved/VBN and/CC hitherto/RB unrecognized/JJ ets/NN response/MULTIGENE element/MULTIGENE (/( GAGGAA/GENE )/SYM ,/, located/VBN 38/CD bases/NNS down-stream/NN from/IN the/DT CAAT/MULTIGENE box/MULTIGENE and/CC directly/RB 5'/CD of/IN the/DT TATA/MULTIGENE box/MULTIGENE in/IN the/DT human/MULTIGENE HER2/MULTIGENE promoter/MULTIGENE ./.
@@28893521237/CD Most/JJS patients/NNS with/IN high/JJ blood/NN pressure/NN (/( BP/NN )/SYM can/MD be/VB managed/VBN by/IN using/VBG one/PRP of/IN 4/CD classes/NNS of/IN compounds/NNS :/: a/DT diuretic/NN ,/, beta/NN blocker/NN ,/, converting/MULTIGENE enzyme/MULTIGENE inhibitor/MULTIGENE or/CC calcium/MULTIGENE antagonist/MULTIGENE ./.
@@91834067035/CD A/DT neonatal/JJ alloimmune/JJ thrombocytopenia/NN with/IN an/DT HPA-3a/GENE (/( Baka/GENE )/SYM incompatibility/NN was/VBD confirmed/VBN ./.
@@106933149372/CD Of/IN the/DT 153/CD patients/NNS studied/VBN ,/, CK-MB/GENE results/NNS were/VBD positive/JJ in/IN 91/NNP (/( 59%/CD )/SYM patients/NNS ;/: ECG/NN revealed/VBD AMI/NN in/IN 72/NNP (/( 47%/JJ )/SYM patients/NNS ./.
@@16343082230/CD Cardiovascular/NNP risk/NN factors/NNS were/VBD measured/VBN by/IN standardized/JJ techniques/NNS ./.
@@39040041473/CD Such/JJ studied/VBN acquired/VBN with/IN low/JJ energy/NN or/CC medium/NN energy/NN collimation/NN and/CC a/DT window/NN centered/VBN on/IN the/DT 159/CD keV/NN 123I/GENE photopeak/NN contain/VB appreciable/JJ septal/JJ breakthrough/NN signals/NNS originating/VBG from/IN Compton/NN scatter/NN of/IN high/JJ energy/NN photons/NNS primarily/RB from/IN 124I/CD ./.
@@94985537096/CD Structural/NNP and/CC evolutionary/JJ studies/NNS on/IN sterol/NN 14-demethylase/MULTIGENE P450/MULTIGENE (/( CYP51/GENE )/SYM ,/, the/DT most/RB conserved/VBN P450/MULTIGENE monooxygenase/MULTIGENE :/: I/NNP ./NNP
@@10748672558/CD Bites/NNS by/IN two/JJ species/NN of/IN adders/NNS (/( Vipera/NN aspis/NN and/CC Vipera/NN berus/NN )/SYM can/MD lead/VB to/IN extensive/JJ swelling/NN with/IN multiorgan/JJ failure/NN ./.
@@62161256024/CD In/NN addition/NN ,/, the/DT overall/JJ chance/NN that/IN a/DT patient/NN would/MD undergo/VB ET/NNP was/VBD greater/JJR in/IN a/DT cycle/NN in/IN which/WDT more/RB than/IN one/PRP follicle/NN 20/CD mm/NN or/CC larger/JJR was/VBD developing/JJ than/IN in/IN a/DT cycle/NN in/IN which/WDT a/DT single/JJ large/JJ follicle/NN was/VBD developing/JJ ./.
@@74712104774/CD The/DT 87K/MULTIGENE protein/MULTIGENE ,/, together/RB with/IN proteins/NNS of/IN 105/CD ,/CD 000/CD and/CC 75/CD ,/CD 000/CD daltons/NNS ,/, are/VBP translated/VBN from/IN leftward/RB transcribed/VBN (/( 1-strand/JJ )/SYM messenger/NN RNAs/NNS that/WDT are/VBP complementary/JJ to/IN the/DT viral/JJ genome/NN between/IN positions/NNS 11/CD ./CD 2/CD and/CC 31/CD ./CD 5/CD ./.
@@115875145987/CD However/RB ,/, the/DT abi1-1/MULTIGENE gene/MULTIGENE product/MULTIGENE has/VBZ no/DT effect/NN on/IN the/DT ABA/NN suppression/NN of/IN a/DT GA-responsive/NNP alpha-amylase/MULTIGENE gene/MULTIGENE ./.
@@114106795109/CD The/DT selective/JJ alteration/NN of/IN the/DT genome/NN using/VBG Cre/NN recombinase/NN to/IN target/NN the/DT rearrangement/NN of/IN genes/NNS flanked/VBN by/IN LOX/MULTIGENE recognition/MULTIGENE sequences/MULTIGENE has/VBZ required/VBN the/DT use/NN of/IN two/JJ separate/JJ genetic/JJ constructs/NNS in/IN trans/JJ ,/, one/PRP containing/JJ cre/NN and/CC the/PDT other/DT containing/JJ the/DT gene/NN of/IN interest/NN flanked/VBN by/IN LOX/MULTIGENE sites/MULTIGENE ./.
@@84972807259/CD Since/IN the/DT regulation/NN of/IN SWI4/GENE is/VBZ required/VBN for/IN normal/JJ cell/NN cycle/NN progression/NN ,/, we/PRP have/VBP characterized/VBN cis-/JJ and/CC trans-acting/JJ regulators/NNS of/IN SWI4/GENE transcription/NN ./.
@@34038269336/CD Which/WDT cineangiographically/RB assessed/VBN anatomic/JJ variable/JJ correlates/VBP best/JJS with/IN functional/JJ measurements/NNS of/IN stenosis/NN severity/NN ?/. A/DT comparison/NN of/IN quantitative/JJ analysis/NN of/IN the/DT coronary/JJ cineangiogram/NN with/IN measured/VBN coronary/JJ flow/NN reserve/NN and/CC exercise/MULTIGENE //MULTIGENE redistribution/MULTIGENE thallium-201/MULTIGENE scintigraphy/NN ./.
@@88137669958/CD The/DT third/JJ ORF/NN generates/VBZ a/DT transcript/NN of/IN 1/CD ./CD 6/CD kb/NN and/CC encodes/VBZ a/DT protein/NN of/IN 382/CD residues/NNS including/JJ a/DT perfect/JJ match/NN to/IN the/DT consensus/NN sequence/NN of/IN a/DT C2H2/GENE zinc/NN finger/NN domain/NN ;/: it/PRP shares/VBP a/DT strong/JJ homology/NN with/IN yeast/NN Mig1p/GENE and/CC Cre-A/GENE from/IN Aspergillus/NNS ,/, Emericella/NNP and/CC E/NNP ./NNP coli/JJ ./.
@@71250646932/CD Parasitological/JJ and/CC pathological/JJ findings/NNS in/IN capuchin/NN monkeys/NNS infected/VBN with/IN Schistosoma/ORG japonicum/NN or/CC Schistosoma/ORG mansoni/NN ./.
@@87747328800/CD To/TO test/VB whether/IN Sp1/GENE and/CC zif268/GENE //GENE egr-1/GENE interact/VB with/IN this/DT motif/NN ,/, gel/NN retardation/NN assays/NNS were/VBD performed/VBN ./.
@@105675896502/CD The/DT multiple/JJ functions/NNS of/IN Pmt3p/GENE described/VBN here/RB suggest/VB that/IN several/DT nuclear/JJ proteins/NNS are/VBP regulated/VBN by/IN Pmt3p/GENE conjugation/NN ./.
@@38301479234/CD The/DT relationships/NNS among/IN four/CD descriptors/NNS of/IN lactate/NN increase/NN :/: lactate/NN threshold/NN (/( LT/NN )/SYM (/( the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN concentration/NN begins/VBZ to/IN increase/NN above/RB the/DT resting/JJ level/NN during/IN an/DT incremental/JJ exercise/NN test/NN )/SYM ,/, LT1/NN (/( the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN increases/NNS 1/CD mM/NN above/RB the/DT resting/JJ level/NN )/SYM ,/, LT2/NN (/( the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN concentration/NN reaches/VBP a/DT fixed/JJ value/NN of/IN 2/CD mM/NN )/SYM ,/, onset/NN of/IN blood/NN lactate/NN accumulation/NN (/( OBLA/NNP ;/: the/DT VO2/NN at/IN which/WDT blood/VBP lactate/NN reaches/VBP a/DT concentration/NN of/IN 4/CD mM/NN )/SYM ,/, were/VBD compared/VBN with/IN aerobic/JJ capacity/NN (/( VO2max/NN )/SYM and/CC 12/CD min/NN running/JJ performance/NN in/IN 19/CD untrained/JJ female/JJ students/NNS ./.
@@79353957931/CD The/DT protein/NN encoded/VBN is/VBZ 114/CD kDa/NN and/CC contains/VBZ eight/CD zinc/NN finger/NN motifs/NNS ,/, seven/NN of/IN which/WDT are/VBP present/VB in/IN two/JJ clusters/NNS at/IN opposite/NN ends/NNS of/IN the/DT molecule/NN ./.
@@118946051801/CD INTERPRETATION/NNP :/: It/PRP is/VBZ probable/JJ that/IN the/DT cognitive/JJ dissonance/NN created/VBN by/IN more/JJ health/NN information/NN on/IN smoking/NN after/IN 1964/CD ,/, i/CD ./CD e/CD ./. the/DT necessary/JJ motivation/NN to/IN quit/NN ,/, was/VBD reduced/VBN as/IN a/DT result/NN of/IN strategic/JJ changes/NNS in/IN the/DT amount/NN and/CC content/NN of/IN advertising/NN ./.
@@113139469835/CD A/DT novel/JJ potential/JJ effector/NN of/IN M-Ras/GENE and/CC p21/MULTIGENE Ras/MULTIGENE negatively/RB regulates/VBZ p21/MULTIGENE Ras-mediated/MULTIGENE gene/MULTIGENE induction/NN and/CC cell/NN growth/NN ./.
@@100262291196/CD In/NN addition/NN ,/, in/IN vitro/FW mutagenesis/NN of/IN both/DT Engrailed/JJ and/CC Pbx1/MULTIGENE sites/MULTIGENE indicated/VBN that/IN other/DT unidentified/JJ sites/NNS are/VBP responsible/JJ for/IN the/DT transcriptional/JJ enhancement/NN observed/VBN with/IN the/DT intronic/JJ fragment/NN ./.
@@29144923620/CD On/IN admission/NN to/IN the/DT ICU/NN ,/, 117/CD patients/NNS (/( 61/CD percent/NN )/SYM had/VBP hypomagnesemia/NN (/( serum/JJ Mg/NN less/PRP than/IN 1/CD ./CD 5/CD mEq/NN //NN dl/NN )/SYM ,/, 66/CD patients/NNS (/( 34/CD percent/NN )/SYM had/VBP normomagnesemia/VBG (/( 1/CD ./CD 5/CD to/IN 2/CD ./CD 0/CD mEq/NN //NN dl/NN )/SYM ,/, and/CC ten/CD patients/NNS (/( 5/CD percent/NN )/SYM had/VBP hypermagnesemia/NN (/( greater/JJR than/IN 2/CD ./CD 0/CD mEq/NN //NN dl/NN )/SYM ./.
@@39135224568/CD With/IN aging/NN ,/, many/JJ aspects/NNS of/IN immune/JJ function/NN change/NN ./.
@@116808354417/CD In/NN the/DT base-case/JJ analysis/NN ,/, total/JJ direct/JJ costs/NNS per/IN patient/NN were/VBD $728/GENE for/IN zoledronic/JJ acid/NN and/CC $776/CD for/IN pamidronate/NN ./.
@@63180911608/CD The/DT splice/NN acceptor/NN site/NN is/VBZ ca/NN ./NN
@@23050142955/CD In/NN the/DT first/JJ series/NN of/IN experiments/NNS ,/, Sprague-Dawley/JJ male/JJ rats/NNS were/VBD implanted/VBN unilaterally/RB with/IN guide/NN cannulas/NNS aimed/VBN at/IN the/DT lateral/JJ ventricle/NN ./.
@@2865502757/CD Double-blind/NNP randomised/JJ trial/NN of/IN intravenous/JJ tissue-type/MULTIGENE plasminogen/MULTIGENE activator/MULTIGENE versus/IN placebo/NN in/IN acute/JJ myocardial/JJ infarction/NN ./.
@@8226118204/CD Up/IN to/IN now/RB the/DT number/NN of/IN patients/NNS examined/VBN is/VBZ about/RB 300/CD ,/, additionally/RB 6/CD persons/NNS who/WP underwent/VBD binephrectomy/NN ./.
@@90962348518/CD An/DT aromatic/JJ stacking/JJ interaction/NN between/IN subunits/NNS helps/VBP mediate/VB DNA/NN sequence/NN specificity/NN :/: operator/NN site/NN discrimination/NN by/IN phage/NN lambda/MULTIGENE cI/MULTIGENE repressor/MULTIGENE ./.
@@78166193310/CD Furthermore/RB ,/, the/DT identification/NN of/IN a/DT Dr1-like/MULTIGENE protein/MULTIGENE in/IN A/NNP ./NNP thaliana/NNP strongly/RB argues/VBZ for/IN the/DT ubiquity/NN of/IN this/DT protein/NN among/IN eukaryotic/JJ genera/NNS and/CC for/IN a/DT conserved/VBN mechanism/NN to/IN regulate/VB transcription/NN initiation/NN that/WDT involves/VBZ Dr1/GENE ./.
@@10326654190/CD According/VBG to/IN pilot/JJ experiments/NNS which/WDT considered/VBD various/JJ durations/NNS of/IN global/JJ no-flow/NN ischemia/NN ranging/VBG from/IN 10/CD to/IN 20/CD minutes/NNS ,/, two/JJ durations/NNS were/VBD chosen/VBP for/IN the/DT present/NN study/NN :/: 20/CD minutes/NNS (/( group/NN 20/CD )/SYM in/IN which/WDT ventricular/JJ fibrillation/NN (/( VF/NN )/SYM was/VBD the/DT predominant/JJ form/NN of/IN arrhythmias/NNS ,/, and/CC 18/CD minutes/NNS (/( group/NN 18/CD )/SYM in/IN which/WDT the/DT prevalence/NN of/IN VF/NN was/VBD markedly/RB lower/JJR despite/IN the/DT small/JJ difference/NN in/IN the/DT duration/NN of/IN ischemia/NN ./.
@@88480134085/CD The/DT nonconsensus/JJ TATA/MULTIGENE box/MULTIGENE in/IN promoter/MULTIGENE B/MULTIGENE plays/VBP a/DT more/RB important/JJ role/NN in/IN promoter/NN activity/NN than/IN the/DT TATA/MULTIGENE box/MULTIGENE in/IN promoter/NN A/NNP ./NNP
@@15164272137/CD High-resolution/NNP computed/JJ tomography/NN in/IN the/DT diagnosis/NN of/IN miliary/JJ tuberculosis/NN ./.
@@45522638991/CD State-approved/NN schools/NNS of/IN nursing--R/CD ./CD Z/CD ./CD ,/, 1972/CD ./.
@@25774588461/CD The/DT discussion/NN focuses/VBP primarily/RB on/IN the/DT newer/JJR drugs/NNS like/JJ angiotensin/MULTIGENE converting/MULTIGENE enzyme/MULTIGENE inhibitors/MULTIGENE ,/, alpha-adrenergic/MULTIGENE receptor/MULTIGENE blockers/NNS ,/, and/CC calcium/NN antagonists/NNS ./.
@@35377219230/CD Based/VBN on/IN our/PRP observations/NNS ,/, we/PRP propose/VBP a/DT model/NN whereby/RB inactive/JJ precursor/NN molecules/NNS produced/VBN from/IN the/DT PEP4/MULTIGENE gene/MULTIGENE self-activate/JJ within/IN the/DT yeast/NN vacuole/NN and/CC subsequently/RB activate/VB other/DT vacuolar/JJ hydrolases/NNS ./.
@@65463924055/CD In/NN this/DT respect/NN C/MULTIGENE reactive/MULTIGENE protein/MULTIGENE concentrations/NNS are/VBP superior/JJ to/IN white/JJ cell/NN count/NN ,/, erythrocyte/NN sedimentation/NN rate/NN ,/, and/CC temperature/NN and/CC the/DT concentrations/NNS of/IN antiproteases/NNS ./.
@@104962847955/CD During/IN both/DT encephalopathy/NN episodes/NNS ,/, CSF/MULTIGENE protein/MULTIGENE and/CC immunoglobulin/MULTIGENE G/MULTIGENE (/( IgG/CONTEXTGENE )/SYM levels/NNS were/VBD elevated/VBN without/IN an/DT increased/VBN IgG/NN index/NN or/CC IgG/NEWGENE synthesis/NN rate/NN ./.
@@11383301232/CD Bulbar/JJ pouches/NNS were/VBD perfused/VBN with/IN solutions/NNS of/IN 0/CD ./CD 9%/CD Na/MULTIGENE C1/MULTIGENE ,/, 0/CD ./CD 1/CD N/JJ HC1/GENE ,/, 40%/NN glucose/NN ,/, 40%/NN NaC1/GENE ,/, and/CC 40%/CD peptone/NN or/CC with/IN 0/CD ./CD 1%/CD solutions/NNS of/IN acetylcholine/NN chloride/NN ./.
@@89429998770/CD Recurrent/JJ G-to-A/GENE substitution/NN in/IN a/DT single/JJ codon/NN of/IN SREBP/NN cleavage-activating/JJ protein/NN causes/NNS sterol/NN resistance/NN in/IN three/CD mutant/JJ Chinese/JJ hamster/NN ovary/NN cell/NN lines/NNS ./.
@@78352733349/CD Insulin-stimulated/JJ glucose/NN transport/NN in/IN adipocytes/NNS is/VBZ mediated/JJ by/IN the/DT insulin/MULTIGENE receptor/MULTIGENE ./.
@@76765877604/CD Veterinary/NNP certification/NN for/IN livestock/NN export/NN ./.
@@26506633327/CD A/DT 0/CD ./CD 5/CD rating/NN was/VBD intended/VBN to/IN characterize/VB subjects/NNS in/IN whom/WP mild/JJ cognitive/JJ impairment/NN due/NN to/IN senile/JJ dementia/NN of/IN the/DT Alzheimer/NN type/NN was/VBD suspected/VBN but/CC was/VBD insufficient/JJ in/IN degree/NN to/IN warrant/NN a/DT diagnosis/NN of/IN definite/JJ dementia/NN ./.
@@38184679797/CD Selenium/NN (/( ./CD 1/CD ppm/NN )/SYM and/CC E/NN (/( 50/CD IU/NNS //NNS kg/NNS )/SYM supplementation/NN of/IN the/DT diet/NN of/IN the/DT sow/NN increased/VBD plasma/NN tocopherol/NN and/CC Se/NNP concentrations/NNS ,/, but/CC did/VBD not/RB increase/VB plasma/NN glutathione/NN peroxidase/NN (/( GSH-Px/NN )/SYM activity/NN ./.
@@105919903642/CD A/DT group/NN of/IN 66/CD DSM-IV/IN paranoid/JJ schizophrenic/JJ in-patients/NNS were/VBD assessed/VBN three/CD times/NNS using/VBG the/DT SAPS/CONTEXTGENE ,/, SANS/GENE ,/, BPRS/VBZ and/CC PAS/NN ./.
@@34202664121/CD The/DT interaction/NN of/IN radiation/NN and/CC hyperthermia/NN was/VBD systematically/RB studied/VBN in/IN the/DT Dunning/NN R3327G/GENE prostatic/JJ adenocarcinoma/NN ,/, the/DT preeminent/JJ animal/NN model/NN for/IN human/JJ prostatic/JJ cancer/NN ./.
@@40738484754/CD Failure/NN of/IN stapedius/NN reflexometry/NN in/IN the/DT diagnosis/NN of/IN myasthenia/NN gravis/MD ./.
@@17543817415/CD As/IN an/DT initial/JJ step/NN towards/IN the/DT characterization/NN of/IN replicative/JJ DNA/MULTIGENE polymerases/MULTIGENE of/IN trypanosomes/NNS ,/, we/PRP have/VBP cloned/VBN ,/, sequenced/VBN and/CC examined/VBD the/DT expression/NN of/IN the/DT Trypanosoma/JJ (/( Trypanozoon/NNP )/SYM brucei/NN brucei/NN gene/NN that/IN encodes/VBZ the/DT DNA/MULTIGENE polymerase/MULTIGENE alpha/MULTIGENE catalytic/JJ core/NN (/( pol/MULTIGENE alpha/MULTIGENE )/SYM ./.
@@78534887102/CD Encapsidation/NNS of/IN poliovirus/NN replicons/NNS encoding/VBG the/DT complete/JJ human/JJ immunodeficiency/NN virus/NN type/MULTIGENE 1/MULTIGENE gag/MULTIGENE gene/MULTIGENE by/IN using/VBG a/DT complementation/NN system/NN which/WDT provides/VBZ the/DT P1/MULTIGENE capsid/MULTIGENE protein/MULTIGENE in/IN trans/JJ ./.
@@7590497486/CD The/DT micromethod/NN uses/VBZ microcuvettes/NNS and/CC substitutes/NNS ferrozine/NN for/IN the/DT bathophenanthroline/MULTIGENE chromogen/MULTIGENE of/IN the/DT ICSH/NN ./.
@@8510647665/CD Beg2/GENE and/CC Beg1/GENE are/VBP regulated/VBN differently/RB which/WDT may/MD indicate/VB variation/NN in/IN storage/NN or/CC utilization/NN properties/NNS among/IN the/DT barley/NN globulins/NNS ./.
@@75717668722/CD An/DT abnormally/RB high/JJ percentage/NN of/IN hypertensive/JJ patients/NNS (/( approximately/RB 30%/CD )/SYM undergoing/VBG cardiac/JJ catheterization/NN because/IN of/IN anginal/JJ pain/NN and/IN //IN or/IN exercise-induced/NN ST-segment/NN depressions/NNS has/VBZ angiographically/RB normal/JJ coronary/JJ arteries/NNS ./.
@@27900097461/CD The/DT mature/JJ protein/NN also/RB contains/VBZ a/DT cysteine-rich/NN ,/, highly/RB hydrophilic/JJ region/NN homologous/JJ to/IN the/DT ovomucoid/MULTIGENE serine/MULTIGENE protease/MULTIGENE inhibitors/MULTIGENE (/( residues/NNS 76-132/CD )/SYM ./.
@@10367646237/CD Severe/JJ hemolysis/NN resulted/VBN in/IN statistically/RB significant/JJ changes/NNS in/IN the/DT mean/JJ values/NNS of/IN the/DT above/JJ analytes/NNS in/IN addition/NN to/IN the/DT following/NN increases/NNS :/: alanine/MULTIGENE aminotransferase/MULTIGENE ,/, calcium/NN ,/, and/CC serum/JJ globulins/NNS (/( P/NN </SYM 0/CD ./CD 001/CD )/SYM and/CC albumin/NN and/CC total/JJ protein/NN (/( P/NN </SYM 0/CD ./CD 01/CD )/SYM ./.
@@94789762582/CD Oncostatin/MULTIGENE M/MULTIGENE stimulates/VBZ c-Fos/GENE to/IN bind/NN a/DT transcriptionally/MULTIGENE responsive/MULTIGENE AP-1/MULTIGENE element/MULTIGENE within/IN the/DT tissue/NN inhibitor/NN of/IN metalloproteinase-1/MULTIGENE promoter/MULTIGENE ./.
@@67347136499/CD Diclofenac/GENE sodium-chlormezanone/JJ poisoning/NN ./.
@@111690801008/CD If/IN you/PRP think/VBP education/NN is/VBZ expensive--try/NN ignorance--Bok's/NNP Law/NNP ./.
@@107044993253/CD Alternatively/RB ,/, PC12-E2/NNP cells/NNS were/VBD submitted/VBN to/IN treatment/NN with/IN antibodies/NNS to/IN the/DT fibroblast/MULTIGENE growth/MULTIGENE factor/MULTIGENE (/( FGF/CONTEXTGENE )/SYM receptor/NN ,/, inhibitors/NNS of/IN the/DT nonreceptor/JJ tyrosine/NN kinase/NN p59/NN (/NN fyn/NN )/NN ,/, PLC/NN ,/, PKC/NN and/CC MEK/GENE and/CC an/DT activator/NN of/IN PKC/NN ,/, phorbol-12-myristate-13-acetate/NNP (/( PMA/NN )/SYM ./.
@@24961093436/CD However/RB ,/, experiments/NNS with/IN S1/NN mapping/NN of/IN in/IN vivo/MULTIGENE transcripts/MULTIGENE ,/, gene/NN disruptions/NNS in/IN the/DT alpha/MULTIGENE region/MULTIGENE ,/, and/CC a/DT single-copy/JJ transcriptional/JJ fusion/NN vector/NN all/DT suggested/VBN that/IN these/DT possible/JJ promoters/NNS were/VBD largely/RB inactive/JJ during/IN logarithmic/JJ growth/NN ,/, that/IN the/DT major/JJ promoter/NN for/IN the/DT alpha/MULTIGENE operon/MULTIGENE lay/JJ upstream/RB from/IN the/DT region/NN cloned/VBN ,/, and/CC that/IN the/DT genes/NNS in/IN the/DT IF1/GENE to/IN L17/GENE interval/NN were/VBD cotranscribed/VBN ./.
@@71923697017/CD A/DT method/NN for/IN determining/JJ cumulative/JJ behavioral/JJ toxicity/NN after/IN chronic/JJ oral/JJ administration/NN of/IN l-alpha-acetylmethadol/JJ to/IN female/JJ rats/NNS ./.
@@8151787969/CD Mapping/NN of/IN intracellular/JJ localization/NN domains/NNS and/CC evidence/NN for/IN colocalization/NN interactions/NNS between/IN the/DT IE110/GENE and/CC IE175/MULTIGENE nuclear/MULTIGENE transactivator/MULTIGENE proteins/MULTIGENE of/IN herpes/NN simplex/JJ virus/NN ./.
@@90874306918/CD However/RB ,/, the/DT same/JJ U1A/GENE peptide/NN ,/, when/CC conjugated/JJ to/IN BSA/NN ,/, inhibits/VBZ vertebrate/MULTIGENE PAP/MULTIGENE ./.
@@1083784643/CD Lymphocyte/JJ subpopulations/NNS ,/, serum/JJ IgE/NEWGENE and/CC total/JJ eosinophil/JJ counts/NNS in/IN patients/NNS with/IN bronchial/JJ asthma/NN ./.
@@91477889090/CD Respiratory/NNP chain/NN enzyme/NN activity/NN was/VBD normal/JJ ./.
@@115616231432/CD The/DT small/JJ copepod/NN Pseudonychocamptus/GENE proximus/NN progressively/RB replaced/VBD the/DT large/JJ Tisbe/NNP furcata/NN in/IN sand/NN filters/NNS during/IN the/DT fall/NN of/IN 1995/CD and/CC was/VBD responsible/JJ for/IN the/DT large/JJ increase/NN in/IN meiofaunal/JJ biomass/NN observed/VBN after/IN spring/NN 1996/CD ./.
@@102218203693/CD An/DT undilated/JJ type/NN of/IN APBD/GENE is/VBZ frequently/RB associated/VBN with/IN AMT/NNP and/CC we/PRP believe/VBP ,/, therefore/RB ,/, that/IN clinicians/NNS should/MD be/VB aware/JJ of/IN a/DT possible/JJ coexistence/NN of/IN APBD/NNP and/CC AMT/NNP ./.
@@97653946761/CD Cotransfection/NNS of/IN the/DT helicase-primase/MULTIGENE proteins/MULTIGENE ,/, one/PRP of/IN which/WDT was/VBD fused/VBN to/IN a/DT heterologous/JJ activation/NN domain/NN ,/, led/VBN to/IN Zta-dependent/NNP superactivation/NN of/IN CAT/NN expression/NN ./.
@@13714136127/CD In/NN addition/NN ,/, the/DT hGCSFR/MULTIGENE gene/MULTIGENE was/VBD chromosomally/RB localized/VBN by/IN Southern/NNP blot/NN analysis/NN of/IN its/PRP segregation/NN pattern/NN in/IN a/DT panel/NN of/IN rodent-human/JJ hybrid/JJ DNAs/NNS using/VBG the/DT radiolabeled/JJ cDNA/NN probe/NN ./.
@@110238538845/CD Concurrently/RB ,/, we/PRP monitored/VBD weather/VBP conditions/NNS and/CC used/VBN time-activity/JJ budget/NN data/NN of/IN free-living/NN birds/NNS and/CC laboratory/NN data/NN on/IN resting/JJ metabolic/JJ rate/NN to/IN construct/NN time-activity/JJ laboratory/NN (/( TAL/NNS )/SYM estimates/NNS of/IN daily/JJ energy/NN expenditure/NN (/( DEE/NNS )/SYM and/CC to/IN partition/NN the/DT verdins'/NN energy/NN budget/NN into/IN thermoregulatory/JJ ,/, activity/NN and/CC basal/JJ components/NNS ./.
@@25573509182/CD The/DT DNA/NN sequences/NNS predict/VBP proteins/NNS for/IN SRP54sc/GENE and/CC SRP54sp/GENE that/WDT are/VBP 47%/JJ and/CC 52%/JJ identical/JJ to/IN SRP54mam/NNP ,/, respectively/RB ./.
@@90370324270/CD The/DT proliferation/NN potential/JJ protein-related/JJ (/( P2P-R/GENE )/SYM gene/NN with/IN domains/NNS encoding/VBG heterogeneous/JJ nuclear/JJ ribonucleoprotein/NN association/NN and/CC Rb1/GENE binding/JJ shows/NNS repressed/VBN expression/NN during/IN terminal/JJ differentiation/NN ./.
@@83843096169/CD The/DT intracellular/JJ basic/MULTIGENE region/MULTIGENE //MULTIGENE helix-loop-helix/MULTIGENE (/( bHLH/GENE )/SYM dioxin/MULTIGENE receptor/MULTIGENE mediates/VBZ signal/JJ transduction/NN by/IN dioxin/NN (/( 2/JJ ,/JJ 3/JJ ,/JJ 7/JJ ,/JJ 8-tetrachlorodibenzo-p-dioxin/JJ )/SYM and/CC functions/NNS as/IN a/DT ligand-activated/MULTIGENE DNA/MULTIGENE binding/MULTIGENE protein/MULTIGENE directly/RB interacting/VBG with/IN target/NN genes/NNS by/IN binding/JJ to/IN dioxin/MULTIGENE response/MULTIGENE elements/MULTIGENE ./.
@@19398784809/CD We/PRP conclude/VBP that/DT solidification/NN could/MD occur/VB in/IN all/DT feeds/NNS containing/MULTIGENE casein/MULTIGENE and/CC that/IN alternative/JJ feeds/NNS should/MD be/VB considered/VBN in/IN patients/NNS with/IN increased/VBN gastric/JJ acidity/NN ./.
@@22720952553/CD These/DT results/NNS may/MD suggest/VB involvement/NN of/IN peripheral/MULTIGENE enkephalins/MULTIGENE in/IN pain/NN modulation/NN in/IN patients/NNS with/IN episodic/JJ cluster/NN headache/NN ./.
@@20758762683/CD The/DT stimulus/NN threshold/NN for/IN EER/NN showed/VBD a/DT less/PRP individual/JJ variation/NN than/IN amplitude/NN ./.
@@107638234882/CD Overexpression/NNS of/IN mcl-1/GENE is/VBZ sufficient/JJ to/IN protect/VB against/IN apoptosis/NN ,/, while/CC transfection/NN of/IN a/DT mcl-1/GENE antisense/NN plasmid/NN causes/NNS cell/NN death/NN ./.
@@7906265844/CD Preliminary/JJ experiments/NNS demonstrated/VBN that/IN it/PRP was/VBD possible/JJ to/IN produce/NN fasD/MULTIGENE mutants/MULTIGENE ,/, whose/WP products/NNS remain/VBP functional/JJ for/IN fimbrial/JJ export/NN and/CC assembly/NN ./.
@@13893622004/CD Porcelain/NN to/IN dentin/NN bond/NN strength/NN with/IN a/DT dentin/NN adhesive/JJ ./.
@@114620049153/CD The/DT role/NN of/IN the/DT Vp1/MULTIGENE DBD/MULTIGENE during/IN infection/NN was/VBD investigated/VBN by/IN taking/VBG advantage/NN of/IN NLS/NN phenotypic/JJ complementation/NN (/( N/NNP ./NNP
@@91811304375/CD Recently/RB we/PRP have/VBP performed/VBN a/DT detailed/JJ analysis/NN of/IN specific/JJ neuronal/JJ populations/NNS affected/VBN by/IN the/DT mutation/NN which/WDT shed/VBP new/JJ light/NN on/IN the/DT role/NN of/IN Krox-20/NEWGENE in/IN the/DT segmentation/NN and/CC on/IN the/DT physiological/JJ consequences/NNS of/IN its/PRP inactivation/NN ./.
@@75595552333/CD Indeed/RB ,/, ERM/NN and/CC c-Jun/GENE synergistically/RB activated/VBN the/DT EBS-CRE/NNP without/IN making/VBG an/DT apparent/JJ ternary/JJ complex/NN ./.
@@82694397976/CD Pentazocine/NNP analgesia/NN :/: is/VBZ there/RB a/DT niche/NN for/IN Talwin/NN Nx/NN ?/. Pentazocine/CHEM can/MD be/VB a/DT useful/JJ analgesic/JJ agent/NN for/IN the/DT management/NN of/IN acute/JJ dental/JJ pain/NN ./.
@@90616971360/CD Myocardial/JJ SPET/NN imaging/JJ with/IN 99Tcm-tetrofosmin/GENE in/IN clinical/JJ practice/NN :/: comparison/NN of/IN a/DT 1/CD day/NN and/CC a/DT 2/CD day/NN imaging/JJ protocol/NN ./.
@@107156022166/CD Animals/NNS received/VBD a/DT dose/NN of/IN dexamethasone/NN (/( 10/CD mg/CD //CD kg/CD i/CD ./CD p/CD ./CD )/SYM prior/NN to/IN the/DT protein-free/JJ surfactant/JJ preparation/NN Exosurf/IN (/( pure/JJ phospholipids/NNS containing/JJ surfactant/NN ,/, Wellcome/MULTIGENE GmbH/MULTIGENE ,/, Burgwedel/NNP ,/, Germany/NN )/SYM and/CC a/DT rSP-C/RB based/VBN surfactant/JJ ,/, respectively/RB ./.
@@111889711029/CD The/DT revitalization/NN of/IN surgery/NN for/IN Parkinson's/NNP disease/NN (/( PD/NN )/SYM has/VBZ fueled/VBN discussion/NN about/RB the/DT best/JJS methodology/NN to/IN define/VB the/DT target/NN ./.
@@1443047345/CD No/DT other/DT changes/NNS in/IN hematopoietic/JJ differentiation/NN status/NN were/VBD observed/VBN in/IN association/NN with/IN Id-SCL/GENE expression/NN ./.
@@112741795885/CD Thus/RB ,/, our/PRP studies/NNS define/VBP Rac/NNP //NNP Cdc42/NNP //NNP Pak/NNP as/IN a/DT module/NN upstream/RB of/IN Raf-1/GENE during/IN its/PRP activation/NN by/IN microtubule/NN disruption/NN ./.
@@76801204947/CD RT-PCR/NN using/VBG 1/MULTIGENE ./MULTIGENE D-specific/MULTIGENE primers/MULTIGENE showed/VBD that/DT kidney/NN ,/, brain/NN and/CC prostate/NN do/NN not/RB express/VB 1/NN ./NN D/NN mRNA/NN even/VB though/CC kidney/NN and/CC brain/NN are/VBP the/DT most/RB abundant/JJ source/NN for/IN aFGF/MULTIGENE protein/MULTIGENE ./.
@@8702807101/CD Conversely/RB ,/, activation/NN of/IN this/DT signaling/JJ pathway/NN by/IN expression/NN of/IN a/DT constitutively/RB active/JJ MKK1/MULTIGENE mutant/MULTIGENE dramatically/RB increased/VBN cyclin/MULTIGENE D1/MULTIGENE promoter/MULTIGENE activity/NN and/CC cyclin/MULTIGENE D1/MULTIGENE protein/MULTIGENE expression/NN ,/, in/IN a/DT growth/JJ factor-independent/NN manner/NN ./.
@@82304458912/CD The/DT product/NN of/IN the/DT vpr/JJ open/JJ reading/JJ frame/NN of/IN human/JJ immunodeficiency/NN virus/NN type/NN 1/CD (/( HIV-1/NNP )/SYM is/VBZ a/DT 15-kDa/NN ,/, arginine-rich/JJ protein/NN that/WDT is/VBZ present/VB in/IN virions/NNS in/IN molar/JJ quantities/NNS equivalent/JJ to/IN that/DT of/IN Gag/DT ./.
@@82125716599/CD Co-transfection/NNS of/IN a/DT tat/NEWGENE expressing/JJ plasmid/NN with/IN these/DT viruses/NNS containing/JJ the/DT tat/MULTIGENE ORF/MULTIGENE mutations/MULTIGENE resulted/VBN in/IN higher/JJ levels/NNS of/IN virus/NN production/NN demonstrating/VBG that/IN the/DT effects/NNS of/IN both/DT mutants/NNS are/VBP tat/NEWGENE specific/JJ ./.
@@67132001036/CD Epileptiform/NNP activity/NN recorded/VBN from/IN superficial/JJ laminae/NNS bordering/VBG layer/NN 4/CD ,/, and/CC into/IN which/WDT layer/VBP 4's/VBZ primary/JJ projections/NNS terminate/VBP ,/, is/VBZ suppressed/VBN preferentially/RB by/IN phenytoin/NN ./.
@@112048973320/CD After/IN allowing/VBG time/NN for/IN absorption/NN ,/, participants/NNS completed/VBD a/DT bridge/NN simulator/MULTIGENE task/MULTIGENE ./.
@@72633742299/CD Static/GENE lung/NN function/NN in/IN puppies/NNS after/IN pneumonectomy/NN ./.
@@76998451522/CD Clinical/NNP studies/NNS SY5555/NN was/VBD administered/VBN to/IN 45/CD patients/NNS with/IN various/JJ infectious/JJ diseases/NNS (/( 2/CD with/IN acute/JJ pharyngitis/NN ,/, 8/CD with/IN acute/JJ tonsillitis/NN ,/, 4/CD with/IN lacunar/JJ tonsillitis/NN ,/, 3/CD each/DT with/IN acute/JJ bronchitis/NN ,/, pneumonia/NN and/CC pertussis/NN ,/, 7/CD with/IN scarlet/JJ fever/NN ,/, 3/CD with/IN impetigo/NN contagiosa/NN ,/, 6/CD with/IN acute/JJ urinary/JJ tract/NN infections/NNS ,/, 2/CD with/IN balanoposthitis/NN and/CC 1/CD each/DT with/IN cervical/JJ lymphadenitis/NN ,/, S/NNP ./NNP S/NNP ./NNP S/NNP ./NNP S/NNP ./NNP ,/, vulvitis/NN and/CC acute/JJ colitis/NN )/SYM at/IN daily/JJ doses/NNS between/IN 3/CD ./CD 4-10/CD mg/CD //CD kg/CD ,/, t/NN ./NN i/NN ./NN d/NN ./NN ,/, for/IN 3-14/JJ days/NNS ./.
@@12973327939/CD This/DT analysis/NN ,/, together/RB with/IN a/DT consideration/NN of/IN the/DT SCBs/NNP found/VB upstream/RB of/IN known/VBP SWI4/MULTIGENE ,/MULTIGENE 6-dependent/MULTIGENE genes/MULTIGENE ,/, leads/VBP to/IN the/DT proposal/NN of/IN a/DT revised/VBN consensus/NN sequence/NN for/IN this/DT important/JJ regulatory/JJ element/NN ./.
@@37572948727/CD Of/IN the/DT cases/NNS with/IN PLD/NN ,/, 50%/NN had/VBP associated/VBN renal/JJ cysts/NNS and/CC 10%/CD of/IN the/DT cases/NNS with/IN APCD/NN had/VBP associated/VBN liver/NN cysts/NNS ./.
@@7255342983/CD It/PRP was/VBD postulated/VBN that/IN persistent/JJ challenge/NN by/IN M/NNP ./NNP leprae/NNS or/CC its/PRP antigens/NNS to/IN the/DT IgA/NN immunocytes/NNS of/IN the/DT intestinal/JJ epithelium/NN might/MD have/VB induced/VBN tolerance/NN leading/JJ to/IN IgA/NEWGENE deficiency/NN and/CC subsequent/JJ subtotal/JJ atrophy/NN of/IN the/DT intestinal/JJ villi/NNS in/IN the/DT patients/NNS with/IN lepromatous/JJ leprosy/NN ./.
@@24445075969/CD Lysozyme/NEWGENE activity/NN was/VBD evidently/RB increased/VBN as/IN well/NN in/RB undiluted/JJ as/IN in/IN diluted/VBN sera/NNS in/IN all/DT our/PRP tested/VBN patients/NNS ./.
@@92302163486/CD Human/MULTIGENE thymine-DNA/MULTIGENE glycosylase/MULTIGENE maps/NNS at/IN chromosome/NN 12q22-q24/CD ./CD 1/CD :/: a/DT region/NN of/IN high/JJ loss/NN of/IN heterozygosity/NN in/IN gastric/JJ cancer/NN ./.
@@111602808548/CD As/IN well/NN ,/, IFN-gamma-induced/JJ expression/NN of/IN IRF-1/GENE and/CC its/PRP binding/JJ to/IN the/DT IRF/MULTIGENE element/MULTIGENE is/VBZ inhibited/VBN ./.
@@17686489546/CD We/PRP exploit/VBP the/DT properties/NNS of/IN LexA/MULTIGENE fusion/MULTIGENE proteins/MULTIGENE to/IN study/NN the/DT dimerization/NN and/CC DNA-contacting/MULTIGENE domains/MULTIGENE of/IN cRel/NN ./.
@@57189945666/CD Endocardial/JJ fibro-elastosis/NN ,/, mitral/JJ incompetence/NN ,/, and/CC coarctation/NN of/IN abdominal/JJ aorta/NN ./.
@@64686326273/CD Endothelium/NNS of/IN the/DT central/JJ ear/NN artery/NN of/IN an/DT anesthetized/JJ rabbit/NN is/VBZ damaged/VBN by/IN placing/VBG artery/NN forceps/NN on/IN the/DT ear/NN directly/RB over/RB the/DT vessel/NN ./.
@@12481241888/CD Total/JJ cholesterol/NN was/VBD measured/VBN in/IN amniotic/JJ fluids/NNS collected/VBN at/IN different/JJ stages/NNS of/IN gestation/NN ./.
@@98117182396/CD These/DT results/NNS demonstrate/VBP a/DT specific/JJ association/NN of/IN SIV/NN and/CC HIV-2/MULTIGENE nef/MULTIGENE ,/, but/CC not/RB HIV-1/MULTIGENE nef/MULTIGENE ,/, with/IN TCRzeta/NNP ./.
@@21319028023/CD This/DT study/NN was/VBD performed/VBN to/IN clarify/VB the/DT location/NN of/IN a/DT transesophageal/JJ echocardiographic/JJ (/( TEE/NN )/SYM transducer/NN when/CC obtaining/JJ the/DT short-axis/NN view/NN of/IN the/DT left/NN ventricle/NN (/( S-LV/DT )/SYM ./.
@@98146377106/CD Low/NNP PbrO2/GENE readings/NNS ,/, however/RB ,/, could/MD be/VB caused/VBN by/IN local/JJ microhemorrhages/NNS ,/, undetectable/JJ on/IN CT/NN or/CC MRI/NN ./.
@@11126806966/CD One/CD of/IN the/DT sequelae/NNS of/IN the/DT antiphospholipid-antibodies/NNS is/VBZ an/DT impaired/VBN uteroplacental/JJ circulation/NN ./.
@@111239127414/CD The/DT structure/NN of/IN the/DT free/JJ SH2/GENE domain/NN has/VBZ been/VBN compared/VBN to/IN that/DT of/IN the/DT SH2/GENE complexed/VBN with/IN a/DT doubly/RB phosphorylated/VBN peptide/NN derived/VBN from/IN polyomavirus/NN middle/JJ T/NN antigen/NN (/( MT/NN )/SYM ./.
@@26918113365/CD During/IN the/DT first/JJ 3/CD min/NN of/IN recovery/NN ,/, plasma/NN potassium/NN fell/NN rapidly/RB in/IN spite/NN of/IN nearly/RB unchanged/JJ blood/NN acidosis/NN and/CC significantly/RB decreasing/JJ bicarbonate/NN concentration/NN ./.
@@95667317880/CD All/DT three/CD genes/NNS have/VBP been/VBN mapped/VBN precisely/RB to/IN a/DT small/JJ region/NN on/IN human/JJ chromosome/NN 16p12/CD ./CD 1-p11/CD ./CD 2/CD (/( homologous/JJ to/IN mouse/NN chromosome/NN 7/CD )/SYM ,/, using/VBG somatic/JJ cell/NN hybrids/NNS and/CC cosmid/NN clones/NNS ./.
@@31239833846/CD The/DT role/NN of/IN neuroplasticity/NN in/IN the/DT response/NN to/IN drugs/NNS ./.
@@2315551660/CD Effect/NN of/IN corticosteroid-containing/JJ antirheumatic/JJ combination/NN drugs/NNS on/IN endogenous/JJ ACTH/NEWGENE and/CC cortisol/NN production/NN ./.
@@91433283962/CD This/DT finding/NN is/VBZ the/DT first/JJ example/NN of/IN utilization/NN of/IN noncomplementary/JJ dinucleotide/NN primer/NN by/IN an/DT RNA/MULTIGENE polymerase/MULTIGENE ./.
@@28947898666/CD Finally/RB ,/, the/DT recovery/NN indexes/NNS represented/VBN by/IN the/DT times/NNS required/VBN for/IN T1/GENE //GENE T0/GENE and/CC T4/GENE //GENE T1/GENE to/IN rise/NN from/IN 25%/JJ to/IN 75%/JJ respectively/RB were/VBD studied/VBN ./.
@@98889944311/CD This/DT Tbx6-subfamily/MULTIGENE gene/MULTIGENE is/VBZ likely/RB to/IN participate/VB in/IN paraxial/JJ mesoderm/NN formation/NN and/CC somitogenesis/NN in/IN human/JJ embryo/NN ./.
@@114593041334/CD Enantiomer/NN separation/NN of/IN venlafaxine/NN and/CC O-desmethylvenlafaxine/NNP in/IN human/JJ plasma/NN ./.
@@82315778215/CD Acid/JJ instilled/VBN on/IN the/DT larynx/NN of/IN maturing/JJ rabbits/NNS resulted/VBN in/IN significant/JJ obstructive/JJ ,/, central/JJ ,/, and/CC mixed/JJ apnea/NN ./.
@@12462101886/CD The/DT calcium/NN ratio/NN (/NN mean/NN ratio/NN of/IN the/DT predicted/VBN to/IN measured/VBN TBCa/NN )/NN in/IN men/NNS was/VBD 1/CD ./CD 000/CD +/NN //NN -/NN 7/CD ./CD 8%/CD and/CC in/IN women/NNS 0/CD ./CD 996/CD +/NN //NN -/NN 7/CD ./CD 1%/CD ./.
@@93664568784/CD METHODS/IN :/: Total/JJ muscle/NN paralysis/NN was/VBD induced/VBN under/IN general/JJ anesthesia/NN in/IN a/DT group/NN of/IN obese/JJ persons/NNS (/( n/NN =/SYM 9/CD ;/: body/NN mass/JJ index/NN ,/, 32/NN +/NN //NN -/NN 3/CD kg/NN [/NN -2/NN ]/NN )/SYM and/CC in/IN a/DT group/NN of/IN nonobese/JJ persons/NNS (/( n/NN =/SYM 9/CD ;/: body/MULTIGENE mas/MULTIGENE index/NN ,/, 21/NN +/NN //NN -/NN 2/CD kg/NN [/NN -2/NN ]/NN )/SYM ./.
@@114712311349/CD In/NN addition/NN ,/, these/DT patients/NNS show/NN both/DT quantitative/JJ and/CC qualitative/JJ differences/NNS in/IN their/PRP infectious/JJ microbiological/JJ spectrum/NN ,/, mainly/RB in/IN clean-contaminated/JJ ,/, contaminated/VBN and/CC dirty/JJ surgical/JJ procedures/NNS ./.
@@1001984115/CD Testing/NN gravity/NN to/IN second/JJ post-Newtonian/JJ order/NN :/: A/DT field-theory/JJ approach/NN ./.
@@87948693686/CD Several/JJ lines/NNS of/IN evidence/NN presented/VBN here/RB suggest/VB that/IN PKC-zeta/DT plays/VBP a/DT role/NN in/IN alpha/MULTIGENE 2/MULTIGENE integrin/MULTIGENE gene/MULTIGENE expression/NN ./.
@@104038396382/CD Comparison/NNS with/IN the/DT bHLH/MULTIGENE //MULTIGENE PAS/MULTIGENE family/MULTIGENE genes/MULTIGENE revealed/VBN that/IN the/DT intron/NN //NN exon/NN splice/NN pattern/NN of/IN mBMAL1/GENE most/RB closely/RB matches/VBZ that/IN of/IN the/DT mAhr/NN ,/, which/WDT suggests/VBZ that/IN BMAL1/GENE and/CC Ahr/GENE belong/VB to/IN the/DT same/JJ subclass/NN and/CC may/MD be/VB derived/VBN from/IN a/DT common/JJ primordial/JJ gene/NN ./.
@@1651232597/CD Each/DT mRNA/NN contained/VBN five/CD or/CC six/CD internal/JJ uridine/NN residues/NNS ,/, which/WDT were/VBD transcribed/VBN using/VBG a/DT mixture/NN of/IN UTP/NN and/CC thio-UTP/JJ ./.
@@90115918971/CD The/DT total/JJ number/NN of/IN specimens/NNS was/VBD 131/CD with/IN 78/CD nonsmokers/NNS and/CC 53/CD smokers/NNS ./.
@@93073128071/CD Evidence/NN for/IN such/JJ peak/NN shifts/NNS has/VBZ been/VBN found/VB in/IN the/DT responses/NNS of/IN auditory/JJ nerve/NN fibers/NNS ,/, cochlear/JJ microphonics/NNS ,/, and/CC the/DT responses/NNS of/IN outer/JJ hair/NN cells/NNS and/CC supporting/VBG cells/NNS in/IN the/DT cochlea/NN ,/, as/RB well/VB as/IN in/IN basilar/JJ membrane/MULTIGENE vibration/MULTIGENE measurements/NNS ,/, and/CC indirectly/RB ,/, in/IN psychophysical/JJ data/NN ./.
@@8708595572/CD The/DT data/NN normally/RB available/JJ are/VBP insufficient/JJ and/CC take/VB no/DT account/NN of/IN the/DT direction/NN of/IN recirculation/NN ,/, which/WDT may/MD be/VB a/DT determining/MULTIGENE factor/MULTIGENE ./.
@@10355085215/CD Subsets/NNS of/IN patients/NNS were/VBD performed/VBN according/VBG to/IN the/DT severity/NN of/IN trauma/NN (/( ISS/NN </SYM 9/CD ;/: 9-17/CD ;/: 18-31/CD ;/: >/SYM 32/CD )/SYM ,/, based/VBN on/IN the/DT different/JJ injury/NN pattern/NN ,/, and/CC survivors/NNS versus/IN nonsurvivors/NNS as/IN well/NN ./.
@@10561153380/CD We/PRP present/VBP a/DT case/NN of/IN carcinoma/NN of/IN the/DT breast/NN presenting/VBG concurrently/RB with/IN SSc/NNS that/WDT subsequently/RB progressed/VBN to/IN dialysis-dependent/JJ renal/JJ failure/NN in/IN just/RB 1/CD month/NN ./.
@@1559734533/CD Accepting/VBG arbitrarily/RB chosen/VBP limits/NNS of/IN maximized/VBN errors/NNS of/IN +/NN //NN -/NN 10%/CD ,/, it/PRP could/MD be/VB shown/VBP that/IN the/DT system/NN did/VBD not/RB work/VB acceptably/RB when/CC the/DT mean/JJ carbon/NN dioxide/NN concentration/NN was/VBD below/RB 1/CD ./CD 5/CD vol/CD ./CD %/CD within/IN the/DT fresh/JJ gas/NN flow/NN rates/NNS (/( 2/CD ./CD 2--7/CD ./CD 7/CD 1/CD min-1/NN )/SYM and/CC the/DT range/NN of/IN minute/JJ ventilation/NN (/( 4--10/NN 1/CD min-1/NN )/SYM employed/VBN ./.
@@95493985463/CD Overall/JJ agreement/NN between/IN rest/NN //NN postnitroglycerin/NN technetium-99m/GENE tetrofosmin/NN SPET/NN studies/NNS and/CC rest/NN //NN redistribution/NN or/CC rest/MULTIGENE //MULTIGENE reinjection/MULTIGENE thallium-201/MULTIGENE SPET/JJ studies/NNS ,/, regarding/IN the/DT presence/NN of/IN myocardial/JJ viability/NN ,/, was/VBD 87%/JJ and/CC 90%/CD ,/, respectively/RB ./.
@@84433418109/CD Southern/NNP blot/NN analysis/NN using/VBG probes/NNS from/IN the/DT 3'/CD portions/NNS of/IN the/DT genomic/JJ and/CC B/NNP ./NNP napus/NN MA/NN and/CC MB/MULTIGENE cDNA/MULTIGENE clones/NNS showed/VBD that/DT MA/MULTIGENE type/MULTIGENE myrosinases/MULTIGENE are/VBP encoded/VBN by/IN approximately/RB 4/CD genes/NNS ,/, while/CC MB/MULTIGENE type/MULTIGENE myrosinases/MULTIGENE are/VBP encoded/VBN by/IN more/RB than/IN 10/CD genes/NNS in/IN B/NNP ./NNP napus/NN ./.
@@98585776514/CD The/DT loss/NN of/IN SKO1/GENE completely/RB restored/VBN ENA1/GENE expression/NN in/IN a/DT hog1/MULTIGENE mutant/MULTIGENE and/CC partially/RB suppressed/VBN the/DT osmotic/JJ stress/NN sensitivity/NN ,/, qualifying/JJ Sko1p/GENE as/IN a/DT downstream/JJ effector/NN of/IN the/DT HOG/NN pathway/NN ./.
@@91499299097/CD Congruent/NNP with/IN empirical/JJ predictions/NNS ,/, the/DT most/RB homesick/JJ children/NNS perceived/JJ low/JJ control/NN over/JJ homesickness/NN and/CC separation/NN ,/, and/CC coped/VBN by/IN relinquishing/VBG control/NN ./.
@@96875116476/CD Downregulation/NNS of/IN FUS/GENE expression/NN in/IN BCR/NNP //NNP ABL-expressing/NNP 32Dcl3/CD cells/NNS was/VBD associated/VBN with/IN suppression/NN of/IN growth/NN factor-independent/NN colony/NN formation/NN ,/, restoration/NN of/IN G-CSF-induced/JJ granulocytic/JJ differentiation/NN and/CC reduced/VBN tumorigenic/JJ potential/NN in/IN vivo/NN ./.
@@105016564381/CD Differential/JJ expression/NN was/VBD confirmed/VBN by/IN Northern/NNP blot/NN analysis/NN employing/VBG multiple/JJ normal/NN and/CC tumor/NN cell/NN lines/NNS ./.
@@82645832849/CD To/TO examine/VB the/DT biochemical/JJ basis/NN of/IN the/DT end/NN joining/VBG ,/, nuclear/JJ extracts/NNS were/VBD prepared/VBN from/IN a/DT wide/JJ variety/NN of/IN mammalian/JJ cell/NN lines/NNS and/CC tested/VBN for/IN their/PRP ability/NN to/IN join/NN test/NN plasmid/NN substrates/NNS ./.
@@8432696172/CD Deletion/NNS of/IN the/DT apeA/MULTIGENE gene/MULTIGENE ,/, either/DT with/IN or/CC without/IN deletion/NN of/IN other/DT proteinases/NNS (/( protease/MULTIGENE IV/MULTIGENE and/CC aminopeptidase/MULTIGENE N/MULTIGENE )/SYM ,/, did/VBD not/RB have/VB any/DT effect/NN on/IN cell/NN growth/NN in/IN the/DT various/JJ media/NN tested/VBN ./.
@@108489939666/CD Genomic/NN DNA/NN sequencing/VBG in/IN the/DT vicinity/NN of/IN methylmalonyl-CoA/MULTIGENE mutase/MULTIGENE gene/MULTIGENE (/( mutAB/GENE )/SYM from/IN a/DT rifamycin/NN SV-producing/NNP Amycolatopsis/NNP mediterranei/NN U32/GENE allowed/VBN us/PRP to/IN clone/NN ,/, sequence/NN ,/, and/CC identify/VB a/DT gene/NN encoding/VBG a/DT novel/JJ serine/MULTIGENE //MULTIGENE threonine/MULTIGENE protein/MULTIGENE kinase/MULTIGENE (/( amk/NN )/SYM ./.
@@63554837757/CD The/DT genes/NNS at/IN each/DT locus/NN are/VBP divergently/RB transcribed/VBN and/CC the/DT coding/JJ sequences/NNS are/VBP separated/VBN by/IN 646/CD base-pairs/NNS at/IN one/PRP locus/NN and/CC 676/CD base-pairs/NNS at/IN the/PDT other/DT ./.
@@13785067409/CD Surprisingly/RB ,/, the/DT full-deletion/JJ mutant/NN showed/VBD a/DT strong/JJ block/NN in/IN virus/NN release/NN ,/, suggesting/VBG that/DT NC/NN is/VBZ involved/VBN in/IN virus/NN assembly/NN ./.
@@5033368589/CD It/PRP has/VBZ come/VBN out/RB that/IN CAEC/GENE is/VBZ between/IN CC/NN and/CC CIEC/NNP and/CC that/IN attacks/NNS of/IN biliary/JJ fever/NN and/CC high/JJ levels/NNS of/IN alkaline/MULTIGENE phosphatase/MULTIGENE and/CC transaminases/NNS in/IN the/DT serum/JJ are/VBP the/DT helpful/JJ findings/NNS for/IN preoperative/JJ diagnosis/NN ./.
@@111057167917/CD CONCLUSION/IN :/: Our/PRP results/NNS suggest/VBP that/IN AIF/GENE peak/NN saturation/NN leads/VBP to/IN a/DT significant/JJ systematic/JJ error/NN in/IN the/DT determination/NN of/IN CBV/NN and/CC CBF/NN values/NNS and/CC has/VBZ necessarily/RB to/IN be/VB taken/VBP into/IN account/NN for/IN dynamic/JJ contrast-enhanced/JJ MR/NN perfusion/NN studies/NNS ./.
@@98624815902/CD The/DT Mig1/MULTIGENE repressor/MULTIGENE is/VBZ a/DT zinc/NN finger/NN protein/NN that/WDT mediates/VBZ glucose/NN repression/NN in/IN yeast/NN ./.
@@30393872180/CD Combined/VBN immunochemotherapy/NN with/IN cyclophosphamide/NN plus/IN BCG/NEWGENE gave/VBD a/DT better/JJR enhancement/NN of/IN the/DT antitumor/JJ effect/NN of/IN the/DT cytostatic/NN than/IN that/DT of/IN the/DT combination/NN of/IN methotrexate/NN plus/IN BCG/NEWGENE and/CC cyclophosphamide/NN plus/IN levamisole/NN ./.
@@106025163089/CD In/NN addition/NN ,/, SLK/GENE displays/VBP high/JJ homology/NN to/IN microtubule/NN and/CC nuclear/MULTIGENE associated/MULTIGENE protein/MULTIGENE (/( M-NAP/GENE )/SYM and/CC AT1-46/NNP ,/, both/DT of/IN unknown/JJ function/NN ./.
@@96559164580/CD In/NN the/DT DNA/NN recognition/NN helix/NN of/IN finger/MULTIGENE II/MULTIGENE ,/, the/DT conserved/VBN Arg/NN at/IN position/NN 62/CD (/( N-terminal/NN side/NN of/IN the/DT first/JJ zinc-coordinating/JJ histidine/NN )/SYM was/VBD changed/VBN to/IN a/DT Leu/NN or/CC Gln/NN ./.
@@97537744419/CD Plants/NNS transformed/VBN with/IN the/DT 35S-1-sst/JJ construct/NN accumulated/VBD the/DT oligofructans/NNS 1-kestose/JJ (/( GF2/GENE )/SYM ,/, 1/JJ ,/JJ 1-nystose/JJ (/( GF3/GENE )/SYM and/CC 1/JJ ,/JJ 1/JJ ,/JJ 1-fructosylnystose/JJ (/( GF4/GENE )/SYM ./.
@@85762622907/CD The/DT IL-8/MULTIGENE receptor/MULTIGENE is/VBZ a/DT seven-transmembrane/JJ spanning/VBG receptor/NN coupled/VBN to/IN specific/JJ heterotrimeric/JJ G/MULTIGENE proteins/MULTIGENE including/JJ Gi/NEWGENE and/CC G16/GENE ./.
@@94275516174/CD The/DT gene/NN contains/VBZ six/CD exons/NNS separated/VBN by/IN 1/CD ./CD 1-5/CD ./CD 8/CD kb/NN introns/NNS and/CC has/VBZ been/VBN localized/VBN to/IN the/DT murine/MULTIGENE chromosome/MULTIGENE 2/MULTIGENE by/IN linkage/NN analysis/NN ./.
@@28447674864/CD RNA/NN blot/NN hybridizations/NNS identified/VBD an/DT 1/CD ./CD 8-kb/CD mRNA/NN common/JJ to/IN cytochrome/MULTIGENE b6/MULTIGENE and/CC subunit/MULTIGENE IV/MULTIGENE ,/, and/CC an/DT intensely/RB hybridizing/VBG 0/CD ./CD 8-kb/CD mRNA/NN specific/JJ to/IN the/DT subunit/MULTIGENE IV/MULTIGENE gene/MULTIGENE probe/NN ./.
@@88913461691/CD To/TO address/VB the/DT biological/JJ effect/NN of/IN specific/JJ isoform/NN expression/NN ,/, NIH3T3/NNP cells/NNS were/VBD transfected/VBN with/IN a/DT eukaryotic/JJ expression/NN vector/NN containing/MULTIGENE cDNA/MULTIGENE for/IN FGF8a/NNP ,/, FGF8b/NNP ,/, or/CC FGF8e/NNP ./.
@@27667453467/CD A/DT hospital-based/JJ study/NN of/IN the/DT relationship/NN between/IN retained/VBN placenta/NN and/CC mastitis/NN in/IN dairy/NN cows/NNS ./.
@@14002179148/CD Mutational/JJ analysis/NN of/IN essential/JJ IncP/MULTIGENE alpha/MULTIGENE plasmid/NN transfer/MULTIGENE genes/MULTIGENE traF/GENE and/CC traG/NN and/CC involvement/NN of/IN traF/GENE in/IN phage/NN sensitivity/NN ./.
@@14201771354/CD Substitution/NNS of/IN either/DT Val33/NN (/( by/IN Gly/NN )/SYM or/CC Gly28/NNP (/( by/IN Ser/NN )/SYM ,/, two/NN of/IN the/DT most/RB conserved/VBN residues/NNS in/IN all/DT protein/MULTIGENE kinases/MULTIGENE ,/, resulted/VBN in/IN enzyme/NN with/IN marginally/RB detectable/JJ activity/NN ./.
@@95452935825/CD Sites/MULTIGENE 1/MULTIGENE and/CC 4/CD in/IN lumican/NN and/CC keratocan/NN are/VBP in/IN a/DT homologous/JJ location/NN ./.
@@883880547/CD Genomic/NN organization/NN of/IN the/DT human/MULTIGENE beta-catenin/MULTIGENE gene/MULTIGENE (/( CTNNB1/GENE )/SYM ./.
@@19180706911/CD We/PRP examined/VBD the/DT binding/NN of/IN purified/VBN T3/MULTIGENE receptor/MULTIGENE alpha/MULTIGENE (/( T3R/MULTIGENE alpha/MULTIGENE )/SYM ,/, overexpressed/VBN in/IN Escherichia/NN coli/JJ ,/, to/IN wild-type/NN and/CC up/NN and/CC down/NN mutations/NNS of/IN the/DT rGH/GENE T3RE/GENE to/IN evaluate/VB whether/IN transcriptional/JJ potency/NN correlates/VBP with/IN changes/NNS in/IN T3R/NNP binding/JJ ./.
@@104589142941/CD Analysis/NNP of/IN the/DT mouse/MULTIGENE STAP/MULTIGENE gene/MULTIGENE isolated/VBN from/IN the/DT genomic/JJ library/NN revealed/VBN that/IN the/DT STAP/MULTIGENE gene/MULTIGENE spans/VBZ a/DT region/NN of/IN over/RB 11/CD kb/NN and/CC comprises/VBZ eight/CD exons/NNS ./.
@@78943591098/CD Glomerular/JJ hemodynamics/NN during/IN abortion/NN induced/VBN by/IN RU/MULTIGENE 486/MULTIGENE and/CC sepsis/NN in/IN rats/NNS ./.
@@25277453530/CD Southern/NNP blot/NN analyses/NNS demonstrated/VBD a/DT low/NN ,/, if/IN not/RB single/JJ ,/, copy/NN number/NN for/IN this/DT gene/NN and/CC conservation/NN of/IN this/DT domain/NN in/IN other/DT vertebrates/NNS ./.
@@9785114986/CD Handling/VBG on/IN PND/MULTIGENE 9/MULTIGENE did/VBD not/RB result/VB in/IN elevated/VBN CORT/NEWGENE levels/NNS in/IN any/DT of/IN the/DT groups/NNS ./.
@@91222154128/CD We/PRP describe/VBP a/DT novel/JJ method/NN using/VBG Saccharomyces/NN cerevisiae/NN for/IN detecting/JJ protein-truncating/MULTIGENE mutations/MULTIGENE in/IN any/DT gene/NN of/IN interest/NN ./.
@@43218612451/CD Familial/JJ glutathione/MULTIGENE reductase/MULTIGENE deficiency/NN and/CC disorder/NN of/IN glutathione/NN synthesis/NN in/IN the/DT erythrocyte/NN ./.
@@80346828209/CD Stable/NN expression/NN of/IN truncated/JJ inositol/NN 1/MULTIGENE ,/MULTIGENE 4/MULTIGENE ,/MULTIGENE 5-trisphosphate/MULTIGENE receptor/MULTIGENE subunits/MULTIGENE in/IN 3T3/CD fibroblasts/NNS ./.
@@84377379299/CD Naval/NNP personnel/NN who/WP exceed/VBP standards/NNS for/IN %BF/NN can/MD be/VB separated/VBN from/IN active/JJ duty/NN ./.
@@110700077708/CD Transcription/NNS of/IN the/DT six/CD EBNA/MULTIGENE genes/MULTIGENE ,/, which/WDT are/VBP expressed/VBN in/IN EBV-immortalized/JJ primary/JJ B/NNP cells/NNS ,/, arises/VBZ from/IN one/PRP of/IN two/JJ promoters/NNS ,/, Cp/NN and/CC Wp/IN ,/, located/VBN near/IN the/DT left/NN end/NN of/IN the/DT viral/JJ genome/NN ./.
@@86435787539/CD Moreover/RB ,/, the/DT Rho/MULTIGENE family/MULTIGENE protein/MULTIGENE Cdc42/MULTIGENE ,/, a/DT conserved/VBN morphogenetic/JJ G/MULTIGENE protein/MULTIGENE ,/, is/VBZ also/RB a/DT potent/JJ regulator/NN of/IN filamentous/JJ growth/NN and/CC FG/NN (/NN TyA/NN )/NN :/: :/: lacZ/NN expression/NN in/IN S/NNP ./NNP cerevisiae/NN ./.
@@108741518384/CD BACKGROUND/IN :/: Gamma/NNP knife/NN radiosurgery/NN (/( GKR/GENE )/SYM is/VBZ a/DT safe/JJ and/CC effective/JJ alternative/NN to/IN surgery/NN for/IN intracranial/JJ lesions/NNS ./.
@@26894395243/CD Furthermore/RB ,/, the/DT 3'-untranslated/JJ regions/NNS of/IN pmGT10/GENE display/NN a/DT marked/JJ degree/NN of/IN homology/NN to/IN the/DT 3'/CD region/NN of/IN the/DT rat/MULTIGENE Yb1/MULTIGENE gene/MULTIGENE ,/, while/CC this/DT region/NN of/IN pmGT2/GENE displays/VBP marked/JJ homology/NN to/IN the/DT corresponding/JJ region/NN of/IN the/DT rat/MULTIGENE Yb2/MULTIGENE gene/MULTIGENE ./.
@@72860577142/CD Based/VBN on/IN AUC/NN infinity/NN analyses/NNS ,/, the/DT pharmacokinetics/NN of/IN buflomedil/NN were/VBD found/VBN to/IN be/VB linear/JJ within/IN the/DT dose/NN ranges/NNS studied/VBN (/( 50/CD to/IN 200/CD mg/NN for/IN i/JJ ./JJ v/NN ./NN injection/NN and/CC 150/CD to/IN 450/CD mg/NN for/IN oral/JJ administration/NN )/SYM ./.
@@19705605855/CD Translational/JJ fusions/NNS of/IN the/DT aroF/MULTIGENE regulatory/MULTIGENE regions/MULTIGENE to/IN lacZ/NN were/VBD constructed/VBN and/CC then/RB introduced/VBN in/IN single/JJ copy/NN into/IN the/DT E/NNP ./NNP coli/JJ chromosome/NN ./. beta-Galactosidase/NN assays/NNS for/IN tyrR-mediated/JJ regulation/NN of/IN aroF-lacZ/JJ expression/NN revealed/VBN that/IN the/DT E/NNP ./NNP coli/JJ TyrR/MULTIGENE repressor/MULTIGENE apparently/RB recognizes/VBZ the/DT operators/NNS of/IN both/DT organisms/NNS with/IN about/JJ equal/NN efficiency/NN ./.
@@43166964929/CD Enzyme/VBZ histochemical/JJ findings/NNS in/IN the/DT ultimobranchial/JJ body/NN of/IN the/DT horse/NN ./.
@@90924935783/CD The/DT integration/NN at/IN the/DT VIP/NNP CyRE/NNP of/IN the/DT Jak-Stat/GENE and/CC AP-1/GENE signaling/JJ pathways/NNS with/IN other/DT pre-existing/JJ proteins/NNS provides/VBZ a/DT cellular/JJ mechanism/NN for/IN cell-/DT and/CC cytokine-specific/JJ signaling/NN ./.
@@113788982578/CD ORF1/GENE (/( 1029/CD bp/NN ;/: EMBL/NN databank/NN ,/, Accession/NNS No/NN ./NN
@@90796503421/CD Members/NNS of/IN the/DT MAPK/MULTIGENE family/MULTIGENE include/VB the/DT extracellular/JJ response/MULTIGENE kinases/MULTIGENE (/( ERKs/GENE or/CC p42/NN //NN 44/NN (/NN MAPK/NN )/NN )/NN ,/, the/DT c-Jun/MULTIGENE amino-terminal/MULTIGENE kinases/MULTIGENE (/( JNKs/GENE )/SYM ,/, and/CC the/DT p38/MULTIGENE //MULTIGENE Hog/MULTIGENE 1/MULTIGENE protein/MULTIGENE kinases/MULTIGENE ./.
@@1088654713/CD Technique/NN for/IN obtaining/JJ refined/VBN ceramics/NN with/IN dense/JJ mass/NN ./.
@@103609472212/CD Employing/VBG fluorescence/NN spectroscopy/NN and/CC circular/JJ dichroism/NN ,/, we/PRP showed/VBD that/IN the/DT binding/NN of/IN Ca2+/NN to/IN ALG-2/GENE induced/VBN significant/JJ conformational/JJ changes/NNS in/IN both/PDT the/DT N-terminal/NN and/CC C-terminal/MULTIGENE domains/MULTIGENE of/IN the/DT protein/NN ./.
@@86447349242/CD We/PRP report/VBP the/DT isolation/NN of/IN human/JJ cDNAs/NNS homologous/JJ to/IN the/DT Drosophila/NN dishevelled/VBN (/( dsh/NN )/SYM segment-polarity/MULTIGENE gene/MULTIGENE ./.
@@111382316265/CD Closeup/NN :/: a/DT resource/NN for/IN nurses/NNS who/WP smoke/VBP ./.
@@116875173023/CD No/DT ISREs/NNS could/MD be/VB identified/VBN in/IN the/DT mouse/NN promoter/NN ./.
@@82128979695/CD The/DT hydrophobicity/NN profile/NN of/IN the/DT methyltransferase/NN reveals/VBZ the/DT presence/NN of/IN at/IN least/RB five/CD potential/JJ transmembrane/JJ domains/NNS ./.
@@84252216153/CD We/PRP describe/VBP a/DT novel/JJ cytoplasmic/MULTIGENE tyrosine/MULTIGENE kinase/MULTIGENE ,/, termed/JJ BPK/GENE (/( B/MULTIGENE cell/MULTIGENE progenitor/MULTIGENE kinase/MULTIGENE )/SYM ,/, which/WDT is/VBZ expressed/VBN in/IN all/DT stages/NNS of/IN the/DT B/NNP lineage/NN and/CC in/IN myeloid/JJ cells/NNS ./.
@@11182931025/CD The/DT data/NN support/NN the/DT notion/NN that/DT suppression/NN of/IN images/NNS during/IN binocular/JJ rivalry/NN is/VBZ independent/JJ in/IN both/DT eyes/NNS ./.
@@111263538926/CD RESULTS/NNS :/: Prevalence/NNS of/IN obesity/NN (/( BMI/MULTIGENE SDS/MULTIGENE >/MULTIGENE 2/MULTIGENE ./MULTIGENE 0/MULTIGENE )/SYM was/VBD </SYM 2%/JJ at/IN diagnosis/NN ,/, but/CC increased/VBD to/IN 16%/JJ at/IN 3y/CD ./CD
@@94269074134/CD The/DT purpose/NN of/IN this/DT investigation/NN was/VBD to/IN describe/VB a/DT new/JJ formulation/NN of/IN silver/JJ sulfadiazine/NN in/IN a/DT water/JJ soluble/JJ gel/NN ,/, poloxamer/MULTIGENE 188/MULTIGENE ./.
@@91701591446/CD These/DT mutations/NNS create/VBP stop/NN codons/NNS in/IN exon/NN 7/CD and/CC 8/CD ,/, respectively/RB ,/, and/CC probably/RB result/VB in/IN truncated/JJ proteins/NNS lacking/JJ HLH-Zip/GENE or/CC Zip/NN structure/NN ./.
@@11195861035/CD Glycogen/NNS utilization/NN was/VBD increased/VBN ,/, but/CC tissue/NN levels/NNS of/IN creatine/NN phosphate/NN ,/, ATP/NN ,/, and/CC lactate/NN were/VBD similar/JJ to/IN those/DT in/NN hearts/NNS receiving/JJ normal/JJ flow/NN ./.
@@93806979443/CD Two/CD sterol/NN regulatory/MULTIGENE element-like/MULTIGENE sequences/MULTIGENE mediate/VBP up-regulation/NN of/IN caveolin/MULTIGENE gene/MULTIGENE transcription/NN in/IN response/NN to/IN low/JJ density/NN lipoprotein/NN free/JJ cholesterol/NN ./.
@@114620046088/CD 2/CD were/VBD nonviable/JJ ,/, and/CC the/DT mutant/JJ Vp1s/NNP unexpectedly/RB failed/VBD to/IN localize/VB to/IN the/DT nucleus/NN though/CC Vp2/GENE and/CC Vp3/GENE did/VBD ,/, suggesting/VBG that/IN the/DT mutated/MULTIGENE NLS1/MULTIGENE acted/VBN as/IN a/DT dominant/JJ signal/NN for/IN the/DT cytoplasmic/JJ localization/NN of/IN Vp1/GENE ./.
@@73957507242/CD Underestimations/NNS by/RB as/RB much/JJ as/IN 35%/NN may/MD occur/VB due/NN to/IN the/DT problems/NNS in/IN the/DT existing/JJ methodologies/NNS ./.
@@40391094822/CD This/DT laser/NN provided/VBD sufficient/JJ power/NN in/IN an/DT amniotic/JJ fluid/NN medium/NN to/IN occlude/VB placental/JJ vessels/NNS as/RB large/JJ as/IN 7/CD mm/NN in/IN diameter/NN within/IN 6/CD seconds/NNS at/IN a/DT power/NN density/NN of/IN 2000/CD W/GENE //GENE cm2/GENE ./.
@@107736675639/CD The/DT HMG/NN domain/NN of/IN both/DT HMG20/MULTIGENE proteins/MULTIGENE is/VBZ most/RB similar/JJ to/IN that/DT of/IN yeast/MULTIGENE NHP6A/MULTIGENE (/( 38%/JJ to/IN 42%/JJ )/SYM ./.
@@91880944212/CD We/PRP have/VBP found/VBN that/IN mcs4-/NEWGENE cells/NNS are/VBP defective/JJ at/IN activation/NN of/IN Spc1/GENE in/IN response/NN to/IN various/JJ forms/NNS of/IN stress/NN ./.
@@17179944973/CD Cloning/NN of/IN a/DT human/JJ cDNA/NN encoding/VBG a/DT CDC2-related/MULTIGENE kinase/MULTIGENE by/IN complementation/NN of/IN a/DT budding/JJ yeast/MULTIGENE cdc28/MULTIGENE mutation/MULTIGENE ./.
@@19564919393/CD A/DT 7-day/CD treatment/NN of/IN amphotericin/MULTIGENE B/MULTIGENE (/( 5/CD mg/NN //NN kg/NN //NN day/NN i/CD ./CD p/CD ./CD )/SYM significantly/RB reduced/VBN the/DT glomerular/JJ filtration/NN rate/NN (/( GFR/NN )/SYM measured/VBN as/IN inuline/NN clearance/NN and/CC creatinine/NN clearance/NN (/( 0/CD ./CD 74/CD +/NN //NN -/NN 0/CD ./CD 29/CD and/CC 0/NN ./NN 16/NN +/NN //NN -/NN 0/CD ./CD 04/CD ml/NN //NN min/NN ,/, respectively/RB )/SYM in/IN comparison/NN to/IN vehicle-treated/JJ rats/NNS (/( 2/CD ./CD 04/CD +/NN //NN -/NN 0/CD ./CD 23/CD and/CC 1/CD ./CD 29/CD +/NN //NN -/NN 0/CD ./CD 19/CD ml/NN //NN min/NN ,/, respectively/RB )/SYM ./.
@@112412151379/CD The/DT mutant/JJ receptors/NNS ,/, as/RB well/VB as/IN sBMPR-IA/JJ ,/, were/VBD expressed/VBN as/IN fusion/NN proteins/NNS with/IN thioredoxin/NN in/IN Escherichia/NN coli/JJ ,/, and/CC purified/VBN using/VBG reverse/JJ phase/NN high/JJ performance/NN liquid/JJ chromatography/NN (/( RP-HPLC/NN )/SYM after/IN digestion/NN with/IN enterokinase/NN ./.
@@51337235392/CD Effect/NN of/IN phenformin/NN on/IN gluconeogenesis/NN in/IN perfused/VBN rat/NN liver/NN ./.
@@111796873485/CD The/DT Ig-related/NN ,/, typical/JJ metazoan/JJ ,/, module/NN is/VBZ classified/VBN to/IN the/DT disulphide/NN lacking/JJ Ig/MULTIGENE members/MULTIGENE and/CC represents/VBZ the/DT phylogenetic/JJ earliest/JJS member/NN of/IN this/DT group/NN ./.
@@89189344603/CD Comparison/NNS of/IN the/DT sequences/NNS of/IN the/DT xFxFG/MULTIGENE repeat/MULTIGENE regions/MULTIGENE of/IN p62/GENE and/CC Nsplp/GENE indicated/VBN that/IN NTF2/GENE was/VBD probably/RB interacting/VBG with/IN the/DT phenylalanine-containing/JJ core/NN of/IN these/DT repeats/NNS and/CC not/RB the/DT intervening/JJ hydrophilic/JJ linkers/NNS ./.
@@38021954631/CD These/DT fusion/NN proteins/NNS also/RB allowed/VBN the/DT localization/NN of/IN the/DT transcriptional/JJ activation/NN and/CC DNA/NN binding/JJ domains/NNS of/IN the/PDT ToxR/MULTIGENE protein/MULTIGENE to/IN its/PRP cytoplasmically/RB located/VBN N-terminal/NN portion/NN ./.
@@97105893891/CD Site-directed/JJ mutagenesis/NN of/IN residues/NNS in/IN this/DT domain/NN (/( R82A/GENE ,/, K85A/GENE ,/, K88A/GENE ,/, and/CC V89A/CONTEXTGENE )/SYM resulted/VBN in/IN proteins/NNS which/WDT failed/VBD to/IN transactivate/VB from/IN the/DT HTLV-1/MULTIGENE LTR/MULTIGENE in/IN vivo/NN ./.
@@68373128491/CD Fibromuscular/JJ intimal/JJ thickening/NN was/VBD seen/VBP in/IN the/DT ascending/JJ and/CC thoracic/JJ aorta/NN of/IN the/DT swine/NN fed/VBN 62/CD ,/CD 500/CD IU/NN of/IN vitamin/NN D3/GENE //GENE kg/GENE of/IN diet/NN for/IN three/CD months/NNS duration/NN ;/: and/CC after/IN 3/CD months/NNS of/IN vitamin/NN D3/GENE withdrawal/NN ,/, atherosclerotic/JJ lesions/NNS were/VBD found/VBN ./.
@@111533025946/CD Naltrexone/GENE hydrochloride/NN is/VBZ a/DT synthetic/JJ opioid/MULTIGENE receptor/MULTIGENE antagonist/MULTIGENE recently/RB used/VBD in/IN efforts/NNS to/IN provide/VB rapid/JJ opioid/JJ detoxification/NN ./.
@@22684612908/CD The/DT survival/NN in/IN the/DT case/NN of/IN these/DT patients/NNS was/VBD studied/VBN five/CD years/NNS later/JJR ./.
@@86629283457/CD Receptors/NNS for/IN interleukin/NN (/( IL/NN )/NN -10/NN and/CC IL-6-type/GENE cytokines/NNS use/NN similar/JJ signaling/JJ mechanisms/NNS for/IN inducing/JJ transcription/NN through/JJ IL-6/MULTIGENE response/MULTIGENE elements/MULTIGENE ./.
@@85016788464/CD This/DT new/JJ knowledge/NN has/VBZ contributed/VBN to/IN the/DT development/NN of/IN a/DT successful/JJ immunoprophylactic/JJ strategy/NN for/IN eliminating/JJ Hib/NN disease/NN ./.
@@78363643142/CD Self/NNP or/CC foreign/JJ cellular/JJ proteins/NNS provide/VBP peptides/NNS for/IN presentation/NN by/IN major/JJ histocompatibility/MULTIGENE complex/MULTIGENE (/( MHC/CONTEXTGENE )/SYM class/MULTIGENE I/MULTIGENE molecules/MULTIGENE on/IN the/DT surface/NN of/IN antigen/NN presenting/VBG cells/NNS (/( APC/NN )/SYM ./.
@@98585720/CD The/DT yeast/MULTIGENE retrotransposon/MULTIGENE Ty5/MULTIGENE preferentially/RB integrates/VBZ into/IN regions/NNS of/IN silent/JJ chromatin/NN ./.
@@64437146249/CD Finding/VBG of/IN Rhodnius/NN prolixus/NN Stal/JJ ,/, 1859/CD ,/, in/IN babassu/NN palm/NN trees/NNS ./.
@@78780409784/CD In/NN the/DT first/NN ,/, homologous/JJ sequences/NNS were/VBD deleted/VBN from/IN a/DT mouse/NN enhancer/NN ,/, resulting/JJ in/IN a/DT tissue-specific/JJ loss/NN of/IN activity/NN when/CC assayed/VBN in/IN transgenic/JJ mice/NNS ./.
@@37760809842/CD Parasitological/JJ post-mortem/JJ examination/NN of/IN all/DT seropositive/JJ animals/NNS showed/VBD five/CD and/CC seven/CD false-positive/JJ animals/NNS when/CC E/NNS //NNS S/NNS and/CC CWE/NEWGENE antigens/NNS were/VBD used/VBN ,/, respectively/RB ./.
@@16870502286/CD Diagnostic/NNP value/NN of/IN cerebrospinal/JJ fluid/NN immunoglobulin/MULTIGENE G/MULTIGENE (/( IgG/CONTEXTGENE )/SYM in/IN pediatric/JJ neurological/JJ diseases/NNS ./.
@@91478329092/CD Children's/NNP temperament/NN and/CC maternal/JJ socialization/NN at/IN Time/NNP 1/CD (/( n/NN =/SYM 103/CD ,/, aged/VBN 2-3/CD years/NNS )/SYM were/VBD considered/VBN predictors/NNS of/IN future/JJ conscience/NN ,/, assessed/VBN using/VBG new/JJ observational/JJ and/CC narrative/JJ measures/NNS ./.
@@114450086622/CD The/DT assay/NN herein/RB described/VBD allows/VBZ the/DT comparison/NN of/IN relative/JJ FGFR/NN expression/NN levels/NNS ,/, both/DT within/IN a/DT single/JJ RNA/NN pool/NN and/CC among/IN multiple/JJ RNA/NN pool/NN samples/NNS ./.
@@113161275918/CD The/DT %SVend/NN of/IN HCM-I/NNP was/VBD significantly/RB lower/JJR than/IN the/DT respective/JJ values/NNS of/IN the/DT HCM-II/GENE and/CC Control/NNP groups/NNS ./.
@@35161899414/CD All/DT patients/NNS then/RB received/VBN suxamethonium/NN 1/NN ./NN 5/NN mg/NN kg-1/NN i/CD ./CD v/CD ./.
@@26375977339/CD Serological/JJ studies/NNS at/IN the/DT early/JJ relapse/NN stage/NN of/IN this/DT disease/NN showed/VBD increased/VBN serum/JJ ANA/NN ,/, IgA/NN and/CC IgM/NN level/NN with/IN normal/JJ IgG/NEWGENE and/CC decrease/NN of/IN C3/NN and/CC C4/NNP ./NNP
@@14837552100/CD Magnetic/JJ resonance/NN spectroscopy/NN (/( MRS/NN )/SYM and/CC imaging/VBG (/( MRI/NN )/SYM are/VBP now/RB well/VB established/VBN techniques/NNS for/IN the/DT study/NN of/IN cellular/JJ metabolism/NN and/CC gross/JJ structure/NN of/IN muscle/NN ./.
@@101956907286/CD The/DT peroxisome/MULTIGENE proliferator-activated/MULTIGENE receptors/MULTIGENE (/( PPARs/CONTEXTGENE )/SYM are/VBP members/NNS of/IN the/DT nuclear/MULTIGENE hormone/MULTIGENE receptor/MULTIGENE superfamily/MULTIGENE ./.
@@79356265167/CD The/DT unexpected/JJ presence/NN of/IN the/DT tRNA/NN (/NN trp/NN )/NN (/NN CCA/NN )/NN -gene/NN transcript/NN in/IN mitochondria/NNS is/VBZ also/RB reported/VBN ./.
@@10713176665/CD Cyclin/MULTIGENE A/MULTIGENE expression/NN is/VBZ repressed/VBN in/IN quiescent/JJ cells/NNS by/IN E2F/GENE acting/JJ in/IN conjunction/NN with/IN its/PRP pocket/NN protein/NN partners/NNS Rb/CONTEXTGENE ,/, p107/GENE ,/, and/CC p130/GENE ;/: however/RB ,/, v-Jun/NN overrides/VBZ this/DT control/NN ,/, causing/JJ phosphorylated/VBN Rb/CONTEXTGENE and/CC proliferation-specific/NNP E2F-p107/NNP complexes/NNS to/IN persist/VB after/IN mitogen/NN withdrawal/NN ./.
@@33448122022/CD Thus/RB the/DT present/NN data/NN also/RB suggest/VB that/DT BP/NN and/CC HR/NN measurements/NNS are/VBP influenced/VBN not/RB only/RB by/IN state-dependent/MULTIGENE factors/MULTIGENE but/CC also/RB by/IN at/IN least/RB three/CD different/JJ factors/NNS that/WDT are/VBP each/DT independent/NN of/IN the/DT state/NN :/: one/PRP leads/VBP to/IN BP/NN and/CC HR/NN values/NNS that/WDT are/VBP influenced/VBN by/IN the/DT cycle/NN the/DT animal/NN is/VBZ in/IN and/CC the/PDT other/DT two/JJ influence/NN ,/, respectively/RB ,/, the/DT ranking/NN of/IN the/DT individual's/NNS BP/NN and/CC HR/NN levels/NNS within/IN the/DT population/NN ./.
@@111213971841/CD The/DT present/NN findings/NNS revealed/VBN that/IN the/DT rib-2/MULTIGENE protein/MULTIGENE was/VBD a/DT unique/JJ alpha1/RB ,/RB 4-N-acetylglucosaminyltransferase/RB involved/VBN in/IN the/DT biosynthetic/JJ initiation/NN and/CC elongation/NN of/IN heparan/NN sulfate/NN ./.
@@81253197654/CD The/DT ipiO/MULTIGENE genes/MULTIGENE code/NN for/IN two/JJ almost/RB identical/JJ 152-aa/JJ proteins/NNS which/WDT do/VBP not/RB have/VB any/DT homology/NN with/IN sequences/NNS present/VBP in/IN data/NN libraries/NNS ./.
@@115054078540/CD RESULTS/NNS :/: The/DT analyzed/VBN fragment/NN has/VBZ significant/JJ activity/NN in/IN EpCAM/NNP positive/JJ cells/NNS ,/, and/CC it/PRP is/VBZ regulated/VBN negatively/RB by/IN tumor/NN necrosis/MULTIGENE factor/MULTIGENE alpha/MULTIGENE (/( TNFalpha/CONTEXTGENE )/SYM ./.
@@11117826957/CD Because/IN PET/NN is/VBZ also/RB useful/JJ for/IN the/DT pretreatment/JJ and/CC follow-up/JJ evaluation/NN ,/, the/DT use/NN of/IN stereotactic/JJ PET/NN in/IN these/DT patients/NNS can/MD enable/VB an/DT accurate/JJ comparison/NN of/IN PET-based/JJ metabolic/JJ data/NN with/IN MR-based/JJ anatomical/JJ data/NN ./.
@@78070023139/CD To/TO do/VB this/DT ,/, segments/NNS of/IN DNA/NN from/IN the/DT 5'/CD flank/NN of/IN the/DT initiation/NN sites/NNS for/IN germline/MULTIGENE epsilon/MULTIGENE RNA/MULTIGENE were/VBD ligated/VBN to/IN a/DT luciferase/NN reporter/NN gene/NN and/CC transfected/VBN into/IN two/JJ mouse/NN B/NNP cell/NN lines/NNS ,/, one/PRP of/IN which/WDT can/MD be/VB induced/VBN to/IN switch/NN to/IN IgE/NN ./.
@@79278388731/CD In/NN eight/CD groups/NNS of/IN subjects/NNS operating/JJ various/JJ hand-held/JJ vibrating/JJ tools/NNS and/CC aged/VBN from/IN 30/CD to/IN 59/CD years/NNS ,/, the/DT prevalence/NN rates/NNS of/IN vibration-induced/NN white/NN finger/NN (/( VWF/NN )/SYM and/CC numbness/NN ,/, pain/NN ,/, or/CC stiffness/NN in/IN the/DT upper/JJ and/CC lower/JJR extremities/NNS were/VBD investigated/VBN ./.
@@10807900518/CD Among/IN non-cirrhotics/NNS ,/, lack/NN of/IN portal/JJ vein/MULTIGENE visualisation/MULTIGENE had/VBP a/DT 90%/CD sensitivity/NN ,/, 88%/JJ specificity/NN ,/, 94%/NN negative/JJ predictive/JJ value/NN ,/, and/CC 83%/JJ positive/JJ predictive/JJ value/NN in/IN the/DT diagnosis/NN of/IN pre-sinusoidal/JJ portal/JJ hypertension/NN ./.
@@103929006701/CD The/DT activation/NN of/IN the/DT HIV/MULTIGENE promoter/MULTIGENE required/VBD the/DT nuclear/JJ localization/NN of/IN c-Abl/GENE and/CC could/MD be/VB correlated/VBN with/IN increased/VBN tyrosine/NN phosphorylation/NN of/IN RNA/NN polymerase/NEWGENE II/NNS ./NNS
@@87404161942/CD The/DT SEB1/GENE homologue/NN thus/RB isolated/VBD ,/, SEB2/GENE ,/, encodes/VBZ a/DT protein/NN 53%/JJ identical/JJ to/IN Seb1p/GENE ./.
@@99905076485/CD CONCLUSIONS/IN :/: Fission/NNS yeast/MULTIGENE SCF/MULTIGENE is/VBZ composed/VBN of/IN Pop1/GENE and/CC Pop2/GENE ,/, two/JJ structurally/RB related/VBN but/CC functionally/RB independent/MULTIGENE F-box/MULTIGENE //MULTIGENE WD-repeat/MULTIGENE proteins/MULTIGENE ./.
@@98907789890/CD Carbohydrates/NNS and/CC glycoconjugates/NNS biophysical/JJ methods/NNS ./.
@@27336907234/CD Molecular/NNP cloning/NN and/CC characterisation/NN of/IN the/DT two/JJ homologous/JJ genes/NNS coding/JJ for/IN nitrate/MULTIGENE reductase/MULTIGENE in/IN tobacco/NN ./.
@@10850329654/CD IL-2/NEWGENE is/VBZ accepted/VBN as/IN a/DT standard/JJ treatment/NN used/VBN alone/RB ,/, or/CC in/IN combination/NN with/IN chemotherapy/NN or/CC biotherapy/NN in/IN the/DT management/NN of/IN metastatic/JJ melanoma/NN and/CC metastatic/JJ renal/JJ cell/NN carcinoma/NN ./.
@@106138743181/CD Cloning/VBG and/CC sequencing/VBG of/IN the/DT upstream/JJ region/NN of/IN pepX/NN revealed/VBD the/DT presence/NN of/IN two/JJ ORFs/NNS of/IN 360/CD and/CC 1/CD ,/CD 338/CD bp/NN that/WDT were/VBD shown/VBP to/IN be/VB able/JJ to/IN encode/VB proteins/NNS with/IN high/JJ homology/NN to/IN GlnR/DT and/CC GlnA/MULTIGENE proteins/MULTIGENE ,/, respectively/RB ./.
@@108285917143/CD The/DT transcript/NN was/VBD initially/RB identified/VBN as/IN a/DT partial/JJ cDNA/NN sequence/NN in/IN the/DT course/NN of/IN constructing/JJ a/DT transcript/NN map/NN of/IN the/DT region/NN between/IN markers/NNS D11S1765/GENE and/CC uteroglobin/NN known/VBP to/IN encompass/VB the/DT gene/NN causing/JJ Best/NN disease/NN ./.
@@16178012200/CD DESIGN/IN :/: Serum/NN aldosterone/NN and/CC plasma/NN renin/NEWGENE activity/NN were/VBD measured/VBN supine/JJ prior/NN to/IN and/CC 60/CD ,/, 90/CD ,/, 120/CD minutes/NNS after/IN oral/JJ captopril/NN ,/, 25/CD mg/NN ./NN
@@68166091983/CD At/NN 43%/JJ blood/NN pressure/NN reduction/NN ,/, PCO2/GENE fell/NN by/IN 0/CD ./CD 53/CD kPa/NN ,/, a/DT decrease/NN which/WDT could/MD not/RB explain/VB the/DT observed/VBN CBF/NN fall/NN of/IN 27%/NN ./.
@@14033912265/CD Chronic/NNP hepatitis/MULTIGENE B/MULTIGENE in/IN adopted/VBN Romanian/JJ children/NNS ./.
@@91902029018/CD This/DT coat/NN protein/NN consists/VBZ of/IN Sar1p/GENE ,/, the/DT Sec23p/MULTIGENE protein/MULTIGENE complex/MULTIGENE containing/JJ Sec23p/GENE and/CC Sec24p/GENE ,/, and/CC the/DT Sec13p/MULTIGENE protein/MULTIGENE complex/MULTIGENE containing/JJ Sec13p/GENE and/CC a/DT novel/JJ 150-kDa/MULTIGENE protein/MULTIGENE ,/, p150/GENE ./.
@@17829822325/CD Felodipine/NNP did/VBD not/RB alter/VB the/DT baseline/MULTIGENE FEV1/MULTIGENE ,/, but/CC showed/VBD a/DT small/JJ significant/JJ inhibitory/JJ effect/NN upon/IN histamine/NN and/CC AMP/NN induced/VBD bronchoconstriction/NN ./.
@@94510036210/CD Thus/RB ,/, Esigma54/MULTIGENE promoters/MULTIGENE are/VBP responsive/JJ to/IN CRP/NN ,/, a/DT protein/NN unrelated/JJ to/IN sigma54/MULTIGENE activators/MULTIGENE ,/, and/CC the/DT repression/NN exerted/VBN is/VBZ the/DT direct/JJ result/NN of/IN an/DT interaction/NN between/IN Esigma54/GENE and/CC the/DT CRP-cAMP/MULTIGENE complex/MULTIGENE ./.
@@91737339821/CD Three/CD different/JJ techniques/NNS of/IN EA/NEWGENE analysis/NN were/VBD used/VBN in/IN the/DT study/NN :/: 1/NN )/NN fast/JJ Fourier/NN transformation/NN (/( FFT/NN )/SYM of/IN EA/NN in/IN a/DT broad/JJ band/NN ,/, 2/NN )/NN developed/VBN by/IN us/PRP alternative/JJ method/NN of/IN non-harmonic/JJ expansion/NN of/IN the/DT EEG/NN curves/NNS taking/VBG into/IN account/NN their/PRP shape/NN ,/, 3/NN )/NN factor/NN analysis/NN of/IN the/DT EA/NN spectral/JJ densities/NNS ./.
@@77134216183/CD We/PRP show/VBP that/IN these/DT three/CD gain-of-function/NN mutants/NNS differ/VBP considerably/RB in/IN their/PRP ability/NN to/IN bypass/NN the/DT sex/NN determination/NN signal/JJ ,/, with/IN SxlM4/GENE being/VBP the/DT strongest/JJS and/CC SxlM1/GENE the/DT weakest/JJS ./.
@@1075247557/CD These/DT studies/NNS identify/VBP several/DT of/IN the/DT signal-transduction/JJ events/NNS involved/VBN in/IN the/DT apoptosis/NN of/IN malignant/JJ B/NNP cells/NNS that/WDT transpire/VBP following/IN ligation/NN of/IN CD20/NEWGENE by/IN anti-CD20/JJ antibodies/NNS in/IN the/DT presence/NN of/IN Fc-receptor-expressing/JJ cells/NNS or/CC secondary/JJ goat/NN anti-/NN (/NN mouse/NN Ig/NN )/NN antibodies/NNS and/CC which/WDT may/MD contribute/VB to/IN the/DT tumor/NN regressions/NNS observed/VBN in/IN mouse/NN models/NNS and/CC clinical/JJ trials/NNS ./.
@@96507897469/CD Orientation/NNS of/IN the/DT nuclear/JJ spin/NEWGENE system/NN by/IN optical/JJ pumping/JJ causes/VBZ an/DT Overhauser/NN shift/NN of/IN the/DT excitonic/JJ energy/NN levels/NNS proportional/JJ to/IN the/DT degree/NN of/IN nuclear/JJ orientation/NN ./.
@@64826656282/CD The/DT findings/NNS demonstrate/VBP that/IN AMPH/DT administration/NN induces/VBZ a/DT significant/JJ increase/NN in/IN the/DT height/NN of/IN a/DT major/JJ electroactive/JJ peak/NN in/IN the/DT caudate/JJ nucleus/NN of/IN pigtail/NN monkeys/NNS ,/, and/CC further/RB that/IN such/JJ amphetamine-induced/JJ increases/NNS can/MD be/VB manipulated/VBN by/IN altering/VBG the/DT affective/NN and/IN //IN or/IN emotional/JJ state/NN of/IN the/DT animal/NN ./.
@@8208540782/CD Cloning/VBG and/CC sequencing/VBG of/IN the/DT corresponding/JJ cDNAs/NNS indicates/VBZ that/IN ,/, via/NN alternative/JJ splicing/JJ ,/, the/DT rearranged/JJ gene/NN codes/NNS for/IN two/JJ proteins/NNS of/IN 84/CD and/CC 85/CD kD/NN (/( p84/GENE //GENE 85/GENE )/SYM which/WDT retain/VBP the/DT DNA-binding/MULTIGENE rel/MULTIGENE domain/NN and/CC the/DT first/JJ five/CD ankyrin/NN repeats/NNS ,/, but/CC have/VB lost/VBP their/PRP carboxy-terminus/NN including/JJ the/DT seventh/JJ ankyrin/NN repeat/NN ./.
@@91930773023/CD Light/MULTIGENE regulatory/MULTIGENE unit/MULTIGENE 1/MULTIGENE (/( LRU1/GENE )/SYM is/VBZ necessary/JJ for/IN and/CC sufficient/JJ to/IN mediate/VB light-dependent/JJ activation/NN of/IN the/DT chalcone/MULTIGENE synthase/MULTIGENE (/( CHS/CONTEXTGENE )/SYM minimal/JJ promoter/NN in/IN Petroselinum/NNP crispum/NN ./.
@@75104617394/CD One/CD patient/NN only/RB had/VBP any/DT test/NN abnormalities/NNS ./.
@@106478178780/CD Isolation/NNS of/IN cDNAs/NNS encoding/VBG gibbon/NN and/CC monkey/NN platelet/NN and/CC T/NN cell/NN activation/NN antigen/NN 1/CD (/( PTA1/GENE )/SYM ./.
@@92347038107/CD JNK/GENE is/VBZ additionally/RB regulated/VBN by/IN the/DT Ras-related/MULTIGENE G/MULTIGENE proteins/MULTIGENE Rac/MULTIGENE and/CC Cdc42/GENE ./.
@@99322885285/CD Expression/NNS of/IN the/DT second/JJ gene/NN (/( XT3/GENE )/SYM was/VBD found/VBN to/IN be/VB conserved/VBN in/IN human/JJ kidney/NN ,/, and/CC partial/JJ sequence/NN was/VBD obtained/VBN from/IN a/DT human/JJ cDNA/NN library/NN ./.
@@100213332649/CD Genetic/NNP experiments/NNS using/VBG mutants/NNS defective/JJ in/IN apontic/NN and/CC bruno/NN reveal/VB a/DT functional/JJ interaction/NN between/IN these/DT genes/NNS ./.
@@93156316508/CD Deletion/NNS of/IN the/DT POR2/MULTIGENE gene/MULTIGENE alone/RB had/VBP no/DT detectable/JJ phenotype/NN ,/, while/CC yeasts/NNS with/IN deletions/NNS of/IN both/PDT the/DT POR1/GENE and/CC POR2/MULTIGENE genes/MULTIGENE were/VBD viable/JJ and/CC able/JJ to/IN grow/VB on/IN glycerol/NN at/IN 30/CD degrees/NNS C/NN ,/, albeit/IN more/RB slowly/RB than/IN delta/MULTIGENE por1/MULTIGENE single/MULTIGENE mutants/MULTIGENE ./.
@@9950394189/CD The/DT history/NN of/IN exposure/NN and/CC carboxyhemoglobin/NEWGENE levels/NNS should/MD alert/VB the/DT physician/NN to/IN this/DT diagnosis/NN ./.
@@65791476343/CD The/DT salient/JJ clinical/JJ features/NNS ,/, the/DT problems/NNS of/IN management/NN and/CC the/DT modern/JJ approaches/NNS to/IN the/DT reconstruction/NN of/IN facial/JJ deformities/NNS seen/VBP in/IN this/DT disease/NN are/VBP described/VBN ./.
@@88941448845/CD CsA/NN alone/RB resulted/VBD in/IN elevated/VBN bone/NN turnover/NN ./.
@@76291224401/CD Mutational/JJ analysis/NN of/IN potential/JJ activating/MULTIGENE phosphorylation/MULTIGENE sites/MULTIGENE found/VBP in/IN NIMA/CONTEXTGENE ,/, NIM-1/GENE ,/, and/CC related/VBD protein/MULTIGENE kinases/MULTIGENE was/VBD performed/VBN on/IN NIMA/NNS ./.
@@4652237671/CD In/NN the/DT 8/CD patients/NNS the/DT difference/NN betweent/NN he/PRP mean/JJ diastolic/JJ values/NNS of/IN delta/NN PU/NN and/CC delta/NN PM/NN was/VBD -/: 0/CD ./CD 54/CD +/NN //NN -/NN 1/CD ./CD 0/CD (/( SD/NN )/SYM mmHg/NN ./.
@@98910613282/CD As/IN expected/VBN for/IN a/DT positive/JJ SpHE/MULTIGENE transcriptional/MULTIGENE regulator/MULTIGENE ,/, the/DT timing/NN of/IN SpEts4/MULTIGENE gene/MULTIGENE expression/NN precedes/VBZ the/DT transient/JJ expression/NN of/IN SpHE/NNP in/IN the/DT very/RB early/MULTIGENE sea/MULTIGENE urchin/NN blastula/NN ./.
@@118585481745/CD The/DT structure/NN has/VBZ been/VBN established/VBN by/IN a/DT study/NN of/IN its/PRP mono-/JJ and/CC bidimensional/JJ NMR/NN spectra/NNS and/CC mass/JJ spectrometry/NN ./.
@@90322332437/CD Interaction/NNS of/IN Ets-1/GENE and/CC the/DT POU-homeodomain/MULTIGENE protein/MULTIGENE GHF-1/GENE //GENE Pit-1/GENE reconstitutes/VBZ pituitary-specific/MULTIGENE gene/MULTIGENE expression/NN ./.
@@88664851892/CD These/DT bacteria/NNS produce/NN and/CC export/MULTIGENE proteins/MULTIGENE capable/JJ of/IN specific/JJ interactions/NNS with/IN key/NN mammalian/JJ cell/NN regulatory/JJ molecules/NNS in/IN order/NN to/IN derail/VB the/DT normal/JJ functions/NNS of/IN the/DT cells/NNS ./.
@@709658711/CD Seventeen/CD of/IN the/DT 35/CD patients/NNS were/VBD randomly/RB chosen/VBP to/IN receive/VB a/DT training/NN program/NN (/( lasting/JJ approximately/RB 1/CD month/NN )/SYM designed/VBN to/IN establish/VB a/DT systematic/JJ strategy/NN of/IN organizing/JJ complex/MULTIGENE visual/MULTIGENE material/NN ./.
@@34760024174/CD Hair/NN and/CC blood/NN samples/NNS were/VBD taken/VBP before/IN vitamin/NN C/NN or/CC placebo/NN supplementation/NN was/VBD started/VBN and/CC at/IN monthly/JJ intervals/NNS thereafter/RB for/IN three/CD months/NNS ./.
@@7222987048/CD A/DT one-way/JJ analysis/NN of/IN variance/NN ,/, performed/VBD separately/RB for/IN men/NNS and/CC women/NNS for/IN differences/NNS among/IN the/DT three/CD phobic/JJ groups/NNS on/IN field/NN dependence/NN ,/, showed/VBD significance/NN (/( rho/NN less/PRP than/IN ./CD 05/CD )/SYM for/IN the/DT females/NNS ,/, with/IN the/DT famale/JJ agoraphobic/JJ being/NN more/JJ field/NN dependent/JJ than/IN the/DT female/JJ simple/JJ phobic/JJ groups/NNS ,/, but/CC not/RB for/IN the/DT males/NNS ./.
@@105019369347/CD Inactivation/NNS of/IN the/DT Neurospora/NN crassa/NN mitochondrial/JJ outer/JJ membrane/MULTIGENE protein/MULTIGENE TOM70/MULTIGENE by/IN repeat-induced/JJ point/NN mutation/NN (/( RIP/GENE )/SYM causes/NNS defects/NNS in/IN mitochondrial/JJ protein/NN import/NN and/CC morphology/NN ./.
@@11255252403/CD A/DT minimal/JJ ER3/MULTIGENE sequence/MULTIGENE of/IN DNA/NN was/VBD further/RB demonstrated/VBN to/RB function/NN as/IN a/DT FXR/GENE HRE/NNP and/CC was/VBD bound/JJ in/IN vitro/FW by/IN FXR-expressing/VBG yeast/NN extracts/NNS ./.
@@51459255398/CD Radiosensitive/NNP nature/NN of/IN paravascular/JJ infiltrate-producing/JJ potential/NN of/IN parental/JJ spleen/NN cells/NNS ./.
@@14382245075/CD 205/CD ,/, 285-290/NN ]/NN and/CC was/VBD subsequently/RB cloned/VBN and/CC sequenced/VBN [/NN J/NN ./NN
@@111066672912/CD Thus/RB ,/, Pet111p/GENE could/MD play/VB dual/JJ roles/NNS in/IN both/DT membrane/NN localization/NN and/CC regulation/NN of/IN Cox2p/GENE synthesis/NN within/IN mitochondria/NNS ./.
@@89323852752/CD Small/MULTIGENE Maf/MULTIGENE proteins/MULTIGENE interact/VBP with/IN the/DT human/MULTIGENE transcription/MULTIGENE factor/MULTIGENE TCF11/MULTIGENE //MULTIGENE Nrf1/MULTIGENE //MULTIGENE LCR-F1/MULTIGENE ./.
@@12067721853/CD A/DT study/NN of/IN chromosomes/NNS of/IN lymphocytes/NNS from/IN patients/NNS treated/VBN with/IN hycanthone/NN ./.
@@2775136841/CD These/DT results/NNS suggest/VBP that/IN HAPE-S-S/GENE are/VBP prone/RB to/IN irregular/JJ nocturnal/JJ breathing/JJ patterns/NNS at/IN high/JJ altitude/NN ,/, which/WDT is/VBZ associated/VBN with/IN the/DT development/NN of/IN AMS/NNS ,/, but/CC it/PRP was/VBD not/RB possible/JJ to/IN determine/VB whether/IN these/DT abnormal/JJ breathing/JJ patterns/NNS are/VBP a/DT cause/NN or/CC an/DT effect/NN of/IN AMS/NNS ./.
@@86607338629/CD Reproducing/JJ populations/NNS of/IN this/DT aphid/NN were/VBD first/RB detected/VBN in/IN Puerto/NNP Rico/NNP in/IN April/NN 1992/CD ./.
@@1358880938/CD The/DT deduced/VBN amino/JJ acid/NN sequence/NN exhibited/VBN 98%/NN identity/NN to/IN the/DT human/JJ cellular/JJ transglutaminase/MULTIGENE sequence/MULTIGENE ./.
@@77062876114/CD However/RB ,/, the/DT inability/NN to/IN export/MULTIGENE RNA/MULTIGENE from/IN the/DT nucleus/NN to/IN the/DT cytoplasm/NN was/VBD not/RB limited/VBN to/IN a/DT particular/JJ phase/NN of/IN the/DT cell/NN division/NN cycle/NN ./.
@@75572764570/CD Alanine/MULTIGENE aminotransferase/MULTIGENE (/( ALT/NNP )/SYM levels/NNS had/VBP been/VBN elevated/VBN for/IN six/CD months/NNS in/IN all/DT patients/NNS and/CC hepatitis/NNP B/NNP viral/JJ infection/NN was/VBD replicative/JJ ./.
@@95832081681/CD Marked/JJ elevation/NN of/IN creatine/MULTIGENE kinase/MULTIGENE was/VBD observed/VBN while/CC serum/JJ albumin/NN ,/, immunoglobulin/NN ,/, and/CC complement/NN were/VBD decreased/VBN ./.
@@72931007151/CD Gastrin/NN secretion/NN during/IN food/NN stimulation/NN in/IN digestive/JJ system/NN diseases/NNS ./.
@@19431842572/CD Endothelial/JJ cells/NNS stored/VBN with/IN University/NNP of/IN Wisconsin/NN solution/NN excluded/VBD trypan/JJ blue/RB better/JJR (/( 1/CD ./CD 0%/CD +/NN //NN -/NN 0/CD ./CD 5%/CD cells/NNS stained/VBN ,/, p/NN less/PRP than/IN 0/CD ./CD 001/CD ./.
@@83578342393/CD A/DT comparison/NN of/IN the/DT predicted/VBN amino/JJ acid/NN sequences/NNS of/IN the/DT two/JJ human/MULTIGENE PKC-delta/MULTIGENE clones/NNS with/IN the/DT rat/NN and/CC mouse/NN homologues/NNS indicated/VBD a/DT greater/JJR degree/NN of/IN sequence/NN divergence/NN (/( 89-90%/CD homology/NN )/SYM compared/VBN to/IN the/DT high/JJ degree/NN of/IN sequence/NN conservation/NN observed/VBN with/IN other/DT human/MULTIGENE PKC/MULTIGENE family/MULTIGENE members/MULTIGENE and/CC their/PRP mammalian/JJ counterparts/NNS ./.
@@55950365610/CD Students/NNS ,/, parents/NNS ,/, teachers/NNS and/CC hearing/JJ disorders/NNS ./.
@@8290278875/CD Therefore/RB ,/, Mxi1/GENE and/CC Mad/NNP might/MD antagonize/VB Myc/VB function/NN and/CC are/VBP candidate/NN tumor/NN suppressor/NN genes/NNS ./.
@@79109468379/CD Analysis/NNP of/IN a/DT set/NN of/IN deletion/NN constructs/NNS in/IN transient/JJ transfection/NN assays/NNS measuring/JJ heterologous/JJ reporter/NN gene/NN (/( luciferase/NN )/SYM activity/NN demonstrated/VBN that/IN the/DT 182-bp/JJ 5'-flanking/JJ region/NN provides/VBZ full/JJ promoter/NN activity/NN in/IN IL-2-stimulated/JJ L2/NN cells/NNS ./.
@@76125577522/CD When/WRB excluding/JJ children/NNS with/IN ocular/JJ and/CC cerebral/JJ pathology/NN ,/, 32/CD matched/JJ pairs/NNS of/IN premature/JJ and/CC control/NN children/NNS remained/VBN ./.
@@100074692785/CD Optically/RB detected/VBN librons/NNS and/CC phonons/NNS in/IN crystalline/NN C60/NN ./.
@@57272225673/CD The/DT effects/NNS of/IN loading/VBG the/DT respiratory/JJ pumps/NNS on/IN the/DT oxygen/NN consumption/NN of/IN Callionymus/NNP lyra/NN ./.
@@86494241212/CD Expression/NNS of/IN the/DT phenylalanine/MULTIGENE hydroxylase/MULTIGENE gene/MULTIGENE in/IN livers/NNS and/CC kidneys/NNS of/IN rodents/NNS is/VBZ activated/VBN at/IN birth/NN and/CC is/VBZ induced/VBN by/IN glucocorticoids/NNS and/CC cyclic/JJ AMP/NN in/IN the/DT liver/NN ./.
@@109132765511/CD From/IN transient/JJ expression/NN studies/NNS ,/, we/PRP could/MD demonstrate/VB that/IN the/DT SH3/GENE domain/NN of/IN PLC-gamma1/GENE is/VBZ necessary/JJ for/IN the/DT association/NN with/IN SOS1/GENE in/IN vivo/NN ./.
@@104908266768/CD EB-1/GENE ,/, a/DT tyrosine/MULTIGENE kinase/MULTIGENE signal/JJ transduction/NN gene/NN ,/, is/VBZ transcriptionally/RB activated/VBN in/IN the/DT t/NN (/NN 1/NN ;/: 19/NN )/NN subset/NN of/IN pre-B/GENE ALL/NN ,/, which/WDT express/VBP oncoprotein/NN E2a-Pbx1/GENE ./.
@@9920930251/CD C3/MULTIGENE toxin/MULTIGENE completely/RB inhibited/VBD RhoA/NEWGENE function/NN ,/, partially/RB inhibited/VBN SRE/NNS :/: Luc/NNP activity/NN ,/, but/CC had/VBP no/DT effect/NN on/IN LPA-stimulated/JJ c-Fos/GENE expression/NN ./.
@@75650497226/CD It/PRP is/VBZ impossible/JJ to/IN define/VB only/RB one/PRP clinical/JJ outline/NN because/IN both/DT symptomatic/JJ and/CC asymptomatic/RB infected/VBN NB/NEWGENE may/MD be/VB found/VB with/IN gestational/JJ age/NN at/IN term/NN and/CC pre-term/NN and/CC when/CC born/JJ with/IN a/DT weight/NN above/RB or/CC below/RB 2000/CD g/CD ./CD
@@97432334718/CD Mutation/NN of/IN either/DT the/DT AP-1/GENE or/CC the/DT ets/NN component/NN of/IN this/DT site/NN also/RB prevented/VBD promoter/NN activity/NN in/IN SMCs/NNS ./.
@@78286002872/CD Binding/NN of/IN SSP/NN to/IN the/DT stage/NN selector/NN element/NN (/( SSE/NN )/SYM in/IN the/DT proximal/JJ gamma-globin/MULTIGENE promoter/MULTIGENE is/VBZ integral/JJ to/IN the/DT competitive/JJ silencing/VBG of/IN a/DT linked/MULTIGENE beta-promoter/MULTIGENE in/IN embryonic/JJ //JJ fetal/JJ stage/NN erythroleukemia/NN (/( K562/NNP )/SYM cells/NNS ./.
@@80936167424/CD Novel/NN 8-base/JJ pair/NN sequence/NN (/( Drosophila/MULTIGENE DNA/MULTIGENE replication-related/MULTIGENE element/MULTIGENE )/SYM and/CC specific/JJ binding/JJ factor/NN involved/VBN in/IN the/DT expression/NN of/IN Drosophila/MULTIGENE genes/MULTIGENE for/IN DNA/MULTIGENE polymerase/MULTIGENE alpha/MULTIGENE and/CC proliferating/JJ cell/NN nuclear/JJ antigen/NN ./.
@@17917543086/CD Mutational/JJ analysis/NN supports/VBP a/DT role/NN for/IN multiple/JJ structural/JJ features/NNS in/IN the/DT C-terminal/NN secretion/NN signal/NN of/IN Escherichia/NN coli/JJ haemolysin/NN ./.
@@35158404197/CD Five/CD out/RB of/IN eight/CD consecutive/JJ cases/NNS with/IN initial/JJ symptoms/NNS of/IN a/DT 'midline/NN granuloma'/NN were/VBD identified/VBN as/IN malignant/JJ histiocytosis/NN (/( histiocytic/JJ sarcoma/NN )/SYM which/WDT within/IN 5/CD months/NNS to/IN 4/CD years/NNS led/VBN to/IN generalization/NN and/CC death/NN ./.
@@7851643777/CD Thus/RB ,/, these/DT studies/NNS indicate/VBP that/IN the/DT 104-kDa/MULTIGENE isoform/MULTIGENE is/VBZ required/VBN for/IN normal/JJ proliferation/NN of/IN female/JJ germline/NN cells/NNS and/CC perhaps/RB for/IN oocyte/NN differentiation/NN ./.
@@75650317455/CD Twenty/CD food/NN products/NNS were/VBD contaminated/VBN with/IN V/NNP ./NNP cholerae/NNS O1/GENE ,/, Ogawa/GENE ,/, toxigenic/JJ and/CC not/RB toxigenic/JJ strains/NNS :/: yoghurt/NN ,/, cream/VB cheese/NN ,/, apricot/NN marmelade/NN ,/, hip/NN rose/VBD marmelade/NN ,/, mayonnaise/NN ,/, italian/JJ pasta/NN for/IN "empanadas"/NN ,/, "dulce/NN de/FW leche"/NN ,/, meat/NN sausage/NN ,/, meat/NN and/CC spinach/NN ravioli/NN ,/, margarine/NN ,/, milk/NN dessert/NN (/( made/VBP with/IN cocoa/JJ ,/, milk/NN confiture/NN ,/, starch/NN and/CC additives/NNS )/SYM ,/, lettuce/NN ,/, tuna/NN fish/NN ,/, ricotta/NN and/CC sterilized/VBN milk/NN ./.
@@83827781718/CD A/DT region/NN of/IN the/DT deduced/VBN protein/NN shares/VBP extensive/JJ homology/NN with/IN a/DT catalytic/JJ region/NN of/IN Raf/MULTIGENE kinases/MULTIGENE ,/, a/DT feature/NN shared/VBN only/RB with/IN TFIIE/NN among/IN transcription/NN factors/NNS ./.
@@71077736913/CD Conjugated/JJ and/CC unconjugated/JJ phenylacetic/JJ acid/NN and/CC m-/NN and/CC p-hydroxyphenylacetic/JJ acid/NN have/NN been/VBN determined/VBN in/IN the/DT plasma/NN of/IN normal/JJ ,/, healthy/JJ subjects/NNS after/IN fasting/JJ ,/, consumption/NN of/IN a/DT meal/NN and/CC ingestion/NN of/IN deuterium/NN labelled/JJ amine/NN precursors/NNS ,/, by/IN high-resolution/JJ gas/NN chromatography--high/JJ resolution/NN mass/JJ spectrometry/NN with/IN selected/VBN ion/NN monitoring/NN of/IN their/PRP trifluoroethyl-pentafluoropropionyl/JJ derivatives/NNS ./.
@@103199556546/CD We/PRP calculated/VBD differences/NNS in/IN late/JJ occlusion/NN rates/NNS by/IN the/DT chi2/GENE (/( chi-square/NN )/SYM test/NN ,/, and/CC found/VB these/DT differences/NNS were/VBD significant/JJ (/( P/CD =/CD ./CD 04/CD )/SYM ./.
@@33196467120/CD Plasma/NN renin/NEWGENE activity/NN does/VBP not/RB predict/VB the/DT antihypertensive/JJ efficacy/NN of/IN chlorthalidone/NN ./.
@@109209061506/CD CONCLUSION/IN :/: The/DT authors/NNS emphasize/VBP that/IN the/DT initial/JJ management/NN of/IN primary/MULTIGENE STS/MULTIGENE should/MD be/VB adequate/JJ and/CC suggest/VB that/IN safty/JJ margin/NN of/IN >/SYM or/CC =/SYM 2/CD cm/NN should/MD be/VB adhered/VBN to/CD ./CD
@@8472750940/CD Nitric/NNP oxide/NN inhalation/NN selectively/RB reduces/VBZ pulmonary/JJ hypertension/NN in/IN porcine/NN endotoxin/NN shock/NN and/CC improves/VBZ arterial/JJ oxygenation/NN and/CC pH/NN with/IN a/DT marked/JJ attenuation/NN of/IN sympathetic/JJ activation/NN ./.
@@95302519490/CD SNAC/NNP or/CC PBS/NNP was/VBD infused/VBN for/IN 6/CD ./CD 5/CD h/NN ,/, beginning/NN 30/CD min/NN before/IN ischemia/NN and/CC continuing/JJ throughout/IN the/DT duration/NN of/IN reperfusion/NN ./.
@@97511141990/CD Wild-type/NNP and/CC mutant/MULTIGENE MyoD/MULTIGENE were/VBD introduced/VBN into/IN cells/NNS using/VBG an/DT E1/GENE ,/, E3-deleted/JJ adenoviral/JJ vector/NN ./.
@@72175231770/CD Results/NNS of/IN the/DT recognition/MULTIGENE task/MULTIGENE revealed/VBD significant/JJ effects/NNS of/IN consonant/JJ voicing/JJ ,/, position/NN and/CC vowel/NN context/NN on/IN syllable/NN recognition/NN ./.
@@13485045631/CD Thus/RB ,/, the/DT pol/MULTIGENE alpha-primase/MULTIGENE complex/MULTIGENE appears/VBZ to/IN act/NN processively/RB for/IN only/RB a/DT short/JJ distance/NN ./.
@@4171664834/CD Pharmacokinetic/JJ profile/NN of/IN clonazepam/NN in/IN rhesus/NN monkeys/NNS ./.
@@110952483724/CD NH2-terminal/NN trimming/NN of/IN Xenopus/NN and/CC mammalian/JJ FGF3s/GENE may/MD therefore/RB be/VB a/DT prerequisite/NN of/IN optimal/JJ biological/JJ activity/NN ./.
@@101947627844/CD In/NN vitro/FW precipitation/NN with/IN a/DT glutathione-S-transferase-fusion/JJ protein/NN containing/JJ the/DT C-terminal/NN transactivation/NN domain/NN of/IN STAT5a/GENE showed/VBD GH-regulated/JJ association/NN of/IN ERK1/GENE //GENE 2/GENE with/IN the/DT fusion/NN protein/NN ,/, while/CC this/DT was/VBD not/RB seen/VBP when/CC serine/NN 780/CD in/IN STAT5a/NEWGENE was/VBD changed/VBN to/IN alanine/NN ./.
@@96863449903/CD The/DT biochemical/JJ and/CC molecular/JJ spectrum/NN of/IN ornithine/MULTIGENE transcarbamylase/MULTIGENE deficiency/NN ./.
@@104642918435/CD IL-1beta/NEWGENE (/( 10/CD ng/NN //NN ml/NN )/SYM drastically/RB increased/VBN both/DT PDGFalphaR/GENE and/CC CCAAT/MULTIGENE //MULTIGENE enhancer-binding/MULTIGENE protein/MULTIGENE delta/MULTIGENE (/( C/GENE //GENE EBPdelta/GENE )/SYM mRNA/NN levels/NNS in/IN a/DT time/NN dependent/JJ manner/NN ./.
@@115698001445/CD Temperature/NN measurement/NN in/IN microfluidic/JJ systems/NNS using/VBG a/DT temperature-dependent/JJ fluorescent/JJ dye/NN ./.
@@94215211291/CD Holliday/NNP junction/MULTIGENE resolvase/MULTIGENE in/IN Schizosaccharomyces/NN pombe/NN has/VBZ identical/JJ endonuclease/NN activity/NN to/IN the/DT CCE1/GENE homologue/NN YDC2/GENE ./.
@@78239646637/CD The/DT negative/JJ regulatory/JJ activity/NN of/IN the/DT N-terminal/NN domain/NN was/VBD antagonized/VBN by/IN a/DT C-terminal/MULTIGENE segment/MULTIGENE of/IN Pho81p/GENE supplied/VBN in/IN trans/JJ ./.
@@83926233994/CD IE2-IE2/GENE interactions/NNS were/VBD mapped/VBN to/IN a/DT domain/NN containing/JJ a/DT putative/JJ helix-turn-helix/NN motif/NN located/VBN near/IN the/DT C/NN terminus/NN of/IN IE2/GENE ,/, between/IN amino/JJ acids/NNS 456/CD and/CC 539/CD ./.
@@97270469018/CD Previously/RB ,/, we/PRP characterized/VBD a/DT DNA-binding/MULTIGENE protein/MULTIGENE ,/, HS2NF5/GENE ,/, that/IN bound/JJ tightly/RB to/IN a/DT conserved/VBN region/NN within/IN hypersensitive/JJ site/NN 2/CD (/( HS2/GENE )/SYM of/IN the/DT human/MULTIGENE beta-globin/MULTIGENE locus/MULTIGENE control/MULTIGENE region/MULTIGENE (/( LCR/CONTEXTGENE )/SYM (/( Lam/NN ,/, L/NNP ./NNP
@@25980343248/CD Middle-latency/NNP auditory/RB evoked/VBD potentials/NNS (/( MAEPs/NNP )/SYM were/VBD recorded/VBN in/IN controls/NNS and/CC patients/NNS with/IN focal/JJ lesions/NNS in/IN dorsolateral/JJ prefrontal/JJ cortex/NN ./.
@@16338167496/CD From/IN the/DT 15-kb/JJ clone/NN a/DT 4-kb/JJ EcoRI/MULTIGENE fragment/MULTIGENE containing/JJ the/DT first/JJ two/JJ exons/NNS and/CC 2/CD ./CD 6/CD kb/NN of/IN the/DT 5'/CD flanking/JJ region/NN of/IN the/DT opn/MULTIGENE gene/MULTIGENE was/VBD sequenced/VBN ,/, and/CC the/DT transcriptional/JJ start/NN site/NN determined/VBN by/IN primer/NN extension/NN analysis/NN and/CC S1/MULTIGENE nuclease/MULTIGENE mapping/NN ./.
@@93964379353/CD With/IN a/DT BMI/NN cutoff/NN of/IN 27/CD ,/, mean/JJ cardiac/MULTIGENE NE/MULTIGENE spillover/NN was/VBD 46%/RB lower/JJR in/IN the/DT obese/JJ subjects/NNS when/CC compared/VBN with/IN the/DT lean/JJ subjects/NNS (/( P/NNP =/NNP ./NNP 017/NNP )/SYM ./.
@@103958276377/CD However/RB ,/, the/DT favored/VBN ,/, parallel/JJ beta/NN helix/NN model/NN is/VBZ a/DT compact/JJ coil/NN of/IN ten/CD helically/RB arranged/VBN beta/NN strands/NNS forming/JJ two/JJ parallel/JJ beta/NN sheet/NN faces/NNS ./.
@@10540015365/CD C-SP/NN duration/NN was/VBD significantly/RB reduced/VBN in/IN ALS/NN patients/NNS compared/VBN to/IN controls/NNS at/IN low/JJ stimulation/NN intensity/NN corresponding/JJ to/IN an/DT MEP/NN threshold/NN increased/VBN by/IN 15%/NN ./.
@@94276271957/CD Small-molecule/NNP control/NN of/IN insulin/NN and/CC PDGF/MULTIGENE receptor/MULTIGENE signaling/JJ and/CC the/DT role/NN of/IN membrane/NN attachment/NN ./.
@@104674033092/CD The/DT Trk/MULTIGENE //MULTIGENE Nerve/MULTIGENE Growth/MULTIGENE Factor/MULTIGENE receptor/MULTIGENE mediates/VBZ the/DT rapid/JJ activation/NN of/IN a/DT number/NN of/IN intracellular/JJ signaling/MULTIGENE proteins/MULTIGENE ,/, including/JJ phosphatidylinositol/NEWGENE 3-kinase/NEWGENE (/( PI/NN 3-kinase/CD )/SYM ./.
@@80694278051/CD Roux-en-Y/JJ gastroenterostomy/NN severely/RB disturbs/VBZ emptying/NN of/IN the/DT gallbladder/NN ./.
@@9219116779/CD Levels/NNS of/IN both/DT PGF/GENE and/CC PGFM/GENE were/VBD significantly/RB higher/JJ during/IN early/JJ spontaneous/JJ labour/NN ,/, at/IN a/DT cervical/JJ dilatation/NN of/IN less/PRP than/IN 4/CD cm/NN ,/, than/IN before/IN the/DT onset/NN of/IN labour/NN ./.
@@116023536474/CD These/DT included/VBN HNF-3/MULTIGENE beta/MULTIGENE ,/, HFH-1/GENE ,/, HFH-2/GENE ,/, HFH-3/GENE ,/, C/CONTEXTGENE //CONTEXTGENE EBP/CONTEXTGENE ,/, and/CC C/MULTIGENE //MULTIGENE EBP/MULTIGENE beta/MULTIGENE ,/, all/DT of/IN which/WDT are/VBP consistent/JJ with/IN the/DT tissue-specific/JJ expression/NN profiles/NNS of/IN the/DT gene/NN ./.
@@76631388346/CD After/IN nadolol/NN ,/, heart/NN rate/NN decreased/VBN (/( -22/CD +/NN //NN -/NN 8%/JJ )/SYM ,/, and/CC so/RB did/VBD PBV/NNS and/CC PBF/GENE (/( 8/CD ./CD 8/CD +/NN //NN -/NN 3/CD ./CD 4/CD vs/IN ./IN
@@78461637697/CD The/DT mRNAs/NNS of/IN the/DT GRF/MULTIGENE genes/MULTIGENE are/VBP encoded/VBN by/IN six/CD exons/NNS interrupted/VBN by/IN five/CD introns/NNS ./.
@@39308946165/CD Changes/NNS in/IN muscarinic/MULTIGENE acetylcholine/MULTIGENE receptors/MULTIGENE in/IN guinea-pig/NN lung/NN :/: effects/NNS of/IN aging/NN ,/, inhalation/NN of/IN an/DT allergen/NN ,/, administration/NN of/IN drugs/NNS ,/, and/CC vagotomy/NN ./.
@@24430283105/CD No/DT reflow/NN occurred/VBN in/IN approximately/RB 30/CD percent/NN of/IN the/DT muscle/NN microvasculature/NN upon/IN reperfusion/NN ./.
@@108654221204/CD All/DT were/VBD tested/VBN for/IN serum/JJ ferritin/NEWGENE (/( SF/CONTEXTGENE )/SYM ,/, hemoglobin/NN (/( Hb/NN )/SYM level/NN and/CC asked/VBN for/IN detailed/JJ histories/NNS of/IN donations/NNS and/CC iron/NN supplementation/NN ./.
@@84457928406/CD Type/MULTIGENE II/MULTIGENE could/MD be/VB divided/VBN further/RB into/IN two/JJ forms/NNS (/( IIA/NN and/CC IIB/GENE )/SYM that/WDT may/MD represent/VB two/JJ underscribed/JJ species/NN or/CC developmental/JJ stages/NNS of/IN the/DT same/JJ species/NN ./.
@@114036631267/CD Net/JJ lift/NN and/CC combined/JJ drag/NN from/IN all/DT 8/CD bearings/NNS of/IN the/DT 4-bladed/JJ impeller/NN are/VBP compared/VBN with/IN predictions/NNS based/VBN on/IN 2-D/JJ theory/NN ./.
@@70754386847/CD Transvenous/JJ serial/JJ xeroradiography/NN ./.
@@26746718620/CD Of/IN the/DT single-stranded/JJ DNA/NN transformants/NNS ,/, 65%/RB resulted/VBN from/IN replacement/NN of/IN the/DT resident/JJ met2/NEWGENE mutation/NN by/IN the/DT exogenous/JJ wild-type/MULTIGENE allele/MULTIGENE ./.
@@10694189611/CD The/DT effect/NN of/IN MIB/GENE on/IN the/DT dose-response/NN curve/NN of/IN externally/RB applied/VBN noradrenaline/NN was/VBD also/RB studied/VBN ./.
@@87139338697/CD Laboratory/NNP evaluation/NN was/VBD normal/JJ ,/, and/CC neuroimaging/NN failed/VBN to/IN confirm/VB obstruction/NN of/IN venous/JJ or/CC lymphatic/JJ drainage/NN ./.
@@102090316739/CD The/DT Fyn/MULTIGENE NH2/MULTIGENE terminus/NN was/VBD necessary/JJ but/CC not/RB sufficient/JJ for/IN interaction/NN with/IN zeta/NN and/CC both/DT Fyn/MULTIGENE kinase/MULTIGENE and/CC SH2/MULTIGENE domains/MULTIGENE were/VBD required/VBN ,/, directing/VBG phosphorylation/NN of/IN zeta/NN ITAM/NNS tyrosines/NNS and/CC binding/JJ to/IN zeta/NN ITAM/NNS phosphotyrosines/NNS ./.
@@2831556591/CD These/DT offspring/NN of/IN the/DT alpha-MSH/GENE treated/VBN mothers/NNS were/VBD less/PRP sensitive/JJ to/IN pain/NN and/CC as/IN adults/NNS showed/VBD a/DT reduced/VBN analgesic/JJ response/NN to/IN morphine/NN ./.
@@75593553346/CD Although/IN eight/CD contiguous/JJ genes/NNS necessary/JJ for/IN urease/NEWGENE activity/NN have/NN been/VBN cloned/VBN and/CC sequenced/VBN ,/, the/DT transcriptional/JJ organization/NN and/CC regulation/NN of/IN specific/JJ genes/NNS within/IN the/DT Proteus/NN gene/NN cluster/NN has/VBZ not/RB been/VBN investigated/VBN in/IN detail/NN ./.
@@110383175041/CD The/DT small/JJ monomeric/NEWGENE GTP-binding/MULTIGENE proteins/MULTIGENE of/IN the/DT RAB/MULTIGENE subfamily/MULTIGENE are/VBP key/NN regulatory/JJ elements/NNS of/IN the/DT machinery/NN that/IN controls/NNS membrane/NN traffic/NN in/IN eukaryotic/JJ cells/NNS ./.
@@77425508944/CD The/DT cases/NNS included/VBN 35/CD de/FW novo/FW diffuse/JJ aggressive/JJ lymphomas/NNS (/( DAL/NN ;/: 19/CD large-cell/JJ ,/, 4/CD mixed-cell/JJ ,/, and/CC 12/CD large-cell/JJ immunoblastic/JJ )/SYM ,/, 52/CD transformed/VBN aggressive/JJ lymphomas/NNS derived/VBN from/IN follicular/JJ lymphomas/NNS (/( TFL/GENE )/SYM ,/, 42/CD indolent/JJ follicular/JJ lymphomas/NNS (/( FL/NN )/SYM ,/, 14/CD mantle/NN cell/NN lymphomas/NNS (/( MCL/NN )/SYM ,/, and/CC 27/CD small/JJ noncleaved/JJ cell/NN lymphomas/NNS (/( SNCL/NN )/SYM ./.
@@80958728070/NN Furthermore/RB ,/, this/DT study/NN demonstrates/VBZ that/WDT reduced/VBD inotropy/NN with/IN timolol/NN helped/VBD uniform/JJ local/JJ contraction/NN as/IN estimated/VBN by/IN the/DT increased/JJ LONG/NNP //NNP CIRC/NNP ratio/NN ,/, a/DT transition/NN that/WDT could/MD improve/VB contraction/NN efficacy/NN ./.
@@37474934416/CD Splenectomized/JJ patients/NNS are/VBP predisposed/VBN toward/IN developing/JJ overwhelming/JJ bacterial/JJ infections/NNS ./.
@@100255062753/CD In/JJ humans/NNS ,/, three/CD tissue-specific/MULTIGENE plastin/MULTIGENE isoforms/MULTIGENE have/VBP been/VBN identified/VBN ./.
@@33778643710/CD Static/GENE magnetic/JJ fields/NNS affect/VBP the/DT diffusion/NN of/IN biological/JJ particles/NNS in/IN solutions/NNS through/RB the/DT Lorentz/NNP force/NN and/CC Maxwell/NNP stress/NN ./.
@@111815642589/CD In/NN the/DT mouse/NN ,/, both/DT genes/NNS reside/VBP in/IN the/DT syntenic/JJ region/MULTIGENE 8E1/MULTIGENE on/IN chromosome/NN 8/CD ./CD
@@105185613938/CD Although/IN upstream/MULTIGENE regulators/MULTIGENE of/IN Tec/MULTIGENE family/MULTIGENE kinases/MULTIGENE are/VBP relatively/JJ well/NN characterized/VBN ,/, little/NN is/NNS known/VBP of/IN the/DT downstream/JJ effectors/NNS of/IN these/DT enzymes/NNS ./.
@@118167791002/CD The/DT drug/NN packets/NNS contained/VBD acetyl/MULTIGENE aspirin/MULTIGENE ,/, acetaminophen/NN and/CC chloramphenicol/NN ./.
@@83439616586/CD Anterior/NNP body/NN pattern/NN in/IN Drosophila/NN is/VBZ specified/VBN by/IN the/DT graded/JJ distribution/NN of/IN the/DT bicoid/MULTIGENE protein/MULTIGENE (/( bcd/NN )/SYM ,/, which/WDT activates/VBZ subordinate/JJ genes/NNS in/IN distinct/JJ anterior/JJ domains/NNS ./.
@@80142283031/CD Sample/NN treatment/NN was/VBD optimized/VBN in/IN order/NN to/IN achieve/VB a/DT complete/JJ extraction/NN of/IN labetalol/MULTIGENE diastereoisomers/MULTIGENE and/CC to/IN avoid/VB racemization/NN during/IN extraction/NN ./.
@@90049878968/CD Serotonin/NNS concentration/NN in/IN the/DT blood/NN of/IN patients/NNS with/IN hemorrhagic/JJ fever/NN with/IN renal/JJ syndrome/NN ./.
@@27083534196/CD Primer/NNS extension/NN experiments/NNS indicated/VBN that/IN the/DT transcription/NN initiation/NN site/NN mapped/VBN to/IN a/DT position/NN on/IN gene/MULTIGENE IV/MULTIGENE that/WDT was/VBD analogous/JJ to/IN that/DT reported/VBD for/IN the/DT structurally/RB similar/JJ P-450e/GENE gene/NN ./.
@@117869451637/CD Actuarial/JJ freedom/NN from/IN ventricular/JJ arrhythmias/NNS at/IN 4-year/JJ follow-up/NN was/VBD 74/CD ./CD 1/CD +/NN //NN -/NN 6/CD ./CD 0%/CD in/IN group/NN A/DT vs/NN ./NN
@@2619814632/CD Similarly/RB ,/, maternal/JJ serum/JJ somatomedin/NN A/NN was/VBD significantly/RB reduced/VBN in/IN rats/NNS nursing/JJ large/JJ litters/NNS ./.
@@9345037857/CD Recently/RB ,/, roles/NNS also/RB have/VBP been/VBN suggested/VBN for/IN the/DT nuclear/MULTIGENE trans-factor/MULTIGENE GATA-1/MULTIGENE in/IN regulating/JJ progenitor/NN cell/NN proliferation/NN ./.
@@105632128222/CD They/PRP self-completed/VBD the/DT SF-36/GENE questionnaire/NN and/CC their/PRP QoL/NN was/VBD described/VBN and/CC retrospectively/RB compared/VBN to/IN that/DT of/IN historical/JJ controls/NNS ./.
@@97947959975/CD Ligand/NN binding/JJ to/IN the/DT receptor/NN complex/NN leads/VBP to/IN tyrosine/NN phosphorylation/NN and/CC activation/NN of/IN Janus/MULTIGENE kinases/MULTIGENE (/( Jak/CONTEXTGENE )/SYM ,/, phosphorylation/NN of/IN the/DT signal/JJ transducing/JJ subunit/MULTIGENE gp130/MULTIGENE ,/, followed/VBN by/IN recruitment/NN and/CC phosphorylation/NN of/IN the/DT signal/MULTIGENE transducer/MULTIGENE and/CC activator/NN of/IN transcription/MULTIGENE factors/MULTIGENE STAT3/MULTIGENE and/CC STAT1/GENE and/CC the/DT src/NEWGENE homology/NN domain/NN (/( SH2/GENE )/NN -containing/NN protein/NN tyrosine/NN phosphatase/NN (/( SHP2/GENE )/SYM ./.
@@19929531928/CD Alanine/MULTIGENE aminotransferase/MULTIGENE in/IN clinical/JJ practice/NN ./.
@@93702763288/CD An/DT open/JJ reading/JJ frame/NN of/IN 2862/CD bp/NN encoding/VBG a/DT 954/CD amino/JJ acid/NN protein/NN was/VBD identified/VBN ./.
@@90508494002/CD In/NN this/DT regard/NN ,/, it/PRP differs/VBZ from/IN a/DT recently/RB reported/VBN BFA-sensitive/NNP ARF-GEP/GENE that/WDT contains/VBZ a/DT Sec7/GENE domain/NN ./.
@@83931434440/CD The/DT Sp1/MULTIGENE region/MULTIGENE ,/, however/RB ,/, is/VBZ converted/VBN to/IN a/DT functionally/RB strong/JJ TRE/NEWGENE by/IN the/DT viral/MULTIGENE tat/MULTIGENE factor/MULTIGENE ./.
@@19045469118/CD Disruption/NNS of/IN the/DT chromosomal/MULTIGENE AAR1/MULTIGENE gene/MULTIGENE in/IN alpha/NN and/CC a/NN //NN alpha/NN cells/NNS conferred/VBD the/DT nonmating/JJ phenotype/NN ,/, and/CC the/DT a/NN //NN alpha/NN diploids/NNS could/MD not/RB sporulate/VB ./.
@@76656337590/CD All/DT clinical/JJ isolates/NNS were/VBD concomitantly/RB tested/VBN by/IN disk/NN diffusion/NN and/CC agar/NN dilution/NN procedures/NNS as/IN outlined/VBN by/IN the/DT National/NNP Committee/NNP for/IN Clinical/NNP Laboratory/NNP Standards/NNPS ./.
@@90846219036/CD Movement/NNP time/NN and/CC kinematic/JJ characteristics/NNS were/VBD analyzed/VBN together/RB with/IN the/DT magnitude/NN of/IN cerebral/JJ blood/NN flow/NN to/IN identify/VB areas/NNS of/IN brain/NN activity/NN proportionate/JJ to/IN task/NN and/CC movement/NN variables/NNS ./.
@@15479572606/CD Using/VBG a/DT degenerate/JJ oligodeoxyribonucleotide/NN (/( oligo/NN )/SYM based/VBN on/IN the/DT N-terminal/NN aa/NNS sequence/NN ,/, plus/IN an/DT internal/JJ oligo/NN homologous/JJ to/IN a/DT conserved/VBN region/NN within/IN the/DT portion/NN of/IN CYP1/GENE and/CC CYP2/GENE that/WDT had/VBP been/VBN deleted/VBN in/IN the/DT genome/NN ,/, a/DT CYP3-specific/MULTIGENE DNA/MULTIGENE fragment/MULTIGENE was/VBD generated/VBN by/IN the/DT polymerase/NN chain/NN reaction/NN (/( PCR/NN )/SYM using/VBG GL81/GENE genomic/JJ DNA/NN as/IN a/DT substrate/NN ./.
@@21589276457/CD We/PRP have/VBP determined/VBN the/DT nucleotide/NN (/( nt/NN )/SYM sequence/NN of/IN the/DT 7/CD ./CD 5-kb/CD COR/NN segment/NN that/WDT encompasses/VBZ a/DT cluster/NN of/IN six/CD genes/NNS (/( CYC1/GENE ,/, UTR1/GENE ,/, UTR3/GENE ,/, OSM1/GENE ,/, tRNA/NN (/NN Gly/NN )/SYM and/CC RAD7/NN )/NN located/VBD on/IN chromosome/MULTIGENE X/MULTIGENE of/IN the/DT yeast/NN Saccharomyces/NN cerevisiae/NN ./.
@@14185423013/CD The/DT effect/NN of/IN sodium/MULTIGENE 18/MULTIGENE beta-glycyrrhetate/JJ (/( SGA/JJ )/SYM on/IN experimental/JJ arrhythmia/NN was/VBD investigated/VBN ./.
@@16551262256/CD Extraction/NNS procedure/NN for/IN the/DT measurement/NN of/IN butyltin/NN compounds/NNS in/IN biological/JJ tissues/NNS using/VBG toluene/NN ,/, HBr/NNP ,/, and/CC tropolone/NN ./.
@@32642993961/CD In/NN untreated/JJ mice/NNS ,/, bactericidal/JJ activity/NN of/IN peritoneal/JJ macrophages/NNS decreased/VBN from/IN one/PRP day/NN to/IN 3/CD days/NNS after/IN ip/NN injection/NN of/IN killed/VBN L/NNP ./NNP monocytogenes/NNS ./.
@@113981345343/CD In/NN conclusion/NN ,/, obesity/NN ,/, alcohol/NN intake/NN ,/, and/CC multimetabolic/JJ disorders/NNS were/VBD determined/VBN to/IN be/VB independent/MULTIGENE predictors/MULTIGENE for/IN the/DT development/NN of/IN hyperuricemia/NN ./.
@@86316854789/CD The/DT structural/JJ gene/NN for/IN copper-/NN and/CC topa/NN quinone-containing/MULTIGENE monoamine/MULTIGENE oxidase/MULTIGENE (/( maoA/CONTEXTGENE )/SYM and/CC an/DT unknown/JJ amine/MULTIGENE oxidase/MULTIGENE gene/MULTIGENE have/NN been/VBN located/VBN at/IN 30/CD ./CD 9/CD min/NN on/IN the/DT Escherichia/NN coli/JJ chromosome/NN ./.
@@115925328431/CD METHODS/IN :/: Humphrey/NNP Field/NNP Analyzer/NNP model/NN 630/CD (/( HFA/MULTIGENE I/MULTIGENE ,/, program/NN 30-2/CD with/IN a/DT rectangular/JJ 6/CD degrees/NNS x/NN 6/CD degrees/NNS grid/NN )/SYM was/VBD used/VBN as/IN the/DT conventional/JJ perimetric/JJ method/NN ./.
@@47182335117/CD Methyl/NN mercury/NN intoxication/NN in/IN rat/NN kidneys/NNS ./.
@@117925861658/CD Cyclic/NNP loading/NN of/IN bone/NN during/IN normal/JJ daily/JJ activity/NN leads/VBP to/IN the/DT formation/NN of/IN microcracks/NNS within/IN the/DT tissue/NN matrix/NN of/IN compact/JJ bone/NN ./.
@@16782877875/CD Because/IN the/DT human/JJ Antp/GENE TATAA/MULTIGENE binding/MULTIGENE protein/MULTIGENE is/VBZ expressed/VBN in/IN both/DT lymphoid/JJ and/CC non-lymphoid/JJ cells/NNS ,/, we/PRP suggest/VBP that/IN this/DT homeobox/MULTIGENE gene/MULTIGENE has/VBZ evolved/VBN a/DT more/RB general/JJ transcriptional/JJ regulatory/JJ function/NN in/IN higher/JJ eukaryotic/JJ cells/NNS ./.
@@16420606765/CD The/DT clinical/JJ application/NN of/IN the/DT antibody-targeted/JJ Phthalocyanine/NN was/VBD performed/VBN in/IN 3/CD patients/NNS suffering/VBG from/IN an/DT advanced/JJ ovarian/JJ carcinoma/NN (/( FIGO/MULTIGENE III/MULTIGENE )/SYM ./.
@@86555558121/CD The/DT DNA/NN sequence/NN immediately/RB upstream/RB from/IN the/DT -/: 10/CD hexamer/NN contained/VBD the/DT TGn/MULTIGENE motif/MULTIGENE described/VBN as/IN an/DT extended/VBN -10/CD region/NN in/IN prokaryotic/JJ promoters/NNS ./.
@@82825016989/CD Because/IN of/IN the/DT small/JJ number/NN of/IN visceral/JJ angiography/NN procedures/NNS performed/VBN (/( 38/CD )/SYM ,/, no/DT definitive/JJ conclusions/NNS could/MD be/VB drawn/VBP as/IN to/IN the/DT differences/NNS between/IN ionic/JJ and/CC nonionic/JJ agents/NNS regarding/IN grade-2/GENE and/CC grade-3/GENE adverse/JJ events/NNS ./.
@@77581676655/CD Growth/NN curves/NNS indicated/VBD that/DT proliferation/NN of/IN clone/MULTIGENE CA9/MULTIGENE in/IN the/DT presence/NN of/IN 10%/CD serum/NN was/VBD reduced/VBN by/IN 60%/CD compared/VBN with/IN clone/MULTIGENE ME10/MULTIGENE ./.
@@30183566/CD Takayasu's/NNP disease/NN :/: association/NN with/IN HLA-B5/GENE ./.
@@9548199500/CD These/DT data/NN suggest/VB that/IN spontaneous/JJ recovery/NN of/IN central/JJ respiratory/JJ function/NN after/IN intoxication/NN with/IN Soman/VB or/CC Sarin/NNP may/MD not/RB be/VB related/VBN to/IN the/DT return/NN of/IN AChE/NEWGENE activity/NN ./.
@@21238771406/CD Additionally/RB ,/, although/IN c-fos/GENE and/CC egr-1/MULTIGENE mRNAs/MULTIGENE are/VBP expressed/VBN at/IN elevated/VBN levels/NNS in/IN stimulated/VBN liver/NN cells/NNS ,/, fos-B/GENE ,/, fra-1/GENE ,/, and/CC egr-2/NEWGENE are/VBP not/RB ,/, which/WDT suggests/VBZ that/IN factors/NNS in/IN addition/NN to/IN the/DT serum/JJ response/MULTIGENE factor/MULTIGENE participate/VB in/IN the/DT regulation/NN of/IN immediate-early/JJ gene/NN induction/NN ./.
@@14481079506/CD We/PRP describe/VBP here/RB 17/CD dominant/JJ GCN2/MULTIGENE mutations/MULTIGENE that/WDT lead/VBP to/IN derepression/NN of/IN GCN4/NEWGENE expression/NN in/IN the/DT absence/NN of/IN amino/JJ acid/NN starvation/NN ./.
@@11239184893/CD Baseline/NN variables/NNS associated/VBN with/IN CD/NN included/VBD a/DT less/PRP frequent/VB use/NN of/IN prestroke/NN aspirin/NN and/CC a/DT higher/JJ incidence/NN of/IN early/MULTIGENE CT/MULTIGENE changes/NNS of/IN edema/NN or/CC mass/JJ effect/NN or/CC dense/JJ middle/JJ cerebral/JJ artery/NN sign/NN ./.
@@4564245033/CD The/DT effects/NNS of/IN intracisternal/JJ injection/NN (/( i/CD ./CD c/CD ./CD i/CD ./CD )/SYM of/IN clonidine/NN (/( 1/CD microgram/NN kg-1/NN )/SYM on/IN blood/NN pressure/NN and/CC heart/NN rate/NN were/VBD studied/VBN in/IN conscious/JJ rabbits/NNS with/IN an/DT implanted/VBN catheter/NN in/IN the/DT cisterna/NN magna/NN ./.
@@34176682830/CD These/DT findings/NNS indicate/VBP that/DT autophosphorylation/NN of/IN Thr286/CONTEXTGENE (/( alpha/MULTIGENE subunit/MULTIGENE )/SYM and/CC Thr287/CONTEXTGENE (/( beta/MULTIGENE subunit/MULTIGENE )/SYM is/VBZ responsible/JJ for/IN transition/NN of/IN CaM-kinase/MULTIGENE II/MULTIGENE to/IN the/DT Ca2+-independent/JJ form/NN ./.
@@77457269297/CD For/IN replication/NN reporter/NN constructs/NNS where/CC E1/GENE and/CC E2/GENE are/VBP supplied/VBN in/IN trans/JJ by/IN the/DT respective/JJ expression/NN vectors/NNS ,/, distance/NN between/IN the/DT half/NN sites/NNS seems/VBZ to/IN play/NN a/DT major/JJ role/NN ,/, yet/RB the/DT phasing/JJ relationships/NNS are/VBP measurable/JJ ./.
@@67841233257/CD Transcripts/NNS of/IN the/DT immunoglobulin/MULTIGENE C/MULTIGENE mu/MULTIGENE gene/MULTIGENE vary/VB in/IN structure/NN and/CC splicing/JJ during/IN lymphoid/JJ development/NN ./.
@@80944649031/CD Within/IN the/DT span/NN of/IN attenuator/MULTIGENE region/MULTIGENE encoding/VBG the/DT three/CD stem-loop/NN structures/NNS of/IN mRNA/NN secondary/JJ configuration/NN ,/, hot/JJ spots/NNS of/IN base-residue/JJ divergence/NN were/VBD localized/VBN to/IN looped-out/JJ regions/NNS ./.
@@71351127621/CD Repair/NNS of/IN a/DT cosmetic/JJ defect/NN of/IN the/DT lower/JJR leg/NN with/IN a/DT myocutaneous/JJ free/JJ flap/NN ./.
@@3198525810/CD In/NN a/DT 112-d/JJ feedlot/NN trial/NN ,/, 105/CD heifers/NNS were/VBD assigned/VBN to/IN light/NN ,/, medium/NN and/CC heavy/JJ weight/NN blocks/NNS on/IN five/CD treatments/NNS :/: dietary/JJ MGA/NN (/( ./NN 5/NN mg/NN ./NN hd-1/NN ./NN d-1/NN )/SYM ,/, control/NN (/( no/DT MGA/NN )/SYM or/CC DEPO-MGA/NNP on/IN d/NN 1/NN at/IN ./CD 5/CD ,/, 1/CD ./CD 0/CD or/CC 1/CD ./CD 5/CD ml/NN //NN hd/NN (/( 30/CD ,/, 60/CD or/CC 90/CD mg/NN MGA/NNP //NNP hd/NNP ,/, respectively/RB )/SYM ./.
@@6650536381/CD Escherichia/NN of/IN a/DT single/JJ sero-anzymatic/JJ type/NN (/( 06a6b/CD :/: K13/NNP :/: H1/NN )/SYM were/VBD isolated/VBN in/IN a/DT group/NN affection/NN ./.
@@77469377702/CD Lung/NNP function/NN tests/NNS (/( EFR/NN )/SYM were/VBD performed/VBN on/IN these/DT patients/NNS for/IN a/DT period/NN of/IN 19/CD ./CD 2/CD +/NN //NN -/NN 3/CD ./CD 4/CD months/NNS ./.
@@111800271737/CD Respiratory/NNP parameters/NNS suggested/VBN that/IN M6G/GENE produced/VBN less/PRP respiratory/JJ depression/NN than/IN morphine/NN ./.
@@106733352089/CD Copyright/NNP 2000/CD Academic/NNP Press/NNP ./.
@@10722509547/CD Eight/CD patients/NNS received/VBN 1/CD ./CD 5/CD mg/NN of/IN adefovir/NN dipivoxil/NN per/IN kg/NN of/IN body/NN weight/NN ,/, and/CC six/CD patients/NNS received/VBN 3/CD ./CD 0/CD mg/NN of/IN adefovir/NN dipivoxil/NN per/IN kg/CD ./CD
@@25954515772/CD A/DT fine-structure/NN deletion/NN map/NN of/IN human/MULTIGENE chromosome/MULTIGENE 11p/MULTIGENE :/: analysis/NN of/IN J1/GENE series/NN hybrids/NNS ./.
@@89133872837/CD Rifabutin/GENE has/VBZ substantial/JJ efficacy/NN when/CC combined/JJ with/IN other/DT agents/NNS ./.
@@86172163007/CD However/RB ,/, only/RB complete/JJ DnaJ/NEWGENE can/MD cooperate/VB with/IN DnaK/GENE and/CC a/DT third/JJ protein/NN ,/, GrpE/GENE ,/, in/IN refolding/JJ denatured/JJ firefly/NN luciferase/NN ./.
@@23300413410/CD Expression/NNS ,/, cellular/JJ localization/NN and/CC in/IN vitro/FW transcription/NN studies/NNS establish/VBP that/IN cloned/VBN hUBF/GENE encodes/VBZ a/DT nucleolar/JJ factor/NN that/WDT binds/VBZ specifically/RB to/IN the/DT upstream/JJ control/NN element/NN and/CC core/NN of/IN the/DT rRNA/NN gene/NN promoter/NN to/IN activate/VB transcription/NN in/IN a/DT binding/JJ site-dependent/JJ manner/NN ./.
@@109957519803/CD We/PRP have/VBP recently/RB discovered/VBN that/IN CCAAAT/NNP //NNP Enhancer/MULTIGENE binding/MULTIGENE protein-beta/MULTIGENE (/( C/GENE //GENE EBP-b/GENE )/SYM induces/VBZ gene/NN transcription/NN through/RB a/DT novel/JJ IFN-response/NNP element/NN called/VBN ,/, gamma-IFN/NN activated/VBN transcriptional/JJ element/NN (/( GATE/NN )/SYM ./.
@@21062872710/CD Spore/NN inocula/NNS (/( approximately/RB 10/NN (/NN 6/NN )/NN //NN coupon/NN )/NN were/VBD dried/JJ onto/IN 0/CD ./CD 5-in/CD ./.
@@78266253198/CD Basal/JJ components/NNS of/IN the/DT transcription/NN apparatus/NN (/( RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE ,/, TATA-binding/MULTIGENE protein/MULTIGENE )/SYM contain/VB activation/MULTIGENE domains/MULTIGENE :/: is/VBZ the/DT repetitive/JJ C-terminal/NN domain/NN (/( CTD/NN )/SYM of/IN RNA/MULTIGENE polymerase/MULTIGENE II/MULTIGENE a/DT "portable/JJ enhancer/MULTIGENE domain"/MULTIGENE ?/. Regions/NNS rich/JJ in/IN serine/NN ,/, threonine/NN ,/, and/CC proline/NN residues/NNS can/MD be/VB found/VB in/IN transcriptional/MULTIGENE activation/MULTIGENE domains/MULTIGENE ,/, as/RB well/VB as/IN in/IN the/DT N-terminal/NN parts/NNS of/IN mammalian/JJ TATA-binding/MULTIGENE proteins/MULTIGENE ,/, where/CC they/PRP are/VBP interrupted/VBN by/IN polyglutamine/NN stretches/NNS ./.
@@79491377926/CD The/DT pretransplant/JJ regimen/NN consisted/VB of/IN cyclophosphamide/NN (/( 120/CD mg/CD //CD kg/CD )/SYM and/CC total/JJ body/NN irradiation/NN ./.
